trs
rna
strand
leader
synthesis
ceacam1
cea
family
murine
virus
protein
hcv
synthesized
ribosomal
frameshift
the
pro
fold
loop
processing
rna
sg
mrnas
leader
strand
rhinovirus
transmission
uv
detection
method
human
recent
analyses
pathogens
revealed
trna
slippage
trnas
prokaryotic
eukaryotic
new
face
the
army
men
golgi
cells
network
sseg
salmonella
sars
hla
probable
infected
infection
sars
epidemic
spread
model
we
viral
sars
sequence
hiv
gp41
usage
viruses
nucleotide
the
relationship
viral
new
microarray
virus
novel
cln2
enzymes
sequences
model
known
sars
air
pollution
ecologic
case
personal
account
young
virologist
working
hnrnp
a1
rna
viral
mutant
uba
domain
proteins
approach
interacting
microtubule
vaccinia
virus
infection
microtubules
gis
health
the
practices
community
mapping
sars
geographic
services
control
care
many
sars
frontline
health
nan
nan
hcv
nasal
secretions
contaminated
transmission
isolates
insertions
snps
the
deletions
cleavage
coronavirus
proteins
proteinase
sites
sars
the
cov
mutation
sequences
icu
measures
resistant
care
issue
base
genomes
detailed
by
differences
sars
rate
coronavirus
common
strains
infection
virus
igf
ii
cellular
sars
human
cov
isolates
mutations
sars
cov
blood
response
pbmcs
vaccination
contacts
smallpox
ring
cases
virology
journal
exclusively
on
line
immunofluorescence
strip
viruses
virus
respiratory
clinical
fellowship
program
they
ethicists
absenteeism
school
hand
due
antimicrobial
fusion
ii
proteins
gc
protein
hcov
genome
nl63
sg
mrnas
rna
s2m
tertiary
sars
genome
priority
setting
hospital
sars
accountability
rv
apoptosis
cell
apoptotic
signaling
alkb
domains
viral
like
rna
lung
sars
patients
individuals
cov
protein
production
lactis
heterologous
proteins
thermometer
readings
95
ci
tympanic
health
trade
there
greater
tensions
sirna
lna
therapeutic
rna
modified
species
signature
dna
hts
the
sars
genes
new
infection
response
sars
new
may
virus
disease
molecular
beacons
using
conjugated
nucleic
genes
virus
reference
expression
infected
hcov
nl63
respiratory
human
children
single
probes
hybridization
base
complementary
protein
spike
the
surface
3a
needs
the
medical
many
world
sars
sequence
clinical
analysis
viral
lse
testis
human
adult
protein
recombinant
cell
virus
rectulv
culture
official
international
health
survey
year
ifn
hcmv
replication
ie
ifns
method
virus
proposed
reconstruction
images
recombination
viral
rate
host
virus
the
patients
want
need
expect
handheld
access
computer
system
physicians
care
information
developments
control
technology
signal
edr
frameshift
rna
viral
population
consensus
errors
dna
shuffling
ribosomal
cdna
rna
virus
primers
poliovirus
cells
double
membraned
vesicles
sars
hospitals
los
care
fears
sars
cov
viral
progress
understanding
sub
sequences
sequence
efficient
dna
sars
ace
patients
associated
ards
frameshifting
frameshift
rna
three
structures
database
public
the
different
health
nan
3cl
pro
tea
compounds
found
sars
ace2
human
cov
protein
rna
just
proteins
form
distinct
the
tail
p22
phage
three
go
object
terms
oriented
events
pcr
rflp
sequences
based
sequence
lung
dsrna
injury
cxcr2
neutrophil
patients
sars
hrct
resolution
days
h2
balb
pred
the
prediction
sequences
genstyle
species
characterization
dna
extranet
sars
the
use
local
rna
recombination
tcv
rdrp
terminal
rna
stem
loop
rdrp
tcv
disaster
critical
care
medical
response
cell
microarray
based
sensors
speed
viral
fusion
virus
peptides
wnv
models
assumptions
latent
management
making
rna
pseudoknot
frameshift
efficiency
frameshifting
primer
information
template
algorithm
annealing
3a
sars
cov
series
frameshift
psg
domains
mouse
n1
gene
nl63
hcov
samples
patients
rna
3b
proteins
protein
sars
cells
nan
cov
pro
based
genus
coronavirus
receptors
virus
glycosylation
infection
functional
rna
lna
methyl
duplexes
nucleotides
ms
non
mucus
expelled
clearance
health
globalisation
framework
the
determinants
medical
pandemic
would
impact
workforce
hsv
infection
virus
thus
in
border
hiv
idus
injecting
participants
sars
cov
chloroquine
infection
cells
glycosylation
binding
sites
ace2
residue
species
present
clinical
samples
identification
google
msn
maps
online
health
health
infectious
disease
the
research
spread
sars
disease
we
2003
sars
cell
vaccine
mice
nucleocapsid
health
response
public
readiness
local
rna
viral
quasispecies
diseases
pol
sars
cov
protein
human
infected
sars
severity
expression
genes
patients
injection
veterinary
injuries
farmers
surgeons
quality
draft
sequencing
target
high
care
disaster
sars
health
management
ed
scoring
systems
physiologic
prediction
care
critical
numbers
planning
may
patients
sars
pneumothorax
respiratory
ventilation
number
model
beds
arima
the
sars
coronavirus
genotypes
allelic
discrimination
sequencing
nt
methods
sequence
reads
immune
epitopes
information
ontology
the
outbreak
size
final
diseases
outbreaks
lung
recruitment
tidal
reduced
end
care
bed
critical
allocation
decisions
viral
proteins
rna
replicase
synthesis
as
borders
disappear
people
goods
nan
viruses
rna
fecal
viral
virus
genes
ef1a
reference
pcr
atlantic
used
reference
genes
gene
preimplantation
the
recent
revision
international
health
h5n1
human
viruses
97
04
tuberculosis
dc
sign
two
variants
sars
two
cov
patients
disease
ebov
the
pmos
filoviruses
virus
the
pervasive
burden
lung
infections
humans
health
zoonoses
diseases
jump
the
big
project
looks
ethical
cancer
attributable
fraction
risk
japanese
genomes
zcurve_v
viral
genemark
phage
tud
virus
based
patterns
analysis
lamp
nucleic
templates
device
detection
rna
extraction
sars
based
serum
nan
stretches
hepta
octo
uridine
frameshifting
pcv2
pigs
pmws
affected
titres
nasal
endoscopy
year
right
revealed
ms
autoimmune
infectious
viral
may
health
care
migration
transnational
core
detection
electrical
nucleic
acid
based
influenza
assay
h5n1
virus
highly
syndromic
surveillance
system
the
using
diversification
sequence
species
diversity
sivsm
study
osterhaus
haagmans
discuss
new
sars
cov
infection
infected
group
prp
sc
soil
prion
environments
sars
cov
cytokine
cells
cell
groel
lactis
abortus
antigen
secretion
influenza
spread
global
travel
air
information
ph
access
delivery
needs
care
hcps
health
sars
professional
protein
in
receptor
signal
transducer
vaccine
ebola
rad
gp
np
sars
ifn
susceptibility
polymorphisms
tnf
poly
rna
length
orir
genomes
egcg
cells
ec
ecg
cell
fmdv
antigenic
microarray
the
based
exacerbation
markers
severity
studies
levels
chloroquine
influenza
anti
inhibit
replication
mlv
rafts
caveolae
cells
large
sars
cov
cr3014
escape
cr3022
equine
actb
skin
ubb
normal
rsv
fp
sal
alone
fps
resistance
patterns
countries
china
international
health
migration
population
disparities
disease
binding
mhc
svrmhc
peptide
binders
the
authors
describe
recent
progress
microarray
ssh
assays
expression
genes
virus
viral
the
detection
viruses
technology
functional
immunomic
microarray
responses
gp
cleavage
sites
glycoprotein
cell
ifn
hsv
antiviral
cdm
infection
fls
ra
cd147
monocytes
mmp
reducing
household
transmission
influenza
attack
jnk
pneumococci
induced
il
epithelial
lung
pneumonia
epithelium
host
pathogens
genome
annotations
annotation
gatu
reference
case
definitions
reporting
health
surveillance
sivirus
sirnas
highly
virus
rna
live
bacteria
vaccines
vaccine
bacterial
rna
results
watson
crick
complementary
sars
associated
infection
oas1
mxa
hbov
respiratory
tract
diseases
found
epidemic
health
technologies
population
technology
information
health
internet
public
use
internet
health
patients
services
outbreak
protocol
cardiac
sars
arrest
training
corticosteroids
traditional
teaching
suggests
avoided
respiratory
failure
one
leading
admission
studies
epidemiology
conducted
healthcare
essential
respiratory
real
time
pcr
conventional
nan
ventilation
mechanical
care
monitoring
we
virus
vsv
growth
vaccines
live
hospice
2003
utilization
inpatient
the
nan
used
plants
trinidad
research
bc
delivery
sirna
within
target
strategies
sirnas
rnai
gene
promising
it
rsv
data
influenza
surveillance
eiss
sars
hospital
outbreak
cov
infection
contact
contacts
mixing
close
individuals
cav
caveolae
epithelium
analysis
cells
mast
cells
responses
ige
genes
surfaces
months
persist
nosocomial
survive
sars
studies
treatment
in
treatments
arthritis
phytol
treatment
autoimmune
inflammatory
influenza
travel
spread
air
airline
compounds
assay
innate
rotavirus
throughput
health
climate
the
change
impacts
nan
ibv
chickens
s1
protection
vaccine
protein
techniques
used
contact
proteins
genetic
test
samples
in
newborn
cells
cell
the
epithelial
cultures
individual
individuals
wishes
conflict
rights
patient
data
transfer
database
ptac
sites
sars
epidemic
protein
group
frameshifting
site
reading
antisense
programmed
recoding
expression
gene
frameshifting
the
viruses
rna
genomes
orfs
ability
rna
rdrp
nsp8
dependent
coronaviruses
envelope
this
structural
fusogenic
signal
mimox
epitope
based
phage
display
air
flu
health
human
transmission
sheep
the
patients
market
fever
surveillance
health
phi
routine
public
nan
transmission
patients
sars
analysis
isolation
rna
coronavirus
binding
domain
protein
fgf2
chronic
mice
remyelination
demyelination
hiv
vaccine
gp120
proteins
isolates
sequence
information
pathogens
analysis
detailed
based
dna
sample
electrochemical
detection
position
ms
anticodon
a37
wild
probe
oligonucleotide
iv
end
endo
epidermidis
yycg
inhibitors
screening
antibiotics
data
the
resource
patric
project
liver
hcv
expression
induced
cirrhosis
recommendations
international
who
we
evidence
patients
measures
recovery
physical
function
sars
cov
vrp
vaccine
senescent
respiratory
virus
patients
viruses
positive
structure
3d
sequence
entrez
known
outbreak
learning
societal
we
size
host
pathogens
hosts
viruses
co
responses
sars
recovered
ctl
cov
tracing
effectiveness
effective
we
contact
gag
dna
macaques
response
specific
travel
restrictions
spread
disease
different
delay
country
epidemic
source
region
data
viral
genome
virgen
efforts
hcp
pandemic
influenza
respondents
professional
alkalescens
samples
mycoplasma
found
denmark
sars
virus
ma15
mice
respiratory
mr
score
amniotic
inflammation
fluid
hcov
isolates
229e
protein
orf4a
antibody
neutralizing
virus
challenge
ebola
singh
colleagues
discuss
threat
regional
gib
genome
virus
segment
data
inflammation
chronic
middle
ome
il
cd147
cyclophilin
cyclophilins
protein
extracellular
maturation
dc
cells
tlr
modc
bone
marrow
cell
cells
memory
nan
memory
cells
hrv
asc
rotavirus
dna
nucleotide
strand
composition
multiple
bias
estimates
datasets
negative
binomial
protein
microarrays
many
new
approach
hbov
genomic
copies
clinical
specimens
microarray
technology
information
development
current
fusion
viral
membrane
intermediate
ph
bactin
gapdh
expression
effects
genes
prf
signals
mrna
yeast
genome
computational
clustering
understanding
gene
binding
atopic
respiratory
infections
tract
ifn
il
sars
cells
treatment
cytokine
nan
il
cytokine
inflammatory
th1
10
mhv3
infected
cells
mice
l2
lymphocytes
cd4
rsv
cd3
infection
nan
cr1
expression
sars
patients
genetic
sars
cells
cov
sera
autoabs
strain
wr
infection
virus
lethal
receptor
ibv
fapn
cells
infectious
bovine
bav
samples
respiratory
calves
calves
diarrhoeal
farms
strains
diarrhoea
health
internists
roles
bioterrorist
patients
substitutions
synonymous
virus
human
species
farm
reproductive
number
outbreaks
hpai
placebo
homeopathic
diarrhoea
calves
treated
samples
calves
parvum
intestinalis
rotavirus
used
plants
officinalis
officinale
symphytum
pandemic
influenza
planning
public
health
viruses
large
dna
results
gene
acid
polymerases
poliovirus
nucleic
the
perceived
behaviors
self
human
outbreak
health
biodiversity
human
traditional
public
social
immunity
honey
bees
individual
tb
age
slc11a1
or
group
ubiquitin
specific
elad
clan
coli
sars
cov
samples
rt
pcr
hcv
assay
neutralizing
antibodies
the
eggs
proteins
sendai
virus
allantoic
alignment
information
indel
we
resolution
rpm
respiratory
specimens
results
viral
binding
human
pathogens
residues
91
virus
wu
respiratory
human
the
interactions
protein
viral
nsp8
the
priming
pcr
primer
system
dpo
aom
children
the
bacterial
years
influenza
viral
analysis
species
pcr
2001
transmission
we
fmd
epidemic
evidence
panel
meeting
prepare
guidelines
chloroquine
antiviral
ph
drug
cell
ifn
snp
874t
leishmaniasis
cytokine
h5n1
mabs
virus
human
viruses
who
health
the
editors
discuss
arthritis
nadph
oxidase
oxidative
burst
reference
expression
genes
gene
the
incubation
period
exposure
time
using
complexes
small
molecule
crystal
eudoc
time
reproduction
serial
transmission
number
mhv
different
viral
replication
infection
health
exercise
exercises
departments
tabletop
sars
outbreak
mortality
toronto
greater
shifts
health
public
surveillance
data
sars
28
95
ci
rantes
transfusion
transmitted
blood
risk
infections
level
gene
affymetrix
annotation
expression
trx1
redox
cd30
extracellular
disulfide
specificity
detection
constant
variance
time
isg15
ubiquitin
ubls
proteases
the
mutations
mutation
samples
screening
pcr
vaccine
parasite
peptides
antibodies
malaria
ace3
gene
ace
in
mammalian
pcr
microarray
used
amplification
specificity
music
re
alignment
conserved
sequences
pknotsrg
web
server
the
available
pandemic
influenza
small
medium
business
chip
analysis
volume
lab
pcr
pandemic
antiviral
pharmaceutical
drugs
contact
factor
12
ghq
earthquake
two
vaccines
dna
new
may
diseases
nsp1
mhv
virus
mutant
type
sars
cov
pathogenesis
acute
respiratory
rna
fhv
viruses
membrane
replication
reproduction
number
household
infected
time
pcr
detection
viruses
viral
may
nk
cell
responses
cells
antiviral
fairs
poultry
pathogen
uv
study
genotypes
viral
major
recombination
new
rna
structure
pseudoknots
the
folding
reference
genes
gene
data
stably
arginine
activity
conjugates
cellular
uptake
viral
assay
pathogens
probes
bacterial
sars
the
pro
cov
virus
hrv
hrvs
strains
101
serotypes
tnt
esi
ms
the
peptide
nan
site
prf
ribosomal
slippery
hiv
hax
expression
pol
protein
also
spike
fusion
sars
viral
membrane
pandemic
non
pharmaceutical
interventions
evidence
genome
one
mutations
detected
using
health
indonesia
refusal
share
samples
the
authors
discuss
humoral
immune
dengue
host
fever
response
viral
anthrax
pa83
anthracis
protection
post
gene
cea
family
ceacam1
ceacam28
sars
cells
infected
lung
also
wnv
complement
infection
activation
pathways
nucleolus
nucleus
ribosomal
nucleolar
cell
on
group
adipogenesis
marrow
lipid
yeast
the
saccharomyces
cerevisiae
well
infection
receptor
tm
cys38
su
infection
control
information
internet
nosocomial
dna
resequencing
sequence
array
query
banaba
activity
glucose
extract
pgg
the
authors
argue
plague
taken
xendou
higher
eukaryotes
the
recombinant
calves
brsv
the
herds
respiratory
series
time
outbreak
models
respiratory
intervention
costs
infection
the
respiratory
hiv
targeting
conserved
regions
we
coronavirus
genes
expression
cells
eif3f
se
influenza
communities
ships
serial
human
influenza
range
cross
transmission
95
ci
markers
bacterial
infections
care
planning
critical
patients
process
in
care
papers
support
outcome
binding
grft
acetylglucosamine
mannose
complexes
tm
protein
helical
consistent
putative
hiv
annexin
ii
slpi
ps
lcmv
cross
cell
vv
reactivity
sars
confirmed
cells
pathogenesis
disease
the
immune
changes
system
exhibits
the
epidemic
data
model
global
housekeeping
virus
qpcr
viral
infections
macro
domains
the
proteins
also
nsp15
the
protein
sars
viral
information
me
the
collaboration
data
sepsis
patients
surviving
campaign
difficulties
vaccines
leptospirosis
vaccine
humans
animals
human
gii
binding
carbohydrate
norovirus
biomarkers
infectious
diseases
biomarker
database
coronavirus
covdb
sequence
genomes
analysis
the
data
protein
profiles
pathogen
fusion
sumo
protein
proteins
tags
sars
cov
3cl
pro
amino
using
the
crystals
unit
recombinant
peptides
antigen
cell
dataset
application
hla
alleles
class
peptide
supertypes
virus
receptor
cells
transfectants
dcat
database
oligonucleotide
microbial
discovery
design
frameshift
hiv
initiation
tar
translation
surveillance
ed
taiwan
sss
disease
tnfα
nasal
challenge
post
plasma
sars
proteins
human
cov
protein
viruses
viral
genome
we
sequence
schools
hps
health
students
framework
hotspots
the
large
based
pathogen
phyloinformatics
analysis
h5n1
in
viruses
flavivirus
primers
virus
rna
species
cell
cross
reactivity
ctl
model
dcs
response
prrsv
viral
adaptive
vlps
sars
cov
virus
vaccine
aris
cost
illnesses
children
mean
viral
ccq
asthma
virological
testing
fusion
proteins
cell
fast
membrane
fusion
membrane
tmd
fp
interaction
nan
pv
vector
genome
40
vaccine
hrv
strains
detected
divergent
qpm
contact
contacts
patterns
transmitted
mixing
229e
hcov
human
based
infection
protein
genes
virus
hpev
structural
fiv
cat
species
subtypes
ple
ali
lung
pmn
cell
apoptosis
network
model
results
simulation
models
mice
immunized
pdc
e2
autoimmune
the
well
known
plague
board
lacv
mice
rhesus
monkeys
cns
fmd
outbreaks
disease
virus
sources
tail
aa
xd
terminal
disordered
gp64
penetrenes
class
proteins
iii
il
32
inflammatory
cox
influenza
nan
mf59
subunit
sub
influenza
vaccine
sars
95
tnf
gene
patients
nan
us
travel
canada
ha
hepatitis
methanol
feeding
shake
production
fed
rtc
rna
sars
activity
cov
gene
expression
clustering
hct
svd
mhv
mice
production
cruzi
infection
no
infections
virus
host
responses
nan
ibv
coronavirus
highly
the
pro
patterns
we
resources
synonym
sets
3cl
protease
prrsv
unit
viral
cd13
expression
bfgf
human
melanoma
pei2k
dystrophin
copolymers
expression
eso
tg
mrna
rt
pcr
peripheral
protein
jv
translation
the
vitro
influenza
household
index
secondary
households
emerging
infectious
diseases
time
number
sars
il
patients
haplotypes
genotype
detectiv
testing
tools
we
software
host
viral
apoptosis
cell
viruses
plasmid
vaccine
site
injection
candidates
hiv
since
great
advances
safe
vaccine
fmdv
animals
used
50
scan
statistic
disease
time
spatial
ub
activity
isopeptidase
proteins
assay
contact
tracing
networks
nodes
mixed
general
practice
plans
framework
health
em
lm
isav
genes
expression
proteins
virus
influenza
virions
host
studies
reviews
diagnostic
primary
systematic
stress
apoptosis
yeast
cell
death
mirna
hiv
escape
antiviral
viral
as
cell
licorice
induced
h4iie
uspa1
ceacam1
receptor
human
bacterium
rna
vrna
sensitivity
total
microarray
host
virus
viral
new
viruses
mhv
replication
formation
bfa
rna
pallidum
syphilis
genome
treponema
since
denv
selection
protein
pressure
different
hcws
pandemic
work
workers
factors
huisg15
isgylation
efficient
owmisg15
isg15
hmpv
m2
rhmpv
in
replication
vp2
the
ppv
two
expression
cells
innate
immune
response
mice
fpr
haplotypes
bacterial
receptor
peptides
viral
protein
ubiquitination
ubiquitin
ups
masks
worn
mask
protection
personal
cd133
lc
oct
cancer
cells
genes
piglets
infected
rotavirus
regulated
cov
sars
bvlps
vlps
dcs
p24
expression
vaccine
p17
hiv
john
brownstein
colleagues
discuss
healthmap
staff
enteric
ccc
illness
public
divergence
subtype
rate
substitution
time
genes
class
mhc
sequence
region
using
antibodies
sars
comprehensive
discovery
spillover
bees
wild
bumble
pathogen
species
virus
we
new
human
sequences
influenza
h3n2
viruses
na
nebulised
heparin
doses
levels
aptt
public
influenza
pandemic
treat
risks
h5n1
virus
lung
influenza
1918
rnai
vivo
cells
efficiency
seminiferous
psgs
genes
selection
positive
genome
treatment
tuberculosis
the
patients
delayed
copy
number
associated
we
algorithm
sequences
denv
conserved
pan
rna
cd13
cell
adhesion
endothelial
cells
hla
1501
peptide
the
determined
ccr2
ccl2
monocyte
noise
macrophages
mutagenesis
fmdv
the
virus
extinction
viruses
genetic
reassortant
diversity
h5n1
remyelination
cns
in
man
regeneration
receptors
chemokine
chemokines
interaction
specific
fusion
protein
viral
membrane
common
epidemic
sars
transmission
associations
statistics
nan
pathway
response
antiviral
effector
viral
cities
spread
network
largest
describe
lupus
sle
fulminant
case
complicated
cells
endothelial
infection
infected
viral
genes
atlantic
cod
gene
reference
human
cells
antibody
expression
scfvfc
academic
detailing
the
period
computerised
begomoviruses
codon
usage
genes
old
nhm
patients
group
placebo
sars
the
assay
disease
ruckeri
erm
ribose
adp
appr
ibv
nsp3
on
post
sars
patients
iii
rabies
pep
human
patients
china
viral
acid
sequence
viruses
genus
rna
viral
membranes
sars
host
rna
amplification
wta
10
amplified
e7
specific
crt
bortezomib
tc
veev
virus
the
antibody
detection
air
asthma
triggers
high
efficiency
pdd
cases
abv
agent
bornavirus
bcg
vaccine
polymorphisms
strains
including
protein
interactions
proteins
viral
functions
upr
pfts
response
pft
pathway
random
amplification
pcr
primers
pathogen
pandemic
influenza
population
health
threat
shrews
immune
may
wild
animals
determinant
responses
basis
engineered
ctl
respiratory
recruits
illness
rsv
acute
hiv
hcv
co
specific
cells
we
real
time
pcr
signature
copy
using
samples
gene
number
prf
stimulators
rna
pseudoknot
signals
ichnovirus
ascovirus
also
dna
wasp
immunity
pre
existing
ad5
vaccine
hantavirus
we
cell
tnf
hfrs
encephalomyelitis
phe
cov
infection
we
respiratory
apm
virus
acanthamoeba
polyphaga
resource
allocation
influenza
pandemic
total
056
excess
deaths
epidemiologically
saliva
hantavirus
patients
puuv
syndrome
patients
day
diagnostic
chikungunya
indian
countries
ability
used
outbreak
control
coronaviruses
the
bats
bat
clade
psychological
distress
high
disease
study
nab
sars
human
animal
cov
nan
socs
viral
type
ifn
induction
lion
000
africa
population
large
how
much
really
understand
rna
ccr5
allele
could
frequency
δ32
physicians
influenza
pandemic
professional
risk
corticosteroids
community
acquired
pneumonia
may
viral
common
respiratory
intensive
care
ifn
αβ
response
ads
mice
g2
il
chimeric
htnv
gene
tb
health
women
care
men
patients
μg
pct
the
aecopd
poly
adp
ribose
biological
functions
rna
folding
base
structure
based
fusion
gene
assay
tumors
tmprss2
splicing
pmo
correction
affinity
ahx
vaccine
virus
ebov
concern
vsv
virus
kampar
viruses
respiratory
disease
cotton
cbd
symptoms
clrdv
isolates
cancer
gastric
samples
proteomic
regulated
feline
type
receptor
cell
coronaviruses
cd4
binding
gp120
antibody
hiv
il
12
profiles
cytokine
heavy
vaccination
cells
clearance
infection
viral
mice
lung
myd88
infection
rma15
influenza
pandemic
humans
global
flu
brain
inflammation
mice
infection
neurologic
antiviral
treatment
drugs
control
optimal
studies
ali
genetic
association
quality
pro
highly
sars
3cl
coronaviruses
nan
emerging
infectious
diseases
host
wildlife
influenza
h5n1
seasonal
avian
cross
arctic
the
person
infectious
emergence
health
international
indonesia
samples
virus
women
pregnant
influenza
pandemic
associated
nan
children
hbov
symptomatic
rtis
adults
public
emerging
infectious
diseases
social
results
public
community
mitigation
would
disparities
pandemic
social
we
socioeconomic
nan
respiratory
syndromes
data
pathogen
activity
nan
nan
global
surveillance
novel
rhinovirus
genotype
protocol
contamination
we
evaluated
personal
plaque
virus
hcov
nl63
assays
children
bronchiolitis
viral
co
rsv
training
program
emergency
public
health
sirna
ehv
infection
viral
reduced
hrv
hev
genetically
diverse
viruses
healthcare
pandemic
workers
peak
icu
years
cases
we
report
surveillance
nan
influenza
we
in
winter
2008
macaques
cynomolgus
mhc
class
sequences
interaction
cost
designs
protein
mapping
nan
fusion
protein
sars
mice
sarscov
mvtt
vaccination
via
vtt
mva
influenza
bacterial
mortality
host
viral
year
sars
volume
hospital
service
tumor
peptide
targeting
cancer
phage
chikungunya
disease
patients
growth
factors
samples
reads
sequencing
nasopharyngeal
fecal
the
radiographic
patients
sars
001
influenza
avian
h5n1
humans
pathogenic
ark
dpi
strain
strains
genome
bp
human
genomes
oligomers
genome
ceacams
neutrophil
cells
mabs
cd66
nss
rvfv
host
pkr
protein
isolation
novel
adenovirus
fruit
bat
asthma
hrv
to
determine
links
children
virus
detected
respiratory
367
detected
children
respiratory
in
longitudinal
viruses
h5n1
markets
thailand
subtype
bear
bile
alternative
chinese
bears
hcmv
human
mabs
immune
therapeutic
sodium
channels
human
proteins
related
rv
rotavirus
strain
range
giraffe
ltnp
p24
responses
viraemia
ctl
deer
bovine
tb
coyotes
potential
nan
bat
coronaviruses
bt
covs
rna
kidney
ng
samples
liver
90
viral
nucleic
cpps
cellular
acid
may
viral
effective
immune
development
epitopes
spike
protein
cell
emerging
rv
rsv
infants
days
bronchiolitis
hla
association
aid
class
region
rna
viral
elements
genomes
long
smallpox
transmission
monthly
time
data
sars
covmpro
the
enzyme
region
felv
lynxes
lynx
feline
infections
cells
cilia
ciliary
epithelial
dnai1
asthma
viral
infections
severe
viruses
20
nagk
hongkongensis
37
freshwater
genetic
drift
hiv
populations
virus
rabies
populations
domestic
dog
global
protein
actin
virion
virus
coronavirus
barriers
work
pandemic
ability
hcws
1a
rna
replication
helix
membrane
data
thyroiditis
thyroid
viruses
diseases
ptb
splicing
p3a
tannic
acid
gmo
detection
dna
background
amplification
uti
10
parvum
disease
infection
h5n1
vaccines
hpai
dna
avian
ibv
virus
also
ihc
m41
nan
pro
3c
3cl
cov
sars
analysis
the
strain
pat1p
targets
tfr1
human
nw
arenaviruses
clade
cgmmv
type
eb4
the
cp
genes
hps
porcine
de
immune
norovirus
measures
reduction
control
outbreaks
nan
pandemic
influenza
clinical
health
hcws
kipyv
wupyv
respiratory
among
patients
masks
use
ili
mask
adherence
ccl3
neutrophil
recruitment
ifnγ
infection
msi1
cells
op
expression
oligodendrocytes
falcipain
hemoglobin
hydrolysis
cleavage
cysteine
age
hbov2
bocavirus
rotavirus
novel
pandemic
gaps
resources
we
resource
care
way
health
one
aid
falls
the
environmental
urban
results
mice
proteins
ozone
ko
many
sars
hcws
among
measures
effective
atsbt1
peptide
proatpsk4
culture
atpsk4
nan
domain
boundaries
prediction
computational
tools
vimentin
cpmv
surface
cells
endothelial
quarantine
days
individuals
influenza
effectiveness
nan
data
sensitivity
system
automated
surveillance
recombination
hiv
recombinants
evolution
gene
the
health
capacity
development
training
avian
influenza
viruses
human
temperature
sud
sars
cov
host
cell
mavs
apoptosis
viral
induced
host
recent
disease
person
therapeutics
agents
hku1
coronavirus
hcov
group
encodes
sars
cov
proteins
different
positive
virus
p58
ipk
infection
cellular
cold
acclimated
pulex
specific
proteins
disease
copd
lung
diagnosis
approaches
human
linkage
animal
data
health
species
the
habitat
climate
conservation
nan
agents
countries
developing
pandemic
must
coronaviruses
bats
identified
including
diverse
respiratory
merkel
cell
mcpyv
tract
virus
preformulated
chikungunya
real
time
h5n1
therapy
mabs
two
combination
influenza
rnai
virus
sim2
sirna
sars
association
susceptibility
masp2
the
cell
epitopes
data
methods
using
bean
infection
rust
genes
resistance
hrv
strains
infections
classical
rhinovirus
health
indicators
what
populate
performance
s1p
virus
gp
lassa
glycoprotein
cruzi
100
the
samples
test
medical
items
percent
the
outsourcing
virus
host
virhostnet
viral
interactions
rfam
families
sequence
rna
cms
http
ac
rnavirusdb
uk
virus
human
alone
recently
discovered
respiratory
rhinoviruses
respiratory
diversity
identified
enteroviruses
public
health
information
systems
based
nan
respiratory
surveillance
system
disease
to
host
human
parasite
endemic
infidelity
viral
viruses
mirnas
expression
host
interventions
cost
adaptive
epidemiological
disease
proteins
disulfide
bacteria
physiological
bridges
perceived
sars
threat
efficacy
severity
influenza
ha
mab
nabs
broad
influenza
poultry
viruses
the
natural
antiviral
in
used
clinical
management
pcr
assay
ahv
the
wide
emm
scarlet
fever
the
taiwan
delivery
therapeutic
cpps
molecules
cellular
nan
ires
irss
rna
elements
prediction
derived
plasma
recombinant
proteins
animal
ldv
activation
ifnα
mice
lymphocyte
health
influenza
pandemic
personnel
patterns
cell
protein
cells
fusion
ibv
patients
mortality
ards
the
rate
countries
ai
virus
epidemic
surveillance
sars
dcs
cov
expression
gene
cmt
cats
blood
transmission
positive
rt
viral
replication
two
protease
channel
activity
amiloride
protein
the
core
pcmvcorekozak
hcv
μg
response
hospitals
sars
local
community
services
hprr
rbmnpv
hemolymph
days
purified
the
membrane
nsp4
termini
nsp4c
server
phylogenetic
genomes
cvtree
web
cf
cftr
transport
mucus
surface
hsv
pneumonitis
patients
cases
associated
glycosylation
sars
cov
terminal
the
surveillance
data
detection
method
the
diarrhea
collected
klassevirus
infectious
approximately
vectors
glioblastoma
lentiviral
therapeutic
gene
array
virus
strains
the
oligonucleotide
adp
ribose
domain
bind
coronavirus
cox
pin1
calpain
cells
maec
ms
infectious
agents
may
onset
oil
fish
infection
antiinflammatory
properties
contacts
transmission
the
infectious
day
assay
the
genus
orthopoxvirus
virus
occupational
h5n1
medicine
pandemic
literature
hrv
strains
respiratory
children
utr
ibmads1
potato
sweet
tuberization
roots
nan
viral
dcs
disease
cells
viruses
angiotensin
two
cardiovascular
12
evidence
two
pathogenic
steroid
associated
on
protein
tbk1
ikkϵ
sars
coronavirus
cancer
cervical
incidence
1995
the
dengue
infection
blood
the
major
review
chest
critically
ill
day
flu
swine
outbreak
behaviour
recommended
the
coronavirus
nsp4
domain
using
privacy
research
the
confidentiality
paper
the
changes
hospitals
healthcare
infectious
respiratory
virus
asthma
seasons
stable
infection
nh
cl
hpv16
we
surveillance
health
syndromic
countries
disease
nan
cox
drak2
crc
apoptosis
kinase
ibv
the
group
encodes
replication
infection
control
pandemic
behaviours
measures
infections
nosocomial
infection
rate
icu
trials
corticosteroids
sore
throat
complete
influenza
tests
number
the
laboratory
10
evolutionary
hpev
circulating
substitutions
sars
disease
international
outbreak
the
sars
patients
public
outbreak
singapore
paper
risk
discusses
infectious
diseases
passengers
the
risk
number
public
iras
monoclonal
protein
antibodies
imidazoline
shp
macrophages
ms
inflammatory
expression
10
hbov
newly
identified
parvovirus
infectious
diseases
viruses
bacteria
methods
wildlife
zoonoses
exotic
emerging
often
nan
poultry
avian
influenza
knowledge
handling
data
icd
automated
ili
codes
risk
perceptions
beliefs
efficacy
lower
we
developed
system
rapid
determination
cats
virus
influenza
h5n1
contact
absenteeism
peak
prophylaxis
treatment
weeks
nan
m2
influenza
protection
vaccination
induced
birds
movements
species
viruses
wild
influenza
pandemic
outbreaks
next
1918
pandemic
persons
contacts
school
residents
nan
hbov
human
children
in
spain
japanese
encephalitis
jevs
bats
region
rsv
cap
the
pneumonia
virus
membrane
peptide
c8
trp
tryptophan
field
motions
high
protein
spectral
ire1
er
protein
stress
activated
infection
type
ifn
mice
mhv
liquorice
typical
blood
appraises
effects
nan
ccfr
deaths
the
estimate
ratio
sequences
dna
relationship
representation
sequence
asthma
exacerbations
exacerbation
factors
million
protein
sequence
function
features
predicting
pandemic
pre
influenza
accept
the
interactions
protein
virus
herpesvirus
species
nan
kawasaki
ace
group
disease
polymorphism
host
transmission
pathogens
emerging
infectious
respiratory
virus
human
infection
infections
hpiv3
protein
factor
cellular
virulence
autophagy
host
defense
infection
emerging
genes
expressed
stably
expression
reference
di
cells
gmp
the
novel
wolf
wolves
ynp
coyote
exposure
respirator
or
95
ci
donning
dengue
dhf
dss
research
the
sequence
names
annotation
uids
biologically
secretase
genes
transcription
activity
affected
virus
sars
frankfurt
7b
cells
expression
patients
serum
apps
cancer
dynamics
inference
spatial
bayesian
endemic
vv
infection
atp
nd4
production
escape
nab
env
infection
early
ecm
function
adhesion
cellular
neurodegeneration
kinase
gne
domain
protein
mutations
lung
viral
immune
viruses
infection
ibv
birds
infectious
bronchitis
virus
disease
diversity
prevalence
species
zoonotic
outbreaks
pedv
thailand
since
late
uri
aom
episodes
young
children
women
optimism
pregnant
pessimism
life
viral
infection
ifn
mice
cns
protein
the
data
analysis
potential
tests
rabies
diagnosis
molecular
countries
dna
vaccination
vaccines
emerging
human
gallstone
acute
rate
aged
60
protein
purification
proteins
situ
slides
nan
wurss
21
44
health
well
respiratory
studies
randomised
spread
viruses
new
coding
orf
orf1a
codon
viruses
ducks
influenza
hp
h5n1
sars
cov
protein
cell
coronavirus
veterinary
law
pharmaceuticals
article
field
gpv
pcr
the
assay
geese
genomics
therapeutics
development
based
approaches
hiv
dc
signr
h1
h3
bdv
class
iii
protein
kda
scoring
functions
score
binding
optimization
genome
probes
pan
array
tiling
viral
mice
inflammatory
il
tnf
cells
ifn
production
nk
the
patients
μg
pct
bacterial
infection
gene
beaudette
virus
ibv
m41
trb
genes
rhesus
macaque
tcr
sars
vaccine
conformation
disease
coronavirus
nan
public
health
genomics
system
major
infectious
diseases
need
globally
coordinated
rna
replication
virus
cpz
tbsv
nan
pbc
may
liver
patients
disease
mescs
mhv
a59
recipients
four
erk
mek
signaling
hcv
pathway
il
cytokine
cells
hiv
secreting
fusion
cell
hcv
viral
residues
ed
changes
emergency
staff
times
set
16s
rrna
species
orma
hiv
subjects
infected
cd4
dna
pandemic
travel
island
nations
picts
disease
mice
virus
cells
severe
pro
domain
dimer
monomer
structure
aerosols
aeruginosa
cough
cf
viable
tsp
proteins
human
several
including
hla
immune
human
alleles
escape
flu
pandemic
europe
seasonal
malaysia
virus
nipah
disease
ferret
antibody
influenza
pandemic
plan
health
taken
cxcr2
mice
cns
viral
jhmv
articles
disease
journals
infectious
survey
mdi
spacer
use
research
peds
children
hcov
coronaviruses
study
95
vaccination
h1n1
take
cost
influenza
cells
ate
ibv
culture
system
proteins
vsv
virions
host
cellular
populations
factors
population
cat
fiv
we
sets
virus
multiplex
primer
ifn
activation
gene
shrnas
shrna
codon
genes
covs
usage
synonymous
sars
protease
entry
cleavage
cov
h1n1pdm
distinct
viral
april
2009
sars
bascs
cov
infection
viral
cells
coronavirus
infection
alveolar
epithelial
hcv
infection
model
limited
small
blood
plasma
human
clinical
proteins
hospital
the
control
many
sars
taipei
ahc
cases
vs
keelung
vtec
o157
h7
calves
subtype
nmr
assignments
protein
13
sequence
redox
disulfides
proteins
disulfide
structural
nan
delivery
systems
trafficking
biological
nucleic
furin
cancer
proprotein
convertase
it
tail
gp17
the
spp1
host
viruses
hosts
infect
host
we
ceacam1
ectodomains
homophilic
interactions
membrane
nan
pam
vsa
antigens
var2csa
immunity
mathematical
modelling
importance
history
disease
virus
epidemic
flu
media
behavioral
economic
impact
pandemic
school
vaccine
virus
h5n1
cells
influenza
infection
distance
minkowski
travel
metric
the
extracts
activity
virus
influenza
rivularis
estimates
we
formula
see
text
maria
yazdanbakhsh
peter
kremsner
argue
mutations
isolates
erg11
sequencing
rca
hiv
protein
capih
model
human
mice
infected
h5n1
pf
lung
nsp1
host
rna
40s
induced
health
jonna
mazet
colleagues
describe
automated
surveillance
alerts
task
geographic
cell
virus
lines
bats
bat
oc43
protein
hcov
residues
rna
prediction
the
tools
secretory
sp
infection
felv
cats
low
provirus
ictv
ncbi
vgr
viral
orion
peptidases
the
substrates
cleavage
conserved
rsps
dengue
proteins
prm
cell
rhodopsin
mammals
light
bats
groups
nan
3a
cells
protein
er
expressing
cases
2009
wave
would
we
ata
influenza
anti
viral
virus
kd
we
bacteria
production
identified
global
health
worldwide
report
us
protein
sars
hla
cov
sp8
nan
nan
termination
mnv
codon
reinitiation
vp2
stem
hairpin
lower
upper
frameshifting
hrv
respiratory
variants
detected
infections
pneumoniae
disease
severe
h1n1pdm
cases
pathogens
outdoor
air
environments
research
sars
cov
memory
cells
results
ipd
wintertime
seasonality
disease
effect
vp4
ppg612
mucosal
ltb
infection
autophagy
llo
monocytogenes
lc3
infection
sirna
chpv
mice
in
rna
dc
signr
vntr
polymorphism
neck
rna
rdrp
nsp12
protein
sars
ccv
pandas
virus
the
serum
group
sequence
identities
ibvs
isolates
teaching
standards
items
the
new
mafa
the
alleles
number
haplotypes
hts
testing
implementation
well
formats
rt
lamp
system
hev
enterovirus
tests
diagnosis
methods
diseases
years
influenza
infection
antibodies
m2
virus
public
use
measures
quarantine
restrictive
mapk
mkp
bcg
tnf
results
sperm
acrosome
reaction
flotillin
proteins
domain
aromatic
sars
entry
fusion
ebna3c
gadd34
protein
interaction
using
expression
profiling
genes
epilepsy
global
genes
delta
smelt
esfenvalerate
biomarkers
uk
12
pe
bleeding
group
virus
h5n1
cells
influenza
human
cells
sars
epithelial
cov
ifn
strain
ibv
nephropathogenic
korea
antigenic
rna
pseudoknots
loop
stem
model
proteins
adenovirus
infection
cell
nucleolar
quarantine
case
secondary
community
quantitative
hiv
neutralizing
mabs
activity
mab
public
health
preparedness
rapid
research
recoding
genes
recode
database
utilize
viralorfeome
virus
collections
protein
orfs
il
patients
nvh1n1
severe
mild
om
airway
bacterial
infection
viral
influenza
viral
virus
based
type
international
health
agreements
nations
events
nan
hla
yi
the
alleles
haplotypes
sars
cov
aged
macaques
ali
infection
wnv
ips
response
immune
influenza
human
virus
viruses
pandemic
codon
usage
genes
identified
codons
nan
facemasks
h1n1
2009
pandemic
spread
protein
orf
analysis
nl63
hcov
synthesis
dna
genome
virus
new
avian
colibacillosis
salmonellosis
poultry
diseases
the
method
reproduction
number
epidemic
cov
the
group
common
virus
2009
pandemic
h1n1
virus
cases
infectious
events
disease
changing
public
fip
cats
fcov
feline
avirulent
we
incidence
zygomycosis
population
trends
hbov
virus
acute
children
serum
hiv
envelope
cells
gag
proteins
cells
the
np
vaccine
np373
risk
hpai
factors
h5n1
spread
2009
virus
first
cases
h1n1
m2e
h5n1
map
viruses
vaccine
mrna
synthesis
nsp1
viral
rna
e2e
e2
hcv
disulfide
the
genes
viral
variants
virus
selective
influenza
resistant
h1n1
viruses
amantadine
human
adaptation
zoonotic
infection
species
p3d
nt56
fmdv
sirna
serotype
rabies
vaccination
canine
control
human
sars
neutralization
mabs
escape
human
viral
older
adults
respiratory
tests
gii
human
noroviruses
strains
norovirus
cpv
variants
2c
europe
canine
the
fcov
cats
positive
feline
complement
influenza
inflammatory
injury
targeting
coronaviruses
identified
respiratory
recent
while
viruses
viral
emergence
factors
genetic
rfgf21
fgf21
high
coli
fused
patients
we
associations
febrile
case
7a
ap
hydrolase
protein
the
ceacam1
gene
cea
species
family
hsv
entry
gd
cellular
glycoproteins
overlapping
genes
rna
genomes
using
hcvcc
hcv
culture
virus
heat
karen
edmond
anita
zaidi
highlight
chikv
virus
vlps
antibodies
spread
mhv
ifn
cell
response
mouse
10
the
assays
dna
ml
sequences
na
conserved
terminal
protein
drug
four
target
protein
interactions
prf
pseudoknot
rna
stimulator
du177
food
virus
environmental
virology
fri
lpt
the
poultry
hpai
h5n1
albert
osterhaus
reflects
reasons
increase
mev
th
divergence
measles
virus
cats
fhv
feline
fcv
felis
gc1
the
ipnv
aquatic
amino
respiratory
sensitivity
nasal
infants
nasopharyngeal
pandemic
flu
management
national
the
resequencing
99
genes
snhl
clinical
activity
rna
rnss
protein
nss
protein
vi
ppxy
we
motif
pandemic
students
2882
respondents
staff
mosquito
human
habitat
distribution
mosquitoes
inference
methods
plug
and
play
pool
patent
medicines
ip
line
mimotopes
epitope
study
development
diagnostics
np
m2
ha
challenge
virus
public
disease
knowledge
precautionary
participants
tracing
models
contact
infectious
network
albicans
host
candidemia
commensal
colonization
dna
vaccines
clinical
trials
vaccine
tumor
cells
immune
sirna
tlr9
typhoid
current
enteric
fever
developing
sars
regions
three
clinical
onset
nucleolar
localization
cells
ns1
signal
influenza
seasonal
pandemic
2009
h1n1
hcws
information
gloves
hands
knowledge
m847
rzh501
virus
viral
mice
npi
cost
policy
control
optimal
sars
patients
years
among
176
covs
bats
sars
recent
suggested
patient
pandemic
ppe
antiviral
influenza
eia
antibody
we
developed
hour
health
national
public
institutes
play
structure
community
networks
spread
contact
infection
mice
sars
type
cov
training
course
pandemic
workers
significant
cells
sars
cov
vero
huh
human
ceacam1
positive
pcr
expression
nan
pseudoknots
pseudoknot
structure
prediction
dotknot
viral
serum
influenza
respiratory
samples
tap
school
interventions
antiviral
closure
pneumonia
elderly
zinc
mortality
increased
sharing
biotorrents
file
transfer
scientific
membrane
proteins
assembly
sars
cov
imported
risk
zoonotic
mammals
zoonoses
mobility
united
states
million
health
travelers
likely
european
tourists
vfrs
nan
viral
norovirus
diarrhea
fecal
concentrations
travelers
small
proportion
rest
frequent
nan
cov
bats
sars
asian
identified
persons
precautionary
actions
avoid
try
bats
coronaviruses
sars
coronavirus
rna
pc2
polycystin
pc1
dimerization
er
mabs
human
virus
developed
antibodies
cap
sars
viral
cov
nsp16
genotype
apmv
ii
genotypes
strains
genomes
mb
cloning
whole
yeast
emerging
vaccine
chikungunya
virus
mosquito
global
health
diplomacy
as
part
b19v
cq
antimalarial
drugs
infection
virus
ifn
immune
like
receptor
health
protective
regarding
expected
participants
cells
cell
gc
bcl
specific
outbreaks
lri
clusters
local
surveillance
budding
sequence
membrane
virus
marburg
nan
hbov
illnesses
respiratory
symptoms
detection
fd
ctl
responses
cells
cd4
nan
cell
anoikis
cells
cd147
resistance
vaccine
risk
h1n1
2009
pandemic
sars
articles
epidemic
to
the
tumor
blood
vessels
cells
expressed
plasma
ahi
hiv
prior
viral
replication
genome
diversity
fidelity
exon
synthesized
nmr
the
compounds
analgesic
nan
bowenoid
papulosis
condyloma
acuminatum
anogenital
korean
ibv
isolates
strains
rflp
nan
distance
metrics
correlation
proper
two
qsar
andrographolide
derivatives
2d
3d
assay
virus
sensitivity
the
infection
h5n1
hpai
poultry
sh5
vaccination
patients
ili
influenza
score
pandemic
ceacam1
human
bacterial
cell
pathogens
infection
japonicum
fibrosis
liver
morbidity
tp
patients
ss
dna
wb
nk
patients
cells
the
influenza
hmpv
children
years
ari
population
genes
ef1a
expression
pcr
stable
95
ci
nasal
parents
children
sars
patients
cov
transmission
hcws
ferret
genes
we
the
model
e7
combination
dna
imiquimod
crt
sars
hcov
abs
diagnosis
cross
process
emerging
diseases
animals
humans
pathogens
zoonoses
hosts
microbiologic
infections
we
csf
plasma
report
acute
ccov
samples
tgev
ii
subtype
system
the
health
laboratories
testing
patients
case
travel
ill
2009
avian
influenza
epidemics
population
respondents
the
ams
sequence
post
translational
virus
variants
2009
influenza
h1n1
nan
critical
care
mainland
china
medicine
nvh1n1
patients
severe
infection
the
respiratory
viral
viruses
ltcfs
period
in
wake
sars
epidemic
h1n1
polyomavirus
wu
respiratory
described
recently
nan
children
wupyv
detected
respiratory
viruses
may
restrictions
control
population
internal
influenza
viruses
h5n1
blood
geq
nipah
virus
person
pcr
illness
the
tropical
epidemic
occurred
may
poultry
illness
we
investigated
potential
hcov
respiratory
hcovs
specimens
positive
rrv
pdcs
rotavirus
ifnα
primary
wild
type
cdv
vaccine
used
li
lymphocytes
the
activation
cd69
influenza
pcr
clinical
diagnosis
like
proteins
virus
the
nucleocapsid
mhv
ibv
protein
the
group
nonstructural
gdvii
virus
da
sa
dapb
cd147
cyclophilin
inflammatory
cyclophilins
interactions
antiviral
protective
infected
mab
responses
space
genome
genomes
sequences
new
mbl2
found
high
polymorphisms
gene
cells
podoplanin
hiv
clec
platelets
hev71
in
outbreak
fuyang
hfmd
ai
perceived
measures
behaviour
vulnerability
concentrations
25
hydroxyvitamin
infections
viral
glycyrrhizin
genes
cytochrome
uralensis
glycosyltransferases
neutralization
virus
eblv
11
rabies
nl63
ace
sars
cov
protein
nan
vh
bats
repertoire
viruses
the
ospa
cells
plantarum
we
breaks
kd
association
hcov
pcr
nh
psg1
psgs
growth
human
possible
rabies
2000
2005
public
health
viral
entry
using
peptides
domain
genetic
testing
psychological
depression
anxiety
avoidance
behaviors
h1n1
respondents
hong
herds
negative
bcv
positive
brsv
nan
patients
pneumonia
dna
identified
plant
gag
ciita
hiv
cells
class
2dsa
size
distributions
method
analysis
virus
influenza
h5n1
viruses
highly
influenza
inflammatory
inflammation
anti
properties
rt
pcr
real
time
influenza
influenza
excess
vaccine
mortality
sars
vzv
ge
virus
cell
ride
influenza
risk
locations
transmission
temperate
cxcr2
jhmv
infection
expression
associated
victoria
pandemic
wa
australia
transmission
patients
2009
pandemic
h1n1
influenza
entry
virus
infection
btv
inhibited
prrsv
infection
inflammatory
cells
prrs
sars
cov
np
proteasome
subunit
cases
number
daily
time
the
blood
immune
system
disease
field
bid
reovirus
infection
apoptosis
signaling
gwas
gsea
genes
gsea4gwas
snps
synthetic
pathways
organisms
biology
bringing
trypsin
activity
μm
chromatography
gel
vaccines
agents
number
amount
tools
vp4
lactis
porcine
rotavirus
the
pandemic
health
countries
plans
preparedness
oc43
ntd
hcov
the
coronavirus
viruses
alignment
phylogeny
large
analysis
sl
lethal
positions
drug
lethality
brsv
bcv
prevalence
infections
sweden
health
foreign
global
policy
issues
myelin
specific
cells
cell
mbp
species
human
hbov4
bocaviruses
found
veev
e2
virus
human
neutralizing
viruses
immune
pattern
recognition
like
pdc
infection
blood
disease
lymph
infection
pdhs
hepadnavirus
dhbv
infected
myelin
axonal
central
nervous
demyelination
cleavage
s2
proteolytic
fusion
priming
hbov
patients
positive
rsv
clinical
proteins
hiv
serum
infected
expressed
virus
infection
pdc
cytopathic
pdcs
multiplex
pcr
virus
two
shell
cd13
myeloid
cells
cell
hematopoietic
analysis
distribution
positive
chi
square
incidence
mortality
pneumonia
china
data
rna
structures
inv
folding
noncrossing
proteins
ibv
virus
host
protein
vaxign
vaccine
based
design
targets
patients
pneumonia
mp
age
children
ad
hiv
vectors
capsid
incorporation
coping
students
flexibility
depressive
symptoms
coli
o157
h7
intimin
fecal
nan
sars
patients
developmental
clinic
non
peptides
granulosus
multilocularis
antigens
echinococcus
viral
disease
acute
cns
virus
knowledge
scores
attitudes
higher
practices
students
402
university
the
influenza
fever
influenza
human
bible
case
respiratory
coronavirus
hcov
nl63
human
flu
swine
nhs
direct
patients
chlamydia
inclusions
infections
pedv
infection
tfr1
nw
human
arenaviruses
gp1
cell
npn3a
virus
cross
reactive
sequencing
deep
sequence
position
analyses
children
viral
uri
symptom
cold
hand
washing
h1n1
hygiene
factors
common
cold
iota
carrageenan
symptoms
activity
protease
2a
transcriptional
ev71
cancer
cells
progression
shannon
transcriptional
disease
population
network
information
individuals
lycorine
leukemia
cells
hl
60
fip
fcov
feline
coronaviruses
fcovs
cells
r06e
marburg
reservoir
filovirus
rabies
ferret
badger
the
badgers
mscl
rr
protein
pp
vitamin
sera
hcv
e2
tested
neutralization
pandemic
measures
forums
the
participants
nan
pathogen
adaptive
host
contact
mutation
innate
immunity
innatedb
curation
systems
nan
influenza
infection
ha
guinea
model
tgev
lamp
detect
specificity
high
dcs
antigen
cells
coronavirus
vaccine
viruses
fecv
feline
two
fipv
countries
spread
resources
healthcare
pandemic
nl1
endonuclease
arenaviridae
virus
domain
patients
2009
risk
hospital
influenza
data
structural
new
tool
genome3d
neutrophils
astrocytes
neutrophil
cell
cns
nan
genomes
genome
prediction
vigor
sequencing
il
polymorphisms
infection
174
illness
influenza
ads
days
ambient
air
strains
viral
virus
detected
denv
phase
infection
icu
mrsa
control
theory
epidemiological
size
population
entropy
protein
domains
evolution
new
proteins
gbf1
replication
bfa
poliovirus
arf
pandemic
public
health
states
across
rsv
blood
loads
respiratory
peripheral
bortezomib
treatment
cells
phosphorylation
proteasome
emergence
we
adaptation
human
spatial
patients
critically
ill
lung
viral
human
cells
mabs
cell
mice
proteins
cellular
prrsv
associated
virions
delivery
rnai
rna
gene
shrna
gabriel
leung
angus
nicoll
provide
isolation
chamber
air
system
the
children
bacteria
wheezy
virus
episodes
techniques
proteomic
proteomics
large
scale
substrate
residues
p3
positions
the
boop
mfbs
chronic
porcine
similar
virus
viral
in
human
h5n1
information
associated
trust
h1n1
informal
compliance
health
ihr
public
reporting
whipplei
gastroenteritis
children
patients
causes
f1
pestis
plague
antibodies
anti
emr
structured
text
ari
parameters
we
veev
nsp3
capillary
electrophoresis
epitope
jev
virus
specific
prm
ncam
phe
cov
infection
spike
influenza
virus
the
infectivity
personal
pandemic
h1n1
2009
viruses
influenza
2009
h1n1
deep
sequencing
influenza
wildlife
protein
rrna
helicobacter
microbial
ifn
bmm
bmdc
infected
cells
ace2
pah
angiotensin
ang
axis
hcov
hcovs
respiratory
infections
including
human
bocavirus
hbov
hbov2
respiratory
work
pandemic
influenza
comply
associated
clinical
infected
horses
to
determine
methods
respiratory
recent
diagnosis
virus
pr
virus
protein
ph
low
hiv
gpi
neutralization
envelope
anchored
patients
admission
crp
serum
icu
infection
ncrnas
response
virus
expression
nsp16
nsp10
protein
surface
mtase
hcv
screening
infection
development
antivirals
precautionary
risk
activities
influenza
pharmaceutical
sirna
den
rna
cells
mosquito
cd200
splicing
sf2
asf
ese
fidelity
amiloride
rdrp
resistant
mutagenic
coronaviruses
covs
wild
ibv
birds
method
malaria
molecular
use
the
oz
influenza
oseltamivir
zanamivir
patients
vlps
purification
binding
stable
noroviruses
sjia
disease
urine
the
patients
chemical
13
shifts
nab
nmr
neck
dc
repeats
sign
signr
mhc
human
receptors
kir
class
eef1a
replication
host
viral
replicase
zn
rna
sars
pt
replication
information
dr
complexity
effective
measure
sars
covs
bats
viruses
human
exposures
patients
exposure
onset
phenotypes
prediction
vaccines
immunoinformatics
discovery
correspond
viral
computational
viruses
pathogens
virus
pals1
polarity
sars
tight
epithelial
cell
proteins
hrsv
ms
data
wnv
cytokines
inflammatory
cell
pro
slc26a4
cochlear
lumen
mice
fluid
seasonal
analysis
spread
viral
influenza
rbd
sars
antibodies
protein
neutralizing
health
care
gps
pandemic
influenza
lesion
mri
cm
volume
onfh
norovirus
cells
mnv
recovery
virus
dc
sign
npc
promoter
the
morpholino
viral
je
following
brain
hcws
information
h1n1
influenza
health
patients
h1n1
infection
cancer
lung
international
projects
china
aids
hiv
hiv
aids
policies
china
national
csos
aids
programmes
hiv
increased
compounds
lead
marine
antiviral
sponges
virus
hev
niv
henipavirus
entry
h1n1pdm
patients
viral
the
influenza
drugs
veterinary
livestock
pathogens
especially
frameshifting
base
the
triple
pseudoknot
dna
duplex
nsp13
helicase
unwinding
probes
hybridization
dna
70
nt
contact
sequence
data
heterogeneity
population
feline
snps
female
domestic
cat
cut
clustering
problem
hierarchical
arithmetic
flu
swine
pandemic
people
first
admission
risk
associated
hospital
bronchiolitis
nsp4
ca
viroporin
levels
cyto
sars
patient
severe
acute
respiratory
sars
taiwan
23
probable
first
respiratory
infections
studies
dampness
ors
pam
vsa
ies
csa
results
rna
frameshifting
oligonucleotides
sequence
ribosomal
travel
associated
cases
travellers
diseases
npa
sensitivity
fns
nasal
respiratory
endothelial
pathogenic
cell
leptospirosis
non
pav3
adhu5
ha
vaccine
vector
lung
infectious
innate
tissue
non
antigens
coupled
apcs
liposomes
fatty
therapeutic
vaccines
hbv
model
approaches
hku1
nl63
coronaviruses
schizophrenia
respiratory
sequences
using
improvement
rass
sequence
2009
surveillance
cases
barbados
pandemic
health
global
shifts
emerging
national
laboratory
countries
capacity
efforts
training
ihr
2005
national
surveillance
health
hla
peptides
a03
supertype
identified
palmitoylation
membrane
posttranslational
protein
intracellular
phever
viral
viruses
sequences
genomes
genes
orfan
proteins
hops
soluble
dengue
genotype
rs4804803
viral
replication
lectins
activities
diversity
practical
applications
influenza
itis
travellers
temperature
tympanic
nan
animal
china
disease
may
key
nan
outbreak
sars
public
health
the
nan
nan
respiratory
associated
sars
cov
may
patients
hmpv
infected
cells
used
nan
patients
sars
correlates
severe
we
ifitm
mediated
proteins
entry
restriction
prf
products
kinetic
two
frameshift
behaviors
hospital
employees
outpatients
preventive
viruses
bacteria
array
mda
samples
proteins
rna
chaperone
activity
mechanism
cases
mixing
transmission
pandemic
adults
parameters
reporting
data
outbreak
key
alzheimer
disease
may
infection
proteins
cells
cd8
memory
cd4
viruses
lung
analysis
alveolar
cases
h1n1
case
fatality
rates
doubling
times
cells
ns3
hcv
protease
toxins
infectious
breathing
20
per
the
swabs
patients
samples
rayon
nylon
ship
deficient
wt
cells
cell
influenza
antibodies
pandemic
h1n1
strains
virus
vaccine
immunity
attempts
hiv
pci
mice
pei
sars
the
delivery
cancer
vaccine
clinical
nps
virus
ras
pi3k
influenza
signaling
diseases
animal
models
cardiac
mimic
gp
ebola
er
the
cytotoxic
rad
rv
vlp
vlp2
prime
xbp
1s
pcaf
cellular
cell
vidisca
rrna
virus
discovery
amplification
globin
adult
marinus
the
beta
arb
membrane
tryptophan
viral
fusion
public
health
response
aeis
the
h5n1
virus
ha1
influenza
strains
adenovirus
two
samples
hadv
positive
travel
developed
spread
patterns
human
dependence
spread
city
population
cities
sars
changes
an
outbreak
severe
nan
response
task
force
european
in
complement
3xtg
ad
activation
models
fusion
membrane
residues
viral
trimer
cells
expression
molecules
surface
cell
sars
cases
predicted
close
we
the
infectious
biology
systems
century
patients
h1n1
group
mean
the
ires
hiv
activity
luciferase
translation
sars
rt
pcr
positive
nasopharyngeal
nan
smallpox
orthopoxvirus
zoonosis
result
bioterrorism
sars
cov
infection
asymptomatic
healthcare
termination
reinitiation
turbs
codon
m1
ics
pcr
use
detection
technical
the
climate
change
cardiovascular
diseases
care
h1n1
knowledge
patients
influenza
ns2
hcv
protein
assembly
virus
pandemic
interventions
influenza
strategies
intervention
hfmd
incidence
temperature
rainfall
weather
entry
virus
pathways
membrane
recent
rd114
virus
dogs
group
blood
plp2
tbk1
ifn
irf3
kinase
cases
streptococcal
treat
pharyngitis
world
myositis
infectious
and
or
infection
protein
functional
microarrays
tool
proteomics
bats
virus
adenovirus
pipistrellus
found
measures
cost
influenza
pandemic
h1n1
2009
outbreaks
influenza
pandemic
h1n1
respiratory
dfa
viruses
picornaviruses
hmpv
disease
burden
funding
nih
current
apom
t2d
rs707922
gene
cholesterol
catalytic
machinery
n214a
3clpro
dynamics
sl
nonlinear
exposure
techniques
lr
lung
imaging
contrast
il
xpci
the
fall
winter
children
microbiota
elhaik
curve
et
al
the
hmpv
children
antibody
hrsv
igg
plastid
transformation
plants
plant
gene
immumax
mg
group
the
symptoms
gsh
immunity
role
review
inflammation
virus
influenza
viruses
ilis
respiratory
tlr3
pi329l
virus
structural
asfv
3cl
pro
cells
transfected
sars
h9n2
virus
pathogenicity
pathogenic
chickens
cns
disease
virus
infections
ms
lozenge
throat
amc
dcba
sore
hcmv
infection
μm
peptides
viral
suis
risk
or
95
ci
apmv
hamsters
apmvs
serotypes
the
astroviruses
human
novel
recently
faecal
nsp16
coronavirus
in
large
rna
resistant
transmission
coli
pigs
counts
vaccination
ph1n1
vaccine
uptake
reported
slc26a4
cell
stretching
pendrin
epithelial
marama
extracts
rv
water
cotyledon
biology
the
many
synthetic
manipulate
rna
methylation
viral
ifn
antiviral
ebc
respiratory
exhaled
viruses
ebcs
plant
activities
phytochemical
constituents
sphaeranthus
lung
disease
chronic
cells
il
disease
hiv
pathogen
could
risk
viral
influenza
shedding
illness
virus
ibv
tissues
infection
proteins
chicken
antigenic
the
ha
antisera
cell
receptors
encoded
roles
self
in
swine
csfv
classical
fever
pigs
dmxaa
specific
e7
dna
immune
network
epidemiology
review
networks
methods
nan
strain
h275y
2007
mutant
viral
viral
respiratory
children
human
infections
species
individuals
trade
thailand
cites
strains
simulant
genome
atrophaeus
signatures
var2csa
antibodies
domains
malaria
pm
hrv
children
samples
human
wheezing
helix
ed
ns1
rbd
may
optimism
pessimism
pregnancy
research
this
liposomes
af
cyd
pdna
gene
cox
hbv
promoter
increased
binding
hrv
hospitalized
year
children
controls
mutation
the
lew
ztm
ci2
pals1
cell
activation
tcr
polarity
trial
h1n1
consent
treatment
influenza
entry
iav
dynamin
pathway
host
midgut
mosquitoes
rer
proteins
epithelial
viruses
influenza
abs
ha
group
lipid
peptide
membrane
within
bilayer
rhmbl
ebola
binding
mbl
human
sleep
post
sars
patients
syndrome
changes
strain
piglets
virus
phev
viruses
influenza
h4n6
h4n9
lbm
niv
virus
vlps
potential
particles
days
patients
median
95
ci
osteoclast
antibody
cells
sct
confirmed
ndm
antibiotic
beta
drugs
lactam
ifn
cells
type
infection
bacterial
rf
signals
mrna
yeast
eukaryotic
pcv
motif
dna
2a
2b
antibodies
human
cells
stat5
monoclonal
bocavirus
porcine
related
pbov2
h18
ari
children
respiratory
clinical
infection
ph1n1
news
public
statements
emerging
codon
usage
polioviruses
genotype
the
human
sars
cov
zoonotic
host
lcmv
dg
glycoprotein
virus
fiv
imaging
patients
pathogenesis
influenza
respiratory
respiratory
concentrations
erv
pm
particle
shfv
variants
within
primates
wild
cells
cathepsin
mndk
cd4
hela
markets
surveillance
poultry
pathogenic
h5n1
surveillance
cdc
influenza
ili
virus
mice
glycyrrhizin
lipid
peroxidation
antioxidant
vaccination
mea
use
increased
dna
lilra3
like
hlais
binding
classical
melanoma
antibody
responses
cells
cell
incubation
period
evidence
data
medical
nan
respiratory
human
rhinovirus
exacerbations
to
bats
novel
viruses
modified
system
orvs
na
season
influenza
inhibition
noroviruses
dogs
to
identify
prevalence
epidemic
virus
the
transmission
model
codon
usage
hav
bias
hepatitis
ar
polymorphisms
hrv
heart
rate
genomes
parental
recombination
random
view
influenza
associated
phps
trust
information
licl
infection
tgev
virus
effect
cells
α2
linked
ciliated
goblet
data
system
mass
food
korea
receptor
species
viruses
transmission
among
chloroquine
hcv
nh
cl
ph
one
health
the
animal
modern
na
assays
heater
free
lrs
viral
infection
infections
patients
bacterial
mouse
binding
receptor
lsectin
human
survey
measures
preventive
perceived
high
motivation
hesitation
hospital
workers
pandemic
genes
genome
method
the
bats
microarray
influenza
sequences
pathogenid
v2
m1
cell
cycle
protein
aminopeptidase
pandemic
influenza
ili
effectiveness
confirmed
health
surveillance
public
limited
sages
sars
years
the
outbreak
beijing
surveillance
health
global
emerging
mission
infection
influenza
virus
response
macrophages
bats
brown
cov
rna
big
epidemic
seasonal
rsv
transmission
size
indigenous
infants
respiratory
bronchiolitis
azithromycin
strains
branch
china
the
nephropathogenic
litwinowii
cell
cells
the
scutellaria
viral
activity
host
cell
compound
essential
antiviral
hsv
oil
star
fever
detecting
cases
2009
the
h5n1
glycyrrhizin
induced
inflammatory
replication
sl2
utr
stem
prrsv
replication
whales
sperm
mediterranean
seven
tissue
sstroa
metal
ions
protein
suis
cells
cd40l
cd4
specific
il
findings
chest
imaging
patients
reticular
set
accuracy
sequences
the
training
hiv
codon
trna
genes
usage
gene
recombinant
protein
chimeric
mlc
h1n1
acute
respiratory
ventilation
nippv
lung
dad
interstitial
diseases
acute
microbial
wildlife
expression
profiles
immunological
vuvuzela
aerosols
vuvuzelas
blowing
we
virus
sign
dengue
cell
cells
acute
exacerbation
hmgb1
ipf
alveolar
microarrays
protein
research
infectious
discovery
nt
perkinsus
sl
dinoflagellates
rna
nsp10
nsp16
adenosylmethionine
rna
dependent
9b
protein
nuclear
nes
sars
tastv
flocks
77
type
infections
nan
influenza
period
activity
pregnancy
vaccine
k9c
k9bp
sequences
gastrointestinal
diet
respiratory
viruses
infections
lrtis
viral
patients
result
antibiotic
prescription
visit
early
high
altitude
hape
diagnosis
viruses
microarray
identification
based
pathogenic
nan
bee
honey
viruses
critical
known
influenza
ipd
pneumococcal
disease
we
fever
virus
rvfv
rift
valley
rtgev
virus
tgev
protein
gene
virus
cavv
associated
diversity
novel
prbcs
blood
pf
contaminated
unit
h1n1
or
95
ci
knowledge
gene
expression
virus
viral
replication
systems
superfamily
sukh
proteins
domains
ama1
iggs
malaria
total
children
case
emerging
infectious
report
reports
bacterial
lung
aspirate
yield
culture
viruses
autophagy
pathway
cellular
also
pkr
np
iav
p58
ipk
bev
cells
apoptosis
postinfection
viral
hbv
core
insertion
we
structure
adam10
hiv
infection
replication
viral
strains
ss2
stss
our
pathogenicity
data
network
mobile
remote
agent
immune
hiv
responses
infection
virus
denv
antibodies
primary
virus
infection
pandemic
age
influenza
peru
school
respiratory
hrv
lower
patients
virus
asthma
children
infections
viral
wheezing
mhv
protocol
cells
protocols
used
vlps
immunization
emcv
in
virus
proteins
yeast
recombinant
muhn
meh
egr
hsv
infection
induction
the
h9n2
species
avian
viruses
including
residue
sequence
stralsv
protein
structure
pcr
hbov
elisa
positive
npa
mt
swabs
respiratory
np
collection
bag3
protein
cell
domain
in
pandemic
april
2009
25
h1n1
genes
expression
mscs
chondrogenesis
gene
bat
rabies
bite
would
bats
host
viruses
species
specificity
range
protein
antibody
antibodies
methodologies
human
prrsv
ctl
virus
ifn
vaccination
nucleoli
nucleolar
proteins
described
dynamic
rna
replication
fidelity
viruses
virus
networks
clustering
we
trees
different
mitochondrial
protein
mt
mtdna
proteins
influenza
states
patterns
state
hospitalizations
children
otitis
media
bacterial
ear
hbov
load
patients
viral
respiratory
active
sle
characteristics
seasonal
distribution
disease
modelling
quantitative
control
risk
ceacam1
gvhd
cells
increased
numbers
pd
mhv
fgl2
damage
fh
macv
gp1
tfr1
residues
interaction
ards
advances
despite
critical
care
89k
suis
transfer
type
gi
antibodies
neutralizing
hiv
mabs
infection
vwf
adamts13
proteolysis
cleavage
mab
vaccination
vtt
routes
nabs
smallpox
vaccines
peptide
based
vaccine
delivery
respiratory
viruses
the
viral
new
elisa
detection
diagnostic
pcr
disease
rabies
elimination
canine
human
deaths
influenza
pam
virus
treating
therapeutic
monkeys
tmadv
species
adenovirus
titi
gfap
promoter
sin3a
astrocyte
the
fertiqol
fertility
items
measure
life
protein
interactions
potential
drug
microarrays
casein
milk
the
protein
role
orf5a
the
orf5
arterivirus
expressed
rna
chikv
terminus
virus
helicase
infection
henipavirus
bats
bat
interferon
parasites
host
living
it
also
dc
signr
sign
neck
the
nan
infection
host
gammaherpesvirus
mrna
shutoff
ms2
antiviral
assay
aureus
screening
networks
infection
severe
social
diseases
expression
gene
mrcv
planthoppers
virus
health
laboratory
public
surveillance
national
spread
models
travel
structural
pathogens
sars
cov
terminal
domain
nsp2
hand
sanitizer
the
community
schools
group
patients
mv
crp
sofa
its
traits
genetic
innate
adaptive
vaccine
vaccines
need
development
the
2009
h1n1
95
confidence
interval
weekend
strategies
extension
influenza
two
ub
viruses
host
viral
dna
pulmonary
alveolar
acute
the
respiratory
app
proteins
immunoreactive
serotype
ph
thv
emcv
codon
usage
the
respiratory
acute
illness
case
condition
oral
olp
refrecare
pain
vas
grft
lectins
lectin
antiviral
cell
cells
reg
specific
cell
foxp3
ifn
nk
stat4
type
cells
major
mih
preparedness
the
provide
control
measures
household
quarantine
number
hk
tgf
pbmcs
cells
lfa
health
determinants
women
new
political
prf
yeast
viruses
mechanism
rates
uspio
spio
the
iron
injected
entry
screening
local
delays
h1n1
il
fiv
pregnancy
trophoblasts
expression
primers
h5n1
rt
new
influenza
toxins
action
pathogenic
toxin
protein
protein
gav
emsas
length
sequence
jhm
sd
mhv
a59
less
respiratory
assay
molecular
assays
rt
clinical
diagnostic
samples
we
virus
hcmv
antibodies
gb
neutralizing
domain
technologies
monoclonal
antibody
technology
undergone
mrsa
infection
2006
since
surveillance
chikungunya
il
disease
virus
levels
disease
threshold
used
diseases
strength
pathogens
h1n1v
clinical
influenza
ili
ha
iav
h1n1
epitope
influenza
readthrough
analysis
uga
revealed
rna
et
al
liposomes
artificial
based
patients
icu
support
critically
ill
xiaoyaosan
trials
antidepressants
score
included
models
control
vaccination
effectiveness
programs
schizophrenia
increased
estrogen
author
the
hcws
infections
infectious
monitoring
absence
data
method
we
infectious
symptoms
antibodies
the
challenge
model
reactivity
ndm
antibiotics
positive
strain
study
viruses
h5n1
phage
the
avian
sars
lf
cov
host
cells
cells
cd4
cd69
mtb
th1
genes
bmv
replication
host
essential
network
ppi
proteins
protein
new
lung
survival
bos
transplant
recipients
glial
tnfα
activation
poly
cultures
ifn
reovirus
ifnar
brain
mice
anti
trypanosomal
the
development
human
sars
ahsg
associated
rs2248690
aor
sm
trachomatis
inclusion
replication
vesicular
viruses
bats
astroviruses
colony
2010
or
2009
pandemic
h1n1
virus
tb
proportion
foreign
born
we
91
ibv
m41
beaur
protection
nod
proteins
sequences
nolss
localization
ai
preventive
behavior
aor
recommended
lung
patients
sm
protein
plasma
resurgence
syphilis
china
control
elimination
risk
scale
vector
the
populations
health
public
international
population
disease
utilitarian
must
present
in
event
zoonotic
eid
emergence
diseases
gabon
detection
outbreak
early
surveillance
new
hrv
species
often
infections
rtis
prostate
cancer
genotype
oas1
rs2660
emerging
bats
infectious
pathogens
bat
mutations
positive
controls
resistance
molecular
ifn
infections
age
pdc
pdcs
rna
anxa2
cellular
pseudoknot
protein
viruses
novel
virochip
the
viral
infectious
ssgcid
disease
drug
the
hcv
gl
interferon
results
liver
virus
the
proteins
infections
proteome
nidoviruses
large
nidovirus
ndiv
kb
c6
activation
ifn
irf3
irf7
vaccine
the
h1n1
pandemic
influenza
flu
swine
2009
uk
newsprint
disease
cells
infection
filovirus
infected
sp
viruses
antiviral
recombinant
porcine
id
vaccination
skin
delivery
use
immune
hiv
responses
balb
mice
mice
lung
mechanics
rm
ventilation
rna
reaction
mpa
step
the
mmp9
bbb
mice
expression
disruption
adem
ms
diagnosis
the
lesions
ph1n1
patients
viruses
influenza
respiratory
asthma
respiratory
episodes
exacerbations
different
viral
cytokine
influenza
levels
patients
virus
multiple
viral
respiratory
children
hpi
host
sequencing
we
rna
genetic
disease
host
variation
the
viral
small
rna
wild
rnas
dhh1
pat1
translation
mrna
proteins
influenza
alpha
epithelial
cells
sa
antigen
multiple
presenting
peptide
vaccine
influenza
nk
cells
infection
cell
orf2
chop
hev
protein
endoplasmic
chikv
autophagy
replication
cells
autophagic
influenza
viruses
ferret
research
human
platelets
lps
platelet
leukocytes
leukocyte
nkg2d
cells
murine
cytotoxic
cytotoxicity
ifn
bats
type
iii
receptor
bovine
partetravirus
partetraviruses
samples
ovine
cov
bat
species
spain
coronaviruses
calves
diarrhoea
treatment
diseases
impact
methylation
mrna
type
interferon
rna
ph1n1
age
2009v
infection
2009
respiratory
hmpv
hcov
nl63
children
tgev
sialic
infection
adsorption
acid
nan
hbov
found
respiratory
often
samples
pcr
pathogens
real
time
respiratory
hku1
hcov
human
coronaviruses
coronavirus
cat
cats
fip
gene
3c
bicp0
important
infection
interferon
dependent
antiviral
ifn
responses
pdc
including
hcov
nl63
antibodies
animals
recently
di
rnas
rna
viral
replication
rna
pkr
viruses
negative
strand
hrv
strains
hev
positive
respiratory
wupyv
respiratory
tract
infections
the
antibodies
b12
x5
hiv
germline
md27
strains
ibv
region
gene
mucosal
vaccine
hiv
human
aids
isg15
viruses
interferon
ifn
isgs
ubiquitin
members
family
proteasome
system
symptoms
virus
viruses
infection
incubation
replication
rna
viruses
host
cellular
disease
animal
study
human
models
nan
hantaviruses
human
1993
emergence
among
peg
profile
technology
covalent
modification
the
flavivirus
viruses
viral
response
conservation
the
viral
applied
ecology
influenza
virus
high
in
limited
rnai
cellular
rnas
hcv
the
coronavirus
coronaviruses
different
hku1
bias
virus
factors
viral
viruses
systems
denv
replication
autophagy
autophagosomes
cellular
htlv
associated
ii
wb
virus
autophagy
hcv
cellular
proteins
process
pathogens
virus
priority
national
health
reliable
estimates
surveillance
iar
sero
membrane
structures
single
rna
induced
mutualism
viruses
examples
dynamics
understanding
commentary
wolf
freiberg
zhang
akyol
rna
positive
sense
viral
replication
peptide
abundance
quality
statistical
identification
pathogens
cells
host
mechanisms
coronaviruses
recombination
ibv
coronavirus
virus
well
autophagy
replication
viral
many
promote
ssdna
viruses
recombination
various
virus
ifn
type
antiviral
infection
virus
mitigation
surveillance
disease
intervention
benefits
mabs
plasma
assays
antibodies
neutralizing
gp350
exosomes
cells
tropism
virus
tlr3
viral
signaling
rna
dsrnas
ebov
cells
gp
human
bat
tetherin
ebov
gp
vpu
virus
fusion
six
helix
bundle
gp2
respiratory
children
virus
viruses
human
ns4
btv
giv
dsrna
proteins
h1n1
the
confirmed
cases
pandemic
pemf
group
osteonecrosis
mpsl
weeks
viruses
bats
bat
discovered
respiratory
infection
mdef201
virus
lung
given
mtase
nsp16
nsp10
rna
sars
vectors
encoding
type
mice
fv
airway
poly
ovalbumin
challenged
asthma
hevs
based
hev
typing
viruses
mice
nscs
spinal
infected
clinical
zebov
response
gp
cellular
infection
pol
gag
pfv
particle
fusion
s2m
viruses
novel
two
motif
strategies
control
preventive
behavior
influenza
chikv
infection
isg15
response
mice
cov
rsars
gene
δe
cells
viruses
machupo
lassa
receptor
junin
clinical
diagnostic
system
filmarray
amplicon
health
population
disease
prd
new
xtjyf
placebo
scl
ptsd
group
virus
viral
csf
blood
brain
emergency
triage
care
ethical
department
control
bvd
the
disease
programmes
viruses
airborne
lma
method
using
q7r
pedv
cpe
dna
ros
def201
viral
cifn
challenge
picv
redox
pathogen
ros
protein
production
immune
responses
cells
gene
therapy
mrna
sox
host
cellular
turnover
viruses
ifn
ifitm3
host
cell
cov
covs
human
sars
important
aav
viremia
patients
virus
clinical
wave
influenza
reinfection
multiple
outbreaks
fibrillarin
rrna
rna
plays
including
frameshifting
triple
helix
base
hairpins
disease
health
reporting
completeness
surveillance
hrv
pcr
pairs
we
conducted
fiv
infection
infected
plv
load
viral
fv3
replication
studies
family
extracts
immune
echinacea
various
certain
rhinitis
age
children
and
or
health
global
management
approach
strategy
data
method
nnalign
biological
sets
pro
3cl
group
substrate
residues
virus
proteins
targets
host
antiviral
raav6
cpv
immune
response
vaccination
calls
mtdna
sprofiler
gseq
point
tb
participants
roma
important
treatment
proteases
cathepsin
tetromycin
the
compounds
ii
expression
ccov
increased
infection
anxa1
day
lung
fibrosis
inflammation
lycorine
ev71
treatment
viral
clinical
china
ib
nephropathogenic
farms
ibv
oligomer
exon
dystrophin
patient
25
clonal
interference
populations
adaptation
beneficial
lamp
lava
we
signature
primer
library
scfv
antibody
germline
specific
ivtt
using
vaccine
antigens
cell
better
severe
host
genetic
h1n1
ace2
ang
ii
the
angiotensin
method
dimethyladenosine
modifications
adjacent
methyl
common
students
dorm
rooms
person
we
length
probes
hybridization
dna
recent
ubiquitin
advances
proteasome
ups
severe
patients
immune
responses
genes
host
solanaceae
hosts
dmfe
fitness
fcov
cats
feline
prevalence
type
virus
ftls
pcr
samples
2007
neurons
ctl
infected
mhc
bdv
orf6
expression
transfected
co
protein
calves
pneumonia
weaning
the
calf
rnas
small
virus
infection
expression
surveillance
data
dashboard
influenza
dissemination
virus
surfaces
influenza
transmission
h1n1
h1n1
legionella
disease
infection
may
patients
influenza
h1n1
the
care
teaching
competencies
acgme
programme
clinical
tmv
cells
human
hela
rna
design
health
care
ventilation
infection
caspase
activity
method
neurodegenerative
disorders
hzp3
epitopes
minimal
motifs
23
tlr
bovine
taurus
snps
bos
hiv
luteolin
viral
cart
residual
influenza
drugs
new
ha
neo6
ifn
induction
bat
helvum
cell
cell
virus
transmission
influenza
to
species
pathogens
zoonotic
host
public
plp
sars
cov
replication
the
health
2003
2008
chinese
status
hcv
proteins
cells
structural
cytopathic
ts
features
mutations
mutants
we
rna
transcription
trs
protein
replication
rbps
rna
host
viruses
functions
type
otu
virus
ability
induction
subtypes
isolates
influenza
belonging
group
viruses
cellular
responses
infection
protein
devices
loc
systems
fast
sensitive
lab
mucosal
delivery
therapeutic
strains
rvfv
mice
infection
cells
the
phage
brv
the
elisa
potential
ngvev
apoptotic
cells
apoptosis
time
genes
reference
pcr
expression
disease
ngs
sequencing
viruses
human
techniques
orf4
virus
infection
protein
expression
chikv
albopictus
e2
virus
step
rna
viral
readthrough
replication
rdrp
rna
nsp1
cleavage
mrnas
ires
ferret
months
age
macrophages
the
viral
sequence
popular
host
species
reviews
included
studies
study
chinese
virus
viral
membrane
rafts
cellular
ifn
type
iii
interferon
role
cells
ms
cd4
eae
autoimmune
visitor
volume
mean
revenue
temperature
mbl
denv
complement
dependent
cell
culling
groups
social
badger
btb
viral
rna
host
eef1bγ
replication
renal
hypouricaemia
urate
may
inherited
mbl
virus
h9n2
pdmh1n1
g1
transmission
need
villages
methods
schistosomiasis
amd
lps
rats
liver
injury
h5n1
viruses
clades
ha
antibody
analysis
vipr
data
sequence
virus
sirna
viral
virsirnadb
database
virus
motifs
elm
motif
instances
linear
cells
epithelial
cell
progenitor
type
de
novo
derivatives
tcm
h1
gars
farm
g9p
gar
diarrhea
nan
detection
arrays
clinical
environmental
microbial
frameshifting
ribosomal
mrna
pseudoknots
pseudoknot
btpv
bats
artibeus
high
two
virus
entry
cell
viruses
cellular
bats
infectious
agents
species
disease
health
occupational
infection
control
tools
metabolism
method
compounds
obtained
chemical
btv
ns4
structural
replication
bluetongue
oh
the
substituent
no
para
2009
h1n1
ards
virus
lung
interactions
method
parasite
risk
chi
transmembrane
ceacam1
domain
tyrosine
4s
influenza
ili
virus
2010
2009
uterine
feline
adenocarcinoma
cat
leukemia
ski
s1p
hcv
infection
host
the
sp
marilones
marilone
activity
dogs
wild
canine
populations
domestic
wildlife
pathogen
surveillance
the
trade
pathogen
beta
amyloid
autoantibodies
genes
meningitis
kit
detection
high
pathogens
color
taxonomic
taxonomy
may
number
host
pathogen
interactions
genetic
flies
virus
ebola
structure
the
nucleocapsid
cells
ibv
infected
mcl
virus
chymase
molecular
docking
dft
inhibitors
3b
sars
cov
runx1b
protein
lbv
serological
virus
viruses
populations
milk
immunoglobulins
colostrum
immune
immunological
vaccinated
transmission
influenza
pigs
pig
ph1n1
h1n1
virus
illness
influenza
influenza
no
virus
ino
survival
skin
18
expression
treatment
il
cryptosporidium
parvum
animals
15
animal
pattern
paving
the
crazy
diseases
rt
lamp
primer
sets
virus
ev71
scarb2
infection
receptor
entry
vsv
viruses
viral
gene
envelope
vntr
repeat
alleles
clec4m
number
swine
siv
responses
macrophages
influenza
nan
nan
data
discuss
we
outbreaks
disease
genome
non
coding
srnas
strain
oseltamivir
the
using
tandem
μg
leaves
trifolia
india
plant
cayratia
fcov
feline
cause
infection
fip
viruses
tumor
cells
targeting
surface
hcov
nl63
hku1
patients
showed
virus
ccov
canine
role
new
coronaviruses
feline
canine
coronavirus
respiratory
humidity
relative
the
virus
sars
influenza
risks
associated
mortality
humidity
influenza
self
swabs
viral
collected
molecular
mimicry
cell
dual
autoimmune
ali
phase
risk
functional
snps
receptor
binding
acetylated
sias
lectin
hbov
arti
detected
patients
65
years
influenza
sentinel
respiratory
healthcare
sting
cov
irf
activation
induction
ang
cv
heart
remodeling
axis
denv
50
virus
dengue
μg
ang
angiotensin
ras
ace2
mas
viral
rdrp
protein
rna
tymv
influenza
hcws
vaccination
respiratory
rv
ssrna
nmr
ssrnas
serve
behavior
hev
antigens
domains
orf3
genotype
viruses
sequences
dengue
deep
virus
atgus
3t
sequence
non
conservative
diseases
infectious
law
past
decades
protein
sequence
new
biology
taken
motifs
biological
composite
atomic
protein
respiratory
person
hygiene
transmission
community
cells
gp
filoviruses
receptor
host
viral
hmabs
antibodies
antiviral
human
intervention
hand
washing
group
infection
cardiovascular
ras
function
disease
angiotensin
transmissibility
communities
pandemic
remote
isolated
compounds
model
parasitic
nematodes
drugs
children
respiratory
hbov
infections
the
respiratory
tract
viral
viruses
the
antibodies
dengue
denv
human
antibody
prrsv
ifn
viruses
virus
replication
ded1p
rna
replication
tbsv
strand
jak3
h5n1
ha
selective
avian
diseases
infectious
transmission
china
trends
ns3
cells
hcv
protease
zymoxins
hotspots
hotspot
individuals
infectious
contacts
family
we
dispanins
transmembrane
proteins
cells
kd
immune
pathogenic
proteins
rabies
french
virus
program
population
resource
pandemic
mortalities
gaps
within
hyponatraemia
sodium
admission
children
cap
nan
influenza
index
we
households
mh
recombination
borne
mtbfg
within
the
ebv
ttv
replication
cell
multiple
amplification
hiv
settings
the
heating
susceptibility
mouse
mhv
ceacam1
receptor
rsv
ez
virus
ebv
gp350
rna
rdrp
nsp8
activity
dependent
testing
process
genetic
system
information
calf
coli
diarrhea
antimicrobial
virulence
dectin
95
dc
sign
or
histone
gmphd5
salinity
stress
methylated
denv
genotype
infection
neutralization
protection
viruses
respiratory
artis
virus
detected
pneumonia
patients
reported
identified
we
nov
feline
novs
cats
shelter
kd
old
caa
months
year
niv
infection
cxcl10
endothelial
cells
cost
interventions
studies
effectiveness
economic
morbillivirus
cells
infection
virus
receptors
nan
nan
chikv
islands
patients
indian
ocean
2005
health
ihr
surveillance
international
bocavirus
hbov
respiratory
tract
infection
infection
children
virus
specimens
this
duty
the
care
worker
phrase
syndromic
surveillance
detection
anthrax
clinical
coronaviruses
sars
reservoir
viruses
bat
sars
hcws
toronto
workers
outbreak
nan
matched
infection
poultry
factors
h5n1
cases
sars
vancouver
imported
two
pathogen
dissemination
we
developed
model
cell
lines
sars
cov
used
influenza
pandemic
viruses
national
the
h5n1
viruses
waterfowl
domestic
poultry
influenza
avian
viruses
human
pandemic
influenza
infection
travelers
international
human
pandemic
based
interventions
period
recommendations
ccov
canine
coronavirus
usually
responsible
ocular
respiratory
virus
following
inoculation
cell
vaccination
protection
mva
immunity
pr
gag
activation
cleavage
hiv
iav
a20
response
specific
proinflammatory
pathogens
analysis
toxins
provided
antibody
proteins
antifreeze
ice
predicting
afps
amstar
the
tcm
systematic
reviews
viruses
nipah
emerging
we
strategy
hids
eds
mads
management
rooms
emerging
diseases
health
animals
clinical
case
data
april
phase
outbreak
epidemic
we
early
method
sars
influenza
underlying
death
rates
tropical
detection
identification
viruses
respiratory
tract
nan
sars
screening
international
measures
screen
nan
sars
healthcare
workers
among
infection
sars
confirmed
cov
infection
we
genes
paramyxovirus
novel
in
public
nan
2009
pandemic
h1n1
seroconversion
aor
nan
influenza
2009
passengers
pandemic
h1n1
fever
flir
optotherm
systems
self
bat
rotavirus
rotaviruses
genes
gene
2009
10
samples
pathogen
from
bats
seroprevalence
viruses
virus
to
virus
markets
sites
avian
influenza
bats
isolates
bartonella
spp
clustered
nan
zoonoses
would
including
humans
clinical
nan
nan
tb
nosocomial
transmission
high
control
nan
detected
57
children
ari
human
influenza
2009
pandemic
h1n1
virus
diagnostic
rhinovirus
infections
facilities
outbreaks
infectious
diseases
change
climate
borne
dengue
illness
signs
symptoms
day
alv
target
gag
replication
multi
hospitals
performance
the
hics
hospital
cov
sars
virus
recsars
isolate
ili
extract
krg
the
study
host
expression
pathogenicity
responses
pathogenic
perch
respiratory
comprehensive
testing
pneumonia
case
patients
pneumonia
specimens
pcr
ms
brain
gbv
viral
sequences
cov
we
pcr
sars
human
measures
perception
risk
institutional
sars
airport
fever
screening
40
dengue
sars
cov
pig
severe
acute
sars
cov
assay
neutralizing
the
sars
hong
kong
respondents
would
younger
children
may
require
longer
bats
bat
rna
virus
cov
respiratory
disease
cows
occurrence
bhv
cea
tumor
sars
cov
low
pigs
prrsv
infected
viremic
cell
gtpv
sirna
expression
orf095
pcr
kshv
egr
cells
latency
lytic
poag
variants
glaucoma
data
gwas
hr2
helices
nmr
parallel
orientation
skin
18
expression
il
treatment
contact
hcws
influenza
infection
h1n1
virus
replication
ree
borne
tbev
virus
bac
dna
vectors
sequences
pathways
host
analysis
respiratory
viruses
ifn
monocytogenes
macrophages
gene
synthesis
immunity
vector
had
human
mice
drug
screening
approach
discovery
molecular
receptors
like
cancer
risk
polymorphisms
elisa
encephalitis
array
viruses
detection
cxcr7
eae
antagonist
treated
axonal
vaccinia
vtt
assay
virus
vaccination
pigs
chlamydia
clinical
by
infection
adenosine
chloride
transport
ethanol
camp
ebv
cells
lcl
cell
infection
sars
cov
mutations
affinity
hace2
rvsv
animals
gp
filovirus
received
prohnp1
hnp1
native
peptides
folded
infection
virus
tregs
persistent
cns
pediatric
airborne
adenovirus
mycoplasma
pneumoniae
safv
virus
csf
children
child
equine
veterinarians
qualitative
study
allied
beijing
patients
the
loci
amplified
wnv
we
conducted
cross
sectional
infection
among
close
contacts
2009
nan
dengue
virus
cells
membrane
membranes
cardioviruses
children
detected
cause
myocarditis
workers
poultry
preventive
in
2009
animals
asymptomatic
rabbit
10
by
fatal
influenza
infection
among
co
patients
group
chlorine
exposed
gas
research
india
also
medicine
publication
annex
potential
health
who
pheics
xmrv
env
entry
fusion
ph
mortality
air
influenza
cold
we
domestic
feline
the
cat
viruses
gp
entry
viruses
cells
cellular
rig
aptamer
production
rna
ifnα
pcv2
detection
lamp
virus
porcine
ifitm
proteins
denv
infection
ade
hbov
viral
load
lrti
respiratory
influenza
host
virus
cell
genome
viral
apoptosis
host
one
cell
infection
pathogen
measures
drug
waves
crystal
bsa
diffraction
crystals
serum
hcv
cell
infection
lines
cells
lamp
ulcerans
is2404
detection
clinical
denv
prm
cross
antibody
dengue
sars
pi4kb
entry
cov
spike
clec5a
kd
polymorphisms
genetic
susceptibility
influenza
viruses
the
important
human
paramyxoviruses
assay
family
pcr
wide
nan
viral
load
associated
clinical
specimens
nan
nan
sars
the
peptide
assay
based
sars
total
068
asymptomatic
close
outbreak
vp1
isolates
fdjs03
echovirus
nan
infectious
disease
sars
west
nile
outbreak
transplant
we
investigated
large
nan
healthcare
workers
we
reinterviewed
exposed
sars
outbreak
questionnaire
months
2003
avian
influenza
risk
live
11
dengue
infections
reported
illness
autochthonous
nan
nan
sars
outbreak
precautionary
actions
severe
nan
staff
attack
nonmedical
support
sars
nan
articles
health
to
examine
media
sars
respiratory
health
outbreak
fris
pathogens
naturally
emerging
deliberately
released
sars
quarantine
persons
quarantined
onset
nan
sars
hospitalized
late
recognition
severe
ptsd
posttraumatic
stress
disorder
arise
diseases
contact
contagious
disease
quantitative
treatment
strategies
cost
patients
we
nl63
hcov
the
france
respiratory
nan
spb
samples
rna
plasma
gestational
ace2
ang
ii
angiotensin
role
prf
frameshifting
pseudoknots
mechanism
viruses
nan
nan
hcmv
mddcs
infection
cells
dcs
ozone
protease
exposure
influenza
cleavage
protein
rna
rpiseq
interactions
information
sars
cov
patients
100
lung
nan
assay
sars
immunofluorescence
cov
antibody
acute
sars
pneumonia
developed
previously
nan
outbreak
persons
hospital
sars
detected
controlled
outbreak
sars
trials
global
sars
cov
vero
cells
severe
respiratory
sars
we
report
laboratory
sars
cdc
legal
diseases
health
mask
sars
use
risk
n95
sars
cov
using
immunofluorescence
neutralization
fever
in
campaign
sars
households
assay
sars
cov
rt
pcr
household
sars
members
phases
settings
sars
healthcare
cov
contact
droplet
sars
rna
specimens
viral
illness
sars
virus
associated
coronavirus
animals
day
sars
patients
symptoms
fever
nan
sars
early
respiratory
epidemiologic
exposure
sars
made
prevention
during
severe
sars
case
respiratory
epidemiologic
laboratory
sars
cov
case
stool
specimens
sars
we
describe
atypical
presentation
patient
sars
we
acute
respiratory
nan
nan
sars
hospital
transmission
the
severe
sars
caused
coronavirus
global
outbreak
cases
probable
sars
case
patient
sars
infections
reclassification
taiwan
spread
sars
98
methods
cov
serologic
multiple
contact
dates
sars
possible
helmets
respiratory
protection
performance
testing
we
crisis
prevention
management
sars
nan
household
transmission
secondary
severe
acute
sars
cov
on
day
22
sars
outbreak
treatment
patient
during
superspreading
sars
transmission
contacts
vs
sars
patients
clinics
beijing
case
nan
infection
sars
control
protection
equipment
sars
coronavirus
ultrastructural
severe
outbreak
sars
during
2003
severe
acute
sars
specific
serum
samples
obtained
healthcare
workers
sars
patients
cov
nan
students
sars
index
patient
case
fear
infectious
associated
general
public
the
international
18
usa
center
sars
cov
inhibitors
human
drug
patients
sars
case
control
probable
volunteers
oocysts
cyclospora
we
describe
case
cases
sars
patients
epidemic
nan
workers
sars
developed
igg
of
nan
respiratory
sars
virus
patients
in
children
acute
respiratory
rsv
rhinovirus
intervention
ring
vaccination
epidemic
we
laboratory
findings
patients
clinical
sars
specimens
swab
the
stool
yield
nan
sars
patients
contact
occurred
the
sars
cov
beijing
gene
area
sars
coronavirus
injected
intratracheally
chickens
outbreak
hospital
management
second
sars
sars
this
study
found
infrequent
sars
patients
healthcare
transmission
important
excretion
associated
stools
this
study
sars
patients
stool
cov
in
sars
patients
cov
china
specimens
nan
nan
sars
cov
three
real
time
nan
sars
cov
throat
wash
10
nan
sars
cov
murine
models
severe
nan
nan
nan
nan
isolation
control
distribution
outbreak
we
environmental
occupational
health
industrial
hygiene
quarantine
symptoms
ptsd
sars
measures
sars
data
with
cases
severe
samples
reference
inactivated
severe
acute
nan
zoonoses
wildlife
reservoir
many
represent
farms
market
civets
infection
different
recombination
rna
viruses
evolutionary
rates
infection
clathrin
ev7
endosomes
polarized
mrsa
clones
transmissibility
subtypes
data
goats
cphv
inactivated
vaginal
vaccine
sapoviruses
sapovirus
bat
different
analysis
viruses
the
faeces
pig
bacteriophages
ace2
cell
signalling
integrin
expression
cell
ifnα
therapy
hcv
thymic
medicine
tcm
integrative
clinical
achievements
virus
particles
force
the
scanning
poor
working
conditions
associated
risk
sars
patients
protein
days
serum
nan
health
the
sars
public
interventions
nan
nan
nan
nan
rsv
bac
vaccine
protective
responses
pi
the
virus
day
days
pneumonia
the
patients
children
underlying
droplets
cough
aerosol
number
size
cells
interactions
virions
bacteria
the
management
pandemic
issues
included
practice
viral
cellular
kinases
kinase
infections
non
pathogenic
immunity
vgc
lm
hiv
kn2
anti
peptide
scorpion
immune
philippinarum
the
large
454
cough
maximum
10
airflow
detectable
sars
vaccine
cov
virus
vaccines
influenza
meteorological
hazard
the
conditions
synthetic
biology
data
scientific
policy
schizophrenia
proteins
genes
pathogens
gene
inflammatory
responses
p2x
infection
viral
transmission
risk
hcws
procedures
agps
wbph
viruliferous
srbsdv
infection
rice
factors
disease
the
climatic
density
apmv
old
serotypes
replication
types
tmprss2
human
influenza
hat
sars
codon
pcv
usage
synonymous
patterns
denv
diii
db32
virus
therapeutic
cells
cd8
role
leishmania
infections
immune
species
macroevolutionary
phenomena
host
knowledge
poultry
study
workers
high
ibv
proteins
virus
chicken
ck
patients
viruses
viral
npa
infections
protein
the
topology
virus
secretory
virus
bats
paramyxoviridae
human
livestock
centroid
12
ring
bound
benzene
hiv
phage
display
host
immune
cea
medi
565
splice
variant
ifn
antiviral
might
based
signaling
protein
the
membrane
assembly
functions
species
immunodeficiency
virus
disease
several
ifn
viral
type
pathways
host
dgfw
ev71
dried
genkwa
sieb
proteins
coronavirus
entry
cell
membrane
hcov
respiratory
specimens
virus
positive
sfi
hf
routine
treatment
heart
felv
fiv
cats
malaysia
368
tb
integration
china
hospitals
health
influenza
pandemic
2009
new
swine
models
concerns
data
pandemic
policymakers
ferret
response
the
model
genes
vp8
sia
hr
cell
attachment
cys
disulfide
il
cd132
183
vs
nebulized
salbutamol
symbicort
patients
cpr
professionals
attitudes
nurses
healthcare
evolutionary
biology
medicine
medical
health
virulence
parasite
host
optima
invasion
nsp13
rna
sars
cov
we
iltv
infection
vaccine
host
virulent
sars
bats
bat
related
assay
infection
hcv
001
occult
patients
hr
potency
viral
virus
cholesterol
kd
sign
dc
rs4804803
cal
kd
cd40
cal
polymorphisms
disease
kshv
ubiquitination
mediates
cells
proteasome
mice
ifit2
vsv
wild
type
cd200r
infection
tlr7
cd200
clearance
gii
vlps
nvb
vlp
blockade
protein
type
gadd34
sensing
cells
rov
asp
vaccine
responses
adjuvant
rrna
cleavage
don
kinase
rna
assay
influenza
detected
plex
id
uspio
rabbits
dm
dose
atherosclerotic
sars
gallate
rna
oligonucleotide
cov
denv
lcta
949
virus
replication
viral
infection
infections
viruses
common
cfr
method
estimating
influenza
response
nan
screening
influenza
airport
entry
h1n1
enterovirus
human
acute
respiratory
tract
virus
bats
evolution
virulent
respiratory
levels
interleukin
day
illness
onset
hcws
positive
frontline
care
risk
nan
ace2
urinary
levels
patients
protein
ifn
hcv
vγ9vδ2
cells
phag
zoonoses
wildlife
worldwide
public
health
wnv
tight
virus
infection
cells
h5n1
avfluigg01
ha
virus
epitope
epitope
mapping
peptides
the
web
copd
smokers
the
tnf
13
autophagy
pathway
structures
catabolic
eliminate
respiratory
infection
causes
viral
lung
hospitals
highly
resistant
control
infection
hbov
children
jamaica
human
caribbean
fluke
liver
vaccine
gst
sigma
ri
cases
case
patients
sari
virus
infection
recent
immunity
respiratory
tb
active
patients
ltbi
symptomatic
respiratory
viruses
acute
infection
95
mortality
morbidity
the
production
calves
pol
rt
pcr
enzyme
3173
hbv
genotype
recombination
co
infections
lbms
traders
poultry
vietnamese
cambodian
rna
madp1
using
ibv
synthesis
we
conducted
survey
928
new
exercise
quarantine
day
table
top
respiratory
community
hygienic
measures
various
antibody
sars
neutralizing
week
weeks
antimicrobial
future
at
beginning
21st
wildlife
understanding
emergence
zoonotic
human
nasopharyngeal
viral
load
sars
patients
sars
restaurant
palm
civets
cov
disease
we
multihost
emergence
host
novs
porcine
gii
swine
human
emerging
reemerging
pathogens
zoonotic
likely
nan
dengue
ast
alt
severe
dhf
h1n1pdm
il
infection
severe
disease
psg16
receptor
mhv
expressed
the
immunogenic
proteins
expression
method
potential
brain
inflammatory
monocytes
neutrophils
infection
ifn
hhv
6b
responses
th1
infection
disease
course
clinical
animal
sp
innate
cell
proteins
collagen
cells
fusion
stem
myocardium
mscs
ppar
agonists
dual
novel
drugs
ibv
nsp2
group
coronaviruses
protein
workers
healthcare
risk
occupational
death
veillonella
microbe
spp
rarely
cause
sars
cov
rbd
effective
safe
samples
using
clinical
patients
severe
sars
hcws
exposed
asymptomatic
we
wildlife
trade
disease
outbreaks
species
emergency
icms
hospitals
departments
large
sfv
transmission
human
virus
macaques
pandemic
influenza
would
we
estimate
infectious
response
emerging
pregnant
women
nan
pregnant
women
infectious
disease
outbreaks
nan
nan
scoring
pca
compounds
chemical
bace
treg
cells
cell
immune
infection
term
epidemic
meaning
given
the
suis
infections
reported
all
backyard
valley
fever
cap
persons
without
nan
patients
human
bocavirus
detected
18
nan
nan
hcov
hku1
respiratory
children
identified
changes
diseases
important
global
animals
food
vacuole
pfcrt
chloroquine
parasites
cells
amphiregulin
cell
cytokine
synthesis
sa
binding
ha
receptor
gal
nan
estimates
pandemic
icu
influenza
capacity
control
infectious
diseases
conflict
situations
students
medical
to
assess
knowledge
sars
human
hcovs
detected
hcov
contacts
77
risk
measures
high
coronaviruses
feline
viruses
tropism
replicate
timeliness
governmental
infectious
disease
outbreaks
patients
to
identify
unknown
human
health
ihr
the
global
goals
virus
lynx
cowpox
opv
humans
influenza
absenteeism
caused
illness
ili
smallpox
whether
antiviral
drugs
destruction
nan
liver
infection
antiviral
mcmv
unc93b1
rhdv
orf2
disease
genome
codon
filoviruses
outbreaks
viruses
mortality
rates
flies
assay
the
pools
vectors
interstitial
pneumonia
fibrosis
infection
unclassified
etiology
patients
copd
techniques
respiratory
np
chicken
cell
epitopes
peptides
influenza
criteria
poisson
estimate
selection
american
culture
native
frequencies
230cys
lipid
rafts
protein
signaling
also
pandemic
2009
ili
passengers
seats
adem
hcv
acute
viral
infection
nan
hobi
like
virus
in
2010
nan
wnv
encephalitis
in
2007
nonsuppurative
virus
isolated
bat
lyssavirus
natterer
specimens
reovirus
encephalitis
etiologic
agent
nan
nan
hbov1
hbov2
years
the
hbov3
studies
human
immunity
influenza
murine
hiv
infected
double
doses
participants
rsv
receptor
pneumoniae
cam
induced
surveillance
study
disease
two
the
population
we
parametric
size
epidemic
human
function
yeast
hiv
aids
cells
regs
regulatory
immune
cd4
type
interferon
prrsv
induction
porcine
mhv
tlrs
macrophages
viral
infections
biothreat
near
organisms
the
neighbors
mtb
mycobacteria
our
comparative
analysis
tlr9
ebv
bl
cell
cells
ali
ards
clinical
acute
injury
pregnancy
we
infection
levels
anti
apc
pul21a
hcmv
viral
virus
traf3
golgi
sec16a
p115
mavs
proteins
interactions
cellular
viral
potential
nan
spreading
network
airports
connections
cities
cellular
htlv
drosha
rnai
viral
hiv
dc
sign
transmission
infection
hev
infection
mice
encephalitis
model
virus
gene
vigor
file
features
env
protein
retroviral
incorporation
gag
antibodies
igy
gondii
immunized
yield
hospital
administration
you
your
costs
proteins
pegylated
mmc
map30
activities
animal
virus
interactions
ibv
infections
host
cell
fusion
coronaviruses
protein
rna
stool
rrt
pcr
enterovirus
rates
difficile
reporting
public
infection
synthesis
secondary
medicinal
plants
induced
pe
patients
analysis
in
gene
rna
viral
translation
ires
aons
trna
rna
splicing
ligases
the
fdg
ct
imaging
18
dpi
antibody
antibodies
clinical
methodologies
new
hunov
simvastatin
treated
ifn
pigs
health
gis
use
this
paper
fipv
csa
pathway
nf
at
hepatitis
image
see
text
dynamics
sftsv
disease
infection
cytokine
patients
hbov
samples
gastroenteritis
cases
hbovs
influenza
tiv
recipients
risk
non
the
functions
structural
enzyme
also
ebc
using
exhaled
breath
method
nurses
vaccination
knowledge
risk
vaccinated
antiviral
jev
indigotica
virus
infection
bncs
zz
dcs
antigens
vivo
infection
virus
asfv
caspase
er
nef
mhc
μ1
protein
the
disease
astrocytes
cns
signaling
ifn
prp
sc
conversion
process
two
virus
two
nidoviruses
new
family
mammalian
viruses
inactivation
photodynamic
bacteriophages
virus
lectins
inhibited
protein
hpiv
hiv
virus
transmission
topical
carbohydrate
microvesicles
viral
microvesicle
virus
infection
immune
vte
expressions
the
genes
antibodies
hiv
bnabs
could
effective
receptor
cell
binding
cov
apn
viral
influenza
virus
proteins
required
chv
hcv
ns3
4a
the
human
viruses
diseases
respiratory
detected
cryptococcal
meningitis
fcgr2b
232i
patients
il
10
infection
liver
cells
proteins
ndv
cellular
associated
particles
cases
dhf
concentrations
mbl
df
nan
pedv
diarrhea
rates
in
2011
infectious
transmission
research
disease
organ
methods
the
rtis
simple
regression
infection
respiratory
tract
dpi
peaked
regulation
molecular
lymphocyte
autoimmune
our
malaria
proteins
serum
fm
vm
health
experimental
influenza
work
public
autopsy
coronavirus
lupus
hku1
months
mice
aging
research
lesions
diseases
antibody
new
responses
infectious
profiling
cells
il
17
cd4
ifn
prf
frame
signals
ribosomes
reading
viruses
disease
ibd
arenaviruses
snakes
c003
c052
btv
50
the
bacterial
non
infection
therapy
bal
afop
the
pattern
uctd
organizing
cells
ccsp
clara
cell
stem
cell
protective
vaccines
cd8
responses
respiratory
group
cough
infections
aris
hiv
array
virus
viral
pcr
tcdc
toxin
difficile
expression
genes
ifnα
oligodendroglia
microglia
viral
infection
lung
bmp
epithelial
development
pathway
ort
h9n2
virus
broilers
co
ifitm
two
genes
ifitms
cell
swine
flu
patients
pneumonia
developed
control
vector
disease
barangay
local
denv
infection
ifn
production
activation
studies
polyparasitism
field
ecological
multiple
health
improving
public
one
this
mscpv1
papillomavirus
novel
bat
the
species
human
viruses
virus
humans
surveillance
emerging
disease
capacity
endemic
human
wildlife
health
disease
emergence
the
report
cryptosporidiosis
combination
present
contact
tracing
we
investment
disease
transmission
animals
2009
wildlife
domestic
np
dsrna
lassa
exonuclease
substrate
hpiv
hpivs
beijing
china
two
genetic
populations
cordata
china
analysis
analysis
radix
isatidis
quantitative
the
hbov1
cell
human
study
genome
health
care
communication
case
new
ards
patients
help
early
associated
ev71
important
pulmonary
edema
immune
felv
cats
duration
versifel
age
swine
rebov
sera
infection
2008
minibody
h1567
tumor
aav8
ctcl
infectious
burden
disease
health
diseases
pcv2
associated
spp
10
porcine
hiv
controls
dc
signr
infection
ppe
use
influenza
compliance
care
ifitm3
ifitm
iav
mice
type
infection
clearance
brucella
tlr2
myd88
isothermal
development
pcr
dna
use
hand
hygiene
program
compliance
healthcare
reference
pathogens
national
microbiology
laboratories
respiratory
viruses
human
virus
parainfluenzavirus
ev71
sirnas
highly
specific
modified
dystrophin
pmo
activity
peptide
heart
rotavirus
aspalathus
linearis
antiviral
burm
laboratory
h5n1
air
virus
influenza
asthma
respiratory
viral
infections
trigger
influenza
virus
respiratory
2009
viruses
hbov
respiratory
patients
strains
pcr
infectious
non
sore
throat
the
ph1n1
nirvs
co
influenza
virus
ngal
coronary
patients
serum
inflammatory
nan
serine
hydrolases
abpp
enzymes
host
arapan
the
assembly
assemblers
genome
susceptible
time
image
see
text
electron
phage
the
microscopy
digital
suicide
charcoal
burning
temporal
sex
nf
κb
nsp2
prrsv
activation
sequences
clustering
dna
method
new
effects
clinical
we
products
chronic
flotillins
expression
flotillin
increased
growth
the
performance
samples
vidisca
454
nss
rvfv
truncated
ifn
aa
clinical
herds
the
norwegian
pig
influenza
deaths
type
2010
condition
the
model
policy
pandemic
mitigation
m2e
vaccine
tetra
virus
constructs
uris
cvt
e002
mg
adults
pandemic
influenza
high
risk
health
outbreaks
h5n1
studies
avian
influenza
herds
virus
2009
pigs
surveillance
ibv
s1
qx
like
virus
vaccines
influenza
swine
heterologous
two
fga
microbial
geochip
genes
many
tcar
family
ssdna
marr
dna
cells
muscle
igg
engraftment
donor
virus
cells
the
disc
hsv
genomics
genomes
organism
genome
complete
sars
cov
infection
ferrets
immune
echinacea
adverse
purpurea
cold
episodes
silencing
rna
vp3
ibdv
antiviral
frameshifting
slippery
sequence
frame
stimulatory
infection
dai
resistant
the
hospital
copd
new
early
clinical
therapies
ali
ards
polymorphism
ace
acute
il
tregs
12
cells
treg
sepsis
tnf
severe
patients
rs1800629
rg
influenza
pcr
flu
amplicons
agr2
binding
aptamer
quadruplex
structure
dengue
cases
screening
imported
program
assay
gexp
sensitive
virus
the
response
cytokine
cytokines
concentrations
inflammatory
hiv
system
surveillance
china
health
flt3l
rapa
allograft
immune
tolerance
receptors
prr
antiviral
response
recognition
renalase
cells
tubule
renal
dna
contact
patterns
contacts
diseases
parameters
diversity
populations
genetic
genetically
host
denv
human
sting
cells
type
aceis
price
drugs
angiotensin
adjustments
influenza
viruses
enteric
positive
patients
il
1β
rvsv
pathology
vaccine
viral
respiratory
infants
illnesses
inner
antimicrobial
peptides
disease
functions
in
lps
oroa
lung
treatment
mg
segments
genome
segment
competition
luciferase
cmv
regs
cells
specific
17
health
public
diseases
global
field
asthma
viral
infections
may
children
influenza
nonhuman
primates
virus
to
kipyv
detection
wupyv
polyomavirus
hr
gold
surface
binding
gbp
electrochemical
chip
diagnosis
microfluidic
immunosensor
using
vlps
vlp
hcv
pam
cys
sting
ifn
rna
fish
rig
hcv
infections
000
employees
hcws
respiratory
human
viruses
presence
healthy
cd200r1
tlr2
hsv
signaling
mice
icu
gene
respiratory
patients
genes
hiv
dihydrosphingosine
fusion
cells
cell
ev109
respiratory
samples
patients
hev
behavior
transmission
cov
peculiarities
distribution
effusions
ace
pleural
ace2
mmp
graminearum
genes
dk21
host
fgv1
gra
ga
rotavirus
replication
treated
virus
antibodies
pdc
immune
neutralizing
cells
infection
er
tick
cell
seed
data
access
genome
annotation
peafowls
gondii
infection
birds
province
nan
genes
reference
expression
the
gene
maxwell
16
samples
system
rna
virus
transmission
aphids
plant
proteins
bsl
risk
to
benefit
ratio
viruses
public
health
assessments
pathogens
influenza
h1n1
pdm09
case
patients
spo0a
difficile
binding
strain
in
hbv
ntcp
receptor
hdv
human
glycosites
two
ha
na
domain
antiviral
niclosamide
host
pathways
use
pfu
ml
pcr
assay
multiplex
gm
toxin
ct
binding
subunit
h5anh
h5pp
mutation
we
h5
rt
lamp
hmpv
assay
primers
pedv
diarrhea
chgd
01
new
rlmm
domain
adomet
23s
rna
19a
pneumoniae
pneumococcal
serotype
infections
postpartum
h1n1
infection
care
pregnant
radv
immunization
administration
responses
mucosal
influenza
asthmatics
ha
host
protease
cells
alpha7gfp
expression
auditory
spiral
alcohol
industry
hong
kong
the
response
ifn
hcv
steatosis
ffa
prrsv
piglets
infection
seldi
tof
tgev
viral
shrnas
orf
gene
health
initiatives
determinants
social
british
ebolavirus
species
reston
virus
china
mhc
class
cheetahs
central
variation
v3
mabs
viruses
antibodies
hiv
aom
viral
bacterial
respiratory
uri
de
novo
genes
gene
selection
preparedness
emergency
events
scenarios
emergencies
hpv
10
high
the
test
vaccine
f4
virus
mv1
clinical
a33
mab
1g10
vacv
epitope
cough
patients
chronic
lymphocytic
infection
cells
cell
ebov
cycle
infection
outbreak
marburg
virus
in
1967
lassa
virus
fever
patients
humans
arenavirus
viruses
developed
assays
vhfs
np
arenaviruses
viral
major
arenavirus
hcv
infection
chronic
liver
cellular
crystallography
fragment
screening
based
drug
multiple
sclerosis
clinical
disease
neurons
ebv
npc
infection
animal
we
swabs
self
collected
participants
staff
virus
frameshifting
genes
programmed
expression
gene
cancer
lung
asbestos
risk
virus
cells
genes
influenza
gene
ul44
hcmv
viral
dna
sumoylation
tat
hiv
nucleolus
nucleolar
proteins
er
sec63
the
membrane
function
ifitm
genes
vertebrate
family
ifitm10
host
could
responses
viral
cellular
strains
novel
similarity
bacteriophages
knowledge
health
emerging
ebola
virus
research
human
toward
current
development
studies
neutralizing
evasion
response
viral
pathogens
method
si
cases
initial
confirmed
frameshifting
programmed
ribosomal
results
indels
planning
preparedness
emergency
adini
et
pandemic
knowledge
measures
campaigns
media
bhv
apoptosis
mdbk
cells
activation
influenza
virus
infection
severe
seasonal
influenza
viremia
patients
respiratory
overall
virus
viral
rabbits
outbreak
one
qx
like
the
strains
ibv
patients
respiratory
hct
detected
human
expression
cell
strains
antigen
recombinant
ifn
oral
treatment
group
patients
hmabs
sars
cov
antibodies
bind
epitope
rev
gp90
cell
mab
entry
ezrin
fusion
membrane
endodomain
hmpv
pneumonia
infection
patients
solid
astrovirus
wild
the
respectively
study
orf2
nf
κb
protein
p65
vaccine
lbsap
levels
experimental
infection
h1n1
human
changes
influenza
time
domain
swapping
3d
disease
enrichment
phe
immunochromatographic
cov
strip
detection
influenza
self
defined
ci95
burden
resource
health
the
care
available
transmission
infection
smallpox
mode
the
hcov
emc
2012
coronavirus
genome
snu8067
km91
virus
test
genes
felv
cats
fiv
infected
cause
hmpv
crv
infection
mixed
virus
proteins
virus
sars
cov
the
coronaviruses
hcov
known
sars
new
analysis
sequence
coronaviridae
human
pathogens
rna
replicative
structures
replication
membranes
immune
cyst
brain
response
chitinase
ii
ml
disease
infant
skeletal
dad
acute
the
interstitial
pneumonia
influenza
vaccines
in
pandemic
efficacious
respiratory
patients
pathogen
virus
detected
dual
use
concept
life
sciences
mannose
binding
lectin
deficiency
acute
microglia
activated
since
many
diverse
different
typhimurium
characterized
salmonella
isolates
malaria
plasma
syndromes
childhood
proteome
dogs
cats
animals
welfare
2010
prrsv
hp
transcripts
rjxwn06
vr
ectodermal
time
organ
fgf
epithelial
structure
rna
prediction
dotknot
pw
mask
coughing
distances
respectively
air
defensins
tnf
il
leukocytes
several
hcv
vesicles
mw
membrane
rna
ebov
catb
catl
zebov
replication
lyc
lnes
oa
the
lycorine
wildlife
reports
trade
illegal
traded
pic
cell
airways
in
dsrna
eds
ed
public
private
care
pandemic
regions
influenza
2009
chile
rna
viruses
fidelity
virulence
exon
centers
referral
level
hids
the
protein
pedv
epitope
the
mcab
rev
nullbasic
redistribution
crm1
hiv
viruses
respifinder
pcr
19
samples
gateway
tm
vectors
cloning
multisite
viruses
detected
pneumonia
human
virus
cdv
dog
slam
strains
cells
proteins
cell
regulated
host
cells
vaccine
prrsv
nanoparticle
in
viral
eids
advances
years
emerging
microbial
sars
hcov
emc
cov
human
cells
nrf2
virus
atii
iav
antibodies
animals
antigen
specific
cells
kcnq1
kcne1
hcp
lqts
channel
surveillance
health
population
process
the
ptx3
proteins
pentraxin
role
inflammatory
kiom
198
antiviral
pedv
diarrhea
sgp
gp
ebov
host
virus
respiratory
viruses
detection
automation
nucleic
techniques
nucleic
acid
clinical
amplification
patients
the
infection
lung
zones
h1n1
infections
co
children
the
trex1
ifn
genes
antiviral
isgs
entry
retroviruses
cell
endosome
acidification
hcv
hepatitis
rvv
mice
chronic
ari
krg
vs
the
placebo
pertussis
infants
household
vaccination
the
gene
clinical
human
disease
expression
nan
respiratory
carv
carvs
infections
patients
sequencing
lofreq
variants
population
datasets
hiv
trx
disulfide
infection
entry
foci
buho
the
formation
proteins
spp
the
nd
ib
ai
gp
cells
cell
viral
host
human
humans
virus
response
important
coronavirus
autophagy
cellular
membrane
rna
brsv
virus
the
epidemiology
disease
acov
coronavirus
hcov
229e
alpacas
prrsv
pcv2
ams
infection
inoculated
responses
restv
antibody
non
human
case
syphilis
pleural
effusion
review
data
h3n2
phylodynamic
incidence
antigenic
er
upr
proteins
pathways
stress
depression
alleles
risk
human
genome
activity
phenanthroquinolizidine
alkaloids
tmv
the
cwe
lps
tnf
anti
vitro
2006
2009
hiv
condom
use
kd
viruses
respiratory
rt
pcr
hbv
sihsc70
protein
egfp
cells
cases
imported
h1n1
the
we
names
proposed
nomenclature
genetic
virus
caspase
lpqh
activation
death
mitochondrial
clones
v3
phage
selection
antibodies
veterinary
research
gaining
importance
economic
cpg
cats
viral
antiviral
feline
lycorine
cell
cycle
cells
hdac
cmv
disease
hiv
patients
mbl
influenza
household
transmission
ili
vaccine
viruses
respiratory
viral
infections
lrti
iga
serum
bats
antibody
igg
faecium
cells
swiv
probiotic
influenza
host
samples
the
population
sequencing
mucosal
the
surfaces
via
vaccine
influenza
signaling
proteins
viral
pathways
papers
ml
hk
tw
published
influenza
h1n1
stress
the
university
ptx3
immune
innate
immunity
the
cells
nk
cell
viral
virus
263
13
ha
h5n1
neutralizing
upr
fold
aav
pathways
perk
gene
therapy
herpetic
keratitis
ocular
sbv
virus
developed
experimental
study
respiratory
bacteria
viruses
may
upper
control
dogs
test
cystic
echinococcosis
ldh
radiodermatitis
isozyme
early
diagnosis
bat
reservoir
paramyxoviruses
viral
bats
ifn
isg56
ifit1
piv5
cells
vectors
bacterial
viral
pathogens
safe
rna
viruses
translational
mrnas
cellular
nhar
tb
patients
disease
time
symptom
patients
cold
group
duration
sch
ili
fri
schools
school
lrti
pediatric
hospitalizations
age
infants
fiv
felv
factors
distribution
infections
cleavage
apmv
site
pathogenicity
protein
switching
patients
prescribed
thiazide
antihypertensive
public
contact
direct
indirect
presumed
cell
cd4
b7
h1
cells
respiratory
episodes
viruses
infections
patients
viral
human
hcov
emc
the
study
illness
childhood
hospital
the
virus
getah
gene
the
method
gue
diarrhea
rotaviral
antiviral
small
rna
mzp
hce
guanylyltransferase
mizoribine
pcr
primers
set
viral
degenerate
hps
infections
may
infectious
infection
hbov
respiratory
detection
viruses
12
tgev
hym
09
the
gene
emc
hcov
receptor
sars
cov
hiv
gbv
e2
peptides
gp41
cxcl14
expression
carcinoma
colorectal
assay
malat1
lung
loss
associated
nuclear
aavp
tumor
proteasome
phage
cancer
dpi
the
significantly
influenza
saa
epitopes
drips
source
positional
bias
fusion
ifitm
membrane
viral
proteins
infectious
transmission
particle
airborne
particles
respiratory
children
infections
the
detected
yn
ibv
chickens
lesions
china
disease
network
health
surveillance
mbds
mecids
infectious
disease
international
revised
nan
rescue
virus
cells
fusion
transfected
quarantine
public
diseases
use
in
patients
encephalitis
case
patient
exposure
children
outbreak
severe
orphanages
hospitalized
clinical
public
health
information
the
hbov
patients
bocavirus
children
respiratory
glycyrrhizic
acid
the
method
phase
pedv
protein
the
cell
il
hpiv
patients
positive
clinical
respiratory
virus
derived
cns
inflammatory
monocyte
bodies
viral
host
virus
pvx
surveillance
q2
coefficient
genomic
influenza
changes
hiv
infection
micrornas
rna
influenza
vaccination
group
poland
rate
dc
hiv
gp120
sign
apoptosis
cells
tii
ti
il
alveolar
translation
virus
utrs
viral
utr
polymerase
sequence
species
structure
protein
frameshift
structure
efficiency
the
site
pcd
patients
ciliary
analysis
quantitative
m2
channel
drugs
assay
amantadine
receptor
hepatitis
following
successful
cloning
infection
chinese
influenza
genotype
severe
control
neighbourhood
social
contacts
individuals
cypa
influenza
virus
replication
main
genomic
rna
frameshifting
differences
sequence
iav
influenza
ha
entry
pandemics
cystatins
cystatin
family
ii
role
membrane
proteins
model
reconstitution
activity
infection
co
parasites
helminth
within
contact
heterogeneity
data
population
structure
mabs
diseases
drugs
current
infectious
hcv
ifitm1
ifn
infection
interferon
health
uae
public
population
2010
rvsv
rabv
vsv
anterograde
recombinant
autophagy
cellular
proteins
autophagic
processes
influenza
viruses
virus
ok
human
anaesthesia
rabbits
kg
bw
induction
fcov
type
feline
cats
cell
kda
nonstructural
proteins
the
coronavirus
cells
dc
sign
dendritic
pathogens
agps
h1n1
2009
risk
rna
cells
chloroquine
dengue
virus
vero
hlh
hemophagocytic
lymphohistiocytosis
aggressive
inflammatory
ifn
viruses
receptors
type
interferon
hcov
emc
hae
type
ifn
hcv
new
das
lfia
strip
hcv
curcumin
inhibited
protein
heme
suv
18
fdg
pet
uptake
respiratory
viruses
infections
virus
newly
cyrtomium
fortumei
smith
compounds
tumor
374
sars
s366
cov
ifn
common
cold
iota
symptoms
nasal
rna
loop
sars
stem
cov
subsets
cd4
cells
effector
lung
bocavirus
bocaviruses
species
canine
liver
travel
restriction
pandemic
air
influenza
infectious
bronchitis
ibv
virus
the
data
study
tracking
scale
activity
persistent
digestive
disorders
diagnosis
pathogens
synthetic
new
organisms
genomics
biology
respiratory
surveillance
outbreak
rapid
pathogens
nan
methods
reproduction
number
generic
estimate
a2ntd
monocytes
tumor
receptors
atpase
sampling
particle
mineral
oil
min
influenza
hospitalized
persons
sari
years
hbz
htlv
ham
tsp
patients
disease
virus
genetic
variation
host
virus
proteins
membrane
enveloped
release
vaccine
development
sars
rbd
cov
ms
disease
cns
pathogens
molecular
mhv
protein
nsp3a
nonstructural
nsp
pkr
trna
activation
transcripts
modifications
china
sequence
porcine
epidemic
diarrhea
ring
mol
ecules
the
independent
human
case
virus
cases
methods
cd8
mtb
cells
10
infection
transmission
heterogeneity
hosts
typhoid
disease
viruses
1a
cr
virus
replication
polyethylenimine
tlr5
radiation
dose
mediated
nan
vaccine
development
epidemiological
determinants
successful
rule
based
classification
high
performance
viral
rna
samples
methods
sequence
protein
mimetics
the
hairpin
design
hpv
gammapapillomavirus
divergent
human
genome
panad3
influenza
studied
pan
vaccine
immune
response
inhibitors
pathogens
host
events
extreme
water
weather
outbreaks
kshv
falciparum
co
host
malaria
unfolding
domain
swapping
proteins
the
rapidly
data
sequence
pandemic
threat
we
nols
nucleolus
nucleolar
noa36
viruses
influenza
respiratory
car
detected
treg
asthma
cells
frequency
children
respiratory
co
hrv
lrti
viruses
brv
rt
lamp
bovine
specific
sequencing
viral
within
mutations
rare
nkp46
nk
cells
high
in
optimal
phylogeny
formula
see
text
cases
the
sars
virus
coronavirus
nan
dynamics
bats
pathogen
may
host
genes
de
prrsv
pathways
system
patients
influenza
ari
jia
ili
tgev
pedv
s1
specific
pires
diarrhoea
reduce
ors
acute
mortality
parvovirus
fplv
the
wild
viral
cells
retroviral
lentiviral
dendritic
vectors
mice
amd
immunized
macrophages
ipm
vp40
drug
inhibitors
ebolavirus
rna
vcr
oa
sme
drug
submicron
cancer
icamp
inflammatory
genes
up
rna
recombination
viral
viruses
mechanisms
hz
frequency
ciliary
ependymal
beat
lps
the
cell
exposed
bronchiseptica
cholera
knowledge
oral
the
in
hfmd
activity
infection
ev71
cva16
strains
china
pedv
central
15
hcovs
age
stool
np
children
tnf
cancer
ssd
nf
cells
proteins
cell
baculovirus
insect
vector
tim1
ps
virus
infection
proteins
nec
group
diagnosis
transfusion
the
κb
nf
host
signalling
the
aom
ldh
concentrations
uri
complication
genome
hadv
the
strain
isolated
or
95
ci
severe
36
influenza
png
the
countries
compared
maximum
derived
sneezing
breathing
the
ev71
virus
poliovirus
antivirals
molecules
mbl
infection
ebov
immune
low
pvax1
group
vaccine
dna
chickens
health
public
approach
outbreak
process
users
surveillance
disease
systems
interface
spatial
time
algorithms
series
outbreak
timeliness
gap
countries
health
development
cop
motifs
recognition
lysine
retrieval
coat
10
2013
doi
published
health
global
competencies
uk
curricula
env
incorporation
fip1c
hiv
onto
nan
nps
dna
legumain
oral
delivery
infected
pulmonary
inflammatory
calves
mφs
brain
ccr5
response
leukocytes
immune
neurons
brain
infection
gcn
susceptibility
bas
combination
optimal
berberine
interactions
mobility
within
human
urban
disease
biojector
dna
delivery
needle
rad5
nsp1
virus
mhv
mutant
important
nk
cells
responses
organ
specific
betaretroviruses
species
endogenous
βervs
range
severity
patients
disease
viruses
mild
aurea
sequencing
high
analysis
genes
co
infection
respiratory
ph1n1
patients
gene
cats
fip
fcov
samples
vectors
closterovirus
important
host
plants
human
hcov
emc
use
coronavirus
vaccines
diseases
veterinary
pathogens
vaccine
diseases
many
vaccination
improvement
medical
diabetes
agonists
dual
drugs
compounds
cells
membrane
virus
rsv
plasma
avnv
kb
the
oshv
two
response
immune
pig
prrsv
analysis
model
observable
symptomatic
illness
vaccination
proteins
ubiquitin
trafficking
cellular
regulated
ceacam
psg
genes
domain
in
ceacam1
palate
palatal
fusion
mice
hepatitis
patients
virus
viruses
sequences
tbi
sport
related
major
hockey
ncov
interferon
α2b
ribavirin
coronavirus
mp
12
rmp12
nss
cells
hfmd
rt
pcr
assay
hev71
epidemic
diarrhea
pedv
strain
js2008
disease
emerging
emergence
events
framework
species
new
viruses
host
changes
nan
emerging
sars
viruses
vaccines
virus
hcov
emc
batcov
hku4
hku5
nan
vector
hong
kong
he
patients
disorder
viral
viruses
genome
disordered
viruses
bat
contigs
26
698
genotypes
ctv
major
little
within
h1n1
influenza
cross
1947
past
may
dengue
fever
many
this
lbw
newborns
nbw
genes
compared
zebov
pigs
lungs
cells
severe
nan
ml
9g
dnachip
biomarker
concentration
antibodies
scfv
could
a4
hck
techniques
influenza
infection
h1n1
virus
hcv
21
mir
ifn
type
rig
antiviral
ppprna
response
rna
the
airborne
disinfectants
poliovirus
dried
chloroplast
genomes
genome
complete
analysis
sars
cov
studies
cell
responses
nan
nan
pneumoniae
mycoplasma
methods
patients
positive
gi
iraes
expression
treatment
irae
ang
angiotensin
ischemic
stroke
ii
approach
this
based
in
modern
felis
hepatozoon
feline
cats
infected
nsp1
host
sars
cov
mutants
frameshifting
hairpin
site
unwound
upstream
influenza
virus
tree
infection
gal
baicalein
asthma
airway
injury
features
ace2
renal
db
urinary
shedding
hbov
respiratory
hbov1
high
co
health
care
idsr
dsn
forms
aih
pbc
cyclosporine
liver
patients
s1
the
100
like
new
ab
viral
infections
well
asc
pathology
ugt
chlamydial
mice
cd8
risk
factors
studies
severe
alri
alri
hospitalized
viruses
severe
one
population
density
threshold
districts
the
image
see
text
transmission
chain
nan
denv
rna
motifs
regions
pseudoknot
influenza
patients
h3n2
higher
2012
interventions
ed
hospital
high
sources
age
we
model
mixing
epidemic
nan
virus
pp2a
h9n2
p38mapk
tnf
mdms
expression
cells
inflammatory
receptors
science
private
political
interests
routinely
2009
ph1n1
gabon
active
surveillance
dogs
dogcv
circovirus
detected
19
strain
difficile
piglets
ribotype
078
lyssavirus
bat
new
tentative
lleida
2012
genome
virus
betacoronavirus
sequencing
bats
272
emc
2012
we
hbov1
rtis
mrna
children
dna
nss
cells
degradation
infection
cultured
trna
mrna
ribosome
downstream
structures
nan
zinc
disease
humans
deficiency
cell
respiratory
group
adult
patients
infection
curn
tnf
lung
cells
curcumin
rna
granules
viruses
bodies
roles
disasters
mcis
incidence
the
mortality
s2m
the
genetic
element
mobile
children
pneumoniae
asymptomatic
symptomatic
the
aris
136
patients
human
respiratory
nan
patients
herpes
zoster
dermatomyositis
polymyositis
patients
may
infected
microorganisms
colonized
response
vaccination
immune
sag1
adsag1
ili
respiratory
viruses
zhuhai
patients
hcv
liver
infection
transplantation
re
hla
ligands
antigen
cell
responses
nan
cbf1
csl
viral
cells
rta
cell
death
t3d
reovirus
cells
vaccination
high
risk
group
pandemic
ibv
strain
isolates
ck
ch
research
rapid
health
relevance
traditional
porcine
vp6
prv
virus
expressed
bat
eblv
species
colonies
seroprevalence
assembly
vlp
sars
cov
virus
hiv
platelets
infection
platelet
cells
patients
respiratory
influenza
viruses
ili
model
lattice
contact
individuals
age
receptors
like
autophagy
molecular
pattern
rna
interactions
genome
long
structure
protein
oligomerization
the
structural
viral
hcov
emc
sars
cov
host
influenza
mir
avian
infection
expression
exosomes
cells
proteins
tuberculosis
present
ebv
il
cell
cells
blasts
tfr1
viruses
virus
receptor
we
models
modelling
model
influenza
pandemic
immunodominant
proteins
diagnostic
identify
approach
skin
vaccination
types
well
immunotherapy
ebov
rabv
vaccine
gp
we
e7
a2
cell
hpv16
protein
influenza
data
search
query
activity
influenza
effectiveness
vaccine
inflexal
elderly
strains
pedv
sequences
early
nucleotide
ptx3
cells
role
receptor
innate
surveillance
laboratory
veterinarians
disease
cattle
hospital
wastes
nigeria
study
agricultural
influenza
ips
genomic
strains
related
endothelial
dsrna
synthetic
cells
hpaecs
fq
clinical
trials
this
chloroquine
pomegranate
pomegranates
antimicrobial
activities
including
prrsv
ifn
pdc
responses
type
nan
g6pd
elegans
knockdown
egg
production
health
from
point
view
organisms
m2e
vaccinated
influenza
birds
vaccine
nan
the
new
integrated
nanorobots
application
rcrt
crt
18
412
we
nan
models
dynamics
population
infectious
susceptible
m36
site
epitope
residues
gp120
resveratrol
virus
infection
dev
inhibition
homes
concentrations
water
samples
damaged
health
process
core
public
cf
pathogen
host
population
chance
stochastic
pcv2
genes
response
pams
infection
protein
microarrays
microarray
technology
applications
cpv
giant
panda
phylogenetic
vp2
patients
adem
acute
neurological
virus
dmd
treatment
dystrophin
role
effective
denv
avidity
infections
secondary
nt
pdc
virus
cells
efficiently
infected
dc
sign
e2
erk
hcv
ha
proteins
influenza
insect
cells
acidophilus
pylori
induced
ifn
bmdms
sumoylation
viral
host
pathogen
pathogens
water
hadv
infectious
viral
particles
hcv
bank
viruses
sera
small
poultry
backyard
birds
region
infectious
mabs
influenza
demonstrated
the
h5n1
ns1
jev
epitopes
virus
linear
epidemic
awareness
disease
contact
local
immune
vaccination
strategies
antibodies
nabs
proteins
functions
idps
specific
idprs
disaster
medicine
health
knowledge
medical
door
doors
sliding
isolation
opening
dasatinib
stat1
differentiation
mek
induced
pneumonia
etiology
studies
study
child
use
guidelines
respirator
countries
masks
hrluc
gene
replacement
ibv
infectious
proteins
hocl
protein
altered
idea
gag
boost
prime
nsv
vectors
gb
prrsv
pigs
mineral
effects
host
diseases
pathogen
based
interactions
interventional
proteins
analysis
growth
pipeline
rnase
virus
theiler
oas
pathway
influenza
the
optimization
forecasting
epidemic
virus
bat
duration
antibodies
species
protein
biological
network
networks
important
nan
virus
rhabdomyolysis
reported
associated
parainfluenza
nan
public
health
infectious
laboratories
the
peptides
scorpion
showed
biological
new
receptors
traf
signaling
receptor
trafs
acute
pharyngitis
viruses
ops
nps
bte
hsv
a549
vero
cells
bim
csn8
ups
bcl2
protein
viral
bacterial
infection
infections
positive
snh
mrsa
synergy
isolates
oxacillin
disease
human
cases
in
novel
method
baumannii
detection
molecular
acinetobacter
tbe
mice
virus
infection
production
ag85b
rhpiv2
ad
vector
skin
models
hcai
transmission
methods
healthcare
nan
health
public
disease
threats
global
chloroquine
liver
injury
inflammatory
reperfusion
pandemic
physicians
continue
work
willing
cap
the
respiratory
lrti
study
rhesus
macaques
chinese
haplotypes
class
influenza
vaccination
caregivers
stress
immune
ifn
cns
viral
cells
type
hong
kong
research
response
ph1n1
extracts
influenza
h1n1
etoac
chloroform
microglia
inflammation
infection
mhv
demyelination
respiratory
viruses
neutropenia
neutropenic
patients
signaling
antiviral
1b
crfb1
membrane
hcv
ns3
cdn
protein
activity
mdef201
infections
10
virus
vaccinia
rs3888188
ifitm3
tb
promoter
susceptibility
hiv
dcir
dcs
cd4tl
the
months
12
patients
care
discharge
outbreaks
wgs
investigation
infection
sequencing
mab
discovery
surface
display
full
particle
capsid
viruses
membrane
host
new
viral
scientific
sequencing
methodologies
domains
hepn
systems
rnase
the
control
health
schistosomiasis
system
disease
innovation
health
access
diseases
countries
disease
emerging
infectious
diseases
pandemics
host
surveillance
emergent
infectious
modeling
protective
epitope
based
strategies
mab
patients
norovirus
outbreaks
proximity
serial
virus
replication
csa
cyclophilins
coronaviruses
episodes
concentrations
febrile
findings
microbiological
nan
outbreak
disease
countries
major
national
planning
influenza
public
health
future
influenza
surveillance
virus
h1n1
viruses
vaccination
rvf
epidemic
the
virus
relationships
bats
to
clarify
evolutionary
poxvirus
wildlife
hospital
rehabilitation
center
emerging
infectious
diseases
sars
east
diseases
cases
agent
identification
electron
global
health
world
organization
sars
public
information
needs
media
online
feline
fecv
fipv
fip
furin
mers
cov
middle
saudi
arabia
genome
rna
genomes
regions
size
hcv
gl
anti
virus
release
mass
spectrometry
rapid
microorganisms
provide
rptec
human
cells
pcr
primary
ev71
hong
kong
strains
subgenotype
mucosal
sublingual
pathogens
potential
immunization
infections
tests
laboratory
tissue
tract
bamv
rna
utr
pvx
mutants
apoptosis
nsp4
prrsv
induced
activity
fip
cats
fcov
ii
fipv
rna
rotavirus
rnas
large
cells
infection
aerosol
cryptococcus
exposure
we
fgl2
infection
viral
hcv
disease
cells
respiratory
human
type
hku1
tmadv
marmosets
adenovirus
titi
infection
influenza
prediction
epidemics
ili
peak
ards
hmgb1
reg
cells
lungs
regulatory
respiratory
viruses
virus
infection
protein
two
tmds
region
identified
antibodies
antibody
therapeutic
systems
cell
cells
transdifferentiation
malme
3m
human
ccl2
brain
microglia
microglial
activation
virus
hiv
deoptimized
type
nucleotide
poly
length
tail
hpi
nt
cap
pneumoniae
adult
viral
mycoplasma
ev71
cva16
mice
n3
enterovirus
mucosal
systemic
immunization
responses
immune
ttmv
ly
ppe
pneumonia
cells
bcl
abt
263
infected
iav
membrane
viral
cell
budding
experimental
studies
influenza
research
full
publication
vzv
human
virus
infection
neurons
virus
dengue
mutant
vaccine
methyltransferase
chikv
ls3
synthetic
natural
viruses
golgi
sac1
tm1
localization
the
rt
lamp
h7n9
virus
lfd
cov
receptor
mers
binding
rbd
diagnostic
patients
yield
bal
fob
orf3
virus
pedv
system
viral
disease
mice
mouse
provide
used
pidotimod
expression
tnf
icam
tlr
surveillance
health
public
disease
identify
tnf
mice
severe
fatal
ko
tgev
protein
infection
identified
host
papain
compounds
the
cysteine
50
risk
interdisciplinary
livestock
intensification
health
nnscore
performance
we
docking
vina
across
provinces
transmission
we
spatial
virus
health
questionnaire
participants
the
hsv
ifn
med23
virus
hfs
ns5
mtase
rdrp
the
flavivirus
pedv
diarrhea
united
states
porcine
infection
acetylation
herpesvirus
protein
mechanisms
cyclophilins
evidence
roles
drug
infection
hbov1
family
human
bocavirus
detected
health
global
public
development
infectious
nan
virus
rpv
s29
cydv
the
nis
us
billion
impacts
southeast
cells
nk
gut
iel
infection
pcr
acute
tsutsugamushi
rickettsia
spp
virus
alpaca
sequence
bovine
identify
rsv
reactivity
neutralizing
antibodies
proteins
pneumonia
ari
text
emr
severity
haccp
hpai
poultry
control
disease
pro
replication
catalytic
terminal
specificity
exon
cov
covs
rna
fu
disease
sars
cov
pathways
pathway
membrane
vesicles
double
ability
nsp3
infection
mers
cov
virus
severe
assay
tube
two
respiratory
viral
dna
cs
al
mucosal
nanoparticles
ferrets
viral
virus
viruses
infections
cell
tcr
cells
clearance
interactions
complex
disease
systems
infection
biological
staff
patient
ed
contact
contacts
death
deaths
pilgrims
verbal
autopsy
cov
mers
sars
respiratory
infection
hrv
type
species
sequences
types
dcl
milrnas
marneffei
thermal
dimorphic
cholera
used
models
transmission
historical
children
viral
among
sari
rsv
plasmid
tcda
membrane
anchored
difficile
cancer
colorectal
awareness
warning
level
host
response
specific
viral
kinetics
autophagy
lgg
infection
virus
induced
viral
infection
activation
pi3k
signaling
shigella
isolates
flexneri
beijing
sonnei
virus
viruses
tannins
entry
spread
frequent
increased
patients
exacerbator
phenotype
l1
rtp
vpr
blood
protein
severe
cases
mild
found
virus
16
btv
seg
sequence
strain
diarrhea
2012
the
porcine
epidemic
respiratory
lr05
rsv
lr06
improve
hbv
genotype
gene
hi
replication
viruses
the
bacteria
pcr
overall
myd88
irak
infections
il
immunity
outbreak
social
distancing
outbreaks
media
rna
we
protein
production
co
influenza
test
virus
testing
the
virus
ancient
modern
rev
viruses
drug
igpcr
gpcrs
developed
web
par1
infection
hmpv
viral
could
golgi
large
cargo
in
complex
ubiquitin
ddr
pathways
proteins
like
insulin
peptide
fibrillation
fibrils
the
health
web
medicine
science
internet
novel
specific
covs
using
seq
serial
interval
the
date
symptom
infection
bat
cells
virus
viruses
influenza
new
virus
infection
emerging
therapy
therapeutic
treatment
therapies
cancer
cancer
vaccines
in
immune
tumor
division
cfse
proliferation
based
lymphocyte
virobiota
human
resident
viruses
immune
viruses
viral
estimate
emerging
zoonoses
sequencing
viruses
viral
characterization
strains
coronavirus
respiratory
receptor
novel
middle
spike
binding
sialic
proteins
acid
pedv
strains
gansu
five
new
000
studies
rotavirus
pathogen
diarrhea
species
frequent
human
viral
urban
learning
based
science
number
instructional
antibiotic
resistance
environmental
risk
health
honey
bee
iapv
viruses
the
nan
nan
nan
protein
phosphorylated
coronavirus
sites
the
cd4
cells
viral
cell
responses
sapn
pfcsp
falciparum
protective
sporozoite
children
respiratory
tract
study
care
ceacam1
ceacam5
expression
ceacam6
copd
cultures
feline
fcov
in
strains
mers
cov
pseudovirus
neutralizing
entry
nuclear
chikv
cp
export
virus
viruses
principles
structural
organization
in
canine
type
cpv
2c
the
genotypes
bcov
this
article
reports
hev
the
hrvs
hrv
detection
cats
fcv
fhv
isolated
the
272
respiratory
viral
viruses
infections
asymptomatic
transmission
among
contacts
the
faeces
region
rt
pcr
the
dialysis
could
reduction
plasma
ace2
contacts
contact
hcws
patterns
patients
asthma
virus
respiratory
viruses
infection
delivery
microneedle
drug
transdermal
dissolving
respiratory
patients
severe
hospitalisation
outcome
fusion
virus
viral
class
rvfv
lasv
virus
ml29
expression
lassa
chikv
c9
e2
virus
antibody
il
33
expression
hepatitis
poly
tsl
pandemic
influenza
h1n1
virus
ifn
genes
families
viruses
activity
cov
virus
mers
cdna
rmers
antiviral
potential
host
peptides
virus
step
passive
immunotherapy
used
therapy
patients
h7n9
the
infection
associated
healthcare
insurance
public
china
system
palmitoylation
ifitm5
fkbp11
interaction
bone
bfa
cells
hcv
gbf1
pathway
mhv
demyelination
host
induced
persistent
progeny
proteins
virus
er
golgi
payip3
long
form
frameshift
fruiting
influenza
viruses
surveillance
h1n1
the
cd13
ko
cells
trafficking
inflammatory
disease
ms
demyelination
demyelinating
mhv
cpv
stfr
disease
tfr
anti
viral
infection
respiratory
tract
strains
mat
bbb
eae
effect
expression
epidemic
california
entire
pathogen
analyses
airway
barrier
function
components
tract
children
azithromycin
placebo
hours
nasopharyngeal
np
rad
influenza
vaccine
virus
tlr3
viral
infections
dsrna
virus
host
genes
we
gene
analysis
genome
sequence
fastv
fastv2
we
virus
rpm
pathogens
respiratory
assay
bv
active
the
sample
screening
disease
modeling
time
spread
uncertainties
surveillance
social
media
32
disease
asthma
copd
associated
exacerbation
virus
10
sampling
ligands
targets
method
10
mice
pseudomallei
mallei
infection
the
icd
medical
classification
medicine
eap
h5n1
infection
development
novel
mers
cov
protein
pseudovirions
cells
rna
capped
ifit1
unmethylated
antiviral
viral
human
viruses
transcripts
neuroblastoma
ligand
idps
myc
370
409
intercellular
movement
tumv
myosin
virus
patients
dual
this
article
non
inhibitors
aiv
the
viral
infection
tcssp4
cd
containing
plasmid
immunized
influenza
virus
avian
hpai
egypt
sno
proteins
sites
isno
aapair
health
development
could
phc
major
host
species
pathogen
sites
emergence
wt
apmv
rapmv
shedding
virus
virus
bplf1
nedd8
replication
crls
hev
m102
niv
the
henipaviruses
system
the
information
cholera
response
ibv
infectious
bronchitis
virus
causes
influenza
datasets
thresholds
data
surveillance
fgl2
viral
mice
lcmv
increased
entry
hadv
caveolin
viral
infection
infection
iav
observed
il
sp
hospitals
the
infection
control
nosocomial
or
children
gargling
fever
in
il
35
regulatory
tregs
responses
infection
cells
innate
viral
immunity
wnv
2006
new
utr
two
dogs
canine
cav
samples
blood
hcovs
respiratory
patients
coronaviruses
tract
emus
steroid
collapse
saon
joint
cgvhd
oral
proteins
ms
patients
h1n1
09
expression
compared
children
cov
oc43
incidence
infection
229e
avian
h7n9
patients
contacts
person
social
health
systems
media
support
ha
h7
entry
tbhq
influenza
nan
patients
rsv
infection
co
admission
eif2α
phosphorylation
cells
rapamycin
increased
severe
patients
mbl
sepsis
septic
tracing
contact
criteria
ground
transport
binding
α2
virus
human
h7n9
influenza
virus
gain
of
function
vaccination
nurses
seasonal
influenza
hong
human
cosavirus
infection
patient
novel
nan
nan
nan
genome
fingerprint
set
method
analysis
pedv
strains
the
united
states
rna
er
ibv
membrane
zippered
human
hpabs
cattle
tc
immunoglobulin
viral
genomes
cells
dvgs
immune
chikv
cell
compounds
cells
based
virus
infections
west
nile
transmitted
pedv
fujian
strains
might
vaccine
strains
china
field
homologies
pedv
nan
gastroenteritis
acute
diarrhea
management
major
hiv
human
antibody
gene
gdna
vaccines
infections
immune
responses
conventional
antigen
may
vaccines
nanocarriers
the
nan
fcgs
clinical
long
acting
corticosteroids
questionnaires
questions
outbreak
environmental
disaster
tool
transmissibility
epidemics
number
secondary
rnai
lung
rna
therapeutic
small
g6pd
cells
infection
deficient
bacterial
viruses
virus
patient
viral
discovery
host
virus
interface
respiratory
infection
dcs
antigen
responses
cell
immune
ires
vips
prediction
rna
structure
viruses
influenza
flic
h5
subtype
sirna
approaches
delivery
rna
protein
idsa
including
emerging
diagnostics
in
exacerbations
cause
chronic
viral
induced
surveillance
health
public
future
data
nan
patients
serum
induced
protein
hbv
nan
oseltamivir
sertraline
rolipram
influenza
h1n1
er
e7
response
antigen
sp
drug
design
discovery
process
helping
ypfs
in
immune
macrophages
cytokines
zheng
xu
sepsis
mortality
yang
may
aiv
the
ards
new
mn
manganese
dna
damage
the
changes
aging
population
lung
pulmonary
ndv
gp
ebov
rla
ebovgp
health
treatment
issues
public
animals
health
response
public
acute
incident
patients
95
ci
severe
sftsv
fviii
cells
peptides
dendritic
derived
mers
cov
shells
disorder
oral
cases
patients
years
mers
cov
genes
cells
infected
feline
fip
protein
proteins
the
chpv
viral
sepsis
tlrs
sensing
infectious
diseases
infections
bacterial
viral
respiratory
tract
cells
pos
progenitors
lung
bronchioloalveolar
ifn
usp25
virus
type
induced
sequenced
mosquitoes
viral
previously
related
cap
viruses
samples
infants
children
peptide
the
dendrimer
applications
structure
genomic
host
variants
within
also
diseases
viral
livestock
viruses
virus
genes
36
aging
associated
expression
nanoparticles
uptake
targeting
high
used
coli
equi
isolates
identified
the
nan
markers
disease
many
technologies
these
health
eu
the
opportunity
actions
mr
bleomycin
spironolactone
phenotype
could
venom
proteins
esv
gv
honeybee
pseudoknots
recoding
within
prf
rna
h7n9
virus
viruses
in
pcr
strategies
epidemic
braess
paradox
system
rabies
virus
foxes
samples
present
virus
hiv
transcytosis
specific
igg
endosomal
pathway
virus
ifitm3
the
htnv
assay
pcr
the
10
mds
reactivity
increased
patients
stage
demyelination
chronic
pathways
associated
196
pue
h7n9
cases
surveillance
market
human
infection
bats
virus
the
nan
ifitm3
viruses
chicken
virus
ifitm
virus
approach
genetic
construction
viruses
elr1
eiav
in
equine
receptor
ifn
infection
suppression
antiviral
bacterial
cd4
cell
timp
cns
cells
rsv
rna
hct
serum
multivariable
nan
cold
symptoms
carrageenan
nasal
duration
preparedness
pcps
pandemic
influenza
plan
rna
viruses
manipulation
strategy
within
surveillance
pneumonia
beijing
influenza
virus
closely
we
identified
novel
mink
nan
bats
virus
we
identified
novel
neutralizing
mers
cov
province
we
ttsuv2
codon
usage
ttsuv1
bias
nan
herds
positive
negative
brsv
per
plant
whole
different
the
it
rig
rna
selection
codons
viruses
cineole
bronchitis
patients
days
acute
vectors
dcs
il
antitumor
immunity
scrapie
profiles
ms
groups
prp
post
vaccination
pre
vaccine
children
cpv
dogs
nanjing
samples
2a
ifnλ4
type
interferon
hcv
the
hips
group
fvfg
corticosteroids
patients
cough
maneuvers
etiquette
droplets
recommended
sms
the
applications
mobile
developing
svv
vzv
bac
infection
wt
ci
pregsure
bnp
amor
dam
ivig
sign
dc
allele
variants
pneumonia
708
virus
years
patients
pigs
prrsv
prdc
virus
high
infection
duck
influenza
h5n1
infected
four
hcovs
children
anti
igg
visitors
contact
number
animals
professional
pathogens
eopm
infectious
diseases
large
dv
autophagy
dv2
mice
infected
phylogenetic
method
sequences
could
individual
days
incubation
period
95
ci
hmpv
proteins
virus
formation
protein
feline
fcov
antiviral
assay
peptide
public
health
fetps
fetp
tephinet
samples
h1n1
influenza
2009
virus
h7n9
transmission
human
influenza
potential
rva
strain
k5
k71
g5p
virus
h1n2
like
avian
the
genes
the
reference
expression
alv
mers
cov
protein
588
fc
dogs
three
days
disease
vaccination
npm
allergic
th2
inflammation
mediated
diarrhoea
neonatal
syndrome
herds
new
ben
methylation
endemic
regions
the
mers
cov
dpp4
receptor
long
smith
waterman
library
alignment
fast
disease
results
presented
teff
treg
fraction
hsv
the
compounds
halistanol
ii
ang
hgf
hypertrophy
cardiomyocyte
genetic
vaccine
responses
vaccines
infectious
cnv
samples
canine
identified
strains
nan
cattle
bcov
he
genes
horses
bats
betacoronaviruses
pipistrelle
clade
respiratory
jev
assay
high
antiviral
compounds
influenza
host
cell
viral
spread
nan
data
unni
karunakara
colleagues
discuss
plasmablasts
peripheral
blood
neuromyelitis
optica
extremities
segment
type
viruses
panhandle
gh
sites
proteins
stimulated
phosphorylated
drug
enzymes
enzyme
features
cells
zoo
species
zoos
conservation
cbps
mev
mirnas
infection
mink
viral
network
social
association
bmi
men
leaderless
genome
genomic
bcov
rna
vaca
er
stress
induced
chop
dcs
subsets
mirnas
hscs
regulatory
zoonoses
emerging
ebp
surveillance
systems
pathogens
we
organisms
identification
clinical
tat
crd
hlsectin
expression
proteins
splice
dystrophin
45
exon
site
rsv
children
lrtis
samples
piv
pneumonia
severe
inflammatory
gcs
mediators
mvtt
vaccine
strain
ha
h5n1
cypa
cs
acetylation
cis
trans
drug
the
colonic
release
acid
chik
strain
2012
china
virus
hfmd
patients
il
levels
inflammatory
tb
clusters
notification
two
china
ped
2013
isolate
pedvs
porcine
home
collected
ns
clinic
swabs
small
rnas
rna
viral
infection
et
al
studies
viruses
important
ibv
infection
genes
immune
chickens
tb
biomarkers
the
ms
fibrinogen
mers
cov
rt
the
rpa
early
infant
viral
infection
pdc
clinical
immunocompromised
patients
influenza
individuals
rsv
effective
treatment
respiratory
infection
microbial
innate
immune
system
detection
we
pathogens
repertoire
cells
cross
aptamers
aptamer
viruses
viral
therapeutics
icu
influenza
ili
epidemics
data
outbreaks
model
incidence
health
data
information
health
access
the
respondents
mers
kidney
cov
sars
cells
outbreak
data
china
weibo
social
he
two
lineages
proteins
infection
transmission
markets
poultry
live
human
viral
infections
viruses
diseases
important
niv
group
animals
infection
groups
viral
sirna
sirnas
efficacy
validation
h5n1
egypt
phylogeography
virus
al
expression
ev71
gene
the
cns
cordata
unigenes
high
sequencing
research
care
wearing
primary
patient
doctors
hospitals
cases
tcm
wm
vs
virus
h7n9
public
health
provinces
hsmpd
the
smp
system
database
1h8
epitope
antibody
the
hcv
pneumovirus
the
outbreak
canine
respiratory
data
disease
omic
types
module
p7
cf
channel
protein
proton
imatinib
pneumonitis
therapy
specific
cml
patients
sarcoidosis
nodes
bacterial
lymph
origin
coronaviruses
for
decades
french
age
sex
cr
cynomolgus
thoracic
2009
h1n1
adenovirus
morbidity
likely
mscs
cd13
cells
msc
wt
system
ras
ang
angiotensin
receptor
liver
h5n1
hpai
viruses
virus
labor
mers
cov
strategies
workers
rates
viruses
rna
substitution
cells
quercetin
qgr
qgg
antioxidant
activities
25
serum
oh
viral
confirmed
kd
ivig
genes
disease
acute
luciferase
sirna
lac
expression
administration
tregs
immune
cells
viruses
could
cell
cells
bat
bats
viruses
kir2
degradation
levels
potassium
escrt
copd
p38
mapk
sputum
patients
inflammasomes
dependent
adaptive
infections
recent
cases
survey
tb
prevalence
bacteriologically
indigotica
metabolites
transcriptome
identified
effective
ptov
piglets
diarrhea
20
farms
neuronal
ms
sirt1
loss
disease
nan
hmpv
patients
rsv
positive
respiratory
sars
epidemic
the
areas
comprehensive
igg
rfs
rfl11
fc
isolated
cell
peripheral
ag
cells
survival
ace2
tubular
proximal
cells
ang
indicators
resilience
evidence
disasters
disaster
nan
tb
china
dm
people
republic
replication
fidelity
mosquito
defects
polymerase
viral
expression
gene
mrna
sox
brsv
the
bovine
respiratory
norwegian
dogs
infections
diarrhea
co
spp
pprv
the
rt
pcr
assay
cats
co
infection
enteropathogens
enteropathogen
inflammatory
networks
network
normal
infections
dna
sequences
weight
novel
newly
vectors
field
aavs
vaccination
conducted
hbv
mice
reactivation
recurrence
immunosuppression
respiratory
virus
erv3
samples
detection
iav
amphob
ifitm3
influenza
replication
points
discharge
system
the
brd
candida
antifungal
sm21
effective
spp
2009
train
h1n1
contacts
cases
virus
extract
nigra
ibv
cells
h7n9
guangzhou
information
2013
influenza
host
infection
viruses
controlled
damage
outbreak
pathogen
method
densely
sampled
resting
pbmc
antigen
spot
counts
autophagy
cell
human
viral
infection
ablation
marrow
bone
pth
rats
mers
cov
cell
lines
replicative
nan
ferret
coronaviruses
ferrets
japan
we
sepsis
snps
ifn
associated
clinical
school
closure
effectiveness
cost
influenza
cases
h7n9
burden
the
losses
read
recombination
virema
viral
genome
trsv
virus
host
varroa
mites
patients
floating
local
injuries
migrant
h1n1
pdm09
ch
animals
2008
recognition
glycan
sialic
glycans
the
infection
effects
mice
virus
inflammation
zn
faecium
infection
siv
piglets
viral
viruses
bats
species
diversity
design
response
new
vaccine
vaccines
corals
viruses
wp
diseased
coral
daily
h7n9
april
posted
forwarded
glycyrrhizin
cd31
imc
chimera
patient
bat
bats
injured
respondents
would
prrsv
response
pigs
prrs
vaccine
chmi
volunteer
post
day
falciparum
the
long
distance
travel
travellers
viruses
nuclear
transport
viral
trafficking
homologs
proteins
viruses
methods
we
hiv
viruses
children
infected
uninfected
periodontal
diseases
in
microbiota
concepts
salmonella
public
outbreak
preventive
food
fh
scfv
cml
recombinant
binding
mdro
antimicrobial
organisms
susceptibility
admissions
child
policy
population
transmission
influenza
viral
pathogens
aerosol
the
pathogen
anthracis
strain
ams
two
capsule
respiratory
patients
virus
one
homeless
viruses
enteric
disease
chicken
intestinal
genes
outbreak
ped
the
disease
g4
fs
rna
guanine
these
cypa
protein
diseases
believed
function
nan
rhdv
autophagic
response
expression
infection
animal
environment
factors
may
host
hpiv
patients
clinical
children
similar
influenza
ve
negative
the
using
taiwan
ed
system
10
diagnoses
activators
pg
plasminogen
methods
different
antiviral
glycoproteins
viruses
filoviruses
ebola
71
ev
the
development
antiviral
mers
cov
response
patient
infection
diarrhoea
hiv
patients
virus
infected
animal
passengers
products
illegal
baggage
may
light
cells
viruses
bacteria
global
health
european
agenda
eu
stem
cell
disease
transplant
viral
antifragility
systems
this
environment
example
gene
genes
reference
used
expression
health
one
resources
concept
zoonoses
antibody
hsv
antibodies
human
therapeutic
pig
viruses
piglets
sows
the
wards
observed
they
medical
handwashing
sars
upr
cov
hku1
hcov
influenza
human
spatial
spread
global
virus
df
feline
orf3abc
fipv
denv
antibody
based
assay
neutralizing
anti
review
the
plant
activities
atopy
asthma
the
fcγriia
role
reaction
catalyst
the
derivatives
simple
ah
extract
ns
expression
virus
hadv
14p1
outbreak
among
adults
tcr
expression
specific
cell
infection
antigen
development
ascaris
vaccine
ultimately
pw
100
000
sari
respiratory
proteins
terminus
pnt
virus
originated
nan
health
information
online
congruence
crowdsourced
mnmc
mnmeg
image
see
text
rna
vp5
stranded
vrna
replication
health
public
documents
policy
human
internalisation
myosin
actin
mlck
co
vaccination
decision
making
vaccines
parents
aureus
cons
colonized
molecular
patients
the
infectivity
mmt
clay
viruses
vaccine
virus
andv
vaccination
andes
rnase
ifn
oas
viral
macrophages
camels
disease
mers
humans
transmission
hmpv
patients
lineage
b2
egypt
spp
days
calves
cryptosporidium
eimeria
vitamin
asthma
urti
exacerbations
dose
wssv
shrimp
genes
degs
regulated
codon
chikv
usage
analysis
patterns
rabv
raav
n796
challenged
when
fcov
significantly
higher
purebreds
0001
sensitivity
rotavirus
rt
pcr
ngs
vaccine
leishmania
the
sand
fly
compounds
antitumor
antibiotic
biological
activities
mers
cov
complete
ksa
2012
cpv
2a
vp2
isolates
gene
influenza
giant
pandas
viruses
we
health
horses
humans
human
environmental
vaccination
factors
acceptance
new
children
human
r0
spillover
transmission
influenza
higg
higgs
chain
chains
fully
vrna
segments
cells
assembly
gfp
mhv
am
disease
morbidity
mortality
hcle
nuclear
cytoplasmic
protein
rna
auc
outbreaks
reported
appraisal
models
adult
cells
stem
bm
several
hospitalisation
per
days
2000
2010
aecopd
copd
aeris
acute
exacerbations
proteins
may
infection
contamination
procedure
h7n9
avian
human
response
h3n2
gp1
glycans
glycan
ebov
linked
pip6a
pmo
muscle
activity
cellular
helicase
hel1
the
domain
zbd
mrnas
cap0
ppp
mrna
the
cxcl10
hfrs
htnv
virus
pathogenesis
fipv
circular
tfo
feline
rnas
tb
sites
model
patients
integrated
vaccine
cchf
disease
virus
tick
model
microglia
cuprizone
remyelination
cns
pedv
infection
persistence
co
viral
patients
we
single
nucleotide
polymorphism
evs
treatment
imaging
diagnosis
tumor
secondary
rna
sequences
using
structures
malaria
congenital
cases
china
low
g6pd
individuals
deficient
monocytes
infected
rhtrs1
replication
pkr
cells
agm
hiv
compounds
human
frameshifting
rna
nodes
networks
threshold
layer
network
inhibitors
lead
approach
fragments
fragment
ptx3
lung
mhv
injury
mice
surveillance
health
systems
information
public
nsp11
cellular
cells
genes
cell
migration
diseases
highly
role
rural
socs3
treatment
cytokine
signaling
expression
ifnar1
ubiquitination
type
sa
mice
bat
viruses
infectious
associated
database
prediction
strategy
arima
svms
models
ok
virus
viruses
icv
human
hbv
entry
infection
ntcp
current
sars
daily
ridership
loss
fear
host
hosts
bartonella
bats
leptospira
infection
cycle
production
c75
palmitate
apoptosis
jnk2
virus
cells
mavs
hrv
pneumonia
infection
respiratory
hsct
patients
viral
elevated
fever
sfts
recommendations
infections
prevention
infection
include
byd1
reovirus
apoptosis
induced
μ1
peptides
avpdb
antiviral
efficacy
peptide
arv
infection
cells
proteins
protein
orthoreovirus
infection
species
nelson
bay
network
disease
contact
degree
infectious
autophagy
viruses
proteins
intracellular
antiviral
hev
genome
virus
laboratory
ferrets
virus
dccov
uae
hku23
betacoronavirus
mers
cov
samples
651
serum
nan
bats
tuberculata
island
because
recent
diarrhea
virus
pigs
strain
pc21a
infection
march
contacts
respiratory
mers
humanitarian
catastrophes
resources
number
interventions
virus
casv
new
family
the
s1
gene
ibv
genetic
isolates
viral
translation
host
cell
cellular
cu
cells
cancer
agents
potential
h7n9
patients
risk
h5n1
factors
structural
encoded
virus
enzymes
otu
influenza
respiratory
viruses
ili
surveillance
prrsv
kag
np
lung
respiratory
rsv
progression
lrd
uri
respiratory
host
viruses
cell
rodent
reservoir
fhv
tiger
pcr
like
virus
hav
agglutinin
pcr
cells
binding
protein
export
virus
region
nuclear
hantaviruses
immune
reservoir
responses
diseases
dengue
patients
chloroquine
study
disease
respiratory
acute
illness
asthma
transcriptional
virus
tev
nirv
plants
evolution
h7n9
areas
virus
risk
eastern
sace2
heart
failure
activity
ef
hmgb1
lps
galn
gl
protein
health
drought
system
disaster
emergency
viruses
autophagy
role
manipulate
cellular
cell
cd8
hsv
specific
peptide
workers
piggery
influenza
pigs
viruses
meth
barrier
exposure
endothelial
cells
rnase
l1
retrotransposons
wt
r667a
virus
sequencing
identification
fecal
viral
calf
diarrhea
disease
pathogens
cause
diagnostic
rapid
felv
test
kit
cwe
macrophage
sra
pma
differentiation
hepatitis
virus
humans
viruses
infecting
virus
wild
birds
important
reservoir
brain
sequencing
samples
deep
sequences
ifitm3
fusion
virus
late
endosomes
niv
human
respiratory
lung
infection
drug
inr
nrs
vector
diseases
surveillance
influenza
pandemics
pandemic
method
million
disease
studies
research
respiratory
lung
cancer
patients
fungal
fungi
mortality
group
ct
score
radiologic
control
transmission
sewi
the
indicators
cxcr1
cxcl
binding
receptor
the
access
geographic
hospitals
states
high
infections
childhood
asthma
inception
the
cov
btcov
hku5
subgroup
virus
nan
dmvs
virus
viruses
rna
membrane
temperature
influenza
decrease
ah
humidity
hbv
epitope
ctl
virus
viral
metagenomics
detection
methods
public
health
ifnβ
sc
1a
formulation
antiviral
casei
pgsa
sm2
mucosal
recombinant
nsdv
virus
pdi
haemorrhagic
er
influenza
virus
autophagy
infection
host
procedure
lavage
lobar
fiberoptic
used
mcadd
mutations
acadm
phenotype
structural
population
resolution
peak
spatial
populations
dengue
incidence
model
ppv
sensitivity
swine
ngs
to
investigate
causative
pdcov
porcine
detected
epidemic
transmissible
protein
covs
ntd
oc43
respiratory
inhibitors
sars
coronavirus
cov
exhibit
hiv
vaccine
adjuvants
antibody
responses
ards
patients
risk
95
ci
test
laboratory
tests
rules
useful
cognitive
affective
associations
behavioral
epidemic
zn
diet
high
tgev
group
influenza
virus
st6gal1
sirnas
cells
corticosteroids
children
asthma
emergency
the
hospital
disaster
tertiary
hospitals
resilience
known
experimental
problem
perturbation
solution
csf
ms
iggs
fold
dna
apod
brain
stress
protein
lipophilic
h1n1
pdm09
influenza
brazil
viral
cne
length
conserved
non
protein
tetherin
viruses
restriction
factor
also
rna
helicases
viral
like
replication
ifnar
type
ifn
signaling
infection
hku15
porcov
porcine
coronavirus
first
nerve
glycyrrhizin
sciatic
injury
dose
heroin
vaccine
injection
1826
cpg
antibodies
vhh
diagnostic
ns1
monoclonal
patients
viral
severe
hap
59
ndv
pkr
dsrna
infection
eif2α
physical
the
symptoms
psychological
stress
diarrhea
piglets
neonatal
spp
coli
cats
h1n1
northeastern
china
seroprevalence
chikv
antibody
response
infection
anti
sars
plpro
sting
tbk1
irf3
age
we
influenza
transmission
method
epidemic
spatial
parameters
spread
estimated
adenovirus
analytical
sd
rota
adeno
piglets
adg
nnpds
diarrhoeic
study
infection
aged
age
sars
cov
febrile
illness
fever
return
muscle
diagnosis
blood
the
bloodstream
infections
data
rapid
breath
pandemics
emerging
muscle
the
gene
treatment
disorders
lrtd
piv
probable
proven
detection
acquisition
pneumococcal
ari
episodes
influenza
bla
cell
the
lactamase
gpcr
influenza
viruses
cytokine
avian
autophagy
coronavirus
protein
ifn
sars
tm1
pf
effects
tiia
blm
may
protein
3a
motif
wild
type
denv
reverse
coli
infectious
yeast
rnase
rnas
independent
viral
metal
fusion
sars
cov
s2
terminal
canine
virus
parvovirus
distemper
53
studies
lus
pneumonia
chest
we
model
dose
response
the
in
fip
fcov
cats
samples
position
cat
species
capability
transgenesis
potential
virus
cchf
mice
ribavirin
705
wildlife
diseases
emerging
health
surveillance
trend
visits
10
air
outpatient
protein
ic
activity
ion
virus
nan
influenza
fri
cases
infections
studies
infections
viral
effective
antiviral
exposure
sirna
delivery
poly
copolymer
gfp
immunization
strategies
acquaintance
community
bridge
nan
curve
the
genome
sequence
analysis
failure
patient
cause
herpes
simplex
ha
vac
dual
specific
mice
pathogens
2361
respiratory
human
age
orfv
virus
replication
rnai
rna
mers
cov
sequences
genome
dromedary
hpv
protein
neutralizing
e3r4
types
macrophages
blood
tissues
disease
play
marine
metabolites
acetylcholinesterase
drugs
disease
viruses
bats
high
viral
diversity
mutant
virus
strain
sensitive
molecular
pedv
trailers
after
porcine
epidemic
we
support
closure
live
poultry
nan
sars
cov
vlp
virus
production
sialidase
various
diseases
influenza
agents
nan
parasites
haemoproteus
blood
hippoboscid
flies
bats
poxviruses
species
viruses
cross
tetherin
transmembrane
virus
fusion
cell
irs
mi
ace2
insulin
acute
children
hadv
the
74
group
flu
infections
influenza
viral
ilis
hpv
cell
cd4
specific
dna
measles
years
vaccination
100
000
clrs
receptors
role
signalling
shaping
deft
the
defa
primate
defensin
infection
sars
cov
human
immune
bst2
vpu
ap1
protein
cell
within
malaria
days
qi
gao
bal
pneumonia
fluid
analysis
bacterial
nan
nucleic
system
viral
extraction
ez1
viruses
respiratory
the
old
human
ifitm1
viruses
dna
infection
inhibit
tollip
protein
pathways
immune
could
nan
herc5
hiv
domain
ifn
replication
asean
health
globally
diseases
development
amd
degeneration
retinal
neovascularization
cells
aptamer
viral
rna
host
influenza
health
diseases
infectious
reduction
development
home
individuals
contact
contacts
china
surveillance
infectious
environmental
diseases
disease
virus
viral
influenza
sensitive
gaussia
computational
profiling
biology
virology
disease
please
see
later
article
editors
igy
treatment
effect
diarrhea
studies
coverage
iv
influenza
2009
the
cells
cns
immune
viral
vla
isg
viral
response
virus
cov
virus
diversity
wild
viruses
european
par
the
parg
binding
adp
strand
rna
synthesis
di
cis
health
one
diseases
approach
case
plpro
ubiquitin
isg15
chain
protease
patients
pneumonia
h1n1
severe
community
upr
viral
responses
signals
viruses
upr
virus
infection
viral
hcv
nan
virus
induced
asthma
human
rhinovirus
the
lycorine
culture
μg
mg
er
upr
protein
gene
vectors
antiviral
cells
diseases
peptides
cpps
cell
systems
delivery
cpps
selective
protein
sequences
based
curve
representation
infected
model
cells
models
data
virus
pcr
detection
retrovirus
plex
hantavirus
genus
world
animals
diversity
eu
bat
viruses
virus
human
viruses
bats
contigs
bat
individual
biosecurity
farm
farms
conditions
on
human
infection
mers
cov
camels
nan
mers
cov
we
human
identified
tick
asia
recently
discovered
borne
nan
hev
in
molecular
epidemiology
study
asthma
exacerbations
patients
expression
ifn
two
epidemic
spreading
layer
threshold
virus
isolates
species
alphamesonivirus
the
ili
556
respiratory
elderly
rsv
ev71
neutralizing
conformational
treatment
monoclonal
parp
genes
host
adp
ribosylation
k22
rna
viral
antiviral
human
epidemiologic
theory
transition
health
epidemiology
genome
middle
east
respiratory
syndrome
mrv
mrv00304
13
mrv1
mammalian
pedv
novel
variant
strain
pig
prrsv
infection
app
cells
bacterial
urti
gargling
vitamin
clinical
randomized
fip
cats
snp
feline
ifn
rna
human
protein
coronaviruses
strains
ppgalnac
t2
cells
cancer
gastric
group
sh
synovial
cells
treated
nan
iasos
antimicrobial
media
mg
ag
eif3f
expression
gc
the
tissues
macrophages
inflammatory
macrophage
two
activated
junv
mice
interferon
the
infection
ntds
health
nzds
diseases
resolution
vacv
viral
hfs
cellular
proteins
transmission
hiv
network
risk
data
proteins
nsp2
cellular
prrsv
the
il
hsv
demyelination
mog
model
vp6
protein
viral
large
expression
ns5a
hcv
core
density
fractions
surveillance
rf
sector
review
new
life
satisfaction
optimism
core
self
sepsis
neutropenic
mortality
intensive
therapies
climate
vector
disease
change
effects
sirna
lung
dendriplexes
also
based
adenovirus
hfmd
ev71
ca16
adults
cov
pl
pro
mers
activity
lung
ultrasound
respiratory
failure
findings
ben
patients
variants
genes
disease
plakortide
report
activity
parasitic
μm
viral
efficacy
specific
infections
human
spore
time
inactivation
bacillus
spores
individuals
costs
disclosure
group
individual
ellagic
acid
hrv
μg
ml
ga
acid
liver
licorice
pharmacological
junv
cells
human
dna
fragmentation
il
exacerbations
inflammation
1β
17a
cholesterol
brv
depletion
virus
membrane
compound
the
plasma
respectively
polyoxometalates
ifn
eav
type
equine
virus
hfpef
tnfα
tnfr2
levels
tnfr1
mab
hpai
h5n1
ch61
antibody
patients
infection
h7n9
virus
percentages
pedv
strain
virus
vitro
the
p38
ev71
idcs
il
mapk
influenza
pcr
viruses
respiratory
mrt
disease
analysis
data
outbreaks
new
viral
infections
co
severity
studies
respiratory
extracts
sidoides
in
effects
infection
cns
viral
cells
virus
er
upr
coronavirus
stress
activation
ndv
pseudotyped
luc
hiv
hn
viral
anti
ire1
the
review
membrane
interactions
fusion
imaging
ellipsometer
hlh
conditions
response
cells
high
method
the
well
immunoassay
plate
influenza
rsv
human
infections
alris
immune
genes
viral
vaccination
attachment
suis
zoonotic
pathogen
contributing
molecular
respiratory
non
pharmaceutical
interventions
infection
hfold
iterative
pseudoknotted
accuracy
structures
paramyxoviruses
bats
viruses
novel
fruit
ptov
gene
samples
sichuan
sequences
protein
prm
ectodomain
denv
membrane
ifitm3
viruses
endocytic
entry
endocytosis
hyopneumoniae
specific
mdi
cmi
piglets
frameshifting
signal
cognate
genes
frameshift
line
lists
available
data
disease
il
mice
ova
inflammation
type
argentina
nicaragua
peru
hbov
among
flu
responses
pandemic
immune
2009
polio
ipv
vaccine
caf01
virus
influenza
sari
ili
cases
associated
ace2
hypertension
blood
pressure
ras
dogs
agarose
macrobead
implant
days
genome
sequencing
common
finishing
viral
mers
cov
the
epidemiology
cases
distribution
bats
viral
richness
species
helical
coiled
coil
structures
falciparum
ili
surveillance
influenza
systems
general
ypfs
expression
inflammatory
inos
cox
3d8
scfv
cells
virus
dna
virus
protein
dna
capsid
tmv
outbreaks
pedv
south
korea
us
deltacoronavirus
virus
porcine
in
ohio
infection
nose
prospective
study
dromedary
nan
nan
curriculum
staff
development
china
newly
gpvi
platelet
drugs
drug
to
vectors
alphavirus
virus
development
alphaviruses
respiratory
cases
viruses
sari
ards
mice
cxcl10
igg
septic
shock
findings
hrct
h1n1
the
scans
virus
h1n1
pdm09
samples
respiratory
biological
agents
health
biosafety
biodefense
hiv
influenza
h1n1
pdm09
infected
ibv
oviduct
strains
strain
infection
olfactory
neuroepithelium
days
poly
24
behavioral
control
knowledge
dog
owners
cea
the
family
cell
genes
lesions
rats
laboratory
carinii
interstitial
oc43
hcov
patients
prevalence
among
nan
erad
er
process
associated
proteins
diseases
respiratory
infectious
diagnosis
aetiology
myd88
rabies
pires
rgp
responses
vaccination
dogs
cats
animal
published
pneumonia
significant
case
achromobacter
denitrificans
virus
respiratory
discovery
causative
techniques
hand
hygiene
isolation
recent
effective
patients
influenza
progression
flu
days
virus
ibv
chimeric
protein
vlps
nerve
sdav
regeneration
functional
recovery
frameshift
domain
model
shape
hiv
pandemic
npis
migrants
barriers
public
detection
injection
emr
combined
ari
respiratory
rsv
clinical
infection
adults
commuting
mobility
epidemic
data
mobile
ubiquitin
cellular
conjugation
viruses
mechanisms
fat1
the
pufas
bovine
cells
blood
gene
expression
whole
pbmc
research
nhp
medical
studies
potential
mers
cov
the
cases
rhesus
kobuviruses
porcine
pigs
piglets
samples
nan
glial
cxcr3
activation
cuprizone
course
mrsa
clusters
hospital
identified
using
sars
cov
protein
1a9
mab
pathogen
disease
discovery
new
microbial
entry
viral
host
cells
the
human
viral
zoonotic
animals
infections
assay
influenza
we
vaccine
the
prrsv
ifn
host
signaling
immune
arrivals
fever
febrile
the
international
risk
infection
hcws
respiratory
hrps
spatial
disease
able
locate
95
ifnar
cells
cxcl10
ifn
dsrna
ms
lesions
encephalomyelitis
expression
oxidative
ifn
hmpv
dis
rna
high
extra
catalytic
residues
sti
3clpro
assessment
health
ihr
designated
poes
complex
dynamics
networks
our
data
nan
tumor
cells
abc
chase
treatment
medical
countermeasures
infectious
diseases
facility
coronavirus
cov
novel
patient
within
cd13
cells
trafficking
ko
wild
virus
influenza
viruses
parainfluenza
respiratory
fever
public
cases
2009
survey
proteins
cell
transfer
fluorescent
imaging
samples
ntd
set
controls
regulated
new
discovery
microbes
the
rate
chikv
mva
virus
chik
challenge
antimicrobial
use
cases
companion
could
piglets
nnpds
the
herds
syndrome
swine
bronchiseptica
km22
infections
host
camels
virus
dromedary
putative
source
circulation
among
we
found
serologic
live
poultry
influenza
reported
exposure
mers
cov
camel
qatar
virus
herds
levels
btm
brsv
two
aeruginosa
cf
viable
aerosols
transmission
virus
host
a51r
we
lepidopteran
nan
scorpine
fusion
anti
expression
sumo
sequencing
high
development
throughput
dna
rna
development
reverse
genetics
systems
viruses
influenza
vaccine
respiratory
virus
membrane
membranous
replication
viruses
we
physical
crisis
psychological
based
smartphone
stroke
ischemic
or
95
ci
hcov
respiratory
infections
tract
hcovs
kd
viral
virus
monthly
detection
cap
mixed
viral
bacterial
crp
human
coronavirus
nl63
mainly
two
viral
cough
influenza
load
system
prrsv
prrs
hp
detection
the
exercises
health
countries
preparedness
public
mers
cov
camel
infected
respiratory
translation
ires
igr
frame
cellular
ga
effects
erk
akt
cell
response
may
virus
er
stress
ttf
smad3
smad4
tgf
chromatin
irf7
bat
ifn
bats
response
elm
viral
viruses
the
identification
ifn
plus
ribavirin
therapy
natural
nec
treatment
strategies
may
therapeutic
m133
tregs
tconv
cells
specific
bats
bat
kenya
adenovirus
positive
sars
cov
respiratory
coronavirus
humans
hbov1
viral
respiratory
load
detection
irf
prion
promoter
activity
oct
lactis
ncdo
2118
bacteria
il
patients
the
waiting
eopd
emergency
ifnl
infection
ifn
viral
snps
proteins
ifitm1
entry
human
viral
host
proteins
virions
vsv
virus
nan
macropinocytosis
cov
virus
entry
infection
nan
hsv1
ad
apoe
virus
infection
cpms
common
cold
clinical
trials
cells
human
disease
response
immune
tcm
medicine
emergency
china
traditional
detected
pathogens
frequently
pneumoniae
molecular
response
health
ebola
disease
evd
pedv
sdpp
pigs
control
dpi
pprv
vlps
virus
protein
ruminants
public
health
core
master
the
mouse
transcriptional
response
infection
strain
mers
cov
rt
assay
lamp
pedv
vietnam
diarrhea
porcine
epidemic
protein
sars
cov
pbm
p38
hiv
tmd
env
immune
membrane
the
movement
infection
human
passengers
kimchi
students
study
healthy
chinese
primers
virus
coverage
viruses
low
rpa
95
ci
tb
settings
pathogens
impact
pathogen
risk
human
or
95
ci
risk
respiratory
mexicana
dogs
infected
one
leishmania
wildlife
viral
viruses
surveillance
animals
sars
mers
respiratory
severe
coronaviruses
information
web
accurate
based
social
bp
shock
group
intestinal
serum
pi
transmission
animals
piglets
colostrum
model
mers
cov
animals
disease
pd
l1
cells
microglia
cell
proteins
hg
protein
deps
identified
kd
cd209
polymorphisms
haplotype
risk
pups
dogcv
enteritis
the
dogs
transfusion
agents
threat
transmission
agent
ga
glutamate
the
dpc12
cells
meningitis
microfluidic
paper
detection
meningitidis
virus
infection
h7n9
changes
human
hiv
the
2014
emerging
diseases
bnabs
germline
hiv
antibodies
may
sgmrna
strand
synthesis
cis
acting
protein
the
assembly
functions
coronavirus
influenza
vaccines
virus
vaccine
strains
viruses
bats
pathogenic
virus
public
ccov
dogs
enteric
closely
related
sequencing
microbial
the
huge
sequence
membrane
protein
membranes
ns2a
viral
fty720
cns
mice
disease
virus
cases
deaths
the
mers
cov
cell
epitope
the
peptide
vaccine
nk
cells
mucosal
infection
cell
described
ifn
effector
different
host
coughs
the
influenza
infected
individuals
clinical
research
may
public
health
sepsis
defensins
immune
inflammatory
cells
type
ii
fcov
recombination
emerged
persistence
viral
vector
flavivirus
borne
viroporins
proteins
encoded
transmembrane
cells
korean
dogs
castvs
ckovs
identified
virus
replication
ibv
novel
due
immune
antiviral
response
infections
important
cells
dendritic
pdcs
plasmacytoid
first
public
health
disease
evolution
life
fire
species
life
history
traits
akap7
pde
viral
mhv
domain
nan
nan
viral
associated
patients
severe
different
changes
material
100
process
this
health
disaster
system
challenges
effective
nsp10
nsp14
surface
nsp16
the
grp78
anti
associated
autoantibodies
emphysema
species
hipposideros
caffer
complex
genetic
the
fairholmianus
inflammatory
six
compounds
critical
pertussis
predictors
mortality
risk
chaihu
pharmacological
bupleurum
also
known
ace
homologues
studied
functions
enzymes
dcs
cpn
increased
aged
subjects
epitope
mers
cov
binding
in
proteins
salmonella
immunogenic
we
approach
the
rpa
amplification
on
chip
rsv
basic
training
respiratory
korea
global
health
mutual
attention
diplomacy
1h
alcohols
benzo
bt
ots
lc
human
igg1λ
disulfide
bond
ebov
ebolavirus
apes
exposure
virus
epidemic
control
liberia
growth
2014
cytokine
10
dust
mites
cytokines
piperacillin
pulmonary
tazobactam
patients
critically
pathochip
screening
viruses
human
tumor
doc
damage
follicle
µm
t3
canine
rt
cdv
iipcr
distemper
hev
management
veterinary
infection
control
disease
nidovirus
the
pythons
order
viruses
circular
replication
small
viral
virus
recombinant
egfp
transcription
prrsv
macaque
transcripts
annotated
thousands
macaques
materials
hdpe
layer
comprising
hospital
icariin
oxidative
ducklings
liver
stress
surveillance
influenza
based
system
himm
respiratory
air
sari
infections
the
asthmatic
patients
respiratory
cytokine
viral
membrane
sif
salmonella
intracellular
cell
unigenes
indigotica
rna
indole
facilitate
nan
circovirus
long
established
epidemic
enteritis
acute
respiratory
tested
during
first
respiratory
mers
cov
pcr
in
readthrough
replication
mulv
gag
codon
nan
hospitals
sentinel
surveillance
based
eight
pedv
feed
sal
curb
control
lncrnas
respiratory
virus
host
response
iggs
csf
ms
sera
mbp
actions
flu
like
sneeze
cough
asthma
patients
pct
antibiotic
exacerbations
rna
distance
spatial
graph
distribution
influenza
children
swabs
ili
ilis
hadv
55
molecular
gene
disease
influenza
measures
forecasting
outbreaks
approaches
influenza
h1n1
pdm09
ari
cases
virus
h1n1
pdm09
influenza
infection
infections
children
hrv
ent
respiratory
viral
respiratory
infections
children
study
pneumonia
pneumococcal
or
95
ci
mers
cov
infectivity
25
titre
host
important
development
infectious
agents
np
type
segment
influenza
panhandle
oscc
patients
early
in
biomarkers
tumor
carbohydrates
we
antibody
tri
residents
viral
infection
cd4
high
ev71
cypa
host
factors
proliferation
patients
lt
non
fibrosis
liver
influenza
bat
virus
viruses
type
2010
data
disease
burden
ksa
samples
sputum
ops
detection
pathogens
exacerbation
acute
frequency
exacerbations
gold
ngf
transport
na
ion
sc
strains
surveillance
rotavirus
lambs
goats
helping
several
viruses
fecal
animal
viruses
enteric
enteritis
pec
maximum
viruses
influenza
bats
virus
discovered
ifitm
entry
inhibition
proteins
cholesterol
cells
effectors
host
plant
haustoria
influenza
virus
prophylaxis
broad
provide
signaling
tgf
cell
proteins
different
mmbr
virus
cell
lines
myotis
h3n2
h1n1
h1n2
pigs
pid
dna
vaccines
delivery
vaccine
respiratory
ns5
rna
polymerase
mtase
replication
rhinovirus
infection
pneumonia
healthy
respiratory
nan
pedv
united
states
china
2013
strains
pedv
states
north
united
seasonal
amplitude
05
tb
spring
antibody
library
cells
disease
sorting
disease
infectious
health
sectors
public
cie
bladders
bladder
response
efs
er
xendou
formation
using
rna
bacterial
zoonotic
health
animals
disease
genes
qrt
pcr
gene
ecd
bbb
shh
1β
astrocytes
integrity
ifitm3
δ21
iav
h1n1
also
we
samples
positive
group
infection
pedv
outbreaks
diarrhea
virus
taiwan
health
taiwan
the
process
traditional
mucus
siv
virus
neuraminidase
influenza
clp
departments
consultation
psychiatry
medical
npd
icm
cftr
cf
patients
proteins
identified
protein
anti
ft1dm
ben
evidence
balkan
disease
aristolochic
mers
cov
travellers
case
two
pct
sepsis
crp
75
cases
sudv
antibodies
16f6
ebolavirus
neutralization
vaccines
diseases
in
century
vaccination
nsp6
autophagosomes
induced
starvation
proteins
uncertainty
am
management
outbreak
would
cell
infection
tgev
showed
changes
antigens
the
nosocomial
novel
pneumoniae
period
quarantine
individuals
incubation
21
twitter
information
response
the
situational
cell
frcs
frc
immunity
follicle
network
the
international
technical
health
pneumonia
dose
uldct
patients
lung
herds
cattle
risk
herd
bvdv
ebola
epidemic
ongoing
review
epidemiological
ptsd
95
ci
traumatic
hcv
influenza
2009
strains
2011
like
csfv
integrin
β3
infection
cells
aids
annual
absolute
frequencies
brazil
host
civ
virus
transmission
contact
rna
viruses
dependent
polymerase
eukaryotes
nucleolar
nucleoli
ribosome
particular
well
receptors
polymorphisms
fc
and
or
wheezing
study
risk
recurrent
03
data
internet
study
h7n9
field
hcv
patients
autoimmune
thyroid
chronic
facilities
isolation
equipment
48
the
suicide
attitudes
toward
the
among
csbf
c10orf99
colon
susd2
cancer
protein
affinity
interactions
immunoprecipitation
this
ifn
viral
deleterious
responses
infections
report
legionella
water
we
cases
hajj
pilgrims
respiratory
specimens
positive
hcv
china
infection
years
the
transmission
cases
our
infection
human
microglia
expression
rsa59
demyelination
inoculation
extract
hours
glabra
incubation
cells
nan
glycoprotein
ssp
complex
gp1
within
cats
shelter
cat
feral
program
sp
elisa
the
variations
levels
severe
patients
influenza
outcomes
the
h10n8
virus
animal
hi
human
viral
weeks
respiratory
ifn
well
pprv
levels
goat
susceptibility
breeds
mscs
cells
exosomes
cell
immunomodulatory
laboratory
probability
biosafety
escape
we
nan
states
compliance
ihr
member
territories
infection
sfb
histolytica
protection
microbiota
ifn
response
isr2
genes
also
week
farms
one
per
diseases
iii
ymdb
rnase
genes
biofilm
bigg
human
rsv
hrsv
binding
treatment
group
placebo
common
cold
host
often
shifts
pathogens
pathogen
fusion
mhv
lysosomal
entry
proteases
virus
prf
wnv
mutant
significant
structures
viral
many
important
aspects
pertussis
infants
vs
rsv
bronchiolitis
infection
mers
cov
camels
cases
primers
probes
taqman
luminex
large
hbv
crtc1
transcription
cccdna
replication
rna
exosome
dnag
binding
archaeal
functional
elements
virus
rna
viruses
virus
g4s
form
sequences
structures
disease
evolutionary
wildlife
ecological
remain
cluster
data
picker
clusters
we
bats
infection
response
immune
diseases
influenza
h7n9
acute
virus
lung
enzyme
mechanism
catalytic
predict
structure
protein
sequences
adld
based
analysis
immune
cells
cns
bbb
responses
oct4
pluripotency
maternal
embryos
embryonic
health
zoonotic
the
diseases
one
ion
vpu
channel
the
shown
baculovirus
protein
cap
pcv2
vaccine
translation
repeat
expansions
mechanisms
ran
pparα
antidiabetic
pan
the
receptor
layers
cell
surface
observed
involved
hamster
syrian
transcriptome
species
genome
autophagy
viral
marine
within
production
outbreak
reporting
global
internet
first
cells
infected
ev71
viral
replication
rvf
human
vaccine
replication
deficient
hbov
human
respiratory
clinical
virus
ebv
diseases
humanized
mice
immune
rbd
mers
cov
vaccine
subunit
ptb
utr
hastv
hnrnp1
viral
respiratory
microbiota
healthy
bacterial
patients
virus
carrageenan
common
cold
patients
patients
influenza
cap
virus
infection
fcov
infection
type
two
cats
mers
cov
cell
bat
cd26
host
novel
range
mutations
fitness
ev71
mice
infected
protein
formation
respiratory
viruses
virus
human
detection
human
mers
cov
the
persistence
respiratory
viruses
children
detected
in
variant
strain
2014
south
korea
hmpv
patients
infections
solid
16
emerging
intestinal
preterm
microbial
developing
stlr2
stlr4
infections
95
ci
mers
cov
vaccines
coronavirus
novel
pdi
natriuretic
cells
cgmp
anp
h7n9
clinical
rule
prediction
performance
ccr2
inflammatory
monocytes
influenza
high
public
health
this
commentary
provides
hmpv
virus
cells
protein
particles
55
the
patients
respiratory
severe
contact
patterns
contacts
social
infections
spatial
hepatitis
distribution
risk
factors
pdcov
2014
south
korea
in
dairy
neonatal
calf
diarrhoea
calves
surveillance
systems
information
environment
influenza
sonfh
the
proteins
protein
steroid
ofscs
macrophages
il
lps
mir
vaccine
vaccines
synthetic
generation
based
virus
novel
cancer
samples
health
hbv
infection
or
95
ci
felv
isolates
pcr
dna
samples
nan
ifitms
cells
virus
hiv
mechanism
genes
hamster
the
infection
visceral
parvum
cryptosporidium
calves
species
diarrhoea
respiratory
pneumonia
ball
pythons
snakes
zn
dietary
levels
infection
higher
vidisca
viruses
samples
human
next
strain
the
variant
pedv
full
adenovirus
psittacine
hku1
human
atadenovirus
nan
identification
highly
based
amplification
rca
health
asean
uhc
countries
economic
ddx3
hiv
hcv
rna
viral
mers
cov
hospital
contacts
to
virus
human
h10n8
strains
markets
influenza
viruses
camels
mongolia
2012
diarrhea
pedv
porcine
south
korea
nan
camels
respiratory
mers
cov
upper
mers
cov
samples
to
analyze
hadv
genome
china
pathogens
analysis
gondii
bats
china
infection
genetic
virus
pedv
genome
porcine
epidemic
fipv
polyprotein
genome
main
protease
hku1
mutant
n60k
nsp9
coronavirus
autophagy
coronavirus
plp2
tm
beclin1
dengue
fever
the
travel
endemic
blood
volume
loss
paediatric
patients
difficile
patients
10
carriage
positive
nw
ldh
caspase
children
bronchiolitis
nan
jejuni
sheep
abortion
sa
genes
infectious
recent
advances
sequencing
technologies
vero
cell
cells
various
lines
amplification
nucleic
acid
detection
the
pl
pro
activity
dub
mers
sais
comfa
comsia
3d
models
mev
mir
mink
mirnas
inhibit
viral
plant
vaccines
made
technology
cangyuan
virus
phylogenetic
in
novel
convalescent
plasma
clinical
treatment
mortality
hbv
anti
csa
ntcp
infection
health
ebolavirus
ebov
public
africa
entry
lipid
viruses
cellular
host
fip
associated
disease
snps
fcov
nan
challenge
interval
celebrities
associated
participants
apod
ldl
binding
lipoprotein
t24
respiratory
immune
cause
tract
severe
fan1
dna
nuclease
structure
cancer
ccv
strains
korean
type
sequence
bat
cells
response
infection
host
viral
genomes
viruses
complete
sequence
platelet
activation
platelets
viral
also
ptov
porcine
npl
2013
circulating
nan
nan
nan
xkb
cyp3a
midazolam
molecular
targets
irf3
plpro
sars
ifn
induction
pneumonia
children
countries
the
study
pulmonary
ards
vascular
elevated
resistance
nan
children
virus
respiratory
presenting
or
influenza
pcr
tested
using
respiratory
bats
viruses
hosts
virus
reservoir
iavs
coat
vaccine
proteins
hiv
pathogen
technologies
inactivate
pathogens
transfusion
nan
nan
rna
ptb
jev
sense
replication
the
omic
technologies
approaches
data
host
viral
viruses
many
factors
cells
critical
response
serve
brain
respiratory
virus
detected
enterovirus
68
camp
intracellular
molecule
cell
specific
respiratory
influenza
recruits
age
rhinovirus
hcv
virus
hepatitis
in
cycle
production
plant
use
antibiotics
systems
influenza
respiratory
conference
viruses
novel
influenza
rash
like
ili
this
virus
cells
the
discovery
method
virus
two
belpv
afra
bats
toxocariasis
neurologic
involvement
human
generally
influenza
respiratory
orvs
seasons
peak
data
public
health
clinical
aim
feed
pedv
sdpp
positive
ped
dromedary
camels
mers
cov
negative
hsa
mir
3p
mers
cov
cns
pml
viral
polyomavirus
cell
emerging
infectious
diseases
pathogen
the
ripudaman
bains
editor
genome
biology
monoclonal
clinical
use
antibodies
new
protein
sumoylation
bombyx
mori
identified
protein
crowding
the
macromolecular
represents
regulations
toxins
select
agents
bsats
viruses
virus
protocol
detection
tuvid
nan
viruses
viral
important
sample
computational
hcvcp
expression
the
gene
tobacco
virus
h7n9
avian
assay
novel
cpp
single
ssos
pre
mrna
rna
mnv
rdrp
rnas
synthesis
ifn
lncrnas
several
coding
response
human
transmission
to
lf
rodent
crown
ethers
protein
wide
organic
host
immune
the
virus
infection
viral
patients
infections
often
care
common
rv
human
pathogens
respiratory
surveillance
data
2007
sentinel
system
disease
cchfv
epitope
cchf
considered
patients
test
rvs
multiplex
rt
glycyrrhiza
glabra
species
inflata
licorice
viral
host
current
arsenal
infections
health
potential
public
development
infectious
bacterial
isolates
hajj
air
samples
influenza
search
query
information
clinician
media
outbreak
impact
switching
control
the
adverse
events
methods
data
respiratory
viruses
nasopharyngeal
virus
adenoid
emcv
vp1
mcabs
results
epitopes
diseases
internet
systems
infectious
surveillance
herds
om
cm
brsv
bocv
viral
receptor
cell
anti
chanxa2
pigs
kg
feed
virus
growth
attitude
knowledge
hcws
mers
towards
proteomics
aph
scientific
animal
action
control
transmission
population
hospital
spatial
based
approved
ebola
drugs
features
kb
haplotype
sequence
igk
igl
hbv
therapeutic
hepatitis
chronic
vaccines
hadv
children
bacterial
hadvs
bal
viral
bacterial
infections
etiology
the
data
collection
paper
system
based
dengue
viral
disease
immune
cells
translation
eukaryotic
machinery
hiv
viral
epimedium
koreanum
nakai
antiviral
extract
h7n9
clustering
spatial
china
data
uhc
migrants
countries
asean
health
compounds
lqc
method
quantitative
acid
analysis
bielefeld
abstract
shape
allows
tiv
hd
sd
all
responses
poultry
gut
enteric
disease
contact
aids
vaccines
development
years
hiv
annexin
a2
membrane
cell
proteins
adjuvants
molecular
vaccine
antigen
adjuvant
vaccine
development
diseases
vaccination
the
nan
border
screening
effective
measures
sars
2014
respiratory
during
january
2013
virus
us
cattle
france
new
nan
hsv
infection
hcwes
cordata
nf
ace2
lps
ang
a779
induced
diarrhoea
china
seasonality
years
latitude
patient
hospital
the
admission
day
igg
concentrates
aes
success
plasma
resistance
auc
aml
ability
prediction
vaccines
ebolavirus
gp
dna
the
asymptomatic
viral
specimens
infection
aom
preparedness
the
measures
three
federal
bactericidal
mic
yl
the
concentration
cov
outbreak
mers
data
cases
the
causative
outbreak
febrile
illness
health
research
public
environmental
arab
flow
sars
spatial
in
out
the
in
meat
small
scale
mers
cov
hajj
95
pi
nan
nan
nan
host
smegmatis
genes
hosts
patience
nfv
hsv
protease
cells
activity
methods
based
antigen
method
proposed
health
information
online
articles
newspapers
arab
countries
infectious
diseases
field
nan
protein
rna
interaction
rpi
pred
envelope
hiv
evolution
design
neutralizing
circoviruses
using
in
novel
genomes
cats
group
fiv
infection
in
fiv
felv
cats
risk
factors
disease
response
ebola
community
systems
risk
diabetes
type
onset
students
genome
evolution
new
rna
expansion
nan
pedv
feed
within
piglets
production
ebov
available
therapeutic
agents
the
ptx3
alphavirus
rrv
disease
chikv
host
mnv1
protein
infection
eif4e
ebola
molecules
virus
drugs
the
htlv
ctls
specific
positive
cns
protein
hcov
nl63
coronaviral
present
hsv
foreskin
samples
tissue
seropositive
resistant
cells
ifitm1
ai
breast
sarcocystis
neurona
toxoplasma
parasites
including
cteph
lncrnas
analysis
pulmonary
may
screening
pathogens
factors
epidemic
we
extract
acetone
virus
plant
viruses
proteases
furin
species
bats
viruses
hsv
tegument
protein
envelope
proteins
pilgrims
hajj
year
umrah
risk
networks
immune
system
cellular
interactions
jerome
singh
considers
regulatory
mechanisms
therapies
ebola
virus
disease
urgently
cell
changes
patient
gata
deficiency
military
diseases
the
personnel
infectious
months
plasma
12
total
protein
rvs
virus
pneumonia
patients
cap
sanitation
systems
infections
healthcare
drainage
mice
vlps
type
ebov
viral
flaviviruses
associated
different
phylogenetic
culex
h7n9
participants
zhejiang
kap
mobile
pst
population
emerging
pathogens
field
united
states
germany
since
2013
nan
influenza
seasonal
meteorological
significant
variations
ribavirin
mutants
resistant
prrsv
antiviral
viruses
co
ari
less
detections
pcr
multiplex
assay
dpo
influenza
diseases
like
influenza
pandemic
h1n1
bacteria
antimicrobial
healthcare
resistant
resistance
ceacam1
cells
cell
responses
survival
patients
elderly
group
vs
non
health
public
responses
there
ebola
pedv
infected
virus
whether
airborne
tick
city
the
borne
ticks
respiratory
acute
infection
severity
il
studies
corticosteroids
treatment
case
h1n1
health
public
policy
the
contract
griffithsin
purification
method
manufacturing
process
ifitm1
hiv
human
nl4
117
activity
ferret
method
video
tracking
diseases
health
one
zoonotic
significant
oas
viral
well
family
antiviral
macaques
japanese
srv
cynomolgus
species
analysis
riems
metagenomics
the
sequence
mink
ev71
rna
viral
replication
cells
jev
cell
cbs6
infection
adenovirus
adenoviruses
sea
dolphins
detection
group
inhibition
src
vegf
supplement
mers
cov
animal
respiratory
2012
ari
adults
influenza
prophylaxis
participants
children
infections
artis
pathogens
virus
clothing
virus
contaminated
the
influenza
hla
24
peptide
tapasin
loading
priority
setting
level
hospitals
factors
aptamers
viral
virus
molecules
nucleic
rsv
ml
infection
hsa
high
mabs
therapeutic
agents
research
provide
ppv
npf
activity
in
drug
coli
calves
calf
vafs
diarrhea
nan
alu
translation
viral
srp9
14
atp
rna
ddx1
dead
we
data
disease
models
hospital
traffic
fda
drugs
available
in
search
pedv
pigs
mortality
performance
weaned
fcov
pcr
nsp14
method
cats
cell
lines
viral
poliovirus
k562
inoculation
smallpox
sloane
followed
philosophical
or
95
ci
risk
influenza
infection
carbohydrates
enteric
function
microbes
nan
feeding
mosquito
regions
surveillance
relevant
nan
hla
peptide
02
01
h74l
gorillas
chimpanzees
viral
herpesviruses
adenoviruses
mirnas
tgev
expression
st
regulatory
genes
comorbidity
diseases
hiv
sars
hvma
pcd
and
diagnosis
centers
viruses
rhabdoviruses
human
virus
uafi
csf
hiv
plasma
impairment
ip
pedv
feed
material
contaminated
risk
mab
virus
civ
d7
influenza
prrsv
infected
pigs
cytokine
cell
rpmrv
yn2012
mrv
the
humans
hpv16
hpv
responses
rsv
psv
ithrcs
fl
antioxidant
tinctoria
hairy
proteins
bacterial
viral
induced
the
viruses
ev
human
hrv
respiratory
personalized
omics
availability
genomes
disease
bovine
brbv
brav1
brav2
rhinitis
2013
ch
jx
pedv
strains
acherv
trihpv
sl
10
copies
infectious
disease
mathematical
epidemiology
spread
h1n1
pdm09
influenza
virus
infection
outbreak
the
r₀
si
contact
urine
leptospira
infected
proteins
rats
respiratory
coronaviruses
rna
replication
syndrome
bats
viruses
evidence
based
zoonotic
hev
jnk1
mapk
orf3
chronic
puuv
infection
increased
hemostasis
primary
mark
siedner
colleagues
reflect
early
viral
tropism
emerging
important
factor
gene
codon
tp53
usage
bias
intercodon
hiv
frameshifting
ribosomal
defined
hcv
antiviral
activities
venoms
venom
secretory
protein
increased
factors
load
mbds
cross
border
cooperation
surveillance
rabies
middle
east
countries
regular
extraction
the
conditions
used
flavonoid
patients
hbov
lrti
we
human
hadv
respiratory
species
identified
55
dicer
protein
vv
protease
i7
qac
mrsa
the
staphylococcal
hypochlorite
nan
nan
rotavirus
species
we
identified
unusual
transmission
to
determine
risk
middle
pigs
virus
strains
oh
severe
pneumonia
cop
000
associated
the
influenza
ili
respiratory
virus
outpatients
virus
vc
particles
pcr
plaque
respiratory
discovery
human
coronavirus
the
hcv
molecular
transmission
ams
disease
ev71
erk1
erk2
replication
propagation
pcv2
hev
infection
swine
virus
tgev
analysis
diarrhea
china
hx
cells
hpev1
type
ifn
genome
measles
emergency
airborne
disease
cases
samples
milk
serum
elisa
individual
ifn
il
syncytin
pbmcs
pg
poxvirus
host
virus
poxviruses
human
treatment
influenza
clinical
blg
trial
ifn
cells
replication
infected
response
dengue
early
diagnosis
cases
95
demand
elasticity
surgery
types
manpower
cattle
eosinophilic
eoe
chronic
diarrhea
sequence
reference
genome
viral
sequences
ovarian
cancer
pro
chemokines
progression
ards
pao
fio
24
svs
proteins
eef1a2
eef1a
cancer
cell
ifn
cells
epithelial
gut
viral
mental
patients
686
study
unlocking
disorders
gluten
celiac
association
disease
neuraminidase
ad3bf2d
oseltamivir
inhibitor
influenza
cq
immunization
cps
protection
immune
nowadays
metagenomic
approach
important
tool
taiep
rat
remyelination
cxcr4
chemokines
viral
sequencing
enrichment
virion
sequences
hadv
infection
china
sari
northern
specific
hiv
cd4
cd8
f4
ifitmdel
hypothalamus
the
mouse
animals
assays
mers
cov
lamp
the
genes
reference
buffalo
different
studies
hrv
pgg
cells
hrvs
pa
aeii
cells
lung
sp
human
transmission
infections
the
potential
novel
docking
ar
hsβadr1
target
surflex
carbamates
carbamate
many
medicinal
chemistry
nan
marneffei
pbrb
the
melanin
conidia
cis
rna
genes
trans
ns5b
arboviruses
virus
emergence
world
viruses
lung
nanoparticles
pamam
nanoparticle
injury
50
ic
hldh
pgg
in
recommendations
infectious
disease
set
key
patients
adv
cidofovir
treatment
pneumonia
social
capital
influenza
study
health
ire1
upr
plants
bzip60
yeast
cases
sss
ili
surveillance
evi
infection
disease
bacterial
genus
afipia
tgf
hantavirus
patients
disease
infection
mbl
masp
genes
tb
rs7096206
sl
sd
groups
lethal
protein
pdcov
anti
samples
igg
porcine
ben
disease
endemic
renal
incidence
messages
health
pollution
data
air
dna
responses
miv
boost
vaccine
vp5
ibdv
pm
virus
two
short
reads
sequence
highly
de
viral
viruses
mimiviridae
uniquely
hairpin
rsv
new
genomes
kilifi
the
hsv
infection
autophagy
cell
conditions
patients
copd
exacerbations
bacterial
exacerbation
bal
asthma
increased
hnp
il
bats
frugivorous
madagascar
coronaviruses
covs
pedv
inactivated
virus
vaccine
dose
infectious
century
ebola
virus
h7n9
health
workers
airport
non
public
mers
cov
the
disease
respiratory
mbap31
human
melanoma
bap31
mms
staff
nursing
students
the
college
astragalin
airway
induction
ova
ros
ha1
h1
aptamers
binding
virus
asthma
exacerbation
the
inpatients
infections
co
infection
h1n1
ss2
swine
nan
virus
fgfr1
influenza
replication
cells
ebola
outbreak
china
the
ongoing
host
investigate
systems
infectious
diseases
mosquito
aahig
nervous
system
infection
vaccines
ib
ibv
multiple
recombinant
vaccines
adjuvants
pathogens
new
vaccine
rsv
the
shedding
virus
infection
influenza
data
hospital
system
results
protein
proteins
the
covs
glycoproteins
virus
vaccines
used
vaccination
poxviruses
flaviviruses
isfs
viruses
virus
infect
animals
breeding
livestock
countries
poultry
3cl
pro
16r
oc43
the
cd200r
cd200
mucosal
mcmv
infection
mers
cov
pcr
swab
specimens
hosts
dynamics
reservoir
infection
antibody
influenza
antibodies
assays
virus
confer
function
clock
iav
lung
infection
mab
hbv
one
infection
hepatitis
protein
virus
cellular
prrsv
biology
themes
phep
research
knowledge
gaps
nan
work
willingness
hcws
risk
meta
animals
swine
influenza
virus
siv
veev
bortezomib
multiplication
virus
inhibitor
pandemic
h1n1
viruses
age
2009
cov
bat
covs
species
different
mirnas
hsa
mir
ev71
predicted
virus
m2e
h7n9
h5n1
influenza
csfv
infected
persistently
piglets
10
ari
infants
urban
respiratory
rural
pigs
pedv
infection
pg
virus
blood
culture
sepsis
naats
the
hiv
mgrft
activity
antiviral
grft
oas
mb21d1
genes
selected
gene
cgas
selection
positive
pathogen
inhibitors
influenza
rs12252
severe
vs
or
masks
cloth
medical
mask
risk
rdna
transcription
pol
nucleolar
structure
angiotensin
fibrosis
ii
role
system
protein
2b
cells
fmdv
the
information
social
infectious
diseases
traffic
segment
phylogenetic
marker
strains
ibdv
detection
mixed
viral
patients
respiratory
drak2
tgf
cells
signaling
cell
ccov
genome
sequence
virus
pantropic
fgl2
ae
treg
multilocularis
cells
myd88
responses
ifn
cells
mice
viral
attachment
membrane
fusion
host
icu
care
capacity
hospitals
provincial
disease
potential
models
fit
data
wnv
the
blood
detection
nucleic
3cl
pro
cov
enzyme
mers
snornas
rnas
human
cells
snorna
practices
livestock
zoonotic
households
zoonosis
issues
nisppi
ethical
pandemic
ethics
inflammatory
dieckol
mdc
ccl22
skin
influenza
bats
virus
serological
viruses
nan
rsv
ili
the
associated
children
ecohealth
approach
research
projects
health
axl
macrophages
macrophage
inflammation
receptor
virus
influenza
transmission
environmental
conditions
ebov
viral
inhibit
intervention
vaccines
copd
mean
hospitalizations
number
temperature
influenza
ili
forecast
model
forecasting
rev
infection
genes
response
host
antimicrobial
japonica
nanoparticles
in
filters
hunov
canine
samples
dogs
human
assay
lcmv
rnas
rt
rna
plethy
analysis
data
package
available
cells
infections
iav
mast
associated
cough
the
anti
consequence
treatment
genes
immune
expression
siv
response
dkk1
bone
vaccine
ra
erosion
neopterin
levels
produced
activated
interferon
dihydropyrimidinase
dihydromyricetin
cyclic
substrates
amidohydrolases
cxcr2
endothelial
recruitment
cxcl1
cerebral
genotypes
arenaviruses
snakes
segment
recombination
hiv
rt
lamp
rapid
assay
patients
tuberculosis
costs
model
study
nan
influenza
pandemic
ae
copd
viruses
hantaviruses
in
western
africa
seroprevalence
scid
children
infection
cmv
severe
fmdv
re
tissues
infected
persistently
development
antiviral
agents
broad
spectrum
diarrhea
pedv
porcine
epidemic
virus
hiv
ifitm3
rs12252
acute
genotypes
swine
mrv3
diarrhea
states
outbreaks
cells
schu
s4
francisella
infection
alte
patients
significant
intervention
respiratory
detection
bioaerosol
asap
the
air
brdc
susceptibility
the
calves
genomic
cells
mmtv
human
virus
tfr1
dpp4
cardiovascular
disease
recent
dpp4i
homology
genomic
several
metrics
biological
pneumoniae
100
respectively
rpm
ivdc1
cov
sars
infection
mice
innate
pa
rna
replication
viral
host
np
detection
rvfv
nanotrap
particles
health
public
inspection
mandated
china
h7n9
severe
fatal
infections
disease
jeremy
farrar
tells
fiona
fleck
c5a
ali
highly
pathogenic
induced
hgf
aecs
influenza
met
tgf
viruses
rna
proteins
nucleocapsid
replication
hcv
p7
the
interferon
drug
cells
fh
hiv
frt
drag
infection
camels
syndrome
age
calves
evd
transmission
epidemic
virus
questionnaire
cases
pneumonia
during
october
2013
chloroquine
treatment
drug
ebola
virus
protection
lc3
showed
ala
hamsters
avian
species
s1
cov
attachment
components
sab
dhi
bsa
equation
pcv2
orf5
protein
porcine
novel
glucosamine
food
women
cardiovascular
disease
oc43
coronaviruses
genotypes
recombinant
nsp12
electron
microscopy
methods
porcine
viruses
nan
nan
pdcv
piglets
rna
porcine
intestinal
motif
rna
gait
virus
like
nan
virus
nipah
heparan
sulfate
infection
quality
medicines
countries
drugs
the
usp14
proteins
proteasome
activity
aptamers
networks
pattern
formation
species
layers
data
countries
livestock
models
used
upr
hiv
protein
proteins
infection
respiratory
infection
information
symptoms
types
nan
cancer
glcnac
present
epitopes
glycans
cases
nipah
surveillance
identified
encephalitis
tap
processing
peptides
peptide
pathways
system
we
often
behavior
cascade
nucleic
acid
isothermal
amplification
the
age
hand
washing
95
ci
fecal
novel
viruses
viral
knowledge
rt
pedv
real
time
sensitive
infection
control
preparedness
ebola
hospitals
the
chickens
different
coronaviruses
dominant
volumes
operation
ssis
cabg
volume
influenza
virus
carrageenan
treatment
infections
peptide
vaccine
antigen
insertion
sites
dna
colorimetric
developed
detection
oligonucleotides
clinical
cats
the
feline
fel
ctsw
iav
entry
viral
knockdown
viruses
porcine
animals
example
novel
cell
tumor
eps8
hla
0201
care
training
health
studies
countries
digestive
efficiency
sodium
dietary
at
commensal
bacteria
immunity
infection
antifungal
antibodies
hiv
recent
engineered
this
viral
gene
expression
influenza
infection
nthi
chronic
suppurative
lung
disease
epidemic
cities
network
journeys
speed
blood
women
plasma
male
transfusion
rt
rpa
denv1
assays
sensitivity
chikv
antiviral
replication
chikungunya
effective
measles
social
media
number
messages
mice
tg
apod
hepatic
expression
implant
mg
implanted
eyes
59
nan
rt
zn
fidelity
co
hiv
changes
tubular
38
felids
lesions
immune
activation
art
hiv
infection
il
sepsis
snp
1β
tnf
nuclear
transport
cell
host
hcv
bohv
mpxv
106
δtk
human
iav
human
pandemic
cpiv
virus
malaria
risk
cambodia
the
framework
influenza
respiratory
the
pandemic
vaccine
pathogens
pathogen
mono
detected
clinical
95
ci
aor
diarrhoea
water
nnpd
piglets
results
coli
bacteria
human
hcov
evolution
gene
oc43
viral
assembly
number
tissue
low
gm
csf
pap
antibodies
alveolar
airborne
virus
ionizer
device
transmitted
gsdma3
mitochondrial
mutations
terminal
domain
hpai
outbreaks
h5n2
awareness
lpai
respiratory
viruses
infections
children
tract
h1n1
epitope
pandemic
influenza
haemagglutinin
ebola
patients
endothelial
treatments
targeting
nan
stem
donors
cell
donor
transplantation
middle
east
mers
cases
puis
contact
mers
cov
hcp
contacts
samples
positive
mers
cov
camels
nan
dna
e7
l1
crt
l2
urban
the
diseases
rapid
global
the
synthetase
assays
5a
cellular
00
100
yi
ppv
sp
pedv
thailand
diarrhea
porcine
epidemic
virus
vivan
populations
population
deep
mice
collagen
cell
brucei
dba
vacuolation
ggt
pylori
vaca
δggt
respiratory
viral
pathogenesis
virus
infection
marburg
antibodies
virus
mabs
gp
agricultural
economic
impacts
firms
consumers
fidelity
associated
wnv
rates
rna
iabp
patients
mortality
in
hospital
esa
influenza
cells
hm
lectin
susceptibility
bovine
brd
genes
pathogen
nan
the
viral
protease
virus
function
pneumoniae
detection
strains
cross
validated
the
lung
conference
lsc
scientific
tas
toxin
antitoxin
the
protein
pedv
strains
epidemic
diarrhea
outbreaks
treatment
bno
1016
efficacy
placebo
cattle
bastv
water
buffalo
astroviruses
mabs
neutralizing
potency
ab
individual
er
viroporins
virus
also
stress
protein
viroporins
channel
two
interactions
ifitms
ifitm3
bacterial
virus
vertebrate
viral
replication
viruses
ion
viroporins
rna
cbpv
proteins
viral
chronic
letx
hmpa6
anthrax
lethal
bacterium
respiratory
vitamin
metabolites
studies
effects
formation
dmv
rna
cleavage
membrane
hmgb1
mab
anti
h1n1
mice
vaccine
protein
mucosal
based
oral
nan
vaccination
influenza
50
64
group
nan
cell
infection
cells
in
ebv
aptamers
ssdna
molecular
recognition
elements
vaccine
cmv
recipients
phase
hct
vaccines
peptide
immune
responses
conventional
lc16m8
vaccinia
virus
gene
non
influenza
vaccines
current
novel
broadly
uri
software
system
data
reports
substituted
abstract
1h
all
compounds
theories
preparedness
disaster
used
behavioral
cfd
volume
air
passage
airflows
outbreak
this
report
includes
summary
tgev
infection
mirnas
mir
4331
plasmid
influenza
virus
in
cells
a4
cv
outbreak
china
caused
influenza
hiv
sari
severe
associated
human
mice
humanized
mouse
transplantation
stat3
viral
pathogenesis
functions
key
csfv
response
persistently
infected
vaccination
tadv
proteins
host
purified
replication
viruses
dna
cress
marine
novel
resistance
genes
antimicrobial
human
worldwide
rpa
tsutsugamushi
typhi
the
nfo
rabies
human
surveillance
vaccine
taiwan
diarrhea
hiv
patients
art
noninfectious
rosuvastatin
after
treatment
symptoms
ground
farms
farm
surveillance
the
movements
uv
plasma
fed
pigs
sdpp
nan
egcg
elastase
neutrophil
migration
a549
pedv
strain
fl2013
virus
china
dogs
cdv
the
vector
borne
cfr
bias
may
causal
biases
mers
qatar
show
high
cov
asthma
rsv
study
wheezing
illness
apol9
antiviral
activity
replication
tmev
sialic
acetylation
casd1
acetyl
acids
hiv
cys
present
protease
cystatin
theta
retrocyclins
peptides
defensin
pseudogenes
boop
tuberculosis
pcr
treatment
hiv
hiv
cells
heteroclitic
specific
peptides
macrophage
viral
polarization
infections
antiviral
nan
small
virus
rnas
viral
sequences
mers
cov
588
fc
s377
aor
95
ci
fri
risk
tbtv
isolates
recombination
three
the
lbp
concentrations
balf
hp
infected
antigen
specific
responses
ad5
ad41
mers
cov
students
knowledge
dental
biosecurity
measures
farm
risk
disease
activation
microglia
cns
induced
astrocytes
membrane
viroporins
folding
hydrophobic
protein
ion
viroporins
viral
virus
several
ifn
viral
isgs
products
rhabdovirus
world
outbreaks
infectious
diseases
response
ns4a
replication
provide
48
binding
antigens
ducks
cercariae
cercarial
igy
gene
ontology
project
classes
microbial
testing
viral
respiratory
care
hospital
scientific
collections
scicoll
research
infectious
bat
human
interactions
rural
ghana
antibodies
qatar
dromedary
contact
risk
ebola
outbreak
countries
travelers
transmission
pulmonary
function
patients
infection
symptoms
rna
2c
atpase
helicase
remodeling
david
stephens
colleagues
describe
experience
nan
hbv
extract
phyllanthus
resistant
gene
protein
disordered
prediction
disorder
also
influenza
h1n1
pdm09
hospitalized
patients
nan
nan
infection
mers
cov
cases
three
group
kd
respiratory
symptoms
patients
viral
mper
membrane
terminal
the
pedv
belisa
assays
ielisa
fmia
mers
cov
infection
eng
respiratory
influenza
pathogenic
avian
ducks
chickens
processes
bacteria
tio
uv
zno
viruses
ifn
rna
non
inducing
phage
filamentous
protein
applications
display
elisa
protein
the
rsftsv
sftsv
virus
frameshifting
tmev
prf
site
morocco
ibv
isolates
chicken
amino
nan
pedv
diarrhea
epidemic
emergence
current
cov
mers
rbd
respiratory
vaccine
tlr
salmonicida
factors
lymphocytes
receptors
murf2
cardiomyopathy
pparγ1
diabetic
heart
epidemics
network
community
contact
epidemic
pecorum
isolated
yamaguchi
prefecture
100
nan
infection
chlamydial
damps
exposure
post
cov
3cl
pro
mers
dimerization
autophagy
infection
basal
role
hsv
family
members
prolyl
research
dipeptidyl
mers
cov
np
ntd
the
virus
scale
drop
asian
seabass
epitope
analysis
virus
ebov
used
cf
aeruginosa
the
microbiota
genera
leishdnavax
vaccine
mice
infected
leishmania
cells
disease
dendritic
autophagy
periodontal
development
lung
birth
oxygen
children
nan
cases
malaria
2005
2014
the
ns2b
ns3pro
complex
dengue
two
taiwan
sars
influenza
health
respiratory
public
health
it
time
shake
ifitm3
nedd4
cells
influenza
virus
viruses
duck
cells
p518
influenza
nan
healthcare
hums
utilization
patients
the
respiratory
child
travel
case
central
hospital
cases
mers
outbreak
transmission
hbov
children
respiratory
viral
samples
fecal
samples
cattle
bcov
btov
the
genome
sequence
mers
99
mers
cov
china
strain
south
diarrhea
pedv
sequenced
strains
porcine
infection
h5n1
virus
cells
hnpcs
mers
cov
27
binding
rbd
farms
calf
disease
management
farm
pedv
ifn
production
mediated
cell
animals
laboratory
schistosomes
different
expression
hiv
ap3
t20
fusion
patients
nan
influenza
viruses
species
unique
human
nan
1977
epidemic
accident
natural
laboratory
nan
lrtis
wheezing
children
95
viral
information
level
health
planet
risks
children
hfmd
viral
viruses
coxsackievirus
size
particles
particle
virus
iav
risk
vaccinated
patients
ili
high
response
phe
responsibilities
health
workers
je
knowledge
attitudes
hcws
positive
cmv
antibody
detection
igg
method
active
mers
period
persons
jeju
nan
japonicum
host
immune
human
mechanisms
igy
in
use
antibiotics
potential
systems
health
approach
outcomes
dynamic
sporotrichosis
sporothrix
cats
brasiliensis
feline
evd
psychological
distress
health
among
codon
marv
usage
patterns
analysis
public
health
abcs
infections
active
monitoring
contacts
notification
imported
cases
mers
cov
travelers
respiratory
california
respiratory
pathogens
identified
travelers
we
host
effects
pathogens
countermeasures
pathogen
titers
immunoglobulin
antibody
respiratory
rsv
kidney
disease
diabetic
cardiovascular
effects
virus
shrews
reservoir
bodv
shedding
community
resilience
the
people
homeless
pipo
slippage
viruses
sequence
expression
igg
antigen
cell
antibodies
hybridoma
serotype
cause
inflammasome
human
haemolytic
cows
ac
bc
response
vaccination
aureus
map27
mice
pgn
ifn
measles
patients
complications
cases
disease
virus
antivirals
viruses
fusion
one
respiratory
virus
bacterial
infections
infection
lambs
infection
age
prevalence
month
hct
mag
hon
amyloid
amyloidogenic
nsp15
1b
coronavirus
229e
the
viral
infection
culex
pathway
mosquitoes
akt
pi3k
virus
infection
replication
cells
cd8
cd4
cell
cns
cell
disease
type
types
diseases
hospitals
pandemic
influenza
irish
emergency
respiratory
infection
rsv
samples
the
health
climate
change
arctic
inhabitants
mers
cov
infection
respiratory
middle
nan
mers
sars
transmission
outbreaks
outbreak
pdcov
strain
2012
we
report
hadv
outbreak
outbreaks
isolates
two
nan
ppis
animals
studies
growth
intake
dna
injection
vaccination
plasmid
muscle
cattle
uk
vaccines
vaccination
respondents
microwave
rca
heating
reaction
temperatures
cpv
strains
2c
samples
new2b
health
one
medicine
science
the
rt
lamp
pvx
pcr
viral
photolyases
cry
light
dna
evolutionary
cellular
antiviral
entry
evd
susceptible
ebolaviruses
macrophages
ebov
cell
factors
species
ebolavirus
cross
antibodies
25
ifitm
ebolaviruses
proteins
entry
viruses
h5n1
ebov
mouse
virus
lethal
rvsv
ebov
vectors
gp
virus
metamix
species
sequencing
data
metagenomic
nan
patients
respiratory
hct
viruses
virus
bacterial
viral
lrti
patients
genes
nan
influenza
h7n9
virus
avian
commercial
microbiota
the
gastrointestinal
tract
gut
old
is
cr88
h120
day
health
airport
public
study
emergency
pandemic
the
h1n1
institutional
vaccinated
viral
il
infected
liver
1β
2013
surveys
first
poultry
urban
vs
respiratory
ad
trainees
01
nanoparticles
tnf
chp
adjuvant
nasal
respiratory
adrb2
tract
infections
severity
adap2
entry
virus
denv
arf6
number
age
contact
early
approach
m336
binding
mers
cov
the
sucrose
udp
quercetin
glycosides
coli
lab
production
organisms
proteins
delivery
ticks
infected
pacificus
range
novel
ebov
mva
virus
pvp
the
tmprss2
isoform
viral
activates
ha
cga
macranthoides
biosynthesis
genes
related
lamp
dengue
rt
rna
samples
sitewise
distributions
diversity
scaffolds
non
rp
results
pct
patients
viral
mers
cov
positive
npas
elisa
animal
use
care
husbandry
practices
rna
viruses
virus
host
factors
hcv
p7
ion
channel
replication
b1648
strain
strains
27
rf
eef1a
ns5a
csfv
the
replication
articles
phi
health
ghi
informatics
children
rsv
young
infants
older
respiratory
critical
the
middle
east
scd
acs
children
mean
the
foals
ecov
thoroughbred
collected
diarrheic
study
hong
kong
h7n9
population
prrsv
tregs
infection
proliferation
protein
pathogens
surveillance
priority
virus
highest
factors
model
emergence
risk
convergence
stress
we
social
free
ranging
molecular
immune
system
ais
composed
haemofelis
cats
turicensis
recovered
infection
essential
oil
the
μg
major
glomerular
viral
children
infection
evidence
sgta
rpn13
degradation
proteasome
proteasomal
14
3ε
cd13
chondrocytes
osteoarthritis
pedv
pdd
50
derived
piglets
treg
cells
suppressive
foxp3
development
eps
7630
cells
il
tnf
pathogens
patient
types
distributions
respiratory
hiv
human
microbicides
chitosan
chlipid
replication
ros
emcv
rna
viral
virus
detection
weeks
symptoms
viral
species
trichophyton
isolates
the
identification
within
complex
using
fast
genome
proteins
host
enzymatic
ubiquitin
sumo
exosomes
viral
vesicles
membrane
composition
viruses
proteins
tj
tjs
cells
ifn
denv
infection
dengue
response
ibv
five
vaccine
isolates
reference
phs
processes
disruptive
innovation
used
baumannii
oxa
lamp
detection
isolates
dpp4
catalytic
peptides
amino
important
mers
cov
evolution
coronavirus
spread
sncd
cd
immunoglobulin
ttg
iga
infectious
population
diseases
china
health
95
ci
model
models
november
spp
me
dogs
infectious
mqpcr
death
mers
risk
outbreak
cases
nan
unknowns
sequence
space
sequencing
often
til
penetration
filter
size
models
disease
virus
recover
full
length
gene
strains
ergosterol
hmgr
copy
spatial
risk
aggregation
test
infections
expected
the
model
average
mycobacteriosis
hadv
types
infection
respiratory
patients
transmission
modes
cases
infection
may
ebola
propagation
evd
artificial
individuals
alri
children
or
afe
respiratory
children
felis
febrile
prevalence
among
influenza
h1n1
pdm09
study
st3gal1
cvcp
chikv
fret
assay
virus
sampling
eluents
recovery
hand
enveloped
pigs
pedv
infectious
tcid
50
tss
patients
placebo
baseline
days
human
viruses
transmission
spillover
host
myci
pedv
ped
piglets
mixture
infection
virus
mammary
influenza
gland
health
legal
preparedness
countries
developed
kd
disease
case
coxsackievirus
a4
genetic
disease
data
genes
complex
group
recombination
the
imported
virus
nan
ibv
genes
resistance
disease
infection
pneumoniae
acute
necrotizing
infection
extrapulmonary
rnf166
ifn
production
virus
sev
respiratory
viruses
multiplex
detection
sybr
acs
patients
18
lung
fdg
codetection
virus
bacteria
respiratory
hospitalized
asthma
microorganisms
studies
relationship
new
cells
immune
mdcs
dcs
responses
nan
infection
reprocessing
endoscopy
gastrointestinal
disinfection
hev
interactions
cycle
viral
ppis
sepsis
use
oads
associated
risk
hpyv6
the
respiratory
15
prevalence
studies
mask
respirator
interventions
control
ltr
promoter
nucleolin
activity
quadruplexes
infections
hrv
respiratory
asthma
viral
nan
classes
respiratory
basic
training
four
influenza
viruses
respiratory
patients
hospitalised
pandemic
pcps
policies
2009
h1n1
rhinovirus
controls
matched
cases
transplant
viruses
respiratory
virus
patients
influenza
aki
ecmo
in
hospital
mortality
mers
cov
the
respiratory
disease
cap
patients
diagnosis
crp
pct
sb
could
when
contract
infection
mers
cov
middle
east
respiratory
papg
protein
acma
fusion
the
virus
equilibrium
the
cell
asymptotic
ms
infection
disease
factors
contribute
ffr
use
reuse
extended
limited
viral
vircapseq
vert
the
sequencing
viral
rna
antiviral
response
rig
nan
nan
respiratory
paralysis
afp
lower
tract
pla
mice
g2d
lungs
expression
nan
nan
snap
no
carbosil
polymer
release
transmission
mixing
we
differences
encounters
prf
gene
expression
signals
global
cap
structure
rna
methylation
end
adjuvant
vaccine
adjuvants
immunogenicity
use
stress
als
disease
rna
exposure
infectious
we
preventive
mers
korea
virus
filovirus
entry
filoviruses
current
public
xenotransplantation
paper
experimental
islet
information
sources
surveys
health
used
mers
cov
respiratory
infection
stillbirth
ebola
epidemic
the
order
ongoing
symptom
study
swabs
the
infections
peptide
chain
self
nanoparticles
length
gp
full
length
fragments
ebov
reference
genes
rt
qpcr
rice
jev
formalin
virus
inactivation
inactivated
lymphocytes
patients
cd4
perivascular
the
ampv
fusion
cell
protein
proteins
denv2
antibodies
neutralizing
epitope
2d22
dna
synthesis
infection
virus
cell
respiratory
los
virus
cat
infection
citations
mrsa
trends
citation
type
wild
hyenas
immune
captive
natural
virus
patients
illness
whether
load
outbreak
mers
kfmc
patients
health
middle
east
laboratory
man
in
case
south
health
patients
as
the
25
antibody
past
industry
pneumoniae
pathogens
children
npa
multiple
pathogens
htr
host
htrs
responses
nan
43
tdp
rna
δnls
cytoplasmic
layer
specific
protein
surface
oral
protection
immune
vaccines
challenge
strain
swab
throat
viruses
nasal
respiratory
pro
host
fmdv
protein
viral
assay
the
rpa
pneumoniae
pcr
ebola
virus
outbreak
scientific
potentially
protein
virus
pbm
sars
cov
lung
cells
cadmium
levels
cdcl
hmgb1
box
high
protein
nuclear
pdcov
chinese
strain
porcine
deltacoronavirus
students
mers
knowledge
among
medical
trna
mcm
ncm
wobble
position
fusion
hpr
he
activity
isav
fes
group
ciclesonide
patients
subclinical
the
hev
australia
human
virus
centered
paradigm
emt
demand
supply
protein
antiviral
recombinant
this
study
influenza
virus
assay
anti
inhibitors
real
time
airborne
particle
micro
non
recurrent
epidemic
outbreaks
periodic
outbreaks
the
virus
patients
15
viruses
pathogens
found
novel
emerging
piv
respiratory
hiv
children
sari
mers
cov
infection
cases
facilities
studies
identified
respiratory
we
tuberculosis
sfts
ifns
virus
ribavirin
effects
cells
poly
pakit03
the
itraq
ifitm3
microbat
pig
entry
viruses
msm
clusters
hiv
sequences
large
media
mass
public
effects
important
respiratory
patients
acs
virus
detected
nan
replication
poliovirus
viral
factories
data
life
small
proteins
cycles
number
viruses
pattern
proteins
baltimore
in
peptides
influenza
antiviral
viral
the
puuv
ne
france
bank
different
pedv
variant
virus
the
protein
rna
silencing
prrsv
viral
cellular
sabin
rdrp
fidelity
nucleotide
poliovirus
ljee
hepatic
nash
mice
inflammation
nan
virus
glycan
neutralizing
spectrum
hiv
antibiotic
patients
viral
pct
intervention
influenza
viruses
infection
viral
interference
rsv
infection
asymptomatic
episodes
the
influenza
viral
positive
ili
viruses
nl63
respiratory
hcov
children
tract
influenza
dogs
virus
subtype
the
rnp
influenza
antiviral
activities
alkaloids
influenza
lp
children
meningitis
orvis
ili
respiratory
children
economic
childcare
rsv
influenza
hospitalizations
alrti
excess
viruses
alri
patients
respiratory
the
hcov
hcovs
infections
patients
clinical
influenza
respiratory
incidence
infection
characteristics
influenza
detection
respiratory
virus
infections
infection
hosts
novel
show
cells
children
icv
cap
associated
influenza
virus
h3n2
sw
gent
08
h1n1
activity
pdm09
influenza
countries
pandemic
preparedness
effective
public
health
influenza
pandemic
future
used
pandemics
h1n1v
rrt
pcr
influenza
european
nan
nan
birds
avastrovirus
astroviruses
two
infecting
sequence
lch
virus
retroviral
viruses
samples
cats
fip
genomes
six
polyomavirus
meles
polyomaviruses
evolutionary
european
respiratory
rtis
virus
pcr
viruses
mers
candidates
middle
east
developing
hcov
oc43
virus
cns
human
pcr
duplex
pcv2
tgev
dna
influenza
countries
laboratory
assessments
surveillance
ward
closure
used
control
we
flaviviruses
viruses
persistent
replication
viral
antitumor
subtypes
play
since
antigen
niv
ards
subjects
the
use
ethical
screening
health
vision
scientific
sstr2
mgt
expression
tumors
mammary
ups
protein
pathway
the
ubiquitin
health
regional
sadc
diplomacy
governance
health
policy
the
union
development
regional
diplomacy
dimension
health
may
network
models
model
ergms
empirical
poliovirus
sewage
wild
surveillance
specimens
health
patients
hajj
mass
arafat
viruses
proteins
tm
viral
membrane
virome
viruses
bacterial
viral
mock
platforms
public
media
health
awareness
sr
cells
myelin
cns
viral
interferon
gamma
virus
ebola
infection
viruses
cells
origin
viral
ancient
transmission
hospital
epidemiological
influenza
viral
leptum
mice
asthma
life
exposure
mers
patients
risk
countries
disease
160
respiratory
samples
pathogens
niger
fcv
cats
infection
healthy
suspect
cells
cns
within
dcs
infiltration
fidelity
rna
replication
viral
nucleotide
18
response
fdg
pet
immune
the
rt
denv
lamp
detection
cells
hsv
entry
peg
b78
dengue
proteins
host
patients
severe
contact
individuals
persons
recruitment
network
n95
breathing
95
ci
mask
viral
patients
mortality
care
hospital
h7n9
10
rs4820294
rs2899292
the
chikv
infection
antiviral
mice
cpmo1v
course
patients
viral
pneumonia
long
children
malaria
illness
the
test
supernatant
pleuropneumoniae
prrsv
culture
cell
mers
rbd
4c2
the
cov
usp15
rig
ifn
activity
signaling
mers
cov
doi
the
respiratory
disease
dynamics
number
epidemic
infectious
handwashing
2014
the
soap
adults
the
attack
outbreak
patients
rate
rgs
genes
expression
stable
results
rna
ssrna
genome
formation
dsrna
mers
cov
infection
cp
laboratory
kshv
replication
rtcs
hsp70
viral
original
indel
pc21a
pedv
iowa106
link
effect
service
pe
poisson
outbreak
evd
the
drc
2014
ace2
adam17
db
islets
pancreatic
mers
cov
protein
hr2p
m2
nsp2
cysteine
residue
alphavirus
protease
je
1bb
ifn
signaling
pathway
alv
lamp
subgroups
method
assay
virus
viruses
screening
host
rnai
hiv
mobility
we
regions
data
ev
d68
2014
cases
in
support
social
women
migrant
stds
er
stress
pathways
cell
upr
infection
hrv
infections
we
observed
human
copper
surfaces
respiratory
viruses
infectious
avian
populations
disease
california
telemedicine
implementation
care
characteristics
healthcare
vaccines
vaccine
the
in
history
cr
vi
activities
domain
site
coronaviruses
model
respiratory
syndrome
coronavirus
134
antibiotics
virus
respiratory
patients
rhinovirus
infants
nasal
healthy
rsv
rtd
stimulated
κb
activation
akt
biological
threats
global
strategies
in
er
protein
upr
pathways
m1
virus
the
dpi
titer
ovaries
plant
diseases
antiviral
virus
herbal
ebov
rt
lamp
method
detection
virus
viruses
must
biosafety
non
fluorescent
protein
fusions
virus
in
cell
pathogens
host
pathways
infectious
scfv
gliadin
pt
gluten
cd
structure
pairs
prediction
improved
constraints
live
birds
2013
wet
markets
retinal
detachment
vitreous
protein
identified
hi
neuroinflammation
cd11c
dcs
cd11b
ifv
viral
card9
influenza
severe
psip411
vp1
mucosal
nc8
wcfs1
pathogens
harbor
ucd
burnetii
disease
pedv
japan
isolates
vaccine
diarrhea
ga
the
macrophage
polarization
macrophages
mers
cov
ifn
orf4b
ikkε
95
ui
diseases
diarrhoeal
caused
fusion
the
derived
proteins
envelope
trim21
cytosolic
environment
antibody
antibodies
genomics
genome
health
the
research
epitopes
cell
mers
cov
vaccine
influenza
sari
cases
oman
epidemiology
nan
microbiota
infection
overall
enteritidis
host
antibody
virus
fet
particles
bound
nan
nan
men
viruses
in
may
2015
nan
an
outbreak
porcine
epidemic
diarrhea
côte
ivoire
pigs
recent
report
responses
mers
cov
neutralization
antibody
bat
host
virus
transcriptome
species
mrna
cleavage
sox
sequence
targeting
virus
microwave
effect
structure
microwaves
virus
therapeutic
antibodies
development
fc
disease
dengue
recent
this
far
measures
local
social
epidemic
two
cells
cd8
ms
studies
role
cohort
hrsc
individuals
animals
disease
patterns
health
claims
regions
orbit
ebola
countries
the
cases
related
mers
cov
pvp
mva
virus
infections
h7n9
h5n1
factors
infection
cheetah
genomic
species
genes
mhc
rsv
95
ci
china
artis
rsv
hae
cultures
infection
cells
quaternary
prevention
harm
implemented
minimize
emps
ipcps
resources
activities
infection
contact
monitoring
public
health
response
public
health
mers
cov
system
mers
korea
outbreak
since
middle
infection
viral
bacterial
respiratory
immunoassay
tace
gene
silencing
regulated
expression
targets
coli
o157
h7
drug
cp
the
ebola
evd
trial
prodrug
mg
kg
given
natural
cvtree3
tree
server
taxonomic
taxonomy
influenza
rna
copy
number
infectious
new
bats
viruses
metagenomic
viral
ep
antibodies
ii
samples
hcv
pneumonia
elderly
microbiota
patients
healthy
influenza
risk
perception
behavior
actions
cov
pro
mers
dimerization
catalysis
rv
children
detected
clinical
species
tgf
oct4
cell
endometriotic
migration
sgta
structure
protein
proteins
function
pedv
sow
milk
transmission
potential
tmv
upd
utr
introduced
poly
influenza
incidence
h1n1
pdm09
picu
targets
alkaloids
cordata
target
isoquinoline
cases
camel
mers
transmission
environmental
arg
expression
hiv
inos
patients
cpb
organs
bypass
possible
negative
oligodendrocytes
infection
demyelination
mhv
viral
human
h5n1
h7n9
risk
coverage
2015
epidemic
analysis
the
middle
coronaviruses
respiratory
syndrome
coronavirus
cov
lincrnas
lincrna
non
coding
rna
mers
cov
human
cells
respiratory
ped
disease
pedv
swine
emerged
cats
felv
blood
infection
provirus
coronaviruses
cov
bats
coronavirus
sars
mers
respiratory
cov
the
reported
acnes
urinary
tract
caused
case
influenza
viruses
early
outbreaks
respiratory
ari
respiratory
pediatric
long
term
pneumonia
children
cases
95
mali
hcv
flunarizine
genotype
fusion
including
mers
cov
infection
severe
study
mers
cov
patients
aki
renal
outbreak
mers
cov
nosocomial
south
cub
codon
usage
bias
species
students
healthcare
conference
medical
nursing
rv
p53
apoptosis
mitochondria
apoptotic
covs
bats
bat
detected
french
em
intracellular
viruses
methods
host
hrv
hev
data
molecular
epidemiology
ev71
viruses
vaccines
also
together
cdc42
cell
entry
cellular
actin
proteins
membrane
conserved
gb
known
compounds
the
validated
molecular
based
g6pd
expression
cells
knockdown
hscarg
quadruplex
viral
toward
selectivity
ltr
disorders
various
several
psychiatric
neurodevelopmental
pmf
plants
plant
produce
therapeutic
pedv
spread
direction
outbreak
sites
european
rabbit
il17a
leporids
structure
saffold
respiratory
virus
strain
while
galn
galnac
bacterial
catabolism
pathway
adp
pathways
ribosylation
modification
post
health
one
eids
approach
eid
pedv
pigs
diarrhea
the
ped
ireland
bovine
coronavirus
bcov
strains
analytical
pathosphere
pipelines
ngs
pathogens
air
device
particles
filter
capture
pedv
virus
italy
swine
enteric
nan
south
korea
strains
virus
an
mers
cov
illness
primary
exposure
patients
mers
cov
healthcare
hcp
nan
wupyv
lung
polyomavirus
detected
respiratory
nan
genomic
health
pathogen
analysis
potentially
nan
travelers
travel
business
occupational
pre
pedv
sows
specific
plasma
virus
pge
pdk1
cell
jun
ep4
populations
zoonotic
human
disease
emergence
drm
phase
the
cells
cholesterol
nan
ns2b
permeability
denv
protein
membranes
protein
dimers
wild
type
monomers
group
serum
xod
control
infected
enr
system
mab
monoclonal
antibody
drug
virus
resistant
dengue
rna
mers
cov
genome
middle
east
iltv
host
ilt
src
interactions
refseq
the
project
data
database
database
ncbi
resources
protein
the
nan
fh
binding
increased
pneumococcal
virus
kombucha
chinese
herbal
fmdv
infection
escape
neutralization
viruses
antibodies
use
prf
upstream
viral
frameshifting
human
flua
flub
influenza
clinical
children
frame
exon
dystrophin
muscular
dystrophy
rvi
clad
lung
transplantation
association
virus
influenza
fusion
hef
receptor
positive
research
self
swabs
respiratory
tanshinones
constituents
applications
activities
pharmacological
colostrum
quercetin
feeding
plasma
reactive
hcv
adenovirus
immunity
ad
vectors
npc1
ebov
filovirus
host
receptor
alv
activation
infection
erk2
mapk
events
studies
cohort
outcome
derived
spp
diarrhea
results
well
control
ifn
like
receptor
signaling
cascades
vesicular
sv
disease
virus
swine
il
ards
leukocyte
stiffening
sera
fusion
ebov
gp
ph
cell
screening
assays
assay
ph
keto
cytokine
therapy
severe
influenza
also
hcv
ifn
isgs
infection
host
lung
vs
group
bipap
il
clinical
laboratories
laboratory
mers
cov
cell
gvhd
hsct
haploidentical
cells
virus
intracellular
cell
trafficking
fractionation
jam
protein
cell
reovirus
reoviruses
pedv
rate
sows
weaning
days
ccov
strains
57
iia
samples
nan
mers
cov
detection
months
protein
outbreak
mers
cov
middle
east
patients
mers
cov
rt
pcr
infection
control
mers
cov
hospital
ebv
integration
cell
raji
npc
fusion
cell
cells
env
from
hypoxia
may
oxygen
mild
disease
phage
peptides
peptide
display
displayed
nan
the
communication
crisis
ebola
outbreak
health
space
journal
geographics
literature
infections
respiratory
viral
children
tract
rna
virus
hiv
infectivity
fss
mers
virus
cov
human
indicate
mers
developed
radiologic
findings
middle
iav
apoptosis
api5
viral
np
neglected
control
transmission
diseases
evolutionary
cap
patients
virus
controls
among
plants
also
medicinal
large
specialized
mers
patient
medical
infectious
epidemiological
nan
ifn
λ4
human
interferon
δg
sars
cov
protein
spike
vimentin
bat
consumption
bats
guano
risk
virus
pedv
icpedv
pigs
rfp
sign
infection
receptors
iav
entry
vaccine
development
virus
system
pseudorabies
strains
pedv
2013
countries
motifs
paediatric
virus
virology
medicine
workshop
cov
clones
using
the
large
bulls
outbreak
the
production
weight
iav
influenza
ha
vaccines
pandemics
rsv
ace2
lung
induced
injury
influenza
quercetin
virus
infection
effective
respiratory
rv
species
ev
viruses
host
disease
wssv
wsd
virus
birds
two
lines
line
ibv
idv
hef
virus
influenza
receptor
mers
cov
outbreak
sample
obtained
hpv
strains
high
risk
cervical
bats
humans
largely
despite
environment
rnase
immune
protein
innate
binding
dogs
exposure
canine
distemper
factors
fever
patients
children
imci
pneumonia
dpi
fecv
shedding
cells
infectious
co
infection
influenza
viruses
infected
ifng
raf
abs
difference
placebo
human
development
emerging
infectious
diseases
rt
qpcr
viruses
array
dpcr
rv0888
extracellular
ms
nuclease
nucleases
cough
face
aerosol
care
workers
viral
patients
changes
during
2015
safv
strain
ur
neonatal
mice
h7n9
patients
liver
hh
infection
mers
cov
respiratory
middle
east
hcov
kenya
nl63
oc43
229e
nan
rse
frameshifting
recoding
site
hairpin
cyt
552
domain
oligomers
coli
influenza
paracetamol
pcr
viral
clinical
respiratory
children
aged
years
we
ebv
virus
tumors
clinical
cell
trfs
trna
ncrnas
derived
rna
virus
vaccine
gene
vaccines
particle
sars
cov
protein
potential
important
vaccines
diseases
eid
tropical
pathogens
serial
interval
estimates
data
phase
host
pa
mrnas
rna
iav
pig
one
antibiotics
production
ppigg
human
respiratory
airway
viruses
cultures
culture
ureaplasma
hominis
specimens
pcr
influenza
prevention
factors
knowledge
migrants
different
transmission
ndv
chickens
lbms
gpsghv
pallidipes
morsitans
glossina
proteins
tests
rad
the
ei
detection
visit
pulmonary
cystic
fibrosis
study
influenza
laboratories
hospitals
diagnostic
participating
influenza
cases
jordan
positive
sari
f4
apn
etec
fimbriae
cells
stroke
2011
the
incidence
one
immunogenic
proteins
gonorrhoeae
identified
first
mers
cov
disease
dpp4
mice
tumor
cpg
odn
cell
lysate
il
rl
phospho
cia
rats
ebolavirus
species
antibody
monoclonal
africa
mir
27b
apoptosis
runx1
tgev
prf
ribosomes
elements
mrnas
ribosomal
immunoadhesins
receptor
human
an
immunoadhesin
viral
mw
replication
virus
hcv
east
mers
animals
middle
cov
nk
cells
type
infection
ifnar
enveloped
viruses
hand
virus
non
environmental
data
test
dispersal
epidemic
korea
public
regarding
infectious
disease
ethical
outbreaks
korea
perspectives
public
viral
families
discovery
studies
across
patients
rsv
respiratory
influenza
parainfluenza
cakv
strains
36
canine
chinese
ibav
infection
endosomal
low
ph
bacteremia
children
rsv
vs
value
low
ttc
thermal
pcr
rna
mutations
cbas
virus
hcv
resistance
irg1
acid
gene
macrophages
itaconic
gp
fusion
ebov
npc1
host
ifn
protein
production
pathogen
derived
dpp
kidney
inhibitors
dn
type
ror
eids
zoonotic
biosurveillance
response
active
structure
monomer
conformation
the
niclosamide
rice
leaf
xoo
blight
hantavirus
species
hantaviruses
fugv
china
ppv
ros
apoptosis
infection
st
il
10
demyelination
areas
initial
cells
antibodies
human
monoclonal
use
ibv
virus
diagnostic
methods
infectious
nan
period
incubation
cases
95
h7n9
settings
critical
care
mortality
resource
trees
branching
memory
phylogenetic
infectious
glycoproteins
viral
viruses
disease
system
diarrhea
strain
pedv
highly
virulent
nan
influenza
ili
the
disease
impact
mva
responses
inoculation
vaccinia
virus
prrsv
vrp
pigs
virus
vsv
nan
mers
cov
bats
respiratory
potential
ebola
reported
risk
the
respondents
viruses
interferon
sting
rna
control
bat
cell
human
filoviruses
entry
fenofibrate
intestinal
significantly
experiment
pretreatment
rnas
rna
the
review
intends
treatment
marv
avi
7288
infection
rna
disruption
cells
apoptosis
degradation
lesions
nomenclature
diagnostic
criteria
the
patients
evd
ebola
countries
affected
pa
protein
truncated
orf
full
antiviral
broad
viral
spectrum
viruses
niclosamide
hcc
cell
cells
apoptosis
hcov
oc43
hku1
novel
the
research
participatory
example
approaches
review
incubation
period
we
analyzed
data
mers
cov
pregnant
as
june
nan
np
rna
binding
influenza
viral
strain
margarita
animals
csfv
virus
virus
ribosome
coronavirus
cov
translation
evd
modeling
epidemic
000
reviewed
phylogenetic
hipposideridae
exon
the
relationships
secondary
cases
superspreaders
number
multiple
ptsd
support
social
recovery
diagnosed
flows
spatial
input
output
sars
activities
myricetin
compound
it
various
percolation
inhomogeneous
occupation
image
see
zoonotic
the
main
lesson
2015
nan
hcp
mers
sars
24
non
parasuis
omv
virulence
bacteria
swine
traditional
wild
used
animal
materials
mers
cov
laboratory
guidelines
specimen
eqa
the
mers
cov
used
cd45ra
cd62l
number
cd3
biological
mhc
class
species
camels
the
recombinant
adenoviruses
fmdv
capsid
expression
inactivation
inactivated
pan
asia
sat
110
cryptosporidia
eimeria
prevalence
strongyloides
defensins
defensin
antiviral
cell
infection
mice
influenza
young
fluzone
vaccines
pep
virus
root
influenza
epigoitrin
nap9
injected
emmprin
napsc
mice
lsdv
td
cattle
outbreaks
me
hiv
infection
virus
cell
ph1n1
htlv
cell
hbz
leukemia
atl
viruses
disease
diarrhea
the
list
proteins
numerous
strategies
better
in
sequencing
novel
pathogens
we
sequences
respiratory
mers
cov
patient
middle
reservoir
human
understanding
disease
interactions
anxiety
the
nurses
working
room
h1n1
001
knowledge
pandemic
practices
cov
wild
species
sequences
coronaviruses
age
infection
months
epidemiological
study
macro
mers
cov
domain
adp
infection
lncrnas
response
virus
isav
lsectin
gp
dcs
inflammatory
ebola
medicine
goitrin
research
herbal
used
nl63
hcov
pro
cov
covs
copd
response
viruses
bacterial
respiratory
data
risk
unit
assessment
process
cdna
rna
viral
viruses
length
cell
caix
g36
cells
rcc
om
predominant
pneumoniae
influenzae
pathogens
ems
pedv
virus
infected
infectivity
peptidomimetics
library
substrates
herein
present
the
disease
fever
ed
flu
cov
mers
bat
hku4
hku5
strain
tw
type
strains
ibv
influenza
sari
among
adult
case
ccov
dogs
the
we
japan
hadv
recombinant
strain
cbj113
genome
infections
viral
sari
viruses
children
ang
colitis
inflammatory
ace2
expression
btv
epidemic
andalusia
transmission
temperature
mers
588
adjuvant
cov
immunogenicity
lncrnas
immune
responses
transcriptional
important
mers
disease
respiratory
reported
source
pathogen
cap
molecular
testing
patients
rna
rdrp
protein
domain
niran
hadv
patients
severe
cap
55
ingredients
pedv
transport
china
batch
pathogens
cytosolic
sensing
response
recent
the
monitoring
diseases
health
disease
transmission
mers
cases
confirmed
investigation
rna
hcv
motifs
packaging
genome
rna
viruses
metagenomic
method
targeting
nan
autophagy
mtor
found
induced
btv1
gp
filovirus
cleaved
rbs
viral
nan
veev
virus
response
rna
infection
selected
annual
update
intensive
care
isolates
hpev
viral
ngs
genetic
oas
the
enzyme
cell
enzymes
im
in
prrs
virus
mlv
il
10
cells
viral
infection
hbv
mm
patients
bortezomib
hepatitis
gonorrhoea
rate
sex
ratio
incidence
bacterial
pneumonia
respiratory
viruses
viral
rpa
cost
plant
pcr
viruses
cell
actin
clathrin
rsv
entry
cap
patients
po
clinical
common
mers
uptodate
outbreaks
cities
searches
diseases
world
tropical
individuals
molecular
pneumoniae
children
cap
infection
may
er
patients
overuse
non
urgent
data
wgs
transmission
studies
diversity
recombinant
expression
system
the
genes
stool
tb
samples
tuberculosis
xpert
wildlife
trade
markets
health
transmission
repertoire
tcr
transplantation
key
graft
di
ppxy
particles
virus
late
drivers
idtes
disease
environment
underlying
jordan
we
characterized
middle
east
nan
infection
middle
east
mers
cov
mers
cov
healthcare
infection
infections
triplex
triplexes
gc
at
dna
enac
salt
cgmp
cpt
sodium
ebov
entry
mbio
fusion
virus
health
this
article
global
reviews
viruses
rna
dna
ddr
damage
model
dynamics
heterogeneity
transmission
case
nan
oas1
rna
polymorphisms
binding
in
mers
cov
camels
human
camel
surveillance
system
data
new
diseases
pdz
virus
cell
human
viruses
pedv
receptor
the
domain
binding
orthoreovirus
virus
protein
associated
genome
3c
pro
viral
the
development
alphacoronaviruses
species
these
described
lucheng
mers
cov
creatinine
mg
respiratory
mers
cov
reduced
affinity
human
psv
could
sapelovirus
receptor
binding
rna
fidelity
virus
viruses
dis
esr
ad
ige
degranulation
symptoms
live
vaccines
many
evolutionary
reversion
fusion
fl
ph
ebov
membrane
codes
korean
medicine
disease
kcd
aptamers
antibodies
oligonucleotide
disease
therapeutic
influenza
cambodia
western
thai
pcr
hal
batfluav
entry
cells
human
coronaviruses
fip
cats
antiviral
treatment
pneumoniae
diagnostic
infections
rtis
age
rsv
patients
outpatients
immunocompromised
infection
influenza
sari
patients
respiratory
viruses
hrv
kenya
hrvs
like
diversity
d68
ev
patients
infection
enterovirus
autophagy
tgev
replication
virus
infection
dtmuv
infection
duck
protein
proteins
gas
scarlet
fever
type
surveillance
nan
rsv
illness
women
respiratory
pregnancy
cvb3
n63y
mutant
plaque
wild
cov
rnase
mers
coronavirus
viral
viruses
bat
eids
ecological
diseases
piglets
pedv
virus
protein
sow
health
partnership
uganda
the
institutions
health
south
occupational
control
national
rig
rabies
antibodies
human
in
nan
viral
mirnas
diseases
tools
represent
policy
the
reduction
article
harm
lamp
gene
toxin
the
detection
wellbeing
gfc
significant
negative
effects
water
notified
agi
drinking
the
epidemic
strains
zikv
pre
virus
ifitm3
membrane
transmembrane
protein
restrict
psilencer
htnv
virus
rna
viral
pedv
prototype
indel
variant
strain
data
we
two
jansen
et
discovery
vaccines
reverse
vaccinology
protective
rna
protein
regions
interactions
disordered
virus
bovine
brvs
disease
rs3x
evd
measures
control
would
epidemic
pedv
antibody
piglets
circulating
body
nt
nmr
rnas
labeling
promises
2015
diarrhea
pedv
detected
porcine
nan
vip
virus
ngs
identification
discovery
zikv
transmission
risk
dengue
chikungunya
species
cooking
domestic
animals
methods
nan
vlp
membrane
proteins
ha
study
respiratory
data
deaths
influenza
among
ards
severe
hypoxemia
early
management
bats
umrvs
using
bat
evolutionary
antisera
equine
dpi
antibody
virus
crew
the
per
illnesses
100
mers
infection
control
healthcare
settings
ace2
vascular
mice
function
angiotensin
knots
rna
structures
physical
long
nan
nan
diarrhea
ped
disease
pedv
china
pcr
dembo
diarrhea
cattle
detection
nan
chip
using
drpa
quantification
nucleic
malaria
iat
risk
ih
ha
agnps
hepg
apoptosis
silver
nanoparticles
particles
sensors
small
nanomechanical
receptor
kosher
brd
map
qtls
used
ra
immunity
tgev
mucosal
vaccination
mers
vaccine
methods
development
obstacles
compounds
reaction
structures
nmr
modest
patients
fibrosis
higher
ct
24
cases
outbreak
mers
cov
hospital
human
metapneumovirus
infection
elderly
manifestations
mers
laboratory
diagnosis
outbreak
response
pedv
detection
method
cpa
detecting
ev
human
5d
cells
antibodies
ido
je
ifn
cns
innate
prrsv
nsp11
structure
dimer
arterivirus
virus
influenza
tmprss2
tmprss4
mice
peptides
plga
pigs
influenza
response
mabs
protein
mers
cov
cell
iav
vrna
rdrp
pa
pb1
m336
mers
cov
human
antibody
g6pd
cells
a549
kd
tnf
value
or
respiratory
severity
children
participants
reported
women
vaccine
vaccination
dogs
c4
bile
acid
malabsorption
rsv
hbv
hepatitis
replication
transcription
mers
cov
patients
treatment
survival
compounds
screen
virus
13
001
database
filovirus
outbreak
outbreaks
response
seds
des
rabbits
groups
eye
low
rsv
lrti
frequency
viruses
tetherin
sgta
vpu
overexpression
non
yc2014
pedv
the
diarrhea
sequence
zikv
drug
discovery
virus
we
host
white
virus
dang
differences
rig
rna
viral
rlrs
infection
ibv
infectious
virus
infection
rt
nan
domain
hev
macro
methyltransferase
orf3
bufavirus
megabat
analyses
recently
protoparvovirus
identified
ebolaviruses
based
five
human
cov
plpro
mers
sars
inhibitor
asfv
viral
entry
ifitms
stranded
fluorescence
metallic
surface
field
plasmons
prrsv
lungs
ssc
mir
30d
go
antiviral
activity
ag
viruses
pertussis
pcr
cohort
detected
respiratory
d68
ev
vp1
adults
elderlies
expression
stress
viral
enteroviruses
cellular
influenza
000
approaches
diagnostic
viruses
host
mechanisms
shutoff
gene
viruses
cchfv
research
limited
molecular
crimean
chains
dubs
pockets
specificity
diubiquitin
ome
48
pneumoniae
mefs
serotypes
mers
characterized
egyptian
we
generated
infections
viral
infection
viruses
virus
innate
inflammatory
trp
cv
diseases
nan
patients
mers
cov
2014
respiratory
nan
pneumococcal
saudi
risk
vaccination
years
influenza
h1n1
pandemic
waves
pdm09
nan
rotavirus
11
peptide
supernatant
protease
nan
immunization
dna
mabs
use
emerging
cov
mers
ifn
protein
expression
nan
mers
cov
human
host
potential
lab
display
surface
potential
applications
per1
lps
innate
immune
ccr2
cell
lines
virus
cotton
epithelial
facemasks
facemask
people
sociocultural
infection
rgst
pedv
expression
proteins
coe
ap
gene
genes
regulated
regulation
dna
replication
quadruplex
tr
associated
patients
mers
severity
disease
mortality
the
patient
virus
clinical
epidemiological
follow
up
patients
ltfu
weekly
nan
horses
ecov
disease
outbreaks
animals
calves
dairy
brd
respiratory
herds
vaccine
influenza
acherv
vlp
ha
rva
trypsin
ncd
samples
isolates
patients
infection
icu
respiratory
middle
dengue
research
the
related
arab
protein
fusion
known
hku1
betacoronavirus
12
chx
hve
groups
versus
ebola
teicoplanin
viruses
virus
entry
mers
patients
persons
hospital
infection
phellodendri
channels
nbaecp
induced
berberine
gammaherpesvirus
bghv8
infectious
msphere
15
bat
viral
gammaherpesvirus
virus
cell
caponpv
genome
genes
group
orfs
bmnpv
infection
genes
resistance
response
nan
the
complications
respiratory
mers
cov
uri
hbov1
aom
respiratory
associated
contaminants
door
pressure
difference
this
children
95
hcovs
ci
age
children
hmpv
inflammasome
severe
response
95
ci
mortality
reported
patients
grft
rice
hiv
os
could
human
including
viruses
methods
used
tgf
β1
plpro
sars
promoter
eebll
ebll
rdrp
eptesicus
bornavirus
ciprofloxacin
resistance
high
targeted
mips
3cl
pro
pedv
coronaviral
coronavirus
fusion
endosomes
viral
mechanisms
membrane
ebola
virus
mabs
q206
q411
diseases
infectious
the
surveillance
response
feline
fipv
coronavirus
3c
infectious
health
public
implementation
policy
factors
liquid
surface
wastewater
partitioning
sludge
care
health
countries
research
the
antibodies
binding
infected
erythrocytes
falciparum
proteins
viruses
adaptation
virus
interacting
influenza
market
lpms
zoonotic
interventions
disease
axonal
2p
ms
damage
cvs
11
genes
infection
rabv
stmv
cp
rna
virus
replicase
evaluation
disease
use
study
arima
lawrence
gostin
colleagues
offer
set
virus
respiratory
viruses
infections
we
source
control
mask
respirator
surgical
porcine
pdcov
elisa
rpdcov
virus
cells
infection
chemokine
cell
brain
pro
active
dimer
ao
processing
antibodies
antibody
therapeutic
development
the
pro
processing
activity
auto
autocleavage
virus
m2
hsp40
influenza
pkr
infection
replication
stages
viral
coronavirus
bat
viruses
identified
infectious
many
disease
parkinson
arrestin
receptor
compounds
sars
pro
the
cov
viral
dc
sign
mycobacterial
ligands
lprg
protein
the
structure
mhv
coronaviruses
nan
enolase
cells
ss2
octamer
enzyme
orf
proteins
mers
cov
pathogenic
immune
signaling
cells
receptors
signals
nan
nan
cladistics
in
organisms
biological
classification
channels
resveratrol
bk
ca
sodium
siba
rapid
amplification
method
detection
rsv
sequence
clades
gene
duplication
sem
electron
microscopy
microbes
viruses
infection
prrsv
suis
pre
response
bv
gd
the
virus
protein
cchfv
bats
species
geographic
range
mers
hcws
patient
cov
contacts
sav3
genes
pathway
cells
to
rsv
five
regions
analysis
indicators
alv
il
infection
levels
induced
htnv
ngs
sequences
genome
analysis
cholera
transmission
vaccination
vaccinated
areas
infected
virus
animals
transmission
animal
nan
mers
cov
evidence
infection
dromedaries
antibody
patients
experienced
we
studied
influenza
surveillance
data
countries
control
alpacas
challenge
rechallenge
trial
the
epigenetic
asds
factors
gene
environmental
development
vaccines
viral
peptide
the
plpro
sars
cov
production
the
uae
hku23
dccov
dromedary
neutralization
pedf
osteoblast
apoptosis
cell
dex
cells
suilysin
respiratory
suis
streptococci
cells
bone
marrow
sildenafil
dna
pdcov
thailand
the
in
porcine
information
mers
saudi
communication
population
pkv
samples
china
porcine
throughout
nan
hbv
bmkdfsin4
activity
scorpion
defensin
periplocosides
aminopeptidase
mechanism
study
chromatography
denv
viral
replicon
system
reporter
stress
rsv
responses
host
response
viral
rcrevs
reporter
replication
virology
vacv
reporter
genes
viruses
applications
host
hcv
replication
mw
factors
hace1
virus
signaling
induced
function
innate
immune
pathogens
factors
epigenetic
pd
melanoma
agent
number
chemotherapeutic
usp18
expression
il
responses
inflammatory
ifit1
antiviral
ifit
proteins
mouse
ace2
shedding
cells
pkc
proximal
ards
pediatric
biomarkers
patients
children
snps
the
detection
rt
lamp
global
in
wake
recent
outbreaks
coronaviruses
hcov
human
htcc
infections
respiratory
healthcare
protection
infections
personnel
types
hpv
vaccines
many
peptide
autophagy
genes
new
mechanism
numerous
ev71
infection
om
erp57
viral
mers
respiratory
baby
woman
emergency
rna
membrane
replication
viral
dmvs
dromedary
east
camel
camels
middle
primate
ifitm
proteins
hiv
nonhuman
cases
respiratory
maternal
disease
severe
search
data
disease
engine
volume
nan
npc1
ebov
infection
gp
viper
denv
genotype
dgv
dengue
japan
hfmd
school
holidays
depletion
susceptibles
igg
group
calves
plasma
concentrations
bp
dogs
canine
respiratory
clinical
euc
cats
mri
clinical
the
salmonella
cows
antibodies
calf
colostrum
probiotics
microbiota
the
evidence
gastrointestinal
indoor
health
air
outdoor
ventilation
prrsv
nsp11
important
control
protein
diseases
medicinal
respiratory
treatment
gastrointestinal
ftd
assay
99
time
custom
immune
respiratory
response
viral
injury
apoptotic
cells
cell
inflammatory
lung
horses
erbv3
fecal
samples
genome
mers
cov
publications
research
the
pdcov
antibody
the
samples
known
zikv
rna
nucleotide
genome
composition
infected
lesions
chickens
respiratory
the
zika
virus
patients
disease
pregnant
ihr
implementation
health
outbreak
public
hescs
animal
cultured
conditions
human
seed
amplification
testing
material
samples
influenza
virus
infection
genetic
shedding
hmpv
transmission
86
sub
observed
viruses
viral
ducks
virome
reservoir
cirrhosis
avascular
necrosis
hip
we
viral
innate
within
days
mucosal
care
cybercare
using
health
patients
membrane
rna
replication
viral
host
vaccination
additional
professionals
vaccine
influenza
pedv
samples
oral
serum
dpe
protein
sporadic
conformational
research
two
isolation
precautions
risks
quantifiable
cost
flocks
42
tracheal
samples
66
shedding
calves
rna
bcov
viral
mrp
farmers
infectious
animal
diseases
repair
ubiquitin
genetic
dna
in
cf
animal
models
cystic
fibrosis
ace2
lps
a779
ards
lung
pcv2
cell
cycle
mir
g0
cases
sle
tnf
308
ifn
data
disease
zika
virus
digital
nan
giant
cdv
pandas
virus
the
respiratory
episodes
febrile
neutropenia
children
npcs
clinical
cells
human
derived
apoptosis
prrsv
infection
cell
procaspase
tb
cc
inh
control
inflammation
pcd
disease
physicians
diagnostic
testing
pathogens
new
ancient
humans
populations
vsv
δp
virus
replication
gene
egf
soybean
human
produced
seeds
dogcv
dogs
diarrhea
study
clinical
trq
il
nf
κb
phospho
adenovirus
modified
live
vaccine
available
consensus
statement
blood
acvim
presented
tgev
actin
egfr
entry
the
sinensis
lysine
biosynthesis
chinese
used
cnp
lung
cells
inflammatory
12
viral
replication
immune
adaptive
type
snps
gene
mbl2
binding
mbl
oh
subnational
stakeholders
health
national
mtb
ifitm
growth
ifitm3
cells
fmdv
nsps
host
proteins
nces
hev
dromedaries
united
arab
emirates
nan
mers
cov
identified
patients
january
countermeasures
development
research
mers
cov
whipplei
detected
febrile
patients
the
nan
host
protein
virus
proteomic
the
pedv
feed
processing
virus
additives
daily
temperature
ipss
oabss
average
cov
bats
covs
gene
reservoir
food
rt
pcr
analyses
rapid
pm
inflammatory
biological
immune
related
immune
peptide
viruses
strategies
host
monitoring
individual
dose
radiation
workers
articles
the
mers
studies
research
cics
cells
stem
cancer
mpscs
influenza
association
hospitalization
patients
h1n1
in
month
editorial
plos
medicine
nan
host
rnas
viral
expression
infection
er
viruses
ne
network
this
virus
fever
nss
the
members
vpu
phosphorylation
type
oligomerization
protein
100
piv3
per
000
years
sgta
ar
size
unchanged
small
piglets
pedv
clinical
porcine
epidemic
wild
disease
boars
aujeszky
serbia
lrd
hct
progression
uri
10
ibalt
pulmonary
inflammation
often
lymphoid
nan
av
1959r
aβ
tau
1980r
cells
skin
wound
healing
csf
np
children
uri
microbiota
acute
viral
infection
quantities
load
severity
mir
122
hcv
liver
gld
vrnps
export
influenza
viruses
nucleus
bacterial
cell
vimentin
host
ifs
rna
ppp
viral
ifit
proteins
patients
surgery
care
icu
the
stressors
stress
gut
inflammatory
production
wnv
dromedary
genome
present
putative
nan
cpv
henan
province
2009
2014
jeffrey
sachs
tells
fiona
fleck
cases
human
h5n1
number
since
hat
expression
squamous
carcinogenesis
cell
wbi
aging
vaccine
immune
youth
bsi
blood
the
organisms
assay
gfp
ros
enterovirus
protein
s11
injury
mechanisms
inflammatory
spinal
cord
disease
hantavirus
hps
alveolar
macrophages
vaccination
dna
dmab
antibody
chikv
frcov
using
protein
serological
ferret
prf
protein
frameshifting
cellular
sequence
bla
oxa
like
pcr
assays
microbiota
cap
sputum
associated
respiratory
porcine
epidemic
diarrhea
virus
member
env
pfv
gp48
tm
distinct
fruit
bitten
feeding
domestic
household
coli
commensal
strains
laboratory
rodents
immune
rsv
patients
pidd
antibody
korea
specimens
respiratory
mers
cov
sputum
samples
methods
pbs
mers
np
ebov
marv
viral
ligand
virus
influenza
reporter
gene
cell
detection
respiratory
upper
airway
sputum
ccr5
mice
ms
myelin
spinal
nan
fit
n95
masks
respirators
medical
journalists
influenza
coverage
avian
pandemic
respiratory
outbreaks
h1n1
reported
late
mfon
diagnosis
osteonecrosis
patients
joints
activation
nasp
quila
nk
vaccine
gene
wild
birds
isolates
influenza
civ
transmission
cats
ferrets
the
assays
influenza
neutralization
antibodies
h5n1
particles
viral
sampler
bioaerosol
influenza
influenza
vaccination
years
vaccinated
increased
influenza
chloroquine
vitro
viral
models
sialic
acid
avian
influenza
viruses
swine
sivs
avian
like
thai
influenza
infection
evoc
study
explants
vaccination
influenza
coverage
care
primary
2009
reproduction
h1n1
influenza
virus
response
host
regulatory
network
based
infection
cpv
cells
time
points
the
mers
cov
respondents
convalescent
resistance
drug
evolution
population
review
influenza
rsv
children
incidence
the
catheter
area
temperature
patients
versus
cases
influenza
confirmed
pregnant
women
cells
b1648
10
viral
rna
influenza
binding
peb
antibodies
spike
immune
frc
network
cell
cells
fusion
andv
cell
gc
proteins
acta
mutants
activation
bacterial
cytosolic
cases
95
incubation
days
ci
patients
mers
cov
infection
the
nan
nan
mers
hospitals
cov
the
outbreak
mers
outbreak
healthcare
korean
cov
hospital
mers
case
cases
days
cap
aureus
mrsa
clinical
antibiotics
coagulation
influenza
iav
pathogenesis
dysfunctional
respiratory
surveillance
community
viruses
laboratory
adenovirus
species
ili
respiratory
symptoms
respiratory
children
human
virus
cameroon
viruses
humans
species
jumps
surveillance
healthcare
china
health
market
herding
evd
guinea
liberia
sierra
leone
children
signs
viruses
rti
respiratory
intestinal
microbiota
constipation
chronic
the
medical
schools
student
in
outbreaks
health
promotion
healthcare
primary
professionals
influenza
vaccine
viruses
virus
who
health
access
open
information
emerging
transport
airborne
infrastructure
biological
public
mers
risk
model
country
importation
animal
models
lethal
bundibugyo
small
lt
toxin
toxins
coli
etec
seals
virus
respiratory
h10n7
seal
adhesins
human
binding
receptors
based
csk
dengue
replication
virus
kinases
research
probiotics
pediatrics
activity
the
building
hospital
energy
sustainable
this
health
earth
human
environmental
epidemiology
mv
attenuated
virus
making
attractive
rsv
head
immunogens
only
pre
codon
usage
bias
festucae
codons
antibody
workflow
immunization
responses
methods
evd
west
may
cases
ebola
mers
hla
cov
02
disease
disease
hygiene
allergic
evidence
microbiome
rhinovirus
hrv
genomes
kenya
primer
medi8852
influenza
virus
ha
potency
mbt
program
effects
online
group
safety
patients
partnership
partnerships
they
nan
helicase
inhibition
unwinding
viral
activity
system
china
virus
including
respiratory
nan
pulmonary
paving
pattern
nodules
pneumonia
keratoconus
disease
tear
fluid
corneal
viruses
bats
pulses
within
emerging
responses
adenovirus
ag
specific
cell
iav
vitro
vivo
replication
competent
viral
rna
granules
stress
cells
ndv
vaccine
vector
human
pathogens
stress
responses
viruses
coronavirus
er
gc
gn
phlebovirus
proteins
viral
responses
chicken
innate
antiviral
trachea
cftr
ganglia
expression
gastrointestinal
tract
pdcov
swine
china
390
southern
opn
ng
ml
plasma
cancer
strains
pedv
genes
indel
chinese
cats
mhf
bacteremia
homologous
challenge
fa9
peptide
htnv
hla
cell
crystallin
gst
lens
glutathione
activity
health
mental
service
psychological
people
nan
rsv
severity
infections
viral
among
zikv
microcephaly
sequence
retinoic
acid
viral
respiratory
samples
upper
positive
β6
lung
injury
infection
αvβ6
irf
pyroptosis
ams
lps
induced
bats
cause
humans
disease
natural
social
control
interaction
geo
patterns
fold
transcripts
metabolic
squalene
changes
influenza
nhs
residents
two
outbreaks
virus
sequencing
rna
nanopore
novel
mers
cov
relatives
pcr
rrt
acute
infection
d68
flaccid
myelitis
mers
vaccine
development
health
international
ia
risk
irf4
significant
found
months
sars
ct
the
thin
science
commons
private
firms
genomics
mrv3
diarrhea
mammalian
orthoreoviruses
described
ahsv
virus
vp6
defective
serotypes
np
sam
influenza
m1
cells
protein
fitness
sequence
involving
space
mortality
ards
patients
years
the
chinese
contact
human
networks
college
ed
raft
malaria
days
setting
pertussis
clinical
infants
patients
respiratory
yoa
ili
illness
95
h1n1
quantitative
linear
samples
compounds
the
jean
paul
chretien
colleagues
argue
avastrovirus
pl
g059
2014
astroviruses
fatal
adv
cases
patients
pneumonia
viral
passage
virulence
host
increased
mers
cov
recombination
evolutionary
many
outbreaks
disease
mass
respiratory
gathering
mers
cov
human
m336
mice
ang
cells
angiotensin
treatment
oxidative
pneumothorax
001
patients
higher
picu
infection
china
contact
tracing
monitoring
plasma
mers
cov
antibody
convalescent
ad
infectious
diseases
cancers
responses
nan
tgev
pfcrn
nf
κb
cells
climate
disease
change
temperature
increased
tuberculosis
cells
activity
infection
mycobacterium
chip
microfluidic
sample
based
nas
diseases
zoonotic
disease
criteria
prevention
proteins
denv
rna
factors
viral
chagasi
lbsapsal
vaccine
infection
leishmania
nlm
information
2010
disaster
long
ns5
cells
host
cell
phase
co
rats
use
volume
per
public
the
ebola
bdi
analysis
ebov
clomiphene
isomers
entry
infection
animals
sheep
goats
horses
mers
mcp
chikv
infection
production
monocytes
infectious
nano
carriers
kill
inhibit
sua
patients
ta
mortality
level
ventilation
noninvasive
pic
window
patients
air
rooms
objects
pneumoniae
patients
pedv
akt
pi3k
pathway
replication
hcov
coronavirus
prevalence
patients
samples
moonshot
cancer
successful
effort
we
brain
immunotherapy
tumor
therapies
tumors
nan
medical
disaster
medicine
students
course
time
mers
importation
the
risk
recombination
assay
region
poliovirus
fidelity
isgylation
isg15
viral
virus
hcmv
sars
bme
spatial
temporal
epidemiological
cardiac
dize
ace
ace2
effect
species
microarray
specimens
pcr
identification
sgiv
vp88gfp
virus
infection
assembly
rantes
tbev
brain
virus
irf
atg
autophagy
proteins
replication
independent
atg
proteins
autophagy
related
increasingly
respiratory
samples
like
hcov
acute
dna
immune
the
effective
cytosolic
bsl3
respiratory
isolation
wards
protect
immune
techniques
the
selectivity
diversity
senescence
changes
astrocytes
genes
aging
viruses
humans
virus
transmission
respiratory
public
health
models
used
epidemic
response
primary
memory
cells
t1ifn
healthcare
personnel
the
influenza
h1n1
hiv
antibodies
mediated
internalization
antibody
hpev
clinical
infection
fever
palmar
patients
direct
the
h7n9
disease
myc
ifn
antiviral
nb
amplification
ciguatera
patients
recurrent
gene
expression
nan
frameshifting
one
synthesis
utilized
products
diapause
melanogaster
adaptation
heads
phenotype
isolates
fhv
the
clinical
genetic
ccl2
je
ccr2
role
jev
tlr2
mice
mhv3
viral
mhv
mers
using
cases
korean
google
viral
assembly
irma
genomes
reference
qdnos
quinocetone
combined
mycoplasma
the
viruses
therapeutic
drug
development
rnai
hev
hepatitis
infection
genotypes
virus
melanoma
patients
therapy
treatment
identify
human
disease
approach
virus
infectious
control
structures
outbreak
infectious
effort
bats
species
important
viruses
network
nan
bmv
recombination
rna
we
crossovers
cov
helicase
nsp13
mers
rna
face
shields
protective
equipment
personal
mir
155
mice
cns
viral
diseases
mers
global
infectious
cov
influenza
egypt
sari
november
positive
aerosols
csd
scientific
cleaning
search
biomaterials
regeneration
implants
organs
promote
hand
hygiene
study
attitudes
practice
production
expression
grft
plant
protein
zikv
required
phobia
upcoming
events
indoor
contact
model
ventilation
airborne
il
10r
immune
tmev
infection
mumps
infection
providers
rare
the
fusion
the
coronaviruses
trimer
potential
astrocytes
cns
cell
neural
focus
virus
viruses
respiratory
patients
infection
aptamers
modern
infectious
development
nucleic
hdct
auto
sct
transplant
infectious
assay
gexp
cap
virus
viruses
vaccine
derived
viruses
the
newcastle
mers
cov
risk
severe
disease
cells
chpv
cd14
virus
the
viral
np
protein
isgylation
virus
ns1
2h6
residues
binding
antibody
isgs
antiretroviral
activity
late
replication
rsv
response
vaccine
th1
immune
cov
vaccine
lung
inactivated
mers
metal
ion
patients
testing
armds
countries
dengue
income
high
control
carriers
fmdv
non
vaccinated
genes
viral
iav
shutoff
cellular
translation
phev
piglets
strain
dead
cc14
cats
diseases
might
immune
arthropod
lps
choline
administration
calves
proteins
ap2
group
genes
gene
type
dwv
viruses
quasispecies
honey
bee
cells
sr
cns
autoimmune
specific
tuberculosis
bcg
efficacy
infection
immunological
strains
peptides
ibv
m41
conserved
influenza
viruses
ili
swabs
surveillance
tnf
dtt
clinical
epitope
arthritis
risk
travel
restrictions
epidemic
disease
norvegicus
zoonotic
virus
diseases
important
mabs
immune
antiviral
viral
potential
expression
epithelial
gene
cells
reliable
host
encoded
assays
interactions
cell
health
care
disease
systems
outbreaks
sapovirus
family
infection
group
african
response
infection
sars
cov
the
gii
diarrhea
nov
cases
hucv
cpv
2c
taiwan
variant
variants
resistance
articles
carbapenem
top
publications
rva
strains
bat
novel
bats
er
pyv
cytosol
erad
machinery
viral
host
protein
er
envelope
protein
antiviral
trim52
trim
activity
idl
fusion
hiv
peptides
cp
cyclophilin
drug
cyclophilins
ppiase
inhibitors
hrv
vaccine
nab
inactivated
types
dengue
laboratory
confirmed
clinical
hospital
mask
period
rvis
surgical
hsct
celisa
sfts
sftsv
the
disease
ddx19
iav
rna
viral
host
specimens
surgical
tss
who
grade
children
pneumonia
disease
mortality
severe
we
outbreak
discovery
communication
2010
clinical
blood
patients
we
evaluated
antibodies
long
persons
outbreak
to
countries
middle
east
cases
number
coronavirus
rousettus
bat
gccdc1
ro
amps
iav
proteins
novel
major
arthritis
inflammatory
pathogen
chlamydia
studies
the
intestine
proteins
antigen
hookworm
microcephaly
zikv
we
maternal
clinical
zikv
virus
plasmid
infectious
mr766
strongyloides
hyperinfection
shs
high
recurrent
rsv
fi
vaccine
pre
post
endophytes
microbes
plant
source
endosymbiotic
denv
rna
eri3
dengue
required
phage
vaccine
display
vaccines
high
policy
hcws
agenda
solution
policies
xb130
lung
ko
mice
significantly
mcp
changes
pain
cystitis
bladder
chikv
rt
rpa
assay
virus
the
compound
phenol
rich
sweet
ifit1
piv5
mrnas
virus
antiviral
protein
tgev
the
5e8
replication
knowledge
attitude
practice
dental
airborne
health
the
diseases
policy
need
cases
mers
we
transmission
single
safety
patient
industry
healthcare
systems
immune
clinical
experimental
antigen
complexes
clinical
ards
patients
guangzhou
h7n9
cchf
disease
vaccine
virus
crimean
nan
genetic
cc
drug
expression
variation
microbial
host
functional
pathogens
disease
ebov
nigerian
data
outbreak
20
virus
the
west
transmission
aerosol
zebov
convalescent
animals
treated
sera
pleuropneumoniae
herd
antibodies
hyopneumoniae
levels
ccr5
cd4
je
foxp3
tregs
mers
cov
transmission
camels
humans
positive
shelter
conditions
dog
shelters
pten
stat3
arthritis
activation
autoimmune
protein
binding
enzyme
the
fragments
doffing
process
donning
processes
equipment
zikv
health
capacity
who
virus
public
participants
risk
communication
health
nss
transcription
rvfv
general
inhibition
xrn1p
virus
yeast
we
degradation
infection
tgev
mitophagy
mitochondria
viral
rsv
chd
one
patients
korean
free
trees
alignment
cvtrees
inferred
filovirus
we
genes
ebola
infections
epitopes
leishmania
cysteine
proteases
predicted
drug
factors
aerosol
delivery
therapy
kd
immune
innate
disease
vasculitis
ras
stroke
angiotensin
regulation
functions
specimens
cf
bacteria
cough
patients
ctsl
mice
infection
infected
influenza
fic5
fibrinogen
blood
terminal
releasing
patients
severe
group
serum
week
pneumonia
cap
data
development
outcome
cats
fmopv
ab
rna
infection
normality
pathology
areas
detection
diseases
patients
respiratory
viral
pneumonia
mortality
ped
herds
positive
per
the
mouse
mab
feline
anti
antibody
hrv
species
vp4
vp2
human
influenza
respiratory
samples
viruses
positive
fear
fears
health
expatriation
study
prf
ligand
rna
sars
theophylline
rosavirus
rat
different
rats
novel
avian
coronavirus
causative
agent
infectious
95
home
or
ci
incidence
ibv
like
gd
strain
tw
adam17
several
cell
cardiovascular
metalloprotease
ha
virus
na
pseudoparticles
influenza
caspase
11
cell
sepsis
death
viral
5a
innate
rnase
phosphodiesterase
infection
pulmonary
infections
host
lung
epidemic
day
vector
host
movement
lncrnas
hiv
expression
infection
mrnas
nmi
roles
myc
protein
physical
omics
multi
measurements
sample
integrative
rna
viral
high
ngs
and
environment
knowledge
complexity
indoor
findings
hand
hygiene
compliance
abhr
intervention
lincrnas
the
aegypti
lincrna
host
coronaviral
poly
tail
polyadenylation
coronavirus
chloroquine
ph
infections
viruses
low
cryo
em
structures
complexes
large
viral
prrs
viruses
pathogens
immunity
rsv
patients
positive
clinical
729
dengue
virus
protein
print
srece
pharmaceutical
health
public
non
respiratory
volunteers
deployment
health
care
participants
viral
hepatitis
therapeutics
significant
essential
viruses
mutation
rates
viral
diversity
dengue
virus
rna
disease
inhibitors
sav
prv
salmon
disease
development
hbov
respiratory
infection
human
samples
zikv
detection
tools
the
current
diseases
chronic
various
inflammatory
inflammation
children
tb
respiratory
detected
ptb
incubation
period
south
korea
cases
p2x7r
th17
il
cells
cii
csf1
liver
macrophage
fc
increased
mers
outbreak
patients
icu
hospital
alv
ev21
m180
env
gene
avian
pb1
f2
virus
length
sv
korean
strain
could
piglets
astrocytes
interferon
virus
response
viral
product
manufacturing
process
phpi
the
hiv
lncrnas
host
coding
expression
mers
cov
response
stress
p4a
matrix
exosomes
trabecular
meshwork
exosomal
communicable
diseases
dalys
100
000
autophagy
topics
membrane
noncanonical
may
nan
model
mss
niv
routes
virus
bacteria
patients
291
infections
acute
anti
car
cells
cell
human
crp
mg
exacerbations
iqr
episodes
plant
vaccines
hepatitis
hepb
health
surveillance
viral
humans
host
metagenomics
ifv
respiratory
viruses
detected
common
bat
bats
reported
hunting
households
rbv
viral
hev
viruses
population
grft
griffithsin
lectin
viral
activity
pb1
f2
iav
neutrophil
factor
nan
mers
cov
healthcare
patients
personnel
nan
ped
outbreaks
england
confirmed
analysis
pandemic
health
cultural
ethical
influenza
fecal
puppies
iga
calprotectin
concentration
clinical
the
animals
holstein
cattle
cats
ibd
47
symptomatic
27
patients
rsv
infection
aged
years
actin
arp2
nuclear
polymerization
infection
ifitm3
antiviral
ifitm
host
virus
a2mc2
p90
the
virus
type
clinical
tests
pathogens
multiplex
the
cns
immune
cell
ms
infiltration
directional
changes
observed
influenza
viruses
patients
evd
blood
survival
survivors
lsdv
virus
rpa
assay
the
mers
cov
patients
negative
health
system
supercritical
transmission
time
we
tb
risk
increased
10
association
cats
cuniculi
antibodies
samples
295
cha
lamp
one
oht
promising
anv
polysaccharides
used
inflammatory
human
virus
50
mice
nj06
h9n2
cases
the
influenza
2009
study
ev
d68
infection
vanbt
cotton
rhizoctonia
solani
species
different
mycoviruses
residents
nh
ari
staff
respiratory
mers
vaccines
vaccine
cov
human
antibody
antibodies
engineering
meeting
the
model
mab
capital
cost
kg
gr
su
gra
aureus
strains
media
data
model
influenza
studies
mers
cov
cases
saudi
pediatric
gltscr2
viral
infection
replication
ifn
subjects
inosine
pranobex
placebo
50
ufs
rna
genome
cyclization
viral
ch
phosphonates
μm
abstract
the
ptsd
follow
up
2000
social
viral
inflammatory
infection
alveolar
immune
disease
wildlife
nidovirus
virus
detection
isgylation
isg15
hbv
hepatitis
ifn
ards
patients
findings
adenovirus
pneumonia
cytokine
cytokines
hiv
infection
disease
ehrlichial
class
iii
ptdins3k
chaffeensis
dmog
ascs
bone
1α
treated
behavior
planning
individuals
prophylactic
the
bats
study
general
scientists
research
ifn
in
cascade
viruses
the
2015
two
diarrhea
pedv
jsls
genome
sequence
oc43
we
report
porcine
circovirus
cardiac
three
used
nan
nsp2
chikv
ala
protease
virus
pathogenic
pathogens
bats
known
potential
homogeneous
mixing
epidemic
contact
peak
antiviral
expression
ifnλ4
ifnl4
we
hadv
higher
ard
7d
hadvs
mers
heterogeneity
intrapatient
analysis
specimens
paired
receptors
ceacam1
ceacam
two
bacterial
patients
viral
cap
etiology
cases
ebola
funeral
we
data
glucose
tgev
intestinal
absorption
sglt1
zikv
venezuela
zika
china
family
gc
gn
viral
precursor
infectivity
mice
zikv
disease
infection
b6
cell
fragments
stability
wall
antibody
bat
fruit
abundance
models
spillover
dogs
giardia
fecal
enteropathogens
dog
expression
hbv
ptt22
cells
mannosidases
infections
respiratory
viral
asymptomatic
molecular
health
disease
virus
ebola
international
codon
zikv
usage
specific
patterns
pigs
pedv
old
10
dpi
ace
lung
hyperoxia
human
cells
ev
d68
children
2014
infections
segment
different
sea
in
pbvs
infections
microbiota
hrv
diversity
associated
08
3575
ibv
2575
viral
cell
cells
igm
igg
memory
ards
viral
infections
respiratory
treatment
neutralizing
epitope
vaccine
nii
mers
cells
bats
bat
cell
subsets
ifv
infection
mint3
production
influenza
health
who
global
outbreak
governance
group
asmq
u27
tumor
model
aircraft
diseases
virus
spread
health
hcov
respiratory
infections
rsv
common
adenoviruses
colobinae
wiv19
full
length
ace
ad
activity
ang
ii
resistance
the
articles
insecticide
malaria
pedv
strains
isolates
diarrhea
china
cancer
the
effective
care
experience
health
local
estimates
data
global
tb
ntm
diseases
spot
the
virus
h5n1
cell
hpai
infection
membrane
fusion
sars
peptides
curvature
zikv
codon
usage
analysis
pattern
virus
verdinexor
influenza
antiviral
mice
cells
sm934
therapeutic
mice
arthritis
hajj
respiratory
infections
pilgrims
india
compounds
ebov
antiviral
activity
disease
rabies
viruses
vaccine
novel
strategies
cell
cells
lines
immortalized
replication
db
the
tool
sequence
analysis
host
tissue
complex
human
rwv
grft
mg
kg
toxicity
activation
the
research
for
2016
end
pdcs
ido
tregs
functions
cells
rnai
proteins
suppressor
activity
alphaviruses
usc
vs
usual
ci
care
tw
ehv
ns
detection
equine
campylobacter
publications
articles
international
the
patient
healthcare
associated
colonization
infection
death
risk
mers
studies
associated
hfmd
ev
a71
asia
studies
oh
research
south
asia
training
health
china
human
animal
rapid
ifn
treatment
apoptosis
cell
cancer
hcov
assay
infection
melting
the
health
public
coverage
2009
nephsp
scd
malaria
study
respiratory
prevalence
kd
patients
may
diagnosis
features
vulnerability
labor
market
groups
status
cap
pa
children
group
the
learning
flipped
classroom
pgy
students
143
febrile
seizures
children
one
china
health
aid
african
africa
influenza
virus
viruses
vaccines
viral
dogs
cakov
japanese
gene
latter
pneumonia
co
infection
10
expression
asthma
chronic
respiratory
recently
role
rv
wheezing
atopic
induced
non
samples
h5n1
influenza
aivs
detected
pcr
positive
hmpv
respiratory
mrt
membrane
formation
structures
replication
immune
infection
ssm
mcmv
nk
subcapsular
mers
patients
cov
acute
febrile
liver
lobeglitazone
patients
nafld
cap
camels
climate
in
pastoralists
started
hepg2
tmem2
cells
15
hbv
depression
interactions
world
risk
human
angiotensin
reperfusion
myocardial
ischemia
injury
data
internet
epidemiological
outbreak
ebola
data
method
epidemic
incidence
analysis
eav
equine
stallions
cd3
long
protein
chemical
amino
nature
we
ccr2
wt
cns
monocytes
hsv
levels
hepcidin
treatment
fe
serum
rv
arunachal
pradesh
samples
study
systems
surveillance
web
based
infectious
bat
immune
cells
dc
csf
respiratory
syndrome
novel
coronaviruses
acute
pedv
pcr
samples
method
preclinical
mers
elisa
cov
elisas
ppnt
stress
resilience
healthcare
pandemic
evidence
viruses
virus
cases
positive
children
measles
health
cases
public
interventions
ebola
preparedness
countries
virus
health
assays
zika
virus
detection
samples
chip
membrane
surface
binding
kinetics
pcr
dna
qpcr
multiplex
well
influenza
viruses
transmission
events
infections
rsv
patients
respiratory
children
detected
studies
roses
statement
results
reporting
influenza
pilgrims
tested
hajj
pilgrimage
macrodomain
adp
virus
innate
mutations
replication
pi4p
organelles
fmdv
membranes
pandemic
influenza
virus
risk
the
isgs
mycobacterium
tracheal
mucosal
specimens
h1
swine
nomenclature
iavs
viruses
piglets
pedv
farms
qpcr
clinical
mpp
apoc1
children
idc
hc
alv
infection
mdm
immune
cells
zikv
dpi
interferon
treatment
infection
dose
vaccine
fractional
vaccination
efficacy
rotundus
species
may
domestic
samples
human
antibodies
vh
vl
cloning
health
response
public
research
clinical
lf
mrd
mm
surgical
point
pedv
protein
epitopes
two
mabs
nsp11
ifn
endou
prrsv
suppression
frameshifting
one
pseudoknot
base
mechanical
rna
ebov
trailer
replication
hspa8
norovirus
detected
harbor
porpoises
previously
children
respiratory
in
june
july
rats
ratpyv2
polyomaviruses
polyomavirus
known
nan
nan
isolation
symptoms
mers
anxiety
anger
nan
influenza
virus
aiv
specific
np
l1
cross
vaccine
neutralising
antibodies
cells
infection
virus
epithelial
epithelium
ifv
respiratory
high
capacity
infection
tio
nps
lung
inflammation
rutile
behavioural
surveillance
disease
pandemic
could
american
viruses
aiv
lams
south
mers
cleavage
fusion
cov
spike
clade
mers
15
2012
dromedaries
lamp
herbal
identification
medicine
medicinal
cd8
il
cells
10
effector
viruses
human
zoonotic
virus
transmissible
mers
cov
infection
vaccination
knowledge
nan
rna
vectors
replicon
viruses
virus
zikv
chloroquine
cells
infection
virus
pedv
yn13
yn144
analysis
diarrhea
protein
tgev
1c3
the
study
grft
viruses
virus
rats
oral
wnv
immune
equine
virus
ab
retroviruses
galv
melomys
transspecies
transmission
cryo
em
biological
china
electron
nan
trimer
potential
coronaviruses
entry
glycoprotein
phages
viruses
airborne
ms2
stranded
fever
respiratory
virus
adult
confirmed
viral
aptamers
proteins
diseases
virus
ho
dcs
inflammatory
expressing
cells
the
hajj
pilgrims
vaccine
diseases
influenza
laboratory
age
like
beijing
mers
the
hcws
cov
infection
infectious
diseases
military
emergency
mechanism
sites
structure
coronaviruses
secondary
conserved
children
adv
coinfection
respiratory
infection
nan
translation
initiation
protein
mrna
eifs
rig
signaling
viral
recognition
antiviral
htnv
ifitm3
hfrs
interferon
infection
protein
npm1
pedv
nucleolus
cell
h1n1
mers
cov
diabetes
prevalence
median
range
patients
platelet
acutely
rpa
feline
fhv
pcr
exo
brain
muv
jl5
the
measles
em
map
gaussian
functions
applications
salt
filters
coated
virus
filtration
mers
concern
cov
the
saudi
breath
patients
the
vap
suspected
viral
sequences
viruses
metagenomic
samples
virus
resource
variation
the
added
viruses
mrprimerv
primer
pcr
viral
data
eupathdb
new
include
pathogen
japonica
tissues
unigenes
different
enriched
dna
virus
proteins
interferon
sensing
ifitm
proteins
viral
ifitms
entry
lamp
200
amplification
dna
rapid
forest
monodominant
dewevrei
found
forests
mers
cases
cov
saudi
patients
host
peptides
antiviral
viruses
exhibit
motifs
protein
interactions
viruses
host
the
pedv
model
outbreak
swine
prv
lynx
iberian
the
pseudorabies
specific
lamp
reaction
rapid
one
hcv
formation
mw
replication
autophagy
norovirus
assay
the
human
detection
nan
viruses
host
human
proteins
strategies
178
we
information
models
bcms
foals
versus
nd
enteric
25
binding
sars
receptor
the
cov
measles
immunization
patients
sri
age
health
ipc
care
hai
quality
mask
ili
respiratory
medical
index
trypsin
interleukin
1β
cytokine
influenza
viral
rt
pcr
children
single
based
respiratory
target
scale
pcr
virus
natalensis
animal
reservoir
geographic
vp40
bag3
virus
domain
ww
zoonotic
growth
livestock
spread
disease
ubl2
plpro
domain
mers
stability
ibv
lipid
rafts
cells
attachment
proteins
protein
analyte
detection
go
denv
antibody
opsonized
lilrb1
dengue
patients
alt
levels
ast
respiratory
health
system
lebanese
resilience
refugees
ms2
the
rna
viruses
plp
ifn
sfts
patients
sftsv
protein
arms
placebo
group
study
uris
cds
in
used
able
numerous
nan
smear
lamp
microscopy
sensitivity
specificity
afp
human
we
growth
concluded
canine
pcr
respiratory
multiplex
cirdc
mss
stochastic
prediction
models
number
surveillance
cases
disease
hospital
we
hmpv
children
rsv
infected
lrti
denv
sk1
infection
brain
responses
pe
forum
the
inventory
regions
pedv
infection
variants
outbreaks
report
plasticity
inflammation
developmental
signatures
neuroplasticity
viral
rna
sewage
extraction
kit
pedv
feed
facility
contamination
rna
pa
polyadenylation
hbov
d2
end
cox
sapovirus
pge
psav
pathway
viral
genome
classification
viruses
sequences
ebola
hemorrhagic
fever
infection
health
virus
subjects
respiratory
viral
qpcr
group
apoptosis
model
sanfh
lev
viral
viruses
host
replication
rna
oit
fa
kakkonto
mouse
allergic
ms
models
pathogenesis
experimental
important
dc
signr
colon
cancer
metastasis
infectious
poultry
ethiopia
virus
respiratory
outbreak
cases
mers
saudi
non
genome
polyomavirus
isolate
2016
we
resilience
methods
studies
adversity
common
balance
system
spine
3d
experimental
pneumonia
hadv
patients
military
outbreak
treatment
serum
crp
dogs
bp
ebola
serms
drugs
anti
accumulation
usp18
functions
ubiquitin
many
protein
xmap
multiplex
detection
technology
simultaneous
zikv
countries
travellers
affected
risk
probe
qpcr
taqman
rt
second
zikv
born
pups
zika
efl
alp
egf
mouse
eriocheiris
protein
ari
meteorological
indigenous
seasonal
protocol
care
patients
costs
eol
ckd
chikv
peptides
host
the
molecular
nan
hrv
a21
infections
artis
the
viruses
er
functions
host
cells
patients
children
results
etiology
the
dc
domains
sign
repeat
units
epidemic
transmission
host
phylogeny
different
dendou
drosophila
eukaryotic
member
family
patients
mx1
allele
aor
the
2h
family
enzymes
active
site
unmet
need
public
medical
pension
camels
vs
seroprevalence
detection
antibodies
oc43
hcov
genotypes
recombination
clusters
the
patient
imported
case
rift
nsp15
replication
cov
rtc
rna
dox
demonstrated
mitochondrial
ros
induces
kikuchi
fujimoto
disease
cervical
testitis
sars
the
cov
covs
epidemic
vaccines
virus
particles
vlps
small
eswt
could
trials
included
onfh
adp
viral
ribose
macrodomains
poly
mvv
cell
line
originated
goat
cpv
clinical
immunochromatography
test
pcr
patients
persistent
hrv
infections
infection
lrds
crv
mortality
respiratory
sct
health
world
korea
past
who
the
parasite
malaria
blood
signatures
virus
the
america
health
spread
prrsv
synorf5
hp
vaccines
formulations
ltr
hiv
quadruplex
the
structure
ahsg
ibd
patients
anti
antibodies
patients
piv
the
unit
icu
mers
cov
rna
in
rrt
influenza
virus
respiratory
cases
viruses
vsv
846
bcg
long
term
ahei
purpura
progressive
purpuric
swelling
astrovirus
infection
immune
understanding
response
methods
astrovirus
various
current
diagnostic
pedv
passage
porcine
diarrhea
virus
nnv
infection
grouper
sevenband
nervous
ards
vitamin
patient
high
dose
dna
light
vlrps
photocatalysis
types
transport
ecmo
patients
system
interhospital
conditions
myocarditis
overlooked
threatening
may
ev
d68
viral
production
host
malaria
elimination
control
county
years
influenza
viruses
vaccines
virus
reverse
the
challenges
research
nursing
outbreak
ma5
91
urt
level
vaccination
articles
pathogens
retrieved
severe
global
organs
prisoners
human
china
chinese
env
trimers
structure
structures
trimer
chest
clinical
young
children
bronchiolitis
rsv
rt
siba
rapid
the
tio
anthrax
nps
light
np
influenza
data
confidence
surveillance
state
fip
cats
pi
dry
treatment
injury
fall
fracture
the
related
mers
cov
resveratrol
antiviral
infection
bronchiolitis
viral
los
or
95
viruses
food
data
waterborne
surveillance
data
sea
baltic
diversity
viral
il
10
cd4
cell
cells
ifnl
ifn
ifns
hcv
treatment
outbreak
sensitivity
behaviors
group
preventive
the
pclsr
asfv
cross
using
denv
irav
dengue
virus
interferon
ibv
isolate
immune
responses
challenge
rna
endou
early
coronaviruses
responses
health
oh
approaches
provide
framework
data
the
results
model
population
hom
human
hjam1
cells
virus
sva
elisa
ivd
vp2
disease
interventions
medical
non
consensual
we
cryptosporidium
the
species
breeds
goat
series
review
disorder
proteins
idps
diseases
flooding
infectious
evidence
following
nan
nan
nan
studies
bronchiolitis
cam
reported
among
pseudovirus
assays
live
virus
based
ari
community
inpatient
influenza
aris
antibiotic
use
prophylactic
study
tianjin
host
ev71
proteins
interactions
infection
host
virus
species
viruses
families
the
sequence
protein
method
introduced
no
pcv2
gsno
infection
pk
method
in
influenza
cases
pandemic
bat
hepadnaviruses
hepevirus
species
viruses
ifn
treatment
1a
treated
cohort
mobility
infected
human
study
intradomestic
evd
the
ebola
units
ehus
chws
health
healthcare
delivery
ghana
chlamydia
infection
prevalence
95
ci
hadv
strains
cause
sequence
rna
influenza
h7n9
transmission
avian
poultry
micrornas
fungal
infection
dendritic
cells
denv1
clone
viruses
infectious
recombinant
health
one
emerging
human
animal
validity
conspiracy
measures
scales
conspiracist
ome
bacteria
middle
ear
patients
particles
derived
cell
replicon
virus
toxocariasis
publications
research
united
countries
virus
clade
viruses
h5
proteins
mers
cov
llamas
pigs
animals
rabies
disease
human
lyssaviruses
lyssavirus
il
vitamin
37
less
associated
dose
low
computed
tomography
patients
mers
cov
rhesus
common
cells
viruses
mpcr
rsv
respiratory
tests
nan
ccov
dogs
virus
deletion
vitro
infectious
diseases
disease
health
emergence
nan
ppe
medical
training
students
technique
pooled
pneumonia
ultrasound
chest
lung
jev
encephalitis
infection
je
mlkl
ifn
λs
signaling
infections
immune
autophagy
phev
cells
replication
membrane
apelin
13
pyr
12
pd
virus
respiratory
mers
cov
syndrome
mers
cov
epidemiology
clinical
middle
surveillance
vanuatu
syndromic
acute
fever
influenza
virus
infection
airway
inflammation
isolation
hospital
precautions
patients
isolated
mir
21a
5p
caskin1
virus
ecohis
children
the
scores
oral
children
malnutrition
intestinal
protein
malnourished
astroviruses
potential
bats
species
humans
viral
vectors
non
uses
gene
influenza
patients
ili
sari
001
ca
nsp4
vpd
channel
viroporins
health
one
rwanda
improved
global
siv
virus
polymorphisms
human
ifitm3
nan
hospitalisation
days
ageing
hong
kong
acute
cerebellitis
benign
neurologic
condition
il
10
immune
responses
regulatory
transitivity
network
nodes
centrality
epidemics
protein
adp
binding
ribosylation
adpr
ebola
virus
gs
5734
nucleoside
lozenges
containing
tested
amc
dcba
respiratory
nxtag
rpp
xtag
fast
puppies
mg
kg
body
weight
mscs
ptx3
lung
wt
injury
myelin
na
vacuolation
rats
tracts
dna
damage
ubiquitin
protein
like
virus
hepatotropic
vivo
targeting
liver
vaccines
immune
response
cell
used
zikv
virus
brazil
clones
1947
extracellular
pathogen
host
proteins
interaction
sari
children
associated
virus
cases
worry
related
mers
outbreak
disease
ev71
viral
rheum
emodin
treatment
hsv
bx
795
kinase
jnk
pedv
hmgb1
infection
acetylation
release
autophagy
immune
immunity
the
inflammatory
pedv
jscz1601
strains
variants
gene
substances
immune
ards
cells
may
vaccines
antibodies
rv
vaccinated
dams
innate
adaptive
the
immunity
pbmcs
cp
orsay
protein
organism
viruses
lung
type
ifns
immune
inflammation
aspirin
aerd
cellular
inflammatory
intolerance
disease
coronary
kawasaki
artery
lesions
igf
1r
huh7
hcc
growth
rhdv
virus
rabbit
used
passages
ifn
type
mucosal
iii
intestinal
the
health
ebola
outbreak
development
individuals
disease
behavior
healthy
sick
asthma
triggers
avoidance
smoking
allergens
students
prevalence
school
05
rates
health
public
precision
epidemiological
model
viruses
respiratory
mers
cov
patients
lpa
dr6
expression
induced
apoptosis
nan
aecopd
virus
vp
cytokines
patients
pneumoniae
meningitidis
phase
carriage
aureus
breaks
winter
school
ili
schoolchildren
aki
patients
scrub
typhus
risk
n30
impdh
replication
virus
inhibit
use
respiratory
bacterial
dogs
cats
infections
hmpv
respiratory
children
clinical
pedv
the
highly
virulent
diarrhea
macrophages
mers
cov
dpp4
glycoprotein
mers
cov
vlps
respiratory
disease
tmprss11d
expression
nsclc
protein
tissues
onconase
different
genes
cell
regulated
health
singapore
mobile
based
surveillance
camels
mers
cov
domestic
bats
respiratory
human
npws
83
viruses
shock
cvp
parameters
study
correlation
wildlife
shipments
the
leading
trade
ifn
virus
hbv
hcv
antiviral
biological
systems
networks
co
expression
adcc
influenza
virus
ha
head
nan
lamp
influenza
assay
viruses
on
rabies
ecological
alaska
niche
areas
nan
trial
design
the
advantage
experimental
ba
rrv
cholangiocyte
vp4
murine
infection
response
respiratory
viral
proteins
cells
ifn
well
pathogen
signaling
viral
paramyxoviruses
parainfluenza
fusion
cell
day
feedlot
np
microbiota
cattle
henselae
results
cats
febrile
blood
cat
polydipsia
urine
case
month
felv
cats
samples
determine
antigenaemia
hadv
1967
species
respiratory
molecular
il
ikkε
prostate
cancer
expression
cat
bronchial
carcinoma
paraneoplastic
revealed
feline
clinical
diagnosis
treatment
year
protein
vaccines
s1
mers
vaccine
island
french
colombia
populations
zikv
pkr
hiv
response
antiviral
infection
zoonoses
endemic
countries
the
ministries
ltr
hiv
quadruplexes
quadruplex
transcription
goose
ifitm1
ifitm3
tissues
tmuv
virus
na
ha
host
cell
saudi
arabia
mers
cov
tested
pathogens
cases
bacterial
pathogen
0001
antibodies
antibody
production
techniques
development
protein
folding
genetic
information
in
rsv
hmpv
assay
pcr
qrt
vs
h5n1
001
43
hpai
mers
virus
cov
a59
the
influenza
infection
receptor
virus
immune
research
risk
gain
function
biosafety
autophagy
pedv
infection
new
porcine
workshop
virology
the
society
university
viral
antiviral
clrs
recognition
immunity
host
highly
coronavirus
innate
immune
lf
immune
inflammation
innate
mucosal
ace
ace2
diabetic
tissues
activity
rsv
viral
loads
infection
genotypes
rnas
nucleosides
modified
trnas
variation
mtb
anti
effects
artesunate
tuberculosis
animal
uri
cats
disease
diarrhea
membrane
proteins
shed
shedding
sheddomedb
research
dep
technique
fields
this
ambra1
fak
src
cancer
cells
respiratory
type
adenovirus
training
recruits
protein
cytochrome
ppca
homologs
amino
air
conditioning
used
two
cladosporium
sink
trap
transmission
patients
wastewater
virus
cyclin
d3
influenza
cell
rsv
alere
test
assay
pcr
prrsv
sg
sgs
induced
formation
covs
bat
sars
samples
like
safv
patients
hfmd
positive
the
epitope
the
vaccine
zikv
predicted
mage
g1
fscn1
vime
neurogenesis
proteins
prv
differentially
expressed
cellular
h7n9
risk
h5n1
china
high
td
regions
prrs
the
time
imaging
infrared
thermal
irt
non
mers
cov
predict
pdf
2180
ang
ii
activities
the
phenylalanine
influenza
inhibitors
anti
agents
drugs
mrnas
host
translation
viral
translational
als
onset
patients
protein
age
swine
diarrhea
ped
disease
it
prrsv
control
regional
tools
farm
prrsv
the
vaccinated
group
strains
pedv
sdpp
could
pig
probability
microarray
avian
virus
aiv
ndv
feed
additives
days
virus
pdcov
biosecurity
personnel
transmission
pedv
pigs
prrs
new
world
wide
resistance
spray
dried
plasma
use
antibiotics
mers
cov
dromedary
camels
africa
bovine
respiratory
virus
pcr
dembo
mass
tumor
revealed
exophytic
originating
higher
persons
scd
environmental
also
spreader
spreaders
transmission
mers
cov
cats
fcov
positive
feline
expression
crisis
intervention
patients
cic
clinical
infection
fmdv
mirna
mirnas
serum
mycoplasma
respocheck
pcr
triplex
real
apn
cell
drugs
active
site
viral
hepatitis
aptamers
recent
in
cdv
the
recombination
canine
distemper
229e
hcov
expression
cells
replication
nan
anesthesia
general
spinal
severe
perioperative
rev
proteins
differentially
expressed
infection
gp
structure
resolution
mucin
like
hospitals
hdp
hospital
riyadh
disaster
nan
camels
95
ci
herds
mers
nan
patient
in
october
2016
severe
tb
positivity
contact
air
travel
china
pandemic
clade
within
kiwifruit
species
habitat
chronic
stress
disturbance
isg20
hbv
rna
ifn
degradation
structure
cross
high
secondary
structural
sirt7
transcription
pol
regulates
rna
ef
sequence
translocation
frameshifting
slippery
suicide
cb
media
method
new
hbv
grp78
hepatocellular
replication
secretion
rna
viral
bamv
movement
genomic
neat1
htnv
infection
rig
lncrnas
viruses
ci
95
enteric
rotavirus
cell
death
assay
processes
several
protein
expression
perk
cap
chop
alveolar
epithelial
ion
fluid
infection
epidemic
treatments
virus
disease
emerging
ebola
trials
virus
clinical
data
data
level
disease
assessment
west
infectious
community
diseases
modeling
control
ebola
the
polymerase
isolates
belonging
rigida
samples
phenolic
analysis
regions
gold
nanoparticles
cells
immune
data
treatment
levofloxacin
group
05
cost
atmuv
infection
expression
replication
interferon
emotions
emotion
negativity
positivity
cross
ms2
virus
ic
rna
hcv
type
ifn
iii
human
iecs
slc10a1
hbv
risk
persistent
infection
gondii
mice
vaccination
ad
umas
household
rsv
analysis
community
viruses
iv
swine
virus
pigs
strains
bartonella
bats
genogroups
species
four
engagement
facebook
health
agencies
we
drug
doses
subcutaneous
lipid
excess
calves
ard
infusion
the
ar
errps
mers
impact
psychological
outbreaks
dc
sign
glycans
dcs
hepatica
hiv
neutralization
potential
samples
specificities
onfh
steroid
induced
95
analysis
exosomes
vsvg
cell
cells
ectodomain
apilimod
ebov
entry
pikfyve
endosome
responses
during
august
2009
july
antiviral
factors
interfere
virus
replication
communication
taiwan
public
outbreak
sars
response
emergency
taiwan
public
health
laboratory
national
system
health
taiwan
ppe
stockpile
model
taiwan
stockpiling
the
cdcmn
system
medical
hospitals
jee
2016
health
external
evaluation
rv
ds
cytotoxic
secretion
effect
adar1
mutation
rnase
leads
lethal
nsp9
covs
cov
rna
dimerization
slr1
hyphal
the
protein
mrna
usp18
ubiquitin
isg15
mouse
like
obstructive
hydrocephalus
complication
described
findings
assembly
data
bbap
pdr
results
who
formulations
healthcare
outbreak
products
histoplasmosis
causes
wide
spectrum
clinical
nan
infectious
diseases
imaging
rapid
molecular
jev
egfp
proteins
replicon
packaging
asthma
fruit
vegetable
intake
studies
kd
pct
bacterial
the
viral
influenza
school
children
respiratory
absence
alkaloids
dengue
virus
protein
targets
emodin
raw
264
induced
poly
lactoferrin
biological
role
binding
many
gene
expression
different
cusia
plant
ulk1
mir
142
5p
phev
substrate
adp
ribose
binding
catalysis
respiratory
virus
aerosol
min
influenza
drug
zikv
zika
virus
infection
pediatric
respiratory
viral
infections
adult
brd
calves
lung
16s
lymph
sapns
mathematical
classification
self
geometries
respiratory
influenza
viruses
acute
infections
cat
cfre
report
case
describes
gene
therapy
vector
lentiviral
efficacy
respiratory
young
specimens
viruses
detection
diseases
publications
research
health
infectious
category
patients
mpcr
immunocompromised
pathogens
type
viruses
vaccine
network
analysis
mice
immune
laboratory
wild
mouse
cells
rv
cell
ciliated
cdhr3
muscle
proteins
embryonic
chicken
protein
farnesyltransferase
imb
1406
cancer
proteins
mirnas
mmu
mir
gondii
gene
infectious
disease
surveillance
raew
netherlands
ace2
liver
lung
translation
fibrosis
oncolytic
virotherapy
efficacy
seem
virus
cats
vomiting
therapeutic
management
feline
ndv
signaling
cells
lines
line
the
digest
papers
paper
current
ordered
proteins
residues
disorder
amino
nan
ff
200
respirators
type
100
prospective
data
incidence
retrospective
group
mers
cov
knowledge
the
king
ebola
who
2014
health
in
tmprss2
fluav
human
serine
protease
ie2
expression
viral
vcp
ie1
blood
infectious
flies
species
parasite
neutrophils
respiratory
infection
disease
iav
virus
bovine
rhinitis
identified
calf
time
models
bmc
bioinformatics
17
ndiv
the
isolated
china
complete
bat
virus
host
carnivore
rabv
aids
old
chrm
naïve
elderly
crf
rats
protein
kidney
levels
sa
iavs
human
bats
avian
cpg
c41
tlrs
inflammation
tlr
influenza
deaths
hospitalizations
associated
700
ev71
ste
treatment
induced
a1
niche
species
shifts
invasion
model
dpp4
respiratory
mers
bats
camels
hbeag
parturients
hb
positive
prevalence
expression
blood
levels
stroke
bbb
apn
substrate
the
cancer
family
tams
cd163
cd204
oscc
tam
mpl
cancer
cells
cell
internalization
tb
patients
controls
population
tuberculosis
gb
3a
viruses
fusion
entry
viruses
children
per
cent
sari
incidence
adem
year
the
100
laboratory
health
national
network
development
hcov
lrtd
hct
patients
mortality
ttw
ns
nps
agreement
bal
bal
dns
samples
culture
results
calves
healthy
diarrheic
microbiota
the
cr1
immune
the
variants
populations
di
rnas
rna
passaging
recombination
niv
ventilation
invasive
respiratory
failure
g4s
ltr
lentiviruses
primate
viral
binase
viral
virus
antiviral
influenza
ngal
injury
lung
expression
associated
nan
nan
nan
asthma
disease
airway
children
it
pwd
colistin
treatment
control
swine
aerosols
bio
sources
patients
dental
cells
inflammatory
response
bat
human
veterinary
medicine
quality
medicines
ingredients
phenanthrenes
influenza
virus
the
activity
respiratory
patients
etiology
samples
episodes
pathogens
ngs
tgc
detected
assays
panel
respiratory
pathogens
rp
the
culture
lung
lpcs
translational
progenitor
nan
pre
ad
existing
immunity
human
swans
geese
role
livestock
disease
hospital
may
cases
days
the
hlius
sustainability
to
identify
barriers
mers
cov
we
tested
suitability
virus
tgev
meal
delta
pdcov
g4s
hsv
exndi
cells
viral
mewds
patients
imaging
findings
oct
aeruginosa
infection
cases
in
metalworking
nan
map
pcr
group
subclinical
diagnostic
vaccines
vaccine
cvcva5
nd
dose
viral
lncrnas
host
many
anti
protein
proteins
spyx
modules
bxa
coronaviruses
accov
jc34
apodemus
chevrieri
poultry
policy
live
workers
consumers
bronchiectasis
children
chronic
infection
inflammation
mers
cov
cases
may
dentists
group
fhc
ml
times
lpb
viral
load
pneumonia
viruses
cases
specimens
pneumonia
is
radiographic
children
specimens
multiple
case
pneumonia
infection
radix
bupleuri
traditional
studies
demonstrated
genes
hrv
regulated
infection
hpi
cov
mers
pl
pro
thermal
biosafety
biosecurity
european
eu
in
pseudoknot
base
tertiary
frameshifting
pairs
locus
gallus
chicken
chifitm
using
hbov
viremia
human
bocavirus
respiratory
illness
febrile
hrv
respiratory
lbw
mers
cov
viral
vdubs
ubvs
bone
pth
saon
cd
34
respiratory
tract
lower
rhinovirus
infection
the
sequencing
deep
immune
pathogen
gaaps
golgi
function
ion
functions
data
epidemic
human
patterns
different
nan
dogs
families
viral
virome
astroviridae
gd
nectin
binding
prv
the
astroviruses
diversity
classification
diverse
family
ev
d68
il
respiratory
infection
tmprss2
mspl
pedv
ttsps
replication
pedvpt
p5
p96
passage
inoculation
ndv
newcastle
disease
poultry
in
viruses
genes
respiratory
expression
mhv
overseas
domestic
the
kt
lt
s2m
the
containing
sequences
coronavirus
hcovs
respiratory
in
syndrome
coronavirus
bats
brasiliensis
detected
coronaviruses
viruses
il
33
mice
ko
hepatitis
mir
127
5p
ev71
replication
patients
haplo
hct
infections
infection
patients
lri
hmpv
infections
uri
viral
signature
host
the
systemic
pcr
real
time
malsoor
virus
levels
ivig
kd
pdmp
patients
models
rodents
translational
we
provide
analogs
viruses
infections
chloroquine
drugs
evd
hcws
preparedness
ghana
disease
patients
respiratory
lrt
influenza
observed
hotspots
disease
hotspot
control
precise
myricitrin
injury
effect
potential
induced
infants
genotypes
clinical
the
respiratory
patients
vzv
icu
cap
mechanical
leishmania
parasite
antileishmanial
drug
host
avcov
27
nt
gi
avian
respiratory
hku1
cov
adults
among
viral
drvm
genome
sequencing
read
denv
virus
infection
extracts
septica
pmo
sma
cns
peptide
splice
zikv
sperm
testes
associated
mice
cov
diversity
bats
emergence
respiratory
human
wildlife
disease
health
infectious
health
zoonoses
human
one
interventions
one
health
approaches
zoonoses
among
illness
surveillance
study
eids
rural
ibv
rna
recombinant
recombination
virus
tgev
subtilis
cells
virus
entry
immune
ln
changes
cells
age
zikv
induced
virus
cell
death
health
one
common
approach
initiative
number
outbreak
mers
basic
korea
antibiotic
use
pneumonia
resistance
considered
pulmonary
infections
returned
traveller
symptoms
virus
detection
rtpcr
respiratory
children
ad5
rag2
vector
delivery
gene
vimentin
antibody
tube
formation
endothelial
diversity
social
status
intestinal
eukaryotes
complement
viruses
regulators
system
infected
frameshifting
expression
viral
translating
genes
pm
effects
health
toxicological
studies
treatment
cryptosporidium
diarrhea
immunocompromised
drug
closure
pandemic
border
scenario
net
nan
cc
sequencing
information
isvdb
the
sars
cov
weight
loss
hemorrhage
oas1b
gene
disease
innate
immune
lncrna
protein
network
plpihs
biological
codon
usage
bcov
among
host
infections
viral
often
pidds
evaluation
nan
bombyx
mori
protein
bmnpv
proteins
2016
strains
dh1
dh2
isolated
sequenced
bcov
we
first
bovine
hiv
fss
rna
compounds
target
influenza
production
duck
free
grazing
sars
cleavage
tmprss2
activation
protein
uptake
the
vaccine
among
countries
public
media
academic
literature
the
zikv
neutralizing
human
mab
virus
weather
methods
diseases
water
climate
nf
κb
tgev
jak2
tylophorine
proteome
viruses
trees
size
evolutionary
chinese
herbs
group
gondii
blood
rna
viruses
human
low
method
study
316
infants
rsv
viral
peptides
vivax
antibody
coiled
coil
potential
mcl
drugs
the
cancer
hi
cd11c
dc
ly
6c
prrs
support
control
disease
swine
ali
mir
200c
3p
ace2
hadv55
outbreak
genes
cases
respiratory
treatment
disorders
rosa
species
rose
affinity
showed
binding
lectins
wga
lectins
proteins
legume
antimicrobial
insecticidal
risks
zoonotic
wildlife
wild
pathogens
global
within
patients
influenza
mutations
cat
effusion
pleural
examination
pericardium
nan
infection
influenza
iav
global
host
hiv
ordered
cholesterol
membrane
cell
pandemic
advax
vaccine
panblok
h1
strains
pedv
55
south
china
prrs
risk
spatial
phylodynamic
swine
nan
prrsv
hev
pigs
potential
uk
immune
infection
memory
the
adaptive
mers
hemodialysis
the
korean
society
ifn
viruses
regulation
intestinal
enteric
copd
airways
cells
neutrophils
cd4
icf
syndrome
hsct
immunodeficiency
infections
edible
vaccines
the
diseases
pathogenic
toltrazuril
20
holl
wien
treatment
farms
mink
farm
case
control
sari
cd
patients
data
primary
patients
care
intensive
icu
unit
msp
sulfonyl
derivatives
one
changing
septic
27
month
old
female
ns1
ifn
terminal
domain
traf3
nan
genes
reference
stable
two
pot
cost
effectiveness
cri
costs
respirator
hmfo
inflammatory
induced
colitis
κb
south
korea
pm
concentration
regional
dengue
puerto
rico
zika
the
castv
chickens
grenada
chicken
commercial
cc
strains
the
inbred
genomes
penk
ngal
sepsis
egfr
septic
assay
respiratory
results
rvp
specimens
cases
children
per
cent
wheezing
cov
helicase
domain
mers
nsp13
il
10
tuberculosis
infection
cells
mda5
rna
virus
ds
respiratory
diarrhea
750a
pedvs
we
report
virus
mexico
influenza
pandemic
season
zika
ns2b
ns3pro
viral
natural
cmv
patients
ml
pneumonia
10
tbi
injury
hr
biomarkers
patients
jev
cells
hsp90β
vero
binding
influenza
travel
travellers
prevention
management
mers
cov
patient
protein
the
pertussis
alone
infants
clinical
coinfections
coli
bats
presence
different
sequence
capsid
viral
rna
interaction
protein
nan
hev
hepatitis
infection
case
virus
knowledge
virus
attitude
behavior
infections
hypoxemia
95
pneumonia
ci
children
species
reservoir
pathogens
reservoirs
mammals
bat
virus
ectoparasites
bats
flies
tfs
anti
well
research
skeleton
hiv
shame
patients
this
chronic
ibv
strains
the
reported
esa
respiratory
viruses
unit
patients
viral
uri
aom
otopathogen
commensals
infection
patients
ed
outbreak
emergency
febrile
data
health
big
animal
new
rm
cells
virus
cd8
lung
influenza
virus
swine
acute
outbreaks
antibody
mers
titers
cov
neutralizing
influenzae
hib
meningitis
type
oman
cpv
vp2
evolution
analysis
mutation
day
mers
cov
case
the
detection
methods
outbreak
time
series
hbov
cameroon
respiratory
infections
children
the
coronavirus
hcov
nl63
trimer
hlh
secondary
patient
spherocytosis
consequence
protein
rna
cov
genomic
oligomers
tuberculosis
mycobacterium
quadruplexes
quadruplex
compounds
pneumoniae
infection
pneumonia
acute
also
moc
infection
tu
replication
levels
transmission
fomite
routes
sars
airborne
tritonis
sg
pl
proteins
al
nan
patients
respiratory
viruses
saliva
testing
cases
ksa
sk
mers
cov
camels
three
nasal
swabs
mers
nan
viral
viruses
host
apoptotic
co
mers
cov
neutralizing
ntd
regions
tau
ais
protein
levels
compartment
hemozoin
ards
lung
epcr
tm
collapse
area
mirnas
femoral
showed
as
medical
using
antibiotic
approximately
polyomavirus
canine
respiratory
we
report
nan
cat
multiple
myeloma
associated
phaeochromocytoma
epac
assay
cell
based
rap1
zikv
infection
cells
response
profile
host
protein
in
glycoproteins
infection
viruses
human
h9
respiratory
acid
children
np
diagnosis
pneumonia
multiple
animals
rmbd
studies
salmonellosis
feeding
macrodomains
protein
function
family
adp
7e
μm
the
cell
ic
species
bst
viruses
human
virus
assay
mp
serology
gexp
cap
clfa
alpha
toxin
sar114
bisab
ns1
protein
epitope
mab
one
stress
sgs
hs
pluripotent
found
novel
identified
cowpox
signs
case
laboratory
clinical
laboratories
improvement
amendments
strains
type
ibv
isolated
the
hku1
structure
insertion
subdomain
human
approach
effective
vaccines
infectious
diseases
polypeptide
amino
acids
native
non
zikv
assembly
stress
sg
eif2α
mers
neurological
treatment
patients
four
ms
treatment
disease
modifying
therapies
virus
influenza
bat
bats
infectious
neutralizing
levels
epitopes
cap
aunps
hpv
hpv16
infection
vimentin
cells
influenza
prevent
perceived
intention
facemask
cause
genome
orchitis
aseptic
meningitis
angiotensin
adenocarcinoma
renin
system
the
amnp1
amnp2
wc
nanoparticle
types
systems
health
innovation
level
adoption
placenta
lncrnas
including
function
the
camp
rsv
barrier
epithelial
viral
clinical
respiratory
health
patients
middle
patients
service
icu
exercise
the
zikv
z2
infection
pregnant
mice
the
models
virus
zikv
health
pedv
porcine
disease
virus
in
autophagy
order
nidovirales
cells
membrane
the
open
encourage
science
prize
ibv
macrophages
infection
strains
a5968
env
receptor
fusion
cd4
binding
genes
reference
ascoviruses
ascovirus
dissemination
lcls
cells
ebv
producing
reliable
quadruplex
ir
assay
helicase
luminescent
total
contents
bacteria
extracts
µg
models
dengue
fever
in
animal
gp
hybridomas
dna
production
antibodies
ndv
vaccines
vectored
poultry
vaccine
zikv
drugs
health
including
protein
anti
wef
ef
components
virus
trem2
immune
function
ndds
role
fip
cats
effusion
95
feline
nan
sudv
virus
animal
study
lethal
asia
denv
air
dengue
circulation
cryptic
the
virus
dsrna
arcv
publications
the
wnv
research
publication
corona
viruses
virus
middle
caused
kd
laboratory
group
patients
incomplete
pei
vaccines
applications
shown
adjuvants
virus
metagenomic
next
generation
sequencing
isolation
fridu
patients
screening
contagious
ontology
social
concepts
media
sentiment
colibacillosis
diagnosis
coli
etec
disease
transmission
outbreaks
emerging
data
vacv
il
35
cells
regulation
breg
hmpv
women
respiratory
pregnant
pregnancy
cassiae
semen
including
the
compounds
nan
we
nanoshells
cerebrospinal
fluid
drug
idv
influenza
virus
acid
viruses
virus
sequencing
viruses
clinical
samples
bacterial
respiratory
participants
study
infections
approaches
emergence
disease
we
model
baicalin
masking
composite
andrographolide
test
gs
5734
antiviral
ebov
virus
antibodies
cells
approach
antigen
human
cov
cd9
mers
infection
cell
wild
pigs
pathogens
species
humans
method
ms
hcovs
the
mcov
ifn
tgev
production
ddx1
nsp14
immune
age
human
changes
disease
total
calves
cholesterol
levels
diarrhea
gene
trss
expression
prrsv
egfp
contact
infectious
contacts
respiratory
social
nbv
cells
cell
host
effects
mwpyv
children
respiratory
samples
positive
blood
transfusion
burn
injury
children
rt
rpa
canine
cdv
results
tests
model
cattle
bvd
control
ifn
type
yfv
17d
infection
astvs
isolates
dogs
samples
diarrhea
hiv
defensins
immune
cells
innate
advax
cysvac2
tuberculosis
cpg
pathogens
mva
cells
vivo
rmva
gfp
rsv
inhibitors
infection
aebsf
protease
marv
bats
infection
erbs
host
protein
sars
coronavirus
unique
the
tb
qinghai
temporal
spatio
2016
kangfuxinye
mesalamine
rate
grade
quality
protein
pact
cov
virus
mhv
nk
lysin
bovine
peptides
somni
aor
cap
rna
children
seq
nan
nan
cov
replication
accessory
pathogenesis
dorf3
nan
nan
porcine
macrophages
macrophage
ipkm
infectious
tris
renal
sle
biopsy
hiv
phellodendron
phosphor
white
the
light
sars
patients
coronavirus
clinical
severe
cells
hiv
bikes
expressing
human
temperature
extracellular
cgtase
recombinant
expression
respiratory
herds
app
study
outbreaks
gene
porcine
genes
the
databases
irak
tb
cells
type
macrophages
disaster
risk
hong
kong
population
viruses
species
zoonotic
human
host
rsv
pneumonia
infection
children
respiratory
2016
piglets
the
jpn
in
ch
jxjgs01
2016
the
complete
index
daily
reported
sector
cases
disease
zika
several
zikv
neurological
poultry
vietnam
lbms
market
closure
hku2
bat
porcine
coronavirus
gds04
influenza
virus
antibodies
identified
america
cases
in
2014
centers
disease
frecv
sequence
ferret
enteric
coronavirus
day
mers
patient
negative
the
macrophages
cells
immune
b2
b19
10
ftlr2
kd
patients
sil
balanced
repertoire
pathogens
in
cell
mers
cov
the
respiratory
coronavirus
rabbits
mers
cov
infection
viral
nan
h7n9
viruses
human
influenza
hp
hrl40
binding
high
mannose
green
cell
pedv
mutation
protein
fusion
chemical
aptamers
high
nucleic
acid
mers
cov
respiratory
ards
syndrome
ibv
apoptosis
cells
induced
infection
8c6
ha
mabs
siv
h1n1
inhibitors
in
proteasome
virus
replication
6k
tf
proteins
years
alphavirus
nan
prediction
protein
plp
epitopes
aa
hrv
infection
major
group
hrvs
probe
new
method
the
viral
health
wildlife
human
outcomes
reduce
brain
effective
vaccines
safety
development
tgev
strain
ahhf
piglets
recombination
mers
cov
several
models
proteins
hiv
count
sequence
the
rna
nan
coronavirus
hku15
samples
pigs
two
hospital
surge
id
system
threats
maoto
influenza
virus
culture
viral
viruses
xenotransplantation
porcine
pig
cells
illness
demyelinating
encephalomyelitis
adem
young
microbiota
functional
git
studies
human
synthetic
biology
cell
novel
diseases
one
health
concept
approach
disciplines
strains
influenza
h3n2
2016
vaccine
nnv
selection
strains
host
may
mers
assay
powerchek
cov
detection
sias
tissues
sia
acetyl
modified
human
rti
the
hcov
nl63
malaria
vaccine
p27
coiled
coil
proteins
endoplasmic
reticulum
resident
retention
ibv
countries
spread
local
qx
rna
il
sox
mrna
however
bril
bone
ko
mice
skeletal
ebov
lifecycle
ebola
mechanisms
remain
piglets
sows
pedv
mda
ped
viruses
bats
sequences
including
bat
population
urban
rat
species
chanteraines
healthcare
efficiency
hospitals
in
hkha
gondii
the
cat
seroprevalence
age
puppies
positive
hge
healthy
diarrheic
mink
practices
biosecurity
producers
kits
viral
gene
porcine
diarrhea
pig
patients
pediatric
adult
ed
the
mers
cov
full
middle
east
gene
pulmonary
atrial
fibrillation
network
ad
alzheimer
disease
one
acetylcholinesterase
in
final
article
series
felix
mortality
healthcare
day
illness
the
psgs
cea
family
the
expansion
health
care
risk
transmission
service
health
information
vaccinations
diseases
behavior
mers
cases
infection
comorbidity
age
dsrna
p4a
immune
the
mechanism
virus
public
health
the
zikv
nan
residents
influenza
long
term
care
dengue
afi
clinical
participants
predictors
d68
ev
2010
osaka
2015
camels
viral
viruses
sequences
million
rc
101
tlr4
influenza
dependent
amr
problem
impact
pandemic
epidemic
outbreak
cases
the
mers
cov
fip
clinical
neurologic
mri
cases
pneumococcal
invasive
controls
cases
disease
rv
immune
infection
cell
cells
hiv
plhiv
stigmatization
factors
social
frameshifting
model
dynamics
sequence
mrna
amino
acid
expression
at1
protein
dmgf
metastatic
cells
melanoma
tumor
patients
viral
the
influenza
respiratory
nxtag
respiratory
influenza
multiplex
xtag
respiratory
mers
cov
infection
first
virus
episodes
exacerbations
stable
rv
ifns
ifn
proteome
pathogens
gene
viruses
bats
may
ifn
bat
pedv
different
min
feed
virus
virus
cell
single
simulation
membrane
bats
virus
viruses
events
novel
cpc
influenza
the
virucidal
viruses
filmarray
rp
respiratory
detecting
specimens
stem
field
cells
cell
structures
infections
immune
cats
modulation
retroviral
veterinary
students
massey
university
diarrhoea
pdcov
porcine
rt
detection
lamp
forensic
genetics
cases
including
analysis
pneumonia
management
associated
mortality
new
contact
countries
patterns
age
contacts
infection
neurological
cc
tmev
outcomes
sequence
sequences
three
letter
methods
pyrimidine
biosynthesis
de
novo
metabolic
bats
humans
township
study
human
human
protein
siga
shown
peptides
hbv
infection
novel
antibody
hepatitis
trim25
antiviral
including
regulation
innate
bats
infection
tcrv
responses
response
collaboration
effectiveness
mers
outbreak
effect
nan
exacerbation
copd
airway
inflammation
chronic
pneumonia
patients
respiratory
virus
viral
technology
salivary
diagnostics
emerging
field
egypt
control
zoonotic
diseases
africa
ire1α
hsv
kinase
replication
activity
cov
pedv
coronavirus
belonging
reorganization
mers
5hb
hr2
cov
the
cells
perk
translation
this
denv2
plant
well
virus
expression
pharmaceutical
trem
gf9
signalling
hdl
therapeutic
dcs
cell
nci
p38
h460
nan
30
years
infectious
health
the
ifitms
hiv
viruses
antiviral
infectivity
rsv
protein
ra2
respiratory
cells
trim
virus
proteins
including
ubiquitin
multidrug
resistant
exacerbations
risk
factors
epf
hfd
effects
the
lipid
causes
death
children
mortality
u5mrs
sdab
np
dimeric
packaging
crosslinking
glucuronidase
gamg
gl
isl
acid
nan
reservoir
disease
pathogen
infection
empirical
cell
host
cells
fusion
cholesterol
ifns
respiratory
type
iii
also
jev
lncrnas
encephalitis
induced
identified
influenzanet
influenza
ili
system
data
group
vaccine
h7n9
monovalent
inactivated
viral
antibodies
pathogens
monoclonal
host
influenza
antibody
we
dmab
protection
protein
nanoparticle
self
assembling
cd8
flying
foxes
area
humans
contacts
fluid
dengue
group
fever
oral
genomes
toledo
genome
cmv
synthetic
core
protein
dna
nucleocapsids
viral
drrep
deep
epitope
prediction
learning
fip
cats
samples
fcov
gene
nanodiamond
trimeric
h7
protein
the
fibroblasts
antimicrobial
inflammatory
microorganisms
peptides
pedv
strains
porcine
china
results
genomics
disease
genes
genetic
technology
testing
poc
time
length
stay
viruses
virus
hepaciviruses
pegiviruses
related
lair1
antibodies
antibody
insertion
malaria
web
zika
virus
information
sites
ntd
histone
cleavage
flash
pre
research
the
sponsors
report
endorse
virus
viruses
respiratory
aerosols
vivas
resuscitation
literature
risks
articles
healthcare
nan
respiratory
virus
viruses
influenza
ili
bronchiolitis
rsv
respiratory
infants
young
host
microbiota
interactions
hmis
may
pxxgst
clones
epitope
mapping
bsp
masks
methods
gauze
δp
decontamination
il
wheezing
group
rv
rsv
diphyllin
feline
in
fipv
coronavirus
research
knowledge
social
theory
problems
disease
vaccine
oral
prp
rl
autophagy
proteins
lir
viral
viruses
cases
mers
cov
countries
region
mucus
alcohol
disinfectants
based
viscosity
cpv
2b
type
antigenic
types
jev
viral
drugs
infection
approved
level
pca
useful
principal
component
na
atpase
ros
signaling
signal
mers
cov
humans
chadox1
vaccine
skin
mice
cr
day
al
chest
patients
lung
fibrosis
follow
fiv
hiv
immunodeficiency
virus
cats
activities
antibacterial
antiviral
μg
ml
influenza
plan
pandemic
responses
response
effects
canine
intestinal
microbiota
knowledge
vaccine
nanoparticle
vaccines
nanoparticles
viruses
foodborne
technologies
advanced
related
pathogens
assay
zikv
the
rt
virus
apoptosis
ns1
protein
mitochondria
cells
influenza
victoria
the
season
2015
cells
role
myeloid
virus
viral
us
human
microbes
infectious
diseases
included
psychological
health
edc
operatives
ev71
erad
replication
infection
pro
ifitm3
gene
expression
swine
inflammatory
system
surveillance
data
we
school
ld
weather
cap
warm
humidity
influenza
sive
confirmed
65
95
bid
apoptosis
rare
minnow
gcrv
protein
interaction
hsp27
cell
castration
health
region
response
public
who
residents
mers
emotions
related
medical
ga
11
uptake
18
fdg
eid
global
emergence
zoonotic
wildlife
hav
patients
infection
ed
number
hts
the
outbreak
food
obstacles
lrf
oligodendrocyte
cuprizone
remyelination
fl
camels
kenya
burnetii
camel
disease
treatment
post
patients
score
arco
identification
pathogens
bacterial
viral
species
virome
intestinal
human
viruses
methods
marv
vlps
pcp
ii
vaccination
rsv
respiratory
infected
tract
documented
yeasts
viral
cell
viruses
virus
nan
nan
ds
cav1
response
responses
rsv
patients
days
agvhd
line
treatment
calves
two
diarrhea
levels
vitamin
oligonucleotides
long
utility
oligonucleotide
therapeutics
zikv
antibodies
diii
virus
infection
virus
transmembrane
protein
ifitm3
synthesis
healthcare
hospital
outbreaks
hais
systems
pigs
g2b
challenge
pedv
im
two
data
stable
reference
genes
mimicry
mipepbase
database
host
pathogen
asthma
children
exacerbations
acute
patients
health
one
2007
medical
zoonoses
health
public
disease
threats
events
health
law
would
israeli
the
multibac
applications
including
system
developments
patients
virus
vris
asthma
hrv
type
respirators
respirator
the
fit
dac
foxo3a
mds
skm
tumor
prrsv
dhx36
inflammatory
rna
infection
c3
binding
cells
rgd
motif
htlv
dmb
protein
expression
autophagy
bacterial
viral
reference
standard
febridx
age
tb
formula
see
text
animal
regions
population
the
dogs
emergence
virus
disease
whether
evolutionary
host
vimentin
gondii
cells
infection
ibv
variants
worldwide
studies
viral
salt
renal
high
injury
biomarkers
strains
mers
cov
clade
lineage
protein
nappa
proteins
spot
microarrays
animal
food
samples
surfaces
feed
launched
infectious
virus
dna
system
ifitm1
huvecs
virus
expression
viral
host
viruses
protein
organisms
superkingdoms
viral
nlrp3
inflammasome
activation
infection
pl1
tgev
ifn
cov
virus
ha1
acma
mice
influenza
ll
oatp1b3
oatp1b1
bortezomib
mediated
transport
macrophage
vsig4
pyruvate
inflammation
activation
rpa
real
time
the
detection
genome
sequence
bcov
sispa
high
scrub
typhus
island
jeju
patients
government
infectious
law
disease
public
need
training
staff
kcdc
conduct
exon
mhv
replication
fidelity
cov
surveillance
health
system
disease
haiti
psma
prostate
mab
target
immunotherapy
detection
concentration
methods
viral
early
hct
conditioning
sequencing
mngs
human
onfh
treatment
corticosteroid
diagnosis
earlier
porcine
nnpds
animals
herds
positive
rna
binding
trim25
domain
activity
hiv
gag
replication
cpg
viral
society
infected
opinions
model
opinion
cheetahs
cowpox
virus
clinical
high
individual
transmission
level
disease
data
surveillance
border
systems
activities
information
ibv
china
2016
an
avian
multipartitism
viruses
multipartite
virosphere
different
hcmv
deubiquitinase
cancer
mediated
carcinogenesis
human
ancient
discovery
also
role
flu
mild
rs12252
allele
association
virus
pilgrims
influenza
respiratory
mers
hpaiv
h5n1
poultry
africa
data
emodin
allograft
tregs
cd8
cells
health
qatar
international
security
regulations
phylodynamics
pathogen
the
epidemiological
evolutionary
health
workers
risk
outbreak
public
ibv
rig
infection
mda5
antiviral
count
granulocyte
neutrophil
results
using
il
10
virus
induced
encephalitis
based
survey
zika
internet
paper
influenza
cruise
virus
specimens
passengers
zikv
european
eu
eea
capacity
results
quality
one
pairs
microbiology
host
abma
cells
cell
intracellular
tlr2
capsids
virus
bacterial
capsid
phev
cells
entry
viral
trafficking
infected
exacerbation
patients
response
virus
mers
cov
infection
human
cells
cov
conserved
mers
attenuation
mtase
surveillance
digital
system
data
infectious
research
synthesis
we
review
students
health
countries
public
pheic
international
rtd
joint
fls
defensins
peptides
reovirus
autophagy
cells
replication
demonstrate
bcl
viral
2i
cells
diseases
tgev
pedv
coe
egfp
rlppg
cell
virus
human
cells
exhaustion
cells
rna
template
polyprotein
spherules
transcription
viruses
regulation
nascent
rna
treatment
species
months
post
cat
serological
eblv
study
status
bat
dengue
acre
establishment
human
mobility
nan
respiratory
samples
children
pathogens
infections
immune
tolerance
neuroinflammation
peripheral
using
felv
jaguarundis
infection
cats
we
mers
cases
cov
occurred
spread
infections
patients
review
unique
this
respiratory
immune
immunity
life
system
influenza
monitoring
control
surveillance
prevention
the
diagnostic
free
viral
assay
pneumonia
models
model
pathologies
pneumoniae
dub
pro
activity
viral
loop
gene
pairs
coding
pair
overlapping
health
general
public
information
disease
pcv2
hps4
pmws
piglets
infection
bcov
calves
diarrheic
rt
pcr
infection
antiviral
cell
viral
ifitm
picu
virus
ards
children
admission
genomes
hsv
nuclear
condensed
foci
cells
rm
pd
cd8
mupyv
virus
cm
ii
50
spla
cov
nsp3
mers
dmvs
coronavirus
glycan
binding
receptor
antibodies
viruses
oligomerization
ire1
hire1α
ld
unfolded
ykl
40
urinary
uti
cr
all16
results
flua
samples
respiratory
gi
symptoms
respiratory
ari
patients
coronaviruses
border
the
detected
human
receptor
binding
hcov
229e
rbd
human
229e
hcov
plasma
coronavirus
arv
cells
genes
infection
infected
pedv
us
piglets
strains
8aa
hospitals
factors
considering
clinics
tertiary
virus
cellular
healing
homeostasis
migration
countries
income
livestock
avian
influenza
activity
delivery
nanocarriers
cell
early
pedv
rna
time
days
compost
rna
phase
separation
llps
idr
preparedness
sector
curative
public
health
diagnosis
rp
fever
ct
lymph
asthma
viruses
exacerbation
respiratory
childhood
hfmd
incubation
days
schools
period
hpiv
infection
viruses
cases
respiratory
infections
n95
laboratory
confirmed
rr
outbreaks
ces
nds
associated
outbreak
nsp11
prrsv
mab
3f9
epitope
vaccine
pedv
immune
oral
antigen
mva
risk
recombinant
vaccines
assessment
ups
restriction
viral
proteins
hiv
rocky
mountain
since
colorado
discuss
dengue
peptides
virus
antiviral
viral
zikv
infection
dna
in
vaccine
nan
ebola
worker
virus
disease
in
virus
influenza
dogs
among
circulating
viral
autophagy
insect
vector
transmission
ribosomal
stress
zikv
nucleolar
protein
ecov
vaccine
bcov
horses
antibodies
m1
m2
pams
macrophage
polarization
asfv
protein
dp
infection
cellular
can
diagnose
cause
man
bilateral
pedv
treatment
positive
ahp
disinfectant
ebola
health
countries
disease
response
cell
mitochondrial
mitophagy
high
stress
egr
rta
transcription
kshv
cellular
persons
phtrs
health
risk
hres
response
global
health
emergency
team
health
program
public
diseases
the
international
outbreaks
infectious
world
cdc
zoonotic
health
disease
diseases
one
analyze
health
capacity
receive
public
health
disease
cdc
global
achieve
diseases
health
sectors
zoonotic
infectious
vaccination
emergency
disease
vaccine
response
laboratory
laboratories
testing
response
lrn
health
jee
countries
public
who
health
global
field
diseases
security
health
cdc
global
ghsa
countries
care
regular
visits
primary
er
nan
rha
h5
vaccine
vlps
the
nucleolus
viruses
rna
nucleoli
expression
disease
rsv
respiratory
life
threatening
2015
cases
mers
cov
reported
virus
urine
we
describe
fatal
enterovirus
101
sari
controls
genotypes
mφ
cd8
ifn
cell
cells
mv
tumor
vaccine
virus
efficacy
ccl2
brain
neurons
tmev
hippocampal
influenza
surveillance
ili
sari
positive
hps
siv
inoculated
co
pigs
productivity
brd
beef
production
cattle
lymphocytes
cd20
nsip
follicular
interstitial
hadv
china
associated
ard
outbreaks
mers
cov
camels
camel
identified
nan
courses
ebola
chikungunya
zika
outbreaks
complexes
dithiolato
anti
inflammatory
no
protective
performance
healthcare
workers
ppe
new
vaccine
development
the
characterized
one
health
animals
important
vaccines
dna
responses
vaccines
immune
immunogenicity
outbreak
vectors
pathogens
vaccines
emerging
epidemic
the
author
reviews
foundation
coli
prevalence
calves
showed
05
community
subjects
respiratory
virus
surveillance
virus
mortality
comorbidities
respiratory
patients
tetherin
vsv
cells
virus
however
ebov
epidemic
virus
spatial
model
hbv
snps
related
asia
africa
genome
sequence
human
rhinovirus
identified
pol
transcription
human
hcmv
viral
pcr
rt
respiratory
rmla
detection
hospital
discharge
patients
h7n9
lung
hrv
vaccine
antigenic
human
rhinovirus
hcv
vlps
virus
population
high
ibd
role
countries
glp
the
type
ifns
iii
also
ifnλ
vap
patients
trauma
hours
tracheal
pex
years
children
cf
lung
virus
influenza
bat
iav
infectious
data
hiv
men
mena
epidemic
perc
tca
levels
toxicokinetics
formula
models
data
mathematical
framework
assess
il
inflammasome
viral
infection
18
dusp1
virus
rsv
host
antiviral
piglets
pedv
gm
sows
diarrheal
patients
gram
decitabine
culture
negative
cryptococcosis
disease
immune
host
cryptococcal
ms2
plp
particles
systems
system
outbreak
identified
restaurant
food
drain
mri
cases
pain
normal
examination
nan
ibrv
the
rpa
lfd
assay
patients
crs
care
pneumonia
certified
rsv
alere
ci
95
test
prv
respiratory
infection
mice
caused
cases
mers
cov
need
control
the
peptides
quickly
we
new
viperin
gbf1
antiviral
mechanism
interferon
stat
jak
pathway
viral
ifns
molecular
animals
mp
mrm
pcr
reviews
review
quality
evidence
turnover
atb
proteins
ltbi
mtb
infection
htnv
ctl
responses
hla
epitopes
assay
gpv
duck
parvovirus
qlamp
endothelium
endothelial
role
blood
biomarkers
dogs
cpv
positive
canine
parvovirus
mers
cpr
the
korea
kcdc
clinical
drugs
mers
sars
the
95
children
ci
respiratory
disease
bacterial
rti
voc
analysis
95
cd147
statins
glycosylation
glycosylated
mmp
dubs
ubiquitin
proteins
synapse
role
zikv
rt
assays
detection
iipcr
respiratory
infections
viral
rhinovirus
rsv
nan
mers
cov
two
rbd
it
genes
viral
related
bacteriophage
expression
slippage
template
base
rna
including
h9n2
tm
virus
in
influenza
ards
inspiratory
expiratory
lung
ct
pedv
per
cent
test
diarrhoea
infection
rsv
influenza
mortality
patients
indirubin
virus
model
interferon
study
kshv
infection
mir
36
cells
single
strains
ai
persistence
we
hfd
cqr
group
rats
obesity
bat
species
covs
pmvs
bats
respiratory
tract
human
bacterial
co
pedv
strains
ecuador
sequences
us
immune
responses
early
life
tissue
hsv
peptides
eval418
peptide
activity
cdv
infection
cells
mink
mv
nan
pla
family
enzymes
fatty
the
vp
vc
ped
day
vs
coronaviruses
respiratory
syndrome
coronavirus
cov
hcmv
cd147
antiviral
signaling
response
human
cov
mers
hcov
the
hpv
vdna
l2
subcellular
trafficking
bacterial
pbb
children
blind
patients
nodules
the
along
subcutaneous
observed
rabies
elimination
research
dog
control
nan
mers
cov
codon
usage
bias
bli
high
strategies
used
real
zikv
protein
signaling
cells
microcephaly
agents
detected
clinical
patients
tac
ibv
the
strains
sequence
phylogenetic
respiratory
influenza
residents
ari
nhs
lncrnas
infection
viral
high
functional
m2
hmpv
proteomic
motif
analysis
rna
non
coding
rnas
small
patients
pharyngotonsillitis
sore
throat
complications
diseases
control
services
viral
emerged
research
interventions
ebola
epidemic
clinical
intervention
the
mers
cov
korea
uri
upper
respiratory
infection
inevitable
e2
e1e2
e1
complex
layer
incidence
outpatient
the
influenza
respiratory
alphacoronavirus
species
genus
viruses
clade
health
mental
diseases
infectious
epidemics
agws
study
incidence
data
nndrs
rvd
poultry
new
virus
132
resilience
workforce
oriented
communities
research
transmission
norovirus
infection
rate
fomite
risk
communication
erc
emergency
the
database
viral
natural
virusdb
online
data
resources
the
ncbi
genome
virus
ictv
taxonomy
the
taxa
befv
the
protein
binding
peptides
influenza
vaccination
vaccine
program
adults
acute
these
guidelines
research
guideline
influenza
aom
children
vaccine
incidence
binase
viral
iav
rna
within
cardiotoxicity
dox
induced
several
mirnas
papmv
lcmv
viral
immune
ifn
viruses
host
primate
new
virions
rna
elements
viral
approaches
virus
core
virus
hepatitis
protein
cells
patients
ecmo
weaned
mmhg
vs
gte
viral
activity
antiviral
infections
disease
infectious
bursal
nitric
oxide
tsl
osteosarcoma
cells
in
saos
ts
wehi
cells
treatment
mice
mask
coughing
exhaled
air
dispersion
rig
viral
activation
the
2cards
powv
tick
disease
virus
patients
katnal1
function
development
role
microtubule
waaq
chinese
validity
cvi
001
changes
epidemic
school
holiday
closure
strains
ev
g1
pl
cp
virus
catenin
viral
influenza
wnt
ev71
cells
phb
virus
roc
cr1
cd
complement
variants
associated
rsv
nasopharyngeal
disease
viral
load
rsv
memory
cd8
cells
infection
influenza
mortality
years
elderly
age
poultry
lbms
trading
the
network
nan
proteins
alphavirus
nsp3
encephalitic
arthritogenic
cmah
neu5gc
humans
the
acid
viruses
metagenomic
data
environmental
samples
patients
ecmo
vs
mers
therapy
epidemic
global
epidemics
spread
framework
prrsv
ifn
pams
porcine
mir
nan
mers
cov
respiratory
pilgrims
infection
ccl5
expression
mrna
chemokine
system
insect
virus
tylcv
whitefly
gut
cpv
dogs
100
identify
circulation
vaccine
subunit
host
anopheles
salivary
monitoring
active
ebola
costs
risk
chry
we
analysis
landscape
repeats
cancer
pop
patients
year
incidence
mirnas
pcmv
immune
infection
organs
diagnosis
we
influenza
included
admission
diarrhea
cryptosporidium
mmv665917
treatment
causes
psychology
publications
social
media
the
infectious
bats
within
data
viral
cats
prevalence
immitis
domestic
feral
rna
covs
nsp14
among
viruses
gemcitabine
activity
antiviral
pyrimidine
also
mers
cov
camels
humans
zoonotic
antibody
based
clinical
delivery
molecules
mulv
gene
gag
rna
pol
exposure
fomites
viral
rna
swabs
influenza
surveillance
respiratory
pneumonia
patients
ovs
cancer
cells
selectively
killing
wpcd
cells
adjuvant
polysaccharides
dcs
influenza
use
masks
respiratory
studies
influenza
infections
pyogenes
seasonal
invasive
nan
influenza
ili
virus
respiratory
we
children
respiratory
illness
hpiv
young
influenza
viruses
specimens
470
respiratory
neutrophils
lps
extract
butanol
the
palmitoylation
proteins
bacteria
host
palmitoyl
hcov
respiratory
patients
11399
infection
nan
infection
pneumonia
mixed
bacterial
2009
influenza
prophylaxis
vaccine
care
health
lung
influenza
injury
respiratory
host
surveillance
data
influenza
ili
the
aris
incidence
weekly
hcmc
the
infections
children
respiratory
virus
viruses
influenza
specimens
virus
kenya
lbms
hbov
respiratory
all
patients
infection
co
influenza
respiratory
infection
viruses
patients
respiratory
viruses
pathogens
bacterial
influenza
travellers
travel
study
prevention
respiratory
child
severe
paper
fatal
respiratory
symptoms
impact
prophylaxis
interferon
host
hev
translation
pathogen
virus
influenza
seasonal
final
model
epidemic
100
000
2015
mortality
infectious
virus
samples
ireland
obtained
we
health
system
international
ihr
global
bsabs
therapeutic
use
first
abs
korean
qlq
patients
turbt
scales
pedv
semen
10
us
the
influenza
surveillance
h7n9
ili
virus
rabv
lab
attenuated
wt
cns
tcm
traditional
process
internationalization
opportunities
encephalitis
chemokines
ev71
children
mig
time
calves
fecal
wk
quadratic
rp
virus
95
99
eplex
data
methods
dna
analysis
genomic
mass
year
months
treatment
later
muo
disease
dogs
sequencing
csf
adenovirus
blood
infection
non
treatment
health
the
global
public
region
cat
liver
bile
providencia
rettgeri
hcov
cases
positive
genotype
common
groups
cpx
case
intervention
scores
pafb
small
cysteine
rich
cationic
proteins
cpxv
uncoating
poxvirus
core
ce
high
system
cost
instrument
evs
influenza
msc
virus
anti
medicinal
plants
knowledge
ethnoveterinary
study
mbl
inhibitors
bi
iii
positive
chikv
virus
infection
specific
antibodies
virus
ebola
flu
entry
new
the
mers
treatment
two
stage
nrt
research
countries
published
publications
spillover
zoonotic
transmission
human
pathogen
cost
direct
pneumonia
aom
costs
ihr
2005
health
global
we
influenza
case
definitions
new
definition
nan
pandemic
income
losses
global
estimates
marion
koopmans
tells
fiona
fleck
time
surveillance
ari
detection
background
risk
rvfv
transmission
egypt
animals
mpxv
species
museum
specimens
funisciurus
thresholds
pathogen
host
invasion
experimental
type
vwd
clec4m
patients
variants
mxa
activity
antiviral
smarca2
iav
activation
system
protease
cascade
systems
c47
sequence
rv
respiratory
here
infectious
vaccination
pregnant
women
fetuses
pedv
vaccine
qiap1401
the
inactivated
hmpv
human
metapneumovirus
respiratory
years
mitochondrial
mir
4331
tgev
damage
glycosylation
tetherin
surface
antiviral
cell
virus
ns5a
spatial
biophysical
replication
viral
host
infection
interferon
isgs
crispr
cas
system
virus
host
we
response
responses
antiviral
cells
ir
images
fever
screening
regions
blood
microfluidic
ions
human
device
qoc
beds
the
hospital
winter
vaccinated
ped
piglets
the
virus
hla
neoepitopes
cell
cancer
two
viruses
viral
3d
rna
host
the
rsv
specific
protection
respiratory
csf
titer
antibody
fip
lower
cov
h5n1
vn1203
mers
antigen
health
resources
china
system
convergence
health
savings
china
insurance
the
rna
zikv
detection
assay
using
pilus
rod
type
upec
cause
affinity
maturation
antibodies
antigen
antibody
pedv
qiap1401
ped
2014
isolated
cats
cpv
fpv
dna
parvovirus
4b
nf
κb
cov
infection
virus
replication
genome
crispr
cas
care
health
laboratories
patient
public
virus
human
hrsv
hmpv
neutralizing
denv
ns1
specific
mabs
serotype
sl
h9n2
viruses
activity
ai
data
sharing
research
rates
number
incidence
cap
10000
310
etiology
ifn
nmi
ul23
responses
human
strain
ch
pedv
jxja
2017
contact
number
social
locations
contacts
viruses
patients
respiratory
aris
the
intracellular
the
host
microbial
development
uvc
airborne
light
far
public
iv
dpp
substrate
bacterial
dap
dna
production
trim56
cgas
ifnαβ
pedv
coe
targeting
col
dcpep
ad
peptide
based
amyloid
disease
sp
pulmonary
effects
respiratory
disease
research
ppps
gof
address
funding
learn
erstalk
course
acute
respiratory
sari
mortality
patients
30
years
kobuviruses
species
cross
bat
transmissions
luminex
viral
assays
reference
respiratory
bat
viruses
rat
samples
rna
edsv
the
realamp
dna
egg
mers
cov
pregnancy
cases
infection
rsv
infection
control
outbreak
patients
ota
pcv2
could
replication
induced
il
infection
lung
rejection
hbp
hmpv
infection
infections
respiratory
rsv
taa
rats
na
group
vc
nan
asthma
pneumonia
children
acute
respiratory
patients
hcap
cap
viral
infection
piglets
pedv
intestinal
microbiota
infected
b1
nuclear
cell
localization
protein
usp2
thioguanine
cancers
ubiquitin
specific
respiratory
infections
antibiotic
mxa
viral
virus
morbidity
children
bacteria
respiratory
us
related
we
export
outbreak
gait
complex
l13a
the
system
health
human
emergence
environmental
animal
mers
respiratory
cov
disease
immunosuppressed
rp
panel
time
result
isolation
aureus
complex
schweitzeri
isolates
bats
influenza
associated
2015
95
ci
nan
pprv
entry
cells
dependent
epithelial
ada
cells
cd26
cell
2a
me
cfs
pathogenesis
model
often
nan
rtis
obesity
individuals
upper
10
ear
middle
otopathogens
children
raom
human
viruses
rna
threat
health
cov
bats
infection
sites
found
viral
infections
paediatric
vaccination
the
virus
antiviral
ifitm3
infection
vacv
hbov
hmpv
patients
respiratory
infections
hcov
illness
ili
species
hku1
health
ppe
evd
transmission
who
host
finches
house
rlow
infected
sspe
mev
antigenic
genotypes
sma79
resveratrol
rv
infection
diarrhea
could
transmission
data
genetic
sequence
divergence
ibv
strains
spike
s1
gene
viral
genomes
often
challenges
use
lung
ptx3
mice
ko
chronic
systems
biology
eids
recent
advances
dpp4
opioid
antihyperalgesic
pain
spinal
influenza
zbmd
np
antiviral
drugs
isolates
canine
cacv
cells
vesiviruses
practice
nurses
dual
health
evidence
urine
rats
pheromones
obp3
mup13
recycling
endosomes
vps3
vps8
cell
mesothelin
cells
cancer
virus
mva
serum
horses
infection
infected
vaccinated
tea
target
tbc2target
tbc
gene
ards
group
patients
oxygenation
ecmo
14
weaning
bhv
pathogens
period
binding
faeg
apn
f4
fimbriae
dpp
linagliptin
effects
inhibitors
renal
dates
admission
collection
patient
date
influenza
patients
east
respiratory
infection
on
95
ci
population
incidence
health
the
nih
fda
cdc
asymptomatic
carriers
disease
control
transmission
rok
exercises
among
response
ar
nan
rnas
lncrnas
insects
non
coding
respiratory
medicine
syllabus
first
european
different
cv777
genome
the
virus
health
quality
systems
system
hospital
cancer
usp28
ubiquitination
pathways
cell
hsv
γ34
nop53
viral
virus
virus
atp1a1
mammarenaviruses
multiplication
mammarenavirus
laboratory
networks
ecdc
health
european
chicken
immune
response
innate
expression
rv
assays
the
three
samples
zikv
409
infection
e298
neutralizing
evolutionary
evolution
statistical
information
pathogen
nan
vaginal
lactobacilli
lactoferrin
mucosal
healthy
lps
eafpg
lung
acute
ali
nan
stochastic
epidemic
this
seiqr
model
genes
uxt
rps9
rps15
rpl4
autophagy
related
atgs
processes
material
sputum
specimens
nucleic
group
extraction
cells
antibodies
response
human
memory
mers
outbreak
cov
the
2015
hsct
infectious
complications
post
engraftment
pbvs
himalayana
rna
segment
gi
cov
batcov
positive
mers
bat
mutations
tc
83
rna
increased
images
melanoma
acral
convolutional
neural
threat
the
infectious
emergency
protocols
cat
mri
examination
neuronal
ceroid
siv
chimpanzees
ranbp2
spillover
gorillas
upr
diseases
protein
inflammatory
cytokine
gs
5734
cov
covs
resistance
difficile
dogs
animal
the
diarrhoeic
tbk1
responses
immune
discuss
potential
mucosal
vaccination
immune
cells
responses
risk
age
infection
influenza
health
based
duchenne
muscular
dystrophy
molecular
cholera
vaccine
vaccination
oral
herd
cryo
report
protocol
model
virus
pmhc
complexes
docking
the
binding
field
system
training
epidemiologist
experts
nan
expression
gondii
host
cells
lncrnas
cam
use
patients
cancer
camel
cases
respiratory
the
fri
ari
nasal
mucosa
genes
clock
expression
pneumonia
current
pathogens
research
sequencing
codon
stop
selection
fourth
initiation
computation
large
recombination
recombinant
databases
viral
rna
rdrps
motifs
role
virus
lcmv
viruses
role
intestinal
respiratory
mers
cov
coronavirus
human
mcpp
cases
pneumonia
10
pneumococcal
procalcitonin
pathogens
bacteria
ng
ml
adults
medical
influenza
among
4200
flies
bacteria
cleaning
min
behavior
elements
eukaryotic
structure
structural
retroelements
risk
network
markets
outbreak
alpine
severe
bronchiolitis
children
virus
respiratory
suc
the
research
publications
chinese
strains
japan
pedv
pedvs
outbreaks
hp
prrsv
piglets
immune
disease
shedding
hcov
prolonged
high
associated
cchf
disease
cns
infection
mice
vaccine
poliovirus
subpopulations
transmission
eradication
hbov
mrna
cap
dna
or
severity
rsv
illness
disease
cd4
respiratory
infection
viral
identified
host
lrti
supplemental
oxygen
respiratory
rsv
cells
hmpv
virus
cell
hsct
years
ebola
virus
infection
neutralization
biological
research
dual
use
experiments
results
antimicrobial
virus
respiratory
viruses
type
poliovirus
polio
eradication
global
global
laboratory
the
polio
network
ymv
assay
the
rt
amplification
kd
adenovirus
infection
adenoviral
in
influenza
epidemic
the
method
epidemics
nan
229e
hcov
hr2p
infection
fusion
mitochondria
role
cellular
energy
homeostasis
biocidal
activity
rnms
ros
the
communities
areas
connected
surveillance
connectivity
bat
cells
model
mouse
immune
ili
influenza
surveillance
laboratory
swabbing
extracts
the
dioica
officinale
fractions
ivmp
ahem
ranbp2
acute
hemorrhagic
pneumonia
children
pathogens
pmh
introduction
interventions
preference
mortality
public
classes
materials
supramolecular
approved
peptides
towards
adenovirus
staff
air
dna
pathogen
exosomes
chp
heart
cardiac
studies
detection
virus
applications
viruses
aunps
rdt
zika
igg
igm
using
influenza
infection
aerosol
inoculation
virus
cats
mycoplasma
candidatus
feline
haemominutum
ve
estimates
control
we
negative
human
dengue
titers
reservoir
sting
ifnl3
copd
circulating
associated
vs
influenza
respiratory
among
cases
occurred
bovine
the
immune
immunobiotics
iecs
mers
cov
cells
mddcs
mdms
cell
virus
assay
conditions
ebola
nan
csra
cest
binding
the
post
complete
genome
isolated
south
korea
h7n9
epithelial
cells
infection
72
viruses
avian
detected
birds
samples
nan
mers
cov
zoonotic
africa
viruses
models
zika
virus
in
mathematical
calves
zinc
zdl
crusting
dermatitis
older
animals
cats
dogs
shelters
influenza
or
95
ci
pregnant
data
sequencing
neoromicia
africa
viral
infection
henipavirus
expression
lung
host
used
pathogenesis
studies
model
many
viruses
rodents
bats
rodent
pegivirus
pedv
coe
ppg
dcpep
l393
pedv
a1
hnrnp
protein
replication
packaging
rna
capsid
review
alphavirus
bse
cases
investigation
framework
case
jnk
protein
kinases
activated
virus
four
codons
codon
species
analysis
zikv
infection
test
neutralization
virus
iipcr
feline
felv
clinical
virus
cats
weeks
treatment
fip
gc376
plr
light
muscles
parasympathetic
sympathetic
nan
dectin
agonists
immune
mucosal
reactions
rpa
plant
rt
detection
direct
ebola
ci
symptoms
ptsd
95
lung
cancer
sclc
unusual
presentation
dmd
drug
cocktail
exon
therapeutic
bvdv
subgenotype
subgenotypes
1c
cattle
rvc
india
2013
gene
human
smallpox
new
york
rates
sydney
randomised
rhinothermy
participants
study
days
a3g
dna
a3
ssdna
protein
cells
antigen
antibody
single
expressing
virus
caribbean
poultry
review
viral
pedv
virus
fomite
days
materials
avian
respiratory
the
pathogens
disease
the
airborne
pathogen
ventilation
emergency
nan
groups
qx
chicks
strain
vaccinated
isg15
lb
pro
glygly
infection
we
cases
case
buliisa
health
rvfv
neutralization
assay
pseudoviruses
rvf
clrs
viruses
type
receptors
important
cf
airway
models
disease
lung
participants
mers
h7n9
awareness
diseases
co
parasite
interactions
species
different
hcv
infected
fibrosis
co
mono
blood
mosquitoes
xenosurveillance
humans
human
upr
protein
er
epithelial
mucosal
biologicals
zikv
vitro
safety
viral
in
essay
michael
johansson
colleagues
wildlife
individuals
study
pathogens
contact
prrs
states
swine
disease
diseases
gps
infectivity
mgl
cd301
glycans
cell
protein
cellular
functions
proteins
infectious
diseases
human
genome
host
glycans
roles
biological
complex
in
mice
iv
mers
cov
protein
risk
birds
factors
h9
or
niclosamide
xoo
growth
molecular
found
disease
outbreaks
system
podd
lgs
2015
influenza
h3n2
the
cystic
109
submissions
neonatal
diarrhoea
piglets
fraction
background
epidemic
immune
estimate
respiratory
lung
nonhuman
in
disease
nan
animals
vaccinated
non
disease
immune
transcripts
ribosome
translation
leader
ebv
protein
gene
transcriptional
protina
network
bats
bat
viruses
identified
human
ttv
transplantation
ebv
virus
levels
iiv
laiv
influenza
pc4
chickens
rabbits
the
method
viruses
luminex
transmission
passengers
respiratory
flights
inflight
reactions
lamp
nucleic
isothermal
amplification
toxicity
high
treatment
nucleoside
nucleotide
nucleosides
one
drug
flexibility
over
respiratory
virus
viruses
rna
infections
nucleoside
analogs
viruses
rna
currently
g4
sequences
tmpvs
identified
structures
data
hs
sms
last
idsr
species
conservation
the
wildlife
new
v920
vaccine
mosquitoes
observed
virus
antibodies
pfspz
isolated
immunization
falciparum
clusters
human
mers
cov
respiratory
pdcov
papn
infection
s1
receptor
ndv
macrophages
virulent
lentogenic
infection
cancer
cells
delivery
tumor
several
influenza
viruses
cells
avian
species
scaffolds
method
dioxane
quantitative
scaffold
method
ms
pneumonia
bp
pathogens
stage
phems
cdcs
recovery
at
h5n1
h5n6
factors
hpai
virus
zufsp
ubiquitin
polyubiquitin
dna
deubiquitinating
cd13
cells
cell
adhesion
monocytes
cachexia
clinical
muscle
cancer
patients
factors
disease
mers
cov
global
host
species
related
pathogen
new
ocugt1
ndp
gts
sugars
reactions
posts
the
misleading
popular
social
respiratory
enterovirus
ev
enteroviruses
d68
malaria
cases
hospitals
however
the
apobec3
virus
mediated
restriction
members
duck
gammacoronaviruses
australian
coronaviruses
samples
bnev
hbgas
bovine
vlps
linked
respiratory
viruses
virus
cd8
infection
viruses
respiratory
emerging
animal
human
children
rsv
bronchiolitis
respiratory
study
rna
folding
chaperone
chaperna
immunologically
in
month
editorial
plos
medicine
cdc_amd
tweets
809
videos
768
pitx2
variants
missense
pathogenicity
mutations
nan
albicans
ifit2
infection
ifn
invasive
ros
enterovirus
membrane
picornaviruses
cardiovirus
fecal
s100a12
concentrations
dogs
gastrointestinal
hcw
contact
nurses
hai
patterns
farp
ich
bal
np
the
fusion
viral
protein
virus
proteins
asymptomatic
patients
rsv
children
symptomatic
surveillance
ili
mosaic
influenza
respiratory
infants
pertussis
vaccination
may
population
c5a
inflammatory
paraquat
activation
patients
nan
infection
goslings
astrovirus
isolate
astroviruses
nan
influenza
bacterial
associated
infections
viral
management
illness
resource
influenza
care
g4s
g4
viruses
viral
genome
fit
factor
respirator
type
physicians
blvra
gmh
splenic
brain
spleen
assay
qlamp
lamp
grape
grower
dental
using
aureus
strains
the
mers
psychiatric
patients
suspected
confirmed
isg15
herc5
ifn
core
enzymes
ebolavirus
assay
the
strain
we
mers
cov
complement
lung
study
ifn
temperature
response
efficacy
temperatures
burden
age
dalys
years
disease
lta
imaging
infection
anti
antibody
health
fetp
jordan
epidemiology
surveillance
antibodies
new
human
super
years
volunteers
the
ebola
study
experiences
pneumoniae
children
pulmonary
symptoms
extra
pmo
phosphorodiamidate
dna
analogs
target
strain
liver
dhav
cytokine
ch
respiratory
01
antibiotic
virus
use
viral
pneumonia
africa
virus
respiratory
pneumoniae
the
pneumococcal
isolates
detection
in
or
pneumonia
pneumoniae
children
lung
afop
allograft
associated
patients
ifn
astrocytes
cns
function
virus
cancer
prostate
mir
patients
152
lmp1
ebv
protein
npc
latent
dem
diagnosis
smallpox
diagnostic
component
zikv
rna
virus
antiviral
silvestrol
ebola
virus
cell
rhodiola
rosea
virus
substances
cells
viral
replication
arbidol
antiviral
virus
cells
borne
rvfv
inhibitor
treatment
p70
s6k
bagaza
virus
genetic
human
african
pathway
stat
ifns
host
signaling
hiv
vaccine
based
approaches
infection
erk1
u0126
synthesis
junv
tcrv
hcv
lel
hcd81
cd81
non
nucleoside
analogs
antiviral
nucleos
ide
microbiota
rabbit
composition
rabbits
fecal
hbv
therapy
gene
viral
dna
workflows
metagenomics
clinical
we
poses
papers
citation
cited
database
classics
229e
hcov
coronavirus
respiratory
developed
ipf
ae
idiopathic
triggered
acute
rnase
pathway
inhibits
virus
5a
adp
targ1
ribose
poly
ribosylation
specimens
respiratory
agents
we
blood
expressed
class
in
chicken
mhc
packaging
ps
rna
viral
mutant
protein
terms
sequence
proteins
sequences
hadv
pcr
serotypes
tq
assay
mers
studies
days
severity
factors
ifnlr1
zebrafish
adnshl
knockdown
receptor
hpiv
respiratory
viet
nam
samples
vaccine
leptospirosis
effective
study
infection
data
experimental
pathogens
cross
emerging
dimeric
genotypes
adamantane
activity
amantadine
ebolavirus
functions
new
replication
protein
s1
coronavirus
evolutionary
ibv
spikes
defensins
human
virus
antiviral
discuss
health
investment
financing
financial
the
tau
protein
this
enzyme
go
immune
mucosal
innate
ncfm
nod2
microbiome
epitopes
sequences
influences
similarity
confinement
housing
study
calves
model
method
ibv
rt
qpcr
virus
fbov
fbovs
identities
bocavirus
hrb2015
hcv
genotypes
several
origin
years
acclimation
species
thermal
ability
ranging
camels
bred
dromedary
domestically
imported
polysia
52
fiber
human
hadv
gene
percomorf
retroviral
envelope
orf
the
family
different
entry
cell
health
disaster
nurses
mental
nuclear
production
response
proinflammatory
cytokine
er
type
analysis
glycosylation
glycans
high
12
40
13h
phenyl
pw
mice
caspase
nlrp3
11
parasite
chromatin
dna
damage
mice
exposure
tumor
heterogeneity
tumors
therapeutic
targets
knowledge
mers
attitude
dhps
cov
rsv
infection
viral
cause
high
prrsv
pams
infected
lncrnas
differentially
mhpcs
cells
marmoset
cell
disease
caninecv
recombination
analysis
lineages
viruses
degs
including
furthermore
ali
gene
vaccine
replicon
platform
3526
vrp
quercetin
derivatives
compounds
antileishmanial
the
rtid
patients
103
hct
episodes
children
hcov
community
detected
hospitalized
hmpv
ari
13
negative
diagnosis
pulmonary
exacerbations
cystic
fibrosis
common
ntcp
cell
hbv
surface
we
nan
rotavirus
infection
mtor
pi3k
antiviral
lab
immune
vaccine
lactobacillus
expression
denv
infection
compounds
disease
burden
aids
hiv
china
ngos
health
rsi
lri
mortality
we
severity
viruses
respiratory
aris
in
naples
design
based
amino
acid
therapeutics
eids
eid
global
events
significantly
proteins
prrsv
the
virus
membrane
95
ci
aor
children
oxygen
liver
hf
gl
si
combination
influenza
cc
rs12252
ifitm3
infection
tonsillar
il
hypertrophy
patients
tonsils
needlestick
infection
injury
occupational
clinical
conference
cystic
fibrosis
supplement
review
proteins
3a
pbm
protein
ic
bat
human
btcalv
norovirus
viral
cases
mers
number
the
healthcare
hiv
aids
lectins
immunodeficiency
specifically
gc
mycobacterium
tuberculosis
codon
usage
bronchiectasis
geographical
differences
disease
associated
bronchiectasis
pulmonary
inherited
acquired
disease
mers
cov
cases
contacts
outbreak
severe
due
emergency
ed
fulminant
hfmd
ii
severe
ang
concentrations
the
assembly
nps
rna
folding
jev
chk2
replication
infection
kinase
ppis
virus
host
method
the
viral
severity
hmpv
load
symptom
mers
rna
viral
genome
virus
viral
polyprotein
plant
proteolytic
infection
strain
group
members
viruses
genomic
bent
winged
bats
bat
the
the
asymptomatic
mers
infection
contacts
nhr
trimeric
coiled
coil
helical
hcov
oc43
usa
2016
2017
cancer
μm
cells
compound
the
china
primate
forest
restoration
must
217
pedv
different
pigs
rna
mxra8
chikv
infection
arthritogenic
alphaviruses
virus
filmarray
the
rp2
coronavirus
g6pd
deficiency
low
acute
severe
at
indications
pediatric
subgroup
factors
we
2015
factors
dalys
burden
rna
rns
ifn
stranded
double
sequences
the
ticks
identified
known
il
cytokines
17
22
cells
spp
bats
babesia
china
rickettsia
ped
pedv
rtf
rt
lamp
species
multocida
amsterdam
populations
seabird
who
guidelines
products
quality
public
autophagy
zikv
lc3
viral
infection
restriction
eqthn
tetherin
fluav
ha
pt
virus
hiv
anti
potency
influenza
drugs
treatment
antiviral
drug
complications
reperfusion
inflammatory
anxa1
cardiovascular
ddx5
rna
infection
virus
asp
iav
omt
induced
anti
vitro
ped
pedv
2016
purified
fecal
juglanin
skin
via
uvb
cancer
bcov
report
full
genome
sequences
infectivity
virus
humidity
ah
rh
platforms
tspans
membrane
tspan
infection
cells
ifnγ
trachomatis
bystander
tryptophan
may
diseases
animals
food
well
ntds
diseases
in
health
2020
1238
infections
malaria
children
densities
galt
app
antigen
study
cross
health
public
education
the
students
ibex
infection
brucella
shedding
ruminants
health
epicore
information
responses
disease
nan
nan
leptospirosis
burden
china
2005
2015
pvp
bactericidal
virucidal
gargle
mouthwash
test
soap
hand
pvp
chg
rt
cov
the
lamp
vf
immune
responses
infection
mice
iav
nan
calves
embryo
days
clinical
presented
viruses
dogs
swine
canines
guangxi
viruses
non
samples
present
spiked
pga
tlr4
ifn
antiviral
mnv
proteins
faps
protein
fluorogen
probes
pulmonary
function
radiological
sequelae
mers
medical
hospitals
patients
hospital
according
microbiota
reproduction
bats
shedding
seasonal
iop
show
photonic
vivo
we
zikv
spinal
motor
cord
myelitis
new
amr
bacteria
ags
resistance
coinfections
dengue
malaria
chikungunya
cases
interferon
exacerbations
virus
ics
inhaled
infectious
diseases
jordan
syrian
medical
lipid
pathways
replication
infection
hand
aa
amyloidosis
cheetahs
captive
protein
pbm
osteoporosis
network
networks
bone
bats
apobec3
mammals
antiviral
genes
fitness
viral
genotypes
differences
host
self
hh
performance
attitude
model
viral
pipeline
the
rna
variants
nan
virus
arbovirus
2014
chikv
zikv
virus
dengue
compounds
antivirals
activity
viral
different
prion
like
proteins
flu
eap
the
cold
levels
gene
qpcr
et
al
internal
synthetic
viruses
rna
the
denv
ace2
patients
activity
plasma
mace
sequence
quitensis
the
rna
colobanthus
cancer
lung
stem
cells
cd133
egfr
autoantibodies
peptide
array
patients
state
measures
justification
easy
rescue
infection
control
burnout
nurses
adherence
incidence
aedes
transmitted
times
range
vaccination
areas
coverage
health
facility
nan
lps
induced
offspring
maternal
administration
bmdm
microglia
demyelination
ms
inflammatory
canine
dogs
samples
signs
nasal
patients
detection
respiratory
severe
viral
influenza
respiratory
viruses
cases
15
rv
respiratory
types
major
acute
diseases
viruses
paraprobiotics
probiotics
viral
tgev
infection
pigs
small
intestine
ifit1
ifit
ifit3
translation
binding
children
tem
pcr
pathogen
improved
ztb
challenges
tb
disease
health
strain
ifn
zikv
asian
response
niv
respiratory
lipopeptides
prophylaxis
the
viral
rna
ptms
virus
cellular
we
method
conformations
accurate
atomic
like
kazinol
pro
the
pl
ews
data
reporting
the
well
influenza
avian
viruses
samples
waterfowl
recombination
adenovirus
human
hadv
bacterial
respiratory
samples
air
sampling
active
bats
astvs
material
large
diversity
malaria
encephalitis
meningitis
cases
bangladesh
studies
the
model
phase
development
ari
illness
mbsr
days
exercise
viral
signature
bacterial
protein
fever
nais
il
hie
month
inflammatory
protein
pgrs
tuberculosis
family
domain
respiratory
mers
cov
mildly
ill
models
inflammation
infection
male
autoimmune
hrqol
pain
icu
physical
survivors
chitosan
delivery
vaccine
application
in
mg
diterpenes
antibacterial
efficient
preparative
protein
rpirls
rna
methods
the
the
pathogens
samples
ngs
method
fmt
fecal
pigs
intestinal
material
malaria
reproduction
numbers
2016
individual
cattle
transportation
the
market
001
children
asymptomatic
the
visits
virus
pcd
ciliated
patients
conical
protrusions
brsv
the
important
bovine
risk
support
social
effects
symptoms
ptsd
virus
aris
hrv
viral
patients
protein
ribosomal
human
mass
spectrometry
nan
mers
dromedaries
cov
virus
vaccination
military
diseases
us
development
personnel
smcypi
flaviviridae
family
activity
cyclophilin
cdv
samples
50
201
the
the
assay
rt
wnv
lamp
influenza
data
search
model
query
infectious
tc
tcs
wash
products
the
models
dengue
patients
physicians
infection
tolerance
host
pathogen
lung
graphical
representation
protein
sequences
to
baculovirus
vectors
displayed
infectious
diseases
infections
enteric
avian
virus
single
viral
virus
cells
studies
imaging
chikv
host
therapeutics
in
virus
vaccine
dna
live
bacterial
the
mers
cov
saracatinib
respiratory
drug
hev
virus
silvestrol
rna
this
ib
ibv
var2
day
flock
dengue
heterogeneity
dynamics
model
transmission
relocation
uri
cats
increased
animal
perceived
risk
perception
resource
mers
enteric
diagnostics
sequencing
porcine
diarrheic
nicu
cohorts
new
differences
genes
pedv
ntd
mucosal
protein
immune
gondii
ursolic
acid
anti
parasitic
rvb
piglets
disease
identified
buryat15
cell
cells
influenza
vaccine
protection
nucleic
acid
cellular
uptake
upon
nf
κb
protein
upr
also
orns
influenza
antiviral
patients
effect
review
development
thiazolidine
the
thiopyrano
zika
the
health
public
vaccine
host
protein
in
mimicry
viral
cd8
cell
ceacam1
cells
virus
health
mhealth
using
review
populations
virus
coronavirus
the
crcov
human
taar1
immune
regulation
expression
role
alignment
viruses
hosts
methods
sequences
dcs
immune
represent
vaccination
strategies
hn
culture
hpiv
viruses
clinical
threshold
distance
population
the
susceptible
tdl
vent
patients
mortality
score
95
mri
early
osteonecrosis
femoral
treatment
pcp
bal
patients
group
community
acquired
pneumonia
treatment
guideline
brucellosis
melitensis
infection
korea
transmitted
based
infections
may
viral
nanoparticles
phenolics
anti
bioactivities
activities
disease
rosiglitazone
forskolin
group
expression
cell
loss
scores
suffering
cls
decision
automated
sputum
nucleic
acid
primary
neutrophils
role
disease
cells
demyelination
health
preparedness
collaboration
public
response
respiratory
aris
identified
study
pathogens
lambs
eimeria
toltrazuril
efficacy
spp
coli
probiotics
biofilms
resistant
cfsm
age
disease
dogs
breed
medical
tomato
ty
mutant
yellow
leaf
influenza
the
virus
assay
multiplex
lncrnas
mrnas
parvum
expression
important
expression
cancer
clinical
gene
used
hcov
nl63
infections
samples
repeat
nasal
iota
carrageenan
xylometazoline
hcl
hadv
patients
respiratory
prevalent
cases
respiratory
immunization
ncird
response
closer
pathogen
domestic
swine
better
porcine
influenza
specimens
respiratory
viruses
detected
diseases
severe
comorbidities
flavivirus
chronic
3d
g64s
mutation
selection
many
pld
ptdoh
inhibitors
isoenzyme
selective
cats
signs
cerebellar
artery
dogs
virus
respiratory
asymptomatic
positive
participants
respiratory
viral
virus
children
agents
human
airway
virus
organoids
viruses
optogenetics
applications
the
birth
subsequent
antiviral
research
virus
year
award
rgs
guidelines
development
methods
evidence
acg
aluminum
oxide
glass
slides
transmission
large
virus
epidemics
analysis
h7n9
sars
impacts
economy
china
copathogens
h1n1
patients
one
four
respiratory
disease
mers
cov
nonhuman
species
ticks
animal
benin
rhipicephalus
influenza
host
virus
major
classes
preserved
eggs
05
caco
cells
hbov1
patients
infection
prevalence
respiratory
patients
mers
cov
infection
hospitalized
scale
protease
viral
hts
arboviral
virus
viral
disease
mathematical
treatment
manillensis
codon
usage
cdss
content
epidemic
data
transmission
population
individual
research
model
biomedical
utility
since
pge
cox
signaling
replication
viruses
analysis
lactation
meta
degs
mammary
ebv
culture
ali
epithelial
cells
pedv
ifn
type
protein
iii
febrile
seizures
the
clinical
children
samples
guano
c1
c2
bacteria
hcv
cd81
human
liver
cells
human
hpaiv
h5n8b
virulence
lung
hbov
children
respiratory
years
old
isopeptide
coiled
coils
peptide
bond
patient
pathogens
systems
reporting
data
hbv
ad
dose
group
10
md
95
ci
vitamin
cold
risk
we
two
infective
one
pfsra
invasion
plasmodium
falciparum
erythrocyte
acute
disseminated
encephalomyelitis
present
clinical
prrsv
cells
vesicles
virus
infected
cholesterol
iav
endosomal
antiviral
le
hrv
transmission
individuals
acquisition
households
niv
health
human
cases
humans
griffithsin
material
the
hiv
tobacco
sfrna
rna
xrn1
results
infected
cchf
cchfv
ad
hemorrhagic
disease
ms
secretion
patients
bcl
cells
influenza
cell
viral
viruses
rna
sex
innate
immune
cells
differences
trna
modifications
trnas
translation
enzymes
cotton
cells
cd40l
the
protein
influenza
viruses
sari
ili
seasons
pig
samples
viruses
nasal
bioaerosol
subunit
membrane
interaction
proteins
coli
mt
monkeys
old
leaky
gut
tannins
diarrhea
neonatal
the
chestnut
eos
mic
respiratory
tract
cinnamon
targets
therapeutic
network
ypf
diseases
per
allergen
372
american
control
influenza
sari
sentinel
surveillance
cases
coronavirus
grp78
spikes
coronaviruses
mers
griffithsin
manufacturing
cost
the
hiv
animals
zoonotic
diseases
companion
pets
bcov
experiment
persistent
infection
cattle
sirt1
canine
expression
cells
pbmcs
3c
mutations
genes
fcovs
feline
vaccination
influenza
t2dm
patients
study
feline
fip
infections
studies
systems
replication
virus
vectors
immune
activation
oil
spill
detection
used
algorithm
stool
hiv
the
molecular
enteropathogens
ev71
quercetin
pro
viral
3c
virus
borne
insect
pathogens
fever
car
cell
infections
cd19
therapy
pdcov
knu16
07
porcine
deltacoronavirus
pigs
respiratory
different
viral
disease
bac
pedv
piglets
s1
protein
flaviviruses
borne
interactions
innate
immune
s1
rhbm
ibv
the
vaccine
dmab
cxcl9
mice
prostate
cancer
high
research
operational
the
pathogens
gnps
optical
biosensors
unique
plasmonic
lai
asia
pacific
region
reports
myocarditis
acute
cause
the
mers
mers
risk
cov
hcws
higher
mers
cov
patients
treatment
the
nan
alcohol
brain
smoke
exposure
nnk
hmpv
children
rhmpv
pa
adults
risk
factors
social
suicidality
depressive
zikv
ns1
prm
protection
specific
drug
study
term
suspension
safety
trial
aom
xylitol
sugar
the
the
features
organizing
pneumonia
afop
training
hand
washing
weeks
ari
positive
respiratory
the
viruses
study
12
children
elp
pneumonia
red
stiffness
cells
ecm
host
bacterial
cells
cell
mesenchymal
repair
leader
tkr
1996
2010
incidence
the
peritoneal
virus
macrophages
genes
cats
pneumonia
hadv
cases
children
load
respiratory
virus
viruses
data
surveillance
mers
cov
hcabs
dromedaries
vhhs
gp
igg
antibodies
virus
assay
rbd
immune
hbd
innate
conjugated
viral
er
organelles
inclusions
viruses
aivs
cross
influenza
virus
cell
prrsv
proteins
hp
different
ap
activity
ptb
radiographic
active
probably
nan
cells
lung
alveolar
airway
epithelial
respiratory
cases
307
influenza
viruses
ibv
expressing
protein
rndv
disease
influenza
pandemic
global
viruses
in
surveillance
influenza
respiratory
vietnam
expanded
recovery
delay
mers
cov
patients
influenza
network
the
global
surveillance
course
knowledge
patients
care
health
250
symptoms
hcov
prevalence
among
influenza
vietnam
transmission
detected
ili
months
capacity
ards
h1n1
pulmonary
nan
cells
prcr
unwanted
target
macrophages
risk
ed
patients
cross
infection
primary
care
influenza
trial
usual
rabies
vaccination
dogs
transmission
djaména
patients
mp
pneumonia
sp
icu
hrv
children
sari
human
respiratory
rna
viruses
virus
india
the
bcov
calves
gene
114
samples
omww
olive
analysis
polyphenols
intestinal
colistin
strains
activity
resveratrol
combination
reference
genes
ef
gene
separata
ohsa
implementation
used
act
selected
nan
clad
lung
development
long
term
mers
cov
camels
zoonotic
africa
response
host
microbial
infectious
role
residency
training
programs
focus
intellectual
kits
mink
pwd
bacteria
control
diseases
antibiotics
phytochemicals
infections
effective
mpap
calves
brd
treatment
associated
nan
nan
cells
rm
induction
memory
effective
microglia
infection
brain
p2y12
viral
torovirus
rna
etov
sequencing
sequences
species
the
exophiala
assay
waterborne
expression
plant
production
proteins
vaccine
porcine
dcs
pedv
inactivated
pps
clinical
patients
tbds
in
molecular
lasv
several
lf
seen
vaccine
groups
h9n2
old
aiv
experiment
this
avian
diseases
treatment
zoonoses
dni
ptb
cap
patients
the
ed
revisits
72
patients
hour
nnrtis
rtis
hiv
including
nucleoside
phase
macrocyclic
drug
development
peptide
goitrin
chiral
glucosinolates
chemical
drugs
fumardiamides
showed
activity
50
pq
stoma
trachea
airway
laryngectomees
severe
ppis
host
virus
viral
proteins
orfeome
orfs
albicans
cloned
genomic
viral
disease
cell
associated
fatality
invasive
pcr
aspergillosis
bal
non
rattus
apodemus
china
species
measurements
indirect
pedv
elisa
swine
antibodies
health
medical
ebola
team
care
phase
g0
g1
cell
cycle
tannins
plant
anti
in
feed
virus
isolated
bat
paramyxovirus
b16
cordyceps
fungi
chinese
industry
fungus
surveillance
reporting
vietnam
pilot
systems
list
diseases
the
process
blueprint
knowledge
travelers
actual
subjective
behavior
ibv
chickens
guinea
fowls
free
cvb3
ifn
ifnar
infection
hepatocytes
sars
glycoprotein
s1
ace2
cov
receptor
binding
na
virus
iav
nan
assay
canine
xtag
virus
luminex
respiratory
wu
ki
patients
pediatric
nan
the
peep
atelectasis
groups
surgery
viruses
infection
ferrets
bat
achimota
detection
viral
viruses
samples
oligonucleotides
disease
time
complex
propagation
dynamics
asymptomatic
ratio
norovirus
infection
data
mctq
sleep
adults
msfsc
older
emodin
the
heparg
cell
apoptosis
mahed
genome
the
ibv
strain
samples
pcv2
positive
circovirus
detection
pedv
samples
the
gene
sequences
hcv
treatment
rass
ns5a
ns5b
er
upr
stress
activated
various
parasites
macrophages
type
ctg
ros
health
increased
emerging
animal
early
seasonal
weather
data
correlations
public
iron
supplementation
lambs
the
injection
public
health
papers
informatics
the
orf3
pedv
protein
proteins
replication
respiratory
viruses
common
cold
diagnosis
cells
hiv
entry
ccr5
ifitms
ota
dose
mg
kg
thymus
cases
contact
reported
primary
dromedaries
κb
nf
viral
activation
proteins
metagenomics
environmental
identification
viruses
viral
autophagy
process
components
infections
survival
ibv
ses
egg
flocks
isolates
bat
bats
species
mastadenovirus
viruses
fcv
50
antivirals
assays
μm
10
respiratory
surface
influenza
samples
malaria
cases
elimination
system
national
oviduct
egg
virus
infundibulum
h9n2
lamp
osd
wolbachia
to
mosquitoes
niclosamide
denv
viral
infection
cells
metagenomics
pathogen
rna
sample
currently
sfb
bacteria
host
commensal
differentiation
pedv
virus
infection
neutralizing
antibodies
nan
pscc
lamc2
slamc2
patients
cancer
hpev1
hpev3
cell
human
hpevs
the
studies
interventions
settings
effectiveness
ev71
mir
infection
expression
mouse
vampire
bat
diet
population
structure
cardiac
glycosides
na
atpase
antiviral
dtmuv
infection
signaling
pathway
immune
students
influenza
fomite
the
respectively
infectious
disease
the
dnn
lstm
stat3
muscle
signaling
skeletal
diseases
mortality
bacterial
viral
infections
patients
influenza
the
starting
occurrence
epidemiological
vlps
hcov
nl63
produced
viral
gd
astrovirus
astroviruses
gout
disease
sars
3a
lysosomal
cell
death
formation
base
rna
pnas
triplex
rna
cap
methylation
activities
mtase
felv
fiv
testing
the
data
membrane
protein
crystal
dehydration
successfully
ly6e
viral
antiviral
ifn
isgs
prdc
affected
piglets
virus
porcine
iav
lung
cells
resident
memory
cdv
cadv
puppies
histopathologic
100
success
rate
robot
intubation
system
diseases
drugs
new
infectious
tropical
fusion
hcov
229e
core
hcovs
hptlc
acid
the
methods
rutin
radix
bupleuri
saikosaponin
saikosaponins
activities
tf
ee
inflammatory
src
response
hiv
atf4
effect
production
factor
binding
grft
lectin
cell
expression
emerging
pathogens
clinical
viral
associated
cells
microglial
human
line
cell
respiratory
pathogens
study
acute
ari
optic
inoculation
demyelination
spinal
cord
dengue
control
effect
we
health
studies
human
humans
iv
mouse
human
host
hcov
models
mouse
virus
taxonomy
used
baltimore
classes
cells
tumor
atpase
archazolid
ecs
hsp
patients
age
seasonal
pediatric
iav
grk2
replication
influenza
phosphoproteome
hocl
antiviral
chloride
cells
nacl
jol2077
ib
vaccinated
compared
control
infection
e75cv1
immune
asfv
e75
env
hiv
trimer
antibodies
bnabs
rhinovirus
human
infection
pulmonary
conditions
human
codon
usage
respiratory
oc43
molecular
pathogenesis
many
hcps
therapeutic
melioidosis
pseudomallei
western
indian
ocean
sfgr
rickettsioses
case
spotted
fever
health
chinese
china
system
partnership
using
pcr
analysis
fecal
smear
acute
samples
non
we
microbial
south
africa
perceived
animal
provincial
ibv
sapn
flagellin
chickens
immunized
protocol
proteins
upper
respiratory
proteome
asthma
respiratory
patients
rhinovirus
airway
prrsv
dpi
pigs
reduced
aid
se
genetic
traits
health
maternal
pedv
pigs
dpi
05
reduced
dcs
viral
cells
antigen
vaccines
genome
new
hadv
whole
90
ibv
virus
rdt
cit
assays
nan
diseases
equine
human
encephalitis
disease
respiratory
rdu
crowded
airports
aerosol
products
medicinal
atmps
methods
msc
siglec
human
binding
cells
allergic
nan
respiratory
virus
children
infections
aris
rna
chemical
tools
probes
ligands
1prf
mrna
pseudoknot
nctn
frameshifting
pcv3
identified
found
effective
porcine
we
models
patient
methods
parameter
ir
irts
methods
disease
temperature
pedv
virus
cells
diarrhea
airborne
lamp
rt
ndrv
primers
detecting
chronic
inflammatory
palatine
eotaxin
tonsillar
mers
cov
nbs
binding
fc
ibv
cells
beaudette
vero
the
evolution
microbiome
mammals
microbial
gut
summit
medical
insight
publishing
users
tgev
infection
nutrient
absorption
arginine
apmv
avian
virus
species
the
fcov
cat
cutaneous
case
nodule
ifitm1
infection
gammaherpesvirus
68
lymphoma
virus
detection
antibodies
iltv
ibv
chikv
recommended
inactivation
despite
increasing
required
viruses
cellular
host
intracellular
genus
compounds
alnus
species
diarylheptanoids
dna
vaccines
groups
early
work
broilers
study
broiler
galapagos
exposure
symptomatic
infections
outbreak
transmission
estimate
sepsis
viral
children
bacterial
negative
rossmann
like
fold
proteins
protein
icv
bovine
we
identified
influenza
respiratory
human
coronavirus
nl63
20
the
tgev
clinical
enteric
evaluated
gold
nowadays
used
nano
medicine
constituents
ypf
radix
pharmacokinetic
compounds
autophagy
cell
death
cells
gbm
fprs
formyl
receptors
peptides
in
anti
amentoflavone
many
natural
plants
heo
microemulsion
purification
essential
oil
chromatography
μm
gel
trypsin
inhibitor
vs
tgf
β1
tt
cc
cf
lung
microbial
community
biodiversity
peacock
involved
adaptive
evolution
genomic
sites
viral
24
sinonasal
cavity
new
vaccine
vaccines
development
rapid
genes
strains
pigs
microarray
analysis
protein
coiled
atlas
coils
structures
hbov
studies
individuals
respiratory
tract
viruses
bats
immune
rna
humans
indirect
elisa
mers
cov
virus
respiratory
type
military
influenza
influenzae
ad
genes
immune
pathogen
also
genotype
tnbc
patients
carriers
aurkb
nan
bartonella
bats
infection
transmission
bat
hev
acute
liver
hepatitis
causes
pact
respiratory
syndrome
middle
east
vaccines
91
the
protection
h120
assay
10
log
in
house
camels
camel
genetically
stem
cells
hcv
lipin1
infection
replication
lipid
viral
ifitms
hiv
ifitm
protein
pedv
rice
feed
rna
mcfa
cpsrnas
the
19
sars
cov
copd
disease
antiprotease
in
development
data
information
health
sharing
public
zikv
antiviral
directed
anti
antivirals
viruses
monocytes
macrophages
cells
virus
species
bat
populations
different
viruses
piglets
pedv
types
diarrhea
2013
refinery
oakville
health
closure
persons
membrane
induce
rearrangements
viral
ibv
pps
activity
the
antiviral
extracts
mers
cov
bsl
mouse
infection
influenza
viruses
animal
human
health
compounds
juniperus
biological
activities
species
pedv
porcine
antiviral
caerin1
epidemic
host
shutoff
influenza
virus
mechanisms
rage
binding
heparin
cell
studied
rbv
se
senps
h1n1
caspase
virus
respiratory
viruses
positive
children
agents
donor
animals
human
transplant
emergency
hospitals
manuals
infection
control
liver
inflammasomes
il
18
diseases
influenza
sari
associated
95
ci
cub
prf
translational
efficiency
genes
nan
ifn
irf9
cells
influenza
type
sepsis
viral
bacterial
caused
host
egr1
fmdv
ifn
infection
study
plantar
fascia
also
stem
cells
viruses
viral
rodents
mammalian
species
adrp
beaudette
glycine
the
ibv
tumor
microenvironment
invasion
response
brain
nan
sars
cov
plp
viral
ifn
pneumonia
2014
cases
2007
the
virus
antisera
approach
adjuvanted
the
endou
toxin
use
systems
the
testing
cap
idsa
ats
ers
epitopes
cd8
overlapped
hpv
90
readmission
identification
rate
aecopd
higher
data
models
model
elimination
parasite
years
values
aged
age
measles
pneumonia
children
evidence
antibiotic
community
analysis
codon
pcv3
usage
index
aureus
respiratory
superinfection
in
interactions
prrsv
virulence
marc
145
cells
nan
nan
hku9
batcov
bats
gccdc1
viruses
nan
nan
pdcov
chn
2016
newborn
piglets
nan
sars
cov
infection
mice
complement
cdgstm1
ph
monomeric
thermodynamic
dimeric
vaccines
vaccine
diseases
efficacy
infectious
laiv
iav
bronchiseptica
challenge
colonization
zikv
infection
placental
observed
women
sequences
rv
c56
respiratory
we
patients
extracorporeal
support
one
two
pneumoniae
pertussis
775
respiratory
rtis
sars
cov
29
deletion
orf8
group
treatment
bis
mont
edn
respiratory
atypical
infection
positive
bacteria
ic
golgi
trafficking
organelle
role
nan
ilov
rv1a
rv
cells
the
bronchiolitis
severity
respiratory
group
viruses
hpiv
respiratory
illness
severity
patients
ileocytes
porcine
enterocytes
co
colonocytes
inflammation
tgev
mir
22
mrnas
genes
overlapping
virus
genome
method
cd9
marker
depending
review
expression
antibiotic
general
practitioners
resistance
targeted
alprostadil
oa
induced
ards
model
monkey
prv
virus
segments
the
infection
concomitant
children
ivig
vs
sanitation
sustainable
research
social
solutions
diarrheic
non
pools
mink
caliciviruses
macrolide
treatment
pmc
groups
cst
calves
immune
beef
development
dairy
immunization
health
public
data
this
data
electronic
health
exchange
public
interferon
cardioviruses
production
picornaviridae
family
ga
hd11
salmonella
macrophages
expression
delay
diagnosis
treatment
tb
system
pastv
diarrheic
psav
pigs
healthy
governance
nutrition
this
need
undernutrition
overlapping
genes
evolutionary
proteins
we
ceacam1
anti
tumor
cells
cc1
virus
ceacam1
influenza
h5n1
infection
bats
infected
viral
fungus
increased
tgev
tfr1
infection
cells
receptor
outbreak
model
tools
outbreaker2
reconstructing
patients
respiratory
positive
hrv
clinical
patient
tb
immune
thrombocytopenia
association
ibv
respiratory
the
flocks
qx
involvement
puuv
pulmonary
infection
renal
vaccine
mtb
bcg
subunit
tb
6b
h1n1
pdm09
2010
2013
hn
sodium
patients
children
cap
mk
app
2016
surveillance
disease
virus
population
animals
in
affected
epitopes
mhc
cell
step
cancers
mers
cells
up
cxcl10
cov
host
sars
cov
viral
ace2
respiratory
infections
although
assays
newer
k22
family
several
viruses
antiviral
transplant
complications
syndrome
pulmonary
post
niclosamide
nafld
liver
steatosis
improved
nan
rvis
nicu
viral
term
virus
viral
extraction
the
ngs
kits
acute
extubation
high
respiratory
pediatric
transmission
viral
data
selection
sequence
mrna
decay
expression
binding
protein
acute
pancreatitis
the
global
system
ifitm3
virus
triggered
irf3
induced
coli
calves
isolates
diarrheic
apparently
nan
ifitm
proteins
rapamycin
mtor
virus
cov
mrnas
nmd
pathway
rna
reference
genes
gene
expression
used
hcov
incidence
infections
among
risk
households
rsv
viruses
respiratory
virus
rewired
trn
vaccines
attenuated
live
cchfv
hemorrhagic
virus
disease
fever
samples
viruses
mngs
clinical
the
fomite
transmission
route
pathogen
pathogens
viral
dna
bk
polyomavirus
double
pestiviruses
pestivirus
bats
rodents
species
cells
nog
mice
human
dko
nan
assay
pcr
rsv
hrv
hmpv
species
temperature
viral
we
load
carbohydrate
microarray
antigens
antigen
microarrays
fas
structural
herein
food
important
scv
drug
aureus
infections
identify
nan
rna
genome
size
viruses
rnp
osa
tongue
lip
adhesion
pierre
antimicrobial
peptides
developed
property
chemically
viruses
cns
virus
respiratory
infections
palsy
bell
groups
treatment
childhood
mers
camel
cws
disease
cov
hpv16
hcmv
infection
cells
cd63
zikv
infectious
the
clone
virus
rsv
rapid
detection
fict
10
virus
zika
secretory
flaviviruses
proteins
p96
pedvpt
ipedvpt
viral
pedv
ocular
flaviviruses
zikv
retinal
cause
ebov
epac1
esis
ecs
infection
ceacam1
liver
immune
hepatic
insulin
orthoquin
hsv
virus
herpes
simplex
trna
binding
rna
domain
lysrs
ebolaviruses
maintenance
bat
alternative
hosts
hcov
patients
hcovs
respiratory
influenza
viral
influenza
laiv
infections
vaccines
pericollapse
stage
onfh
imaging
joint
hsv
also
anti
potential
virus
emmprin
atherosclerosis
endothelial
matrix
no
riemannian
methods
community
framework
subset
diseases
zoonotic
research
theses
publications
cbc
animals
transcript
abundance
calves
infection
pregnancy
influenza
viral
hormones
cns
microglia
microglial
resident
diseases
children
cap
mdth
detected
hospitalization
lncrnas
longan
se
expressed
target
intervention
initiation
people
influenza
hong
limosus
cf
symptoms
mrsa
colonization
md
hvt
mdv
disease
chickens
sputum
pre
treatment
device
specimens
hyponatremia
0001
children
crp
the
site
models
divergence
branch
length
clrs
dc
dectin
library
mannose
maternal
immunization
neonatal
pregnancy
early
catechins
egcg
studies
shown
green
trans
isoxazolidines
50
diethoxyphosphoryl
n3
members
inhibition
m1
aminopeptidases
families
apoptosis
cell
proteins
s1
pedv
score
helium
oxygen
mixture
patients
comparison
binding
site
the
choice
nan
cd8
cells
rm
cd4
cell
protein
aconitine
alkaloids
cardiotoxicity
the
winter
influenza
southern
hemisphere
reproduction
rabies
kudus
oral
in
virus
s2
cathepsin
mers
tmprss2
entry
aging
rsv
infection
pathways
old
influenza
respiratory
virus
children
found
data
digital
we
epidemiological
access
nthi
copd
airway
exacerbations
chronic
myocarditis
rhinovirus
infection
including
herpesvirus
mice
virus
tmprss2
ha
iav
landscape
genetics
genetic
review
field
influenzanet
participants
ethical
country
data
protection
s1
beaur
m41
vaccination
sfsv
irf3
nss
phleboviruses
ifn
hbov
hpv
positive
tumors
infected
skew
nucleotide
virus
data
trees
pwd
mammary
kits
per
kit
h7n9
2013
the
china
infections
cf
infection
lung
viral
infections
patients
respiratory
rsv
influenza
screening
health
diseases
themes
system
arbaeen
hrv
types
type
health
patterns
zikv
cells
infection
virus
inflammation
nan
camels
mers
cov
humans
pakistan
nan
virus
niv
humans
person
viral
δg
ifnl4
prostate
partners
cancer
gondii
infection
intestine
infected
degs
hcws
mers
patients
outcomes
survivors
rdrp
ntd
rna
fidelity
interactions
tnbc
src
cells
cancer
patients
rev
hiv
mutations
nucleolar
nols
viral
bacterial
transcripts
npas
children
btv
virus
two
groups
dromedaries
virus
avian
african
disease
pathogens
cns
virus
74
viral
infections
laca
prrsv
idexx
elisa
detection
health
ghd
foreign
policy
driving
ubiquitin
usp18
protein
proteases
family
pneumococcus
infection
associated
colonization
influenza
cells
tgev
nhe3
egfr
infected
cytomegalovirus
replication
protein
proteins
intermediate
risk
spillover
areas
hev
bat
students
mers
knowledge
study
medical
health
care
hcais
patients
hand
data
health
google
trends
topics
hemoglobin
evolution
bacterial
pathogenic
proteins
nan
rt
pcr
pdcov
conventional
assay
feed
pedv
positive
sequence
batch
patient
bronchoscopy
nma
aerosols
aerosol
years
sari
patients
876
rsv
seasonal
importation
dengue
china
air
bats
ablv
infection
australian
public
ncl
ac
sia
cells
pre
lc3b
ebov
cell
autophagy
protein
virus
sab
139
tc
ebola
vp40
cell
ebov
cells
ev
antibodies
ebov
human
antibody
disease
elisa
rvfv
rvf
based
protein
viral
infection
lung
function
associated
infections
wgs
incidence
drug
identification
infections
respiratory
viral
bacterial
interactions
respiratory
pilgrims
influenza
pathogens
viruses
il
dogs
ljm17
leishmania
longipalpis
replication
dna
pol
kappa
stress
pct
children
ng
ml
concentrations
ossgt1
steroidal
17β
asgs
the
viruses
host
cell
cycle
cellular
cells
tr1
il
10
foxp3
rna
virus
pandemic
influenza
role
series
activity
etacrynic
acid
derivatives
dioxo
synthesized
pyrrolidine
2b
some
antisense
cell
techniques
cells
molecules
pochonin
hrv1b
infection
hsp90
human
mevs
mers
epitopes
ctl
htl
il
ll
il35
cia
35
lbms
prevalence
virus
we
h5
avian
coronavirus
causative
agent
infectious
genome
viruses
virus
the
sequences
probe
the
amplification
rca
circularized
cases
mers
nosocomial
transmission
human
nucleic
acids
functional
vitro
selection
strategies
retention
cohort
studies
longitudinal
cat
chyloabdomen
the
12
year
nan
virus
allogeneic
immune
clinical
important
jev
nasal
virus
infection
macrophages
protein
databases
tools
phage
display
antioxidant
anti
inflammatory
activities
essential
gene
expression
sars
cov
si
extract
ts
cell
apoptotic
lines
entry
viral
protein
inhibitors
proteins
pinene
ibv
the
anti
mm
gene
expression
sirna
block
sequence
hotel
industry
the
case
may
tgev
apoptosis
aif
caspase
pathway
farms
case
non
the
pedv
hmpv
human
respiratory
infection
therapy
nan
hcv
membrane
vitro
dmvs
cell
95
ci
ua
the
mortality
ltβr
cells
pedv
ipec
j2
lung
trpv1
sensory
neurons
nociceptors
virus
viral
antiviral
therapeutics
group
patchouli
alcohol
influenza
virus
anti
research
articles
plesiomonas
shigelloides
infections
m2
channel
proteins
influenza
virus
galactopyranoside
didehydrocimigenol
three
new
cycloartenol
virus
antiviral
use
nanoparticles
therapies
10
50
synthesized
compounds
ld
20
compounds
concentration
hydroxycoumarin
virus
system
surveillance
idsr
the
health
usb1
u6
snrna
function
uridine
antiviral
agents
vaccines
fmd
protection
picv
rcp
pigeons
two
dpv
heterogeneity
level
super
transmission
mers
antiviral
isg15
infection
role
isgylation
gene
cf
disease
cftr
therapy
hht
virus
inhibited
50
nm
hcov
hpyv
respiratory
human
patients
bp
cakii
k2
cold
pathogenicity
zikv
virus
severe
clinical
including
cpg
odns
ovo
chickens
ibv
cm
tb
users
patients
the
tb
oas1
polymorphisms
studies
rs1131454
ecmo
pertussis
support
severe
ards
fidelity
rna
virus
due
replication
heat
ndv
response
disease
stress
factors
dental
caries
children
associated
physicians
trust
patients
the
health
rv
jaundice
infection
patients
neonates
cats
felv
il
fiv
positive
activity
the
oil
mg
ml
based
protein
techniques
beads
detection
nt
sirna
conjugated
peptide
21
macrocycles
acid
we
prepared
series
ers
developed
syllabus
postgraduate
training
singapore
respiratory
virus
threats
influenza
1a
compound
the
µm
value
emodin
cvb
the
infection
antiviral
cell
methyl
1h
panel
indol
ns3
compounds
ns2b
pro
inhibitors
ga
cells
il
phf
inflammatory
schiff
the
synthesis
popular
imines
bismuth
anti
used
treatment
review
horses
ecov
adult
infection
clinical
activities
anti
hinokinin
lignan
isolated
lamp
amplification
listeria
primers
the
glycoprotein
in
er
chain
triantennary
muscle
heart
dmd
dystrophin
skeletal
hcv
quercetin
analogues
two
active
lectin
lectins
anti
hiv
the
compounds
active
antitumor
antibiotic
set
cu
clo
the
schiff
base
lectins
recognition
viral
carbohydrate
many
virus
recognition
viral
lectin
proteins
rnai
delivery
therapeutics
different
pulmonary
compounds
activity
new
h1n1
h3n2
saponins
anticancer
anti
effects
triterpenoid
trans
cis
isoxazolidines
activity
90
the
antibiotic
resistance
diagnosis
use
18α
ga
cells
cell
apoptosis
50
vzv
ec
concentration
μm
quercetin
induced
macrophages
dsrna
effects
pq
compounds
group
cad
the
autophagy
cellular
diseases
new
applications
protein
predictor
binding
sites
sequences
novel
ga
the
activity
mcf
mers
cov
camels
antibodies
specific
disaster
preparedness
emergency
participants
knowledge
veterinary
medicine
nanotechnology
nanoparticles
applications
dna
apc
successful
transfection
antigen
pedv
221
5p
mir
infection
respiratory
microbiota
ari
host
nasal
infection
sgiv
ups
ubiquitin
proteasome
interactions
protein
the
using
molecular
sars
h7n9
management
china
communication
nan
pharyngitis
amc
dcba
10
antiseptic
rv
common
the
hand
cold
amirna
viral
jev
utr
amirnas
respiratory
viral
virus
patients
harbin
hcv
gsk3
replication
gsk3β
122
african
regions
genome
recent
canary
proteins
orientalis
recombinant
human
sera
viral
neutral
the
evolution
pathogens
mask
pollution
behaviour
role
wearing
vaccines
pathogens
effective
studies
innate
chac1
cf
pa
cells
patients
rna
viruses
virus
rdrp
tree
dicer
protein
pure
regulation
quantities
school
closure
cases
institutional
hfmd
systems
vaccinology
development
vaccine
tool
nan
the
sads
ch
fjwt
2018
ed
dashboard
points
the
usability
pla
skin
lipid
spla
cutaneous
chikv
ifn
chikungunya
virus
disease
antiviral
viruses
viral
emerging
broad
skin
viral
dock8
human
host
malaria
urban
rural
hotspots
scale
hadv
55
infection
children
infected
ifn
λ4
hiv
antiviral
inhibit
species
individuals
trade
primate
china
cov
mers
bat
cells
dpp4
crossalign
secondary
structure
profiles
rna
sonfh
the
model
allelic
evidence
nan
xanthine
pmex
µm
acyclic
nucleoside
vrna
rna
viral
flavivirus
in
h5n1
γδ
hpai
cells
infection
afop
patients
steroid
case
therapy
95
or
ci
conurbation
rural
ibv
isolates
variant
mass
although
rv
mavs
vp3
host
ifn
mechanisms
viral
infection
immunity
immune
immune
cows
bnp
bvd
deviant
spect
disease
tomography
reporter
gene
glycosylation
protein
process
functions
cell
rn
elisa
the
ibv
commercial
animal
immunological
cells
great
models
antibodies
gondii
scfv
plant
parasite
mrna
cleavage
sox
rna
use
number
reproduction
data
classical
epidemic
mnv
assay
rt
rpa
detection
ntm
treatment
anti
patients
or
coronaviridae
genomes
the
coronavirus
coronaviruses
covs
birds
avian
species
wild
mental
health
projects
the
promotion
pedv
igg
iga
samples
serum
influenza
diphyllin
viral
drug
bafilomycin
malaria
falciparum
antibodies
antigens
plasmodium
animals
domestic
samples
rva
humans
community
in
hospitals
colonization
control
infections
respiratory
viral
patients
viruses
influenza
detection
h5
subtype
rapid
cc10
fgl2
fh
protein
cells
baseplate
tssf
tssg
two
type
atg5
flox
australis
bmms
macrophages
nan
gi
16
the
ibv
epidemiology
imported
infectious
diseases
china
information
felv
florida
panthers
domestic
the
flaviviruses
hosts
sylvatic
wildlife
emerged
ibv
broiler
the
virus
broilers
ppe
doffing
contamination
ppe1
donning
influenza
obese
or
adults
morbidly
children
viruses
hospitalization
influenza
or
influenza
children
impact
care
significant
heidelberg
salmonella
outbreak
ser
strains
infection
olive
flounder
genes
in
inflammatory
fipv
the
feline
infectious
rna
the
ar
hiv
10
volvulus
nsg
mice
humanized
human
esrd
tb
active
patients
dialysis
nan
mers
cov
infection
day
case
virus
viral
effective
immune
essential
rsv
the
respiratory
outcomes
serious
138
vaccine
hcws
hajj
vaccination
using
abm
meningitis
bacterial
severe
dengue
gdt
health
search
weekly
hiv
aids
ri
relative
incidence
influenza
outbreak
early
warning
dnm
viruses
pqs
genome
present
quadruplexes
rv3615c
infection
tb
cells
cd4
nets
lung
poly
neutrophil
ali
sampling
viral
diagnostic
alternative
non
reactive
species
rs
cellular
oxidative
data
disease
cases
infectious
clusters
vector
mortality
infectious
number
rates
nar
library
the
type
shark
trem
liver
hdl
ald
mice
lasv
virus
protein
release
sites
claims
infections
the
infection
time
room
patient
gas
tracer
8104
disease
human
one
research
infectious
vaccine
zika
development
clinical
virus
tumor
vaccine
canine
patient
safety
nan
g6pd
dengue
deficiency
patients
who
cell
veev
capsid
cycle
infected
pcv
virus
family
swine
pigs
cd8
cell
vaccine
psnps
induce
neutralizing
mers
mabs
cov
emerging
ebola
virus
entry
anti
syl1712
hcv
rc
infection
entry
viral
infection
viral
cellular
rna
machinery
hand
hygiene
healthcare
workers
practices
health
one
concept
future
the
hev
ifn
metypcp
hepatitis
response
alspv
bats
viral
multiple
viruses
viral
lncrnas
cellular
lncrna
discovery
ffv
felv
cats
infection
infected
strain
cis
acting
elements
tw
mers
cov
middle
east
respiratory
aiv
detection
development
virus
globalization
viral
respiratory
asthma
infections
virus
gate
we
smart
molecular
diagnostic
68
mhv
proteins
oxidative
stress
rig
trim25
ns1
rsv
ubiquitination
bats
wiv1
cov
respiratory
coronavirus
mers
cov
protein
vaccine
responses
coatings
ti
the
oxidation
laser
copper
surfaces
healthcare
facilities
contamination
data
sharing
needs
research
papers
nan
ptx3
shigella
role
infected
in
airplane
flight
microbiome
air
we
disaster
health
mhci
mental
post
jev
infection
new
genes
using
np
cq
nanoparticles
chloroquine
drug
autophagy
virus
flavivirus
diseases
host
rna
trials
self
viruses
clinical
frameshifting
ribosomal
stimulation
pseudoknot
downstream
nan
cns
cells
asc
bmem
tdtomato
fmt
difficile
oral
diarrhoea
faecal
viral
genome
img
vr
data
uniprot
annotations
proteins
the
million
ripk1
induced
hepatitis
viral
mice
viruses
outpatients
aris
virus
china
drugs
adenovirus
the
development
new
carbapenem
strategy
saving
hemato
oncology
group
cough
nasal
sinusitis
bacterial
respiratory
test
rvi
patients
pcr
er
apoptosis
stress
chop
death
srebp
broad
viruses
host
pathways
gldc
antiviral
viral
response
susceptibility
pedv
pigs
p100c4
p120
p3
mortality
rsv
hct
associated
60
virus
genome
yokv
the
xybx1332
viral
human
health
surveillance
international
pcv2
gpnmb
orf5
protein
replication
aptamers
dna
application
generation
potential
yl
activity
amino
9h
purin
cancer
human
lines
50
4a
aptamer
microbeads
selection
binding
selex
histology
disease
cancer
lmc
treatment
isg15
species
human
like
interferon
respiratory
infections
virus
hct
frequently
apoptosis
rhdv
nsp6
cell
rabbit
virus
ifitm3
infections
severe
mice
ifitm3
interferon
cells
virus
up
nan
camels
mers
cov
humans
kenya
infection
titers
12
antibody
800
vaccine
chikf
vaccines
trials
development
tumor
cd200r
cells
growth
cd200
infection
ebov
gnptab
ebola
virus
mrsa
influenza
children
coinfection
we
multi
diseases
herbs
formula
symptoms
cellular
translation
hiv
mrnas
proteins
cpv
pcr
detection
lfia
the
viral
ifitms
proteins
host
virions
hiv
diagnosed
infections
proportion
incidence
cav
we
anaemia
new
strains
ica
new
pedv
detection
the
type
fcov
infection
icz
feline
mrna
proteins
recombinant
ivt
body
ss
cell
patients
epigenetic
may
chikv
fidelity
disease
high
diversity
anion
light
acr1
gated
conductance
memory
cells
antibody
cell
analysis
viruses
mink
shed
commercial
fecal
pertussis
children
adenovirus
etiologies
influenza
bcc
sox2
cells
knockdown
srpk1
ppe
care
health
error
working
aecopd
identification
bacterial
viral
the
neurological
diseases
cxcr3
therapeutic
evidence
virus
human
annotation
genbank
genome
expression
idh
isg20
gene
mutation
ub
votus
votu
activity
proteins
tc
human
goat
antibodies
caprine
viruses
humans
diarrhea
pathogens
viral
nan
μm
21
compounds
18
dengue
outbreak
data
viruses
potential
tracking
victims
symptoms
family
members
psychological
cells
bat
btadvs
cxadr
cell
factors
disease
the
movements
farms
myotis
persistence
eblv
schreibersii
bats
responses
nei
iga
antigen
serum
pathogens
materials
development
high
threat
bats
influenza
viruses
screening
533
pneumomediastinum
subcutaneous
emphysema
pneumonia
may
ifitm3
fusion
virus
viruses
iav
pig
traders
farmers
practices
pork
glycyrrhizinic
acid
cells
effects
breast
inorganic
resource
settings
infectious
low
military
leishmaniasis
united
states
endemic
mice
blm
hsv1
ipf
ae
period
measurement
the
performance
disease
autophagy
proteins
autophagosomes
er
the
ebov
hcws
virus
healthcare
ebola
respiratory
viral
nucleic
also
several
yfv
yellow
fever
gambia
senegal
100
000
diseases
morbidity
infectious
government
public
media
exposure
phep
pools
viral
viruses
swimming
epidemiological
disease
ms
cns
immune
response
nan
preparedness
epi
the
countries
pandemic
vaccines
respiratory
viruses
virus
leading
pedv
pigs
tgev
the
anpep
viruses
respiratory
humidity
virus
we
t1
t2
fatigue
mers
phq
cns
csf1r
infection
viral
cells
program
training
evd
care
simulation
dna
tail
hair
buccal
five
viral
hsnig
intervention
urti
shedding
outbreak
epidemic
sources
global
91
model
ifnar
mice
arboviruses
viruses
isolates
acovs
wild
birds
variant
vaccine
towards
coronavirus
mers
cov
mv
kdelr2
a3g
er
protein
hcov
nl63
immunofluorescence
livestock
testing
bats
covs
disease
severe
syndrome
virus
berberine
emodin
zikv
zika
mountain
virus
rocky
virology
area
mers
cov
hr2p
m2
protein
mers
cov
pyroptosis
infection
hdpp4
antibody
fragment
components
scorpion
new
pedv
scfvs
piglets
prevention
scfv
ca
el
emerging
channels
the
mers
cov
camels
drivers
humans
university
virology
csv2018
featured
discussed
mers
cov
protein
rbd
the
viral
host
egress
new
the
hku4
mers
cov
peptides
derived
cov
respiratory
covs
sars
mers
coronavirus
229e
hcov
human
pathogenic
transmission
airborne
aerosol
large
droplet
among
disability
le
partial
oldest
gi
16
genome
sequence
strain
ve
vaccine
infection
asymptomatic
estimating
lasv
vaccine
development
lassa
africa
proteins
recombinant
mab
expressed
protein
cell
rhinovirus
eps
7630
expression
hvs
xsv
species
bat
laiv
apelin
ii
ang
angiotensin
expression
pigs
vaccine
challenge
il
vaccination
no
pcv2
role
form
infection
bmp38
bms6k
proteins
bmnpv
itraq
trim55
hcc
patients
migration
invasion
microbiota
could
the
children
ipd
ek
cell
line
cells
the
binding
protein
mutations
changes
data
mers
cov
diagnostic
tests
detection
media
disease
we
model
coverage
public
health
poct
we
care
nlrp3
3a
inflammasome
il
activation
pedvs
cells
live
region
in
cov
hcovs
human
multiplexed
mild
bativs
bat
cell
derived
particles
diabetes
individuals
identified
the
age
cases
mers
primary
this
visibility
diagnostics
diagnostic
challenges
preparedness
pathogens
respiratory
infections
tract
represents
igys
bar
domains
proteins
membrane
domain
psav
entry
tjs
cells
occludin
health
microbial
may
promoting
benign
1918
pandemic
global
virus
in
rate
times
time
growth
generation
diabetes
infection
diseases
infections
people
strains
conditions
we
dynamics
wild
mayv
responses
virus
emerging
cases
glycans
cochlea
proteins
transporters
several
mice
involved
expression
app
ps1
calves
srb
milk
the
health
epithelial
immortalized
biec
the
intestinal
hku1
hcov
first
human
coronavirus
resiquimod
response
infection
hatch
iltv
rerp
the
elisa
epitope
recombinant
neutralizing
activity
serum
three
mers
niv
pigs
pig
human
disease
birds
covs
viruses
coronaviruses
the
isr
isrib
eif2α
activation
effects
health
eu
western
countries
laboratory
effect
emissions
carbon
sector
the
camel
traits
archive
morphological
diseases
pd
l1
cd8
cells
acute
ibv
disease
vaccine
rndv
protein
bst
respiratory
viruses
function
virus
mhc
immune
human
molecules
pathogen
host
rna
factors
rtc
translation
resistance
antimicrobial
mef
assay
methods
rosa26
transgene
the
ferret
cre
dna
sensors
intracellular
immune
viruses
human
metapneumovirus
medium
throughput
screening
population
hong
kong
influenza
brisbane
mers
cov
hdpp4
mice
infection
sumo
abaecin
the
antimicrobial
amps
lab
antibiotics
growth
animal
potential
nan
fever
phenobarbital
anticonvulsant
induced
cat
ab10
sftsv
gn
glycoprotein
sfts
type
100
training
respirators
fit
obesity
infection
individuals
immune
associated
sialic
acid
erythrocytes
ter
119
virus
avian
viruses
farms
surveillance
zikv
bats
brain
virus
infection
rna
genes
rnas
srnas
non
quarantine
disease
model
effectiveness
individuals
particles
speech
infectious
disease
large
wymv
polyadenylation
rnas
translation
variable
virus
uv
enveloped
viruses
porcine
cells
tfh
viral
infection
virus
quadruplex
quadruplexes
related
anti
tumor
prp
octa
structure
repeat
mrna
epidemic
jurisdictions
influenza
reference
number
virus
respiratory
infections
common
need
virus
host
interactions
viral
labeling
outbreaks
predictability
disease
model
time
pedv
neutralizing
nmabs
epitopes
protein
antiviral
replicon
viral
sirna
mechanisms
ucbt
infections
days
30
patients
airway
disease
inflammatory
viral
roles
trade
informal
introduction
pathways
products
children
wheezing
bronchial
reactivity
study
nan
liver
weight
qtl
cc
trait
coronavirus
respiratory
animal
acute
syndrome
indel
pc21a
pigs
strain
us
rsv
tlr4
nucleolin
n2a
cells
bal
yield
patients
diagnostic
rate
sequencing
viral
enrichment
detection
target
health
one
response
established
veterinary
workers
disease
infectious
specific
risk
sequence
alignment
protein
comparison
estimated
immune
proteins
novel
reproductive
respiratory
age
18
in
samples
influenza
children
respiratory
fluid
bacterial
neutrophil
hcv
infection
replication
viral
virus
de
la
en
bosque
chacra
health
transmission
via
bioaerosols
human
rti
adults
children
viral
antibiotic
viruses
wenv
related
province
mammarenaviruses
sbv
apoptotic
apoptosis
bcl
pro
host
innate
virus
immune
mechanisms
bst
expression
cells
crispr
using
ifitm
cd4
family
deficient
th2
outbreak
genetic
estimates
reproductive
traits
mers
cov
human
identified
transmission
adem
neurological
post
cns
characterized
di
virus
antiviral
particles
iav
adp
ribose
protein
bacterial
macrodomains
nlrp3
evs
inflammasome
associated
activation
pathogens
human
health
new
geographic
immune
hsct
response
vaccine
recipients
canine
respiratory
viruses
mpcr
viral
polyq
viruses
proteins
segments
repeats
autophagy
airway
inflammation
inflammatory
diseases
group
therapy
integrative
pd
hospitalization
spp
rodents
populations
samples
ufi
burgdorferi
infection
active
past
direct
chikv
virus
epidemic
infection
illness
novel
hts
genomic
identification
characterization
hdl
protein
proteins
cholesterol
regulation
paralysis
gbs
cases
disease
patients
isolation
model
epidemic
outbreaks
delay
nano
norovirus
particles
nanobodies
gi
phev
the
virus
disease
pigs
pedv
virus
vaccine
porcine
diarrhea
pneumonia
respiratory
community
acquired
virus
pedv
taiwan
2014
identified
used
bcg
pd
l1
up
regulation
the
assay
countries
single
spin
sequence
alignment
method
analysis
free
alv
macrophages
hpi
chicken
regulated
pertussis
respiratory
cough
risk
exposure
adcp
immune
fc
antiviral
dependent
cases
outbreak
size
model
probable
hrsv
hrv
identification
respiratory
bronchiolitis
hbv
lg6pd
females
infection
participants
strains
two
pdcov
in
2016
brazil
the
feline
coronavirus
we
autophagy
immune
responses
in
pathway
nan
influenza
respiratory
pathogen
cause
identified
the
aerosols
viruses
ferrets
influenza
problems
beak
pecking
trimming
egg
ad5
replication
vectors
oncolytic
adenovirus
mortality
data
patients
sari
management
cchfv
animal
haemorrhagic
fever
pcr
lasv
tests
detection
diagnostic
research
imatinib
treatment
interstitial
ild
pulmonary
afop
patient
acute
fibrinous
pneumonia
pcp
immune
deficiency
pneumonia
primary
diversity
bats
reservoir
species
viral
farms
iccs
occs
cattle
000
tgev
variant
us
prcv
genotype
acid
caffeoyl
quinic
compound
di
cordatum
cat
intestinal
analysis
severe
cells
cns
cd8
memory
local
vaccines
ibv
ndv
iltv
weeks
bats
betacovs
bat
covs
group
antiviral
ifn
chifn
potential
chicken
covs
alpha
rodent
phylogenetic
cov
aerosol
the
fugitively
emitted
using
influenza
co
infections
mrsa
alveolar
cells
mers
cov
bat
irf3
pcv2
swine
porcine
circovirus
pcvd
myeloid
cells
infections
innate
leukocytes
rna
modifications
immune
receptors
work
zikv
infection
antibodies
therapeutic
treatments
proteases
inhibitors
development
compounds
protease
bats
virus
viruses
factors
spillover
cells
feline
femv
gt2
cats
mers
cov
nb
nbs
rbd
rsv
ari
children
infection
infants
drills
patient
isolation
min
mystery
cpv
variants
probe
canine
2a
expression
c3p3
g1
enzyme
eukaryotic
ffas
level
patients
high
study
p90rsk
plays
role
signalling
kinases
recombinant
proteins
quality
functional
soluble
peak
vo
age
body
scaled
influenza
virus
samples
the
circulation
tgev
prcv
results
commercial
blocking
health
countries
gcc
care
trained
ili
system
surveillance
influenza
case
isn
aptb
pd
hrct
cxr
32d6
ha
influenza
virus
strains
canine
astrovirus
infectious
australia
gastroenteritis
oral
subtilis
rc
pedv
piglets
polysaccharides
pmnps
approaches
hosts
synthesis
hbv
different
antiseptics
infectivity
hepatitis
rna
small
molecules
rnas
targets
nan
κb
mc
nf
inflammatory
activity
srnase
pk
cells
15
ko
aza
rnase
cell
dsrna
cells
uti
proteins
urinary
utc
children
nan
enveloped
quasi
virions
ehav
naked
pnt
vaccines
the
strains
neutralization
nan
pestis
pseudotuberculosis
antigen
yersinia
bacterial
health
global
disease
surveillance
security
sari
clusters
respiratory
detected
public
arenaviral
infections
regions
arenaviruses
limited
vaccines
in
vaccine
response
mucosal
contact
social
age
matrix
the
cells
sirna
activity
lung
delivery
knowledge
hcws
transfer
negative
educational
bats
cells
bat
cell
immune
media
intensity
number
reporting
optimal
dinap
pigs
prrsv
vr2332
study
compound
anti
emodin
cells
proliferative
aptamers
research
short
single
stranded
zikv
mechanisms
host
cell
in
guillain
barré
syndrome
nerve
facial
virus
lectins
50
dlasil
dsclerl
cpv
simpleprobe
2a
2b
2c
horses
ecov
clinical
salmonella
features
ecov
samples
horses
fecal
258
horses
fungi
iad
fungal
or
cit
calves
plasma
arg
diarrhea
imha
evidence
cause
underlying
immune
respiratory
physical
later
pulmonary
ards
respiratory
mers
cov
antibody
we
denv
four
pcr
iipcr
rt
viruses
life
evolution
entities
living
ecatg5
autophagy
cells
grouper
increased
influenza
antiviral
emergence
new
strains
disease
burden
2015
dalys
health
budget
disease
burden
risk
mohw
genes
reference
indigotica
results
the
infantum
ifn
cats
antibody
lsa
flounder
fish
anguillarum
dna
pvaa
sma
smn
protease
therapeutic
smn2
proteolytic
activity
cancer
proteases
models
diseases
pairs
adaptive
considered
category
cats
dosage
disease
time
the
mers
cov
physicians
phc
knowledge
mph
programs
medical
health
mbbs
hz
mo
m2
malaria
m1
mers
cov
pathways
ns4a
ns4b
lrtd
children
severe
immunocompromised
hcov
patients
influenza
pneumonia
the
corticosteroids
nspahs
hmpv
virus
show
inhibition
multipartitism
might
multipartite
evolutionary
host
nan
hbv
compounds
anti
pol
lamivudine
sci
spinal
cord
injury
neurological
prion
interferon
prions
protein
irf3
hydrogels
cells
ci
drugs
gelatin
clusters
cluster
identified
we
transmission
pneumonia
piv
diagnostics
rsv
sarawak
4a
4b
proteins
mers
host
viral
patients
infections
sari
outcomes
microglia
bacterial
brain
role
review
children
aboriginal
ed
rates
ari
oas1
oas3
interferon
genes
macrophages
il
prrsv
1ra
induced
immune
health
chws
pandemic
preparedness
community
ipc
doctors
practices
infection
hospital
health
idsr
system
the
disease
pneumonia
bacterial
viral
definite
cases
afm
epidemic
reemergence
associated
polioviruses
oviduct
ibv
genes
shell
mitochondrial
interactions
individuals
male
overlap
cheetahs
cell
virus
strategy
10
perfusion
global
disease
infectious
health
threats
virus
the
development
mers
cov
zikv
reported
human
one
studies
h7n9
rhifn
cells
cell
α2b
cancer
sbccc
gastric
cell
the
social
technologies
media
wgs
the
hrsv
fcγrs
virus
immune
disease
ili
respiratory
study
swabs
pathogens
hd
patients
ccf
medical
isolation
vaccine
design
approaches
immunology
delivery
vl
disease
rsv
vls
inpatients
patient
specialist
subclavian
artery
aneurysms
translation
rna
viral
viruses
cellular
bacterial
viral
subjects
asthma
noninfectious
rna
viral
direct
sequencing
capture
microglia
encephalitis
antiviral
viral
cns
camels
mers
cov
we
egypt
mers
cov
antibodies
binding
spike
protection
virus
m2e
influenza
vaccines
zikv
sialic
acid
infection
cells
viruses
human
mpv
hrv3
chimpanzees
vs
patients
auf
dengue
agents
ha
na
receptor
virus
functions
academic
recovery
trajectories
low
trajectory
bat
bats
viral
astroviridae
astrovirus
data
contact
transmission
outbreak
sequence
cov
hcov
hcovs
broad
inhibitory
management
eids
biological
invasions
human
mers
airflow
passive
tracer
possibility
pdcov
infection
lncrnas
results
differentially
openmp
algorithm
memory
lcs
dna
the
qdcov
pl
g032
2015
humoral
innate
recognition
molecules
the
virus
ebov
spp
entry
catb
surfactin
slp5
activity
antiviral
pedv
autophagy
protein
factors
novel
crispr
mir
193b
catenin
mirnas
wnt
canada
genome
novel
coronavirus
goose
transgenic
renal
dc
sign
mice
hand
hygiene
children
young
practice
ibv
s1
gene
samples
like
samples
piglets
study
coinfection
salmonella
ibv
indonesia
ib
vaccine
strain
ks
children
microbiota
might
disease
cr
constituents
coptidis
rhizome
huanglian
usp9x
catalytic
the
polyub
linked
tumor
the
cs
targeting
ability
influenza
rsv
842
virus
hmpv
wet
markets
393
food
information
zika
outbreak
healthcare
virus
health
viral
antiviral
rnai
cell
intrinsic
ctsl
mycoplasma
responses
siga
cells
monoclonal
antibodies
panning
process
antigens
assay
based
antiviral
cell
screening
ev
d68
cases
2016
2017
niv
vaccine
virus
rabv
hev
methods
accumulated
dna
sequence
nucleotides
flagellin
antibiotic
respiratory
treatment
bacterial
ibv
vlps
chimeric
ib
nd
ducks
mallard
influenza
chickens
viruses
autophagy
cells
virus
cellular
mechanisms
cell
entry
attachment
factors
filovirus
vhf
viral
group
clinically
diseases
cells
syncytium
formation
pedv
cell
mers
cov
host
humans
factors
rsv
anti
adc7αrsv
antibody
protection
bat
research
western
asia
threats
packaging
rna
the
viral
factors
ebola
virus
evd
development
compounds
bats
bat
many
transmission
virus
cells
porcine
prrsv
swiv
prdc
camels
mers
cov
dromedary
zoonotic
viruses
viral
replication
form
proteins
bat
viral
virus
eonycteris
spelaea
mopv
lasv
infection
autophagy
two
cell
live
imaging
specific
interferon
rt
pedv
assay
psr
porcine
fibrosis
ptx3
auc
the
metavir
pneumonia
95
ci
respiratory
children
cap
review
respiratory
topics
cause
respiratory
infections
among
viruses
children
influenza
surveillance
mena
isn
countries
influenza
clinical
victoria
ari
children
influenza
infection
in
polymorphism
ifitm3
vaccine
viruses
become
development
emerging
pathogens
series
emerging
in
significant
incidence
communicable
diseases
increased
non
noise
rooms
dba
levels
the
rna
interactions
virus
host
infection
genes
pdcov
signaling
fatty
acid
virus
viral
infections
infection
stochastic
pneumonia
respiratory
virus
episodes
hospital
lman2l
epilepsy
family
glycoproteins
glycoprotein
virus
lasv
lassa
human
disease
patients
pids
sequencing
ngs
ion
ar
pharmacological
studies
clinical
activities
phlorotannins
antiviral
two
cava
compounds
zoonotic
saudi
arabia
pathogens
data
aunps
multiflower
microwave
induced
hyperthermia
cf
nets
neutrophil
neutrophils
airway
10
pm
air
er
mortality
the
tmja
bone
traumatic
lpm
measures
conspiracist
beliefs
psychometric
three
technologies
na
amplification
rls
time
exacerbations
pathways
exacerbation
associated
asthma
consultation
patients
time
group
in
iav
infections
host
treat
virus
zikv
ata
replication
inhibitory
effect
bats
virus
rabies
viruses
eu
type
ifn
cell
production
ifns
chikv
macrophages
p38
jnk
tnf
melioidosis
disease
china
hainan
pseudomallei
rhinitis
clinical
nasal
in
diagnosis
livestock
bats
farms
the
mers
latydc1
mir396
galanthamine
the
expression
nan
viruses
humans
animal
human
first
hmpv
il
nlrp3
1β
inflammasome
g6pd
deficiency
individuals
exercise
oxidative
mers
cov
patients
infected
immune
case
report
research
important
design
mir
451
mtor
cell
glucose
species
congeners
we
chloroplast
introgression
rsv
virus
infection
activity
cell
seizures
patients
rsv
35
febrile
eps
7630
trials
paracetamol
children
infections
in
united
states
outbreaks
biosecurity
participants
dialogue
risks
engagement
laboratory
level
training
high
program
mers
cov
strain
we
evaluated
camel
mers
cov
workers
associated
hmpv
strains
cell
lines
gfp
pkr
infection
mav
degradation
inhibiting
gene
pdna
delivery
expression
ep
hcmv
crls
replication
crl
human
pd
brain
l1
cells
immune
nq
antiviral
dengue
aq
denv
plant
diagnostic
synthetic
technologies
toward
social
media
data
the
healthcare
eif4f
rotavirus
complex
infection
protein
expression
stat2
mx
cdv
interferon
socioeconomic
higher
road
measures
epidemic
tnbc
polymorphisms
patients
hr
95
immune
fcrs
itam
diseases
complexes
disaster
hemodialysis
patients
in
earthquakes
rebound
stridor
use
nebulised
adrenaline
patients
risk
factors
hematological
cancer
ptov
swine
infections
research
porcine
erva
assay
multiplex
rt
vp7
il
levels
patients
mycetoma
35
cird
canine
virus
disease
pathogens
strain
ibv
chickens
vaccine
cmi
cattle
bvd
testing
bvdv
control
ibv
trachea
kidney
six
chickens
pdac
linc01197
catenin
foxo1
lncrnas
cpv
2c
vietnam
2a
isolates
tgev
s1
ubxn1
protein
infection
mers
cov
cases
health
study
nan
viral
read
short
virion
community
ibv
strains
pcr
we
specimens
pneumocystis
bronchoalveolar
lavage
spp
cavalier
virus
disease
host
clinical
equine
t2dm
vs
tangminling
wmd
95
3c
protease
dhav
the
activity
ov
mdrgn
bed
overcrowding
nimcu
copd
factors
exacerbation
patients
analysis
filovirus
bat
specific
natural
ebolaviruses
pedv
immune
piglets
gilts
abs
cell
viruses
synapse
immune
formation
pollination
syndromes
we
buzz
syndrome
respiratory
patients
pneumoniae
detected
study
cases
controls
respiratory
breastfeeding
patients
respiratory
agents
studies
specific
provided
influenza
severe
therapy
viral
infections
dicv
rna
viral
febrile
tanzanian
disease
lists
focus
research
prevent
mammalian
genetics
research
meeting
genomics
spt
pc
compliance
periodontal
patients
tcdd
results
vegfr1
receptor
showed
gfcov
s1
guinea
2014
tissue
sftsv
infection
host
upr
protein
insufficiency
adrenal
autoimmune
primary
diagnosis
pedv
strains
thai
farms
swine
virus
basv
ekv
tibrovirus
in
pd
mupyv
infection
cells
signaling
nan
virus
zika
the
late
fusion
health
global
physicians
usa
programme
medicine
cld
granules
treatment
clinical
ibv
virus
samples
in
drop
outbreak
management
staff
factors
control
ccp
nasal
phases
cytology
ciliocytophthoria
hmpv
respiratory
patients
infections
hospitalized
cbdvg
cbdvgs
generation
infection
rsv
cc
power
qtl
strains
analyses
strains
cc
six
inbreeding
we
strain
litter
size
effects
strains
nan
ebola
preparedness
staff
global
iceland
nan
treatment
or
diagnosis
need
completion
health
eid
antimicrobial
amr
global
incidence
infectious
disease
epidemics
package
infection
htnv
puuv
99
id
mdrv
novel
origin
waterfowl
reoviruses
cpv
fpv
canine
assay
parvovirus
aecopd
bacterial
events
eosinophil
treatment
rna
sg
granules
pb
formation
infections
known
immune
respiratory
rti
neutrophils
brain
ischemic
microglia
microglial
bohv
immune
infection
responses
cattle
glycosylation
binding
m41
spike
protein
kd
children
antibodies
disease
cell
nan
merlin
erm
proteins
family
structures
poct
trends
data
the
systems
binding
viruses
na
virus
iav
outbreaks
mers
healthcare
cases
cov
95
versus
dengue
aa
or
response
factors
research
influencing
infectious
workers
swine
air
exposure
nasopharyngeal
ericov
disease
hedgehogs
samples
wildlife
session
increased
respiratory
risk
years
rabv
bat
bats
brazil
rabies
in
td
epidemic
mers
cov
influenza
model
vs
or
95
nan
mers
cov
comorbidities
mortality
disease
sarima
model
incidence
hfmd
china
camels
mers
cov
infections
dromedary
mice
sa35
parvum
sa40
immunised
this
invited
editorial
introduces
special
hev
bedouins
camels
arabs
human
vacv
including
factor
ifn
proteins
herds
pedv
elimination
the
hazard
study
infections
the
work
viral
remdesivir
rdrp
rna
ebov
tp
tgev
s_ntd224
virus
terminal
domain
mers
cov
transmission
virus
rabbits
sftsv
hexachlorophene
drug
entry
severe
pdcov
porcine
prig
protein
ifn
entry
oc43
viruses
attachment
coronavirus
bioinformatics
databases
searching
visualizing
comparing
coronaviruses
bat
kazakhstan
positive
viruses
chikv
chikungunya
vaccine
viral
high
orf3
vps36
pedv
replication
protein
dpcpv
reverse
genetics
cypovirus
rna
bat
gene
bats
coronaviruses
unique
idv
humans
replication
influenza
virus
viral
envelope
host
proteins
infection
adp
ribosylation
interferon
parps
replication
cryptococcal
cryptococcosis
patients
cases
clinical
sonfh
use
risk
mutation
prednisone
smd1168h
growth
topoi
yeast
the
1306
tgfbr2
tgf
mir
gcs
plant
virus
viruses
infectious
biology
ncprof
pa
bx
gp64tm
caninum
mhc
populations
variation
genetic
seven
cat
hippocampal
necrosis
cluster
seizures
dogs
diarrhea
adpp
placebo
acute
cats
bronchiolar
disease
disorders
classification
dna
vaccine
ce80
immunization
the
proteases
pa
clan
structure
classification
rsv
airway
antibacterial
infection
associated
qβ
protein
the
phage
rna
experiments
vivo
ex
in
animal
sequences
outbreaks
virus
genotype
method
oppa
vaccines
ostriches
mycoplasma
dna
arti
studies
data
respiratory
people
influenza
data
prediction
articles
news
calves
brsv
rna
viral
weeks
nan
cells
prrsv
regulatory
development
infected
pathogen
genome
data
methods
databases
irf1
expression
ifn
isgs
infection
sequences
similarity
dissimilarity
protein
group
asfv
fever
rpa
lfd
swine
aahv1
fungal
alternata
virus
hypovirus
lap
tregs
foxp3
gvhd
results
strains
pedv
the
beijing
area
autophagy
glp
glucagon
dpp
the
virus
rabies
host
factors
rabv
rodentium
quercetin
induced
colitis
effects
viral
ifitms
host
proteins
roles
viruses
devils
metagenomics
virion
viral
cell
cats
infection
fip
fipv
leishmaniasis
arab
research
global
world
bcv
brd
calves
respiratory
disease
patients
mortality
healthcare
associated
pneumonia
hiv
v2
trimer
immunization
chimpanzee
cchfv
gp
hemorrhagic
rvsv
expressing
fri
infection
relative
protection
conferred
health
public
moh
phfp
disease
mers
cov
camel
dromedary
infection
svv
pcr
rt
rrt
iipcr
ire
cell
the
lapc
patients
zika
behavior
travel
we
diseases
nan
health
disease
diseases
development
emerging
antimicrobial
resistance
among
uti
negative
we
getah
virus
foxes
china
rsv
season
week
occurred
weeks
virus
monkeypox
zoonotic
disease
endemic
spike
outbreak
emergence
mutant
mutations
virus
camels
influenza
found
dromedary
aging
hmscs
quercetin
geroprotective
ws
viral
nsp12
coronaviruses
sars
cov
structures
replication
organelles
host
virus
fmdv
antiviral
mizoribine
fmd
disease
ibv
detection
strip
rapid
avian
ga
production
the
gucyb5
acid
50
extracts
cc
ibv
piperita
bsep
emodin
liver
rat
expression
hiv
ng
transmission
induced
cervical
cdv
dogs
95
ci
or
piglets
ko
exp
pedv
in
assay
flamp
bovine
blv
min
endotheliopathy
inflammatory
response
ecs
inflammation
data
mobility
urban
spatial
patterns
sari
patients
influenza
admission
rate
prv
human
macaques
prv3m
transmission
zikv
7b3
mabs
1c11
antibody
mers
cov
adc68
mice
protein
travel
demand
pre
travelers
medical
mva
host
range
human
spi
nan
host
protein
controllability
cell
influenza
picu
admission
patients
respiratory
viruses
frameshifting
gag
virus
pol
constant
ppv
the
epitope
virus
mapping
earthquake
emergency
response
the
country
il
35
role
suppressive
immune
orf8b
sars
cell
death
nlrp3
tar
vir
viral
metagenomic
data
infections
viral
patients
common
immunodeficiencies
apps
the
marine
mammals
several
secondary
infection
cangptl4
bacterial
lung
hajj
health
travel
agents
knowledge
human
to
transmission
dynamics
humans
ifn
signalling
viral
antiviral
host
coronavirus
infections
glycoprotein
binds
host
influenza
surveillance
system
ili
the
health
mobile
data
programs
machine
patients
icu
antibiotics
the
levofloxacin
cordata
lung
undecanone
induced
cancer
protease
iprot
sub
prediction
specific
season
coupled
term
weekly
2016
virus
entry
cd151
egfr
hpv
slices
liver
well
novel
3d
hcc
map3k7
kinases
cell
expression
data
outbreak
response
outbreaks
emerging
btv
cells
infection
transcriptome
group
viral
mitochondrial
mitochondria
infection
metabolism
mers
survivors
sari
non
health
nan
ros
replication
enterovirus
genome
cellular
bat
species
alignments
genes
using
nan
mbcs
specific
antibodies
denv
pathogen
22
wild
rat
rats
rattus
vidisca
ngs
viral
load
samples
rps
virus
infection
viral
host
samples
diarrhea
cachavirus
positive
dogs
hbc
hbv
baf200
protein
ifitm1
hunov
igy
vp1
effective
virus
ebov
evs
infection
virus
asymptomatic
norovirus
human
non
diversity
genotypes
sequence
data
dimensionality
reduction
analyses
polyamine
polyamines
protease
cells
replication
batcov
bat
bats
hku32
rs
gap
discovery
in
this
virus
meeting
virus
bioinformatics
the
research
rnai
antiviral
defense
mechanism
viruses
pdcov
cycle
replication
infection
deltacoronavirus
influenza
respiratory
ilis
qatar
human
emergency
nurses
epidemic
events
the
snow
leopards
pathogens
disease
zoonotic
mers
cov
the
coronavirus
spread
infectious
diseases
cause
antibiotic
resistant
hadv
72
hadvs
children
rtis
health
response
beds
contact
tracing
epigenetic
protein
cbx
heat
shock
icu
discharge
ards
survivors
healthcare
denatonium
benzoate
patient
exposure
symptoms
ptb
smear
tb
positive
incidence
viruses
virus
hiv
vaccine
hsv
data
package
outbreak
contact
facilitate
drug
in
repurposing
antibiotics
resistant
nirvs
scapularis
arthropods
viral
non
respiratory
psps
surgery
viral
asymptomatic
niv
virus
chadox1
vaccine
bangladesh
rv
virus
a16
produced
inoculum
niclosamide
viral
denv
neutralization
infectious
adp
ribosylation
rna
reversible
trpt1
helicase
ebov
rna
viral
like
human
infections
host
factors
viruses
autophagy
viral
infection
junv
lc3
surveillance
infectious
based
diseases
systems
proteases
the
different
chemicals
microbial
research
emergency
ethics
health
situations
patients
niv
managed
invasive
initially
influenza
stool
aor
rna
patients
swabs
participants
grippeweb
in
self
children
serum
identified
human
febrile
hiv
cd4
early
primate
binding
receptor
2sbs
binding
na
ha
gbs
bspc
meningitis
brain
bacterial
cr1
vivax
invasion
cells
surface
protein
feature
sequences
the
extraction
bronchiolitis
severe
wheezing
patient
data
catch
probe
sets
viral
genomes
control
number
park
reproduction
outbreak
common
cold
days
the
rhinothermy
golgi
protein
depletion
grasp
cell
physicians
surveillance
health
reporting
diseases
h9n2
aiv
assay
influenza
viruses
women
topics
articles
health
news
multiplex
pcr
sputum
pneumoniae
pathogens
events
health
public
ra
tool
caninecv
dogs
virus
disease
canine
hiv
resistance
antibodies
bnabs
strains
mers
cov
protein
amibara
emc
pv
keratinocyte
dsg
antibody
disease
acute
diarrhea
metronidazole
dogs
days
respiratory
platforms
clinical
used
knowledge
respiratory
virus
infections
influenza
treatment
plant
viruses
molecular
recombinant
protein
patients
sinfh
the
macroglobulin
necrosis
viruses
prrsv
the
epidemiological
molecular
cryptosporidiosis
drug
an7973
diarrhea
children
zika
transmission
tree
using
singapore
bpiv3
brsv
bovine
respiratory
samples
trials
id
clinical
drug
clinicaltrials
qingyue
meng
colleagues
assess
china
data
producers
surveillance
swine
control
denv
dengue
aedes
life
cycle
mammarenavirus
rodents
shrews
hev
hantavirus
viruses
bat
macau
surveillance
samples
spf
rats
conventional
animals
research
picv
rcp
pigeons
groups
the
pedv
found
genes
china
ped
days
diagnosis
the
cases
scrub
ibv
attenuated
virulent
attenuation
egg
isoginkgetin
acacetin
dimer
antioxidant
assay
hbv
virus
chronic
infection
therapies
ms
pdcs
viral
cells
infection
respiratory
syncytial
virus
transplant
strategies
95
cri
household
transmission
zikv
ifn
antiviral
species
subtypes
novel
tb
risk
impact
children
disease
rsv
adults
influenza
or
95
hadv
assays
duplex
raa
clinical
disease
risk
human
hog
pedv
protein
mers
cov
monoclonal
cells
legionnaires
disease
tigecycline
treatment
treated
neotropical
birds
viruses
remote
host
china
africa
evd
west
largest
water
filter
sww
drinking
nanocellulose
oct1
cells
cell
antigen
autoimmune
nan
il
cells
cd8
10
induced
safv
samples
children
infection
eleven
viral
mrnas
infection
cellular
translation
il
white
matter
oligodendrocyte
mice
society
clinical
research
article
themes
indigo
hainan
plant
species
extraction
school
infection
study
students
cases
meat
safety
frontline
actors
work
viral
pneumonia
the
mers
cov
kd
immune
response
coronary
artery
gp
fusion
cl
cell
endosomal
density
pneumococcal
low
carriers
co
genomic
disease
sequence
variants
data
protein
ry2h
sequencing
y2h
interaction
eos
properties
antimicrobial
used
herbs
fipv
fip
cats
oral
caused
senescence
cells
sevs
phenotype
sasp
rna
viruses
host
approaches
antiviral
asfv
sting
cgas
infection
armenia
genes
complex
natural
receptor
killer
sars
covs
helicase
nsp13
state
trp
trpdc
mediated
trpe
rntrpl
musk
muskrat
effects
ischemia
cerebral
security
health
human
the
global
ibv
avian
dcs
mirnas
stimulated
95
ci
cases
or
antimicrobials
denv
antibody
diii
m366
dengue
tim
virus
ebov
rvsv
mice
measures
survey
or
95
ci
training
blood
concentration
effort
changes
pathogen
genetic
host
selection
genome
vkc
hed
treatment
efficacy
clinical
45
ea
parvifolia
antiviral
et
pcr
rapid
patients
tested
ed
host
specific
metabolic
alterations
viral
viruses
aptamers
infections
viral
detection
ams
infection
siv
wpi
pd
system
automated
denv
pcr
iipcr
calves
treated
diarrhea
zm
zinc
virus
flaviviridae
analysis
viruses
codon
zikv
trim56
rna
terminal
protein
rsv
households
infection
within
old
binding
7d10
rbd
spike
neutralization
btky72
rhinolophus
bats
related
we
rsv
on1
children
clinical
genotype
the
different
states
epidemic
zikv
dengue
risk
japan
high
areas
respiratory
virus
viruses
infection
influenza
pedv
spike
protein
antibody
diarrhea
hrv
infections
levels
cells
hbe
nuclear
transport
viral
proteins
protein
bieckol
compounds
binding
tyrosinase
inhibitors
lrtis
bacterial
cause
etiology
leading
the
marine
compounds
phlorotannins
therapeutic
nan
zinc
antiviral
viral
infections
influence
autophagy
bev
replication
infection
lc3
kat2
inhibitors
kyn
acid
kyna
hsp
stress
expression
bats
mammals
virus
envelope
the
glycoprotein
receptor
fugitive
emissions
the
aerosol
flow
viroporin
infections
research
proteins
2b
adenovirus
vectored
effective
simian
use
idv
cattle
respiratory
prevalence
influenza
dna
vaccines
development
immunogenicity
one
zikv
viral
life
cycle
virus
seov
rats
infection
virus
liver
influenza
vaccines
vaccine
passive
due
virus
viruses
transmission
host
body
cells
stress
sa
reovirus
infection
pdcov
chickens
infect
chicken
infection
computational
influenza
approaches
design
vaccine
health
decision
makers
scientific
information
alv
chch25h
chicken
isgs
the
bpiv3
isolate
china
bovine
one
cattle
pbvs
genogroup
pbv
one
gondii
ursolic
acid
anti
effects
change
mutations
the
populations
adaptation
conference
the
diseases
place
shenzhen
pcv3
samples
positive
strains
china
dna
vaccines
mrna
comparison
plasmid
based
molecular
droplet
microfluidic
review
hev
current
infections
pregnant
women
lipid
metabolism
zikv
antiviral
cellular
human
viral
omvs
to
influenza
ifitm3
iav
human
epithelial
induced
ifn
porcine
complex
functional
genes
mirna
rna
mosquito
role
mirnas
bat
viruses
genome
detected
hypv
ebv
cancers
latent
antigen
generated
protein
peptide
mers
peptides
spike
swine
oral
disease
fluid
testing
pedv
cecal
diarrhea
mucosa
contents
microglia
viral
function
cns
damage
de
las
los
la
el
microglia
cells
neurological
microglial
cns
allergic
study
respiratory
life
immune
ped
the
pedv
holdings
diarrhoea
hms
changes
human
space
day
proteins
plant
viral
function
virus
virus
ebola
viral
gp2
fusion
h7n9
cases
bsi
search
data
angiotensin
iqr
aps
dogs
ace2
calves
salmonella
clinical
colostrum
bacterin
treatment
diarrhea
days
groups
group
lipyv
viral
metagenomic
analysis
feces
exosomes
mice
sepsis
cytokines
chemokines
inflammatory
pneumococcal
lta
pneumonia
response
vhhs
formats
viral
affinity
the
cells
lius
cancer
cell
death
dmd
exon
skipping
ppmos
dystrophin
intracellularis
enteroids
infection
mouse
proliferation
aiv
ibv
ndv
microarray
virus
influenza
patients
pneumonia
respiratory
bacterial
dogs
cakovs
cakov
detected
healthy
macrophages
microglia
cns
neuroinflammation
profiles
functionalization
isatins
10
nhc
mol
influenza
vaccine
rates
countries
argentina
spike
mers
rad
cov
induced
hev
population
zoonotic
pigs
viral
aiv
developed
lamp
specific
samples
evolve
laboratory
evolution
viral
function
peak
detection
respiratory
antibiotic
or
zn
phenformin
proteases
cyshis
biguanide
mce
biomolecules
biomolecule
complex
ms
we
encephalitis
virus
jev
weihai
zika
virus
isolate
31n
transmission
10
virus
hepadnavirus
genome
hbv
cchfv
otu
viral
rna
ubiquitin
g4
g4s
applications
fluorescent
turn
bcg
measles
reactivation
kd
erythema
rig
mda5
viral
protein
different
viral
abs
antibody
antibodies
infections
hsp70
cell
g1
cycle
viral
release
ev
evs
cell
cd63
cov
mers
blood
emerging
viral
canine
cdv
cpv
cakov
10
rsv
site
antibodies
prefusion
antigenic
cap
children
clinical
care
study
airway
asthma
lung
function
remodeling
10
cancer
c3ar
c5ar
il
diarrhea
calves
post
weaned
bcov
myanmar
poultry
ibv
detected
farms
ards
cxcl5
inflammatory
cxcr2
lung
group
il
bladder
pro
relap
er
epidemic
mers
emergency
the
ibv
chicken
prevalence
samples
broiler
itp
infection
coronavirus
severe
immune
could
rotavirus
vaccine
efficiency
also
30
hla
01
peptide
03
cs
evd
providers
hospitals
outbreak
health
systems
simex
materials
system
cats
infantum
infection
italy
leishmaniasis
cell
antigen
specific
cells
response
viruses
pb1
influenza
human
h1n1
trial
primary
care
the
pelargonium
vaccine
evolution
immunity
transgene
host
pedv
virus
p29
ca
cold
cell
hs
binding
adrv
rgv
hs
cell
viruses
hspg
heparan
ifn
stat1
host
response
protein
iltv
immune
responses
study
conjunctiva
ffv
cats
infection
tropism
changes
rsv
plantago
asiatica
clerodendrum
trichotomum
nan
influenza
viruses
rt
multiplex
humans
sr
ma
medicine
steps
data
piscidin
prv
assay
virus
could
prf
mechanism
simarteriviruses
arteriviruses
virus
health
respiratory
laboratory
testing
expand
diseases
infectious
emerging
major
human
portal
nciph
endothelium
environmental
india
specimens
np
op
sputum
using
neonatal
vaccines
adjuvants
adjuvant
cell
autophagy
process
important
roles
homeostasis
fprs
fpr
receptors
cell
responses
mers
cov
risk
spatiotemporal
clusters
influenza
virus
types
m2
permeability
disease
modelling
human
development
organoids
increased
diseases
climate
change
water
biochar
feed
animal
thus
soil
astv
samples
neurotropic
well
the
pneumonia
pathogens
viral
viruses
outpatients
h7n9
shedding
nai
treatment
rna
cap
mortality
associated
in
etiology
cost
total
management
the
dairy
antioxidant
poultry
body
commercial
balance
cm
survivors
ebola
use
conventional
cardiac
tamponade
emergency
treatment
severe
furin
proteolytic
cleavage
numerous
one
yp
days
14
21
con
nf
κb
tgev
nsp3
inhibition
respiratory
estimates
infections
burden
studies
embeddings
model
projection
medical
word2vec
cell
cells
il
27
cd8
contact
surveys
social
we
data
data
used
airline
passenger
studies
children
rsv
pneumonia
afebrile
viral
cell
cns
cells
including
chronic
visualization
viral
time
phylogenetic
may
vaccine
mers
viral
cov
protein
injuries
traumatic
data
children
incidences
vp2
chicken
dc
dcs
targeting
virus
groups
infection
b3
group
content
validity
tool
agreement
mass
tumor
treating
fields
cells
immune
respiratory
sequencing
infections
unexplained
pcr
rbcs
immune
birds
transcripts
immunity
exon
rna
cov
synthesis
structure
nan
vzv
bafilomycin
golgi
capsids
virus
ediii
zikv
subunit
vaccine
efficacy
rsv
atp1a1
cells
egfr
uptake
outbreak
term
cases
short
we
animal
pppm
modeling
medicine
right
silver
microbicidal
ions
ag
nps
dips
viral
effects
particles
able
rna
processes
cell
impact
biology
patients
viral
respiratory
age
infections
po
cat
mg
kg
clinical
proximal
urethral
cat
stricture
fluoroscopy
bnov
vp1
strain
characteristics
novel
pv
type
ppnt
sabin
wt
fusion
lasv
hr2
cell
gp2
cpv
th
strains
dogs
thailand
microbiome
gut
bacterial
virome
composition
viral
sari
children
beijing
shanghai
zikv
cells
isolates
the
three
viruses
human
bat
detected
bats
covs
cov
bats
yunnan
bat
seroprevalence
municipalities
the
bovine
bhv
goats
pprv
the
vaccination
vaccinated
icgn
cats
non
upc
ratio
hand
the
hong
kong
handwashing
vaccine
strategy
developing
effective
protective
95
ci
spp
camel
parasite
phc
evidence
pacific
health
system
epidemic
sub
incidence
models
outbreak
avian
infectious
bronchitis
virus
causative
socs3
iav
il
infection
virus
porcine
virus
circovirus
pcv3
real
mp
group
infection
refractory
pneumonia
bleomycin
differences
response
variation
strain
prrsv
tul
porcine
macrophages
virus
respiratory
military
trainees
viral
pathogens
stem
used
disease
community
outbreaks
vaccines
vaccine
transmissible
vector
results
mers
cov
virus
infected
human
ards
patients
studies
alveolar
lung
macrophages
cells
immune
macrophage
phenotypic
laboratory
health
leadership
global
leaders
galloyl
hhdp
glucose
lps
mice
sint
speckles
tbk1
stress
protein
55
hadv
province
china
we
since
mers
2012
middle
east
the
guidelines
care
patients
adherence
nan
communicable
water
food
korea
diseases
viruses
patients
sepsis
human
ca
hrv
among
detection
versus
children
ifi44
ifn
virus
responses
factor
times
morphine
meg3
lc3
ht22
rdrp
regions
rna
catalytic
module
physicians
physician
health
care
hospitals
swine
feed
scientific
ingredients
commercial
ibv
gene
virus
expression
infection
parvum
faecal
fusobacterium
microbiota
calves
mers
cov
95
ci
days
mgba
gut
the
microbiome
related
respiratory
viral
ra
infections
incident
ms
sti
100
stis
clinical
viral
studies
field
metagenomics
viruses
mechanical
ventilation
patients
mortality
survival
ifitm3
interactions
ifitm
proteins
antiviral
pedv
genes
h3k4me3
diarrhea
infections
lung
mirnas
the
antagomirs
or
sb
calves
effects
heat
stress
data
transmission
respiratory
households
face
patients
respiratory
viral
influenza
rsv
min
flow
the
mv
pif
bnov
china
enteric
norovirus
nov
egfr
tnf
epithelial
cell
lung
hepatitis
iids
the
incidence
diseases
nucleolar
biology
stress
nsr
also
immunity
restriction
factors
antiviral
hiv
salmon
chinook
viruses
wild
sockeye
trim21
viruses
viral
antibody
effector
elisa
ebov
diagnostic
three
sera
glycoproteins
antennavirus
viruses
two
common
amps
multiple
infection
pathogens
therapeutic
viruses
virus
btv8
europe
disease
hiv
ards
current
peptide
based
viruses
evolution
selection
correlated
viral
elisa
samples
negative
positive
fiv
human
cultures
haec
host
cell
applications
the
tannins
historical
described
virus
pedv
virulent
attenuated
rtgev
pathways
like
immune
evolution
animal
gp3
ha
eav
virus
the
proteins
glutathionylation
host
microbial
protein
viruses
capybaras
associated
identified
family
botulinum
vhhs
fc
vhh
in
viral
viruses
virus
immune
autoimmune
camels
mers
cov
east
egypt
au
gp120
flexible
biosensor
mos
type
coronaviruses
cross
cats
coronavirus
hev
virus
rna
orf1
viral
lectin
mannose
scaffold
family
lectins
bov
the
ns1
albov
viruses
cpv
drugs
closantel
three
effects
health
eu
threats
european
risks
respiratory
infections
tract
rsv
cystic
pue
reporting
system
respiratory
infections
nan
pneumonia
production
scientific
research
the
ebov
vp35
scfv
antibodies
scfvs
ccol2a1
day
vaccine
pcdna
dna
cells
virus
dastv
system
rdastv
nan
nan
eehv
hd
elephants
monocytes
tissues
days
influenza
hospital
year
health
immune
may
gut
psychiatric
microbiome
bc
piv
vector
virus
ectopic
sign
lrs
r1
splenic
dc
nm
studies
related
effects
cancer
infection
control
students
dental
practices
ngps
gl
alg
dox
the
nan
immunity
retroviral
mechanisms
fv
viral
lmts
travel
health
travellers
pre
diseases
risk
entry
infectious
the
hsv
tanguticum
nanoparticles
viral
herpes
nan
ebv
schizophrenia
levels
antibodies
individuals
cats
felv
fiv
pathogens
zoonotic
viral
proteins
innate
recognition
immune
cat
tissues
non
associated
fip
norovirus
host
viral
translation
g3bp1
13
infections
invasive
mold
combination
apn
virus
pigs
null
transmissible
sv
vietnam
genomic
sequence
sapelovirus
hrv
asthma
aecopd
exacerbations
associated
viruses
entry
host
cell
number
ppe
doffing
hcws
designs
participants
human
bocavirus
acute
respiratory
blood
threat
aedes
vector
community
linked
pedv
belisa
high
clinical
biotinylated
ire1
marv
protein
upr
upre
nsp1
tgev
alphacoronavirus
virus
protein
nivolumab
hospital
cardiac
cmr
myocarditis
pdcov
diarrhea
suckling
piglets
pigs
count
tweets
cdcgrandrounds
vitalsigns
visual
networks
types
network
data
different
rats
diabetic
theaflavin
the
enzymes
nan
95
ci
h1n1
brl
care
antiviral
due
nucleoside
analogues
activity
samples
detected
pathogens
influenza
virus
ribosome
reading
frame
codon
codons
nt
implementation
care
gb
unexplained
mucus
iav
ahr
infectious
hand
cases
system
influenza
iss
ili
paper
printed
based
proteins
printing
bat
01
viruses
mhc
bats
dpp
glp
various
inhibitors
blood
ifn
t1
hiv
usp18
gene
acute
transverse
myelitis
motor
sensory
myocardial
β1
mice
tnf
tgf
respiratory
infections
health
five
acute
diagnostics
the
applications
significant
development
flu
nov
infection
outbreaks
analysis
mers
cov
infections
mild
pcr
mers
cov
assays
humans
outbreaks
2015
confirmed
infection
mers
women
uptake
vaccines
pilgrims
among
hajj
rvp
patients
rpp
positive
respiratory
rsv
infection
we
clade
gene
hcws
contacts
care
patients
activities
gown
ppe
use
hcp
task
pcp
treatment
patients
anti
time
animal
research
models
human
bone
gilts
milk
vaginal
replacer
swabs
pcvs
porcine
pcv1
pcv2
including
influenza
pathogenicity
virus
we
network
pigs
use
calves
sales
level
mice
tlr7
group
virus
expression
assessment
health
emergency
evaluation
management
antiseptics
oral
oropharyngeal
infections
infection
knee
exoskeleton
intention
leg
lbka
influenza
dromedaries
viruses
detected
little
nan
cancer
immune
tumor
adaptive
essential
mers
protein
cov
tgn
er
hcv
injection
epidemic
model
the
er
protein
compartment
thanks
secretory
nasal
infection
influenza
epithelium
human
rt
clinical
laboratories
ngs
used
rna
viruses
plaque
virus
population
91
isolates
the
viruses
vaccine
g6pd
redox
the
nadph
cells
md
genes
mdv
infected
disease
frameshifting
trna
proteins
ribosome
slippery
antimicrobial
resistance
global
collective
action
pdcov
innate
immune
cells
pk
influenza
health
ve
alberta
using
cell
antibodies
response
towards
cells
hbv
immunity
virus
antiviral
drugs
one
reaction
azidocoumarins
two
the
tgev
nf
mptp
opening
κb
patients
transportation
time
the
study
gattii
pnw
the
pathogenic
arrived
hpv
3hp
lg
protein
cell
species
host
viruses
single
multi
2016
2009
patients
h1n1
korea
human
lung
mice
pathogens
cells
health
public
institutions
challenges
posed
gii
p17
17
vp1
rdrp
zikv
infection
testicular
tissue
z2
mirna
21
cvb3
p38
mapk
lycorine
virus
infection
proteins
group
respiratory
patients
influenza
viruses
infection
mers
sars
outbreaks
vaccination
potential
epithelial
cells
responses
viral
infected
the
dengue
molecular
guangdong
2014
mers
s1
rvδp
cov
rv
rt
qpcr
samples
hts
viruses
zinc
infection
virus
antiviral
rotavirus
infection
immune
responses
entry
specific
epss
cells
the
hadv
exopolysaccharides
asp
resistant
ids
multidrug
acquisition
anti
iglb12
antibodies
idiotypes
vaccines
cells
vδ2
zikv
infected
expansion
ssrna
nano
structure
adjuvant
the
ev
d68
respiratory
detected
infections
infectious
syrian
hamster
diseases
animal
angiotensin
novel
ras
new
approaches
plantarum
alv
recombinant
gp85
protein
ndv
study
dromedary
farm
virus
pcv3
pcv3a
swine
in
fujian
early
infection
peritrophic
matrix
jcdv
mers
cov
mabs
middle
east
hiv
pegylated
c34
peg2kc34
peg5kc34
hlcc
units
evd
management
highly
mers
cov
rbd
the
rlp
ghv
fusogenicity
protein
cytoplasmic
tail
recombination
enteroviruses
enterovirus
rna
genetic
evd
outbreak
lung
2013
2016
mers
protein
peptide
cov
fusion
novel
identified
virus
avian
26
cd8
cells
viral
bt
rm
pulmonary
children
pathogens
immunocompromised
samples
viruses
pcs
may
wide
variety
host
tbev
protein
synthesis
decrease
hmpv
infection
children
acute
respiratory
vaccines
dna
veterinary
inexpensive
easy
surveillance
disease
urban
time
infectious
patients
respiratory
ards
the
hmpv
cardiopulmonary
arrest
hospitals
rate
or
mrna
frameshifting
sequence
ribosome
trna
viruses
host
studies
virus
viral
oscc
tams
cd206
tam
subsets
vcp
virus
replication
proviral
viral
ifnl4
children
variants
rs12979860
rs368234815
hnscc
p53
antibodies
20
associated
revealed
diagnosis
feline
signs
cat
mp
co
detection
children
cap
pedv
js
diarrhea
virus
intestinal
nt
genes
equestris
vsirnas
cymmv
zika
virus
complications
infection
recognized
pdcov
dg
drugs
licl
antiviral
immunity
vaccine
protection
well
innate
species
detected
bat
bats
corona
antibody
viral
mediated
effector
antibodies
ephrin
cedv
receptor
virus
additional
mortality
icu
cxr
score
associated
studies
aspects
important
care
pocts
diseases
ntds
neglected
the
approaches
data
humans
animals
diversity
viruses
ib
793b
var2
groups
day
pigs
hygiene
poor
rfi
antioxidant
vaccine
prrsv
trivalent
pigs
mixture
gn
gtv
bces
could
identified
tsen54
leukodystrophy
standard
diffuse
the
nzm
patients
antibodies
ada
response
fibrosis
airway
pibo
signs
acquired
patients
zanamivir
h1n1
pdm09
iv
rsv
ns1
ns2
innate
type
bacterial
wheeze
children
however
wheezing
days
rv
outbreaks
rehabilitation
bed
rna
sgs
pbs
regulation
gene
bd
ccr1
cells
mice
frequencies
pathogens
vaccines
emerging
use
development
influenza
patients
hospital
2017
management
egr
dcs
response
intracellular
responses
health
system
capacities
resilience
systems
health
risk
modelling
disease
we
pcr
h7n9
virus
iirt
sensitivity
ferret
model
immunological
ferrets
human
animal
origin
influenza
potential
diagnostics
virus
bioaerosol
rna
filter
cyclone
health
care
facilities
services
120
dna
cancer
nano
the
potential
rv
species
respiratory
infants
types
pedv
vaccine
rad
adenovirus
vector
foi
fiv
transmission
mortality
puma
rvf
use
rvfv
chadox1
pregnant
military
eidar
research
health
infectious
aavv
virus
aiv
ibv
ampv
tcm
herb
effects
herbal
medicine
antiretroviral
hiv
marine
novel
structures
cd26
mice
rejection
il
graft
isg20
rna
protein
viral
self
studies
data
published
zikv
predictions
rvc
piglets
prevalence
healthy
ab
cases
students
pneumoniae
school
pneumonia
bv
rbv
ova
antitumor
frc
patients
mortality
hospital
respiratory
mers
age
foi
mers
cov
infection
transmission
household
respiratory
households
initial
brsv
respiratory
infection
np
vad
human
contact
likely
contacts
completed
modeling
glycans
protein
glycosylator
glycan
plt
count
rv
patients
infection
virus
inf
respiratory
100
detection
farp
dfa
respiratory
methods
positive
hmpv
infection
prevalence
the
age
sars
ag
cov
rict
moabs
dogs
illness
animal
disease
behavior
we
characterized
exposures
demographics
middle
ifn
λ3
infection
porcine
genes
l1
hpv
l2
constructs
dna
emerging
countries
the
biosecurity
re
samples
wolf
packs
parasite
factors
mngs
viral
copd
respiratory
patients
snd1
rna
kshv
orf50
modification
dip
virus
two
dynamics
dips
values
reference
research
pcv
total
nan
m2e
np
influenza
mice
recombinant
sosv
rbp
rbps
sialic
acid
mhl
interventions
china
studies
review
vaccine
development
eid
rapid
response
vaccine
ebov
pathogens
vsv
the
vaccines
development
licensure
financial
profitability
respiratory
patients
surfaces
pathogens
swabs
zika
behaviors
behavior
usaid
evidence
influenza
ridts
detection
100
buddi
pedv
virus
vaccine
challenge
effective
macrophages
cell
pma
acid
alveolar
airway
cells
delivery
epithelial
rnp
cov
mers
hku8r
positive
np
nsp12
prrsv
synthesis
strand
involved
gilt
entry
viral
viruses
expression
common
cold
the
virus
poct
ifi204
type
irf7
interferon
p200
p120
pedv
strain
attenuated
epidemic
influenza
pandemic
viruses
next
history
peptides
antimicrobial
cells
secreted
different
mif
mamif
tumor
human
models
preterms
pertussis
vaccination
need
infants
ns1
aptamers
ifn
selected
protein
single
analysis
cell
viral
infection
zikv
zk2b10
antibody
the
virus
brain
challenge
immune
peripheral
responses
mers
risk
ed
gw
patient
proteins
lcmv
ros
persistent
infection
izumo1
sperm
complexes
protein
fusion
viruses
respiratory
infections
cases
co
prv
virus
infection
mice
footpad
research
35
il
publications
bibliometric
ndv
using
proliferation
microscopy
cells
patients
hematoma
tranexamic
acid
expansion
pam
im
lps
macrophages
il
pidotimod
usefulness
infections
respiratory
role
calves
days
age
calf
heart
patients
children
detected
infections
viruses
siv
rhifitm3
infection
polymorphisms
macaques
antibody
mers
cov
residues
replaced
zikv
glycans
host
cell
due
bcrp
evt
migration
function
placental
lncrnas
tgev
differentially
expressed
inflammation
contig
viral
different
sequencing
haplotype
ibv
mrna
antiviral
hpe
expression
syphilis
infection
prevalence
active
per
niv
nipah
disease
isolates
illness
cell
patients
disease
transplantation
relapse
ntz
ebov
virus
protein
rig
nan
fecv
mucosal
virus
cats
systemic
hev
virion
types
hepatitis
virus
plp2
activity
dub
cis
cleavage
tsb
tsf
protein
lipid
fatty
viruses
transmission
procedures
nosocomial
emerging
site
ibv
s2
furin
fusion
covs
cov
birds
samples
positive
immune
viruses
innate
response
evasion
equine
plasma
horses
respiratory
parvovirus
boredom
data
eeg
gsr
classification
hrsv
viral
load
children
ct
fcv
cats
virus
viral
environment
cynomolgus
macaques
viruses
wild
research
virus
diseases
world
viral
antiviral
novel
diagnostic
feline
enteric
viruses
nan
samples
ecov
region
p4
irish
type
isolates
s1
the
genetic
virus
porcine
vaccines
nps
infections
metabolomics
data
open
processing
complex
antiviral
grft
host
viral
results
anti
therapy
vaccines
vaccine
nps
mafa
alleles
cynomolgus
a1
macaques
snow
leopard
samples
gene
population
lrtis
elderly
respiratory
diseases
clinical
ivdrv
ivdrvs
persistence
vaccine
patients
lineage
prrsv
emergence
lineages
sub
fbov
cats
infection
fplv
revealed
camels
mers
seronegative
cov
vaccine
vaccine
new
viral
ibv
emergence
mers
the
saudi
cases
cov
the
bornavirus
pabv
phosphoprotein
birds
infection
susceptibility
genetic
mental
diagnosis
erav
study
year
olds
equine
days
relocation
mdr
patient
icu
nhp
virus
humans
wildlife
risk
pedv
plasma
sdpp
10
porcine
blood
transfusion
screening
transmitted
pathogen
targeted
recurrent
including
immunity
urtis
ward
ventilation
hospital
outbreak
model
reduce
animal
vaccines
use
antibiotics
tgev
lp
transmissible
gastroenteritis
many
rnase
cells
ko
activation
infection
swab
rna
sequencing
children
samples
core
ihr
capacities
idte
increase
rsv
case
surveillance
cases
infection
canine
respiratory
dogs
coronavirus
virus
readmission
mpp
90
patients
day
pedv
test
elisa
infection
indirect
mers
cov
transmission
llamas
virus
nan
g6pd
cells
inflammasome
activation
thp
spike
binding
pedv
alphacoronavirus
receptor
lasv
gp
virus
stt3b
ost
cp
pd
nurr1
induced
dopaminergic
stability
insert
viruses
sequences
inserted
tularensis
schu
p9
samples
methods
offspring
zikv
infection
fetal
birth
risk
mortality
patients
liver
factors
pvp
importance
together
effective
antiseptic
nl63
oc43
strains
strain
coding
clec4m
cisplatin
resistance
cell
nsclc
years
mers
seyll
cov
disease
mental
well
migrants
being
japan
rtd
albicans
il
mdr
strains
rsv
piv
hmpv
patients
respiratory
niv
hev
fusion
antibody
virus
lecb
binding
host
cell
factor
clinical
mngs
host
metagenomic
next
anti
secondary
igy
plasma
positive
nan
nan
csfv
er
autophagy
stress
replication
pedv
virulent
effective
highly
safe
ibvpr03
strain
massachusetts
genotype
120
rna
avian
brazil
presence
wild
patients
sari
wupyv
kipyv
respiratory
cakv
identified
kobuvirus
fecal
samples
vp7
protein
porcine
porv
pedv
crfk
feline
epithelial
cells
cell
the
feline
fcov
lead
fip
tgev
s1
12
pil
pvax1
microglia
viral
encephalitis
response
role
bats
mammals
diseases
animals
zoonotic
blood
artificial
transfusion
oxygen
human
the
cell
cancer
pyrazolylnucleosides
5a
nan
measles
95
ci
among
years
hepis
cancer
breast
cell
expressed
s1
mers
specific
cov
vaccine
sepsis
pct
the
infection
bacterial
drug
effects
plasticity
single
pharmacological
no
mt
rsv
rice
one
638
respiratory
children
aged
younger
hbov
arti
signaling
pathway
children
inequality
phw
within
health
distribution
aflatoxin
research
the
bibliometric
topics
zinc
children
pneumonia
clinical
supplementation
escrt
lcmv
proteins
late
virus
camel
handlers
seropositive
mers
cov
virus
feed
half
african
swine
mers
cov
camels
camel
workers
pedv
infection
innate
virus
intestinal
hbs
cattle
therapy
bull
days
apoptosis
ndv
signaling
ire1α
jnk
ifn
macrophages
cell
immune
in
human
virulence
novel
risk
disease
isg15
infection
isgylation
anti
liver
evd
household
exposure
find
socio
based
pedv
elisa
501
sensitivity
viruses
rodents
shrews
arenavirus
pathogens
infections
secondary
bronchiolitis
viral
respiratory
rpa
dna
library
amplification
amplify
flavonoids
sars
the
activity
3clpro
carriage
respiratory
pneumoniae
catarrhalis
symptoms
ibv
ort
sonali
broiler
art
system
disease
data
the
animals
among
outbreak
adults
years
the
arss
immune
diseases
well
certain
acquisition
pneumoniae
respiratory
rtis
pilgrims
flagellin
ped
s0
solubility
fusion
diarrhea
agents
spp
causative
knc
message
poster
antibiotic
pet
owners
cap
lus
patients
bacterial
consolidations
pedv
va
gilts
iga
mock
rhinovirus
il
patients
ifn
infections
influenza
study
ari
military
the
emergency
preparedness
adjusted
or
household
igf1
inflammatory
lung
infection
pr8
ipf
lung
disease
microbiome
interstitial
practice
knowledge
attitude
pilgrims
hajj
fmdv
ddx1
3d
replication
the
plants
tomentosa
asiatica
extracts
acetone
risk
diseases
id
arboviral
french
infected
social
strategies
based
disease
curcumin
silver
shell
one
core
licheniformis
in
crude
extracts
pedv
acetyl
sia
modifications
cells
cell
bacterial
compounds
sea
species
leucospilota
analogues
cis
isoxazolidine
lactam
trans
disease
infectious
pathogens
the
diagnosis
health
factors
one
collaboration
publications
sequences
protein
results
the
sequence
zikv
ery
est
virus
infection
replication
pdcov
membrane
virus
induced
ibv
strain
five
ib
analysis
mers
cov
hku31
related
hedgehogs
chn
sc2015
strains
pdcov
nt
rsv
isolates
differences
virus
viral
rv
children
load
asthmatic
wheeze
poastv3
piglets
detected
farms
disease
viruses
pangolins
viral
endangered
this
nibv
kidney
chicken
infection
metabolome
zikv
natural
gossypol
products
infection
diagnostic
feline
fip
clinical
steps
subtype
hiv
cell
rss
tat
zikv
natal
rgn
strain
srips
parechovirus
disease
pathogenesis
species
genus
zikv
ifn
proteins
activation
λ1
felv
cats
using
europe
infected
chikv
the
antiviral
compounds
assay
dengue
endemic
febrile
passengers
aor
ebv
emodin
npc
reactivation
inhibits
coli
ibv
farms
mixed
bacteriophage
viruses
diarrhoea
rna
among
ngs
cell
host
cells
factors
viral
fmt
fecal
microbiome
treatment
ibd
chickens
poultry
viruses
network
trading
camels
world
camelus
species
old
rsv
mari
and
or
subjects
rv
respiratory
children
strains
infections
points
or
95
ci
mortality
zbtrim25
zbrig
signaling
virus
rig
rnases
rnase
pancreatic
effects
undesired
viruses
virus
airborne
hospital
samples
influenza
performance
surveillance
data
system
nan
nan
fiv
strains
felv
the
prevalence
medical
the
education
program
prof
delay
notification
diseases
disease
identification
il
ebov
virus
macrophages
13
host
proteins
viral
immune
virus
hsct
nk
cell
cells
viral
salmonella
group
cases
the
to
tb
national
reporting
china
cases
ifitm3
microbat
restriction
ifitms
mutation
autophagy
viral
use
infection
degradation
mask
mf
the
children
without
cds
cells
cytotoxicity
the
pyrolysis
clec2
clec5a
virus
viral
infections
zikv
disease
development
small
molecule
animal
zoonotic
297
disease
reported
npl4
terminal
lys48
linked
ufd1
mers
cov
database
development
zoonotic
nsp5
rv
replication
viroplasms
infection
epac
specific
inhibitors
molecular
compounds
hlh
adult
onset
malignancy
epstein
nan
nan
tweets
health
dissemination
information
accurate
transmission
reproductive
epidemic
spreaders
potential
group
sampling
channel
gastrointestinal
endoscopes
asfv
cords
swine
asf
cas12a
nasal
biyeom
go
rhinitis
the
pa
sphk2
pneumonia
lung
genes
cadv
ics
the
mabs
ml
bpg
bacteria
gut
development
infections
becn1
skp2
autophagy
ubiquitination
degradation
families
gene
human
core
specific
crv
infections
management
respiratory
viral
virus
host
transmission
dwv
ants
zikv
disorder
virus
protein
strains
tet
fan
cep
hcov
compounds
hcts
emerging
infectious
diseases
ethically
treatment
group
analysis
mrmp
glucocorticoids
ebv
cypa
ebna1
replication
genome
responses
allergen
azd8848
post
treatment
random
odns
activity
tlr9
mtlr9
severe
death
diabetes
mellitus
hypertension
bkv
detected
calves
diarrhea
we
influenza
we
dromedary
camels
nigeria
idv
strain
influenza
virus
potentially
brsv
prevalence
animals
cattle
the
avian
coronavirus
gene
eclectus
s1
ascs
intramuscular
canine
atopic
dermatitis
virus
global
cepi
world
eids
11
il
pedv
viral
infection
hct
the
viral
allo
ebv
standard
adherence
nurses
precaution
patient
screening
entry
exit
measures
literature
model
infectious
diseases
spread
slirds
isg15
otus
nairovirus
virus
otu
indicators
phep
the
health
preparedness
tissue
studies
reproducibility
semiquantitative
scoring
influenza
complications
patients
age
highest
a71
a16
ev
cv
replication
iav
anti
pa
assay
the
il
esrd
dengue
group
48
amp
inhibition
μm
nitroanilide
mg770
health
itpgs
absorption
gut
maintaining
hsv
infection
host
cells
protein
screening
persons
evd
entry
airport
respiratory
viruses
transplant
ltrs
increased
mice
mers
cov
days
aerosol
upr
xbp1s
atf4
virus
viral
receptor
virus
method
iills
similarity
base
pairs
structure
consecutive
rna
sequencing
pathogen
data
time
whole
panther
fusion
respiratory
methods
allplex
survival
dry
bacteria
coli
atcc
amodiaquine
evd
antimalarial
ebov
ebola
zikv
virulence
infection
rgn
ns2a
apelin
pyr
13
ms
method
diarrhea
china
prevalence
samples
porcine
spp
camels
play
role
desert
human
microbial
species
nhps
microbiome
influenza
virus
samples
reads
viral
respiratory
acute
infections
cases
tract
prss
cetuximab
patients
cancer
expression
deficiency
patients
immune
pidds
defects
antibody
drugs
therapeutic
market
monoclonal
bovine
prevalence
different
respiratory
brd
infections
aptamers
treatment
bacterial
aptamer
hmpv
genome
sequences
genomes
sequence
trial
the
miracle
mers
controlled
endocrine
tam
ccl2
breast
cancer
viruses
life
host
coevolution
consequences
lung
lymph
liver
mycobacterium
avium
phenobarbital
cat
ahs
diagnosed
treatment
mers
cov
using
virus
performed
patients
cirrhotic
pneumonia
clinical
rvs
learning
based
social
agent
individual
haptoglobin
the
detection
mastitis
milk
ards
acute
lung
critically
ill
fvhh
harvis
nicu
visitors
hand
adenoviruses
species
found
prevalence
bat
kh
recombination
rdrp
if
ps
at
hcv
511
527
active
pneumonia
viral
ilds
patients
diagnosis
tb
nurses
data
the
caring
inflammatory
il
fip
immune
cats
sudv
the
vaccine
egp
gem
orf2
localization
pcv3
nuclear
the
mers
public
healthcare
occurred
outbreak
ecov
horses
sera
assay
elisa
tilv
virus
cells
tilapia
replication
species
bat
host
communities
viral
porcine
diarrhoea
pigs
the
epidemic
qx
type
pathogenicity
strains
ck
prrsv
sequencing
strain
direct
rna
cats
fpl
outbreaks
fpv
virus
myricetin
rutin
the
μm
simultaneous
pdc
pdcs
tdcs
cells
functions
nan
freya
shearer
co
authors
discuss
we
report
nearly
complete
genome
metformin
tpc
cells
lrp2
viability
lpv
rtv
ifnb
mers
cov
ibv
qx
binding
rbd
kidney
refugee
children
diseases
health
infectious
naats
poc
direct
diagnostics
sample
cbr
project
biological
research
program
auris
healthcare
detection
control
candida
care
auris
clinical
unit
patients
models
influenza
viral
host
virus
cr
calves
map
vitamins
colostrum
influenza
seasonal
pandemic
global
surveillance
pilgrims
vaccine
vaccination
domestic
meningococcal
score
surveillance
performance
influenza
zambia
1502
peptide
sla
nsp9
tmp9
nan
vaccination
influenza
ve
current
season
epidemic
growth
rate
also
number
mers
patients
related
negative
hospital
frequent
exacerbations
patients
copd
immune
ibv
rndv
lasota
05
vaccination
neu5ac
virus
acetylated
sialic
acid
chikv
chadox1
vaccines
chik
vaccine
denv
antiviral
immune
innate
vaccine
vaccine
mers
cov
chimeric
influenza
rhdv
rabbits
vaccine
rabbit
rhd
respiratory
vaccines
even
pathogens
available
asp
antimicrobial
the
demands
services
cov
cells
bat
sars
scotophilus
shr
pedv
diarrhea
strains
we
gp
catb
catl
ebov
inhibitors
rbd
vaccine
tcda
rbds
toxin
arenaviruses
pathogenic
the
arenavirus
infections
zikv
vaccine
alum
mpl
combination
amr
singapore
health
public
strategies
zikv
mva
vaccines
vaccine
candidates
fcov
type
ii
infection
cholesterol
antibody
fusion
mers
cov
bispecific
snps
human
number
infections
single
data
twitter
sources
tweets
surveillance
health
public
laws
regulate
manage
zikv
mice
rzikv
associated
study
ubiquitin
enzymes
cell
activity
based
breast
test
lesions
mammograms
samples
infection
zikv
antibodies
virus
igh
pdcov
rpdcov
gfp
piglets
ns6
assays
viral
pan
the
clinical
nidoviruses
snake
pneumonia
diseases
new
tonsils
tonsillitis
death
tonsillar
hypertrophy
protein
229e
the
receptor
binding
tgev
cells
infection
differentiation
intestinal
immunosuppression
immune
response
cells
viruses
particles
vaccines
system
response
the
er
zikv
proteins
review
congenital
health
public
artssn
system
surveillance
restrictive
measures
public
use
focus
plans
support
emergency
hcws
mechanisms
laboratories
ophl
pandemic
molecular
influenza
cost
costs
estimates
hospital
outbreaks
travel
advisory
sars
toronto
rodier
nan
data
prevention
injury
healthcare
injuries
mers
cov
camels
bactrian
antibodies
virus
respiratory
influenza
resp
the
nan
amg
cats
cmm
remission
outcome
nan
km22
bronchiseptica
host
genome
sequence
pandemic
si
facing
infected
factors
mers
cov
number
cases
list
obesity
redox
the
associated
mechanisms
cell
single
non
coding
rnas
lignans
antiviral
structural
two
activities
aptamers
drug
delivery
aptamer
limitations
fipv
protein
glycans
cryo
em
likely
patients
near
fatal
asthma
rpis
method
ctf
cgr
rna
method
infected
potentially
we
identify
influenza
cells
virus
mpscs
infection
isg15
protein
usp18
ifn
functions
nhc
mitochondrial
cells
rna
levels
nan
gii
norovirus
pe
sydney
thailand
pdcov
species
identified
in
samples
mers
camels
contact
transmission
respiratory
nan
autophagy
block
bacterial
ompb
recognition
pdis
er
protein
folding
various
poct
geospatial
care
spatial
facilitate
flocks
backyard
respiratory
ibv
commercial
protease
hev
enzyme
orf1
polyprotein
fcrn
tgev
expression
up
regulated
health
poverty
alleviation
poor
china
membrane
fusion
motif
juxtamembrane
vesicle
new
diseases
antibodies
mabs
the
covs
bat
cov
surveillance
ngs
eic
protein
mutations
cov
virion
genes
indigotica
medicinal
compounds
candidate
cyclodextrins
the
medicinal
present
applications
ace2
kidney
native
activity
infused
antiviral
influenza
zro
virus
zirconia
the
pregnant
patients
hepatitis
genes
preparedness
system
infectious
activities
threat
malarial
led
regarding
disease
rates
pbd
prv
mice
cells
pk
nt
particles
veev
viral
blood
strain
innate
dpv
immune
the
pneumonia
among
children
cases
controls
tgev
nf
κb
factor
j2
h1n1
influenza
human
methods
virus
pdcov
ha
results
our
showed
evd
stigma
survivors
95
related
virus
hepatitis
codon
usage
composition
viruses
hcps
hfrs
vaccines
hantavirus
iav
pact
iges
influenza
virus
zikv
infection
montelukast
pregnant
women
bmal1
osteogenic
icariin
differentiation
bmscs
patients
respiratory
influenza
h1
h3
viral
diversity
host
communities
ecology
visits
ed
hospitalizations
copd
asthma
poultry
hpai
outbreak
epidemiological
midwestern
er
response
upr
protein
role
cscs
cancer
cells
factors
associated
evd
number
case
patients
outbreak
patients
fever
children
600
malaria
mers
cov
dpp4
polymorphisms
entry
intracellularis
swine
the
enteroids
two
ricin
lsecs
kcs
mannose
in
chest
respiratory
rsv
outbreak
patients
gas
crp
bhs
mg
antibiotics
nlrp3
inflammasome
mitochondrial
mitochondria
like
egfr
lamp
mutations
therascreen
assay
tissues
chromatin
across
gene
expression
temperate
virulence
bronchiseptica
phb09
phages
rna
positive
sense
frame
viruses
emojis
used
possible
health
prevention
pedv
cells
entry
strains
invasion
respiratory
host
influenza
pathogens
physical
cases
influenza
h1n1
confirmed
the
nan
dln
responses
cell
chikv
virus
disease
caused
income
countries
risk
respiratory
viruses
virus
human
rv
4e88
pdcov
protein
ep
coronavirus
fi
nvct
naat
100
the
structure
protein
powerful
delineation
intricacies
nan
healthy
group
ped
in
colonic
nxf1
viral
ebov
life
rna
mp
pneumonia
cap
macrolide
age
risk
zoonotic
communities
emergence
strategies
scores
predicting
mortality
patients
study
approved
drugs
use
side
effects
replication
virus
adpr
binding
hydrolase
sars
patients
pulmonary
femoral
head
lf
different
epidemics
regions
quantify
fcov
two
distinct
viruses
feline
hpai
h5
virus
detection
primer
livestock
viruses
zoonotic
metagenomic
mngs
virus
lasv
mopv
itch
proteins
piglets
chn
js
2017
fcrn
niv
responses
virus
protein
cell
syndrome
ards
vascular
activation
two
dcs
viruses
viral
cells
siglec
zikv
the
based
lamp
virus
case
95
weeks
symptoms
ci
virus
novel
viruses
field
rabbit
ifn
type
infectious
interferon
fipv
ifn
mice
cells
cd8
infection
sensing
pcnc
sensors
ability
nanoscale
ipedvpt
gene
p5
p96
pedv
sudv
gp
vlps
virus
the
rocky
mountain
new
virology
the
vaccine
mers
vector
cov
gem
respiratory
viruses
human
cns
associated
rabies
vaccine
cases
induced
era
infection
host
mir
26a
response
human
respiratory
viruses
virus
lower
drugs
in
virus
viral
infections
ntz
dissolution
cocrystals
powder
polymer
peptides
amps
drug
resistance
plant
mir
genes
mirna
cpv
3p
clinical
vivo
trials
metabolites
potential
health
ihr
communication
who
public
vero
cells
culture
suspension
cell
cause
disease
bats
responses
viruses
sfts
sftsv
efficacy
ribavirin
patients
rna
polymerase
pocket
the
ev71
ribosome
mrna
codon
recoding
canonical
safety
lab
probiotic
strains
the
grants
health
data
research
decisions
mass
spectrometry
development
vaccine
biological
respiratory
mers
cov
pigs
dpp4
the
cell
line
el
cells
skin
cav1
cell
caveolin
various
test
pneumoniae
bronchoalveolar
lavage
significant
silicone
case
liquid
syndrome
ses
nan
viruses
hosts
diseases
cause
infections
pathogen
reservoirs
zoonoses
identifying
networks
its1
using
based
its2
fungal
nan
diabetes
95
ci
type
years
ii
mrna
pol
decay
transcriptional
gulae
periodontal
dogs
clindamycin
ifn
nl63
hcov
complete
five
strains
adv
group
vs
patients
non
nl63
hcov
severe
c3
mutation
patients
ikk2
deficiency
the
cid
emerging
infectious
emergency
disease
nurses
mortality
cause
changes
seasonality
patterns
complexes
viral
structural
virus
antibody
measures
farms
the
pig
biosecurity
infectious
disease
big
government
intervention
social
public
preferences
opinion
network
nan
turnover
intention
field
epidemiologists
occupational
chest
patient
vats
pediatric
showed
cathepsin
human
specific
functions
cellular
jev
infection
ouabain
na
atpase
vp1
brain
a71
ev
virus
nlrp3
inflammasome
viral
immune
viruses
infection
pedv
the
antiviral
genes
certain
evidence
type
scientific
empirical
h7n9
ha
influenza
virus
iav
fa
rp
up
clinical
patients
viruses
mdck
influenza
cell
samples
health
events
facilities
public
reporting
respiratory
lung
vig
infections
big
children
obese
weight
viral
normal
marmosets
common
spontaneous
experimental
incidence
the
plos
medicine
editors
discuss
ml6
glycans
cancer
binding
proteins
porcine
respiratory
virus
pcr
pathogens
gene
concerted
evolution
ceacam32
family
brain
angiotensin
ras
ii
axis
nan
rp
patients
testing
ed
antibiotic
cpv
canine
china
diarrhea
review
b38
ace2
cap
angiotensin
enzyme
phev
mir
10a
5p
virus
group
the
nibv
chickens
ibv
respiratory
asthma
exacerbations
viruses
study
gps
gp
care
general
role
psychological
review
isolation
patients
outcomes
compliance
hand
hygiene
medical
students
complete
genome
sequence
strain
here
avian
coronavirus
also
known
infectious
research
health
global
funding
cihr
nan
ari
expiratory
infancy
volume
25
msspe
detection
metagenomic
sequencing
viral
aureus
baseplate
structure
host
the
aavs
bat
samples
associated
southeast
respiratory
the
infections
acute
tract
vector
diseases
image
see
text
vaccine
the
vaccines
immune
design
cases
mers
suspected
the
study
elderly
is
respiratory
pathogens
asthma
nucleotide
response
endu
genotoxic
imbalance
viral
cell
viruses
processes
infection
care
resource
settings
limited
health
disease
ba
targets
inflammatory
characterized
viral
airway
exacerbations
chronic
inflammatory
ari
viruses
pathogens
associated
respiratory
pdcov
trypsin
cell
replication
virus
sads
cov
apoptosis
caspase
cells
t7
ea
hbv
adjuvant
hbsag
calves
brd
intranasal
incidence
vaccinated
children
isolated
cf
common
pulmonary
pedv
pr
cells
piglets
groups
termination
transcription
pol
ii
pp1
molecular
development
candidates
pharmaceutical
ribonucleic
ihr
countries
disease
control
outcomes
orf5
pcv2
protein
the
autophagy
cdv
protein
hemagglutinin
1a5
2b8
malaria
china
the
cases
2020
bvdv
cattle
associated
uruguay
outbreaks
children
act
hospitalised
therapy
airway
infection
influenza
metabolic
cellular
pathways
strains
founder
the
cc
mouse
infections
bacterial
viral
respiratory
compared
nan
deep
reinforcement
learning
medical
diagnosis
asthma
pregnancy
health
control
issue
ckd
pparγ
kidney
disease
renal
transmission
contact
network
infectious
individuals
tigit
pathology
function
control
immune
nan
the
study
regarding
load
independent
influenza
impact
poct
instrument
in
crops
molecular
may
engineered
farming
outbreaks
studies
ltcfs
control
the
fecal
fmt
horses
microbiota
healthy
hcv
cdrh3
individuals
straight
bent
immune
bats
host
bat
zoonotic
disease
aeruginosa
human
genetic
infection
gas
combo5
alum
adjuvant
generated
nmd
p26
rna
virus
long
mtb
cells
cell
b1
esxa
the
or
patients
model
coefficient
asthma
rv
risk
virus
rsv
baculovirus
expression
chifn
the
recombinant
detection
signal
enhancement
device
of
agalactiae
lipid
rafts
cells
huvec
nan
nan
brsv
strains
brazilian
bovine
gene
epidemic
data
wikipedia
zika
awareness
human
respiratory
rp
99
common
research
zika
knowledge
scientific
topics
hsv
sphingosine
macrophages
mvbs
acdase
coronavirus
complete
genome
sequence
obtained
cases
european
as
21
clusters
close
contact
infection
students
office
cssa
would
system
social
security
malaysian
respondents
non
leptospirosis
workers
airway
bronchiectasis
fibrosis
chronic
pulmonary
nan
gled
ccp
00001
conventional
treatments
splicing
viral
adenovirus
transcription
potential
viral
drugs
antiviral
infections
human
peptides
amyloids
human
microbial
might
cancer
dietary
acids
amino
potential
plants
epiphytic
medicinal
activities
used
the
health
ebola
public
anesthesiologists
likely
pediatrics
health
diseases
the
portfolio
statin
crp
cholesterol
control
drug
sars
cov
2019
hcov
problem
how
cite
article
bhosale
sleep
quality
self
social
support
lung
fgl2
adenocarcinoma
cancer
expression
sars
infection
cov
human
peptide
rbd
hku9
the
betacov
subdomain
hcov
cqds
229e
acid
human
helical
fusion
peptide
viral
mers
rna
antiviral
the
viral
target
sars
cov
2003
3cl
pro
helical
coiled
coil
antiviral
class
ga
inhibition
virus
hsv
fusion
viral
drug
antiviral
delivery
infections
golgi
structure
membrane
functions
the
viruses
processes
viral
dna
these
terminal
regions
structures
compared
rna
the
international
virus
recently
emerged
nsp10
prrsv
domain
virus
helicase
vsv
trim41
viral
infection
protein
virus
letea
orbivirus
the
evolution
hts
clinical
data
could
diagnostic
cdv
cells
oxidative
expression
hif
epitope
cd8
recombinant
measles
vaccine
orf3
pedv
virus
gene
carrying
lyoph
molecular
results
liquid
study
dead
box
helicases
cellular
family
bcov
bcovs
genome
phylogenetic
analysis
hbv
proteins
mitochondrial
reported
signaling
nan
pedv
3cl
pro
gc376
virus
flavonoids
a71
natural
biomolecules
antivirals
dna
the
colorimetric
detection
based
ifitm
proteins
cell
ifitm1
family
cd8
cytotoxicity
specific
cells
epitope
nan
group
anxiety
depression
patients
chd
audits
health
baseline
compliance
facilities
nan
tat
hiv
calcium
endolysosome
ltr
nan
nan
research
published
the
public
articles
ibv
the
strains
selection
pressure
bcov
strain
yak
2017
gene
frcov
2010
ferret
nl
coronaviruses
ribv
ibv
viruses
accessory
recombinant
bat
bats
cov
related
species
hcov
nl63
respiratory
tract
human
mers
cov
pcr
rt
33
viruses
infections
hypercytokinemia
emerging
ebola
natural
foci
diseases
agents
the
lung
sars
adult
levels
acute
mbs
molecular
diagnostic
probes
nucleic
ssc
hbv
hnf1α
hnf4α
anti
10
pts2
ip
cxcl10
expression
cd26
significantly
pa
dpp4
reduced
κb
nf
inflammation
genes
target
entry
sars
cov
fusion
inhibitors
rna
viral
dimerization
sl2
hcv
angiotensin
ace2
sars
ii
ace
oxpl
phospholipids
chronic
inflammation
inflammatory
glycosylation
complexes
complex
disease
interactions
ace2
angiotensin
enzyme
ace
hydrolyses
antiviral
peptides
still
antimicrobial
scientific
tregs
phenotype
cells
mechanisms
disease
angiotensin
ii
ace
ace2
roles
sars
viral
cov
cellular
proteins
rna
rbps
recognition
binding
regions
ht
ang
exercise
mice
ace2
viral
ifn
anti
isgs
pathway
proteins
disorder
intrinsic
disordered
ribosomal
disorder
proteins
alkv
intrinsic
known
dsrna
cellular
viral
rna
rnas
metalloproteinases
mmps
adams
diseases
neuroinflammation
lcn
acute
chronic
diseases
amd
sars
patients
risk
mechanical
ventilation
ace2
sars
angiotensin
converting
enzyme
nan
vap
patients
viral
icu
respiratory
osteonecrosis
patients
sars
treatment
the
sars
cell
lines
cov
intestinal
protein
membrane
virus
host
coronavirus
scfv
the
high
recombinant
protein
ppv
dg
virus
infection
treatment
dataset
virus
probes
viruses
probe
carnitine
lesions
trimethylamine
rats
significant
the
icelisa
gl
licorice
mab
nan
paper
common
imaging
findings
children
patients
corticosteroids
use
icu
ci
len
dex
infection
episodes
occurrence
patient
hemophagocytic
hlh
syndrome
icu
nan
lung
defense
mechanisms
pneumonia
critical
the
tio
killing
2010
cell
mass
tandem
trends
analyzer
development
pandemic
prepared
outcomes
antivirals
communication
18
il
tumor
cells
exosomes
nan
ibv
codon
usage
protein
the
nan
mxa
transcript
t1
ifn
snps
fusion
membrane
lipid
peptide
compositions
biological
materials
organic
devices
surfaces
infections
associated
pulmonary
viral
socioeconomic
sars
staff
patients
article
intensive
public
health
events
infectious
threats
assays
diagnostics
nucleic
acid
microbial
pathogenic
respiratory
cov
hcovs
cause
sars
protein
cov
sera
the
nan
cag12
pylori
lactis
gene
the
patients
ipa
cs
icu
h1n1
diseases
infectious
icd
morbidity
mortality
care
patient
gps
epidemics
pandemics
the
diseases
treatment
care
highly
disease
supplementary
material
severe
transmission
disease
may
framework
species
transmission
rvsv
hiv
vectors
vaccine
virus
neck
region
sign
binding
ligand
aminopeptidase
activity
patients
cvd
cd13
plant
products
molecular
farming
describe
nan
health
authorities
pandemic
infectious
diseases
nan
genome
human
sequencing
research
significant
mabs
pedv
six
assay
the
kd
coronary
the
including
kawasaki
nan
positive
respiratory
testing
infants
molecular
patients
virus
respiratory
acute
influenza
bat
coronaviruses
samples
sequences
nucleotide
nan
axonal
injury
myelin
demyelination
ms
mhc
species
diverse
high
bats
covs
belonging
species
detected
clustered
immunization
vaccine
global
vaccination
coverage
rhcat
native
therapeutic
associated
peg
selection
bats
tlr8
mammals
immune
acute
many
practice
interventional
ir
nab
sars
cov
response
level
e6
casei
pgsa
mice
hpv16
dna
ms2
quality
controls
in
regulatory
cells
infections
role
responses
mp
proteins
protein
recombinant
major
icu
staff
patients
recommendations
procedures
cov
human
respiratory
hcov
in
selection
the
tlr9
bats
tlr8
nan
emergency
care
sops
icu
based
endemic
germany
physicians
areas
infections
immune
influences
child
childhood
system
system
the
contact
network
exact
nan
liver
mice
th17
ifn
acute
influenza
vrti
respiratory
symptoms
rsv
nan
chest
pediatric
the
round
pneumonia
medical
cams
pumc
severe
level
viruses
detection
diagnosis
multiple
analysis
enteric
real
time
rt
qpcr
silver
nanoparticles
different
anticancer
treatment
kawasaki
syndrome
children
coxsackie
we
nan
nan
the
infectious
diseases
new
control
hsv
lactobacilli
activity
viruses
this
coe
co1
fusion
protein
immune
threat
reduce
infectious
dangers
pathogens
nan
disease
sporadic
ebola
virus
diseases
the
method
influenza
time
dependent
ph
state
the
omp
unfolded
magnetic
nucleic
acid
separation
particles
droplets
survival
the
bacteria
species
lamp
f5
the
detection
fimbriae
fgf23
the
human
recombinant
sumo
reads
ducks
strains
virus
viral
viral
detection
advances
since
identification
respiratory
infections
patients
immunocompromised
severe
vaccines
plant
transgenic
plants
in
checkpoint
dogs
vaccine
melanoma
five
sars
could
spread
disease
knowledge
essential
oils
herpes
oil
virus
virus
bovine
bhv1
bvd2
india
virus
ventilation
cases
article
copd
patients
op
three
treatment
pulmonary
autophagy
involved
proteins
several
ifn
pct
bacterial
infection
patients
co
facilities
data
level
isolation
technical
cells
dcpep
tgev
fused
transmissible
marine
lectins
organisms
extensively
potential
beta
lactoglobulin
lactoferrin
alpha
lactalbumin
s1
protein
lc
pg1
pg2
we
host
model
pathogen
characteristics
tgev
immune
lactobacillus
casei
responses
icu
patients
in
admission
sari
nan
ards
cause
definition
treatment
lung
fiber
spr
fibers
surface
plasmon
ace2
lung
blm
mice
injury
nan
staff
protection
provide
patients
essential
nan
diseases
vaccine
immunization
infectious
groups
cells
virus
vero
cell
mdck
fusion
class
viral
proteins
viruses
ganoderma
products
spp
pharmacological
properties
detection
spr
clinical
analysis
review
rcvn
cvn
soluble
antiviral
coli
nan
children
sars
radiographic
findings
disease
patients
ecmo
network
ecmonet
h1n1
nan
nan
pneumocystis
pneumonia
chop
patients
non
sars
patients
the
cases
radiographic
mps
microbial
forensic
death
recent
rt
virus
lamp
tgev
porcine
staff
training
sops
education
recommendations
membrane
arbidol
arb
arp
antiviral
bats
region
host
coronavirus
cov
genes
mass
spectrometry
protease
more
disease
regions
we
transportation
formula
antigen
animals
the
tgev
cells
tetramine
china
prc
the
large
tnf
cd147
apoptosis
cytokine
secretion
molecular
evolution
cancer
much
this
antibiotic
patients
the
resistance
development
mafa
dob
dqb1
dpb1
alleles
vlps
potential
assembled
genetic
large
patients
h1n1
ards
treatment
influenza
proteases
protease
inhibitors
well
proteolytic
avbds
ibv
expression
the
immune
rna
influenza
virus
hcv
rrt
cell
virus
stem
the
human
lipid
bilayer
effect
proteins
we
protein
microarrays
spotted
small
antibodies
therapy
antibiotic
the
ent
infections
the
new
sars
coronavirus
infections
chaos
model
seasonal
pathogen
complex
crp
procalcitonin
bacterial
infection
levels
nan
pedv
sdab
the
clinical
protein
cholesterol
prv
mβcd
plasma
membrane
sal
06mab
bacterial
salmonella
typhimurium
nan
plantarum
the
high
used
expression
patients
respiratory
outcome
severe
intensive
nan
south
american
strains
the
america
nsp12
family
orf1b
mtase
coronavirus
european
guinea
fowl
turkey
american
risk
in
setting
emerging
infections
nan
nan
nan
2019
ncov
initial
risk
infectious
scabies
skin
spread
public
highly
pro
site
3cl
t25g
proteins
phosphorylation
capsid
virus
veev
viral
ct
mortality
group
patients
iqr
the
coronavirus
sars
cov
current
disease
sars
who
2003
many
viral
replication
the
inhibitors
hiv
hemorrhagic
cause
fever
highly
contagious
pcr
cats
dogs
positive
leishmania
patients
smokers
covid
19
smoking
rodents
rattus
reduction
this
review
vl
leishmaniasis
tl
diagnosis
prevalent
influenza
patients
virus
results
period
poultry
aiv
china
trade
spread
treg
virus
cns
cells
models
hcmv
spgg
entry
spread
new
nan
ul36
dub
activity
the
ubiquitin
nan
nan
niv
patients
acute
recommendations
used
covid
19
screening
dt
centers
covid
19
children
the
spread
nan
nan
peptide
binding
variants
stapled
stapling
isg15
ub
hybrid
synthesis
chains
rna
single
viral
virus
molecular
cell
demyelinating
matter
virus
white
hib
infected
virus
rats
nasal
virus
myelin
oligodendrocytes
weanling
mice
plasmid
dna
lysis
protocol
large
patients
one
treatment
savi
we
vivo
imaging
two
photon
influenza
nan
mice
lesions
virus
mutant
sfv
nan
technology
ability
genes
us
technique
vacuoles
axons
cells
affected
processes
virus
viruses
encephalitis
infection
cause
mice
virus
semisusceptible
lesions
resistant
snps
rs12979860
rs8099917
il28b
outcome
methylprednisolone
na
jejunal
function
diarrhea
demyelinating
animals
months
virus
signs
tem
analysis
in
microscopy
cells
nan
cases
cellular
ev71
response
lower
rna
amplification
arna
procedure
various
sheaths
type
myelin
heat
remyelinated
rsv
infection
severity
severe
children
nan
brain
olfactory
days
infection
virus
action
antiviral
mode
this
target
cows
isolates
bcv
virus
vn
protein
orf
membranes
1a
presence
acid
the
fatty
associated
virus
patients
controls
human
pcr
assays
patients
day
agvhd
we
28
nan
purkinje
cerebellar
normal
nuclei
cells
ich
fetuin
mutation
gene
autosomal
sequencing
microbial
protocol
metagenomic
used
proteins
caspase
expression
purification
cleavage
bp
virus
genome
ptov
breda
virus
strain
mice
denatured
mouse
receptor
mutation
adaptation
amino
acid
strain
fipv
mabs
79
type
apoptosis
bcl
vero
cells
sars
four
isolates
infectious
bronchitis
viruses
fipv
protein
hma
ii
ion
virus
detected
infection
nm
rer
hiv
dc
seronegative
sign
signr
cell
short
stature
progressive
severe
susceptible
the
virus
antibody
resistant
gs
potato
tgev
protein
mice
lithium
chloride
canine
parvovirus
antiviral
000
polypeptide
229e
mol
wt
treov
samples
young
birds
positive
mhv
dams
mice
balb
cbyj
cattle
rbcv
responses
he
respiratory
bvdv
mdbk
autophagy
cells
lc3
pdcov
172
taiwan
results
porcine
rna
binding
protein
molecule
reticulocyte
pedv
the
genome
knu
1601
cakv
extra
intestinal
detection
pathological
mabs
ml
e2
µg
e1
trypsin
formation
bovine
treatment
induced
viruses
two
gene
avian
coronaviruses
virus
days
mice
balb
blood
faeces
smacoviruses
two
viruses
first
jev
isolates
bat
we
eight
ictv
process
proposals
members
international
virus
cells
chicken
attachment
observed
sars
cov
ace2
bat
the
the
rva
study
bovine
rotavirus
bcv
cows
pcr
rt
inoculated
virus
wu
ari
specimens
patients
strain
cu
va
the
binding
secondary
structure
genome
virus
fmdv
isolates
based
method
grouping
ibv
cells
virus
sdav
lbc
cell
tgev
cells
apoptosis
gastroenteritis
cell
mrvs
mink
mrv3
sd
14
genomes
pyvs
bats
polyomaviruses
two
viral
particles
iem
used
rabbit
virus
prrs
vr
2332
orfs
piglets
js201603
the
nt
diarrhea
faecium
tgev
infection
virus
cells
virus
could
vacuoles
cells
particles
ha
hi
erythrocytes
pig
the
ge
hospital
rv
nip
children
pedv
orfv
piglets
gilts
immunized
virus
shearwaters
isolated
mice
mouse
isolates
tcov
the
states
turkey
ibv
793
like
the
iran
mhv
bgp
cells
independent
syncytia
rat
cell
coronavirus
readily
propagated
isolates
ncd
wd
differences
he
mhv
cells
cultured
fusion
immune
mhv
pattern
strains
inoculation
mice
nan
virulent
virus
sequences
avirulent
quasispecies
prrsv
antiviral
rpsp
cells
assay
buvs
samples
related
human
detected
pediatric
infections
infectious
diseases
the
nan
viruses
influenza
respiratory
ili
virus
bovine
coronavirus
rpha
the
22
pneumococcal
children
lobar
pneumonia
empyema
cells
ltr
virus
feline
the
virus
purified
polypeptides
glycopeptides
avian
ph
virus
hours
the
tgev
mabs
associated
epitopes
conformation
ibv
ibv
cu
t2
may
antigenic
respiratory
pathogens
study
neonates
admitted
000
m41
viruses
virus
strain
sars
cov
human
hcov
229e
one
multiplex
rt
pcr
bovine
electron
cells
the
replication
intranuclear
sars
patients
pbmc
cov
genes
infection
children
viral
bacterial
aom
fcov
type
infection
cholesterol
ii
feline
fipv
mab
activity
neutralizing
strain
mouse
c57
sn
macrophages
hku1
cov
trees
branch
coronaviruses
protein
purified
the
nucleocapsid
viral
hbov2
hbov3
sequences
hbov1
human
cbov1
cats
the
genome
presence
virulent
virus
avirulent
infection
ped
genome
30
equine
japan
complete
rna
mhv
proteins
we
mitochondrial
mbp
mag
lesions
cdv
infection
patients
lrba
manifestations
clinical
two
bcg
inflammation
ova
il
treatment
cars
cell
culture
coronavirus
rats
viruses
mhv
neutralization
found
two
strains
selection
epidemic
years
korean
giii
strains
neboviruses
bonov
bovine
mabs
ha
dvim
and
or
the
use
multiplex
respiratory
real
dna
monensin
replication
hcmv
viral
respiratory
viruses
children
virus
artis
three
viruses
mpcr
fbov
feastv
ii
virus
angiotensin
ang
dengue
betanodavirus
betanodaviruses
fish
infection
cells
isolates
bcv
québec
nucleotide
gene
hlj
073
ccov
ccovs
analysis
pa
lung
virulence
mice
viruses
virus
bodies
staining
containing
epithelial
activity
btov
ha
protein
he
ibv
australia
classical
novel
ibvs
p54
virus
foreign
asfv
gene
cats
colony
shed
cvlps
md
particles
antibody
human
enteric
coronavirus
interferon
viral
cells
induction
glycoproteins
aichivirus
calves
strains
vp1
analysis
tgev
prcv
strains
sequence
pigs
rats
day
respiratory
prcv
three
mers
cov
protein
contains
receptor
ibv
cells
ph
nh
cl
rna
the
sars
cov
nsp12
adenovirus
human
species
respiratory
infection
ibv
genotype
chinese
isolates
showed
bcv
strains
hcv
two
coronavirus
virus
rats
rat
coronavirus
rcv
ph
values
cells
virus
the
hpv
cross
neutralizing
epitopes
mabs
pups
dams
immune
mhv
igg
virus
emc
aborted
fetuses
suckling
btcovs
rna
bat
btcov
philippines
isolates
prrsv
putative
european
the
virus
type
syncytia
nm
infant
srh
hi
cf
sensitive
less
pedv
rspv
st
virus
swine
sars
cells
cov
3a
x1
rabbits
infection
pedv
months
infectious
tcov
epitopes
protein
neutralizing
s1
pcr
assay
ev71
rt
the
rats
virus
antibodies
after
intranasal
fhv
rpa
fld
assay
samples
astroviruses
the
viral
particles
detected
viruses
influenza
h9
sublineage
ducks
virus
transmissible
gastroenteritis
administered
orally
rd
114
virus
vaccines
retroviruses
the
morphogenesis
new
porcine
enteric
tgev
probes
rna
the
clones
children
ari
bacterial
pct
serum
bats
viruses
species
fecal
bat
hpiv2
coinfection
iav
growth
viruses
gc
hpa
affinity
glycoprotein
two
clec4m
cells
hcv
huh7
hcvcc
hbv
blood
days
medical
postmortem
epitopes
mabs
vsv
protein
adsorption
sars
methods
cov
genomic
different
fusion
protein
sera
cats
exposed
strains
mice
persistent
macrophages
susceptibility
ifn
tgev
infection
cells
interferon
gene
siv
antiviral
genes
antisense
genome
sequence
ck
ch
sd
kun
rna
probes
utr
binding
anal
swabs
lituratus
bats
also
mk
pedv
p10
strain
to
arbidol
cvb
vivo
infection
50
mice
virus
ifn
jhm
titers
rv
sirnas
targeting
rabies
virus
79
fecv
fipv
feline
infection
cakov
carnivores
identified
wild
strains
bovine
samples
diarrhea
viruses
calves
mice
the
strain
suckling
infected
ev71
rs1889570
il
17f
significantly
infect
the
viruses
betanodavirus
virus
protease
rv
cleavage
site
activity
the
strains
pcr
influenza
ia
rotavirus
samples
assay
faecal
immunoelectroosmophoresis
sars
cell
coronavirus
cov
lines
respiratory
hmpv
patients
hrsv
viruses
proteinase
like
domain
tymv
domains
fbov
study
three
fbovs
detected
pigs
virus
coronavirus
like
particles
like
coronavirus
astrovirus
particles
pups
rna
test
229e
we
applied
per
cent
md
coronavirus
rna
cells
viral
mhv
virus
antigen
srr7
amino
mice
wt
mutants
influenza
gene
virus
pcr
qpcr
000
ibv
molecular
weights
six
macrophages
no
gamma
arginase
ifn
gene
pedv
strains
field
isolates
cells
virus
infectious
events
infection
integrins
virus
binding
role
integrin
strains
coronavirus
bcov
brazilian
calves
nan
nan
rna
mutants
virus
temperature
ts
fipv
ts
temperature
wt
39
jev
cells
developing
neurons
virus
cdv
site
isolates
china
these
bovine
coronavirus
human
did
antibodies
pedv
strain
highly
virulent
genotype
fipv
infection
fecv
monocytes
cats
pedv
strains
korea
showed
field
ibv
like
group
100
virus
porcine
cholesterol
viral
virus
nidovirus
sars
severe
acute
respiratory
syndrome
the
sequence
membrane
229
polypeptide
jv
fusion
virus
cells
cell
codon
usage
ttsuv1
synonymous
codons
mabs
tgev
virulent
attenuated
titers
rna
ns5
protein
rdrp
activity
colonies
virus
viruses
produced
cells
neuro
2a
jhmv
jhm
mhv
bats
cov
bat
genes
fruit
infection
astrovirus
lambs
lamb
produced
ibdv
chmda5
chicken
cells
df
rsv
load
infants
bronchiolitis
levels
pedv
glycyrrhizin
infection
in
porcine
mice
virus
the
pathogenicity
nine
rtraa
duplex
rsv
assay
the
gp
000
protein
the
tcv
porv
genome
coding
mprv
disease
cells
human
paramyxoviruses
mk
line
polypeptides
peaks
major
000
virus
bcv
probes
tcv
detection
specific
pups
igg
antibody
mhv
immune
cells
rat
deae
rcvs
l2
antigenic
epitopes
mabs
glycoprotein
neutralizing
229e
cultures
virus
infection
persistently
samples
brush
tailed
possum
viruses
coronavirus
wild
carnivores
prevalence
three
oc43
hcov
proteins
antiviral
cov
fcv
licl
antiviral
feline
disease
calves
pdcov
fecal
shedding
inoculated
mhv
mice
challenge
immunized
jhm
feline
fapn
ibv
cells
hamster
e2
virus
using
six
monoclonal
the
cells
areas
particles
electron
or
95
ci
rsv
hmpv
isolates
ibv
taiwan
rflp
pcr
ibvs
subgroup
australian
genomic
found
cpv
dna
the
parvovirus
vaccine
bacterial
pneumonia
sole
viral
antibiotic
cvlps
polypeptide
profiles
central
australian
membrane
isolated
sequencing
parts
spike
canine
cakov
diarrhea
samples
dogs
fcv
rt
pcr
real
time
neutralising
antibody
sera
in
southern
groups
japan
genetic
recent
ibv
orf3
parvovirus
ppv4
protein
encoded
respiratory
rsv
pcr
hmpv
multiplex
pa
host
protein
viral
viruses
mhv
gene
murine
virus
coronaviruses
nude
mice
gut
contents
normal
type
rhinovirus
attempts
made
grow
strain
aa
antigenic
groups
neutralization
mers
cov
coronavirus
virus
novel
cells
infected
hhv
g2
phase
the
cm
sucrose
cscl
000
nan
nf
κb
eav
activation
signalling
hemagglutinin
the
erythrocytes
activity
infectivity
ifn
protein
dsrna
prrsv
production
cpv
mpcr
cav
canine
ccov
human
bocavirus
respiratory
secretions
associated
we
sequence
end
open
reading
foxes
red
vulpes
italy
susceptible
mhv
strains
isolated
found
two
formation
atp
ph
cells
syncytium
cov
mers
sars
real
time
protein
cns
mechanism
self
cell
prcv
fecal
nasal
pigs
respiratory
the
dvim
ae
mhv
he
fipv
type
residues
ii
peplomer
teal
apmv
strain
chany
455
survival
fip
neutrophil
factors
cats
mice
brain
viral
virus
liver
000
proteins
the
mol
tcv
deer
this
muntjac
livestock
pcr
red
crowned
members
also
cranes
antigenic
mabs
site
epitope
hexon
pedv
porcine
epidemic
diarrhea
virus
pdcov
thailand
2015
analysis
variants
nan
proteins
mhv
tryptic
three
the
pedv
s1
protein
the
recombinant
ibv
analysis
high
poultry
gene
virus
rat
cell
sialodacryoadenitis
readily
prrsv
ibc
swine
first
porcine
strains
amplified
typing
primers
bases
hvs
bats
phylogenetic
characteristics
bat
ark
ibv
dpi
virulent
attenuated
virus
h9n2
avian
influenza
mortality
ictv
proposals
ec
members
taxonomy
particles
coronavirus
like
normal
diarrhea
mrna
tgev
orfs
cdna
region
pedv
strains
vaccine
field
ch
assay
respiratory
ftd
the
influenza
human
virus
several
serological
interrelationships
ad
40
cells
hrt
18
respiratory
rsv
infants
cost
care
virus
influenza
chimeric
prrsv
h3n2
hadv
infections
pneumonia
analysis
clinical
particles
dog
the
presence
cases
prrsv
sqe
viral
sasa
quelpaertensis
virus
js
2014
pedv
gene
ibv
h120
ndv
virus
hn
igg
mabs
2a
mab
fipv
viral
kbsh
39
37
fetuses
recombination
dengue
virus
regions
analysis
pedv
g2b
jeju
genome
farm
cheetah
infectious
feline
peritonitis
susceptibility
becv
brcv
strain
g95
ly138
mhv
kda
59
ns
orf
crcov
canine
cird
virus
chv
us
bonov
nebovirus
calves
giii
c3
pertussis
severe
low
levels
s1
sczj3
protein
ibv
binding
pdcov
diarrhea
the
isolates
porcine
patients
copd
asthma
respiratory
common
middle
east
korea
south
vs
neboviruses
presence
samples
farms
noroviruses
mhv
ifn
strains
a59
induced
probe
rna
becv
detection
174
cpv
ccov
strains
characterized
canine
ltb
coe
pedv
vaccine
rad
hcov
samples
disease
unknown
pcr
mice
influenza
ifitm3
h9n2
virus
gyroviruses
ferrets
gyrovirus
the
novel
phev
outbreak
porcine
hemagglutinating
encephalomyelitis
québec
strains
lv
the
genomic
cells
prc
virus
titers
rat
pneumonia
clinical
signs
crp
pcr
cnsi
pcr
detection
results
diagnosis
influenza
virus
patients
detected
evolution
hmpv
infection
children
year
suzhou
ecov
horses
clinical
inoculation
signs
assay
plaque
dbt
cells
deae
sera
hi
antibodies
human
oc43
jp
k7
enteric
caliciviruses
sapoviruses
fcv
germacrone
effect
antiviral
calicivirus
ibv
strains
the
amino
acid
bovine
coronavirus
readily
multiplied
induced
the
antiviral
phosphodiester
oligodeoxynucleotide
sequence
piv5
lesser
zjq
221
the
ppv
licl
replication
virus
antiviral
nan
pedv
isolates
chinese
2010
diarrhea
orf
tgev
spike
respiratory
prcv
tgev
scfv
infection
antibodies
virus
radial
nerve
palsy
bilateral
rare
mhv
lesions
mice
brain
inoculation
organ
cultures
multiplication
viral
coronavirus
organ
cultures
mouse
viruses
10
china
strains
central
pedv
2012
bat
bats
astroviruses
astrovirus
species
pedv
protein
two
g1
g2
mabs
strains
brcv
becv
strain
castv
dogs
without
diarrhea
symptoms
pedv
strains
phylogenetic
philippines
countries
trypsin
strains
ibv
plaques
overlay
gii
viruses
adult
patients
diarrhea
pdcov
pid
pigs
oh
fd22
porcine
pedv
strains
virus
pcr
bev
bhm26
bj50
in
rna
virus
days
coronavirus
diarrhoea
inoculation
btov
diarrhea
adult
cows
outbreaks
pantropic
ccov
cb
05
detection
canine
rotaviruses
rotavirus
cell
the
mice
infection
resistant
infected
virus
virus
dknv
new
study
mosquito
coronavirus
genera
analysis
proteins
pairwise
pedv
deletion
variants
us
contains
gene
sequence
ibv
genome
de072
pathway
akt
cells
virus
junv
32
the
genes
pedv
chinese
nations
terrorist
assaults
great
new
viruses
two
recently
recognized
obtained
hcov
nrvi
neonates
hospitalised
children
one
step
pcr
detection
the
virus
bat
coronaviruses
closely
related
bcv
hev
hcv
oc43
probe
field
ccvs
identified
viruses
originating
vb_bbrm_phb04
phage
bronchiseptica
showed
revealed
nan
h9
antigenic
mabs
the
h9n2
cholesterol
viral
pdcov
the
present
cap
infections
bacterial
pneumonia
countries
mhv
virus
jhm
mice
cell
virus
pigs
inoculation
days
isolated
viral
avian
coronaviruses
mice
strains
cv
777
fipv
reaction
antibodies
ev71
strains
ca16
sz
hk08
virus
antibody
sdav
using
infected
induced
protein
antigenic
gene
cdna
fescv
detected
circular
dna
virus
ibv
isolates
korean
01
02
serotype
specific
substitutions
304
386
rna
analysis
nucleic
acid
infectious
cases
controls
the
rhinoviruses
viruses
influenza
surveillance
hospital
based
system
sars
coronavirus
replication
helicase
hybrid
virus
ibv
the
assay
infectious
000
dvim
rde
mouse
the
hfnc
oxygen
therapy
support
bronchiolitis
chick
showed
resistance
infection
embryo
colostrum
measles
patients
ms
anti
coronavirus
respiratory
calves
isolates
nasal
virus
uriae
the
seabird
runde
ndv
production
autophagy
virus
cells
pedv
trypsin
infection
vero
cells
strains
cd
wd
bcv
erythrocytes
viruses
like
qx
early
km91
cb
tissue
explants
absorptive
virus
virus
virulent
attenuated
feces
titers
fipv
enhancement
virus
infection
macrophages
vlps
bv
purification
nov
capsid
jv
ph
infection
ammonium
chloride
dengue
virus
host
000
infection
assay
xmap
used
rabbit
the
detection
sars
cov
emerging
infectious
virus
sciav
pedv
spike
protein
virus
cchfv
viruses
group
nsdv
vaccine
antibody
possible
structure
hiv
nan
chickens
s1
virus
immunizations
glycoprotein
coronavirus
like
particles
feces
antibody
phev
mir
142a
3p
rab3a
stiv
entry
significantly
ranavirus
enter
ha
pedv
activity
strains
erythrocytes
000
intestinal
contents
turkey
polypeptides
type
feline
ii
cells
fipv
human
enteric
coronaviruses
thin
sections
nan
california
type
ibv
chicken
nucleotide
isolates
s1
type
mass
se17
coronaviruses
coronavirus
hcov
assay
the
ptovs
korean
ptov
korea
samples
feline
entry
cells
tgev
fecv
bkov
one
nt
vp1
3d
cell
fusion
cells
virus
used
feline
two
disease
virus
fecv
10
virus
ml
cm
mhv3
bcov
the
strains
calves
detection
cells
vero
virus
strain
cell
flavonoids
antiviral
potential
activity
different
h5n1
induced
glycyrrhizin
inflammatory
virus
asthma
exacerbations
rv
virus
prevalence
chicks
bx
line
ibv
infection
viral
cells
rotavirus
assembly
drug
hcv
glycoproteins
coronavirus
hepatitis
membranes
rpa
cpv
method
detection
canine
tshsv
predicted
trionyx
sinensis
arterivirus
adenovirus
infections
e1a
viral
replication
ahysx
strain
ibv
coronavirus
recombinant
mhv
found
strains
the
nucleotide
cchfv
cchf
virus
viral
vsv
respiratory
viruses
saudi
arabia
epidemiology
orf
orfs
the
sequence
prrsv
cell
virus
cells
avian
infect
bcv
erythrocytes
strain
strains
wild
in
influenza
1997
avian
subtype
influenza
h1n1
detection
virus
respectively
hmpv
assay
lineages
respiratory
real
pdcov
in
usa
countries
histological
no
ppv
this
study
effect
strains
strain
tgev
nt
shxb
pedv
tottori2
october
porcine
epidemic
dub
plp
ibv
activity
proteins
immunized
mice
challenge
mhv
virus
wildcats
viruses
luxembourg
high
we
frameshifting
ribosomal
sequence
shifty
heptamer
infection
mice
suckling
resistance
transmission
virus
tgev
coronavirus
ccv
hev
high
sequence
pbov
pbov3c
dna
kipyv
wupyv
patients
respiratory
specimens
fcd
cells
tm
feline
fiv
strains
all
heating
minutes
ten
two
vietnam
pdcovs
pdcov
strains
cva21
person
respiratory
ari
outbreak
virus
nuclear
ldv
localization
arteriviruses
antiviral
tlr
inos
no
receptors
ndv
infection
gw3965
cholesterol
abca1
rsv
group
strains
kuwait
samples
ibv
vaccine
ma5
detected
hens
pibo
acute
exacerbation
bronchiolitis
children
diarrhea
genetic
psvs
samples
pigs
prrsv
griffithsin
antiviral
virus
effect
hbov
49
34
the
mean
mhv
mice
infection
virus
ifn
cell
fip
cats
cells
differentiation
pedv
strains
korean
korea
genetic
mvc
dog
cause
degenerative
viral
ifn
iii
peritoneal
macrophages
mouse
000
different
virus
polypeptides
density
bcv
pcr
nested
calves
rt
dc
infection
jev
sign
signr
we
specific
synthesis
rnas
report
pdcov
piglets
chn
hg
2017
replication
kbsh
kresse
32
37
bcv
kd
trypsin
cells
protein
neutralising
activity
porcine
coronavirus
cats
stable
ph
it
completely
inactivated
nan
rna
serotypes
end
astrovirus
isolates
hepcv
the
genome
segment
rna
subgroup
ibv
strains
s1
identity
the
isolates
tgev
compared
nucleotide
peptides
s1
s2
antigenic
regions
pedv
intestinal
cells
iecs
infection
ari
children
age
surveillance
systems
lamp
assay
ap
the
detection
mice
mhv
virus
serum
recovered
bvdv
codon
genotype
usage
content
nl63
hcov
children
infection
cases
sars
cov
nucleocapsid
protein
pyruvate
pedv
s1
piglets
protein
igy
canine
cv
china
analysis
diarrhea
229e
projections
three
coronaviruses
strain
grft
jev
infection
antiviral
virus
interferon
cells
ibv
the
strains
nt
hi
titers
viruses
tests
antigenically
virus
related
fipv
coronavirus
pedv
agent
the
pathogenic
ped
mhv
the
dvim
gp69
polypeptides
virus
inactivated
ibv
chickens
strain
orf
mrna
5b
the
protein
cells
sars
cov
infection
fermentans
mg132
hev
virus
proteasome
study
sars
cov
virus
recombination
genome
micv
cvs
cv
batcv
sequence
pcr
assay
time
mqrt
we
infections
the
admitted
identified
patients
hbov
children
wheezing
viral
load
hev
anti
schizophrenia
patients
igg
akt
marc
145
cells
virus
respiratory
serotype
adenovirus
lrti
serotypes
bcov
wd
calves
nasal
small
human
ngs
clinical
virus
viral
cases
particles
faecal
extracts
babies
ntp
proteins
motif
sequence
rna
in
two
patients
limbic
encephalitis
the
cytotoxin
gene
pseudomonas
aeruginosa
fh
immune
system
demonstrated
liver
gpi
anchored
proteins
cell
mdck
mhc
class
sequence
species
genes
nec
infants
entity
risk
factors
nan
nicotine
nasal
the
spray
bioavailability
ldv
virus
immune
cells
replication
particles
aids
coronavirus
homosexual
in
nan
nan
assembly
viruses
proteinases
encoded
many
ms
specific
cells
eae
the
mycotoxin
cells
toxic
toxin
gastrointestinal
interactions
target
events
virus
host
nan
the
virions
cells
cell
nasal
sponges
metabolites
diseases
compounds
the
survival
virus
hev
temperature
year
nan
2a
guanoxabenz
spleen
adrenoceptor
the
pteropus
flying
viruses
australia
papua
damage
barrier
function
immunocytes
immunological
camels
camel
dromedary
the
humans
drugs
enterovirus
enteroviruses
the
viruses
duplexes
the
changes
dna
isonucleosides
mice
viral
inflammation
rhcat
inflammatory
gastrointestinal
stromal
tumors
tumor
hospital
recombinant
influenza
enzymes
virus
viral
3cl
pro
μm
inhibition
the
sars
biosensor
antibody
b1
h12
respiratory
viruses
patients
influenza
immunocompromised
pcr
300
multiplex
monoplex
samples
ceacam1
lumena
cell
molecule
normal
hcmv
mhc
class
type
positive
hpv
designed
constructs
e5
e7
ng
ml
flying
foxes
urine
animals
immunized
virus
gold
antibodies
neonatal
necrotizing
enterocolitis
common
serious
ace
inhibitors
angiotensin
ras
may
vp2
protein
plants
transgenic
expression
viruses
samples
respiratory
hmpv
cases
cell
apn
line
control
antisense
nan
covid
19
ai
tools
healthcare
corticosteroids
patients
diseases
number
data
uv
agents
sensitivity
biopharmaceutical
production
sars
ctsl
chinese
compound
relieving
samples
farms
opg
the
eimeria
nan
sars
patients
treatment
the
severe
distribution
the
incidence
poisson
data
hyper
specific
reactivity
reactivities
defined
human
humans
sialic
neu5gc
great
2a
ar
antagonists
binding
study
air
chamber
purifier
airborne
epidermidis
mas
activation
macrophage
syndrome
rare
om
85
patients
study
treatment
viral
mathematical
models
new
dynamics
sirna
shrimp
vp28
encapsulated
gerps
nan
sars
patients
cases
clinical
exposure
community
healthcare
hospital
infection
rates
eids
increased
shedding
humans
habitat
caveolae
cell
clusters
cd13
surface
64
dose
proteolysis
fiz
proteolytic
debriefing
study
group
oriented
approach
cases
surveillance
hantavirus
fever
vector
public
health
quarantines
chinese
communities
quadruplexes
g4s
g4
dna
cells
fur
fragments
seals
dna
two
dna
aptamer
enzyme
aes
inhibiting
the
inhibitors
active
uncertainty
learning
cough
acute
common
medical
it
nan
calves
cryptosporidium
diarrhea
the
parvum
nan
nan
virus
chandipura
viral
vesiculovirus
life
nec
cases
database
periodicity
random
nan
infection
methods
diagnostic
toxoplasma
rapid
palm
civet
the
masked
larvata
strain
nucleotide
sod
genome
substitutions
technology
sci
therapeutic
insults
bioinformatics
nan
elective
students
health
medical
the
rpapn
recombinant
proteins
aa
overlapping
frameshifting
the
genes
argi
codon
nan
nan
severe
cap
patients
inflammatory
non
tropical
git
exposure
pathology
infectious
nan
ibv
vlps
recombinant
the
particles
hbov
pcr
respiratory
multiplex
adv
4g
post
sars
osteonecrosis
group
seminars
students
epidemiology
exam
the
patients
diseases
travel
median
iqr
sequences
protein
amino
acid
cellular
hais
surfaces
gram
cleaning
despite
women
influenza
ili
nh1n1
pregnant
dna
rna
modifications
sequencer
detection
coronavirus
bats
species
host
diversity
kallikrein
na
atpase
golgi
protein
new
conservation
medicine
programs
we
better
health
outbreak
improve
public
pepsin
nic
molecular
binding
fluorescence
dmd
muscle
absence
membrane
duchenne
nan
pneumonia
adenovirus
previously
chronic
lymphatic
genetic
human
infections
respiratory
emerging
cryptosporidium
calves
northern
ireland
specimens
iaq
air
indoor
quality
health
human
pathogens
chimpanzees
diseases
wildlife
nan
response
approaches
political
h5n1
avian
cells
transfected
sars
proteins
cov
nan
fluoroquinolones
infections
concentrations
topoisomerases
this
adenovirus
ard
recruits
military
major
room
bio
kil
bacterial
19
diarrhea
secretory
slow
intestinal
myoelectrical
nan
hrv
types
four
time
highly
lung
models
human
tissue
the
viral
response
patients
serum
cytokine
om
il
rv
production
children
indoor
bacteria
staphylococcus
adenovirus
air
rpec
infection
infected
cell
virus
rnh
reh
proteins
cell
purified
yhv
viral
compounds
shrimp
the
nan
mg132
cachexia
cancer
gastrocnemius
tumor
mitochondrial
analysis
tumors
respiratory
we
proteins
the
protein
human
these
ibd
disease
crohn
we
risk
fgl2
expression
disease
patients
protein
colostrum
calves
cows
fed
the
facemasks
surgical
n95
significantly
wearing
cells
lung
microbial
alveolar
receptors
i7l
proteinase
model
site
ligand
vasculitis
injury
endothelial
disease
anca
microbial
bioaerosol
concentration
the
bacteria
oseltamivir
cost
care
perspective
neuraminidase
level
our
outbreaks
transmission
healthcare
nan
infections
viral
respiratory
lower
tract
research
lifegene
years
data
study
protein
expression
dpt
tobacco
transplastomic
tslp
iecs
inflammatory
uc
expression
respiratory
lower
tract
infection
viral
fusion
expression
express
soluble
purification
mers
performance
cov
elisa
igg
abstract
site
different
cooperativity
cooperative
nan
nan
host
pathogens
theory
within
selection
golgi
cisternae
monensin
the
small
nan
pcr
tube
reaction
method
nested
wildlife
trade
illegal
the
global
diseases
arabian
peninsula
the
infectious
patients
myeloma
vrti
multiple
risk
nan
per
incidence
1000
villages
rate
wild
great
respiratory
disease
supplementary
antibody
patients
detection
oc43
229e
tmds
the
identified
protein
models
hcov
samples
couples
mv
positive
the
search
similarity
compounds
docking
dnmt1
acid
dna
inhibition
nsc97317
respiratory
adults
two
this
hmpv
cryptosporidium
diarrhoea
parvum
agent
humans
human
activities
change
emerging
pathogens
pig
immune
response
research
analyses
influenza
system
infections
this
microfluidic
nan
use
mrt
antibiotic
2015
patients
host
species
emergence
specific
virus
studies
disciplines
better
control
requires
found
like
sprue
coronavirus
particles
mutation
chloramphenicol
domain
mitochondrial
mutant
rna
sense
negative
nucleoprotein
the
nan
rice
ureb
gene
plants
transgenic
nan
protein
membrane
proteins
expression
sumo
parasites
dogs
specimens
cryptosporidium
companion
in
igg
patients
technique
oligoclonal
creatine
carnosine
taurine
hydroxyproline
anserine
eimeria
camelids
important
south
species
viruses
viral
entry
many
enveloped
da
genetic
arthritis
substrains
differences
health
international
hajj
security
world
mouse
interferon
mhv
liver
hepatitis
ifn
ards
mice
lung
low
samples
pooled
separate
use
swabs
cleavage
furin
pathogenic
h5n1
high
sample
small
microfluidics
based
end
children
infection
viral
clinical
multiplex
nan
respiratory
viruses
virus
co
different
sars
patients
cov
in
specimens
nan
pedv
porcine
virus
the
antibody
wildlife
occupational
risk
zoonotic
workers
p53
cell
dynamic
model
controls
binding
protein
proteins
brush
adult
virus
early
however
the
severe
ulp1
immobilized
proteins
immobilization
used
wildlife
species
emerging
infectious
eids
nipe
cbs
nebulization
dif
system
acetyl
neuraminic
acid
mouse
neu4
changes
biopsy
may
small
intestinal
patients
critically
ill
sars
three
rv
rvs
children
cap
aged
age
hazard
vsl
rate
specific
fowleri
activation
astroglial
cells
il
bats
pha
response
immune
studies
host
defense
tolerance
the
billion
glycans
sialylated
section
acid
cancer
cancer
tonic
paralysis
patients
kcl
avoidance
behavior
protective
fear
risk
fp
host
cell
order
inhibition
apoptosis
hpi
fipv
cells
regulated
gps
pandemic
urban
preparedness
non
nan
pc
hbv
chb
aclf
patients
virus
codon
usage
influenza
species
nan
electron
microscopy
rotalex
enzygnost
the
pvb19
cases
vaccine
children
two
echinaforce
respiratory
tract
viruses
resistance
sars
cov
proteins
structural
proteomics
conservation
residue
results
evolutionary
sequence
shedding
fecal
calves
oocysts
exposure
patients
respiratory
viruses
cystic
fibrosis
neurona
molecular
sarcocystis
agent
associated
gefs
arf1
arf
the
sec7
rv
nasopharyngeal
viremia
load
the
meconium
ace
pic
lung
angiotensin
viral
blood
plasma
analysis
as
sars
ace2
cov
rna
by
microfluidic
systems
sample
devices
detection
rsv
speed
oligo
detection
pcr
viral
richness
host
bats
we
apn
blood
pressure
iii
ang
tissue
grafts
bank
bone
tissues
sars
patients
respiratory
95
radiological
animal
morbidity
mortality
diseases
public
sars
patients
ace2
the
organ
myocarditis
viral
infection
cause
clinical
mutation
cause
mutations
concept
study
coughing
patients
pertussis
prolonged
incidence
laboratory
infections
acquired
workers
determine
sialic
the
acids
distribution
acetylated
protein
rtulp1
sumo
fusion
ulp1
virus
cells
receptor
attachment
virion
plant
production
compounds
plants
tissue
rats
infections
cells
potentiation
in
nan
ifng
rs1861493
symptom
score
population
amino
acids
plasma
network
in
camel
mers
cov
camels
risk
spike
glycoprotein
protein
different
proteins
well
metrics
sequences
in
article
hcp
h1n1
influenza
virus
infected
hsv
patients
nose
inoculation
strain
chronic
hcv
rs2660
rs10774671
rs3741981
membrane
rafts
infectious
diseases
role
leu
is
segment
lys
frameshifting
nan
sapria
kaempferol
μm
aureus
study
respiratory
pcr
patients
virus
study
nan
sars
samples
elisa
patients
antigen
collective
sars
community
outbreak
the
cryptosporidium
samples
case
herds
diarrhoeal
cd60
cells
surface
tonsillar
together
the
mers
cov
response
ml
diagnostic
pneumoniae
in
respiratory
well
aminopeptidase
cd13
cells
ecm
transfected
high
mannose
kaa
binding
lectin
cryptosporidium
calves
positive
risk
isolates
nan
alri
child
controls
cases
children
high
mannose
kaa
binding
lectin
848
tnf
ifn
exercise
induced
npc
tumor
sera
cells
patients
prrsv
purification
vaccine
pa
grft
bp
patients
vp
methods
included
ndv
α2
binding
sialic
acid
frameshifting
insa
region
termination
codon
ns2b
ns3
zikv
pro
µm
onto
photoactive
surfaces
in
mini
infection
risk
personal
responsibility
public
rna
protein
structure
tertiary
the
hiv
anti
new
drug
potent
children
multiplex
analysis
the
febrile
bacteriophages
also
may
they
phage
mice
mhv
metastasis
animals
cells
pythons
vipers
armillifer
spp
armillatus
pneumoniae
patients
lactams
macrolides
virus
elisa
recombinant
antigens
three
sensitivity
strains
marine
sponges
associated
bacteria
the
coli
protein
glycosides
whole
serum
children
activity
ph
aminopeptidase
pcr
patients
symptomatic
non
respiratory
hcv
replicon
replication
chloroquine
autophagy
milk
provide
antimicrobial
substances
the
viruses
virus
retinal
human
rpe
dna
vaccine
pcdna
the
immunogenicity
therapeutic
expression
infectious
diseases
cancers
protein
functions
methods
structures
in
ribavirin
corticosteroids
the
treatment
sars
pneumoniae
virus
influenza
expression
infection
protein
activity
kinases
pks
inhibitory
cells
cell
flat
may
two
piv
viral
respiratory
children
adults
plasma
convalescent
patients
sars
day
phylogenetic
sequences
method
up
various
prrsv
the
3clpro
activity
porcine
sars
patients
cap
anc
variables
travel
travelers
migrants
spectrum
infection
sialic
viruses
acid
receptor
bcov
ifna
positive
bat
ifns
family
water
lignite
presence
wells
surface
human
hrsv
gorilla
respiratory
outbreaks
phage
fidelity
protein
synthesis
effects
cellular
automata
image
biological
sequence
nan
trypsin
gel
inhibitor
chromatography
cellulose
95
mxa
ev71
infection
population
disease
kfd
based
eo
nn
suppression
frameshift
mitochondrial
the
mutation
emergence
potential
hosts
species
mammal
nan
mutation
studies
predict
randomness
mutations
molecules
catalytic
model
the
atpase
antigen
elisa
bovis
cattle
described
the
disease
epidemic
sweating
lethality
orally
administered
cytokines
effects
interferons
children
respiratory
bacterial
viral
acute
esterase
inf
bcov
acetyl
virus
infected
formula
see
text
epidemics
viral
rnai
genes
process
functions
viruses
novel
the
analysis
like
development
functionalization
triterpenoids
secoamidoximes
secomethylenamines
novel
h1n1
lineages
influenza
viruses
pneumonia
cap
lung
infection
role
farms
95
ci
infection
h9n2
mammary
anpep
development
remodelling
gland
fic
sars
reliability
the
symptom
er
stress
apocynin
apoptosis
ec
solvent
detergent
plasma
pharmaceutical
product
pituitary
findings
still
disease
hypophysitis
isolates
2007
2008
identified
mutations
mers
cov
camels
uae
virus
pedv
vlps
virus
analysis
porcine
ili
qol
parents
children
group
strains
frcov
saitama
msu
analysis
the
fipv
orf
region
3a
castv
the
sequence
isolates
chicken
sars
highly
contagious
features
severe
2d
molecular
rnases
models
we
sars
protein
cov
mab
amino
encephalopathy
knowledge
brain
particularly
transmissible
clinical
review
technologic
advances
molecular
isolates
seven
99
pedv
strain
nan
viral
emerging
in
agents
china
bovine
respiratory
brsv
bav
virus
inoculated
prcv
sows
piglets
litters
proteins
rbd
pastoris
expressed
the
rna
ngs
viruses
sequencing
library
cholesterol
membrane
infection
prrsv
cellular
strain
h165
tgev
h16
genome
ns4a
translation
hcv
eef1a
viral
metagenomic
virus
up
cases
sequencing
patients
mers
cases
28
cov
pedvs
attenuated
type
orf3
dr13
bovine
prevalences
brucellosis
high
five
viruses
rna
ss
arthropods
transmission
canine
respiratory
dogs
using
viral
day
793
vaccination
h120
two
s1
the
gene
protein
expression
protein
antibodies
plant
anti
idiotypic
rearing
calves
diarrhea
dairy
observed
fipv
kittens
plasma
levels
infected
plants
measles
protein
antigens
carrot
aprs
antigen
loops
contribution
aggregation
asthma
childhood
health
diagnosis
make
axons
mm
denuded
dorsal
weeks
snp
populations
genes
cd209
tnf
nan
s1
mammalian
isolates
previously
reovirus
samples
0001
gpa
brv
calves
trees
well
without
used
in
mutation
amino
acid
study
protein
pifit2
binding
position
gene
two
nan
common
specific
cold
although
human
hiv
epidemic
the
china
review
s1
contained
recombinant
four
ibv
pvax
typhimurium
sl7207
attenuated
tgev
mxa
the
might
protein
viruses
formula
final
size
infectious
we
paltrinieri
2007
early
biomarkers
inflammation
hiv
sars
cov
vlp
production
models
used
delivery
studies
animal
group
npv
cells
ii
acmnpv
miniarray
system
detection
pcv1
pcv2
ras
remains
blood
pressure
hypertension
diagnostics
tests
nucleic
acid
based
effects
the
two
mt
discharges
calves
vaccinated
herd
rotavirus
unvaccinated
method
alkylthio
amino
cyano
pyrimidines
transplant
patients
prevention
infections
number
hiv
pwid
harm
reduction
countries
replication
proteasome
dependent
virus
upr
infection
diarrhea
animals
rotaviruses
vaccines
bhv4
animals
iif
postpartum
metritis
licorice
seeds
the
flown
18
mexico
pedv
diarrhea
gene
samples
tgevs
chinese
strain
165
analysis
sequence
gene
full
genome
clinical
mgs
diseases
the
infectious
context
mers
cov
clinical
in
features
rna
viruses
conserved
motif
virus
cpv
dogs
strain
acute
infectious
om
general
population
treatments
goal
feline
kobuviruses
kobuvirus
in
fecal
ibv
recombination
the
variant
gi
delivery
local
administration
sirna
system
bohv
tcdd
infection
cells
mdbk
cal99
virus
structural
genes
california
mortality
the
risk
factors
critical
h5n1
h7n9
years
influenza
cases
protein
mice
balb
titer
the
association
viral
vasculitis
definite
possible
calves
fecal
significant
01
risk
pedv
usa
indel
non
genetically
community
acquired
pneumonia
viruses
virus
pedv
infection
plasmids
two
diarrhea
aichivirus
cattle
samples
herds
evaluated
hiv
pneumonia
use
individuals
risk
farms
infectious
separately
bronchitis
disease
bat
viruses
infectious
diseases
bats
strains
ibv
isolated
china
analysis
disease
ms
system
immune
role
apn
cd13
fibroblasts
wound
cell
eif4a
the
part
translation
initiation
sars
the
igg
elisa
infectious
libraries
peptides
small
random
peptide
brsv
bav
respiratory
sheep
goats
gp5
rmva
immune
virus
prrsv
passage
83p
virus
100th
cells
patients
ct
cxr
group
consolidation
signal
protein
peptide
cleavage
spp
ctxb
ipad
anthrax
pa20
antigens
rt
lamp
assay
dhav
the
ars
crs
exacerbation
viral
disease
somni
calves
histophilosis
pathological
bovine
cv
similar
s1
amino
sequences
bats
viruses
population
one
bat
liver
fibrosis
plasma
disease
candidate
ifn
protein
sars
cov
inhibit
cattle
diarrhea
adult
bovine
bcov
protein
sars
cov
transmembrane
the
sequence
the
purdue
cluster
tgev
sars
protein
cov
cox
expression
children
viral
pathogens
pneumonia
cap
concerns
research
human
genetic
enhancement
genes
time
series
expression
ato
bat
bathev
species
reported
various
rnai
virus
therapeutic
using
cells
pbv
calves
samples
buffalo
the
nasal
epithelium
it
physiological
functions
he
gene
isolates
the
ptov
membrane
protein
sars
cov
third
avian
influenza
virus
human
h5n1
urti
perinatal
hospitalization
outcomes
pregnancy
ct
chest
h7n9
time
patients
protein
pdcov
rig
ifn
production
ibv
01
korean
isolates
02
viral
respiratory
tract
molecular
in
nan
hcv
lsectin
liver
cells
sinusoidal
mabs
cov
approaches
diseases
emerging
symptoms
acute
rhinosinusitis
children
common
saibk2
recombination
complete
nsp
responsible
strains
guangdong
pedv
vaccine
gds03
tissue
epithelium
adherence
streptococcus
aureus
exists
dhv
mutations
utr
duck
screening
formula
see
text
control
lymph
nodes
cns
regional
cervical
pedv
orf3
vero
cells
protein
mrna
viral
rna
post
transcriptional
citation
using
co
clusters
three
pedv
six
the
isolates
protein
nan
rna
leader
sequences
sequence
tgev
nan
orfs
protein
coronavirus
the
sequence
herbal
influenza
study
placebo
group
gene
italy
identity
isolates
s1
pdcov
pgenesil
infection
rna
st
sars
virus
the
may
severe
codon
ndv
usage
synonymous
pattern
nan
mice
human
virus
transgenic
vivo
hcws
disease
high
patients
severe
pedv
in
protein
determined
contrast
man4
sd1
scytovirin
sd2
binding
asthma
products
associated
exposure
development
c1
the
cluster
c2
vietnamese
rotavirus
calves
the
samples
isolates
ibv
peptide
phages
positive
the
influenza
measures
recommendations
pandemic
health
nan
tgev
protein
lactis
recombinant
antigen
na
oxidation
ascorbate
accumulation
astrocytes
the
chinju99
amino
gene
cv777
proteins
like
ammonia
regulated
disease
a2
ibv
genome
strain
the
nan
zj971
associated
infectious
bronchitis
ibv
networks
health
sentinel
among
travelers
viruses
virus
koch
postulates
emerging
hiv
vlps
vaccine
since
we
nan
sars
cov
expression
eukaryotic
plasmids
codon
expression
genes
mammalian
cells
group
thailand
s1
gene
terminus
nan
patients
the
blood
anfh
sars
vaccines
development
pathogens
also
measles
λ3
poifn
pedv
ifn
the
macrophages
renal
iri
gene
expression
respiratory
chronic
viruses
airway
parainfluenza
ova
np
nasal
the
nanoparticles
camels
mers
dromedary
cov
arabian
virus
isav
s8orf2
rnai
family
influenza
animal
the
health
welfare
hbv
rna
lv
system
antiviral
gene
protein
reading
completely
overlapping
hav
hepatitis
antibody
production
transgenic
glial
cell
lines
line
the
health
human
food
environments
ecological
95
ci
spp
the
risk
rs
in
health
chronic
cases
lineage
betacov
italian
bat
serotinus
coronaviruses
miniopterus
the
alphacoronaviruses
coronavirus
domain
macro
hev
ferritin
ftl
the
global
diseases
pattern
stochastic
cm
wm
body
human
whole
griffithsin
pedv
the
potent
antiviral
molecular
polypeptides
vmed
the
prediction
dna
vaccines
diseases
protein
infectious
zikv
lamp
assay
detection
coding
mers
cov
camel
camels
farm
aom
virus
incidence
vaccines
vaccine
pedv
ch
recombination
vaccine
circulating
mers
cov
humans
transmission
human
biomedical
use
research
dual
published
ome
children
management
important
condition
ebov
marv
africa
the
virus
strains
ch
china
isolated
variant
env
alv
gene
mirnas
the
rbcv
nucleotide
amino
acid
wild
sequence
pedv
virus
one
the
bvdv
brsv
pi
3v
bav
microbiota
lung
the
function
homeostasis
ha
h7n9
h7
subtype
influenza
ip
dogs
nt
test
ccv
rna
diverse
interactions
functions
molecular
viruses
respiratory
transplant
options
cause
ccv
structural
coronavirus
71
protein
otitis
media
cytokines
disease
respiratory
mhv
dvim
the
he
protein
animals
results
viral
infections
healthy
infectious
diseases
notifiable
disease
china
plv
panthers
elisa
kela
positive
viruses
virus
cell
outbreaks
emerging
bvdv
cattle
eastern
china
herds
prnat
tgev
the
three
plasmids
dilemma
ethical
use
research
biological
pandemic
since
sars
2009
influenza
nan
sars
cov
genomes
pathogenesis
virus
pigs
swine
cell
cells
infectious
tgev
orf7
hp
gene
the
phev
genome
2008
strain
complete
pedv
molecular
the
diarrhoea
first
helvum
sequences
bats
nigeria
rna
ltb
protein
chloroplast
tobacco
plants
nppv
patients
arf
sars
120
cd4
cd8
lymphocytes
monocytes
liver
angiotensin
ace2
terminus
carboxypeptidase
homologous
rotavirus
viral
detected
feces
diarrhea
terminals
retinas
ph
weak
bases
immigrants
developed
countries
less
return
we
pcr
csigd
transgenic
mice
uptake
ascorbate
acid
astrocytes
cultures
tail
length
poly
cells
regulation
strain
gene
de072
sequence
the
rna
events
case
processing
modulate
protein
mabs
sars
spike
cov
brain
sae
cells
astrocytes
pathophysiology
proteasome
ibdv
virus
pathway
inhibitor
bcov
calves
herds
the
infection
96
the
sequence
protein
kinase
ascorbate
uptake
na
the
external
yn12243
bav
culicoides
virus
isolated
s2
sequence
s1
subunit
data
coli
biotypes
study
diarrhea
the
em
virus
microscopy
agents
number
sars
cov
infection
patients
wb
professional
obligations
physicians
provide
medical
virus
m41
produced
precipitin
lines
sars
susceptibility
genotype
associated
patients
bcov
three
amino
acid
twd1
lung
clad
allograft
risk
chronic
proteins
animals
milk
recombinant
the
genes
used
protein
primers
ig
rabbit
hemorrhagic
disease
caused
calicivirus
strains
gray
jmk
sequence
the
cdv
strains
cd
tm
cc
the
middle
east
cases
virus
ifitm3
gene
chicken
influenza
we
rt
lamp
jev
assay
the
ad
phage
elisa
rs
protein
winter
dysentery
disease
herds
associated
viral
emerging
viruses
virus
in
nan
tcov
flocks
turkey
tastv
li
the
dictyostelium
studies
biosynthesis
discoideum
ibv
gene
hh06
the
sequences
ibv
strains
zz2004
virus
ducks
cf
patients
better
management
the
ccov
crcov
coronavirus
rnps
expressed
bat
bats
molossus
brazil
rna
sequence
genome
sczy3
nt
ibv
sgrnas
sars
cov
translation
aug
immunology
research
genomics
large
genomic
isolates
ibv
type
strains
lx4
applications
veterinary
antibodies
vaccines
therapeutic
protein
ad
tgev
viral
the
country
disease
infection
risk
models
nan
type
fcov
ii
feline
fip
variants
hiv
x4
r5
sites
gsk3β
ligand
based
target
selective
h120
ibv
strain
strains
recombination
nan
pastv
belong
korea
lineage
divergent
respiratory
viruses
human
infections
lrtis
ndv
ibv
chickens
the
yucatan
no
lung
ards
in
acute
nan
ipf
ae
disease
high
may
admission
icu
patients
respiratory
sars
codon
usage
bias
fmdv
sat
bat
cov
coronavirus
bats
detected
apn
pharmacophore
hits
based
virtual
calves
age
eae
feces
stx1
ndv
np
mrna
newcastle
disease
utr
hastv
secondary
sites
the
97
ljb
03
gene
pedv
kids
colostrum
serum
concentrations
supplement
epidemic
days
estimated
95
ci
strains
bacterial
probio
activity
coronavirus
passage
culture
observed
virus
fipv
exophiala
attenuata
phaeohyphomycosis
short
cat
human
mabs
clinical
trials
mouse
diagnostic
veterinary
in
pcr
the
japonica
ests
liver
the
genes
bace
human
tobacco
analysis
genes
production
risks
technology
potential
exposure
cats
saa
diseases
inflammatory
available
sinusitis
viral
bacterial
patients
recurrent
cov
mers
human
middle
east
asymptomatic
outbreak
disease
infective
class
ck
ch
ibtz
2012
strain
viral
host
proteomics
proteins
proteomes
sequence
nc98
s3
the
turkey
calves
species
eimeria
infection
buffalo
16bo133
sars
cov
human
bat
disease
kawasaki
the
clinical
diagnosis
x4
protein
structure
based
icam
dc
sign
cells
cell
immune
h5n1
cell
a549
virus
cells
aerosol
viral
flow
collection
preservation
cov
mers
cases
outbreaks
the
translation
scanning
plant
mrnas
ribosome
tre
cells
extract
induced
sh
dc
sign
the
article
crd
ace2
ang
ace
role
angiotensin
isolates
ser
mass
serotype
insertion
bovine
samples
cattle
kobuvirus
the
stilbene
material
review
compounds
belonging
piglets
infections
identified
etec
tgev
sabin
strains
recombination
rna
2c
sars
protein
plasmid
pet23a
pcr
coronavirus
novel
human
emc
respiratory
ascorbate
transport
uptake
the
activity
prrsv
no
nap
effect
virus
rt
porcine
virus
pedv
lamp
angiotensin
ace2
converting
enzyme
recent
pbvs
samples
compared
prevalence
breed
pedv
analysis
sm
sample
the
nan
ev
118
the
strain
genome
strains
isolated
salmonella
spp
coli
region
btcov
bat
coronaviruses
detected
bovine
viruses
virus
cell
line
carbohydrate
specific
roles
non
glycoproteins
bcov
wd
strains
in
gene
samples
detected
bec
k99
dairy
vaccinated
ili
influenza
healthcare
workers
yeast
environmental
ferrets
cryptococcosis
cryptococcus
pedv
peptide
peptides
protein
s1
sars
outbreak
transmission
severe
acute
drug
impact
aag
protein
binding
disease
kd
ivig
management
patients
antibodies
samples
virus
swiv
porcine
human
229e
hcvs
15
coronavirus
samples
bats
velifer
dna
2017
trim22
prrsv
virus
protein
replication
assay
duplex
nanopcr
pedv
tgev
virus
gastroenteritis
protein
the
may
the
ndv
detection
rpa
nalf
vaccines
ibv
viral
h120
ma5
hmbov1
hmbov2
bovs
himalayan
bov
2014
sows
january
2013
outbreak
pedv
dr13
attenuated
changes
the
dpol
gene
pcr
using
partial
the
chinju99
sequence
amino
gene
cattle
the
bastvs
group
bastv
respiratory
pediatric
recipients
viruses
solid
otitis
media
viruses
acute
studies
emodin
the
virus
antiviral
rsv
phev
pigs
samples
age
farms
protein
sars
cov
nc
proteins
efficiency
peis
cross
delivery
pei
dengue
denv
china
2014
guangdong
protein
the
domain
sars
cov
attenuated
chickens
viruses
pathogenic
virus
isolates
species
respiratory
pneumonic
camels
influenza
parainfluenza
picu
admissions
children
asian
air
dust
samples
one
virus
immunoglobulins
the
manufacturing
high
tgev
ts
sequence
strain
strains
ibv
protein
recombinant
using
elisa
nan
worry
pandemic
swine
flu
infection
pneumonia
etiology
study
community
research
sl
sars
cov
two
determinants
method
the
authors
describe
efficient
at1r
stroke
angiotensin
ischemic
ii
image
see
text
virus
candidate
genes
independent
viruses
h1n1
infection
knowledge
attitudes
influenza
vaccines
edible
vaccine
disease
causing
sars
covn
protein
cxcl16
the
class
h7n9
2013
three
2014
glycyrrhizin
hairy
root
lines
one
pneumonia
pneumococcal
disease
vaccines
serotypes
se
viral
vids
hosts
deficient
secretory
granins
tgn
aggregation
proteins
elution
virus
viruses
hav
enveloped
sars
pcr
genome
development
assays
flowers
flower
peduncles
aloe
virus
isolates
genes
f5
adhesins
one
pl
pro
cov
the
mers
proteins
done
based
vaccine
identify
nan
pertussis
infants
infection
bronchiolitis
clinical
nan
nan
hcov
hcovs
years
detected
oc43
rotavirus
calves
gut
microbiota
analysis
fgl2
crc
the
patients
metastasis
air
mengovirus
ahu
filter
buildings
response
infection
viral
cns
host
disease
cells
viral
pathogenesis
ms
cov
sl
sars
protein
immune
supplementary
material
image
see
text
vaccine
vlps
emerging
viruses
major
autoimmune
diseases
infections
healthy
disease
antibodies
specific
also
yolk
attractive
live
systems
antigens
attenuated
pathogenic
pseudoknot
mrna
ribosome
stability
complex
coronaviruses
entry
cells
pseudotyped
virus
coronaviruses
host
human
antiviral
respiratory
ibv
dpi
upregulated
ifn
kidney
em
viruses
fast
identification
allows
hajj
ili
pilgrims
respiratory
mers
cov
proteases
highly
diseases
the
nan
rv
virus
lenti
11
mice
polar
proteins
profile
virus
ebola
interactions
rna
surface
method
chip
encephalitis
inflammation
brain
in
infection
regulated
exocytic
pathway
understanding
constitutive
cimiside
cancer
µm
gastric
cells
nan
kcnk3
membrane
we
depolarization
vpu
marine
polysaccharides
various
therapeutic
the
sars
chinese
communities
risk
perceptions
cov
infection
severe
acute
respiratory
mds
visualization
information
proposed
the
bat
sequence
two
betacoronaviruses
study
nmr
assignments
protein
nsp3
sars
alkaloids
ml
hsv
extract
μg
image
see
text
keiskei
health
anti
human
treat
expression
sirna
rdrp
envelope
rna
the
balf
diagnostic
bal
patients
fcv
bgmf
bcs
log
10
detection
the
rapid
time
emerging
sumo
hkgf
fusion
protein
the
laboratories
emerging
infectious
disease
tests
probiotics
consumption
pre
tract
the
nucleolus
processing
functions
also
cell
cefs
h5n1
aiv
study
expression
cells
infection
cyclin
d1
jev
virus
cell
binding
attachment
the
me
highly
infectious
remains
survey
infection
cx43
mhv
glial
brain
immune
in
our
studies
disease
nan
bone
sawing
saw
particles
the
met
kinase
inhibitors
docking
active
hsp70
levels
fever
subjects
immunoglobulins
virus
mabs
antibodies
disease
potential
mrna
gene
expression
process
pre
sign
e2
hcv
raf
mek
antiviral
mnv
virus
h1n1
bacteria
virus
h5n1
avian
influenza
highly
throat
clinical
sore
pharyngitis
diagnose
species
bats
coronavirus
bat
coronaviruses
viral
disease
neurons
infections
nervous
viral
infection
jhm
mhv
anti
health
care
workers
wuhan
vs
prrsv
sirna
expressing
plasmids
p2
dss
rodentium
group
mice
ct
bronchiolitis
the
viral
respiratory
clinical
image
see
text
hev
47832c
encoded
met
hepatitis
based
risk
the
outbreak
research
epitope
protein
15e2
ibv
motif
painless
vaccines
vaccination
delivery
they
wu
virus
vp2
ari
positive
prediction
tools
epitopes
different
cell
portal
hypertension
microvascular
thrombosis
hsc
the
virus
gene
metapneumovirus
family
mers
cov
viral
orf1ab
gene
infectious
viral
vaccines
diseases
virus
chinese
sars
information
avian
flu
still
disease
respiratory
diseases
severe
rotavirus
antiviral
ifn
ruminis
infection
pd
environmental
may
factors
including
viruses
control
process
rna
pcr
znso
virus
mm
this
report
vlps
vlp
based
in
used
asthma
family
serine
proteases
cd26
activity
derivatives
antiviral
aromatic
diketoacid
children
gastroenteritis
electron
microscopy
viral
apod
apoe
promoter
e3
expression
ecklonia
therapeutic
health
the
genus
nan
nan
antimicrobial
antiviral
textile
fabrics
sodium
pseudotypes
ha
h5n1
influenza
vaccines
rna
proteins
chaperones
rnas
viruses
nan
effects
diseases
antimalarials
various
quinine
antibody
elisa
ac
samples
cpv
bioinformatics
hong
kong
new
government
prrsv
replicon
viral
infectious
particles
degree
hscr
genes
expansion
segments
sars
infection
control
the
virus
coli
o157
h7
china
the
apod
neurons
ka
tg
induced
ifn
biological
protein
interferon
critical
hrv
lower
respiratory
assay
upper
bovine
recovery
glass
wool
water
nan
human
sl
dr
chinese
covs
macro
mers
cov
domain
structural
siv
farms
positive
prdc
porcine
rpe
cell
immune
retinal
reactivity
prrsv
disease
prrs
porcine
pandemic
nan
sars
pro
cov
terminal
domain
sars
cov
cell
nucleocapsid
gene
antigen
ab1
id
antibodies
induced
hpiv
743
viruses
respiratory
found
cns
gjs
cx43
cx47
ms
p6
sars
cov
proteins
ifn
nan
the
disease
model
individuals
optimal
agents
substances
environment
health
obvious
children
clinical
infants
respiratory
hmpv
sars
the
outbreak
finns
study
bv
mlt
properties
antiviral
virus
prrsv
the
k418
chimeric
virus
amplification
pcr
isothermal
several
nucleic
qpcr
panel
rt
respiratory
detection
tlr4
may
disorders
lps
tlr
replication
rna
prrsv
viral
virus
mers
cov
reported
epidemic
genome
rnai
disease
technology
research
associated
entry
viral
binding
residues
ebola
rt
lamp
assay
detection
porcine
food
deaths
may
infectious
agents
bats
viral
bat
ifnβ
davidii
disease
factors
infectome
infectious
development
evolution
influenza
global
virus
the
rsv
detected
infections
pcr
100
peptides
the
antiviral
diseases
viral
spike
protein
localization
cytoplasmic
sars
asthma
include
management
children
treatment
the
expression
scfv
chain
variable
angiotensin
stroke
at1r
ischemic
ace
ts
wu
ts18
replication
mutant
csfv
golgi
proliferation
gbf1
rab2
pregnancy
immunity
responsible
alterations
animal
bronchitis
exacerbation
chronic
treated
antibiotics
adem
ms
infectious
following
virus
sars
cov
mucosal
vaccine
inactivated
respiratory
sars
the
cases
disease
pedv
lact
plantarum
cfs
antiviral
nan
responses
disease
demyelinating
inflammatory
virus
sgta
cell
steroid
protein
receptor
μg
ml
extract
jev
emodin
epitopes
pyogenes
vaccine
selected
streptococcus
angelica
tenuissima
nakai
antiviral
in
cap
rna
mechanisms
coronaviruses
the
viruses
respiratory
lettuce
10
recovered
supplementary
material
image
see
text
organ
donation
donors
death
donor
kd
the
criteria
immunoglobulin
recently
reporter
virus
viral
based
systems
hrv
assay
time
method
nasba
ifn
cells
cns
blood
brain
protein
we
coordinates
cartesian
spherical
rabies
virus
monoclonal
specific
antibodies
human
respiratory
pneumoniae
pathogens
infants
respiratory
neonates
neonatal
service
infections
hbov
arti
children
samples
respiratory
sars
health
transmission
the
disease
carv
allo
hct
first
respiratory
expression
transgene
plasmid
vectors
the
ivc
housing
rodents
racks
many
sars
cov
leader
sequence
sirna
amino
acid
aibv
sars
vaccines
rats
densities
the
high
weeks
hcov
infection
patients
hsct
respiratory
targeted
adenovirus
cd40
responses
administration
angiotensin
ii
h7n9
disease
patients
teaching
hospital
hong
kong
respiratory
detection
antibody
production
tests
traditionally
protein
approaches
mutations
amino
acid
male
ferrets
urethral
obstruction
used
cmv
vl
patients
bal
plasma
carbon
dioxide
cage
euthanasia
ferret
lamp
70
122
protein
responses
car
hl
pncms
cells
coxb3
nan
infections
emerging
spread
dental
patients
in
field
lab
scientists
across
the
method
system
mice
rodent
vaccines
veterinary
adenovirus
vectors
effective
nan
mice
rats
prevalent
virus
spp
epidemic
diseases
new
phenomenon
easy
epithelial
cells
apical
polarized
adenovirus
sars
infectious
infection
many
highly
caspase
cell
cleavage
substrates
death
nan
cypd
methods
inhibitors
compounds
mitochondrial
protein
sars
cov
the
n1
disease
autonomic
system
progression
ms
nan
dental
city
hong
kong
potentially
nan
bats
though
common
small
rodents
nan
rsv
luc
mice
respiratory
virus
genome
mechanisms
gene
new
genes
nan
human
cells
cancer
coronaviruses
feline
hr
ia
01
occurrence
allo
nan
plp2
coronaviruses
a59
ifn
cells
nan
sirna
rna
interference
disease
mrna
mers
cov
fusion
hr2p
cell
nan
droplet
dental
aerosol
the
transmission
models
swine
the
pig
biomedical
nan
nan
gene
clinical
transfer
trials
years
juglone
hpfabz
inhibition
hpcgs
coa
sirna
duplexes
expression
sequence
rna
cell
surface
internalization
also
processes
stress
mice
chronic
corticosterone
the
cfu
bioaerosols
bioaerosol
the
using
sars
the
cov
collected
igg
hiv
transmission
infection
gene
perinatal
effects
subset
cell
cd8
age
h5n1
ace2
lung
avian
influenza
monitoring
research
agents
rodent
health
cyclind1
the
proliferation
asmc
pcdna3
patients
hsct
the
syndrome
sds
resting
space
cages
unsoiled
days
protein
s2
sars
cov
spike
rnai
therapies
strategies
viral
must
adaptive
mutations
fitness
chikv
host
sars
cov
entry
cells
virus
ifn
infection
antiviral
genes
sars
baculovirus
cells
gene
insect
mammalian
rsv
ri
002
immunosuppressed
immunocompromised
nan
sars
cov
3cl
pro
activity
prevalence
mice
rats
mouse
virus
responses
compared
immune
hcv
mva
apical
airway
epithelia
amphotropic
gene
diarrhoea
patients
episodes
allogeneic
sct
her
adv
neu
breast
antibody
gene
expression
tet
the
hd
rsv
patients
pneumonia
influenza
respiratory
antiviral
viruses
virus
infections
development
aav
bat
capsid
aav2
genes
ang
axis
ace2
angiotensin
system
nan
nan
patients
pulmonary
one
complications
cell
viral
rna
rnai
gene
expression
rats
buprenorphine
weight
extended
release
vitamin
respiratory
tract
25
infections
nan
egr
gene
hsv
binding
intron
copd
acute
disease
exacerbations
chronic
bb
qpcr
dogs
culture
healthy
antiviral
viral
pognp
target
iv
contagion
patterns
susceptible
infection
formula
nan
data
china
human
to
health
integrin
patches
cell
cd151
use
the
cov
sars
human
coronavirus
diseases
infectious
membrane
in
cell
rc
proadm
hsct
ri
levels
metabolites
many
secondary
microbes
made
geldanamycin
virus
mouse
vagina
herpes
gene
therapy
africa
progress
important
bkv
excretion
fecal
10
40
adenoviral
vector
10
50
bont
pulmonary
complications
diagnostic
common
the
the
microbiota
nutritional
role
microbiome
disease
ceacam
meningococcal
haplotypes
associated
group
treatment
pulmonary
german
working
nan
nan
nan
post
ecmo
icu
ards
patients
has
world
populous
nation
learnt
ribosome
mrna
pseudoknot
frame
frameshifting
bioterrorism
emerging
diseases
spur
building
biodiversity
evidence
transmission
current
reduce
race
claim
patents
sars
virus
rjhm
compared
ra59
chemokine
levels
nan
nan
funds
must
forthcoming
effective
eu
nan
hcv
virus
the
infected
genotype
nan
could
programme
cuts
prompt
brain
infection
rats
demyelinating
lesions
cns
nan
nan
mhv
tunel
apoptosis
a59
staining
with
united
states
high
alert
the
health
animals
humans
environment
tnf
neurological
brain
functions
normal
individual
variation
population
infectiousness
superspreading
the
us
government
well
communicate
tmev
cells
disease
mice
infection
nan
the
reservoir
coronavirus
sars
animal
nan
infections
infectious
diseases
microorganisms
centuries
nos2
mhv
mice
nitric
oxide
angiotensin
acute
lung
ace2
ii
experts
pressure
china
samples
analysed
nan
hantavirus
hcps
hantaviruses
nervous
system
iκbα
mv
cells
neuronal
degradation
protein
microarrays
coming
age
development
nan
cells
sars
ace2
cov
transfected
instruments
studying
microbes
biological
containment
antibodies
ha
maturation
influenza
human
prone
infectious
disease
outbreaks
guangzhou
mig
cells
sjl
astrocytes
infected
coronavirus
sars
novel
recently
identified
flu
early
detection
rapid
response
mice
demyelination
virus
cns
in
bhv5
mir
155
viral
olfactory
nan
as
bodies
piled
united
states
demyelination
virus
infection
ts8
chronic
cns
demyelination
mhv
system
immune
the
discovery
many
new
species
influenza
1918
number
pandemic
reproductive
nan
klaus
stöhr
moves
who
industry
hhv
infection
6a
viral
cells
could
next
sars
like
virus
mhv
spike
neurovirulence
a59
the
china
there
bigger
acute
microbial
virus
demyelination
responses
cns
diseases
the
discovery
new
coronavirus
associated
from
earliest
beginnings
cities
brought
membrane
proteins
protein
in
cell
cns
mice
infiltration
recruitment
disease
drugs
could
lessen
death
toll
tgev
aminopeptidase
characterized
host
virus
the
time
come
china
start
analyses
contact
tracing
data
spread
human
increase
pathogen
number
novel
animals
diseases
origins
infecting
major
fusion
protein
structure
the
complex
despite
warning
shots
sars
last
egfp
gene
viruses
mouse
virus
the
end
near
eradication
simple
despite
gains
threat
bird
flu
hepatitis
mhv
demyelination
gene
a59
bcx4430
human
filovirus
disease
virus
influenza
h5n1
advanced
organ
support
the
2009
pandemic
arrived
suddenly
aki
patients
early
mortality
late
human
viral
virus
central
nervous
nan
nan
nan
nan
mystery
epidemic
pneumonia
serves
timely
global
agricultural
authorities
harmonize
public
the
world
celebrating
news
sars
myelin
mbp
demyelinating
disease
specific
reduce
attack
rates
pandemic
strategies
nan
models
smallpox
must
biological
disease
intestinal
ace2
amino
acid
malnutrition
demyelination
gene
hepatitis
mutations
the
cns
ccl2
expression
transgenic
disease
international
scientific
collaboration
best
defence
hcov
emc
human
dpp4
coronavirus
cleavage
cell
fusion
protein
to
nan
response
epidemics
crisis
integrated
this
cov
the
mers
cd26
receptor
mv
infection
oligodendrocytes
cell
human
cleavage
p65
p50
site
sequence
having
suffered
heavily
avian
influenza
nan
sars
disease
may
supplementary
severe
nan
sars
responses
cov
dna
antibody
it
less
four
months
since
nan
nan
brain
authors
transfer
splenocytes
mice
the
acute
adem
disseminated
encephalomyelitis
hcv
human
229e
aminopeptidase
oc43
orf
lr
bhv
mutant
infected
sars
caught
china
unawares
but
the
diverse
histories
china
cities
nan
the
disease
sars
world
novel
the
bold
ambitions
one
institute
both
bottom
up
top
down
from
moment
mysterious
illness
known
nan
global
health
remains
firmly
g8
it
time
assess
worked
global
nan
nan
ebola
virus
adv
gp
highly
nan
sars
cov
acute
lung
failure
sirna
sars
scv
therapeutic
the
hcov
the
human
coronavirus
virus
nan
nan
nan
infection
antibodies
neutralizing
10
protection
cellular
technology
molecular
genetic
diseases
neutrophils
infections
also
mechanisms
describe
immune
innate
adaptive
infection
the
the
importahce
preserving
biodiversity
extends
nan
virus
children
metapneumovirus
human
netherlands
nan
rsv
fusion
virus
syncytium
formation
host
pathogen
many
viruses
human
article
viruses
associated
pneumonia
version
disease
anderson
forced
scandal
leave
diseases
human
infectious
disease
emergence
nan
an
untested
herbal
product
south
viral
solutions
meeting
research
distinct
nan
vaccines
vaccine
new
the
two
meningococcal
adhesion
meningococci
endothelial
human
the
size
speed
potential
reach
if
battling
viral
illness
week
hiv
although
future
science
uncertain
ace2
two
studies
show
enzyme
advances
precision
respond
infectious
genome
health
inglesby
center
bioterrorism
public
ace
activity
gpi
peptidase
the
diseases
emerging
infectious
global
risk
the
international
response
ongoing
ebola
nan
scv
sars
type
damage
pneumocytes
the
fusion
first
structures
compounds
health
mers
cov
supplementary
as
nan
nan
nan
sars
coronavirus
virus
global
progress
infectious
diseases
pathogens
agents
technologies
nan
laboratories
health
public
massachusetts
massbiologics
us
increase
in
december
government
lipkin
identified
technology
viral
virus
nan
nan
nan
nan
virus
cells
specific
kidneys
persistence
elife
making
changes
policies
peer
acid
base
changes
model
dogs
cryo
em
development
structural
electron
the
first
finland
2020
days
sars
cov
coronavirus
paucisymptomatic
case
several
factors
taken
account
comes
lab
delivery
antigen
different
therapies
proteins
viral
security
host
defences
disease
outbreaks
human
modelling
large
recent
work
highlights
requirement
methylation
cns
virus
infection
mechanisms
host
contacts
health
quarantine
the
workers
liver
lsecs
within
immune
sinusoidal
host
pathogen
interactions
genetic
evolutionary
south
collaboration
the
developing
countries
diseases
region
the
new
conditions
viruses
membranes
intracellular
association
cytoplasmic
bioterrorism
scale
the
threat
potential
wildlife
sea
neoplasia
species
until
prizes
scientific
endeavour
inspire
researchers
genome
policy
policies
public
health
folded
structures
mrnas
stimulate
reprogramming
nan
virulence
virus
understanding
evolution
based
viral
infections
asthma
influence
development
srsf7
binding
protein
rna
nmd
research
japan
tradition
immunological
discoveries
dengue
fever
hemorrhagic
cd209
variant
vaccination
effective
individuals
would
disease
rnai
based
therapeutics
rna
specific
new
method
allows
rapid
identification
nsp8
coronavirus
structure
nsp7
supercomplex
nan
what
role
theragnostic
patents
upstream
dcm
clinical
diagnosis
ventricular
impaired
nan
nan
hcov
nl63
children
coronavirus
respiratory
supplementary
chinese
government
support
sea
pseudoknots
rna
viral
also
the
nan
rna
evolution
change
viruses
mechanisms
developing
countries
advances
technology
benefit
interferon
ifn
reigned
supreme
decades
group
pedv
virus
bayesian
isolates
bats
nlrp3
viral
inflammation
viruses
rsv
respiratory
virus
effective
vaccine
mouse
years
tinkering
immune
system
proteins
retroviruses
replication
synthesis
viral
nan
evolutionary
pathogens
analysis
many
organisms
skin
immune
environment
defence
in
an
in
depth
look
membrane
hiv
vaccine
induction
antibodies
field
virus
glomerulonephritis
related
nephropathy
associated
genetic
adaptation
host
surveillance
virus
diarrhea
fever
patients
infectious
cells
bats
viruses
species
viral
others
nan
past
ancient
genomics
study
genomes
the
first
proofreading
protein
identified
diagnostics
health
assured
since
rapid
research
the
genetics
use
one
clinical
laboratories
in
changes
new
pandemic
influenza
remains
single
greatest
signalling
clrs
immune
pathways
receptors
reaction
multiplexed
detection
code
encoding
this
report
describes
advances
understanding
cells
lung
stem
progenitor
tissue
development
hdt
factors
viral
infections
sars
sign
infection
cov
encoded
cns
cells
virus
responses
infection
angiotensin
system
renin
cardiovascular
receptor
ambitious
efforts
catalog
viruses
across
bacteria
viruses
autophagy
the
cellular
mrna
capping
cellular
eukaryotic
ends
new
carbohydrate
carbohydrates
drugs
class
mimicry
virus
viruses
apoptotic
entry
viral
proteins
viroporins
cell
several
isg15
host
response
viral
infection
health
care
knowledge
pandemic
global
respiratory
viruses
the
responses
regulated
research
the
china
supplementary
an
organ
donor
infections
transplantation
organs
antibodies
fish
infectious
diseases
recombinant
areas
scientific
data
new
therapeutic
hurdles
although
overwhelming
pressure
funding
phages
molecular
primary
role
questions
the
emergence
diseases
microorganism
host
cells
frcs
group
ilcs
lymphoid
level
addressing
infectious
diseases
empirical
oncolytic
viruses
tumour
agents
anti
hcov
infections
respiratory
in
human
oa
research
dogs
humans
spontaneous
nan
world
rabies
day
28
september
autophagy
process
this
viral
cells
agents
viral
progress
development
targets
proteases
cells
different
cell
development
lysosomal
disorders
diseases
roles
processes
angiotensin
the
cardiovascular
ace2
ras
data
deposition
preprints
many
journal
genome
sequence
virulence
aureus
with
funding
biodefense
spurring
new
vaccine
wgs
important
clinical
increasingly
in
virus
immune
ebola
responses
damage
sex
immune
responses
based
differences
nan
rna
host
protein
viruses
replication
nan
clinical
microbiology
supplementary
in
twenty
nan
lymphoid
nalt
tissues
induction
mucosal
vaccine
human
animal
ebola
virus
rnai
the
specific
potent
drug
adjuvant
design
innate
immune
new
antiviral
increased
infections
viruses
demand
virus
cns
cells
immune
the
nan
technical
advances
structural
biology
beginning
classes
viral
fusion
proteins
hairpin
as
line
dividing
human
wild
host
translation
viruses
cells
viral
immune
data
epitopes
self
epitope
microbes
gems
the
rdna
biosphere
structural
biology
mechanisms
murnau
making
influenza
np
antiviral
available
drugs
sars
coronavirus
severe
caused
mediated
monoclonal
antibodies
diseases
anti
infective
us
research
the
entered
new
nan
nan
sars
epidemic
the
114
day
delivery
antiviral
medicinal
viral
used
ms
disease
human
cns
systems
nan
nan
patents
genome
gene
patenting
familiar
om
hearing
ear
loss
otitis
transgenic
livestock
this
the
techniques
kd
disease
cause
agent
kawasaki
immune
adaptive
innate
the
responses
respiratory
pathogens
human
immune
response
viruses
rna
classes
seven
replication
pathogen
data
the
genotyping
disease
nanotechnology
range
the
new
immunomodulatory
human
response
natural
antibody
monoclonal
epitopes
vaccines
immunogenic
might
pathogenic
two
recent
studies
provide
new
disease
viral
this
mers
in
lists
microbial
microorganisms
list
research
new
rna
virus
study
dominant
building
the
anisotropic
block
applications
adp
proteins
marylation
ribosyl
function
novel
synthetic
biology
devices
diseases
antibody
mab
transgenic
milk
the
research
durc
studies
debate
benefits
nan
in
responding
future
influenza
pandemics
diseases
polymicrobial
humans
caused
organisms
antiviral
mabs
development
human
mab
nucleolus
cell
the
structure
rna
gilead
norbert
bischofberger
former
cso
virus
paramyxoviruses
cause
unique
henipavirus
with
growing
need
better
plentiful
infectious
new
diseases
world
used
arthritis
chronic
rats
different
associated
infections
range
travellers
acquiring
associated
bear
stearns
nr
this
report
the
new
cov
sars
supplementary
nan
nan
crowdsourcing
efforts
involved
escherichia
coli
vaccination
cross
reactive
antibodies
yf
dna
molecular
structures
diagnostic
engineering
mortality
adults
years
the
influenza
mechanisms
antimalarial
agents
long
used
host
rna
viruses
antiviral
responses
mmps
we
matrix
metalloproteinases
implicated
the
creation
global
health
security
rna
seq
clinical
based
promise
autophagy
suggested
on
basis
vitro
rnai
treatment
therapeutics
delivery
in
mers
cov
renal
smad7
human
rna
positive
strand
viruses
important
ibis
t5000
identification
pathogens
the
years
five
us
anthrax
attacks
mathematical
analysis
modelling
disease
epidemiology
geographic
mapping
pathogen
emergence
risk
diseases
infectious
sources
better
development
proteins
oas
cgas
linked
antiviral
ifn
ifns
clinical
potential
effectiveness
human
peptides
peptide
libraries
bioactive
measles
worldwide
control
elimination
remains
nan
respiratory
rna
rnai
clinical
preclinical
genome
this
month
watch
discusses
the
infectious
disease
new
anthrax
vectors
therapeutic
gene
therapy
target
viruses
cell
cells
host
receptors
viruses
host
range
many
pandemics
clinical
inhibitors
dub
ubiquitin
proteasome
rnai
rna
proteins
therapy
triggers
mers
cov
receptors
α2
attachment
epithelial
viruses
host
cell
receptors
nan
pathogens
survival
subvert
processes
host
inflammation
damage
oses
oxidative
the
pathways
receptors
prrs
infection
viruses
hiv
subtypes
the
subtype
virulence
autophagy
cell
modulation
related
cellular
respiratory
the
tract
human
communities
individual
genomes
genomic
variation
approaches
will
increasing
understanding
virus
host
health
the
surveillance
pathogen
public
nan
adp
ribosylation
enzymes
modification
adpr
peptide
mhc
cell
tcr
specific
viral
genomes
defective
virus
viruses
inflammatory
molecules
evolved
partly
protect
pathways
the
ubiquitin
like
protein
small
molecules
dominated
antivirals
decades
mice
implanted
human
lung
tissue
nan
virus
viruses
hosts
term
host
this
month
genome
watch
highlights
influenza
avian
pandemic
therapeutic
strategies
base
pseudoknot
two
interactions
ribosomal
covid
19
on
2020
health
cell
entry
viral
proteins
molecular
protease
enteroviruses
proteases
near
cell
respiratory
sars
severe
acute
syndrome
nestled
atmosphere
resembles
national
park
cars
imaging
cellular
microscopy
biomolecules
viruses
viral
also
therapeutic
several
an
amphipathic
peptide
engineered
capable
immune
zoonotic
human
species
in
lncrnas
transcription
processes
the
discovery
rnai
gene
silencing
specific
disease
dna
production
de
novo
large
vaccines
century
major
twenty
first
nan
non
invasive
respiratory
support
plays
nan
influenza
avian
iv
mask
human
gas
assay
siba
the
pyogenes
outbreaks
may
viruses
molecular
viral
nan
mathematical
models
infectious
diseases
designing
the
training
may
triathlon
injury
a59
mab
il
mhv
anti
diversity
sequences
microbial
samples
air
sars
cases
coronavirus
patients
infection
management
facilities
the
human
remains
bus
h1n1
trip
transmission
2009
infants
nec
term
full
the
mirnas
viral
therapeutic
diseases
new
infection
health
care
prevention
controls
sars
also
contact
the
infection
nan
biological
membrane
model
important
virus
greek
law
health
we
legislation
rnai
clinical
gene
use
associated
studies
workers
occupational
animal
exposures
nan
2019
ncov
coronavirus
transmission
in
nan
nan
infections
or
ci
oxygen
use
hcw
alert
two
sickness
absences
17a
il
cells
infection
rv1b
hcov
hbov
human
pcr
influenza
febridx
patients
test
viral
infections
risk
transmission
proteins
disease
plasma
asthma
pathogens
childhood
practitioner
therapy
viruses
enveloped
wastewater
two
mhv
sars
cov
sirnas
studies
treatment
2019
novel
coronavirus
pneumonia
activity
respiratory
patients
positive
viruses
employees
hmpv
children
the
hbov
infections
nan
patient
respiratory
failure
we
report
nasba
false
positives
sequence
poc
nan
health
uk
european
eu
relationship
nan
patients
hmpv
associated
lrti
hsct
in
model
animal
consideration
drug
f4
papn
fimbriae
f4r
etec
infectious
public
health
the
syndrome
influenza
2009
h1n1
pdm09
2010
nec
bacteria
infants
may
disease
rsv
picu
associated
mortality
respiratory
ace2
ang
chd
levels
circulating
cough
therapy
elderly
infections
viral
rsv
antibiotic
hmpv
infections
treatment
rnai
sirnas
target
hiv
cells
exposure
science
health
disease
human
environment
built
health
microorganisms
microbiology
tetraspanins
membrane
proteins
domains
tems
plant
molecular
pharming
recombinant
expression
ribavirin
women
pregnancy
months
exposure
sars
cov
44
patients
samples
influenza
illness
care
significant
pandemic
einer
der
wenn
er
bei
diosmectite
diarrhea
disease
ort
acute
infants
respiratory
viruses
transmission
nicu
infants
respiratory
vri
nicu
vs
health
public
trade
international
emergencies
outbreaks
infectious
diseases
social
they
infants
los
rvi
respiratory
viral
lung
immune
inflammatory
cases
strategies
man
ist
durchsucht
die
deutschsprachige
health
international
strategic
collaborations
way
viral
κb
pathways
nf
factor
outbreak
database
infection
may
as
countries
middle
east
mers
cov
epitope
antibody
antibodies
ability
based
nan
amiodarone
drug
since
extracardiac
side
nan
nan
nan
nan
infections
respiratory
rtis
common
sot
broad
spectrum
tilorone
antiviral
years
die
und
regelung
kbv
gkv
nan
hypopharyngeal
acute
pharyngitis
however
pneumoniae
patients
acute
sars
lung
showed
nan
cov
sars
2002
using
protein
cells
tumor
oncolytic
replication
quiescent
group
onfh
mpsl
corticosteroid
activity
mabs
viral
virus
infections
either
enteric
respiratory
also
effects
supplementary
ethical
outbreak
disease
issues
preparedness
pmns
malaria
severe
cases
neurological
nan
sirna
antiviral
delivery
viral
viruses
nan
sars
proteins
coronavirus
hypothetical
structural
fluoroquinolones
may
mpc
ratios
pneumoniae
infectious
evaluations
disease
interventions
economic
rotavirus
the
gastroenteritis
viral
human
ampligen
hemispherx
treatment
syndrome
in
nan
sars
early
diagnostic
assay
accurate
aso
potential
molecules
inhibit
gene
respiratory
rt
pcr
specimens
100
hpiv
patients
children
acute
leukemia
resistance
antibacterials
use
prescribing
antimicrobials
transplant
respiratory
viruses
population
recipients
mucosal
tissues
surface
mucins
the
sera
titer
the
hi
population
h5n1
human
anticipated
the
respondents
sars
avian
influenza
exposure
patients
ifnα
patients
treatment
ifn
preparations
port
crew
members
suspected
cases
health
digital
quality
curve
telehealth
conference
the
cancellations
may
researchers
health
public
surveillance
sources
ibss
attack
scenarios
future
homeland
response
und
die
zu
der
erreger
sfts
cells
cd3
cd4
lymphocytes
viral
balf
virus
tests
positive
h9n2
infected
viral
infection
mice
covid
19
hospital
nurses
as
fungal
immunocompromised
boydii
organism
known
neuromuscular
prolonged
may
disorders
patients
patients
40
oiv
chest
observed
lung
dc
signr
cancer
patients
viral
load
patients
ct
influenza
sp
levels
patients
h1n1
risk
nan
nan
osa
lv
patients
ob
diastolic
sars
ifns
caused
scv
the
coronavirus
infection
covid
19
efforts
coronavirus
highly
pathogenic
coronaviruses
respiratory
nan
mers
cov
factors
cases
transmission
downstream
virus
manufacturing
cell
culture
new
pneumonia
molecular
tests
diagnostics
display
iavs
filamentous
viruses
specific
the
filmarray
rp
respiratory
sensitivity
changes
extrapolation
recent
disease
history
pneumoniae
the
site
care
well
tests
molecular
major
assays
infectious
sars
rna
coronavirus
cov
specific
new
diagnostic
infections
assays
molecular
pneumonia
treatment
cause
children
number
assays
surveillance
respiratory
the
authors
cads
antivirals
antiviral
effects
represent
professor
clinical
covid
19
patients
nan
adjuvants
immune
pathogens
innate
vaccines
care
point
respiratory
of
viral
solid
organ
infection
sotrs
treatment
nan
hcp
management
exposed
infectious
healthcare
disease
severity
score
the
vivi
ri
002
ig
rsv
001
amplification
techniques
pcr
isothermal
diagnostic
respiratory
infections
viral
diagnosis
detection
covid
19
spike
glycoprotein
ligand
infections
viral
immunocompromised
patients
respiratory
ebola
disease
quickly
care
stop
rna
drug
delivery
new
based
asthma
exacerbations
acute
disease
morbidity
pneumonia
or
hospital
common
diagnosis
ccl5
chemokine
diseases
targeting
clinical
pneumonia
countries
pathogens
viral
children
children
clinical
families
14
result
derivatives
pyrazoline
activity
applications
pyrazolines
respiratory
vlp
vaccines
viruses
virus
protein
display
mrna
selection
used
mers
cov
clinical
respiratory
case
vlp
vaccines
clinical
vaccination
diversity
sars
cov
coronavirus
the
human
research
sars
researching
coronaviruses
forty
nan
nan
health
public
capacity
countries
covid
peer
review
jem
covid
19
nan
nan
19
march
2020
first
case
nan
sars
cov
inhibitors
well
could
the
detection
molecular
technologies
diseases
analytical
miniaturization
genetic
new
sized
vaccines
large
innovative
research
programs
research
the
bioterrorism
new
proteomic
sars
vaccines
vaccine
data
strategies
protein
microarrays
proteins
made
recent
viruses
vaccines
respiratory
preparation
available
pandemic
term
the
covid
19
prrsv
sappan
extract
prrs
extracts
bal
pneumoniacheck
tm
virus
patients
microbial
compounds
vocs
produced
voc
ibv
taiwan
gene
poultry
the
ibv
it
isolant
infectious
bronchitis
ibv
group
siamp
embryos
inoculated
pi
tcv
response
14
experiment
poultry
gastrointestinal
viruses
tract
infections
triterpenoid
saponins
triterpenoids
recent
genes
flocks
viruses
coronavirus
infected
diarrhea
pems
groups
group
growth
experiments
mbl
the
response
chickens
12
ihc
samples
ileum
pcr
tcov
proteins
subcellular
membrane
pips
aquaporins
if
group
wk
diet
pullets
ibv
pcr
types
flocks
disease
rbm
receptor
sars
amino
acids
turkeys
tastv
samples
viruses
virus
pq
pr
group
poults
turkey
cells
sst
cell
lines
turkey
quail
coronaviruses
ibv
pheasant
avian
ai
h9n2
ibv
infections
mixed
pes
poults
experiments
given
intestinal
gel
oocysts
vaccination
vaccine
post
castv
chicks
the
white
30
chickens
tea
saponins
oxidative
groups
cases
positive
viruses
tastv
turkey
ibv
attenuated
viruses
challenge
vaccines
vaccine
pcr
time
field
rt
genes
expression
gene
eucalyptus
analysis
embryos
ibv
gizzard
microscopic
lesions
cla
immunosuppression
peripheral
blood
lymphocytes
ibv
ampv
vaccination
clinical
poultry
nan
nan
hbov
infection
children
study
months
vasculitis
infection
relationship
may
infections
h9n2
h5n1
nd
h5n8
ai
cypa
mmp
cd147
monocytes
macrophages
influenza
avian
disease
diagnosed
characterized
gsls
se
ndv
ibv
antibody
cd
melatonin
accumulation
uptake
detoxification
fever
rvf
the
virus
rvfv
sars
5h10
cov
human
virus
clinical
associated
mortality
fever
first
nan
pneumonia
recurrent
children
patients
underlying
alignment
based
methods
free
accuracy
cells
cav
ife
ibdv
in
syndrome
varicella
myocarditis
12
year
nan
mixture
tcdd
dioxin
offspring
μg
aom
nasopharyngeal
microbiota
infants
families
ibv
isolates
pathogenicity
qx
like
sars
respiratory
disease
new
may
nan
virus
mice
hev
niv
henipavirus
associated
protection
schistosomiasis
mbl
significantly
pcbs
ndl
lps
j774a
immune
cryptococcal
meningitis
mbl
patients
or
organ
donor
risk
donors
infection
virus
hev
patients
hepatitis
ppr
fadv
organs
damage
chickens
vaccination
viruses
respiratory
illness
multiple
onset
viral
infection
children
cf
pulmonary
hbov
rsv
coinfection
infection
alone
virus
respiratory
specimens
we
influenza
theanine
diet
treatment
basal
jejunum
shapu
patients
vf
ocular
anelloviruses
viruses
human
influenza
avian
lung
vaccines
virus
niv
aav
hev
mers
cov
cells
viral
protein
epidemic
large
simulation
models
different
nan
mers
cov
cells
human
apoptosis
vaccines
vaccine
in
virus
chikv
nan
cov
mers
in
coronavirus
respiratory
viruses
disease
severity
associated
virus
hcov
positive
patients
nl63
samples
outbreaks
usually
often
filoviruses
ebola
cov
mers
sars
infected
mdms
2012
mers
cov
ifa
coronavirus
mers
cov
risk
factors
the
hajj
vaccination
mers
cov
pilgrims
human
mers
cov
antibody
infections
nan
nan
research
gof
highly
respiratory
syndrome
nan
cell
line
hcov
emc
human
nan
hrv
types
species
community
ari
nan
nan
nan
sfts
sftsv
patients
patient
japan
nan
nan
samples
mers
cov
specimens
tracheal
covs
sars
sl
rhinolophus
bats
influenza
severe
h1n1
expression
the
hmpv
children
rsv
rti
we
mers
treated
animals
clinical
mmf
hrv
genotypes
epidemiology
childcare
cocirculation
positive
respiratory
asymptomatic
among
samples
nan
infection
hrsv
virus
h1n1
pdm09
nan
influenza
ili
virus
respiratory
infections
ppmv
pigeons
both
respiratory
infected
alrti
cases
respiratory
ari
virus
fvdes
respiratory
viruses
infants
hrv
ifitm3
tlr3
influenza
ahr
95
pneumonia
hmpv
patients
clinical
features
nan
id
physicians
system
value
healthcare
children
respiratory
symptomatic
viperin
nasal
viruses
2009
vitro
virulence
2010
mers
hdpp4
cov
batcov
spike
bronchiolitis
recurrent
wheezing
infants
children
antibody
gp
ebola
rgp
tcb
h9n2
virus
aiv
house
experiment
hcov
rtis
associated
children
controls
rocv
macrophages
ccr2
increased
show
afe
or
adults
ari
older
cap
review
recent
current
community
mers
cov
neutralizing
activity
mabs
hmpv
children
lrti
1000
95
cla
la
diet
the
rats
nan
tcv
beetles
transmission
turkey
virus
ipd
pcv13
serotype
incidence
era
nan
virus
infections
mortality
infection
clinical
calves
diarrheic
lactate
acidosis
significantly
stewardship
pediatric
antimicrobial
programs
asps
bacteria
bacterial
dissemination
many
poultry
flies
ndv
exposed
house
virus
antiviral
tbk1
ikkε
signaling
mitochondrial
fr
rats
al
mrna
food
virus
aiv
flies
present
persistence
urt
lrt
recipients
respiratory
rv
seb
sdap
diet
diets
rats
nan
nan
mers
cov
the
proinflammatory
response
respiratory
detected
syncytial
virus
season
viral
cns
persistence
infections
experimental
hadv
95
ci
singapore
patients
age
rotavirus
children
nip
years
virus
children
influenza
respiratory
infection
rvi
hsct
respiratory
recipients
within
kd
group
incomplete
median
disease
rev
virus
trapped
farms
mosquitoes
global
health
efforts
epidemic
ebola
p2y
adp
13
virus
extracellular
viral
sepsis
cap
patients
138
rad5
s1
mers
cov
human
virus
newcastle
disease
endv
pools
nan
visitor
restrictions
respiratory
transmission
associated
common
children
malaria
increasing
led
illness
respiratory
hajj
pilgrims
preventive
pneumonia
travelers
returning
frequent
cause
nan
rates
synonymous
rna
viruses
variation
nan
communication
awareness
pandemic
mers
outbreaks
rvi
transplant
associated
pediatric
sot
surveillance
hajj
infectious
diseases
health
zoonoses
transmission
the
potential
household
surveillance
appropriate
based
public
health
sars
imported
cases
singapore
measures
mutations
single
deleterious
random
protein
nan
nan
binding
ha
in
molecular
index
transitions
conservative
transversions
amino
acid
health
media
public
reports
mass
selection
viral
viruses
species
host
sari
influenza
egypt
sentinel
patients
the
who
receive
reports
state
nan
prrsv
evolutionary
estimated
10
viruses
models
clock
model
data
method
hajj
mers
cov
pilgrims
aware
respiratory
human
tested
coli
campylobacter
rsv
hospitalizations
children
aged
associated
mers
cov
application
case
definition
biosecurity
systems
dual
use
bioterrorism
pjqpcr
npas
jirovecii
positive
dna
health
influenza
care
military
2009
nan
respiratory
mers
cov
we
evaluated
or
ic
95
infection
infants
nan
climate
health
change
migration
communicable
travel
travellers
3460
illnesses
we
lariciresinol
indigotica
iiplr1
roots
rna
infection
muscle
trimethoprim
sulfamethoxazole
dermatomyositis
treatment
respiratory
infections
common
symptoms
ia
qpcr
patients
bal
95
cats
pneumocystis
lungs
pcp
presence
health
public
declaration
international
pheic
animal
models
different
fungal
infections
unnatural
assessment
scoring
systems
epidemics
sequencing
mutations
minion
data
reads
nan
hku1
hcov
patients
samples
obtained
ward
influenza
bay
index
patient
sars
absolute
count
the
community
cap
cases
nr
rec
results
tests
the
respiratory
use
current
respiratory
influenza
pcr
viral
human
nan
case
transmission
physician
care
we
patients
respiratory
sars
tuberculosis
in
bocavirus
human
children
detected
acute
respiratory
bal
acute
lung
viral
dengue
sars
diagnosis
laboratory
features
time
pcr
real
nested
method
viral
bacterial
cap
children
infections
nan
virus
the
respiratory
sars
gown
influenza
statins
pandemic
agents
studies
we
report
findings
high
resolution
management
care
guidelines
infants
children
sentinel
diseases
clinicians
diagnostic
public
respiratory
virus
sct
viral
culture
methods
patients
pcr
pneumoniae
etiology
acute
otitis
media
bacterial
infection
pneumonia
influenza
virus
viruses
respiratory
neutrophils
h5n1
avian
influenza
viral
nan
nan
nan
nan
nan
2009
tiv
ili
ph1n1
school
nan
health
care
support
workers
sars
wards
sars
factors
or
95
nan
health
care
resource
this
disease
hbov
respiratory
the
infection
results
case
respiratory
sars
we
report
activity
ace2
ckd3
circulating
cv
sars
patients
psychosis
we
acute
specimens
np
throat
saliva
swab
sars
the
coronavirus
first
cases
carbohydrate
surfaces
body
pathogens
immune
chikungunya
virus
epidemic
fever
parts
pathogens
diagnostic
tests
detection
respiratory
ward
the
sars
spread
outbreak
sars
area
clean
contaminated
air
nan
pneumonia
coronaviruses
229e
respiratory
severe
viruses
bats
emergence
the
several
respiratory
pathogens
specimens
detected
hospitalized
nan
no
therapy
sars
inhaled
effect
nan
nan
nan
adults
virus
pneumonia
viruses
the
pcr
time
real
105
methods
new
lack
assays
infectious
diseases
sars
samples
swab
hospital
surfaces
viral
load
peak
sars
progression
respiratory
infection
hcovs
identified
bronchoalveolar
adults
antibacterials
fluoroquinolones
episodes
rhinosinusitis
nan
nan
patients
influenza
diagnostic
tests
treatment
nan
pathogens
molecular
detection
respiratory
rapid
nan
ards
patients
disease
mild
group
influenza
test
rapid
antigen
we
fda
clearance
new
respiratory
diagnostic
nan
lassa
fever
ribavirin
postexposure
guidelines
hmpv
respiratory
human
metapneumovirus
tract
sars
hcws
associated
cov
health
nan
pathogens
environmental
nosocomial
contaminated
evidence
prognosis
sars
model
degree
hypoxemia
exacerbations
molecular
detection
viral
additional
abroad
care
medical
infections
may
rsv
cap
adults
infection
cases
mbl
studies
patients
associations
deficiency
ap
hr
may
edema
pe
hcov
nl63
children
oc43
coronavirus
mphi
patients
ctr
hs
hsp72
the
virus
vaccination
smallpox
pre
nan
diagnostic
pcr
patients
real
time
de
la
el
los
influenza
influenza
avian
health
care
infection
hbov
virus
children
patients
protein
influenza
respiratory
negative
vaccination
virus
sars
cov
patients
associated
nasopharyngeal
patients
case
control
asymptomatic
persons
viral
viruses
transplant
virus
emerging
residents
respiratory
illness
rhinovirus
during
nan
nan
hbov
control
case
children
gastroenteritis
viruses
hcov
patients
nl63
hbov
bacteria
aom
found
viruses
cases
ards
pneumonia
respiratory
the
seems
sars
brain
coronavirus
tissue
human
diarrhea
sars
10
the
coronavirus
nan
laboratory
infections
acquired
infection
risk
echinacea
placebo
recipients
evaluate
infection
microarray
hpiv
viral
clinical
pan
nan
nan
pneumonia
years
community
acquired
cases
case
sars
asymptomatic
2004
outbreak
patients
crag
hiv
cm
infected
disease
infectious
value
practitioner
healthcare
nan
mers
patients
cov
environmental
virus
rsv
illness
years
respiratory
patients
ace2
ace
monocytes
hd
angii
ksa
pilgrims
positive
respiratory
departing
guideline
the
recommendations
penicillin
intended
infectious
diseases
health
care
process
nan
mers
control
emerging
transmission
cov
vs
isolation
pre
transmission
super
infectious
diseases
number
medical
positions
mers
cov
air
samples
viral
nan
nan
mers
case
asymptomatic
during
outbreak
viral
respiratory
antibodies
lrt
neutralizing
diagnoses
ebola
patients
febrile
illnesses
nan
patients
vs
or
case
mers
nan
nan
influenza
hcws
respiratory
symptoms
positive
nan
nan
nan
nan
the
sars
outbreak
spread
temporal
oral
aerosolized
rbv
day
rsv
influenza
rvi
vaccination
lower
recipients
smokers
copd
patients
expression
dpp4
infants
rvis
respiratory
preterm
years
mngs
method
pathogen
infectious
need
tests
respiratory
viruses
studies
rapid
infections
tests
laboratory
document
system
hhv
positive
encephalitis
review
15
pneumonia
countries
children
pneumoniae
developing
95
ci
meta
respirators
analysis
rsv
associated
deaths
children
patients
contagion
building
hospitals
well
the
healthcare
the
transmission
hai
total
pneumonia
cases
caused
proportion
pneumococcus
nan
nan
clinical
ebola
disease
outbreaks
trials
protein
sars
epitopes
the
cov
presatovir
rsv
patients
placebo
lymphopenia
nan
sars
pcr
cov
rt
samples
prescribing
antibiotic
viral
patients
testing
influenza
particles
detected
air
virus
respiratory
bacterial
detected
limited
infections
10
ip
week
chemokines
outcome
nan
ce
microchip
clinical
analysis
rapid
pertussis
aged
years
severe
infants
rsv
flu
periods
advanced
outbreak
nan
nan
hmpv
clinical
associated
subtype
genotype
sars
cov
protein
synthetic
peptides
nan
sars
serum
plasma
the
samples
nan
nan
sars
proteomic
patients
identified
serum
antibiotic
respiratory
antibiotics
patients
bpa
mp
infection
auc
symptoms
cap
nan
nan
nan
nan
wnv
laboratories
samples
lineage
containing
sinusitis
uris
uri
children
uncomplicated
swine
influenza
participants
virus
exposed
id
physicians
public
health
role
patients
sars
saa
increased
sera
cells
responses
mers
cell
patients
pev
children
community
based
infections
sars
peptides
coronavirus
the
synthesized
nan
nan
presatovir
rsv
placebo
respiratory
patients
sars
protein
we
antigenic
identified
studies
virus
diagnostic
accuracy
impact
protein
microarrays
dna
disease
use
ms
analysis
based
identification
methods
recipients
transplant
kidney
metagenomic
donor
targets
champs
testing
covering
laboratory
rifn
rbv
mers
patients
90
transmission
mers
cov
household
case
hpv
types
hpvs
specific
papillomaviruses
respiratory
diagnostic
sensitivity
poct
viruses
patients
symptoms
infective
pcr
identified
respiratory
children
tract
clinical
presentation
sars
acute
samples
fever
early
nan
rpa
molecular
the
isothermal
method
influenza
ami
chronic
ihd
deaths
viral
proteins
infections
mx
mxa
clinical
chemistry
laboratory
the
discipline
ms
maldi
pcr
esi
tof
detection
multiple
microarray
virus
pcr
dpp4
actions
exert
inhibitors
mechanisms
nan
children
virus
alone
coinfections
cap
symptoms
differences
patients
respiratory
virus
incubation
period
heterogeneity
studies
distribution
cepi
vaccine
development
epidemic
preparedness
mers
cov
health
asymptomatic
care
calcium
pmca2
mammary
car
epithelial
ace2
shedding
calmodulin
ectodomain
enzyme
respiratory
viruses
females
experienced
viral
nan
ha
proteases
influenza
cleavage
virus
fetal
placenta
viruses
trophoblasts
viral
particles
nanotrap
capture
infectious
low
nan
nan
host
viral
proteins
protein
interactions
serum
antigens
pneumoniae
rp1
patients
cmpa
the
intracellular
protein
domain
cattle
transmission
heterogeneities
coli
super
risk
infection
emerging
zoonotic
occupational
secretion
protein
the
expression
casei
amiodarone
virus
ebola
infection
drug
mice
may
embryos
used
research
sars
patients
recovered
infectivity
asymptomatic
multiple
nf
κb
cascade
viruses
nan
nan
high
throughput
bead
beads
the
antimicrobial
metaphylaxis
brd
prophylaxis
morbidity
cam
the
rat
glycans
type
animal
the
high
containment
emergence
dystrophin
expression
aos
protein
muscle
nan
testing
disease
poc
tests
quality
nan
nan
inflammatory
infection
response
responses
pro
biologics
animal
studies
involve
cells
rna
viruses
involved
zoonotic
disease
human
hma
models
microbiota
model
zoonoses
emerging
animal
health
animals
pmo
muscle
fibers
dy
3k
infections
virus
rodents
facilities
resistance
frataxin
glial
lipid
frda
cells
clpp
mitochondrial
the
in
clpx
influenza
virus
herbs
janus
functions
gm2
brefeldin
golgi
synthase
membrane
diseases
human
infectious
macaques
virus
uc
virus
samples
viral
onset
microbial
infections
gem
new
host
health
infectious
regulations
quarantine
nonhuman
cells
cd8
cns
high
dengue
migrants
migration
animals
migrate
successfully
nag
patients
antibodies
directed
endothelial
mbl
crd
mmbl
flexneri
2a
ve
cadherin
endothelial
cells
human
mites
rodent
laboratory
mesostigmatid
colonies
virus
protein
angiotensin
converting
enzyme
nan
cells
reg
cell
follicular
immune
ccl2
hiv
viremic
genes
chemokine
nan
research
nonhuman
primate
current
vaccine
sars
cov
virion
inactivated
vaccine
sars
measures
control
government
singaporeans
specific
self
heterologous
epitope
autoimmune
protein
sialic
casd1
acids
involved
epidemic
respondents
among
hand
washing
nan
health
literacy
among
patients
information
parkin
usp15
pd
mitochondria
mitochondrial
reproductive
species
laboratory
research
studies
glycosylation
viral
enveloped
proteins
viruses
ferret
ferrets
research
animals
the
covs
cattle
disease
different
species
health
care
level
pandemic
public
masks
mask
homemade
volunteers
surgical
nan
model
system
dynamics
respiratory
syndrome
cases
hcp
transmission
healthcare
case
nan
covid
19
forecasting
confirmed
cases
number
cases
confirmed
february
based
isolation
quarantine
individuals
infected
use
animal
health
transport
land
bioaerosol
hcv
replicons
lcta
949
derivatives
practice
in
best
infection
control
sars
ribavirin
ifn
effect
treatment
sars
95
hla
0703
or
43
strain
oc
coronavirus
children
animal
agricultural
produced
technologies
efficiency
adsorption
acid
mips
extraction
glycyrrhizic
influenza
h5n1
apoptosis
trail
97
secondary
codon
rna
position
protein
ccr5
cells
cruzi
infected
mice
fatality
changes
who
estimator
disease
nan
2009
virus
matched
vaccine
animals
cf
infection
infections
chronic
the
brd
morbidity
performance
diets
cattle
sars
nf
κb
cov
protein
hrv
hsct
recipients
bal
samples
hcov
oc43
respiratory
patients
virus
jev
cells
p10882
antiviral
infection
amplification
methods
isothermal
malaria
molecular
95
leishmania
samples
ci
the
ifitm1
endometrial
cd10
adenocarcinoma
areas
viral
asthma
rtis
diversity
viruses
nan
antiviral
ndv
chifn
significant
ifns
signaling
prrs
mediated
κb
triggered
pedv
pork
united
states
impacts
rv
asthma
patients
exacerbations
adults
substrings
viruses
viral
host
proteins
hmpv
hrsv
bronchiolitis
dual
infection
f4
f4r
pigs
etec
anpep
mab
201
sars
viral
associated
species
mycobacterium
dnaa
sequences
gene
adenovirus
recruits
new
ad
the
protein
proteins
enteral
duodenal
delivery
ata
100
µmol
the
mice
responses
patients
lyme
disease
igm
mers
the
cov
cases
management
nan
nan
hiv
virus
infants
respiratory
hmpv
the
influenza
pathologic
findings
alveolar
human
coronavirus
hcov
novel
population
demyelination
lesion
cells
inflammation
myelin
nan
methods
sequencing
diagnostic
based
nowadays
rna
mh
poly
mouse
purified
gene
therapy
clinical
despite
first
children
1000
95
ci
hospitalizations
nan
hospital
disinfection
surfaces
several
strategies
sars
research
needs
respiratory
2003
hbov
specific
vp2
vlps
cells
nucleic
acids
endosomal
tlrs
molecules
ifn
allele
sars
coronavirus
mxa
229e
sero
infections
the
coronavirus
human
ebov
virus
host
interactions
ccr2
heart
cruzi
cc
chemokine
laboratory
systems
health
aids
diseases
fibrin
colds
subjects
rhinovirus
control
dimer
residues
protease
3cl
pro
sars
cross
hcov
reactivity
hcovs
structures
rna
the
processes
life
nan
ovarian
cell
hh
expression
molecules
sars
patients
phage
peptide
serum
epidemic
case
fatality
ratio
two
pap
ruminal
mt
exp
fn
sars
hcws
patients
exposed
infection
sars
viruses
syndrome
disease
study
nan
cov
respiratory
sars
the
infections
sars
testes
known
damage
reproductive
sars
cov
the
protein
antigen
vs
kg
cows
weaning
subirrigated
groups
cheetahs
patterns
genetic
regions
embryos
mhv
embryo
transfer
exposed
health
nutrients
deficiencies
optimal
mineral
units
fri
closed
rates
population
proteolytic
sites
proteins
the
results
epidemiology
disease
infectious
increasing
intellectual
ceacam1
expression
serum
cancer
the
ppmo
denv
ag129
infection
mice
thrips
species
identification
rapid
onion
protein
sars
hfgl2
cov
transcription
sars
cov
associated
risk
transmission
nan
epi
investigations
aids
health
epidemic
hbov
patients
infection
pneumonia
detected
pathogens
respiratory
received
viruses
pcr
fxr1p
the
fragile
btf
using
ceacam10
seminal
vesicle
mice
sperm
infection
coronavirus
children
229e
oc38
cell
protein
extract
synthesis
activity
incubation
period
sars
days
would
reovirus
children
age
infections
common
sars
l386del
variant
cov
clinical
outbreaks
gastroenteritis
in
srsv
infection
molecular
techniques
enabled
major
advances
rsv
virus
influenza
lrti
infants
rna
alignments
mutations
script
color
coronavirus
patients
rhinovirus
coronaviruses
respiratory
nan
substrate
assay
could
peptide
based
interaction
receptor
virus
viral
receptors
pheromone
lure
lesser
mealworm
laboratory
infections
pulmonary
virus
viral
declines
copies
ml
ebolavirus
detection
assay
hla
sebov
fatal
outcomes
disease
scores
natural
colds
day
total
surgical
smrs
n100
two
sms
sera
coronavirus
hcv
oc43
patients
glu54
like
protease
activity
proteolytic
angiotensin
ras
ang
treatment
lp
patients
influenza
cancer
vaccination
treatment
pestis
plague
antigen
responses
ad
nan
pcr
respiratory
viruses
patients
samples
avidity
days
infection
mean
sd
atp
er
transport
ants
the
antibody
respiratory
229e
seasons
infection
respiratory
viral
the
hrv
infections
hcov
infections
patients
pneumonia
year
alignment
sequences
memory
constrained
sequence
nan
network
tools
human
biology
molecular
respiratory
rhinovirus
infections
illnesses
aged
hcv
cells
vγ9vδ2
immune
replication
plasma
intestinal
seb
galt
proteins
sequences
sequencing
short
novel
dna
rabbit
coronavirus
dilated
cardiomyopathy
infection
month
patients
titers
igg
antibodies
hcov
nh
swabs
nl63
kd
ribavirin
ev71
drug
infected
virus
hmpv
respiratory
tested
specimens
period
analysis
it
information
sequence
based
hmpv
respiratory
identified
human
the
influenza
virus
infections
first
clinical
cell
peripheral
subsets
patients
sars
risk
contact
transmission
fingerprint
the
ili
surveillance
ari
text
respiratory
viral
systems
myocarditis
host
primary
chikv
infection
immunoglobulins
recently
disease
nan
calves
treated
mel
calf
diarrhea
mbl2
polymorphisms
rti
children
year
pigs
infected
pig
batch
feed
respiratory
identified
novel
genotype
viruses
sars
cov
phylogenetic
coronavirus
protein
hz
50
exposure
magnetic
fields
virus
induced
oxidative
stress
cells
sses
occurrence
symptomatic
hong
kong
hcv
derivatives
rdrp
inhibitors
mop
parv4
study
subjects
hiv
b19
1966
1969
collected
titer
1968
sars
viral
patients
cov
10
sars
infection
atypical
pneumonia
pulmonary
pigs
lines
lrfi
endotoxin
hrfi
sdpp
uv
sdbp
pigs
phase
adhesins
spaan
the
experimental
availability
tgf
signaling
smad7
smad
cell
nan
health
genomic
public
developing
technologies
nan
fragilis
diarrhea
strains
samples
isolated
nan
sequencing
viral
analysis
quasispecies
guide
pa
w1
w2
scfvs
anthrax
immune
delivery
systems
the
goal
pap
steers
sb
fed
ruminal
mice
mhv
approach
receptor
antibody
nan
virus
the
rats
mice
coronavirus
respiratory
use
throat
infection
upper
pdcs
ifn
production
vivo
cytokines
pigs
prrsv
act
infected
il
proteins
hla
class
cell
models
h5n1
patients
ards
days
clinical
nan
infectivity
assay
pcr
inhibition
log
olfactory
viral
epithelium
bulb
mhv
pc
am
pi
treatment
kg
diseases
infectious
pathogens
this
analysis
transmission
cross
species
viruses
traits
pyridine
oxide
cov
derivatives
activity
viruses
bioinformatics
the
supplementary
evolution
sars
cov
hab18g
cd147
cells
genes
essential
information
human
predicted
virus
influenza
the
pandemic
two
sao
ss2
protein
suis
proteins
diaperinus
resistance
lc
µg
cm
cba
virus
binding
coronaviruses
cell
sars
patients
response
elisa
the
disease
health
investigations
cdc
global
respiratory
viruses
important
asthma
infection
brd
genetic
igg
respiratory
immune
department
epidemiology
chairs
1919
johns
kd
acute
bronchial
epithelium
ciliated
rsv
receptor
infection
fosfomycin
paf
nsp5
protein
the
proteins
sars
respiratory
virus
infection
hct
tract
hav
participants
hepatitis
seropositive
dsst
sars
cov
mab
mabs
mice
ii
ang
feb
induced
xo
cd8
lymphocytes
brain
blood
barrier
nan
egfp
reuteri
promoter
ptrkh3
promoters
nk
sars
cells
cd158b
pneumoniae
nan
sars
plasma
convalescent
cov
hcw
virus
h1n1
new
influenza
the
b2m
mice
deficient
breeding
the
sars
in
coding
genes
polyprotein
infection
marv
macaques
ang
rnapc2
nan
nan
assays
influenza
detection
antigen
rapid
ferrets
vaccine
sars
virus
enhanced
in
new
influenza
negative
virus
the
systems
biology
disease
pharmacogenomics
patients
lymphocyte
levels
reduced
sars
hg
csf
stress
proteins
coli
protein
scov
antigen
sars
reactivity
ebov
dc
sign
cell
lines
ph
low
buffers
reduced
human
epitope
the
pepitope
tool
peptides
measles
elimination
transmissibility
methods
95
importin
proteins
nuclear
kpna2
aptamers
birds
influenza
avian
virus
the
sars
transmission
probability
onset
symptom
symptom
placebo
recipients
intranasal
rifn
yeast
errors
also
new
studies
ata
ev71
viral
activity
replication
hours
ed
filmarray
respiratory
viral
hku1
cov
pneumonia
patients
community
lung
associated
lc
brd
cattle
cns
viral
infections
strategies
neurons
viral
system
central
nervous
infection
alexandrium
species
lamp
detection
the
enzyme
domain
the
chymotrypsin
like
nucleic
viral
isolation
acids
magazorb
hpv
ifn
gene
irf
mucosal
influenza
virus
cells
the
pandemic
signaling
viral
viruses
innate
type
sars
cov
patients
antibody
infection
epidemic
sars
the
regions
outbreaks
sirnas
zebov
ebov
guinea
pigs
rti
hcovs
hcov
patients
severe
cows
wr
greater
ps
ns
mice
inoculated
air
animals
olfactory
nan
expression
gene
stable
hkgs
tissues
nan
hcov
illnesses
ldi
respiratory
associated
nan
ercc1
expression
mrna
genetic
variants
pneumoniae
infections
viral
chronic
bronchitis
influenza
virus
infections
mabs
treatment
eosinophil
children
exacerbations
levels
chemokines
prevention
diagnosis
treatment
hap
issues
protein
sars
recombinant
the
cov
sars
95
ci
2003
health
autophagy
cellular
pathogens
positive
stranded
generation
antihistamines
colds
second
first
localization
golgi
in
particular
transmembrane
alphaviruses
globally
capable
urban
human
influenza
virus
h5n1
avian
mdms
protein
scfv
sars
cov
a17
27
nm
virus
particle
like
viral
rna
clearance
concentration
symptom
cell
entry
amiodarone
filoviruses
virus
95
influenza
odds
ratio
ci
antibiotic
resistance
prescribing
reflections
developments
predictions
methods
systems
mhc
the
h5n1
virus
influenza
vaccine
cross
sars
cov
cell
vγ9vδ2
cells
nan
lower
respiratory
tract
disease
children
calves
dams
con
heifers
lo
nan
fiscal
value
years
covid
19
respiratory
influenza
laboratory
surveillance
febrile
cag7
ct383
protein
lactis
pylori
bcg
inoculated
coronary
arteritis
development
nadc
in
renal
wistar
rats
the
ns3
jev
helicase
ntpase
mhv
cells
kupffer
mice
induced
chromosome
death
mice
risk
locus
ifns
virus
nasal
antiviral
increases
diving
sars
in
complications
period
use
mice
choice
dangers
this
sars
cov
3cl
pro
the
no
dengue
oxide
peroxynitrite
pathogenesis
amplification
using
marneffei
specific
the
mabs
antibodies
protective
antigen
pa
ifn
cvb3
bw001
induces
anti
enteropathogens
early
piglets
artificially
diarrhea
amps
exercise
experimental
role
susceptibility
ureb
mice
response
pylori
orally
mosquitoes
dengue
field
aegypti
virus
vascular
endothelium
dengue
dhf
dss
line
facs
disease
infection
study
increased
cp
dietary
linearly
vfc
pneumoniae
asthma
positive
pcr
infection
transgenic
animals
antibacterial
proteins
lysostaphin
gfp
pnies
stlt
reuteri
mice
hepatic
acute
injury
chronic
review
sars
korea
usfk
respiratory
infectious
dv
dengue
dhf
dss
infants
the
response
epitope
major
filamentous
sars
cells
cov
akt
vero
hev
antibody
43
coronavirus
titer
social
capital
sleep
quality
anxiety
responses
polymorphisms
poor
adverse
relationship
npas
hbov
fecal
samples
study
gastroenteritis
hbov
study
detected
the
if
mf
05
wk
controls
sftsv
protection
dna
gn
gc
cases
per
cent
viral
two
virus
h7n9
ali
lung
treatment
travelers
brazil
specific
ill
returned
epidemic
synchronization
networks
theoretical
study
epidemic
responsive
immunization
vaccination
value
health
diseases
infectious
countries
global
niv
patients
respiratory
epidemic
use
evacuation
icu
care
evacuating
the
ari
we
aris
rochester
marshfield
mers
cov
patients
influenza
singapore
baboons
ksa
merscov
hamadryas
human
viral
co
infection
respiratory
infections
nan
cases
mers
cov
literature
increases
mers
patients
mortality
day
study
cases
mers
cov
series
reported
parvum
calf
calves
faecal
spp
patients
human
nasal
group
respiratory
nan
quarantine
preparedness
exercises
critical
in
cases
mers
cov
healthcare
patients
nan
pacific
covid
19
2020
health
medicine
disaster
articles
public
health
nan
nan
covid
19
2019
work
experience
herds
practices
management
case
herd
vics
australian
genes
del
protein
ibv
avian
commercial
poultry
may
er
virus
stress
replication
signaling
lectins
biomedical
algal
glycoproteins
non
viral
rss
viruses
identified
chicken
cell
host
vaccine
production
viruses
sars
peptide
membrane
membranes
cov
strains
recombination
ibv
spread
recombinant
finland
ibv
production
clinical
2011
viruses
human
methods
animal
origin
hmpv
rsv
risk
factors
severe
research
mice
immune
immunodeficient
genetic
se
cows
hay
alfalfa
calves
diseases
infectious
per
100
000
filovirus
cell
attachment
factors
potential
ifn
used
infections
ifns
recombinant
currently
influenza
virus
vectors
used
vaccine
diseases
animal
technologies
infectious
nan
ltx
carv
15
lung
patients
antibiotic
therapy
infections
acute
common
resistance
icu
infection
resistant
bacteria
cf
infections
mortality
clinical
airway
nan
adem
syndrome
disorders
interpretation
clinical
cns
infection
diagnostic
patients
many
pedv
plant
2c10
diarrhea
mab
asthma
virus
infection
remains
respiratory
patients
viral
infections
influenza
admitted
covid
19
health
information
the
nan
systems
microarrays
protein
biology
holds
epidemic
inhomogeneity
spreading
speed
in
cases
transmission
malaria
elimination
estimate
quarantine
formula
see
text
malaria
nan
cov
sars
infection
fusion
coronavirus
cases
250
95
cri
sustained
hcw
positive
respiratory
tested
hospitals
nan
covid
19
sampling
in
response
95
ci
cfr
estimated
ifr
atp
early
cpe
based
indicator
bovine
samples
calves
weeks
rva
colorimetric
molecules
detection
aunps
mers
pedv
protein
region
s1
antibodies
nan
nan
nan
influenza
the
national
surveillance
poland
nucleic
therapeutics
based
antiviral
antisense
influenza
the
level
antibodies
hemagglutinin
al
et
mers
cov
the
respiratory
infections
tract
visits
children
peptides
hplc
chromatography
value
proteins
rsv
piv
virus
influenza
coinfections
human
cell
monoclonal
cells
bcr
coronavirus
host
replication
coronaviruses
respiratory
samples
influenza
years
viruses
old
method
gel
filtration
chromatography
popular
metal
shadowing
biological
specimens
specimen
emergence
health
global
spread
epidemics
ibv
proteins
virus
3a
3b
system
mammalian
two
hybrid
protein
silver
in
ancient
times
water
cells
cell
fusion
epigenetic
reprogramming
sars
cov
first
animal
studies
ub
enzymes
ubiquitination
posttranslational
modification
type
respiratory
infection
disease
viral
arthropod
arboviruses
vertebrate
hosts
studies
restriction
site
clone
dna
type
influenza
2015
h3n2
virus
viruses
influenza
2017
season
2018
virus
disease
cc
host
genetic
susceptibility
wnv
development
effective
vaccine
therapeutic
ras
angiotensin
renin
rass
ace
s1p
receptors
the
chemical
genetic
infections
the
respiratory
rtis
travelers
viruses
receptor
sialic
acid
cell
sialic
acids
acetylated
regulation
apoptosis
virus
sequence
clone
coli
transcription
patients
infections
pneumoniae
atypical
immunocompromised
antibodies
antibody
reagents
methods
affinity
viral
emergence
evolutionary
species
whether
sars
rt
pcr
cov
detection
dub
dubs
activity
enzymes
cells
rnai
viruses
virus
antiviral
rna
structural
cells
virus
virions
viruses
virus
viral
replication
host
specific
coronaviruses
human
respiratory
novel
coronavirus
diseases
region
regional
health
zoonotic
immune
autophagy
innate
system
immunity
coronaviruses
coronavirus
expression
genes
increased
the
used
filmarray
panel
respiratory
virus
recombinant
rna
coronavirus
step
sirnas
sirna
respiratory
virus
rsv
highly
response
activities
used
infectious
y2h
system
screening
the
protein
somni
disease
cattle
bison
the
infectious
diseases
phage
immunisation
diagnostic
mirnas
cellular
expression
viral
gene
genome
coronavirus
strain
replication
virus
gof
biosafety
debate
arguments
type
image
see
text
parasite
disease
discovery
drug
clinical
plant
gfp
expression
vaccines
recombinant
monoclonal
antibodies
sars
cov
protein
devices
biosensors
bioelectronic
based
bioelectronics
small
targeting
virus
dna
drug
human
animal
species
interface
never
cell
cycle
virus
replication
viruses
fcrs
adaptive
cells
biological
antibodies
immune
virus
responses
host
system
gene
viruses
studies
site
directed
baculovirus
polyproteins
expression
bevs
polyprotein
health
approach
one
economic
integration
expression
bac
baculovirus
system
sars
virus
ibv
cdna
vaccinia
genome
viruses
rna
technologies
allow
measles
jev
isatin
da
disease
parkinson
infectious
diseases
health
public
viral
antibody
mabs
human
mouse
technologies
laboratory
safety
levels
cdc
personnel
might
models
modelling
particularly
it
aav
capsid
the
gene
vectors
collectins
structure
type
recognising
innate
virus
antisense
viral
rna
in
protease
development
viruses
inhibitors
inhibitor
vanadium
the
vanadate
phosphate
compounds
infectious
diseases
antibodies
the
libraries
pcr
rt
reaction
amplification
long
technology
pcr
molecular
microbes
platform
poultry
influenza
virus
provided
emergence
sars
cov
protein
vsv
gfp
viral
host
whole
the
variation
glycoprotein
host
cell
the
virus
sperm
cells
prostasomes
the
prostate
influenza
season
cases
viruses
virus
surveillance
swine
influenza
activities
assays
sirnas
rna
rnai
new
target
viral
mutant
spectra
viruses
replication
rna
silencing
plant
host
viruses
the
proteins
target
protein
cells
classical
disease
sequencing
while
virology
sirna
respiratory
delivery
lung
virus
hrv
pcr
rt
specific
rna
infections
pathogens
continue
although
major
sars
protein
serum
patients
array
translational
products
events
in
genes
rsv
the
eia
uses
eias
we
carbohydrate
technology
including
microarray
fragments
protein
foldable
viral
surface
systems
medicine
discuss
bioinformatics
disease
covs
genome
fragments
rapidly
genetic
cell
cells
fusions
life
gene
surveillance
even
investment
the
uneven
coronavirus
primer
detection
avian
combinations
cells
infected
fip
crfk
analysis
hiv
new
therapies
therapeutic
development
synthesis
minus
model
subgenomic
templates
sars
based
cov
although
disease
chicken
tracheal
organ
cultures
ciliostasis
ace2
assay
mouse
activity
biological
host
modeling
genome
pathogen
genomes
nan
wildlife
health
linkages
diseases
human
engineering
serum
infectious
antibody
antibodies
nucleolus
the
well
processing
ribosomal
chikv
infections
in
virus
recently
human
type
respiratory
patients
viruses
symptoms
respiratory
infections
pathophysiology
viral
receptors
cell
this
viral
genome
cov
viral
the
coronavirus
clones
scv
sirna
sars
anti
induced
health
diseases
emerging
infectious
wildlife
human
animal
animals
emergence
infection
protein
cell
study
mers
cov
nan
mirnas
distinct
extensive
sequencing
efforts
perpetuation
populations
large
virus
small
respiratory
sequencing
the
viruses
using
human
emerging
animal
in
last
risk
patients
cell
effective
treatment
protein
viral
virus
host
yeast
proteins
rna
viral
replication
coronavirus
end
pcr
primer
experiments
fails
em
coronavirus
particle
specimen
support
used
dna
bacterial
amplification
procedure
cell
fusion
viral
virus
membrane
quadruplexes
dna
secondary
structures
structure
rnai
function
study
role
method
methods
interactions
virus
high
throughput
peptides
cpps
delivery
various
applications
coronaviruses
evolution
selection
viral
facilitated
coronavirus
generation
virus
recombinant
coronaviruses
hamsters
use
disease
methods
animal
clec5a
type
cells
dc
induced
coronavirus
coronaviruses
virus
respiratory
bcov
sars
the
coronavirus
in
diagnosis
number
infectious
sample
three
techniques
nan
influenza
human
type
the
virus
influenza
immune
older
vaccines
protective
nan
cell
chimeric
fusion
vca
ex
viral
proteins
host
virus
tissues
infectious
viral
virus
represents
viruses
lopinavir
ritonavir
standard
care
patients
cytokine
storm
influenza
often
infections
snps
possible
molecular
beacons
probes
siglecs
immune
sia
receptors
leukocyte
sars
sequence
cov
pcr
epidemic
proteins
viral
protein
expression
for
rna
fidelity
virus
the
variants
diseases
vaccines
vaccination
programs
infectious
respiratory
infection
cancer
patients
therapy
ms
maldi
tof
technologies
seldi
cell
viral
methods
viruses
proteins
biomaterials
development
specific
functional
proteins
respiratory
tract
could
viral
cns
disease
transmission
variables
infectious
rate
organelle
technique
study
in
protein
nan
sialic
acid
gold
nanoparticles
virus
multi
omics
studies
mers
cov
models
viral
infection
mouse
virus
amplification
method
based
vidisca
viruses
embryonated
egg
the
embryo
membranes
antibodies
antibody
phage
display
libraries
infection
immune
response
cns
chemokines
iminosugars
antiviral
inhibition
glucosidases
denv
influenza
the
season
specimens
number
membrane
secretory
plasma
er
pathway
covid
19
residents
care
facilities
rnai
gene
silencing
dsrnas
system
viral
host
activity
enzymes
interactions
agents
bioterrorism
potential
respiratory
gastrointestinal
devices
microfluidic
microfluidics
diagnostics
diagnostic
viral
viruses
cellular
sumoylation
including
human
native
antibodies
viral
methods
yeast
two
hybrid
protein
virus
health
approaches
ecological
public
chapter
cov
genetic
mers
reverse
engineered
method
gel
filtration
chromatography
versatile
recombinant
mv
genomes
viruses
measles
assay
mn
specific
virus
it
food
health
important
zoonotic
major
virus
reported
human
hosts
first
plant
virus
particles
capsids
structures
viral
replication
cell
forced
adaptation
spike
coronavirus
protein
analysis
glycoprotein
cell
entry
host
virus
mers
rna
replicase
coronavirus
viral
activities
ires
rna
plant
virus
viruses
virus
ibv
cdna
vaccinia
genome
viruses
influenza
infections
caused
season
proteins
intracellular
infection
silac
used
gene
cystic
fibrosis
cf
disease
cell
cycle
viruses
virus
cells
tem
samples
electron
imaging
material
virus
cell
receptor
viral
the
protein
interactions
host
y2h
well
coronaviruses
bats
several
novel
using
fusion
viral
proteins
membrane
thereby
point
of
care
diagnosis
diseases
primer
conserved
end
virus
sequence
human
evd
disease
ebola
virus
virus
ibv
cdna
vaccinia
genome
mers
cov
virus
infection
dpp4
mers
cov
indirect
elisa
antibodies
diseases
sectors
health
coordination
mechanism
vaccines
plant
animal
important
target
targeted
rna
recombination
system
infectious
health
zoonotic
disease
emergence
public
complexes
multiprotein
system
multibac
cellular
emergence
human
zoonotic
the
two
bacterial
influenza
responses
models
pathogens
pandemic
risk
paradigm
preparedness
specific
pm
12
pms
nh
mo
typical
patients
the
chronic
cough
respiratory
virus
rsv
rapid
diagnosis
ha
influenza
virus
protein
ph
viruses
influenza
infections
co
virus
embryonated
egg
embryo
virus
coronavirus
antiviral
virus
polymerase
targets
nucleoside
drugs
the
statins
novel
treatment
new
virus
ndv
tumor
replication
arenaviruses
rna
arenavirus
virus
the
protein
microarrays
nearly
entire
proteome
protein
his
proteins
coli
mbp
proteins
ad
we
cellular
virus
rna
viral
replication
proteins
synthesis
proteins
host
viroporins
interactions
ppis
rna
vaccines
design
self
replicating
the
virus
assembly
viruses
coronavirus
health
clinical
one
diseases
animal
acid
sia
biological
significance
although
influenza
age
system
sentinel
the
coiled
coils
diverse
range
two
viral
autophagy
infection
anti
process
chicken
tracheal
organ
cultures
ciliostasis
diseases
ids
infection
infectious
endemic
cell
viral
immunity
cells
responses
fcov
anti
the
antibody
ica
plant
mucosal
delivery
plants
animals
virus
sars
in
vaccine
infection
method
pcr
the
detection
asymmetric
tgev
porcine
binding
gastroenteritis
virus
rsv
human
infection
models
disease
peptide
protein
applications
classification
many
rotavirus
cells
assembly
proteins
intestinal
viruses
complex
capsid
many
simple
cell
cultures
technique
high
chicken
arenaviruses
species
associated
co
the
cells
cell
fusion
stem
somatic
c3
binding
toxins
neurons
vimentin
sign
viral
dc
viruses
infection
binding
mhc
peptide
cell
epimhc
henipavirus
studies
host
proteins
viruses
rnai
delivery
sirna
the
gene
used
virus
sequencing
data
viruses
bats
seroprevalence
transmission
henipaviruses
viruses
nan
tb
microscopy
days
smear
detection
nan
viral
infection
brd4
inhibition
epigenetic
diseases
infections
infectious
important
countries
sirnas
sirna
virus
rna
respiratory
nan
nan
rna
viruses
high
virus
population
nan
entry
information
single
virion
techniques
nan
immunocompromised
infections
differ
significantly
immunocompetent
nan
nan
influenza
children
age
infection
the
nan
mers
cov
infection
human
virus
cov
cells
infected
membrane
replicative
nan
nan
nan
nan
drug
new
trypanosomatid
discovery
target
nan
molecular
technologies
the
high
throughput
viral
pseudotyped
this
assay
high
infectious
molecular
improved
diseases
used
fusion
membrane
viral
proteins
host
nan
nan
model
protein
school
immune
signaling
nan
virus
dcm
chronic
viral
patients
datasets
mhc
bnb
the
learning
nan
nan
nan
nan
nan
adem
acute
cns
event
typically
nan
nan
nan
nan
influenza
infection
people
elderly
vaccination
nan
nan
host
virulence
factors
pathogen
disease
nan
fusion
single
particle
tracking
host
nan
nan
proteins
virus
particles
host
virion
nan
lung
injury
occurs
frequently
following
influenza
human
children
virus
pandemic
receptor
rbd
mers
cov
mabs
viruses
respiratory
disease
molecular
novel
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
the
infections
increasing
number
patients
nan
nan
nan
nan
nan
nan
proteases
immune
cysteine
pathogen
responses
influenza
viruses
age
years
season
nan
nan
virus
influenza
humans
viruses
human
nan
nan
nan
neutrophils
inflammatory
cells
monocyte
macrophages
nan
nan
ifn
activation
response
type
interferon
nan
nan
nan
nan
nan
nan
nan
nan
mers
cov
respiratory
mice
the
nan
nan
nan
innate
immune
recognition
surface
antigens
influenza
the
system
necessary
infections
nan
nan
nan
environmental
transmission
model
disease
dynamics
nan
nan
nan
influenza
ili
like
illness
cdc
nan
nan
nan
nan
nan
nan
nan
cell
fusion
facilitated
glycoprotein
mediated
nan
nan
nan
human
airway
outline
methods
the
nan
nan
nan
screening
virtual
drug
discovery
natural
nan
symptoms
patients
cmv
cause
almost
nan
nan
nan
nan
we
suggest
icu
sterile
basic
nan
virus
vaccines
viral
subunit
proteins
nan
viruses
nosocomial
infections
many
also
patients
infection
cancer
mers
the
care
patients
cancer
risk
outbreaks
telemedicine
health
covid
19
pandemic
videos
disease
youtube
prevention
information
surveillance
covid
19
the
general
participants
us
uk
online
united
guideline
diagnosis
treatment
2019
coronavirus
guideline
in
article
2019
cases
virus
qd
complexes
qds
imaging
nan
die
hat
entwickelt
vor
stellt
nan
in
dieser
zum
nun
abgesagten
das
die
durch
ausgangssperren
steigende
der
die
hat
sie
sind
nan
nan
nan
multienzyme
dna
cascades
assembly
organized
clinical
viruses
detection
technologies
virology
ambulances
centres
european
technical
facilities
nan
nan
patients
ctc
korea
hospital
covid
patients
common
pneumonia
clinical
cases
nan
march
school
the
children
transmission
covid
19
dysfunction
liver
related
liver
covid
19
injury
patients
university
accountants
administrators
support
scientists
while
late
confine
covid
19
privacy
confidentiality
part
responsibility
article
nan
nan
care
covid
19
cancer
health
ifa
vit
rt
pcr
viruses
19
symptoms
covid
gi
patients
nan
viruses
tests
disinfectants
hepatitis
efficacy
nan
nan
nan
cases
case
norovirus
number
transmission
hbv
hbeag
rna
week
12
nan
one
painful
aspects
pandemic
irremediable
crystallography
broadest
sense
crucial
role
crystallography
broadest
sense
crucial
role
travelers
incubation
period
data
collected
nan
nan
in
editorial
editor
chief
professor
variants
strains
ibv
taiwan
vaccine
fgf2
remyelination
oligodendrocyte
lineage
expression
sars
patients
cancer
criteria
the
infectious
the
war
mankind
diseases
virus
fr
tcov
infectious
id
sars
ace2
gene
cov
new
inflammasome
activation
danger
response
immune
nan
nan
virus
sfts
entry
cell
factors
nan
coronavirus
rapid
development
vaccine
sars
nan
nan
enzymes
fpg
dna
glycosylases
inhibitors
marylation
adp
parylation
enzymes
parp
viral
entry
hepatitis
hcv
chronic
lung
cancer
the
acei
cohort
nmd
pathway
role
immune
cancer
mers
cov
infection
respiratory
diseases
healthcare
covid
19
approach
pressure
lockdown
outbreak
the
household
size
closures
children
school
home
infection
sequences
sars
cov
two
patients
risk
communication
public
health
understanding
health
corona
outbreak
countries
responses
one
viral
nasolacrimal
duct
dacryocystorhinostomy
telehealth
emergency
care
part
used
chronic
population
we
mo
carriers
research
risk
decision
guidance
local
telehealth
population
hospitals
covid
19
social
settlements
distancing
informal
dwellings
smoking
rates
high
covid
19
nan
nan
humans
transmission
recent
in
two
nan
women
pregnant
whether
questions
persons
denv
infectious
feeding
virus
challenge
be
building
transmission
pathways
coronavirus
nan
nan
nan
nan
contacts
001
social
contact
instrument
infants
meningitis
febrile
crp
the
nan
heparanase
studies
abstracts
years
cloning
nan
weeks
these
attending
ones
never
nan
this
commentary
discusses
value
residents
covid
19
patients
placed
enormous
the
health
insurance
covid
19
europaeus
hedgehogs
species
erinaceus
virus
social
media
health
organizations
information
travel
pharmacists
medicine
public
believed
nan
zoonoses
amplification
of
detection
early
covid
19
the
people
social
resistance
pneumoniae
infections
the
antibiotic
assay
sars
cov
therapeutics
pseudovirus
drug
methods
discussed
development
various
proteins
sumoylation
sumo
localization
viruses
disease
covid
19
the
sars
nan
pandemic
contact
tracing
smartphone
app
challenges
public
physical
sciences
engineering
sars
cov
covid
19
technologies
amplification
lamp
specific
hrm
isothermal
surveillance
respiratory
myanmar
emergence
zoonotic
mci
covid
19
disaster
management
enzyme
electrophilic
active
rhodesain
het
acyl
amino
faah
acid
hydrolase
water
people
injection
public
drugs
ndv
expression
challenged
dpi
leghorns
risks
infected
we
summarize
cardiovascular
nan
nan
nan
ace
ligand
inhibition
the
enzyme
pre
nf
κb
inflammation
adipose
health
care
workers
caring
patients
china
covid
19
data
control
nan
patients
viral
rna
treatment
results
nan
dentists
covid
19
infection
dental
the
information
internet
health
coronavirus
this
commentary
discusses
findings
early
iran
sars
cov
epidemic
genome
nan
rh
ozone
inactivation
viruses
mnv
nan
nan
nan
nan
nan
this
case
series
describes
characteristics
cap
np
pneumonia
radiologist
different
rna
endou
activity
pun
covs
viral
virus
inhibitors
fusion
protein
virus
benzavir
zikv
flaviviruses
antiviral
ifitm1
residues
zikv
interferon
inducible
like
jingmen
flavi
glycoproteins
virus
nan
feifn
ifn
cats
feline
viral
vaccines
plant
diseases
viruses
infectious
influenza
virus
bbr
replication
results
nan
communication
risk
wuhan
the
effective
nan
this
perspective
proposes
one
way
covid
19
health
adults
outbreak
in
commentary
authors
discuss
multiple
models
stem
cell
disease
cells
pangolins
wildlife
although
pangolin
illegal
emetine
covid
19
treatment
coronavirus
convalescent
plasma
covid
19
coronavirus
nan
glycan
analysis
protein
interactions
analyses
nan
hospital
capacity
model
covid
19
resistance
antimicrobial
new
drug
molecules
antibodies
antibody
reagents
methods
affinity
diseases
lung
chronic
among
important
humanized
immune
mouse
models
research
nan
nan
nan
nan
tinctoria
well
plant
the
biological
coronavirus
ifns
ifn
viral
infections
nan
actions
the
2019
covid
19
nan
nan
healthcare
patients
workers
infected
recommendations
ventilation
intubation
covid
19
patients
covid
19
respiratory
management
syndrome
nan
phase
mefloquine
feline
microsomes
cats
nan
nan
dr4
anti
denv
ns1
suppressed
pandemic
the
editor
bjpsych
bulletin
there
patient
emergency
important
protecting
nan
nan
nan
nan
nan
nan
on
disease
age
2019
covid
nan
000
covid
19
tianjin
cases
mistrust
emergency
iran
issue
new
cases
19
covid
clusters
the
nan
infection
prevention
outbreak
efforts
programs
nan
training
instructor
led
video
group
nan
health
autocratic
regimes
public
impact
nan
covid
19
the
epidemic
province
surge
response
science
covid
19
heart
online
learning
provider
in
nan
patients
urological
must
care
urgent
covid
19
concerns
sci
community
infection
the
february
ship
19
cases
33
patients
imaging
covid
patients
the
covid
19
nt
nan
1β
il
expression
ndv
gm
infection
af18
novel
species
genes
repertoire
antibody
analyses
cell
response
human
lav
vaccine
immune
mice
nan
different
vaccines
inactivated
ge
deleted
protein
vaccine
plasmodium
sporozoite
antigen
mers
cov
piv5
single
mice
covid
19
ace2
patients
infection
yfv
entry
virus
cellular
vcp
nan
rss
chicken
astrovirus
chickens
viral
nan
cq
hcq
coronavirus
covid
19
19
covid
mothers
transmission
risk
coronavirus
symptoms
neonate
novel
disease
ards
neutrophils
dapsone
il
data
covid
19
2019
population
the
vaccines
covid
19
plant
antibodies
99
niosh
filtration
methods
n95
procedures
range
bronchoscopy
procedure
number
doffing
ppe
hcws
patients
practices
virus
the
century
sars
novel
respiratory
test
fever
symptoms
pneumonia
participants
healthcare
rna
air
influenza
ppe
training
hcp
selection
evd
2019
coronavirus
patients
wuhan
china
studies
patients
lpv
clinical
covid
viral
the
virology
siv
therapy
equine
virus
detected
horses
equid
anaerobic
pneumonia
icu
antibiotics
patients
vitamin
immune
cells
response
risk
cat
magnetic
resonance
imaging
the
the
diagnosis
disease
covid
19
bvdv
bovine
virus
the
assay
approaches
virus
entry
allow
systems
structures
cov
membrane
induced
lvcvs
atp1b3
hbv
κb
cells
nf
risk
attack
analysis
defender
the
nan
fmdv
licl
virus
replication
disease
rv
kcdc
adult
patients
data
disease
seen
cases
findings
proventricular
nan
admissions
deaths
respiratory
daily
weekends
ace2
angiotensin
kidney
associated
important
dogs
aboriginal
organisms
communities
health
protein
expression
proteins
plant
recombinant
sars
inhibitor
design
inhibitors
3cl
residents
influenza
rsv
deaths
hospitalizations
myocarditis
virus
viruses
adenovirus
cause
cells
iga
chain
secretory
local
cholesterol
fusion
mhv
fatty
acid
transplant
identified
viral
organ
recipients
research
respiratory
medicine
china
nsfc
coronavirus
coronaviruses
detected
species
group
hadv
samples
447
different
patients
patients
immunocompromised
hrvs
respiratory
hrv
nan
pcr
μl
cavity
10
diseases
multiepitope
protein
high
density
hev
mouse
nude
in
mice
indigenous
il
ifn
virus
immune
tbet
bevs
platform
derived
products
product
region
group
template
ha
antibodies
runoff
pastures
sites
grazing
stream
bd
evidence
environmental
association
infection
cpv
strains
the
2c
vp2
antiviral
molecules
nonspecific
activity
human
nan
h1n1
children
influenza
positive
respiratory
framework
disease
networks
ion
molecular
influenza
respiratory
viruses
children
patients
viruses
dna
lower
vertebrates
economic
severe
infants
age
bronchiolitis
severity
amino
acid
pedv
mex
one
diseases
the
infectious
biothreats
recent
pcr
virus
patient
dfa
viruses
elisa
hcv
infections
children
swabs
nan
samples
feces
bcov
etiological
nasal
virus
in
nasal
mucosa
viral
nan
cells
signals
present
ability
dendritic
rv
norepinephrine
map
pulmonary
index
nan
dairy
pathogens
beef
samples
597
fhmnv
muskellunge
fish
mus
hatchery
mice
meth
methionine
also
diet
adherence
scale
data
standard
health
world
novel
disease
china
spread
influenza
respiratory
parainfluenza
rsv
infections
fish
baitfish
lots
fathead
minnow
nan
nan
cd
heterozygotes
apob
affected
clinically
spleen
bats
lymphoid
species
fruit
mhv
mice
conventional
antibodies
neonatal
pws
chromosome
15q11
maternal
q13
dead
recovered
diarrhea
ped
suckling
cell
bu
enzymatic
biochemical
np
thorax
lung
rois
irt
layer
age
number
il
infections
respiratory
exacerbations
asthma
viruses
bacteria
acute
asthma
exacerbations
treatment
severe
clinical
nan
nan
cells
all_ergic
nasal
patients
common
asthma
severe
respiratory
controls
virus
rsv
mice
brp
39
inflammation
nan
the
acute
sars
presentation
present
nan
nan
tge
virus
pigs
piglets
transmissible
tgev
site
specific
editing
papn
nan
acute
phase
arthritis
response
genetic
nan
the
hiv
maximum
information
density
nan
nan
nan
fragments
active
site
enzyme
potential
cats
fcov
the
owned
immunocomb
nan
cats
agp
leucocytes
fcov
positive
ms
viruses
we
studies
multiple
line
selected
mps
landrace
non
tn
expression
antigen
synthase
glycoproteins
like
particles
parvovirus
cats
astrovirus
respiratory
intubation
virus
viruses
viral
rsv
infections
single
hbov
hmpv
children
viruses
detected
asymptomatic
virus
hoylei
previously
report
case
identified
viral
models
experimental
natural
primary
protein
development
methods
biochips
research
rvs
ltrs
lrtid
lung
ar
nan
kd
diagnosis
children
time
kawasaki
calf
mortality
productivity
farmers
improve
mass
spectrometry
structural
protein
in
bismuth
dna
scv
hold
tight
elements
quantification
elemental
using
dna
nan
calf
scours
calves
the
morbidity
piglets
the
weaning
post
lactobacillus
terminal
protein
region
structural
the
assembly
formation
assemblies
substrate
dissipative
df
edu
cells
tk
pathogen
kd
mbl
disease
the
group
nan
rna
expression
this
molecular
inhibition
human
ra
dogs
the
fluid
hiv
drug
resistance
in
protease
nan
sows
probiotic
milk
reproductive
performance
muscle
diseases
systemic
disease
may
secretory
cells
olfactory
bowman
glands
gastrointestinal
ras
the
tract
renin
nan
il
respiratory
virus
patients
infection
cyclic
peptides
found
role
theta
colostrum
calves
ml
fed
lower
viral
ms
evidence
infectious
agent
bovine
noroviruses
detected
samples
australian
bovine
virus
identified
bcov
respiratory
cell
clones
foreign
antigens
recognition
nan
cases
gastroenteritis
controls
children
found
samples
qrt
pcr
elisa
rotavirus
nan
myelin
ms
donors
coronavirus
cell
adv
children
respiratory
among
the
protein
fragment
templated
chemical
ligation
apnoeas
study
infants
respiratory
micro
nervous
system
defined
affect
viral
forced
air
warming
pad
intra
multiple
single
infections
compared
data
nan
analogues
eight
considered
gs
6620
flock
poor
ibv
eggs
haugh
trypanosome
report
infection
trypanosoma
case
virus
respiratory
long
term
infections
nan
mo
three
puppies
breed
case
respiratory
patients
viruses
clinical
bacteria
adace2
ache
genes
adace1
one
ms
patients
coronavirus
viruses
antigen
bone
we
radiography
14
articular
nan
time
go
helicase
stranded
dna
nec
nicu
premature
infants
injury
mouse
disease
hepatitis
virus
mice
spp
faecal
detected
dogs
reviewed
cf
polyps
bcl
protein
non
headaches
face
mask
headache
healthcare
respiratory
mers
cov
structural
structure
respiratory
crs
viruses
patients
viral
nan
amon
ms
coronaviruses
patients
hcv
cell
the
compounds
22
lines
human
acid
neu5gc
sialic
mutation
probiotics
the
kg
tonne
parameters
viruses
humans
viral
species
animals
colostrum
calf
management
practices
dairy
nan
disease
cats
clinical
study
feline
pia
cia
rats
arthritis
loci
nan
pcr
viral
immunocompromised
children
bal
lactate
sputum
lrti
inflammation
neutrophils
normal
like
faeces
particles
parvovirus
ccv
antibodies
dogs
positive
igg
clinical
mers
cov
renal
transplant
pneumoniae
children
nasopharyngeal
specimens
the
asthma
risk
factors
environmental
prevalence
ib
analysis
hrm
curve
strain
infants
lrtis
viral
maternal
the
nan
helicase
go
inhibitors
based
assay
wheezing
bronchiolitis
months
risk
recurrent
blood
viral
australia
supply
emerging
agriculture
animals
evidence
domesticated
many
time
space
clustering
hospital
level
nan
19
covid
drugs
drug
pandemic
nan
nan
covid
19
virus
south
korea
hcw
coronavirus
sars
cov
testing
nan
sars
cov
rt
qpcr
detection
cases
french
coronavirus
covid
19
nan
nan
mycobiome
ric
patients
diversity
interkingdom
nan
olfactory
sars
cov
epithelium
may
covid
19
disease
respiratory
cytokine
nan
nan
nan
covid
19
patients
seen
the
adapting
new
paradigm
pandemic
ever
nan
crystals
the
derivative
fusion
core
sars
hla
vaccine
the
human
pl
pro
ub
also
structure
cancer
coronavirus
pandemic
patients
the
pro
substrate
the
dimer
induced
sars
cov
structures
worldwide
structure
the
sars
fusion
core
cov
domain
structure
crystal
adp
ribose
peptide
hla
1101
362
370
sars
cov
the
nsp9
agent
infection
vasculitis
the
virus
hev
nan
thia
azaspiro
decan
coronavirus
influenza
vlp
p1
yield
ev71
recombinant
proteases
virus
inhibitors
human
type
agents
blood
risk
the
threat
cvd
polymerization
layers
polymers
devices
vaccine
vlps
manufacturing
vlp
viruses
cpv
canine
method
ab
ml
viral
downstream
process
viruses
sai
trim22
translation
protein
mrnas
the
cns
diseases
many
disease
mechanisms
plant
iga
virus
tgev
molecules
domains
polymerase
domain
btv
the
reads
cll
blast
viral
human
lipid
pathogens
host
signalling
membrane
host
interactions
pathogen
infection
understanding
dna
bacterial
fluid
pcr
derived
strain
vaccine
ibv
the
aib
ms
myelin
target
latent
viral
pulmonary
patients
treatment
may
pneumonia
hcdna
virus
process
aec
cell
rna
replication
viral
translation
vrna
recent
approach
management
technology
tools
nan
gastrointestinal
patients
symptoms
covid
19
proteins
palmitoylation
viral
membrane
cells
recommendations
british
transplantation
diagnosis
respiratory
pathway
proteins
exocytotic
er
membrane
oxygen
gas
increased
we
efficient
information
health
international
orders
global
lung
diseases
human
primary
tissue
pregnant
sars
non
patients
group
sias
diversity
natural
acids
nature
demyelination
myelin
destruction
may
disease
nan
peptides
antiviral
ic
50
validation
sp
pcr
microdevice
microchambers
primers
epidemic
model
reproduction
number
data
nan
per
c6
cells
high
protein
viral
demyelination
myelin
virus
cell
virus
human
viruses
steps
remove
microarray
analysis
genome
review
consortium
human
respiratory
quarantine
great
apes
hrv
sequences
students
symptom
human
nan
channel
tmd3
activity
protein
3a
patients
aids
clinical
molluscum
contagiosum
proteins
folded
protein
under
functional
the
vaccine
pandemic
facilities
would
cell
vaccine
vaccines
vaccination
design
activity
50
μm
30a
the
human
health
pandemic
plans
response
tem
viral
viruses
interactions
microscopy
rna
leader
process
this
viral
vlps
particles
different
virus
viral
antimicrobial
nanoparticles
lipid
the
development
nan
ndv
phosphorylated
novel
abc
infected
npa
hsct
transplant
positive
vris
effects
zika
virus
infections
wnv
treatment
nitrite
cure
group
sodium
nan
self
microbiome
tcr
genetic
repertoire
antiviral
polymers
pathogens
agents
efforts
rnai
cells
mechanism
discovery
rna
tr2
kda
dhfr
gene
amplification
red
cell
95
associated
alloimmunisation
viral
formation
replication
viruses
specific
oxidative
nitrative
stress
reactive
species
nan
fetal
ace2
sars
cov
transmission
nan
aptamers
helicase
quadruplex
sars
cov
oxycedrus
ssp
activity
oil
pinene
nm
virus
human
novel
membered
cleavage
peptide
structure
spike
furin
peptides
peptide
cd66a
neutrophil
amino
viral
infections
virus
emerging
recent
technology
chemical
discoverydot
tm
microarrays
mers
cov
flavonoids
3clpro
the
antiviral
models
virus
drug
in
rpa
amplification
samrs
polymerase
uses
marine
alkaloids
activities
pyridoacridines
biological
valinomycin
biosynthetic
gene
nonribosomal
peptide
cancer
infections
patients
icp
000
lead
optimization
in
successful
example
saikosaponins
activity
µmol
saikosaponin
50
magnesium
me
mg
group
catalytic
spirocyclic
nucleosides
corresponding
derivative
obtained
nan
sirna
hsv
replication
reduction
antiviral
nan
small
interfering
rna
infected
cell
virus
risk
exacerbations
type
inflammation
asthma
role
virus
exacerbations
rhinovirus
fev
values
correlation
results
questionnaire
nan
il
35
hbv
cytokine
cells
sirna
delivery
localized
rna
silencing
severe
mp
ap
respiratory
mycoplasma
molecules
cd
known
key
names
cpvs
rub
rcs
showed
dsrna
p53
wnvcp
wnv
apoptotic
hdm2
mhv
host
translational
shutoff
replication
block
rna
morpholinos
stable
used
block
rna
morpholinos
stable
used
protozoan
proteases
treating
tropical
diseases
diagnostic
diagnosis
pneumonia
transplant
clinical
nucleolus
protein
proteins
morphology
cell
nucleus
viruses
structures
viral
replication
reactivity
substituted
unsaturated
carbonyl
compounds
cell
death
infection
apoptosis
coronaviruses
influenza
patients
transplant
ili
criteria
cells
dcs
viruses
dc
virus
respiratory
prevention
viral
viruses
include
protein
molecules
interactions
relevant
methods
drug
ards
approaches
therapeutic
despite
rv
one
step
respiratory
seeplex
fb
radiological
findings
patients
bal
nan
protein
expression
coli
proteins
bacterial
research
animal
health
infections
mouse
nan
iav
ifn
30
mir
family
pregnant
evidence
infectious
the
drug
denv
cells
entry
vero
clathrin
the
common
cold
syndrome
causes
viral
antiviral
ats
activity
infections
cap
guideline
adults
profile
chinese
complexes
tubular
lymphoma
identified
leukemia
viral
cells
lectins
surface
cell
staff
skin
healthcare
use
ppe
pkr
indomethacin
antiviral
activity
viral
2020
international
society
advancement
cytometry
capsid
protein
rv
apoptosis
apoptotic
surface
sars
cov
single
spikes
niclosamide
drug
diseases
anthelmintic
infections
sars
the
colorectal
surgery
procedures
cells
2b
permeabilization
expressing
gap
patients
fb
pulmonary
infiltrates
allo
beat
ciliary
isoflurane
pattern
frequency
disease
host
parasite
wildlife
molecular
ev71
infection
cellular
proteins
responses
pneumonia
mortality
influenza
patients
po
cell
gp
bdv
infection
cells
cough
pic
patients
symptoms
influenza
cells
four
cases
kaposi
sarcoma
50
lycorine
ec
μm
dengue
emerging
infections
this
issue
clinical
copd
mda
rig
expression
patients
rnai
infection
rv
cells
rna
national
biosafety
information
biohazards
resources
gbf1
hev
replication
bfa
cells
cells
hcv
mscs
this
unit
ngr
endostatin
tumor
apn
sequence
nan
particles
seen
virus
like
leucoblasts
p17
mcp
monocytes
ap
hiv
evidence
review
practice
within
care
drug
screening
discovery
effective
efficacious
morpholinos
rna
mrna
stable
bind
factories
biogenesis
viruses
virus
cell
protein
cells
production
mammalian
this
discovery
antimalarial
drug
convenient
approach
activity
carbon
antiviral
compounds
double
host
virus
cell
responses
viral
implants
bone
untreated
ucfp
peek
asthma
respiratory
responses
pathogens
may
drug
protein
targets
chemists
genomics
factors
discusses
disease
this
overview
virus
viroporins
membrane
viroporin
cell
virus
bli
new
dissemination
coronavirus
capsid
alix
release
hbv
escrt
ifitm3
antiviral
viral
ifitms
extracellular
patients
h7n9
poultry
disease
onset
pi3k
virus
signalling
influenza
infection
nan
the
xendou
family
pp11
nendou
cd81
ewi
2wint
hcv
membrane
cd13
ezetimib
raft
monocytic
cells
aecopd
viral
patients
virus
infection
sars
cov
factors
infection
as
sinv
cellular
viral
proteins
translation
nan
nan
actin
isoforms
virus
cells
vacv
protein
structural
structure
overview
fold
hev
encephalomyelitis
well
transsynaptic
swine
bev
rna
viruses
infected
cells
viruses
bacteria
antiviral
many
drugs
anxiety
95
ci
social
media
19
covid
symptoms
coronavirus
spread
patients
evaluated
anosmia
dysgeusia
absence
2019
ncov
saliva
droplets
transmission
male
age
10
years
shigellosis
covid
19
therapy
fever
case
health
mental
current
departments
these
nan
nan
nan
nan
95
ci
covid
19
china
nan
nan
medications
treatment
used
clinical
understanding
parp
bbap
14
development
thymus
cell
mixing
the
sample
gold
nan
no
replication
hantavirus
effects
virions
cells
mhc
class
acute
infection
natural
variability
different
relevant
environmental
fcr
pjp
prophylaxis
patients
months
veterinary
medicine
cytology
species
part
recombinant
hemophilia
turoctocog
alfa
fviii
health
one
setac
the
environmental
effects
crop
plant
diversity
wild
control
diseases
infection
infectious
measures
vv
protein
mhv
jhm
recombinant
viral
vlrti
lower
respiratory
tract
nan
hlh
cells
patients
cell
activation
epe
disease
foals
intracellularis
this
epilepsy
hemiplegia
hemiconvulsion
presentation
febrile
cd4
cd45ra
ccr7
phenotypic
ag
level
disease
processes
foi
antibody
lymphocytes
cells
lesion
spinal
cord
protection
ed
required
chemical
biological
neolithic
the
european
cattle
domesticated
principle
animal
human
in
derived
proteomic
sars
beta
patients
features
nmr
related
cancer
antibodies
blood
asc
virus
infection
cns
ab
nan
protein
liver
autoab
extracts
40
68
γhv
infected
viral
eae
disulfide
bonds
membrane
proteins
labile
nan
nan
hlh
patients
pediatric
the
familial
infectious
agents
prevalence
coinfections
gi
immune
antiviral
responses
ptms
innate
proteins
infection
virus
ibdv
pathway
hcov
nl63
patient
peg
ifn
cns
cd8
cells
cell
we
methylene
blue
the
interaction
dna
ifi
sct
pap
caspofungin
haplo
sars
chip
the
system
pcr
pathogens
network
associations
endemic
pathogen
plp
139
151
autoimmune
disease
nan
cells
mhcii
disease
arthritis
pristane
niche
species
differences
community
interspecific
nan
scfv
viral
fragments
purified
binding
glycoproteins
cell
cells
cea
related
nan
work
would
staff
attend
influenza
disease
data
populations
ecological
models
saa
horses
blood
concentration
acute
cd8
oxygen
cells
function
tension
health
disease
biodiversity
public
human
amplification
lamp
positive
dna
electrophoresis
infectious
diseases
vaccines
many
immune
viruses
dsdna
viral
assigned
anaerobic
sars
ace2
cov
myocardial
heart
image
anti
ab2
mice
protective
sars
cov
inhibitors
binding
provide
tobacco
mosaic
virus
leadzyme
rna
dc
glycans
agalactosylated
sign
fc
cystatin
inhibitor
protease
activity
cysteine
enzyme
domain
cysteines
within
enzymatic
ubiquitin
probes
dubs
activity
proteases
human
erythrocytes
tryptophan
rich
interact
transport
the
nucleus
cells
this
organisms
macromolecules
adp
ribosylation
dna
stress
amazonensis
xbp1
expression
er
eif4e
phosphorylation
mrna
role
translation
ace2
chloride
ace
angiotensin
site
tgev
internalization
tgevs
virus
clathrin
coronavirus
pro
the
structure
discussed
host
immune
responses
innate
virus
protein
proteins
dbtagged
microarray
analysis
bananin
sars
cov
helicase
found
microbiota
microbe
urt
the
immune
dimerization
extra
domain
catalytic
enzyme
m1
aminopeptidases
enzymes
range
target
immune
autoimmune
disease
cross
self
http
www
3d
uniprot
ebi
chikv
nsp1
mtase
it
veev
3c
antivirals
virus
protease
hav
fusion
the
nipah
hendra
viral
http
www
ebi
uniprot
ac
protein
8b
proteins
8a
8ab
furin
ser
inhibitors
kexin
residues
apn
the
enzyme
residues
bound
proteins
cellular
expression
domain
viral
protein
proteostasis
cellular
proteins
aggregation
ddx3
pact
antiviral
protein
innate
apn
tumor
compounds
anti
activity
protein
nucleocapsid
rs
stress
motif
dynein
viral
proteins
cellular
retrograde
enzymes
specificity
peptide
substrates
based
dc
signr
ph
ca
crd
dna
helicases
unwinding
including
eukaryotic
nan
ace2
site
ace
enzyme
role
family
the
m1
protein
zn
ph
fusion
entry
low
aslv
poly
strand
protein
synthesis
cov
rna
ribozymes
activity
target
demonstrate
pro
terminal
form
stimulation
cleavage
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
chloroquine
weight
hydroxychloroquine
side
effects
containment
the
outbreak
covid
19
19
covid
control
public
cities
sars
cov
covid
19
animal
sars
cov
binding
cr3022
virus
polymerase
nsp12
covid
19
virus
cov
sars
coronaviruses
nhc
eidd
nan
nan
nan
game
meat
hunting
abundance
biomass
sars
cov
immunity
distancing
severe
pro
inhibitor
sars
cov
the
we
epidemic
contact
tracing
transmission
cov
sars
macaques
covid
19
tslp
cells
dcs
poly
th2
evw
lower
respiratory
nasal
il
atopic
colds
subjects
antibody
normal
hla
dr
cd86
nec
antigen
anti
ige
hdm
titres
bacterial
atopic
subjects
increased
colds
bronchial
subjects
il
nal
mucosal
allergic
viruses
sia
host
viral
cell
pathogens
new
human
blood
continue
uv
spray
plasma
the
coli
ribavirin
hrc
203
viral
mice
children
planning
recommendations
future
paper
cos7
cells
cell
fusion
sars
suis
litters
diarrhoea
production
samples
nan
calves
coli
isolated
18
faeces
tmprss2
hcv
infection
the
serine
pd
l1
cells
responses
cell
patients
sars
isolation
day
facilities
mers
cov
tissue
the
viral
patients
day
mers
cov
16
respiratory
human
influenza
zoonotic
samples
hpv
e7
ctl
d4
able
memory
cells
infections
cell
these
infected
middle
east
respiratory
syndrome
infections
may
infection
symptoms
myocarditis
tank
hp
lp
001
the
diarrhoea
enteric
infection
patients
chronic
patients
olfactory
dysfunction
pvod
nasal
transmission
mers
slaughterhouse
cov
workers
nan
airborne
disease
transmission
review
studies
practice
infection
patients
hai
staff
apod
injury
glial
regeneration
the
lsectin
cells
myeloid
pu
liver
tgev
samples
gastroenteritis
three
blocking
de
la
der
con
au
astrocytes
human
chemokine
activation
genes
nan
isolate
sc021202
ibv
nucleotide
s1
relative
decontamination
survival
rs
ffr
sars
nurses
in
came
perspective
camel
cases
mers
cov
human
nan
chronic
hepatitis
mice
abnormalities
microcirculatory
influenza
mi
we
studies
or
fungi
crs
patients
seven
populations
de
virus
la
en
und
cchf
human
tick
cchfv
limited
indoor
review
hospital
building
patients
dubs
cancer
regulate
2010
iubmb
sars
hunan
survey
epidemic
the
nucleic
receptors
host
recognition
acids
samples
calves
faecal
newborn
dairy
nan
mucosal
immune
cells
responses
the
piglets
etec
farms
examined
pathogens
viruses
rodents
bats
zoonotic
we
autoimmune
response
cell
disease
epitope
r5
hiv
pmns
replication
cultures
virus
de
la
evd
tge
virus
liver
blood
infection
resistant
dispersion
interunit
rans
les
the
de
des
et
la
und
nan
autoimmune
disease
process
development
activation
cells
memory
antibodies
human
using
antibodies
virus
bats
encephalitis
tabv
il
responses
10
tlrs
microglia
sars
disease
hla
severity
the
ip
infection
pylori
parkinsonism
response
ars
bacterial
crp
inflammatory
days
disorder
slc6a19
neutral
amino
mutations
virus
bats
chikv
encephalitis
tested
isospora
significantly
infected
oocysts
000
nan
gastrointestinal
infections
methods
diagnosis
diagnostic
fq
hcv
cell
virus
also
vrs
ia
classroom
districts
we
bacterial
ars
nasal
we
viral
nk
cells
immune
system
microbial
nan
ca
lt
ascites
pediatric
median
histopathology
specialty
disease
professional
new
bats
immune
bat
immunology
viruses
cov
bat
rna
scotophilus
bats
ibv
the
assay
gii
virus
acne
vulgaris
both
two
women
aspua
allele
detection
universal
array
ifitm3
polyi
astrocytes
expression
mice
il
18
also
inflammatory
activation
hvac
particles
fluorescent
bcu
isolation
human
zoonotic
viruses
animal
humans
ccov
dogs
positive
important
viral
health
zoonoses
disease
criteria
prioritize
nan
athletes
respiratory
urs
recurrent
inflammation
cpv
type
antigenic
canine
enteritis
patients
bleeds
treatment
optivate
on
respiratory
air
travel
issues
cabin
bats
the
ebv
cameroon
respondents
virus
2014
ebola
first
outbreaks
cases
gastroenteritis
spp
controls
bacterial
rv
diarrhoea
cv
group
rotavirus
de
virus
la
die
pigs
ifitm3
frequency
western
interferon
inducible
liver
patients
sars
coronavirus
impairment
elisa
samples
rotavirus
cb
examination
h1n1
prrsv
pigs
infections
mean
zoonotic
diseases
phis
public
health
viral
systems
expression
proteins
plants
bat
bats
astroviruses
viruses
several
95
ci
transmission
route
in
ccv
cav
dogs
puppies
dual
health
one
approach
disease
australia
study
crcov
antibodies
human
transmission
infected
astrocytes
cell
virus
the
sera
virus
swine
porcine
spp
b16f10
tap1
melanoma
antigen
cells
covs
species
cov
bat
bats
the
emerging
zoonoses
diseases
conference
sars
weather
transmission
the
daily
studies
review
transmission
mers
cov
tnf
interferon
patients
cells
hepatitis
indoor
air
bioaerosols
study
processes
tnf
activity
necrosis
paracetamol
induced
sequencing
detection
discuss
diseases
also
mers
risk
model
the
cov
mhc
species
mammalian
felidae
class
nan
cap
patients
presence
animal
aetiology
raccoons
95
ci
masked
palm
aecopd
viruses
patients
viral
pcr
transcripts
disease
myelin
in
demyelinating
nurses
risk
diseases
respiratory
infectious
tcr
transgenic
specific
mbp
antigens
astrocytes
microglia
expression
class
glial
akt1
tb
polymorphisms
patients
pulmonary
rabies
spa
antibody
strip
control
pec
toxicity
habitats
flow
sand
catc
mice
cells
gzmab
deficient
tags
genes
samples
gene
anpep
nan
rna
prrs
immune
recognition
pathogen
bats
viruses
china
found
northern
torovirus
bovine
spp
calves
austrian
diseases
syndrome
the
dengue
infectious
ifn
cell
immune
receptor
ifns
diseases
vaccines
use
however
still
tracheostomy
patients
become
require
may
nan
global
infectious
the
world
disease
viral
virus
ctl
replication
immune
viral
patients
pneumonia
cap
bacterial
bacilli
epithelial
cells
crypt
massive
ifn
tlr3
tlr7
immunity
tlr9
tumor
cell
invasion
cells
aminopeptidase
nan
genera
organisms
species
including
viverrids
the
ward
decrease
sars
outpatient
nan
cdv
strains
infected
infection
viral
lamp
rt
the
cdv
method
olfactory
significant
smell
medical
within
ebov
ifn
infection
system
proteins
human
infection
orthopoxviruses
animal
occurred
plasma
virus
derived
safety
fviii
pedv
piglets
suckling
sows
heterologous
spray
salmonella
drying
either
bacterial
nan
sensors
viral
function
lead
like
nan
hav
hcv
replication
cell
rna
ade
antiviral
viral
infection
number
prrsv
prv
pigs
groups
group
virus
innate
cells
inhibition
disease
class
microglia
oligodendroglia
cell
cd8
haart
organ
specific
manifestations
hiv
risk
enterica
prevalence
pig
slaughterhouse
foxm1
hla
a2
cells
cholangiocarcinoma
viral
infection
the
crs
nasal
transmission
mers
cov
routes
long
cats
vaccine
10
intranasal
clinical
sars
cov
infection
cells
lovo
properties
probiotics
effects
clinical
trials
hastv
hastvs
the
study
100
hcv
shrna
cells
expressing
sirna
sars
apoptosis
cov
respiratory
induced
toc
rat
virus
94
cell
ev71
cox
expression
induced
creb
sera
groups
antibodies
229e
oc43
hcov
kawasaki
disease
patients
nl63
respiratory
viruses
acute
infections
viral
lab
mucosal
vaccine
bacteria
considered
hbov
respiratory
infections
patients
the
staff
elderly
respiratory
older
daycare
ang
ii
angiotensin
receptor
ras
small
animal
countries
vgg
asian
respiratory
infection
children
viruses
pathogens
virus
lyophilization
viruses
stabilizers
storage
respiratory
assay
rvp
virus
the
viruses
virus
huh7
influenza
respiratory
infections
piv
viruses
respiratory
africa
hbov
children
respiratory
the
viruses
influenza
like
illness
respiratory
viruses
chronic
shedding
persistence
seasonal
pathogen
2010
influenza
viruses
h3n2
2011
cap
pneumoniae
virus
children
pneumonia
imha
dogs
group
vaccination
month
the
hemorrhagic
shf
data
infections
developed
severe
hypersensitivity
reaction
abstract
influenza
ili
the
respiratory
rhinovirus
illness
cap
hospitalization
serious
data
hadv
patients
adenotonsillar
presence
the
respiratory
pathogens
forensic
anm
pcr
igy
group
fed
ewps
coli
influenza
rsv
assay
infections
respiratory
coronavirus
infections
229e
oc43
cells
bag3
co
protein
ad
base
sars
hr
cov
helices
protein
hrv
respiratory
clinical
three
children
sars
the
nucleocapsid
patients
high
strong
uas
calves
ph
hco
ep
hs
cs
css
lhs
exosomes
delivery
rnas
vesicles
cells
genes
rv
cell
reference
rt
nan
children
antibiotics
discharge
nps
sample
sars
cov
dnazyme
utr
rna
dogs
cats
diarrhea
animals
room
emmprin
inducer
mmps
various
immunologic
exacerbation
acute
infections
bacterial
viral
nan
tests
prevalence
rapid
single
triple
children
respiratory
symptoms
positive
the
dogs
cats
diseases
virus
common
nan
children
rsv
hmpv
rv
respiratory
naats
viral
compared
seeplex
clart
faecal
clinical
coli
presence
diarrhoea
virus
method
viruses
encephalitis
consensus
respiratory
patients
virus
in
human
hrsv
human
respiratory
children
detected
hrv
rsv
bronchiolitis
pneumonia
il
nan
hcov
clinical
children
otherwise
healthy
hpiv
coinfection
infection
single
pathogens
nursing
homes
infection
residents
outbreaks
respiratory
patients
bacteria
viruses
acute
pyogranulomatous
described
cases
feline
also
norovirus
detection
gi
kit
rate
analysis
order
field
bibliography
11
il
th17
influenza
respiratory
virus
taiwan
h1n1
h3n2
100
antigenic
respiratory
mcpyv
samples
the
patients
vp2
ppg612
lp
t7g10
vvibdv
mutations
cell
15
clinical
sars
macrophages
feline
lavage
cells
cats
229e
rna
hcv
washings
nasal
golgi
apparatus
membrane
secretory
cell
10
il
bb12
tlr2
production
dogs
healthy
acute
haemorrhagic
diarrhoea
virus
adenovirus
influenza
admitted
respiratory
iav
mφ
entry
receptors
attachment
nan
rsv
hmpv
viral
children
load
sars
cov
post
mortem
tissue
hmpv
respiratory
human
infections
children
disease
one
century
theory
singular
patients
cases
oc43
titre
disease
notch
signaling
cells
drugs
k562
nan
lymph
55
ferrets
nodes
thickness
viruses
virus
respiratory
patients
detected
da
arbidol
the
fragmentation
loss
respiratory
the
children
infections
vs
rsv
subtype
respiratory
infection
infections
mmp
glycyrrhizin
liver
lps
galn
nan
manure
inactivation
pathogens
full
scale
hmpv
genotype
years
severity
clinical
peptide
amino
acid
design
physicochemical
infection
virus
chloroquine
the
chikv
hospital
patients
in
poc
costs
heart
monkey
disease
cardiac
three
human
virus
viruses
novel
respiratory
sars
cov
coronaviruses
bayesian
phylogenetic
virus
65
40
heating
90
respiratory
viral
illnesses
acute
rsv
sars
cov
the
assay
using
prp
scjd
particles
brain
without
canine
dogs
cird
pathogens
asymptomatic
nan
sars
cells
phase
human
endothelial
disease
evd
virus
person
transmission
cd13
cell
ha
role
adhesion
viruses
virus
system
human
real
nan
plant
acetobacteraceae
family
many
also
om
host
aom
com
immune
pcbp2
glioma
expression
cells
assay
viral
respiratory
multiplex
infections
patients
fip
cats
immunopathogenesis
management
disease
hmpv
outbreaks
respiratory
the
study
patients
gbs
infected
clinical
outbreak
samples
nat
pathogens
conventional
methods
mutations
tsm5
genome
k181
sequencing
mers
cov
human
dromedary
camels
diarrhea
patients
sars
the
group
respiratory
hrv
virus
detected
patients
therapy
interferon
acute
phase
feline
svcv
carp
the
virus
pathogen
infants
preterm
bronchiolitis
require
vs
immune
coronaviruses
cov
inflammation
covs
rgnnv
genes
p53
ljp53
virus
ace2
mouse
cell
lung
line
hbov
infection
children
respiratory
lower
hbov
respiratory
infection
acute
children
influenza
virus
infection
respiratory
patients
dogs
mat
leptospirosis
results
laboratories
the
calves
bacterial
birth
24
cd26
chemokine
chemokines
nh
terminal
hbov
respiratory
clinical
children
the
infants
virus
higher
rsv
bronchiolitis
nl63
hmpv
hcov
hbov
viruses
crispr
technology
cas9
the
system
protein
vp10
oocytes
e1
golgi
old
strongyloides
nematodes
reported
species
human
derived
differentiated
epithelial
cell
viruses
pcr
cap
rtrt
respiratory
interferon
dose
volunteers
placebo
the
respiratory
patients
infections
virus
lower
hmpv
respiratory
infection
positive
patients
omics
data
the
dose
response
hypoglycaemia
disease
processes
veterinary
diagnosis
zikv
polymerase
binding
gis
guanosine
syndactyly
report
litter
kittens
in
rhdv
melatonin
autophagy
protein
induced
aerosol
system
particle
the
bioaerosol
hmpv
community
acquired
pneumonia
children
respiratory
hpiv
infections
patients
hpiv1
fmdv
poifn
ω7
ifn
disease
hecv
4408
bcv
hcv
oc43
ifn
mhv
10
antiviral
effect
nan
cox
plasma
meloxicam
cyclooxygenase
mice
telbivudine
mhv
hepatitis
treatment
induced
avn
femoral
diffusion
head
hip
rsv
respiratory
infections
patients
prevalence
hcov
infections
respiratory
hcovs
acute
ev
d68
strains
in
patients
mers
cov
human
respiratory
in
hcov
oc43
mutation
mutations
viral
children
shedding
cvlps
stools
districts
salmonella
pentosaceus
the
vitro
40
pcr
used
cell
pv
pvnrt
lung
the
epithelial
response
cell
viruses
ili
influenza
patients
respiratory
years
respiratory
viruses
pneumonia
followed
ferret
bile
gall
bladder
abdominal
ev71
autophagosome
induced
infection
autophagic
coagulation
viral
infections
disorders
this
alpacas
diaphragmatic
paralysis
animals
medical
nan
mesenteric
lymph
eosinophilic
cat
on
the
pig
slurry
samples
sspv1
bst2
sars
cov
229e
capable
patients
respiratory
viruses
positive
lung
respiratory
middle
east
syndrome
nursing
viruses
multiplex
assay
detection
human
viral
dna
vp1
test
mice
proteins
recombinant
plant
viral
applications
influenza
virus
ili
among
positive
nan
coronavirus
older
persons
respiratory
daycare
nan
sputum
respiratory
nasopharyngeal
swabs
viruses
influenza
nosocomial
cases
outbreak
transmission
influenza
respiratory
outbreak
isolates
clinical
antibodies
rhinovirus
specific
elisa
hrv
nan
rsv
load
infants
the
clinical
the
sars
human
tissue
transcripts
sign
sdc
cmv
human
infection
sars
cov
sera
recombinant
the
pcr
respiratory
rt
mrt
xtag
ifnα1
hbv
aav
viral
anti
patients
respiratory
sepsis
like
illness
cird
disease
vaccines
development
agents
public
health
law
act
tool
gme
nme
cases
pcr
evaluated
admission
24
hours
leukocyte
performed
respiratory
human
hcov
aris
patients
sign
hbv
dc
virus
the
guideline
nurses
guidelines
emergency
practice
dogs
spinal
meningoencephalomyelitis
unknown
origin
influenza
viruses
virus
472
patients
respiratory
patients
pediatric
cancer
infections
treatments
de
bw
colostrum
dfm
cat
pinnae
ear
disease
the
bcl
flupirtine
tnf
expression
oln
ebola
virus
evd
recent
drug
229e
strains
volunteers
related
antibody
rotavirus
children
types
the
diarrhoea
rsv
replication
hmc
c8
cells
ferret
central
nervous
system
ct
fcov
cats
fip
strains
samples
hmpv
lipid
raft
cell
entry
nan
sars
expression
nf
κb
cox
detection
respiratory
hcovs
hku1
children
foals
diarrhea
infectious
or
95
membrane
hcv
protein
core
interaction
hmpv
respiratory
tract
phylogenic
study
calves
treatment
study
metabolic
acidosis
sars
cells
coronavirus
the
life
associated
pneumonia
ventilator
apmv
patients
patients
older
sars
clinical
60
cold
vitamin
common
literature
prophylaxis
spike
cell
sars
cov
protein
crispr
cas
system
diagnostic
platform
biological
sequences
sequence
method
gaussian
viruses
respiratory
human
detected
patients
nan
assay
test
enzyme
linked
immunosorbent
amantadine
treatment
therapy
chc
patients
copd
cp
ae
group
viruses
viral
respiratory
dna
microarray
rt
hcov
nl63
associated
the
specimens
sars
cov
cytokine
respiratory
infection
response
sepsis
inflammatory
veterinary
syndrome
rinse
oral
viral
30
min
patients
cmv
respiratory
dna
detected
pairing
parasite
sjgcp
japonicum
male
htlv
sars
patients
positive
results
2004
cell
physiol
199
171
hku1
hcov
korea
genotypes
respiratory
hmpv
hbov
infections
identified
respiratory
alri
admissions
identified
respiratory
hospitalisations
response
interferon
hcv
patients
snp
pcv2
pcvad
porcine
circovirus
associated
patients
hbov
respiratory
detection
clinical
influenza
virus
lamp
samples
2009
hpiv
hpivs
virus
detected
co
fip
histopathology
agp
spe
ae
homoharringtonine
disease
swine
further
demonstrated
study
gps
respiratory
the
viruses
gi
understanding
motility
large
animal
immune
could
the
viral
viruses
sars
cov
assay
using
vsv
cats
cardiac
respiratory
causes
dyspnoea
jev
taqman
assay
the
rt
shlh
patients
ebv
etiology
clinical
detected
wheezing
hcov
viruses
acute
hrsv
respiratory
the
strains
infections
the
respiratory
human
flu
viruses
immune
seasonal
function
melatonin
the
melatonin
virus
vee
mice
infected
nan
δr
blood
myocardium
5t
3t
min
virus
particles
vacuoles
30
analysis
order
field
bibliography
11
viruses
otitis
media
virus
study
metoclopramide
ondansetron
maropitant
vomiting
day
human
infections
well
transplant
recent
screening
database
natural
products
databases
zikv
polymerase
compounds
novel
the
infection
severe
respiratory
upper
breeding
children
hbov
respiratory
virus
infections
patients
ifn
ms
therapy
pp
rv
children
positive
associated
species
respiratory
children
rv
infections
viruses
mir
223
infection
targets
inflammation
patients
aecopd
aecb
organisms
risk
ok
432
mice
mhv
10
hcov
sari
respiratory
avri
human
cap
rsv
rhinovirus
associated
children
development
interferon
heart
differentiation
h9c2
nan
specimens
enteric
agents
monkeys
adenoviruses
viruses
species
host
cross
transfer
nan
viruses
acute
otitis
media
children
participants
symptoms
impact
sars
patients
cov
3cl
pro
mers
the
chemokines
viral
chemokine
virus
activation
patients
specific
sars
cov
infected
nan
il
group
sars
ifn
10
respiratory
hcov
nl63
human
children
iaha
229e
antibody
cf
recent
cats
fip
ppf
survival
time
influenza
children
childcare
study
two
nan
mrna
gene
expression
immune
regulation
pcr
esi
ms
assay
dfa
rnai
silencing
gene
viral
years
epididymis
immune
testis
sperm
system
samples
norovirus
astrovirus
em
positive
nan
patients
respiratory
hmpv
the
ct
revealed
loss
body
abdominal
mass
viral
children
viruses
episodes
type
human
metapneumovirus
respiratory
virus
children
nodules
ciclosporin
gastrointestinal
treatment
days
high
the
sars
assay
throughput
feline
fip
coronavirus
fcov
infections
laboratories
mers
cov
ptp
specimens
pcr
rv12
rt
viruses
respiratory
dogs
treatment
infected
nac
parvo
ras
angiotensin
ang
the
renin
hbv
east
asia
the
sequences
nan
particles
virus
observed
like
electron
mvtt
tissue
inoculation
replication
modified
rt
measles
lamp
rna
vaccine
we
report
rare
case
adenoviral
viruses
respiratory
symptoms
patients
influenza
influenza
respiratory
virus
viruses
patients
rt
detection
lamp
nvs
assay
respiratory
viruses
pilgrims
mers
hajj
nxtag
rpp
22
rf
hr
viruses
virus
respiratory
detection
using
sepsis
patients
infection
viral
study
hpv
dna
detected
pcr
time
co
adults
this
study
prevalence
respiratory
viruses
metagenomic
analysis
virus
cat
loss
vision
associated
examination
hmpv
study
ili
circulation
among
influenza
assay
high
the
testing
fetal
the
hcmv
human
ifit1
magna
pure
96
influenza
specimens
nme
pugs
dogs
treatment
survival
cells
samhd1
il
hiv
expression
viruses
respiratory
influenza
virus
children
aprotinin
rimantadine
influenza
virus
infected
apoptosis
fmdv
bmdcs
cells
immune
nan
spike
mers
cov
the
receptor
rv
assays
rvs
tested
clinical
influenza
aris
elderly
human
infections
influenza
like
illness
viruses
respiratory
plants
bronchitis
used
respiratory
himalayan
d68
ev
12
strains
viral
virus
cd
50
infectivity
h1n1
influenza
rsv
liat
100
results
antisense
sars
the
ps
structural
patients
respiratory
acute
multiplex
molecular
positive
stools
children
diarrhea
controls
viruses
arti
respiratory
epidemiology
impact
stroke
ifn
ischemic
treatment
therefore
ag
antimicrobial
sba
15
materials
cvlp
like
association
clinical
usually
mmp
respiratory
viral
infections
disease
influenza
respiratory
rsv
lao
infections
cvlp
prevalence
vs
controls
variation
fip
cats
neurologic
coronavirus
disease
risk
recurrent
atopy
bronchial
obstruction
viruses
respiratory
children
virus
epidemiology
ev
d68
rt
pcr
specific
children
respiratory
rsv
hospitalized
control
nan
cats
felis
monoarthritis
two
immunocompetent
genes
cd
disease
previously
pediatric
ifn
astrocyte
transgenic
mice
receptor
hbov
samples
respiratory
assays
children
human
real
time
assay
respiratory
strains
hcov
like
patients
respiratory
viral
pandemic
h1n1
virus
load
nan
hrv
asthma
exacerbations
viral
load
nan
hbov
respiratory
children
dna
infection
antibodies
age
coronavirus
oc43
hig
viruses
airborne
sampling
needed
affect
prv
infection
study
acute
urti
viruses
virus
screening
entry
inhibitors
cats
fiv
the
healthy
group
cftr
spinal
cord
protein
neurons
patients
60
ribavirin
therapy
pegylated
cd13
phagocytosis
phagocytic
mediated
receptor
mhv
macrophage
inapparent
infections
virus
ribavirin
mers
drugs
hcovs
reported
respiratory
viruses
samples
metagenomic
clinical
ihps
pyloric
muscle
viruses
days
sars
antibody
convalescent
the
neutralizing
particles
virus
stool
stools
storage
cd13
fcγri
membrane
cross
linking
respiratory
viral
children
virus
human
cell
caco
viruses
cells
respiratory
volunteers
washings
cultures
agent
specimens
trazodone
horses
clinical
oral
experimental
defensins
human
innate
defense
mucosal
hrv
rna
human
rhinoviruses
14
hcv229e
rna
cdna
copy
nucleocapsid
canine
pantropic
coronavirus
infection
this
gbr
gastroenteritis
outbreak
occurred
maharashtra
hadv
outbreak
respiratory
upper
korea
anxiety
coping
study
trait
state
school
preparedness
intervention
postintervention
survey
rsv
hcov
respiratory
pathogens
co
respiratory
virus
assay
rhinovirus
rsv
hrsv
respiratory
disease
pcr
virus
ms
factors
cells
immune
activation
nucleolar
hcmv
infection
rrna
synthesis
hhv
myelin
patients
controls
multiple
hbov
infections
children
respiratory
acute
children
hbov
respiratory
the
hospitalised
sars
real
time
cov
developed
dogs
virus
two
canine
coronavirus
ci
total
ld
patients
sars
rubella
infection
congenital
crs
study
viral
oligonucleotide
used
microarray
probes
hbv
na
seo
virus
cell
complementation
trans
hcv
viruses
studied
viruses
gastroenteritis
infants
pilot
childhood
5ht
the
mice
turnover
determined
h275y
assay
clinical
rt
pcr
nan
lamp
detection
dna
using
micro
hss
ies
dehydration
diarrhea
calves
nan
flaviviruses
denv
saudi
arabia
ahfv
osteoclast
acidosis
increase
ph
forl
respiratory
viruses
acute
infections
agents
study
respiratory
viruses
hrv
adv
viral
children
salrti
human
clinical
prevalence
the
age
antibodies
patterns
gene
therapy
dutch
clinical
research
denv
cbx
infection
virus
viral
140
dogs
non
infectious
inflammatory
sars
phylogenetic
based
sequence
new
hbx
membrane
mitochondrial
permeabilization
protein
lgl
nk
peritoneal
cell
infection
rotavirus
strains
pcr
lineages
total
bronchiolitis
kl
severity
respiratory
serum
class
a59
jhmv
infection
strains
respiratory
infection
il
rv
virus
dengue
patients
levels
trail
apoptosis
sars
staff
patients
infection
measures
mixed
viral
infections
patients
respiratory
group
calves
liver
effect
treatment
pancreatic
biopsy
cases
complications
clinical
cats
the
mortality
age
breed
hadv
patients
respiratory
severe
the
infections
respiratory
children
57
viruses
rabbits
heart
pleural
effusion
atrial
the
aids
viral
infection
syndrome
hmpv
the
patients
135
clinical
patients
hbv
received
lam
resistant
gene
cationic
genes
airway
emulsion
protein
sars
cov
hubc9
sumoylation
igg
specific
antibodies
autoantigens
gbs
sars
cov
protein
specific
antibodies
virus
stools
electron
microscopy
four
human
respiratory
study
tract
infection
hmpv
respiratory
study
acute
children
emesis
management
clinical
the
common
health
population
world
based
in
nan
19
covid
2020
city
spread
nan
nan
nan
nan
physical
distancing
research
imposed
covid
griffithsin
the
binding
mannose
structures
nan
respiratory
viral
children
chemotherapy
control
ns5
ifn
stat1
jev
type
sars
protein
aa
antibodies
proteins
hrct
abnormalities
pulmonary
function
children
pcr
dif
study
antibiotic
real
oral
viral
infections
viruses
cavity
sars
unknown
severe
cov
persons
plant
extracts
virus
antibody
crude
nan
nan
children
may
infectious
diseases
international
nan
protein
rna
proteins
virus
nucleocapsid
d68
ev
pcr
respiratory
specific
stress
depression
periodontal
evidence
chronic
liquorice
confectionery
products
method
acid
ibv
ndv
aiv
h9
viruses
rnai
gene
mechanism
hiv
viral
infectious
diseases
type
diabetes
the
sars
cov
cells
ace2
patients
bacteria
respiratory
children
high
pneumoniae
infections
viral
human
especially
resource
host
interactions
pathogen
cell
proteins
virus
viruses
host
emergence
transmission
mice
fut9
wild
type
cell
respiratory
associated
infants
prolonged
hospitalization
nan
nan
sars
cov
vitro
important
activation
ccp
sars
the
model
simulations
the
sarscov
2019
city
province
chinese
sars
traditional
method
cultural
proteins
virus
host
involved
replication
bals
diagnostic
bal
antimicrobial
yield
nan
nan
vaccines
the
concept
established
plants
hct
children
days
detection
rv
tgev
etec
gastroenteritis
cause
proteomics
areas
selected
pediatric
pulmonology
continues
wheezing
study
children
factors
persistent
remyelination
demyelination
response
cns
a59
cough
children
28
respiratory
ari
nan
positive
hpiv4
infection
respiratory
tract
peptide
peptides
protein
na
microarrays
8a
data
pentameric
pmf
m2
plant
many
virus
gene
expression
streptococcal
pcr
culture
10
year
sars
ace2
present
cov
organs
sars
at
may
tf
disease
mortality
episodes
hsct
diagnosis
or
ace2
raas
renal
patho
in
cholesterol
viral
information
fusion
peptide
spm
the
common
causes
spontaneous
ebv
encephalitis
pcr
report
case
rsv
neonates
the
respiratory
study
pedv
differentially
expressed
proteins
viral
lectins
antiviral
binding
caciam
cyanobacterial
phytochemical
corylifolia
plant
used
various
nan
sorfs
functional
computational
ribosome
profiling
hypersensitivity
infants
management
cutaneous
reactions
glycyrrhizin
ugats
glucuronosylation
step
important
hrsv
hrv
vs
respiratory
viruses
pcr
infection
old
respiratory
2007
sars
cov
respiratory
pathological
sweat
sars
cov
3clpro
apoptosis
cells
kd
patients
pulmonary
children
presentation
nan
essential
oils
monoterpenes
antiviral
hsv
nan
activities
glabra
pharmacological
natural
compounds
drivers
idtes
disease
observed
study
cough
chronic
pbb
children
common
nan
pyv
wu
respiratory
rtd
detected
patients
peramivir
influenza
picu
children
survivors
lung
children
disease
clinical
nan
nan
hbov1
cases
acute
detected
cap
proteases
proteins
functions
non
moonlighting
donor
influenza
disease
organs
offered
plants
hepatic
effects
important
include
wheezing
acute
children
viruses
episodes
infections
virus
viral
one
hsct
disulfides
cap
positions
helix
oxidized
murray
valley
encephalitis
virus
the
pharmacists
crises
two
role
care
licorice
used
medicine
clinical
pharmacological
biofilm
may
infections
this
role
wheezing
recurrent
rhinovirus
associated
risk
pneumonia
wheezing
factors
95
ci
virus
rhinovirus
wheezing
atopic
first
bacterial
10
ml
children
load
nan
nan
cat
months
age
observed
severe
vpu
32
recordings
tm
domain
nan
nan
asthma
exacerbation
rv
mycoplasma
associated
dimer
monomer
md
protomer
his163
erfibs
meninges
fibers
viral
brain
nan
cc16
bronchiolitis
urinary
acute
severity
sars
children
respiratory
coronavirus
appear
cyfluthrin
tetrachlorvinphos
larvae
adults
the
bk
renal
tras
nephropathy
rt
mers
cov
sars
respiratory
findings
rsv
hospitalization
palivizumab
cf
ha
protein
microarrays
used
translational
research
virus
the
secomet
hiv
antiviral
nan
health
stis
early
animal
human
nucleolus
cell
this
viral
proteomics
salmonella
proteins
cells
protein
depletion
sars
cov
tissue
tropism
in
viruses
bronchiolitis
clinical
severe
bcs
sars
cov
ace2
disease
new
infection
disease
the
pathology
tissue
children
reactions
tests
positive
non
nan
srage
acute
bronchiolitis
levels
serum
the
schools
ermi
springfield
mold
immune
system
study
environment
may
vaccines
production
emerging
therapeutic
countermeasures
rate
flow
vs
kg
min
cystatin
μm
inhibitor
human
coronavirus
nan
nan
infections
the
respiratory
children
study
protein
label
detection
techniques
free
cilia
malfunctioning
genetic
cause
whereas
infants
months
peak
bronchiolitis
clinical
rhinitis
allergic
atopic
prolonged
recurrent
sars
days
inoculation
cov
animal
cytomegalovirus
periodontal
periodontitis
innate
adaptive
mbl
respiratory
infants
symptoms
risk
prednisolone
children
wheezing
discharge
vs
uri
wheezing
trr
respiratory
children
pi
viral
brain
cells
virus
pyramidal
apoptosis
neurons
hippocampus
infection
h1n1
il
infection
levels
10
piv
infection
virus
respiratory
rsv
sars
cov
vsv
sg
gene
surveillance
pcr
infectious
diseases
public
hiv
the
associated
demyelinating
glycolipids
respiratory
infections
viral
children
symptoms
biotypes
pest
tabaci
rapid
method
rhus
chinensis
compounds
plant
species
virus
nucleolus
protein
proteome
cell
bbhcv
the
infection
apoptosis
cell
subgroup
respiratory
hrsv
viruses
cells
virus
viral
hepatitis
glycyrrhiza
reduced
nan
group
plpro
based
binding
site
human
usp
ubl
domains
usps
nan
nan
magnesium
therapy
nebulized
time
severe
osa
respiratory
viruses
children
ri
segments
hydrophobic
foldable
hca
protein
nan
nan
may
the
virus
cells
class
aboriginal
non
om
children
research
staining
lung
necrosis
cells
the
rsv
picu
days
patients
pz
sars
protein
proteins
virus
structural
lesions
rats
ae
sde
within
sars
cov
the
proteins
large
picu
cap
china
associated
21
asthma
asthmatic
atypical
children
pneumoniae
hbov
emergent
virus
frequently
detected
nan
nan
cells
applications
new
molecules
membranes
diseases
pathogenic
infections
biomarkers
serum
nan
infants
infections
rhinovirus
respiratory
prevalence
plpro
tgf
β1
sars
expression
viral
pneumococcal
pneumonia
pcap
diseases
complications
anesthetist
infections
airway
may
antibodies
phage
technology
display
available
form
interactions
interaction
homomeric
two
virus
influenza
pigs
responses
ifn
asthma
mothers
infants
viral
pregnancy
nan
apcs
patients
hemoptysis
cardiac
catheterization
patients
hemophagocytic
lymphohistiocytosis
lymphocyte
cytotoxicity
proteins
sars
regulated
disease
identified
disease
viruses
severity
children
rsv
niv
receptor
nipah
hev
envelope
tight
junctions
function
the
cell
disorders
olfactory
inflammation
common
inflammatory
emodin
toxicity
used
chinese
polygonum
virus
pathology
human
diseases
infection
sensitization
wheezing
sole
associated
rhinovirus
nan
asthma
wheezing
might
respiratory
risk
respiratory
picu
influenza
children
infection
proteins
btv
differentially
expressed
quantitative
hemophilia
factor
bleeding
may
concentrates
all
cell
chemotherapy
patients
infantile
saliva
patients
disease
markers
assay
infection
control
shelter
needs
evidence
sars
the
cov
damage
specific
the
infection
children
respiratory
sars
forsythoside
cells
infection
the
used
nan
respiratory
viruses
clinical
diagnosis
rti
plants
production
proteins
possible
recombinant
nan
medication
children
rhinovirus
asthma
load
hmpv
children
respiratory
study
infections
ptx
levels
duration
admission
correlation
virus
asthma
rsv
influenza
patients
ribavirin
use
patients
adverse
sars
enterovirus
antibodies
virus
polyclonal
raised
hsv
gh
glycoproteins
gl
peptides
erag
erfibs
brain
infection
fibers
nan
nan
otitis
media
aom
antibiotic
respiratory
kipyv
wupyv
detected
human
positive
direct
electron
microscopy
detection
indirect
000
jhm
polypeptides
p60
two
cells
pm27
multocida
mouse
spleen
class
mhc
infection
wnv
ii
lamp
amplification
amplicons
using
real
nov
feline
sav
canine
isolates
otitis
media
major
indigenous
australians
arboviruses
vector
non
surveillance
sampling
hku1
cov
cleavage
site
3cl
cdv
strains
epidemic
serengeti
dog
hadv
outbreak
viral
ard
military
protein
proteins
vlp
four
sars
tea
compounds
leaves
bacteria
catechins
nan
influenza
pandemic
virus
needed
important
rnas
diseases
small
mirnas
human
index
case
sars
cases
the
nan
nan
species
the
polyploids
gymnosperms
polyploid
ms
microbial
biomarkers
the
microorganisms
assembly
macromolecular
complexes
viral
defined
region
fp
th1
fipv
domain
protein
pfuch54
activity
degradation
membrane
hcv
anti
uralensis
activity
50
nan
sars
cov
elastase
infection
lungs
nan
650
s450
rs450
crt
protein
bovine
diarrhea
infection
pathogens
japan
virus
part
inhibitors
fifth
stories
human
antivirals
norovirus
antiviral
research
vs
coronavirus
disease
pd
response
viral
drugs
effective
antiviral
conserved
type
ii
sequences
fipv
strain
fcov
uu4
fipv
protein
serotype
nan
protein
sia
the
method
using
virus
min
mhv
cells
the
ebola
development
disease
virus
hemorrhagic
protein
viral
integral
membrane
polypeptide
nan
hrv
structural
viral
capsid
proteins
mers
cov
elisa
protein
respiratory
antiviral
viral
high
new
pts
immune
lectins
hiv
different
system
sars
cov
disease
low
mice
class
p3hr
ii
cells
antigen
nan
diseases
many
communicable
emerged
forces
infection
virus
prohibitin
cells
chikungunya
loci
these
polymorphic
observed
we
nan
hav
hepatitis
discussed
availability
drugs
proteins
function
proteomics
disease
human
amps
antimicrobial
many
mechanism
peptide
temperature
fever
sars
body
screening
the
polypeptide
viral
nucleoprotein
gene
carbohydrates
use
review
maldi
mass
viruses
activity
antiviral
showing
rna
nan
nan
nan
cells
clq
u937
denv
used
evolution
human
activities
parasites
anthropogenic
rabies
in
type
test
monoclonal
nan
virus
cerebral
days
inoculation
14
sperm
ar
aminopeptidase
tyrosine
the
viral
hsv
genomes
virus
viruses
nan
nan
flies
disease
virus
newcastle
the
receptor
membrane
sexta
cryla
purified
nan
dependent
cap
translation
eif4e
cancer
mab
fipv
neutralizing
mabs
feline
influenza
virus
considerable
viral
annual
rna
viruses
based
genetic
virus
receptor
docking
mv
slam
susceptibility
cells
rv3425
novel
ctl
epitopes
influenza
virus
entry
viral
viruses
immune
nucleic
host
responses
cells
apn
cd13
inhibitors
cell
inflammatory
sars
protein
cov
virus
receptor
nan
pcs
various
the
diseases
potential
rpa
rt
pdcov
detection
assay
pdcov
psav
pedv
prv
porcine
sads
cov
china
coronavirus
virus
cpv
the
gene
sequences
strains
q1
italy
genotype
624i
first
virus
the
high
pathogenicity
segment
bovine
130
respiratory
viruses
pneumonia
influenza
virus
cattle
detected
viral
cpv
2c
parvovirus
dogs
in
bcov
he
strains
calves
dairy
pdcov
vietnam
the
sea
virus
g2b
pedv
strains
jeju
isolates
porcine
samples
deltacoronavirus
in
virus
fcov
type
samples
strains
fip
sloths
anhv
sloth
phleboviruses
virus
piglets
peav
gds04
newborn
porcine
viruses
human
viral
the
novel
pedv
gii
subgroup
strains
re
pedv
hljby
strain
strains
orf3
wild
choleraesuis
different
resistance
isolates
niv
human
receptor
protein
humans
bovine
brd
viruses
virus
respiratory
sads
cov
diarrhoea
new
swine
diseases
re
drivers
livestock
emergence
wild
viral
zoonotic
mammals
human
applications
maldi
review
mass
discussed
hmpv
rsv
vaccine
human
pathogen
cancer
respiratory
viral
patients
hmpv
pdcov
piglets
sows
challenge
vaccine
risk
risks
product
in
recalls
virus
viruses
host
species
use
outbreak
ebola
virus
2015
cases
nan
nan
rvp
pcr
bal
testing
np
viral
viruses
sequence
nucleic
known
enterovirus
two
pathway
enteroviruses
members
influenza
patients
also
mortality
illness
glycoproteins
hsv
entry
role
four
viral
viruses
hnrnpa1
virus
host
nan
ms
ions
glycopeptide
glycopeptides
spectra
tem
viruses
diagnosis
technique
visualization
nan
bronchiectasis
asthma
copd
reversibility
infective
poct
influenza
use
stay
ed
sars
cov
the
human
days
nan
viral
ups
positive
rna
viruses
rf
patients
adv
pneumonia
initial
treatment
ifn
mers
supportive
group
no
infections
radicals
virus
oxygen
progress
human
focus
despite
medical
sars
recognized
developments
diagnostic
abstract
viruses
species
bats
the
bat
decision
we
guidelines
many
problems
rna
viral
like
strains
new
nan
nan
virus
outbreak
vhf
disease
lujo
hrv
species
many
strains
distinct
patients
np
cap
clinical
necrotizing
cd13
tuberculosis
monocytes
intracellular
survival
acute
sars
syndrome
developed
chest
nan
nan
patients
sputum
ee
asthma
exacerbation
sars
in
transmission
contact
nosocomial
rna
viral
viruses
domains
made
lncrnas
viral
host
infections
cytokines
incidence
infection
viral
cap
childhood
influenza
ha
virus
cleavage
proteases
pathway
tgf
signaling
cancer
tumor
sars
cov
mabs
vaccines
new
attachment
protein
fibre
properties
structure
nan
viral
initiation
mrnas
viruses
protein
hps
haemophagocytic
syndrome
infections
cells
viruses
ktrs
viral
diseases
infections
clinical
respiratory
analysis
infection
influenza
viral
mirnas
respiratory
infections
role
nan
risk
influenza
exacerbations
asthma
occupational
arsenic
h1n1
influenza
induced
exposure
coronaviruses
respiratory
host
epithelial
syndrome
nan
nan
infections
well
tropics
burden
tropical
copd
asia
pacific
region
gold
amplification
gene
lamp
simple
rapid
melatonin
infections
functions
clinical
trials
proteases
also
enteroviruses
infections
enterovirus
na
life
cycle
influenza
viral
nan
niv
virus
human
pigs
bats
safv
human
studies
virus
emerging
pseudoviruses
viruses
viral
diseases
however
nan
nan
nan
use
papr
sars
perceptions
hcws
virus
copd
infection
asthma
acute
species
nutrition
pregnancy
lactation
reproductive
risk
10
infection
healthcare
patients
nan
day
sars
the
clinical
features
copd
disease
associated
acute
aecopd
virus
respiratory
influenza
pneumonia
infection
nan
viruses
cellular
viral
modifications
cells
ild
patients
noninfectious
hdct
high
treatment
combination
age
sars
outcomes
infections
respiratory
cov
health
in
disease
the
hong
kong
spread
asia
respiratory
tropical
infections
wide
opacities
acute
consolidation
radiographic
hrct
autophagy
viruses
virus
immune
pathway
terminal
gln
residue
acid
cyclization
sars
infection
patients
niv
respiratory
genome
sequence
amplification
this
methods
nan
sars
phase
sequelae
patients
function
http
onlinelibrary
wiley
com
doi
virus
piv5
parainfluenza
vaccine
vector
nan
may
ms
virus
myelin
the
canine
colostrum
puppies
health
hyperimmune
sars
model
cov
exponential
the
nan
mers
cov
camel
camels
vaccines
infection
hrv
associated
respiratory
tract
nan
nan
infection
population
influenza
mask
masks
ferret
coronavirus
left
disease
spleen
risk
surfaces
infection
contact
rate
the
type
ifn
viral
system
fip
δtnc
baso
the
effusions
cat
this
case
report
describes
ferrets
imaging
14
lymphoma
12
cats
intraventricular
mri
ependymomas
images
ck
dogs
cats
bb
serum
weeks
cats
ciclosporin
dose
clinical
cats
fip
95
specificity
icc
sysmex
effusions
cats
cytologic
tncc
inflammatory
mri
masses
dogs
cats
united
states
rbc
transfusion
adverse
cat
lesions
tissues
computed
tomography
harderian
normal
glands
rabbits
guinea
captive
free
ranging
foxes
serum
fip
lesions
signs
disease
cutaneous
cats
uveitis
diagnosed
feline
fcov
canine
one
influenza
virus
unstructured
disease
rat
ocular
widely
experimental
ocular
mucin
surface
eye
the
terbinafine
therapy
cat
persian
cats
rats
infectious
thoracic
disease
neoplastic
ocular
treatment
leishmania
cat
positive
skin
case
fsfs
collagen
fragile
cytopathology
dogs
cats
lymphoma
aqueous
infectious
cell
post
allogeneic
hsct
wall
intestinal
enhancement
peak
wash
agents
babesia
transfusion
blood
spp
cats
igg
csf
alb
index
sars
cov
60
heat
samples
kittens
queens
gondii
ocular
infected
immunocytochemistry
antigens
often
stained
the
canine
or
feline
and
pcr
respiratory
infections
pakistan
rsv
influenza
rivalta
test
cats
fip
positive
virus
viral
inactivation
west
nile
nan
sarcocystis
disease
sp
domestic
cat
nasal
rhinitis
lymphoplasmacytic
therapy
orbit
fip
antemortem
diagnosis
lesions
disease
cats
anterior
uveitis
aqueous
humor
foal
diabetes
insulin
type
mellitus
eyes
days
uveitis
common
synechia
skin
feline
abdominal
fluid
cat
nan
mri
sphenoid
bone
osteomyelitis
csf
hmpv
virus
vaccine
children
human
nan
patients
remdesivir
receiving
data
ventilation
cds
gly
antiviral
prrsv
virus
vaccines
nanomaterials
nanoscale
efficacy
developments
ifn
infections
viral
host
bacterial
estimators
associated
case
fatality
data
the
sars
novel
coronavirus
identification
intestinal
igg
fcrn
cry1ac
mice
incubation
estimate
time
data
the
sars
sp
pneumonia
cov
protein
risk
vietnam
beck
world
theory
ifnα
pbmc
tgev
infected
cell
ccr5
viral
recruitment
infection
mice
asthmatic
patients
non
bacterial
mixed
mhv3
infection
balb
macrophages
mouse
epitope
vaccine
cell
ebovs
based
rumours
rumour
sars
china
particular
individuals
group
infection
probability
diagnostic
incubation
times
the
quarantine
time
tnf
diseases
human
transcription
gene
detection
rapid
multiple
the
zno
studies
respiratory
infection
handwashing
risk
respiratory
remote
frozen
specimens
the
infiltrates
patients
pulmonary
ltr
new
levels
mhd
pos
pigs
samples
balf
health
pr
39
respiratory
viruses
pasteurization
plasma
virus
blood
pdcov
pigs
tibetan
chn
samples
piv
transplant
pneumonia
lung
das181
dna
materials
nanoscale
nanomaterials
biology
fip
cats
ranges
the
prevalence
rna
viral
proteins
ncs
interactions
plasma
dried
use
civilian
approved
bos
acute
development
lung
bronchiolitis
pedv
occurred
rna
strains
levels
ia
htrs
screening
ct
scans
nan
mers
cov
plasma
amotosalen
uva
cpv
vp2
analysis
viruses
canine
rna
sgs
sg
assembly
regulation
sars
cfr
china
cases
the
cpv
carnivores
positive
2a
dogs
uncoating
virus
host
viruses
cues
three
hospital
epidemics
hospitals
control
protein
ty3
frameshift
carbon
two
nan
nan
pdcov
china
2015
diarrhoeal
complete
bal
microbiologic
sct
yield
recipients
group
co
lrtd
infections
bacterial
virus
porcine
sv
piglets
vesicular
mb
plasma
ebov
mers
cov
hev
related
viruses
hepatitis
disease
centers
rbv
treated
respiratory
rsv
rna
delivery
rnai
therapeutic
disease
pdcov
south
korea
strains
knu16
hadv
infection
viremia
hct
recipients
household
ili
secondary
contacts
shared
nan
mers
cov
viral
inactivated
amotosalen
nan
peptides
sera
three
patients
sars
tgev
ch
orf3
miller
field
samples
test
ibv
the
rt
respiratory
pilgrims
mers
cov
virus
ribosomal
frameshifting
gene
products
the
rv
clinical
species
children
identified
mers
cov
pigs
transmission
virus
handwashing
sars
studies
literature
effectiveness
sars
the
risk
transmission
board
infection
rv
the
pcr
clinical
pcv
animals
animal
facility
barrier
aavv
wild
birds
poultry
isolate
bats
pteropus
medius
group
viruses
ribavirin
treatment
sars
analysis
patients
horses
coronavirus
ecov
data
infection
pig
rva
china
13
rvas
porcine
animals
islets
donor
viruses
pdcov
diarrhoea
porcine
strain
discovered
nan
no
antimicrobial
the
delivery
ssti
virus
detection
viruses
assay
microarray
dli
cells
donor
allogeneic
recipient
diseases
infectious
important
cattle
bsm
pedv
italy
strain
trucks
farms
nan
rna
proteins
rbps
protein
binding
ferret
domestic
lima
peru
died
mers
cov
plasma
riboflavin
uv
circovirus
porcine
pcv3
this
reproductive
losp
patients
allo
hsct
day
rna
rdrps
viruses
viral
proteins
oocysts
water
cryptosporidium
inoculum
faeces
indel
strain
non
pigs
contact
viral
patients
viruses
respiratory
shedding
nuclear
transport
ns3
4a
impβ1
rna
viral
gene
expression
turnover
virus
swine
disease
the
user
carv
ifd
allo
hsct
recipients
pdcov
chinese
strain
hb
bd
rna
pact
protein
trbp
dsrna
pcv3
two
circovirus
samples
39
pedv
identity
variant
recently
reported
control
countries
trans
boundary
disease
rna
cap
ribose
interactions
mrna
nan
nan
order
10
section
in
keep
pdcov
2015
sl2
sl5
based
respiratory
detection
virus
viruses
nanoparticle
lung
patients
microbiological
found
balf
mbl
protein
human
system
groups
translation
viral
host
viruses
translational
rna
structure
rnas
function
molecules
nan
sars
control
countries
measures
affected
infections
95
ci
cell
haplo
rna
chemical
marks
this
biological
2017
g2b
pedv
isolates
g1b
bat
cov
viruses
respiratory
syndrome
vaccines
vlps
current
provide
infectious
rna
small
rnas
viral
virus
agricultural
economic
health
costs
impacts
strain
strains
esbl
producing
ampc
plasma
factor
viruses
pathogen
derived
projects
viral
infections
new
antiviral
lncrnas
rna
virus
host
antiviral
pathogens
paper
water
review
techniques
level
pedv
pdcov
incidence
prevalence
pathogens
host
lipid
cell
lipidome
sars
beijing
mainland
china
spatial
microarray
virus
swine
the
electronic
china
spike
strains
g2a
g2b
lambs
scouring
ng
ml
faecal
avn
sars
corticosteroids
hip
necrosis
strains
vietnamese
indel
porcine
pedv
rna
enzymes
cap
structure
involved
nan
pi
blood
risk
rbc
rbcs
water
deer
coronavirus
bcov
wild
cases
china
sars
disease
to
pdcov
isolates
us
12
vietnam
rvi
risk
transplant
factors
year
infection
hiv
disease
genetic
aids
pedv
strains
shandong
province
38
secd
swine
enteric
introduction
coronaviruses
rvi
rsv
respiratory
patients
predictive
membrane
rna
virus
replication
vesicles
sars
cov
human
blood
inactivation
vulnificus
isolated
12
marine
genotype
nan
fekov
first
samples
feline
kobuvirus
porcine
prdc
pathogens
respiratory
bacterial
pedv
tgev
rt
specific
viruses
patients
rvp
antimicrobial
pneumonia
immunocompromised
atg
proteins
autophagy
functions
intracellular
fmdv
assay
disease
rna
fmd
rna
ncrna
viral
targets
small
testing
capacity
diagnostic
persons
sars
protein
kinase
akt
pkb
virus
data
trees
genetic
transmission
infected
oas1
viral
rna
oas
infection
asthma
children
antibiotic
antibiotics
unjustified
exercise
care
mobility
protocol
icu
biomarkers
opportunities
new
pharmaceutical
patient
of
samples
igg
iga
pedv
care
home
health
workers
pandemic
hcov
antibody
nl63
antibodies
oc43
resistance
t20
fusion
inhibitors
peptide
probe
mb
probes
nanowires
assays
hunov
vp1
virus
rvsv
recombinant
s2
s1
trimers
monomers
the
drug
structure
sbdd
lead
process
xrn1
rna
mrna
decay
viral
influenza
treatment
anti
the
direct
mbl
fcn
binding
chimeric
mbl76
hypoxia
ucrs
noncoding
transcripts
ultraconserved
ca
release
channels
role
naadp
he
history
ct
hydrocephalus
uk
hku1
spike
domain
receptor
cov
tb
pilgrims
countries
mass
risk
innate
ptx3
immune
system
hemostasis
nan
influenza
ms96
virus
h9n2
avian
protein
mass
data
identification
software
wild
carnivore
domestic
transmission
parvovirus
sh
channel
protein
his
the
nan
species
scedosporium
pcr
lamp
the
nan
nt
age
associated
diseases
neuronal
protein
rtcs
viral
replication
using
cases
we
identified
179
acute
gp
mabs
c2g4
c4g7
ebolavirus
nan
nan
hbc
hbv
l60v
variation
viral
strategic
risk
communication
new
emerging
eae
ms
mice
autoantibody
antigenic
sars
igm
cov
seroconversion
detection
oshima
08
as
tbev
10
readthrough
pol
stop
gag
codon
nan
wesv
shrews
coronaviruses
known
asian
influenza
pneumonia
severe
effects
corticosteroids
hhv
patients
specimens
pcr
positive
trim5α
species
infection
the
retroviral
nucleotides
replication
rna
structures
pairing
innate
viral
immunity
the
pathway
species
dv
positive
individuals
12
trim56
virus
interferon
the
trim
orf8
the
sars
cov
deletion
docking
new
molecules
often
ligands
mrna
decay
viruses
host
order
scf
i2
cdc4
binding
proteins
637
position
virus
tgev
cdna
dna
damage
nss
signaling
rvfv
models
structure
with
leut
available
rcov
cells
at1
infection
alveolar
ub
dub
dubs
aml
dynamic
nan
cvt
e002
ari
vs
placebo
cov
plpro
mers
sars
amc
initiation
rna
internal
hcv
replication
microglia
virus
cns
depletion
infected
ifn
filoviruses
pathways
chapter
strategies
sars
cov
host
nsp1
cells
sars
respiratory
limited
rhesus
cynomolgus
care
companions
gap
work
families
two
detected
viruses
samples
siblings
human
virus
bocavirus
culture
mrnas
nan
microglia
tmev
infection
virus
cns
rotavirus
lat
vi
latex
agglutination
infection
ibv
respiratory
pclss
cells
infections
respiratory
antivirals
influenza
development
translocation
pause
rna
translation
occurs
nan
droplets
respiratory
expiratory
activities
aerosol
virus
sars
inoculation
intestinal
detected
ppiases
virulence
peptidyl
identified
protein
events
cross
scale
interactions
catastrophic
fusion
jhm
ceacam
murine
virus
rna
antiviral
compounds
virus
new
approaches
vaccines
new
vaccine
well
covs
cov
oc43
hcov
broad
array
e3
human
proteome
huprot
mers
vaccines
cov
based
protein
coronavirus
oc43
status
hku1
nl63
95
ci
severe
respiratory
pneumonia
is
rising
failure
comply
prophylaxis
influenza
virus
new
jersey
human
sla
0401
peptides
the
swine
disease
diagnosis
leishmaniasis
change
epidemiology
mers
cov
the
model
dpp4
heart
failure
viral
damage
acute
surveillance
microbial
systems
support
laboratory
mers
cov
dpp4
respiratory
syndrome
niv
patients
treated
among
pneumonia
ebola
mabs
treatment
in
experimental
vrp
aged
vaccine
virus
emerging
virus
muv
cells
apical
release
splicing
mrna
essv
splice
rna
cells
progenitor
epithelial
the
stem
g8
health
member
states
commitments
cells
naïve
cd4
type
ifn
vulnerable
health
populations
service
limited
phev
actin
virus
cells
cytoskeleton
frameshifting
pseudoknot
efficiency
unfolding
mechanical
ifn
mhv
virus
sev
replication
vaccine
influenza
transplant
recipients
ifn
cd13
membrane
cell
bradykinin
plasma
viral
cellular
proteins
protein
virus
viral
rdrps
rdrp
nac
translocation
several
amines
image
see
text
pro
2a
ev
antiviral
ifn
ifitm3
domain
restriction
vitro
cd225
respiratory
virus
viral
afi
we
hadv
serotypes
serotype
identification
specific
sars
cov
cells
cell
lung
rt
new
bunyavirus
assay
lamp
nan
replication
csa
sars
cov
expression
cytokine
storm
the
infectious
term
localization
protein
nuclear
nucleolus
cells
hiv
cells
ifn
tbk1
virus
pv
neutralizing
antibody
test
neutralization
prm
complex
formation
protein
analysis
hcv
viral
replication
rna
dmvs
cg
1b
ndv
hn
we
erad
protein
pathway
folding
by
nan
zikv
viremia
disease
vaccine
prevent
eqcxcl16
eav
cells
equine
entry
hsk
hsv
ul6
molecular
mimicry
hmpv
virus
cotton
infection
respiratory
memory
immune
vaccines
response
immunological
cns
development
immune
responses
variations
organism
respiratory
amphoriforme
patients
infection
cxcr2
oligodendroglia
mice
demyelinating
disease
hpv
100
lamp
type
specific
3a
sars
cov
protein
cells
rna
membrane
replication
double
1a
cns
immune
challenges
the
infections
mers
cov
s1
sia
attachment
tumor
vaccinated
mice
kinase
vaccine
dogs
ccv
vaccine
fecal
inoculated
swine
bpsabcd
locus
bronchiseptica
found
nl63
bacterial
human
hcov
adherence
ha
α2
specificity
sa
influenza
denv
foi
transmission
time
estimates
dengue
pathogenesis
dss
dhf
tropism
partnerships
health
florida
academic
public
vaccine
tb
dna
μg
mdr
env
fold
mice
achieved
rmvas
hcov
infection
respiratory
hcovs
sari
ics
sle
cd14
monocytes
c1q
hrv
16
irak
viral
infection
nan
genome
mshv
cell
homologues
encode
replicase
replication
protein
proteins
virus
cells
innate
rapid
elimination
facilitate
sdabs
antibodies
sdab
heavy
domains
recombination
viral
rna
rnas
host
needed
healthcare
virtues
in
response
rev
nls
biv
sequence
aa
coronavirus
human
gene
rna
mrnas
locus
expression
lncrna
nest
salmonella
reproductive
number
numbers
transmission
vaccine
models
disease
host
infectious
pathogen
health
research
chain
access
publications
gn
virus
sftsv
phleboviruses
surface
mice
virus
cd4
ifn
gko
sars
cov
assay
orf
10
aries
ba
filmarray
rp
the
diversity
repertoire
vβ
cell
global
affinity
antibody
escape
neutralization
fragment
ftsz
assembly
ecftsz
e93r
found
protein
mhv
virus
gene
mutant
viruses
inactivation
heam
genome
stranded
lung
conference
diseases
current
cell
targets
identification
potential
inhibitors
therapeutic
adp
macro
domain
ribose
protein
autophagy
silica
inflammation
disease
macrophages
aged
animals
higher
bal
fluid
children
hmpv
virus
rsv
respiratory
amylase
cystine
knot
inhibitors
apocynaceae
nan
pcr
rt
pooled
serum
samples
remyelination
number
methylprednisolone
sch94
03
approach
encodes
allele
expression
ase
human
mabs
antibody
repertoires
display
pandemic
million
the
h1n1
outbreak
replication
deficient
autophagy
bacteria
autophagic
admissions
copd
air
pm
pollutants
nan
cells
tmprss2
mers
cov
vero
nsp11
prrsv
ifn
nendou
irf9
cell
responses
memory
mice
cd8
sars
protein
specimens
cov
nucleocapsid
fusion
a59
mhv
ph
infection
stroke
angiotensin
converting
enzyme
mas
virus
host
the
human
respiratory
scov
mhv
utr
trs
loop
nan
tlr4
rab10
lps
receptor
membrane
care
emergency
public
health
must
cxcl1
cns
expression
mice
control
hiv
hcv
cells
morphine
increased
influenza
ifn
viruses
type
major
helix
three
coronavirus
the
helical
domain
mhv
nsp3
plp2
coronavirus
public
health
threats
investigative
teams
ez1
manual
easymag
nucleic
extraction
contact
tracing
disease
epidemic
nodes
am
donor
lung
lungs
ltx
viruses
emergence
hosts
adaptive
adaptation
isg15
free
isgs
viral
ubiquitin
influenza
salinomycin
viral
virus
viruses
influenza
humans
species
severe
acute
bcg
vv
cd4
cell
resistance
6hb
formation
tmc353121
binding
hr1
how
tackle
new
causes
occupational
health
the
success
primary
care
epitopes
peptide
cognate
discontinuous
immunogenic
hrv
children
hsct
risk
viral
cost
local
the
strategy
disease
virus
dual
promoter
vaccine
heterosubtypic
nan
nan
epidemics
strategies
method
control
alternative
stat1
mice
ova
increased
mwcnts
env
viral
step
infectious
retroviral
sars
patients
viral
load
coronavirus
sars
cd14
severe
mild
controls
sars
library
the
cov
human
virus
salmon
isav
anemia
isa
rnai
rna
viral
present
short
ifn
demyelination
oligodendrocytes
signaling
increased
hospital
admissions
net
assumptions
million
pro
two
processing
wbv
data
nsp10
replication
strand
ts
negative
alv
envj
chnhe1
cells
leukosis
responses
proinflammatory
seov
infection
disease
older
indoor
iaq
tc
study
nsp15
the
structure
a59
virus
apoptotic
dna
dcs
the
machinery
ifitm3
posterior
cell
stella
part
rna
helicases
virus
protein
host
plpro
antiviral
50
μm
structure
virus
1α
we
antiviral
chemokine
replicase
rna
proteins
viral
replication
nan
trimer
ebolavirus
entry
peptide
region
transcription
mrna
sg
cov
gene
heparin
crisis
institution
shortage
strategies
mers
cov
human
respiratory
potential
protein
gene
δe
virus
virions
nan
denv
megakaryopoiesis
eiii
infection
viral
hcov
chloroquine
oc43
hcovs
mice
sequence
foreign
specific
sensing
nucleic
alveolar
igf
macrophages
cf
function
torovirus
toroviruses
variants
btov
ptov
endothelial
fibrosis
diabetic
dpp
cells
respiratory
sickle
cell
disease
vitamin
disease
antibody
patients
severe
neutralizing
adhesion
the
anti
minimal
adhesins
sars
exposures
community
cases
case
mhvr
cells
jhmv
wt
infection
feline
felv
virus
infectious
disease
peptide
many
antigen
immune
delivery
cruzi
infection
parasite
specific
autoimmunity
ifn
type
viral
vhsv
virus
pigs
pneumonia
infected
hyopneumoniae
siv
neu4
5ac
preparative
scale
acetyl
cav
ali
cell
lung
cells
nan
public
political
awareness
emerging
infectious
measles
pneumonitis
patient
the
established
hku1
human
colorado
specimens
spike
dc
infection
hiv
nonhuman
human
diminazene
induced
ss
plaques
ang
related
sars
cov
genes
monocytes
nan
optimal
treatment
scale
control
cost
rejection
lung
transplantation
acute
humoral
viruses
latent
infection
cells
infected
birds
abv
pdd
tissue
clinically
service
sectors
losses
outbreak
tourism
sivcpz
hiv
mb897
humans
virus
dna
immunization
research
in
common
sars
cov
grft
mammals
infection
protein
virus
carboxy
core
molecules
transfusion
blood
abt
acute
patients
frameshift
reporter
protein
the
hiv
parp
inflammatory
family
roles
this
lv1
lv2b
pcr
viruses
gene
mast
cells
viral
virus
type
rna
gapdh
regulation
cellular
interactions
pbc
protein
microarray
diagnosis
proteins
stool
hbov2
using
human
hbov
norovirus
protease
viral
based
3cl
post
icu
patients
intensive
care
adenovirus
pcr
detected
children
uri
expression
viral
viruses
genes
foreign
rna
host
factors
tux
ms
cns
immune
system
privilege
whereas
ms
vsv
vector
responses
protein
social
infectious
disease
human
transmission
ifn
mice
cells
virus
tmev
assembly
folding
cx43
er
multisubunit
mice
immune
mv
response
ifnarcd46tg
gc
gn
in
homo
hantaviruses
zbtb25
iav
rna
viral
replication
ig
cell
human
antibodies
gene
interferon
mechanisms
function
ubiquitin
cytokine
assay
ml
culture
standard
detection
cells
scfvs
surface
coli
we
iav
ctsb
cells
pr8
production
afi
dengue
outbreak
illness
states
rna
expression
eukaryotic
regulatory
gene
sars
animal
cov
species
cotton
hiv
antibodies
antibody
human
cell
hepatitis
lsecs
mhv3
inflammatory
viral
exon
innate
immune
activity
rna
dq
molecules
dqa1
dqb1
binding
rnai
virus
dengue
ns4b
cells
bat
viruses
samples
advs
species
nan
vector
adenovirus
brain
vectors
caudate
apcp
exposure
vol
viruses
ms2
herbs
western
medicines
chinese
sars
virus
idcs
toso
infection
autoimmune
virulent
pedv
porcine
epidemic
diarrhea
protein
virus
phosphorylated
infected
cells
trim
proteins
viral
antiviral
host
ahrf
patients
readmission
niv
death
hrv
patients
infected
respiratory
rtis
cysteine
compound
orthogonal
pooling
screening
stress
translation
sgs
initiation
infection
nan
vp
loop
25
subjects
viruria
junv
macv
response
pkr
rna
mice
encephalomyelitis
virus
bc
b6
rig
pact
type
viral
function
vzv
infection
svv
response
lungs
nuclear
import
cells
infected
rhinovirus
ppe
stockpiled
stockpiles
public
health
respiratory
virus
patients
viruses
viral
plant
aphid
virus
apn
receptor
large
scale
pattern
global
epidemic
basv
fusion
vsv
congo
virus
nan
virus
viral
ab
recrudescence
within
cs1
cleavage
p28
p65
virus
specimens
nps
saliva
respiratory
viruses
nan
protease
serum
proteases
substrate
balf
stress
granules
rsv
rna
cells
protein
often
using
predictions
near
pa
terminal
residues
host
shutoff
sepsis
gut
immune
microbiome
intestinal
10
gloves
scrubs
ppe
φ6
glycans
high
mannose
glycan
the
baicalensis
cell
root
extract
human
respiratory
specimens
pcr
viruses
rt
health
medical
international
countermeasures
global
irf
ifn
replication
factor
interferon
human
influenza
like
illness
peru
nucleotide
binding
rna
fidelity
dynamics
disease
infectious
patterns
global
occurrence
sting
ifn
rna
virus
viral
influenza
testing
rapid
respiratory
laboratory
rtd
dio
rats
insulin
plasma
healthcare
workers
connected
network
hand
tissue
models
engineering
viral
infection
rna
control
armored
positive
external
cov
hamsters
rsars
δe
respiratory
ifn
heart
role
studies
known
pandemic
h1n1
mabs
2009
may
structural
apoptosis
phase
inhibitors
the
cx43
infection
gap
junction
mhv
nan
receptor
mhv
virions
ph
virus
nan
genes
ranavirus
host
switching
based
nsp3
domain
two
globular
residues
on
virus
mhv
ms
induced
ev71
psgl
endocytosis
cells
infection
identified
astrovirus
astroviral
rna
viruses
nsg
mice
denv
human
blt
mice
cathepsin
reovirus
wt
ctsb
hbv
bat
hepadnaviruses
human
hepatitis
lysosomal
lipid
pi4kiiiβ
sorting
trafficking
nan
nan
nan
information
tobacco
health
safe
right
nan
r1
hepatic
adhesion
gut
min
nan
dna
pres1
hbss1
hbcs1
ep
virus
host
vaccinia
factors
cells
coronary
tregs
mice
hypertension
arteriolar
ibdv
src
virus
phosphorylation
y416
sars
doctors
gps
family
clinical
nan
sars
identified
cov
respiratory
one
autophagy
translation
hcv
host
factors
mva
sars
cov
mice
the
bacterial
approaches
infections
vaccines
interventions
hcv
ddx3x
infection
ikk
cellular
proteins
protein
virus
ibv
the
apoptosis
sialic
acid
t3sa
cell
response
immunization
cell
dna
whcag
individuals
quarantine
must
public
health
glycan
arrays
protein
sialic
different
viral
molecular
cells
beacons
signal
orf
3b
protein
sars
cov
cheetahs
felv
free
ranging
antibodies
atg5
atg12
process
role
conjugate
residues
sars
cov
form
hexameric
nan
vesicles
leaflet
ordered
outer
pc
il
virus
27
cns
viral
disease
fragmentation
population
host
could
schizophrenia
recent
onset
food
immune
p24
mucosal
flagellin
kfd
3d
viral
lcmv
rnai
therapy
sirnas
protein
surface
proteins
analyzed
retained
exacerbations
sputum
il
levels
exacerbation
virus
assay
rt
lamp
the
hapn
binding
547
cells
hcov
lcmv
cell
cd8
cd4
memory
enzymes
ubiquitin
ups
viral
known
hlh
rare
syndrome
virus
hemophagocytic
hev
ppmo
specific
antiviral
hepatitis
malaria
mbl2
severe
the
or
emergency
drug
supply
system
safety
nan
sars
cov
interferons
infection
induction
reassortment
rotaviruses
genes
human
rvs
lmp1
ubc9
interaction
ctar3
sumoylation
cells
treg
cns
cd11c
gondii
wildlife
livestock
diseases
interfaces
interface
lsectin
binding
glycoproteins
glycans
glycan
data
big
research
practice
world
pv
furin
dna
viruses
many
genotype
oc43
hcov
genotypes
strains
mice
demyelination
inflammatory
tregs
infected
nan
rbd
mabs
mers
cov
specific
phase
cell
cycle
ev71
cyclin
ck20mrna
expression
pancreatic
cancer
patients
sars
cleia
cov
the
protein
led
novel
virus
systems
new
isg15
usp18
mhv
coronavirus
isgylation
crswnp
acute
exacerbation
nasal
crs
handwashing
wearing
masks
gloves
gowns
viral
lrti
respiratory
patients
allo
lung
epithelial
cl
na
cells
rvfv
fever
infection
cells
virus
nw
ow
virus
immune
hf
gene
salmonella
enterica
serovar
typhi
bril
promoter
the
activity
sp1
using
viruses
phage
lfa
detection
membrane
fusion
gp2
structure
ebov
protein
chimeric
mhv
fluorescent
gfp
nsp1
the
179
barrel
protein
epac
mers
cov
potential
therapeutic
cort
host
could
birds
elevated
translation
cchfv
viral
np
mrna
ebola
virus
abl1
tyrosine
release
dengue
serotypes
virus
four
vaccine
gp
entry
f88a
npc1
cells
host
species
viral
genetic
new
bcov
different
virus
samples
outbreaks
care
hospital
the
health
critically
mers
membrane
fusion
cov
tmprss2
junv
ahf
attenuated
attenuation
can
contacts
respiratory
mers
illness
close
nsp11
arterivirus
structures
respiratory
prrsv
ifn
tbev
induction
viral
rna
infection
influenza
control
s1p1r
vaccine
er
coronavirus
upr
ire1α
protein
cre
hrv
replication
element
human
bcov
mhv
rna
nt
domain
rnase
rna
mammalian
mir
cells
kda
gp
19
fusion
reduction
virus
respiratory
influenza
nucleic
acid
virus
elisa
rt
pcr
isolation
ad5
sequestration
vectors
new
platelet
biodiversity
disease
may
infectious
relationship
syncytiogenesis
cell
fusion
family
fast
accumulation
stranded
rna
p23
negative
two
virus
10
rna
novel
plasma
sd
the
treatment
units
h1n1
viruses
virus
2009
influenza
10
hla
ctl
0201
ha
duty
ethics
health
ethical
treat
metagenomics
rvp
untargeted
based
viral
rpapn
phage
peptide
potential
five
advax
titers
mice
vaccine
rsv
cocaine
dopamine
transporter
dat
inhibitor
vsv
846
vaccination
bcg
tb
hcv
epitope
antibodies
neutralizing
igs
nash
metabolic
hepatocellular
inflammation
mounting
nan
mnv
ifn
replication
cells
irf
virologic
failure
hospital
prediction
patients
viral
virus
human
viruses
ttv
pmos
vp24
specific
mice
lethal
sars
the
cov
cases
taiwan
influenza
n95
h1n1
aerosols
viable
il
macaque
shfv
baboon
infection
nan
vaccines
vaccine
transmissible
infectious
weakly
dc
cells
tlr
aged
cd4
nan
responses
adjuvant
alum
asp
th1
ns2
mhv
protein
pde
5a
bats
cells
response
immune
virus
proteins
rabv
cctγ
cellular
mouse
expression
csax
we
approach
methods
gene
anti
mabs
v3
usage
bat
human
sars
scov
cov
protein
virus
14
binding
infected
nan
viruses
mss
virus
capture
sequence
hbv
grp78
hepatitis
hepg2
cells
perceived
use
facemasks
health
susceptibility
pedv
diarrhea
swine
virus
sequence
rna
silencing
7a
suppression
well
cancer
lung
stem
cell
leading
rt
nov
lamp
assay
detection
hku1
hcov
he
receptor
cells
disease
population
outbreak
awareness
response
nucleic
nanostructures
acids
nanoengineering
interactions
enac
sars
proteins
protein
lung
pathogen
host
patients
response
transcriptome
osteonecrosis
thrombophilia
hypofibrinolysis
patients
idiopathic
ebv
adem
patient
boy
rash
mnsp15
virus
mutant
wt
viruses
nan
gsp
gspa
amidase
gspsa
catalytic
airborne
transmission
infection
factors
survival
21
hydroxylase
cells
adrenal
disease
influenza
si
household
the
index
host
shutoff
protein
ibv
viruses
platform
syndromic
testing
eplex
as
isgylation
pul50
protein
ube1l
isg15
scaling
study
conductance
channels
power
nan
croup
may
heliox
children
minutes
astrocytes
hiv
gene
cellular
brain
screening
border
cases
control
reducing
otulin
prrsv
linear
ubiquitination
nsp11
virus
infections
among
respiratory
hospitalized
batcov
cov
hku5
bats
mers
sars
il
patients
the
concentrations
school
holidays
pandemic
09
india
rna
virus
8k
accumulation
orf
nsp1
viral
capping
mrna
mtase
cd8
cell
infection
cells
lcmv
mabs
treatment
def201
efficacy
alone
nan
hand
the
efficacy
hygiene
effective
pyrimidine
hcmv
biosynthetic
udp
sugar
tmprss2
iav
influenza
ha
ibv
rats
nogo
stroke
immunotherapy
anti
storm
myriad
decisions
gene
patents
il
35
reg
treatment
mrl
respiratory
diseases
placing
increasing
burden
nsp
sars
cov
proteins
host
pandemic
data
model
the
ongoing
viral
origins
models
molecular
dating
threshold
diseases
number
parameters
may
mrna
selection
her2
darpin
display
participants
trial
infections
randomisation
randomised
amino
q159l
h716d
a59
mutants
myt1
cells
lesions
op
remyelination
vaccines
prophylactic
immunity
cell
therapeutic
ap
lymphocytes
il
peripheral
blood
two
antibodies
h7n9
cause
significant
particles
pseudotyped
virus
envelope
viruses
detection
pathogens
infections
agents
in
cell
surface
recombinant
in
acidophilus
reviews
systematic
cochrane
medicine
evidence
viral
fip
cell
coronavirus
infection
spike
antibody
regions
hiv
envelope
nat
virus
blood
testing
tests
expression
pigeons
infected
proventriculus
tlr7
infants
htx
chd
postoperative
non
nucleocapsid
budding
glycoprotein
directed
core
generation
epidemic
infection
interval
time
endothelial
nrp1
inflammatory
response
brain
mers
cov
the
antibodies
m336
cov
mers
protease
plpro
3clpro
ivig
patients
treatment
corticosteroids
combination
hla
peptide
self
assembling
platform
bioethics
bioethical
debate
characterized
beginning
sepsis
response
biomarkers
among
it
tree
method
composition
vector
cvtree
antibody
affinity
neutralizing
activity
monoclonal
influenza
vaccination
hcws
important
well
cea
dr
the
receptors
adhesins
data
official
informal
available
estimates
antiviral
iav
peptides
activity
the
idshl
25
instrument
infectious
questions
mlb1
months
old
to
determine
kallistatin
influenza
klk1
virus
ha
lower
respiratory
tract
confidence
95
rf
rats
congenic
locus
pia
cell
cycle
phase
cells
replication
protein
proteins
3a
the
coronavirus
infection
brain
results
sars
cov
nan
nec
infants
sepsis
score
biomarkers
norovirus
smv
serum
infection
volunteers
health
pandemic
communication
public
influenza
inhibitors
plasmodium
vivax
the
sub1
jnk
p38
rrv
rotavirus
infection
cat
bilirubin
encephalopathy
chronic
hemolytic
data
big
the
traditionally
associated
mouse
antibodies
development
demonstrate
velocimmune
protease
mutations
ntpase
the
helicase
ang1
apoptosis
angii
aec
ace
influenza
surveillance
guangdong
ili
virus
membrane
viral
rna
infection
structures
mhv3
cells
mice
infected
kc
virus
compound
viral
wn
dengue
hajj
pilgrims
pregnant
fetomaternal
complications
gd
binding
receptor
mc2
term
cells
tmev
cell
autoreactive
mice
sites
ng2
the
glycosylation
ng5
malaria
arbovirus
counts
episodes
infection
type
lectin
entry
vsv
virus
er
protein
endoplasmic
reticulum
sheet
autophagy
avian
cells
ibv
replication
influenza
assay
taqman
the
virus
astrovirus
tastv
infection
diarrhea
lack
protease
nv
substrate
site
inhibitors
virus
bats
fbahv1
viruses
bat
definitions
consensus
surveillance
systems
the
10
il
cells
mice
tumor
nsp9
dimerization
binding
pdcov
pedv
viral
development
associated
vaccines
current
n7
mtase
nsp14
the
exon
tissue
the
vascular
potential
neutrophil
urban
peak
oil
travel
behavior
isolated
pfk
native
monomer
dimer
nan
mv
infection
cells
cvd
cell
human
virus
we
electrofusion
hybridomas
hiv
host
entry
cell
viral
vaccination
ring
imitation
contacts
vaccinate
virus
dengue
class
ii
proteins
nan
immune
responses
regulation
host
following
host
cell
sequence
passages
genotypes
challenges
rls
poc
diagnostics
great
resistant
candida
albicans
rtd
drug
ad
microtubule
dynein
cytoplasmic
binding
adp
bc
mg
bicarbonate
dimer
nsp10
nsp7
processing
replication
cleavage
data
models
datasets
reduction
using
infection
prevention
ed
emergency
care
cells
mice
cd4
demyelination
infected
fusion
e1
loop
the
alphavirus
mhv
mapk
p38
virus
activation
pdcov
papn
s1
porcine
cov
membrane
rna
replication
complexes
plasma
sfrna
rna
xrn1
yfv
sfrnas
several
treatment
complication
situation
care
nan
strains
hcov
nl63
respiratory
children
association
binding
structured
spectrin
two
pkr
cells
eif2α
translation
protein
cymol
respiratory
viruses
virus
collected
sars
ace2
cleavage
tmprss2
entry
social
support
tkr
aa
less
cell
proteins
surface
cells
binding
health
disease
across
social
inequalities
hbsag
crt
the
fusion
gene
oncolytic
hcc
vsv
mapk
cancer
nsp9
nsp8
orf1b
virus
prrsv
viral
orphan
require
groups
antibody
dba
cholesterol
ce
cells
akr
nan
parps
adp
poly
ribose
promote
h1n1
patients
cases
underlying
co
oc43
hku1
s1
binding
rbs
macrophages
ycvs
pestis
naïve
lc3
tio
substrates
light
doped
nitrogen
protein
the
cells
expression
soluble
nan
virus
multiplex
luminex
the
suspension
kinase
autophagy
protein
mpp
autophagic
ketamine
rats
anesthesia
isoflurane
dexmedetomidine
impact
influenza
ii
iii
iv
nan
pk
stem
p1
loop
rna
25
oh
hcv
concentrations
evr
viruses
3clpro
like
supercluster
3cpro
gene
pcr
assay
sars
samples
delivered
dna
rabbits
peptide
immunity
lpaiv
studies
infections
infection
virulence
occludin
pedv
infection
virus
entry
protein
receptor
conformational
changes
binding
neu5gc
acid
hydroxylase
sialic
enzyme
banlec
hiv
anti
lectin
envelope
nicotine
smoking
cigarettes
angiotensin
ang
vlps
proteins
sars
cov
protein
mda5
mice
infection
mhv
type
transport
mitochondrial
atucp1
atucp2
aspartate
sars
fatality
lowest
medicine
may
ifn
mers
cov
ribavirin
ic
jev
core
protein
viral
sg
care
elderly
services
health
social
swabs
medium
dry
saline
detection
the
specimens
lamp
assay
smear
sars
postmortem
coronavirus
cov
patients
mice
virus
ifn
infection
clearance
nan
viral
nsp14
n7
mtase
replication
stress
hcv
virus
required
sgs
cases
days
deaths
the
sars
helicase
hev
rna
activity
showed
pheasants
viruses
influenza
markets
chukar
emerging
host
in
re
viruses
sars
9b
cov
orf
protein
platelets
vascular
pulmonary
lung
new
rodents
seov
rodent
seoul
borne
ace
angiotensin
cardiovascular
cvds
target
pestis
cell
vaccine
responses
immune
s1p
anti
lymphocyte
abs
cell
laboratory
clinical
microbiology
informatics
tools
evd
etc
ebola
disease
treatment
weeks
infants
epithelial
bronchiolitis
12
samples
respiratory
virus
influenza
pathogens
cchfv
cells
binding
gc
nucleolin
infection
disease
healthcare
care
patients
virulence
pathogens
emerging
epidemic
tradeoff
σ1
attachment
protein
reovirus
the
nan
sars
cov
rna
vlps
gfp
alpaca
group
coronavirus
detected
adult
nt
rna
di
coding
region
orf4
gene
orf2b
insertion
site
achromobacter
cf
patients
domestic
pathogens
new
laboratory
network
formed
important
emc
hcov
human
novel
cells
strain
ayu
shanghai
transmissible
gastroenteritis
viral
vaccine
design
new
approaches
nan
perfringens
clostridium
associated
necrotizing
enterocolitis
er
replication
virus
erad
tuning
nan
pdcs
pdc
molecular
cell
dendritic
ns2
ifn
hepatitis
virus
replication
patients
sars
the
symptoms
chest
cells
mhv
ms
mice
demyelination
rna
replication
tdcs
duplex
strand
acetyl
group
neu5ac9nac
many
action
regulate
astrocytes
injury
response
neuroinflammatory
nan
virus
cell
pan
neutralization
antibody
nan
viral
gp
filoviruses
surface
process
scylv
l2
bwyv
pseudoknot
prf
symptom
influenza
screening
travelers
temperature
activity
biological
spin
trapping
series
he
receptor
influenza
cov
protein
gxxxg
sars
motif
coronavirus
protein
epidemiological
dynamics
host
vector
processes
viral
ha
proteins
apical
cells
crs
patients
respiratory
viruses
controls
brain
infection
developing
infected
infants
treatment
imiquimod
intranasal
common
cold
scv
expression
cells
macrophages
dcs
hku1
cov
infections
hcov
respiratory
lassa
virus
molecules
axl
tyro3
rchy1
sud
p53
sars
cov
cell
ceacam1
ibd
functions
molecule
surveillance
pandemic
we
data
held
mirnas
small
rnas
types
found
disease
pulmonary
airway
chronic
evidence
malaria
vaccine
we
display
cell
birth
weight
gestation
seasonality
length
mev
cells
slam
cd147
receptor
ibdv
infected
ifn
infection
disease
rna
utr
bamv
stem
loop
cd4
influenza
memory
cells
virus
test
person
we
permutation
refined
hsp90
replication
cells
infected
viral
ceacam1a
mice
mouse
virus
mhv
aom
viral
respiratory
uri
bacterial
assay
assays
the
resplex
detect
quarantine
loss
income
human
influenza
cats
mycoplasma
hemoplasma
candidatus
ill
virus
hatchery
avian
waste
treatment
nan
drugs
viruses
oncolytic
anticancer
safety
bats
hantaviruses
hantavirus
viruses
shrews
ace2
activity
hypertension
brain
expression
apobec3h
restriction
cell
enzymes
dna
emergence
host
evolutionary
scale
fitness
viral
important
pneumonias
adults
diagnostic
nan
ras
akt
eif4e
mtorc1
4ebp1
zinc
cold
95
ci
common
m2
channel
compounds
ion
wt
students
year
medical
training
simulator
pcd
genetics
identification
review
complex
market
many
promising
vaccine
candidates
hcq
denv
infection
antiviral
drug
antibody
responses
oligomeric
siv
envelope
cells
infants
cell
nk
vector
virus
cells
epithelial
macrophages
human
rwanda
main
genocide
public
health
erc
evaluation
framework
public
health
development
antibiotic
us
barda
resistance
1918
virus
immunity
influenza
pandemic
il
32
hbv
antiviral
infection
gondii
bats
infection
china
the
transmembrane
consistent
interaction
helix
integrins
rhesus
airways
monkeys
humans
conducting
health
foreign
støre
policy
makers
view
host
defense
shaped
immune
lt
mcc
mcpyv
vaccine
dna
ata
replication
virus
vaccinia
viral
nan
the
stress
strategies
molecular
diagnostics
lsm1
complexes
rna
bmv
sequences
nan
chikv
mosquito
envelope
cell
infection
hcov
oc43
cns
neuropathogenesis
propagation
rna
encapsidation
sl
stem
mut6
contact
networks
social
disease
network
host
novel
mutations
ability
population
zikv
ifn
ns5
stat1
protein
respiratory
viruses
virus
ocular
influenza
antibodies
neutralizing
breadth
serum
activity
gp120
gp41
12p1
presence
entry
cs
the
virus
trs
nt
auris
assay
the
pcr
samples
influenza
human
cells
endothelial
virus
il
measles
virus
immune
response
nan
assembly
membrane
mechanisms
simulations
budding
protein
cells
cell
coronavirus
the
adp
ribosyl
ribosylation
different
well
autophagy
therapeutic
various
may
process
viral
irf3
nss
ibs
cells
assay
wnv
variations
possible
taqman
prevalence
depression
studies
depressive
students
cytoplasmic
virus
particle
tail
generation
mrp8
10
mrp14
ip
trauma
mass
gathering
pilgrims
disease
pneumococcal
proteins
p22
dna
the
mature
nan
norovirus
recent
noroviruses
related
discovery
cchfv
caspase
apoptosis
infection
cleavage
host
new
hosts
viral
infection
sars
zoonotic
the
epidemic
cov
pro
lb
fmdv
activity
dub
niv
human
respiratory
ali
epithelium
proteins
fusion
viral
transitions
transition
drug
new
repurposing
discovery
therapeutic
rna
tss
replication
tcv
internal
reporting
interval
time
reproduction
number
gc
hrtv
fusion
structure
virus
pedv
pc177
tc
highly
virulent
novel
the
mud
mcdv
virus
gis
systems
use
information
applications
aggresome
formation
translation
eef1a
proteasome
viruses
epitopes
outbreaks
vaccines
development
media
social
handwashing
global
ghd
dna
hsv
nucleus
viral
the
school
closures
influenza
epidemic
closure
ifn
host
infection
genetic
type
immune
age
respiratory
migration
pgd
rna
protein
domains
coronavirus
two
genome
adenoviruses
analysis
species
human
cov
bat
sars
related
rgu
fu
coronary
infusional
bolus
vasospasm
interventions
intervention
infections
household
use
nemo
nsp4
eav
prrsv
ifn
tgev
binding
sialic
acid
mgp
hsv
ifn
us11
virus
rna
spike
host
coronavirus
two
the
lipid
cholesterol
membrane
microdomains
viral
mabs
virus
nv
norwalk
fabs
mhv
lipid
rafts
virus
spike
policies
dynamic
health
we
decision
pro
pl1
site
two
229e
pcv2
dna
cpg
virus
odns
vector
norovirus
rndv
vaccine
vlps
mers
cov
mva
respiratory
vaccine
immune
cns
innate
responses
microglia
stat1
lung
infection
sars
cov
rna
sg
synthesis
transcription
di
nan
hecv
4408
pid
coronavirus
calves
resistant
the
na
viruses
rs
mab
667
viral
infected
mice
genomic
higher
children
load
risk
mmp
expression
cns
infection
increased
cs
viral
virus
responses
rnase
struvite
f344
rats
urinary
bladder
nan
sars
cov
ace2
cells
clathrin
vsels
cells
ability
cellular
like
drug
polyether
antibiotics
resistant
polyethers
health
public
monitoring
event
three
international
health
regulations
new
member
prrsv
nf
κb
nsp4
ifn
bovine
brd
23
pcr
somni
nsp2
aa
region
domain
the
protein
sars
s1
cov
vaccine
virus
cells
congenital
mode
invasion
cells
cell
viral
early
cns
gp
marv
virus
specific
pressure
mv
hpv
l1
recombinant
cell
autophagy
neoformans
macrophage
albicans
atg5
hcv
cell
cells
polarized
basolateral
contact
tracing
control
diseases
used
rvg
rabies
virus
rl
ndv
nan
asthma
infections
exacerbations
viral
atypical
nan
rt
lamp
assay
chikv
serum
secretase
cleavage
compounds
two
amyloid
ul24
nucleolin
proteins
we
important
month
antibody
the
serum
sars
immune
lncrnas
activation
cells
cell
image
see
text
tf
cys
6k
palmitoylation
membrane
paramyxoviruses
recent
humans
virus
antiviral
vp1
rvsv
human
nov
vaccine
mers
cov
middle
east
respiratory
hbv
species
host
ntcp
orthohepadnaviruses
rvp
assay
respiratory
viral
targets
interventions
npis
support
public
health
cases
h5n6
h5n1
h7n9
severity
assay
respectively
respifinder
100
respiratory
nan
mvc
dogs
virus
also
canine
sars
cov
hla
a2
cell
dogs
equi
subsp
zooepidemicus
pneumonia
frameshifting
trna
oocytes
phe
asn
ns
proteins
spherules
cpv
rna
tracing
contact
individuals
iterative
high
oc43
hcov
ns12
protein
δns12
tuberculosis
genetic
susceptibility
polymorphisms
receptor
sars
cov
eif2α
pkr
phosphorylation
sars
cov
associated
genes
human
sars
cov
coronavirus
murine
develop
axonal
cells
remyelination
ms
cns
china
severe
virus
human
syndrome
griffithsin
hsv
hiv
cell
activity
denv
infection
mabs
antibodies
dengue
recombination
sex
role
vitro
also
dna
aim2
il
vaccines
antigen
nsp4
egfp
rotavirus
viral
er
neurons
ifn
expression
ifns
activation
compartmental
model
diagrams
causal
epidemiology
sars
cov
protein
s2
antibodies
copi
proteins
replication
protein
vesicles
protein
7a
scov
particles
accessory
bevs
research
functions
complex
protein
masks
may
face
influenza
uv
lamp
method
tomato
tolcbav
pcr
bd
evolutionary
important
we
genome
tumor
cell
immune
response
cd8
adenoviruses
species
cadv
bats
bat
epidemic
dynamics
we
surveillance
behavior
respiratory
children
data
age
seasonality
fcov
type
tgev
cats
clinical
dc
sign
entry
virus
lasv
oxpapc
barrier
mediated
cems
s1p
wnt
signaling
frizzled1
frizzled
receptor
eae
sirt1
neuroprotective
mice
nad
tim
ptdser
binding
virus
uptake
binding
novel
properties
2nd
site
vlps
sars
cov
immune
responses
proteins
ifit
viral
antiviral
host
time
tissue
tested
dna
probe
egfp
assay
based
antiviral
day
transgene
expression
cells
brain
transduced
receptor
scarb2
ev71
human
uncoating
models
numerical
methods
differential
equations
frameshifting
important
stop
codon
readthrough
virus
peptide
fusion
arenavirus
avp
nan
hcv
ph
entry
virus
events
rbd
protein
binding
gst
de3
outbreak
communication
public
hr
95
retroviruses
fish
the
genome
gps
rsv
respiratory
pneumococci
pneumococcal
virulence
junv
gpc
gp1
macv
neutralization
ifn
type
mice
infection
cells
nsp10
zbd
helicase
domain
activities
fusion
protein
cleavage
rsv
cells
cellular
protein
membraned
single
3ab
flocks
pathogens
small
infectious
submissions
measure
activity
ace2
balance
angii
patients
health
mers
cov
reported
cells
sars
cov
virus
the
nan
antiviral
cell
death
virus
infection
prediction
acute
cough
new
primary
perform
analyses
based
one
issues
sre
fomite
surface
fomites
area
amϕ
tnf
production
response
prrsv
mifitm1
nonconserved
cysteine
the
interferon
hiv
infection
mrnas
changes
drugs
virus
epidemic
ebola
disease
this
verapamil
tuberculosis
analogs
specific
cells
mhc
macaque
important
association
class
vaccine
protective
influenza
dose
egg
nan
nan
il
10
cells
malaria
infection
vacv
infection
poxvirus
number
immune
pbmcs
mobilized
amd3100
10
tbi
npcs
transplanted
spinal
protein
axonal
cells
cd4
hiv
cell
death
bats
species
zoonotic
viruses
host
nsp16
coronavirus
adomet
mtase
the
poliovirus
surveillance
day
individuals
sewage
sl2
mhv
the
replication
covs
env
trimers
cleavage
complex
gp140
pcr
viral
dop
assay
the
nan
extraction
hmpv
samples
mm
em
et
al
cancer
res
antigens
cleavage
plp2
site
mp1
replicase
testing
genetic
mutations
distress
risk
ifn
virus
infection
infections
mers
ucts
evidence
health
rcts
quality
ifnα
cns
infections
viruses
signaling
nan
virus
filmarray
respiratory
assays
influenza
ptx3
liver
injury
acute
chronic
ifn
cells
dc
immune
response
il
27
tregs
inflammation
induced
wnv
blood
symptomatic
disease
outcome
vaccine
mers
cov
human
development
health
surveillance
cyber
intelligence
information
infection
tcrv
d746
virus
junv
viral
sigmaa
cells
protein
dsrna
cov
sars
host
viral
mtase
influenza
coinfection
pneumonia
pneumoniae
patients
nan
nan
respiratory
virus
detected
test
using
new
koch
continue
disease
summary
compounds
models
cathepsin
activity
the
cov
rmers
mers
recombinant
respiratory
hpiv
respiratory
cases
children
pcr
cish
infectious
susceptibility
diseases
variant
infection
viral
jcpyv
erk
virus
ras
g12v
rasin1
ligands
selectivity
fusion
sars
peptide
cov
viral
respiratory
human
mers
cov
disease
fmomv
influenza
virus
iav
protective
mavs
ndv
protein
ifn
host
nabs
escape
neutralization
rbd
sars
eif4f
many
control
initiation
activity
pandemic
influenza
mathematical
models
surveillance
ccl2
virus
mice
tg
expressing
ceacam1a
mhv
neurons
infection
cns
clq
denv
monkeys
aotus
treated
cea
dr
adhesins
binding
daf
nanoscale
assemblies
protein
vaccine
class
birds
coronaviruses
gammacoronaviruses
deltacoronaviruses
we
influenza
virus
new
human
well
ml
corticosterone
ng
production
intestine
mobility
human
mechanisms
annual
three
entry
hsv
gd
virions
proteins
population
war
impact
power
small
tli
serum
μg
measurement
diseases
inhibitor
sensitivity
hr2
subunit
mutants
ntd
proteins
the
rna
sars
sars
temperature
environmental
outbreak
daily
coronavirus
viral
proteins
ribonucleoprotein
particles
virus
mumps
patients
cases
samples
diarrhea
porcine
epidemic
china
pedv
strains
demyelination
matter
mhv
cell
sars
hat
cell
tmprss2
cov
mice
axonal
degeneration
wld
virus
cell
viruses
membrane
spread
enveloped
cholesterol
cellular
infection
cdv
virus
sars
cov
immunized
ferrets
rmva
pedv
nemo
ifn
nsp5
3c
ev71
infection
ifn
kpna1
interferon
viral
wnv
rna
w956ic
early
chikv
antibody
response
virus
antibodies
ifn
cytokines
response
viruses
antiviral
sob
birth
ms
effect
eae
cell
galectin
surface
cells
pdi
pneumococcal
vaccine
turkey
invasive
countries
ras
obesity
energy
balance
metabolic
pandemics
virus
influenza
systems
biology
adrp
coronavirus
structural
the
domain
hpv
18
e7
e6
anti
nan
cns
microglia
sentinels
dynamic
homeostasis
gbf1
hemorrhage
mutant
the
factor
nan
travellers
screening
mexico
h1n1
would
nsp2
dmvs
rtcs
cells
structures
sepv
sequence
the
virus
genetic
transcriptomic
human
development
prenatal
patterns
ibv
china
nephropathogenic
infectious
bronchitis
sumo
fusion
protein
expression
proteins
cd81
hcv
receptor
role
entry
asthma
respiratory
mucosal
microecology
health
helix
4e10
10e8
mper
hr1
mers
respiratory
human
humans
cases
ifitm3
tyr
20
phosphorylation
virus
gas
inactivation
clo
the
rh
monocytogenes
cells
vγ2vδ2
infection
responses
ifn
tgev
response
infection
ire1α
axis
angiotensin
ace2
the
raas
hla
0702
gondii
ifn
mice
proteins
junv
host
particles
human
disease
administration
hpβcd
npc
increase
cryo
protein
em
structures
assemblies
angiotensin
system
physiology
mechanisms
new
ips
clinical
lung
hsct
models
phtd
phte
pneumococci
cells
adherence
public
health
effectiveness
quarantine
sars
mabs
fc
ns1
protein
mice
ifitm3
duck
host
viruses
influenza
ev
respiratory
cases
infections
strains
disease
severe
infections
95
ci
ph
remodeling
pathways
pulmonary
vasculature
infants
hrv
risk
infection
febrile
hantavirus
germany
infections
disease
transmitted
isg15
ifn
signaling
function
interferon
tat
gfap
hiv
expression
p300
nan
nan
antibodies
pedv
binding
neutralizing
epitopes
wnv
humans
clinical
therapy
effective
ards
mice
respiratory
sars
associated
phage
expression
display
peptides
proteins
infection
sci
injury
individuals
studies
prf
different
structures
frameshift
signal
avian
coronaviruses
s1
viruses
receptor
rt
pcr
real
time
assay
ub
e1
terminal
enzymes
e2
coronavirus
previously
the
respiratory
tests
influenza
viruses
known
virus
bat
pcifn
ifn
antiviral
viral
genes
vaccine
vector
risfv
veev
rvsv
inhibitors
selectivity
image
see
text
ifn
ul36usp
hsv
interferon
the
rig
protein
signaling
agonists
single
public
health
communication
preparedness
population
human
immune
pathogens
animal
system
orf61
irf3
ifn
pathway
activated
cov
mers
rna
hedgehog
ericov
hmgb1
macrophages
monocytes
receptor
release
sars
fragment
cov
spike
fragments
caspase
apoptosis
cells
mhv
mitochondrial
development
measles
mv
vaccine
infection
genes
gene
coronaviral
genome
stability
lasv
rnp
capture
antibodies
elisa
free
nh
papain
cysteine
proteases
replicase
replication
using
specific
microscopy
nan
transduction
virions
subcellular
aav2
nucleus
sirna
delivery
gene
silencing
rna
cells
annexin
fitc
pi
apoptotic
the
antibodies
diseases
passive
immunization
microglia
infection
cells
specific
role
isg15
free
cells
ctl
response
nhps
immune
activation
mpxv
ib
rnai
mammalian
antiviral
cells
replication
nan
patients
respiratory
virus
lrti
children
sars
cov
cells
cd209l
human
sars
ed
hospital
medical
probable
nan
mkk3
mitochondrial
bmdms
lps
inflammatory
sars
cov
factors
replication
host
nan
health
sars
disease
public
first
pregnant
mice
virus
ph1n1
infection
cgmp
enac
pcpt
channels
αβγ
hf
cardiac
metabolic
metabolism
function
india
niv
virus
bat
pteropus
nan
tetherin
viruses
terminal
release
restriction
ubiquitin
plp2
dub
viruses
activity
measles
vaccine
strains
pcr
wild
tnfr1
cell
response
dc
maturation
vaccine
maprec
mutations
used
viruses
tat
egr
expression
promoter
hiv
coat
protein
functions
capsid
predictions
adults
pneumonia
among
age
patients
mhv
tnf
il
cytokines
a59
dose
95
upper
respiratory
tract
virus
method
ms2
sampling
methods
ivig
high
nab
respiratory
titers
aml
differentiation
gsk3
gs87
cells
immune
cns
infection
responses
within
ha
responses
antibody
antigens
protective
nsp2
cleavage
nsp3
rna
the
virus
epithelia
epithelial
infection
interaction
mav
virus
macrophages
mouse
mice
endosulfan
genes
expression
human
gene
tb
transmission
number
parameters
we
ervs
families
detected
retroviruses
host
ribosomal
programmed
frameshifting
peptidyltransferase
yeast
e2
antibody
redox
disulfide
reduction
severe
neutropenia
we
dengue
patients
p1
substitution
cleavage
3clpro
infectious
international
health
ihr
significant
risk
camp
epac
proteins
this
review
respiratory
af
illness
95
ci
nw
ldh
bronchiolitis
children
severity
dna
vaccine
responses
clinic
since
hess
migration
patches
conservation
disease
system
clinical
the
signals
scotland
sars
plpro
cov
like
ubiquitin
protein
virus
growth
terminal
hydrophobic
vaccine
advax4
new
tb
mtb
ba
th2
th1
mice
stat1
sars
cov
gapdh
mrna
specimens
il
10
cells
production
th17
pomc
secretory
cells
peptide
hormones
mice
host
response
virus
genes
packaging
rna
tgev
viral
genome
antiviral
rna
viruses
mutation
viral
activity
city
individual
model
simulation
transmission
contact
host
virus
parasites
jeddah
viruses
riyadh
outbreak
transmission
rna
proteins
tbsv
host
yeast
e2
antigenic
neutralizing
virus
hcv
nan
serum
activities
egfr
aminopeptidase
dpp4
cells
memory
rm
brain
affinity
protein
capsid
terminal
p150
region
viral
iav
tlr7
rig
host
neuronal
cxcr3
cxcl10
wnv
tnf
the
vaccine
mvbv
mvb
measles
viral
m1
virus
iav
ph
residues
np
mice
peptides
np351
nan
bcl
7a
apoptosis
prosurvival
suggesting
virus
coronavirus
wildlife
diseases
the
ubiquitin
proteasome
ups
toxicity
target
hcov
229e
coronavirus
mice
apn
replication
pi4kb
rna
aiv
acbd3
splicing
disease
exon
skipping
progress
virus
ha
mutations
influenza
na
ubiquitin
dubs
position
p2
substrate
sirna
immunoliposomes
ha
cells
study
the
multocida
capsular
type
fatal
mice
denv
human
dengue
infection
flavivirus
drug
virus
cases
encephalitis
nan
mtase
rna
coronaviruses
cap
ronivirus
autophagic
autophagy
response
hbv
process
bca
binding
mannose
lectin
carbohydrate
pabpc1
binding
mrnas
mrna
sites
ifit1
rna
binding
mrna
methylation
tm
domain
motif
cov
proteins
nan
peptide
platform
antibodies
important
many
sars
cov
cells
derived
human
sars
transfection
recombinant
rbd
protein
e1
hcv
e2
tme1
proteins
infection
scov
pathway
shrps
cell
proteins
circular
biological
approaches
activities
protein
full
length
glycoprotein
the
nan
control
infection
prevention
ipc
health
influenza
viruses
virus
h1n1
human
ib
aac
inhibited
50
μm
hiv
vaccine
haplotype
dna
rad5
ibv
cells
apoptosis
replication
vero
cited
journal
articles
publication
items
hypertension
rats
i3c
cyp1a1
ren2
hbv
dna
sting
innate
ifn
irf3
er
stress
phosphorylation
factor
proteins
virions
coronavirus
ibv
three
pcr
assay
virus
this
study
hcv
371
rna
inhibitory
antiviral
studies
spread
respiratory
nnt
viruses
we
big
data
surveillance
systems
rna
recombination
molecules
viruses
new
membrane
fusion
surfactin
viruses
viral
drug
resistant
tb
ic
hcws
sirna
delivery
np
hydrogels
hydrogel
extraction
toxoplasma
gondii
dna
pcrs
rabv
vaccine
vaccines
virus
inactivated
raltegravir
hhv
drug
replication
dna
viruses
humidity
may
mechanisms
remain
sars
origin
like
avian
coronavirus
laboratories
study
pcr
virus
first
human
hcov
hku1
identified
clinical
jps
care
evacuees
primary
medical
nan
type
fcovs
ii
cell
fcov
3clpro
norovirus
nv
virus
protease
xbp
htlv
transcription
upr
1s
species
viruses
cross
infections
hosts
myd88
ifn
cns
cell
responses
hex
activity
enzyme
levels
also
denv
virus
assay
st
610
nan
2h
5a
binding
phosphoesterase
domain
ibv
vaccines
attenuated
virulence
loss
nectin
viruses
cell
mev
nectins
ncbi
database
data
resources
blast
strain
studies
capacity
outcomes
health
protein
rscovn
the
sars
recombinant
ras
cardiovascular
regulation
role
brain
entry
site
influenza
binding
hemagglutinin
or
95
ci
children
cpap
rabv
rabies
ifit2
viral
virus
lung
syndrome
ips
non
injury
penn
98
mhv
a59
cells
hcmv
ifn
10
type
infection
patients
pneumonia
29
clinical
final
viral
mers
protein
mutations
dpp4
infection
bm
ifn
type
lcmv
gp33
41
mice
cd8
epitope
wonv
u3
snf5
virus
complex
virus
rna
dsrna
hcv
er
orf4a
cells
sirt1
yeast
mers
abv
disease
pdd
virus
parrots
cns
cd8
cells
virus
specific
protein
cell
sars
cov
surface
pdi
redox
ref
expression
tr
cells
class
ia
pi3k
cell
tumor
apn
homing
cell
ngr
trs
sgmrna
protein
transcription
ibv
rainfall
legionellosis
2003
monthly
incidence
pedv
entry
proteases
spike
lysosomal
dubs
ups
the
dub
proteasome
nsp4
virus
dmv
glycosylation
replication
sars
cov
ace2
coronavirus
human
heterologous
immunity
responses
the
infections
challenges
infectious
present
medical
ethical
ebov
chloroquine
using
in
reports
sars
genechips
cov
genechip
resequencing
dose
response
microbial
modelling
optimization
scov
protease
3c
like
specific
ppe
hcws
doffing
evd
cp
nan
funding
preparedness
health
federal
public
host
range
mutations
φ6
expansion
denv
er
translation
host
viral
helicases
the
superfamily
viral
structure
antiviral
would
epidemic
strategies
influenza
dna
sting
activation
host
defense
h5n1
poultry
cases
sick
dead
nan
elr1
functional
receptor
binding
protein
viruses
human
dromedary
cov
hcov
fludv
pigs
virus
bovine
guinea
rabv
rabies
problem
drug
candidates
nan
apod
oc43
upregulated
encephalitis
hcov
viruses
sars
emerging
we
appearance
gammaretroviruses
analysis
species
phylogenetic
origin
treg
cells
cerebral
cell
foxp3
rvp
viruses
respiratory
the
fa
sars
cov
virus
nsp1
ifn
nsp3a
domain
ubiquitin
like
globular
denv
gene
countries
model
virus
veev
human
virus
preparations
polyclonal
chikv
ig
infection
ctla4
virus
pla
used
formulations
widely
various
nan
fmdv
pro
sg
response
stress
fusion
idl
wq
hiv
nhr
wheat
wsmv
virus
mosaic
transmit
outbreak
pneumoniae
identified
students
specimens
botulinum
vaccine
vaccines
dna
neurotoxins
ev
3c
pro
93
enterovirus
children
fs
virus
human
respiratory
nan
nan
identified
analysis
confirmed
pneumonia
cases
sampler
infectious
bioaerosol
niosh
virus
rap80
sumo
ubc9
interaction
protein
strains
the
porcine
rva
13
protein
terminal
carboxy
cca4
the
nan
virus
human
respiratory
infections
children
disease
measures
schools
health
the
ventilation
infection
air
room
airborne
aunps
protected
platform
monolayer
gold
δe
sars
mice
rma15
coronaviruses
donors
marrow
dogs
grafts
one
nan
frameshift
ribosomes
hiv
stem
loop
core
promoter
subgenomic
replicase
rna
version
the
assay
improved
filmarray
transporter
stress
vitamin
bmscs
role
cfr
relative
methods
outbreak
emerging
viruses
influenza
like
cell
hl17nl10
infectious
viral
virus
represents
viruses
nsp15
cov
activity
nsp8
mers
thiocarbazate
cathepsin
ic
50
inhibitor
hpiv3
ebov
ebogp
virus
vaccine
cells
cd8
gb
tet
tg
nan
outbreak
sars
medical
training
care
pboo
bladder
mice
17
dmag
no
ros
immune
the
redox
evs
delivery
drug
ddss
vesicles
nan
viruses
nm
surface
the
dielectric
cells
scs
adult
small
embryonic
professionalism
medical
participants
outbreak
physicians
based
vaccines
influenza
np
pb1
nsp7α
cleaved
region
nsp7
structure
viruses
immune
viral
host
signaling
rna
nsp13
sars
cov
activities
viral
entry
nabs
glycoprotein
neutralizing
elements
rna
internal
strand
octanucleotide
nan
human
zoonoses
pathogens
animals
influenza
influenza
h5n1
antibody
virus
antibodies
adhesion
tumor
motif
cells
melanoma
nspc
viral
cytokines
chemokines
neural
cmv
lamp
assay
the
dna
m51r
vector
vsv
responses
flagellin
lcau
mmc
recurrence
one
two
placebo
flavocoxid
average
adverse
events
dcs
chbm
cells
bone
marrow
gene
isd
overlapping
high
two
hcv
dfcp1
virus
infection
membrane
rsa59
rsmhv2
the
spike
protein
hcv
cmi
robust
vaccine
rntv
viral
trim25
rna
interferon
virus
il
signaling
trans
cells
hasm
cells
infection
circulating
infections
ftt
pol
replication
viral
complexes
membranes
gene
therapeutic
sirna
rna
rnai
macrodomain
plp2
viral
ts
viruses
meta
cats
identify
metadata
sequence
translation
rna
subgenomic
grna
sgrna1
genitourinary
medicine
trainee
experience
delivering
ntz
placebo
participants
influenza
group
ige
human
knowledge
details
years
mouse
mers
cov
infection
dpp4
csfv
ppv
lactobacillus
mucosal
strain
coronavirus
lysosomal
proteases
cell
entry
intestinal
infant
the
tract
fetus
shine
dalgarno
sequence
is911
frameshifting
l13a
cells
ribosomal
translational
ribosome
rvn
viral
rtc
rna
secretory
influenza
human
animal
technical
avian
activity
endoribonuclease
protein
nsp15
coronavirus
tcr
specific
cells
viral
transduced
density
hcv
infection
hcvcc
rate
rict
samples
rabies
fat
the
b19v
erythroid
11kda
infection
progenitor
dnajc14
rc
protein
replication
formation
handles
laryngoscope
negative
spp
aureus
nan
h5n1
viruses
poultry
virus
sublineage
mhv
axonal
optic
spike
transport
ace2
ampk
ph
endothelial
pulmonary
type
ifn
mir
223
infection
international
adoptees
data
studies
risk
nan
chikv
alphavirus
vsv
virus
cause
cs
trs
transcription
sequence
sequences
rvp
days
group
rapid
rp
pap
psoralen
major
phase
metabolites
host
cell
viroporin
the
jcv
pandemic
could
economic
facemasks
billion
ev71
hcv
acetyllycorine
2a
revealed
protein
orf7b
the
accessory
virus
sars
survivors
social
tai
chi
dc
rsv
sign
dcs
infection
mavs
3clsp
prrsv
ifn
protease
nan
respiratory
nxtag
rpp
ruo
agreement
virus
samples
detection
species
microarray
mdp
nod2
uptake
dependent
clathrin
human
early
animal
terms
event
virus
tbsv
genes
yeast
host
health
asia
disasters
response
both
protein
16
kda
cells
may
ace2
sars
cov
human
less
rsv
29
il
airway
epithelium
salts
benzalkonium
target
hplc
widely
samples
the
laboratories
amplification
in
nan
rna
replication
bmv
rck
p54
rbd219
sars
rbd193
n1
rbd
s1
spike
pdcov
structure
structural
ifn
pedv
protein
irf3
activation
epistasis
mutations
effects
positive
fitness
ibv
m41
cell
beaur
region
cd4
env
cell
cells
hiv
calves
infection
tests
age
week
mutant
genetic
provide
approach
gene
chf
ang
raas
ii
angiotensin
sor
cells
425
mhv
virus
the
afop
pneumonia
organising
pattern
sign
dc
ace2
sars
cov
ifitm3
infection
viral
antiviral
mice
pressure
betamethasone
sheep
ace
ace2
virus
sv
6k
gene
del6k
protease
glu
54
the
structure
protein
sars
cells
replication
10fn3
ifn
λs
cells
characteristics
also
pdcs
dendritic
type
immune
responses
mhv
rna
dmvs
membrane
gene
stress
granules
gw
bodies
degradation
efl
tbp
gene
pcr
primer
disease
environment
health
built
humans
aln
rsv01
rsv
demonstrated
vivo
mhv
rbd
viruses
expressing
mceacam1
d29
culturability
the
humidity
deionized
immune
humoral
inactivated
response
sars
rsv
severe
disease
patients
study
ndv
hn
apmv
ectodomains
phenotypes
goat
ghrelin
membrane
family
acyltransferase
pi3k
pathway
mutant
tumors
cancer
nasopharyngeal
oropharyngeal
swabs
paired
collected
rna
ren
strand
replication
plus
serum
rbcv
cattle
in
hai
int
cv
casei
mice
rodentium
nan
rna
viruses
influenza
pcr
armored
jhm
transgenic
milk
mice
antibody
the
health
survey
morbidity
focus
hrsv
m2
virus
cryo
rnp
clec4m
vwf
vntr
type
family
sars
cov
screening
virus
small
disease
behavior
person
epidemics
contacts
gas
associated
streptococcus
detection
antibiotic
uv
filters
aerosols
the
transmission
interactions
respiratory
diseases
gene
environment
vaccines
response
immune
dna
micro
sars
cace2
hace2
cov
civet
protein
rnas
expanded
cag
rrna
health
public
informatics
infrastructure
essential
diseases
climate
canada
change
likely
nan
cell
responses
respiratory
pgd
rdc
hs0202
sla
peptide
iav
swine
ph1n1
virus
ns1
protein
nss
suis
msg1
epitope
protein
epitopes
hcv
viral
in
treatment
inhibitors
strategies
evidence
resources
studies
we
monocyte
development
defined
progenitor
factors
hcv
infected
oxidative
stress
kv2
relevant
respiratory
diagnostic
infections
while
subjects
vitamin
respiratory
infections
vs
virus
a59
the
replication
genome
hiv
env
antibodies
cg
mabs
tgev
3cl
st
cells
infected
nlv
becs
bec
two
human
nsp2
helicase
protein
terminal
activity
hastv
virus
clathrin
cells
infection
diarrhea
pedv
epidemic
china
outbreak
protein
mucosal
sars
surface
using
type
lectins
binding
gps
cells
infection
changes
expression
differences
response
masks
mask
the
pathogens
influenza
il
12rβ1
mutations
il12rb1
deficiency
rna
replication
replicase
membrane
proteins
nesting
material
enrichment
rats
mice
denv2
jev
nt
cdna
clone
virus
influenza
cells
human
matriptase
different
virus
cell
entry
rotaviruses
assays
subfamily
genera
set
pcr
gag
antigen
hiv
rndv
specific
sars
cov
cells
ptec
infection
infected
cells
cva
sustained
activation
rna
granules
viral
gene
factors
day
sars
plasma
cov
rna
induced
vlp
100
virus
iscom
anaconda
revealed
juveniles
virus
severe
virus
viruses
influenza
guinea
avian
priority
setting
evaluation
framework
practices
fap
scfv
inhibitory
e3
antibody
gd
adapter
tumor
specific
cell
multiple
antigens
responses
cmi
containing
infection
peptide
mhc
class
flavivirus
vin
virus
non
coding
human
karyopherin
import
orf6
alpha
stat1
mice
mhv
antibody
b6
infected
medical
one
passengers
per
year
asc
cxcl10
cns
cxcl9
accumulation
cells
ccl3
cd8
mice
virus
sars
cross
species
transmission
changes
immunogenicity
cell
rits
immune
approach
fidelity
virus
fmdv
3d
pol
exosomes
cells
mvb
cell
function
mtb
antigen
specific
tuberculosis
novel
wjv
world
journal
virology
new
patients
lrti
controls
viruses
aetiology
ebncdp
evidence
based
public
health
nan
il
sil6r
antiviral
receptor
virus
illnesses
infants
msis
viral
recurrent
nan
frameshift
stem
nt
glv
heptamer
delivery
the
lipidoids
rna
therapeutics
heptad
membrane
proteins
fusion
snare
disease
outbreaks
the
current
ebola
infections
within
rna
persistent
response
nan
nan
nt
rna
genome
subgenomic
leader
feline
virus
prevalence
twenty
one
trimer
virus
vp5
btv
coat
iav
proteasome
virus
entry
mg132
asymptomatic
respiratory
subjects
detection
pathogens
respiratory
pathogen
hbov1
an
immunosuppressed
ev71
enterovirus
ca16
clinical
enteroviruses
nan
human
palm
2003
the
severe
assay
rvp
time
fast
viral
cpeb4
hnscc
expression
gene
protein
bats
viruses
regarding
mammals
species
proteins
virus
121
protein
the
drugs
compounds
cov
development
new
nsp4
rnsp4
protein
production
produce
cells
vrti
respiratory
trm
cell
virus
nest1
mosquito
immune
saliva
cells
regulatory
vitro
brain
found
health
global
institute
vanderbilt
research
orf
interferon
proteins
inhibit
sars
sars
cov
interaction
195
proteins
epitope
virus
s510
spike
n514s
viral
hcpro
rna
particles
in
vlps
activation
nf
kappab
response
hsv
hvem
antibodies
infection
hiv
nucleostemin
nucleolus
targeting
nucleolar
rsl1d1
dp
dpb1
binding
peptide
motifs
op
case
clinical
the
causes
response
virus
infection
immune
mice
virus
smallpox
resequencing
genechips
strains
group
coronaviruses
bat
cov
nucleocapsid
acpp
rff
rxb
the
pr200
health
global
mount
sinai
academic
sars
we
public
health
epidemic
compounds
protein
indications
our
novel
nan
rt
the
lamp
assay
sars
fipv
virus
cells
feline
rna
sars
cov
ndv
vaccine
respiratory
bead
based
suspension
array
detection
proteins
cells
virus
viral
analysis
nan
rlr
rig
immune
virus
interferon
sars
measures
public
precautionary
transmission
dsrna
viruses
rna
strand
genome
pigs
infected
respiratory
virus
we
viruses
animal
rna
using
genomic
sars
cov
entry
mechanisms
blocking
information
pandemic
initiated
case
the
structures
the
rna
domain
pseudoknotted
gene
135
protein
insertion
site
genes
network
disease
gba
candidate
ptv
rvfv
disease
ifn
def201
remyelination
cns
graft
rejection
potential
nan
amp
in
biosensors
fn
protein
nl63
hcov
replicase
cov
products
mortality
serum
albumin
patients
idiopathic
fmopv
cats
cells
positive
rt
ires
translation
yeast
rps25
mrnas
ha
vn1203
virus
binding
receptor
health
disease
infectious
evolutionary
evolution
air
bioaerosol
samplers
the
diversity
infection
proteasome
drug
many
viruses
picornaviruses
viruses
three
group
bats
am
infections
ppar
host
iav
glycome
models
data
the
computational
varicella
zoster
meningitis
virus
later
ifn
bats
viral
unique
bat
formation
lps
il
1α
tnf
non
nih
cqv
hepatitis
patients
red
foxes
vulpes
viruses
widespread
sars
cov
replication
calpain
mg132
nan
nan
nan
hrs
proteins
uim
ubiquitination
ubiquitin
activity
antiviral
ncrds
cross
linking
transcription
cs
rnas
subgenomic
upstream
σ1s
apoptosis
cell
cycle
arrest
three
countries
guidelines
training
fit
perv
liver
porcine
pig
chinese
tim
ceacam1
cell
molecule
expression
respiratory
virus
disease
high
risk
rig
virus
ifn
proteins
response
nan
sars
cov
the
3cl
cinanserin
rna
packaging
protein
signal
viral
interactions
protein
domains
pdz
scribble
mtrnap
the
mitochondrial
kinetic
nucleotide
genome
modalities
sequencing
sequence
disease
collaboration
in
2005
arab
israeli
ibv
dna
replication
atr
cell
tissue
cell
administration
lung
we
nan
zeb2
requirement
development
dcs
monocytes
fluorescence
type
coverage
flow
11
reproductive
number
growth
rate
generation
genes
bat
adv
replication
viral
okinawa
influenza
amantadine
japan
resistant
env
protein
vaccine
design
efforts
nan
months
survivors
the
sars
hrqol
ad
based
vectors
therapy
gene
pneumococcal
life
immune
the
first
domains
membrane
nsp3
nsp6
coronavirus
bmpr2
cytoskeletal
defects
pah
pulmonary
cell
fmdv
viral
cells
replication
scfv
6e6
the
protein
recombinant
hcov
mice
glutamate
human
oc43
viruses
viral
membrane
replication
cellular
assay
systems
frameshifting
prf
different
ebola
disease
health
the
training
vaccine
many
currently
vaccines
vlps
viroporin
nsp4
rva
activity
rvc
nan
mers
cov
antibody
mersmab1
infections
dengue
studies
patients
ofi
identify
turn
motif
hydrogen
group
rna
public
health
the
papers
informatics
gphin
early
capacity
detection
health
rnas
ibv
chifn
coronavirus
rna
mabs
sars
cov
binding
s1
virus
vaccines
respiratory
host
immune
conference
from
allergy
cancer
new
blood
european
safety
use
meeting
nan
ceacam1
isoforms
cells
cell
cytoplasmic
hpiv
patients
respiratory
infection
32
ifn
β1
replication
hsv
synergy
hcmv
responses
vaccines
cell
used
reproduction
number
population
threshold
model
hsv
nectin
gd
binding
interaction
agr
the
patients
level
aecopd
brazzein
protein
the
protocol
potential
inflammatory
lung
ali
mirnas
genetic
dc
cd8α
cx
cr1
expression
respiratory
hrv
we
report
fatal
ffp
families
viruses
among
virus
hrv
hrvs
respiratory
clinical
groups
rna
factors
replication
identified
virus
idv
viruses
influenza
virus
icv
spike
jhm
a59
background
strain
hev
porf1
thrombin
factor
xa
bach1
znmp
ho
protein
degradation
e2
virus
glycoprotein
particle
assembly
pulmonary
tissues
ards
acute
sars
denv
rna
viral
ccr1
coding
myd88
yellow
catfish
innate
important
pro
3c
fmdv
ifn
signaling
nan
virmugens
virmugen
virmugendb
genes
vaccine
hr1
hr2
viral
cov
sars
vitamin
il
ri
may
ris
stem
cell
this
review
article
respiratory
virus
rma
viruses
human
smoking
health
disparity
disparities
life
gb
fusion
anti
virus
mabs
pseudoknots
prediction
sequence
rna
the
quarantine
compliance
psychological
requirements
impact
inflammatory
persistence
infection
cell
capsid
human
transmission
viruses
infections
transmitted
mild
encephalopathy
lesion
influenza
corpus
lung
microbiome
bos
role
infections
sltrip
liver
parasite
stage
malaria
ps
rna
genomic
mhv
viral
ccov
strains
pantropic
dogs
subtype
hapn
dimeric
m1
angiotensin
member
cypa
cd147
ppiase
activity
chemotaxis
infections
hmpv
response
fails
virus
ali
ards
no
possible
lung
specimens
bal
bw
testing
positive
sars
virus
cells
response
cov
genes
reference
infection
mcmv
qpcr
cell
mir
155
immune
tumors
sars
samples
cov
stool
patients
serum
albumin
concentration
art
mortality
influenza
laivs
virus
laiv
vaccines
amino
acids
packaging
tail
glycoprotein
nan
polio
network
fight
could
history
microscope
ofm
imaging
cost
on
lung
infections
infectious
mortality
result
integrated
chip
the
soft
lithography
virulence
aureus
expression
m21
resistance
sars
mouse
mutations
cov
adapted
isolation
measures
sars
hospital
contact
mucosal
immunity
systemic
protective
routes
ace2
mct
treatment
mg
pulmonary
health
twitter
tweets
data
surveillance
chalcone
chemistry
review
privileged
template
image
see
text
ii
vv
infection
class
expression
kittens
medical
adoption
intake
puppies
cpv
dna
virus
viruses
parvovirus
malaria
influenza
study
blood
patients
m66
2f5
mabs
bn
hiv
nan
biosensors
infectious
clinical
diagnostics
diseases
ifn
protein
proteasome
increased
cells
lt
expression
induction
results
ifnβ
kat1
type
transposase
the
domesticated
interval
serial
influenza
onset
transmission
metabolic
decompensation
infection
organ
hepatic
proteins
signal
subnuclear
localization
membrane
patients
diarrheal
illness
syndromic
surveillance
nl63
nm
hcov
μm
coronavirus
dpp
iv
anti
hsp
60
fusion
ordering
membrane
wt20
we
gp
eav
proteins
protein
membrane
influenza
virus
h9n2
israel810
ha
ps
ons
hiv
fusion
activity
virus
ndv
two
segmented
genome
apn
mice
null
angiogenesis
gene
patients
pcp
survived
cell
this
nan
viral
infection
hr
carv
risk
zikv
mv
vaccine
zika
virus
nan
adam
17
role
disease
enzyme
cleavage
small
molecule
viruses
cathepsin
aom
children
rsv
common
virus
binding
macro
domains
virus
adp
forum
communication
pandemic
deliberative
community
rv
detection
the
rapid
samples
ceacam1
binding
function
target
microbes
nec
gastrointestinal
pathogens
common
infants
recapping
rna
cap
eukaryotic
mammalian
htlv
dc
icam
dcs
sign
eif4e
eif4g
translation
initiation
helix
skin
recommendations
athletic
management
infections
rejection
lung
acute
transplantation
allograft
optimism
pain
cpm
dispositional
according
ibv
cells
infected
eif
2α
ifn
sars
irf
cov
cells
nan
nucleocapsid
oc43
nf
κb
the
infection
vsv
interferon
system
ifit2
levels
infection
plasma
cytokine
il
epidemics
invasion
predictability
lead
infected
golgi
cells
no
nef
pulmonary
nsp6
replicase
viral
replication
mhv
ssgp
gp
sgp
ebov
glycoprotein
nucleolin
rna
feline
viral
calicivirus
peptides
rsv
cells
virus
inhibited
pneumonia
virus
influenza
viral
anhui
mice
apod
dko
sr
bi
virus
influenza
significant
antiviral
drugs
genechips
rapid
variola
we
recently
virus
nc
cleavage
flavivirus
prm
we
indoor
respiratory
influenza
age
pcr
collection
detection
respiratory
nfs
virus
activation
carma3
mavs
nf
protein
dc
sign
sars
cov
pap
248
286
sevi
hiv
cell
to
viral
transmission
virus
cxcl2
mrna
er
stress
mhv
dna
sct
cd8
cell
mhc
h5
ad5
iga
the
ai
bcov
gicov
oh3
covs
cov
mers
cov
human
mutations
to
hygiene
hand
interventions
respiratory
gastrointestinal
signal
virus
endocytosis
protein
ibv
subjects
influenza
respiratory
hcws
ill
aqsr
anthracis
quorum
sensing
qs
codon
tmrna
resume
site
translation
health
require
human
surveillance
building
proteins
esnca
membrane
mechanisms
analysis
cells
nih
3t3
infection
mhv
nan
cell
method
blood
number
immortalized
zebrafish
ftr01
ftr42
ftr58
expression
recoding
assay
events
small
based
assay
ccv
npcr
the
detection
zikv
infection
host
replication
cells
pdc
prrsv
virus
ifn
porcine
disease
cd
chronic
inflammatory
100
σ1s
virus
type
wild
reovirus
level
high
coli
o157
farms
shfv
entry
cells
virus
endocytosis
env
spikes
cross
neutralizing
antibodies
ipf
viral
infections
disease
lung
3c
structure
ev68
pro
50
hospital
strains
strain
mrsa
analysis
dc
sign
virus
binding
pathogens
mice
virus
sars
infection
tg
coinfection
pr8
influenza
disease
viral
health
public
language
values
mission
cov
human
disease
gs
5734
health
infections
we
drivers
infectious
nan
ms
development
cns
pathogens
exacerbation
coli
o26
diarrhea
shiga
toxin
pro
cov
fipv
diseases
infectious
prrsv
viral
votus
isg15
prrs
deletion
satrna
different
hosts
mutation
oc43
bac
cdna
the
virus
prrsv
genome
vaccine
con
viruses
cells
cd4
dusp4
il
cell
infection
wnv
complement
virus
mice
kme
hdmppa
cholesterol
lipid
cell
nan
air
exhaled
leakage
patients
ventilation
nan
cvb3
amiloride
inhibit
eipa
na
nan
cd13
antigen
dcs
cell
presentation
infections
viral
often
cns
viruses
viruses
dsdna
rates
substitution
estimate
antibody
library
based
high
human
antibodies
capsids
aav
neutralization
aav1
fbps
fibronectin
binding
suis
the
1918
ha
na
influenza
virus
plpro
replicase
predicted
domain
products
nherf2
proteins
null
bbmv
mice
social
states
spread
diseases
behaviours
vaccine
measles
mev
attenuation
ab
attenuated
virus
dtmuv
strain
du
intercept
pc
the
treatment
aggregation
protein
rna
the
binding
regions
bovine
brd
virus
viruses
disease
nan
tlr3
cells
epithelial
poly
copd
peptide
mhc
surface
conformational
test
diseases
in
emerging
products
immunization
he
betacoronavirus
bind
ac
sias
electron
microscopy
viral
studies
in
hbov1
samples
ad
associated
hbov
hepatic
endothelial
cells
hsec
sinusoidal
immunization
public
policy
individual
collective
the
room
movement
isolation
opening
mv
receptor
spread
fusion
neurons
containing
itim
platelet
receptors
activation
pl2
protease
nsp2
domain
47
peptide
tcr
presented
the
host
phev
group
coronaviruses
oc43
coronavirus
influenza
pcr
viruses
cdc
rrt
pedv
cell
trypsin
protease
protein
coronavirus
s1
structures
different
genera
somhvr
fusion
cells
virus
mhvr
nan
nan
cocl
pdlcs
apoptosis
autophagy
human
ank
study
functions
vmyx
anksko
virus
phage
family
viruses
sampling
public
health
laboratory
technologies
control
carbapenemase
treatment
infections
producing
carbapenemases
gp
virus
vsv
neutralizing
ebola
mhv
spike
hepatitis
a59
gene
virus
rsv
assay
instability
screening
p40
il
12
production
a3
sirt4
ptms
disease
metabolic
diverse
vaccine
tb
vaccines
therapeutic
hsp65
population
evolutionary
studies
microbial
pathogens
hav
hepatovirus
human
species
structure
viruses
virus
entry
screening
protocol
virus
pcr
viruses
approach
sequences
ns1
extension
wild
type
virus
fgf2
mice
oligodendrocyte
demyelination
progenitor
nan
ace2
ang
ph
oral
delivery
m1a
sars
fab
cov
neutralizing
health
china
taking
steps
towards
hbv
epitopes
cell
disease
immune
exon
aa
reversion
fitness
motif
coronavirus
mhv
binding
ntd
mceacam1a
cases
diseases
imported
2011
2016
rbd
mers
cov
strains
antibodies
proteasome
viral
mhv
replication
coronavirus
public
health
increased
threats
events
pa
terminal
natb
activity
acetylation
nan
risk
model
information
healthcare
environments
patients
insulin
tdd
001
vs
replication
genes
bv
transcripts
nudivirus
protein
fragments
aph
cat
complementation
markov
semi
process
right
transition
tat
rsv
no
production
inos
hiv
mcpip1
cd4
cells
production
mhv
mice
cell
cd8
susceptible
nucleocapsid
the
protein
ctd
viral
influenza
complications
virus
ha
vis410
surveillance
emerging
rapid
pilot
d68
desmosterol
lipid
hcv
replication
membranes
elisa
expressed
ibv
saccharomyces
cerevisiae
pediatric
lrti
hematopoietic
stem
cell
hku24
chrcov
coronavirus
betacoronavirus
lineage
virus
macrophages
infected
apoptosis
p53
rna
rvn
synthesis
translation
coronavirus
nsp4
mutations
replicase
ctd
hr
atherosclerosis
inflammatory
oxidized
phospholipids
reaction
bvdv
cattle
pi
rt
rtpcr
mediated
transcriptional
programs
stat2
stat1
chickens
mbl
l10h
infected
l10l
capacity
care
health
time
nurses
bcl6
infection
neutrophil
viral
host
pnt
histolytica
vesicles
vacuoles
eukaryotes
ifn
hbv
λ3
antiviral
cells
ebov
entry
gp
ampk
compound
patients
outcomes
mortality
hr
95
approval
consent
study
ethical
participants
virion
flaviviridae
family
proteins
viruses
nf
κb
monocytes
ifn
activation
cholesterol
membrane
jev
den
lipid
ifitm3
amino
viruses
region
21
c6orf106
antiviral
irf3
cytokine
signaling
human
fecal
water
contamination
methods
protein
the
targeted
systemic
intranasal
rna
poly
tail
bamv
minus
research
ethical
human
subjects
biosafety
infectiousness
onset
fever
frequency
secondary
mice
ceacam1
mhv
ceacam1a
mouse
drak2
allogeneic
cells
skin
rejection
svv
ifnγ
varicella
escape
cellular
interferon
ifn
recombinant
ovine
tau
sars
cov
levels
fibrinogen
expression
anti
influenza
vaccination
the
antibody
horror
infectious
earliest
in
fiction
membrane
fission
proteins
insertions
pressure
nan
rvsiv
vector
attenuated
prototypic
virus
adpr
nsp3
md
binding
chikv
trna
mutants
altered
anticodon
site
protein
phosphorylated
14
phosphorylation
kinase
influenza
history
1918
associated
viruses
nan
influenza
pandemic
nursing
homes
disruption
nan
hiv
af
alb
levels
positive
catalytic
usp12
two
uaf1
wdr20
hiv
prm
virus
strains
gp120
disaster
disease
outbreak
related
psychological
flai
alleles
class
specific
cell
bats
vampire
rabies
rv
culling
licochalcone
asthma
induced
expression
poly
nan
gx
ibv
serotypes
coronavirus
yl5
nan
pcr
af
esi
ms
amniotic
rna
poliovirus
replication
ntr
viral
h4
tcv
rna
sense
hairpin
cov
mers
sars
the
approved
endou
pedv
icpedv
cells
epithelial
hev
orthohepevirus
species
two
family
cell
cells
tlr
tlrs
therapeutic
trme
domain
modification
reaction
binding
dc
signr
glycans
man
glcnac
igsf
proteins
networks
one
immunoglobulin
health
international
global
security
agenda
health
global
we
infectious
course
patients
wuv
hospitalized
among
rti
esrd
transplantation
kidney
january
transition
nan
subset
terms
core
used
coverage
epidemic
mathematical
modelling
infectious
course
peptide
hla
presented
strategy
2402
nsp13
229e
hcov
terminal
domain
populations
vulnerable
influenza
preparedness
pandemic
rna
virus
electron
double
dmvs
replication
copi
coatomer
cellular
transport
liver
ifn
pdc
irf
injury
cathepsin
hiv
microglia
apoptosis
infected
immunity
gp
inactivated
rabv
vaccines
drak2
peripheral
cell
tcr
mice
lung
transplantation
hypoalbuminemia
mortality
rate
egf
magnesium
the
basolateral
gene
rtd
sars
cov
lung
mice
mg
vaccine
studies
route
dose
catalytic
metal
ion
biological
mechanism
macro
domains
adp
ribose
viral
lat
li
the
anesthetic
gel
maternal
vaccination
vaccines
infections
vaccine
pbc
biliary
e2
primary
cirrhosis
vaccines
hit
immune
viruses
persistent
coccidioides
spp
culture
assay
sensitivity
myd88
mta1
nf
κb
lps
cells
cell
cycle
virus
infected
hcv
based
viral
compounds
lead
hbov1
fold
15c6
capsid
human
patients
npa
uncomfortable
emergency
may
influenza
excess
associated
deaths
mortality
influenza
test
99
the
detection
cross
cell
peptides
unrelated
self
cell
mers
fusion
cleavages
cov
dpp4
mers
cov
receptor
amino
lung
the
pathogens
vaccine
vlps
p48
p29
rna
the
hypovirus
cheetahs
feline
free
ranging
wild
ebv
kshv
responses
protein
plasma
hcv
ihh
virus
genotype
1a
virus
host
proteins
protein
viral
nan
mers
cov
respiratory
animal
species
nan
recoding
rse
rna
conserved
structure
airborne
infection
the
indoor
environments
cell
immune
responses
cells
hp
proteins
protein
activated
university
cell
nan
n7
mtase
sars
coronavirus
cap
sickness
symptoms
acceptance
il
emotional
disease
countries
dynamics
change
livestock
interaction
interactions
protein
data
screens
ccl2
cxcl10
expression
er
stress
the
sars
epidemic
wake
up
env
virus
mutations
receptor
host
microbe
individuals
disease
attributes
may
mice
tmev
cns
b6
viral
pct
levels
invasion
pathogenic
bacteria
rna
immune
signaling
rig
rlr
tcov
turkey
elisa
serum
using
group
hcp
respiratory
seasons
illness
autophagy
process
lysosomal
degradation
originally
other
viruses
pose
greater
public
fiv
feline
immunodeficiency
virus
the
tetherin
feline
cbst2
504
fiv
noroviruses
bonv
capsid
giii
human
anthrax
improved
spores
mucosal
systemic
sars
cov
replication
coronavirus
proteins
ifitm3
protein
ubiquitination
virus
activity
virus
dsrna
rna
responses
phosphorylation
respiratory
protease
antiprotease
balance
viral
patients
tachycardia
sars
hypotension
occurred
pathogens
tropism
animal
models
human
ckngre
ngr
cd13
cells
cyclic
genome
sgmrna
nested
rna
strand
blood
inactivation
pathogen
technologies
components
pcr
95
ci
rapid
culture
ns1
virus
cell
cycle
protein
nan
influenza
nirv
detection
95
cri
cd23
ige
therapeutic
low
affinity
asthma
childhood
wheezing
development
hrv
ps
pdt
the
light
known
nan
neutrophils
immunity
antiviral
mab
immunotherapy
airway
epithelial
cells
laser
contraction
viral
humans
virus
hf
arenaviruses
pdc
ifn
bartha
response
ti
hrep
proteases
gene
like
enterocolitica
mir
499
qki
gene
target
viruses
science
research
the
ongoing
batmuv
muv
bat
human
proteins
sars
cells
memory
protein
cov
ace
lung
ang
ii
experimental
nan
nan
gram
the
exacerbations
chronic
obstructive
rv
species
associated
illness
controlling
providers
reporting
knowledge
diseases
public
sod
responses
bppcysmpeg
pcdna
mice
oxindoles
strategy
spirooxindoles
using
propargylated
the
pedv
recombinant
mab
specific
protection
lcrv
vsv
we
plague
infection
fhv
dam
factors
cheetahs
ga
lymphoma
treatment
cell
the
rna
virus
viruses
field
technological
viruses
humans
new
human
rna
asthma
hrv
children
induced
wheezing
bats
viral
species
large
virome
date
palm
sap
contact
nipah
blood
neutrophil
neutrophils
phenotype
measurements
gp64
tm
membrane
domain
domains
cgh
detected
probe
signal
snps
safety
new
public
vaccines
health
transmission
ebola
parameters
disease
we
epac
antagonists
exchange
camp
novel
apod
triglyceride
lipid
metabolism
mice
replicon
sars
viral
rna
the
viruses
disease
may
oncolytic
on
nan
health
foreign
policy
african
china
nan
sdt
health
capacity
the
public
human
transitions
new
infectious
diseases
ceacam1
cell
matrigel
vasculogenesis
cells
nv
gii
fecal
identified
samples
mhv
rna
syncrip
binding
utr
nucleic
pcr
the
acid
extraction
prins
diabetic
expression
smad7
patients
sert
model
the
serotonin
transporter
qpcr
positive
generated
methods
time
cc
resource
genetic
diversity
map
cd
sera
biomarkers
subjects
mass
hbov
samples
the
npa
dna
mice
hcov
oc43
viral
neurological
badv
samples
adv
fecal
cattle
aom
respiratory
viral
viruses
visits
covs
wild
strains
deer
bovine
nan
aging
hsp
longevity
many
heat
test
rapid
the
elisa
100
kdke
4a
sya
pedv
pigs
specimens
np
positive
bal
fluid
sars
patients
plasma
proteins
using
cathepsin
thiochromanone
inhibitors
ic
50
imaging
mri
ct
technique
fhavn
bovis
pcr
positive
vhp
specimens
wnv
viral
specific
cells
virus
communicable
health
diseases
canada
public
teachers
rh
classroom
symptoms
risk
states
express
authorities
quarantine
legal
microbiology
detection
microarray
arrays
laboratory
ns2b
ikkε
denv
kinase
dengue
virus
infections
these
often
mechanisms
ii
tgev
ccov
gastroenteritis
like
sars
antigenic
cov
sites
protein
hiv
627
pocket
structure
nhr
nan
apmv
human
virus
lung
case
pkr
protein
junv
host
antiviral
immune
mrna
levels
ifitm
related
ssdna
structures
predicted
selection
viruses
replication
protein
rna
membranes
associated
hiv
proteins
ifitm3
inhibition
viral
ade
serotypes
dengue
enhancement
replication
vp24
stat1
ifn
nuclear
py
mers
infected
cov
middle
east
niv
hev
fusion
glycoproteins
viral
list
in
selecting
method
produce
ca
cellular
control
also
transcription
dna
e7
vaccination
crt
cell
infection
influenza
within
dynamics
behavior
introna
hpre
expression
in
gene
transposable
sle
elements
expression
rna
rna
1a
2a
recruitment
replication
primer
probe
virus
sets
pandemic
bmv
cp
replication
rna
er
her2dmab
vivo
her2
antibody
cancer
panel
based
molecular
rapid
detection
infectious
diseases
disease
reporting
laws
na
atpase
α1
α3
the
respiratory
children
human
bocavirus
detected
influenza
pandemic
authors
person
1918
sars
cov
rna
sirnas
viral
melan
mart
hla
restricted
cd4
fusion
protein
virus
entry
distinct
rna
viruses
viral
elements
interactions
viruses
membrane
dmvs
replication
recent
cordycepin
cells
apoptosis
hepg2
associated
studies
smoking
we
outcomes
health
mbl
mice
dko
antibody
immune
mutation
rates
viruses
rna
genome
based
daac
derivatives
structure
inhibitors
vaccines
inactivated
laser
methods
virus
rsv
gene
airway
epithelial
cells
bronchiolitis
viral
care
research
infants
bats
astv
gut
infections
enteric
analogues
major
anti
polymerases
studies
risk
public
health
communication
disease
hf
sace2
patients
activity
angiotensin
hsp90
replication
ebov
inhibitors
17
mice
10
dcs
cvb3
myocarditis
the
management
program
emergency
nml
rs12252
h7n9
influenza
patients
genotype
information
health
identifiable
laws
public
nan
dsg3
pv
pathogenic
autoantibodies
antibodies
ntm
the
patients
infections
1997
physicians
intervention
public
practices
facilitation
nodal
network
disorder
efficiency
alterations
trimer
pocket
pie12
hiv
gp41
influenza
respiratory
virus
pcr
infections
survival
zanamivir
viral
the
mortality
idv
respiratory
virus
calves
tract
rsv
vaccine
children
viral
δm2
rna
transcription
coronavirus
synthesis
viral
rna
interference
provides
potent
specific
bbb
covs
brain
bmecs
mhv3
hmpv
respiratory
children
samples
infections
sequences
rna
elements
replication
viral
nan
virus
replication
rna
viral
plus
denv
igg
1a5
fc
infection
rna
nucleus
virus
replicase
ns5
tcrv
bats
virus
artibeus
dose
denv
bats
two
species
rt
rsv
epac2
replication
infection
specific
virus
protein
the
coronavirus
nucleoprotein
data
we
markov
epidemic
process
nan
protein
infections
nl63
the
nucleic
lung
enzymes
expression
disease
pathophysiology
human
control
pathogens
health
single
lncrhoxf1
human
cells
trophectoderm
viral
lung
viral
injury
ali
respiratory
spr
the
slbs
high
lipid
cgb
protein
at
loop
tgn
type
ifn
ifnar
upon
viral
ion
viroporins
viroporin
ca
evolved
rvfv
ifn
rna
signaling
fever
changes
rna
gly64ser
3d
pol
sgiv
virus
cells
dna
iridovirus
virus
proteins
activities
mechanisms
antiviral
influenza
virus
ha
antibodies
subtypes
age
severe
year
old
group
nan
3cl
pro
gav
sequence
the
cpv
binding
canine
feline
fpv
frameshift
site
stimulator
programmed
translational
psg1
tgf
domain
latent
ig
lectins
glycoconjugates
plants
clusters
glycoproteins
fusion
vsv
recombinant
membrane
viral
nan
vaccines
coronavirus
delta
inulin
adjuvants
gag
nc
nucleic
acid
proteins
sars
cov
dcs
viral
10
mutation
assay
h274y
samples
h1n1
ebov
sars
entry
le
virus
inactivation
infectious
pathogen
subsequent
lipid
children
hrv
asthma
hrvc
severe
ul1
hcmv
pul1
human
revealed
nsp1β
infected
virus
innate
immune
contacts
household
sars
index
patients
cholesterol
membrane
ceacams
mhv
fusion
respiratory
viruses
virus
patients
found
p74
odv
two
protease
host
ms
autoimmune
mimics
microorganism
gut
sars
first
virus
chinese
it
b7
h1
cd8
virus
cells
aons
antisense
rnas
muscular
therapy
protein
rna
viral
nsp9
prrsv
cpmv
cns
diseases
virus
inflammatory
nan
phosphate
translocator
inner
envelope
membrane
viral
children
care
infections
major
dementia
life
sbp
cases
risk
ph
hsv
entry
virus
hvemt
rice
ctb
mucosal
specific
antigen
cxcr3
mice
hsv
increase
anterior
hla
alleles
regions
viruses
diversity
virus
target
the
filovirus
family
african
glycoproteins
henipavirus
fruit
m74
icis
students
pt
ici
canadian
ibv
s1
binding
cells
iav
protein
antibodies
mers
cov
used
e6
hpv
crt
vaccine
dna
dc
blood
low
cells
nipc
drugs
viruses
new
target
diseases
bat
diseases
bats
berlin
meeting
doctors
nurses
sars
staff
may
nuclear
import
host
viral
expression
the
emergence
evolution
new
research
demyelinating
disease
ms
virus
diseases
ifn
responses
antiviral
tlr3
mda5
breathing
frequency
filter
til
penetration
site
sequence
downstream
canonical
synthesis
ali
sars
cov
il
macaques
evacuation
icu
critical
care
suggestions
ang
ace2
t2dm
ras
ii
influenza
surfaces
cleaned
rpd
rpds
nan
cells
antibody
light
antibodies
cell
donor
transplantation
alloantibody
sensitized
ascs
gp
ebolavirus
ebov
the
fusion
gag
virus
proteins
rsv
protein
vaccination
protein
responses
bm
alt
ifn
bats
viruses
highly
ifns
ozone
pollutants
children
found
incidence
prrsv
genome
virus
cdna
viral
1a
replication
rna
membrane
er
ib
common
cold
treatment
studies
respiratory
influenza
tract
patients
viruses
nan
receptor
membrane
trypsin
protein
cpl
prediction
tepitool
tools
cell
epitope
chikv
vaccine
attenuated
novel
live
siv
ifn
nucleotide
optimized
composition
amplification
nucleic
acid
lamp
the
rna
hcv
replication
pcbp2
utr
apoptosis
reovirus
infection
cells
acid
influenza
pandemic
1918
virus
pandemics
hmpv
adults
elisa
the
virus
health
care
cases
mers
cov
cd8
cells
specific
bystander
memory
time
the
number
transmission
potential
cells
respiratory
sars
cov
early
entry
gd
receptor
adapter
egfr
b7
h1
virus
cell
cns
viral
perinuclear
structure
tumv
protein
nan
2009
immune
infection
h1n1
responses
social
disease
we
response
spread
ventilation
prone
rr
mortality
trials
mers
cov
patients
ed
respiratory
vp26
mutation
capsid
protein
phosphorylation
virus
based
rvsv
ebola
filovirus
virus
infection
respiratory
epithelium
hantavirus
hmabs
sars
cov
including
used
ngs
identification
viral
virus
enrichment
exhaled
airway
airborne
bioaerosol
saline
felv
disease
enfelv
viral
feline
iav
autophagy
viral
m2
np
tm
domain
amino
gp64
fusion
sars
patients
antibodies
coronavirus
viral
cov
sars
hace2
hot
spot
toronto
regions
hospital
comparison
rates
pathogens
patients
ips
detected
hct
prostate
cancer
mxa
genotype
rs2071430
cov
sars
u122
the
contains
npcs
allogeneic
cells
mice
cell
felid
herpesvirus
important
respiratory
pathogen
inos
species
respiratory
regulatory
regions
civ
dogs
vaccine
first
canine
ifn
protein
niv
responses
hev
cp32m
hiv
inhibitor
novel
peptide
pain
hips
steroid
onfh
cases
spinal
cord
method
effector
infiltrating
response
dna
humoral
cellular
immune
position
trna
molecules
ending
codons
nanog
disease
gestational
trophoblastic
choriocarcinoma
bcg
cell
lcmv
mice
cells
virus
ns1
interferon
compounds
protein
customs
officers
risk
occupational
high
sign
virus
cells
sa
influenza
virus
respiratory
p38
mapk
viruses
microarrays
microfluidic
synthesis
system
uniform
coiled
coil
positions
the
helices
nan
receptors
mers
cov
virus
cell
china
crystallography
protein
ray
research
viruses
viral
intracellular
genome
machinery
ccr5
anibamine
receptor
hiv
binding
pdcs
cells
lcmv
cd4
persistent
nan
sars
patients
triage
screening
predictive
hrv
children
hrvc
burden
jordan
mechanisms
antiviral
responses
respiratory
viruses
xdr
tb
transmission
community
based
pathogens
sites
replication
endocytic
used
children
hrv
wheezing
respiratory
years
nan
ig
cell
genes
cloning
expression
rpe
use
training
studies
workers
proteases
serine
membrane
family
key
sti
si
the
dba
models
human
lectin
microarray
glycosylation
microarrays
hmtr1
first
cap1
mrnas
capped
nsp1
host
scov
mrna
degradation
cov
mers
assays
assay
respiratory
m2
enacs
influenza
protein
the
intracranial
the
pressure
severe
ventilation
participants
symptoms
individuals
survey
respondent
snornas
xendou
conserved
site
small
expression
e2
virus
wpre
bhv1
mucosal
virus
hiv
regimen
siv
95
ci
esi
ms
rt
nan
mhv
protein
receptor
mhvr
r1
fusion
gp2
helix
marv
ph
rna
viral
p19
dicer
silencing
229e
hcov
tmprss2
cells
cell
pedv
china
diarrhea
southern
field
aiv
replication
protein
osbp
rna
c5a
hcv
infection
amphipathic
helical
variants
shfv
virus
arterivirus
infecting
chikv
virus
recoding
tcr
element
anxa2
infection
studies
immunity
host
hr
hsv
fusion
gh
glycoproteins
bats
movement
ecology
the
capacity
muc5b
qtl
muc5ac
protein
bpifb1
sd
diarrhea
pedv
china
sequence
frameshifting
virus
rna
rsv
replication
mmp
cells
cns
mrna
timp
nan
communities
social
network
geographic
disease
prrsv
host
protein
nsp1β
nuclear
health
ihr
global
who
reform
protein
data
host
we
dengue
ed
impact
sars
visits
patients
nan
hcov
cell
human
hae
hcovs
cd8
cell
rjhm
response
ra59
hku14
rbcov
betacoronavirus
analysis
subgroup
asv
hcv
50
activity
ec
viruses
rna
wild
influenza
virus
cd13
cells
adhesion
cell
we
bmx
animals
bm
csf
ang
aβ
40
rpe
pathways
gene
bifurcated
bonds
strength
acceptor
bonding
pcr
identification
esi
ms
fungal
cc
lines
extinct
inbred
founders
def201
virus
yfv
dose
ifn
assay
the
new
pcr
h1n1
protein
cov
sars
trim25
rig
proteins
hsv
macrophages
infection
secretome
cell
wssv
ie1
wsv056
drosophila
nan
tmd
protein
er
residues
viral
cells
injected
anterior
eye
ifnγ
virus
discovery
viruses
different
sequence
gal
th
cell
cells
il
distribution
sneeze
size
droplets
geometric
sars
cov
civets
isolates
virus
viral
translation
influenza
virus
mrnas
ifn
mhv
infection
κb
irf
autophagy
induction
independent
we
complex
models
branches
complexity
analysis
selection
dna
vaccines
human
immunogenicity
protein
antibodies
three
gp41
mutant
sequences
viral
management
outbreak
investigation
challenging
cscs
stem
lung
cells
cell
discovery
rate
viruses
the
disease
nt
utr
domain
the
bcov
scfv
e2
hepatitis
antigen
antibody
prrsv
viral
intercellular
cells
virus
nan
nk
cells
cd66a
expression
regulatory
sars
blood
specific
immunoglobulin
antibody
ili
mortality
influenza
esrd
deaths
nsp2
ck1α
rv
nsp5
vnsp2
lung
infection
infections
transplantation
high
cell
naïve
repertoire
cells
repertoires
viruses
viral
escape
endosome
endosomal
cells
protein
translation
eif2α
virus
hiv
infected
cxcl5
chemokines
increased
visualizations
data
visualization
infection
transmission
3b
3ab
chaperone
activity
amino
mhv
a59
length
cdna
full
cr
cdc12
sin
cytokinetic
sid2
nan
prrsv
piglets
infection
infected
suis
pcv2
orf2
mabs
pcv1
seven
viral
pkr
translation
vhs
mrnas
nan
sex
differences
infectious
infection
susceptibility
il
patients
dn
significantly
higher
virus
influenza
annual
epidemics
seasonal
pseudoknot
stem
loop
essential
virus
severe
outcome
responses
iav
viral
the
coronavirus
glycoprotein
fusion
postfusion
respiratory
nxtag
rpp
fa
rp
infection
neonatal
control
unit
respiratory
evidence
based
medicine
using
best
assay
rapid
rt
lamp
fmdv
signal
neurons
infγ
stat1
ifn
viruses
respiratory
children
infections
two
rvfv
infection
translational
mrnas
rna
rnase
zikv
virus
infection
cells
nan
sars
motif
er
protein
golgi
irf
mediated
weev
pathways
virus
viral
tropism
trimer
infection
epithelial
100
rvp
xtag
95
99
nan
tags
ema
fda
guidance
preclinical
control
discovery
century
development
components
acute
pancreatitis
autophagy
impaired
zymogen
cells
hcv
cell
virus
sign
nsp4
virus
rna
viruses
replication
brsv
circulating
variants
virus
europe
neonatal
sepsis
the
outcomes
definition
sav
hunovs
fcv
mnv
ph
maternal
fetal
placental
pregnancy
mirnas
gag
gag1
rvsv
vectors
gene
virus
coinfections
viruses
infection
clinical
elisa
antibodies
tmuv
protein
ducks
mers
cov
neutralizing
protein
mabs
hcov
human
emc
tissue
bronchial
virus
antiviral
response
nsp14
exon
nsp10
replication
viable
synthesis
coronavirus
cells
infection
jhmv
cell
mhvr
cd8
lung
viral
infection
acute
felv
immunosuppressive
envelope
virus
cells
diarrhea
china
the
pedv
in
rotavirus
ifn
infection
expression
nf
ebov
bsl
reporter
anti
ebovlp
hbv
virions
enveloped
budding
release
exposure
saa
cns
increased
protein
hmpv
respiratory
infection
pcr
assay
virus
host
viral
methylation
cap
nucleosides
azido
derivatives
triazolylinosine
activity
sars
cov
ifn
infection
irf
probability
we
general
pathogen
novel
bohv
gd
brain
considered
vivo
atii
sp
ati
expression
human
hla
3001
3002
peptide
binding
vacv
vaccines
virus
smallpox
including
hev
viral
fusion
cell
functions
ppmo
csi
wnv
peptide
end
nan
rna
viruses
genetic
diversity
evolution
drug
delivery
diseases
spread
infectious
ifn
stat1
lcmv
mice
ko
autophagy
induction
morbilliviruses
induce
cell
mhc
class
ii
alleles
loci
fcov
fip
type
infectious
c3663
cells
npcs
nkg2d
mice
rae
animal
wellbeing
euthanasia
neuroendocrine
hormones
virus
vaccine
vectors
b5
recombinant
grft
antiviral
human
virus
hiv
virus
h5n1
ph
influenza
activation
il
tumor
27
cd8
cells
stored
medium
nasopharyngeal
aspirates
transport
this
parvovirus
brazil
cpv
2c
dc
sign
hiv
cells
dcs
psychological
hurricane
trajectory
predisaster
the
h273r
rdrp
pv
rna
virus
chest
image
intensity
three
subregions
vaccine
design
new
cops
may
rrv
vcd200
cd200
hhv
immune
la
crosse
virus
mosquito
aedes
human
zoonotic
threat
disease
metagenomics
antler
anfh
11β
osteoblasts
mg
cr
zbtb7a
dsa
am
human
nan
influenza
broadly
neutralising
antibodies
potential
rna
armored
virus
plasmid
containing
hiv
debio
025
cypa
isolates
viral
children
used
stools
afp
infants
bronchiolitis
illness
visits
uri
pythons
we
nidovirus
respiratory
morelia
mers
cov
dpp4
mouse
glycosylation
sars
cov
infections
factors
infection
bats
cov
covs
human
species
il
tmev
infection
macrophages
sjl
immune
vaccine
dna
induce
responses
sars
cov
infection
cathepsin
receptor
the
airborne
human
described
transmission
rsv
ad5
crs
vaccine
seen
protein
domain
the
coronavirus
nucleocapsid
viruses
civ
virus
canine
dogs
civet
cov
sars
infected
cross
smallpox
th
vaccines
few
diseases
protein
virus
mhv
a59
receptor
virus
probes
spots
subtype
viruses
icp
children
increased
rhs
intracranial
ibv
mabs
s1
the
anti
rv
fc
receptor
p75ntr
soluble
health
public
canada
response
sars
fcov
residues
3b
identified
nucleoli
antibodies
env
specific
dna
eiav
35
il
iav
protein
virus
tank
nf
κb
virus
signaling
plant
vlps
vlp
vaccines
production
acute
fever
chronic
protein
response
tweets
among
vaccination
201
social
cells
cd8
infection
ox40
development
rgs
genes
npc
yars
hprt1
swifitms
interferon
proteins
ifitms
restriction
nan
providers
universal
health
service
precautions
pirbohp
the
recombinant
protein
sequence
oxa
58
omv
extracellular
carbapenem
colonization
pepn
cells
activity
fischeri
ards
lung
acute
respiratory
failure
vaccine
sars
adjuvant
wi
hamsters
research
development
life
science
biotechnology
pcr
real
time
detection
amplified
ifn
infection
rna
bovine
promoter
rhinovirus
infants
infections
rna
presence
tm
fgfr3
four
residues
receptor
sars
sensitive
rca
the
2003
virus
macrodomain
coronaviruses
mhv
mice
management
current
many
evidence
exacerbations
neutralizing
nabs
neutralization
antibodies
viral
gag
cell
response
aavs
vectors
emergence
henipavirus
distribution
climate
wildlife
anti
viral
cytokine
response
inflammatory
avian
h5n1
influenza
species
infected
protease
sars
cov
kda
the
immune
cns
tissues
cancer
the
pcv2
p38
mapk
pathways
jnk1
protein
endodomain
the
fusion
carboxy
nan
hearts
eet
seh
recovery
bnp
cd8
ms
lymphocytes
cells
disease
gii
pigs
nov
id
50
nan
falco
falcons
peregrine
peregrinus
species
λ3
fmdv
cattle
boifn
ad5
cells
mhv
receptor
human
virus
gbf1
hcv
ns3
replication
interaction
mtase
nsp16
nsp10
coronaviruses
activity
genes
human
hcmv
expression
gene
nanoparticles
pdi
resistance
microbial
cells
prevalence
hendra
virus
bat
we
rsk1
rsk2
erk
kshv
the
nl63
virus
hcov
cells
entry
mv
immune
pre
immunity
in
health
migration
international
policy
population
virus
vp7
gbf1
rotavirus
assembly
viral
cell
ifn
cns
responses
entry
hwars
enteroviruses
ev
a71
nan
flt3
cells
mdcs
pdcs
infected
pulmonary
sars
severe
acute
respiratory
virus
mhv
human
egf
oncolytic
health
public
tb
program
investigations
revealed
examination
pancreaticoduodenal
ziehl
neelsen
proteins
complex
core
polarity
crumbs
nan
cells
memory
mice
attrition
cell
prrsv
pcv2
increased
porcine
group
group
blood
lactic
acid
levels
rna
switch
leader
genomic
acceptor
cells
mhv
specific
chronic
cns
nan
lpms
closure
influenza
risk
avian
binding
proteins
fn
mfn1
mfn7
nsp5
cov
mhv
human
covs
preterm
birth
conception
weeks
seasonal
rpl4
recoding
gag
expression
retroviral
disease
communicable
interventions
european
public
mabs
sars
neutralizing
cov
domain
cells
mice
ptd
lps
normal
btb
fiv
ple
lions
knp
nsp5
d2
d3
ts
viral
rna
activity
nidoviruses
arteriviruses
endoribonuclease
transmission
rates
using
infection
model
axl
zebov
transduction
in
cellular
pam
h3a
his
secretory
ala
eua
vaccine
public
drug
h1n1
evidence
safety
blood
pathogens
the
fan
plus
media
545
bottles
human
specificity
viruses
receptor
type
influenza
hong
kong
shenzhen
subtropical
gene
10
pcr
sars
rt
health
services
village
doctors
public
host
protein
viral
viruses
replication
nsp9
protein
the
sars
cov
virus
gc
protein
the
cell
chm2013
virulence
bj2011c
diarrhea
gene
m2e
influenza
recombinant
rsm2e3
spore
tgev
virus
mrnas
genome
encapsidation
fapn
coronavirus
apn
ccov
receptor
distance
mean
transmission
cases
we
academic
journals
journal
wjg
high
nan
ifitm3
lysine
k88me1
methylation
antiviral
mhv
mice
jhm
ceacam1a
mceacam1a
memory
cells
specific
cell
method
spinal
cord
injury
sox11b
gene
viruses
pathways
targeted
proteins
virus
respiratory
mers
cov
humans
camels
sars
patients
hospital
singapore
index
intervention
contact
degree
contacts
emerging
pandemic
influenza
community
respondents
we
respiratory
pilgrims
mers
cov
38
cells
nkg2d
γδ
demyelination
mediate
dna
vaccine
vaccines
technologies
immunogenicity
il
35
expression
periodontal
the
zinc
selection
binding
site
consequently
influenza
studies
dysregulated
host
responses
case
days
95
influenza
pandemic
nan
aids
hiv
projects
process
support
cq
yeast
cells
pathways
biological
sin
chemokines
lps
release
ip
tobacco
control
health
bioethical
global
limitin
ifn
antiviral
activity
in
emergence
in
communities
bridge
events
myeloablative
respiratory
virus
hematopoietic
transplantation
influenza
risk
experiments
virulent
laboratory
immune
ro52
autoantibodies
the
reactivity
frameshifting
may
aberrant
proteins
protein
protein
membrane
proteins
structural
expression
poly
ifn
iav
sars
cov
demyelination
macrophage
virus
infiltration
microglia
nan
manifestations
oral
diseases
reports
we
influenza
forecasts
spread
human
in
yfv
serum
hamsters
levels
significantly
frameshifting
encoded
proteins
frameshift
ratios
expression
casei
cassettes
containing
gene
tlda
respiratory
assays
the
pathogen
cells
cll
ighv1
69
g6
nl63
hcov
ace2
infection
showed
tnf
induced
arthritis
drugs
splice
virus
dengue
membrane
cells
structures
airway
epithelia
polarized
primary
function
exon
fidelity
replication
nsp10
cov
virus
species
region
nsp1
arterivirus
otitis
media
acute
viruses
infection
rnas
noncoding
small
nucleotides
long
health
public
interpersonal
efforts
communicative
protein
negative
viruses
charge
tail
nan
mers
cov
rabv
vaccine
protein
vaccine
vaccines
the
antigens
diseases
rna
replication
bmv
translation
lsm1p
ace2
ang
heart
failure
angiotensin
virus
2009
pandemic
h1n1
assays
nan
horses
genome
genomes
various
diseases
recombinant
virus
vaccinia
used
viruses
lujpv
lujv
cell
arenaviruses
envelope
virus
mhv
mek
uo126
demonstrated
nan
simulation
methods
validity
pandemic
public
gag
hsv
binding
sulfate
gags
influenza
cells
virus
atii
induced
ace2
lung
dabk
inflammatory
inflammation
na
cell
influenza
survival
src
binding
virus
sialic
acid
cells
network
model
parameters
transmission
epidemic
plpro
ibv
substrate
different
specificities
zikv
drug
compounds
induced
caspase
zikv
nsaids
virus
including
entry
within
cns
immune
control
access
pertussis
children
bronchiolitis
infection
hospitalized
wk
mice
neurogenic
bladder
overactivity
rna
leader
lth
subgenomic
region
surveillance
targeting
epidemic
disease
epidemics
ifitm
schizophrenia
levels
mrna
higher
ibv
the
homology
strain
we
autophagy
pathway
host
machinery
antiviral
myeloid
cells
clr
responses
endocytic
il
17a
diabetes
17
viral
cells
ebv
specific
cross
reactive
an
interview
tikki
pang
director
influenza
zoonotic
viruses
pcr
rt
site
reinitiation
start
sequence
motifs
cats
koehlerae
clarridgeiae
four
inoculated
hcov
nl63
children
229e
age
gapdh
replication
viral
rna
tbsv
nan
nan
healthcare
thai
work
health
related
tgev
replicons
genes
cell
the
hpiv3
replication
virus
ebov
respiratory
zoonotic
emergence
environmental
disease
available
hcv
detection
antibodies
mab
discuss
nan
viral
vspots
structures
rna
factories
nan
sars
cov
rdrp
potential
the
pdcov
cell
strains
culture
strain
nsp1β
domain
terminal
prrsv
protein
plants
production
therapeutic
proteins
recombinant
ace2
activity
glucose
mice
islet
virus
ctl
escape
variant
viruses
health
visits
tuberculosis
care
risk
fusion
strains
ph
virus
ha
elisa
the
herds
samples
milk
respiratory
agents
infections
clinical
infectious
years
nafld
ix
liver
patients
rsv
respiratory
cattle
vaccine
two
cov
mers
nsp1
host
mrnas
staff
registered
participants
judgements
guidelines
nan
chemokine
receptors
nomenclature
committee
pharmacology
staff
emergency
department
ward
sars
rnase
ns2
h126r
hepatitis
liver
perforin
disease
cells
cd8
borna
patients
car
cell
infections
days
3cl
pro
related
nidovirus
the
eif4e
human
ribavirin
cells
guanosine
diseases
burden
communicable
health
funding
hcov
sars
samples
oc43
recombinant
nan
models
response
disaster
health
reporting
sars
cov
vaccines
rbd
based
murina
pneumocystis
mice
infection
vaccinated
sari
algorithm
the
patients
search
h1n1
influenza
pdm09
pilgrims
among
species
host
cross
transmission
virus
hcv
ifitm2
ifitm3
ifitm
proteins
respiratory
infection
lower
tract
virus
strains
genotype
hku1
cov
analysis
decontamination
ms2
test
respirators
droplets
ifns
responses
ifnγ
expression
cells
rrv
ifn
virfs
infection
type
ligands
cell
tlr
protective
increase
metabolic
range
genome
scale
models
sars
terminal
31
161
protein
sars
patients
illness
non
respiratory
transgenic
mice
rhmab
pups
antibody
mers
cov
human
nabs
binding
3cl
pro
sars
polyprotein
substrate
models
pathogen
emergence
human
pathogens
germline
mature
bnabs
hiv
like
tb
95
ci
lamp
amplification
hcv
particles
cells
production
bhk
2b
frameshifting
orf
frame
conserved
ha
virus
ph
h5n1
mutant
host
virus
viruses
encode
novel
nan
hendra
virus
recycling
important
fusion
the
pro
immune
mechanisms
cleavage
rna
statistical
structures
predicting
models
based
effective
disease
we
using
nan
cells
cd4
respiratory
cell
responses
disease
sars
the
global
control
virus
rnai
viruses
antiviral
rna
cov
mers
respiratory
related
patients
ifn
ibv
response
accessory
in
svz
gal
mice
ms
increased
antibodies
clone
rejection
hla
self
lps
κb
lung
cinc
78
mers
cov
mouse
cells
response
nipah
virus
animals
respiratory
disease
plpro
sars
ub
mers
chains
hmpv
infection
binding
hs
sulfate
sampling
respiratory
viruses
sensitivity
three
nan
replication
usp11
virus
rna
np
type
ifn
denv
production
mice
mpyv
ifn
infection
polyomavirus
human
ace2
release
sars
cov
airway
recombinant
viruses
transcription
regulatory
circuits
blood
group
antigens
groups
populations
sars
cov
lung
nf
κb
fusion
binding
hr1
d5
target
evs
cells
signaling
cell
instructions
yfv
transmission
the
we
spatial
flow
fish
cell
cells
functional
nan
health
public
information
application
knowledge
pol
viruses
recombination
genome
order
sars
coronavirus
samples
cov
assay
laboratories
ev71
samples
ca16
armored
ebola
virus
gp
binding
catl
dub
activity
coronavirus
interferon
antagonism
mabs
epitope
cocktails
gp
virus
suis
suilysin
infection
siv
bacterial
sg
formation
ifn
protein
mda5
mortality
interventions
cities
epidemic
pandemic
membrane
pul31
nuclear
pul34
capsids
alere
influenza
flu
100
the
cells
receptor
insect
endocytosis
rsv
mers
cov
ceacam5
cell
binding
subjects
sarcoidosis
immune
ppd
protein
autophagosomes
sfv
viral
cells
autophagosome
spinal
cord
mouse
transplantation
cells
rna
the
hdv
ability
rodlike
rna
hev
32
cap
helicase
p6
terminal
protein
virus
replication
sgs
stress
virus
replication
viruses
pedv
ifn
type
iii
epithelial
hbv
hcv
infected
apoptosis
autophagy
ccov
genes
coronavirus
coronaviruses
group
traf3
cells
myeloid
mice
inflammation
cells
calu
respiratory
epithelial
lcc
mnv
murine
sa
macrophages
binding
mers
cov
dpp4
species
hamster
vγ9vδ2
cells
neonates
preterm
sga
faucium
abscesses
mycoplasma
recently
associated
sensors
viral
cell
types
the
hcv
microtubules
core
virus
infection
discovery
trials
drug
the
clinical
wnv
cholesterol
lipid
rafts
depleted
dystrophin
dmd
systemic
muscle
chimeric
samples
sars
cov
serum
protein
health
systems
surge
capacity
concepts
virus
influenza
soiv
human
seasonal
sign
dc
hiv
crd
cell
tim
receptor
expression
cell
cellular
this
paper
presents
case
community
ifn
btv
pdcs
dsrna
dcs
nan
respiratory
flocks
paragallinarum
pcr
infectious
liver
irf5
hepatic
fibrosis
macrophages
ct
labeled
airway
afferent
we
host
pathogens
two
kapusinszky
et
prf
frameshifting
protein
expression
sequence
clades
h5n1
we
dna
subclades
sars
patients
sera
infection
coronavirus
cleavage
processing
sites
site
within
ceacam2
collagen
platelets
platelet
type
pro
sars
cov
dimer
dimerization
cell
death
oc43
hcov
neuronal
tmprss2
cell
virus
cells
protein
cell
jev
eps
cells
prm
virus
apoptosis
vp90
vp70
processing
norovirus
effective
cells
discovery
the
zikv
virus
infection
recent
outbreaks
rna
ifit1
viruses
negative
sense
the
avian
influenza
ha1
lactis
plt
risk
ards
lrrc16a
at
flocks
diseases
infectious
small
health
cd4
chimpanzee
virus
binding
glycosylated
nan
2009
based
estimation
transmissibility
pandemic
hbv
tetherin
virions
ifn
virion
ns5a
d2
domain
spectroscopy
cyclophilins
isav
fusion
protein
he
viral
95
ci
guinea
liberia
sierra
icp0
hsv
entry
proteasome
tegument
influenza
students
knowledge
biology
understanding
glycyrrhizin
amyrin
11
cyp88d6
derived
sh
tm
protein
helical
transmembrane
dsrna
innate
binding
proteins
antiviral
cells
volume
vero
channels
cell
patients
hepatic
abnormal
sars
liver
nan
wildlife
international
species
the
search
tb
tbims
data
information
system
rna
capped
using
cap
dna
nan
network
we
structure
air
transportation
pathogens
cholesterol
host
metabolism
rafts
fusion
membrane
amino
domain
ptm
influenza
threat
pandemic
latest
world
kolev
rhabdovirus
virus
although
novel
nan
nsp2
viral
prrsv
purified
structural
days
fever
showed
hospital
admission
cell
virus
loss
day
influenza
coronavirus
mrna
229e
gene
transcription
dpp4
recent
atherosclerosis
cardiovascular
effects
restv
ebov
infection
infected
tlr4
sars
curve
interventions
the
infection
no
inhibits
replication
cycle
sars
nan
cruzain
compounds
these
enzyme
nmr
agents
human
therapeutic
either
vaccines
elisa
test
days
sars
samples
demyelination
cuprizone
induced
ms
inflammatory
clfa
apoe
aureus
binding
human
hbov1
hbov
children
infection
occurred
ards
variant
mbl
patients
codon
rna
binding
a1
hnrnp
mhv
mutations
channel
activity
ibv
protein
virus
tax1bp1
apoptosis
mavs
infection
hod
dogs
clinical
treatment
signs
hiv
exposure
pep
risk
source
patients
cancer
significant
infections
often
replication
rna
viral
rluc
rlucrep
nan
nanotrap
particles
virus
detection
respiratory
nsp1
rna
di
nt
replication
mhv
a59
pneumovirulence
genome
gene
cells
sars
cov
vero
caco
ccov
puppies
found
intestinal
variants
zoonoses
endemic
world
health
developing
hku1
hcov
cells
hla
virus
day
sdav
virus
respiratory
cells
virus
neurons
cells
control
likely
gene
ibv
products
coronavirus
ns
proteins
virus
autophagy
nsp6
cellular
cases
90
ci
outbreak
vaccination
lung
regeneration
stem
cells
human
sl2
virus
mhv
c47
g50
autophagy
response
components
within
essential
human
viruses
virus
study
diversity
ang1
apoptosis
aecs
er
stress
strain
ch
virulent
pedv
porcine
cells
sars
lungs
cov
infection
cells
club
human
cell
small
group
95
eye
protection
ci
alveolar
the
fluid
influenza
epithelial
id
training
ccm
medicine
care
incubation
interval
days
h7n9
distribution
tgf
β1
cancer
lung
levels
rotavirus
atthrv
wa
vaccine
vlp2
gatherings
transmission
hajj
mass
diversity
cns
viral
immune
response
non
sars
cov
genome
full
length
rsv
age
vaccination
elderly
states
pcv2
prrsv
porcine
microbead
assay
vesivirus
cavv
four
dogs
strains
coronavirus
mers
human
cov
respiratory
ace2
cardiopulmonary
ang
actions
gut
nan
sequence
hsv
hg52
sd90e
genome
dcs
jhm
mhv
infection
cells
safv
passaged
mice
neonatal
strain
heparan
sulfate
cells
virus
rvfv
pertussis
parapertussis
bordetella
aries
assay
activity
increase
polymer
hiv
50
ifnγ
cell
neurons
responses
may
viral
rna
tv
rnai
replication
norovirus
infection
viral
therapeutics
3c
viral
viruses
envelope
cell
evolution
replication
fcov
cyps
csa
cells
spherules
replication
membrane
large
the
pathogen
acquisition
transmission
individual
behaviours
host
viral
infection
mass
spectrometry
vaccines
mucosal
gastrointestinal
pathogens
immune
viruses
virus
clinical
diarrhea
samples
the
domain
structure
ykud
protein
ifn
response
specific
rotavirus
reovirus
respiratory
lung
cells
immune
memory
ceacam16
hearing
mice
tectorial
membrane
vectors
proteins
dc
sign
envelope
rna
eukaryotic
endoribonucleases
endonucleases
pathways
cvb3
p38
mapk
viral
induced
respiratory
vaccines
viral
cause
pathogens
nan
virus
bats
may
hosts
viruses
rna
fidelity
rdrp
nsp12
viruses
sars
protein
patients
sera
the
sars
cov
mlv
pseudotypes
cell
sexually
transmitted
diseases
populations
spreading
ang
ace2
right
ventricular
axis
test
influenza
demonstrated
flu
rapid
nan
nan
pdcov
apn
receptor
porcine
cells
human
hepeviruses
hev
bat
viruses
assay
hsv
lamp
samples
herpes
obesity
cell
thymic
induced
related
ibv
s1
glycoprotein
chickens
potatoes
immune
virus
tregs
ms
mediated
virus
jdv
techniques
10
disease
elongata
endocarditis
infective
case
valve
culture
amniotic
species
intra
inflammation
vaccine
div
aged
young
heterologous
ifitm
virus
rvfv
we
restricted
nan
replication
tbsv
replicase
proteins
ts
species
bat
retroviruses
bats
identified
prf
wnv
structural
ns1
expression
contaminant
the
data
air
airborne
plpro
sars
cov
replicase
protease
ras
regulation
various
body
angiotensin
pathogens
xenosurveillance
mosquitoes
surveillance
limited
picv
infection
lasv
cholesterol
clathrin
50
bms
791325
hcv
nm
exacerbations
asthma
allergy
viral
infections
influenza
seasonal
pandemic
viruses
both
sars
protein
cov
bcl
apoptosis
reproduction
data
estimates
we
method
bcov
ntd
mhv
protein
sugar
hdac6
iav
influenza
virus
cells
stem
iv
loop
group
higher
nan
sars
cov
rv
vaccine
protein
asthma
exacerbations
viral
hrv
cold
rna
autophagy
evidence
process
cellular
patients
mers
dental
infection
control
hmpv
uri
aom
children
respiratory
gb
cmv
interferon
antiviral
pathway
human
pathogens
toxins
canada
oversight
e7
hpv58
peptide
peptides
vaccine
research
epidemic
clinical
the
ebola
virus
type
reovirus
wild
mutant
nan
csa
arterivirus
nsp5
inhibitors
rna
viral
er
stress
influenza
virus
the
stable
tgev
cells
insertion
virf
mitochondrial
antiviral
signaling
mdrm
binding
m2
ion
channel
adamantane
cenp
aca
ssc
sera
positive
hbov1
infection
human
airway
hae
host
dub
anti
infective
c6
vsv
hnrnpa1
protein
export
infection
rvis
infections
recipients
respiratory
common
cell
fusion
entry
jmd
alanine
administration
mice
dmd
mdx
activity
hbv
c2
b2
patients
hepatitis
response
ifn
viruses
variety
including
emc
values
we
patterns
amino
mers
responses
specific
cell
cov
hku1
hcov
the
pro
structure
hmpv
children
tested
infection
titer
sepsis
ards
patients
early
expression
paramyxoviruses
human
mtase
attenuated
hmpv
fty720
npcs
treatment
demyelination
resulted
virus
gp
fc
ebolavirus
cell
protection
antibodies
mediated
functions
fc
immune
response
host
innate
rig
antibodies
cross
reactive
important
encephalitis
virions
gn
gc
hantaan
virus
il
plague
patients
the
serum
immune
viral
innate
respiratory
host
rsv
iav
assay
reporter
strain
ifn
infection
hcov
oc43
viruses
isav
entry
hemagglutinin
esterase
receptor
codon
bm2
m1
stop
expression
enos
sirt1
cell
min6
cells
tk
frameshifting
expression
polypeptide
chord
clinical
microbiology
laboratories
test
potentially
influenza
virus
50
ag879
a9
gtpases
cellular
bacterial
conserved
cell
mva
gfp
virus
vaccine
mice
11
rotavirus
infectivity
glycans
bovine
mucus
barrier
layer
epithelial
delivery
antibody
m860
her2
adcs
method
sud
651
527
structure
sars
transduction
raav1
ferret
lung
asf
polyamines
synthesis
small
molecules
nucleic
virus
degeneration
axonal
infection
neurotropic
mutual
aid
emac
states
must
fission
membrane
proteins
structure
mechanism
protein
interactions
signal
transduction
diseases
ibv
3a
protein
puncta
coronaviruses
igg
cells
umbilical
pcr
human
ns2
rnase
mhv
a59
induced
chikv
assay
vector
nt
chikungunya
domain
nsp2
otu
virus
nf
cesarean
delivery
respiratory
elective
among
mortality
1918
pandemic
mexico
excess
lamp
leishmania
dna
sandflies
direct
fmdv
fidelity
attenuated
type
high
attachment
virus
assay
use
rna
declaration
epidemic
effect
state
emergency
pcv2
the
recombinant
nucleocapsid
protein
nsp1
pedv
host
expression
structure
neu5gc
virus
binding
acid
α2
cns
viral
clearance
mechanisms
immune
sputum
specimens
np
op
versus
cov
sars
bat
genomes
civet
blood
patients
transfusion
jehovah
witnesses
rna
ibv
virus
recombinant
viruses
hbv
cells
infection
early
viral
disease
avoidance
disgust
stigmatization
labels
viruses
sites
glycosylation
influenza
additional
chloroquine
the
viruses
humans
screening
extraction
methods
cov
sars
stool
nan
discovery
sequencing
surveillance
well
the
nucleolus
nucleolar
proteins
protein
targeting
frameshift
sites
fsfinder
sequences
genomic
nan
ifn
us3
irf3
viruses
host
rotavirus
bovine
assay
group
ics
proteins
previously
7a
apoptosis
viral
nan
rt
pcr
detection
qpcr
assay
nan
cells
siga
small
mucosae
nasal
cells
cell
progression
recovery
patients
protein
sars
cov
infection
mediated
protein
affinity
target
self
module
genomics
epidemiology
the
impact
importance
ecological
structure
rna
viruses
emerging
fusion
cleavage
cov
s2
peptide
activation
fyn
muscle
ire1α
mtorc1
cardioviruses
virus
specimens
disease
saffold
laboratory
agents
lpx
laboratories
review
jhm
virus
acute
two
viruses
transmission
zoonoses
used
emerging
pathways
inhibitory
co
receptors
cells
recent
enterovirus
uorf
up
virus
enteroviruses
mhv
mceacam1b
mceacam1a
receptor
differences
kd
viral
the
respiratory
patients
rfs
fc
rf
ighv1
69
influenza
virus
infection
h5n1
strains
gentiana
scabra
macrophages
ldl
chinese
hmpv
children
infection
respiratory
disease
nan
rotavirus
vaccine
in
study
infection
replication
rotavirus
ubiquitin
mg132
yield
dimerization
sars
3cl
pro
respiratory
capping
replication
1a
domain
rna
adh5
vectors
antigen
vector
we
infectious
dynamics
whooping
cough
diseases
ire1α
xbp1
cells
the
protein
outbreak
virus
angolan
specimens
viruses
spectrum
antiviral
the
high
cost
orfx
sars
sl
wiv1
rwiv1
comorbidity
index
physical
functional
sf
influenza
regression
h3n2
seriousness
like
oc43
coronaviruses
hcov
bcov
genome
junv
arenaviruses
antibodies
virus
neutralizing
virus
species
viruses
host
animal
nan
antibodies
pentamer
hcmv
neutralizing
cell
global
new
approach
infectious
diseases
sivmac239
cells
infection
responses
δ5g
rig
denv
response
chikv
viruses
b12
gp120
b2
peptide
the
biosafety
containment
effectiveness
level
measures
the
coupling
social
biological
contagion
o157
stec
high
genes
nucleotide
casp8
cells
fadd
ripk3
protein
epidemic
covid
19
china
we
inhibitor
resistant
virus
protease
viruses
respiratory
mers
cov
syndrome
recommendations
amniotic
inflammation
intra
sterile
delivery
health
malaysia
global
regional
international
chv
dogs
itb
canine
pathogen
sars
the
respiratory
cov
acute
rna
mrnas
viral
translation
cellular
mavs
ns3
4a
human
viruses
chβ2m
chicken
cells
mab
3d1
shp
mice
inflammatory
tmev
cns
pedv
trypsin
fusion
cell
virus
sars
antigen
the
assay
detection
virus
murine
heparan
sulfate
binding
analogues
inhibitors
infections
nucleoside
acyclic
ace2
ang
ii
at
activity
human
systems
epitope
discovery
major
contact
infectious
hazard
data
interval
rna
homologous
bmv
crossovers
recombination
receptors
fprs
formyl
human
fpr2
pathogen
nucleic
acid
surveillance
sequence
mrna
sequence
rna
the
sequences
swine
prn
fha
respiratory
disease
brv
calves
igy
egg
yolk
rna
sg
viral
mechanism
mrna
ifn
immune
proteins
infections
current
vγ2vδ2
cells
hmbpp
cell
mtb
compounds
hcv
discovery
virus
antiviral
fip
tests
blood
pcr
utr
enac
channel
asic
channels
role
nan
virus
samples
2009
molecular
testing
sci
patients
neuropathic
pain
autoantibodies
rsk
orf45
erk
kinase
we
es
orf4
prrsv
pigs
identified
method
number
epidemic
reproduction
using
fusion
ph
membrane
mediated
virus
rnase
ko
cells
oas3
5a
nan
infectious
surveillance
diseases
identification
public
vp7
vp4
different
11
antibody
neonates
pediatric
sepsis
consensus
definition
systems
health
science
tools
population
virus
vaccinia
lc3
lipidation
autophagy
endothelial
virus
h5n1
cells
viruses
peptide
peptides
bioavailability
hiv
fusion
haos
hai
healthcare
infections
there
jhm
liver
wu
proteins
sd
catheter
lock
we
evaporation
catheters
btv
ns3
pathway
mapk
erk
ebola
virus
antibody
therapy
tcb
bax
oligodendrocytes
ampa
kainate
calpain
uk
cell
les
rv
brv
bd
pathogen
genomic
declines
virulent
mers
cov
camels
respiratory
strains
nan
respiratory
assay
viral
xtag
rvp
rvfv
mediated
endocytosis
caveolin
dn
sars
cov
antibody
if
patients
stress
bodies
granules
translation
mrnas
as
rna
viral
odns
cvb3
ards
cells
mscs
patients
including
nan
hpv
vaccine
dna
hcrte6e7l2
cervical
hmpv
infection
sign
cells
attachment
replication
ns4b
hcv
virus
mutants
mva
promoters
many
immunogenicity
improve
assays
tests
use
pathogens
first
infection
cells
neurons
virus
survive
sirna
delivery
rna
target
also
sars
cov
cells
specific
memory
fbs
hgf
lung
ali
ards
protease
binding
zn
rubv
ns
stat2
ns5
mouse
dengue
virus
virus
10
il
cells
clearance
cs
vaccine
influenza
ha
tpp
p28
cell
expression
p53
cycle
nan
respiratory
infections
viral
infection
pcr
srebp
fatostatin
scap
er
golgi
virus
steps
the
validation
process
mscs
bal
pigs
lps
lung
cns
system
immune
cells
the
cats
fhv
felis
lesions
study
malaria
roles
diseases
caused
this
ace2
hf
expression
increased
adipose
principle
proportionality
may
degree
public
dna
vaccines
use
this
bacterial
eav
viral
persistence
tissue
stallions
n1
na
h5n1
virus
domain
nsp3
formation
the
arterivirus
nsp2
public
health
use
investigational
drugs
htfr1
arenaviruses
hemorrhagic
five
nw
detection
flocks
hpai
thresholds
mortality
hes
sias
receptor
domains
he
pandemic
cfr
clinical
influenza
severity
translocation
rdrp
polymerases
rna
nucleotide
infection
cov
protein
proteasome
ups
nvu
drug
cns
current
neuron
cov
human
sars
coronaviruses
mers
cells
low
ph
acmnpv
via
reovirus
nt
infection
cells
virus
mv
cells
infection
respiratory
epithelial
nhps
models
animal
human
disease
pericardial
primary
synovial
sarcoma
symptoms
acr
hcv
genes
hcvrec
set
80r
sars
binding
amino
in
infection
zikv
diii
denv
di
prv
gd
infection
pass
host
nan
influenza
virus
verdinexor
replication
therapeutic
coronaviruses
different
bats
group
bat
asthma
respiratory
infections
wheezing
may
mpxv
orthopoxvirus
pcr
pan
assay
virus
the
m2
influenza
protein
no
myelin
expression
death
human
airway
rsv
distal
ns2
epithelial
nmr
systems
sets
highly
studies
ifn
type
signaling
plasmodium
cdcs
nan
hbv
cells
specific
patients
using
cyhv
rpa
assay
koi
detected
sars
antibodies
exposed
different
assays
receptor
alv
tva
stva
quail
influenza
among
outpatients
testing
positive
cells
dcs
dc
sign
blood
elicit
vaccines
protective
neutralizing
antibody
virus
evolution
evolutionary
rna
data
lf
virus
patients
lasv
the
great
microarray
detection
surface
nowadays
nan
emergencies
global
countermeasures
various
trial
dna
therapeutic
agents
cancer
nucleoside
pathogenicity
h5n1
aivs
mammals
cleavage
pdcss
type
ifn
responses
cells
cell
cd8
cd4
cns
cells
prrsv
autophagy
bad
replication
beclin1
strains
elisa
based
sp4
epidemic
asthma
ifn
people
to
inhaled
peptide
hpebp4
cancer
hla
analogs
contact
interval
we
data
argue
influenza
data
mortality
ili
general
the
safety
clinical
program
blood
lung
chronic
mda5
development
the
immune
regulated
chemical
the
activation
il
17ra
influenza
infection
acute
found
cells
cell
populations
show
silybin
iav
infection
s3
autophagy
memory
cells
responses
protective
subsets
h5n1
ha
virus
highly
influenza
ifn
ie1
gene
hhv
protein
virus
melaka
respiratory
human
disease
protein
virus
host
viral
networks
ecological
place
health
obroh
planning
cell
graft
hsct
viral
infections
rna
virus
replication
rcnmv
membrane
nsp3
rna
plp1
synthesis
adrp
entv
env
jsrv
ph
fusion
mavs
mda5
pro
cvb3
enterovirus
astrovirus
erk
viral
erk1
rna
pertussis
140
patients
pneumoniae
detected
bat
coronavirus
sars
cov
cell
outdoor
risk
cats
infection
domestic
tace
tnf
rtd
defensins
inhibition
ageing
life
systems
immune
understanding
nan
lectins
host
sugar
binding
viral
u274
contains
proteins
sars
cov
cov
tmprss2
infection
mers
coronavirus
splicing
rna
mutually
exclusive
dscam
rna
viral
cp
bmv
regulate
rdrp
rna
truncated
vrc
activation
virus
influenza
biosampler
filters
infectivity
viruses
new
respiratory
human
discovered
lamp
assay
sheep
capvs
goats
viruses
influenza
wild
transmission
virus
raav1
pa
lf
vectors
anthrax
hydrogen
rna
scylv
c27a
bond
virus
hpiv3
ebov
surface
δf
mers
cov
receptor
coronavirus
coronaviruses
the
50
compound
concentration
hits
vaccination
virus
smallpox
traditional
spread
sars
cov
infection
immune
cells
nan
licl
pneumoniae
liver
mice
infections
isatin
18
ring
11
the
testing
viral
ed
rapid
use
sars
cov
wound
healing
ali
nan
orf3
hev
function
hepatitis
virus
onset
cmva
either
life
early
filovirus
tim
fusion
entry
npc1
mlv
cathepsin
moloney
infection
virus
ubl
viral
domain
protease
adjacent
hiv
developing
therapeutic
vaccines
broad
ev71
codon
usage
genome
bias
membranes
autophagy
cvb3
prolc3
viruses
cns
cd19
asc
cell
cells
surveillance
systems
ebs
data
health
patients
dose
methylprednisolone
outbreak
sars
sars
cov
routine
genome
sequencing
sepsis
presepsin
diagnosis
new
biomarker
behaviour
spread
disease
human
infectious
virus
fusion
proteins
cell
entry
cells
mutant
dsrna
decapping
e3
kfd
brain
the
lesions
level
nan
sting
rig
immune
innate
rna
3clpro
16
sars
inhibitors
covalent
cells
virus
host
defense
cxcr2
rdrp
rna
component
viral
coronavirus
hiv
cells
ferret
virus
species
ols
twitcher
pgds
apoptotic
positive
coronaviruses
coronavirus
animal
sars
cov
tm
protein
fusion
interactions
virus
nan
sars
cov
human
using
zoonotic
controlled
ventilation
acute
pcv
trials
ifi44l
ifn
responses
induced
negatively
surfactant
sp
pulmonary
proteins
associated
ed
patient
δt
analysis
temperature
sars
protein
n13
specific
antibody
nan
bats
little
coronavirus
brown
coronaviruses
conference
institute
vaccines
salk
themes
biomarkers
protein
the
new
novel
hbz
tgf
cell
htlv
enhanced
chikv
protein
sgs
g3bp1
g3bp2
proteins
bp
coronavirus
cysteine
virion
air
chest
pneumomediastinum
mediastinum
the
peptides
membranes
peptide
membrane
lytic
lab
hrv
pigs
cytokine
il
nan
replication
rna
proteins
replicase
cells
receptors
microglial
cns
injuries
microglia
signs
symptoms
associations
meta
analysis
tumor
npc
chromosome
mipol1
14
new
vector
lineage
strains
viral
superspreading
disease
individuals
epidemic
sses
prb
nsp15
protein
coronaviruses
endoribonuclease
bioterrorism
response
emotional
behavioral
public
viruses
influenza
the
h1n1pdm
virus
infections
hmpv
respiratory
rsv
virus
60
blg41
nuc
lactis
specific
viral
virus
infections
antiviral
ev37
influenza
surveillance
epidemic
dynamic
data
the
qsar
inhibition
aβ
aggregation
treg
memory
antigen
specific
secondary
dm
melanoma
ga
cells
natural
nan
svi
disasters
vulnerability
across
population
isg15
protein
viral
zf
antiviral
nan
cells
infected
tmev
cd8
mice
igm
showed
transglutaminase
sigmd
cd
mhv
oligodendrocytes
apoptosis
virus
induced
health
the
evd
sierra
leone
chemokines
rabv
overexpression
found
virus
sars
cov
sera
acute
proteins
pec
vlps
cell
capsid
elisa
sequons
selection
thr
asn
glycan
nsp3
protein
coronavirus
rna
interaction
avium
subsp
paratuberculosis
ifn
infected
spo
group
patients
the
oxygen
proteins
created
protein
overlapping
de
nsp1
translation
initiation
complex
ires
vaccines
animal
provide
veterinary
tool
influenza
vaccines
pandemic
production
deployment
cpmps
cytosol
endosomes
endosomal
hops
cells
tumour
il
the
microenvironment
hcov
nl63
isolates
children
2006
gx
ibv
nn09032
recombination
isolated
glycans
cell
derived
cells
linked
sars
recombinant
assay
antibody
cocktail
sars
cov
studies
infected
macaques
baff
cell
molecules
system
responses
nan
pcd
patients
ciliary
large
diagnosis
sars
coronavirus
it
novel
people
mice
cells
infection
cxcl9
treated
helicobacter
sp
woodchucks
liver
tumors
prrsv
181
mir
viral
host
quasispecies
viruses
mutant
virus
spectra
samples
149
hbov
saliva
detected
bmv
rna
cp
box
viral
health
federal
research
climate
support
virus
tgev
cell
lines
gene
ace2
adam17
renal
diabetic
urinary
tetracyclines
action
anti
class
developed
health
security
threats
one
approach
ebola
gaps
results
critical
care
traf3
myeloid
innate
cells
new
vp3
ctd
ns2
pde
5a
cbss
services
availability
china
elderly
nan
env
fv
protein
mulv
ecotropic
sirna
cells
vegf
transfected
cell
afa
dr
daec
intestinal
cell
nan
care
face
protection
health
providers
influenza
data
timely
health
tests
pmo
sars
virus
viral
cov
strains
virulence
m1
event
increased
virus
viral
uvrag
entry
membrane
membrane
sars
cov
region
regions
new
infectious
diseases
human
population
on
cns
ms
inflammatory
optic
cd134
cells
fiv
infection
expression
severe
infection
h5n1
viruses
disease
rt
denv
assay
rpa
the
19
fab
msp
falciparum
human
isg15
interferon
protein
function
prrsv
rop18
host
targets
toxoplasma
kinase
viral
jnk
encephalitis
cns
apoptosis
sepsis
the
irak
severe
survival
diagnostic
2009
h1n1
assay
used
nsp10
structure
the
coronavirus
transcription
pi4kiiiα
hcv
kinase
replication
inhibitors
sars
coronavirus
nsp
viral
proteins
ifn
ifns
host
bats
lyssaviruses
responses
severe
fatal
ebola
type
patients
hrv
2009
ph1n1
this
physical
rehabilitation
approaches
stroke
intervention
splicing
alternative
splice
therapeutic
oligonucleotides
hbv
sting
hepatocytes
cgamp
replication
replication
dna
srrnas
bkv
small
nan
expressing
fluorescent
influenza
viruses
ibvs
ep
anti
protein
false
positives
s2
cleavage
fusion
site
protein
cd4
cells
virus
ifn
antiviral
tlrs
damage
receptors
host
innate
viral
load
lung
lesion
patients
hrv
clinical
isolates
rhinovirus
assays
sars
cov
cells
apical
epithelial
aom
uri
viral
infants
bacterial
ace2
diabetic
angiotensin
nephropathy
mice
viral
dna
zebra
lytic
binding
ube3a
as
ga
cellular
brain
nan
host
generalism
mutations
cost
genetic
exosomes
brain
tumor
tumors
cell
platelets
acute
effectors
activities
injury
the
rna
loop
genome
two
novel
ibvs
classical
ibv
the
nan
vsv
virus
aiv
vaccine
based
colorectal
catenin
niclosamide
cancer
wnt
nan
isg15
rsv
virus
antiviral
respiratory
rsv
er
stress
infection
response
dna
vaccines
many
years
human
hcv
vitisin
helicase
ns3
antiviral
env
infected
cells
hiv
surface
dicer
nt
21
sirnas
fidelity
ace2
apelin
angiotensin
mice
ras
depletion
monocytes
nonhuman
cells
macrophage
the
structure
active
substrates
form
cells
human
nhps
cd4
il
rc
viral
rcf
synthesis
replication
vsv
vorinostat
nf
κb
genes
htnv
nf
κb
protein
p65
remdesivir
rna
the
nucleotide
analogue
veev
virus
prf
encephalitis
viruses
sign
feline
dc
infection
entry
nv
vlps
attachment
norwalk
virus
rna
mhv
replication
42
genome
pcr
one
rt
assays
sars
feline
tetherin
type
fethn
release
outbreaks
system
health
the
systems
tmprss2
influenza
protease
mice
virus
covs
bats
cov
human
nl63
meningococcal
disease
invasive
cases
me
the
ib
inhibited
50
amikacin
xnt
ace2
ii
ang
effect
hcv
infection
cell
assay
hts
emcv
cd1d
cell
infection
ifn
exposure
rvf
rvfv
severe
disease
an
introduction
theme
issue
includes
10
il
cells
cd4
infection
protein
ceacam1a
viruses
mutations
receptor
influenza
strains
np
human
may
nan
trailer
region
virus
rsv
genome
ifih1
respiratory
viral
infections
previously
ub
isg15
votu
otu
cchfv
rsv
antibodies
specific
vaccination
antigenic
lamr
csfv
receptor
attachment
virus
copd
smokers
emphysema
subjects
candidate
lung
sars
cov
immune
infection
nan
capsid
fcv
receptor
changes
soluble
nan
nan
membrane
lysis
cholesterol
mβcd
hiv
siv
influenza
infection
surveillance
pigs
ifn
mice
viral
rv
immunized
hcv
autophagosomes
lipid
rafts
membrane
viruses
disease
virus
replication
host
nan
ebov
antibody
ecp
evd
plasma
bank1
cpg
cells
signaling
reduced
hvr
mhv
rna
synthesis
region
hbv
response
mouse
agonists
replication
microbiota
ari
tracheal
baseline
examining
lecs
primary
immune
cells
lec
patients
ebolavirus
pcr
the
rt
global
health
research
authors
in
disaster
training
preparedness
education
nursing
viruses
humans
recent
populations
emergence
ifn
mhv
production
infection
factors
genetic
perinatal
background
po
diet
cells
virus
influenza
ph1n1
2009
vsv
hdct
antigen
specific
responses
vs
ace2
ko
wt
mice
h5n1
vlp
hpai
challenge
multi
hepatitis
patients
liver
severe
expression
sars
cov
ifa
based
virus
pbc
novosphingobium
triggers
autoimmunity
association
hiv
infection
membranes
human
immunodeficiency
cl
carnosine
mce
detection
homocarnosine
low
coronavirus
rt
the
limit
identity
amino
acid
giv
novs
nan
nsp1
scov
rna
viral
utr
assay
sars
cov
the
assays
acute
otitis
media
change
there
airway
airways
epithelial
barrier
respiratory
psychiatric
health
care
disorders
sars
sars
emergency
department
2003
gta
recombination
rhinovirus
intraspecies
interspecies
polyprotein
viruses
polyamine
rna
replication
molecules
lamp
serotype
mdv
the
virus
denv
ns5
nucleolus
nucleolar
protein
eosinophils
eosinophil
virus
mice
nitric
respiratory
mers
cov
response
accessory
research
care
critical
clinical
pandemic
cd13
229e
hcov
the
caveolin
malaria
mda
illness
benefits
potential
ha
pep87
conformation
entry
ph
95
ci
western
studies
medicine
bbrmv
banana
virus
isolates
the
mhv
rna
temperature
virus
brts31
recombination
viruses
in
virus
evolution
sd
clinical
cases
x10
features
antibodies
expression
based
aav
cultures
the
pevs
we
report
complete
mhv
ifn
macrophages
type
infection
il
35
treg
tregs
regulatory
increased
ccl7
siv
monocyte
brain
imaging
luciferase
systemic
mcmv
m78
protein
core
virus
jev
mutant
coiled
structure
methods
orientation
alpha
asthma
omalizumab
inner
city
children
rna
viral
genome
two
linear
entry
virus
gp
cells
cell
dpp4
cell
potential
proteins
stem
protein
the
form
cleavage
fusion
nan
rna
host
strains
seq
influenza
hcv
cd81
events
infection
rho
respiratory
cf
viral
viruses
infections
99
119
stability
fragments
protein
viral
viruses
microarray
the
spectrum
pct
bacterial
coinfection
patients
admitted
isg15
ubiquitin
isgylation
specific
biological
oxidation
cubic
phase
cells
intrinsic
rna
transcription
genome
complementarity
cov
virus
protein
kda
the
species
public
health
emergency
preparedness
concepts
bamv
gapdh
satbamv
rna
rnas
viral
emerging
sequencing
genome
re
hiv
glycoprotein
cd4
envelope
gp120
public
health
principles
ethical
we
rhil
pil
toxicity
antitumor
cells
cov
mers
human
coronavirus
east
rna
binding
3c
viral
site
children
innate
genes
like
otitis
229e
replicase
coronavirus
domain
hcov
mers
cov
furin
entry
s2
disease
the
following
challenge
10
hlius
laboratory
hhcds
risk
equipment
exosomes
precision
therapeutics
molecular
engineering
cancer
initiation
eif4f
many
translation
pseudoknot
rna
ise
stem
stimulatory
hmpv
strain
infection
pan
virus
cov
protein
ibv
secretory
sars
env
antibodies
neutralizing
hiv
bnabs
cyanobacteria
strains
terrestrial
freshwater
extracts
digest
paper
papers
issue
disorder
pabpc
cytoplasmic
expression
mrna
rna
nan
hcv
autophagy
upr
induction
virus
who
sars
specimens
pcr
hamburg
protein
hybrid
interactions
assays
two
dengue
pcr
real
time
phase
nsp4
replication
complexes
membrane
the
host
species
phylogenetic
parasites
infect
therapies
cov
mers
there
respiratory
nan
smallpox
varv
vacv
subunit
based
encapsidated
viruses
bind
cell
surface
eaf2
smad3
tgf
signaling
vitro
rvp
test
dfa
xtag
alone
nan
ifn
poly
iclc
inflammation
pulmonary
uorf
virus
wt
orf1
aug
respiratory
effective
viral
tract
infections
conventional
children
methods
tests
viruses
home
cage
induction
chamber
compared
rna
hnrnp
a1
mhv
transcription
zikv
adc7
vaccine
immunity
development
ervs
vaccines
retroviruses
infectious
study
nan
dpp4
t2dm
cardiovascular
role
agents
nan
shrew
hbv
hbvs
cshbv
hbeag
virus
intranasal
inhalation
sars
cov
va1
astrovirus
viral
genotype
rna
nan
mers
cov
the
hcws
outbreak
bag3
proteasome
critical
cell
interactome
pa
div
crt
dna
responses
spatial
epidemic
disease
states
century
entry
cov
ifitm
proteins
ifitm3
viruses
ha
influenza
human
proteases
respiratory
influenza
viral
march
ili
sars
digestive
severe
acute
respiratory
flulum
h1
pcr
influenza
2009
oas
rnase
ifn
basal
virus
shfv
plp1s
three
catalytic
sites
mice
sars
cov
differences
sex
fever
rvfv
infection
rift
valley
e7
11
20
mhsp110
epitope
trs
leader
body
subgenomic
rna
adenovirus
the
chimpanzees
disease
sequences
virus
rrna
we
novel
viruses
nan
cll
cells
cell
ebv
culture
mm
mel
flufen
melphalan
cells
replication
virus
hsv
the
gene
hcov
coronaviruses
respiratory
viruses
four
protein
cov
errs
golgi
proteins
plasma
sfts
therapy
case
exchange
ifn
extended
response
neurons
signaling
prdx6
activity
aipla
nox2
lung
ptx3
inflammation
innate
immunity
humoral
sli
loop
kissing
interaction
substrate
cell
proteases
protease
coronavirus
fusion
particles
prm
size
virus
mature
cells
cd40
ligand
apoptosis
bezafibrate
specimens
pcr
fa
virus
positive
viral
factors
cells
facilitate
virus
humans
bat
colony
novel
rhabdovirus
microbes
murine
pcr
ivc
immunodeficient
sars
china
also
disease
2003
scov
protein
virus
particles
proteins
coronaviruses
hcov
respiratory
cov
humans
outbreak
sars
case
the
fatality
adhesion
vsmc
gfn
fn
native
cva22
strain
coxsackievirus
a22
belongs
design
vectors
plasmid
burden
high
cov
hr1
hr2
sars
fusion
public
sars
health
global
response
virus
deletion
a35
vaccine
gene
ferrets
diseases
endocrinopathies
endocrine
years
cats
h1n1
influenza
virus
china
orfs
trss
mrnas
sg
identified
activity
domain
hcv
ns3
protease
antifungal
toxoflavin
fungal
human
activity
pcr
the
respiratory
hmpv
samples
hev
hepatitis
therapeutic
virus
viral
nan
china
pedv
porcine
epidemic
diarrhea
virus
influenza
h5n1
ferrets
lesions
prrsv
nsp1α
critical
virus
infections
syndrome
mirage
success
hematopoietic
stem
db
ace2
exercise
renal
metformin
nsp15
dsrna
macrophages
rna
sensors
care
pandemic
pediatric
pandemics
highly
mhv
ifn
gene
a59
5a
ul99
pp28
tegument
encoded
amino
cells
mhv
cyclin
infected
17cl
mab
9f4
h5n1
ha
viruses
aβ
ccl2
ad
activation
cell
china
dengue
denv
despite
outbreaks
rna
sl
the
stem
elements
the
assay
pedv
using
development
hcv
infection
pcr
amplification
hepatitis
transmembrane
domain
toxgreen
toxcat
cat
nan
1918
virus
ha
influenza
gene
dispositional
optimism
americans
younger
older
patients
snps
significance
10
or
non
respiratory
human
copd
viral
degradation
mrna
although
factors
cleavage
cpv
tfr
receptor
species
dogs
sars
nsp13
ssya10
001
cov
ifnar1
kinase
cells
p38
ifnα
oil
allspice
lemongrass
citral
antiviral
viral
viruses
agents
infections
technologies
phe
p2
terminal
p3
autoprocessing
fmdv
ifn
pro
3c
nemo
patients
enose
aspergillosis
diagnostic
ia
social
contact
networks
epidemics
model
hbov
vp1
protein
age
new
media
twitter
polio
content
english
cov
btcov
mers
hku4
hku5
cov
orf1a
mers
sites
selected
nan
mechanisms
human
drosophila
innate
immune
virus
rescue
applications
vaccination
recombinant
isav
esterase
acid
acetylated
sialic
norovirus
protease
human
3cl
we
genetic
disease
parasites
infectious
processes
hbv
replication
pi3k
pathway
cells
cov
sars
replication
cell
bag3
cov
fusion
fps
covs
amino
ahr
host
infection
response
many
nsp15
the
coronavirus
rna
endonuclease
public
health
courts
emergencies
need
hfr
influenza
severity
estimates
2009
fusion
spike
protein
proteins
cathepsin
lectin
esterase
type
ii
specificity
infection
cns
immune
responses
cells
ent
infectious
emerging
clinical
diseases
infection
myocarditis
viral
virus
cardiomyocytes
tfs
bc
star
prom
synthetic
nan
case
health
electronic
public
reports
nov
rh
kg
humidity
ah
pdcov
nsp5
ifn
stat2
protease
chimeric
mouse
antibody
fab
we
tgev
replication
er
stress
perk
il
10
tils
cd8
complement
health
disease
public
pathogens
human
nan
myd88
expression
il
df
cells
cell
pb
response
hantavirus
virus
nan
mavs
cells
wnv
virus
brain
rnase
replication
complexes
deficient
cells
sh
protein
channel
his
viroporins
cov
protein
ma15
rsars
attenuation
sales
gastrointestinal
respiratory
data
products
proteins
fusion
membrane
mediated
viral
pompe
disease
infantile
onset
severe
household
transmission
cases
index
secondary
mhv
packaging
protein
rna
mrna
dc
clinical
ad
cancer
vivo
neurovirulence
il
may
ability
virus
sepsis
risk
pparγ
genotypes
allele
ndv
human
viruses
vector
virus
mice
disease
mhv
c3h
sars
viral
host
transcripts
degradation
infection
rv
cdhr3
associated
asthma
infections
antibody
de
novo
dodecapeptide
binding
rna
sg
transcription
viral
mechanism
als
sgs
the
genes
tdp
viral
protein
domain
virion
identified
replication
coronavirus
rna
cellular
infected
nan
mice
ifn
cns
ifngr1
virus
rat
substitutions
s2
region
sars
hcv
pseudotype
antibody
enhancement
virus
adam17
prrsv
cd163
infection
expression
respiratory
npas
tract
infections
pathogens
human
hadv
genome
pathogen
adenoviral
scov
protein
3a
particles
infected
pd
viral
cd8
impairment
infection
cell
drug
based
assays
viral
proteins
the
protein
cross
small
il
27
iav
levels
elevated
rsv
vaccine
strategy
virus
safe
nan
virus
viruses
influenza
bats
distinct
dimerization
inhibitors
sars
3cl
pro
farp
np
bal
patients
farps
h7n9
patients
virus
province
reported
fluid
human
analysis
body
advances
rig
trim25
proteins
virus
protein
da
sclc
patients
pattern
protein
virus
system
uuk
minigenome
expression
ifitm3
risk
influenza
allele
cd8
stat1
mice
interferon
sars
cov
fgl2
fibrinogen
protein
biological
like
cells
vδ2
vγ2
human
γδ
detection
activatable
probes
the
early
ampv
virus
paramyxoviruses
mtase
attenuated
virus
infectious
total
aerosol
influenza
united
dps
the
various
military
angiotensin
system
renin
actions
blood
immunostaining
macrophages
aif1
species
tissue
specimens
positive
pcr
testing
influenza
lentiviral
vectors
transgene
expression
types
coiled
coils
self
medical
developed
cross
virus
reactive
cell
ebv
hepatitis
chronic
virus
whv
woodchuck
rubv
within
cp
virus
genome
influenza
viruses
cell
viral
might
bvdv
calves
virus
experiment
infected
hmpv
virus
respiratory
the
major
ebolavirus
cells
endolysosomes
model
enters
sars
covs
like
human
bat
sars
sputum
patients
samples
compared
the
antiviral
lectins
grft
cv
torc1
mekk1
creb
activation
phosphorylation
erad
pathway
virus
hcv
production
linker
rich
nsp3a
residues
sr
pseudoknot
mrna
ribosomal
frameshifting
bwyv
tp5
ppsg
phase
sustained
drug
cpv
united
kingdom
type
dogs
nan
pedv
culture
10
first
cell
nan
diarrhea
pedv
china
suckling
piglets
viruses
dna
test
chip
respiratory
nan
007
ingn
ad5
vector
early
nm
uv
light
skin
222
antibodies
human
new
monoclonal
including
grft
protein
dimer
gp120
linker
transmission
hosts
pathogen
per
cent
nan
de
novo
proteins
specific
native
ms
virus
disease
chronic
ocbs
machinery
decay
rna
viruses
the
rna
di
stem
iii
utr
oligoadenylate
synthetase
protein
antiviral
gene
nan
host
lassa
changes
disease
virus
migratory
animals
migration
pathogen
risk
sputum
pcr
samples
rt
nts
microarray
activity
enzymes
substrates
array
nsp1
protein
tgev
host
cell
virus
niv
ephrin
structural
host
fgl2
sfgl2
mfgl2
fred
hepatitis
hcov
oc43
human
two
sars
sequencing
time
real
pcr
next
mrna
immune
pseudouridine
lipid
response
rna
cap
0ppp
virus
denv
esensor
rvp
time
real
pcr
niv
rvsv
vaccinated
expressing
hamsters
nan
nan
hbv
mucroporin
m1
hnf4α
peptide
renal
ace
intrarenal
system
hypertension
spla
ω3
metabolites
colitis
acid
rna
protein
viruses
genomes
proteins
ar
translation
cellular
demonstrate
initiation
hnrnp
rna
mhv
a1
proteins
3clpro
inhibitors
antiviral
activities
feline
viral
th17
cells
replication
immunopathology
ceacam1
eae
severity
mog
35
hong
kong
china
sars
cross
influenza
virus
survival
different
viruses
sirna
3p
specific
virus
antiviral
rna
pseudoknots
model
structure
stability
rna
rdrp
cavities
viral
cavity
pcr
detection
samples
blood
severe
redox
the
proteins
specific
signaling
rna
viruses
genetic
equine
mutation
pmn
infection
rcov
viral
response
gp
catb
entry
prefusion
ebov
cavity
nm
resonant
optical
binding
μ1
apoptosis
reovirus
signaling
pathways
model
tb
infection
human
nhps
osteonecrosis
childhood
cancer
survivors
risk
mice
irf3
levels
ifn
infection
nan
10
chimera
hcv
fl
j6jfh
kallikrein
ha
influenza
cleavage
activation
rv16
xtag
rv15
positive
rhinovirus
uae
deltacoronaviruses
transmission
birds
coronavirus
desert
dust
regions
may
health
sequence
proteins
fcov
genome
analysis
sars
cells
tmprss2
viral
cell
clinical
features
sars
the
include
ebov
entry
infection
monocytes
monocyte
vhf
fever
disease
syndrome
viral
pathogen
cell
epitope
based
vaccines
cftr
m2
activity
cells
oocytes
immunity
cell
heterologous
viral
alter
erad
yos9
proteins
misfolded
er
coronaviruses
species
bats
coronavirus
bat
meditation
exercise
illness
group
severity
sars
the
samples
immunoblot
assay
recombinant
protein
subunit
vaccines
pastoris
opcs
antiviral
denv
expression
ifn
gd
hsv
guinea
pigs
anti
viruses
viral
genomes
proteins
frequent
ato
atf4
macrophage
functions
arsenic
pandemic
influenza
public
measures
compliance
37
mcm
34
lys3
uuu
fiv
species
analyses
specific
genetic
hmpv
virus
cell
infectious
cells
cartilage
induced
arthritis
collagen
extra
influenza
virus
ha
caused
drugs
nan
host
translation
prrsv
shutoff
pathway
influenza
vaccination
countries
vaccine
rate
vp3
ibdv
rna
viral
golgi
hcv
e2
structural
determined
ectodomain
nan
trim56
virus
antiviral
hcov
oc43
mers
cov
related
bat
coronavirus
cov
sars
cross
covs
protein
intelligence
medical
security
global
health
aids
sars
mental
health
knowledge
the
adenovirus
outbreak
serotype
outbreaks
membrane
viral
cell
viruses
different
nan
influenza
human
viruses
virus
h5n1
cellular
retroviruses
life
cycle
hiv
the
ct
findings
time
hrct
dv
vaccine
cell
responses
serotypes
pregnancy
proteins
plasma
normal
changes
pnag
pathogens
microbial
gram
antibody
modification
sumo
cellular
proteins
modified
case
covid
19
tocilizumab
we
polyamine
cells
molecular
found
permeases
cells
group
oxymatrine
ob
hsc
feline
fipv
orf3abc
the
strain
receptor
new
mas
ang
angiotensin
piv
respiratory
resplex
ii
flu
epo
jm
molecule
tissue
the
tax
htlv
production
atl
ifn
pedv
ifn
plp2
infection
rig
site
trna
anticodon
mutations
frame
trif
anti
may
both
viral
evd
detection
ebola
the
disease
prrsv
virus
pseudoknot
recognition
ifn
ceacam1
a2
000
mw
isoform
eav
replication
lc3
autophagy
dmvs
viral
hiv
infections
patients
may
vlps
proteins
h5
virus
insect
infectious
paragallinarum
signs
ibv
coryza
ribavirin
cap
guanosine
analog
viral
mhv
mice
infection
immune
response
rnase
ifn
independent
antiviral
response
autophagy
viral
process
anti
intracellular
ns2
inf
virus
mhv
a59
cov
3a
sars
dna
sl
gp4
gp2a
interactions
cd163
prrsv
cchfv
rig
rna
antiviral
response
epistasis
sign
magnitude
viral
emergence
influenza
viral
virus
host
factors
nov
polyprotein
processing
order
sites
reporter
assay
data
statistical
systems
plp2
plp1
cleavage
cs1
p4
economic
rapid
region
paper
policy
influenza
iav
virus
rna
swarm
reovirus
infection
proteases
respiratory
uncoating
health
social
distancing
departments
concerns
dbsv
murinae
associated
hantaviruses
virus
hcov
nl63
229e
the
infections
assembly
self
order
symmetry
sapn
mbl
sars
binding
viral
interactions
mannose
binding
alpha1
recognition
showed
antibody
participants
subjects
smallpox
vaccinated
virus
family
coronaviridae
represents
within
nan
influenza
virus
pigs
nasal
infected
mosquito
ns1
cells
caveolin
secretion
rna
replication
bmv
genes
virus
surface
autodisplay
autotransporter
proteins
used
fusion
ph
coronavirus
entry
cell
lamp
human
results
here
describe
since
avian
influenza
this
year
rna
replication
host
membrane
spherules
several
amantadine
strain
show
compounds
we
method
serial
interval
infectious
chikv
e2
e1
mabs
fusion
cells
ebv
cd40l
agonists
tlr
prcv
dex
pid
pigs
cells
ms
chronic
npcs
mouse
model
ha
protease
tmprss11a
target
serine
viral
antiviral
entry
agents
useful
fusion
cell
pore
ax1
formation
s2
host
range
s1
v51
multicode
plx
system
viruses
specimens
virulence
ck10
gs10
pa
h5n1
concerns
biosecurity
remain
unresolved
debate
amplicon
targeting
gene
sars
cov
health
state
september
11
policies
protein
calnexin
sars
cov
pseudovirus
laboratories
poc
rapid
diagnoses
core
studies
n95
respirators
surgical
masks
epitope
protein
design
scaffolds
interface
nsp4
structures
protein
coronavirus
shown
229e
infection
cpl
found
coronavirus
gasseri
immune
treatment
response
lactobacilli
influenza
patients
care
five
pandemic
proteins
virus
pdz
cellular
viral
copper
viral
norovirus
surfaces
mnv
p17
hnrnp
a1
nucleocytoplasmic
shuttling
influenza
performance
test
the
rapid
rvf
rvfv
nss
fever
viral
pregnant
women
pandemic
meeting
health
mers
cov
rbd
vaccines
protein
scedosporium
species
the
pseudallescheria
screening
fiv
gene
airways
gp64
mouse
species
cellular
viruses
host
infect
nan
readthrough
codon
rna
uga
ctfv
isknv
entry
cells
infection
mff
virus
protein
rna
oka
used
ras
cardiovascular
control
research
hypertension
virus
flaviviruses
encephalitis
inflammatory
cns
w09
egfr
pathway
autophagy
induced
influenza
vaccine
ha
challenge
responses
nan
mv
viruses
proteins
protein
complex
cells
adult
stem
scs
tissues
laboratory
clinical
the
without
walls
95
ci
sars
cov
seroprevalence
policy
health
public
to
devise
nan
ang
the
control
function
ras
sars
protein
cho
development
cov
symptom
monitoring
strategies
disease
nonpharmaceutical
cases
cats
fip
feline
26
ifn
cd4
cells
virus
replication
antihistamine
prescription
patients
years
prevalence
rna
replication
membranes
proteins
virus
yfv
yellow
fever
bdaa
antiviral
viral
samples
metagenomic
approach
high
nan
cs2
plp1
cs1
mutant
rna
fcov
recfcov
system
in
study
sampling
viruses
used
airborne
the
influenza
2009
h1n1
infection
virus
the
complex
gp2
fusion
viral
cns
involvement
infection
oas1
children
viruses
replication
virion
proteins
evolutionary
gp
complexes
kda
lcmv
protein
ifn
rv14
irf
infection
cells
nan
virus
effective
ppmo
complementary
viral
receptor
s1
coronavirus
recognition
recognize
ifn
hsv
receptor
host
cell
cd317
cells
expression
vivo
viruses
cd26
mers
ys110
cov
anti
emerging
infections
pregnant
women
embryo
gc
cell
like
phenotype
cells
hmpv
children
samples
respiratory
pcr
households
animals
hygiene
practices
cohabitation
nan
optimal
strategies
group
travel
individual
group
doa
vaccinated
groups
the
disease
transmission
within
infected
deer
sars
cov
severe
acute
respiratory
methods
modeling
computational
better
function
nan
models
structure
contexts
model
epidemics
filmarray
diagnosis
influenza
respiratory
infections
cov
mers
camels
the
neocov
asc
cns
cxcr3
recruitment
virus
htt
sirna
delivery
brain
treatment
eif4b
host
virus
iav
protein
influenza
respiratory
vaccination
children
risk
ns5
virus
the
disease
ifn
rsv
pkr
eif2α
protein
kinase
ddx1
rna
protein
nsp14
ibv
studies
vaccine
plasmid
dna
toxicology
ewns
airborne
chemical
based
in
2c
like
rna
activity
eov
cholera
50
cholerae
vaccine
disease
sars
cov
down
regulated
kinase
pneumonia
chest
respiratory
cases
lower
tmprss2
mice
iavs
cleavage
iav
mva
protective
mice
immunization
virus
asc
cns
survival
baff
april
charged
residues
viruses
negatively
coronavirus
sars
protein
cov
human
actin
detection
platform
settings
technology
capture
vaccine
muv
genotype
circulating
mumps
clinical
outbreak
bovine
piroplasmosis
reported
cv
ahc
receptor
a24v
a24
risk
estimation
obtained
patients
h1n1pdm09
cov
mers
macrophages
mddcs
replicate
cells
antibodies
isolation
supernatant
monoclonal
genes
lr
expression
ph
regulated
health
systems
we
africa
opportunity
clever
stabilin
endothelial
liver
hsec
cells
ezrin
cell
hiv
cellular
glycoprotein
sars
cov
amino
acids
bacterial
the
development
rapid
dissemination
host
trade
off
evolution
pathogen
il
10
cells
cd8
acute
skin
ep
cells
cell
death
nk
cd56
cells
ifn
dim
mlv
cells
via
entry
pit2
sars
assays
coronavirus
recombinant
severe
outbreak
workers
healthcare
factors
sars
public
provision
ethics
individual
good
ethynyl
44
46
si
deoxy
health
workplace
care
policy
hcws
nan
inflammatory
anti
pro
iid
spla
aid
ganp
cells
igv
shm
igf2
m708
igf1
igf1r
ir
occupational
health
respiratory
protection
nurses
ibv
ires
virus
rna
rnas
age
cases
enteric
pathogens
included
mice
mouse
susceptible
mav
virus
prrsv
ifn
pigs
response
ad5
amps
svm
membrane
known
sequences
coronavirus
murine
dc
infection
immune
mhv
he
a59
the
receptor
mice
ifn
ifit2
sev
virus
gm
ia
patients
pcr
positive
79
fipv
fecv
feline
macrophages
229e
hcov
cathepsin
endosomal
cells
palm
civets
sars
market
animals
hemoplasma
species
cat
isolate
anemia
mers
cov
infection
infected
human
nov
canine
an
outbreak
norovirus
ace2
mice
angiotensin
endothelial
wt
research
international
herbal
medicine
ethical
opcs
following
remyelination
jhmv
mice
ebov
the
pt
used
rna
paratuberculosis
avium
subsp
test
samples
rnase
cells
rna
ifns
translation
sars
rats
cov
virus
young
aged
mice
age
influenza
virus
assay
rna
pcr
orf
1b
hct
the
inflammatory
ra
anti
votus
ub
nairoviruses
specificity
originating
enf
peptides
hr2
resistant
fusion
viruses
agms
vaccine
influenza
humans
hcv
infection
ccz
treatment
the
cells
nkg2d
human
interaction
cd8
caspase
proteins
disease
alzheimer
neurons
protein
fusion
studies
scale
production
protein
core
binding
nucleocapsid
concentrations
rna
viral
genome
length
rnas
mice
mhv
sjl
a59
infection
nan
t7
mg3
vaccines
cells
antibody
bat
mrvs
humans
mrv
based
glycyrrhizin
amyrin
11
30
p450
protein
p1
ϕ29
ftsz
subtilis
ubiquitin
protein
dubs
specificity
dub
plant
found
host
endophytes
may
bacterial
viral
ari
classifiers
acute
respiratory
children
among
infections
viruses
sirna
rna
potential
therapeutics
clinical
capsid
fold
human
study
tissue
5a
rnase
ifn
prostate
cancer
sars
group
specific
orfs
cov
curcumin
clinical
various
nanoformulations
review
type
fip
fcovs
recombinant
ii
ns4b
hcv
protein
flaviviridae
family
nan
global
health
responses
outbreak
political
vpa
lcmv
progeny
acid
production
upregulation
socs
expression
virus
cells
biochip
the
mycobacterial
assay
accurate
oct4
stem
cells
somatic
well
network
data
cpis
high
contact
ang
ii
ace2
ras
ace
ace2
sars
nl63
cov
recombinant
nectin
herpesvirus
prv
soluble
form
isg15
human
mouse
isgylation
e3
ifn
type
virus
receptor
mice
nl63
hcov
ari
children
coronavirus
ubiquitin
viral
innate
the
system
governance
sars
infectious
outbreak
trends
sars
cov
proteins
respiratory
protective
ageing
anti
acid
chinese
tcm
nan
furin
mers
cov
cell
entry
bnabs
hiv
elicitation
antibodies
bnab
pp11
human
rna
protein
expressed
nan
human
molecular
antibodies
viral
the
dengue
infection
denv
year
adults
may
infectious
agents
pathogenesis
systemic
ifn
type
cells
iii
virus
mva
sars
neutralizing
using
cov
protein
rna
mhv
coronavirus
nsp3
epidemic
we
method
incidence
daily
ephrinb3
ephrinb2
niv
hev
usage
nl63
cells
virus
observed
human
nan
rv
34
virus
outbreaks
11
pvm
human
sera
rsv
cells
amphiregulin
basophils
il
cells
expression
nan
older
sepsis
adults
diagnosis
monitoring
saliva
virus
nebulizer
suspensions
particle
macrolide
npcr
ce
pneumoniae
mutations
il
rsv
10
cells
cd4
model
human
cholera
behavior
basic
enac
activity
channel
cells
na
analyses
historical
gcbrs
events
the
dengue
serum
df
patients
proteins
mutant
fitness
viral
spectrum
new
ifn
ifit2
mhv
viral
cns
molecules
infection
host
may
exosomes
mek1
erk
mek2
virus
hsv
cytokine
s1p
signaling
virus
storm
nsp4
rna
regions
tm1
replication
phosphorylation
eif2α
prv
ie180
early
sarcoidosis
clinical
study
microbiome
pathobiology
ards
pi3
stage
acute
diagnosis
nan
nsp1
coronavirus
host
structure
suppression
mbl
c3
the
lectin
masp
antibody
sequencing
immune
functional
repertoires
rnase
activity
viral
vp3
infection
mice
sars
mhv
infected
developed
nan
persons
quarantine
severe
acute
respiratory
cells
virus
cell
infection
antigen
protein
export
nuclear
ibv
the
scattering
data
the
use
small
norovirus
small
molecule
an
understanding
hajj
samples
swab
taken
bla
infection
hcv
rig
immune
acute
p53
response
coronavirus
innate
human
collections
microbial
destruction
regulations
destroyed
macaques
tuberculosis
humans
study
model
nan
data
annotation
recent
this
biological
tgev
infection
emt
etec
cells
nan
virus
receptor
viruses
host
receptors
bdcov
hku22
genome
gammacoronavirus
bwcov
mers
health
singapore
public
risk
hiv
replication
potent
tryptophan
dendrimers
sars
aged
mice
age
mortality
membrane
peptides
activity
envelope
antiviral
infected
changes
lungs
influenza
pathophysiological
wae
cells
differentiation
wound
cell
transcription
the
cs
negative
mrnas
cleavage
np
apoptosis
caspase
infection
replication
cvb3
viral
autophagosome
autophagy
cells
vero
infected
pedv
protease
cells
migration
ms
within
cns
vacv
cidofovir
sib1r
sig7l
virus
type
ifn
cells
fmdv
pdcs
pe
membrane
topology
lacy
topological
hmpv
pcr
bronchiolitis
rt
assay
donor
selection
recipient
appropriate
organ
gianotti
crosti
syndrome
papular
remission
viruses
immune
arenavirus
infection
arenaviruses
inhibitors
the
high
throughput
screen
cells
bbb
transmigration
leukocyte
chemokine
isolates
campylobacter
helicobacter
spp
positive
secretion
cells
studies
amino
acids
nan
bax
ku70
ubiquitylated
apoptosis
cells
rna
genes
recombination
host
viral
ceacam3
grb14
domain
cell
sh2
sevoflurane
95
psd
levels
mice
nan
coughing
schlieren
human
surgical
n95
dc
sign
cells
receptor
internalization
di
viruses
virus
infectious
rnas
the
sb105
a10
peptide
surface
demyelination
axonal
mice
mhv
damage
exposed
anthrax
health
authorities
study
protein
structure
chrna7
along
interaction
potassium
gtp
hydrolysis
domains
mnme
membrane
rna
structures
double
replication
sia
binding
site
na
human
tumor
cancer
mouse
human
breast
asthma
patients
viral
exacerbation
acute
virus
dsrna
rna
staining
infections
nan
ptb
transcription
cov
rna
trs
bats
rvas
rva
bat
viruses
rna
structures
translation
control
gene
pifn
ad5
combination
dose
protected
hr2
domain
neutralizing
mabs
epitopes
nan
multipartite
viruses
viral
segments
replication
rtd
neutrophil
ali
recruitment
chemotaxis
intervention
the
service
providers
hospitals
host
viruses
arboviruses
veev
rna
protein
virus
mhv
the
carboxy
dna
binding
multiplexed
detection
nucleic
cells
virus
influenza
pam
human
neutralization
strains
the
properties
antigens
nan
influenza
hajj
evidence
saudi
pandemic
nats
respiratory
rvp
virus
in
nsp15
pdcov
forms
monomers
may
ilc1
intraepithelial
il
innate
responses
zikv
placental
fetal
il
infection
nan
ifn
virus
cell
mice
infected
antibody
minc
assays
protein
microarrays
replication
dna
nicking
vitro
b19v
garlic
common
cold
trial
treatment
viruses
aom
viral
middle
ear
nan
households
income
we
needs
basic
public
new
drugs
vaccines
health
treated
infection
integrin
antibody
reactivation
v1c7
binding
v5c1
affinity
toxin
membrane
er
cell
lamellar
lipid
isoforms
importin
cargoes
the
human
h1n1
test
kit
pcr
2009
gag
hiv
ndv
virus
enhanced
silencing
rna
p20
cp
intercellular
super
infection
sars
outbreak
hospital
ips
hct
st2
pneumonia
controls
ha1
fc
mucosal
responses
h5n1
h1n1
healthcare
reported
crisis
influenza
niv
virus
single
dose
nipah
sars
cov
ace2
human
species
ifi27l2a
cell
infection
wnv
viral
mitochip
generation
v2
sequencing
mitochondrial
support
pandemic
government
health
measures
human
mice
mouse
fully
antibodies
nan
fip
cats
95
specificity
icc
fusion
cell
hendra
viral
protein
prrsv
lps
inoculated
respiratory
disease
virus
influenza
viruses
human
bats
markers
research
patient
centric
important
kpna6
prrsv
replication
zikv
nuclear
nan
rna
synthesis
viral
strand
near
gp26
the
structure
xenon
helical
infection
outcome
patients
indirect
previously
viral
virus
dna
a10l
gene
is
patients
cap
there
dos
infection
cf
species
the
summary
cell
entry
cov
sars
ace2
dna
replication
uncoating
deletion
68k
data
quality
time
proteomics
sample
sars
cov
tmprss2
cell
entry
ms
cns
lymphocytes
cells
cell
nan
uvc
led
uv
mercury
array
rnase
rnas
cleavage
viral
iav
sars
isolation
quarantine
control
optimal
virus
atp1a1
vsv
infection
cov
hiv
resveratrol
cells
virus
inhibit
mers
cov
respiratory
virus
mva
lung
microbiome
research
human
health
ifn
ifnlr1
viral
iecs
enteric
nan
influenza
respiratory
rsv
patients
hmpv
rubicon
ifn
signaling
type
irf3
rrv
tlr7
mice
myd88
induced
checkpoint
cd8
pd
function
blockade
emmprin
kshv
cells
tumor
invasiveness
allplex
assay
time
pcr
advansure
nan
detection
dna
single
new
nucleic
s1
terminal
region
antigenic
receptor
sars
laboratory
infection
transmission
evidence
nl63
ace2
sars
entry
human
school
cohort
entry
terms
model
viral
proteins
5a
oas
antiviral
antiviral
viruses
mastoparan
mp7
nh
proteasome
virus
ubiquitin
system
involved
among
viruses
plaguing
humans
hiv
pro
etov
domain
corona
arteri
cov
mers
virus
respiratory
severe
the
frameshift
prf
apc
aaa
integrin
cells
catl
infection
gp
np
sars
cov
mabs
anti
mers
cov
dpp4
entry
receptor
hsv
activity
no
antiviral
the
hev71
effective
vaccine
infection
the
reovirus
rab
gtpases
cells
early
traf
molecules
inflammation
inflammatory
evidence
ace2
liver
cirrhosis
expression
activity
group
nt
iia
coronaviruses
190
delivery
sirna
pulmonary
systems
barriers
cyhv1
cyhv3
cyhv2
genes
the
lysine
arginine
structure
kex2
peptidyl
pa
host
cal
virus
influenza
ns5
polymerase
mtase
rna
interface
sars
uv
cov
lungs
inactivated
the
influenza
pneumonia
annual
found
this
article
reviews
antitumor
anti
nan
reovirus
cells
infected
spread
σ1s
antibodies
cd134
su
anti
virus
hcv
vaccine
virus
neutralizing
effective
dysgalactiae
report
subsp
we
case
sars
patients
days
probable
antibodies
hpi
calves
jv
infection
norovirus
the
autophagy
response
infection
hcmv
ards
techniques
applications
may
this
ev70
binding
infection
daf
sialic
respiratory
hcov
viruses
infections
samples
influenza
plex
id
assay
h1n1
2005
health
ihr
nations
international
arb
viruses
virus
antiviral
infection
pandemic
influenza
uri
respiratory
lri
sialic
acids
cell
modulation
immune
lung
vaccines
cancer
cell
may
type
ifn
ifns
identified
iii
nan
baff
asthma
polymorphism
associated
exacerbations
potential
applications
nanomaterials
chemical
human
bal
patients
pneumonia
molecular
respiratory
hav
food
survival
mnv
rh
viral
outbreaks
disease
genomic
analysis
report
severe
acute
catheter
ecmo
hrsv
years
among
children
aged
honokiol
hsv
new
combination
clinical
peptide
lvlqtm
2a
vivo
hrv
protease
gii
novs
nov
structure
nan
ad5
injection
vaccine
10
clinical
helicases
human
targets
like
discussed
sars
epithelia
ace2
cov
differentiated
5a
pde12
oas
rnase
virus
cov
mers
sg
replication
formation
g3
sirna
man
cde
mannose
d68
respiratory
ev
hrv
disease
denv
pcr
assay
qrt
rt
wnv
days
human
corneal
virus
flt3
oncogenic
inhibitors
kinase
target
hcv
packaging
subgenomic
particles
rna
50
compounds
μm
si
agents
cells
lung
oct
stem
in
plpro
protease
inhibitors
virus
efficacy
epidemic
infection
risk
new
disease
quadruplex
quadruplexes
fold
intramolecular
discrimination
protein
mutant
mhv
the
δe
cypa
shbs
secretion
levels
hbv
diseases
infectious
health
tropical
global
compound
kinase
enterovirus
replication
activity
hcov
strain
10
50
229e
cx
monocytes
cd16
liver
hepatic
ib
chicks
10
baileyi
virus
signaling
dp1
pydc3
pgd
expression
virus
dinucleotide
host
composition
species
stau1
stau2
upf1
smd
rna
virus
ifitm3
amphipathic
helix
fusion
1β
il
ns1
protein
secretion
dpp4
role
injury
lung
activation
nan
ifn
virus
the
we
mhv
ms
redox
changes
components
mechanisms
nan
nan
sialic
acid
sialoglycans
modifications
linkages
defensins
human
peptides
leukocytes
rhesus
sars
coronaviruses
the
virus
cov
catalysis
dimerization
3clpro
3c
protease
illness
based
surveillance
web
childcare
sars
phase
public
second
hong
lung
prrs
pigs
prrsv
mtb
nan
reactions
mol
aryl
pd
oac
ribavirin
rna
virus
the
fmdv
sars
epidemic
interventions
public
health
ibv
protein
secretory
golgi
cov
cov
sars
respiratory
syndrome
mers
protection
facemask
facemasks
source
expiratory
nan
sdpp4
haematopoietic
concentrations
lymphocyte
activation
tcm
ingredients
information
herbal
the
patients
piv
infection
nasal
wash
nan
influenza
recent
human
host
viral
antibody
vitro
production
pbmc
cells
nan
coronavirus
motif
feature
group
spike
rna
297
glu
3dpol
fold
prrsv
sets
genotype
breakpoints
one
tb
hospitals
dispensaries
cases
internet
hts
pathogens
bsl
high
drug
antibodies
viruses
recently
virus
effective
protein
dna
ns3
ns3h
duplex
cdia
toxin
immunity
ct
protein
asthma
paediatric
worldwide
burden
number
gcrv
transcription
core
reconstruction
virion
sars
case
il
inflammatory
anti
snps
microarray
design
probes
dna
anti
330
denv
ns1
levels
rsv
ppmo
infection
viral
aug
ad
complement
disease
amyloid
plaques
annotation
sequence
genomic
3d
comparative
virus
resistance
viral
genetic
host
nan
tfv
entry
endocytosis
mediated
frog
junv
lc3
virus
autophagy
cells
aptamers
pa
influenza
virus
selected
asthma
asthmatics
positive
pcr
rhinovirus
stat3
prrsv
signaling
the
responses
ha
ptx3
am
hc
complex
mers
mouse
model
cov
infection
rna
replication
fatty
membrane
acid
phv
virus
nih
cqv
used
nedd8
ifnr
ifn
protein
jab1
antibody
ha
the
analyses
monomer
nan
cchfv
nss
apoptosis
demonstrated
residues
hrv
strains
species
common
npas
course
learners
learner
discussion
based
niv
prnt
bsl
containment
neutralization
pandemic
rates
death
1918
1919
plague
we
severe
village
cluster
ciliary
epithelial
beat
cilia
frequency
communicable
infection
control
diseases
ems
species
transmission
lemurs
cross
viruses
somhvr
protein
changes
proteinase
srr7
slc26a4
thyroid
cochlear
hypothyroidism
mice
group
spike
escape
mab
neutralization
genes
expression
levels
reference
showed
nan
mamu
02
rhesus
macaque
two
ribavirin
viramidine
phosphorylation
kinase
vivo
sars
infection
cov
human
2003
pathogenic
ifn
highly
arenavirus
lasv
weibo
social
networking
sites
public
nan
vaccination
data
outbreak
may
real
detected
wild
astroviruses
novel
poultry
nan
pcv2
inoculated
pigs
prrsv
syndrome
cell
proteases
virus
viral
tems
nan
studies
nasal
decongestants
used
decongestant
trapp
vesicle
tethering
transport
proteins
irf
mda
nf
κb
bax
sars
cov
outbreak
antibodies
isolates
influenza
gene
expression
blood
virus
adjusted
or
95
ci
sars
homogeneous
models
network
host
contact
fusion
proteins
viral
membrane
distinct
sars
3a
cov
orf
golgi
palmitoylation
post
translational
membrane
modification
virus
antiviral
spread
infection
ultimately
sting
cgamp
2a
ns4b
replicon
lung
repair
cell
injury
cells
db
ace2
urinary
mice
activity
substrate
proline
active
channeling
domain
rabies
protein
rb2c
virus
rabv
fab
the
rabies
virus
antibody
ebov
compound
gp
virus
binding
cxcl10
rsv
viral
specific
cxcr3
sars
inhibitors
cov
structure
potent
ebov
signaling
tgf
infection
kinome
nan
positive
patients
pneumococcal
serotype
cases
nan
cells
cytokines
lesions
cytotoxic
lymphocytes
armp
12
12δnsm21
384
prnt
global
health
critical
pulmonary
care
ibv
eg3
virus
the
protein
hbv
virus
phh
hepatitis
could
influenza
virus
ha
mediated
50
nan
nan
peep
fi
higher
managed
lower
virus
cov
cell
ibv
abl
protein
rj
virus
viral
sars
scid
human
cells
tissues
mice
ns4b
rab5
hcv
protein
gfp
caf1
1β
hil
caf1m
chaperone
nan
pandemic
icu
would
work
uk
strain
virulent
viruses
vp2
im
rsv
outbreak
patients
strains
samples
otitis
media
the
review
immunology
virus
gp33
cd8
a59
epitope
rna3
replication
sgrna
transcription
strand
ifnα
viral
pdcs
production
memory
host
cellular
virus
vaccinia
shutoff
nan
human
assays
caliciviruses
gastroenteritis
virus
rop18
rtn1
protein
the
toxoplasma
viral
6k
cell
vrna
virus
nasal
temperature
mucosal
patency
subjective
recent
rnai
genes
host
in
batcov
hku10
bats
hi
interspecies
residues
viruses
sev
respiratory
tmprss2
health
oral
inequalities
global
multiple
ang
ii
race2
ace2
activity
eye
rsv
respiratory
lung
infection
ari
virus
households
respiratory
etiology
furin
ibv
cells
site
s2
elisa
sars
cov
based
igm
pdcs
cells
virus
ifn
responses
nan
nendou
conserved
rna
residues
synthesis
astrocytes
infection
immune
cruzi
response
diseases
vaccines
million
health
cases
control
infections
measures
respiratory
airborne
science
students
nature
school
may
ifn
fusion
iavs
ph
viral
proteins
cruzi
vaccine
parasite
chagas
virus
influenza
type
directigen
flua
poults
day
35
sib
growth
sars
niclosamide
drug
cov
antiviral
viral
cellular
drug
resistance
importin
id
health
physicians
years
experience
kshv
pi3
viral
lr
rhoa
lung
stat
injury
deleted
respiratory
slcov
scov
bat
sars
direct
pmo
ebov
cell
infection
rna
msr1
fh
mhv
mice
a59
ace2
renal
disease
tubular
glomerular
sars
dna
cov
crt
antigen
coronaviruses
natural
years
evolutionary
found
ci
mers
cov
transmission
reservoir
outbreak
the
exercise
academic
emergency
response
soy
antibody
responses
infection
pvan
specific
genes
gene
kidney
pcr
rt
mumps
lightcycler
real
vaccine
monkeypox
vaccination
smallpox
virus
care
yearbook
coordination
health
information
apod
bsg
internalization
cells
in
prcv
dex
pigs
infected
bal
lcmv
disease
infection
chorioretinitis
ocular
nan
rdrp
motif
change
t362i
pv
m2
virus
targeting
membrane
replication
gene
assays
hsv
genes
qpcr
sn
lh
release
pituitary
lβt2
evolutionary
virus
viruses
hosts
recent
mucosal
immune
stis
genital
tract
pcr
real
time
rt
kit
influenza
duck
genes
pathogenic
infection
influenza
viruses
chip
virus
pcr
l1
poxvirus
vaccines
antibodies
protein
dcs
cells
tolerance
cell
dc
nan
autophagy
cq
lysosomal
hcq
inhibitors
epitope
cell
responses
functional
avidity
bsl
compounds
virus
platform
10
nsp14
rna
nsp10
the
exon
nan
hiv
must
drug
because
one
bat
covs
cov
sars
bats
epidemic
percolation
networks
sir
models
incubation
period
association
severity
patients
il
β1
mice
skin
transgenic
tia1
cell
tiar
proteins
regulators
nsp5
ts
v148a
virus
alb
acute
exacerbation
viral
idiopathic
pulmonary
denv
responses
disease
infection
infected
children
hmpv
rsv
lrtis
years
devil
disease
term
long
pathogen
antiviral
agents
efficacy
drugs
2014
mice
activity
ceacam1
insulin
cc1
transcripts
tcr
cell
csf
hepatitis
ifn
vp41
mita
gcrv
phosphorylation
viral
expression
clones
related
conditions
samples
isolates
recognized
ccov
type
asp
the
mrna
residues
glu
virus
based
materials
broad
applications
hela
cells
virus
persistent
infection
tmevpg1
genes
transcription
expression
noncoding
alf
levels
patients
day
μg
icsz16
k479n
sars
human
cov
rv
siv
animals
macaques
expressing
cov
respiratory
models
study
disease
p28
replication
replicase
viral
complexes
magnetic
ascs
detection
antibody
cells
infections
aris
decreased
we
evaluated
students
infection
control
health
knowledge
expression
the
ifitms
ifitm2
in
viral
vesicles
protein
rna
vesicle
dc
targeting
antigens
bffp
vivo
within
foot
ngs
viral
populations
metastasis
cell
cd147
migration
invasion
nan
rpe
hcws
knowledge
perceptions
using
models
cholera
epidemic
interventions
model
respiratory
viruses
amplification
multiplex
laboratories
mers
cov
s1
domain
bind
jev
entry
cells
internalization
ph
the
patients
sars
lopinavir
outcome
nsp1β
virus
immune
porcine
prrsv
kshv
latent
infection
expression
infected
ceacam1
cell
homophilic
432
gxxxg
phage
display
development
antibodies
anti
palmitoylation
protein
activation
palmitoyl
cell
ebov
antiviral
virus
alisporivir
outbreak
er
upr
innate
immune
cell
10
il
increased
early
infection
alcohol
abuse
dependence
outbreak
symptoms
new
scientific
biotechnology
industry
per
transmission
factors
environmental
role
agricultural
nsp8
rna
coronavirus
activities
activity
cytokines
severe
il
study
inflammatory
type
ifns
antiviral
ifn
iii
antigen
immune
receptors
human
activation
sftsv
mab
sfts
fever
virus
species
target
viruses
dna
conserved
rsv
protein
six
helix
bundle
apnea
or
inpatient
children
bronchiolitis
pausing
frameshifting
pseudoknot
phase
reading
ups
lung
disease
cellular
homeostasis
veev
nhc
anti
virus
resistance
niv
infection
cells
virus
targeting
rv
mog
rubella
infection
causes
protein
kda
isav
proteins
22
her2
hsp70l1
dcs
protein
341
ctsl
mice
infection
mycoplasma
responses
mwcenm
proteins
elastic
network
model
clinical
surpi
ngs
pathogen
based
vaccinia
mitoxantrone
the
viral
identified
prv
mice
infection
becker
virus
ibd
factors
bowel
due
environmental
aav
aavs
isolates
virus
novel
ex
chf
ace2
ace
rvlm
nan
virus
inflammatory
domain
mhv
mutant
hcv
antiviral
slices
infection
gns
alt
patients
sars
clinical
hepatitis
cells
bronchospheres
stem
gene
epithelial
frameshift
hiv
signal
stimulatory
the
health
human
environmental
global
beings
human
antibodies
specific
fully
antigen
influenza
recent
novel
agents
entered
protein
crystals
domain
macro
carrier
peptides
hr2
sars
hr1
the
prrsv
antigen
assay
pcr
rt
18
il
influenza
mice
infection
lman1
protein
trafficking
receptors
gaba
nan
nan
reproductive
numbers
outbreaks
estimate
data
snv
hamsters
disease
infection
virus
proteasome
inhibition
viral
the
ubiquitin
ha
matriptase
cleavage
virus
influenza
virus
mice
influenza
fdc
h5n1
substrate
norovirus
structure
3c
like
protein
nl63
hcov
virus
cell
mucociliary
defense
tissues
particles
injury
nan
response
virus
gene
infection
host
mers
cov
marv
lap
virus
iiv3
rov
asp
adjuvanted
immune
nan
pedv
cell
cleavage
3cpro
culture
activity
no
cystatin
inhibitory
peptide
carbohydrates
biological
capable
carbohydrate
recognition
vivo
mutat7
mutagenesis
dna
evolution
autoimmune
cd4
peripheral
damage
nervous
neurons
hsv
ifn
response
virus
functions
production
several
nlrs
inflammasome
pro
coronaviruses
pl1
two
like
mers
cov
coronavirus
rbd
receptor
diseases
livestock
health
new
infectious
or
virus
hrv
clinical
infections
ns5a
hcv
virus
replication
foci
patients
cytokines
biochemical
the
snps
lung
cf
disease
infections
antibiotics
ifitm1
virus
ifitms
viruses
dibasic
mice
injured
immune
responses
viral
229e
hcov
infection
ams
cells
mice
mir155ko
mir155
wt
significantly
protein
vaccine
virus
strain
envelope
toxin
shiga
coli
the
virulence
infection
adults
hmpv
respiratory
identified
sars
epitopes
proteins
cov
specific
virus
the
structure
based
design
influenza
populations
vaccine
response
critical
hmpv
2005
epidemiological
isolation
vero
influenza
humans
virus
case
pathogenic
mir
192
os
expression
mmp
ct
stage
lung
later
quantitative
rha
muc1
mice
anti
tn
nan
dub
inhibitors
target
structure
proteins
pv
cough
flow
airborne
distances
rna
replication
region
cis
nsp1
virus
activity
prv
within
dub
fusion
mers
cov
hr1
hr2
biocrystallography
biology
the
structure
field
orf45
irf7
phosphorylation
we
ikkε
antiviral
vivo
defensins
vitro
defensin
cells
transgene
rna
gene
expression
pdcov
accessory
ns6
ifn
rig
hyb
phosphotyrosine
domain
δc
hakai
rna
ntd
cov
mhv
trs
h5n1
viruses
poultry
virus
the
interferon
pact
us11
binding
production
receptors
scavenger
national
definition
workshop
ev71
cva16
proteases
structures
3c
avium
subsp
paratuberculosis
mycobacterium
chain
dc
cells
sars
mφ
epithelial
pcr
respiratory
rt
sputum
samples
systems
antigen
delivery
viral
protein
nan
cp
wt
bmv
virus
vesicle
parvum
the
specimens
calves
factors
protein
melanoma
synthetic
machinery
development
herpes
schizophrenia
viruses
studies
used
aromatase
the
xhn27
assay
breast
patients
rescue
hospital
survival
therapy
ebola
activity
virus
marburg
entry
prevention
healthcare
control
hai
infection
membrane
curvature
protein
cellular
physical
ap
2α
apoptosis
tnf
caspase
rv
human
cys529
asthma
versus
transmission
tree
disease
events
sampled
viral
rna
denv
based
sera
group
alemtuzumab
induction
renal
donor
young
ferrets
associated
infection
disease
sirna
cpg
tlr9
dicer
endosomes
homeless
sars
outbreak
toronto
service
jhm
genes
spike
hepatitis
a59
reactivation
viral
latency
expression
immediate
hmpv
ifn
response
expression
immune
response
based
evidence
the
internationally
sars
80r
s1
cov
human
nan
infection
acute
lung
pneumonia
respiratory
denv
antibodies
specific
hmabs
human
tbm
assay
lamp
nested
pcr
ang
cardiac
heart
angiotensin
ii
performance
health
countries
mortality
country
hmpv
infections
incidence
patients
respiratory
health
this
commentary
argues
100
ace2
cos7
cell
adam17
kda
methods
pcr
pathchip
viral
respiratory
crp
receptor
fcγriia
sepsis
we
htlv
tax
sirt1
expression
cells
networks
viral
covariances
virus
positions
protein
coronavirus
interactions
the
membrane
ngal
expression
vascular
mmp
vessels
gbr
study
calves
strains
level
pdtc
hsv
viral
inhibit
virus
bronchoscopy
adverse
effects
occupational
healthcare
ns1
virus
influenza
sumo1
sumoylation
nan
h5n1
viruses
virus
ifn
human
autophagy
jev
lc3
replication
virus
17
prrsv
il
production
pi3k
hospital
log
transfers
cdi
we
phev
ulk1
trka
rab5
signaling
nan
approved
antiviral
therapeutics
one
drug
lp
hiv
50
20
fusion
ang
ischemic
mas
month
mice
nb
virus
protein
lacking
influenza
prrsv
socs1
porcine
immune
signaling
bst
sars
cov
orf7a
identified
ventilation
airborne
the
transmission
respiratory
vaccines
influenza
virus
viruses
emerge
extinction
path
random
optimal
many
lamp
assay
positive
pcr
quantitative
acylation
proteins
protein
function
recent
h5n1
vaccine
viruses
vectors
vsv
ciliary
motion
defects
pcd
disease
pandemic
h5n1
influenza
virus
avian
aav
gene
dogs
antibody
neutralizing
npcs
olig1
remyelination
mice
associated
peptide
protein
in
key
provide
prrsv
pcbp1
pcbp2
viral
cells
health
issue
this
explanation
global
respiratory
samples
pathogens
testing
filmarray
bcf
genome
dioum
kita
complex
gene
midge
vector
htnf
alpha
ubiquitin
ubl
protease
format
the
infection
cns
immune
viral
following
epidemic
sars
beijing
cases
number
respiratory
virus
pcr
assays
identified
wbv
sequence
the
nidoviruses
study
mecp
cells
ecp
protein
egfp
human
fab
antibody
ig
variable
cd5
cells
ken
rabbit
glycan
tlr4
cd13
innate
response
activation
nan
law
public
health
reform
state
cells
csfv
nk
γδ
attenuated
geneticin
denv
activity
μg
ml
bacterial
influenza
infections
virus
clinical
respiratory
virus
pcr
real
time
nitrosylation
protein
post
translational
modifications
plp
tov
recombination
enterovirus
virus
flush
droplet
nuclei
bowl
water
denv
immune
serotypes
responses
serotype
innate
rig
immune
signaling
dubs
nan
bdv
mice
mutations
polymerase
viral
influenza
host
response
virus
h7n9
viruses
coronavirus
mhv
rnase
pdes
lbd
pbd
hiv
hr
sequence
orf35
uorfs
kshv
orf36
37
mda5
infection
wnv
cns
rlr
hcv
replication
iiialpha
pi4k
required
hepatitis
liver
cells
influenza
damage
cells
cell
icam
clustering
results
sars
cov
spike
protein
ace2
rna
rdrp
e416k
virus
fidelity
research
diseases
infectious
intensity
burden
nan
frameshift
mrna
hiv
utr
efficiency
fidelity
replication
viral
the
mutations
dc
cells
hcv
sinusoidal
e2
virus
vaccine
nonhuman
primates
protection
nan
type
ii
cells
primary
sars
specimens
pneumoniae
p1
mlva
type
bvg
phase
mutant
system
bronchiseptica
influenza
np
viruses
viral
signature
emc
hcov
ifn
human
coronavirus
samples
giardia
duodenalis
tissue
the
c1q
schizophrenia
onset
non
immune
cathepsin
oxocarbazate
human
virus
nm
igg
sars
samples
protein
serum
influenza
virus
rpm
human
the
bpf
in
children
outbreak
disease
virus
eiav
replication
pseudotyped
env
cov
mers
respiratory
syndrome
coronavirus
rna
complex
replication
nsp12
polymerase
nan
mers
cov
analysis
kinase
infection
hbv
biocides
virus
the
use
plp
sars
cov
ifn
antagonism
tf
mice
group
treated
000
95
transmission
ci
individual
disease
hiv
cells
infected
eliminate
adcc
ns
protease
polyprotein
site
the
risk
health
communication
public
provincial
sel
lt
sp
in
mice
transmission
cases
superspreading
ebola
dynamics
health
us
global
the
globalization
well
fears
our
modern
world
nan
cvb3
ccf
sttg1
cells
cell
sars
cov
pseudotypes
cell
patients
vp16
irf
host
hsv
ifn
rna
viral
synthesis
initiation
rdrp
nasal
lung
lungs
immunity
immune
assays
coronavirus
specimens
days
three
virus
infection
antibodies
zikv
disease
cov
sars
the
viruses
nsp9
respiratory
infections
viruses
hpiv
influenza
structure
rna
secondary
rnas
accurate
surface
microcantilever
stress
sensors
changes
rt
the
lamp
assay
jev
binding
proteins
rna
svm
non
protein
fusion
viral
spike
subunits
tgev
gfp
replicon
cells
transcripts
ari
rsv
nasopharyngeal
infants
subsequent
4f
niclosamide
oral
lesion
mice
respiratory
viral
infections
acute
laboratory
influenza
studies
children
questions
remain
eae
ifn
oligodendrocyte
study
ms
prevention
cancer
history
diseases
throughout
sev
δm
cell
protein
vector
virus
vaccine
vlps
influenza
titers
influenza
reproduction
number
brazil
population
sadia
ismail
graham
mulley
discuss
ns1
cell
proteins
host
protein
public
health
research
systems
the
interactions
among
multiple
species
across
ldnh36
dg2
hydrolase
major
scale
nsp8
rna
nsp7
length
fcov
hiv
expression
sr
show
proteins
viruses
new
virus
thorough
understanding
clinical
sample
extraction
method
viral
virus
sa
19
influenza
ha
mrna
poly
pabpc
nuclear
gene
ceacam1
15
low
expression
cervical
sarsr
covs
orf8
human
sars
a59
jhm
nucleocapsid
hepatitis
strain
hev
zinc
salts
replication
infection
sars
acute
tests
illness
diagnosis
question
how
stressful
events
negative
ctcl
ccr4
high
affinity
mab1567
isknv
virus
fish
mcav
mandarin
enzyme
evolution
this
the
study
viruses
bat
strains
species
host
bat
ebolavirus
fruit
species
replication
fusion
amino
ct
mutations
glycoprotein
emergency
department
visit
residents
visited
sars
ifn
cov
irf
infection
tm
su
env
activation
viral
phe
cov
vaccine
immune
response
trials
platelet
platelets
pathogen
participants
the
cysts
rats
ms
buprenorphine
respiratory
acute
distress
due
patient
membrane
viruses
replication
cellular
membranes
rna
readthrough
rtsl
translational
structure
he
protein
oc43
infectious
hcov
vsv
structures
sg
tia1
like
ifn
mhv
production
protein
induced
ibv
cd59
complement
protein
infection
nan
gbf1
bfa
replication
rna
replicons
tifn
ifn
expression
hepatitis
regulated
nan
gb
ph
fusion
entry
changes
p2y
rats
overexpressing
the
sjögren
protein
poly
tail
coronavirus
translation
marmosets
tamarins
common
colitis
the
nan
respiratory
viruses
human
patients
tract
copd
major
exacerbations
burden
risk
chickens
virus
intestinal
avian
infectious
respectively
collected
nasal
ns
saline
virus
rna
the
virology
human
new
technologies
existing
emerging
health
response
gadd34
dcs
protein
in
cells
ti
cell
express
phenotypic
endosomal
entry
acidification
inhibitors
vacuolar
compounds
treatments
diseases
some
others
ifitm3
wnv
cells
infection
viral
ifn
infected
luciferase
lacv
cell
positions
protein
heptad
fusion
mutations
cases
transmission
data
often
the
tgev
binding
sedimentation
density
sialic
strain
hrt
18
torovirus
btov
animals
expression
cell
vaccine
immunized
hcv
infection
persistent
virus
vitro
oseltamivir
household
index
influenza
cases
filmarray
rp
time
real
pcr
hpiv1
hae
virus
rhpiv1
r84g
cx43
cx47
mhv
a59
infection
ipf
lung
fibroblasts
tgf
autophagy
hastv
antibody
capsid
spike
domain
mv
mers
cov
vac2
vaccine
hev
ifn
induction
orf1
cells
arenaviruses
density
bilayer
leaflet
enveloped
sars
cov
proteases
severe
mechanism
ifn
prrsv
signaling
stat2
infected
sialic
prrsv
acid
infection
psn
initiation
cancer
translation
anti
essential
sars
cells
specific
cd8
memory
nsp16
cap
rna
nsp10
cov
radiological
patients
abnormalities
physiological
sars
nan
drak2
mice
cell
np
cells
mcpyv
st
cell
merkel
virus
66k
viral
replication
rna
rdrp
viral
infections
transplant
following
seen
fepv
cats
samples
picornaviruses
picornavirus
rsv
animals
fi
13
il
cln3
jncl
aav2
retinal
severe
receptor
amino
hapn
229e
papn
hydroxysclerosporin
the
isolated
sclerosporin
activity
eiav
entry
cells
ph
low
sars
cov
respiratory
hamsters
replication
rather
waiting
new
drugs
surveillance
membrane
fusion
lipids
phase
promoting
porcine
perv
group
samples
transplantation
nan
response
ibv
activation
ifn
cells
pi4kiiiβ
effectors
rab11
phosphatidylinositol
small
residues
2b
pore
fmdv
protein
jsrv
entry
ph
virus
low
h5n1
viruses
human
isolates
hk
vzv
epidermis
infectious
varicella
zoster
nec
clusters
cases
nicu
study
viruses
filmarray
rp
xtag
rvp
hnrnp
replicase
viral
proteins
virus
rna
polymerase
replication
polymerases
viruses
nsp1
transcription
rna
synthesis
replication
ards
cxcl10
cxcr3
nonviral
viral
virus
specific
cells
cxcl10
chronic
nan
pedv
pandemic
study
china
epidemics
mrna
methylation
cap
vsv
defective
genome
sequence
coverage
cat
annotated
isgs
antiviral
ifn
viral
infection
nan
spatial
we
data
using
question
influenza
virus
viruses
pcr
the
cells
cathepsin
u251
increased
radiosensitivity
plasma
ipa
pseudomonas
proteins
analysis
cell
rna
molecules
exosomes
cellular
disease
menkes
atp7a
copper
zebrafish
carbon
dioxide
euthanasia
rats
vd
receptor
spike
protein
mers
cov
hiv
ly6e
ifn
promotes
infection
cells
brain
immune
expression
loss
pandemics
strategies
we
globally
coordinated
influenza
leaps
virus
peptides
dcs
il
mice
infection
cns
infected
health
global
security
the
public
infection
immune
autoimmunity
however
autoimmune
cg
standards
p190fg
bcr
abl1
a2
k187
hla
epitope
r187
children
rvp
severe
clinical
pneumonia
adenoviral
chimpanzee
vector
one
cancer
resistance
t2635
mutations
fusion
gp41
sl4
sl2
deletion
sl1
sl4a
ub
the
chains
linkage
binding
type
ifns
infection
response
infected
proteins
minor
virus
arterivirus
envelope
health
alcohol
china
studies
research
assay
rsv
xpress
flu
xc
mers
cov
cases
health
risk
respiratory
hrsv
ba
children
artis
virus
influenza
na
formalin
triton
ifn
α2a
il
dcs
cells
vaccine
responses
hiv
mg
measured
ii
signaling
ang
at
pathways
osteonecrosis
levels
patients
diagnosis
dimer
surveillance
health
region
care
public
capnocytophaga
cat
spp
isolation
sp
complement
receptors
new
data
wang
countries
ic
health
icps
care
alphavirus
rna
the
genus
viral
nan
nan
care
the
illness
young
critical
cov
mers
pdcs
human
ifn
rna
helicase
viral
replication
chikv
nodes
networks
tracing
contact
random
viruses
contigs
china
reads
sequences
the
human
hiv
aids
vaccine
dqp
1105
new
receptors
lower
virus
compounds
west
nile
protease
canine
astrovirus
dogs
virus
infection
acid
sialic
low
neurovirulence
residues
env
high
the
trimer
hiv
income
health
the
inequality
china
china
surveillance
health
response
2013
sl
pv
ibv
s1
vaccines
vaccine
rubella
genetic
humoral
immunity
tlr3
ssdnas
human
the
response
time
motivational
subjective
future
becomes
dr
afa
daec
strains
afae
mers
cov
diabetes
mice
diabetic
crae
mirnas
treatment
cancer
cells
viruses
sewage
sludge
viral
diversity
inflammation
tau
ad
pathological
agents
nan
nan
diseases
vasoregression
vascular
pathways
molecular
cacv
calicivirus
infection
dogs
epidemiologically
evd
cases
outbreak
africa
health
virus
myd88
infection
mice
influenza
rna
genomic
category
bamv
strand
sars
coronavirus
the
antibodies
protein
mdr
baumannii
95
ci
patients
rnas
gene
expression
small
important
covs
cov
group
three
novel
canine
dogs
virus
sapovirus
provide
chlamydia
pathogenesis
using
cytokine
polarization
cov
ace2
nl63
receptor
group
gp64
binding
amino
receptor
virus
respiratory
crv
ms
samples
viruses
experiments
rna
simulations
end
hairpin
nan
glutamate
ace2
activity
in
the
inclusion
bodies
viral
ebolavirus
mcherry
exosomes
function
promote
exosome
shown
ems
care
health
microbiomes
hais
m101
hev
binding
fusion
the
sars
cov
replicase
proteins
antibodies
sars
ifn
patients
responses
immune
coronaviruses
coronavirus
virological
surveillance
rna
wild
viruses
pathogens
monkeys
nonhuman
hyd4c
cells
hepg2
50
triphosphate
envelope
coronavirion
structure
mhv
nm
nan
bvdv
vi
calves
infection
ihc
ns7
pdcov
protein
accessory
mabs
campylobacter
chicken
source
human
infection
h7n9
h5n1
cases
the
china
viral
virochip
known
viruses
successfully
frameshifting
efficiency
downstream
structure
ribosomal
virus
rhabdovirus
genes
protein
rhabdoviruses
ifn
antiviral
cells
hfrs
effects
coronavirus
strain
ebcv
bovine
respiratory
dna
biological
artificial
reaction
network
respiratory
influenza
pandemic
health
human
viruses
archaeal
virus
host
viral
nan
utility
postmortem
evidence
microbiologic
examinations
mnv
cells
ph
murine
norovirus
isg15
proteins
interferon
induced
targets
hsv
infection
lytic
alkaloid
proved
mers
vaccine
human
coronavirus
cov
bont
f90g5
bonts
50
antibodies
nan
et
al
2006
2007
sites
prf
expression
nsp2tf
mechanism
prrsv
cell
sapn
platform
mice
challenge
ifitm2
hiv
x4
δ20
r5
nan
bacterial
ambulance
counts
services
fungal
nan
brain
apolipoproteins
the
lipid
organ
gl
cell
fusion
membrane
hiv
disease
viral
ms
immune
demyelinating
mhv
clathrin
entry
mediated
expression
nsp14
the
exon
domain
proofreading
h7n9
vaccine
influenza
infections
viruses
jev
ns5
ifn
irf3
nf
pparγ
insulin
receptor
this
effects
species
rna
transcripts
methods
sensitivities
sars
cov
egfr
infection
pf
pedv
tgev
strains
two
antigenic
cmv
convallatoxin
infection
toxicity
effective
sars
the
effect
hospital
infection
ifn
cells
immune
discuss
type
hpev
pcr
could
vp1
rt
hpv16
e7
cd8
hla
a2
a71
ev
hwars
infection
ifn
pullorum
rats
bn
infection
positive
virus
peptide
antisense
morpholino
oligomers
program
surveillance
the
syndromic
biosense
outbreaks
past
continue
outbreak
basic
dogs
respiratory
coronavirus
specimens
obtained
virus
lasv
drugs
entry
viruses
health
clinical
the
international
cchf
data
effect
size
intervention
metrics
protein
ergic
signal
cytoplasmic
coronavirus
peptides
fusion
cholesterol
membrane
viruses
ace2
brain
transgenic
system
angiotensin
ev71
igy
cva16
cross
antiviral
furin
cell
cleavage
spike
protein
nl63
associated
respiratory
disease
coronaviruses
rotavirus
domain
vp3
capping
structure
dc
infection
sign
signr
viral
ns1
protein
nls
nuclear
localization
sars
cov
protein
elisa
based
cpv
assays
puppies
we
slide
hepis
transcription
373
bp
factor
ns6
cleavage
protease
glu
sapovirus
protein
antibodies
spike
epitopes
neutralizing
nan
protein
fusion
membrane
hra
viral
hbx
rnai
screening
hbv
the
models
inference
model
differential
statistical
strength
mobility
respiratory
muscle
associated
dna
f1
vaccines
gene
protective
antihistamines
filovirus
anti
repurposing
potential
fusion
gp41
loop
cell
hiv
c14nef5
2n5
cell
cells
antigen
technologies
new
disease
detection
public
prrsv
linear
infection
lubac
nf
sars
cov
children
cross
infected
recruitment
viral
leukocyte
brain
infection
ifn
rna
response
replication
nv
receptor
cells
virus
cns
expression
expression
argt
virulence
regulated
protein
public
health
transparency
emergencies
open
receptors
molecular
knowledge
regarding
invasion
class
mhc
chain
molecules
single
denv
infections
dcs
immune
virus
respiratory
viruses
influenza
differential
clinical
zikv
replication
virus
dna
infection
nan
ifn
bat
cells
ebov
the
human
hbov1
cells
profile
bocavirus
egfr
pedv
activation
infection
virus
erα17p
erα
related
cell
peptide
asthma
infections
inception
prevention
the
ctfs
protein
app
novel
degradation
raf
sirna
hk
polymers
tumor
individual
transportation
networks
social
policy
memory
cd8
cells
plasmodium
infections
antibodies
ra
citrullinated
antibody
autoantibodies
peptides
cholesterol
virus
tagged
peptide
emerging
viral
antivirals
particular
targeting
elisa
prrs
prrsv
two
eu
protein
rna
binding
phosphorylation
phosphorylated
sars
cov
infection
ciliated
human
sle
belimumab
systemic
lupus
erythematosus
influenza
risk
infections
infection
virus
cftr
nherf1
nm
cooh
terminal
vaccination
protein
proteins
peptides
encephalitis
candida
krusei
pneumonia
infection
the
nl63
human
coronavirus
hcov
first
lineage
influenza
strain
taiwan
viruses
cancer
cells
anti
immunotherapy
antigen
transcription
sgrna
sequence
sars
cov
autophagy
calcium
kinase
pathway
viral
cells
cell
cycle
infected
hrsv
frameshifting
pseudoknot
mechanical
stability
structures
aeruginosa
mdr
isolates
aac
iae
mers
cov
genome
isolates
viral
structural
domains
transformations
systems
modification
data
spatial
time
disease
rapid
hcv
mv
e2
protein
virus
lassa
positive
virus
fever
model
methods
modeling
public
health
pandemic
nl63
found
sequences
colorado
viruses
protein
proteins
virus
viral
cellular
hadvs
virus
partial
hexon
hadv
strain
ha
vectors
expressing
ability
influenza
h1n1
pdm09
virus
estimated
nan
rvfv
disease
infection
favipiravir
virus
infection
sars
cov
mice
ac70
respiratory
controls
virus
clinical
pcr
p1
3cd
bac
ev71
assembly
amplifiers
tuberculosis
detection
treatment
institutional
cells
memory
antigen
cell
antibody
apoptosis
istk
kinase
host
civ
il
10
cells
cd8
memory
eif3f
expression
her
neu
gc
ferret
revealed
abdominal
mass
mesenteric
influenza
h5n1
lung
injury
virus
bats
astroviruses
viruses
bat
human
nan
cd11a
cd49d
cells
antigen
specific
virus
wt
protease
resistance
hiv
stat1
mice
epithelial
airway
infection
foresight
study
mutation
rates
rate
viruses
many
nan
ethical
research
high
implications
legal
equine
trait
susceptible
cd3
resistant
mfi
using
mouse
sera
s2
dystonin
mutation
mice
gene
cns
pancreatic
cancer
immune
as
vaccination
tb
inflammation
susceptibility
growing
old
fusion
ph
ebov
gp
loop
ifn
injected
anterior
eye
hsv
lymphatic
vessels
immune
system
in
2c
ikkβ
pp1
ev71
enteroviruses
cmv
cycmv
hcmv
rhcmv
viral
coronavirus
cap
eif4f
coronaviruses
enteric
months
peak
01
function
lower
influenza
respiratory
sari
surveillance
pandemic
bacterial
within
host
infectiousness
control
could
science
technology
solve
developing
person
h3n2v
identified
to
transmission
aav
degradation
cellular
pathways
transduction
pedv
enteroids
intestinal
infection
porcine
cubicles
multi
zone
model
airflow
rbc
hps
anti
antibodies
ebv
trs
rna
transcription
synthesis
minus
clinical
army
challenges
microbiology
the
astroviruses
human
species
astrovirus
identified
gp
rabv
virus
rvδg
live
social
support
tkr
aa
less
spread
worldwide
infectious
model
the
hiv
tat
critical
tar
nucleolar
intestinal
advances
considered
topics
diarrhea
eav
replication
csa
virus
prrsv
ev71
3c
protease
50
assay
pedv
motifs
motif
yxxφ
protein
cell
fusion
cytoplasmic
transmembrane
domain
ribavirin
oral
patients
21
group
cap
scap
among
atypical
pathogens
hand
vb
moist
towels
volunteers
virus
prrsv
semen
pcr
boars
ifitms
virus
hcmv
replication
human
isg15
species
votus
virus
ub
cpg
nipc
odn
cells
high
human
hace
abs
severe
acute
nan
olfactory
cmv
ob
infection
deficits
replication
mrna
ifit1
rna
jev
virus
entry
coronavirus
protein
luciferase
rna
synthesis
dsrna
viral
nascent
rotavirus
intussusception
induced
lps
infection
peptide
amyloid
molecular
self
assembly
swine
t3ss
bronchiseptica
disease
respiratory
linked
er
glucosidases
glycoproteins
viral
virus
tropic
ccr5
cells
mdcs
autoantibodies
antibodies
anti
cytokine
human
myocarditis
the
association
respiratory
viruses
proteins
p21
cell
bglf2
p53
fmdv
nucleotide
consensus
2001
substitutions
tabs
ffrs
straps
ffr
doffing
pedv
receptor
pig
human
porcine
pdcs
virus
infection
pdc
influenza
cns
cells
disease
eae
important
islet
t1dm
homeostatic
il
expansion
prrsv
vimentin
mab
7g10
blocking
cytokines
peripheral
central
upregulation
brain
fibronectin
mlv
infection
intracellularly
nih
apobec3g
hiv
two
terminal
rna
infection
sgs
stress
sg
crpv
settings
acute
febrile
illness
resource
the
virus
human
species
samples
hrv
pi4kiiiβ
series
compound
aminothiazole
pools
rvfv
species
culex
districts
vector
pathogens
emerging
borne
diseases
gh
cell
fusion
virus
membrane
influenza
h5n1
across
human
pandemic
gold
we
single
hybridization
assay
rna
exon
replication
fidelity
cov
assay
mers
cov
the
rapid
mers
cov
mice
virus
ma
mhv
mice
cxcl10
infected
nkg2d
hcv
as
replication
antiviral
50
wild
anas
lake
hpai
h5n1
necroptosis
infection
rna
virus
following
isolate
btov
infected
pcr
cells
sequencing
rna
transcriptome
many
read
ifitm3
cells
reovirus
infection
entry
de
lung
dust
exposure
increased
wd
6f
ev
mice
cholesterol
ab
mem
circulating
immunity
provide
discovery
drug
computational
development
methods
ifn
isg54
ifit2
cellular
infection
memory
cells
cd8
cell
effector
serodiscordant
hiv
mda
partners
seronegative
respiratory
outbreaks
rvp
virus
samples
activation
icp27
p38
virus
jnk
mers
cov
the
cases
disease
nan
fv
ldv
virus
infection
mice
chimeras
aptamer
sirna
prostate
expressing
human
fcγr
variants
fc
nhp
suicide
chinese
factors
older
adults
influenza
vaccination
ethnic
groups
we
isr
hiv
hand
patients
cart
we
heated
cold
2017
studies
mers
virus
human
coronavirus
respiratory
viruses
plants
persistent
acute
chronic
specimens
hts
viruses
clinical
pipeline
the
expression
gene
trs
sequences
nan
infections
hematopoietic
stem
cell
transplantation
membrane
viral
order
known
rearrangement
team
critical
scientific
teams
efforts
ibv
gadd153
induction
protein
kinase
respiratory
panel
lower
specimens
lrts
v3
mabs
neutralizing
design
cameroonian
ace2
ang
local
cardiovascular
expression
2b
ev71
bax
apoptosis
cell
mhv
protein
infection
nuclear
import
diarrhea
qpcr
10
cryptosporidium
however
doxy
le
hours
std
dppc
01
mhc
ptal
bats
hev
ifn
gene
t1l
virus
m1
detected
kırklareli
virus
calicivirus
neonatal
ddx3
knockdown
cells
target
mrnas
health
public
sars
the
challenge
virus
viruses
cells
host
lcmv
10
ip
nf
κb
expression
reovirus
t3d
system
rescue
t1l
vaccination
vector
mucosal
cell
activation
feline
viral
viruses
cats
single
pcr
10
oc43
229e
qrt
viral
cell
culture
virus
disease
viral
infection
immune
the
virus
rvrp22
mlv
rvrp13
ribavirin
mutants
he
expression
protein
activity
virus
virus
fcv
receptor
family
viruses
healthcare
hiv
providers
hospital
care
nan
inkt
cells
pig
th2
ahr
frameshifting
hiv
site
slippery
mutations
mi
influenza
associated
hospitalizations
deaths
fiv
fca
evolutionary
subtypes
recombination
antibody
pedv
cross
tgev
the
pyrosequencing
detection
protocol
influenza
variants
orov
ifnar
irf
cells
mice
models
erlang
time
epidemic
discrete
cells
cns
viral
mhv
infection
antibiotic
disease
exposure
antibiotics
associated
sftsv
cell
gn
gc
entry
cov
vaccine
coronavirus
future
methyltransferase
myocarditis
sle
elevation
cardiac
coronary
sars
epidemic
control
efforts
severe
hev8
hev
zoonotic
china
potential
proteosome
vaccination
unstable
resistant
ctl
structure
pseudoknots
rnas
rna
predicted
fusion
tm
protein
virus
pre
replication
nsp2
nsps
expression
proteins
isolation
mers
cov
virus
respiratory
rnase
oas
rna
viral
stranded
fmdv
autophagosomes
formation
lc3
induced
patients
day
95
ci
the
bbb
mcp1
brain
including
integrity
ace
renal
wu
angii
damage
common
cold
vaccines
we
healthy
function
cardiac
renal
dialysis
ahus
hku4
mers
cov
human
receptor
control
outbreaks
public
health
in
dna
immunization
mab
toxin
studies
rv
type
mice
trigas
genes
chikv
patients
or
95
ci
pedv
monoclonal
ac
elisa
antibody
domain
pro
3d
swapped
hydrophobic
hcv
autophagic
protein
upr
autophagosomes
protein
nucleolus
cells
proteins
cell
nan
tbev
infection
cells
type
ifn
he
history
low
grade
pyrexia
surfactant
lipid
also
lung
lipids
detection
bacterial
specific
pathogens
probe
the
penetration
tested
particle
aerosols
vp8
the
s2
recombinant
protein
emodin
hsv
nuclease
activity
alkaline
nan
camels
human
mers
cov
among
rf
human
monoclonal
we
mabs
phase
cell
cycle
virus
cells
plpro
sars
cov
protease
50
protein
cell
alveolar
type
cells
replication
gbf1
cellular
viral
viruses
model
disease
behaviour
epidemic
transmission
host
virus
interactions
primate
evolutionary
sirna
mrna
p38
map
kinase
β1
lung
tm5275
tgf
fibrosis
content
moisture
storage
stability
formulations
remains
pathogenesis
h5n1
influenza
humans
cocaine
vaccine
gne
1826
cpg
autophagy
dc
rsv
induced
innate
influenza
rig
antiviral
duck
chicken
sars
respiratory
patients
fever
droplets
adcp
bm
hiv
abs
activity
fhl
expression
immune
genes
il
oc43
hcov
antiviral
luciferase
roc43
proteins
coronavirus
assembly
secreted
protein
ang
ace
bradykinin
receptors
we
protein
virus
norwalk
terminal
golgi
influenza
vaccines
based
vaccine
ad
adp
virulence
nsp3
macrodomain
chikv
classes
the
sars
crisis
prenatal
rna
nt
replication
packaging
gene
lymph
injection
afferent
site
vaccination
ifitm3
multiple
antiviral
least
post
nan
diseases
disease
new
complex
genetic
infection
respiratory
prrsv
prcv
innate
poly
length
tail
sequencing
tailfindr
nan
pneumonia
children
deaths
illness
usually
myd88
kshv
rta
innate
tlrs
hcov
oc43
pcd
infection
caspase
nan
virus
mitochondrial
like
mitophagy
protein
host
infection
cells
apoptosis
viral
chikv
3e7b
neutralization
mice
infection
glycosylation
emv
emvs
cell
protein
sars
cov
elisa
pneumonia
assay
cns
igm
mediated
cells
antiviral
reporting
disease
response
data
system
receptors
medicinal
immune
polysaccharide
innate
canine
cpiv
samples
chv
population
adjuvants
peptide
based
vaccines
safe
nan
il
mice
10
cells
cd4
hrv
hcov
100
patients
infections
nan
membrane
mpa
pathogen
protein
virus
bismuth
glutathione
drugs
human
mrp
health
scientists
virologists
public
science
binding
capsids
infection
tfr
capsid
np
ndv
ide
virus
specific
dogs
cnpnv
respiratory
disease
united
cell
sars
cov
cells
glycoprotein
membrane
replication
rna
bmv
spherules
assay
antivirals
50
btv
the
cov
hku1
coronavirus
respiratory
sars
spread
cell
cytoplasmic
pathway
lysis
mabs
rabbit
antibody
hiv
responses
drying
damage
freeze
sugars
protect
research
scientific
health
disaster
responder
hcv
infection
liver
chronic
viral
fusion
based
multiple
hr2
peptides
viruses
species
humans
human
rna
ns1
b19
activation
the
genes
mers
cov
dpp4
binding
functional
pd1
gag
based
cd8
antigen
vil
ppmo
cells
pel
kshv
hn
codon
usage
genes
bias
viral
guano
viruses
bat
bats
virus
hepatitis
chlorcyclizine
the
vivo
hhv
cells
infected
6a
mechanisms
adam17
hypertension
ace2
activity
hypertensive
229e
hcov
bat
viruses
related
15
prrsv
il
infection
production
nan
lps
luteolin
induced
ali
neutrophil
patients
mrvd
adult
ari
pcr
pel
ppmos
cells
virf
kshv
encapsidation
rna
viruses
plus
strand
alri
cases
incidence
children
hospitalized
epec
etec
release
in
induced
collagen
altered
mice
function
disruption
fusion
hr1
hr2
coronavirus
protein
nan
mers
cov
mice
infection
hdpp4
rna
sg
body
trss
synthesis
protease
helicase
ns3
conformation
protein
infections
respiratory
syndrome
commercial
academic
health
behavior
belief
model
influenza
39
272
laminarin
rcrt
mice
rsv
peptide
respiratory
virus
work
nan
reassortment
viruses
respiratory
tract
viral
protein
sars
cov
vaccine
dna
prmt4
site
dna
rna
methylation
rna
ns3
ntpase
conserved
activity
ndm
bla
detection
lamp
the
protein
sumoylation
interaction
we
vitro
rvsv
δg
pseudotypes
virus
vsv
virus
proteins
protein
cysteines
mutant
rna
rnas
method
sequencing
cyclic
resistance
innate
ligands
immune
lungs
health
obesity
growing
public
problem
spca1
viral
host
required
viruses
ubiquitin
tegument
protein
based
activity
influenza
immune
virus
gene
ferrets
andv
phv
ifn
activation
cells
hapn
human
hcov
229e
spike
ga
hsv
cells
cell
cycle
care
critical
mass
equipment
task
patients
flua
h1n1v
infections
infected
virus
disease
borna
cells
d1701
pertussis
pli
confirmed
cases
131
passengers
measles
flight
the
exposure
sars
cov
ace2
tace
respiratory
samd9
function
m062
in
human
golgi
orf7b
protein
tmd
localization
eids
diseases
humans
eid
health
nsp2
rna
replication
viral
mhv
transfusion
patients
the
pc
mean
infectious
disease
influenza
human
the
rh
surfaces
survival
virus
viruses
phage
mammalian
chain
domain
system
peptides
cysteine
cell
containing
mhc
gene
rna
microrna
splicing
regulation
isg
isgs
interferon
jak
stat
hiv
population
geographical
prevalence
risk
host
cells
gp
interaction
filovirus
je
vaccines
vaccine
virus
jev
tumor
sting
cdn
cells
immune
virus
unit
recombinant
cells
vaccinia
hcv
mmp
bcl
stat3
erk
infectious
igg
diseases
the
clone
ebov
viral
sequence
peptide
infection
west
nile
virus
infection
the
gene
rna
the
discovery
expression
phes
study
vaccine
blueprint
designs
cap
rnas
gpppn
rna
synthesis
anti
ad
based
route
tumor
gp
domain
cytoplasmic
viral
entry
nan
anti
dsdna
antibodies
annexin
ii
rsv
tgf
replication
cell
cycle
18
fdg
imaging
pet
ct
sars
cov
macrophages
virus
human
ifitm3
antiviral
target
virions
negative
nan
hiv
abs
adcp
thp
neutrophils
apn
peptide
proteins
aminopeptidase
cell
pneumoniae
the
characteristics
nine
children
gm1
cell
binding
vp1
surface
nspahs
activity
influenza
carrageenans
sulfonated
evolution
dhss
immune
trim
differences
gp160
hiv
mucosal
route
ndv
hcv
arb
genotypes
fusion
hepatitis
gene
virus
replication
sars
apoptosis
pdcov
coronaviruses
recently
respiratory
fusion
golgi
ibv
domain
protein
targeting
egr
jcv
grs
pml
gel
virus
npa
ns
respiratory
detection
public
health
court
compulsory
individual
peptide
mhc
pmhc
peptides
interactions
fast
membrane
formation
pore
proteins
symptom
influenza
screening
travelers
temperature
autophagy
mutants
francisella
antigen
cytosol
pa
virus
pathogenicity
host
protein
type
fcovs
fip
strain
fcov
ome
the
group
adenoid
microbial
nan
tetherin
gp
ebov
virus
llov
nmr
structure
protein
determination
chemical
brain
cells
tregs
glial
long
feline
serotype
infectious
peritonitis
lethal
3a
3b
protein
proteins
gene
sace2
activity
clinical
patients
systolic
sars
cov
plpro
ubiquitin
enzyme
nfps
events
panel
the
median
diagnostic
influenza
pandemic
methods
assays
responses
immune
cell
evaluated
vaccine
07
ibv
field
tunisian
h120
mers
cov
protein
4a
virus
mice
response
macrophages
showed
senescent
c3
mice
brain
neutrophil
injury
virus
wnv
early
particles
trafficking
group
utr
coronavirus
mhv
the
upr
viral
er
proteins
translation
bovine
brd
viruses
animals
associated
nan
nan
serum
control
immunoglobulin
animals
elisa
nan
nan
denv
ifn
response
inhibit
signaling
aerosol
particle
viable
chamber
concentration
pro
cov
ibv
structures
substrate
virus
ifn
cell
sinv
csm14
mers
cov
deisgylase
activity
plpro
protein
upr
sars
er
cov
nsp1β
kpna1
degradation
isgf3
prrsv
hcv
ravs
natural
resistance
genes
disease
outbreak
wgs
pathogenic
organisms
immune
adaptive
in
immunity
age
mhv
bhk
amino
acid
insert
ontario
dynamics
virus
the
distance
scfv
domain
we
scfvs
framework
golgi
protein
proteins
composition
sorting
broad
spectrum
activity
target
flaviviruses
nan
snornp
snorna
proteins
rvb2
biogenesis
viral
viroporins
viruses
host
cell
hiv
virip
viral
mutations
fitness
viruses
included
bats
bat
viromes
in
new
grand
challenge
synthesis
consolidation
severe
adenovirus
pneumonia
initial
pseudoknots
pk1
pk4
pk3
prf
autoimmunity
infectious
in
autoimmune
diseases
influenza
pandemic
strategies
egg
vaccine
used
model
reservoirs
host
selected
hrqol
studies
determinants
ards
impaired
virus
coronaviruses
system
mhv
ii
10
ip
hrv
pg
ml
nan
batcov
hku9
ro
subgroup
bats
class
ii
cell
immune
large
sars
cov
array
resequencing
genome
liposomes
ova
admixed
charged
net
children
pneumonia
years
community
acquired
befv
α1
protein
cells
infected
ccr3
cells
sirna
release
eotaxin
nos
pin
ifn
activity
treatment
ifitm3
transmembrane
topology
proteins
membrane
rna
pact
virus
di
vaccine
structure
siv
rna
loop
hiv
g6pd
392g
131g
knockout
cells
new
naats
genitalium
19
reference
rnai
delivery
κb
vivo
lung
cd4
cells
cns
ccr5
mice
data
mining
databases
knowledge
discovery
parasuis
disease
sw114
pigs
isolates
rna
genomes
viruses
various
fitness
viruses
bat
bats
derived
worldwide
smad7
tgf
signaling
smad
smads
the
enzyme
hsdhodh
peptide
microdomain
treatment
convalescent
infectious
diseases
blood
necroptosis
mlkl
iav
ns1
protein
hserca2a
cardiac
expression
aav6
dogs
egy
var
ibv
group
the
cell
wm
injury
mature
experimental
rhinovirus
ari
adults
associated
or
patients
cap
fever
viral
virus
host
interferon
important
viral
viruses
bacterial
vaccine
laiv
carriage
density
pomc
peptides
processing
in
different
alt
virus
viral
production
pathogens
self
renewal
signaling
differentiation
smad
patients
glucosidase
er
this
viruses
hct
donor
recipient
we
virscan
cov
ssya10
001
sars
shown
trim56
tlr3
antiviral
mediated
signaling
mitochondrial
mir
222
tgev
dysfunction
pv
bax
activation
jnk
cells
cov
sars
sl
ace2
receptor
protein
nss
smrna
encodes
initiation
capsid
fez1
hiv
trafficking
ca
ub
isg15
otu
domain
viral
dd
trifluoroketone
the
peptidases
compounds
norovirus
novel
gii
variants
sites
cyunnpv
group
genes
the
genome
niv
hev
infection
virus
respiratory
nan
virus
infected
infection
macrophages
apoptosis
foldon
s1
protein
spike
domain
nan
transmission
markets
poultry
hpai
within
rotavirus
er
stress
rotaviruses
host
epidemic
waves
clinical
influenza
multiple
mabs
serotype
specific
mab
poliovirus
68
mhv
usp
virus
orf64
pseudoknots
type
energy
pseudoknot
dotknot
pcr
multiplex
nested
respiratory
virus
assays
assay
pcr
the
two
protease
the
cat
virus
papain
tat
rev
hiv
proteins
transcription
coronavirus
sw1
virus
whale
genome
mrna
the
prf
we
structure
nan
h5n1
hpaiv
virus
damage
infection
methods
silico
pharmacology
activity
targets
nan
mers
cov
viral
based
gfp
virus
encephalitis
indo
bangladesh
outbreaks
pedv
stat1
ifn
degradation
infection
rna
nendou
coronavirus
stranded
viral
dengue
pcr
rt
denv
of
straw
bedding
wheat
rats
mice
pandemic
million
public
health
in
type
treatment
child
failure
the
lab
responses
hrv
expressing
induced
rna
ns3
norovirus
human
activity
protein
rna
aconitase
kda
mitochondrial
nsp1
virus
cov
mers
cells
nan
respiratory
we
studies
2010
october
abs
uri
episodes
children
risk
mhv
cell
spike
entry
fusion
dengue
infection
models
associated
early
nan
protein
rna
tgev
chaperone
activity
pcr
coronaviruses
based
findings
small
zika
ns3
ns2b
protease
flavivirus
lana1
kshv
isoforms
associated
nuclear
termination
frameshifting
euplotes
uga
erf1
pdc
type
ifn
cells
potent
transgene
raav
long
responses
memory
pneumonia
influenza
related
children
cases
50
avp
adenovirus
ic
developing
transcription
rna
gene
regulating
trs
piv5
virions
structure
prefusion
f1
nb
the
bec
strains
virus
axonal
demyelination
mhv
ms
demyelinating
devolving
responsibility
implementation
local
authorities
hbov
case
postmortem
human
bocavirus
cell
e6
e7
lines
patients
catb
kda
catl
virus
gp
protein
coronavirus
replication
transcription
structural
amniotic
prom
inflammation
preterm
intra
tuberculosis
influenza
vectors
mycobacterium
bcg
four
amplification
detection
pcr
capillary
interferons
proteins
pattern
recognition
receptors
strains
gene
natural
genes
strain
coronavirus
mink
genus
mcovs
alphacoronavirus
ebv
cyclin
d1
infection
npe
replicase
structural
proteins
mhv
gene
hcw
noncompliant
single
patients
peripatetic
hajj
vaccine
strains
influenza
pilgrims
particularly
evolution
infectious
diseases
systems
il
17
term
immune
memory
prrsv
nsps
proteins
network
cells
protein
7a
apoptosis
cellular
expression
day
nucleocapsid
protein
sars
cov
tpgus79a
gl
gamg
acid
glycyrrhetinic
immune
sepsis
paralysis
immunity
cell
hcv
host
factors
infection
viral
crystals
situ
ray
protein
capillaries
95
ci
oseltamivir
treatment
zanamivir
pandemic
preparedness
european
assessment
plans
influenza
pandemic
virus
h1n1
2009
nan
nsp10
zn
rna
the
first
cxcl10
ifn
apoptosis
treatment
cell
10
virus
ip
infected
pneumonia
genes
human
hcmv
expression
gene
antiviral
nsp
modified
nsqc
virus
immune
schizophrenia
related
reported
pyramidal
cns
virus
disease
chemokines
chemokine
cells
cns
cd8
replication
virus
cd
gas
the
study
materials
fret
ifn
within
among
fluorescent
respiratory
virus
infections
detected
illness
virus
based
antivector
immunity
alphavirus
apoptosis
er
stress
upr
induced
229e
hcov
infection
cytopathic
effects
ha
domain
influenza
rbd
virus
virus
cnts
npa
patients
influenza
rpd
health
care
use
explore
avidity
antibody
igg
serum
samples
bcov
strains
wd
adult
cattle
strains
sfv
humans
sfvs
infection
cytokine
storm
virus
response
pvm
virgen
viral
genome
genomes
data
cells
tgvhd
donor
thymic
cell
ace2
nep
diabetes
urinary
patients
protein
3a
scov
released
virus
rv
asthma
viral
children
washes
poly
proteins
expanded
containing
mislocalization
protein
signature
targets
genome
unique
infectious
risk
models
hazard
covariates
delivery
intracellular
review
membrane
disruption
dad
clad
lung
injury
risk
prrsv
the
isolate
protein
using
hepatitis
fgl2
fibroleukin
fibrin
viral
cov
respiratory
antivirals
mers
two
nan
ifn
akt
pathway
responses
activation
lung
protection
innate
bacterial
pneumonia
pna
beads
18s
rrna
nucleic
responses
hcv
rov
asp
human
nan
nan
rlr
rlrs
rna
immunity
signaling
vdrec
recombinant
vaccinees
the
genomic
stress
cells
virus
factor
cd8
amenable
deaths
public
health
medical
mutant
fip
gene
cluster
virus
nan
infections
residents
infection
rtis
care
prrsv
hp
pathogenicity
replication
classical
psac
serinc3
ap
the
protein
sars
group
antibodies
cov
individuals
global
health
security
infectious
disease
infection
the
purpose
article
review
staff
measures
sars
ed
infection
protein
golgi
sars
cov
coronaviruses
tmd
membrane
yeast
sorting
proteins
ct
diagnosis
influenza
oiv
pneumonia
nan
children
hcov
hospitalized
respiratory
viruses
india
spatial
influenza
mortality
factors
biochip
technology
this
profiling
randox
dengue
virus
vaccine
four
serotypes
replication
er
rna
spherules
virus
china
who
will
gain
influence
op
abscessus
acute
respiratory
infections
protein
fusion
the
triggered
soluble
hbcag
mutant
amino
mutants
the
il
12
23
anti
cns
trim56
influenza
virus
viruses
activity
teb4
ubiquitin
ring
er
finger
sarsr
rh
batcov
bats
cov
nan
pneumoniae
we
compared
performances
three
xmrv
neutralization
blood
donors
virus
rabv
colonies
seroprevalence
roosts
brazilian
nan
nan
mers
50
cov
infection
model
17
22
il
concept
mucosal
ribosomal
sequence
translocation
frameshifting
mrna
rna
705
2cm
nov
rtp
virus
antibodies
dengue
rsv
infections
delays
outbreaks
hypotheses
global
pheics
hev
hepatitis
swine
pathogenesis
infection
data
transmission
tree
genetic
epidemic
infection
sgs
cvb
formation
cvb3
m41
beau
beaur
protein
apathogenic
pmo
treatment
5term
antiviral
effective
retrocyclins
anthracis
rc1
spores
cells
virus
obatoclax
viral
fusion
entry
50
μm
hbv
hyd4c
ec
virus
dengue
the
flavivirus
antiviral
hcv
grft
infection
liver
prevent
selection
among
viruses
genes
rna
hpev
complete
genome
ch
zj1
power
health
liberty
public
personal
nan
hairpin
dynamics
stimulatory
unfolding
prf
form
the
mutant
type
membrane
infection
stillbirth
may
cause
maternal
cathepsin
ebolavirus
et
al
zaire
sars
patients
cases
tears
tear
protein
stress
mrna
transcription
xbp1s
nan
ifn
hcv
λ4
allele
infection
influenza
virus
rsv
viral
like
cleavage
site
virus
sites
the
ga
cohesin
rnapii
ctcf
binding
hev
rabv
virus
vaccine
expressing
include
immunization
htr
populations
provider
mers
cov
95
ci
infected
imaging
ir780
fmk
nir
cells
nan
nan
virions
viral
proteins
rrv
herpesvirus
replication
following
respiratory
mice
intranasal
antibodies
cells
neutralizing
form
protein
children
influenza
pandemic
population
planning
exacerbations
inflammatory
factors
treatment
aetiology
protein
disulfide
linkages
shown
homodimers
papr
n95
fitting
heat
facepiece
upr
er
protein
stress
viral
smoking
sam
rates
year
attributable
stefin
nucleus
cathepsin
histones
in
viruses
disease
spillover
humans
serious
mice
dissemination
yfv
vertebrate
barriers
nl63
hcov
cov
infection
sars
influenza
viruses
enia
we
report
hcov
nl63
229e
the
genotype
three
cap
rules
curb65
low
ub
cchf
votu
congo
fever
epidemic
model
scale
spatial
ratio
elongation
translation
recoding
in
highlight
legionella
assay
pneumophila
specimens
clinical
nan
channels
enac
epithelial
human
cells
measures
two
symptoms
infectious
success
type
ifns
iii
ifn
bat
rt
processivity
rts
marathonrt
family
ms
molecular
applications
high
these
np
immune
exonuclease
activity
lassa
hcv
infection
ifn
ihh
virus
promed
health
emerging
public
global
tetherin
fluav
ha
na
antiviral
pathway
hiv
endocytosis
endosomal
macropinocytosis
nan
pnrc
nols
rna
polymerase
nucleolus
nsp1
cov
sars
activities
proteins
sars
cov
proteins
the
genes
hla
influenza
cross
cell
virus
hts
screening
chemistry
compounds
it
domain
virus
production
viruses
protein
sars
the
antibodies
specific
cov
bk
virus
important
pathogen
kidney
viral
virus
replication
infections
enforced
hia
health
policy
foreign
impacts
cf
rtd
airway
lung
infection
tcr
mhc
vδ1
binding
molecules
public
health
legal
response
up
ceacam1
granulopoiesis
host
mice
lm
necrosis
femoral
head
treatment
atraumatic
virus
translation
rna
eefs
replication
gh
ebv
cells
cell
fusion
nan
structures
replication
rcs
system
mnv
protein
rna
viruses
microarrays
method
rv
cells
icam1
replication
airway
pyelonephritis
cxcl10
ip
10
maternal
nan
ampv
protein
tmprss12
proteolysis
cleavage
h5n1
infected
ferrets
infection
influenza
nsp1α
zf
domain
interferon
ifn
influenza
95
ci
years
sari
drug
hepatotoxicity
liver
toxicity
vivo
virus
na
influenza
cell
h5n1
ecs
cells
salmon
atlantic
rbcs
mobile
health
data
human
mobility
vaccine
phase
fda
cancer
feasible
sctpa
scupa
pulmonary
delivery
single
salmonella
tgev
spic
fimbriae
promoter
bovis
cmml
mice
murine
immunodeficient
virus
cov
recombinant
wild
type
ns3
virus
west
nile
substrates
il
12
mice
23
p35
coronavirus
bc
birds
gene
novel
patient
hospital
diagnosis
course
pneumonia
milk
formula
nec
powdered
12
cells
ti
lps
ras
alveolar
vpr
extracellular
hiv
cells
processing
coronavirus
ccv
uwsmn
canine
novel
rna
activity
cov
synthesis
sg
rv
rt
pcr
assay
virus
proteins
aeruginosa
study
cystic
fibrosis
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
targets
real
time
pcr
nucleic
nan
nan
nan
nan
nan
coronaviruses
molecular
cellular
biology
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
transfusion
bacterial
related
this
problem
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
manual
travel
medicine
health
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
viral
poly
respiratory
rna
viruses
publications
provide
list
the
purpose
publications
provide
list
the
purpose
nan
nan
nan
nan
nan
nan
journal
virology
days
the
reviewers
nan
nan
nan
nan
nan
nan
nan
nan
nan
aptamers
ligands
surface
cells
used
virus
influenza
extracts
echinacea
species
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
care
respiratory
ventilation
patients
chronic
nan
nan
nan
nan
nan
the
infection
control
treatment
2015
nan
nan
nan
nan
kim
lee
young
park
asthma
nan
nan
nan
viral
bat
vbr
within
populations
there
weeks
left
get
early
nan
interventions
control
community
surveillance
effective
nan
nan
nan
cristina
anca
daniela
alina
hiv
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
virus
moth
abisko
transcriptome
autumnal
nan
nan
hrv
risk
infants
days
rr
ppe
paint
process
doffing
well
gs
5734
gilead
employee
salary
rp
results
antimicrobial
the
pct
95
ci
rd
pathogen
pathogens
patients
isolation
fridu
screening
respiratory
influenza
ili
recruits
among
week
adults
cov
respiratory
coronavirus
common
hcov
respiratory
reported
positive
oc43
nan
nan
this
global
health
security
agenda
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
data
sharing
equitable
public
health
nan
nan
nan
exploration
infection
disease
the
book
nan
nan
de
les
des
et
infections
infection
transmission
office
policies
specific
lri
hcov
infections
respiratory
hct
respiratory
hiv
infected
patients
viruses
oc43
hcov
luciferase
ifn
promoter
niv
influenza
iv
including
vpcr
residents
influenza
respiratory
aris
among
167
patients
influenza
cases
iancs
mers
cov
infection
patients
cases
pep
mers
cov
infection
workers
nan
nan
farms
elisa
swine
porcine
genetics
nan
nan
the
congress
2018
academic
emergency
nan
sequential
influenza
season
infection
case
pneumonia
cases
severe
thailand
surveillance
health
kenya
one
disease
global
communication
risk
china
sars
capacity
kenya
laboratory
health
diagnostic
dlsp
nan
influenza
cnic
surveillance
china
the
viral
viruses
virulence
evolution
groups
covs
cov
bats
two
alpha
mers
cov
zoonotic
dromedaries
africa
mers
east
cov
africa
camels
camel
hku23
cov
recombination
229e
nan
quarantine
community
level
contagiousness
lethality
cases
antibiotics
panel
bfpp
antibiotic
bov
hct
respiratory
recipients
post
respiratory
viruses
lc
tof
virus
patients
rvi
days
antibiotic
duration
patients
risk
hospitalization
among
obese
mers
patients
ts
history
positive
coinfection
respiratory
infants
influenza
illness
rv
viral
load
infections
subjects
nan
children
cc
illness
years
homecare
sepsis
patients
fluid
shock
septic
nan
nan
foxo
cell
proteins
critical
transcription
research
disease
health
public
infectious
prone
positioning
patients
pao
fio
nan
fear
response
films
illustrate
ways
tumors
primary
cns
tumor
study
nan
china
the
2019
covid
19
diseases
the
infectious
new
confirmed
cells
il
10
ica
cd8
btv
strains
2013
israeli
in
patients
covid
19
severe
study
patients
19
covid
cells
mscs
nan
diagnostic
diagnosis
model
markers
the
major
cov
drug
protein
the
nan
man
the
sars
pandemia
epidemic
regulations
science
veterinary
apvma
products
sars
mabs
infection
human
different
cells
eo
mgc
803
fortumei
cells
inhibitor
antifungal
activity
chromatography
nan
nan
nan
social
network
understanding
networks
approach
compounds
derivatives
3b
ketoprofen
4a
respiratory
syndrome
acute
coronavirus
severe
hcov
hcovs
system
although
initially
acyl
evaluated
cell
virus
acetylated
problem
customers
search
we
covering
activity
compounds
derivatives
the
antiviral
membrane
membranes
replication
virus
proteins
nan
stat3
viral
transcription
factor
activated
mers
cov
risk
spread
middle
trypsin
inhibitor
glytine
the
activity
conjugates
the
synthesized
lactam
50
amino
the
no
substituted
prepared
nan
firm
private
spillovers
we
public
activity
mycobacterium
strain
method
compounds
nan
airway
infections
upper
paediatric
antibiotic
probe
method
design
data
genomic
mers
cov
virus
major
available
ptms
proteins
protein
cov
modifications
methodology
mitigation
strategies
pandemic
the
isatin
compounds
synthesized
activity
abstract
cov
sars
spike
human
receptor
sars
cov
protease
inhibitors
hiv
vaccines
safety
established
module
brain
cdc42
cell
gene
the
cycle
plants
glycoprotein
transgenic
recombinant
tgev
knowledge
zikv
hcps
study
among
respiratory
infections
viruses
children
viral
organoids
respiratory
alveolar
stem
alveoli
nan
nan
nan
nan
nan
cvlp
infants
sx
gi
stool
cvlp
em
fecal
elisa
using
nan
ctcf
sites
insulators
tandem
enhancers
birds
wild
different
ibv
species
the
otter
microflora
isolates
lutra
disease
budget
stage
contagious
decision
the
compounds
µm
virus
abstract
10
thrombocytosis
examination
revealed
initial
addresses
places
postal
names
addressing
lynx
feline
dnp
populations
sm
species
invasions
aquatic
humans
invasive
nan
masks
viral
aerosol
face
protection
aerosol
mask
viral
filtration
efficiency
human
health
biodiversity
agency
research
pollutants
spectrometry
levels
electrophoresis
atomic
mers
cov
protein
monoclonal
antibody
affected
information
vulnerable
population
health
nan
swine
flu
anxiety
behavior
vaccine
extraction
the
method
mae
phase
infectious
diseases
emerging
social
ecological
probability
trade
particular
increasing
species
markets
market
intervention
legal
ethical
human
viruses
respiratory
one
among
virus
the
immunosensors
detection
avian
system
surveillance
region
diseases
project
abstract
phosphonoalkyl
uracils
compounds
activity
nan
anthropogenic
new
zealand
disturbance
establishment
lamp
esrb
tarda
reaction
detection
nan
synthesized
antimicrobial
indicated
ic
50
pheasants
infectious
present
avian
population
abstract
new
trans
dihydronarciclasine
phenanthridone
viral
the
adenovirus
ahus
study
mountain
lions
sierra
nevada
genetic
isolates
h9n2
ha
viruses
the
ica
sdv
using
anti
monoclonal
ft
mining
data
patterns
the
body
air
ventilation
passengers
in
the
iip
assay
rt
pcr
world
diseases
increasing
the
human
activity
several
new
containing
epiandrosterone
virus
nebulizer
rh
30
airborne
parasites
pathogens
birds
effects
information
vaccine
school
dose
effective
closures
students
disease
virtual
infectious
natural
ace2
angiotensin
ace
role
also
influenza
carbon
viruses
virus
the
the
flow
micro
pattern
technique
droplet
based
technologies
significant
utility
iran
samples
humans
dromedarius
human
viral
rna
viruses
gorgonian
ventalina
pandemic
responsive
behavior
individual
influenza
biosensors
microfluidic
poc
microfluidics
sample
nan
cub
mange
scabiei
presence
female
feline
antibodies
wildcats
serum
pairs
lynx
iberian
interactions
interspecific
killing
qpcr
aerosol
culture
method
quantification
dogs
the
months
prevalence
infection
methods
pathogens
new
molecular
in
ch
oh
analogs
abstract
phosphonates
infection
probability
time
control
could
canis
dog
revealed
peripheral
blood
infection
single
calves
concurrent
rotavirus
landscape
prevalence
avian
parasite
we
coli
k99
f41
etec
neonatal
infected
human
time
equation
normalized
different
sampling
solution
sm
survival
rabies
kudus
oral
baits
target
bat
heat
die
weather
mass
viruses
multiple
cells
the
virus
jd
used
puerarin
acid
decoction
muticum
extracts
extract
activity
viscozyme
rotavirus
coronavirus
calves
diarrhea
severe
lbsa
hp
saa
ibv
acid
wild
feral
far
feline
the
wild
virus
the
porcine
ppv
calves
clinical
hp
saa
diarrheic
wildlife
trade
the
consumption
china
health
population
disease
control
infectious
ace2
angiotensin
ace
role
also
virus
positive
swine
porcine
samples
patients
pathogen
often
course
disease
step
by
evaluation
dual
labeled
nan
nan
stress
surface
designs
cantilever
type
synthesized
compounds
study
antiviral
activity
pathogens
infections
lung
data
spectrum
glycyrrhizin
enhanced
glabra
plant
root
endoplasmic
reticulum
golgi
transfer
apparatus
we
populations
canine
cpv
cecov
image
see
text
in
review
classification
sequences
2d
dynamic
graphs
cystatins
various
the
they
conditions
cough
chronic
children
common
lower
antiviral
dialkylaminoalkylamides
hydroxy
oxo
4h
nan
wild
canine
canids
21
70
calves
clinically
healthy
diarrhea
days
mannose
glycans
high
isolectins
amino
health
one
ebola
west
africa
golgi
apparatus
16
membranes
stack
cmv
infection
infants
gastrointestinal
association
the
image
see
text
known
canine
packs
analysis
virus
the
ethyl
hydroxy
methyl
trans
phenylcyclopropyl
activities
health
incorporating
the
germs
calves
colostrum
supplement
group
birth
assays
squirrel
pcr
internal
control
venom
components
phase
scorpion
multifaceted
lectins
anti
red
algae
various
release
pheasants
we
management
released
social
disease
response
diseases
outbreaks
cats
fagp
feline
hagp
protein
il
buffaloes
expression
the
group
nan
sars
virus
genome
associated
the
infectious
diseases
model
the
spread
health
humans
zoonotic
network
countries
pandemic
virus
the
influenza
us
sars
research
literature
technical
sci
h1n1
spreading
early
severe
potential
risk
health
planning
social
pandemic
policy
new
design
disproportionate
contrast
protein
ova
ctb
surface
cotb
protein
tgev
recombinant
the
membrane
proteins
viral
cell
host
drosophila
procedure
virus
simple
rapid
preparation
s1d
protein
ctb
expression
fusion
glycosylation
viruses
host
bacteria
linked
viral
filtration
filters
cellulose
water
medical
patients
data
wireless
resources
nan
the
acid
ga
ii
activity
patients
cd
stage
showed
sars
nan
ecl
abei
gc
immunosensor
higg
transfection
cells
cell
electroporation
huh
tb
community
survey
drinking
smoking
emerging
disease
human
well
diseases
plant
the
studies
review
australe
air
catalysis
pollutants
wastewater
review
the
ring
npos
nics
functions
tgev
piglets
igy
specific
prophylactic
protein
sars
cov
15
mer
vitro
raised
spectrum
glycyrrhizin
cell
vaccine
the
aluminum
hydroxide
sars
tube
microarray
system
detection
hybridization
sars
epidemic
control
model
measures
protein
studies
molecular
beacon
probes
nan
bovine
cells
bcv
cell
culture
health
framing
one
collaboration
disciplines
sinensis
transcriptome
mature
biosynthesis
expand
nan
immunology
biology
life
sci
china
acid
derivative
ag7088
valine
an
cit
bismuth
en
bi
citrate
pathogenic
microorganisms
literature
pathogens
research
giant
panda
ccv
the
population
host
signaling
type
receptors
ifns
gene
nucleocapsid
protein
the
transmissible
replicate
cells
cell
growth
used
data
algorithm
communication
big
medical
centrality
network
papers
within
journal
tmhs
membrane
proteins
mscwt
the
series
time
method
similarity
clustering
transmission
the
game
cooperative
model
equilibrium
disease
basic
reproduction
hiv
treatment
group
patients
icwm
wm
msw
soil
waste
agricultural
solid
knowledge
discourse
creation
discourses
the
synthetic
biology
china
development
since
anti
lycorine
effects
biological
functions
antibodies
methods
monoclonal
well
new
reovirus
sars
beijing
severely
affected
the
viral
frg
bovine
infectious
paulownia
geranylated
flavonoids
structural
activity
influenza
transmission
changsha
meteorological
h1n1
transport
nucleus
cytoplasm
processes
proteins
influenza
positive
virus
rsv
cases
species
houdyshelii
aurea
the
radiata
production
vlp
development
the
techniques
fronts
science
methodology
identify
areas
na
epitopes
cell
the
gd
plant
exploiting
vaccines
targeting
sequences
china
literature
sars
h7n9
influenza
correlation
sars
variables
multiple
regression
sars
cov
isolates
previously
12
officinalis
antioxidant
flavonoids
extracts
activity
ibv
genome
beijing
isolate
coronavirus
sars
passage
vaccine
strains
inactivated
treatment
the
chemistry
mechanism
action
microwave
viral
inactivation
direct
irradiation
rna
thermometers
enterica
structures
known
ctb
the
pedv
s1d
protein
water
human
hadvs
recovery
efficiencies
animal
vaccines
plant
vaccine
the
group
icwm
wm
sars
cs
beluga
whale
population
amur
serological
plants
gene
hbsag
the
antigen
plant
compounds
isolated
tomentosa
active
spatial
space
diseases
control
epidemic
model
the
network
agent
transmission
hcv
host
daas
targeting
htas
guhmgr
hmgr
analysis
molecular
showed
autophagy
viral
immunity
innate
cellular
rna
silencing
phenomenon
gene
mechanism
faas
ha
h5n1
found
amino
sars
epidemic
beijing
spread
period
sars
the
cases
model
cumulative
svm
lda
ia
ha
proteins
properties
sirna
isoa
asons
rnai
timofer
results
toxicological
pharmacological
studies
cav
signaling
diseases
caveolin
proteins
μg
ml
cytostatic
compounds
50
nan
nan
communication
cultural
response
flood
culture
rna
recombination
viruses
mechanisms
replicative
carbohydrate
important
biomarkers
cell
types
nan
nan
bat
urban
species
brazil
one
rna
thermometers
known
structures
enterica
information
health
context
rhetorical
motif
study
epidemic
developing
epidemics
cases
nsp14
protein
the
fusion
tag
igy
ph
tgev
activity
oral
immunization
vaccination
free
endemic
global
influenza
vaccine
elderly
immune
response
ben
genetic
study
well
affected
diseases
infectious
acute
zoonotic
chronic
ga
antiviral
drugs
new
based
sars
cov
proteins
protein
coronaviruses
health
national
sars
disease
spread
sars
cov
phylogenetic
tree
human
microarray
the
sars
60mer
coronavirus
pom
na
10
pti
40
sars
adults
the
cov
virus
past
methods
epidemic
numbers
infected
aiv
rnai
chickens
resistant
transgenic
explanations
medicine
disease
mechanistic
topological
avian
influenza
human
bird
spreading
sars
virus
associated
coronavirus
receptor
species
inophyllum
calophyllum
development
research
risk
the
dengue
fever
industries
nan
stolon
regeneration
vitro
proliferation
medium
archaea
phylogenetic
bacteria
proposed
free
icwm
patients
treatment
sao
sars
time
methods
mdd
sensor
sampling
tongue
patients
sars
picture
changes
temperature
this
significant
study
day
nan
hiv
ctl
epitope
vaccine
dna
elisa
species
the
hbsag
mab
citation
sars
publication
outbreak
early
infection
spreading
sars
model
the
nan
genes
china
genetic
diseases
gene
orf
the
fmdv
bm
silkworm
pgus1
hybrid
cahpo
nanoflower
gamg
separation
peptide
protein
research
advances
fresh
map
packaging
technology
safety
plant
production
biological
use
plants
mhc
iia
bp
utr
five
ct
sars
lung
patients
shadow
virus
ehf
ebola
epidemic
the
icwm
the
group
sars
medicine
expression
cells
baculovirus
mammalian
insect
model
transmission
control
parameters
sars
delay
conditions
in
nonlinear
epidemic
mers
cov
geographic
system
users
sites
substitution
protein
coding
sequences
entry
virus
hcv
proteins
the
galanthamine
clones
alkaloid
the
investigation
water
deficit
root
weak
production
transmission
cities
towns
epidemic
disease
virus
the
biological
antiviral
activity
recombinant
plant
systems
immunogenic
expression
ferns
plants
many
secondary
metabolites
nan
health
mass
gatherings
covid
19
coe
the
cell
surface
yeast
nan
viruses
transmitted
via
often
may
inactivated
sars
antibody
cov
neutralizing
the
structure
protein
tm
model
model
ffd
markov
chain
transient
food
environmental
virology
become
important
viruses
infection
dose
virus
infective
crp
rays
rs
antibiotic
infants
viral
plant
cellular
viruses
replication
exposure
direct
exhaled
contaminants
indirect
cov
viral
mers
viruses
diseases
health
home
basis
medical
people
envelope
features
dispersion
interunit
presence
wnv
cases
hot
areas
west
system
cell
culture
isolation
viruses
chinese
became
public
health
professionals
mrfp1
temperature
variants
proteins
mrfp
sl
cov
protein
sars
the
transmission
infiltration
inter
building
wind
sbd
pha
scve
in
proteins
the
hbx
cellular
hepatocellular
carcinoma
activity
ru
mm
mutans
mutansucrase
protein
interaction
ace2
sars
cov
sars
cov
sensitive
cell
based
extraction
licorice
separation
acid
mg
viruses
viral
via
contaminated
surfaces
hpv16
hbe7
protein
e7
nih
transgenic
ltb
coe
fusion
lettuce
viruses
bats
diverse
recently
reservoir
egcg
hma
g1
inhibitors
μm
research
evolutionary
medical
health
care
the
china
sequences
06
genes
fnes
seasons
patients
according
pathogens
virus
nanowire
oligonucleotides
complementary
sequence
bats
viruses
zoonotic
human
also
na
inhibition
acid
μm
influenza
droplets
manikin
μm
htpa
zone
large
scale
airflow
aisle
region
infection
sars
ventilation
rate
infected
sars
murine
lungs
mfgl2
gene
assays
plasmonic
applications
sensitive
use
silver
coronavirus
copper
log
10
the
ebola
monitoring
patients
cloud
pulmonary
infiltrate
sot
recipient
diagnostic
hpiv1
fomites
office
isolated
different
manifold
neighborhood
patterns
cells
the
water
coronaviruses
the
wastewater
tap
sequence
prrsv
ningxia
strains
nucleotide
nan
nan
clay
biomedical
applications
drug
hybrid
public
health
disease
control
data
the
preterm
infants
bronchiolitis
term
protein
nanocages
self
assembly
surfaces
species
mindoro
pagodarum
new
bat
measuring
full
set
society
assets
spatial
structures
viral
scale
scales
nan
nan
theaflavin
mg
kg
wt
rats
infectious
diseases
agricultural
food
projected
nan
nan
patients
therapeutic
over
100
000
nan
griffithsin
based
viral
hiv
plant
survival
h7n9
patients
nomogram
probability
nan
hadv
keratoconjunctivitis
dissemination
infection
adenoviral
nan
wind
buildings
environment
the
high
nan
nan
flu
gripping
account
spread
bird
nan
nan
carl
zimmer
primer
viruses
entertains
nan
nan
nan
nan
nan
more
deadly
first
world
war
with
yearly
exodus
labs
lecture
countries
science
advanced
enormously
past
andrew
jermy
travels
hugh
pennington
nan
nan
nan
nan
nan
nan
protein
algan
gan
sars
interaction
nan
nan
nan
nan
nan
nan
nan
nan
timeline
events
brief
history
important
dramatic
government
biomedical
research
2013
nan
nan
nan
covid
19
pulmonary
hape
edema
calves
colostrum
samples
days
the
samples
cpv
bp
strains
using
rca
target
dna
amplification
detection
nan
detection
stis
microarray
agents
real
nan
nan
nan
nanoparticles
ga
cell
the
safety
nan
nan
nan
nan
rumours
public
temper
this
society
nan
nan
nan
nan
nan
nan
nan
nan
nan
reproductive
ef
metals
induced
chemokine
nan
nan
nan
nan
nan
nan
species
raccoon
invasive
potential
vector
nan
nan
nan
nan
nan
our
monthly
round
infectious
diseases
nan
nan
structural
genomics
efforts
spurred
continuing
biological
objects
carbon
the
mass
our
developing
scientific
understanding
complex
health
biological
philosophy
level
social
surface
the
gc
content
signal
rna
sars
interference
used
related
available
supplementary
thirty
years
ago
nan
nan
nan
nan
nan
false
analysis
selection
evaluations
faculty
nan
sars
assay
time
the
cov
nan
blood
direct
buffer
developed
nucleic
in
celebration
tenth
anniversary
revisit
ace2
rbd
cells
sars
binding
nan
nan
nan
nan
does
popularity
recent
online
photonics
nan
nan
nan
month
by
rundown
follow
up
nan
nan
nan
nan
sources
information
mass
media
personal
health
the
authorities
reported
019
cov
respiratory
sars
viral
covs
sars
disease
cov
similar
coronavirus
sars
cov
nabs
therapeutic
coronavirus
sars
cov
virus
outbreak
coronavirus
hcovs
cov
the
evolution
covs
patients
rna
cases
in
nps
nan
covid
19
residents
knowledge
attitudes
covid
19
patients
psychiatric
disorders
sars
treatment
cov
tcm
patients
health
mental
covid
19
psychological
nan
infants
disease
covid
19
four
pandemic
also
must
planning
the
highly
contagious
diseases
patients
like
pain
bscb
cci
cxcl10
induced
risk
social
processes
subjectivity
either
camels
animals
milking
usually
arid
nan
nan
nan
anti
herb
pharmacological
uses
plant
equilibrium
we
time
model
asymptotically
carvs
respiratory
viruses
associated
community
the
detection
rapid
time
emerging
food
diversity
production
network
resilience
rt
reverse
transcriptase
real
time
public
pandemic
h1n1
the
pandemics
infections
viral
respiratory
transmission
measures
health
public
outbreak
the
sars
rhinitis
pm
disease
clinical
precision
diagnosis
disease
ped
diarrhea
loss
death
living
beings
sentinel
devices
ionic
extraction
liquid
flj
enzyme
nan
environmental
cleaning
resource
limited
settings
nan
therapeutic
production
bio
the
proteins
evs
cancer
cells
derived
enveloped
units
hlcc
medical
infectious
disease
nan
nan
clinical
vaccine
development
respiratory
mers
nan
tropical
neglected
diseases
among
live
nan
emergence
aerosol
transmission
2003
respiratory
model
two
transmission
infectious
diseases
recoding
large
scale
attenuation
viral
travel
respiratory
diagnosis
transmission
infectious
cough
acute
chronic
non
bronchitis
emerging
infections
emergence
tackle
several
india
virus
human
gujarat
emerging
diseases
viral
india
importance
vaccines
montmorillonite
drug
pharmaceutical
drugs
delivery
nan
virus
diseases
recent
emerging
pathogens
nan
respiratory
hi
virus
viruses
provide
nan
nan
targets
the
pharmacological
activity
drug
viruses
food
foodborne
purpose
review
sepsis
diagnosis
include
neonatal
clinical
disease
evd
patients
consistent
require
mers
cov
studies
virus
human
knowledge
adrs
participants
the
mean
nan
surveillance
laboratory
influenza
programs
respiratory
treatment
vaccination
disease
formula
see
disease
dynamics
infectious
data
methods
pedv
duckweed
spike
protein
lemna
rt
lamp
s2
ibv
gene
mers
cov
clinical
animal
development
adenoidectomy
procedure
non
children
sleep
lung
dysfunction
bronchiolitis
bos
however
outbreak
control
infectious
disease
healthcare
nan
imaging
role
respiratory
review
emerging
factors
hfe
prevention
infection
human
locust
east
africa
experiencing
worst
nan
nan
inhibited
protease
rna
attractive
viral
health
healthcare
china
reform
system
nan
nan
ards
acute
ali
associated
high
dsrna
the
antiviral
abstract
review
gastroenteritis
acute
cause
disease
management
de
als
en
van
pestilentieën
de
van
en
het
door
de
van
surveillance
het
en
het
van
de
en
met
de
een
en
ouderen
met
nan
influenza
van
het
niet
dat
bacteria
magnetotactic
apparatus
isolate
simple
spatial
sars
spatio
temporal
response
flow
spatial
epidemic
characteristics
the
infectious
transmission
disease
diseases
change
mers
cov
cases
humans
human
nan
health
new
biological
we
risk
regional
the
article
interregional
integrative
health
regional
challenges
global
asean
ward
hospital
management
rfid
platform
viren
die
dass
irgendwo
auf
tipping
points
change
global
human
covid
19
may
we
report
individuals
covid
19
th
there
risk
high
public
health
assessments
nan
cfr
march
rd
rates
recovery
patients
hfnc
failure
therapy
niv
exacerbation
microbiota
bacterial
disease
viral
respiratory
virus
genetic
analysis
human
coronavirus
clinical
trials
medicines
clinicaltrials
evidence
patients
covid
19
nsaids
covid
19
evidence
drugs
il
gmca
proteins
mutant
the
activity
lactis
h9n2
strain
recombinant
virus
pedv
cell
cycle
arrest
chk
virus
corona
alignment
mutations
algorithm
pressure
differential
packed
bed
increasing
parasites
diseases
transmission
among
hosts
nan
arctonyx
genus
distributed
china
eastern
oc43
hcov
proteins
antiviral
cov
respiratory
hocv
patients
hsct
infection
infants
respiratory
viruses
rt
pcr
drills
isolation
patients
patient
identify
women
ari
pregnant
among
respiratory
de
les
et
des
infections
lessons
public
health
global
moral
nan
infectious
disease
healthcare
hcws
institutions
data
respiratory
pathogen
pathogens
sites
nan
respiratory
positive
patients
rapid
pcr
pneumonia
infection
mers
severe
respiratory
dog
public
hygiene
mess
management
pedv
group
bovsdp
pigs
plasma
nan
diets
pigs
fed
sdpp
app
feed
sdpp
time
additives
treated
cows
supplement
born
weaning
range
pigs
nc
groups
group
05
sdp
formaldehyde
diet
pigs
experiment
66
oil
pedv
mcfa
treatment
pig
hc
health
commercial
economic
nan
calves
weaning
two
stage
itm
nan
nan
masked
palm
range
activity
males
disease
wild
populations
infectious
species
group
lofoten
virus
ticks
of
disease
red
wolves
coyotes
species
nan
sampling
method
geounits
methods
studies
nan
nan
nan
publisher
error
this
article
published
drug
hpc
in
computational
discovery
rna
cap
n7
mtase
guanine
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
ebola
dr
gao
west
africa
nan
nan
nan
nan
international
china
since
last
human
nan
nan
nan
nan
nan
nan
nan
nan
nan
bat
rna
ncrna
expression
ncrnas
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
cardiac
care
adult
critical
division
nan
who
the
authority
health
global
nan
norm
health
contestation
article
china
nan
nan
nan
vaginal
coyotes
species
behavior
levels
small
cb
pygmy
growth
survival
madagascar
comoros
sites
rousettus
genetic
disease
model
mers
cov
human
nan
nan
nan
nan
nan
nan
pathogen
wildlife
hosts
disease
infectious
nan
nan
nan
sample
the
rp2plus
respiratory
samples
nan
recent
studies
emerging
infectious
diseases
nan
ph
00
virus
water
infectivity
root
outgroup
method
mpr
data
antibody
colostrum
serum
titers
antibodies
tgev
delta
pdcov
meal
virus
nan
nan
nan
nan
nan
nan
lower
respiratory
tract
disease
children
disease
respiratory
cattle
incidence
milk
nan
economic
health
public
the
financial
nan
vt2y
apoptosis
primary
chicken
recently
foodborne
food
viruses
illness
increase
nan
matrix
virus
proteins
protein
their
virus
diarrhea
porcine
epidemic
this
dna
gene
mini
genetic
tn5
na1
bovine
enteric
infection
virus
nan
nan
nan
nan
nan
peptides
2019
ncov
the
coronavirus
co
droplets
occupant
inhalation
mouth
chitosan
loading
microsphere
release
microspheres
fccs
setup
wavelength
nm
cross
model
entropy
based
thermodynamic
epidemics
management
healthcare
medical
it
data
technologies
shall
tools
business
in
stampedes
management
crowded
technologies
many
covid
19
patients
high
dose
sars
des
der
virus
coronavirus
sirna
vegf
ht
29
cells
paper
response
taiwan
china
relatively
der
die
und
ist
ambulant
zur
pflanzlichen
therapie
von
kindern
de
ebola
een
bij
en
van
de
er
een
te
de
en
een
nieuwe
richtlijn
networks
epidemic
interactive
interconnected
dynamics
nan
airborne
microorganisms
dust
transmission
emitted
dental
surgical
masks
used
fungal
2006
poccia
et
al
1244
2007
journal
seligman
quasi
species
nosocomial
infections
icu
viruses
patients
rna
spatial
large
molecules
functional
cleavage
in
paper
demonstrate
machine
chitosan
also
chapter
materials
control
cell
expansions
tce
age
related
viral
infections
virus
human
patients
disease
vector
borne
zoonotic
diseases
health
development
world
the
bank
chapter
design
activity
this
summarizes
contracting
states
measures
shall
time
changes
behavior
we
models
impact
otolaryngology
conditions
discussed
this
chapter
systems
bioterrorism
nanomaterials
the
new
technology
field
plant
based
this
svm
data
information
several
learning
angiotensin
ang
ii
mechanisms
system
gene
products
based
system
clinical
cftr
cf
gene
respiratory
epithelial
findings
incidental
tmj
also
calcifications
sugar
carbohydrate
moieties
we
technology
infectious
uveitis
due
origin
many
acute
infection
copd
aecopd
clinical
sensors
detection
cantilevers
cantilever
small
chitosan
mainly
research
decades
chemical
cap
children
infections
frequent
viral
patients
viruses
viral
common
respiratory
global
health
security
events
disease
duox
tract
family
respiratory
reactive
his
anti
proteins
tagged
rgs
security
human
threats
the
provides
nan
nan
nan
microcantilever
fip
type
virus
coronavirus
in
throughput
molecules
compounds
inhibitors
patients
rsv
alri
ari
severe
nan
nan
rsv
associated
countries
risk
disease
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
new
drugs
covid
19
declared
public
em
providers
covid
19
nan
emerging
pathogens
health
recent
in
cap
patients
microbial
pneumonia
cultures
drugs
host
viruses
epidemic
pandemic
patients
hsv
cmv
although
reactivation
cap
severe
atypical
bacteria
viruses
nan
viral
genomes
stranded
viruses
genome
hcov
recognised
rt
pcr
human
belief
every
chapter
epistemological
theory
viroporins
channel
viroporin
membrane
including
asthma
children
wheezing
severe
difficult
molecular
techniques
microbiology
advanced
methods
genomes
eukaryote
discussed
genome
general
center
indian
medical
tertiary
care
coronavirus
humanes
gruppe
nan
hiv
receptors
chemokine
infection
viral
urban
growth
world
cities
towns
molecules
membrane
every
living
cell
host
viral
immune
virus
antibodies
ribavirin
used
19
it
antiviral
udp
golgi
hirschberg
et
al
vaccine
diseases
infectious
formulation
considered
van
een
ziekte
men
en
databases
organisms
information
related
genomes
mirnas
host
found
disease
micrornas
dna
rna
enzymes
cleaving
targets
frameshifting
structure
ribosomal
elongation
ribosome
agents
disease
viruses
bacteria
fungi
asthma
patients
disease
and
causes
dynamics
infections
understanding
control
viral
diagnostics
the
recent
zika
ebola
allergic
dermatitis
contact
in
chapter
emerging
viruses
viral
infections
transplant
pneumonia
the
pulmonary
interstitial
inflammation
class
infectious
diseases
according
law
pneumonia
deaths
leading
united
states
diseases
infectious
livelihoods
poor
rural
ad12
cells
dna
viral
in
role
modulating
cutaneous
biology
proteolytic
lectins
plant
many
various
applications
cell
viruses
host
viral
surface
sepsis
syndromes
critical
like
care
een
zijn
ziekten
van
de
ecov
equine
real
time
rt
de
van
het
nasofarynx
door
molecular
blood
safety
screening
infectious
nan
food
borne
metaphors
risk
diseases
sepsis
biomarkers
the
response
omics
since
identity
respiratory
pathogen
known
de
van
luchtwegen
bovenste
en
mass
object
one
scale
microscopic
role
inflammatory
microglia
macrophages
related
sponges
source
substances
found
symbiotic
respiratory
infections
leading
cause
illness
the
endophytes
bioactive
compounds
production
vaccines
prophylactic
including
past
health
protein
intrabodies
intracellular
binding
diseases
health
field
epidemiology
training
fetp
threat
environment
drivers
intelligence
emerging
de
van
het
hypertrofie
lymfoïde
wildlife
human
nonhuman
animal
transmission
pcv2
porcine
circovirus
pcv
associated
tumor
new
the
gene
therapy
diseases
human
populations
infectious
humans
disease
outbreaks
hev
niv
animal
tcov
turkey
antibodies
specific
virus
vasculitis
clinical
vessel
histologic
systemic
de
en
gastheer
micro
organismen
states
goods
air
contracting
cargo
respiratory
tract
infections
common
community
respiratory
infections
clinical
common
virus
light
well
focus
laser
dissolved
north
species
western
canada
this
die
gentherapie
ist
eine
junge
niv
patients
acute
ventilation
respiratory
sources
air
human
airborne
germicidal
ferret
coronavirus
disease
systemic
genotype
nan
march
hospital
et
al
health
impact
economic
losses
disease
value
section
15
cchf
considers
work
molecular
microbiology
techniques
clinical
laboratory
van
het
en
een
de
respiratory
disease
the
syndrome
virus
viral
virus
host
rnases
the
diseases
animal
swine
fever
infectious
nan
et
al
herbal
medicine
anti
pneumonia
the
chapter
acquired
management
deaths
infectious
diseases
africa
million
used
jinyinhua
sprawling
twining
lianas
infections
many
experience
recent
viral
erreger
der
die
und
ist
disease
poultry
farmers
h5n1
international
progress
we
talk
endlessly
moral
plastid
engineering
genome
transformation
several
mers
sars
cov
the
pandemic
issues
nonhuman
primates
research
information
health
stress
education
communication
depression
ahrf
may
acute
respiratory
ards
porcine
virus
evolution
coronaviruses
swine
infections
cultures
secondary
endogenous
exogenous
common
sinus
show
hyperintense
t1
asthma
incidence
past
years
deaths
decision
making
students
issues
reasoning
china
media
her
news
vulnerability
human
sialic
cell
acid
biology
vaccines
cell
vaccine
potent
epitopes
children
vitamin
supplements
united
states
hazards
the
natural
origin
affecting
infectious
person
disease
diseases
air
the
liquorice
ayurveda
ancient
beneficial
lung
vascular
injury
tissue
endothelial
health
animal
new
high
tools
ligands
in
ctls
structure
ctl
disease
contingency
pathogen
this
introduction
blood
transfusions
infectious
result
infections
vaccines
properties
liposomal
liposome
liposomes
hong
kong
flu
in
avian
health
the
disease
climate
change
viruses
classic
hepatotropic
injury
virus
nan
diseases
health
highly
infectious
bioterrorism
tgev
piglets
vaccines
commercially
pathogen
tcov
turkey
specific
10
atrophic
nan
infections
vaccines
prevention
information
may
education
biological
biology
would
research
ct
immunocompromised
patients
pulmonary
infections
nan
malaria
complications
mortality
critical
care
saudi
countries
migration
gcc
arabia
complement
system
activation
lectin
immune
edible
vaccines
vaccine
plants
easy
ews
warning
hazards
communities
rather
ad12
cells
hamster
dna
methylation
organizing
pneumonia
lung
reaction
parenchyma
covs
rna
viruses
animal
emerging
virus
ab
mediated
infection
acute
patients
hospital
risk
infections
infection
highly
avian
influenza
infectious
pathogenic
niv
icu
respiratory
patients
general
effects
parasites
host
trait
hosts
pandemic
influenza
capacity
care
severe
isolation
strict
infection
highly
resistant
pneumonia
the
disease
age
may
nan
nan
astroviruses
human
discovery
novel
discovered
surfaces
care
dental
pathogens
transmission
transplantation
lung
first
in
1963
emerging
infectious
diseases
eids
including
the
temperature
earliest
medicine
human
palmitoylation
sites
methods
sensitivity
basis
analysis
policy
epidemic
control
framework
livestock
infectious
animal
health
diseases
viral
detection
alignment
free
zcgcc
pseudoknot
structures
method
search
model
pneumonia
pregnant
common
influenza
cause
vaccines
production
plants
plant
transgenic
patients
ventilator
associated
pneumonia
occurs
hong
kong
the
chapter
western
diseases
viral
million
hepatitis
people
patients
hiv
infection
viral
infections
human
population
global
organisms
the
chapter
treatment
infections
ecological
approach
propinquity
proximity
city
design
neighbors
asia
infectious
diseases
this
chapter
clustering
algorithms
temporal
infectious
diseases
oath
the
medicine
hippocratic
medical
urban
cities
social
capital
come
biomarkers
pathologies
cancer
chapter
lungs
diagnostics
microarrays
clinical
dna
devices
newborns
may
present
vague
signs
antiviral
drugs
agents
main
host
diseases
eids
contagious
health
infectious
nan
phylogenetic
estimation
problem
pep
versions
protein
technology
detection
microarrays
potential
global
us
eu
assistance
africa
an
overview
general
pediatric
infectious
nan
healthcare
high
risk
hcais
hcai
protein
vpu
channel
hiv
membrane
nan
infections
lung
diagnosis
infection
the
avian
influenza
epidemic
virus
birds
ang
ii
angiotensin
cell
heptapeptide
astrovirus
structural
capsid
studies
virion
et
al
1996
hiv
cxcr4
allow
agents
implemented
improve
the
psittacosis
infectious
disease
chlamydia
psittaci
ifn
virus
hcv
hepatitis
current
hiv
encephalitis
infection
virus
viruses
plague
the
pandemic
million
great
system
the
renin
angiotensin
ras
icu
patients
discharged
life
occur
fitness
exercise
health
physical
programmes
mhv
demyelination
pathogenesis
virus
genomic
und
dieses
kapitel
gibt
kurz
wnv
antibody
responses
important
experimental
health
data
disease
provincial
division
cat
feline
disease
domestic
species
acute
sinusitis
the
sinus
children
droplet
airborne
air
nuclei
infection
nan
avian
influenza
plague
infectious
disease
vaccines
key
range
development
offer
nan
cases
h7n9
avian
influenza
human
parenchymal
cells
apoptosis
hepatitis
mhv
news
the
event
annotations
summarization
public
health
issue
flu
one
climate
change
global
warming
damages
resilience
threats
conditions
expression
steady
cell
genome
host
viruses
consequences
respiratory
children
risk
rsv
infection
il
35
cells
12
family
rabies
developing
countries
disease
one
biomarkers
diagnostic
laboratory
field
microbiology
tcr
cell
immune
molecular
the
human
microbiome
research
species
understanding
singapore
sars
this
disasters
epidemic
sars
2003
et
al
taiwan
animals
infectious
zoonoses
diseases
indirectly
resistant
early
patients
severe
scap
diseases
infectious
incidence
geographic
range
observable
directly
infectious
must
remembered
production
protein
the
proteins
large
clinical
infectious
specific
in
detection
een
de
van
op
zijn
health
public
local
departments
many
cleaning
environment
decrease
pathogens
healthcare
der
mit
die
luftnot
einem
recommendations
health
found
immediately
activities
de
ziekte
met
tot
ziekten
nan
proteins
cell
protein
represent
tools
een
met
bij
infecties
dat
influenza
viral
measles
sars
mers
astroviruses
avian
type
enteritis
origin
rehabilitation
orthopedic
like
concepts
gravity
en
van
zie
paragraaf
door
measures
individuals
the
geographic
areas
bronchiolitis
respiratory
organ
oxygen
produces
the
microorganisms
discussed
taxonomy
bacteria
disease
sickle
cell
vaso
occlusive
cell
knowledge
genomic
proteomic
approaches
anemia
leukopenia
thrombocytopenia
drug
toxicities
astroviruses
species
the
first
date
roles
genome
peptidases
the
particular
demyelination
process
axonal
damage
mice
biological
emerging
agents
events
chronic
disease
illness
health
concepts
definitions
in
het
hoofdstuk
de
vorige
der
die
und
das
sich
on
steroid
associated
model
using
diseases
infectious
china
ambient
temperature
viruses
fever
human
viral
including
pulmonary
ang
diseases
angiotensin
respiratory
pneumonia
community
acquired
antimicrobial
therapy
cause
aris
human
hrvs
acute
uv
medicinal
plants
plant
radiation
venous
thrombus
factors
thrombosis
vte
control
epidemic
one
investigate
multi
travellers
travel
may
infections
destinations
vaccine
global
innovation
market
this
grid
microscope
methods
search
virus
the
room
waste
disinfection
good
masks
face
impact
epidemic
spread
immune
patients
transplantation
population
opportunistic
patients
ventilator
associated
pneumonia
occurs
tests
appropriate
diagnosis
viral
also
biocontainment
facilities
units
highly
hazardous
plant
life
human
the
john
risk
infections
therapy
patients
leukemia
technology
medical
care
effects
health
ibv
virus
tracheal
serotypes
important
emerging
diseases
infections
infectious
public
resources
community
society
risk
disasters
chapter
provides
overview
medical
neuropsychologist
construction
industry
building
materials
nanomaterials
level
objectivity
articles
science
nature
nan
viral
drugs
anti
novel
compounds
ecmo
patients
severe
network
italian
models
angiotensin
altered
physiological
in
hiv
china
policy
epidemic
policies
area
techniques
airport
travel
spread
nan
terpenes
also
properties
plants
major
rna
viral
targets
small
molecule
respiratory
viral
infections
virus
human
examination
the
chapter
describes
diagnostic
human
rapidly
changes
health
recognized
influenza
virus
pa
h1n1
pandemic
infectious
informatics
the
disease
clinical
life
solar
system
viruses
may
host
virus
rna
protein
plus
viral
many
development
vaccines
must
infections
diagnosis
respiratory
clinical
associated
epiglottitis
acute
croup
laryngitis
children
nan
ebola
crisis
africa
case
hope
virus
infections
viral
signaling
viruses
respiratory
infections
mortality
cancer
responses
sewage
antarctic
effluent
disposal
wildlife
pedv
virus
genome
method
complete
nan
teachers
science
efforts
nos
programmes
risk
respiratory
tract
infections
transplant
asthma
infections
the
levels
past
pathogens
host
hspgs
hs
cell
angiotensin
ang
actions
ii
cardiovascular
re
emergence
diseases
the
vector
vlps
vaccines
virus
based
formulations
infections
pulmonary
imaging
patterns
ct
virus
vaccines
disease
research
emerged
dental
care
and
or
fluids
performed
laboratory
poct
tests
point
science
phenomena
10
studies
today
nan
viral
expression
organisms
host
gene
transcriptional
coding
development
non
also
nucleolus
cell
viruses
involving
targeted
mice
pai
nasal
response
pa
would
clinical
dengue
features
diagnosis
risk
infections
period
infection
autologous
us
many
mountains
diseases
today
anti
lychee
fruit
litchi
chinensis
tissues
the
transplantation
donor
recipient
field
hospital
medicine
pediatric
care
antibodies
development
antibody
the
production
use
lab
bacteria
delivery
vehicles
virus
platelet
thus
interplay
complex
diagnostic
signs
medical
full
imaging
air
pollution
many
disasters
lead
the
cold
common
acute
congestion
vaccines
immune
response
vaccine
new
mechanisms
ms
autoimmune
tolerance
central
rnai
heart
type
myocardial
therapeutic
diseases
microbiology
plays
important
role
pandemic
in
disease
social
research
sect
biodiversity
value
human
the
new
based
assays
nucleic
acid
fusion
membrane
viral
host
cell
diseases
there
information
new
emerge
protein
13
nmr
structures
validation
be
behavior
models
epidemiology
infection
nan
progress
national
program
targets
china
genetic
specific
delivery
site
better
welfare
health
consider
individual
status
ubiquitin
ups
proteasome
multiple
inhibitors
new
conditions
agents
eold
diseases
sirna
delivery
rnai
targeted
system
rna
viral
splicing
dna
spliced
ellipsometry
technique
in
chapter
discussed
bug
season
flu
year
going
viral
molecular
diagnostics
detection
infections
respiratory
viral
acute
syndrome
failure
codon
usage
mutation
bias
translation
cattle
bcov
cause
respiratory
used
mitochondria
membrane
hatefi
1985
mitochondrial
viruses
infected
may
food
contaminated
sfts
the
virus
acute
patients
contact
disease
network
sna
tracing
biological
pathogen
population
prevention
risk
respiratory
infection
residents
nursing
risk
science
public
well
newspaper
coverage
the
transmission
environment
evaporation
in
please
check
hierarchy
sections
correct
cells
different
immune
cell
age
models
disease
health
inform
behavioral
the
oligonucleotides
idea
sequence
specific
health
public
germany
federal
the
coronaviruses
chronic
demyelination
cells
infection
mucosal
delivery
accumulation
site
administration
de
in
dit
hoofdstuk
komen
structure
sequence
alignment
search
algorithm
severe
hong
kong
2003
sars
lung
transplantation
pulmonary
disease
common
de
luchtwegen
en
tot
onderste
infections
resistance
new
the
antimicrobial
traditional
viral
isolation
cell
culture
diagnostic
methods
diagnosis
virology
various
viruses
tools
viral
animal
field
de
en
bovensteluchtweginfecties
recidiverende
middenoorontstekingen
viral
evolution
the
lecture
covers
risk
used
context
chapter
pandemics
retinal
rpe
cell
immunity
immune
health
cities
new
medical
many
rna
cchfv
bunyaviridae
crimean
congo
english
singapore
global
language
chapter
disease
epidemic
oxford
dictionary
pp
infections
species
virus
in
use
techniques
sequences
granch
pandemic
analyses
dna
sensors
types
viral
the
acute
airway
children
obstruction
several
fiv
infection
cell
immunodeficiency
aids
in
intellectual
property
security
place
ces
older
services
health
day
news
different
differences
we
levels
2003
outbreak
sars
early
unknown
imv
associated
niv
respiratory
upper
stem
hsct
cell
patients
this
the
technologies
advanced
described
chapter
protein
layer
ellipsometry
film
also
military
the
bulgaria
public
paper
structures
rna
secondary
known
many
clinical
often
thus
post
transplant
pedv
antigens
tissues
in
ihc
bovine
diseases
development
vaccines
available
the
viral
blood
clinical
process
renal
kidney
diseases
infections
may
microarrays
detection
well
high
application
the
lung
left
lungs
right
ang
ii
cardiovascular
signaling
specific
astrovirus
gastroenteritis
viral
cause
identified
een
de
in
het
kinderen
rnai
rna
silencing
gene
one
infections
parasitic
ipis
developed
communities
pneumonia
older
adults
home
the
viruses
human
health
indoor
assessment
techniques
molecular
clinical
microbiology
diagnosis
health
threat
bioterrorism
italy
public
die
und
das
seit
den
health
public
contribute
medical
manager
een
en
van
bij
onderzoek
social
mental
relationships
digital
many
cells
control
infection
viral
cns
vitamin
human
the
body
chapter
ventilation
procedures
the
organisms
causing
cell
vs
to
retroviruses
synapse
nan
the
important
vegetable
vegetables
gene
nan
vaccines
ad
development
viral
cancer
infections
the
liver
carries
may
health
gis
29
the
disease
chest
trauma
infection
imaging
evaluation
section
describes
metzincin
procollagen
stromal
ms
myelin
cell
could
autoimmune
immune
immunological
system
important
decline
either
inflammatory
response
and
or
viral
cells
cell
infections
hsct
devil
dftd
tasmanian
conservation
the
microbiome
the
probiotics
prebiotics
like
de
zijn
micro
organismen
niet
cells
subsets
specific
host
defense
plant
plants
compounds
molecules
production
novel
ncrna
sequence
structure
algorithm
plant
proteins
production
derived
products
us
harm
various
medical
giants
infection
defined
pathogenic
pathologic
process
models
ms
animal
virus
to
cibotium
barometz
plant
habit
fetal
the
maternal
antibodies
mother
important
microbiology
caused
in
order
chapter
disease
dynamics
questions
help
field
in
chapter
summarize
important
verzorgenden
van
zorgvragers
en
de
sars
cov
et
al
2005
weeks
sinusitis
inflammation
nasal
mucosa
the
respiratory
deaths
among
from
van
de
bij
kinderen
alle
glycoproteins
transport
et
al
2003
nan
long
flight
passengers
international
haul
cytokines
recombinant
synthetic
infectious
diseases
nan
10
month
old
male
presented
scientific
sars
models
in
authentic
camelids
diseases
emerging
owc
infections
epidemic
we
outbreak
time
data
renal
may
kidney
diseases
infections
mass
wildlife
extinction
trade
defaunation
transplantation
the
lungs
transplanted
organ
ibv
used
rt
pcr
avian
china
control
prevention
global
program
heart
lung
transplantation
infections
since
factors
chronic
several
environmental
air
nan
africa
human
development
security
people
diseases
developing
countries
infectious
regions
health
security
chapter
key
including
respirators
healthcare
airborne
use
respiratory
upper
respiratory
infections
enormous
also
infection
antimicrobial
patients
problems
infections
system
lymphatic
drugs
disease
solid
human
be
health
effects
ecosystems
nan
pharyngitis
acute
gas
patients
group
respiratory
cause
rsv
occur
tract
pulmonary
hemorrhage
life
blood
high
npm1
family
aml
the
npm
infectious
consolidation
lower
respiratory
tract
splicing
protein
proteins
splice
sr
children
family
the
study
drawings
data
immune
ontology
epitope
database
uncertainty
estimation
parameter
data
estimates
vlps
virus
vlp
vaccine
protection
reye
1963
one
et
al
upt
poct
bioterrorism
agents
based
secretory
soluble
proteins
constitutive
protein
healthcare
pandemic
influenza
workers
antiviral
het
en
de
luchtweginfecties
algemeen
microorganisms
posing
working
biosafety
problems
de
van
en
hoesten
voor
secondary
metabolites
plants
important
root
dental
patients
number
today
medical
fungal
vaccines
years
health
antibodies
simulation
analysis
searums
diseases
epidemiological
virus
animal
agents
fever
human
aquatic
water
contamination
activities
environs
een
neusverstopping
van
de
het
antimicrobial
phytochemicals
compounds
bacteria
beneficial
barrier
capillary
brain
prevent
nvu
identification
fields
forensics
field
individual
protein
layer
ellipsometry
film
also
may
via
right
protection
pathogenic
term
asthma
it
believed
coined
iga
present
et
al
immunoglobulin
disease
inos
early
demyelinating
mice
health
public
information
data
without
se
zn
aging
immune
may
cns
autoimmune
discuss
autoimmunity
disease
food
health
diseases
important
animals
et
al
recombination
genetic
viruses
vasculitis
vasculitides
disease
systemic
childhood
vaccine
fiv
virus
cats
effective
spatial
risk
epidemic
case
temporal
vaccines
infectious
diseases
since
vaccination
opinion
public
chapter
analysis
media
nan
agent
attack
may
biological
known
intensive
care
medicine
defined
science
screening
surveillance
identify
limitations
health
infection
prophylaxis
control
measures
antimicrobial
pids
pid
immunological
however
tested
carcinoma
nasal
region
benign
malignant
risk
human
viruses
risks
process
microbial
sequencing
identification
pathogen
the
pathogen
multi
host
characterized
domestic
jaar
de
per
van
krijgen
bpd
pulmonary
infection
respiratory
development
animal
oie
health
disease
level
learn
what
how
events
joined
für
sich
die
und
zu
development
goals
molecule
may
set
system
cell
analysis
operation
integrated
und
die
von
für
oder
allo
hsct
transplantation
infection
chapter
pneumonia
invasively
niv
case
requires
care
infection
control
health
associated
virus
contagious
why
mass
shootings
disease
security
outbreaks
the
relationship
at
early
beginning
21st
century
nan
nan
this
chapter
review
two
common
nan
cause
diagnosis
viruses
bacteria
main
ccov
canine
dogs
strains
coronavirus
immune
system
age
many
components
to
learn
epidemiology
aetiopathogenesis
clinical
the
cells
maternal
system
fetal
belangrijkste
verwekkers
en
bacteriële
bij
terrorism
asia
pacific
threats
security
receptors
clrs
like
pathogen
type
vasculitis
immune
mechanisms
primary
commonly
nanowires
gate
in
sensing
biofets
security
human
borders
states
hand
model
headlines
we
news
generates
die
der
und
von
eine
de
van
het
in
deel
time
number
epidemic
reproduction
transmissibility
viral
proteins
ifns
pathways
antiviral
care
may
providers
disasters
food
remyelination
growth
factor
mhv
a59
viruses
person
food
the
enteric
virus
ibv
cdna
vaccinia
genome
influenza
children
severe
risk
annual
viruses
virus
human
antivirals
also
et
al
helicases
nucleic
acids
ski
s1p
human
arenavirus
gpc
lower
airway
upper
inflammatory
airways
bats
immune
viruses
responses
mammals
animal
food
products
the
modified
akute
einer
entzündliche
reaktionen
bzw
big
data
ethical
public
health
bacteria
bacterial
the
detection
tsm
nan
viral
diseases
disease
emerging
animals
threatened
educational
bat
like
animals
balkan
nephropathy
disease
etiology
many
pards
risk
factors
acute
ards
patients
pathogens
cf
mucus
clearance
infection
disease
virus
the
chapter
icu
patients
number
increase
treated
health
globalisation
implications
vulnerabilities
considered
nan
coronavirus
infecting
including
variables
disease
analyte
detection
different
mass
sensitive
crises
we
new
disasters
types
fip
feline
fcov
coronavirus
infection
influenza
genomic
sars
data
large
heat
shock
virus
replication
viral
multisubunit
complexes
structures
biological
large
tests
decision
diagnosis
health
rule
vap
mechanical
patients
associated
ventilation
immune
due
senescence
models
challenges
tge
disease
pigs
virus
tgev
human
includes
virus
rsv
metapneumovirus
intelligence
bio
threat
risk
this
athlete
pulmonary
in
football
system
fab
fragments
human
antibody
phage
healthcare
viral
infections
may
associated
phytochemicals
diverse
antiviral
activities
studies
science
scientific
curriculum
first
cdc
nan
proteins
tm
prediction
non
svm
security
health
regional
human
global
research
bioemergencies
challenges
human
subjects
animal
models
vaccine
model
translation
databases
proteins
available
carbohydrates
different
structure
algorithm
the
algorithms
predict
de
met
mijn
dat
heeft
een
de
naar
longproblemen
tijdens
bats
unique
flying
mammalians
occur
capabilities
devices
rapid
tests
healthcare
patients
drugs
infections
management
early
lung
et
al
sterility
components
bos
cmv
infectious
long
literature
ppe
care
patient
protective
putting
saponins
plant
biological
activity
synthesis
neutropenic
fever
patients
mortality
infections
nan
sociology
health
social
medical
problems
vitamin
copd
deficiency
inflammation
it
this
chapter
presents
survey
zoonotic
myelin
tmev
virus
anti
autoimmunity
hla
vaccine
short
peptide
development
vaccine
antibody
possible
structure
hiv
mbl
pathogen
recognition
type
immune
symptoms
sleeping
waking
brain
scientific
vaccines
livestock
health
successful
pathogens
nan
sind
bei
erkrankungen
häufig
sie
surveillance
data
global
public
health
te
de
van
als
gezondheid
molecular
chapter
clinical
diagnostic
methods
ards
respiratory
cell
the
acute
health
ecosystems
aboriginal
the
human
lungs
pulmonary
disease
death
chapter
infections
may
plague
in
empiric
rationality
science
the
many
kuhn
disease
data
the
series
influenza
viruses
continent
hemisphere
whereas
usually
human
animals
meat
bushmeat
since
he
72
year
old
male
nan
hiv
zikav
risk
transmission
the
een
op
zoönose
ziekte
die
nan
infected
infectious
diseases
contact
tracing
learning
3d
in
the
depth
objectivity
scientific
research
understanding
science
water
viruses
enteric
resources
indicators
cell
the
cultures
biosafety
culture
carbohydrates
based
take
advantage
carbohydrate
patients
infections
immune
highly
response
spread
infection
patients
scenarios
serious
infection
the
isolation
spread
may
prior
presented
diarrhea
days
care
biological
agents
concepts
for
stimulating
wnv
inhibitors
based
molecular
small
patient
infection
control
family
care
tcov
turkey
infection
coronavirus
effective
health
care
infection
prevention
setting
coronaviruses
infections
human
respiratory
caused
bioportal
information
support
surveillance
design
infections
age
viral
respiratory
cause
chapter
legal
displacement
the
movements
nan
techniques
great
diagnostic
since
thermostable
infectious
patient
agents
patients
perioperative
the
range
control
livestock
poultry
nan
aircraft
territory
contracting
state
navigation
zoonotic
emerging
emergence
outbreaks
global
2016
2014
ebola
outbreak
disease
corporate
communication
relations
company
communicators
data
naturally
occurring
sources
health
bat
diseases
people
disease
populations
infection
dangerous
microbes
high
agents
aminopeptidase
enzymes
neuropeptides
nervous
system
de
van
en
luchtwegen
die
outbreak
stochastic
chapter
distributions
initial
method
probe
design
oligo
probes
nan
pcs
furin
proteins
viral
the
urban
this
citizens
crops
problems
risks
risk
perspective
different
knowledge
ionic
liquids
reaction
this
chapter
infectious
diseases
the
human
frequently
animals
future
parasites
enter
plants
management
crisis
risk
stakeholders
risks
vaccines
fc
recombinant
antigen
cells
tlr
signaling
macrophages
tumor
role
protein
ceacam1
the
mhv
mouse
countries
downturn
oil
sources
food
disease
the
sars
high
new
traveled
25
year
old
otherwise
infection
animals
cryptosporidium
disease
veterinary
travel
diseases
the
ease
air
transfusion
niarts
adverse
blood
infectious
vaccines
derived
immunome
vaccine
epitope
proteases
host
antiviral
virus
viruses
interactions
microorganisms
interaction
networks
plants
the
new
different
diagnostic
medical
the
sequestered
excreted
drugs
aminoquinolines
arf
patients
pulmonary
complications
especially
ignorance
arguments
health
york
called
slecht
worden
door
waar
mensen
cold
common
the
respiratory
low
sepsis
condition
bloodstream
fighting
systemic
disease
despite
control
infectious
efforts
assays
et
al
biomarkers
infectious
viral
diagnosis
lamp
pcr
found
van
de
en
luchtweginfecties
bovenste
cleavage
prediction
method
rules
site
cells
viral
cell
infections
subsets
cancer
cells
tumor
stem
genetic
species
infections
gram
pathogens
patients
biopsy
the
patient
lung
established
state
citizens
human
rights
security
biological
the
issues
flu
scientific
pathogens
trade
infectious
frequency
spread
pedv
diarrhea
disease
porcine
the
global
health
negotiation
governance
issues
microbes
environment
may
living
pathogenic
nms
exposures
health
effects
particular
health
climate
change
human
quality
lower
respiratory
tract
acute
children
modelling
mathematical
analysis
may
help
influenza
diseases
patients
acute
respiratory
drug
delivery
new
efficacy
billion
myocardial
inflammation
diseases
myocarditis
remains
police
infections
disease
may
infectious
throughout
book
chapters
researchers
highlighted
respiratory
acute
sars
disease
may
virus
mhv
demyelination
disease
acute
den
die
und
ist
bei
nan
measles
respiratory
infectious
acute
disease
nov
vlps
plant
the
vaccines
cov
protein
humans
sars
mers
food
countries
safety
water
many
frameshift
loop
viral
rna
plant
health
viral
global
foodborne
threats
zijn
en
ontwikkeling
aandoeningen
ieder
allograft
bos
dysfunction
lung
recipients
tissue
investigate
human
research
vitro
bronchiectasis
patients
aeruginosa
disease
associated
en
infecties
van
de
zijn
virus
chicken
the
respiratory
abstract
nan
family
pet
dog
health
dogs
de
bronchiën
zijn
vertakkingen
van
activities
animals
biomedical
waste
medical
et
al
pathogens
changes
waterborne
nan
development
techniques
drug
new
biotechnology
clinical
methods
may
pathogens
immunological
hiv
aids
years
nineteen
ago
the
acute
otitis
media
coalescent
isotope
nmr
labeling
proteins
protein
protein
expression
tcov
the
histidine
indoor
air
pollution
control
china
bats
species
immune
responsible
large
units
icus
in
rate
ventilation
sea
coast
extreme
help
cities
lung
proteases
important
role
antiproteases
proteases
serine
trypsin
like
proteolytic
respiratory
in
mainly
viruses
the
immune
system
studies
activity
involving
abrs
acute
bacterial
rhinosinusitis
costs
ari
respiratory
viruses
bacteria
interactions
en
van
de
op
onder
viruses
et
al
rna
coronaviruses
patents
patent
genes
genetic
tests
dna
vaccination
discussed
gene
delivery
molecular
techniques
drug
the
research
cd8
cell
mhv
epitopes
c57bl
nan
viral
human
community
viruses
discovery
genome
genetic
fcovs
generation
recombinant
influenza
virus
swine
outbreak
human
social
structure
contacts
community
epidemic
sirna
fungi
rnai
mycoses
gene
antimicrobial
would
development
biomaterials
great
dna
vaccination
antigen
platform
in
viruses
exposures
workers
occupational
viral
food
the
safety
chapter
discusses
nanoparticles
nanotechnology
use
systems
silver
influenza
h1n1
infectious
respiratory
disease
disease
highly
hpai
poultry
pathogenic
ards
mortality
interventions
evidence
based
van
de
dit
het
openbare
rejection
lung
acute
amr
specific
future
actors
this
chapter
deals
methods
assays
immunological
viral
care
proteins
dcg
membrane
secretory
pathway
bovine
trichomonosis
the
mainly
trichomonad
sequences
the
distribution
standard
on
to
conflict
disaster
situations
health
viral
may
host
factors
viruses
detection
technologies
biosensor
presented
this
infections
risk
infection
patients
transplant
proteins
membrane
transmembrane
viral
viruses
influenza
human
avian
viruses
humans
pcr
gene
corresponding
bp
reaction
liver
disease
may
the
determine
sars
protease
protident
proteases
sequences
liquorice
foliage
units
hlcc
diseases
care
highly
infectious
acute
sars
respiratory
pneumonia
et
al
animal
models
cardiac
cns
within
ms
infection
chemokine
after
reading
chapter
know
answers
nan
tauchgebiete
befinden
sich
oft
exotischen
gastroenteritis
common
viruses
acute
among
zinc
ageing
selenium
immune
old
inflammatory
mmps
the
infection
virus
influenza
inhibitors
na
patients
viruses
the
pain
effective
opioids
opioid
the
acute
rhinosinusitis
evidence
common
pandemic
influenza
health
also
role
the
word
genomics
first
coined
ecov
horses
clinical
associated
infection
contacts
geographical
disease
patients
social
und
die
das
wie
werden
blood
safety
the
donated
infectious
models
animal
human
disease
diseases
effects
ophthalmic
toxicology
toxicologic
lenses
viruses
foodborne
potential
control
retail
influenza
increase
2009
sharp
hospitalization
cells
local
apoptosis
inflammatory
particularly
viral
infections
detection
diagnosis
public
sfts
china
reported
cases
infection
camel
diseases
transboundary
market
countries
group
disease
virus
risk
medical
prevention
infections
associated
infection
measurement
care
pandemic
health
medical
demand
tcov
turkey
flocks
among
isolates
disease
children
kawasaki
mucocutaneous
lymph
pseudoknot
structures
method
search
model
course
69
year
old
man
years
rate
min
oxygen
58
nan
factors
spatial
diffusion
disease
modelling
nan
lung
patients
transplant
life
complications
nan
small
bronchioles
the
airways
conducting
nan
security
airport
cargo
aircraft
the
data
the
visualization
tool
middle
human
infectious
disease
represent
significant
vaccines
plant
made
virus
well
peritoneal
isotropic
neoplastic
retroperitoneal
spaces
model
quarantine
isolation
containment
epidemics
und
erreger
mykobakterien
viren
diagnostik
practice
forensic
pathology
histopathology
histological
gene
experiments
viral
behavioral
behavior
world
spread
disease
prevent
we
exposure
indoor
microbial
health
studies
nan
metal
malaria
many
plasmodium
compounds
oil
essential
anti
plants
the
nan
nan
cells
cell
responsiveness
elderly
ageing
sars
cases
deaths
china
disease
oh
health
approach
relationships
international
probiotics
effect
studies
viruses
in
nan
cough
acute
infection
weeks
respiratory
public
the
in
health
refugee
resistant
pneumonia
associated
patients
severe
in
new
small
molecule
microarrays
women
hiv
aids
vulnerability
transmission
cell
specific
targeting
transgene
strategies
stochastic
gryphon
based
infectious
diseases
nan
social
hong
kong
conditions
economic
name
herpesvirus
name
virus
human
metapneumovirus
influenza
viruses
include
virus
the
building
wind
typologies
pedestrian
level
laboratory
care
highly
facilities
laboratories
issues
time
air
change
place
exercise
infections
influence
respiratory
immunity
macroevolution
science
hps
educators
topic
disease
theoretical
outbreaks
urban
factors
frameshift
sites
ribosomal
frameshifting
genes
he
symptoms
31
year
old
pandemic
communities
behind
when
pandemics
transplantation
infections
virus
viruses
transplant
immune
the
system
cells
pathogens
ms
disease
role
000
cases
immunotherapy
brain
tumor
immunology
clinical
nan
virus
viruses
human
treatment
several
protein
important
research
applications
characterization
dc
sign
icam
receptor
type
und
die
der
von
eine
chapter
emergence
spread
analyses
recent
hsw
work
it
key
chapter
nan
county
in
early
april
2009
formula
see
text
hiv
disease
viruses
foodborne
hepatitis
human
diseases
using
posts
data
time
internet
sequencing
this
next
generation
genome
biotechnology
insect
cells
products
industrial
nov
infection
gastroenteritis
studies
outbreaks
biological
carbohydrate
carbohydrates
recent
microarrays
data
real
time
disease
assimilation
medical
chapter
writing
journals
there
dpv
ul16
gene
codon
usage
active
virus
immunization
passive
vaccination
nan
he
year
old
days
55
clones
cloning
system
labs
organs
plasma
concentrates
aes
transmission
clinical
halloween
others
crowd
along
air
und
die
das
werden
der
chronic
disease
respiratory
exacerbations
aecopd
bats
humans
diseases
bat
via
tgev
pedv
porcine
pdcov
associated
dubs
various
cancer
protein
proteasome
data
big
chapter
biodefense
the
nan
influenza
vaccines
humans
pandemic
animal
bsmab
detection
diagnostic
diagnosis
use
cell
polarity
cancer
invasion
also
vitamin
children
poor
deficiency
infants
nan
psvs
several
viruses
psv
amplification
infect
dis
clin
north
am
sequences
algorithm
viruses
alignment
algorithms
significant
viruses
hepatitis
may
influenza
negative
platelet
activation
regulators
provide
mers
cov
infections
measures
the
behavior
transmission
epidemic
size
changes
rna
discovery
virtual
screening
drug
lectins
type
the
plant
proteins
nan
epidemic
end
disease
surveillance
epidemiological
risk
infectious
diseases
well
influenza
health
taiwan
governance
risk
the
travelling
countries
advice
before
thorough
mongooses
genet
species
auropunctatus
europe
die
und
proben
der
von
the
respiratory
syndrome
coronavirus
cases
models
spreading
time
analytical
treatment
mas
hlh
infections
rheumatic
disorders
die
infektion
eine
als
mit
response
us
national
threat
enhance
cough
patients
illness
chronic
duration
species
calanthe
cymbidium
large
herbal
coronavirus
hcov
2012
failure
the
bioaerosols
variability
igp
north
forest
pandemic
the
influenza
virus
time
agents
vaccines
immune
available
new
donor
infections
donors
derived
areas
nan
diseases
control
africa
the
chapter
disease
infectious
health
risk
countries
protein
ppi
ap
ms
signal
hiv
china
aids
early
body
bats
buildings
may
humans
synanthropic
disease
children
etiology
kawasaki
reported
human
security
rights
state
it
health
it
threats
risks
chapter
zikv
disease
area
introduction
autochthonous
health
animal
eu
the
diseases
biology
synthetic
various
understand
biological
respiratory
rsv
transplant
hmpv
patients
patients
diseases
including
ae
transmission
devices
analytical
on
environmental
applications
er
upr
protein
stress
diseases
nan
to
health
public
adequate
infrastructure
information
who
world
epidemic
the
viruses
respiratory
illness
patients
the
flight
bombs
board
since
events
rhinitis
avr
nasal
viral
clinical
material
1796
jenner
transfers
cowpox
three
terms
in
chapter
elaborate
health
one
animals
human
outbreaks
nan
laboratory
utilization
hospitals
test
tests
pulmonary
complications
late
onset
noninfectious
biochips
discussed
dna
briefly
development
system
exploited
pipkin
security
vulnerabilities
world
economic
infectious
diseases
emerging
care
pediatric
medical
highly
hazardous
security
human
east
norms
asians
death
deaths
natural
disease
diseases
reptiles
use
traditional
folk
medicine
asthma
et
al
allergic
the
endogenous
genes
infectious
envelope
proteins
vaccines
live
attenuated
development
in
ebola
disease
outbreaks
chapter
health
diseases
transmissible
epidemiology
science
population
compounds
cold
antivirals
common
agents
und
infektionen
die
der
virus
helicase
12
dna
protein
ambiguous
infectious
the
infections
incidents
even
network
et
al
disease
population
sars
infection
responses
disease
cov
government
ebola
sierra
growth
study
who
health
peoples
the
un
die
der
und
den
das
illness
athletes
recovery
acute
sports
computational
biosensor
detection
classification
vitro
nan
et
al
infants
respiratory
rvis
fungal
health
mechanisms
aerosolization
microorganisms
reviewed
diagnostic
testing
common
airway
narrative
inquiry
research
in
chapter
driven
peptide
self
structures
these
antibodies
passive
immunity
animals
sources
hydrocephalus
in
species
birds
underlying
nan
care
critical
icu
nursing
patients
health
it
responsibilities
state
national
health
international
chapter
h5n1
sars
hmpv
respiratory
children
rsv
viruses
pandemic
influenza
capacity
care
severe
pediatric
covid
19
population
review
respiratory
immunocompromised
viruses
clinical
infections
africa
mortality
the
chapter
epidemics
colonization
islands
galapagos
mechanisms
successful
nan
hairy
secondary
metabolites
root
valuable
nan
chapter
viruses
provided
this
addresses
superspreaders
models
outbreaks
disease
individuals
cells
receptors
copd
inflammatory
the
nan
viruses
man
due
emerging
new
viruses
bats
hosts
reservoir
thus
apoptosis
bcl
years
ago
this
propolis
also
activity
it
means
species
evolution
phylogenetic
phylogenetics
similarities
sars
protease
coronavirus
main
3c
methods
microbes
classical
used
molecular
air
in
vehicle
environment
indoor
nan
cell
carbohydrate
glyco
carbohydrates
diversity
patients
viruses
emerging
viral
infections
paper
based
applications
the
devices
applications
surface
polymers
polyesters
the
surfaces
transmission
pathogens
patients
disinfection
nucleolus
ribosome
biogenesis
subunit
functions
nan
argument
use
public
cognitive
health
infectious
diseases
passengers
airline
flights
infections
mortality
postoperative
early
lung
viral
ncrnas
host
infection
rnas
skills
public
health
the
need
conditions
this
chapter
reviews
otolaryngology
fibers
electrospinning
fabricate
energy
metal
tianyi
square
redevelopment
1990s
analyzes
the
ge
age
contaminated
mortality
disaster
korea
disasters
future
resilient
non
viral
gene
muscle
local
china
communicable
health
diseases
major
biotechnology
biological
the
posed
weapons
patients
psychological
ebola
infectious
isolation
the
rtis
clinical
disease
respiratory
derive
diseases
viruses
immune
in
nan
system
exploited
vulnerabilities
weaknesses
software
by
providing
disease
therapeutics
study
disaster
disasters
risk
this
book
rhinitis
affect
the
rhinosinusitis
inflammation
graft
allograft
acl
donor
anterior
organism
host
symbiont
associated
examples
transmission
signal
individuals
groups
transmitted
conditions
acute
upper
respiratory
infections
the
cancer
patients
infectious
problem
aom
otitis
media
antibiotic
use
ptv
disease
several
infection
porcine
flavonols
anti
flavonoids
plants
induced
accuracy
mers
cov
classifiers
classification
helicase
rna
12
10
protein
bri
chapter
sreb
this
consolidates
cathepsins
locations
cells
viruses
proteolytic
influenza
vaccines
humans
animal
research
und
patienten
nosokomialer
infektionen
viele
patient
relationship
principles
doctor
the
expression
gpifn
codon
usage
bias
burden
infectious
health
international
diseases
influenza
avian
virus
occurred
children
nan
pediatric
medication
assessment
medications
many
small
fluorescence
ppi
molecules
kinetic
transplant
organ
recipients
healthcare
infections
use
immunological
involving
infectious
availability
health
ebola
care
women
outbreak
bw
use
biological
weapons
threat
immers
the
chapter
states
previous
nan
een
van
de
neusverstopping
voor
sars
cov
virus
pathogens
difficult
health
infectious
population
ai
epidemics
vaccines
sars
cov
animal
vaccine
past
improvements
management
organ
complications
people
approach
exploiting
level
features
antimicrobial
agents
ocular
new
infectious
kd
disease
coronary
developed
remains
bushmeat
diseases
zoonotic
eids
people
human
be
health
effects
ecosystems
pathogens
host
species
domestic
virus
outbreaks
lasting
effects
history
social
tufts
csdd
public
mcm
chapter
imaging
diagnosis
infection
cns
cross
black
death
spanish
flu
pandemic
ards
cancer
general
underlying
causes
health
global
technology
public
implementation
prevention
patients
zoonoses
cancer
theme
respiratory
virus
viruses
viral
cause
man
animal
the
often
outside
data
big
framework
analytics
disease
vaccines
vaccine
the
one
children
biotechnologies
biodefense
development
new
objectives
lns
the
neck
head
classification
influenza
human
avian
viruses
humans
systems
food
security
also
foodborne
coronaviren
und
die
zum
genus
ards
respiratory
cell
the
acute
disease
coronary
artery
kawasaki
acute
systems
information
surveillance
disease
detection
molecular
devices
assays
the
high
infection
control
biological
also
disease
conference
world
may
18th
2013
focusing
disaster
policy
event
response
antiviral
novel
activity
viral
peptides
eids
human
diseases
the
infectious
enveloped
plant
antiviral
viruses
antimicrobials
visitors
healthcare
infection
transmission
may
clinical
infectious
diseases
ipc
well
een
en
van
bij
de
system
exploited
vulnerabilities
weaknesses
software
phyllosphere
environment
plant
host
microbiome
respiratory
infections
host
repeated
episodes
protein
interactions
helix
membrane
specificity
patients
acute
respiratory
pediatric
treatment
the
research
biology
medicine
field
vaccines
attenuated
vectors
bacteria
live
system
immune
cells
self
cell
nanoparticles
the
potential
control
oral
the
open
microbial
system
paracellular
die
und
der
aerogen
ist
biological
family
natural
synthetic
new
disease
cities
model
city
the
biologics
production
proteins
treatment
disease
this
chapter
aims
give
clear
dna
microarrays
also
genotyping
resequencing
health
environmental
water
global
factors
biological
rapid
biotechnology
enhance
bioterrorism
systems
wild
viruses
animal
ranging
product
donor
importance
cellular
risk
pbm
blood
abt
cost
clinical
spike
tgev
th98
strain
protein
als
der
die
von
des
modern
wallace
states
in
context
may
pui
specific
in
patients
sars
west
nile
virus
clinical
viruses
population
genome
rna
human
infection
kidney
transplant
cause
transplantation
respiratory
acute
infections
common
presentation
risk
modelling
man
made
cover
human
the
variety
factors
related
function
structure
diseases
techniques
measurements
compounds
protect
properties
some
prevent
early
warning
emergency
management
comprehensive
virus
influenza
vaccines
production
the
cytokine
immune
storms
fatal
cytokines
environmental
ecological
systems
risk
human
infections
hsct
the
therapy
type
viruses
respiratory
species
in
infections
pcr
qpcr
fluorescent
molecular
real
acid
saponin
reported
this
aglycone
kingae
disease
bloodstream
the
type
current
many
people
engaging
medical
ethics
health
public
care
individuals
occupancy
rates
fell
on
16
der
neue
erreger
die
bei
disasters
disaster
definition
historical
usage
immunoglobulin
therapy
patients
immunoglobulins
diseases
vaccines
diseases
vaccine
introduction
vaccination
nan
tonsillitis
peritonsillar
abscess
one
common
irt
screening
temperature
accuracy
thermography
dangerous
transport
goods
air
annex
nps
optical
properties
bacteria
antimicrobial
detection
identification
rapid
the
organisms
marine
the
compounds
derived
anti
viral
cell
surface
glycoproteins
envelope
tgev
spike
antigen
sites
dot
disaster
disasters
documented
law
korea
nan
human
interfaces
primate
ecological
parasites
common
cold
transmission
methods
preventing
health
food
nutrition
systems
increased
licorice
diseases
used
medicine
low
health
public
medical
practitioners
notification
nan
resilience
thinking
venetian
early
disease
sot
infections
respiratory
rvs
remains
der
dem
und
kehlkopf
die
nan
cities
the
correlations
dengue
human
airport
global
space
chapter
movement
converting
enzyme
angiotensin
10
13
und
die
mediziner
wissenschaftler
müssen
immunomodulators
system
immune
galt
targeting
buildings
the
systems
types
industry
viruses
cells
infectious
nm
bacteria
compounds
garlic
essential
oil
17
mass
gatherings
global
infectious
diseases
virus
name
measles
protein
13
nmr
structures
validation
care
infectious
disease
one
common
gene
antibody
therapy
vectors
transfer
plant
etc
biotechnology
products
bioactive
first
new
kendall
hench
inflammatory
disaster
every
disasters
defined
using
isotope
labeling
methods
methyl
stereo
viral
acute
rhinosinusitis
ars
bacterial
extraction
amplification
good
the
method
respiratory
cflis
viruses
the
cause
spillover
emerging
human
diseases
complex
ghs
health
security
workforce
threats
avipoxviruses
vaccines
avipoxvirus
strains
viruses
protein
et
al
work
structure
proteins
accessory
protein
membrane
the
the
original
scientific
strategy
behind
icu
treatment
infectious
diseases
chapter
liver
fibrosis
in
protein
fibrinogen
nan
chemistry
biology
physics
connected
web
films
number
infectious
cause
contemporary
the
pulmonary
conditions
intent
chapter
agents
bioterrorism
potential
biological
zoonotic
gambling
review
chapter
court
addiction
diseases
microbiology
plays
important
role
ebola
isolation
early
diagnosis
the
corona
der
virus
sich
viren
development
mathematics
there
demand
africa
pcr
dna
advances
scale
reaction
health
public
surveillance
possible
use
asian
economies
southeast
upgrading
countries
infections
risk
related
neutropenia
prolonged
influenza
increase
2009
sharp
hospitalization
nan
safety
food
human
ensure
as
the
human
body
limited
ability
und
der
organ
des
angeborene
viruses
liver
acute
virus
infection
healthcare
surfaces
hai
environment
environmental
epidemic
two
type
branching
the
infectious
disease
may
spread
human
nan
health
one
human
chapter
explores
theory
social
universalistic
the
collapse
injuries
cpr
cardiopulmonary
secondary
resuscitation
bacterial
infections
the
chapter
common
name
virus
coronavirus
viruses
respiratory
common
cold
virus
network
disease
contacts
individuals
edges
disasters
oriented
public
health
communitarian
respiratory
filters
use
patients
increase
case
outbreak
public
health
tuberculosis
human
security
national
in
dimension
outbreak
ebola
west
africa
health
care
unit
this
chapter
covers
nan
proteins
plant
systems
production
products
coronavirus
rna
sars
virus
large
cli
virus
vurti
risk
infection
copper
nano
antimicrobials
chapter
function
quality
improvement
chapter
the
all
drug
drugs
compounds
number
active
chemical
medicinal
glabra
pharmacological
source
die
und
in
diesem
kapitel
und
der
bei
tag
nach
children
also
imaging
respiratory
agents
epidemic
wuhan
number
march
february
clinical
research
cov
review
sars
nan
intervention
management
patients
mets
self
nan
cases
covid
19
patients
lesions
turnover
intention
village
work
doctors
nan
epidemic
models
mathematical
science
modeling
nan
chapter
innovations
crisis
increasing
services
the
transmission
formula
see
text
nan
nan
symptoms
anosmia
ageusia
covid
19
cancer
covid
19
care
patients
transmission
the
rapid
increase
clinical
nan
nan
nan
asfv
detection
cas12a
mediated
paper
covid
19
patients
ecmo
japan
nan
coronavirus
covid
19
ocular
route
global
health
meeting
the
in
und
die
der
zu
es
nan
covid
19
radiation
oncology
university
the
shigellosis
cases
transmission
95
covid
19
cov
coronavirus
china
nan
nan
nan
nan
future
the
impending
update
european
nan
epidemic
policies
predict
tendency
official
pandemic
current
covid
19
resources
model
covid
19
china
future
prevention
medical
institutions
information
epidemiological
model
ishr
the
disease
covid
nan
cyprus
system
healthcare
implementation
the
model
epidemic
ea
differential
hubei
nan
de
van
een
die
het
scientific
sars
science
nos
research
opioid
use
disorder
covid
19
use
disorder
covid
19
people
hydroxychloroquine
treatment
conditions
potential
essential
conditions
coronavirus
disease
2019
patients
face
care
the
covid
19
covid
19
clinical
current
sars
development
green
china
five
major
nan
shrnas
used
stem
19
bp
diseases
information
first
infections
plagued
dna
fggmtv1
genome
also
circular
nan
nan
nan
nan
chinese
traditional
herbal
medicine
covid
humanes
sars
coronavirus
the
protein
structural
helices
sheets
infections
transfusion
medicine
emerging
pathogens
bei
ein
wie
sars
vor
auf
und
bei
verdacht
akute
nan
crisis
io
autonomy
time
pressure
legal
ihr
global
first
post
im
wurde
mers
cov
das
nan
imperial
college
covid
19
2020
inclusion
we
social
custodians
places
covid
19
clinical
research
intervention
immune
pathogens
host
infections
inherited
epidemic
deaths
health
outbreak
virus
health
pandemic
central
public
maryland
patients
icu
respiratory
admission
covid
tokyo
suburbs
changes
national
urban
voor
het
met
en
isolatieverpleging
wuhan
china
verpleegkundigen
het
zijn
het
stress
hoge
werkdruk
personeelstekorten
zorg
wie
niermala
baidjnath
verpleegkundig
die
der
infektionen
aspergillose
luft
und
et
al
den
noch
nan
nan
nan
nan
covid
19
clinical
coronavirus
disease
nan
nan
nan
nan
nan
nan
age
host
evolution
group
in
covid
19
africa
coronavirus
virus
sars
epidemic
cov
severe
like
trim62
viral
replication
rev
infection
nan
nan
met
die
soms
voor
en
nan
nan
nan
en
de
een
waar
vanuit
nan
nan
nan
nan
fip
fcov
feline
infectious
cats
sars
the
epidemic
economic
asia
crisis
the
paper
practical
sars
agents
molecular
new
respiratory
the
nan
like
animals
pet
companion
birds
drugs
2019
binding
features
ncov
covid
19
cell
diao
et
nan
microglial
disease
subset
states
homeostatic
hadv
years
among
epidemiological
trends
nan
nan
sars
cov
people
infection
older
nan
nan
nan
fluorinated
carborane
polyurethane
temperature
resistance
countries
developing
we
livestock
production
mir
in
we
references
sentences
nan
esophageal
cancer
mortality
water
rivers
pis
human
0101
11s
globulin
privacy
theory
god
human
right
risk
travel
factors
the
purpose
rna
pseudoknot
process
unfolding
structure
barriers
health
political
h1n1
who
extraction
umae
compounds
phenolic
foshou
security
air
human
remains
cargo
article
book
industry
booksellers
this
fear
the
individual
characteristics
study
the
common
marmoset
could
useful
in
vitro
studies
identified
rna
red
fluorescent
protein
rfp
expressing
mouse
studies
suggest
mutant
form
crystal
structures
mers
cov
spike
health
emerging
one
approach
virus
human
neutralizing
mabs
mers
cov
cell
culture
studies
suggest
targeting
bats
shedding
coronavirus
species
spillover
cell
culture
studies
identified
ddp
nan
weaning
health
welfare
problems
factors
mirnas
viral
aris
biomarkers
response
infectious
new
states
outbreaks
since
disease
formula
see
text
equilibrium
nan
nan
nan
nan
nan
china
us
ftas
products
protection
nan
nan
nan
nan
nan
nan
nan
nan
nan
global
diplomacy
international
science
policy
nan
nan
nan
nan
nan
nan
nan
nan
nan
sinupret
group
medicine
syrup
viral
nan
nan
nan
nan
nan
growth
south
korea
recent
high
nan
nan
coordination
outbreak
disease
knowledge
transfer
nan
microbial
fomites
transmission
humans
recent
nan
nan
failure
hospitalization
exacerbations
chronic
aecb
nan
nan
nan
nan
respiratory
hi
virus
viruses
provide
nan
nan
der
und
bei
fieber
nach
risk
ant
management
in
the
insurance
animal
producers
disease
interested
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
en
dit
nummer
al
klaar
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
ook
er
het
de
en
de
je
dat
sinds
16
zijn
van
kunnen
ook
je
de
vanwege
maatregelen
rondom
het
nan
barley
functional
chronic
diseases
ingredients
amr
threat
chinese
health
international
it
aureus
habitats
canis
wide
margarita
felis
species
low
loche
lynx
species
it
canadensis
canada
human
pathogenic
microbial
life
microbe
cat
braccatus
wild
it
considered
life
the
definition
definitions
biology
ihr
health
new
international
law
reporting
outbreak
policy
capacity
states
international
law
rights
convention
un
hiv
eqa
results
care
testing
new
antibiotics
the
macrolides
antitumour
lfa
methods
signal
low
quantification
cases
emergency
the
patients
response
ibv
vaccine
region
lineages
gi
misinformation
tweets
19
covid
epidemic
rna
cardiovascular
disease
non
coding
water
quality
initiatives
the
country
bernoulli
royale
epidemic
it
eminent
die
und
für
wir
von
nan
patients
covid
19
inflammatory
bowel
covid
19
pediatric
clinical
disease
chapter
stakeholders
intelligence
community
threats
system
immune
the
also
diseases
systems
classification
medical
morbidity
healthcare
china
aid
ebola
disease
the
wild
wildlife
animals
many
interventions
der
werden
und
proteine
antikörper
van
een
met
contact
de
life
adaptation
changes
global
physical
tumor
dcs
gene
cells
antigen
tb
treatment
respiratory
significant
diseases
hct
acute
pulmonary
complications
pneumonia
mass
object
scale
gravitational
molecular
bal
pneumonia
cause
complications
may
virus
neurotropic
immune
strains
mhv
microbial
global
gmi
genome
sequencing
sbs
building
related
illnesses
buildings
infectious
processes
trachea
airway
tracheal
urban
fad
wind
data
map
cells
immune
innate
host
molecules
acute
respiratory
disorders
failure
pulmonary
water
health
climate
change
related
dna
vaccines
vaccine
diseases
cancer
covid
19
world
first
wuhan
post
truth
human
new
history
infectious
diseases
emerging
eids
characterized
von
der
den
menschen
sich
den
als
der
die
1918
de
een
van
en
zijn
nan
nan
patients
2019
19
the
covid
covid
19
philippines
initial
january
nan
sars
cov
covid
19
patients
vaccine
cell
tools
epitopes
fever
natural
diversity
chemical
based
new
brd
cattle
animal
measures
herds
ib
vaccine
the
live
attenuated
five
ibv
isolates
chinese
protein
tcov
days
virus
temperatures
turkey
vaccine
gene
molecular
virus
pcr
human
viruses
cause
recent
disease
chickens
passage
vaccinated
virus
spf
ibv
protection
virus
vaccines
chickens
ibv
strains
chicken
infectious
infection
ibv
cell
licl
virus
rna
the
ibv
variants
strains
discussed
vaccine
vaccines
virus
disease
use
severe
covid
19
inflammatory
storm
nan
nan
der
und
infektion
im
zusammenhang
nan
der
in
die
eine
und
nan
die
ein
neues
bundesgesetz
soll
nan
nan
minion
genome
among
hadv21
illumina
masks
system
distributing
public
compared
nan
nan
nan
nan
number
cases
positive
italy
function
patients
isolation
traumatic
post
stress
ncp
tcm
cms
patients
hospital
r0
interval
event
scenarios
sars
nan
nan
covs
cov
children
novel
severe
sars
cov
3cl
pro
compound
nan
protease
sars
3cl
pro
drug
nan
the
hennig
student
society
new
llo
aso
heat
activity
assay
water
samples
viruses
river
quality
nan
nan
nan
fmt
veterinary
man
indications
efficacy
domestic
carnivores
wild
disease
pathogens
sars
health
behaviors
response
avoiding
network
connection
analysis
guidance
system
water
needless
say
safety
treated
dogs
computed
tomography
diagnosis
brain
assembly
formation
assemblies
substrate
dissipative
die
und
der
zur
chemische
dna
scv
die
und
der
chinese
citizens
backwardness
events
1999
nan
consumption
as
discourses
practices
events
this
article
summarizes
currently
known
synthesis
linderaspirone
bi
linderone
photogenic
nan
sars
people
outbreak
may
the
die
go
dna
und
mit
nan
nan
und
mit
die
quantifizierung
dna
severe
respiratory
illness
patients
novel
nan
disease
horses
financial
effect
bovine
yellow
head
viruses
research
complex
virus
transmembrane
protein
ifitm3
synthesis
cells
bcv
ca2
ca1
caco
nan
governance
may
urban
new
disease
virus
yhv
the
reported
cultivated
patients
transplant
this
report
highlights
behaviors
preventive
practicers
sars
participants
person
described
novel
coronavirus
associated
inhibitoren
helicase
sars
der
go
df
edu
cells
tk
pathogen
uv
strains
light
parvum
oocysts
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
energy
green
wto
chapter
within
de
een
van
managers
zijn
simulation
improve
responses
crisis
we
nan
nan
de
van
en
speeksel
een
case
sars
interorganizational
networking
public
in
sars
local
plague
politics
chapter
account
ways
data
epidemics
ssas
money
states
opioid
state
dea
patients
drug
administration
opioid
last
month
american
medical
association
vaccine
mers
cov
nanoparticle
novel
nan
nan
damian
treatment
odyssey
house
addiction
protective
personal
graphene
clothing
hazards
drinking
job
are
people
locked
nan
adaw
study
effective
psychotherapy
aa
nan
stores
day
liquor
last
week
pandemic
h1n1
health
this
anxieties
nan
hpaiv
rapid
avian
influenza
virus
going
000
methadone
medication
one
sages
responses
delivery
antigenic
specific
ecmo
covid
19
day
vv
billion
treatment
trillion
adaw
so
protein
pdz
domains
networks
95
treatment
small
businesses
patients
centers
influenza
h5n1
virus
the
in
study
phenylchroman
one
derivatives
anti
image
see
text
face
opioid
treatment
otps
covid
telepsychiatry
telemental
health
telepsychology
teletherapy
million
health
kessler
senate
house
telepsychiatry
telemental
health
telepsychology
teletherapy
sinus
tetracycline
graft
abrs
infection
nan
emergency
medical
in
january
covid
nan
nanoparticles
production
protein
processes
viral
derived
downstream
processes
cell
culture
allergic
infection
subjects
experimental
virus
diphenyl
reactions
bis
described
synthesis
nan
die
der
von
moderne
medizin
sufferers
sars
acute
psychological
factors
this
appendix
lists
cluster
differentiation
fresh
produce
foodborne
viruses
contamination
pathogens
supramap
influenza
information
host
following
david
eckersall
in
paper
supramap
web
we
influenza
service
respiratory
disease
infectious
many
generally
3cl
pro
structures
the
coronavirus
sars
cov
carnivores
chiroptera
humans
green
organic
trends
products
energy
individuals
μm
exhaled
50
symptoms
health
sars
infectious
public
2003
chapter
account
ways
data
epidemics
tarin
immunomodulator
cells
potential
taro
nan
nan
nan
nan
viruses
monitoring
enteric
in
water
nan
seizures
seizuring
cat
case
appropriate
nan
viruses
membrane
dmvs
replication
recent
chapter
account
ways
data
epidemics
sars
chapter
social
people
issues
health
one
world
congress
the
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
in
chapter
present
reflections
heutagogy
passengers
number
march
stations
social
human
the
food
pathogens
disease
nan
cochrane
review
published
issue
ebch
hybridization
slides
the
modified
surface
infectious
diseases
distributions
biogeography
management
nan
respiratory
studies
measures
we
the
measurements
drug
genomic
qpcr
development
ed
testing
viral
rapid
children
nan
nan
global
growth
year
gdp
coronavirus
lysine
poly
electrodes
coated
cyclic
outbreak
bcov
et
al
farm
nan
nan
nan
species
based
trade
we
economic
nan
reaction
me
ca
sime
thf
foals
diarrhoea
among
common
clinical
cochrane
issue
ebch
review
published
cattle
buffalo
fmd
hnp
season
nutrition
foal
enteral
diarrhoea
nutritional
nan
interactions
infectomics
viral
host
antiviral
linked
welfare
beef
disorders
inadequate
nan
nan
food
viruses
criteria
foodborne
also
vaccine
target
omics
technologies
based
nan
pedv
reported
ped
countries
impact
ecov
horses
clinical
coronavirus
associated
detection
bioterrorism
biohazard
agents
environmental
policy
process
bricoleur
european
paper
nan
ped
reported
impact
2014
eu
sepsis
horses
infection
common
sirs
nan
protected
areas
abundance
species
we
nan
nan
nan
emergence
disease
invasions
phases
control
global
change
vulnerability
vulnerabilities
market
infection
social
status
low
fitness
eos
the
respiratory
tract
infections
nan
nan
nan
nan
years
sea
temperature
abundance
water
nan
cholesterol
sars
cov
important
cells
nan
saliva
covid
19
salivary
diagnostic
cases
number
covid
19
total
nan
nan
nan
nan
rare
earth
also
the
mining
species
habitat
specialised
the
requirements
population
the
captive
cheetah
1986
ssp
species
plan
long
population
respiratory
the
bovine
brd
complex
nan
nan
disease
health
process
approach
management
sequencing
portable
data
surveillance
sequencers
health
policy
across
article
one
species
landscape
hoverfly
hoverflies
resources
nan
nan
infection
epidemic
acute
sars
nursing
nan
urban
article
health
the
perspective
nov
group
the
derived
cretaceous
the
cheetahs
fund
cheetah
declining
virus
viruses
host
species
sharing
nan
disease
role
in
fourth
article
nan
nan
vaccination
children
policy
the
voluntary
calf
management
taken
calves
changes
de
tge
la
en
bl
clinical
encountered
factors
syndrome
porcine
captive
population
1994
cheetah
jubatus
human
rights
viruses
in
scientists
survival
population
study
greylag
first
calf
purchasing
all
this
article
river
las
pitas
cal
yr
nan
fiv
fipv
feline
virus
cheetahs
diseases
the
factors
changes
emerging
nan
science
commons
innovation
information
life
disease
diarrhoea
common
important
causes
cheetahs
feline
infectious
coronavirus
captivity
covid
19
features
radiomic
we
saprolegnia
eggs
anti
strain
prussian
firms
affiliated
stock
event
politicians
analysis
order
field
bibliography
11
nan
this
paper
gives
summary
present
coronavirus
feline
infections
cats
infectious
nan
fish
species
group
sensory
strong
nan
nan
humans
simulations
animals
bird
diseases
surfactants
antimicrobial
the
need
products
sd
group
calves
kg
feeding
disease
theory
ecology
management
wildlife
nan
cyst
cat
lesion
spinal
cord
molecules
used
screening
enzyme
designed
nan
nan
china
region
populations
masked
palm
species
community
trait
characteristics
we
nan
cases
used
feline
direct
immunofluorescence
resilience
leaders
relational
crisis
connections
ovalbumin
hdoa
noa
shown
nac
nan
regional
trading
blocs
tourism
the
pro
structural
models
coronavirus
structures
governmental
agencies
communication
outbreak
study
industry
airline
change
consumer
increased
singapore
crisis
tourism
the
sudden
ccv
cdv
canine
rv
per
nan
feline
disease
virus
factors
viral
nan
sars
protein
cov
qds
chip
nan
2019
covid
isolation
confirmed
surgical
sars
cov
monkeys
old
caused
covid
19
coagulation
dysfunction
consensus
2019
covid
19
novel
coronavirus
health
global
pandemic
outbreaks
canada
rights
policy
constitutional
makers
note
nan
nan
nan
nan
nan
enveloped
viruses
peptides
membrane
membranotropic
disordered
development
peptide
vaccines
antigens
swab
the
covid
19
sars
nan
nan
nan
nan
nan
review
coronavirus
resources
community
college
nan
avian
influenza
risk
communication
strategies
we
vaccination
vaccine
populations
dose
staff
increased
mental
health
disorders
nan
cases
000
united
states
new
medicaid
eligible
business
loans
nonprofit
mental
health
as
country
continues
nan
health
mental
behavioral
ppe
care
value
sac
cepi
proposals
cost
march
23
2020
marked
10th
the
largest
coalition
national
organizations
package
the
senate
approved
estimated
americans
anxious
nearly
possibility
getting
new
yorkers
health
reach
the
covid
19
states
telehealth
services
care
state
system
dcfs
illinois
model
tdd
ncp
time
delay
the
services
care
health
keep
health
mental
massachusetts
beds
services
nan
covid
19
000
considered
epicenter
nan
biological
biosensors
composites
sensing
various
services
psychologists
the
psychological
apa
safe
in
wake
covid
19
states
approved
waivers
medicaid
act
research
the
psychology
university
awarded
sequences
numerically
characterize
dna
graphical
pharmacists
editorial
patients
pharmacy
guidelines
ifnγ
tnfα
mscs
hsd11b1
inflammatory
nan
kcg
disaster
accountability
sewol
ferry
nan
nan
nan
governments
pandemics
challenges
future
throughout
nan
nan
mortality
life
events
increase
major
nan
nan
blood
transfusion
patients
patient
management
aetiology
pneumonia
the
latent
class
nan
pathogen
blood
reduction
inactivation
technologies
nan
apoptosis
human
veterinary
disease
data
nan
nan
nan
covid
methods
based
19
china
nan
nan
nan
tpa
patients
covid
19
ards
nan
bonding
proton
processes
bond
pt
nan
hybrids
hybrid
the
studies
compounds
ifn
immune
including
system
response
nan
nan
teams
epidemiological
medical
detectives
working
models
fitting
transmission
outbreak
data
nan
nan
china
nationalism
this
paper
role
policy
public
model
testing
designing
nan
students
hospital
sars
anxiety
level
potentiation
actions
mechanisms
occur
different
nan
activity
antiviral
viruses
enterovirus
tick
rapid
sensitive
pathogenic
colorimetric
nanomaterials
sars
hla
vaccine
the
specific
nan
nan
rna
families
viral
possess
positive
nan
infectious
diseases
one
common
cause
problems
crisis
asymmetric
information
management
leaf
area
weeds
photosynthetic
specific
influenza
national
health
pandemic
efforts
sars
risk
infection
protective
factors
nan
nan
wildlife
china
conservation
utilization
approach
sars
management
business
world
impact
feline
virus
felids
mountain
lions
nan
nan
nan
nan
nan
theme
parks
visitors
visit
sars
nan
preparedness
evd
republic
complex
humanitarian
nan
country
policy
france
disease
covid
nan
nan
nan
nan
nan
nan
nan
posts
attention
covid
19
outbreak
viral
the
386
samples
clinical
mortality
patients
platelet
associated
thrombocytopenia
respiratory
patients
the
severe
acute
sars
cov2
protein
present
ion
injury
covid
cardiac
disease
19
nan
covid
19
studies
results
polyprotein
flu
patients
time
the
diagnosis
wild
animals
the
human
ethnobiology
nan
sars
cov
covid
19
fet
nan
disease
an
australian
infectious
epidemiologist
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
sars
cov
evolution
bat
time
cases
covid
19
hospital
screening
nan
nan
nan
medical
team
covid
19
rescue
nan
nan
nan
nan
nan
nan
nan
nan
secretory
molecular
recent
membrane
pathway
nan
nan
nan
nan
pm
method
microbial
airborne
epidemic
nan
nan
nan
nan
students
anxiety
health
college
depression
covid
19
nlr
severe
the
samples
voriconazole
heat
inactivation
ms
nan
ct
stage
chest
disease
days
secondary
cerebral
infarction
elderly
disease
nan
nan
nan
samples
antibodies
sars
cov
detection
nan
nan
nan
de
la
en
los
las
the
virus
detection
epidemic
patients
nan
nan
nan
nan
nan
nan
intubation
patients
tracheal
the
clinical
treatment
patients
ami
transport
the
nan
nan
the
actual
h7n9
estimated
loss
nan
pneumonia
like
associated
dandelion
sign
nan
sleep
quality
interns
isolation
analysis
patients
covid
19
type
clinical
nan
nan
nan
ili
pathogens
virus
influenza
the
health
outbreaks
diseases
the
economics
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
sle
klh
twins
immunization
humoral
gastroenteritis
viral
significant
world
problem
pneumonia
infections
agents
common
adults
respiratory
tract
effective
abstract
pharyngitis
acute
bronchitis
amoxicillin
loracarbef
results
la
microsomal
three
metabolites
hydroxy
acetylated
virus
the
influenza
activity
cov
proton
gramicidin
concentrations
phospholipid
aminopeptidase
cross
breakdown
products
kda
antibodies
reductase
antigen
two
nitrate
cyd
viruses
rna
virus
antiviral
cyd
ce
antiviral
viruses
rna
nan
dog
consistency
faecal
the
diet
immune
mediated
diseases
the
involve
nan
nan
nan
virus
h3n2
characterization
isolated
showed
the
ranges
blood
swine
sows
cells
mhv
infection
dc
alterations
data
reporting
laboratory
rapid
diagnostic
nan
cells
inoculated
animals
observed
type
cells
conjugates
bound
poliovirus
natural
nan
nan
nan
protein
myelin
proteolipid
similarities
viral
translational
abstract
an
increasing
number
proteins
helicases
helicase
subunits
structural
fusion
baculovirus
cell
recombinant
proteins
activity
antiviral
virus
aprotinin
fragments
tgn38
41
tgn
protein
truncated
lph
phosphorylation
tail
pka
intracellular
lactase
sucrase
activity
enzyme
villus
immunodeficiency
virus
patients
diarrhea
enteric
glutamine
oral
mucosal
transport
rotavirus
cl
absorption
infected
jejunum
na
nan
virus
agents
crohn
disease
the
compendium
different
keywords
abstract
reviews
reference
compendium
reviews
the
format
reference
compendium
reviews
included
author
roach
cross
polyclonal
antibody
bands
dogs
rotavirus
infected
contact
diarrhoea
outbreak
severe
high
the
features
the
disease
reaction
leptomeninges
matter
iep
analyzing
mixtures
use
abstract
hig
test
sensitivity
hemolysis
in
antibodies
mcas
rotavirus
isotype
iga
antibodies
antigens
elisa
infected
cell
iga
conjugate
anti
peroxidase
abstract
nan
nan
bbv
sequence
rna1
the
bases
sequences
spike
proteins
terminal
two
two
the
nuclear
imino
stem
crystals
group
cell
abstract
two
particles
abstract
doughnut
shaped
55
virus
the
da
cells
chronic
patients
csf
levels
serum
the
nu
c57bl
6j
mice
balb
recombination
dna
aspect
important
rearrangements
subjects
mood
performance
week
results
weight
oxytocin
rats
substrain
gain
due
diarrhoea
diarrhoeal
disease
children
nan
rotavirus
associated
subgroup
diarrhoea
page
tropical
lesion
sprue
primary
malabsorption
diet
rats
ain
76a
fed
mhv3
c57bl
dieldrin
macrophages
peritoneal
exposure
weeks
animals
dose
significant
dma
nasal
mucociliary
flow
rats
cells
o3
exposure
ozone
tracheal
edu
ozone
lung
exposure
pretreatment
nan
electron
cell
particles
mμ
contained
cells
assembly
infected
mosquito
virus
nan
influenza
viruses
ducks
duck
the
cells
mice
virus
sjl
c57bl
jhmv
rna
mutants
synthesis
neuropathogenesis
sulfhydryl
vsv
reagents
infectivity
iodoacetic
33
recombinants
113
ho
virus
rna
activity
rdrp
infected
the
bv
virus
acmnpv
64k
protease
virus
mice
infection
mtlv
lineage
cells
arginine
peptidyl
chloroalkyl
ketones
trna
base
frameshift
anticodon
loop
mv
brain
measles
tissue
the
protein
30
kda
orf1
mhv
rub
rna
the
sequence
genomic
ldv
sequence
protein
genome
nucleotides
cellular
the
viral
bvdv
ubiquitin
orf
camv
protein
reverse
transcriptase
glycoprotein
abstract
the
oligosaccharide
side
virus
hev
the
kb
rna
nt
tomrsv
rna1
rna2
the
tmv
rna
created
kda
orf
ag35
surface
vaccinia
envelope
polypeptides
plants
p12
p3
cp
deletions
amino
acid
orf
the
strain
orf
small
rice
dwarf
phytoreovirus
hc
pro
gly
site
the
amino
acids
flaviviruses
sequence
proteins
epitopes
ha
vn
mab
virus
rna
cv17
cdna
clones
rnas
the
influenza
virus
site
activation
nan
nan
nan
beluga
whales
animals
st
lawrence
compost
organic
dust
municipal
risk
cysteine
peptidases
the
families
family
nan
nan
disease
it
ms
evidence
process
cocaine
dose
significantly
response
accumbens
da
the
cocaine
ht
accumbens
cocaine
da
ht
vta
induced
cocaine
da
ht
release
mg
ht
da
cocaine
release
vlnacc
ibogaine
cocaine
behavioral
release
behavior
induced
virus
wheezing
asthmatic
children
ige
levels
acute
infection
decrease
allergic
children
sensitization
immunologic
11
airway
may
upper
asthma
lower
release
histamine
virus
basophils
cell
nan
nan
nan
proteins
rna
single
recombinant
virus
cells
53fc3
epitope
golgi
protein
exon
rna
medrna
we
minrna
nan
transcripts
rna
we
vaccinia
late
nan
golgi
er
bfa
cis
medial
translational
frameshifting
event
gcg
agu
nan
nan
cell
peptides
peptide
structural
viral
space
the
complex
decisions
incipient
nan
ari
treatment
supportive
care
ampicillin
nan
patients
hcv
sjögren
syndrome
chronic
nan
nan
thalidomide
this
agent
graft
gvhd
molecules
cell
adhesion
cells
normal
two
transmission
abstract
feline
infectious
infectious
peritonitis
disease
paper
feline
anti
un
rotavirus
antibodies
rota
alveolar
macrophages
mdp
derivatives
mechanisms
the
poli
if
induces
weaning
bhv1
infections
virus
infection
the
nso
taurine
media
abstract
feline
body
kg
doses
interferon
the
calves
brsv
virus
the
days
bp
scp
anti
cross
hyperimmune
nan
nan
nan
liver
cells
microcirculation
processes
represent
liver
the
arachidonate
products
damage
picornavirus
agents
animal
the
inhibitors
nan
nan
nan
felv
whole
kittens
gp70
developed
k99
pilus
antigen
etec
mouse
bovine
anti
monoclonal
antigen
used
igg1
clearance
125i
gastrointestinal
tract
fusion
pbls
bovine
sensitized
the
antibody
the
bovine
abortus
monoclonal
ige
levels
the
transfer
age
felv
associated
infectious
infection
feline
rhuifn
cats
104
responses
kg
porcine
rpoifnγ
il
the
effect
fusion
bovine
cells
cell
generation
rotavirus
infected
cytotoxic
activity
cell
sla
class
macrophages
ii
macrophage
cats
developed
lymphoid
hyperplasia
clinical
nhuifnα
piglets
natural
outbreak
tge
vaccination
groups
minimum
schedules
maximum
γδt
cells
ileal
lymphocytes
populated
virus
resistance
macrophages
natural
viruses
il
cells
cell
vivo
secreting
cells
cd13
til
lung
cancer
tumor
the
phenotype
altered
gene
csf
mice
mouse
animals
virus
cells
hla
cns
molecules
expression
tcls
cells
rubella
cd4
cd8
tnf
ifn
expression
astrocytes
class
disease
relapse
myelin
protein
mbp
myelin
protein
isoforms
x2mbp
cell
kda
mbp
tcls
specific
18
exon
peptide
mbp
eae
ms
class
mhc
icam
retinal
ii
ome
children
inf
ifn
recurrent
nan
rosettes
the
sucrose
density
containing
virus
rubella
sepharose
2b
yields
electron
ferritin
abstract
simple
indirect
sfv
gel
red
hig
serum
virus
procedure
analysis
structural
proteins
enzyme
immunoassay
murine
parvovirus
infectivity
the
tfa
nanb
agent
virus
29
rd
serotypes
ht
skco
sera
elisa
positive
antibodies
human
method
calcium
phosphate
faecal
specimens
probes
end
enteroviruses
genome
detected
nc
protein
rna
isolation
nucleocapsid
sera
ibrv
values
vn
negative
influenza
pcr
the
specific
rna
rna
pcr
method
paraffin
embedded
hard
data
laboratory
specimen
patient
influenza
used
virus
pcr
hef
epitopes
cell
this
abstract
identification
interferon
effect
tested
rhinovirus
infection
virus
infections
drugs
antiviral
treatment
cells
targeting
virus
liposomes
antiviral
rv
mdl
20
610
uncoating
assay
system
mulv
activity
antiviral
virus
mice
liver
ribavirin
significantly
acid
erythrocytes
invasion
175
sialic
mrna
initiation
region
nucleotides
rna
tap
site
zinc
enzyme
amastatin
mhc
expression
regulation
antigen
abstract
viruses
rna
dna
vectors
expression
protein
areas
engineering
in
review
protein
rna
measles
brain
virus
ts
different
recombination
regions
genome
rnas
fcv
rna
infected
cells
nan
substrates
acid
influenza
virus
acetylesterase
lb
the
gene
expression
protein
nan
the
coat
protein
non
coding
l2
field
isolates
btv
17
particles
the
cells
infected
disease
two
protein
amino
sequence
abstract
mice
infection
macrophages
peritoneum
mhv
bfa
ifn
antiviral
emcv
5a
splicing
trans
mrnas
cis
systems
spliced
translation
abstract
influenza
viruses
rna
recombination
abstract
the
wide
mhv
infection
mdp
the
induced
nan
nan
airborne
infections
nosocomial
may
pathogens
the
cluster
deaths
felt
investigation
opa
endoscopes
used
35
studied
hospital
wards
spread
abstract
children
nedocromil
stabilizer
it
currently
available
influenza
uri
residents
vaccine
gmt
phosphatidylcholine
plasma
inner
outer
synaptic
mob
animals
age
the
changes
characterization
status
laboratory
animals
microbiological
virus
vaccines
vector
potential
vaccinia
inactivation
vaccines
viral
antigens
inactivated
nan
nan
milk
weeks
antibodies
maternal
samples
symptoms
morbidity
women
gender
differences
treatment
brown
related
ht
generations
wk
ppm
hcfc
141b
000
protein
interfere
glycosylation
oligosaccharide
inhibitors
abstract
this
article
reviews
current
day
the
drug
shedding
clinical
lambs
diarrhea
newborn
infection
age
calves
infection
giardia
farm
diarrheic
nan
nan
nan
monensin
golgi
apparatus
cisternae
exchange
nan
nan
disease
viruses
caused
epidemiological
abstract
virus
this
hiv
natural
recombinant
animals
treatment
oxygen
hepatic
enzyme
nan
aa
3h5
region
mab
within
the
gene
region
cstc
mouse
piglets
days
villus
virus
infection
assay
virus
cytopathic
microtitration
used
ribavirin
rhuifn
antiviral
doses
fipv
nan
ifn
porcine
protein
recombinant
class
response
rotavirus
mares
foals
serotype
viral
immune
mechanisms
may
diseases
calves
diarrhea
morbidity
in
among
virus
cats
the
several
months
ss
resistant
disease
pigs
inheritance
isolates
probe
vtec
calves
one
strain
brv
ns
strains
b641
pigs
brucella
antigens
infected
cft
use
vaccine
described
abstract
control
f9
isolates
six
monoclonal
antibodies
pigs
sows
virus
vaccinated
serum
rats
germ
free
conventional
ossme
proteins
hydrophobic
columns
problem
also
proteins
chromatography
integral
membrane
bilayer
variability
survival
the
analysis
curves
list
microbial
nomenclature
changes
many
urine
ph
shell
specimens
the
ad
em
eia
specimens
vc
cdna
rna
template
viral
optimized
nan
diagnostic
pharyngitis
streptococcal
abstract
acute
infection
host
flora
may
invasion
bestatin
hiv
the
effect
anti
fusion
virus
serogroup
cells
like
type
reovirus
in
strain
induced
nan
virus
the
cell
information
structure
kg
mg
day
idpn
200
nan
oil
rats
adjuvant
fia
induce
nan
hypothesis
cd4
abstract
experimental
clinical
nan
nan
nan
may
villous
enterocytes
reduced
gut
nan
nan
nan
nan
nan
nan
nan
the
water
aquaporins
abstract
long
nan
nan
proteinases
abstract
many
viruses
encode
nan
nan
rna
viruses
heterologous
sequences
strand
nan
nan
nan
nan
nan
nan
internal
ribosome
mechanism
entry
abstract
nan
surface
abstract
mycoplasmas
excel
infectious
abstract
the
novel
role
antibody
tropism
receptor
viral
host
virus
golgi
viral
glycoproteins
proteins
abstract
vector
plant
viruses
mouthparts
proteins
long
antibody
term
despite
extensive
viruses
the
ability
genetically
manipulate
physiological
muscle
receptor
direct
mechanical
reading
frames
secondary
hidden
in
reading
the
different
frames
occurs
sperm
cell
two
sp
whose
nan
esterase
abstract
thiomethylmercuryl
acetamido
deoxy
elisa
snt
igg
results
positive
virus
pseudoknots
rna
frameshift
predicted
disease
asthma
public
health
abstract
viruses
lipid
envelope
virus
found
felv
leukemia
virus
the
evidence
nan
nan
nan
fusion
viral
the
glycoproteins
membrane
cryo
em
electron
single
particle
role
host
genetic
human
disease
nan
ibv
india
sequence
strains
virus
the
bats
córdoba
encephalitis
captured
diseases
borne
food
water
infectious
the
operatory
contamination
infection
control
nan
nan
nan
genes
neck
region
cd209
innate
nan
respiratory
infections
illnesses
studies
illness
influenza
may
complications
pneumonia
infection
nan
idc
heart
failure
disease
myocarditis
influenza
years
may
viruses
type
nan
jhm
demyelination
antibodies
infected
cells
sars
animals
viral
cov
infected
demyelination
jhm
cells
cell
ifn
respiratory
hmpv
associated
infection
dpi
respiratory
cells
brsv
virus
syncytial
hfgl2
gene
fulminant
hepatitis
the
rsv
patients
pneumonia
three
cases
antiviral
rna
viruses
agents
method
25
oh
2d3
gene
expression
light
glands
12
activity
lingual
fusion
lipid
membrane
e1
sequence
nan
rats
mucin
mrna
pathogen
airway
cd13
galectin
aggregation
anti
homotypic
article
author
elsevier
this
retracted
cells
hiv
mab
wr321
phosphatidylinositol
a59
mpro
mhv
structural
hepatitis
phosphorylation
nucleocapsid
sites
peptides
derived
adpr
diseases
pathogenesis
human
modification
antigen
binding
10
receptor
salmonella
nan
virus
biotype
cp
ruminant
pestiviruses
nan
prrs
virus
disease
control
respiratory
acid
enzymatic
synthesis
acetamido
galactopyranosyl
clinical
microbiology
laboratory
utilization
management
nan
sars
imaging
abstract
severe
acute
nan
pbb
children
control
subjects
likely
asthma
chronic
disease
children
therapy
nan
exacerbations
asthma
copd
major
studies
yr
fev1
patients
decline
faster
cough
common
cold
upper
viral
nan
de
los
en
genes
la
approved
analogues
antiviral
agents
nucleoside
like
proteinase
system
zcurve_cov
cleavage
rna
molecules
qβ
abstract
this
mutant
virus
cbas
exposure
hiv
cells
apn
half
the
life
rna
recombination
the
homologous
abstract
fed
necrosis
rats
diet
diets
cells
vlps
type
epithelial
rnv
produce
cause
coli
cells
studies
alisporivir
hbv
hbsag
cells
dna
diarrhea
infected
na
transport
jejunal
segments
permeability
patch
virus
infection
the
enterotoxic
supernatant
calves
effect
ifn
rotavirus
cells
alpha
gamma
elisa
95
confidence
interval
neospora
respiratory
syncytial
virus
neonatal
intensive
hplc
protein
hn
could
proteins
pathological
myelin
clinical
globoid
gld
horses
respiratory
transport
three
pyrexia
somnus
cases
less
alveolar
lungs
immunodeficiency
present
range
tissues
cats
rats
endotoxin
ageing
months
24
endothelial
summary
two
cats
unusual
ptv
cns
pigs
lesions
spinal
prrsv
hybridization
in
situ
the
protein
colostrum
plasma
igg
casein
bedding
calves
long
wheat
straw
cows
rotavirus
calves
mos
serum
antigen
coli
antibody
days
fetus
disorders
factors
abstract
enteric
respiratory
colostrum
sodium
bicarbonate
calves
starter
escherichia
coli
calves
enterotoxigenic
disease
gossypol
free
800ppm
calves
consumption
colostrum
groups
group
calves
dried
fat
replacer
high
starter
low
average
gain
mo
daily
pneumonia
manure
environmental
especially
water
quality
hcd13
antigen
cells
cell
scfvs
influenza
virus
disease
infection
viral
shrimp
diseases
americas
disease
industry
stem
base
junction
pseudoknot
structure
template
transfer
recombinogenic
homology
complementarity
quasispecies
memory
model
data
viral
rna
virus
the
domain
rabies
3c
inhibitors
viral
hav
cysteine
rna
template
qβ
legitimate
initiation
dsrna
viruses
rna
complexes
genome
human
viruses
viral
communities
hosts
ste24
membrane
factor
protein
protease
binding
receptor
tailspike
protein
structure
rna
synthesis
viral
bmv
study
cmv
enteritis
newborn
cytomegalovirus
birth
nan
children
viral
virus
one
febrile
influenza
tiv
vaccination
group
95
neurologic
children
underlying
conditions
disorders
afm
associated
early
acute
flaccid
diarrhea
gastroenteritis
sodium
small
piglets
nan
infection
ebv
patients
current
recent
nan
nan
nan
kawasaki
syndrome
first
patients
high
nan
nan
viruses
respiratory
the
epidemiology
cause
rsv
children
disease
respiratory
hospitalization
ppsp15
leishmania
vaccine
protein
tropical
hhv
ms
viral
human
mrna
autoimmune
disease
viral
vaccine
viruses
il
lungs
extracorporeal
swine
days
incontinence
urethral
correlation
stress
profile
infection
atypical
mycobacterial
urinary
tract
rabies
model
human
china
dogs
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
isolates
pcr
the
clindamycin
incidence
diarrhea
diarrheal
stools
children
studies
nan
viral
enteritis
rotavirus
diarrhea
new
nan
hrvs
icam
receptor
virus
single
whole
carcass
tenders
weight
doa
pems
poults
mortality
immune
infected
model
period
decision
mortality
the
semen
health
frozen
the
domestic
mortality
cold
related
1995
2016
members
families
rotavirus
survey
young
gastroenteritis
outbreaks
laboratory
may
many
dogs
the
cpv
gastroenteritis
canine
strain
indel
pedv
na
prototype
ibv
aiv
h9n2
mixed
variant
diarrhea
calves
daily
oregano
essential
ocular
the
long
shedding
cahv
codon
usage
bias
pedv
orf3
dogs
lymphocytes
cells
ibd
normal
nan
samples
respiratory
wu
ki
polyomaviruses
prrsv
virus
helicase
proteins
putative
protein
sgrnaβ1
the
site
proteins
hsv
bac
virus
hsv2
gene
nan
ad41
enteric
respiratory
ad
cells
bo
uk
the
norovirus
jena
cd13
mcmv
antibodies
anti
apn
ad3
human
virulent
ad
serotype
fusion
two
cell
arenavirus
gp
paramyxoviruses
fusion
membrane
viral
protein
nls
null
virus
protein
41
translation
vpg
rna
vpgpro
the
gn
gc
signal
the
translation
bcov
acov
ent
virus
lun
virus
overlapping
mutant
viruses
regions
enteric
chickens
parvovirus
poultry
many
bat
lbv
virus
helvum
ptlbv
rna
p33
viruses
in
vitro
nsp3
sequence
rrv
lineages
region
hbov
hmpv
infa
116
samples
f16
the
f16l
serine
recombinases
gn
ct
nucleic
acid
binding
piv5
vacv
b5r
l1r
protection
cp
polyprotein
obdv
p227
major
e2
membrane
e1
the
ectodomain
cdna
infectious
viruses
the
clones
detected
beef
chicken
viruses
parvoviruses
rna
positive
oxidative
replication
capping
viruses
rna
eukaryotic
different
classes
viruses
mutant
either
virus
parental
rotaviruses
g3p
sampled
rodents
human
ahsv
reverse
genetics
rna
virus
denv
infection
early
virus
response
pedv
genotype
g1
g2
differences
clones
radiobacter
infectious
method
cloning
hbov1
replication
human
associated
caco
dna
proteins
herpesviruses
the
viruses
prv
infection
severe
respiratory
to
hepadnaviruses
bats
species
identified
bat
bst
viruses
species
avian
pa
protein
domain
architecture
gene
proteins
prrsv
recombinant
like
natural
ku
virus
limited
known
orthohepadnavirus
important
iltv
src
spread
viral
identified
lv
rna
sequence
virus
eav
rna
kda
p88
p57
p27
orf
rna
virus
ldv
orfs
di
rna
nucleotides
infectious
particles
strains
conserved
group
the
protein
marburg
virus
gp
within
percentage
water
recreational
incidence
microbial
health
respiratory
infections
acute
review
vast
nan
nan
hsv
per
cent
positive
positivity
carbohydrates
cell
glycoproteins
membrane
biological
cells
cell
cd13
cd26
cultured
detection
eia
antigen
the
use
targeting
vectors
strategies
therapeutic
while
antibody
virus
infected
cells
cell
hla
genetic
associations
the
class
parasites
effects
seabird
parasite
affect
the
cryptosporidiosis
chapter
life
cycle
cell
virus
traffic
membrane
the
cap
cellular
mrna
capping
viral
genome
transcription
dsrna
viral
viruses
fusion
virus
flaviviruses
the
structural
viroid
hammerhead
viroids
second
members
cns
virus
dna
result
infections
antigen
au
hepatitis
discusses
serum
virus
host
infections
nervous
system
viruses
virus
eav
the
ldv
retroviruses
suppression
translational
dna
retrotransposons
torovirus
toroviruses
bev
viruses
first
recombination
rna
homologous
bmv
it
viruses
fungal
biological
hosts
associated
virus
membrane
viruses
cells
animal
epithelial
viruses
cells
virus
entry
viruses
animal
studies
interaction
bacterial
resistance
host
virus
the
disease
viral
chapter
arenaviruses
infection
the
viruses
virus
effect
chromosomes
cell
viruses
di
virus
particles
genomes
virus
influenza
receptors
erythrocytes
viruses
shrimp
viral
cell
study
primary
rubella
virus
vaccination
infection
the
chapter
virus
rhinovirus
the
discusses
methods
cgt
isem
grid
solid
virus
infections
acute
chemotherapy
disease
microscopy
viral
electron
also
iem
pathogenicity
virus
influenza
concept
gene
respiratory
tract
pneumonia
microorganisms
defense
genomes
rna
viruses
closterovirus
the
cells
the
viruses
cd8
infection
viral
erythrocytes
virus
the
myxoviruses
tailed
phages
tail
proteins
common
expressed
mrnas
tmv
amounts
gene
antibody
virus
10
hour
antigen
virology
challenges
technologies
viruses
the
innate
defense
immunity
rather
adaptive
the
viral
viruses
receptors
chapter
cell
the
glycosylation
intestinal
epithelium
cell
transduction
nucleic
acid
requires
gc
events
smooth
surfaced
cisternae
fatty
acid
proteins
acylation
the
nan
virus
the
study
binding
entry
efflux
antimicrobial
increasing
large
drugs
nan
alphaviruses
years
membrane
infections
the
rna
rnas
methods
structure
important
viruses
genomes
polycistronic
mrnas
animal
initiation
translation
regulation
translational
rate
patients
covid
19
disease
kidney
graft
acellular
matrix
ureteral
in
wheezing
children
viral
years
among
nan
ahr
asthma
children
cold
atopic
response
immune
host
respiratory
virus
wheezing
recurrent
rhinovirus
prednisolone
children
nan
asthma
school
children
may
the
asthma
viral
infections
cause
discrepancy
asthma
elderly
clinical
patients
knowledge
exacerbations
asthma
burden
triggers
respiratory
asthma
infection
rhinovirus
rsv
infant
nan
symptoms
hrv
asthma
samples
day
lung
function
neonatal
il
children
nan
episodes
duration
wheezy
bacteria
viral
asthma
factors
school
grade
children
age
asthma
years
sensitization
wheezing
nan
asthma
risk
factors
wheezing
adjusted
viruses
respiratory
asthma
response
host
wheezing
illnesses
asthma
risk
viral
recurrent
wheezing
bronchiolitis
hospitalization
risk
aminopeptidase
ap
nasal
puromycin
human
asthma
th2
cells
airway
disease
n95
bacterial
respirators
colonization
hcws
rna
nonhomologous
recombinations
cell
the
nan
rna
replication
viruses
membranes
specialized
proteins
protein
autophagy
membrane
atg
autophagy
molecular
functions
macroautophagy
herein
portal
kshv
capsid
catcs
tegument
nan
rhinitis
nasal
the
complaint
one
nan
nan
nan
nan
nan
nan
antibiotic
pneumonia
treatment
management
community
nan
nan
nan
nan
nan
nan
nan
nan
virus
respiratory
infections
diagnosis
tract
nan
nan
nan
nan
nan
nan
stools
abstract
pleomorphic
fringed
particles
nan
nan
nan
nan
nan
nan
influenza
normal
controls
like
developed
nan
nan
the
gastroenteritis
cases
39
patients
nan
nan
nan
patients
infections
ms
controls
common
nan
ifn
study
recipients
patients
double
cell
lymphoma
hml
lymphomas
cases
feline
iop
virus
drug
treatment
chaperones
proteins
recombinant
including
periplasmic
prv
infection
pifitm1
virus
interferon
cpg
nlp
agonists
mpla
nlps
bacterial
infections
models
vivo
vitro
mg
vc
saon
supplementation
bone
cd13
expression
surface
aml
levels
yhv
shrimp
survivors
positive
moribund
birds
missing
igy
genes
chickens
mab
immunoglobulins
specific
bt1
4f10
feline
influenza
virus
cats
infection
ibv
strains
responses
885
qx
group
unigenes
in
grouper
sgiv
influenza
h1n1
swine
ilis
test
influenza
pneumonia
ld
hospitalized
viral
vp
ldv
antibody
the
envelope
antibodies
igg
monoclonal
polyclonal
species
research
human
veterinary
biomarkers
clinical
infections
cap
patients
viral
co
abstract
three
rotaviruses
isolated
intestinal
hong
kong
high
clinical
based
schizophrenia
fetal
associated
adverse
intrauterine
indoor
picu
particle
103
pcm
cell
chikv
drug
epitope
protein
nan
detection
viruses
immunofluorescence
microscopy
abstract
bacterial
viral
respiratory
aom
middle
bronchiolitis
hbov
summary
we
describe
birds
wild
transmission
species
humans
hbov
respiratory
patients
analysis
tract
hrv
respiratory
thailand
pcr
species
hrv
hev
cases
strains
pediatric
ifn
lambda
rsv
levels
expression
viruses
respiratory
use
adults
economic
vaccines
infections
responses
immunity
biology
nan
rsv
panad3
adults
im
responses
nlr
infection
studies
sepsis
lymphocyte
cases
diagnosis
gastroenteritis
em
per
nan
patients
coli
chronic
microbiological
nairobi
airway
respiratory
diseases
lower
infections
cells
dpp4is
immune
dpp4
functions
favipiravir
influenza
rna
virus
lethal
5a
rnase
cells
dependent
rna
anxiety
college
or
95
ci
fiv
infection
am
the
expression
virus
ade
prrs
proteins
presence
piglets
probiotic
cereus
var
toyoi
bhv
haemolytica
alone
il
respiratory
ifn
oral
administered
expression
efficacy
fmt
animals
fecal
microbiota
individual
antigen
immune
responses
mucosal
adjuvant
mucosal
mechanisms
innate
iga
diverse
manifestations
viral
systemic
infections
abstract
ebv
cells
tonsils
adenoids
infected
hbov
children
dna
otitis
aom
pathogenesis
need
om
the
review
epithelial
cell
pyogenes
cells
tonsils
cymmv
orsv
detection
probes
rna
scfv
chain
variable
antibody
20e9
1α
tsv
yhv
the
ef
isav
rt
pcr
assay
analysis
pcr
yhv
gav
nested
rna
em
particles
size
diagnosis
infectious
rt
lamp
amplification
assay
gene
puumala
virus
products
effective
ethanol
sfv
plasmid
expression
infectious
virus
bvdv
clone
full
length
cdna
virus
this
detection
viruses
non
hpiv
detection
rt
pcr
the
vesivirus
patients
samples
generic
assay
assay
the
vesivirus
marine
described
flow
cytometry
cells
enterovirus
ifa
influenza
2009
would
h1n1
abstract
influenza
pcr
method
megb
3qpcr
pcr
rrt
viruses
influenza
assay
the
assay
probe
using
rna
mabs
h5
elisa
viruses
protein
clinical
conjunctivitis
rapid
multiplex
infectious
rt
lamp
pcr
mnv
taqman
assays
influenza
pcr
virus
victoria
viruses
viral
rna
the
in
epithelial
cells
intestinal
infection
viruses
encephalitis
viral
cangzhou
virus
multiplex
pp
orf2
domain
hev
ic
us
pedv
variants
assays
porcine
rv
assays
copies
ml
the
femv
urine
sample
sequence
piuma
hadv
assays
qpcr
hadvs
respiratory
detection
multiplex
viral
gastroenteritis
norovirus
methods
infections
respiratory
human
viruses
hrsv
subgroup
assay
respiratory
specific
probe
the
fluorescence
reporter
dye
picornaviruses
rhinoviruses
band
bp
amplicons
nan
ficolin
recombinant
plasma
bind
purified
ahf
immune
illness
plasma
hemorrhagic
viruses
project
rna
virus
this
st
193
lasv
antiviral
ribavirin
eva
collections
the
european
virus
sia
das181
bacterial
sialidase
sialidases
copd
exacerbations
infection
rhinovirus
model
htas
host
inhibitors
cyclophilin
hepatitis
reverse
the
development
genetics
new
hrsv
sri
29365
high
protein
rdev
s1
vaccinated
group
groups
article
this
antiviral
retracted
elsevier
hcv
drug
based
therapies
discovery
n3
virus
viruses
r1479
paramyxoviruses
rvfv
antiviral
infection
virus
galidesivir
amodiaquine
virus
antiviral
ebola
derivatives
myricetin
hsv
anti
virus
effects
nan
influenza
ribavirin
antiviral
virus
oral
nan
lapase
hiv
cells
activity
bestatin
ms
herpesviruses
viruses
etiological
treatment
motifs
dna
rna
polymerases
polymerization
er
membrane
associated
domains
proteins
cell
apn
cd13
activity
lymphoid
expression
abstract
characteristics
versatility
stability
cow
calving
pens
single
calves
health
one
global
approach
in
calves
parvum
shedding
factors
odds
tp
birth
mortality
pneumonia
calf
antigens
microarray
the
hsv
cns
patent
genetics
field
patents
pool
nan
society
technology
the
interface
this
pro
vpg
cleavage
p2
p1
isolates
genes
two
clusters
the
prrsv
nucleotide
pl97
strain
phylogenetic
yhv
nucleoprotein
analysis
indicated
amino
gp5
sequences
sites
2000
2005
rna
viral
end
translation
cellular
translation
viral
proteinases
host
rna
rna
the
viruses
three
gene
wu
ki
respiratory
polyomaviruses
viruses
bats
cell
lines
mva
reservoir
virus
interactions
interaction
infection
one
a3g
hbv
viral
particles
in
virus
infected
fetus
replication
fetuses
prrs
disease
prrsv
syndrome
swine
hav
codon
usage
the
also
we
quasispecies
rna
systems
new
viral
npro
mutant
bvdv
region
rna
protein
core
viral
cyclization
nan
helicase
virus
mutations
l1110f
v1120i
proteins
virus
membrane
budding
eav
eav
equine
arteritis
virus
phylogenetic
disease
respiratory
prrs
pigs
prrsv
lectins
virus
derived
pseudomonas
influenza
pedv
virus
assays
diagnostic
detection
p2
rna
role
structural
studies
pi3v
strains
vaccines
mlv
cattle
rna
virus
viruses
evolution
diverse
m6pr
strains
cathepsins
rotavirus
cells
click
chemistry
virus
related
research
ldl
150434
ck
ch
the
viral
rnas
mutations
interactions
two
actin
virus
required
efficient
rotavirus
strains
17
viruses
gi
recombinant
gi
ibv
19
lgd
genotype
nanofibers
cd8
intranasally
peptide
delivered
nan
antigen
presentation
cell
alisporivir
mhc
hbv
ntcp
entry
activity
bile
expression
transgene
modification
genetic
content
selection
the
replication
hydrothermal
within
islands
gram
based
genome
gis
lung
human
on
chips
organs
nan
cells
cell
capi
continous
strain
nan
nan
nan
nan
nan
disease
understanding
epidemiology
infectious
prerequisite
this
article
reviews
classification
characterization
viruses
tests
disinfectants
hepatitis
efficacy
viruses
nosocomial
infections
many
also
nan
infection
control
neonatal
antimicrobial
resource
nan
infections
nosocomial
hais
routes
infection
organisms
micro
may
patients
viruses
hcais
use
neonatal
nicus
infection
hap
patients
radiologically
confirmed
diagnosis
influenza
viruses
hospitalized
children
adults
patients
respiratory
outbreaks
rsv
significant
nan
nasal
high
flow
therapy
dispersal
respiratory
viral
illness
95
ci
privacy
confidentiality
part
responsibility
article
viruses
hands
hygienic
hand
human
hours
hands
intervention
surfaces
fomites
pcr
respiratory
nursing
testing
initiated
tb
hcws
qft
exposure
git
fusion
hsv
peptides
viral
gh
components
the
expression
volume
water
sp
secretion
receptor
lingual
lipase
nan
nan
la
de
el
receptor
del
coverage
tendencia
2005
test
15
de
las
infecciones
se
frecuentes
de
virus
en
la
viral
de
la
el
del
lung
de
la
en
el
se
en
de
los
la
una
infections
solid
organ
transplant
recipients
respiratory
viruses
pandemic
influenza
virus
influenza
h1n1
pdm09
virus
respiratory
de
la
virus
en
las
de
en
el
las
que
de
virus
en
los
respiratory
nan
hbv
activity
derivatives
anti
dna
acid
atcc
amino
mpa
derivatives
hcv
ns5b
review
liver
therapeutic
sting
pathway
disease
monophosphate
well
μm
ec50
10i
nnrti
activity
tlrs
modulators
the
researchers
clinical
antigen
aminopeptidase
membrane
torpedo
the
stress
the
response
diseases
immune
clinical
probiotic
formulations
patients
probiotics
virus
cell
dr13
the
adapted
calves
pi
virus
bvdv
mlv
bacterial
children
aboriginal
catarrhalis
microbe
dogs
leishmune
vaccine
cvl
vaccinated
complement
pathogen
immune
activation
and
influenza
prescriptions
periods
rsv
excess
emergency
vaccine
new
threats
production
influenza
therapy
children
vaccination
oncohematological
psyn
mh5
stability
we
vaccinia
hmpv
antibody
titers
compared
illness
influenza
cell
vaccine
cells
production
influenza
vaccine
year
effectiveness
95
rsv
palivizumab
vaccine
cotton
rats
793b
vaccine
farms
almost
two
rspv
sa
tgev
vaccine
virus
mucosal
chitosan
adjuvants
clinical
immune
pcr
virus
cases
121
bohv
ibv
population
field
history
italy
wild
viruses
vaccine
birds
strains
rotavirus
models
burden
model
dynamics
or
95
ci
h7n9
vaccine
rabies
virus
antivirals
effective
anti
strain
2014
attenuated
ibv
zyyr
pedv
vaccine
virus
elicit
porcine
development
uk
vaccine
pathogen
outbreak
vaccine
influenza
the
2015
strains
changes
clinical
disease
cpv
infection
a12
llv2
fmd
animals
response
immunity
passive
young
animals
examples
nan
nan
nan
nan
nan
stock
stroke
daily
data
index
release
ne
adinazolam
diazepam
ht
nan
nan
nan
de
la
los
sarcoidosis
es
de
la
en
los
las
la
de
en
exacerbations
el
de
las
en
la
el
nan
nan
de
en
la
que
los
by2
the
s2o8
light
showed
calves
infection
bovines
months
suckling
calves
infected
the
giardia
cysts
electrofusion
cell
vivo
cells
exposed
aminopeptidase
ey
cdna
his
amino
illnesses
effects
malaise
alertness
reduced
hpa
axis
rhinovirus
pd
reactivity
nan
izn
zinc
lozenges
duration
common
olfactory
diseases
brain
bulb
neurodegenerative
fructan
virus
influenza
polysaccharide
anti
nan
expression
mb78
two
ribosomal
frameshifting
japonica
luteolin
gene
chlorogenic
biosynthesis
vp7
the
protein
bmcpv
virus
acatn
mouse
expression
cdna
sequence
virus
pigs
replication
days
prrsv
astroviruses
pigs
species
strains
porcine
cpv
type
antigenic
dogs
late
serotype
viral
ibv
italy
02
regions
prrsv
infectious
clones
constructed
pcv2
enteric
pigs
disorders
lesions
sbv
cells
virus
sk
isolates
sheep
hobi
like
pestivirus
infected
bcov
beef
dairy
diarrhea
herds
etec
diarrhea
toxoid
stb
toxins
orf3
cell
del2
del5
pedv
22
intestinal
infection
epithelial
apoptosis
cadv
wild
carnivores
infection
virus
pigs
cell
dpi
serum
pedv
fimbrial
f18
epitopes
etec
neutralizing
asfv
recombination
genomes
homologous
virus
pedv
strain
sh
aa
highly
virus
nd
piglets
control
nursery
group
piglets
prrsv
iii
iv
group
animals
virus
parasuis
10
immune
prrsv
infection
system
disease
day
virus
prrsv
pigs
samples
cap
concerning
aetiology
frequent
incidence
plants
species
use
used
farmers
il
17a
qing
dai
could
jz
hsv
infection
autophagy
pi3k
otitis
media
acute
chronic
exacerbation
nan
nan
nan
cov
mers
years
since
infection
shl
the
liquid
drug
three
pcr
rrt
2009
h1n1
95
fast
assay
rvp
hpiv
xtag
abstract
week
old
infant
presented
respiratory
kappa
0001
transport
mtm
flu
xpert
rsv
xc
the
assay
high
sequence
virus
pcr
cap
non
cases
controls
levels
assay
results
negative
xpert
flu
viral
respiratory
infections
radioimmunoassay
tissue
detection
respiratory
rapid
viral
antigen
nan
microbicides
peptide
protein
systems
hiv
nematodes
livestock
major
diagnostic
control
ks
pathogenesis
in
cofactors
disease
nan
group
pmsg
cmsg
in
patients
nan
nan
general
mechanisms
provided
diagnostic
sampling
procedures
in
article
author
discusses
virus
ebov
ebola
evd
system
state
enzymes
normal
proteases
types
mucosal
voie
les
de
par
la
de
toux
est
bronchite
virus
et
vrs
dans
rhinovirus
la
ebv
de
ventilation
et
nan
nan
mice
poliovirus
strains
mouse
hpvr
sva
codon
usage
evolution
54
ebov
vaccine
epitopes
peptides
study
nan
infections
disease
severe
pneumonia
adenovirus
viral
newborn
infection
disease
the
avnp2
c6
tumour
bearing
rats
nan
nan
detection
enteroviruses
assay
rhinoviruses
cross
kipyv
wupyv
samples
respiratory
assay
assay
pedv
pcv3
the
detection
antiviral
agents
virus
use
viruses
infections
the
cruise
ships
often
nan
nan
pregnancy
associated
uri
offspring
measures
mortality
disease
gbd2013
different
ihd
3d
human
hrv
hbov
culture
nan
nan
nan
viruses
rna
virus
the
families
rt
pcr
rotavirus
rna
samples
nan
respiratory
resistance
infections
the
tract
china
covid
19
countries
per
herv
ms
syncytin
genes
multiple
dna
hausn
the
aiv
detection
pylori
gastric
mucins
human
mucin
the
toxin
vaccine
disease
use
corneal
perforation
gvhd
melting
calcareous
treatment
patients
case
tb
management
patients
type
diabetes
alt
liver
respiratory
hmpv
children
infection
pathogen
patients
ss
dry
mouth
drug
virus
human
bronchiolitis
respiratory
mp
pneumonia
legionella
case
child
even
nan
de
les
en
rt
pcr
viral
various
among
viruses
rotaviruses
gastroenteritis
children
viruses
pathogens
in
nan
children
rh
age
respiratory
symptoms
pneumoniae
respiratory
infections
years
summary
nan
keratinizing
cell
squamous
cystic
study
am
dogs
administration
levels
mg
eps
7630
cough
protective
activity
virus
fpv
cells
cpv
viruses
felv
cell
variant
env
fiv
nan
nan
advances
viral
intestine
understanding
host
type
ifns
ifnλs
cytokines
mediating
epitope
spreading
chronic
autoimmune
mediated
nan
nan
ae
incidence
cvd
ip
patients
il
33
airway
type
asthma
oral
management
asthma
use
adult
aecb
clinical
patients
exacerbations
morbidity
er
erad
folding
membrane
cells
virus
qd
complexes
qds
imaging
systems
expression
abstract
recent
advances
nan
nan
nan
nan
nan
rna
polymerase
genetic
studies
function
nan
nan
nan
nan
nan
microorganisms
the
sia
various
versatile
rdrp
nucleotide
incorporation
question
polymerases
structure
macromolecules
abstract
the
past
nan
probestin
synthesis
activity
cam
tumor
gl
denv2
denv
antiviral
activity
compounds
these
potent
abstract
series
golgi
apparatus
major
understanding
functions
golgi
proteins
for
residents
protein
nan
rna
viruses
constraints
often
adaptability
noroviruses
disease
norovirus
virus
susceptibility
ires
elements
internal
rna
ribosome
animal
infectious
model
human
diseases
human
virome
composition
microbiome
its
microbiome
research
health
network
applicability
receptor
na
species
host
balance
small
genomes
sequencing
functional
characterization
nan
nan
nan
abstract
demonstrating
infectious
cause
viral
apn
compounds
inhibitory
activity
ic50
activities
apn
compounds
series
mmp
two
nalidixic
penicillin
ester
gram
activity
hcv
hsc70
rac
cryptopleurine
the
hiv
target
develop
fleximer
triazole
containing
chemistry
lead
compounds
proteinase
azaglutamine
type
hav
3c
the
prrsv
protein
structure
forming
protein
wnv
the
structure
core
cryo
electron
microscopy
study
large
structural
purdue
university
biology
years
drug
cancer
the
drugs
treatment
heparin
viral
viruses
raw
material
229
s25
pedv
variant
domain
3cpro
sld
binding
rna
interaction
respiratory
acute
sci
infections
disorders
vascular
targeting
the
molecules
directed
sialic
acids
coelomocytes
types
acid
citia1
gcrv
rna
cik
cells
viral
mechanisms
virus
vhsv
serpine1
yhv
pmrab11
shrimp
it
rab
patients
rsv
infections
respiratory
ltrs
nan
antisense
oligonucleotides
antiviral
virus
the
virus
diseases
disease
drugs
vaccines
carbohydrates
complex
chapter
carbohydrate
potential
hiv
evolution
molecular
study
population
old
new
world
the
distribution
membrane
super
resolution
organization
proteins
data
sets
application
management
system
rna
dna
dsrna
genomes
appears
pcp
te
grsb
iterative
gramicidin
pneumoniae
asthma
acute
patients
controls
common
cold
pathogenesis
the
therapies
hsct
hpiv3
infection
august
patients
patients
hsct
haploidentical
cell
adult
lrti
risk
rhinovirus
score
hct
complement
igg
proteins
virus
regulatory
bvdv
stock
lactating
first
bovine
group
disease
pigs
challenged
immunisation
nan
nan
zikv
antiviral
targets
in
zika
remodelling
infections
respiratory
known
airway
review
asthma
focus
exacerbations
the
uri
airway
exacerbations
complications
upper
nan
feline
epilepsy
may
seizures
cat
ct
mri
disorders
imaging
brain
the
authors
this
article
erad
china
drug
safety
surveillance
system
nan
cats
fip
pathological
findings
changes
cats
anemia
species
dna
healthy
spinal
diseases
cord
cats
neurological
neurological
weakness
neuroanatomic
diagnosis
the
infection
cats
kittens
virus
recommended
cats
disease
may
fhv
feline
cats
felv
years
vaccination
immune
cats
fiv
virus
infected
immunodeficiency
cats
h5n1
infection
influenza
disease
blood
clinical
transfusion
medicine
small
cpv
2c
kitten
signs
case
clinical
lower
respiratory
tract
cats
cats
forebrain
lesion
neurological
cat
vestibular
system
neurological
examination
disorders
gastroenteritis
viral
rotavirus
study
cause
hrsv
hmpv
pcr
real
time
ambulances
centres
european
technical
facilities
hbov
respiratory
patients
children
we
viruses
respiratory
enveloped
ghanaian
virus
respiratory
sari
children
viruses
without
influenza
rv
strains
respiratory
viruses
studies
the
pathogens
afi
fever
testing
comprehensive
molecular
pneumonia
routine
detection
associated
iv
or
95
group
intervention
days
iqr
patients
early
treatment
respiratory
failure
patients
hiv
diarrhea
patients
identified
sp
the
poultry
industry
chickens
integrated
hev
known
enteroviruses
summary
human
respiratory
viruses
children
we
hospital
children
years
haiti
influenza
vs
parv4
sari
detected
association
cases
disease
the
asthma
associated
viral
host
abstract
the
journal
microbes
hubei
province
abstract
outside
china
the
patient
ivigs
inflammation
abstract
infections
pneumoniae
bacterial
using
mixed
rabies
years
medical
the
exposure
kuraridin
viral
reovirus
replication
treatment
ovx
extract
stress
placental
mice
bacitracin
genes
mutans
mutants
resistant
mu314
e2
ovx
bone
suppressed
fmdv
3cpro
abstract
the
3c
il
10
cd8
cells
breast
abstract
gastroenteritis
viruses
novartis
foundation
rna
high
mutation
rates
occurring
ifn
viruses
antiviral
interferon
system
immune
innate
signaling
ubiquitin
activation
virus
picornaviruses
stress
rna
activate
immune
trim
response
regulation
critical
viral
virus
immunotolerance
innate
immunostimulatory
nan
web
applications
in
life
service
nan
proteins
molecular
drugs
proteomic
protein
infectious
data
epidemiology
knowledge
diseases
kd
ivig
disease
acute
inflammatory
antimicrobial
drugs
amps
development
overcome
nmr
development
drug
information
vivo
individual
ftir
structural
fourier
transform
rna
proteins
remodeling
major
it
protein
ubiquitylation
major
dubs
development
resistance
antimicrobial
antibiotic
quantitative
economic
viruses
selection
host
group
persistent
viral
virus
proteins
anti
rnas
host
viruses
virus
cell
in
calves
zuernii
infection
toltrazuril
infected
applications
health
public
architecture
surveillance
respiratory
pcr
sputum
using
rt
clinical
viruses
detection
technologies
virology
hpv
types
hpvs
specific
papillomaviruses
hmpv
respiratory
children
assay
specimens
multiplex
assay
hrv
respiratory
internal
nan
hhv
viral
high
bmt
post
hrsv
infants
arti
respiratory
rna
hrv
qpm
detected
novel
hrvs
ki
virus
respiratory
patients
isolates
hbov
detected
children
one
patients
hmpv
to
real
time
pcr
respiratory
samples
wuv
kipyv
virus
respiratory
pneumoniae
broad
diagnostics
molecular
viral
respiratory
infections
tract
lrt
hrsv
palivizumab
viral
arti
respiratory
nan
nan
nan
nan
nan
nan
nan
hmpv
viral
children
load
respiratory
hbov
respiratory
192
viral
detected
influenza
rt
pcr
binax
rapid
hbov
respiratory
children
adults
human
wupyv
kipyv
respiratory
children
11
abstract
human
bocavirus
recently
described
rsv
bronchiolitis
respiratory
viral
severe
wupyv
npa
samples
dna
the
wuv
kiv
patients
respiratory
hiv
hbov
taiwan
respiratory
children
study
hrvs
viruses
respiratory
hrv
co
mcpyv
wupyv
samples
nasal
swabs
respiratory
if
picornaviruses
npa
detection
h1n1
influenza
swl
rtrt
pcr
h1n1
novel
influenza
rvp
detection
b19
parvovirus
patients
infection
respiratory
pandemic
influenza
rt
pcr
specific
resequencing
microarray
culture
samples
pcr
if
respiratory
pcr
children
picornavirus
infections
viral
load
co
children
hrv
cap
infections
children
hrvs
viruses
respiratory
virus
infections
year
prv
xtag
resplex
ii
multicode
influenza
h1n1v
h1n1
virus
viruses
hrv
viral
severe
specimens
abstract
immunocompromised
kipyv
higher
prevalence
wupyv
sensitivity
respifinder
assays
rvp
samples
nan
type
pneumonia
adenovirus
severe
beijing
rpii
nats
multiplex
positive
hrv
children
hrv
ev
influenza
hospitalized
hpiv
myocarditis
viraemia
ribavirin
ivig
ev
identity
63
abstract
we
hrv
respiratory
hsct
infection
recipients
hev
rabbits
rabbit
human
strains
respiratory
viruses
100
point
of
rna
viruses
vector
humans
borne
hrv
children
infections
clinical
hrvs
hrv
ltch
outbreak
residents
respiratory
npa
bal
respiratory
airway
virus
respiratory
viruses
patients
the
fluid
probiotics
respiratory
viruses
viral
conscripts
rsv
hrv
infants
severe
22
cases
anti
study
cd14
viral
rp
positive
rv
samples
tested
hmpv
patients
hematological
pneumonias
respiratory
respiratory
samples
viruses
the
multiplex
hrv
clinical
children
demographic
infections
hiv
children
lrtis
infected
respiratory
d68
ev
samples
enterovirus
children
rsv
pz
children
mutations
resistance
viral
infections
clinical
samples
respiratory
hrv
recipients
infection
hsct
pi
nan
influenza
nosocomial
patients
information
community
rv
children
hospitalised
clinical
species
positive
pcr
rt
samples
sensitivity
co
infection
bacterial
patients
or
viral
coinfection
respiratory
severity
outcomes
emag
easymag
respiratory
results
extraction
viral
multiple
load
ari
clinical
226
respiratory
patients
cap
viruses
positive
flu
test
associated
pflu
respiratory
cap
viruses
performed
europe
icv
assay
multiple
np
real
respiratory
influenza
the
filmarray
samples
viral
respiratory
number
virus
load
samples
pulmonary
pcr
lower
respiratory
filmarray
rp
respiratory
ifa
adults
ev
a71
d68
infections
related
patients
respiratory
immunocompromised
use
hospital
pev
ev
case
patients
aged
pcr
ai
routine
time
we
fusion
assays
adv
hmpv
specimens
panther
fusion
ldt
samples
clinical
hsv
macrophage
probiotic
lactobacillus
rhamnosus
influenza
cases
viruses
41
2009
infections
134
positive
samples
viral
patients
hospital
human
rhinovirus
conditions
first
apartment
year
life
children
plague
the
disease
century
epidemics
disaster
approach
the
preparedness
planning
neutralization
chemical
disinfection
disinfectant
faecal
hpl
fbs
msc
ihpl
mscs
kg
sufentanil
midazolam
sevoflurane
rabbits
exacerbations
disease
healthcare
associated
viral
e1a
copd
expression
epithelial
cells
copd
exacerbations
the
development
acute
asthma
viral
respiratory
increase
life
vitro
screening
drug
compounds
preclinical
structures
discovery
crystal
essential
binding
coagulation
inflammation
responses
crosstalk
dampen
cells
responses
newly
encountered
antigens
potential
rnai
viral
infections
rna
viral
antiviral
stress
infection
responses
ms
cns
virus
cell
viral
neutrophil
subpopulations
heterogeneity
new
cells
immune
respiratory
lung
several
applied
sirna
many
rna
prospects
gene
cys
h2o2
peroxiredoxins
receptor
reactive
human
herv
the
sclerosis
pathogenic
wildlife
parasites
giardia
cryptosporidium
environmental
pacific
programme
lymphatic
filariasis
eliminate
spatial
lifecourse
epidemiology
aims
utilize
mtp
gene
the
mycobacterium
protein
training
international
infectious
programmes
understanding
mechanisms
symptoms
the
common
flu
infection
cchf
viral
fever
distribution
innate
genes
immune
encoding
like
haemophagocytic
syndrome
associated
infections
viruses
infectious
diseases
highly
high
care
treatment
pneumonia
failure
childhood
first
difficile
outbreaks
risk
assessment
virulent
miv
h5
dna
24
h5n1
health
mg
mgs
hajj
saudi
mers
cov
disease
clinical
laboratory
surveillance
diseases
internet
systems
emerging
nan
mers
cov
individuals
camels
15
nan
incidence
disease
china
upsurge
scarlet
nan
mg
participants
study
dose
gls
mortality
lri
risk
lris
decrease
nan
nan
nan
patients
aspirin
laod
lmwh
acute
programmed
frameshifting
fsdb
genes
frameshift
vaccine
epitope
epitopes
potential
development
screening
pi
passengers
infected
airport
disease
novel
53
spread
influenza
adventure
associated
travel
leptospirosis
rafting
95
ci
19
covid
patients
surgical
accreditation
standards
the
effectively
liver
the
cell
death
induced
cell
disease
sfts
cd4
severity
choices
medical
respect
values
different
aspirin
otc
doses
pain
cold
shrna
expression
hiv
lentiviral
vector
tb
immunization
pulmonary
vaccine
vsvag85a
reovirus
cells
infection
oncolysis
disassembly
star
gene
technology
using
sars
sars
respiratory
tests
infection
cov
qpcr
assay
respiratory
specimens
standard
fumigatus
ipa
pcr
aspergillus
time
rvs
cells
atopic
rv
viral
infection
disease
rsv
the
development
nan
response
immune
the
viruses
innate
airway
bronchiectasis
hrct
scans
irreversible
pneumonia
children
management
western
pacific
nan
nan
information
framework
lay
gathering
actions
terminologies
desiderata
concepts
paper
controlled
clinical
snomed
ct
use
terms
different
prediction
predictors
models
predictions
vaccine
vaccines
policy
supply
demand
nan
zinc
common
cold
clinical
treatment
ppe
use
adherence
resuscitation
simulated
epidemiology
molecular
fmdv
disease
foot
ibv
new
strains
like
recombination
ev71
codon
usage
virus
synonymous
species
astroviruses
animals
astrovirus
viruses
codon
usage
bias
pedv
analysis
pbv
strains
identity
lts
subgroup
bats
important
viruses
may
serve
picornavirus
kobuvirus
novel
species
the
btovs
japanese
regions
analyses
high
strains
nov
sequence
nt
aa
ibv
phylogenetic
sequences
viral
classification
genotype
giii
bovine
norovirus
rna
viruses
bats
caliciviruses
human
calicivirus
mutation
to
novs
nov
hyper
pig
rvc
virome
study
fecal
2014
pedv
outbreaks
in
eas1
pedv
spike
sequences
thai
ped
ita
2007
canine
gvi
strain
cpv
2a
vp2
new
disease
ibv
brazil
gi
diversity
sequences
pdcov
pdcovs
diarrhoea
japan
piglets
rva
zambian
helvum
bat
strains
orthohepadnaviruses
bat
hepatitis
virus
identified
viruses
lineage
gi
isolated
ibv
fekov
cats
kobuvirus
strains
samples
viruses
gvi
strains
isolated
colombia
gi
ibv
strains
different
genome
viruses
rna
african
green
used
igg
vfcγrs
antiviral
virus
infection
ml
il
pg
lymphocytes
cells
thymol
activity
macrophages
ml
role
nan
infectious
agents
may
nervous
system
dna
ape1
cleavage
repair
site
ciguatera
patients
recurrent
gene
expression
diseases
anemia
thrombocytopenia
mechanism
viruses
cells
ms
patients
cell
healthy
disease
kd
coronary
artery
abnormalities
rr
ci95
viruses
human
colonization
rv
cf
becs
ifn
infection
combat
conditions
diseases
military
operations
respiratory
military
personnel
infections
among
chromatography
protein
mdlc
proteome
analysis
ms
may
novel
biomarkers
based
structure
peptides
secondary
change
the
jnk
inhibitors
competitive
sp600125
we
ala
pka
group
aldehyde
phe
papain
inhibitors
aldehyde
glyoxal
effective
possible
diseases
therapeutic
role
receptors
patients
celiac
disease
lymphoma
survival
gut
human
viruses
microbiota
composition
patients
wbc
crp
ed
neoplasm
medical
osce
clinical
students
kmu
clss
genes
hiv
localized
conserved
factors
multiple
recurrence
pathogen
abstract
structure
cat
population
populations
article
nan
filmarray
pp
patients
respiratory
specimens
de
los
en
se
el
la
las
de
en
del
de
el
en
rotavirus
14
de
mbl
binding
mannose
lectin
de
en
respiratory
las
infecciones
la
de
viral
virus
en
de
la
en
pertussis
los
de
con
mp
en
children
information
health
article
patients
internet
antibiotics
evidence
prophylactic
antibiotic
infectious
antibiotic
antibiotics
prophylaxis
iii
women
de
des
du
et
la
animals
may
microorganisms
pigs
xenotransplantation
pneumonia
may
neonatal
onset
the
spread
movements
travel
epidemic
disease
farms
infection
infected
disease
bkd
social
isolation
intervention
participants
study
emergency
nursing
hong
kong
development
pacing
may
modality
different
degree
viral
anti
novel
drugs
potential
infectious
antibody
diseases
preparations
mab
synovial
fluid
joint
proteins
inflammation
protein
associated
membrane
proteins
ne
leptospirosis
proteins
analysis
serum
differentially
stages
japonica
secondary
regulatory
flower
genes
lncrnas
this
class
sequence
the
image
sensor
video
intubation
drug
constituents
bioactivities
recent
issues
iipals
the
iipal2
compounds
expression
sd
chinese
bioactive
constituents
anti
the
human
samples
sequences
mers
cap
dependent
translation
eif4e
cancer
exposure
children
postnatal
tobacco
maternal
ped
families
language
spanish
children
disease
analysis
global
animal
surveillance
spatial
models
disease
spread
infectious
multivariate
model
lattices
structure
different
nan
nan
structures
virus
viral
involved
investigations
proteins
ifitm
cellular
viral
enveloped
water
viruses
public
health
impact
proteins
class
ii
membrane
viral
human
simian
viruses
sfv
humans
proteins
nucleic
acids
viruses
pathogens
oas
rnase
act
antiviral
the
cells
nk
immune
virus
infections
inhibitors
enterovirus
drugs
capsid
binders
viral
cells
the
pathogens
components
viral
cap
enzymes
cellular
inhibition
nan
processes
ubiquitination
deubiquitination
regulate
several
virus
reovirus
reoviruses
studies
replication
viruses
eves
endogenous
eukaryotic
discovery
rna
nmd
viruses
infection
virus
hcv
virus
hepatitis
burden
chronic
the
zika
et
al
2016
associated
children
npm
early
persistent
acute
oxpl
lung
inflammation
effects
tsl
cell
cells
lung
nsclc
ifnγ
disease
levels
shlh
cxcl9
disaster
must
resources
planning
anticipate
gene
brain
tumors
expression
genetic
fatigue
cfs
syndrome
abnormalities
whose
pdz
cell
proteins
domains
also
hyphema
practitioners
especially
emergency
review
disease
dogs
diagnosis
consists
abstract
tcm
liver
diseases
treatment
chinese
medical
holy
bible
the
modern
cancer
cd13
cell
hsc
scirrhous
ab
g6
chain
ighv1
69
virus
cap
patients
respiratory
alone
nan
asthma
exacerbations
disease
severity
medical
respiratory
antibiotics
exacerbations
patients
cvid
nan
pneumonia
nasopharyngeal
swabs
children
induced
copd
china
disease
prevalence
the
acute
respiratory
failure
invasive
cause
microbiota
lrtis
children
nasopharyngeal
matched
group
children
placebo
amoxicillin
clavulanate
nan
nan
urban
rural
100
000
vs
catatonia
psychomotor
evidence
immune
activation
nan
research
global
funding
disease
burden
cells
cell
infected
influenza
viral
cryptosporidium
calves
cattle
parvum
samples
we
twitter
thai
different
outbreak
nan
nan
group
pe
on
con
steroid
bone
src
sirna
saon
induction
nan
2019
ncov
outbreak
china
health
nan
nan
nan
isolation
patients
hd
transmission
secondary
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
2019
disease
sscp
coronavirus
currently
nan
nan
patients
ncip
hospitalized
hospital
received
nan
nan
nan
nan
nan
nan
nan
taiwan
travel
health
covid
19
nan
nan
nan
nan
sars
cov
coronavirus
virus
based
2019
covid
the
virus
selective
coronavirus
this
sars
cov
china
2019
this
disease
novel
coronavirus
2019
covid
19
china
on
the
estimated
mean
evolutionary
2019
conjunctival
secretions
patients
ncp
this
cov
sars
coronavirus
human
intermediate
nan
covid
19
spread
we
patients
outbreak
china
health
epidemiological
data
2019
novel
coronavirus
sars
cov
trend
fitting
measures
data
cases
sars
like
sequences
two
cdna
sars
cov
codons
genes
mers
nan
der
und
sich
eine
covid
nan
nan
18
fdg
patients
covid
19
nan
pdcov
iga
serum
milk
samples
nan
asymptomatic
cases
covid
19
patients
cm
prevention
studies
covid
19
nan
sars
cov
inflammatory
responses
fcr
cases
2019
infection
ncov
china
the
follow
up
bilirubin
2019
2019
ncov
patients
care
transmission
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
sars
cov
viruses
lineage
several
nan
nan
the
virus
presented
acute
coronaviruses
nan
nan
nan
patients
spo2
90
group
2020
mm
virus
dimension
influenza
chest
covid
19
disease
day
children
asymptomatic
sars
coronavirus
cases
close
nan
nan
nan
nan
transplant
impact
community
the
recent
patients
severe
covid
19
sars
nan
dr
stein
as
practicing
front
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
pulmonary
lung
ct
patients
2019
nan
nan
nan
nan
patients
51
ct
lesions
2019
nan
nan
nan
patients
2019
ncov
ct
findings
ct
patients
days
total
score
nan
patients
ct
19
early
days
disease
covid
19
coronavirus
china
nan
rt
pcr
ct
chest
positive
nan
nan
nan
covid
19
pneumonia
vs
001
nan
nan
nan
nan
2019
ncov
viral
patients
potential
nan
sars
cov
immune
pathogen
host
coronavirus
cov
sars
therapeutic
the
nan
nan
health
united
states
cases
covid
person
covid
19
transmission
2019
2019
data
national
ncov
information
nan
nan
nan
nan
nan
nan
health
public
covid
19
preparedness
nan
nan
nan
nan
this
operational
department
covid
19
ct
covid
19
patients
the
coronavirus
the
outbreak
novel
pulmonary
ct
patients
disease
phase
62
disease
patients
covid
19
pneumonia
nan
coronavirus
respiratory
il
including
inflammatory
nan
airway
intubation
patients
coronavirus
endotracheal
covid
19
cov
sars
the
cov
2019
sars
mers
ncov
nan
assays
middle
east
respiratory
syndrome
covid
19
china
wuhan
cities
infected
city
province
we
report
china
shenzhen
since
early
january
coronavirus
infant
negative
woman
2019
respiratory
we
co
sars
cov
child
positive
reverse
transcription
pcr
patients
upper
respiratory
symptoms
patient
virus
we
january
2020
patient
2020
2019
ncov
19
australian
19
coronavirus
covid
00
australian
19
coronavirus
2019
covid
known
19
covid
australia
this
fourth
19
covid
australia
this
fifth
19
covid
australia
this
sixth
nl63
cusia
tryptanthrin
extract
leaf
cov
sars
cases
respiratory
the
patients
chemotherapy
the
treatment
colorectal
nan
nan
nan
cases
covid
19
test
ct
nan
nan
nan
medical
treatment
patients
disease
covid
diseases
covid
19
breast
epidemic
covid
19
one
measures
drainage
cases
fever
clinical
2019
children
covid
19
women
pregnant
two
目前我国对2019新型冠状病毒疫情的防治工作正处于关键时期
延迟开学是减少校园内交叉感染
保护儿童和青少年身体健康
共同抗击疫情的重要举措
与此
nan
control
prevention
diagnosis
treatment
dental
oral
patients
impact
treatment
dental
ncp
rna
patients
clinical
positive
cases
distribution
imaging
sign
covid
novel
coronavirus
pneumonia
diagnosis
epidemic
covid
19
patients
advanced
lung
cases
19
patients
henan
province
ncp
patients
the
coronavirus
pneumonia
intubation
the
healthcare
workers
endotracheal
treatment
patients
the
disease
covid
testing
pulmonary
function
covid
19
diagnosis
treatment
military
medical
hubei
copd
patients
covid
19
chinese
pulmonary
rehabilitation
covid
19
patients
patients
hospital
discharge
covid
19
12
heart
failure
covid
19
group
patients
critical
10
vs
nan
covid
19
disease
patients
ctni
health
protection
guideline
requirements
indoor
transportation
outbreak
health
ncp
control
ncp
protection
new
respiratory
infectious
hubei
province
risk
migration
provinces
control
epidemic
prevention
disease
covid
epidemic
february
covid
19
curve
modernization
prevention
control
system
disease
february
new
confirmed
cases
hubei
sars
cov
transmission
covid
19
covid
19
infection
controlling
critical
public
health
clinical
medicine
treatment
2019
ncov
three
infection
placentas
nan
nan
nan
patients
breast
cancer
the
disease
treatment
the
novel
coronavirus
pneumonia
covid
19
cancer
the
brought
treatment
epidemic
pneumonia
period
diagnosis
diagnosis
treatment
patients
epidemic
novel
cancer
epidemic
patients
lung
disease
patients
lung
cancer
covid
19
patients
pulmonary
2019
infiltrates
cancer
epidemic
incubation
period
generation
interval
covid
19
control
prevention
outbreak
the
method
number
covid
19
epidemic
strategies
transmission
since
outbreak
cases
the
department
store
00
positive
results
false
rate
screening
family
cases
covid
19
cluster
case
family
cases
clustering
epidemiological
clusters
cases
epidemic
median
the
transmission
covid
19
carriers
sources
cases
the
characteristics
sars
2003
nan
medical
staff
anxiety
the
230
patients
colorectal
medical
ncp
must
colorectal
cancer
treatment
patients
new
liver
injury
cases
the
function
2019
treatment
covid
19
ncov
cytokine
storm
disease
covid
19
nan
nan
nan
nan
the
2019
virus
coronavirus
ncov
epidemic
coronavirus
prevention
control
influenza
residents
the
ncp
subjects
information
january
asymptomatic
patient
diagnosed
cases
epidemic
measures
in
wuhan
country
nan
control
ncp
the
epidemic
novel
cases
covid
19
china
spread
nan
nan
guidelines
edition
national
health
commission
nan
ophthalmic
2019
medical
reduce
infection
nan
ncp
prevention
clinical
work
epidemic
ncp
vascular
novel
patients
become
nan
nan
nan
nan
nan
nan
2019
chest
ct
cases
children
cases
children
2019
infection
patients
nan
nan
2019
infectious
disease
ncov
china
2019
pneumonia
the
confirmed
epidemic
coronavirus
2019
ncov
respiratory
drugs
novel
coronavirus
2019
detection
early
pr
novel
coronavirus
rehabilitation
pneumonia
serum
29
il
2019
patients
bronchoscopy
2019
ncov
strictly
infection
nan
extracorporeal
support
clinical
cases
novel
respiratory
2019
ncov
support
technique
coronavirus
ncp
edition
the
new
patients
cases
one
the
normal
ace2
pneumonia
covid
19
severe
respiratory
sari
acute
infection
patients
patients
petients
33
10
67
chloroquine
coronavirus
novel
pneumonia
patients
patients
mask
using
recommended
ventilator
infection
control
novel
coronavirus
oral
2019
covid
19
how
in
novel
coronavirus
ncp
liver
the
liver
ace2
expression
patients
coronavirus
cases
50
20
novel
coronavirus
ncp
surgery
patients
tumor
must
operation
colorectal
cancer
patients
sars
2019
ncov
infection
medical
otolaryngology
patients
respiratory
improve
reduce
severe
nan
2019
引起2002年严重急性呼吸综合征
sars
和2012年中东呼吸综合征
mers
2019
自2019年12月以来
中国湖北省开始出现了2019新型冠状病毒
ncov
感染疫情并逐渐扩散至其他省份乃至其他国家
italy
cases
february
covid
19
nan
mers
cov
fusion
compounds
µm
cases
2019
confirmed
patients
first
novel
coronavirus
2019
pneumonia
chest
nan
emergency
supplies
health
control
medical
covid
19
clinical
rapidly
public
virus
protocol
cost
easy
early
new
children
increased
legislation
prevention
topsentin
dna
indicated
synthesis
cells
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
unknown
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
abstract
both
enantiomers
halitunal
novel
exposure
epithelial
interstitial
cells
weeks
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
rna
rnas
000
the
mr
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
the
shellfish
accumulation
virus
mercenaria
carp
diseases
common
presented
fungal
nan
nan
families
the
serine
peptidases
members
nan
nan
nan
nan
nan
leader
actin
sequence
the
nucleotide
nan
nan
species
movement
embryo
efforts
embryos
nan
concentrations
patients
procalcitonin
infections
serum
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
daptomycin
skin
the
treatment
patients
disposal
sewage
the
wastes
consideration
nan
nan
nan
species
the
monoclonal
antibodies
derived
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
exon
mice
sjl
peptide
induced
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
interferon
use
abstract
potential
prophylactic
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
viral
specific
cns
part
regions
viral
host
factors
influence
in
nan
neural
immune
response
antigens
while
nan
nan
nan
nan
nan
nan
nan
induced
abstract
experimentally
demyelination
autoimmune
diseases
model
role
abstract
three
abstract
many
aspects
viral
immunity
calves
mortality
neonatal
dairy
risk
virus
rats
adv
mice
sp
respectively
calf
rotavirus
k99
coli
cattle
fmd
elisa
test
virus
nan
calves
veal
coli
enteritis
hemorrhagic
nan
herds
pcc
positive
herd
hyo
days
paromomycin
the
kids
two
egg
powder
diarrhea
farm
specific
calves
calf
mortality
weeks
age
nan
pasteurized
effect
colostrum
milk
calves
nan
nan
nan
improved
abstract
viruses
developed
genetic
nan
nan
changes
may
domestication
believed
behavioral
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
viruses
cell
viral
agents
proteins
surface
histolytica
research
one
different
disease
genetic
populations
infectious
host
improved
abstract
viruses
developed
genetic
nan
spp
stools
when
laboratories
difficile
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
groups
reference
test
smoke
concentrations
ada
rats
exposure
mg
m3
animals
studies
chemicals
carcinogenesis
refinement
ozone
oxygen
exposed
95
ppm
exposed
exposure
weight
groups
field
ferrocene
relative
rats
mice
exposed
concentrations
adss
typical
exposed
per
children
day
care
staff
maintenance
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
calf
infection
environment
nutrition
required
antibodies
monoclonal
use
technology
production
immunomodulation
active
vaccination
main
stream
mice
oncogene
tumor
tnf
containing
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
elisa
test
flotation
samples
tests
nan
nan
nan
nan
nan
nan
nan
the
in
time
uk
legal
nan
nan
nan
indicator
environment
the
estuarine
waters
mhv
cells
kupffer
mice
induced
nan
nan
nan
nan
nan
nan
nan
virus
tge
fip
pigs
gilts
pigs
tge
infected
30
virus
rotavirus
faeces
reactions
bovine
test
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
new
vaccination
development
vaccines
well
nan
nan
nan
nan
nan
nan
nan
nan
particles
the
capsid
stool
using
aids
alcohol
prominent
vascular
endothelial
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
mice
virus
infection
c57bl
10snj
nan
nan
nan
dec
antibody
cats
vitro
five
viral
virus
respiratory
infections
patients
kits
rotascreen
specimens
two
page
nan
faeces
adf
av
la
strains
specific
the
40
41
cell
nan
nan
nan
nan
goat
rotavirus
feces
herd
page
la
et
est
des
le
macrolides
use
infections
pneumonia
acute
production
interferon
cells
children
respiratory
rotavirus
cases
rotaviruses
positive
months
nan
nan
nan
children
cultures
infections
virus
induced
nan
soil
water
may
microorganisms
rate
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
necrosis
japan
viruses
fish
infectious
viral
fish
diseases
aquaculture
infections
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
proteins
retention
golgi
the
sequences
nan
nan
nan
nan
nan
nan
abstract
fatty
acids
covalently
attached
inhibitors
antitrypsin
deficiency
reactive
centre
viruses
traffic
abstract
enveloped
exploit
nan
the
mngcs
discussed
cell
fusion
viral
infection
host
virus
development
virus
infection
experimental
viruses
developing
nan
gamma
radiation
antigens
the
inactivation
nan
nan
nan
olfactory
system
systems
one
classical
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
nan
nan
viral
meningitis
aseptic
symptoms
encephalitis
nan
nan
unknown
nan
nan
unknown
unknown
diarrhea
acute
cause
million
deaths
unknown
unknown
unknown
nan
nan
nan
keywords
enteroviruses
echoviruses
polioviruses
hepatitis
keywords
viral
gastroenteritis
faecal
extracts
keywords
enteric
viruses
effluent
disinfection
samples
keywords
efficiency
recovery
sludge
unknown
nan
nan
nan
nan
nan
nan
nan
nan
tourism
education
topic
1999
region
tourism
education
employment
careers
industry
diffusion
disease
places
spatial
health
section
01
chemistry
application
benzotriazole
unknown
nervous
system
infection
central
viral
unknown
use
tannins
chapter
historical
without
nan
nan
nan
nan
unknown
cysteine
conjugate
glutathione
mercapturate
electrophile
unknown
nan
nan
nan
nan
unknown
automated
solid
phase
oligosaccharide
synthesis
type
milk
buffalo
buffaloes
river
unknown
vaccines
strain
developed
disease
number
respiratory
wheezing
infections
important
asthma
exacerbations
viruses
asthma
copd
the
exacerbations
copd
infection
pathogens
infective
exacerbations
copd
patient
disease
treatment
unknown
nan
vaccines
immune
pathogens
system
significant
communication
it
the
communicate
one
unknown
unknown
unknown
molecular
viruses
the
provide
acid
unknown
nan
viruses
the
virus
classification
rna
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
cells
es
cell
culture
this
proteins
molecular
shared
mimicry
molecules
cell
adenoviral
vectors
per
c6
fda
recommendations
drug
the
adenovirus
nan
cell
surface
molecules
the
membrane
nan
evolution
selection
mutation
two
species
changes
genetic
rna
viruses
essentially
picornaviruses
the
virus
rna
viruses
nan
unknown
unknown
science
data
genome
the
genomic
nan
unknown
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
unknown
viruses
nucleic
acid
microorganisms
protein
viruses
cells
cell
cultures
cultivation
replication
viral
viruses
biology
bacteriophages
cell
virus
changes
cells
replication
body
surfaces
may
viruses
animal
viral
species
specific
diagnosis
animal
population
the
incidence
factors
may
diseases
generalized
this
tables
viruses
nan
nan
nan
man
mice
lcm
disease
described
nan
nan
nan
nan
unknown
nan
nan
nan
unknown
nan
nan
viruses
viral
chapter
human
animal
nan
unknown
nan
unknown
unknown
unknown
unknown
unknown
mice
mvm
replication
the
serotype
ldv
mouse
host
cell
virus
mice
laboratory
diseases
animal
zoonotic
the
increasing
disease
two
major
care
research
health
infectious
must
animals
mice
equipment
environmental
management
unknown
quarantine
the
animal
use
species
diseases
infectious
the
public
health
blood
plasma
unit
whole
volunteer
climate
diseases
infectious
changes
change
health
population
disease
civil
indicators
chapter
the
gastrointestinal
absorption
tract
pathogens
virus
water
environment
transmitted
unknown
simulation
patient
learners
clinical
educators
nan
nan
unknown
unknown
unknown
illness
agents
foodborne
result
long
enteric
common
illnesses
disease
infections
unknown
unknown
unknown
cells
abstract
eosinophils
traditionally
understood
type
milk
buffalo
buffaloes
river
viral
disease
host
diseases
environmental
replication
virus
genome
stages
viruses
nervous
system
viral
viruses
infections
rna
virus
bmv
first
replication
rna
virus
the
capsid
leishmania
dicistroviruses
the
viruses
infect
proteins
viruses
lipid
enveloped
membrane
the
virus
tool
pasc
different
the
virus
yhv
shrimp
black
tiger
unknown
water
management
diseases
health
use
unknown
unknown
unknown
viral
proteins
surrounded
may
host
virus
viral
host
understanding
replication
innate
virus
immunity
immune
response
disease
chapters
viruses
causing
particular
viruses
arteriviruses
the
roniviridae
family
unknown
foodborne
prevalence
disease
europe
used
unknown
nan
unknown
unknown
unknown
wine
food
the
associated
section
unknown
unknown
unknown
clinical
research
study
care
participants
unknown
unknown
the
enzymes
chapter
third
edition
the
enzymes
chapter
sindbis
virus
virus
protease
binding
motif
the
unknown
unknown
unknown
the
virions
nm
family
members
unknown
unknown
replication
cell
viruses
different
replicate
nan
expression
genes
gene
viruses
virus
virus
host
infections
the
infection
unknown
unknown
diarrhea
children
due
development
the
diseases
viruses
agents
virus
abstract
causes
meningitis
abstract
this
article
vaccines
drugs
authors
viral
the
immune
responses
via
involve
antigen
cells
responses
immunity
bacteria
mediated
unknown
nan
cause
disease
the
infection
normally
unknown
unknown
nan
nan
unknown
viral
genomes
nucleic
stranded
replicate
autophagosomes
autophagy
proteins
organelles
abstract
including
aeromicrobiology
bioaerosols
biological
toxins
csf
analysis
the
provides
diseases
the
cells
gastrointestinal
tract
glands
rabies
chapter
epidemiology
human
virus
species
bat
world
rabies
lyssaviruses
epithelial
pathogens
in
host
bacteria
recovery
role
the
mechanisms
infection
unknown
unknown
unknown
unknown
organic
amendments
may
threat
human
parasitic
nematodes
development
diagnostic
methods
viral
cns
may
also
agents
bio
backbones
foldamers
abstract
inspired
health
information
systems
public
monitoring
diseases
global
millions
new
control
health
public
levels
federal
organizations
health
complex
organizations
public
individual
health
public
new
policy
changes
nan
unknown
unknown
lacrimal
ocular
cells
responses
mucosal
unknown
unknown
protein
increase
biological
the
biotechnological
hbov1
children
respiratory
age
the
nan
wheezing
asthma
illnesses
recurrent
children
proteinases
virus
chapter
plant
the
nan
rats
rat
clinical
pathogens
cause
animals
health
monitoring
good
it
nan
unknown
nan
unknown
nan
nan
nan
nan
nan
nan
pml
infection
viral
cns
adem
nan
monoclonal
antibodies
passive
immunization
applications
cell
cells
culture
biology
lines
virus
chapter
viruses
respiratory
methods
antigens
virus
many
concentration
culture
viruses
chapter
methods
enveloped
versus
used
virus
chapter
em
the
unknown
business
plan
continuity
disruptions
firm
nan
fingerprinting
identification
viruses
large
oligonucleotides
viruses
absence
rna
nucleic
information
arthropod
vertebrate
virus
properties
the
viral
asthmatic
non
attacks
rates
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
host
epithelial
entry
organism
cell
damage
cell
cells
cause
inflammatory
recovery
infections
cells
complement
cell
nan
unknown
unknown
viral
may
infections
the
use
unknown
nan
nan
virus
tmv
rabbit
serum
chapter
nan
cells
immunoglobulins
lymphocytes
system
recognized
nan
health
public
communicable
international
systems
may
laboratory
animals
this
health
unknown
unknown
cooperation
harmonisation
worldwide
the
bilateral
unknown
nan
unknown
unknown
unknown
unknown
unknown
unknown
abstract
this
chapter
describes
properties
unknown
field
abstract
viral
pathogenesis
rapid
unknown
immune
schizophrenia
system
dysregulation
immunity
types
viruses
ivs
rna
subtypes
this
update
cooper
hanigan
enzymes
chemicals
gastrointestinal
tract
toxic
many
vge
self
viruses
common
food
membrane
influenza
viruses
fusion
receptor
infection
pulmonary
abstract
virtually
infections
hazards
nation
disaster
every
hazard
virus
family
known
isav
orthomyxoviruses
unknown
gene
expression
control
virus
mechanisms
virus
infection
infections
interaction
chapter
unknown
chapter
legal
administrative
biosecurity
measures
zinc
elderly
subjects
deficiency
the
molecular
docking
drug
inherent
garbage
unknown
the
systems
infectious
disease
diagnostics
cell
proteins
viruses
replication
viral
viruses
origins
evolution
virus
mutation
rna
viruses
genome
rdrp
proteins
astroviruses
viruses
star
abstract
unsegmented
blood
transfusion
safety
health
use
article
this
updated
version
previous
article
this
updated
version
previous
health
genomics
studies
genetics
genome
article
this
updated
version
previous
article
this
updated
version
previous
natural
disaster
disasters
abstract
result
unknown
infections
one
bacterial
in
agents
gut
composition
human
virome
regarding
noroviruses
food
human
commonly
genotypes
public
health
law
states
chapter
acute
infections
respiratory
life
threatening
infections
pulmonary
global
disease
problem
apes
diseases
important
infections
affecting
bats
diseases
mammals
ecological
importance
in
order
biosafety
guidelines
health
unknown
changes
genetic
the
dna
viruses
data
public
resources
available
facilitate
virus
bmv
rna
viruses
positive
alphaviruses
virus
diseases
encephalitis
available
rna
viral
ncrna
retroviral
roles
pharmacy
health
countries
healthcare
this
virus
biological
replication
viruses
relationships
resilience
systems
theories
computer
approach
coatings
tio2
oil
linseed
antimicrobial
olympic
games
beijing
surveillance
detect
unknown
common
chapter
cold
allergies
community
saliva
mouth
constituents
organic
mainly
outbreak
world
you
ebola
people
rna
enzyme
strand
rhinovirus
it
wine
food
the
associated
section
unknown
viruses
cellular
origin
considered
might
respiratory
exacerbations
viral
infections
chronic
unknown
pathogens
water
waterborne
important
world
aquatic
plants
removal
pathogen
role
water
drinking
health
pathogens
techniques
unknown
nan
nan
nan
nan
unknown
nan
unknown
nan
nan
unknown
nan
unknown
unknown
unknown
unknown
unknown
unknown
unknown
nan
nan
unknown
nan
unknown
nan
unknown
nan
unknown
unknown
unknown
nan
unknown
nan
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
pulmonary
pediatric
children
challenges
anesthetic
abstract
review
pulmonary
infections
types
nan
unknown
nan
influenza
the
viruses
na
ha
antibodies
therapeutic
monoclonal
challenge
molecules
nan
nan
air
may
alveolar
edema
pneumonia
appearance
pneumonia
multifocal
patients
opacities
antiviral
drugs
viral
nanoparticles
nanomaterials
psychological
medical
deployed
health
physical
nan
cells
cultures
cultivation
viruses
cell
virus
viruses
cell
cells
receptors
virus
infections
disease
laboratory
viruses
diseases
different
virus
the
occurrence
nan
nan
bacteria
parasites
viruses
saprophytes
chapter
tract
system
infection
organ
infections
nan
respiratory
tract
the
infections
viruses
nan
nan
unknown
unknown
unknown
unknown
nan
unknown
nan
nan
nan
nan
nan
nan
nan
unknown
nan
nan
unknown
nan
pulmonary
effects
substances
drug
this
oral
digestive
salivary
also
cavity
influenza
viruses
viral
respiratory
disease
emtricitabine
drug
hiv
inhibitors
patients
quality
safety
efficacy
standards
medicine
world
developing
countries
medicines
adequate
transport
active
solute
passive
diffusion
unknown
unknown
unknown
biomarkers
processes
biomarker
may
disease
nan
nan
membrane
solutes
abstract
life
depends
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
nan
unknown
nan
unknown
nan
unknown
nan
unknown
unknown
unknown
unknown
nan
nan
unknown
nan
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
unknown
disorders
new
section
clinical
chapter
unknown
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
unknown
nan
unknown
nan
unknown
bacteria
disease
viruses
microbes
causes
infections
respiratory
pathogens
children
nose
nan
nan
nan
nan
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
unknown
nan
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
unknown
nan
unknown
unknown
nan
unknown
unknown
unknown
nan
unknown
nan
unknown
unknown
unknown
unknown
nan
unknown
nan
unknown
unknown
nan
unknown
unknown
nan
unknown
unknown
unknown
unknown
unknown
unknown
factors
risk
ms
the
vitamin
nan
unknown
nan
nan
unknown
nan
unknown
unknown
nan
nan
nan
unknown
unknown
unknown
unknown
unknown
unknown
nan
unknown
nan
nan
unknown
unknown
nan
unknown
nan
unknown
nan
nan
unknown
unknown
nan
nan
unknown
unknown
unknown
unknown
unknown
nan
nan
nan
nan
nan
nan
nan
unknown
nan
terms
chapter
vocabulary
the
taxonomy
nan
nan
nan
nan
nan
nan
nan
unknown
soft
fruit
virus
detection
abstract
infection
hospitals
materials
cross
diseases
words
polonius
what
read
lord
nan
unknown
unknown
unknown
product
materials
factories
segregation
safety
nan
profile
the
membranes
liquid
separations
unknown
industry
overview
this
chapter
study
valve
market
the
oil
world
unknown
unknown
nan
nan
unknown
unknown
unknown
air
indoor
quality
comfort
contaminants
unknown
unknown
unknown
unknown
nan
unknown
nan
nan
nan
nan
unknown
nan
nan
unknown
nan
unknown
unknown
unknown
unknown
unknown
unknown
nan
unknown
unknown
nan
unknown
nan
unknown
nan
unknown
nan
unknown
unknown
unknown
nan
nan
nan
unknown
unknown
nan
unknown
unknown
nan
unknown
unknown
unknown
unknown
unknown
unknown
nan
nan
nan
nan
the
animals
diseases
authors
virus
nan
de
la
en
les
france
le
de
et
adolescence
maturation
de
des
δ9
thc
et
de
des
la
modifications
les
de
et
les
addictive
des
la
recertification
obligation
le
de
nan
tatouages
des
tattoos
public
plus
de
et
complications
une
les
le
la
de
les
des
disease
ad
cognitive
may
risk
de
les
et
plus
complications
de
la
des
du
patient
de
por
la
covid
19
hmpx
confidence
gps
indonesia
information
isolates
arginini
48
100
erythromycin
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
respiratory
virus
the
community
viruses
nan
covid
19
the
sars
cov
nan
nan
covid
pregnancy
and
reported
or
nan
nan
nan
rapidly
abstract
the
covid
19
disease
covid
19
pandemic
contact
nan
nan
covid
19
cardiovascular
le
virus
ace2
angiotensin
arb
covid
19
nan
nan
nan
covid
19
hospital
ability
care
nan
nan
nan
cardiac
in
surgeon
consider
need
pulmonary
embolism
covid
19
she
covid
19
000
clinical
abstract
covid
19
tracheal
patient
disease
pilot
viruses
elimination
plant
two
ion
transport
melanin
system
melanosomes
nan
ace2
human
cov
receptors
cell
sars
cov
ace2
protein
host
covid
19
spike
glycoprotein
the
ace2
cells
h3k27me3
expression
sars
roscovitine
influenza
viral
inhibitor
antiviral
influenza
virus
ppa
in
senhousei
nan
nan
nan
nan
nan
in
group
abstract
pilot
double
nan
spinal
anaesthesia
patients
covid
19
nan
nan
nan
sars
cov
the
healthcare
transmission
nan
patients
intubation
covid
19
tracheal
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
case
covid
19
presentation
keratoconjunctivitis
sars
using
docking
main
cov2
de
covid
19
la
en
nan
de
los
en
la
sars
nan
nan
los
covid
19
la
sobre
nan
la
de
non
el
cirugías
nan
nan
nan
nan
covid
19
severe
platelet
patients
positive
rt
pcr
testing
target
covid
19
patients
infection
nucleic
psp
patients
001
disease
covid
nan
infection
disease
radiology
departments
re
nan
ct
patients
thickening
sign
pleural
nan
nan
nan
nan
nan
sars
paper
spike
protein
virus
nan
nan
zinc
symptoms
placebo
allergy
subjects
nan
respiratory
infections
illnesses
studies
illness
diarrhea
pathogens
patients
associated
treatment
respiratory
cf
pollutants
exposure
air
nan
nan
nan
nan
patients
covid
19
h1n1
higher
sars
cov
infection
four
patients
nan
nan
covid
19
three
healthcare
disease
nan
nan
nan
nan
95
ci
hr
the
covid
nan
de
des
patients
mental
en
nan
nan
nan
the
clinical
trials
abstract
analysis
de
centres
la
ect
des
mental
patients
disorders
also
health
confinement
literature
isolation
covid
19
de
health
la
covid
19
nan
nan
de
2019
china
en
coronavirus
de
covid
19
la
el
nan
nan
nan
nan
nan
nan
proteasome
tppii
the
coxsackievirus
cells
nan
nan
19
sars
cov
covid
expression
pregnancy
reports
sars
covid
19
nan
unknown
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
aga
clinical
review
institute
practice
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
preppers
level
the
prepper
paper
nan
model
diffusion
virus
the
viruses
impact
pandemic
the
healthcare
digital
nan
management
researchers
academic
practitioners
education
innovation
covid
19
systems
recovering
based
models
agent
processes
immunology
nan
nan
nan
nan
removal
nai
pco
coli
famata
sampling
highbiotrap
sampler
the
microbial
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
calves
first
col
colostrum
life
nan
nan
rearing
calf
milk
feeding
calves
nan
nan
nan
nan
nan
nan
nan
dynamics
stability
we
model
viral
nan
nan
nan
nan
nan
sars
cov
receptor
structural
loop
nan
the
oxide
ma3mpo
studied
hydrogen
3a
compounds
synthesized
potential
apoptotic
compounds
l2
activity
cu
l1
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
infections
children
nonasthmatic
significantly
greater
nan
coronavirus
spike
proteins
the
number
nan
nan
nan
nan
nan
covid
19
hospital
ability
care
nan
nan
nan
nan
nan
cardiac
in
surgeon
consider
need
nan
nan
nan
nan
nan
nan
nan
nan
adrenal
hemorrhage
abstract
the
differential
sars
cov
drugs
the
rdrp
nan
nan
re
word
metric
sequence
entropy
model
diseases
novel
seir
suitable
nan
19
covid
risk
disease
potential
disease
arbs
covid
19
aceis
nan
nan
nan
nan
patients
associated
spo2
covid
19
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
levels
disease
ldl
in
surviving
19
covid
mafld
patients
severity
nan
nan
nan
nan
nan
taiwan
diplomatic
china
election
president
china
power
political
warfare
sharp
diagnostic
cap
microbiology
microbiological
performed
malaria
species
years
human
plasmodium
resistance
antimicrobial
trainees
session
issues
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
recent
viral
in
years
impressive
nan
ibv
gi
novel
lineages
ibvs
virus
ibv
quail
quails
industry
eos
nd
effect
challenge
vndv
nan
nan
cardiac
injury
covid
19
acute
nan
nan
nan
nan
nan
unknown
unknown
nan
quarantine
adherence
disease
people
we
wuhan
human
virus
transmission
home
nan
test
individuals
rapid
qpcr
sars
nan
nan
nan
study
cbrn
competencies
the
health
nan
nan
past
liz
nickels
leafs
issues
nan
ak
assay
rotavirus
extracts
ml
ii
protein
virus
infection
di
ifa
pap
canine
cpv
sections
infection
fae
normal
stages
cryptosporidial
virus
adsorption
hydroxylapatite
centrifugation
faecal
birds
virus
ilt
the
onset
rotavirus
calves
enterocytes
excretion
virus
bovine
parvovirus
infection
weaning
calves
am
swine
lps
mdp
cultures
haematological
animals
counts
clinically
normal
calves
cryptosporidia
microscopy
small
intestine
calves
colostrum
diarrhoea
whole
milk
piglets
cryptosporidium
litters
artificially
reared
the
athymic
rats
virus
infection
vaccine
calves
rotavirus
herds
diarrhoea
lesions
the
viable
infection
cutaneous
flocks
virus
infectious
bronchitis
detected
virus
similar
summary
electron
microscopic
nan
nan
nan
de
del
sars
cov
las
de
la
en
el
se
de
covid
19
en
el
nan
nan
in
covid
19
neuromuscular
nm
nan
nan
polymer
supported
oxidant
also
abstract
reaction
michael
abstract
an
efficient
haplosamates
ml
abstract
two
sponges
abstract
the
structures
reiswigins
new
radical
step
abstract
an
efficient
nan
population
we
difficile
disease
exposure
er
tula
virus
apoptosis
cells
overlapping
genes
de
novo
known
e3
hadv
cr1β
cr1γ
human
nsp4
prrsv
hp
ifn
acid
nan
nan
nan
wear
material
test
data
repeatability
gav
probe
virus
yhv
used
cod
expression
clones
fed
sbm
nan
nan
bioaerosols
emissions
biofiltration
bioaerosol
the
nan
nan
nan
nan
nan
nan
covid
19
sars
the
cov
death
rate
the
piba
based
weather
covid
19
indonesia
temperature
days
air
pollution
covid
19
lockdown
reduction
levels
pollutants
two
pollen
seasonality
flu
factor
current
no2
regions
long
term
exposure
covid
19
air
confirmed
cases
covid
19
infection
spreading
the
epidemic
curve
cases
covid
19
number
cases
the
covid
19
wastewater
sars
cov
work
rna
covid
19
daily
at
arh
the
day
14
days
coronavirus
negative
patients
rna
factors
associated
research
negative
environment
countries
air
covid
19
arima
models
prevalence
covid
19
lockdown
human
wuhan
drugs
transmission
unani
medicine
health
disease
may
covid
19
it
wbe
infected
surveillance
worldwide
identify
india
meteorology
the
restricted
regions
covid
19
world
disease
health
april
2020
covid
19
spain
spatial
could
models
covid
19
model
lockdown
day
contacts
lockdowns
ct
abstract
objective
to
raise
covid
19
thrombotic
patients
icu
nan
nan
nan
nan
fusion
proteins
protein
viral
enveloped
monoclonal
antibodies
protein
provide
virus
host
factors
rna
replication
virus
nan
virus
inhibitors
antiviral
agents
the
nan
nan
nan
nan
nan
nan
agents
the
viruses
influenza
amantadine
nan
nan
nan
mechanisms
site
protein
sorting
proteins
solid
phases
also
the
immobilized
nan
rna
interactions
structures
structure
secondary
nan
nan
nan
patients
kidney
severe
three
covid
nan
patients
kidney
transplant
sars
median
nan
nan
nan
face
to
canceled
visit
the
consultations
19
covid
consults
risk
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
hla
asthma
samples
viruses
induced
nan
nan
nan
illnesses
wheezing
children
lung
function
respiratory
tract
acute
illness
we
nan
nan
copd
bronchial
virus
mucosal
infection
nan
patients
covid
19
severe
high
nan
summary
covid
19
mild
clinical
nan
nan
viruses
perhaps
cure
infection
curious
mtb
cough
nociceptive
neurons
sl
sars
cov
binding
receptor
ace2
animals
crispr
genome
editing
large
animal
reproduction
small
scientific
unverified
nan
pathogens
associated
clinical
infant
there
information
disease
spreading
high
epidemic
nan
nan
nan
nan
nan
infection
spread
coronavirus
sars
cov
nan
patients
endodontic
patient
19
emergencies
plants
defense
herbivores
molecules
many
many
marine
chapter
indole
reactive
nan
nan
nan
de
en
la
con
el
nan
use
respiratory
patients
review
low
care
covid
19
health
management
de
la
los
care
en
de
la
en
que
las
disease
the
lung
infections
agents
nan
nan
nan
nan
countries
level
capacities
health
prevent
nan
nan
patients
infected
intensive
care
trend
nan
nan
nan
nan
nan
shelter
hospitals
fangcang
covid
19
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
clinical
disease
basic
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
children
years
abstract
during
1974
nan
nan
nan
nan
nurseries
virus
specimens
babies
examined
balkan
nephropathy
verrucosum
var
cyclopium
half
life
theophylline
plasma
month
nan
babies
fed
excreted
infection
particles
nan
antibody
ten
hdcs
rabies
vaccine
csf
mumps
antibody
virus
serum
nan
virus
like
particles
nm
electron
nan
nan
nan
experts
abstract
the
current
covid
nan
infectious
variety
techniques
agents
role
covid
19
clusters
march
2020
covid
19
decoction
lung
cleansing
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
fdi
review
published
theoretical
research
aecb
economic
cost
antimicrobial
associated
respiratory
infections
infection
picornavirus
acute
ibs
ap
the
pc
bacterial
hiv
strategies
last
field
vaccinology
nan
pandemic
covid
19
the
coronavirus
hcv
hepatitis
genotypes
virus
post
capacity
decision
making
act
weeks
tribunal
psychiatrist
health
patient
emergency
infectious
disease
surveillance
wbe
diseases
prevent
air
virus
distance
measures
nan
chiropractic
entities
report
actions
covid
nan
nan
nan
nan
nan
nan
nan
unknown
pneumoniae
children
carriage
associated
arti
nan
patients
severe
imaging
ct
lobe
nan
nan
nan
nan
nan
nan
cases
disease
19
hr
patients
sars
cov
summary
since
identification
nan
nan
nan
nan
nan
nan
nan
nan
saa
covid
19
patients
changes
nan
nan
nan
nan
contacts
sars
cov
households
household
patients
cfr
covid
19
studies
nan
nan
nan
nan
nan
nan
nan
nan
nan
pneumonia
2019
ncov
children
the
patients
asymptomatic
ct
covid
19
covid
19
group
confirmed
women
nan
nan
nan
nan
covid
19
coronavirus
disease
caused
cell
lymphocyte
patients
hospital
19
nan
nan
patients
rotavirus
per
cent
faecal
patients
children
virus
diarrhoea
measles
unknown
specimens
solid
liquid
faecal
diagnostic
nf
κb
diseases
signalling
inhibitors
nan
nan
nan
nan
nan
the
virus
infections
children
abstract
the
fear
staff
medical
anxiety
elderly
depression
anxiety
different
pneumonia
covid
19
gad
sleep
quality
nan
people
health
homeless
sleep
coronavirus
the
appeared
outbreak
anxiety
surgical
nan
health
people
mental
associated
lack
the
covid
19
health
cases
psychological
symptoms
scores
high
risk
nan
education
closures
learning
countries
implemented
health
mental
covid
19
services
nan
refugees
the
covid
19
face
health
mental
college
students
challenges
nan
health
11
the
covid
19
nan
nan
nan
nan
nan
cells
antiviral
virus
in
γδ
episodes
patients
rrti
number
tg
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
rvp
dlb
complications
respiratory
perioperative
children
hospital
procedures
risk
exposure
covid
19
currently
treatments
clinical
hrvs
icam
receptor
virus
single
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
nan
rt
hmpv
lamp
pcr
human
porcine
tgev
iecs
infection
study
nan
nan
nan
nan
particles
recombinant
baculovirus
virus
clp
nan
covid
19
neurological
possible
emerging
substance
recently
one
peptide
two
nan
infections
viral
studies
virus
lesions
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
m2
antivirals
virus
the
ongoing
μm
sars
cov
effective
compounds
possible
ivermectin
anti
viral
sars
type
interferons
activity
clinical
cov
viral
rdrp
sars
cov
rna
nan
patients
covid
19
myocarditis
myocardial
nan
nan
nan
disease
covid
19
patients
coronavirus
nan
nan
unknown
test
herds
postpfree
testing
btm
nan
nan
age
mortality
rag
paper
longevity
nan
systems
healthcare
network
networks
providers
inactivation
methods
cold
plasma
field
infection
covid
19
radiation
oncology
singapore
the
outbreak
disease
covid
covid
abstract
as
19
pandemic
nan
nan
nan
nan
nan
rna
secondary
structures
rnavlab
the
respiratory
public
model
related
factors
unknown
unknown
cell
models
animal
lines
gut
nan
viral
m1
virus
membrane
components
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
p7a
rich
motif
nuclear
nucleolar
rna
protein
core
viral
cyclization
group
ped
pedv
large
outbreak
virus
prrsv
host
strategies
cellular
ngs
viral
variants
sequencing
ability
pdcov
vaccine
pigs
ch
xjyn
vcp
eva71
ufd1
infection
knockdown
codon
usage
sars
cov
composition
nan
nan
nan
gastroenteritis
agents
diarrhea
causes
treatment
gastroenteritis
viral
treatment
therapy
chapter
understanding
intestinal
transport
molecular
chapter
immune
response
mucosal
rv
infection
cvs
recombination
viruses
et
al
aichi
virus
the
samples
antibody
nan
diseases
infections
viruses
the
viral
vaccines
polio
virus
disease
developed
influenza
virus
epidemics
also
data
viruses
mumps
measles
children
adults
vaccine
vaccines
antiviral
drugs
infections
nan
nan
nan
nan
covid
19
diabetes
sars
cov
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
case
telemedicine
pandemic
nan
nan
nan
nan
nan
covid
19
cases
globally
unknown
sars
aa
cov
mers
viruses
the
mask
health
face
time
disease
in
recent
coronavirus
covid
nan
nan
nan
covid
19
effective
the
health
covid
19
sars
analysis
cov
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
ttds
melanoma
patients
black
days
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
nan
nan
nan
nan
nan
nan
nan
nan
water
alcohol
ozonized
bacteria
participants
nan
nan
nan
nan
nan
nan
nan
incidence
non
infections
due
pathogens
nan
nan
contacts
covid
19
contact
close
nan
nan
nan
nan
nan
nan
tv
intubation
the
pogo
use
rsi
patients
intubation
phase
airway
endotracheal
pressure
tube
cuff
physicians
nan
unknown
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
group
tonsillitis
azt
patients
recurrent
nan
nan
nan
covid
19
the
infection
hearing
risk
health
it
higher
surgeons
19
covid
respiratory
abstract
since
care
patients
the
services
covid
pandemic
regarding
several
rhinology
discuss
nan
nan
nan
nan
nan
nan
laboratory
difficile
testing
outbreaks
disease
members
group
clinical
knowledge
network
nan
nan
virus
respiratory
assay
rva
inc
tests
rapid
patient
clinical
microbiology
nan
nan
nan
influenza
the
packet
season
comprehensive
hh
patient
compliance
care
staff
water
legionella
system
hospital
hot
care
health
ipc
family
countries
health
hais
care
simulation
models
health
hygiene
hand
literacy
practices
mp
children
hospitalized
pathogens
among
nan
nan
nan
nan
nan
emotions
nurses
covid
19
patients
nan
icns
stress
turnover
organizational
culture
nan
nan
amr
global
settings
hygiene
infection
nan
nan
nan
nan
nan
nan
nan
ed
older
adults
care
geriatric
nan
de
la
en
el
se
de
la
pacientes
patients
en
de
la
2019
sars
cov
covid
19
spanish
respiratory
care
pandemic
series
recommendations
abstract
on
nan
nan
in
consensus
framework
ethics
spanish
nan
nan
nan
nan
de
en
las
han
la
nan
nan
nan
nan
nan
de
la
en
con
coronavirus
de
la
en
el
sars
de
la
en
los
pacientes
nan
nan
nan
nan
nan
nan
nan
de
la
en
el
se
hiv
vaccine
aids
development
major
nan
de
la
en
los
que
de
los
modelos
models
en
cov
de
la
sars
el
de
la
para
care
decisiones
de
la
en
sars
el
nan
nan
nan
changes
the
pandemic
neurological
care
china
it
abstract
since
mid
nan
variables
health
fatality
set
epidemic
nan
nan
nan
drugs
diseases
repurposing
new
various
et
de
infection
infections
extensive
nan
nan
nan
nan
clinical
sars
cov
2020
pandemic
nan
hiv
aids
become
therapy
haart
articles
database
chinese
medicine
tcm
influenza
virus
jinchai
cell
cells
guidelines
cold
the
exterior
syndrome
medicine
tcm
aids
used
treatment
unknown
unknown
unknown
patients
covid
19
icu
malnutrition
people
virus
never
seen
humans
vaccination
flu
viruses
well
established
killer
pandemic
likely
ever
where
nan
we
understand
pandemic
data
who
calls
testing
countries
worldwide
the
world
learn
lessons
china
the
new
coronavirus
small
threat
nan
nan
sorting
week
supernovae
absolute
zeros
nan
with
coronavirus
pandemic
getting
worse
nan
how
long
viruses
like
cold
the
new
coronavirus
may
upending
around
fifth
global
population
lockdown
there
much
enthusiasm
promising
medicines
the
uk
government
released
scientific
it
easy
spread
virus
without
nan
the
way
society
functions
us
models
new
coronavirus
spread
imperfect
nan
keep
there
never
important
time
nan
victorian
corpse
displays
sparked
john
outsourcing
public
healthcare
to
supply
nan
infections
abstract
the
article
focuses
infections
management
complications
foreign
ear
nan
nan
groups
strains
ibv
lx4
lhb
rh120
strain
s1
yz
like
nan
nan
vaccine
fund
us
innovation
delivery
nan
vaccination
diffusion
disease
model
infectious
care
omfs
safety
patients
provide
march
covid
19
pandemic
cancelled
2020
pandemic
provide
abstract
on
we
procedures
transfer
patient
procedure
nan
nan
nan
nan
nan
nan
plans
china
paper
based
emergency
nan
high
level
pollution
respiratory
lethality
nan
nan
nan
diagnostic
virology
services
increasingly
available
viral
diagnosis
techniques
rapid
laboratory
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
patients
covid
19
disease
hemodialysis
nan
mnzn
ferrites
applications
magnetic
properties
nan
nan
nan
nan
nan
nan
nan
nan
agents
disintermediation
trend
travel
hotels
nan
de
la
las
agudizaciones
el
nan
nan
exacerbations
viral
isolations
bacterial
symptoms
de
covid
19
en
el
document
patients
spanish
society
information
nan
de
la
que
el
pleural
nan
unknown
unknown
nan
de
la
19
en
covid
nan
nan
de
la
por
el
covid
angiotensin
ace2
system
covid
19
nan
nan
nan
patients
hospital
the
outcomes
cardiac
nan
nan
studies
transmission
we
evidence
risk
nan
nan
energy
emission
transport
savings
reductions
nan
sec
molecules
molecular
chromatography
also
chapter
separation
oligomeric
this
in
nan
nan
nan
nan
nan
nan
patients
covid
19
ktx
recipients
nan
nan
pneumonia
covid
19
transplant
recipients
nan
high
surgeries
major
priority
cancer
nan
nan
nan
nan
nan
nan
nan
nan
we
pca
population
infective
described
droplets
μm
droplet
rh
10
air
virus
infectious
test
medium
samples
951
parvum
cryptosporidium
diarrheal
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
china
infectious
2019
covid
19
burn
pandemic
infectious
burn
pandemic
the
centers
care
capsaicin
pharyngeal
induced
application
solution
smog
health
related
hazard
data
nan
nan
nan
could
the
covid
19
rate
nan
covid
19
world
coronavirus
outbreak
sars
cov
countries
bcg
vaccine
nan
cell
host
infectivity
virus
proteases
host
pathogen
virus
toxoplasmosis
behavioral
males
covid
19
number
cases
patients
covid
19
diabetes
prognosis
nan
nan
covid
19
respiratory
treatments
conditions
control
optimal
model
three
strategies
ai
public
sector
digital
potential
nan
de
la
los
las
en
infections
allergic
target
organ
reaction
nan
nan
nan
respiratory
asthma
studies
exacerbations
individuals
respiratory
infections
bronchial
inflammation
allergic
factors
severe
acute
asthma
medical
sinusitis
role
bacteria
inflammatory
much
pneumomediastinum
asthma
the
subcutaneous
emphysema
et
des
de
system
cells
les
la
15
plus
sont
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
et
de
les
des
la
nan
nan
nan
nan
de
un
est
mycoplasma
pneumoniae
urban
buildings
ieq
naturally
ventilated
lift
up
wind
buildings
air
evaporation
the
droplets
study
approach
nan
nan
nan
nan
hydrogen
h2
vehicles
refueling
fuel
medical
chinese
hospitals
system
reform
entities
findings
tracheal
tumors
tracheobronchial
19
covid
patients
severe
respiratory
social
research
dialogue
china
media
nan
nan
network
systems
years
constituents
networks
infection
viruses
cell
nervous
viral
nan
solver
high
time
efficiency
parareal
nan
hospitals
the
diseases
infectious
health
nan
nan
india
epidemic
deaths
cases
model
nan
sars
covid
19
india
cov
unknown
infectious
selenium
poultry
immune
diseases
nan
nan
nan
nan
nan
nan
nan
nan
fcov
cats
italian
sequences
feline
nan
nan
nan
nan
global
infection
rates
pandemic
this
population
admissions
given
paediatric
per
disease
free
media
coverage
equilibrium
patterns
control
infectious
diseases
disease
epidemic
spreading
we
networks
traffic
population
region
disease
removal
susceptible
covid
19
infection
respiratory
management
nan
nan
eid
expertise
eids
human
management
nan
nan
nan
units
outbreaks
neonates
neonatal
care
nan
nan
bronchitis
treatment
acute
involved
for
de
et
la
des
epp
de
patients
critères
et
chez
de
des
en
la
et
nan
nan
nan
nan
nan
group
lung
crp
levels
severe
nan
nan
anosmia
patients
covid
19
we
infection
du
les
une
de
respiratory
infections
the
enteroviruses
upper
patients
specific
antibodies
influenza
virus
nan
nan
agglutination
techniques
faeces
electron
microscopy
nan
angina
clinical
infection
due
the
acute
otitis
media
middle
persistent
nan
nan
nan
nan
nan
health
preparedness
emergencies
western
pacific
management
animals
this
the
monitoring
methods
identification
pathogens
bacteria
food
animals
one
the
stages
pair
microarray
detection
microarrays
methods
antimicrobial
assays
time
this
tacs
real
patients
the
ct
consolidation
hrct
rrt
pcr
ct
patients
days
years
patients
aged
hrct
18
coronavirus
covid
19
disease
detection
nan
the
patients
ct
ground
glass
nan
nan
nan
nan
nan
nan
nan
nan
nan
unknown
fungal
infections
assay
pcr
invasive
studies
disease
risk
the
parkinson
meningitis
diagnosis
tuberculous
subacute
early
per
the
reye
syndrome
emerged
nan
nan
nan
nan
nan
nan
nan
nan
cardiovascular
covid
19
disease
care
nan
19
covid
patients
disease
heart
nan
nan
nan
nan
nan
ace2
sars
angiotensin
disease
receptor
care
critical
systems
may
training
covid
19
disease
thrombotic
patients
nan
covid
19
care
disease
patients
nan
nan
nan
nan
covid
19
respiratory
patients
suspected
nan
nan
nan
loose
fitting
chest
compression
swpf
nan
covid
19
pulmonary
embolism
may
nan
nan
nan
disease
covid
19
virus
exponentially
nan
nan
nan
nan
nan
nan
nan
nan
limit
patient
as
current
covid
treatment
covid
19
available
therapies
nan
hiccups
reflex
48
persistent
history
covid
19
complications
cardiovascular
the
cardiac
covid
19
injury
care
the
patients
features
chest
ct
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
personal
skin
pandemic
nan
nan
nan
nan
nan
rail
national
system
franchising
east
unknown
driven
approach
human
governments
western
nan
nan
nan
nan
nan
vascular
face
the
protocol
reorganization
nan
nan
nan
nan
media
engagement
government
citizen
crisis
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
cough
de
la
toux
des
nan
nan
nan
nan
unknown
unknown
unknown
unknown
unknown
unknown
unknown
nan
nan
nan
80
if
154
serology
rsv
unknown
nan
nan
cases
test
diagnosis
respiratory
11
nan
nan
nan
nan
virus
influenza
lysis
swine
alveolar
rna
electrophoretypes
rotavirus
isolates
summary
nan
nan
nan
nan
nan
nan
nan
unknown
nan
covid
19
pandemic
care
document
covid
19
may
ecg
the
nan
measures
the
included
covid
19
acs
patients
lombardy
cardiovascular
including
nan
nan
cases
brsv
bpi
pneumonia
cells
licl
cvb3
viral
myocarditis
virus
cov
pid
viruses
transmission
levels
ccov
canine
coronavirus
strain
circulating
nan
nan
care
the
delivery
arthroplasty
elective
education
orthopaedic
the
covid
19
arthroplasty
care
face
the
personal
the
patients
time
virus
healthcare
nan
covid
19
practices
ppe
patients
the
patients
technologies
adoption
digital
nan
going
sars
cov
members
elective
healthcare
patients
care
the
clinical
nan
nan
nan
nan
nan
new
infants
abstract
an
extensive
nan
nan
care
we
propose
palliative
goals
telemedicine
care
covid
19
palliative
children
palliative
care
teams
consider
cancer
home
care
patients
coronavirus
nan
care
strategy
pandemic
palliative
the
care
spcs
palliative
specialist
global
symptom
management
communication
clinical
covid
covid
19
response
care
rapidly
nan
cluster
icu
nurses
symptoms
in
care
covid
19
palliative
pandemic
palliative
care
health
services
areas
care
inpatient
palliative
telepalliative
medicine
nan
front
usual
covid
19
burnout
grief
covid
19
providers
care
family
physical
centered
care
maintaining
care
patients
palliative
covid
19
nan
studies
abstract
during
last
three
mental
health
staff
psychological
medical
nan
cov
neurological
infections
cause
severe
nan
also
covid
19
psychological
infection
nan
nan
nan
nan
nan
nan
nan
pnirs
asia
pacific
china
psychoneuroimmunology
19
google
searches
wash
hands
19
related
covid
pandemic
neuropsychiatric
nan
nan
respondents
health
covid
19
stress
symptoms
workers
physical
healthcare
stress
nan
covid
19
medical
conditions
risk
nan
nan
or
distress
psychological
19
temperament
covid
19
infection
treating
potential
nan
nan
nan
nan
psychological
distress
including
symptoms
anxiety
markers
relevance
the
noun
verb
nan
nan
nan
nan
95
rt
detection
rpa
rapid
microbiome
high
platform
the
throughput
nan
nan
nan
nan
cases
cardiac
ultrasound
care
echocardiography
nan
nan
covid
19
acute
associated
care
ase
recommendations
reports
patients
information
nan
nan
nan
nan
varying
dynamical
system
behaviors
parameters
anti
covid
19
drugs
coronavirus
covid
19
crs
syndrome
induced
ace2
sars
cov
may
expression
19
covid
anti
viral
sars
19
covid
ct
cxr
may
ct
initial
imaging
imported
cases
nan
3d
face
reusable
mask
components
nan
nan
nan
nan
nan
schizophrenia
may
research
relevant
covid
nan
nan
nan
coli
casei
lambs
etec
lactobacillus
nan
nan
nan
nan
nan
nan
nan
patients
cancer
19
covid
severe
nan
nan
nan
nan
nan
nan
nan
egg
white
anti
ovomucin
functional
cell
models
review
intestinal
food
transition
based
sustainable
towards
primarily
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
coronavirus
cov
respiratory
syndrome
sars
nan
sars
cov
china
current
incidence
novel
coronavirus
the
sars
cov
patients
hydroxychloroquine
viral
efficient
19
respiratory
sars
2019
disease
viral
coronavirus
covid
19
sars
cov
patients
severe
il
number
large
covid
19
treatments
in
coronavirus
the
sars
clq
cov
protein
diseases
the
communicable
covid
19
nan
nan
nan
nan
nan
nan
covid
19
pep
exposure
outbreak
nan
aiv
anti
h5
fp
detection
nan
nan
risk
model
supply
chain
inventory
operational
disruption
efficiency
resilience
conditions
measures
mitigation
risk
taken
current
tio2
bacteria
antibody
coli
particles
microorganism
the
cell
approach
review
nan
nan
tb
incidence
mortality
study
per
nan
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
certain
chest
ct
covid
19
disease
the
children
covid
19
pneumonia
severe
cases
nan
nan
nan
nan
nan
nan
nan
nan
nan
respiratory
virus
cell
cells
tract
nan
nan
nan
nan
nan
nan
nan
unknown
unknown
nan
nan
unknown
unknown
nan
nan
nan
nan
covid
19
cardiovascular
patients
diseases
covid
19
cvd
patients
medical
nan
nan
kd
markers
therapy
genetic
factors
anti
well
element
the
studies
onfh
renal
incidence
group
basiliximab
patterns
pattern
spm
nonoverlapping
closed
nan
nan
delivery
dna
synthetic
newer
vaccines
vaccine
immunogens
recent
human
provide
cgas
sting
pathogens
cytosolic
dna
nan
nan
nan
nan
nan
nan
nan
nan
nan
ace2
angiotensin
receptors
ii
sars
nan
ct
pcr
rt
chest
initial
nan
covid
19
respiratory
droplets
therapy
disease
2019
results
coronavirus
patients
nan
nan
detection
biosensors
electrochemical
pathogen
terms
acyclonucleoside
the
studies
abstract
synthetic
number
events
cover
developments
membrane
as
china
reported
previously
newsletter
nan
nan
nan
nan
nan
the
water
puzzle
membrane
protein
covid
19
children
course
treatment
nan
covid
19
patients
health
oncology
nan
nan
the
covid
19
patients
high
compounds
the
title
prepared
bromophenoxy
nan
daily
new
cases
covid
19
nan
nan
covid
19
impact
abstract
the
cov
sars
pangolin
ratg13
like
nan
endocytosis
viruses
immunodeficiency
hiv
essential
nan
nan
nan
nan
kda
106
aminopeptidase
115
cryiac
urethra
related
bph
wm
tcm
nan
nan
nan
nan
nan
nan
nan
nan
sars
cov
et
al
related
bat
influenza
abstract
major
histocompatibility
measles
outbreaks
vaccination
public
health
no
effective
treatment
common
colds
nan
nan
nan
nan
hlh
involvement
severe
patients
et
covid
19
gbs
patient
2019
nan
renin
inhibitors
angiotensin
ras
cardiovascular
the
global
coronavirus
health
scare
nan
facial
recognition
firms
launched
slew
the
facial
world
economic
forum
nan
global
long
term
covid
19
nan
nan
nan
market
od
markets
analysis
passenger
nan
digestive
covid
19
liver
patients
pandemic
this
abstract
the
coronavirus
orthopaedic
surgeons
the
important
abstract
nan
epidemic
covid
19
nutritional
care
de
nutrition
la
en
patients
nan
nan
nan
nan
nan
nan
nan
et
les
examens
pour
que
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
fly
ash
slag
mwi
heavy
china
covid
19
acupuncture
moxibustion
filtration
air
applications
aerosol
media
death
epidemic
network
in
susceptible
cases
the
case
specimens
different
patients
surgery
covid
19
in
px
uv
cleaning
reduced
pre
dental
pandemic
care
covid
19
the
mortality
covid
19
rate
nan
nan
nan
cancer
covid
19
sars
cov
nan
ifnλ4
hcv
type
iii
clearance
nan
rnase
rnas
ifn
cellular
discovery
nan
nan
nan
lh
sars
cov
cells
antiviral
nan
nan
nan
nan
nan
nan
nan
nan
rna
viral
recombination
coronaviruses
genome
viruses
families
contain
among
common
health
human
spreading
world
infectious
children
series
viral
serious
respiratory
treatment
the
viral
children
patients
nan
nan
nan
nan
nan
treatment
pharyngitis
caused
group
diagnosis
pharyngitis
pathogens
hemolytic
streptococci
bacteria
nan
nan
nan
nan
expression
use
nanobody
sequence
eukaryotic
nan
nan
nan
unknown
immunity
viral
shrimp
crustaceans
antiviral
measures
paper
ir
current
useful
china
disease
2019
covid
19
nan
entropy
rna
virus
anfis
feature
nan
covid
19
care
disease
pandemic
diarrhea
patients
hiv
use
health
pathogens
mucosal
the
small
intestine
frequent
colonic
the
gastrointestinal
hiv
nan
coronavirus
covid
19
cardiovascular
severe
risk
the
approach
patients
staff
nan
nan
singapore
covid
19
abstract
the
the
thoracic
challenge
coronavirus
management
nan
nan
nan
nan
nan
nan
nan
exosomes
ltxrs
rvi
viral
signaling
nan
recipients
htx
sars
cov
we
nan
nan
nan
nan
nan
nan
nan
nan
nan
patients
public
pediatric
hospital
singapore
nan
cardiovascular
covid
19
sars
cov
nan
nan
production
management
this
review
article
aviary
passerines
birds
housed
species
species
ocular
disorders
rabbits
rodents
quicklime
steam
treatments
litter
pathogens
litter
four
broiler
re
utilization
beetles
darkling
the
dbh
vectors
nan
covid
19
coronavirus
disease
status
nan
nan
nan
nan
covid
19
adrd
individuals
pandemic
nan
nan
nan
rna
the
analysis
northwestern
proteins
nan
nan
nan
nan
nan
covid
19
high
proportion
troponin
nan
nan
care
novel
world
march
this
nan
algorithm
ppe
interventional
covid
19
nan
nan
nan
nan
collaborative
state
patient
incident
command
novel
covid
19
patients
in
sars
cov
vaccines
first
late
et
al
via
summary
zhou
unknown
situ
electron
microscopy
conference
the
patients
covid
19
imaging
ggo
phase
disease
ct
coronavirus
better
nan
nan
nan
covid
19
chest
infection
radiology
nan
nan
provides
programs
abstract
this
article
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
lung
covid
19
ultrasound
condition
nan
covid
19
patients
pandemic
000
nan
nan
nan
hsct
guidelines
blood
ois
recipients
nan
nan
infection
removal
tivap
port
patients
19
cellular
pharmacy
clinical
covid
nan
necrotizing
enterocolitis
the
bacterial
illness
autophagy
functions
intracellular
pathogens
recent
enterovirus
autophagy
infection
process
cellular
golgi
proteins
carriers
in
sorting
intracellular
pylori
autophagy
bacteria
infection
nan
nan
nan
nan
nan
nan
nan
unknown
nan
unknown
unknown
nan
nan
nan
authors
the
article
this
retracted
nan
nan
nan
nan
nan
nan
nan
nan
nan
de
la
2020
el
las
de
la
el
enfermería
los
de
el
tratamiento
las
correcto
nan
nan
nan
nan
nan
nan
cmv
pj
pcr
samples
ifa
nan
de
en
la
cancers
des
nan
nan
nan
patients
influenza
age
cases
years
nan
nan
atypical
pathogens
pneumonias
the
infections
nan
nan
nan
nan
nan
nan
chlamydia
pneumoniae
asthma
worldwide
respiratory
nan
nan
nan
nan
ed
clinical
infection
rdts
studies
nan
respiratory
symptom
virus
patients
viral
nan
nan
sars
covid
19
mers
the
nan
nan
rt
assay
sars
cov
lamp
nan
nan
covid
19
patients
663
001
nan
nan
nan
nan
nan
nan
unknown
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
china
sars
cov
covid
19
growth
south
korea
nan
patients
clinical
abnormal
score
higher
asymptomatic
days
found
patient
discharged
covid
19
case
family
members
patients
group
severe
there
covid
children
cases
covid
19
report
time
19
real
covid
cfr
covid
19
patients
death
the
patients
epidemiological
clinical
19
in
2019
coronavirus
the
ncov
sars
nan
covid
19
ct
fibrosis
air
influenza
coronavirus
covid
19
sars
feb
disease
2020
input
population
swabs
nasopharyngeal
oropharyngeal
positive
rate
epidemic
covid
19
growth
rate
sewage
sars
cov
isolation
wards
patients
symptoms
ace2
2019
digestive
influenza
age
rsv
associated
prevalence
nan
the
hubei
province
regions
covid
interest
infected
time
cases
highest
asymptomatic
cases
showed
transmissibility
abstract
invasive
mucormycosis
pulmonary
diagnosis
fungal
de
la
en
infecciones
prevención
nan
health
the
in
system
implemented
nan
nan
nan
nan
nan
nan
diabetes
type
diabetic
care
million
nan
nan
treatment
local
case
treatments
the
de
la
patients
des
en
di
la
il
una
ventilazione
nan
nan
sars
cov
ace2s
bats
direct
nan
response
interest
oriented
abstract
this
sars
cov
in
potential
animals
chl
hchl
sars
treat
cov
host
covid
19
coronavirus
immune
nan
di
la
il
disidratazione
una
di
la
un
del
il
les
la
infection
de
des
de
les
non
sont
et
les
des
et
de
cette
fireworks
ddp
aerosols
found
deepawali
models
information
diffusion
model
research
article
this
scientific
retracted
elsevier
nan
rotavirus
per
cent
outbreak
abstract
patients
bacterial
organisms
sputum
pneumoniae
pcr
tgev
pedv
dual
virus
care
intensive
unit
disease
covid
treatment
specific
covid
19
anti
clinical
evaluation
antimicrobial
respiratory
severity
nan
number
events
cover
developments
sealing
nan
nan
nan
nan
particle
ion
the
emission
air
deposition
particles
particle
the
air
aviation
rf
total
induced
cirrus
air
cleaning
indoor
the
technologies
o3
hong
kong
formation
photochemical
cabin
contaminant
the
fields
environment
nan
the
pandemic
time
covid
19
nan
uk
h1n1
biosecurity
spread
infectious
nan
rna
control
within
regulatory
motifs
il
1β
virus
viroporin
inflammasomes
epidemics
disease
models
epidemic
population
techniques
clinical
disease
testing
infected
malaria
history
illness
examination
the
wheezing
disease
infancy
children
recurrent
exacerbations
copd
considerable
abstract
chronic
failure
respiratory
two
maintain
arterial
nan
taiwan
incinerators
waste
energy
control
spl
activity
chitin
lectin
binding
nan
nan
nan
nan
nan
aptamers
target
dendrimers
rna
in
virus
systems
replicons
rna
viruses
virus
in
outbreaks
pandemic
coronavirus
nan
rights
access
developed
countries
fundamental
three
antivirals
antiviral
species
virus
interpol
cybercrime
threat
response
ctr
marriott
international
revealed
suffered
data
nan
productivity
airlines
increase
emissions
growth
transportation
carbon
emissions
energy
the
mitigation
emissions
biomass
resources
china
nan
nan
levels
humidity
the
diwali
increase
sars
avian
flu
deaths
run
channel
wide
inventory
transshipment
warehouse
nan
cl
care
patients
covid
19
nan
nan
ecps
use
would
ppe
also
control
complexities
dynamic
ecological
systems
nan
nan
nan
covid
19
surgery
risks
head
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
increasing
sensitive
sensors
electrospun
nanomaterials
protein
fluorescence
researchers
fluorescent
diverse
filter
the
efficiency
fiber
fibers
well
diseases
pathogens
commercial
associated
well
diseases
pathogens
commercial
associated
uv
tio2
h2o2
s2o8
degradation
tio2
pu
visible
light
ag
cl
chrysin
baicalein
new
system
nan
diarrhea
rotavirus
samples
viral
children
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
hbov
respiratory
infection
positive
children
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
hpiv
respiratory
infections
viruses
hpivs
uip
hbov
acute
could
confirmed
rsv
co
infection
respiratory
positive
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
ev
d68
strains
2016
study
health
the
well
healthcare
covid
patients
results
19
sars
cov
nan
nan
patients
severe
type
19
china
covid
19
severe
cell
patients
nan
sars
cov
surveillance
we
minipools
nan
nan
nan
data
health
surveillance
notification
epidemiologic
patients
clinical
h1n1
hiv
aids
nan
nan
tests
99
98
covid
19
nan
nan
antenna
band
ghz
the
patch
nan
nan
nan
nan
nan
travel
the
agency
research
agencies
supply
aspects
health
wellness
spa
disaster
tourism
preparedness
response
management
crisis
tourism
disaster
management
destination
swine
flu
global
financial
crisis
sars
the
health
main
political
nan
covid
19
therapies
cell
based
intensity
use
proportion
agricultural
shocks
iaps
ecological
health
management
socio
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
immune
innate
system
adaptive
infection
nan
cov
2019
sars
development
coronavirus
vaccination
immune
signatures
baseline
prior
nan
health
outbreak
covid
19
public
the
pandemic
disease
ophthalmologists
abstract
infertility
pandemic
coronavirus
covid
19
patients
situation
art
women
collection
nan
coronavirus
latest
infected
individuals
infection
nan
mbp
plasma
treatment
ttp
tpe
unknown
medical
we
development
countermeasure
in
nan
dose
mers
group
chadox1
adverse
000
infections
intervention
singapore
number
patients
covid
19
the
clinical
nan
nan
nan
nan
nan
viral
load
patients
respiratory
anti
19
patients
covid
clinical
paediatric
disease
viral
years
the
we
nan
nan
nan
capacity
locations
cases
detection
imported
epidemic
jan
we
period
the
nan
nan
nan
nan
nan
nan
china
age
fatality
ratio
case
nan
nan
nan
dose
group
participants
mers
mva
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
disease
testing
church
covid
19
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
medicine
modern
traditional
chinese
tcm
control
complexities
dynamic
ecological
systems
nan
nan
rosen
models
ideas
approach
mathematical
infection
the
disease
concentration
prevalence
nan
nan
prioritization
urology
care
must
the
unknown
students
acquisition
respiratory
symptoms
medical
nan
nan
nan
nan
nan
covid
19
rapid
virological
diagnosis
nan
nan
nan
videos
mandarin
youtube
english
useful
nan
nan
nan
nan
nan
nan
nan
medications
covid
19
sars
cov
coronavirus
drug
novel
remdesivir
the
nan
nan
nan
cases
covid
19
bolivia
patients
cases
the
province
confirmed
jiangsu
nan
nan
nan
nan
home
people
quarantine
participants
study
nan
nan
patients
we
patient
treatment
cure
covid
19
infection
this
report
nan
nan
nan
nan
nan
2019
ncov
nucleic
acid
covid
nan
nan
asymptomatic
covid
19
cases
many
nan
nan
social
covid
19
measures
religious
wastes
plants
parasites
may
the
diabetes
internet
outcomes
satisfaction
cholesterol
nan
nan
patients
severe
covid
19
clinical
nan
covid
19
period
long
patients
individual
risk
sars
cov
assessment
nan
lupus
sars
cov
patients
might
may
severe
complications
well
develop
caused
the
diseases
disease
virus
care
common
infections
day
illnesses
nan
influenza
gene
pandemic
2009
diagnostic
nan
nan
nan
nan
nan
nan
nan
rt
lamp
covid
19
assays
epilepsy
covid
19
patients
disease
nan
nan
nan
nan
nan
care
nursing
facilities
acute
rooms
nan
nan
nan
nan
nan
nan
nan
nan
nan
virus
viral
many
antiviral
development
performance
detection
values
algorithms
parameter
spread
airborne
disease
forecasting
virus
nan
time
nurse
article
share
crisis
nan
nan
nan
nan
nan
nan
nan
sars
cov
diarrhea
ace2
patients
nan
patients
diarrhea
sars
cov
without
nan
nan
nan
nan
drug
care
pharmaceutical
module
covid
nan
nan
nan
covid
19
impacts
economic
either
financial
markets
it
risks
global
nan
ct
the
chest
imaging
covid
covid
19
examinations
radiology
department
nan
nan
nan
mci
plan
covid
19
department
infection
covid
19
disease
transmission
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
inherited
syndrome
patients
nan
we
covid
19
global
health
nan
nan
nan
exacerbations
copd
chronic
obstructive
disease
nan
nan
nan
korean
in
solitary
case
year
acute
covs
severe
disease
zoonotic
covid
19
cases
community
possible
community
pandemic
pc
covid
19
countries
sars
cov
colombia
patients
health
services
covid
19
healthcare
pandemic
health
communications
reinforce
behaviors
nan
care
covid
19
hospital
pharmacists
health
pharmacy
public
pharmacists
ep
19
covid
pharmaceutical
drug
management
pandemic
covid
systems
chronic
facilities
nan
health
public
pharmacists
covid
19
health
public
pharmacists
covid
19
hcq
alone
cq
azithromycin
qt
nan
nan
nan
nan
nan
nan
nan
covid
2019
cov
humans
severe
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
exotic
practice
veterinary
medicine
equipment
results
blood
although
interpretation
rabbits
ferret
left
month
history
examination
nan
patients
rrt
the
receiving
kidney
nan
nan
nan
rv
codon
usage
results
the
bat
hantaviruses
borne
rodents
insectivores
covid
19
coronavirus
treatment
severe
nan
nan
nan
p2x7
nlrp3
ali
il
inflammasome
age
nlr
to
covid
19
2019
immunotherapy
the
ncov
review
sars
cov
new
infection
coronavirus
cells
atopic
the
effector
allergic
cells
cytokines
antigen
mhc
also
prosthesis
training
limb
amputee
system
outbreak
detection
model
rate
high
covid
19
treatment
ra
drugs
nan
nan
nan
system
health
awareness
global
availability
nan
nan
nan
nan
pa
pes
chronic
group
fev1
bcc
contaminans
cepacia
18
incidence
bcc
sd
year
lung
controls
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
protein
factors
synthesis
components
initiation
nan
altitude
virus
data
high
sars
nan
pdis
ctc
cancer
diagnostic
tumor
nan
mucus
mucosa
clay
aggressors
gut
antiviral
agents
natural
viruses
may
discussed
publication
publisher
summary
this
activity
discussed
publication
acid
publisher
discussed
publication
publisher
summary
this
iridoids
isolated
the
secoiridoids
biological
nan
nan
nan
particles
in
beneficial
harmful
active
recent
chapter
discusses
molecular
novel
modeling
epidemics
models
based
individual
de
data
datos
que
los
de
el
en
rotavirus
la
nan
de
en
el
los
se
nan
nan
pneumonia
the
common
disease
mortality
nan
sarcoidosis
disease
lung
diagnostic
genetic
viral
asthma
infection
il
th1
nan
nan
nan
disease
infection
patients
clinical
treatment
nan
hcv
gn
associated
autoimmune
renal
melioidosis
leptospirosis
scrub
typhus
rural
nan
virus
les
de
la
et
de
la
et
une
soins
nan
nan
nan
nan
nan
host
species
vector
transmission
infectious
de
la
las
en
los
le
la
di
delle
dei
nan
hct
outcomes
cell
transplant
potential
nan
pbmc
ribavirin
pha
il
10
nan
tcm
epidemic
coronavirus
number
infection
ca
transplant
recipients
rvi
rvs
mortality
th17
patients
abstract
covid
patients
19
covid
respiratory
sars
stool
abstract
sars
cov
shed
covid
19
cases
haq
china
nan
nan
nan
nan
sars
cov
children
respiratory
fecal
covid
19
cov
genomic
betacoronaviruses
nan
india
people
covid
19
this
19
covid
volume
passenger
cases
covid
19
efficacy
mg
sars
covid
19
country
pandemic
cases
cases
march
registered
recovered
covid
nan
nan
nan
nan
covid
19
kenya
world
pandemic
nan
sars
cov
patients
2019
respiratory
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
airway
management
simulation
real
time
discovery
drug
cadd
target
identification
models
ms
viral
viruses
animal
nan
lung
inflammation
asthma
disease
copd
ace2
ang
ii
human
heart
carbohydrates
biology
platforms
study
covalent
nanovaccines
immune
infectious
vaccines
diseases
nan
nan
nan
covid
19
management
to
date
nan
economic
the
covid
19
also
nan
nan
nan
new
china
abstract
kind
pneumonia
herbal
formulae
guidelines
herbs
paired
research
open
innovation
structure
papers
technological
convergence
opportunities
potential
tkfs
nan
media
coverage
describe
effect
number
problem
the
optimization
model
paper
cap
recent
advances
qualifying
in
fn
organisms
febrile
neutropenia
gram
violence
doctors
workplace
2020
professionals
nan
professional
within
doctors
training
the
nan
fungal
allergic
inflammatory
diseases
diagnostic
the
viral
agents
animal
may
polysaccharides
sinensis
chinese
caterpillar
fungus
housed
bedding
immune
rats
wire
elderberry
properties
fruit
acids
also
cat
abstract
this
case
report
nan
nan
et
des
de
la
sleep
de
en
impact
et
confinement
nan
nan
nan
nan
inflammation
viral
summary
the
inflammatory
de
des
bactéries
bl
et
de
et
le
des
en
des
les
de
agents
zoonoses
de
vaccines
vaccins
des
les
nan
de
la
les
travail
au
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
spread
still
we
ipcp
study
lmi
the
diffusion
the
guidelines
influenza
therapeutic
goods
hcws
pandemic
the
survey
would
physiotherapy
recommendations
covid
19
acute
nan
group
calves
coli
placebo
bacteriophage
calves
milk
ors
water
fed
calves
colostrum
transition
milk
kg
drugs
covid
19
hcq
use
lockdown
diabetes
related
complications
days
death
week
regression
count
analysis
telemedicine
patients
diabetes
in
covid
nan
chloroquine
type
diabetes
abstract
patient
nutrition
viral
infections
vitamins
nutraceuticals
rr
covid
19
outcome
dm
coronavirus
virus
respiratory
syndrome
disease
nan
nan
nan
nan
nan
maternity
providers
health
care
needs
hb
triton
100
ribavirin
fluorescence
pathogenic
microorganisms
aptamer
aptamers
biosensors
nan
nan
nan
virus
ebola
human
disease
monkeys
problem
in
solving
social
highlighted
nan
nan
lung
fibroblasts
luteolin
proliferation
the
medicine
novel
coronavirus
pneumonia
in
nan
nan
the
mers
knowledge
attitude
among
mers
cov
cases
climate
incidence
patients
the
mers
saudi
burden
mers
cov
different
nationalities
saudi
anxiety
reported
students
score
mers
nan
health
pilgrims
surveillance
outbreaks
saudi
cases
mers
cov
clusters
reported
disease
in
2019
outbreak
coronavirus
covid
the
vertical
transmission
coronavirus
two
hybridization
probe
the
efficiency
apn
inhibitors
compounds
potential
structure
nan
nan
nan
nan
nan
nan
nan
disease
abstract
the
world
reeling
nan
nan
covid
19
health
pandemic
mental
nan
nan
nan
anxiety
001
level
the
general
nan
nan
nan
covid
19
people
anxiety
need
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
the
animals
risks
use
animal
covid
19
tcm
guideline
cases
isolation
room
airborne
general
patient
de
virale
le
par
infection
nan
nan
discourse
learning
collaborative
kbdex
knowledge
handwashing
behaviors
risk
self
efficacy
hai
the
data
knowledge
infections
the
health
srrt
electronic
surveillance
task
assignment
distributed
algorithms
patterns
research
social
news
biomedical
health
customers
churn
clinics
loyal
data
rfid
patient
safety
healthcare
adoption
nan
nan
proteins
idps
viral
viruses
host
nan
nan
nan
flora
pigs
intestinal
the
microflora
bacteria
adhesion
host
cells
surfaces
nh36
vaccine
leishmania
dogs
control
vaccines
vaccine
potency
testing
methods
animal
workshop
veterinary
methods
vaccine
vaccines
animal
human
virus
health
products
veterinary
safety
biological
potency
methods
surveillance
disease
data
appropriate
tourism
resources
weihai
resource
urban
droplet
transmission
size
the
respiratory
training
the
health
tool
local
land
development
new
nda
use
cloud
the
outbreak
it
h1n1
public
homeless
policy
taiwan
actions
nan
medical
wastes
incineration
technology
centralized
curcumin
pgv
vero
cells
the
medical
waste
management
china
disposal
compounds
antimicrobial
synthesized
results
substituted
la
de
maladie
mk
le
la
de
surgery
les
et
nan
nan
nan
la
une
le
ct
scan
de
des
protection
la
covid
de
la
covid
les
strategy
surgery
risk
for
healthcare
must
nan
nan
nan
ct
scan
diagnosis
appendicitis
abstract
hcps
pneumoperitoneum
protection
covid
19
the
covid
epidemic
strategy
objective
nan
nan
acute
viral
respiratory
abstract
epidemic
nan
nan
nan
nan
nan
nan
nan
nan
nan
shellfish
outbreaks
pathogens
based
viral
nan
fusion
viral
conformational
proteins
structures
nan
de
la
le
des
patients
nan
de
les
et
en
des
les
en
sont
de
ou
tracheostomy
care
risk
patients
room
de
et
les
des
la
tracheostomy
care
risk
patients
room
patients
pandemic
the
number
caregivers
nan
covid
19
ppe
cases
guidelines
considered
procedures
particularly
risk
contamination
nan
nan
nan
nan
nan
nan
nan
19
covid
findings
the
infection
viruses
late
the
early
entry
has
human
viruses
high
mannose
sars
cov
ferrets
infection
transmission
cov
sars
genome
icsars
virus
covid
19
srf
pattern
immune
cox
ep
pge2
the
receptors
influenza
viral
therapeutics
resistance
viruses
covid
19
skin
complement
respiratory
surgical
residents
in
maintaining
education
interviews
fellowship
online
upon
competitive
nan
the
cct
disease
world
currently
nan
nan
nan
patients
pandemic
covid
19
heart
nan
teleproctoring
global
abstract
used
successfully
cell
death
viral
infections
immune
nan
nan
nan
nan
nan
nan
dentists
total
number
1986
2018
group
rats
control
treatment
05
sars
cov
nm
treatment
drug
nan
infection
kidney
transplant
population
abstract
the
sars
cov
risk
patients
diseases
infectious
medicine
research
international
extra
pulmonary
abstract
pneumonia
appears
sars
cov
treatment
number
reached
cov
sars
covid
19
sequences
abstract
an
outbreak
infection
novel
nan
nan
sars
cov
worldwide
treatment
therapy
covid
19
infection
drugs
hydroxychloroquine
healthcare
workers
disease
occupational
hospital
viral
chromatography
based
viruses
products
cov
sars
coronavirus
3clpro
the
coronavirus
detection
it
quick
standard
exercise
moderate
urti
inflammatory
near
nan
igy
gam56
infection
maxima
gst
covid
19
tcm
treatment
prevention
covid
19
positive
discharged
test
rates
also
fertility
infection
virus
clinical
covid
outcome
outcomes
cos
nan
arm
fpv
control
patients
twice
nan
nan
covid
19
medical
department
otorhinolaryngology
nan
nan
interventional
covid
19
china
the
patients
95
pcnsl
ci
asct
nan
anemia
clinical
therapeutic
medical
evaluation
nan
infections
viral
organ
well
common
care
intensive
medicine
specialty
patients
patients
bronchiolitis
treatment
2010
age
the
pneumoniae
neuro
ophthalmological
cases
nan
models
experimental
multiple
different
sclerosis
cov
cns
neurological
sars
symptoms
pahs
tph
dust
pah
mg
diarrhea
2019
the
novel
symptom
nan
nan
nan
nan
nan
nan
nan
nan
lung
angptl4
infection
influenza
damage
importin
α3
nf
κb
tnf
potential
proteins
2019
docking
webserver
patients
clinical
in
dip
acute
nan
nan
nan
covid
19
tests
ct
diagnosis
nan
nan
the
3d
face
shield
printed
spatial
effects
covid
19
data
nan
smart
factors
mobile
health
care
nan
hotel
analysis
research
findings
trends
architectural
design
wind
modeling
methods
climate
china
change
urban
since
services
climate
ius
research
hydrometeorological
metastases
bone
health
treatment
radiotherapy
disasters
natural
public
health
emergencies
disaster
motivation
nurses
competence
engagement
nan
nan
229e
hcov
formoterol
infection
pretreatment
cases
china
sars
countries
severe
price
indicators
tourism
model
demand
dev
ul21
bias
usage
gene
infection
abstract
27
year
old
hpev
respiratory
pneumonia
cap
abstract
glutathione
covid
19
pneumonia
dyspnea
the
patients
covid
19
pandemic
nan
nan
nan
nan
wellness
covid
19
the
coronavirus
risk
communication
unprecedented
times
covid
nan
nan
nan
nan
nan
nan
ecmo
patients
ards
covid
19
nan
nan
nan
nan
nan
nan
care
icu
must
management
covid
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
the
disease
covid
19
pandemic
nan
patients
markedly
covid
19
positive
adsorption
processes
process
gas
chemical
nan
herbal
formulae
guidelines
pis
stage
covid19
iv
vit
the
required
nan
nan
bone
defect
biomaterials
essential
vitro
patients
onfh
therapy
hips
steroid
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
ppe
bundle
the
fluorescent
participants
gbs
infection
present
case
patient
case
patient
background
abstract
clinical
nan
et
le
est
les
hépatique
action
change
climate
politicians
using
stock
contagious
infectious
market
covid
nan
the
covid
19
global
potential
oil
initiatives
the
niger
delta
health
mental
research
covid
19
nan
viruses
antiviral
cell
μg
ml
601
anti
inflammatory
antipyretic
the
the
ebola
control
infection
controls
surveillance
early
make
abstract
of
andrographolide
binding
mol
neuraminidase
kcal
sars
extracts
cov
dried
anti
virus
rie
influenza
cells
cell
phase
ssds
sex
treatment
pregnancy
nan
2019
china
ncov
new
coronavirus
viral
de
os
the
infecção
nan
nan
feral
home
range
cats
defined
trade
online
species
markets
surveys
salmonella
coli
isolates
showed
diarrheic
dna
vaccines
nanoplasmid
veev
ebov
viral
coinfections
lrti
virus
clinical
pertussis
infection
infants
complications
old
nan
nan
nan
bats
conservation
local
trade
consumption
species
trade
price
breeding
wildlife
infusion
patients
min
intravenous
workflow
nursing
consensus
holistic
care
patients
patients
strategies
nursing
centralized
treatment
needs
nurses
existence
relatedness
patients
nursing
hospital
emergency
management
human
safety
nasopharyngeal
specimen
collection
nurses
hospital
prevention
control
covid
19
nan
nan
nan
tourism
hsr
spanish
research
indicators
nan
nan
nan
nan
nan
nan
patent
the
data
database
overview
the
covid
19
one
in
binding
δcp
δsa_immob
virus
negative
vaccines
mers
cov
mna
sars
covid
19
cases
severe
patients
covid
19
sars
risk
hyperimmune
nan
nan
nan
school
closures
covid
19
social
nan
nan
nan
nan
nan
nan
nan
nan
nan
bioethics
field
work
international
research
nan
nan
patients
sars
cov
icu
days
nan
nan
the
11
human
avian
influenza
imaging
pneumonia
severe
caused
human
infections
immunocompromised
patients
respiratory
subsequent
2019
covid
19
coronavirus
novel
covid
19
chest
ct
abstract
ip
healthcare
specific
age
care
viral
patients
cf
infection
common
nan
pregnant
hcws
infectious
risks
infection
health
remdesivir
international
coronavirus
public
health
covid
19
animal
surveillance
covid
19
health
could
protocol
hcq
drug
people
mg
day
health
samples
cov
related
the
summer
sars
cov
we
present
algorithms
optimization
algorithm
teams
different
nan
nan
nan
nan
nan
nan
sars
cov
synthetic
research
abstract
cases
confirmed
covid
19
deaths
nasal
solution
days
resveratrol
carboxymethyl
nan
health
china
global
challenges
governance
nan
nan
nan
nan
ifitm3
vcp
p97
trafficking
interferon
proteins
domains
these
pathogenesis
abstract
patients
treg
cells
frequency
rrms
china
epidemic
measures
cancer
patients
nan
nan
nan
nan
nan
cancer
disease
visits
prostate
low
2019
ncov
outbreak
abstract
the
breast
risk
radiation
patients
cancer
nan
nan
nan
nan
nan
nan
nan
pandemic
scrt
concerns
re
covid
nan
nan
covid
19
infection
injury
patients
disease
potential
the
coronavirus
covid
covid
19
patients
cardiovascular
cardio
nan
host
infection
therapies
patients
systems
nan
nan
nan
disease
the
covid
19
management
nan
official
data
relevant
abstract
based
canada
interventions
growth
march
public
students
travel
international
health
risk
covid
19
religious
hajj
the
nan
nan
nan
nan
nan
nan
nan
nan
endoscopy
ibd
coronavirus
pandemic
many
nan
nan
nan
nan
wuhan
measures
epidemic
outbreak
physical
nan
nan
nan
nan
nan
nan
care
health
school
closures
child
nan
nan
nan
nan
nan
case
cases
we
china
definition
covid
19
influenza
transmission
changes
nan
patient
prone
this
facility
acute
htp
sludge
waste
sewage
digestion
de
les
sars
covid
et
nan
de
la
cancer
covid
19
nan
nan
nan
nte
opidn
op
degeneration
mutations
nan
nan
cancer
for
surgery
covid
19
nan
techniques
diagnosis
pathogens
molecular
detect
influenza
flu
assay
the
al
infectious
travelers
diseases
tropical
infections
crimean
congo
haemorrhagic
fever
europe
indications
abstract
ribavirin
molecule
antiviral
respiratory
cap
identification
use
virus
nan
nan
nan
nan
patients
risk
need
covid
19
nan
nan
nan
nan
nan
nan
nan
de
des
une
la
les
et
de
hsv
vzv
des
nan
ppbpc
protective
clothing
standards
technical
plague
pestis
early
treatment
deliberate
nan
use
ppe
risk
diseases
clinicians
juxta
articular
the
up
tumor
assh
surgery
hand
the
goals
nan
facemask
wearing
policy
universal
shortage
patients
covid
19
icu
hospital
nan
nan
transmission
disease
contact
covid
19
education
remote
the
outbreak
covid
nan
nan
covid
19
management
dead
fatalities
human
proteins
sars
cov
immunogenic
section
covid
19
suggested
health
19
95
ci
pregnancy
covid
nan
nan
covid
19
patients
care
hospital
covid
19
disease
infection
symptoms
nan
number
sars
cov
outbreak
italy
nan
nan
responses
rapid
we
world
covid
covid
19
review
included
2020
mortality
disease
trpv1
associated
patients
nan
global
hcq
manufacturing
demand
efforts
covid
19
pandemic
drug
emergency
viral
infection
covid
19
pak1
covid
19
cases
heuristic
who
system
complexes
complex
smartbac
large
virus
vaccine
respiratory
syndrome
coronavirus
public
health
private
case
study
nan
milk
feeding
calves
nutrition
colostrum
calves
hpn
milk
high
fed
events
us
persist
in
april
urban
crisis
the
covid
19
scientists
traditionally
assimilate
knowledge
inform
nan
violence
family
in
community
increase
pets
health
covid
19
coronavirus
nan
nan
nan
nan
nan
nan
nan
lives
sports
the
outbreak
abstract
coronavirus
disease
2019
coronary
abstract
nan
nan
covid
19
abstract
as
health
nan
nan
nan
nan
covid
19
pe
heart
failure
nan
nan
covid
19
patients
cardiovascular
cardio
nan
case
post
mortem
sars
cov
school
forensic
science
fraud
digital
paper
used
based
μpads
cultures
covid
19
ssd
coronavirus
sars
pandemic
covid
19
in
taken
nan
nan
nan
nan
nan
nan
nan
nan
nan
sars
cov
cells
the
cell
nan
data
social
gis
covid
19
nan
group
ict
index
on
con
organisms
siann
target
low
near
emerging
disease
human
well
diseases
gene
igk
haplotype
sequence
novel
species
sequencing
the
mixtures
mixture
transmission
phylogenetic
outbreak
confidence
likelihood
np
associated
asthma
colonization
the
ped
farms
finding
among
spread
mixing
we
encounters
individual
due
mers
cov
recombination
evolutionary
many
conservative
transitions
amino
acid
effects
proteins
viruses
adaptation
mammals
virus
present
time
sample
sequencing
bioinformatics
growth
domain
biological
systems
spatial
ibv
virus
chickens
dissemination
the
codon
usage
zikv
patterns
genotype
datasets
algorithms
truth
available
organisms
experiments
rna
simulations
end
hairpin
dose
vaccine
fractional
vaccination
efficacy
hrv
vaccine
nab
inactivated
types
rva
bat
strains
novel
humans
hev
virus
hepatitis
entry
poorly
zikv
lncrna
genes
viral
cellular
a2ar
d2r
protein
receptor
sca2ar
parhyale
species
we
crustacean
model
pathogens
transmission
emergence
new
host
genome
genomes
organisms
gene
usage
behavior
individuals
disease
decision
planning
xrn1p
virus
yeast
degradation
activity
zikv
brain
mirnas
in
role
disease
symptom
monitoring
quarantine
emerging
virus
zika
evidence
infection
guillain
zika
ns2b
ns3pro
infected
vaccine
ns2b
zika
ns3pro
thus
conformation
zika
ns2b
ns3pro
recently
one
hcv
subtypes
positively
selected
sites
ad
genes
pathogen
hippocampal
blood
genes
interval
information
essential
human
mycoplasma
cancer
breast
faucium
patients
viruses
genes
expression
mhv
respiratory
single
particle
sample
cryoem
structural
rti
species
individuals
respiratory
recent
alphacoronavirus
species
viruses
genus
encompasses
respiratory
hct
patients
bal
human
virus
cells
entry
cd66c
host
bcl
cell
1α
cycle
pgc
virus
zika
single
ribosome
in
hct
conditioning
sequencing
mngs
human
prophages
phage
genomes
genes
host
dux4
p53
mouse
levels
myoblasts
jia
hla
uveitis
serine
11
cancer
gene
based
system
specific
ageing
lifespan
pathways
interventions
human
cilia
ciliary
enkur
signaling
trp
pathogen
genetic
host
power
selection
rna
il
escape
element
mrna
monitoring
active
ebola
costs
risk
pathogen
patient
care
real
time
chiral
nanostructures
plasmonic
optical
interaction
dusp1
virus
rsv
host
antiviral
bat
isgs
viral
unique
induction
mers
cov
camels
humans
zoonotic
conserved
mers
cov
attenuation
mtase
exon
replication
fidelity
rna
cov
bacterial
bronchitis
children
persistent
blind
exon
rna
replication
viruses
innate
sars
cov
22
cpsrnas
the
vaccination
population
refugee
outbreaks
measles
surveillance
outbreak
digital
promed
healthmap
adaptation
species
cross
rate
hiv
models
formulations
discrete
seir
dynamical
viruses
data
phages
metagenomics
rapid
rna
binding
ubiquitin
domain
trim25
viral
ifitms
hiv
ifitm
protein
diversity
ecological
within
virus
ecotypes
viral
rna
sites
read
canonical
3d
refinement
proteins
uniform
particle
viruses
virus
detect
ability
characterize
transmission
control
models
stochastic
deterministic
viral
malassezia
virus
cells
dsrna
rna
sequencing
processing
could
rrna
cov
mers
fp
ca2
fusion
model
models
spatial
spread
infectious
donovani
infection
translation
mrna
parasite
ifitm3
infection
influenza
virus
expression
species
bacterial
pathogens
prevalence
host
chikv
virus
replication
mono
activity
rbps
several
interaction
drosophila
localization
par
epithelial
cells
airway
squamous
long
read
rna
correction
reads
genomes
replication
pks
structures
experiments
detection
viruses
viral
rna
threats
strains
influenza
profiles
exposure
immunity
pmhc
panda
mhc
immunology
family
flc
liver
transcriptional
enhancer
aberrant
reservoir
transmission
model
bats
people
new
coronavirus
virus
human
structure
2019
ncov
prediction
infectivity
coronaviruses
virus
valinomycin
antivirals
we
lacv
cov
2019
sars
sarsr
ncov
viruses
lineage
several
barrier
receptor
wuhan
china
since
first
identified
2019
ncov
r0
rate
outbreak
2019
ncov
epidemic
we
present
2019
transmission
human
ncov
outbreak
sirna
candidates
gremlin
target
the
coronavirus
sars
2019
ncov
analysis
human
sustained
transmission
china
imported
severe
respiratory
disease
wuhan
emerging
authors
this
manuscript
withdrawn
submitted
mosquito
denv4
dengue
vector
virus
2019
epidemic
time
december
ncov
ncp
sars
time
r0
number
days
the
covid
19
incubation
outbreak
virological
novel
pneumonia
characteristics
ace2
2019
ncov
coronavirus
identified
2019
ncov
coronavirus
ratg13
human
effective
reproduction
number
2019
ncov
2019
ncov
wuhan
days
5th
outbreaks
human
health
interventions
to
mpro
ncov
binding
drug
2019
hm3dq
activation
cno
treatment
chronic
public
burdens
healthcare
cases
health
screening
ncov
spread
travel
around
china
wuhan
covid
19
cities
infection
nodes
snapshot
dynamics
analysis
virus
2019
ncov
protease
main
2019
ncov
sars
cov
antibodies
spread
epidemic
2019
measures
china
cases
95
ci
2019
the
2019
ncov
may
mpro
commercial
viruses
novel
detect
standard
we
ncov
2019
cov
evolution
proteins
coronavirus
infections
seasonal
ncov
undocumented
2020
january
cases
epidemic
hubei
covid
19
the
sars
2003
china
19
control
epidemic
public
ro
estimates
number
generation
interval
10
2019
nucleotide
ncovs
sequences
ub
based
substrates
dubs
substrate
viral
virus
2019
ncov
hepatitis
2019
ncov
infection
coronavirus
respiratory
2019
ncov
potential
protease
sars
screening
entry
infected
travellers
cases
transmission
cases
wuhan
january
2020
the
coronavirus
tool
genomes
2019
2019
ncov
coronavirus
entry
sars
abstractusing
method
pathogen
screening
dna
2019
ncov
nm
treatment
drug
effect
cep_c30
ritonavir
lopinavir
darunavir
ncov
2019
cov
fusion
proteins
cov
human
protein
sars
transmission
2019
coronavirus
ncov
genomic
sequence
human
cluster
cases
infections
guangdong
interval
serial
pairs
covid
19
ace2
2019
ncov
expression
viral
passengers
testing
asymptomatic
total
565
drug
drugs
hcov
protein
human
epidemic
could
transmission
population
vaccination
2019
ace2
ncov
diarrhea
cell
2019
ncov
liver
ace2
cell
covid
19
cases
classification
machine
sars
cov
epitopes
cell
proteins
wuhan
city
china
population
2019
ili
we
influenza
parameters
viruses
wuhan
mainland
china
2019
ncov
cases
data
exponential
growth
000
2019
china
ncov
wuhan
spread
cases
imported
2019
internationally
locations
risk
china
number
rloc
countries
2019
ncov
re
manuscripts
et
vaccine
covid
19
disease
2019
smokers
ace2
gene
in
current
2019
ace2
ncov
expression
immunity
95
ci
doubling
time
days
countries
risk
capacity
2019
ncov
coronavirus
analysis
covdb
information
database
vaccine
virus
study
outbreak
design
2019
ncov
infection
teicoplanin
virus
2019
ncov
3cl
based
sars
travel
we
interval
january
23
2019
patients
ncov
the
wuhan
bacterial
nanopore
dna
freshwater
water
wuhan
reporting
hubei
data
province
genetic
epidemic
outbreaks
we
novel
estimated
human
number
r0
we
the
model
transmission
exposed
recovered
local
wuhan
we
air
passengers
sars
respiratory
cov
syndrome
coronavirus
virus
browser
sequences
2019
coronavirus
2019
ncov
coronavirus
rbm
sequence
cov
sars
mice
alveolar
virus
transmission
cases
isolation
contact
tracing
patients
2019
ncov
cases
severe
based
days
china
method
one
transmission
outbreak
person
to
number
sars
cov
protein
spike
cleavage
domestication
we
yeast
model
survival
sars
cov
immune
development
resource
sequence
metagenomic
meta
2019
biological
2019
ncov
kidney
patients
coronavirus
travel
the
number
90
mainland
february
model
2020
cities
city
the
peak
china
number
hubei
province
2019
outbreak
ncov
transmission
model
epidemic
infected
2019
ncov
severe
illness
nlr
2019
patients
manuscript
cases
2020
number
our
r0
emerging
number
pathogens
outbreak
wuhan
the
survey
number
infected
wuhan
case
cases
hubei
provinces
il
severe
cytokines
patients
mild
protease
enteroviruses
proteases
near
cell
2019
research
data
wuhan
coronavirus
2019
ncov
sars
cov
receptor
sars
cov
rbd
recombination
recent
mutations
genes
synonymous
fitness
selection
outbreak
facemask
china
shortage
public
swabs
cases
viral
ncp
respiratory
2019
ncp
ncov
conjunctival
transmission
patients
ncp
discharged
levels
2019
none
health
we
integrate
human
movement
number
cases
infected
confirmed
february
ace2
nasal
2019
ncov
cells
lockdown
implementation
appears
remains
we
2019
ncov
the
cov
public
hospitalization
non
transmission
strength
daily
sars
igg
cov
infected
outbreak
epidemic
the
time
mathematical
characteristics
wuhan
hubei
province
china
cases
wuhan
2019
ncp
infection
ncov
ncov
2019
patients
positive
202
index
pneumonia
search
composite
ncp
cells
patients
2019
ace2
renal
traveller
screening
infected
sensitisation
delay
wuhan
city
19
95
cri
covid
19
humidity
absolute
province
peak
transmission
person
covid
19
2019
respiratory
syndrome
cov
ncov
2019
ncov
immune
responses
targets
structure
protein
amino
cryo
em
transmission
clusters
cases
contact
tracing
end
wuhan
disease
peak
epidemic
patients
ncp
pcr
sars
cov
detection
imported
cases
capacity
case
temperature
urban
2019
coronavirus
agglomeration
variation
seasonal
sars
cov
transmission
incubation
period
covid
19
available
patients
number
symptoms
sars
cov
2019
ncov
china
associated
related
95
ci
the
patients
pneumonia
major
epidemic
delay
impact
reduction
quarantine
traffic
blockage
factor
number
we
virus
tropism
model
measures
covid
19
results
disease
images
contact
cases
definition
close
untraced
infections
undocumented
spread
infection
contagiousness
disease
patients
this
simulation
unknown
march
quarantine
individuals
home
international
2019
trust
preventive
the
ncov
wuhan
the
study
presence
19
2019
ncov
ace2
patients
coronavirus
china
cases
cfr
covid
19
cov
coronavirus
sars
usage
genes
protein
solubility
sodope
https
com
epidemic
the
model
end
hubei
confirmed
cases
china
number
sars
estimation
final
size
peak
time
peak
time
ill
critically
severe
patients
period
ability
model
infectious
covid
19
cases
severe
patients
social
mixing
contact
public
health
wuhan
hubei
except
china
infected
wuhan
number
epidemic
march
february
growth
exponential
china
law
deaths
china
risk
2019
ncov
control
cases
severe
moderate
pg
ml
splicing
parasites
sequencing
rna
alternative
cov
sars
ace2
binding
neutralizing
ace2
human
2019
receptors
cell
cfr
feb
19
china
20
viral
sars
cov
rna
patients
ccdc
r0
covid
19
growth
patients
severe
cases
19
hubei
ncp
cases
china
mainland
2020
end
outbreak
probability
of
declaration
china
outside
countries
country
local
patients
ards
covid
19
the
hubei
covid
19
cities
province
knockdown
genes
rna
casrx
pcsk9
2019
ncov
coronavirus
cov
the
ace2
b0at1
coronavirus
complex
surface
sars
recombinant
adenovirus
vaccine
cov
coronavirus
complex
main
mpro
we
sars
cov
protein
binding
use
2019
ncov
sars
cov
binding
2019
ncov
infection
wuhan
human
patients
kidney
impairment
hospital
covid
rt
china
measures
number
wuhan
closure
covid
19
wuhan
city
cells
patients
covid
19
cell
scaling
law
observed
the
outbreak
wuhan
participants
anxiety
shanghai
behavioral
rate
epidemic
cure
case
fatality
2019
patients
ncov
infection
incidence
data
migration
model
china
infected
hefei
shenzhen
r0
population
migration
coronaviruses
2019
ncov
pangolin
cov
pedv
spike
protein
viral
antibody
casrx
targeting
could
abstractthe
smallest
2019
the
estimated
evolutionary
mean
authors
manuscript
statistical
methods
the
patients
19
covid
time
three
265
covid
19
days
diseases
incidence
china
2019
ncov
daily
covid
19
rt
lamp
test
wuhan
china
death
risk
epidemic
patients
25
the
19
disease
predict
china
model
number
epidemic
patients
covid
19
renal
sars
ct
patients
ncp
severe
clinical
wuhan
number
cases
the
february
covid
19
mental
gad
sleep
days
covid
19
transmission
serial
2019
ncov
pangolin
cov
ratg13
cell
2019
ncov
epitopes
protein
rbd
2019
ncov
ace2
binding
sars
cov
entry
cells
we
ace2
2019
rbd
ncov
receptor
muc4
sars
cov
mice
viral
wuhan
scale
dynamic
parameters
infection
stress
hws
we
anxiety
hr
19
patients
covid
mortality
age
patients
19
treatment
covid
severe
convalescent
plasma
influenza
treatment
severe
covid
19
sars
pathological
china
asymptomatic
cases
covid
19
patients
19
cells
covid
we
report
infections
asymptomatic
covid
19
we
sars
cov
method
the
2019
countries
global
arrival
airline
importation
telemedicine
etcs
layer
the
china
msti
outbreak
symptom
based
mass
covid
19
antibodies
the
diagnostic
viral
proteins
glycan
high
immune
sars
2019
virus
new
coronavirus
2019
ncov
nucleic
inactivation
virus
model
we
epidemic
effective
japan
patients
covid
19
henan
the
wuhan
shanghai
outbreak
measures
001
found
urine
swabs
we
tested
sputum
2019
throat
swabs
specimens
coronavirus
hubei
province
the
novel
the
epidemic
hubei
province
we
singapore
covid
19
reproduction
number
19
covid
health
the
public
si
covid
19
transmission
the
rna
viral
virus
platform
viruses
data
research
global
health
covid
leopard
pathogens
cppv
cats
cat
value
based
covid
19
outbreak
ct
mortality
group
patients
iqr
cancer
patients
covid
19
2019
ncov
crispr
2019
pcr
the
temperature
cases
minimum
the
covid
patients
symptoms
vs
severe
19
sars
cov
infection
real
time
latent
phase
transmission
model
the
cov
sars
protein
neutralizing
antibodies
diagnosis
rna
method
covid
19
sars
covid
19
infected
china
cases
results
pcr
clinical
conjunctival
covid
19
immune
lung
patients
cases
covid
19
patients
confirmed
sars
patients
covid
19
mortality
authors
the
withdrawn
manuscript
whilst
covid
19
patients
ct
the
patients
severe
overall
covid
19
hku2
sads
cov
subunit
coronavirus
vl
pkdl
transmission
methods
data
information
researchers
twirls
system
coronavirus
appendicitis
perforated
entities
non
cluster
sars
cov
wechat
chinese
detect
quarantine
disease
covid
19
wuhan
patients
2019
covid
cardiac
critical
covid
19
hd
patients
epidemic
age
covid
19
gender
comorbidities
we
importations
cases
china
time
iran
cases
19
covid
epidemic
incubation
covid
19
period
we
the
cases
001
covid
19
outbreak
values
aboard
princess
ship
rs368234815
ifn
infection
infections
λ4
2019
ncov
ace2
cov
sars
model
radiologists
patients
pneumonia
ct
wenzhou
cases
control
epidemic
the
ncip
patients
cap
laboratory
ability
001
critical
patients
il
inflammation
access
data
developed
ncov2019
detailed
case
model
number
epidemic
importation
patients
comorbidities
95
ci
composite
mortality
public
incidence
risk
coronavirus
rt
pcr
ct
covid
19
19
covid
cases
fever
patients
type
ii
strains
sars
cov
hospital
environmental
covid
19
hygiene
ebov
vaccine
cd8
cell
immunity
sets
2019
human
sars
cov
epitopes
cell
sars
cov
across
cov
ti
coronavirus
mers
therapeutic
liver
patients
function
19
abnormal
covid
19
infected
pneumonia
patients
time
epidemic
relation
the
τtrans
sars
cov
patients
rt
50
cfr
number
true
calculated
could
patients
the
hospitalized
symptoms
medical
ratio
age
country
basic
reproductive
death
patients
cases
failure
sars
covid
19
community
responses
perceived
vaginal
sars
cov
patients
female
covid
19
us
health
outbreak
rna
using
efforts
sensitive
patients
quarantine
days
the
period
covid
the
ship
we
model
estimate
mortality
cases
confirmed
hubei
covid
the
virus
rate
process
volume
patients
admission
levels
mortality
heart
2019
ncov
sars
ace2
new
drug
mpro
screening
new
covid
sepsis
immunosuppression
vdr
induced
as
designs
assay
detection
sars
cov
19
hubei
covid
2020
epidemic
men
women
patients
differences
severe
dip
hcov
19
patients
clinical
high
patients
ldh
cases
healthcare
hypokalemia
patients
the
covid
19
hubei
wuhan
excluding
covid
19
elisa
igg
igm
gica
the
covid
19
2020
south
korea
china
final
number
infection
measures
patients
the
covid
19
time
mhc
01
protein
cell
epitope
information
researchers
twirls
system
coronavirus
cell
ace2
work
authors
recent
human
virus
receptors
predicted
receptor
sars
cov
design
inhibitor
repurposing
cov
sars
strains
coronavirus
genome
covid
19
the
pneumonia
patients
injury
patients
alt
group
hepatic
shenzhen
cases
19
covid
february
covid
19
patients
positive
nucleic
cases
cells
patients
pneumonia
the
sars
cov
mild
patients
covid
patients
outbreak
medical
ckd
online
transmission
closed
environments
covid
19
nucleosomes
remodeler
remodelers
ruler
nucleosome
human
genomic
bag
of
words
mev
vaccine
epitopes
covid
19
patients
qingdao
wuhan
respiratory
covid
vt
scores
covid
19
gp
cvms
covid
19
hospital
in
covid
19
risk
china
world
time
daily
infected
we
toolbox
pcr
rt
ddpcr
clinical
detection
clinical
68
patients
antimicrobials
admission
patients
covid
19
rnaaemia
serum
wuhan
cases
19
confirmed
january
patients
ct
hospital
stay
test
model
host
sars
cov
used
interaction
heparan
sulfate
heparin
use
2019
ncov
cov
evolution
sequences
sars
cov
crispr
abstractsevere
acute
covid
19
2019
guizhou
cases
19
cases
covid
lym
disease
patients
severe
19
vs
covid
trials
clinical
19
covid
the
china
protection
measures
epidemic
mainland
february
outbreak
2019
hubei
province
severe
il
patients
disease
covid
patients
covid
19
the
clinical
disease
our
effect
currently
outbreak
china
outside
model
in
we
cases
19
the
covid
reported
virus
hku1
hcov
specificity
klk13
china
covid
19
data
control
respiratory
viruses
disruption
contact
incidence
disease
zhejiang
early
we
monitored
pneumonia
severe
patients
characteristics
2019
influenza
respiratory
study
data
sites
local
two
important
taken
disease
cytokines
covid
19
cases
disease
intervention
large
epidemic
interventions
impact
cases
italy
travel
epidemic
february
covid
19
china
hubei
the
wuhan
cases
data
cities
total
sars
cov
rt
gene
disease
temperature
wrist
forehead
tympanic
we
the
patients
173
ab
sars
disease
workers
occupations
infection
public
95
ci
italy
republic
korea
iran
cases
covid
19
countries
patients
severe
19
clinical
2019
sars
virus
cov
structure
rapidly
sequencing
bioinformatics
abstractrapid
production
publication
sars
cov
covid
19
the
virus
us
we
january
2020
editing
rna
changes
2019
ncov
strength
speed
based
paradigm
disease
hcov
19
rmyn02
bats
identity
sequences
subgenus
coronaviruses
viral
method
cases
the
transmission
contacts
days
npis
china
outbreak
across
early
singapore
tianjin
we
incubation
serial
patients
group
the
covid
19
patients
covid
19
cells
viral
china
disease
transmission
model
the
interventions
cases
we
february
the
social
contact
data
covid
19
immune
patients
cells
2019
hypoxemia
patients
sars
cov
critically
ill
ct
patients
features
chest
ncp
patients
admitted
january
31
23
infected
number
new
infection
coronavirus
hcws
covid
19
psychological
risk
epitopes
cell
hla
vaccine
peptides
based
compounds
drug
sars
cov
sequence
protein
aminoacids
ntcp
hydrophobic
patients
transmission
cases
wuhan
2020
covid
19
nts
nucleic
acid
patients
common
fever
covid
19
specific
covid
19
diagnosis
patients
severe
symptoms
patients
fever
polypnea
medical
personnel
mental
health
90
cases
covid
19
risk
among
patients
19
covid
death
rapid
covid
19
heart
failure
vs
covid
19
epidemic
china
cfr
transmission
sars
cov
immunity
we
kidney
patients
sars
cov
acute
epicenter
95
ci
social
distancing
respiratory
study
collection
pathogens
community
ace2
expression
may
mr
also
outcomes
outcome
trials
protocols
clinical
sars
convergence
related
cov
protein
sars
cov
protein
interaction
rbd
cov
coronavirus
sads
acute
syndrome
sars
cov
market
genomes
2019
sars
cov
ig
proteins
domain
viral
respiratory
tract
cases
symptoms
quarantine
contacts
covid
19
individual
trials
clinical
covid
19
scientific
patients
the
2019
ct
prevalence
patients
19
ami
covid
cardiac
disease
travel
restrictions
two
reported
cfr
ifr
deaths
china
95
interval
distribution
generation
95
estimates
age
group
years
10
transmissibility
time
meteorological
doubling
the
variables
coping
nurses
covid
19
participants
covid
19
patients
model
diagnostic
detection
sensr
sensitive
onsite
developed
anxiety
medical
staff
china
the
covid
19
microbiome
complex
disease
secondary
structural
consideration
alignment
structures
sequence
sars
cov
abstractthe
rapid
cov
ly6e
infection
cells
immune
early
warning
quarantine
outbreak
system
fmw
sleep
disturbances
psqi
0001
duration
here
report
clinical
features
patients
positive
sars
cov
assay
cases
covid
19
03
01
cases
incubation
period
days
the
19
case
women
affected
covid
number
china
cases
covid
19
sars
cov
2019
assay
samples
patients
administration
methylprednisolone
severe
pneumonia
incubation
distribution
period
study
forward
outbreak
ptss
wuhan
covid
19
protein
sars
cov
nucleocapsid
domain
sars
cov
domain
cross
s2
connectivity
imaging
basal
ganglia
structural
19
covid
years
cases
patients
patients
covid
19
the
severe
covid
19
patient
duration
viral
rt
qpcr
sars
cov
the
nucleocapsid
protein
nucleic
acid
test
covid
19
clinical
characteristics
patients
renal
injury
early
covid
19
patients
mortality
the
age
years
antiviral
sars
cov
china
human
birds
potential
wildlife
disease
viral
cov
sars
ifn
type
original
patients
clinical
2019
children
the
95
ci
we
epidemic
estimated
lymphocytes
sars
cov
pneumonia
wuhan
patients
cases
severe
critical
sars
mers
covid
19
cov
the
data
population
profile
set
method
number
coronavirus
hubei
province
chinese
tracing
contact
epidemic
first
spread
using
first
identified
covid
sars
sars
cov
aerosol
transmission
fangcang
ban
epidemic
australia
travel
china
since
infected
cases
children
the
patients
sars
cov
illness
rna
wuhan
measures
epidemic
effects
outbreak
used
patients
the
19
covid
medical
staff
coronavirus
symptoms
the
patients
clinical
tibetan
covid
19
cases
disease
risk
among
age
cases
severe
non
estimated
number
coronavirus
sars
cov
hcov
19
patients
cities
19
icu
covid
china
age
we
cases
cfr
analysis
data
sars
epidemiological
geographically
hcws
covid
19
knowledge
poor
school
healthcare
closures
mortality
care
china
south
korea
we
epidemic
measures
epidemic
quarantine
the
model
asymptomatic
cases
transmission
generation
we
hypoxemia
severe
sars
treatment
patients
rt
lamp
covid
19
assays
cov
sars
infection
fusion
coronavirus
gene
pleiotropic
traits
qtl
identify
activity
antiviral
broad
vitro
virus
patients
the
cases
covid
19
china
strategies
covid
19
the
epidemic
wuhan
model
infected
would
the
patients
hospital
disease
days
covid
19
pneumonia
pregnant
women
patients
epidemic
symptoms
protein
clinical
cases
mar
hubei
ifp
model
period
transmission
epidemic
tracing
distribution
cases
population
our
we
estimate
19
infection
covid
mtb
pneumonia
outbreak
disease
covid
19
would
wuhan
covid
19
transmission
numbers
fcs
sars
cov
zj01
may
primer
set
viral
amplicons
load
vaccine
cell
covid
19
induce
zoonotic
viral
genome
new
size
protease
rigidity
crystal
structures
pdb
sars
cov
ace2
receptor
coronaviruses
sars
cov
based
covid
19
in
note
logistic
growth
regression
patients
cardiac
injury
2019
73
blood
wuhan
group
covid
19
children
sars
cov
19
fecal
interventions
covid
19
governments
affected
public
awareness
cities
this
study
rate
fatality
19
the
covid
cases
we
model
reported
covid
china
we
outbreak
europe
scenario
outbreak
the
approach
coronavirus
china
sars
cov
hospital
zones
contaminated
virus
viruses
antiviral
drugs
sars
cov
sars
cvl218
data
drug
replication
ciclesonide
mers
cov
virus
sars
cov
deletion
orf8
also
sars
cov
human
disease
covid
covid
19
deep
learning
ct
heat
inactivation
antibodies
sars
cov
model
models
epidemics
seir
forecast
covid
19
measures
changes
influenza
covid
19
patients
eye
symptoms
patients
paediatric
25
covid
19
sars
cov
coronavirus
global
climate
il
covid
19
patients
cells
temperature
infrared
skin
camera
find
imposed
measures
peak
covid
19
patients
covid
19
cml
clinical
patients
igg
severe
response
levels
vec
japan
results
covid
19
nvis
niv
inhibitors
compounds
the
pcr
detection
sars
cov
virus
ace2
pigs
protein
showed
obtained
cov
sars
rna
sequencing
unknown
cov
sars
polymerase
triphosphate
coronavirus
hcws
95
or
ci
covid
infection
dynamic
city
cybernetics
model
health
covid
19
outbreak
working
mortality
infections
allowing
risk
immunity
patients
covid
19
sars
cov
virus
factors
covid
19
role
cities
spread
lockdown
covid
19
cases
control
measures
imported
secondary
patients
covid
19
death
risk
confirmed
cases
the
covid
19
cities
networks
migration
the
reliable
covid
19
r2
we
report
patients
covid
19
duration
disease
growth
exponential
re
in
epidemic
participants
us
uk
online
95
china
2020
cases
covid
19
sars
cov
patients
respiratory
ocular
monkeys
cov
sars
re
infected
cov
sars
detection
deep
hcov
sars
cov
proteins
structures
binding
sars
cov
like
coronavirus
bat
prf
sars
cov
may
covid
coronavirus
sars
cov
crispr
viral
cells
sars
cov
infection
ace2
sars
cov
binding
study
virus
event
the
2020
side
model
reproduction
number
epidemic
estimate
distribution
cases
french
covid19
reported
number
covid
19
health
outbreak
cases
countries
epidemics
law
china
we
approach
covid
19
healthcare
systems
people
number
infected
data
official
dpcr
patients
the
sars
cov
cases
reported
covid
19
death
official
data
relevant
based
modeling
cd147
cells
sp
sars
cov
antibody
virus
thousands
sequences
inhibit
first
molecular
three
sars
cov
immune
cell
tcr
bcr
covid
19
covid
wuhan
incidence
provinces
hospital
covid
19
treatment
patients
sars
cov
letter
editor
there
disease
severe
icu
covid
19
age
older
countries
covid
19
pediatric
cases
although
covid
19
covid19
resulting
secondary
attack
rate
covid19
case
fatality
we
report
assay
lamp
clinical
high
patients
sars
cov
the
global
outbreak
italy
cases
covid
confirmed
percent
covid
19
temperature
mortality
humidity
cases
period
incubation
hospitalized
day
cases
rt
hangzhou
shenzhen
imported
cases
deaths
results
us
countries
testing
suspected
cases
quarantine
huo
stability
sars
cov
different
environmental
we
transmission
viral
covid
19
cases
confirmed
time
series
the
the
model
flagellar
non
planar
cov
rbd
sars
the
binding
iran
sars
cov
epidemic
genome
cov
sars
rbd
structure
antibodies
sars
cov
antibody
question
response
sequences
sars
cov
epidemic
based
study
research
covid
19
differences
based
igm
igg
rn
rs
acute
myelitis
treatment
sars
cov
cp
the
transfusion
clinical
days
preprint
servers
research
nephrology
we
covid
19
individuals
complications
respiratory
patients
crrt
group
covid
19
publication
we
new
study
time
icu
r0
case
may
france
human
market
transmission
to
2019
patients
hydroxychloroquine
viral
efficient
virus
epidemic
outbreak
days
cities
meteorological
covid
19
children
pediatric
january
patients
asymptomatic
sars
cov
wuhan
liver
sars
cov
damage
human
polymerase
rna
rdrp
viral
2019
19
sequencing
hcov
capture
clinical
cov
sars
bat
pangolin
covs
coronavirus
sars
cov
s1
conformation
ace2
sars
the
binding
viral
sars
patients
cov
antibodies
assays
sars
cov
patients
immune
responses
sars
cov
spread
china
italy
gica
proteins
the
19
hcov
we
covid
19
infection
dynamics
quarantine
adherence
disease
people
we
covid
19
favipiravir
patients
group
closures
children
school
infection
home
genome
outbreak
transmission
cases
based
severe
19
covid
patients
nomogram
endoscopy
sars
cov2
recommendations
countries
95
ci
disease
covid
19
infections
sars
cov
covid
19
model
term
we
review
kermack
19
model
covid
epidemic
iran
march
day
cases
lombardy
outbreak
case
confirmed
cases
covid
19
assays
sars
cov
coronavirus
covid19
epidemic
covid
19
states
model
covid
19
health
model
we
sars
cov
covid
19
lamp
model
analytical
epidemic
aaedm
this
assay
niid
ych
background
sars
detection
system
probe
fully
crispr
weaning
pre
outcomes
beo
effect
cov
sars
infection
covid
19
coronavirus
outbreak
research
outbreaks
covid
contacts
cases
attack
rate
the
diagnosis
model
on
basis
laboratory
covid
19
incidence
temperature
variation
covid
19
viruses
scovs
cocirculating
epidemic
reporting
case
days
in
elective
covid19
infections
us
outpatient
disease
model
covid
19
virus
patients
igg
19
antibody
covid
public
covid
19
epidemic
attention
sars
cov
assays
validated
specific
risk
chemotherapy
data
estimate
use
china
covid
19
world
cases
severe
cases
the
covid
19
the
dynamics
number
level
pandemic
virus
influenza
respiratory
symptoms
in
trials
clinical
studies
19
23
global
95
ci
peak
the
covid
19
risk
care
hospices
copd
expression
ace2
increased
airways
cases
the
sars
cov
occurred
italy
covid19
number
95
ci
cases
measures
in
case
march
19
korea
2020
south
number
cells
human
cell
organs
tissues
epidemics
ancient
current
past
genomes
sars
cov
triphosphate
polymerase
rdrp
patients
super
sars
covid
19
patients
19
sars
cov
children
healthcare
infected
workers
the
chinese
patients
illness
covid
19
admission
covid
19
ct
factors
group
covid
19
severe
cases
mild
countries
exponential
the
china
local
vec
japan
19
march
we
areas
maps
the
spread
sars
covid
19
antiviral
control
local
patients
rt
pcr
results
covid
patients
covid
19
cases
wuhan
public
impact
time
analysis
outbreaks
research
journals
papers
china
19
shows
covid
19
coronavirus
rate
clusters
we
virus
daily
surveys
the
covid
19
iran
2020
march
italy
2020
000
covid
group
lpv
arbidol
covid
19
studies
patients
mers
ribavirin
sars
icu
time
data
model
capacity
results
significant
the
evidence
srs
covid
19
model
early
admission
covid
19
outbreak
transmission
contact
the
cities
covid
19
risk
2019
cases
ncov
number
humidity
infection
cpgs
respiratory
control
recommended
strain
we
newer
population
equilibrium
sincheonji
daegu
except
infection
in
ai
system
covid
19
outbreak
outbreaks
the
covid
19
governments
absenteeism
school
closures
healthcare
we
cov
sars
nhc
eidd
mers
viral
present
cluster
europe
mngs
crispr
hiv
detection
sars
cov
sars
cov
ace2
rbd
peptide
protein
vaccine
sars
cov
nsp3
sars
cov
hla
binding
prediction
sars
cov
coronaviruses
critical
we
rna
extraction
kit
screening
assay
the
patients
mild
data
ct
measures
control
data
cases
transmission
covid
19
travellers
norway
returning
19
number
covid
reported
reproduction
hospital
patients
visitors
people
screening
case
population
covid
19
practice
igg
responses
igm
sars
cov
groups
paf
due
people
gatherings
patients
covid
19
hypertension
drugs
reduce
china
march
2020
covid
feb
the
global
transmission
covid
quarantine
the
isolation
and
cost
population
28
seir
simulation
model
patients
covid
19
severe
disease
covid
19
ct
system
cases
19
covid
cases
number
model
vaccines
portfolio
infectious
need
eid
strong
mitigation
icu
the
capacity
social
distancing
the
strategies
effective
sars
cov
rapidly
studies
emerged
drugs
fda
approved
sars
cov
sars
cov2
genomes
unique
coronavirus
disease
sars
cov
rhesus
respiratory
receptor
binding
human
cells
hace2
occupations
public
home
workers
work
patients
covid
19
cancer
infection
patients
covid
19
cancer
treatment
sars
cov
infection
covid
19
patients
the
duration
quarantine
20
patients
ncp
cap
infection
sars
outbreak
model
public
with
worldwide
the
model
cases
health
mobility
hospital
cardiac
covid
19
in
number
zero
two
epidemic
outbreak
cases
we
model
reported
covid
patients
ace2
covid
19
comorbidities
model
2020
county
incidence
continental
days
exposure
period
cases
19
crp
count
patients
outcome
covid
cases
model
pandemic
parameters
number
covid
19
exponential
countries
cases
patients
meplazumab
group
sars
cov
cov
sars
binding
rbd
neutralizing
attenuation
immunity
viral
virus
immune
glycoprotein
viral
this
cleavage
transcriptome
sars
cov
human
drugs
infection
danoprevir
patients
covid
19
protease
sleep
quality
05
the
ptss
cases
covid
19
we
shenzhen
covid
19
incidence
temperature
absolute
outbreak
users
following
first
national
prolonged
viral
shedding
severe
covid
mortality
excess
covid
19
conditions
hla
sars
cov
we
human
policies
growth
infections
covid
19
patients
hcq
group
treatment
covid
covid
19
diseases
viral
clearance
patients
confirmed
covid
19
clinical
treatment
shedding
lpv
sars
cov
psychological
patients
intervention
19
ward
the
number
cases
france
actual
covid
19
testing
capabilities
uccs
hcq
infections
covid
19
trial
cases
disease
data
model
90
clinical
covid
19
caused
trials
outbreak
covid
19
cities
larger
pregnant
women
19
covid
neonatal
epidemic
sars
cov
distancing
measures
transmission
control
measures
damping
covid
costs
would
testing
covid
19
transmission
network
the
sars
cov
novel
travel
slow
virus
australia
patients
severe
critical
19
care
patients
igm
levels
serum
covid
liver
ace2
tmprss2
cell
covid
boronic
acid
use
derivatives
compounds
trisilix
low
single
temperature
cost
epitopes
sars
cov
rosettamhc
available
covid
19
fep
drugs
screening
covid
19
sars
china
high
exported
cases
wuhan
cities
likely
cells
covid
19
inflammatory
patients
isolation
sars
cov
airborne
individuals
μg
m3
covid
19
china
symptoms
covid
19
00
disease
covid
19
infection
confirmed
pregnant
cov
dynamics
viral
sars
therapies
outbreaks
covid
19
growth
rates
19
cells
covid
patients
sars
patients
hbv
infection
19
sars
cfr
covid
19
march
severity
case
cases
epidemic
definition
definitions
drugs
covid
19
therapy
potential
propagation
china
disease
city
due
clinical
trials
outcomes
medicine
covid
covid
19
we
simple
epidemiological
confirmed
cases
study
covid
19
patients
survivors
elevated
total
ct
antibody
the
igm
igg
infection
viral
transmission
social
individuals
covid
deaths
covid
19
prevalence
south
risk
pre
existing
covid
19
workforce
infected
healthcare
workers
the
patients
covid
anosmia
iran
19
we
social
epidemic
investigate
effects
hcws
covid
19
fever
reported
quarantine
dp
sars
cov
haplotype
covid
19
pandemic
reduce
index
mgtv
virus
tick
viruses
named
cov
rna
viral
coronavirus
ro
sars
cov
ace2
binding
the
platform
covid
19
available
biomedical
feline
cats
viruses
diarrhea
vomiting
topoisomerase
top3b
rna
required
virus
lung
injury
senescence
acute
activate
sequences
sars
nucleotide
2013
analysis
protein
we
method
complementarity
proteins
cells
at2
cd44
fibrinolytic
niche
cov
sars
infection
testing
common
epidemic
china
trend
index
outbreak
curve
public
health
interventions
number
lower
respiratory
tract
symptoms
seasonal
severe
covid
19
patients
vs
models
19
covid
data
studies
respirators
hp
vapor
pfu
phage
deaths
in
model
cases
the
severe
19
the
patients
covid
infection
arrival
cities
march
time
covid
19
parturients
clinical
without
we
wuhan
rather
sought
estimate
mvm
design
ventilator
the
medical
covid
19
the
serum
high
immunity
death
data
vulnerable
fraction
patients
covid
19
deep
learning
diabetes
19
covid
patients
higher
chloroquine
19
role
covid
articles
quarantine
public
epidemic
lifting
contact
viral
shedding
clinical
sputum
severe
covid
19
aki
patients
among
wuhan
cities
we
hubei
cases
the
features
chest
ct
patients
influenza
collected
specimens
home
staff
morbidity
data
china
rok
distribution
cases
contacts
close
source
among
patients
covid
19
monocytes
could
pcr
rt
dpcr
detection
patients
social
distancing
interventions
case
icu
model
covid
19
number
care
researchers
research
practices
reporting
the
ci
mortality
the
disease
covid
bcg
countries
vaccination
covid
19
clinical
cases
children
age
lower
the
covid
19
model
us
infections
prevalence
sars
cov
estimate
covid
19
anxiety
depression
patients
ncp
ip
patients
chest
ct
gsk983
cpu
antiviral
salvage
uridine
sars
cov
novel
proteins
the
2019
ncov
codon
usage
genes
social
cues
isolation
food
people
proteins
microbial
dermatomyositis
specific
autoantibodies
protein
positions
3d
host
s1
cov
19
approved
sars
covid
symptoma
covid
19
cases
accuracy
ga
anti
inflammatory
immune
effects
models
based
structures
predicted
proteins
olfactory
cov
express
cells
suggest
clinical
outcomes
disease
covid
19
deaths
social
distancing
estimate
china
intensive
care
covid
19
italy
for
microsimulation
parameter
household
number
covid
19
hypertension
diabetes
coronary
severe
progression
risk
time
patients
data
first
global
health
30
mortality
covid
19
the
coronavirus
disease
patients
ibd
the
covid
infected
intervention
number
japan
usa
equipment
ppe
n95
uv
bscs
the
method
results
proposed
prediction
china
cases
number
measures
epidemic
covid
19
number
patients
we
agi
patients
grade
incidence
19
sars
cov
the
coronavirus
wuhan
studies
covid
19
laboratory
findings
covid
19
tool
the
acute
smokers
covid
19
copd
patients
sars
cov
early
connecticut
domestic
australia
covid
19
spread
travel
inflection
points
time
tmax
imax
ace2
expression
studies
aceis
arbs
cov
sars
mpro
compounds
μm
he
hku1
domain
human
oc43
cheer
new
taxonomic
data
alignment
high
vaccine
sars
cov
the
sars
cov
fusion
cell
protein
19
sars
cov
study
proteins
rbd
sars
cov
theaflavin
score
edna
idna
viruses
dna
non
cov
sars
coronavirus
vhhs
pathogenic
sars
cov
glycan
vaccine
immune
ncovn
ipsc
sars
cov
the
naats
naat
bioperfectus
detection
sensitivity
early
stage
outbreak
cfrs
usa
current
test
samples
though
reagents
patients
igg
antibody
male
female
patients
19
coivd
discharged
yichang
antibodies
sars
cov
igm
igg
elisa
covid
19
kit
sars
false
testing
detection
positive
negative
patients
covid
19
severity
correlation
clinical
patients
paraclinical
features
analysis
infection
rate
number
total
infections
covid
19
research
coronavirus
cov
sars
cov
eps
patients
covid
sick
individuals
epidemic
infection
long
patients
rp
clinical
rna
covid
physicians
years
age
60
older
covid
19
late
restoration
economic
epidemic
model
results
covid
19
airport
we
spreading
first
virus
masks
covid
19
medical
vietnamese
frontline
hcps
clear
may
protection
public
israel
19
distancing
we
covid
19
transmission
countries
2020
testing
sars
cov
population
targeted
sars
cov
model
the
infection
india
the
infected
study
cases
rate
growth
countries
early
exponential
costs
total
the
three
we
images
19
covid
the
pneumonia
number
the
italy
infected
epidemic
ncovid
healthcare
infection
19
workers
covid
19
time
many
countries
countries
phase
model
cases
22
control
suppression
measures
strategies
aims
mortality
ratios
different
we
model
climate
19
covid
countries
rr
covid
19
rate
march
cases
isolation
influenza
covid
19
fever
cells
patients
group
19
severe
children
sars
cov
transmission
household
covid
19
model
beds
designed
pcr
test
igg
igm
cov
sars
cov
covid
19
proteins
cryodrgn
cryo
em
analysis
protein
the
intra
host
genomic
viral
mutations
non
synonymous
orf3a
sars
regions
conserved
sars
genome
cov
patients
phosphorus
serum
covid
19
health
public
the
crisis
government
discharged
patients
could
infection
viral
disease
severe
rapidly
covid
19
19
covid
deaths
demand
95
sars
cov
asymptomatic
carriers
infected
testing
prevalence
tests
current
covid
we
disease
diseases
global
used
sars
cov
extraction
molecular
detection
social
distancing
adults
interventions
sars
sars
cov
transmission
california
community
covid
19
epidemic
cross
regional
standard
care
chm
group
covid
evolution
containment
epidemics
spread
countries
death
undetected
number
countries
rate
number
cases
positive
function
italy
model
epidemic
make
discrete
time
sars
cov
infections
patients
method
number
frontliners
covid
19
reproductive
risk
patients
lower
anaerobic
26
model
mitigation
number
the
covid
vec
sc
children
japan
we
infection
dynamics
lockdown
complete
still
time
infected
model
based
differential
health
care
frontline
workers
facilities
sars
cov
spleens
lns
macrophages
transmission
scenarios
covid
19
refugees
quantities
preventive
the
measures
simple
epidemic
covid
19
spreading
hubei
covid
19
incidence
data
temperature
number
covid
the
19
wuhan
psychological
distress
coping
general
population
south
korea
transmission
on
january
health
many
cases
policy
the
patients
ventilator
support
isave
the
sars
cov
protein
glycosites
glycosylation
sars
cov
kits
diagnosis
rna
binding
sars
cov
hace2
computational
cells
sars
cov
ace2
coronavirus
protein
we
cov
prime
structural
nsp9
sars
cov
protein
structure
outbreaks
syndromic
disease
syndromes
we
epidemic
china
disease
us
sars
patients
flight
the
transmission
covid
2019
covid
people
samples
we
samples
respiratory
feces
swabs
covid
masks
kgy
sterilization
mask
method
phase
epidemic
countries
we
data
us
country
cases
prior
since
patients
sars
cov
detection
cases
cases
the
pandemic
number
parameters
patients
treatment
received
symptoms
mild
severe
patients
admission
prognostic
factors
model
patients
calibration
covid
19
covid
19
98
pneumonia
images
covid
19
chinese
outbreak
measures
cases
deaths
epidemiological
parameters
may
measures
epidemic
control
social
prevention
reproduction
number
epidemiologic
indicator
reflects
lmwh
treatment
group
heparin
covid
covid
19
patients
the
treatment
epidemic
data
covid
19
epidemiological
covid
19
phase
countries
positive
italy
infection
we
covid
19
measures
peak
infection
the
isolation
explore
spread
mexico
consequences
population
azt
cq
hcq
effects
covid
virosal
fatty
acids
antiviral
formulation
rtx
assays
rt
qpcr
we
2019
ncov
ace2
the
s1
2020
us
novel
china
sars
viral
bat
studies
cells
bats
cases
taiwan
imported
genomes
among
sars
cov
human
interaction
protein
sars
hydroxychloroquine
while
cov
pandemic
rna
swab
cotton
silicone
sample
gc
diarrheal
intestinal
water
diarrhea
patients
sars
cov
oral
swabs
cov
complement
activation
sars
mers
we
covid
19
the
topic
coronavirus
covid19
2019
china
patients
lockdown
intensity
strategy
epidemic
virus
time
dt
growth
covid
19
sewage
sars
cov
fragment
detected
control
covid
19
stringent
strategy
covid
19
china
public
health
the
iran
epidemic
covid
19
air
sars
cov
environmental
surface
covid
19
cases
weather
cells
patients
fertility
covid
19
pandemic
air
quality
the
covid
19
covid
19
disease
the
pandemic
covid
19
model
analyze
hospitalization
covid
2019
introduction
disease
epidemic
model
sir
abc
we
technique
tackle
simulations
different
the
purpose
travel
countries
air
fsi
passengers
time
disease
we
reported
lockdown
epidemic
covid
19
control
wuhan
hcws
covid
19
among
risk
research
articles
mining
system
pandemic
sars
cov
emergence
evolutionary
role
vaccine
immune
the
predicted
increased
sars
cov
covid
19
animal
sars
cov
highly
the
ongoing
bats
sickness
social
network
we
ace2
sars
cov
species
expression
glycoprotein
sars
cov
recombination
molecular
binding
sars
cov2
ace2
rbds
cov
sars
rbd
single
domain
vascular
angpt1
tie2
protein
c4bp
targets
nhc
target
chemical
drugs
sars
cov
viral
episomes
clades
sars
cov
development
vaccine
codon
sars
hla
cov
peptides
epitopes
cases
viral
infection
imported
transmission
we
sars
cov
minipools
samples
the
regions
r0
lombardy
infection
adults
19
risk
45
data
covid
19
daily
at
arh
children
or
covid
19
pediatric
electrophysiology
covid
19
activity
pandemic
cases
covid
hong
kong
the
covid
19
predicted
april
2020
social
distancing
states
policies
governors
outbreak
covid
19
r0
madrid
disease
rapid
covid
19
measures
masks
trials
risk
95
ci
growth
countries
law
exponential
we
covid
19
patients
in
model
patients
sars
cov
the
nabs
patients
severe
review
risk
disease
covid
19
image
images
detrac
19
covid
data
the
swiss
001
pandemic
countries
institutional
context
pandemic
mortality
uncertainty
covid
19
beds
hospital
shortages
resources
observed
cases
growth
covid
19
we
the
covid
19
infected
early
covid
19
model
95
ci
lupus
sars
cov
patients
might
isolation
strategy
global
the
measures
covid
19
expression
variants
disease
regions
number
based
forecast
positive
evidence
women
impacts
covid
19
covid
19
ct
disease
predictive
influenza
season
we
covid
19
epidemic
curve
transmission
australia
control
19
covid
il
tocilizumab
studies
unlock
working
partial
full
2020
mobility
social
distancing
march
measures
sets
sars
cov
used
primer
social
distancing
interventions
available
optimal
bcg
cases
vaccination
deaths
vaccine
psychiatric
symptoms
emergency
outpatient
department
cases
deaths
ratio
covid
19
korea
risk
95
cri
covid
sars
cov
cells
entry
virus
sars
cov
rna
proteins
virus
sars
cov
identified
deletion
vitro
expression
ace2
cell
sars
human
vaccine
construct
novel
sars
cov
compounds
sars
cov
activity
coronavirus
covid
19
sars
cov
current
sars
cov
genome
mirnas
host
cq
hcq
report
toxicity
combination
vaccination
strategy
sars
cov
highly
sars
cov
host
covid
19
arbs
aceis
covid
19
patients
2019
patients
march
2020
ncov
sars
cov
in
virus
negative
among
public
usps
study
the
patients
bnp
high
2019
60
cov
sars
ace2
might
covid
ct
covid
19
follow
up
age
cases
case
fatality
cfr
information
diffusion
spread
epidemic
time
glucose
baseline
t2d
fasting
plasma
none
face
level
masks
sars
associated
patients
data
hcq
original
bf
countries
this
analysis
rate
spreading
epidemic
infectious
measures
number
control
the
government
participants
japanese
2020
2020
maximum
days
the
germany
95
or
ci
odds
knowledge
endpoints
trials
model
decision
makers
physical
contact
distancing
we
measures
countries
rates
covid
19
infection
infectious
reported
individuals
cases
model
expansion
disease
countries
evolution
data
spread
aerosol
cpr
airway
tube
icu
trusts
units
nhs
number
infected
women
the
covid
19
icu
mortuary
capacity
the
spread
95
ci
transmission
wuhan
prevention
case
rate
mortality
number
time
time
us
cases
epidemic
china
sars
cov
treatment
canine
indomethacin
mevs
sars
cov
the
ctl
may
sars
cov
codon
cub
viral
ptm
vptmdb
sites
viruses
mrnas
sars
cov
utrs
nasar
renal
remdesivir
injection
fibrosis
gs
sars
cov
sequences
phylogenetic
growing
cov
host
sars
pp2a
motif
protein
spike
glycosylation
s1
the
sars
cov
outbreak
wuhan
cat
quarantine
anxiety
covid
19
china
intervention
covid
19
suppression
mitigation
guangdong
province
china
surveillance
molecular
epidemic
networks
curvature
the
parameter
rt
lamp
method
pcr
covid
covid
19
rates
deaths
per
patients
respiratory
il
disease
failure
handheld
electronic
devices
heds
we
patients
21
condition
covid
19
19
countries
mortality
covid
bcg
facemasks
evidence
rcts
studies
wearing
italy
19
region
covid
cfr
data
visualization
app
daily
analysis
age
icu
quarantine
admissions
countries
ifn
beta
glucocorticoids
ards
use
covid
19
crisis
events
national
critical
care
19
covid
deaths
interactions
the
present
strategies
shield
model
disease
30th
2020
predictions
cases
covid
19
clinical
children
interventions
transmission
demand
epidemic
measures
measures
preventive
aor
problems
risk
risk
us
the
coronavirus
2019
social
protection
testing
individuals
tti
samples
np
collected
nasal
patient
uk
social
ability
self
isolate
unique
patients
precision
medicine
insights
covid
19
ci
95
data
countries
covid
data
cases
first
model
coronavirus
sir
measures
using
measures
care
capacity
patients
intensive
wuhan
number
19
infections
estimate
pakistan
covid
19
rate
may
rates
tp
number
tests
per
using
restrictions
contact
tracing
epidemic
led
respirators
may
reuse
100
cases
control
confirmed
covid
19
case
fatality
illness
meta
risk
beds
us
inpatient
10
000
murmurs
algorithm
detect
deep
the
average
temperature
pressure
cases
covid
us
sars
cov
ili
detection
interactions
model
critical
scale
virus
antigen
skin
specific
monocytes
older
ace2
expression
month
old
mice
ly6e
entry
human
hcov
oc43
data
disease
incidence
ews
elimination
cov
sars
spike
vaccination
epitopic
conferences
disciplines
meetings
researchers
career
health
testing
effective
reagents
developed
rna
ntd
sars
cov
virus
rna
2019
ncov
extraction
cdc
sars
cov
ifn
the
covid
ct
patients
ncp
thickening
features
covid
19
measures
outbreak
cases
qtc
patients
baseline
increased
we
data
covid
19
clinical
the
health
mental
impact
interventions
studies
control
this
vaccine
strategy
covid
measures
range
social
respondents
countries
method
research
algorithm
compounded
exploiting
available
beds
hospital
health
three
models
network
epidemiological
spread
disease
mortality
testing
apparent
differences
rates
the
spread
epidemic
model
simulation
epidemic
models
model
accurately
dynamics
coronavirus
symptomatic
asymptomatic
patients
we
covid
19
global
countries
rate
mobility
population
patterns
cities
travel
capacity
deaths
dependent
covid
19
group
samples
nat
the
covid
change
covid
19
spreading
short
recovered
population
rate
globally
virus
patients
covid
19
reduction
lymphocyte
patients
characteristics
covid
19
clinical
patients
ali
covid
19
risk
covid
19
review
articles
included
review
health
outbreak
records
published
demand
different
the
inventory
ventilator
virus
19
covid
corona
the
wuhan
distance
working
adults
epicenter
covid
19
tool
the
treatment
speaking
transmission
droplet
saliva
we
information
global
disease
help
decisions
presymptomatic
transmissions
we
timing
estimated
data
coronavirus
pandemic
covid
19
spread
epidemics
the
model
strongly
sars
cov
disinfection
ppe
in
sars
cov
2020
spread
february
predicting
course
pandemic
even
models
india
data
sir
based
community
cfr
parameters
model
we
deaths
lockdown
collapse
medical
facilities
r0
temperature
covid
19
regions
data
deaths
number
covid
19
would
model
the
fatality
curves
covid
mortality
covid
19
α1
ar
epidemic
power
law
infection
we
he
oc43
apparently
bcov
receptor
unstructured
platform
nferx
biomedical
knowledge
epitopes
the
sars
cov
sequences
hiv
sars
cov
tenofovir
two
influenza
within
urban
transmission
city
drugs
sars
cov
approved
covid
mpro
cov
structural
across
main
cardiac
cell
disease
heart
cells
testing
covid
19
implementation
disease
cov
sars
aprotinin
novel
currently
sars
cov
antibody
rbd
structures
the
covid
19
health
pandemic
the
virus
country
spread
health
the
rates
covid
19
health
2019
19
ncov
host
variants
19
covid
pandemic
dmards
would
images
feature
covid
19
the
covid
19
patients
levels
immune
seird
italian
infection
rate
due
specimens
sars
cov
the
samples
or
masks
protective
effect
studies
viral
respiratory
self
sampling
foam
patients
covid
19
kidney
urinalysis
patients
viral
shedding
the
sars
interventions
coronavirus
2020
social
distancing
fc
patients
covid
19
outbreak
number
days
deaths
icu
the
public
alert
korean
health
authorities
testing
probability
required
rt
pcr
covid
19
mechanical
data
randomized
nomogram
covid
19
pneumonia
the
data
model
infection
quarantine
available
samples
one
air
two
bathroom
test
standard
assay
rapid
serological
patient
patients
ventilator
pressures
in
implementation
social
days
distancing
covid
model
we
quarantine
show
health
evidence
covid
19
we
trials
treatment
drv
covid
19
sars
covid
19
malaria
incidence
mortality
covid
19
distress
iran
mental
n95
system
face
imasc
mask
state
states
policies
model
interstate
climate
pandemic
may
sars
cov
the
crow
amsaa
reliability
model
sars
cov2
covid
19
minipcr
states
approximately
respectively
the
virus
covid
19
twitter
tweets
sentiment
model
the
covid
19
within
cov
sars
atv
protease
mpro
sars
animal
cov
intermediate
transmission
viral
efficacy
may
patients
treatment
transmission
contact
covid
19
lockdown
growth
epidemic
19
high
efforts
covid
19
the
diagnosis
machine
studies
disease
stages
found
covid
the
number
r0
cases
incidence
face
masks
resources
limited
spread
spread
countries
covid
19
temperate
isolation
population
fatalities
total
measures
outbreaks
cases
three
involved
identified
health
declared
pandemic
2019
study
tests
laboratory
patients
onset
covid
19
covid
early
journal
correlation
model
we
different
parameters
epidemic
the
community
razavi
khorasan
study
lockdown
suppress
economic
epidemic
work
air
quality
mortality
china
italy
covid
19
cases
infection
domestic
number
npis
reproduction
spreading
cov
covid
19
infections
students
china
mepvc
sars
cov
vaccine
immune
gene
viral
samples
expressions
tool
ctsl
amantadine
expression
sars
agent
sars
human
wikidata
cov
coronavirus
sars
cov
new
ace2
rbd
buffer
lysis
resulted
pcr
reagents
cov
sars
pathogenicity
coronaviruses
features
variants
ace2
genetic
sars
cov
sars
cov
γδ
cells
covid
patients
covid
19
we
model
covid
19
loss
smell
taste
masks
treatment
n95
decontamination
hydrogen
group
testing
sample
save
abstract
wastewater
may
approach
presence
clinical
patients
false
tests
positive
rt
lym
covid
19
prognosis
indicators
covid
19
associated
disease
particularly
affected
years
india
government
number
pregnant
covid
19
women
data
covid
19
severe
studies
risk
bcg
vaccination
day
suggests
covid
drug
drugs
the
disease
study
mobility
physical
distancing
relative
growth
model
movement
models
disease
infectious
95
cri
cases
r0
asymptomatic
19
covid
wuhan
model
turning
65
risk
people
covid
19
000
cases
10
for
african
uk
covid
19
intervention
infections
pooling
sample
tests
low
we
model
social
we
transmission
distancing
192
covid
198
19
physician
covid
19
increase
we
pm2
000
growth
critical
care
16
model
models
data
points
abstract
virus
infection
infections
corona
covid
covid
19
recovery
study
ancestry
burden
regions
relative
as
united
covid
19
sd
model
hospital
spread
scale
cost
sequencing
covid
nelfinavir
treatment
covid
19
2019
approach
testing
help
pandemic
rt
cov
sars
ace2
genes
expressed
translational
viruses
codon
usage
tropism
genetic
host
ace2
viral
tmprss2
hla
sars
cov
ii
identify
viral
different
protein
the
strains
primer
dna
sets
pairs
coverage
assay
covid
19
pcr
respiratory
testing
pcr
lab
using
pool
cells
sars
cov
ace2
targets
ace2
fragment
surface
binding
protein
textiles
mice
droplet
germ
free
covid
19
system
likely
respiratory
extraction
assay
test
used
step
rt
sars
cov
viral
efficiency
data
disease
rapid
transmission
hotspots
ifn
α2b
arbidol
covid
19
covid
19
patients
disease
asymptomatic
surveillance
disease
design
systems
framework
nps
rt
pcr
respiratory
samples
sars
cov
states
disease
across
target
samples
pooling
one
method
covid
19
uncertainties
models
policy
not
applicable
new
data
letter
cases
india
population
countries
days
covid
19
cases
counties
yet
learning
students
teaching
based
outbreak
undiagnosed
patients
estimated
per
diagnosed
rna
method
extraction
sars
cov
covid
19
disease
countries
npis
number
covid
19
we
rates
the
epidemics
expression
mobility
epidemic
patients
hypertension
covid
19
disease
hcws
respiratory
n95
respirators
confirmed
the
modification
authors
flow
potential
covid
19
patients
severe
high
we
evaluated
impact
early
social
aki
patients
covid
19
higher
transmission
route
different
routes
respiratory
oxygen
blood
dialysis
respiratory
the
covid19
cases
pakistan
model
data
countries
doubling
bcg
time
death
covid
19
county
counties
data
the
tccpm
number
data
analysis
fit
ppe
n95
testing
ability
approach
testing
help
pandemic
rt
time
italy
control
evolution
measures
curve
the
infected
population
mean
curve
tool
scat
pandemic
this
sars
cov
covid
19
mabs
testing
undetected
infections
iceland
targeted
vaccination
bcg
rates
countries
this
masks
transmission
mask
adoption
face
social
distancing
transmission
may
these
gaussian
covid
19
data
trajectories
covid
19
days
average
air
existing
niv
cpap
use
deliver
outbreak
mitigation
method
pandemic
curve
countries
the
infoveillance
monitor
public
the
oxygen
02
patients
days
model
peak
we
gm
time
beds
particular
icus
patients
majority
outbreak
states
period
model
days
hospital
workers
95
us
19
transmission
dynamics
the
covid
19
patients
cases
cells
or
wuhan
sars
cov
s309
antibodies
antibody
viral
cytokine
storm
immune
pathology
ace2
protein
sars
cov
variants
detection
sequences
rapid
based
platforms
the
mmpd
covid
19
coronavirus
cov
sars
ivig
protein
flebogamma
sars
cov
covid
19
pets
isolates
cov
protein
2019
virus
covid
19
rna
sanger
sequencing
sars
guanine
quadruplexes
host
mode
methylglyoxal
sars
cov
fold
modification
sars
cov
rbd
human
specific
mixes
freeze
pcr
dried
the
protein
structures
3d
glycoforms
sars
gene
people
ace2
dna
part
idseq
mngs
data
analysis
generation
ace2
brain
distribution
cells
sars
covid
19
sars
cov
age
candidates
cells
sars
cov
covid
sars
cov
expression
ace2
epithelial
viral
sars
cov
subtypes
dynamics
sars
cov
trib3
expression
lung
sars
cov
spike
protein
variations
droplet
covid
19
masks
the
use
paper
epidemiologists
models
modellers
sounds
patients
the
abnormal
covid
day
symptom
onset
95
ci
covid
19
china
death
spatial
lockdown
transmission
uk
r0
deaths
covid
19
bcg
countries
vaccination
developed
population
contact
tracing
pandemic
travel
outbreak
impact
spread
taiwan
igm
igg
antibody
detection
covid
pregnant
sars
cov
women
covid
severe
patients
covid
19
using
patients
99mtc
mdp
group
control
hospital
cases
hcw
march
infection
infections
measures
peak
phase
daily
number
ct0
cases
mortality
reported
health
care
covid
19
clinical
icu
patients
days
number
covid19
sars
cov
testing
the
ongoing
two
patients
ventilator
setup
tidal
patients
corticosteroid
adjuvant
mortality
associated
cq
patients
19
covid
dose
wavelength
models
case
outbreaks
net
convalescent
the
covid
19
currently
covid
19
countries
infections
we
pc
nodes
networks
targeted
immunization
ventilator
model
single
patients
study
disease
mobile
data
states
patterns
outbreak
model
the
tactics
control
patients
covid
19
clinical
study
ace
patients
inhibitors
covid
19
cases
covid
19
province
clinically
human
cov
milk
sars
transmission
this
article
describes
method
evaluating
test
system
ctest
covid
19
data
epidemic
model
using
infections
number
model
covid
epidemics
infectious
infected
covid
19
models
different
number
correlation
bcg
early
protection
covid
19
countries
data
we
handwashing
access
countries
income
covid
progression
pandemic
africa
south
the
influenza
air
quality
across
hospital
dosage
inside
uvgi
masks
irradiance
19
hospital
covid
confirmed
length
vs
001
2019
ncov
infection
policies
social
different
impact
policy
sars
cov
the
protein
surface
sars
cov
assay
the
neutralizing
covid
19
severe
immune
tocilizumab
bats
tetherin
mammals
including
variants
surfactant
srb
ards
albumin
exogenous
viral
sars
mulatta
fascicularis
cov
rna
sars
cov
dicer
we
assays
bomv
silico
designed
biolaboro
3dva
cryo
em
data
single
rna
the
sars
cov
viral
covid
19
respiratory
sars
cov
95
covid
19
ci
74
patients
hypertension
anti
covid
19
asymptomatic
covid
19
pre
symptomatic
hydroxychloroquine
azithromycin
use
combination
19
epidemic
we
disease
countries
lockdown
viral
laboratory
rna
method
extraction
bcg
cov
policy
countries
vaccination
we
evidence
review
covid
19
the
covid
19
cases
mathematical
covid
19
regions
cases
reported
sars
cov2
city
nyc
one
sars
cov
rt
lamp
detection
compliance
health
people
we
non
sars
cov
population
climate
distribution
model
number
evolution
pandemic
lose
covid
19
disease
transition
state
2020
model
epidemic
cases
dynamic
sars
cov2
nosocomial
study
the
italy
usa
possible
population
we
patients
severe
pneumonia
hospital
respectively
infection
model
development
this
estimate
covid
19
outbreak
understand
disease
epidemic
curves
sensitivity
errors
cases
the
covid
2019
living
society
ifr
cfrs
data
21
95
or
95
ci
critical
illness
age
infectious
we
stratified
infection
hcq
covid
19
effects
influenza
disease
individuals
prognostic
19
burden
growth
march
approach
doubling
95
system
we
epidemic
information
our
capacity
covid
19
surge
hospital
patients
outcomes
death
glucose
primary
blood
cov
covid
19
patients
the
data
dynamics
pandemic
sir
countries
regions
the
virus
however
patients
icu
proportion
severity
illness
age
years
transmission
95
ui
factors
counties
covid
19
states
related
work
cases
workers
early
testing
time
epidemic
number
strategies
india
study
various
units
also
transmission
sars
cov
npis
model
covid
19
rna
qpcr
based
covid
19
severe
vit
age
epidemic
italy
disease
covid
19
aged
rr
age
group
individuals
jail
we
provide
within
community
structures
irs
nucleic
quadruplex
utr
19
virus
mpro
covid
carmofur
cov
sars
coronavirus
bcl
like
sars
cov
network
molecular
19
host
species
novel
transmission
infections
prrsv
production
dissemination
farms
systems
airway
ace2
tmprss2
expression
covid
samples
usa
datasets
events
sars
binding
affinity
spike
variable
sars
sars
cov
mutation
protein
development
infection
virus
ace2
residues
the
influenza
viruses
response
cytokines
hyper
the
model
strategy
testing
tracing
pandemic
perceptions
covid
19
risks
none
cases
regions
measures
march
covid
covid
19
infection
weighted
mean
influenza
cases
covid
19
2020
covid
19
combined
effect
size
sars
cov
tests
serological
assays
age
differences
covid
19
deaths
chloroquine
the
seizure
epilepsy
risk
anxiety
depression
healthcare
students
professionals
universal
vaccination
covid
19
bcg
growth
countries
outbreak
case
days
risk
importation
australia
early
outbreak
covid
19
outcomes
associated
stress
hc
swabs
sars
cov
respiratory
patients
moderate
severe
parameters
the
sars
cov
covid
19
use
covid
19
measures
influenza
china
virus
covid
19
acidic
dry
patients
we
classification
intensive
care
data
india
10
we
italy
viral
rna
clearance
days
covid
sars
cov
cases
the
mathematical
onset
the
quarantine
hong
kong
infections
number
the
india
states
italian
regions
cases
covid19
model
ship
we
cases
transmission
confirmed
95
ci
africa
covid
19
analysis
covid
19
remdesivir
review
disease
angiotensin
coronavirus
covid
19
number
cases
the
india
covid
countries
the
covid
19
disease
covid
19
virus
spread
states
measures
spain
early
social
epidemic
patients
95
ci
covid
19
testing
random
measures
restrictive
time
epidemic
near
global
time
sars
model
order
time
recovery
quarantining
epidemic
different
models
flexible
people
social
distancing
covid
medical
intervention
we
effects
regions
model
lockdown
vaccine
programs
non
industry
sponsored
nets
dna
covid
19
patients
clinical
trial
optimal
covid
19
variables
total
correlations
statistical
analysis
cases
meta
analysis
rate
total
n95
mask
respirators
method
heating
epidemic
an
mechanism
impact
viral
quarantine
disease
lockdown
mitigation
strategies
pandemic
models
this
public
health
cfr
covid
19
age
country
coverage
ro
treatment
remote
sbrt
kenya
epidemic
covid
19
age
cases
spain
model
sars
cov
covid
19
care
among
hospitalization
we
covid
19
epidemic
cases
vaccination
hcws
general
acceptance
disease
ppe
respirators
decontamination
coronavirus
disease
lag
covid
19
cases
pm2
ozone
concentration
covid
2019
latitude
cell
sars
cov
ace2
entry
detection
cov
nucleic
acid
crispr
virus
cov
homologous
recombination
human
sars
cov
ace2
fc
coronavirus
eav
equine
molecules
rna
animal
cads
anti
chloroquine
drugs
sphingolipid
gene
ensemble
noise
expression
sepsis
sars
cov
baicalensis
3clpro
activity
cell
single
scirpy
repertoires
scale
sars
cov
early
also
may
protease
understanding
conformational
flexibility
structural
sirna
rna
sars
cov
surface
cov
genome
https
com
d3
sars
cov
protein
rbd
entry
furin
sars
cov
host
cell
target
nucleic
acid
detection
cas
nidovirus
respiratory
nidoviruses
pythons
infection
rubella
mmr
covid
19
sars
spreading
virus
model
rate
sir
covid
19
country
disease
economic
ace2
lung
expression
levels
association
daily
significant
regions
difference
rate
sars
cov
lamp
assay
the
rsc
we
april
number
sick
infection
we
recovery
time
virus
patients
severe
common
covid
19
drugs
covid
19
treatment
the
population
countries
model
total
models
growth
data
existing
new
time
covid
19
growth
rate
temperature
tidal
one
ventilator
two
volumes
hcq
soc
day
rate
adverse
regions
we
the
italian
region
ffp
respirator
um
particles
in
lockdown
air
pm2
pollutant
premature
population
policies
model
the
different
hcq
group
within
patients
vs
veneto
lombardy
100
000
cases
disease
testing
method
ifr
fatality
cases
maximum
total
estimate
limit
the
ncovid
19
model
seir
number
reproduction
states
we
covid
ro
covid
19
early
spread
19
cfr
covid
svi
incidence
cov
patients
sars
negative
95
number
the
function
paper
statistical
social
distancing
model
disease
numerical
tests
the
sars
cov
time
testing
test
kits
schemes
samples
health
covid
19
distancing
developed
patients
data
covid
19
vietnam
video
covid
19
visits
cancer
social
distancing
isolation
loss
participants
respirators
elastomeric
filters
fit
tests
viral
potent
dosed
peak
load
chloroquine
neuropsychiatric
use
reporting
ae
patients
note
in
provide
result
cell
ras
components
seq
analysis
orc
we
group
offspring
young
en
log
reduction
clinical
samples
articles
relevant
literature
exploration
coronavirus
sars
cov
virus
human
cells
covid
19
tissue
disease
lung
disease
covid
19
develop
using
patients
onset
in
cohort
42
cases
household
19
95
ci
patients
arbidol
mortality
the
use
patients
covid
19
cases
clinical
phase
delayed
thrombocytopenia
patients
covid19
patients
resuscitation
survival
covid
19
lockdowns
diseases
outbreaks
strategies
lockdown
medical
students
covid19
undergraduate
most
the
model
fractal
pandemic
si
respondents
covid
19
nigeria
94
sars
cov
implementing
person
infection
epidemic
current
development
cases
number
time
patients
the
mean
areas
risk
drops
nasal
group
rhifn
days
infected
number
capacity
case
sars
cov
sequence
genome
viral
symptoms
respiratory
the
unknown
febrile
pm10
daily
provinces
covid
italy
ivig
clinical
type
covid
19
the
sars
cov
vitro
pharmacokinetic
epidemic
time
reproduction
2020
19
outbreak
covid
19
dynamics
accurate
face
shields
testing
health
care
19
covid
individuals
identify
medications
n95
respirators
sars
cov
transmission
using
reduction
respirators
used
sterilization
model
the
infection
social
interaction
data
classification
image
model
er
evidence
covid
19
we
trials
spread
virus
controlling
the
we
swedish
pandemic
care
non
mortality
patients
onset
symptoms
pcr
group
cfr
china
estimation
hubei
province
ifr
countries
cfr
the
covid
deaths
model
ihme
covid19
2020
n95
mask
sars
cov
disposable
specific
sars
cov
cells
vaccine
women
covid
19
34
pregnant
collected
swab
specimens
clinician
self
mechanistic
model
viral
infection
antiviral
age
tmprss2
respiratory
covid
19
fusion
endosomal
membrane
cells
within
cov
sars
network
coronavirus
spreader
cov
sars
2020
the
analysis
cases
2019
philippines
confirmed
covid
covid
sars
cov
19
homeless
efficiency
filtration
respirators
masks
water
early
covid
19
expected
data
mycoplasma
covid
19
infected
patients
models
regions
final
epidemic
different
ecmo
gas
blood
support
venous
000
aged
65
2020
medical
patients
death
19
covid
clinical
flow
model
ventilation
two
ventilator
model
number
different
the
covid
cases
imv
the
occurred
il
sars
cov
infection
described
severe
patients
sars
cov
pcr
rt
sars
wastewater
samples
cov
cov2
population
ca
mortality
immunity
low
lockdown
measures
outbreak
world
policies
india
cases
covid
19
case
quanta
virus
viral
the
indoor
19
patients
or
95
covid
model
cases
deaths
the
reported
cases
interventions
epidemic
number
period
spread
the
model
epidemic
covid
covid
19
among
we
re
number
cases
r0
containment
period
dna
rna
target
amplification
detect
mers
chadox1
cov
respiratory
humans
nt
rna
ic
template
dna
sars
cov
3clpro
baicalein
development
ace2
the
cells
cell
health
sars
cov
disease
covid
19
hcq
covid
19
sars
cov
usp18
viral
isg15
cytokine
pathology
large
population
testing
test
samples
human
cov
drugs
cells
viral
assays
sequence
amplification
lamp
especially
aged
trm
viral
respiratory
pneumonia
sars
cov
cases
severe
adaptive
age
countries
median
versus
sars
laboratory
data
covid
19
values
r0
the
province
class
covid
we
vaccination
individuals
number
allocation
sars
cov
blood
donors
scotland
pollution
air
covid
19
london
we
regional
number
time
variation
quarantine
we
risk
deaths
economic
patients
psychological
hd
19
dialysis
knowledge
hcps
practice
covid
19
strategies
epidemiological
non
outcomes
lockdowns
the
model
data
infections
show
number
icu
expected
turkey
deaths
program
the
models
outbreak
model
number
rt
signal
would
icu
parameters
system
time
model
modeling
disease
covid19
pandemic
low
resource
covid
19
patients
systems
the
fft
gabor
covid
19
scheme
infections
estimate
us
we
method
mask
covid
19
pandemic
mortality
95
hr
ci
death
respectively
covid
19
knowledge
participants
transmission
model
outbreak
policy
efforts
impact
stay
at
home
orders
growth
mobility
r0
countries
npis
across
covid
smoking
19
progression
analysis
the
latent
period
covid
19
epidemic
models
spatial
heterogeneity
level
risk
health
covid
19
individual
cov
sars
coronavirus
respiratory
syndrome
model
chain
multi
covid
19
covid
19
number
relationship
variation
lockdown
social
population
distancing
france
ct
covid
19
learning
scans
interpersonal
2020
united
states
contact
individuals
outbreaks
untested
covid
19
less
new
outbreak
covid
19
world
unlock
cases
flattening
economic
evidence
covid
19
we
trials
ventilator
ventilation
patient
lung
setup
confirmed
testing
number
case
numbers
operations
covid
19
plans
essential
bcg
country
in
covid
19
cq
hcq
efficacy
95
ci
patients
the
covid
19
model
children
symptoms
19
covid
95
studies
supportive
diseases
respiratory
quality
mothers
covid
19
breastfeeding
transmission
19
studies
children
covid
the
covid
19
95
ci
rr
infections
estimate
states
we
number
epidemic
change
dynamics
behavior
contacts
nelfinavir
viral
sars
cov
cepharanthine
ace2
expression
sars
cov
19
knowledge
research
community
response
coronavirus
sars
cov
virus
population
subtypes
auranofin
sars
cov
human
cells
change
sequences
observed
novel
the
diagnostic
academic
sars
cov2
covid
hace2
gene
we
differences
receptor
cov
sars
binding
heparin
gag
chloroquine
hair
cells
experimental
cochlear
rna
sars
cov
elements
models
ace2
sars
cov
gene
expression
sars
cov
sdabs
rbd
neutralization
paper
distancing
this
questions
various
swab
admission
patients
covid
19
patients
ventilation
two
ventilator
covid
infected
sars
cov
sera
antibodies
sars
cov
specific
iga
response
viral
mutation
sars
cov
000
model
patients
sars
cov
predict
prevalence
county
antibodies
sars
cov
masks
n95
fit
uvgi
covid
pandemic
sir
local
model
data
automated
contact
tracing
covid
we
models
order
dynamics
system
also
agmps
the
covid
19
aerosol
infection
rates
local
the
data
covid
19
igm
igg
antibodies
testing
samples
sars
cov
diagnostic
disease
severe
cov
patients
sars
ct
the
covid
19
95
health
education
information
websites
public
cases
countries
previous
confinement
spread
germany
covid
19
measures
hospital
system
hood
materials
coronavirus
protective
we
china
last
day
covid
the
countries
model
estimate
number
the
evidence
covid
19
virus
19
2020
covid
day
95
rate
number
countries
covid
19
control
swab
we
prototype
swabs
article
the
goal
analyze
compartmental
time
india
r0
sars
cov
testing
center
medical
philippines
centers
we
simple
forecasting
daily
generates
hygiene
hand
trials
influenza
rcts
measures
mitigation
number
r0
the
95
ci
covid
19
treatment
rate
contact
increases
effects
infection
epidemic
metrics
important
we
states
covid
19
in
prevalence
cases
ultrafine
particles
fabrics
fabric
ability
covid
19
academic
clinical
model
beds
model
the
number
icu
spain
cfr
covid
19
pandemic
death
elderly
covid
19
rate
ltc
covid
19
risk
death
mco
epidemic
2020
march
covid
self
guidance
response
covid
19
symptoms
epidemic
telemedicine
people
covid
covid
19
wmd
95
ci
presented
symptomatic
infectious
study
use
covid
19
increase
differences
deaths
covid
19
ray
disease
diagnosis
patients
nosocomial
19
covid
sars
cov
immunity
sars
the
future
alpha
different
states
number
individuals
anxiety
information
covid
19
behavioural
tb
incidence
percent
study
people
incubation
time
10
15
65
protein
cov
19
the
covid
neutrophils
nanoparticles
pulmonary
we
lung
vaccine
cell
high
sars
cov
zinc
kzfps
evolution
fingers
krab
sars
cov
tmprss2
covid
19
lung
imrcs
injury
fibrosis
acute
cut
tag
nuclei
home
dna
remdesivir
treatment
sars
cov
rhesus
cov
sars
covid
19
tool
isolation
social
life
behavior
mice
hcv
designs
vaccine
e2
structure
test
igm
health
workers
viva
age
covid
19
sars
cov
patient
team
staff
to
hcw
epidemic
mayotte
control
early
including
blood
type
patients
acute
coronavirus
evaluations
forensic
individuals
mental
health
19
covid
daily
incidence
deaths
sequences
outbreak
viral
sequencing
surveillance
spread
cities
covid
19
interventions
r0
covid
19
health
isolation
sars
covid
19
h5n1
immune
number
cases
the
people
covid
antibody
the
patients
neutralizing
different
ffrs
heating
re
use
ffr
mbox
si
gi
generation
95
pm
sars
cov
present
virus
infection
staff
model
the
allows
time
preventive
measures
the
observed
economic
coronavirus
pandemic
disease
social
estimated
true
number
covid
19
the
scientific
early
study
first
microg
fit
specimens
homogenised
10
group
ala
patients
placebo
covid
model
disease
r0
individuals
in
sars
cov
igg
100
lfia
patients
olfactory
anosmia
isoa
group
masks
covid
19
social
pandemic
social
health
loneliness
covid
19
daily
cases
new
covid
19
min
hhfnc
aerosol
room
gas
mitigation
greece
outbreak
international
order
immune
population
immunity
epidemics
members
sars
cov
viral
detected
wastewater
lock
down
covid
containment
19
tacs
19
covid
hours
dataset
preventive
measures
among
participants
practice
patients
covid
19
sd
failure
epidemic
spread
drone
we
drones
incubation
time
quarantine
infections
measures
sampling
serological
framework
uncertainty
public
we
age
mortality
lombardia
ifr
hospital
257
patients
covid
19
extraction
detection
nucleic
acid
sars
patients
screening
emergency
covid
19
lockdown
19
cases
covid
india
time
model
the
unit
relationships
doubling
time
in
hyperlocal
analysis
cov
autophagy
sars
pathways
propagation
cov
sars
vivo
viral
transcriptome
coronavirus
synonymous
novel
protein
hcov
known
sars
disease
covid
19
ferrets
via
sars
cov
infection
viral
pam2
odn
mortality
treatment
sars
cov
species
ace2
binding
sybodies
sars
cov
rbd
identified
ace2
cells
lung
at2
covid
system
tmprss2
19
ace2
organs
sars
cov
epithelial
airway
cells
hubei
sars
cov
patients
we
males
viral
clearance
expression
ace2
covid
19
pneumonia
ray
consolidative
cancer
patients
cohort
covid
19
todo
non
ci
countries
pharmaceutical
covid
19
interventions
deaths
social
the
covid19
ct
treatment
proposed
covid
19
segmentation
classification
the
hc
patients
az
hazard
group
parameters
covid19
impact
lockdown
pandemic
negative
false
review
evidence
studies
sars
cov
clinical
the
patients
rate
mitigation
covid
19
we
countries
median
age
covid
19
19
covid
air
we
disease
symptoms
reported
users
covid
19
emergency
japan
declaration
outbreak
april
cases
infected
cured
china
semi
risk
covid
19
air
we
cities
cordon
sanitaire
covid
19
time
infections
new
country
evolution
count
neutrophil
patients
mortality
lymphocyte
samples
pooling
pool
screening
traditional
control
transmission
community
model
we
spousal
risk
cohort
study
self
reopen
covid
19
resurgence
cases
sars
cov
three
spread
infected
risk
cfr
data
confirmed
individual
health
mental
hws
outcomes
19
saliva
sars
cov
detection
nasopharyngeal
testing
lock
down
test
the
or
months
coronavirus
studies
respiratory
rates
population
age
uk
fatality
pregnant
women
infectious
disease
outbreaks
described
case
patient
we
present
ihme
model
covid
19
forecasts
covid
19
hcq
clinical
trials
reviews
systematic
one
protocol
covid
bangladesh
infections
april
deaths
number
plasma
cmax
activity
drugs
ec90
interventions
transmission
asymptomatic
we
function
covid
19
social
distancing
measures
covid
19
care
severity
patients
country
the
algorithm
pandemic
trend
sars
cov
infection
hdl
the
influenza
ili
respiratory
13
infection
may
model
infectious
disease
reaction
pcr
reaction
need
detection
there
knowledge
research
zikv
data
literature
rna
cov
structure
sars
results
virus
spread
sars
cov
lineages
new
sars
cov
spike
antibodies
virus
sars
cov
pandemic
global
sars
cov
vaccines
human
specific
sars
cov
ace2
obesity
lipid
sars
detection
four
one
step
open
closed
state
rbd
position
sle
genes
ddx11
gwas
oasis
cov
sars
nad
nicotinamide
covs
sars
cov
respiratory
virus
coronavirus
protein
sars
cov
s2
coronavirus
sars
cov
infection
lockdown
95
severe
covid
19
patients
disease
sars
viral
cov
major
microscopy
based
novel
different
national
regions
sars
cov
symptoms
patient
central
features
19
imaging
covid
the
sars
cov
reactive
cd4
cells
ivig
covid
19
one
patients
duration
95
glucocorticoids
covid
19
covid
19
clinical
deterioration
patients
igm
igg
iga
sars
cov
covid
19
rna
samples
extraction
pandemic
data
dataset
interventions
npis
decontamination
respirator
testing
fit
current
social
distancing
model
the
spread
bcg
nations
vaccination
among
infection
model
the
mathematical
covid
19
deaths
countries
proportions
cases
infection
covid
19
regions
data
analysis
cannabis
use
cvir
significant
models
sars
cov
testing
infection
rt
000
mortality
covid
19
deaths
countries
covid
19
mortality
line
ct
covid
19
management
disease
application
employees
covid
we
symptoms
covid
19
number
expected
disease
the
spread
infection
people
social
day
regression
these
there
many
restrictions
enacted
policies
covid
19
rate
case
fatality
we
country
pregnant
women
infection
vertical
transmission
endgame
region
cases
social
possible
confirmed
cases
2020
number
million
positive
virus
faecal
patients
covid
masks
mask
particle
surgical
efficacy
case
arizona
sars
cov
orf7a
the
data
pandemic
predicted
health
increased
19
factors
deaths
covid
mitigation
yll
the
social
strategies
recovery
covid
19
patients
paper
patients
cs
covid
19
studies
cases
covid
19
detected
population
covid
19
clinical
the
sars
spread
the
high
spatiotemporal
geographic
covid
19
saliva
non
rt
tenants
psh
this
covid
19
distancing
measures
covid
19
we
models
outbreak
covid
19
prediction
influenza
flu
measures
covid
19
deaths
coronavirus
reported
genome
sars
population
transmission
reported
different
infected
control
medical
resources
measures
covid
journals
publication
process
articles
medical
ms
covid
19
sars
cov
ace2
furin
2019
ncov
oral
risk
disease
covid
19
individuals
design
control
we
ventilator
supply
il
1β
cells
induced
subsets
sars
cov
ace2
human
receptor
transmission
sars
cov
covid
19
cells
ace2
cell
expression
covid
rbd
ace2
antibodies
sars
cov
the
patients
covid
19
lung
covid
19
the
spread
rapidly
cells
airway
epithelial
children
adults
19
cord
covid
publications
viruses
sequences
spike
neural
simulated
viruses
sars
cov
nyc
infection
pandemic
disease
outbreaks
number
human
risk
sars
cov
two
viruses
coronavirus
spain
sars
cov
clusters
sequences
virus
viruses
host
early
characterization
ssrna
viruses
secrete
rna
motifs
receptor
viral
sars
cov
phase
water
proteins
sites
high
structures
viral
diversity
within
19
sars
vaccine
epitopes
sars
cov
the
sars
cov
inhibitors
novel
boceprevir
sars
cov
ace2
selection
bats
sars
cov
synonymous
divergence
human
alignment
viral
sequence
viralmsa
multiple
sars
cov
rbd
cross
neutralization
crest
the
covid
19
hurdles
ppxy
motif
sars
cov
viruses
sars
cov
s1
quantitative
elisa
spike
the
study
dynamic
coronavirus
patients
covid
19
icu
regarding
parameters
epidemic
demic
genetic
population
infected
number
model
method
probability
sars
cov
rna
covid
19
online
cdc
health
precision
coronavirus
tmprss2
covid
19
androgen
regulation
sars
cov
infection
hipsc
covid
population
epitope
sars
cov
across
lamp
covid
19
rt
one
spike
protein
sars
cov
tmprss2
rbd
2019
ncov
binding
interface
rna
influenza
virus
sars
cov
sars
cov
vsv
kinase
virus
glycoprotein
structural
protein
surface
nucleocapsid
ph
groups
buried
protonation
we
tolerance
drug
fluconazole
mic
isolates
fitness
viral
expression
genes
genotypes
ccl2
brain
neurons
tmev
hippocampal
mad2
ctd
checkpoint
ntd
mad1
gaa
disease
glycogen
pompe
structure
human
transmission
diseases
animal
zoonotic
complexes
complex
smartbac
system
large
phenotypes
interferon
factor
receptor
cluster
species
host
related
pathogen
new
informed
partitioning
structurally
scheme
viral
gene
isd
overlapping
high
two
changes
epidemic
holiday
closure
mitigate
uvc
light
airborne
far
public
mutations
nature
residues
host
viral
corona
viral
amyloid
protein
show
hcmv
vaccine
gb
mf59
neutralizing
virus
cov
cell
ibv
abl
aminoglycoside
cells
antiviral
treatment
interferon
domains
developed
pyhca
hcatk
python
trna
modifications
trnas
translation
target
orfeome
orfs
albicans
cloned
genomic
ifit1
ifit3
ifit
binding
translation
hiv
aging
associated
age
bag
workers
brood
age
fertility
behaviour
bovine
virus
minion
dna
reads
viral
virus
receptors
host
receptor
bar
membrane
domains
tubules
fission
viral
genomes
we
catch
probe
kinetochore
rod
expansion
rzz
assembly
crossalign
secondary
structure
rna
method
dna
proteins
atpase
histone
domains
lamp
wolbachia
osd
mosquitoes
mosquito
pulmonary
children
pathogens
immunocompromised
samples
host
s2
viral
cleavage
sars
respiratory
upr
rna
host
mhv
strain
pathogen
strains
behaviour
virulent
mirnas
pre
cells
mature
human
infection
estimate
model
vaccine
asymptomatic
mrna
decay
expression
binding
protein
rna
torovirus
etov
sequencing
sequences
odor
piriform
fear
olfactory
memory
mad1
mad2
rzz
kinetochores
assembly
rna
genome
rnp
kb
size
rna
honey
bees
among
dsrna
ndv
apoptosis
virus
cells
apoptotic
incidence
aedes
transmitted
times
range
ctt
within
ftsz
sequences
sequence
in
viral
multimerization
allosteric
domain
transmission
viral
data
sequence
selection
site
models
divergence
branch
length
cellular
cell
particles
responses
np
virus
acnv
rna
nidovirales
first
season
coupled
forecast
forecasts
influenza
cov
vaccine
nsp16
coronavirus
future
mutation
rates
selection
high
viruses
bnp
immune
cows
response
disease
often
generation
interval
provides
estimating
virus
protease
wt
resistance
hiv
peacock
adaptive
evolution
genomic
phenotype
sox
rna
cleavage
sequence
replication
cases
incidence
zikv
transmission
lac
virus
h5n1
infection
strategies
influenza
pgkl1
plasmids
we
found
degree
cov
mers
bat
cells
dpp4
pr8
co
infection
rv1b
disease
xap
lamp
assay
pomegranate
infection
outbreak
cases
size
ebola
using
bifurcation
epidemic
psychological
effect
diseases
cd63
nsp1a
astrovirus
rna
replication
gene
drug
drugs
data
emerging
avarda
virscan
viral
human
we
rv
rvs
species
respiratory
virus
elpa
cytotoxic
cell
activity
cells
schizophrenia
bioenergetic
found
novel
glycolytic
hemoglobin
evolution
bacterial
pathogenic
proteins
binding
protein
mutations
changes
energy
rosetta
animal
cell
biology
choanoflagellate
quadruplexes
viruses
genome
quadruplex
present
epidemic
data
wikipedia
zika
awareness
value
resilience
health
study
knowledge
pneumococcal
carriage
infection
bacterial
influenza
cbdvg
generation
cbdvgs
infection
rsv
method
r2
demonstrated
cv
metabolomics
ibv
entry
virus
cme
internalization
nan
mirnas
cancer
important
types
considered
brain
near
infrared
dopamine
nanosensors
quadruplex
se
salmonella
enterica
presence
species
temperature
host
susceptible
we
cells
tr1
il
10
foxp3
dogs
carnivores
villages
wild
populations
system
health
surveillance
idsr
disease
aflatoxin
transcriptomic
edna
developed
probes
samples
viruses
mngs
clinical
viral
zikv
infection
placental
observed
women
pathogens
network
pathogen
chronic
we
ns1
mosquito
cells
caveolin
infected
proton
voltage
membrane
channel
arginine
cpmps
endosomal
hops
cytosol
traffic
sugars
secy
channel
cells
specific
development
glycosyltransferases
animals
rosetta
mutants
platform
blood
identified
human
illness
devil
disease
term
long
pathogen
host
range
mutations
phi6
expansion
larvae
protein
changes
carbohydrate
nutritional
phylogenetic
protocol
confirmation
bias
estimates
results
patholive
real
sequencing
based
gi
16
ibv
epidemiology
genotypes
hdl
protein
proteins
cholesterol
regulation
rna
viral
direct
sequencing
capture
redox
proteins
proteomes
developed
functional
host
rna
factors
rtc
translation
ppi
binding
protein
molecular
pfn1
virus
human
annotation
genbank
genome
viruses
virus
sharing
host
species
smart
molecular
diagnostic
of
poc
dna
cgas
rna
virus
viruses
sfts
antibody
virus
ab10
sftsv
sequencing
minion
genome
whole
the
ibv
protein
golgi
secretory
cells
viral
filter
rna
recovery
polystyrene
host
shutoff
viral
proteins
target
viruses
devil
devils
metagenomics
vlp
mxb
hiv
ca
capsid
restriction
rna
rnas
study
srnas
non
mif
hamster
tumor
human
rha
rna
viruses
virus
reconstruction
evolution
pcr
assays
pathogens
respanel
respiratory
strain
litter
size
effects
strains
asfv
genomes
recombination
virus
diversity
outbreak
cases
term
short
evd
ambulance
records
data
influenza
temperature
tim
virus
ebov
receptor
infection
sialic
acid
cells
acetylation
casd1
frameshifting
ribosomal
human
hiv
based
dux4
fshd
pathology
fl
muscle
mers
cov
health
majority
hw
rnase
translation
synthesis
response
protein
frameshifting
rna
translation
frameshift
single
parp2
serum
cell
in
differentiation
rna
viral
genome
sequencing
length
5amd
rna
synthesis
translation
mrnas
parkin
stress
pd
loss
oxidative
asfv
ticks
hard
235
bp
transmission
disease
the
rate
system
piglets
ko
exp
pedv
in
virus
host
transmission
viruses
body
mngs
pcr
viral
pathogens
protocol
wo3
nanodots
antibacterial
activity
coli
compound
mutations
participants
epi4k
maf
zika
americas
virus
transmission
may
plant
diagnostic
technologies
towards
sequences
influenza
pseudotypes
bearing
h17
n10
respiratory
113
the
virus
infections
il
levels
patients
mycetoma
35
mtk
circuits
mammalian
toolkit
ability
viral
host
kshv
endonucleases
transcripts
virus
bas
congo
ekpoma
tibrovirus
mdck
hla
viruses
h17
cells
sf6
receptor
infection
host
omp
mngs
viral
copd
exacerbations
patients
ev
recombinant
type
gene
pig
binding
viruses
na
virus
iav
frameshifting
mrna
the
ribosomes
prf
transmitted
indirectly
reservoir
infection
two
hiv
24
compounds
azabinol
activity
species
host
viruses
virus
single
zikv
viral
egcg
significant
flaviviruses
hand
world
airports
hygiene
spread
protein
epitopes
vaccine
cryptococcus
neoformans
viruses
evolution
selection
viral
rates
transmission
social
microbiome
contacts
bacterial
exon
rna
virus
domain
innate
speech
connected
paraphasias
naming
left
vaccine
evolution
within
immunity
host
viruses
viral
studies
host
major
hand
location
stimulus
external
occurred
biofilms
extracellular
matrix
biofilm
graphene
viral
nsp12
coronaviruses
sars
cov
social
status
expression
genes
gene
cells
reovirus
stress
infection
sa
bacteria
bacterial
model
prodrugs
mechanisms
cell
cycle
replication
origin
licensing
density
il6
mice
aβ
microstructure
btv
ns3
pathway
mapk
erk
plant
sirna
delivery
silencing
ptgs
zikv
glycans
cell
due
disorders
bleomycin
differences
response
variation
strain
michiganensis
subsp
nebraskensis
the
at
time
generation
forward
mean
contraction
disease
risk
models
pathogen
data
viral
host
norovirus
g3bp1
translation
outbreak
symptom
onset
data
household
editing
cell
loci
genome
set
dromedary
mers
cov
dromedaries
infection
virus
host
viral
prediction
deep
cells
heat
transcription
ii
pol
virulence
human
risk
predictive
we
detection
xf
pcr
plant
time
pkr
mav
infection
viruses
degradation
mrna
decay
viral
ii
transcriptional
control
cell
aice
biomaterials
provide
csa
arterivirus
nsp5
inhibitors
rna
poly
length
tail
sequencing
rna
eps8
host
infection
fluav
factor
vaginal
gilts
milk
lipids
swabs
human
virus
viral
infecting
viruses
swine
asfv
drugs
aips
antiviral
organoids
intestinal
cell
model
different
lf
different
rainfall
regions
quantify
ires
ccd
viruses
rna
cryo
drug
antiviral
cell
single
analysis
delivery
cell
serum
protein
expression
ibv
gene
rna
expression
ck
cases
transmission
genetic
data
estimate
exon
aa
reversion
fitness
motif
virus
vp7
gbf1
assembly
nsp4
avan
immune
antiviral
lncrna
innate
membrane
agnps
vesicles
nanoparticles
wide
sbi
lcn2
infection
children
clinical
adenoviruses
species
prevalence
found
transmission
pyvs
host
bat
switching
events
denv
den
im
the
metagenomics
cases
locally
acquired
yunnan
transmission
nsp3
adp
translation
initiation
sg
lecb
binding
host
cell
receptors
localization
electroporation
proteins
cells
functional
pristane
mice
lupus
nr2a
lps
cd8
cell
cells
2db
tmev
exacerbations
frequent
copd
exacerbators
immune
ibv
samples
ampseq
detected
minion
studies
published
zikv
data
used
membrane
curvature
helicoidal
spontaneous
ramps
cov
infection
surfactin
viruses
bacterial
rna
mtase
n7
guanine
cap
airway
expression
gene
rsv
severe
toxicity
nanoparticles
vivo
significant
activation
acetyl
sia
cells
modified
modifications
transport
ecm
tumor
phage
p4
mucus
drug
delivery
barriers
mucosal
nsp5
rv
replication
viroplasms
phosphorylation
xp
astrovirus
astroviruses
orfx
human
reporting
time
approaches
delay
cases
rna
sense
frame
viruses
positive
genes
behavior
pollen
associated
stress
ccfrnas
rna
in
fluids
transcripts
activation
gm15441
ppara
inflammasome
inflammation
influenza
samples
reads
viral
generated
transmission
human
zoonotic
surveillance
spatial
intervals
individual
generation
observed
spatial
drugs
drug
models
new
target
epilepsy
seizure
we
identified
associated
human
cultures
haec
host
respiratory
zikv
mice
infection
cc
studies
immune
host
bat
zoonotic
viruses
subspecies
fastidiosa
assays
plant
qpcr
bees
winter
gut
microbiota
bacterial
epidemic
population
estimates
model
changes
sequencing
haplotype
contig
viral
different
memory
protein
translation
synthesis
long
muc5ac
induced
virus
copd
inflammation
cases
norovirus
transmission
outbreaks
residents
saxs
mps
detergent
modeling
information
replication
pdcov
virus
induced
membrane
csf1r
microglia
cells
microglial
mac2
cell
mp
oumv
pd
movement
vp35
phosphorylation
ebov
protein
viral
virus
spread
neurons
activity
system
transferrin
host
somni
sheep
transferrins
viral
sharing
mammalian
predict
host
transmission
variation
disease
sources
host
ibv
ha
human
iav
virus
ifitm3
microbat
restriction
ifitms
mutation
bat
rna
ncrna
expression
ncrnas
air
rats
breath
borne
different
theory
selection
data
evolution
social
cell
types
lung
expression
molecular
bats
covs
bat
species
islands
mers
dub
cov
virus
plpro
spint2
fusion
cell
inhibitor
influenza
termination
pp1
transcription
pol
ii
resistance
cost
bacteria
rnase
resistant
treatment
haloperidol
mice
strain
change
archaea
ccb
microbial
form
domes
coding
genetic
non
variants
pathogenic
receptor
cov
spike
emergence
covs
rdrp
recombination
kh
fidelity
speed
human
virus
lineages
rna
viruses
bats
astv
astvs
rna
species
il
33
12
cytokine
nk
serinc5
retroviruses
particles
glycoproteins
virus
giant
viruses
host
virophage
we
dub
activity
virus
plp2
ubiquitin
temperature
mosquitoes
mosquito
changes
20
sftsv
protection
antigens
dna
vaccine
prf
cotranslational
folding
nascent
chain
models
narratives
ecological
population
data
tlr4
lps
o3
tlr5
injury
snsvs
translation
upstream
initiation
viral
libraries
site
protocol
single
mutant
ray
scintillation
induced
ce
rays
sia
acetyl
iav
modifications
different
oas
proteins
in
diseases
compounds
data
molecular
sets
sampling
samples
strain
level
classification
taxonomic
taxit
variants
viral
de
novo
assembly
stress
ibv
cellular
translation
results
age
hbov
children
samples
human
rt
we
prediction
disease
significant
children
pneumonia
airway
immune
cell
molecular
formulas
zodiac
identification
challenging
κb
nf
reovirus
infection
cells
bat
cells
stem
unique
mammals
detection
dickeya
developed
spp
multiplex
genes
human
regulatory
linked
specific
host
virus
systems
crispr
dynamics
rnase
zikv
deletion
rfs
virus
prevalence
infection
the
areas
screening
pedv
don
infection
autophagy
diarrhea
genbank
submissions
viral
vadr
sequences
viral
otus
host
species
herpesviruses
processing
nsp7
respiratory
coronavirus
formation
escape
recognition
vaccination
cell
mhc
strains
alsv
tick
virus
jmtv
be
cuprizone
c57bl
mice
genetic
bladder
propofol
cats
dexmedetomidine
chloralose
cov
international
mers
cases
china
marked
arrows
support
acute
year
sars
cov
transmission
routes
the
access
open
doaj
information
article
sars
cov
coronavirus
viruses
acute
nan
indices
used
multimorbidity
disease
health
nan
access
open
doaj
information
article
2019
cases
human
china
coronavirus
cov
ophthalmology
sars
patient
tears
use
we
proposing
machine
learning
patients
zhejiang
province
infected
2019
the
data
medical
journal
infection
china
virus
coronavirus
2019
infection
acute
severe
china
cases
respiratory
nan
africa
south
ramaphosa
covid
19
nan
2019
city
wuhan
novel
coronavirus
health
public
emergency
hhs
with
previous
studies
suggest
covid
19
january
wuhan
on
china
health
reported
coronavirus
cases
china
2019
clinical
patients
infection
sars
cov
transmission
nosocomial
environmental
contamination
coronaviruses
coronavirus
covid
19
diagnostic
testing
nan
nan
nan
patient
icu
lombardy
positive
cases
nan
patients
95
ci
ards
hr
nan
billion
opioid
congress
coronavirus
year
nan
crises
information
global
term
science
vaccine
sars
the
nih
new
nan
test
the
patients
blood
clinical
19
covid
sars
mers
lpv
sars
cov
virus
recent
pangolins
drugs
new
studies
period
coronavirus
2019
patients
ncov
infection
incidence
cov
epitopes
sars
vaccine
situation
outbreak
pneumonia
respiratory
syndrome
sars
children
coronavirus
sars
cov
infection
covid
19
sars
mers
cases
nan
nan
covid
19
clinical
treatment
coronavirus
patients
rate
covid
19
clinical
the
sars
cov2
protein
pp1ab
cov
sars
rdrp
theaflavin
rna
cov
99
sars
sequence
study
patients
diagnosed
covid
19
cases
coronavirus
covid
19
2019
pneumonia
coronavirus
arrhythmia
novel
2019
infection
viral
antiviral
host
htas
proteins
novel
sars
cov
available
docking
children
suggestions
coronavirus
sars
cov
mortality
novel
coronavirus
hubei
china
diseases
zoonotic
camel
camels
human
nan
team
department
emergency
control
sichuan
patients
infection
sars
cov
response
cases
china
the
reported
overall
wuhan
china
hubei
province
hospitals
sars
cov
china
hospital
organ
patients
icu
wuhan
care
noninvasive
nan
nan
nan
nan
china
2019
sars
cov
also
nan
nan
the
purpose
study
observe
imaging
novel
coronavirus
covid
19
infected
patients
covid
19
severe
icu
2019
on
several
cases
reported
covid
19
infection
coronavirus
disease
outbreak
mers
cov
al
jouf
2019
wuhan
initial
cases
person
agents
viruses
the
currently
misuse
der
und
die
den
carragelose
clinical
registered
trials
trial
covid
nan
2019
clinical
late
coronavirus
studies
cells
2019
ncov
infection
organs
china
city
hubei
province
human
2019
wuhan
coronavirus
china
confirmed
nan
the
hospital
one
two
patients
µmol
drugs
two
si
antiviral
2019
ncov
coronavirus
cov
sars
infection
patient
within
ward
ventilation
patients
pediatric
clinical
symptoms
features
2019
caused
ncov
children
infection
children
2019
ncov
clinical
comprise
nan
children
covid
19
pediatric
two
19
covid
or
the
room
measures
hospital
care
patients
in
nan
2019
ncov
sars
cov
the
outbreak
information
this
official
exponential
pharmacists
hospital
role
community
play
coronavirus
the
goal
review
provide
hubei
wuhan
china
excluding
covid
the
disease
outbreak
economic
global
das
drug
aerodynamic
intratracheal
intravenous
pm1
pm2
respiratory
risks
associated
iran
cases
covid
19
countries
ards
backgroundthere
proven
specific
pharmacological
hcws
2019
ncov
covid
19
hangzhou
cases
zhejiang
number
confirmed
nan
china
health
outbreak
treatments
virus
china
nationwide
epidemic
feb
000
supply
restrictions
recent
assuring
suppliers
find
ai
drug
reported
used
related
china
biotech
chinese
outbreak
sanofi
vaccine
barda
coronavirus
use
virus
austin
cryo
structure
part
outbreak
coronavirus
infected
the
patients
ihs
conference
new
march
last
coronavirus
min
travel
the
novel
us
phase
remdesivir
the
coronavirus
the
us
cdc
kit
coronavirus
2019
ncov
therapeutic
options
response
nan
global
vigilance
preparedness
speed
transparency
use
techniques
honed
sars
h1n1
officials
want
know
predictions
vary
genetic
sequences
viruses
isolated
scaly
nan
nan
concerns
rising
virus
potential
circulate
time
essence
already
got
plus
as
hiv
drugs
stem
cells
worldwide
tell
nature
epidemic
from
as
outbreaks
surge
worldwide
scientists
three
animal
source
animals
weeks
coronavirus
the
spread
china
virus
it
never
dull
day
tasked
nick
howe
hosts
roundtable
discussion
nan
nan
nan
the
launch
track
july
europe
we
must
urgently
develop
measures
health
world
three
officials
size
as
scientific
meetings
cancelled
worldwide
tests
coronavirus
international
teams
worked
existing
antivirals
knowledge
gained
sars
how
researchers
react
quickly
sars
nan
nan
nan
nan
nan
mutations
virus
outbreaks
mutation
the
acute
coronavirus
covid
19
cardiovascular
sars
cov
ace2
outbreak
china
nan
nan
telemedicine
virtually
perfect
covid
19
the
pandemic
influenza
in
covid
nan
2019
ncov
dynamic
system
external
2019
ncov
virus
samples
coronaviruses
education
people
crisis
impact
covid
nan
chinese
coronavirus
health
media
china
pakistan
china
chinese
january
countries
disease
thailand
china
health
international
respirators
hcws
use
facemasks
paprs
sars
mers
aerosol
who
patients
may
suspect
cases
covid
19
covid
19
human
well
month
covid
19
patients
refractory
fever
china
covid
19
spread
risk
covid
19
associated
the
outbreak
health
coronavirus
covid
19
abstract
diabetes
we
covid
19
medical
covid
19
pregnant
recommendations
women
2019
ncov
infection
summary
as
protection
skin
related
mucous
membrane
nan
nan
in
medical
healthcare
ijcp
world
march
covid
19
outbreak
2020
n95
respirators
rcts
laboratory
confirmed
nan
bats
important
bat
zoonotic
potential
cov
sars
coronavirus
liver
severe
h1n1
kobe
city
on
may
the
mgft
mers
saudi
points
nan
the
global
health
summary
interplay
covs
dominant
ddcovs
cdcovs
pdcovs
editorial
virus
an
covid
19
nan
the
week
brain
last
science
virus
china
says
cases
spread
coronavirus
wuhan
week
sars
virus
the
china
tests
and
january
tedros
the
who
staff
ebola
nan
virus
many
china
world
the
the
one
covid
19
media
nan
nan
people
beyond
china
thailand
country
new
outbreak
comes
tedros
adhanom
novel
coronavirus
the
seeming
precision
guidance
19
uk
covid
healthcare
face
now
calm
start
dolling
could
uk
government
plan
healthcare
doi
plan
covid
19
pandemic
health
warned
nearly
90
million
would
cases
nhs
three
whitty
we
the
short
answer
as
emergency
medicine
the
nhs
departments
service
nhs
england
care
patients
emergency
medicine
the
nhs
departments
says
risk
health
ppe
must
health
patients
covid
19
bmj
schools
portugal
medical
cases
confirmed
uk
agreement
european
must
bma
the
us
tax
president
payroll
china
reported
new
cases
march
video
consultations
crisis
care
face
nan
nan
medicine
chinese
covid
19
treatment
nan
nan
nan
nan
ct
covid
19
chest
diagnosis
nan
china
confirmed
2020
health
reported
nan
ptsd
intention
turnover
nurses
outbreak
nan
in
light
emergence
new
coronavirus
health
richard
griffith
senior
lecturer
2019
novel
epidemic
challenging
global
patients
sars
cov
coagulation
healthy
nan
pcr
diagnostic
rt
coronavirus
respiratory
nan
transmission
2019
aerosol
dentistry
dental
通过对浙江大学医学院附属第一医院急诊科筛查出的
例新型冠状病毒肺炎
新冠肺炎
病例进行分析
探讨急诊科在新冠肺炎精准筛查和诊断中的作用
2019
2020
オープンサイエンスの効果はさまざまに論じられてき
たとえば経済協力開発機構
oecd
hcov
sars
mers
humans
transmission
coronavirus
outbreak
transmissibility
between
december
nan
2019
ncov
coronavirus
in
female
the
covid
19
novel
virus
nan
patients
results
19
covid
positive
ct
disease
covid
19
literature
de
la
en
una
que
virus
the
sars
cov
disease
nan
il
19
inflammatory
cytokine
covid
drugs
approved
sars
fda
the
sars
cov
ability
binding
human
sars
cov
binding
compound
protease
sars
cov
3clpro
inhibitors
drugs
2019
ncov
thiol
new
tos
la
de
des
et
les
nan
nepal
wuhan
china
government
2019
wuhan
china
epidemic
covid
19
gansu
province
covid
19
epidemiology
china
we
estimated
case
fatality
virus
transmission
to
determine
possible
nan
nan
nan
covid
19
pneumonia
symptom
imaging
nan
covid
19
health
vietnam
2020
risk
recently
novel
coronavirus
pneumonia
emergency
chinese
medical
china
rsquo
2020
health
covid
19
february
online
learning
teaching
teachers
education
nan
patients
gynecological
tumors
treatment
covid19
novel
coronavirus
aerosol
transmission
pneumonia
patients
myocardial
injury
severe
covid
nan
genome
2019
ncov
genomes
viral
cases
family
subsequent
index
symptoms
nan
alveolar
observed
2019
ncov
epithelia
nan
cases
19
onset
covid
days
cases
covid
19
tianjin
135
covid
19
pandemic
global
china
sampling
respiratory
covid
19
upper
pulmonary
fibrosis
covid
19
2019
nan
2019
doaj
access
imported
cases
wild
agents
infectious
diseases
animals
disease
transmission
clinical
features
diseases
lopinavir
ritonavir
infection
target
used
disease
2019
covid
19
china
nan
covid
19
in
global
flu
patients
the
outbreak
number
patient
response
2019
disease
covid
19
variation
seasonal
sars
cov
2020
nan
nan
nan
sars
cov
virus
2019
china
coronavirus
sars
disease
china
cases
2019
hospital
infection
we
novel
2019
japan
assays
ncov
wuhan
forecast
epidemic
data
forecasting
model
nan
care
health
sars
many
patients
nan
autopsy
important
patient
data
help
sars
care
critical
outbreak
toronto
protein
membrane
nucleocapsid
the
viral
health
public
effective
legal
frameworks
leader
rna
transcription
exogenous
vitro
glycoprotein
the
intracellular
virus
protein
region
f2
ribosomal
frame
shifting
virus
infection
influenza
surface
cells
mrnas
cytoplasm
positive
stranded
genomic
sars
patients
acute
respiratory
syndrome
nan
nan
nan
nan
nan
genes
neck
region
cd209
innate
macrophages
a59
virus
mhv
responses
nan
knowledge
includes
12
essentials
this
cell
cells
mice
chronic
disease
liver
cells
viral
cell
alpha
o3
exposure
immune
response
effects
arthritis
mineral
rats
products
oil
eau
disease
model
ocular
inflammatory
waterborne
disease
water
pathogen
drinking
infectious
studies
respiratory
the
agents
formaldehyde
the
carcinogenicity
effects
panel
nan
demyelination
jhm
cells
cell
ifn
sars
animals
viral
cov
infected
respiratory
hmpv
associated
infection
dpi
respiratory
cells
brsv
virus
syncytial
nan
nan
sars
respiratory
tests
infection
cov
hfgl2
gene
fulminant
hepatitis
the
star
gene
technology
using
sars
nan
nan
cells
virus
particles
dense
samples
ribophorins
cells
proteins
terminal
characteristic
schwann
cells
linked
cell
castanospermine
fatty
cell
fusion
acids
peg
vp7
61
hydrophobic
protein
er
cytoplasmic
protein
domain
membrane
transport
ii
chain
membrane
signal
protein
golgi
secretory
exocytic
pathway
cells
domain
first
membrane
transmembrane
protein
addition
e1
oligosaccharides
acetyl
galactosamine
membrane
insertion
proteins
hn
nascent
amylase
vp7
61
delta
h2
golgi
tgn
degrees
surface
the
dpap
membrane
vacuolar
protein
sec18
globin
alpha
somatostatin
propeptide
transport
membrane
lactose
permease
vesicles
enzyme
apical
basolateral
cells
domain
cell
cells
o4
oligodendrocytes
spinal
cord
ak
chain
beta
alpha
molecules
dcvs
prohormone
peptides
bag
cell
cells
2a
lineage
mice
glial
er
signal
sequence
protein
chain
brefeldin
golgi
tgn
er
trans
antigen
antibody
excess
complexes
apc
hbenvag
class
ii
used
antigen
pca
mhv
animals
infection
antibody
vla
lm
nk
cells
beta
membrane
nuclear
lbr
transmembrane
inner
virus
membrane
vaccinia
inv
cell
golgi
retention
dpap
membrane
protein
amino
terminal
domain
lbr
nuclear
tgn
localization
protein
chimeric
proteins
golgi
caffeine
20
degrees
stack
gm1
sds
golgi
domain
oligomer
compartment
golgi
er
budding
rough
the
1993
biol
membrane
spanning
vesicular
rab1a
vsv
golgi
vesicles
regulated
secretory
protein
within
pathway
p63
protein
retention
membrane
intracellular
connexins
membrane
insertion
microsomes
the
golgi
mnn1p
modification
alpha
linked
sis
golgi
protein
fusion
e1
receptor
well
compartment
cells
tgn
ergic
er
domain
53
golgi
och1p
invertase
tgn
fusion
kex2p
er
sec12p
domain
transport
two
export
er
complexes
budding
cargo
repressor
protein
vacuole
mutant
domain
core
β1
glcnac
glycans
α2
ibv
localization
golgi
pdmp
ceramide
fusion
mutants
change
the
ph
vv
disulfide
proteins
core
imv
gag
membrane
cell
plasma
surface
tgn
localization
golgi
retrieval
dpap
mice
mhv
swiss
virus
pr
pplo
brain
swiss
mhv
mice
mice
macrophages
back
cross
susceptible
pma1
delivery
sop
genes
mutant
mice
resistance
virus
hepatitis
age
variant
virus
mhv
pri
macrophages
virus
cells
genetically
resistant
mice
clathrin
coated
buds
igs
secretory
cftr
cf
truncated
cell
surface
pmps
pex19
membrane
peroxisome
peroxisomes
release
histamine
interferon
virus
exposed
mice
macrophages
treated
resistant
vitro
cells
neuronal
mouse
virus
strains
mhv
pca
mice
response
pbm
syngeneic
gvhd
normal
irradiated
rats
age
sgvhd
marrow
animals
effect
bcl1
chromosome
12
ch
igm
via
olfactory
virus
mhv
pathway
astrocytes
inducibility
jhm
class
strains
cells
target
class
ii
syngeneic
sgvhd
splenocytes
normal
transfer
incidence
resistant
cells
fluid
genetic
resistance
alpha
tnf
gamma
ifn
lps
sy11
sy2
proteins
golgin
sequence
dna
target
membrane
ctl
cells
mhv
class
expression
strains
a59
rhumig
human
cells
cho
cell
plt
slc
mice
cell
cells
cns
cells
specific
naive
transgenic
nk
virus
mab
cell
mcmv
hcv
ctls
virus
aih
cells
opa
cd66
protein
receptors
binding
cells
cd4
acetylated
acetylation
sialic
cns
infection
virus
disease
lcmv
golgi
h1
cytoplasmic
domain
the
complexes
golgi
protein
association
formation
kre2p
golgi
mnt1p
membrane
protein
golgi
copi
copii
pre
er
ii
sorting
endocytic
signals
cytoplasmic
atpase
epithelial
cells
we
signals
e1
e2
golgi
glycoproteins
rv
dna
endonucleases
activity
human
tears
nan
nan
nan
health
human
social
multiple
levels
nan
secretory
variant
regulated
secretion
cells
bfa
golgi
cells
ptk1
complex
secretory
tgn
aggregation
proteins
the
alpha
mannosidase
ii
clones
golgi
bfa
glycosaminoglycan
golgi
synthesis
sulfate
cenp
centromeres
localization
amino
centromere
golgi
apparatus
17
residue
st
secretory
regulated
cells
vesicles
constitutive
ribophorins
cells
molecules
er
linked
e1
compartment
rer
golgi
site
hbsag
pdi
er
compartment
oligomers
dpap
vacuole
domain
membrane
cytoplasmic
kex1p
golgi
membrane
apparatus
localization
gp210
the
pore
sorting
membrane
protein
membrane
golgi
spanning
e1
crp
binding
microsomes
protein
acute
hydrophobic
domain
msaldh
membrane
er
tf10
tf
recycling
receptor
tfr
compass
protein
predictions
method
alignment
exacerbations
antibiotic
trials
risk
clinical
infection
transmission
office
policies
specific
nan
the
using
virus
identification
advantages
laboratory
microscopy
methods
diagnostic
virology
mhc
immune
extended
response
haplotypes
in
discovery
microscope
bacterial
cultures
nan
virus
em
methods
used
specimen
this
review
discusses
commonly
employed
patients
ms
virus
the
cns
oryx
upgma
16s
rrna
cyt
farms
nlvs
calves
pigs
viruses
copd
pulmonary
life
aecopd
associated
infection
care
facilities
long
term
the
age
population
health
care
respiratory
infections
nosocomial
viral
cause
extraction
acid
licorice
the
glycyrrhizic
hbov
copd
ae
patients
infection
molecular
dates
researchers
routinely
adopt
genome
data
som
signatures
dna
nan
crc
ap
serum
profiles
tissue
influenza
patients
cause
underlying
lung
lifespan
evaluated
models
prediction
individual
viruses
influenza
species
novel
swine
vn
may
the
eye
autoimmunity
rna
secondary
structures
rnavlab
the
cell
surface
cin
gene
geo
isatin
activity
also
metabolites
many
treatment
patients
hospital
radiotherapy
weekends
based
models
agent
processes
immunology
infants
breastfeeding
hospital
length
nutritional
nan
t10b9
cells
lymphocyte
the
depletion
tianjin
disease
causes
death
deaths
apod
lipid
density
metabolism
increased
children
the
common
hmpv
respiratory
nan
nan
pneumonia
cap
pneumoniae
symptoms
children
alcohol
brain
animal
models
human
nan
conformational
epitopes
episearch
phage
display
polyphenols
plant
health
diseases
secondary
stress
various
disease
psychological
these
opportunities
professors
residents
compliance
hygiene
cancer
patients
herbal
therapy
effects
water
quality
diarrhoea
tank
khandanama
facemasks
respiratory
droplets
facemask
protection
models
the
based
model
pandemic
patients
icu
h1n1
2009
influenza
nan
idrc
focus
health
developing
countries
nucleic
molecular
therapeutic
gene
based
cyp
cis
trans
plays
cellular
viral
virus
drug
targets
hiv
prrsv
pams
hp
infection
porcine
disorders
olfactory
according
therapy
underlying
caring
care
students
infectious
used
2009
findings
h1n1
influenza
patients
protection
mucosal
baculovirus
amoebic
ala
health
public
sub
saharan
africa
prp
iprp
cells
t183a
prion
the
health
public
feltp
disease
comply
willing
willingness
health
levels
mice
dispase
cells
labeled
immune
dna
immunogen
immunization
approach
well
health
public
research
we
quebec
beetles
truncata
pigeons
infected
nematode
pcr
specimens
influenza
tested
rsv
birth
defects
prevalence
the
2008
china
cdc
health
progress
years
gp
ebola
charged
residues
the
image
classification
fuzzy
anfis
neural
assays
influenza
virus
in
ha
animals
recombinant
proteins
two
using
influenza
ha
human
pseudotypes
group
sars
antibodies
igg
patients
cov
iv
igf
dpp
lung
tissues
nan
electrochemical
sensors
analysis
demanded
modern
licl
pa
inflammatory
apoptosis
staining
commitment
professional
nursing
phase
profession
dose
clinical
drv
chronic
therapeutic
emerging
infectious
diseases
india
response
cell
line
bat
bats
ceylonicus
licorice
spaceflight
the
activity
breeding
ldh
enzyme
human
mg
ml
ageing
cells
decline
immune
immunity
extracts
kellalensis
the
50
rotavirus
sars
50
cov
extracts
dried
virus
rie
influenza
cells
cell
malaria
plasmodium
worldwide
species
vaccines
travellers
canadian
travel
malaria
fever
pathogen
recent
surveillance
field
discovery
the
therapy
urti
prescribed
symptomatic
treatment
wm
patients
tcm
the
virus
transmission
influenza
spread
data
eav
p34
peptide
activity
canine
nan
patients
transport
extracorporeal
membrane
oxygenation
nan
cats
00
feline
fcv
felv
ibv
ndv
duplex
pcr
rt
respiratory
viruses
children
virus
infections
nan
influenza
care
article
use
antiviral
respiratory
viruses
virus
viral
human
zoonotic
the
people
diseases
therefore
xbp
1s
gcn5
pcaf
protein
tylophorine
myc
mrna
ribonucleoprotein
complex
articles
stem
pluripotent
cell
cells
arti
years
study
patients
aged
nanoparticles
gla
the
loaded
plga
health
respiratory
public
addressing
disease
nan
bronchiolitis
group
children
hospitalized
virus
modelling
research
health
public
practice
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
ebola
virus
health
hemorrhagic
fever
ata
yoph
binding
active
site
nan
nan
nan
nan
basigin
tumour
mmps
action
glycolysis
on
cs
dose
patients
high
influenza
virus
must
respiratory
order
influenza
drugs
antiviral
compounds
in
respiratory
mers
cov
disease
growing
nan
tumor
cancer
human
lung
ctl
clptm1l
npc
snps
tert
in
hbov
respiratory
samples
and
detected
coronavirus
mers
middle
east
respiratory
epidemic
ebola
virus
health
countries
garlic
extract
group
virus
ibv
platform
point
of
within
technologies
health
units
autonomous
integrated
structures
factors
mt
the
study
iran
human
virome
virus
host
classification
fanc
protein
etec
igy
specific
saliva
salivary
medical
health
dry
infectious
afflicted
refractory
seizure
fever
g6pd
sepsis
deficiency
the
neonates
health
china
development
diseases
programs
hiv
using
triterpenes
isolated
anti
ibv
pcr
ib
rt
primers
hcovs
respiratory
samples
positive
iran
disease
ifn
cns
multiple
role
cases
influenza
rare
two
interstitial
health
cqi
public
barriers
facilitators
sry
gene
lamp
samples
assay
china
accountability
health
right
mechanisms
researchers
viral
genbank
records
phylogeography
the
viruses
samples
farms
strains
evd
the
vaccines
ebola
virus
saudi
pilgrims
the
study
mers
sequences
human
brain
specimens
demyelination
diseases
infectious
significant
eids
rids
nan
nan
nan
antioxidant
cyclic
myricanone
myricanol
glucopyranoside
backyard
chickens
ibv
flocks
iran
cap
ed
care
patients
emergency
diseases
could
role
emerging
infectious
nan
infection
zika
virus
disease
clinical
sites
in
surveillance
environmental
introduced
rbd
glycoprotein
rad5
mers
the
nan
respirators
consistency
health
using
questionnaire
health
mental
in
community
danwei
nan
nan
nan
nan
vv
virus
wrapping
membrane
vaccinia
dogs
pigs
ccv
days
three
pro
gene
gag
the
reading
rotavirus
strain
human
this
neutralization
nan
rats
haemophilus
isolated
sp
bacteria
nan
nan
we
sore
throat
interventions
systematic
health
public
response
agencies
federal
recombination
homologous
sequence
rna3
nt
stress
diet
protein
race
commercial
rt6
diabetes
cells
bb
rats
nan
the
particles
chloroquine
eclipse
results
oocysts
parvum
the
oocyst
significantly
nvg
two
the
hospital
100
cells
bystander
specific
cns
cd8
nan
spread
outbreak
countries
traffic
reductions
rna
codes
protein
murine
hepatitis
asthma
associated
respiratory
mean
infections
nan
protein
formation
domains
complex
terminal
frameshifting
mammalian
antizyme
yeast
the
organ
cultures
virus
tissue
culture
viral
cd46
neurons
spread
mv
nan
assay
wells
enzyme
rate
12
health
public
principles
summit
resource
nan
nan
presence
hsv
tunicamycin
gc
protein
htlv
sequence
level
frameshifting
human
ifn
responses
γr
role
immune
prcv
the
nt
rna
deletion
enterocytes
newborn
pigs
tgev
binding
eia
samples
microscopy
cryptosporidium
oocysts
nan
bvdv
calves
type
the
study
rnas
ris
rf
mhv
seven
orf
replication
di
rna
frame
rna
region
di
replication
iv
protein
coronavirus
rna
recombination
mhv
virus
cord
sera
influenza
maternal
pneumoniae
rtis
children
the
cases
nan
vhp
equipment
sterilization
xylosus
ivc
loop
tar
rna
consensus
the
autoantibodies
infection
mcmv
organ
virus
giv
recombinant
the
glycoprotein
antibodies
bav
bovine
replication
e1a
defective
titers
antigen
antibody
cl
ha
salmonella
mhv
salmonellae
infection
mice
disease
systems
data
article
we
must
health
public
care
the
sugar
intolerance
hospital
acute
gastroenteritis
loops
catheterized
intestinal
within
whether
mhv
receptor
membranes
cea
the
the
spike
175k
three
coronavirus
patients
vte
complements
complement
ch50
samples
serotype
viruses
g6
11
rna
subgenomic
mrnas
leader
eav
nan
rna
polymerase
synthesis
early
late
shift
the
aag
frame
pairing
fertilization
mice
mhc
embryos
infected
model
eae
ms
therapeutics
may
nan
delivery
mirnas
based
mirna
biological
fiv
antibody
cells
vpg15
feline
nan
nan
rats
melatonin
light
circadian
rhythms
ad
vectors
vector
immune
development
nan
crazy
paving
appearance
lungs
computed
infectivity
a59
mhv
vlps
virus
000
molecular
the
virion
species
nan
group
hp
saa
calves
levels
sth
clpg
coli
cs31a
cell
hn
molecules
mutant
transport
cytoplasmic
nan
rats
infected
control
litter
noninfected
aphidicolin
herpes
virus
resistant
antibiotic
nan
b2
virus
vaccinia
infection
epitope
synthetic
biology
translational
pathways
major
nan
golgi
slbpa
distribution
complex
to
ibv
the
vaccine
bird
ontario
74
positive
transmissible
gastroenteritis
fluorescent
fiv
infection
population
prevalence
virus
frameshifting
hiv
htlv
rna
sequence
sars
patients
tests
cov
results
nan
95
ci
or
respiratory
sars
e2
p7
infectious
virus
bvdv
gag
pro
pol
htlv
translation
bacteria
attaching
effacing
lesions
enterocyte
bvdv
infection
ova
post
inoculation
negative
strand
length
subgenomic
synthesis
infection
patients
antibiotic
pathogens
evidence
oil
essential
the
revealed
constituents
mhv
the
track
xi
system
we
croup
upper
airway
obstruction
nan
virus
mutants
mutagenesis
mouse
hepatitis
nan
novel
coronavirus
influenza
incubation
period
coli
clinical
pathological
findings
cases
the
bovine
antibodies
test
microcultures
virus
age
like
particles
patients
il
mrna
tg
gamma
alpha
hvec
hsv
346t
gd
immunoglobulin
nan
gt
domain
golgi
membrane
terminal
virus
mouse
the
inoculation
sensitivity
protein
6b
er
fipv
signal
receptor
binding
protein
virus
330
frameshifting
mof2
ribosomal
translation
gene
days
micrograms
kg
animals
the
nan
days
farms
treated
calves
first
tras1
sequence
ltr
inserted
telomeric
intergenic
di
rna
subgenomic
region
virus
fragment
gene
sequence
analysis
gondii
transmission
humans
routes
different
nan
nan
1a
rna3
rna
increased
2a
subgenomic
mrna
transcription
nsp10
mbd
nan
methods
enterovirus
pcr
rna
specimens
nan
frameshifting
mutants
peptidyl
trna
5s
pcr
assay
map
immune
the
nan
rna
hnrnp
a1
protein
ig
virus
sjl
resistance
mice
cell
health
data
the
systems
making
eav
mbp
proteins
fusion
immunoblot
astrovirus
cells
virus
infected
breda
rrv
cells
transport
rotavirus
apical
hi
factors
levels
antibodies
decline
rna
proteins
poliovirus
negative
strand
amino
hydrophobic
glutamine
transformation
acid
heavy
exercise
urti
athletes
data
rpd
rst
infection
healthcare
hospitals
nan
trp
syndrome
implicated
eosinophilia
ems
showed
mhv
mice
routine
peritoneal
children
water
drinking
among
rates
mortality
rsv
associated
influenza
weekly
cell
to
tm
ectodomain
ability
mutation
virus
rna
subgenomic
mrnas
dpp4
heart
failure
cardiovascular
inhibitors
rats
struvite
calculi
urine
urinary
rna2
rna3
synthesis
rna1
viral
binding
ptb
utr
rna
transcription
co
isoflurane
anesthesia
group
compared
rna
replication
genome
orfs
the
particles
viral
large
small
golgi
the
plaa
gene
loescheii
frameshifting
coli
o111
nm
isolated
calves
amino
encoded
pp1a
pp1ab
pcp1
outbreaks
hcov
oc43
facilities
virus
mice
isvps
replication
suckling
virions
assay
kinetics
based
enzyme
linked
ubiquitination
ubiquitin
inflammatory
the
inflammation
ifn
mice
jhmv
infection
infected
il
ifn
infection
29
atiis
nan
organism
infected
horses
ehrlichia
macrophage
nan
gene
enteric
tgev
respiratory
virus
nan
fipv
cats
ucd
79
1146
electrolyte
glutamine
calves
glycine
oral
mice
ifn
prv
ge
tk
ast
samples
the
10
assay
10
activity
rna
cells
virus
gown
the
contamination
operating
part
cats
csf
signs
this
study
water
mice
ivc
humidity
tewl
bdv
infection
platelets
calves
circulating
medical
practicing
yxqg
costs
we
nan
hev
swine
farms
hcv
strain
prrsv
persistence
virus
150
dpi
hemagglutination
parvovirus
electron
microscopy
intestinal
disease
allocation
strategy
locations
spread
peptide
dogs
synthetic
vaccine
the
zebov
ad
cagoptzgp
treatment
def201
respiratory
infections
influenza
illness
medical
gamma
nucleotides
codon
dnax
kda
ifn
cells
alpha
infected
tgev
cd8
mice
protein
cells
virus
gp4
lv
protein
mabs
amino
hcv
outbreak
gastroenteritis
children
asymptomatic
ms
inos
lesions
nitrotyrosine
acute
cell
fusion
ph
type
acid
students
phase
sars
anxiety
ii
prv
9112c2
gb
infected
glycoproteins
group
samples
rotaviruses
adult
positive
rna
rnas
the
sindbis
virus
bvdv
virus
pi
animals
viral
pv
cells
binding
different
uptake
excretion
mice
assay
mash
mhv
nan
nan
nan
ctl
virus
central
nervous
system
nan
mutation
suppressor
mutations
systemic
mutant
nan
hypovirulence
control
natural
fungal
viral
travel
medical
persons
medicine
illness
rats
handled
handling
levels
control
networks
hcw
patients
healthcare
social
viral
e1
nucleocapsid
the
isolated
tgev
fipv
antibody
protein
virus
virus
mdl
860
inhibit
ml
antigen
reactive
viral
lymphocytes
reactivity
peptide
ligands
over
past
year
lamp
sputum
assay
specimens
aecopd
surveillance
health
public
pewss
program
mice
macrophages
mhv
alpha
susceptible
nan
nan
protein
rna
open
reading
entirely
nan
afrp
factor
mature
terminal
amino
ifn
alpha
beta
mrna
expression
nan
nan
inhibitory
activity
the
blood
lymphocytes
the
rna
gene
structure
stem
cdna
virus
lv
infectious
cells
mice
cells
sci
cd4
cns
viruses
children
in
samples
collected
nan
000
molecular
weights
kb
28
rdrp
rna3
bmv
rna
activity
il
11
viral
detected
airways
mice
cd4
c57bl
cells
mhv
acne
treatment
population
varying
singapore
utilization
technique
immune
electron
microscopy
the
eav
orf1b
genome
orfs
nan
alb4
rna
the
deletion
synthetic
hev
mabs
orf2
protein
two
virus
had
inoculation
technique
chicken
cd8
specific
cell
the
cells
antibody
reaction
dot
ncs
results
ibdv
used
detect
rna
tissue
predicted
3clp
cleavage
processing
ibv
felv
myc
lc
tumors
containing
studies
vivo
estrous
cycle
injury
isolates
24
virus
antisera
strains
siv
infection
iel
cd4
cell
approvals
new
indications
regulatory
activities
cells
multivesicular
compartments
infected
insect
mhv
virus
esterase
acetyl
he
genes
imiquimod
expression
alpha
ifna
adenovirus
children
culture
viral
infection
cd4
cells
virus
central
nervous
group
old
villi
days
pigs
epidemic
percolation
network
model
in
neutralizing
monoclonal
antibodies
peplomer
carboxyl
piglets
diarrhea
in
january
2014
protein
fusion
rvv
cells
cleavage
rna
utr
mhv
region
positive
rna3
parental
role
in
order
nan
nan
nan
cid
variants
hbv
core
protein
foetuses
lesions
observed
aborted
nonaborted
virus
hsv
retrograde
anterograde
spread
nan
rna
ptb
protein
mhv
leader
ebola
outbreak
health
preparedness
response
rna
ntr
sin
kb
two
nan
no
mhv
macrophages
mice
virus
iron
rats
overload
rat
tfr2
hyopneumoniae
pcv2
challenged
prrsv
vaccine
rats
cells
cns
virus
infected
gpi
tgn
trc
targeted
sequence
nan
genome
mhv
sequence
igs
leader
persons
outbreak
illness
diarrhea
human
nan
tgev
hybridization
positive
situ
formalin
leader
mrnas
sequence
length
rna
membrane
replicase
viral
rna
orf1a
acid
ha0
fusion
membrane
ph
nan
melatonin
creb
src
pka
osteoblast
mutant
tfc
the
stem
arm
il
27
responses
tumor
ctl
hrsv
infection
upper
airway
time
cattle
epizootics
lung
rbcv
pasteurella
il
mice
alpha
gamma
clearance
nan
region
nsp3
mutants
ts
cr3
he
expression
terminal
dimerization
the
nan
infections
influenza
respiratory
90
medical
nan
plague
usually
bubonic
pneumonic
agent
subgenomic
strand
rna
mechanism
mrna
coronaviruses
the
coronavirus
frameshift
potential
nan
frameshifting
mrna
organisms
the
efficiency
packaging
mhv
nucleotides
di
rna
nan
nan
zinc
binding
dsrna
sigma
activities
nan
stem
loop
structure
rna
segments
health
china
shown
non
democratic
structure
hcv
ncr
pseudoknot
translation
public
health
emergency
federal
government
virus
cats
coronavirus
229e
antibody
isolates
site
sizes
the
fragments
sequence
nt
transcription
rna
mrna
mice
mnv4
infection
ibd
disease
nan
cats
shedding
urd
times
status
nan
cats
disease
csf
fip
the
ty1
integrase
nucleus
cell
transposition
inhibitor
cysteine
cystatin
potent
proteases
canine
month
old
pug
oculonasal
proteins
membranes
cellular
protein
tm
fimbriae
fasa
antibodies
987p
foreign
viral
rna
dna
sequence
cloned
in
health
individual
physicians
patients
nan
influenza
vaccine
strains
past
flu
calves
housed
cold
degrees
experiment
ctl
epitope
mhv
jhmv
specific
cats
fiv
fecv
infected
rm
infection
pigs
the
nervous
system
asthma
patients
admitted
allergens
hospital
mnt
system
the
95
greater
nan
gal
niv
fusion
cell
envelope
space
breeding
cage
floor
litter
pain
opioid
buprenorphine
postoperative
surgery
illnesses
respiratory
rates
infection
age
sequence
frameshifting
ribosomal
within
slippery
strains
field
attenuated
four
purdue
day
fb
bronchiseptica
groups
group
baculovirus
ifn
cells
mammalian
activity
rats
rice
used
animal
breeding
ifn
virus
protein
alpha
the
instruments
health
measures
preparedness
public
parvum
coli
rotaviruses
agents
animals
tgev
nucleotide
amino
acid
sequence
samples
porcine
isolated
slurry
enteroviruses
the
fever
endocarditis
aortic
diagnosis
cleavage
site
hemagglutinin
basic
arginines
rats
bn
infection
cns
le
calves
identified
submitted
cryptosporidia
organisms
nan
diarrhoea
gastroenteritis
seen
faeces
adults
virus
agent
diarrhea
particles
microscopy
model
legislation
state
bioterrorism
states
rna
strand
protein
poliovirus
viral
jcv
sialic
receptor
persistence
lymphocytes
apn
cells
canine
ccv
fipv
concanavalin
virus
envelope
phytagglutinin
binds
hydrocephalus
rats
pulmonis
hamsters
induced
nan
symptoms
uv
room
placebo
questionnaires
cells
wall
the
microorganisms
blood
bones
animals
marmosets
the
several
mv
antibodies
viral
rats
neutralizing
methods
molecular
detection
microorganisms
pcr
domain
terminal
receptor
mouse
virus
nuclei
activity
nad
pyrophosphorylase
liver
serum
antigen
reactivity
kinetics
based
cells
virus
rns
hs
infection
nan
protease
ns
rub
nsp
orf
nan
nan
elisa
kelisa
endpoint
required
fold
serotype
rotavirus
bovine
rotaviruses
antiserum
cells
degrees
infected
infection
persistently
dogs
severely
affected
muscle
present
nan
nan
patients
pcr
20
acas
rhinovirus
immune
system
response
viral
infection
1998
giardia
cryptosporidium
parvum
cr
signaling
cytokine
socs
receptor
proteins
rvb
diarrhea
cows
farms
outbreak
group
calves
cr
antibodies
bovine
protein
virus
p12
cells
kda
we
systematic
review
following
clinical
the
forensic
threat
bioterrorism
biocrime
strand
rna
plus
rnas
synthesis
drak2
autoimmune
cell
cells
signaling
bovine
virus
viral
diarrhea
dna
control
translation
mrna
molecular
posttranscriptional
ada3
gene
general
activation
mutant
calves
serum
igg
concentrations
the
protein
proteomics
proteomic
advances
technology
vesicles
viral
virus
replication
observed
plasma
meloxicam
pediatric
pups
rats
feline
virus
domestic
animals
wildlife
np
actin
virus
cytoplasm
influenza
nan
mabs
ade
specific
fipv
neutralizing
virus
pig
cells
isolation
transmissible
influenza
virus
isoprinosine
volunteers
challenged
diagnostics
use
oral
salivary
virus
rna
viral
flock
house
virus
di
rna
rnas
defective
transcripts
rna
structure
hdv
found
binding
respiratory
pigs
pathogens
porcine
virus
nursing
infections
infection
antimicrobial
homes
antigenic
fipv
e2
mabs
the
particles
patients
virus
electron
agent
amino
acid
the
mr
000
nan
nan
virus
rt
pcr
assay
influenza
calves
return
metabolic
acidosis
without
purified
coronavirus
infected
antigen
elisa
mice
titers
c57bl
interferon
mhv3
nt
utr
mrna
regulation
translation
nan
nan
protein
sigma
dsrna
binding
activity
risk
world
would
states
vaccine
nan
influenza
macrophages
mice
cells
virus
samples
immunodiffusion
fecal
electron
microscopy
ty3
proteins
gag3
fusion
particle
mhv
a59
mhvr
virus
species
nan
orf
viral
rna
sequence
astrovirus
virus
mouse
proteins
gp90
gp26
nan
nan
echinacea
blinded
pills
groups
placebo
nan
gottfried
osu
porcine
gene
serotype
influenza
life
the
support
need
lesions
fip
multiple
skin
feline
nan
papn
tgev
site
apn
the
nan
myelin
demyelination
autoimmune
virus
cells
jhm
demyelination
antibodies
infected
cells
nk
iel
cell
activity
cells
ibv
the
afghanistan
45
ib
virus
receptor
icam
complexed
hrv16
calves
k99
f41
the
monoclonal
nan
nan
p1a
proteins
gene
15
22
pbsx
the
particles
genes
pcf
nan
wistar
inoculation
rats
days
jhmv
rna
subgenomic
promoter
di
leader
protein
fusion
alanine
leucine
position
cells
st
hsv
virus
entry
fiv
cats
epidemiologic
features
disease
sequences
virus
the
end
specific
e2
cell
virus
glycoprotein
cells
the
carinii
effective
model
compounds
nan
respiratory
infections
viral
children
pathogens
information
consumer
health
risk
addressing
nan
dp
peptides
178
virus
antiviral
autophagy
macrophages
cholesterol
vacuoles
response
rna
rna3
homologous
the
recombination
nan
region
translation
hcv
rna
rnas
response
mice
hepatitis
partial
hepatectomy
foxo1
pdac
tissues
cell
proliferation
isolates
pedv
strains
genogroup
100
astrovirus
children
particles
found
child
pups
fostering
age
mice
younger
ph
dimers
trimers
virus
protein
nan
mhv
mice
pretreated
pac
virus
diarrhea
producers
veterinary
usage
herd
cd4
nef
degradation
virus
surface
cell
tgev
caspase
host
apoptosis
t01132
dhpg
hcmv
antiviral
in
nan
signaling
model
chain
receptors
immune
virus
ld
residues
cytotoxic
lymphocytes
human
would
respiratory
arise
massive
er
wild
type
trimers
subunits
nan
calves
dying
tissues
myocarditis
92
nan
nan
poly
ic
poifn
yields
the
nan
iron
deferoxamine
treatment
calves
bacterial
rna
virus
subgenomic
nucleotides
sindbis
tev
hc
pro
the
deletion
antigenic
mutants
antibodies
site
ii
health
assessment
cases
mers
cov
rna
mhv
recombination
different
virus
gene
mhv4
mhv
viral
pathogenesis
nan
health
public
care
system
china
facility
this
cryoem
bsl
select
rsv
alveolar
macrophages
infection
cell
the
supercourse
website
collects
hundreds
dogs
titers
canine
control
age
apolipoprotein
day
serum
concentration
salmonellosis
ifn
pm
no
aa
expression
nan
sand
rats
hematologic
serum
data
host
mice
seroprevalence
mouse
study
mars
patients
levels
il
the
golgi
peptide
tail
g1
residue
signal
6k
sequences
proteins
translocation
hrv
specific
volunteers
antibodies
infection
nan
iol
an
18
month
old
rats
lhrha
et
estrus
rat
coronavirus
cie
calf
intestinal
contents
incidents
chemical
who
35
identified
flammability
surgical
n95
ppe
fda
infection
jhm
major
histocompatibility
complex
nan
health
public
departments
north
carolina
patent
sars
rights
may
health
nan
infectious
disease
gps
fps
outbreak
nan
rna
di
mhv
subgenomic
negative
assembly
domain
particles
protein
mutations
nan
subgenomic
transcription
nsp10
virus
eav
ocular
interferon
the
safety
tolerance
conservative
three
presented
treatment
diagnosed
the
poly
protein
helicase
putative
assay
denv
dengue
well
compound
macrophages
cells
canine
distemper
reactive
samples
rotavirus
coronavirus
detected
cows
nan
nan
hbv
cytokines
hepatitis
replication
gene
nan
nan
inos
tmev
mice
days
sjl
virus
mouse
hepatitis
a59
central
cleavage
p28
amino
site
hepatitis
bcv
packaging
region
coronavirus
signal
transfusion
blood
noninfectious
serious
related
fcov
rt
cats
npcr
plasma
receptor
virus
mhv
domain
receptors
helicase
rna
mhv
viral
complexes
hypoglycemia
common
problem
this
emergency
antibodies
the
treatment
success
challenges
filtration
hepa
filter
prrsv
low
coronavirus
bovine
influenza
erythrocytes
virus
mhv
antibodies
hepatitis
mice
neutralizing
selectin
cells
membrane
granules
att20
er
dilysine
motif
glycoprotein
hfv
herds
cutoff
herd
auc
test
strand
dna
plus
primer
virus
golgi
protein
membrane
domain
m1
nan
pcv2
pcv1
type
pk15
cells
rotavirus
eia
ncdv
antisera
developed
peptides
antimicrobial
amps
peptide
spiders
lesions
the
cases
necrotic
colitis
agent
laboratories
ped
rabbits
pallidum
nan
nan
coverage
measles
vaccination
we
model
viruses
nebraska
cases
detection
techniques
cells
expressed
gamma
delta
antigen
nan
lactase
activity
the
calves
days
region
binding
e1
the
bpv
nan
nan
the
strategies
model
sars
demonstrated
abscess
neurological
respiratory
gastrointestinal
signs
virus
mutants
murine
hepatitis
specific
leader
rna
sequences
mrnas
virus
nan
nan
nan
nan
infection
human
coronavirus
229e
infected
respiratory
children
infections
siblings
the
transgene
upa
dna
tumors
mice
antigenic
sows
immune
response
tgev
g2
g1
golgi
transport
complex
systems
health
information
sectors
social
abdominal
pain
children
viruses
found
ibv
protein
levels
virus
cells
nan
response
viral
challenge
cell
study
difficile
diarrhea
elk
clostridium
associated
virus
infectious
astrocytes
produced
viral
cells
mhc
cd8
oligodendrocytes
antigen
anesthesia
pups
isoflurane
sevoflurane
hypothermia
nan
binding
particles
ns28
cells
infected
rna
rnas
interaction
mhv
specific
replication
rna
virus
sequence
within
nan
tslp
dsrna
th2
epithelial
cells
nan
transfers
patient
inter
facility
patients
area
odds
high
mortality
diarrhea
rats
lung
lesions
carinii
rrv
ras
local
angii
tissue
production
mav
mice
viral
b6
adult
infection
persistent
viral
hucv
cell
ubiquitin
proteins
enzymes
ptm
specific
cross
wk
litters
mhv
paradigm
rats
analgesic
buprenorphine
doses
response
nan
nan
fcv
fpv
lions
viral
infections
nan
nan
nan
rna
di
a59
packaged
virions
coli
o157
h7
calves
shedding
vlps
cell
rnv
binding
cells
di
rna
strand
negative
transcripts
feline
fip
the
diarrheic
young
cheetah
fip
antibody
indirect
fluorescent
health
public
primary
care
international
brd
brsv
higher
arrival
titers
lpa
group
responses
virus
pigs
gene
8b
t1l
t3d
induction
exacerbations
disease
rapid
acting
bronchodilators
nan
adjuvant
da
arthritis
rats
cell
ribosomes
site
frameshifting
slippery
pause
public
tabletop
the
five
health
rotavirus
diarrhea
children
newborn
babies
virus
oc
chicken
ibv
embryo
sonfh
tnf
polymorphisms
hypoxia
factors
monitoring
biocos
blood
pressure
treatment
eight
cases
transient
acute
polymyalgia
col5a2
in
onfh
mp
treatment
herds
small
large
owners
calf
swine
animals
feral
in
antibodies
protease
cleavage
gly
site
contains
standardized
hemagglutination
inhibition
viruses
the
fmdv
cattle
detected
antibody
responses
houston
prepared
cities
2001
al
spike
sdvs
sequence
rna
region
bovine
calves
cows
associated
group
nan
ear
prevalence
children
infections
agar
virus
variant
disease
central
nervous
sk
sd
coronavirus
human
murine
infected
technique
sections
bovine
an
mmi
virus
response
doses
μg
rna
strand
proteins
protein
end
cells
cns
mhc
class
microglia
cov
sars
oc43
respiratory
reactivity
skin
tumors
findings
among
long
coronavirus
particles
like
feces
cat
nan
astrocytes
tnf
cns
interleukin
virus
nan
nan
cell
tge
virus
swine
testes
tgev
papn
virus
membrane
infection
rna
rnas
fusion
orf
deletions
mhv
we
virus
fusion
identified
hrv
14
monocytes
cell
il
frameshifting
site
stimulator
ty3
analog
epidemic
the
sars
showed
easy
tnf
etec
f18
piglets
expression
viral
vzv
infected
antibodies
virus
hepatitis
patients
ast
pt
liter
e1
virus
golgi
cells
could
interferon
respiratory
patients
placebo
chronic
acidosis
calves
age
severity
signs
activity
antiviral
virus
treatments
greater
density
virus
cesium
chloride
concentration
nan
cenp
dna
agm
satellite
alpha
mhv
packaging
signal
rna
particles
virus
membranes
mice
binding
mouse
antigen
purified
chromatography
the
antigens
nan
nan
infection
gastric
virus
routes
lcmv
ribosomal
signals
frameshifting
programmed
frameshift
pvx
protein
within
virus
rna
nan
tumor
tumors
colonic
volume
method
assay
enzyme
linked
immunosorbent
antibody
ketoprofen
rats
study
lesions
barrier
mice
saline
temperatures
core
body
viral
microbiology
laboratories
guidelines
service
enucleation
animals
rodents
standard
care
rats
virus
mast
days
inoculation
electron
microscopy
detected
particles
fecal
synthesis
rna
length
rf
temperature
viruses
dinucleotide
dna
kb
available
macrophages
demyelination
mhv
demyelinating
in
ires
translation
protein
proteins
elements
nan
nan
rna
edi
genome
eav
virus
nan
virus
particles
transmembrane
rubella
assembly
vp4
viral
cell
fusion
rotavirus
the
infectious
virus
coronavirus
disease
mcp
virus
measles
proteins
protein
assays
use
technology
reagents
infectious
open
reading
translation
frame
common
ferrets
diagnosis
systemic
coronaviral
disease
pcp
virus
alpha
beta
nsp1
virus
coronavirus
genome
dot
hybridization
hcv
eia
229e
oc43
sera
nan
gags
pathogens
cell
strategy
major
protein
deletions
hydrophobic
hydrophilic
domain
sequence
imprecise
au
homologous
rna3
enzyme
linked
immunosorbent
assay
rotaviruses
musfiblp
prothrombinase
mhv
clone
demonstrated
cells
yac
cell
virus
mhv3
time
rats
kx
anesthesia
anesthetic
education
hand
sanitizer
rates
transmission
virus
protein
fmhv
ability
cells
enterovirus
pcr
hybridization
rhinovirus
clinical
cells
fiv
specific
infected
autologous
nan
nan
ldv
rna
eav
virus
rnas
satbamv
potexvirus
bamv
nt
sgp
astrocytes
adult
human
cells
infection
nan
cells
ctl
infected
encoding
nucleocapsid
virus
mhv
bovine
esterase
he
coli
calves
the
like
epithelium
ibv
chickens
study
infectious
bronchitis
delta
rna
antigen
hdv
binding
rotavirus
calves
enterotoxigenic
coli
age
gag
frameshift
efficiency
pol
kda
rats
infected
methods
method
elisa
rna
virus
a59
jhm
contain
virus
pcr
asfv
dna
bp
nan
protein
he
proteins
complexes
consisting
proteins
virion
we
viral
structural
rnas
rna
species
viral
10
nan
water
use
low
used
disinfectant
viral
diarrhea
rats
rotaviruses
the
calves
time
pregnancy
parturition
two
nan
fusion
recombination
mhv
recombinants
end
prcv
tgev
herds
positive
sera
trna
depletion
method
described
depleting
calves
intraepithelial
disease
ileal
infected
mnv
mice
dams
infected
neonatal
perforin
mice
mediated
virus
cns
nan
nan
stage
myocarditis
qrs
superacute
electrocardiograms
influenza
respiratory
virus
rapid
rsv
viruses
rotaviruses
virus
capsid
layer
antirotavirus
antibodies
colostrum
milk
immunoglobulin
kd
among
disease
children
accurate
thymic
defects
bb
rats
epithelial
diseases
respiratory
cause
acute
severe
transport
air
ground
dogs
mean
phage
292
strain
fulminating
septicemia
rnas
virus
rna
cells
molecular
hiv
nb
dnj
entry
inhibitor
trp
animals
ems
associated
ebt
nan
virus
cells
cd4
cd8
clearance
tcv
bcv
proteins
turkey
coronavirus
protein
reference
particles
porcine
virus
golgi
budding
proteins
virus
mhv
hcmv
infection
cd13
human
cells
nan
nan
jhmv
cells
ctl
target
lines
bev
sequence
rna
rnas
by
nan
nan
mhv
receptor
mhvr
jhm
jhmx
rna
synthesis
mrna
uv
mrnas
bovine
bvd
sera
elisa
viral
risk
the
super
spreading
events
nan
viral
rna
gene
mhv
proteins
protection
virus
b641
b223
challenge
culture
bvdv
typed
42
carriers
av
ea
infections
ab
group
classification
icd
cm
clinical
10
respiratory
peak
flow
reported
expiratory
wolf
surgical
sterilization
females
wolves
jejuni
cows
campylobacter
fetal
isolated
nan
carinii
rat
karyotypes
rats
among
virus
disinfectant
sodium
chemical
surfaces
cats
felv
treatment
disease
protein
pigs
tgev
virus
three
serum
nan
rna
synthetic
mutations
mhv
recombination
cd4
pulmonary
sarcoidosis
case
idiopathic
virus
the
spike
protein
feline
primers
iaf
exp91
prrsv
pcr
piglets
fed
fasted
min
activity
vte
patients
infection
group
lymphocyte
ptv
release
bfa
virus
golgi
rna
binding
transcription
ig
sequence
sl2
utr
cal
binding
structure
virus
detected
hepatitis
cells
protein
protein
mabs
11f
10g
the
nan
infection
mouse
hepatitis
virus
type
nan
mhv
cruzi
infection
thymic
mice
nan
iss
sg
transcription
produced
different
nan
nan
global
health
the
actors
who
cells
cns
mice
infected
tmev
nan
nan
replication
rotavirus
protease
babim
intestinal
di
region
rna
gene
genome
winter
dysentery
coronavirus
bovine
fecal
nan
nan
envelope
proteins
membrane
tmds
hcv
sa
tge
virus
antigen
complement
hcv
protein
core
rna
region
promoter
sgrna1
bydv
rna
transcription
acronyms
initialisms
mesh
interfaces
the
virus
calves
calici
like
bovine
e1
protein
cells
the
hcv
ly217896
influenza
virus
mice
effective
ibv
flocks
disease
broiler
respiratory
mice
mhv
cell
pca
induction
tmev
antibody
mice
susceptible
susceptibility
virus
liver
hepatitis
mouse
mhv
health
public
canada
cnphi
data
nan
di
rnas
protein
two
mhv
antibody
coronaviruses
strain
volunteers
oc43
ibv
hybridomas
m41
cell
nucleocapsid
nan
cells
mhvr
infection
17c1
mhv
nan
pcp
eav
cleavage
replicase
terminal
nan
respiratory
episodes
wheezing
infection
patients
liver
fibrosis
cells
activation
treatment
length
infectious
construct
tgev
full
cats
pancreatic
a1
pancreatitis
disease
may
disease
infection
mucosal
cattle
the
animals
factors
necessity
for
nan
plants
p2
rna
rnas
p1
rna
ns5b
hcv
conserved
region
glvr
amphotropic
mulv
receptor
mrna
helicase
helicases
hsv
hcv
replication
mice
sjl
balb
pfu
cns
minus
strand
plus
rnas
genome
canine
hospital
parainfluenza
virus
veterinary
acute
phase
response
animal
infection
nan
nan
nan
mrna
virus
mouse
hepatitis
oligonucleotide
nan
hrv
associated
bronchiolitis
studies
the
first
respiratory
ph1n1
2009
identified
nan
global
health
monitoring
new
capacity
protein
antibody
response
infection
titers
cows
vaccine
six
vaccinated
enterotoxigenic
virus
ev
anguilla
the
viral
s1
protein
330
mabs
s1n
di
rna
subgenomic
sequence
mhv
e2
subunits
virions
mabs
glycoprotein
in
adult
onset
still
disease
coronavirus
nc99
coronaviruses
protein
group
editing
site
mrna
run
virus
20
micrograms
ml
mdl
concentrations
ecv
bcv
coronavirus
elk
protein
rrna
mhv
28s
cleavage
cells
papillomavirus
seen
this
study
reports
course
alone
treatment
three
days
is911
insertion
bp
shigella
two
rotaviruses
viral
agents
found
children
biomonitoring
emergency
decision
responders
exposure
specific
virus
antibodies
proteins
volunteers
frameshift
sequence
pseudoknot
large
cerevisiae
igy
dogs
cpv
the
egg
rats
ivc
food
water
otc
strain
ncdv
th
produced
plaques
dogs
tickborne
diseases
clinical
signs
dogs
ir
elisa
burgdorferi
collected
sda
bang
mutant
seizure
gene
doxycycline
dogs
prednisolone
rmsf
anti
nan
virus
eav
two
found
semen
nan
treatment
infectious
diseases
assays
high
macrophages
viral
monocytes
key
components
test
mfa
mnt
pr
the
nan
nan
mrna
genome
protein
assembly
antigenome
virus
antibodies
attachment
internalization
proteins
research
without
especially
challenging
protocols
di
rna
intergenic
sequence
subgenomic
cyanobacteria
metabolites
freshwater
terrestrial
the
antibody
transgenic
mice
genes
10
suis
oocysts
farms
study
piglets
tge
epithelial
cells
tubules
viral
macrophages
cells
peritoneal
activated
stimulated
serovar
typhimurium
987p
fas
asd
protein
cells
the
expression
membrane
nan
nan
developing
trips
intellectual
property
the
cleavage
rv
ns
pro
trans
parvovirus
acute
respiratory
distress
syndrome
in
virus
wnv
outbreak
epidemic
mhv
rna
kb
a59
13
selection
intense
age
we
affect
cancer
the
combination
drug
therapies
nan
serum
bovine
lots
25
samples
antibodies
monoclonal
bvdv
strains
anti
production
months
we
bioengineered
pandemic
nan
segment
recombination
gene
the
insertion
calves
brsv
mlv
respiratory
primed
pcv
virus
swine
porcine
pmws
rotavirus
diarrhoea
patients
days
children
group
wd534tc
calves
rotaviruses
diarrhea
fiv
hiv
infection
the
immunodeficiency
interaction
tertiary
potential
rna
structure
fiv
cats
felv
infection
infected
dog
propofol
an
year
old
mice
storage
laboratory
susceptible
cryptosporidium
nan
protein
tgev
carboxy
mabs
exposed
mouse
mhv
receptor
cea
the
asc
rotavirus
iga
pigs
inoculated
cells
sfv
antigens
murine
teratoma
temperature
ts
virus
protein
viruses
virus
prrsv
the
pigs
vaccine
nan
viruses
diarrhea
calf
play
roles
interferon
mouse
mixed
cell
cultures
mhvr
virus
a59
receptor
mhv
gl
protein
complexes
virus
synthesized
vaccination
rbd
sars
cov
raav
rna
structure
viral
amplification
pseudoknot
heifers
bvdv
calves
bohv
serum
mhv
rna
replication
vitro
extracts
cells
ileum
reovirus
epithelial
the
rna
recombination
mhv
different
strains
influenza
vaccine
effectiveness
95
ci
nan
cdv
pcr
rt
virus
infection
domain
apa
terminal
kda
45
isolates
rotavirus
pig
group
porcine
inoculated
pi
the
recv
particles
nan
di
frame
virus
rnas
orf
peptide
cells
specific
vaccine
responses
porcine
interferon
virus
sensitive
viruses
infection
october
specimens
persons
calves
processing
orf1a
the
protein
eav
monoclonal
antibodies
hemorrhagic
enteritis
virus
mabs
10
virus
mab
tge
virus
pml
brain
dna
jc
2c
rna
strand
negative
cloverleaf
mabs
gp160
conformational
reacted
epitopes
dexamethasone
plasma
extravasation
capsaicin
respiratory
kda
proteins
virus
protein
31
nan
nan
gene
mhv
gfp
rna
inserted
nan
health
public
rural
practice
describe
cathepsin
molecular
screening
development
targets
jev
proteins
rna
the
strand
porcine
virus
ontario
epidemic
diarrhea
gd
virus
hsv
cells
protein
e1
er
proteins
e2
retained
nan
nan
local
healthcare
community
communities
public
blood
produced
localized
flow
in
virus
cells
infected
wt
mrnas
sia
golgi
fitc
cmp
in
nan
diseases
wapiti
north
america
review
pi
viruses
viral
outer
capsid
vp8
rvp8
ha
erythrocytes
to
influenza
douglas
fleming
general
practitioner
lambs
cryptosporidium
etec
animals
rotavirus
nan
monoclonal
antibodies
variants
e2
selected
patients
protein
il
lymphocytes
p55
nan
virus
changes
mouse
hepatitis
cloned
pi
herds
calves
viral
bvdv
copper
calves
kg
the
cows
cd13
breast
normal
tissues
antibody
nan
type
cells
human
ii
cultures
mrna
2b
transcriptional
mhv
orf
plp
cleavage
viral
vitro
trans
rna
hiv
rt
bmv
structure
bcv
he
mucosal
adbche
immunization
protein
mabs
virus
amino
acids
treated
amprolium
furazolidone
piglets
infected
a2
site
neutralizing
residues
fipv
lpv
binding
cell
receptor
lines
amino
acid
sequence
glycoprotein
domain
sars
samples
biochemistry
laboratory
severe
virus
tnf
alpha
rats
increased
nan
cell
acute
wall
rats
chronic
nan
rna
mhv
di
describe
strategy
the
mof2
mof5
strains
mof6
nan
nan
capsids
b19
vp2
parvovirus
cells
protein
rna
p28
the
mhv
nan
membranes
poliovirus
induced
membranous
structures
gp
protein
sgp
the
prrsv
antibiotic
use
care
urtis
asia
proteins
rna
ibv
virion
synthesis
protein
nsp10
poly
the
arterivirus
sequence
orf1b
amino
gene
ribosomal
rna
dissf
domain
virus
the
dog
rare
presentation
extraskeletal
osteosarcoma
pomc
isgs
secretory
unregulated
the
protein
g71
g180
g230
amino
orf1b
processing
kda
polyprotein
eav
000
astrovirus
pigs
porcine
specimens
triolein
mice
virus
activity
res
disease
healthcare
including
agent
outbreak
rna
10
species
virus
genome
health
surveillance
program
this
article
porin
type
blastogenesis
responses
vaccines
ctl
mhv
a59
virus
specific
leader
trs
transcription
sg
sequence
nan
mers
cov
mn
studies
dromedaries
kda
cleavage
protein
gly
41
sin
genome
cse
motifs
genomes
furin
tgn
cytoplasmic
membrane
the
calf
virus
coronavirus
neonatal
diarrhea
nan
patients
virus
antibodies
common
infection
rna
protein
capsid
rubella
virus
monensin
virus
g1
g2
glycoproteins
ypt5
cells
pombe
gene
mammalian
rotavirus
eias
the
specimens
latex
nan
eav
orf
protein
2a
arteriviruses
ccr2
dc
recruitment
mice
response
hrvla
detection
stools
assay
results
pt
anti
peptides
antisera
s4
piglets
infected
jejunal
less
villus
mice
cells
paralysis
lymphocytes
rabies
guidelines
respiratory
control
patients
infections
rats
infected
infection
pregnancy
gd
replicase
eav
membrane
orf1a
proteins
virus
microtiter
plates
infectivity
antibody
nitrate
antibodies
plant
reductases
enzyme
nan
mediated
leukocytes
cell
cytotoxicity
peripheral
mhv
mice
virus
microscopy
intestinal
nan
calves
days
cp
cloned
faecal
agents
sentinels
wk
mice
old
rotavirus
electropherotypes
epidemics
australia
type
hsv1
naked
mole
rats
replication
patients
associated
virus
children
gastroenteritis
nan
rabbits
practices
biosecurity
disease
on
virus
smears
antigen
buffy
coat
nan
virus
viruses
expression
genetic
sequences
protein
coronaviruses
viruses
structural
helical
mhv
mouse
virus
peritoneal
adherent
many
laboratory
mice
rats
rabbits
receptor
mhv
mice
kda
sjl
ribosomal
programmed
frameshifting
virus
viral
antibody
virus
enhancement
infection
feline
hsv
latency
kb
lats
lat
apoptosis
tgev
induced
the
infection
nan
er
e1
e2
retention
hcv
nan
viruses
rna
pig
dna
replicated
gb
mutant
glycoproteins
membrane
hydrophobic
mice
sdav
virus
antibody
mhv
intubations
per
trauma
training
session
acute
hepatitis
liver
cirrhosis
au
virus
host
receptor
cell
entry
nan
tmv
5b19
virus
protein
epitope
pulmonis
infection
fetal
rats
placenta
calves
bcv
bovine
coronavirus
neutralizing
respiratory
diseases
viruses
deaths
disease
viruses
important
acute
diarrhoea
epidemiology
rotavirus
ics
rv
100
rotaclone
health
the
threat
new
disease
pirodavir
serotypes
rhinovirus
group
61837
nan
nan
frameshift
10a
10b
frameshifting
10
feline
animals
virus
antibodies
antibody
activity
tgev
sialic
acid
binding
cells
epithelial
primary
adenoid
origin
nan
nan
illness
upper
respiratory
athletes
may
calves
virus
infection
hrvl
using
nan
gdvii
viruses
cause
full
neurovirulence
nan
pigs
viral
tissues
exposure
titers
okadaic
acid
protein
24
cell
cases
bovine
abortions
cause
abortion
virus
parvovirus
mink
feline
panleukopenia
he
botv
gene
protein
kb
nan
nan
milk
calves
the
feeding
fed
octanucleotide
elements
rna
levels
sgrna
fas
mediated
the
virus
cytotoxicity
bovine
viroligo
virus
database
the
nan
orf
1b
nucleotides
1a
ibv
receptor
human
rhinovirus
cells
antibody
tcl
mbp
the
cell
ms
nan
hydromyelia
the
hydrocephalus
one
year
the
turkey
specimens
enteric
viruses
group
rotavirus
mabs
rotaviruses
porcine
kda
protein
proteinase
27
gene
kd
lymph
node
cervical
reads
docking
discovery
structure
ligand
actually
nan
nan
virus
dafl3
disease
infectious
mice
virus
plaque
test
transmissible
gastroenteritis
scid
the
pediatric
respiratory
distress
pedv
samples
15
rt
pcr
proteins
protein
the
envelope
particles
rna
sg
eav
leader
body
virus
gp
gp2
coiled
coil
fapn
receptor
serogroup
human
porcine
ns3
ns2b
termini
vitro
cleavage
mv
epithelia
human
airway
apical
frameshifting
context
promotes
aag
trna
herd
milk
the
muenster
cows
strains
hcv
oc43
229e
group
patients
cancer
igg
breast
peptide
rna
binding
rotavirus
protein
proteins
akr
ankyrin
chlorotic
the
gene
zipper
envelope
hiv
leucine
monomeric
diarrhea
onset
the
intestinal
lesions
lpv
virus
binding
cell
bja
mutation
orf
nt
virus
mhv
rna
di
infectivity
turnip
virus
nan
lymphocytes
cytotoxicity
the
cell
mediated
isolates
eav
isolate
amino
acid
tissue
culture
micromethod
described
adenovirus
the
mhv
gene
protein
reading
pmws
pigs
groups
immunostimulation
the
cells
rotavirus
cell
lines
infection
agents
student
nurses
influenza
occupational
poly
strand
nucleotides
primer
end
mice
cells
cystatin
cysc
injection
60s
mak
mutants
subunits
genes
nan
public
health
medical
school
bioterrorism
nan
patients
antibiotics
symptoms
thought
indicated
nan
nan
calves
cd4
cd8
antibody
rotavirus
000
coronaviruses
polypeptides
229e
oc43
nan
cell
fusion
leucine
to
alanine
cells
edmonston
measles
virus
marmoset
elisa
prrsv
rapid
inexpensive
enzyme
bmv
rnas
single
stranded
rna3
hdag
hdv
rna
open
reading
nan
nan
calves
samples
brv
hybridization
test
influenza
1993
smokers
people
1992
rna1
fhv
rna3
strand
replication
malaysia
innovation
science
based
academy
children
years
indian
event
lcpd
p39
membranes
surrounding
imv
core
dicistronic
cistron
gene
expression
downstream
diarrhoeic
goat
kids
lambs
non
mice
mpv
cages
determine
cage
mice
c3h
protein
restricted
cells
rna
virus
60s
the
isolated
laboratory
mean
pine
voles
lower
rats
days
inoculation
neonatal
weanling
nan
nan
dogs
crcov
shelter
cpiv
bronchiseptica
bvdv
bulls
steers
semen
the
who
scientific
workshop
health
research
type
astrovirus
eia
samples
one
immune
innate
infections
prrs
detect
antiserum
229e
oc43
antigens
recognized
mnn1p
protein
golgi
invertase
complex
nan
anti
idiotypic
antibody
the
virus
rna
pseudoknot
a14
stability
unpaired
vaccination
statistical
support
obtained
association
strain
equine
serotype
kentucky
rotavirus
jv
the
genome
nlvs
orf
titer
brd
arrival
calves
titers
sars
care
health
impacts
epidemic
prcv
herds
antibodies
tgev
elisa
hepatitis
infectious
the
antigen
serum
influenza
clinical
diagnosis
virus
study
nitric
oxide
poliovirus
infection
the
cats
prevalence
henselae
the
feline
nan
mxa
mv
virus
vsv
cells
nan
nan
virus
glycoprotein
the
hn
involved
nan
proteins
ct1a
viral
replication
mhv
orf
rna
anv
the
1a
ms
disease
axonal
demyelination
damage
nan
rna
stranded
virus
species
negative
sequence
end
mhv
rna
mrna
recf
sequence
epsilon
hexapyrimidine
translation
virus
proteins
terminal
mhv
fipv
phenotypic
intratypic
recombinant
polioviruses
isolated
2a
cultures
growth
cells
type
nan
cells
virus
mk
nci
h292
frameshifting
ribosomes
shift
pseudoknot
translational
nan
synthesis
rna
strand
viral
minus
infectivity
titers
infectious
the
storage
cleavage
p62
cell
fusion
sfv
flagellin
the
flaa
expression
antibodies
rsv
palivizumab
infants
nunavut
age
nan
dogs
enteropathogenic
coli
infection
disease
nan
serum
hepatitis
negative
immunodiffusion
complement
rna
oligonucleotide
genome
rnas
the
nan
ask1
ubiquitin
proteasome
like
signaling
hcv
ns3
polyprotein
proteins
processing
protein
trafficking
coronavirus
neurons
virus
nan
nan
patients
respiratory
symptomatic
study
index
health
public
providers
receiving
communication
dose
in
host
airborne
pathogen
sjl
mouse
mhv
virus
infection
particle
infectious
norwalk
gastroenteritis
evidence
variants
deletion
rna
viral
spike
virus
htn
vaccinia
recombinant
glycoproteins
cells
cytomegalovirus
virus
lacz
mice
genome
replication
rna
alphavirus
elements
nan
protein
reporter
byv
gus
genes
antigen
tests
hepatitis
blood
donors
men
antibody
influenza
virus
isolation
virus
mutants
deletion
mhv
selected
ns3
scfv
mab
zx10
ntpase
spla
lps
ge
activity
induced
core
clones
cell
peptide
the
nan
asthma
viral
exacerbations
respiratory
tract
the
blood
animal
bovine
virus
helicobacter
diarrhea
may
the
species
cells
lamb
pseudomonas
epitope
surface
nan
mhv
protein
apoptosis
cells
expression
demyelinating
diseases
subacute
rats
inoculation
nan
sars
new
health
emergence
global
pd
nocardia
spp
panel
patients
rna
capsid
protein
binding
di
10
rnas
mw
defective
the
nan
ldv
mhv
cells
infection
macrophages
rats
blue
infections
free
ammonia
nan
mabs
protein
prrsv
anti
two
cleavage
3clpro
22
mhv
sites
virus
infected
variant
mice
cells
rats
doses
mice
pain
mg
ari
acute
respiratory
health
the
elisa
bovine
coronavirus
we
compared
pedv
ped
nb1
present
porcine
nan
cecitis
butyricum
the
weight
clostridium
nan
rna
rnas
recombination
sin
nonreplicative
injection
intracardiac
tumor
cells
cell
osa
molecular
sleep
changes
domains
eav
orf1b
processing
nsp10
van
vp60
component
rabbit
hemorrhagic
disease
placebo
interferon
given
virus
in
replicase
plp2
domain
mhv
polyprotein
nan
golgi
ii
p33
medial
enzymes
hrv
patients
culture
pcr
negative
mhv
rna
monoclonal
antibody
specific
subjects
isolation
bas
england
virus
sars
outbreak
levels
pts
related
nan
piglets
blood
the
severe
neonatal
mice
virus
the
chronic
a2g
nan
sequence
vida
database
protein
families
il
cytokine
10
lymph
nodes
gg
hsv
cells
the
virus
method
supernatants
coli
the
hly
1a
kda
encoded
10
polypeptide
nan
wurss
21
illness
rasch
single
spinal
cord
virus
spread
jhm
sh
rat
species
antibody
the
ibv
rna
infectious
purified
sedimentation
health
medicines
who
essential
states
nan
oc43
eia
antibody
coronavirus
serum
japanese
deer
parapoxvirus
serows
the
nan
health
professionals
initially
disappointed
top
virus
inner
the
structure
porcine
protein
mhv
interaction
nucleocapsid
cells
virus
avian
antibody
levels
people
nan
membranes
protein
cells
fusion
beta
animals
virus
lymphoid
14
positive
nan
budding
proteins
protein
viruses
membrane
hucv
viral
cell
lines
oc43
ftt
tumor
mice
mdck
pups
nan
patients
infection
reactive
arthritis
in
nan
nan
calves
necrosis
myopathy
diagnoses
included
feline
coronavirus
virus
infectious
peritonitis
airway
infection
associated
hyperresponsiveness
eosinophilic
cells
mhc
antigens
tax
gene
nan
nan
we
systematic
review
following
clinical
rats
brown
norway
estrogen
treatment
nan
colostrum
group
cows
rotavirus
calves
sodium
pigs
tge
virus
jejunum
elastomerics
use
themes
elastomeric
healthcare
virus
small
rice
orfs
mrna
pendrin
asl
airway
induced
asthma
virus
viral
m1
protein
played
histamine
micrograms
capsaicin
ml
95
virus
hsv
prv
cells
infection
mice
sda
virus
evidence
infection
bhv4
ipmas
cattle
indirect
elisa
cases
seen
distribution
less
01
gene
read
pol
gag
murine
volunteers
concentrations
antibody
infected
infections
cages
washed
pathogen
bedding
disposal
nan
class
ii
tmev
astrocytes
cns
nan
rna
it
virus
the
coronavirus
vp
ldv
proteins
disulfide
bonds
cdc
response
first
case
mers
dose
effect
interferon
10
iu
dhbv
dcpd
protein
cells
the
ldv
mice
neuropathogenic
10
ability
tests
the
available
whatever
vomition
sars
hospital
case
patients
period
calves
abomasal
over
years
24
enterovirus
patients
specific
dilated
cardiomyopathy
gc
g1
g2
virus
proteins
nan
imaging
ngr
probes
tumor
peptide
bats
hepatic
colony
lipidosis
environmental
assays
viability
oocyst
infectivity
vitro
nan
capsaicin
nasal
mucosal
exudation
plasma
viruses
possible
stools
implicated
methods
tgev
mabs
type
6a
c3
nan
arthritis
pristane
mhc
induced
rheumatoid
type
vlp
the
an
virus
nan
human
cea
col
cells
v51b
nan
rna
cre
strand
replication
positive
fit
test
model
niosh
respirator
rats
pulmonis
infected
specific
igg
nan
iron
infected
livers
uptake
virus
di
transcription
sequence
mhv
rna
rotavirus
human
strain
canine
cu
villus
the
toxins
cells
toxin
virus
antibodies
transmissible
immunodiffusion
test
nan
g1
golgi
complex
virus
tail
galnac
hsv
cells
glycoproteins
the
mutants
virus
group
ha
within
cmv
induction
dr
cells
infection
virus
hev
cells
unlike
red
immune
changes
system
age
related
nan
proteins
glycoproteins
infectious
viral
oligosaccharides
ad5
porcine
swine
the
infection
nan
rna
hcv
end
primer
template
the
scientist
helped
confirm
identity
gd
igf
1r
patients
receptor
like
reo
the
coli
viruses
nan
rotavirus
tests
strain
this
found
sg
rna
accumulation
sequence
mrna2
jhmv
differentiation
expression
oligodendrocytes
protein
prcv
isolates
orf
gene
the
virus
mice
inoculated
study
nude
gp41
human
env
antibodies
recognized
mhv
mhvr1
receptor
murine
mouse
m33
mcmv
open
reading
ul33
pain
low
back
osteonecrosis
hip
pcv
dna
specific
pcr
amplified
pedv
cells
virus
cell
porcine
viral
proteinases
processing
many
genome
sars
cov
cuhk
genome
world
cat
mhc
fla
class
definition
virus
cell
mice
mhv
amino
ape1
rna
cleaves
mrna
vitro
venous
thromboembolism
vte
prf1
mutation
pp1a
pp1ab
3cl
pro
coronavirus
virus
asf
membrane
p73
envelopment
calves
life
guard
revibe
milk
drug
activity
amantadine
viruses
influenza
antibodies
ldv
monoclonal
neutralizing
mice
nan
cp
deletion
codons
coding
sequence
the
open
reading
bases
fcv
half
days
antibodies
virus
biological
dogs
challenge
day
canine
parvovirus
iga
infection
nasal
infants
secretory
nan
receptor
mhv
activity
mhvr
mab
papr
performance
test
work
lpm
nan
cleavage
viruses
site
oligosaccharide
side
the
use
genetic
tests
improve
last
month
who
declared
hiv
proteins
particles
er
knowledge
properties
the
infectious
proteins
diseases
structural
viral
apical
cells
tgev
membrane
distemper
effect
vaccination
failure
weeks
nan
transcription
genome
expression
mrna
subgenomic
sg
hairpin
bmv
rna
loop
acid
hepatitis
virus
nucleic
extracted
infections
respiratory
illnesses
reported
station
calves
rates
morbidity
mortality
trials
bcov
bovine
respiratory
disease
role
gb
bhv
prv
cleavage
cell
gp
amino
lcmv
acid
cleavage
human
cell
hapn
infection
lines
nan
brd
information
in
pneumonia
canada
protein
strains
murine
hepatitis
virus
ketoprofen
gastrointestinal
rats
mg
kg
hrv
pigs
wa
serotype
rotavirus
studies
infection
virus
route
laboratory
piglets
cpb2
perfringens
diarrheic
the
nan
nan
clearing
house
patent
access
diagnostic
nan
rna
mrnas
ski2
translation
the
p53
cancer
pathway
mdm2
inhibitors
cows
vaccine
the
animals
antibody
mabs
rainbow
trout
fibronectin
three
nan
gh
virus
cell
type
hsv
treatment
improved
disseminated
intravascular
coagulation
virus
rna
theiler
disease
cells
enterica
kela
enteritidis
sn
sp
feline
cpv
canine
fpv
host
nan
mhv
rna
dissa
virus
synthesis
golgi
gpp130
early
proteins
late
nan
bdv
cells
cell
replication
sk
cells
pathogen
immunopathogenesis
human
peptide
mice
genital
gamma
tract
infection
cases
the
clinical
community
acquired
trans
encapsidation
capsid
proteins
virus
viruses
different
the
respiratory
symptoms
previously
undescribed
obligate
intracellular
bacterium
coli
o157
h7
days
one
rotavirus
mice
diarrhea
bacterial
intestinal
infection
control
course
health
care
kit
sirna
asthma
inflammation
intranasal
oblv60
mice
virus
gamma
no
ph
37
degrees
virions
coronavirus
research
health
response
rapid
required
neutropenia
an
18
month
old
nan
iron
serum
qsm
uspio
compounds
health
patients
staff
the
sars
centre
zsuzsanna
jakab
head
new
nan
nan
p1
p6
site
sequence
hiv
protein
glycosylation
important
disease
microarray
p68
p72
rna
ddx5
ddx17
sars
mask
places
travellers
returning
iha
229e
titers
cell
cultures
orf
polypeptides
translation
encoded
1b
mlt
vlps
pigs
rotavirus
vlp
pi
cells
viruses
sigma1
cured
calves
arrival
brd
titer
titers
bvdv
animals
ubrd
titer
bcv
human
cga
regulated
secretory
vesicles
pulmonis
sdav
group
rats
followed
nan
diseases
myocardial
cardiotoxicity
animals
cardiomyopathies
ad
vector
vectors
immunity
approaches
class
antigens
expression
hla
corneas
hospital
cases
sars
transmission
case
drug
organelles
delivery
targeting
specific
mhv
bgp2
cells
mouse
gene
di
sequence
leader
rna
jhm
mhv
virus
brain
receptor
receptors
hygromycin
mhv
antiviral
aminoglycoside
virus
glycoprotein
region
role
mutations
leucine
mhv
human
receptors
murine
cea
biopharmaceuticals
plants
produce
recent
cost
mice
virus
infected
jhm
mutations
nan
type
ii
viral
cells
replication
incidence
ard
1969
epidemiological
since
nan
sars
transmission
risk
control
beijing
activity
tgev
acid
prcv
sialic
protein
mv
translation
specific
proteins
protein
nucleocapsid
the
sequence
dna
bulged
promoter
crna
viral
two
cd
91
rna
61
ibv
relative
aggregation
electron
antigen
antibody
tgev
mrnas
rna
negative
sense
nan
tge
disease
pigs
the
pig
trypsin
cell
fusion
observed
bovine
diarrhea
piglets
intestinal
group
rotavirus
nan
nan
sigma
coiled
nm
tail
two
nan
gag
hiv
pol
viral
pna
the
rna
1b
hast
1a
responses
ctla4
mice
replicating
cell
nan
products
hypochlorite
disinfectants
laboratory
animal
curcumin
ga
cell
pten
akt
nan
specific
rubella
igg
levels
antibody
nan
glycoprotein
disease
virus
identification
viral
frameshifting
gene
region
viruses
frameshift
nan
b1d
ifn
polymorphism
the
874
recombination
mhv
ts
genome
studies
nan
bmv
viral
recombination
fragment
rna1
pparβ
null
mice
controls
tpa
editing
run
sev
bpiv3
sequence
interleukin
12
gamma
interferon
secretion
ped
following
outbreak
testing
clinical
sequence
subgenomic
mrna
transcription
leader
mcmv
the
nacif
elisa
antibodies
poly
tail
replication
rna
coronavirus
demyelination
mhv
nos2
induced
mice
nan
eae
ia
bn
rats
cells
nan
golgi
apparatus
plant
trans
cisternae
sars
patients
pathogens
cov
ruling
nan
calves
calf
treatment
the
in
bb
dogs
antibody
responses
whole
nan
expression
ia
enhanced
rats
synovial
virus
rna
base
flock
house
t3d
sigma
infectivity
treatment
virions
piglets
seen
farms
coccidia
identified
nan
fingerprints
distinct
infectious
bronchitis
virus
the
japanese
encephalitis
tests
test
rna
utr
replication
pseudoknot
tertiary
eradicating
human
pathogens
young
science
nan
body
weight
condition
tumor
mice
momp
aid
anti
mab
dp10
disease
two
hemorrhagic
fevers
emergence
nan
nan
like
coronavirus
3c
proteinase
substrate
equine
human
obesity
ms
risk
mhv
mice
r1
r2
receptor
peritonitis
primary
case
patients
five
nk
cells
pe
analysis
expression
group
virus
rotavirus
rotaviruses
strain
ifn
alpha
beta
mice
nk
nan
rna
proteins
shfv
cellular
ncr
nan
global
health
issues
cross
science
membrane
the
protein
virus
microsomes
nan
nan
rna
bc
stranded
virions
vitro
rsv
class
restricted
frequencies
ii
lymph
year
old
neutered
male
the
recombinant
modules
mab
10
rna
secondary
region
virus
hcv
afop
lung
lesions
consolidation
occupying
beta
replicase
plasmid
phage
derived
diseases
infectious
major
cause
death
nan
calf
serum
colostrum
calves
coli
bulk
milk
caninum
farms
herd
piglets
supplementation
enzyme
diets
degrees
nan
cases
occurred
nec
two
in
infection
virus
cns
the
viral
orf1b
bev
the
coronaviruses
sequence
mhvr
a59
mhv
isoforms
mmcgm2
sequence
rna
transcription
cis
acting
signs
clinical
bottom
cages
animals
mhv
strains
virus
type
e2
astroviruses
enteric
disease
nucleotide
sequence
receptor
human
rhinovirus
intercellular
adhesion
calves
cells
hv24515
myeloid
virulence
virus
pneumoniae
allergic
nonallergic
subjects
nan
nan
alpha
tnf
jhmv
infected
virus
difference
mouse
adenovirus
type
adult
viral
cells
rna
mutant
infected
synthesis
patients
antibody
intrathecal
the
ibv
reaction
the
gene
typing
mhv
gene
mrna
genes
ns4
vectors
pseudotypes
lentiviral
virus
gps
rna
it
10
molecular
weight
euthanasia
methods
method
aesthetically
procedure
nan
tissues
virus
aib
strain
susceptible
protease
cleavage
positions
acid
p1
bioterrorism
aetps
health
response
responded
diarrhea
blood
bvdv
after
cows
infection
thymus
lymphocytes
cells
a59
biocommons
the
for
profit
university
gb
nuclear
envelope
protein
proteins
nan
pseudoknots
pseudoknot
bacteriophage
frameshifting
junction
vlps
administered
cholera
toxin
rotavirus
nan
sepsis
patients
dcs
expression
oxpapc
cells
mice
infection
il
production
nan
cells
rv
neuroblastoma
sf21
sites
cells
wt
mutants
synthesis
c1300
nan
nan
health
public
new
social
eras
mhv
a59
spike
gene
q159l
coronavirus
monoclonal
antibodies
assay
reactive
cholesterol
srf
sfv
fusion
e1
nan
nan
sequence
leader
rna
di
transcription
health
public
core
integrated
curriculum
uvgi
history
renewed
transmission
infections
serine
virus
influenza
esterase
amino
virus
minireovirus
sequence
like
norwalk
respiratory
two
cases
agents
porcine
mhv
receptor
cells
virus
glycoproteins
nan
human
hcov
ms
oc43
viral
nan
mabs
immunotoxicity
clinical
induced
effects
queries
unique
month
top
information
coronavirus
ecg
mink
like
particles
hcv
antibody
rises
the
infections
2a
recombination
1a
mf5
bmv
ph
dhbv
infection
hepatocytes
the
nan
rnas
common
termini
ctv
showed
rotavirus
1982
patients
1984
infections
influenza
virus
specimens
viruses
respiratory
leader
rna
di
element
ucuaaac
cells
viruses
rotavirus
pi
persistent
nan
nan
vinsonii
subsp
berkhoffii
strain
bartonella
hbsag
within
particles
cells
surface
borders
iom
health
public
qss
demyelination
rna
viral
infection
dav
rna
rnas
species
genome
form
nan
mrna
replication
minus
plus
strands
nan
dams
parvum
principals
suckled
controls
transmissible
gastroenteritis
pigs
feeder
swine
rrv
intestinal
iga
wc3
specific
nan
brv
mabs
bovine
assay
hybridomas
patients
sars
severe
experienced
hospital
subgroup
fsc
erythroid
cells
felvs
stools
infants
the
examined
this
diagnostic
tests
laboratory
molecular
interpretation
pigs
diarrhea
age
common
diarrheic
torovirus
pcr
calves
specimens
rt
group
test
anti
induced
il
proteinase
like
3c
hcv
229e
membrane
capsids
binding
dhbv
nucleocapsid
bovine
fetuses
antibodies
virus
aborted
asthma
crs
cough
acute
children
dmpge2
hepatitis
10
mice
infected
rna
strand
the
di
region
su
rsu
sequence
drosophila
protein
nan
anesthesia
rats
propofol
medetomidine
fentanyl
nan
health
urban
migrants
workers
care
elisa
e2
virus
tgev
test
perfusion
human
blood
system
surgical
nan
ebola
batch
we
misinformation
2014
e1
polyclonal
carboxy
terminus
coronavirus
monoclonal
antibodies
coronavirus
elk
protein
ne
khf
antigen
detected
antibodies
cenp
kinetochore
protein
region
in
vaccine
understanding
correlates
systems
numerous
nan
module
dre
ltr
elements
trna
nan
nan
hk
mice
infected
483
486
rna
leader
coronavirus
mrna
transcription
nan
virus
mice
inoculated
disease
10
nan
nan
nan
vaccines
calves
vaccine
producers
the
nan
nan
nan
nan
coronavirus
proteins
structural
bovine
mouse
circadian
cages
rats
red
light
nan
nan
nan
health
thailand
assessment
the
public
prrsv
semen
boar
swine
the
calves
hypernatremic
sodium
five
diarrheic
the
un
food
agriculture
organisation
antibodies
immunodominant
domain
structure
murine
molars
this
abnormal
here
describe
enzyme
linked
immunosorbent
assay
murine
travelers
cdc
contact
investigations
commercial
infected
macrophage
cultures
virus
polykaryons
system
testing
performance
public
health
gene
expression
vi
genes
polycistronic
toxin
epitopes
tetanus
antibodies
different
nan
respiratory
method
pathogens
clinical
assay
protein
histolytica
mabs
antigen
cdna
respiratory
virus
rhinovirus
upper
tract
mhv
ns2
gene
cells
isolates
stec
cattle
o26
h11
detected
animals
virus
challenged
lesions
sda
nan
elisa
canine
assays
correlation
samples
coli
enterotoxigenic
treated
glycoprotein
glycans
henipavirus
paramyxoviruses
emerging
animal
henipaviruses
diarrhea
calves
protocol
kg
severe
vaginal
rats
impedance
cytology
hormone
patients
ifn
infection
in
disease
nan
disease
spread
we
infectious
patterns
virus
infection
two
critical
steps
serotype
specific
protein
s1
epitopes
nan
nan
nan
agents
brd
positive
pathologic
processes
day
ctl
virus
response
lysis
dubs
infection
ubiquitin
known
host
antibody
monoclonal
billion
antibodies
anti
nan
gp
ebo
processing
required
glycoprotein
gene
prv
mhc
class
product
isolates
bovine
rotavirus
quebec
produced
nan
turnip
size
sequence
di
rna
the
protein
orf
rna
coat
nan
gp70
disulfide
pr15e
complexes
cells
calf
virus
four
specimens
diarrhea
dextran
sign
dc
receptors
applied
nan
glcnac
ti
golgi
stack
cells
nr
mrna
levels
nra
nitrate
difficile
patients
colitis
antibiotic
the
palindromes
length
sars
genome
sequence
poifn
beta
ifn
porcine
antiviral
histone
h3
protein
pi
viral
nan
an
unusual
presentation
highlighted
unique
glycoprotein
mhv
he
infection
cells
viruses
virus
patients
influenza
infections
mav
mice
infected
hepatic
histopathologic
dogs
respiratory
control
positive
presence
nan
nan
antigens
virus
subcomponents
specific
antibody
nan
mrna
regions
levels
leader
intergenic
ribozyme
interaction
evolving
group
species
3a
3c
3b
orfs
translation
mhvr
cells
mhv
cytopathology
cell
antibody
virus
made
rises
various
farms
coli
calves
jejuni
increased
slpa
protein
layer
slh
thermophilus
bladder
rats
sci
72
spinal
mhv
virus
a59
jhm
h2
cell
e2
cells
fusion
lines
mir
592
crc
ccnd3
cell
nan
nan
pigs
temperature
signs
virus
clinical
rna
mhv
recombination
rnas
genomic
microscopy
coronavirus
samples
direct
electron
promoter
nt
rna
sgrnas
bydv
rna
di
genomic
subgenomic
replication
ifn
serum
response
early
cells
il
bone
cytokine
10
sars
membrane
proteins
two
p16
p8
nan
rna
recombination
template
switching
retroviral
virus
lcmv
binding
cell
lines
transcription
virus
ctv
like
sgrnas
nan
cells
virus
cd8
viral
specific
lactose
fermenting
the
salmonella
strains
lcmv
lv
cells
specific
virus
hml
cases
cells
cell
negative
receptor
gamma
ifn
the
astrocytes
nan
antibodies
au
patients
antigen
chronic
wag
rats
rijy
normal
decreased
nan
nan
virus
cells
transformed
a59
al
replication
leader
rna
di
coronavirus
protein
rna
gene
terminal
cleavage
virus
piglets
maintained
found
the
extract
proteins
also
use
translation
screening
respiratory
the
illness
influenza
nan
cells
released
virions
a59
virus
foals
the
immunocompetent
platelet
scid
vig
induced
virus
vhsv
gene
mhc
expression
demyelinating
diseases
autoimmune
pigs
virus
parv
gnotobiotic
porcine
gi
ge
terminal
the
cell
nan
nan
associated
mabs
he
wd
antigenic
mice
gvhr
nk
cells
anti
surface
antigen
host
cell
ehrlichial
nan
calves
sal
samp
significantly
amp
calf
ncd
two
like
diarrhea
nan
nan
nec
comprehensive
review
necrotizing
enterocolitis
gp70
linked
treatment
pngase
removal
nan
protein
p28
gene
the
genome
adenovirus
infection
serum
ml
distinct
nan
lactose
rotavirus
diarrhoea
infection
lambs
p22
p16
polypeptides
core
like
two
superfamily
2h
families
processing
win
51711
rhinoviruses
concentrations
plaque
tgev
antibodies
pbl
antigen
piglets
nan
the
sars
cov
spike
glycoprotein
immune
viral
mhv
acute
system
nan
detection
pcr
specific
rotavirus
samples
falls
group
exercise
balance
control
structure
replication
rna
genome
poliovirus
rnas
results
synthesis
these
infection
nan
bone
ethanol
consumption
gel
treatments
bcs
mice
weight
rats
noninvasive
nan
nan
nan
rna
sat
c1
tcv
rnas
transmissible
gastroenteritis
virus
intestinal
contents
fusion
rotavirus
cell
virus
cells
virus
smallpox
health
vaccination
data
mv
pbls
observed
suppression
measles
test
tests
sn
incubation
sera
di
eav
rna
genome
kb
gene
proteins
viral
membrane
rna
he
bcv
polypeptide
hemagglutinin
virus
elisa
ria
bovine
coronavirus
antibody
nan
adenoviruses
children
serotypes
stools
nine
surveillance
hiv
china
aids
data
pcr
brsv
assays
products
the
health
occupational
public
state
integration
nan
plan
pandemic
influenza
laboratory
animal
men
six
12
wintering
isolated
patients
multiple
sclerosis
csf
amino
hepatitis
patients
viral
antigen
evidence
mice
demyelination
mhv
adoptive
transfer
cultures
mouse
infection
sjl
virus
hepatitis
viruses
virus
human
herpesvirus
fatal
case
hemorrhagic
enteritis
young
mhv
coronavirus
pcr
mouse
two
feline
apoptosis
cell
infectious
peritonitis
nan
e1
mabs
rv
e2
proteins
specific
cell
virus
cells
responses
cell
system
frameshifting
vp4
efficiency
onfh
or
95
ci
abcb1
tested
cats
fipv
feline
assay
colds
alcohol
clinical
risk
smoking
interferon
we
looked
presence
digestive
prrsv
sequence
vr
2332
lv
treatment
diarrhoea
months
found
developed
jhmv
rna
neurons
in
situ
ev
mab2s
70
mab
12
croup
we
oral
respiratory
severe
strains
neuraminidase
clostridium
butyricum
one
feline
macrophages
virulent
coronavirus
avirulent
amplification
techniques
detection
diagnostic
results
patients
sars
haematological
outcome
included
demyelination
mhv
virus
gene
determinants
responses
sars
cell
cov
immune
exudation
mucosal
subjects
common
cold
rotavirus
antibody
intestinal
cells
producing
prevalence
ntm
isolation
pulmonary
2007
raf
ras
binding
activation
rafc1
group
rotaviruses
genome
electropherotypes
cows
nan
measles
virus
ia
tnf
mhc
brsv
calves
maternal
antibodies
vaccination
fastidious
viruses
responsible
gastroenteritis
children
em
care
health
prevention
public
health
zoonoses
disease
research
determinants
health
physicians
preparedness
public
care
nan
fetuses
bovine
fetus
utero
days
antibodies
protein
virus
neutralizing
tgev
cardiovascular
diseases
losartan
system
heart
hepatitis
mouse
the
nude
virus
nan
time
data
series
evaluate
impact
nan
activity
binding
receptor
amino
protein
global
health
root
the
infectious
pcr
real
time
application
invention
22
month
old
indoor
outdoor
virus
substantia
nigra
brain
neurons
virus
parainfluenza
the
influenza
hong
nan
ifn
tgev
cells
protein
activity
stools
ahaggar
immunoelectronmicroscopy
tissue
culture
tsa
mg
fip
cats
the
nan
study
iid
risk
factors
costs
nan
pv
spinal
cord
onset
paralysis
isolates
eav
leader
strain
the
nan
bcv
z3a5
mab
reacted
monoclonal
boars
positive
22
20
negative
nan
nan
il
cytokine
hiv
cytokines
type
nan
eav
proteins
gs
gl
virus
calving
several
outbreaks
diarrhea
good
interferon
the
acute
respiratory
infection
rna
viral
polymerase
the
capsid
nan
nan
virus
cell
antiviral
activity
the
nan
000
molecular
60
weight
cells
in
study
hybridomas
ibv
shown
rna
gag
codons
rnas
unspliced
nan
nan
nan
eradication
control
disease
countries
eliminated
patients
herpes
virus
strains
viral
mr
processing
aminopeptidase
polypeptide
swainsonine
hyphema
the
sudden
onset
unilateral
hiv
iga
mucosal
patients
serum
responses
myelin
the
autoimmune
symptomatic
procedures
many
antibodies
enzyme
immunoassays
nan
nan
40s
structure
complex
translation
mrna
nan
free
day
20
time
90
nan
rats
sda
virus
animals
prc
lps
ace2
mir
1246
induced
am
brsv
alveolar
inoculation
calves
crfk
vectors
virus
the
feline
antigens
detection
specimens
fixed
diagnosis
virus
antibody
transmissible
gastroenteritis
day
virus
day
pe
pigs
prrs
nan
nan
patients
pathogens
duodenal
biopsy
aids
rotavirus
adults
infections
diarrhea
28
inoculated
piglets
respiratory
prcv
contact
procoagulant
hepatitis
virus
the
murine
viral
cells
virus
the
infected
nan
nan
virus
antibodies
particles
linked
caev
cs31a
protein
coli
strains
using
cats
canis
isolated
diarrhea
role
interventions
outbreak
non
pharmaceutical
influenza
antibody
mice
pathogenicity
antierythrocyte
infection
25
hcc
hc
fabp4
cells
irap
recycling
surface
endosomal
within
proteinase
activity
domain
residues
kb
nan
students
case
microscopic
difficult
microbiology
poliovirus
vaccine
certification
wild
polio
china
experience
sars
important
implications
deer
coronavirus
isolates
feces
wild
nan
patients
stage
gastrointestinal
infective
iv
rna
di
mhv
replication
end
h1n1
associated
thoracic
infection
radiographic
test
single
cases
radial
haemolysis
months
prevalence
high
rotavirus
period
nan
cell
marsh
rice
epitheliotropic
lymphoma
cd22
cell
antibodies
therapeutic
binding
di
a59
virus
rnas
the
nan
the
rna
minigenome
replication
packaging
protein
the
bcv
receptors
erythrocytes
antibody
sera
piglets
porcine
indirect
nan
viruses
virus
parainfluenza
types
isolated
frameshifting
peptidyl
trna
slip
ability
k99
mca
calves
specific
diarrhea
sars
the
assays
respiratory
within
mhv
strains
oligonucleotides
the
rna
piglets
rotavirus
calf
vaccinated
rotaviral
pid
mpv
cages
14
mice
iha
test
antibody
tge
virus
anti
id
mm
113
bhv
the
clinical
laboratory
findings
group
protective
agents
enzymes
factors
digestive
integrin
thrombi
β2
β3
acute
dna
strand
rnase
reverse
rna
the
election
microscopic
examination
allantoic
nan
nan
ifn
liver
α2
hepatitis
hd
study
rats
we
survival
liver
findings
puppies
canine
ccov
cpv
nan
nan
specimens
specimen
scores
antibody
virus
p1
delta
p1luc
rna
capsid
nan
nan
er
cell
also
compartment
markers
diabetes
rat
lew
rats
the
children
gastroenteritis
detected
isolated
epec
cages
light
circadian
clear
rats
mice
infection
adult
resistance
jhm
rna
replication
kun
deletions
nonstructural
lambs
cryptosporidium
small
diarrhea
12
arf
treatment
renal
care
albeit
antibiotic
treatment
cough
side
effects
virus
bovine
diarrhea
persistently
infected
leader
rna
virus
mrnas
mhv
cocaine
ifn
mφ
secretion
cells
elk
mortality
disease
veterinary
diseases
pcv
homology
organs
strain
pigs
rna
capping
replication
helicase
bmv
vpu
type
protein
membrane
the
di
we
rna
analyzed
atypical
mouse
hepatitis
virus
virulence
hepatocytes
mice
virus
mutations
epitope
infected
sufs
gga
gene
trna
alleles
cdv
dogs
vaccines
strains
isolates
mutants
temperature
protein
one
wild
nan
nan
toxin
rabbit
receptor
binding
ileal
e1
protein
golgi
cells
membrane
reagent
fusion
cysteine
ellman
virus
pseudoknot
pseudoknots
structure
bp
stem2
virus
milk
pr
tge
titers
il
10
infection
gamma
following
isolates
prcv
three
new
shown
nan
nan
particles
temperature
ts16
virus
permissive
spike
protein
recombinant
coronavirus
virus
pe2
e2
trsb
ptrsb
linked
vmc24
cd4
immune
lymphocytes
recipients
shift
site
frameshifting
mmtv
rna
nfkappab
asfv
gene
cytokines
antiviral
exposure
tracheal
days
o3
epithelium
three
isolates
united
two
possessed
vaccines
vaccine
influenza
pandemic
virus
residues
mabs
peptides
consisting
the
sp
iel
nk
activity
cell
nan
kda
protein
membranes
viral
ergic
dogs
diarrhea
coli
genes
vt1
test
la
particles
rotazyme
latex
comparison
17
infectious
bronchitis
virus
sequence
encoding
protein
the
nucleotide
rna
mhv
the
end
protein
graduate
time
employment
new
nurses
nan
frameshifting
frameshift
virus
hiv
downstream
pedv
feces
pigs
ml
control
receptor
gp86
human
hel
cell
nan
nan
nan
transport
amino
aminopeptidase
na
dependent
identified
in
organisms
species
cases
mo
age
aging
the
rats
genome
cp
sequence
coding
ntr
rna
poly
sin
tail
genome
hct
recipients
infections
respiratory
viruses
rdna
frame
mof
copy
mof9
orfs
shfv
sequence
orf
virus
a3
mhv
cells
es
cell
bedding
cages
corncob
experimental
ammonia
nan
ifn
kinase
pi
responses
genes
electrophoretic
procedure
rotaviral
double
stranded
mhv
spleen
infection
mice
dna
nh3
mrm
rats
pulmonis
environments
the
distribution
morphological
types
australia
nan
nan
sars
hospital
patients
respiratory
guidelines
isolates
shs
clones
loci
strains
nan
rna
ibv
like
sequences
structural
rats
pulmonis
group
days
isolated
values
rna
pseudoknot
the
set
domain
glycosylation
hpvr
binding
cell
sars
cov
mabs
protein
chimeric
cleavage
site
proteinase
second
the
10
analytical
sensitivity
prrsv
siv
replicon
protein
vee
eav
particles
protein
dtt
disulfide
golgi
reducing
adenoviruses
type
identified
group
found
response
capacity
preparedness
regional
emergency
virus
ebola
gp
region
fusion
nan
public
health
veterinarians
veterinary
identified
di
translation
orf
a59
mhv
the
yields
human
coronavirus
229e
vaccines
infectious
diseases
children
could
alpha
sr
mrna
translation
membrane
tgev
sera
virus
protein
recombinant
nan
disease
brd
cattle
factors
calves
protein
sdav
gene
coronavirus
aa
somnus
exposure
haemolytica
ubrd
association
method
immunohistochemistry
using
tissues
direct
cartilage
rp
the
rats
protein
virus
mhv
a59
cells
specific
lpv
receptor
tunicamycin
cells
the
competitive
results
elisa
e1
anti
cd4
cd8
alpha
binding
domain
virus
antibody
breda
enzyme
sera
time
winter
space
dysentery
regression
strains
locus
disease
multiple
sclerosis
nan
host
intracellular
bacteria
brucella
melitensis
fipv
antigenic
e2
cell
79
transgene
expression
vectors
hdad
in
cell
ceacam1
actin
cytoskeleton
adhesion
disease
foodborne
microorganisms
may
well
bvdv
cattle
serum
nasal
swabs
pneumoniae
detection
samples
respiratory
infections
hemolysis
test
treated
the
23
eradication
results
pinworm
egg
shedding
nan
gondii
cats
infected
fiv
cells
virions
infected
cells
viral
different
infectious
highly
day
sars
avian
rats
vitamin
fed
albumin
diet
virus
mice
cells
rabies
infection
virus
inoculation
mice
activity
immune
nan
hiv
ois
viral
suppression
patients
adenovirus
the
ml
march
could
defective
proviruses
truncated
htlv
cell
nan
mhv
bhk
virus
a59
cells
nan
nan
nan
agent
piglets
infected
reovirus
like
virus
ts342
wild
type
infected
pth
ct
secreted
vitro
activity
cattle
cases
hemorrhage
dark
common
practices
intervention
control
hand
gel
rapid
viruses
well
viral
routine
dtt
rotavirus
cells
disulfide
assembly
rotavirus
strains
g14
serotype
two
bcv
esterase
activity
receptor
destroying
leader
rna
is
mrna
sequences
nan
nan
rv
antigenome
genome
rna
ambisense
nan
virus
protein
measles
specific
rats
virus
c6
36
viruses
growth
hiv
structure
type
gag
pol
sera
maternal
hi
activity
specific
pab
group
detector
capture
rotaviruses
psychogenic
illness
media
group
induction
e2
cell
peptide
epitopes
protein
anti
ab2
antibodies
specific
idiotype
tumor
virus
oncolytic
ad
antitumor
rna
viral
hygromycin
leishmania
virus
nan
vsv
er
signal
protein
six
euthanasia
anesthesia
participants
distress
bias
nan
hcws
respiratory
factors
research
pathogens
dengue
virus
phage
human
peptide
nan
bcg
immune
response
sporozoite
the
nan
nan
helicases
viral
inhibitors
virus
function
lung
development
cancer
may
genomic
mice
mpv
b6
deficient
wpi
the
use
lyphogel
virus
particles
pandemic
research
influenza
health
the
type
fcov
79
ccv
strain
rna
single
nascent
strands
ri
e2
e1
er
complex
cd4
air
room
in
hepa
technology
ribosomal
frameshifting
programmed
viral
pap
subjects
bronchial
two
hyperreactivity
work
the
alb4
deletion
protein
wild
stva
tva
receptor
avian
aslv
61e
infected
immunodeficiency
amino
acid
splicing
factors
mrna
asf
studies
volunteers
drug
type
resistant
dependent
mhvr
mhv
glycoprotein
domain
virus
jhm
sdav
prc
proteins
rat
we
sore
throat
review
interventions
cells
hcmv
infected
pbmc
specific
lymphoid
bowel
lymphocytes
response
systemic
heart
fetal
genes
the
several
psittaci
b577
elisas
peptide
chlamydia
adcc
using
cells
response
sera
bhv
induced
virus
cattle
vitro
board
risk
hospital
governance
practices
ced
rats
opaque
enrichment
normal
calves
brsv
vaccinated
challenge
inactivated
nan
nan
hsv
cells
cell
gro29
infected
asc
group
rotavirus
wa
tissues
fusion
cell
cleavage
spike
virus
dichromate
solution
floatation
fecal
oocysts
virus
mice
protein
he
mabs
thiry
vella
loops
loop
surgery
hiv
entry
development
inhibitor
env
nan
sera
interferon
virus
ped
isolated
foals
10
severe
combined
immunodeficiency
nan
virus
gd
cells
fusion
entry
virus
golgi
compartment
particles
membranes
shfv
virus
rna
the
genome
we
sore
throat
interventions
systematic
mhv
infection
macrophages
pca
mice
group
the
infected
patients
cells
readthrough
uga
codon
termination
codons
fatty
acids
milk
antiviral
lipids
infections
respiratory
30
tract
acute
subgroup
human
rotavirus
strains
serotypes
sp
virus
rnas
rna
transmissible
recombination
rna
viruses
shown
homologous
research
training
strategies
trainees
funded
nan
stress
system
immune
infectious
disease
hemorrhage
four
month
old
simmental
influenza
pandemic
h5n1
avian
emerging
host
virus
cells
mhv
mhvr
programs
training
needs
curriculum
successful
antibody
surface
protein
e2
virus
health
treaty
many
problems
require
dogs
canis
sp
infectious
canine
we
mean
days
interval
south
nan
enzyme
the
10
purified
albicans
virus
producing
persistent
latent
an
torovirus
etv
botv
potv
recognized
infections
virus
respiratory
reported
viruses
nan
p23
proteins
family
gp36
gp31
immature
cells
dermatitidis
killing
mice
nan
ge
gi
000
endoh
sensitive
virus
v22
fusion
glycoprotein
la
rs1800450
sepsis
serum
polymorphism
mbl
polypeptides
virus
vp1
bromelain
surface
parvum
infection
virus
doses
type
rotavirus
techniques
ria
elisa
sensitive
nan
calves
seronegative
bovine
colostrum
herpesvirus
bb
dogs
intranasal
vaccines
reactive
nan
response
antibodies
hiv
methods
human
infection
early
agents
concentrations
mm
nan
nan
the
rnas
sizes
templates
synthesis
encoded
pp1ab
coronavirus
gene
polypeptide
health
ghg
global
governance
we
group
femoral
head
system
the
mhv
infected
virus
clones
antigens
cdna
the
rna
coronavirus
virus
fiv
felv
positive
parameters
infection
nan
cells
demyelination
mice
mhv
results
nan
protein
kda
membranes
21
gene
nan
benzer
apod
seymour
it
got
nan
bup
sr
rats
thermal
hypersensitivity
hypersensitivity
bupivacaine
thermal
mechanical
kg
rna
di
leader
replication
virus
attacks
patients
virus
pollen
allergy
nan
virus
release
e1
alanine
domain
nan
knowledge
owl
inference
network
methods
pseudoknot
the
sequence
structure
frameshifting
rna
strand
minus
synthesis
plus
iv
linezolid
vancomycin
mrsa
cost
nan
nan
nan
frameshifting
plrv
pseudoknot
two
region
golgi
e2
rv
e1
targeting
patients
status
sclerosis
therapy
performance
apn
cells
cell
aminopeptidase
cd13
pca
induction
bacteria
mhv
response
calves
diarrheic
lactose
increase
breath
plasma
pac
measured
evans
blue
receptor
binding
330
s1n
activity
nan
students
phase
sars
anxiety
ii
suppression
read
through
pol
uag
fgl2
liver
mhv
prothrombinase
gene
virus
conjugates
bovine
diarrhea
prepared
nan
cells
venous
immune
cell
balancing
rotavirus
children
cvlp
detected
viruses
rna
sgp
activity
nt
base
volunteers
library
managers
attitudes
the
nsp13
constructs
nucleic
gst
atp
disulfide
sindbis
virus
thiol
protein
infections
infectious
disease
coinfection
burdens
nan
nan
cells
mhv3
cns
cultured
viral
cell
a59
infection
mhv
cleavage
host
viral
viruses
translational
cell
health
technology
technologies
policy
used
physicians
family
public
health
emergencies
antibodies
tge
class
milk
animals
iddm4
rats
diabetes
wf
bbdr
cells
virus
cell
rd
plaque
nan
sr
bup
hypersensitivity
melox
cg
apical
surface
229e
airway
hcov
nan
10
mice
dose
cfu
disease
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
still
sars
cov
nan
nan
covid
19
2019
vertical
transmission
nan
patients
95
ci
analysis
hospitalized
covid
19
data
iran
committee
covid
19
data
iran
committee
infection
covid
19
could
studies
covid
19
data
iran
committee
number
isolation
covid
19
cases
covid
19
data
iran
committee
covid
19
data
iran
committee
health
using
portal
the
moh
clinical
epidemic
epidemiological
aspects
evidence
covid
19
gynaecological
the
urgent
19
covid
rt
pcr
cases
nan
nan
number
italy
iran
death
south
antiviral
covid
19
efficacy
current
patients
covid
19
ards
causes
covid
19
cases
we
currently
2020
covid
19
cases
condition
nan
nan
nan
nan
pbs
week
events
including
television
nan
deals
politicking
characterise
contest
new
nan
bbc
radio
february
pm
rating
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
gps
ppe
the
cases
well
nan
nan
nan
nan
de
les
et
des
infections
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
federal
health
care
providers
need
nan
director
general
world
health
organization
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
eds
bernd
sebastian
kamps
christian
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
pr
chief
says
must
learn
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
virus
data
infections
11
infection
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
ards
lung
acute
injury
predisposing
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
protein
sequence
orf
astrovirus
abstract
coronaviruses
china
animal
also
zoonotic
nan
nan
nan
2019
ncov
infection
neonatal
neonates
2019
ncov
nicu
response
the
2019
ncov
cases
infected
wuhan
ncp
epidemic
china
prevent
control
nan
nan
cases
ct
19
the
images
patients
19
covid
balance
the
nan
sars
humans
outbreak
cov
hcov
patients
10
covid
19
absolute
infection
transmission
disease
cases
the
nan
cov
health
sars
in
epidemic
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
covid
19
new
disease
coronavirus
lt
gt
2019
ncov
clinical
lt
gt
2019
ncov
infection
lt
gt
ncp
vascular
novel
lt
gt
studies
lpv
clinical
coronavirus
2019
respiratory
novel
ncov
2019
ncov
hcovs
respiratory
coronavirus
cases
2020
china
coronavirus
2019
scientists
china
outbreak
the
group
infection
severe
2019
ncov
acute
scov
market
viral
like
viruses
patients
trauma
ncp
severe
emergency
de
saúde
da
em
vigilância
severe
cells
covid
19
cases
control
epidemic
health
care
workers
covid
19
2019
china
case
patients
covid
19
epidemic
fracture
2019
ncov
results
test
rt
novel
coronavirus
pneumonia
emergency
asymptomatic
infection
children
bronchoscopy
sars
cov
la
de
del
covid
19
de
la
los
en
se
2019
mngs
ncov
sequencing
pcr
19
conjunctivitis
covin
covid
2019
virus
coronavirus
protein
number
people
detection
prevention
control
pcr
assays
patients
covid
19
control
epidemic
hospital
system
ncp
diagnosis
treatment
ncovid
19
non
patients
2019
covid
19
patients
refractory
fever
patients
viral
rna
treatment
results
coronavirus
disease
covid
19
the
de
quot
boletín
bibliográfico
bibliomed
covid
19
china
chief
md
transmission
cdc
multiple
federal
agencies
aps
meeting
society
000
denver
si
r0
days
covid
19
vs
what
19
coronavirus
testing
vs
what
19
coronavirus
testing
correction
31
january
2020
updates
covid
19
aki
disease
it
covid
19
infection
caused
onset
transmission
the
covid
19
carriers
pneumonia
prevention
control
order
radiology
medical
records
based
hospital
patients
medical
children
epidemic
screening
isolation
hospital
epidemic
diagnosis
prevention
designated
de
declaratoria
emergencia
en
salud
singapore
covid
19
despite
multiple
infection
control
novel
coronavirus
oral
transmission
research
covid
19
vertical
clinical
research
the
epidemic
novel
clinical
laboratory
outbreak
disease
19
el
documento
contiene
la
declaración
el
de
documento
contiene
los
de
el
en
health
salud
de
con
la
el
para
de
pacientes
el
protocolo
contiene
de
pacientes
el
protocolo
contiene
de
em
saúde
emergências
pública
de
la
las
laboratorio
para
studies
diabetes
coronavirus
covid
19
de
em
saúde
resposta
ao
la
de
los
para
casos
2019
ncov
caused
china
health
related
device
pressure
injuries
virus
cases
united
states
fourteen
diagnosed
treatment
epidemic
pneumonia
period
diagnosis
2019
ncov
among
health
care
protection
skin
related
mucous
membrane
isolation
contact
tracing
outbreak
covid
2019
virus
ncov
detection
hospital
infectious
control
nuclear
medicine
coronavirus
2019
covid
19
how
in
patients
covid
19
epidemic
operating
2019
ncov
infectious
nucleic
detection
like
efficient
spread
overall
mortality
cancer
epidemic
patients
lung
disease
2019
ncov
pneumonia
coronavirus
characteristics
2019
cells
pulmonary
novel
coronavirus
singapore
antibody
test
covid
19
mers
cov
cases
children
2012
de
en
la
2019
wuhan
laboratory
virus
biosafety
clinical
testing
rna
the
list
since
compound
drosten
virus
genome
sequences
coronavirus
modelers
trying
forecast
virus
move
china
the
says
and
science
coronavirus
noval
infected
pneumonia
guizhou
coronavirus
2019
ncov
cov
corona
novel
coronavirus
medical
pneumonia
ncp
diagnosis
children
fever
treatment
prevention
ncp
prevention
clinical
work
epidemic
japan
sars
cov
covid
19
cabin
hospital
tongji
since
rapid
logistics
support
needs
hospital
hospitals
antiviral
combination
triple
time
therapy
ethical
review
emergency
research
covid
february
new
confirmed
cases
hubei
covid
19
ct
screening
587
ct
examination
room
prevention
design
the
method
number
covid
19
information
system
epidemic
auxiliary
prevention
research
covid
19
new
sars
research
health
public
system
technology
patients
cases
the
clinical
elevated
clinical
covid
19
the
treatment
severe
group
lt
05
non
ct
acute
manifestations
sars
mers
cases
mainly
clinical
severe
treatment
cases
patients
clinical
17
10
reagents
detection
results
orf1ab
2019
cases
the
department
store
00
2019
detection
ncov
igg
nucleic
aerosol
the
pm2
pm10
air
cases
covid
19
one
four
covid
19
control
prevention
outbreak
treatment
the
patients
lopinavir
ritonavir
patients
106
health
19
anxiety
covid
19
vascular
surgical
patients
data
control
epidemic
the
confirmed
cases
short
up
term
patients
group
patients
critical
10
times
ncp
patients
recipients
transplant
the
radiotherapy
patients
radiation
2019
methods
regimen
group
patients
lpv
ncp
covid
19
severe
lt
01
cases
patients
ct
lung
clinical
research
health
scientific
projects
emergency
prevention
perioperative
infection
19
patients
cases
ncp
mean
cluster
among
lym
alb
levels
group
patients
chi
19
lt
01
covid
women
anc
pregnant
health
covid
12
heart
failure
covid
19
cases
suspected
diagnostic
criteria
children
cases
the
group
patients
blood
covid
19
216
gastroenterologists
physicians
family
aggregation
covid
19
epidemic
2019
ncov
three
infection
placentas
case
clinical
infection
treatment
2019
emergency
medical
core
2019
score
ncp
severe
ct
clinical
58
2019
ncov
antibodies
test
nucleic
patients
ncp
10
exposure
early
cases
february
incidence
2019
novel
cases
confirmed
the
january
shanghai
cases
ct
patients
the
chest
cases
lesions
lung
hrct
distribution
patients
lung
hrct
the
lesions
cases
hrct
patients
the
ncp
serum
igm
positive
2019
ncov
medical
staff
anxiety
plusmn
the
2019
ncov
positive
respiratory
cases
patients
pulmonary
2019
infiltrates
cancer
nurses
clinical
risk
crisis
psychological
cities
cases
number
wuhan
top
group
patients
the
ratio
vs
cases
confirmed
number
2019
countries
cases
plusmn
10
times
treatment
network
rcp
system
prevention
risk
covid
19
infection
2020
one
pneumonia
2019
ncov
successfully
woman
patients
laboratory
2019
ncov
confirmed
patients
group
iqr
glucocorticoid
the
patients
critical
group
201
vs
covid
19
medical
cases
emergency
mathematical
models
statistical
infectious
diseases
ncp
141
patients
hrct
shadow
papers
literatures
research
published
chinese
family
cases
covid
19
cluster
epidemic
patients
symptoms
clinical
pneumonia
5g
epidemic
prevention
control
medical
cases
model
february
seir
hubei
de
la
que
las
para
de
en
salud
del
health
the
new
slack
wu
clan
os
coronavírus
uma
de
desde
hospitals
public
outbreak
novel
coronavirus
cov
severe
inflammatory
pathogenic
respiratory
patients
care
network
physicians
lombardy
de
atendimento
priorizar
casos
suspeitos
de
del
para
el
coronavirus
2019
ncov
clinical
pneumonia
manifestations
say
researchers
people
epidemic
true
washington
people
disease
state
seattle
share
japan
ship
cruise
port
children
emergency
the
patients
coronavirus
sars
cov
transmission
covid
19
ncp
2019
orthopedic
trauma
patients
patients
covid
19
ovcf
2019
health
covid
19
2019
diabetes
epidemic
strategies
transmission
since
outbreak
ncp
conjunctivitis
patients
two
cases
patients
support
severe
attention
2019
2019
virus
neonates
chinese
novel
radiological
staff
protection
control
infection
cabin
hospital
wuhan
hospitals
management
diagnosis
treatment
patients
epidemic
novel
ncp
transmission
infection
2019
epidemic
coronavirus
going
post
since
let
sars
cov
some
researchers
china
tests
test
the
cdc
labs
ship
japan
19
covid
cruise
patients
diseases
chronic
treatment
wounds
severe
respiratory
children
coronavirus
ncp
based
internet
hospitals
prevention
control
2019
ncov
infection
women
pregnancy
epidemic
dermatology
the
2019
novel
the
authors
23
09
26
disease
nbsp
characteristics
prevention
control
modernization
prevention
control
system
disease
responses
the
grief
family
abnormal
19
nutritional
covid
the
target
the
epidemic
health
battle
caused
may
treatment
coronavirus
covid
also
the
laboratories
test
labs
fda
three
the
theory
syndromes
methods
the
march
meeting
aps
cancelled
camels
rna
mers
cov
imported
control
prevention
infectious
disease
epidemic
patients
patient
ophthalmologists
coronavirus
infected
novel
coronavirus
people
may
infected
the
novel
coronavirus
outbreak
raises
medical
coronavirus
disease
covid
19
2019
ncov
risk
medical
return
patients
breast
cancer
the
disease
2019
children
adolescents
chronic
heart
sars
cov
vaccines
the
virus
dental
strategies
infection
epidemic
period
system
prevention
mechanism
disease
control
novel
coronavirus
ncp
prime
pediatricians
ncp
severe
treatment
the
outbreak
rehabilitation
patients
covid
19
consensus
2019
infection
medical
ncov
prevention
elderly
treatment
2019
novel
coronavirus
the
emerging
respiratory
infectious
diseases
prevention
control
ncp
burn
wound
detection
nucleic
acid
clinical
novel
clinical
trials
period
management
subjects
medical
prevention
the
covid
19
the
china
tests
and
january
every
day
goes
the
silver
coronavirus
health
disease
novel
the
anesthesia
rate
medical
2019
plusmn
pandemic
businesses
plans
business
plan
this
guideline
applicable
disinfection
personal
this
guideline
applicable
infection
prevention
hotels
health
protection
requirements
reconstructed
schools
educational
institutions
this
guideline
conference
designated
hotels
this
guideline
guideline
medical
organizations
ncp
this
evaluation
resource
thousands
people
united
patients
10
covid
19
absolute
cases
hrct
patients
the
ncp
patients
observation
syndrome
ncp
tcm
infected
thousands
children
one
updates
respiratory
illness
infected
tens
thousands
2019
ncov
host
cells
receptors
novel
coronavirus
the
throat
swab
sars
cov
model
3c
like
the
patient
coronavirus
acid
day
day
mother
the
nucleic
acid
dalton
white
house
came
coronavirus
values
health
why
concept
behavior
elderly
patients
hip
consensus
fracture
laboratory
biosafety
specimen
chinese
guideline
ncp
2019
patients
management
novel
nursing
treatment
pneumonia
disease
patients
patients
fractures
medical
ncp
elderly
ray
imaging
diagnosis
infection
protection
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
nan
transfusion
transmitted
viruses
hepatitis
diseases
measures
across
disciplines
emergency
hospitals
autophagy
optical
imaging
cells
degradation
nan
aecopd
viral
patients
virus
the
sars
coronavirus
bhpiv3
immunisation
respiratory
nan
lamp
amplification
method
tube
scanner
nan
nan
sars
proteins
viral
cov
studies
hepatitis
hcv
masp2
functional
patients
hhv
polymerase
chain
reaction
an
physical
chemical
feed
pathogenic
bacteria
virus
detection
pneumoniae
children
rhinovirus
outbreak
public
health
outbreaks
the
casei
antigen
recombinant
expressing
salmonella
receptor
rbd
sars
neutralizing
mabs
china
borrelia
lyme
disease
bactrian
hackathon
disease
described
innovation
marathon
nan
ph
tfr1
mmtv
virus
fusion
cats
feline
clinical
positive
fiv
ldv
mrnas
the
terminal
infected
nan
growth
global
disruption
2020
gdp
nsp14
cap
in
protein
methyltransferase
nan
ifn
ifna1
promoter
ipnv
activation
des
patients
premature
cad
results
peptide
ctry2459
hcv
peptides
drugs
protein
fusion
the
proteins
heterologous
ace2
angiotensin
mice
kidney
collagen
nan
viral
receptor
host
virus
viruses
2019
ncov
transmission
person
the
nan
phev
cells
caspase
caused
apoptosis
infections
travelers
common
travel
sick
tci
systems
use
function
to
de
las
en
il
viral
rooms
isolation
patients
pressure
negative
nan
nan
nec
neonatal
necrotizing
enterocolitis
important
cells
dc
including
hiv
infection
viruses
infection
co
porcine
influenza
nan
group
patients
days
mers
cov
rna
the
assay
family
coronaviridae
nan
nan
rna
di
strand
transcripts
positive
dc
targeting
carriers
vaccine
immune
nan
rna
106
synthesis
subgenomic
bcv
respiratory
pneumonia
virus
infections
calf
nan
pandemic
hospitals
plans
influenza
tested
antimicrobial
herds
cows
treatment
calves
rnp
protein
complexes
mhv
nucleocapsid
nan
il
27
patients
sputum
the
viroporins
small
viral
biological
roles
amino
protein
acids
coronavirus
bcv
swabs
cf
study
children
viruses
nan
diseases
molecular
tests
this
infectious
evolution
viruses
virus
host
quasispecies
nan
rabbits
housed
care
skin
covered
2019
wuhan
cities
cases
china
nan
swine
influenza
guangdong
poultry
infection
mers
human
mabs
cov
respiratory
learners
task
planning
writing
pre
nan
k22
replication
virus
antiviral
viral
network
infectious
disease
the
method
bvdv
hybridization
dot
blot
serum
obfuscation
writing
the
different
corporate
virus
fusion
immunodeficiency
biv
hr2
hcov
respiratory
229e
high
children
nan
protein
virus
lv
orfs
the
hunnivirus
proposed
study
genome
novel
mhv
autoab
liver
ccl4
hepatitis
treatment
cwb
evd
convalescent
blood
dbd
reactor
efficiency
bioaerosols
inactivation
ca
the
antigen
cell
response
peptide
membrane
negatively
charged
in
nosocomial
respiratory
significant
neonatal
human
proteins
pathogenesis
review
coronavirus
mhv
nan
nan
nan
memory
infections
apoptotic
cells
viruses
nan
mortality
early
late
pneumonia
increasing
cases
secondary
the
outbreak
ipc
d68
ev
hrv
compounds
ketoamide
nan
nan
nan
arboviruses
viruses
present
human
health
device
thermal
dna
pcr
on
antibodies
monoclonal
matrix
el
glycoprotein
nan
amplification
viruses
gene
rapidly
adaptive
sarsr
cov
sars
covs
bats
triage
incidents
this
review
provides
ica
cjnp
fcov
test
anti
unknown
nan
pediatric
ais
symptoms
emergency
acute
end
primer
recommendations
pcr
triplets
mers
cov
pneumonia
patients
hiv
years
colony
cats
pathogens
among
gp4
virus
membrane
lipid
the
nan
infectious
diseases
athletes
athletic
may
cd147
cyclophilin
interactions
activity
receptor
cypa
dc838
inhibitor
activity
reported
impulsive
infected
individuals
vaccination
restricting
tourism
demand
decomposition
ensemble
approach
nan
ibv
vaccine
virus
field
genotypes
hrsv
et
les
des
infections
nan
bovine
cells
bie
antiviral
intestinal
comparative
models
we
abstract
in
calves
bonov
fecal
shedding
the
spontaneous
pneumomediastinum
hospital
we
cases
rapid
sensitive
the
accurate
diagnostic
nan
dna
taq
method
exonuclease
polymerase
tgev
fibrillae
hybrid
cs31a
epitopes
nan
reproductive
number
days
estimated
around
nan
lrg
acute
phase
il
leucine
di
rna
orf
ne
rnas
virus
taxonomy
viruses
classification
taxa
dna
nanomedicine
topologies
abstract
application
nan
de
la
exacerbations
les
asthme
hai
issue
who
europe
international
influenza
pcr
virus
ili
picornavirus
flocks
ibv
infectious
bronchitis
broilers
the
study
enteric
diarrheas
leukocytes
protein
cows
differential
expression
mastitis
the
management
regional
national
scientific
nan
23
compounds
three
new
isolated
lesions
chest
ct
covid
19
nan
blood
products
screening
risk
plasma
sars
rvv
nt
cov
antibodies
cities
urban
services
ius
integrated
respiratory
hr
exposure
hct
patients
nan
p102
lepidoptera
endoribonuclease
residues
noctuidae
sequence
dna
in
novel
representation
chicken
h7n9
wtp
risk
perception
nan
health
goals
global
financing
international
nan
de
des
la
human
les
nan
nan
droplet
the
dispersion
source
droplets
normal
ribavirin
abstract
we
describe
synthesis
rna
eav
sg
virus
recombination
mhv
rna
frequencies
virus
positive
virus
pcr
sequences
controls
vectors
successful
use
adenoviral
may
rrna
microarray
analysis
viral
microarrays
microspheres
dna
mannose
chitosan
complexes
nan
cases
the
sfts
infection
hubei
nan
nan
virus
host
infection
dose
may
pcr
validation
high
biotechnology
genetic
de
la
el
2020
2019
time
aefi
clinical
pre
options
sars
protease
peptide
enzyme
substrate
dogs
positive
difficile
perfringens
cpv
nan
century
emerging
viral
diseases
fever
grft
the
hiv
using
expression
data
forests
terengganu
chiropteran
untouched
sars
cov
cell
responses
coronavirus
viral
region
the
quasispecies
composition
sars
respiratory
acute
syndrome
highly
nan
amino
two
f15
led
sequence
nan
air
ventilation
isolation
room
this
human
coronavirus
hcov
respiratory
cov
influenza
pm2
ambient
risk
lag
nan
ncds
public
pandemic
global
diseases
sensors
biosensors
used
clinical
analysis
rna
protein
packaging
ps
mhv
patients
rehabilitation
dialysis
care
home
nan
bcv
he
sequences
strain
ly138
viral
rna
rnas
large
the
nan
cells
mrp2
activity
ssb2
expression
e2
protein
cells
the
jhmv
pcv2
ups
replication
infection
porcine
air
global
airports
airport
regions
p72
antigens
responses
mva
boost
mers
cov
respiratory
virus
viral
nan
may
processing
methods
include
steps
pri
kd
coronary
study
pmf
assays
respiratory
ftdrp
in
house
spike
ibv
binding
acids
chicken
nan
nan
cross
antibody
ebov
rbs
ebolavirus
sars
cov
molecular
outbreak
knowledge
sars
protease
abstract
series
benzylthio
nan
nosocomial
alris
versus
community
acquired
patients
mers
statistically
corona
05
de
en
los
un
el
the
sars
cov
protein
structures
nan
nan
include
supportive
specific
electrolyte
inflammatory
water
main
microbiology
microbial
quality
nan
cpv
fly
flies
canine
facility
viruses
ptdser
pveers
receptors
entry
group
mers
cov
care
emergency
nan
nan
nan
nan
nan
stat1
ifn
bat
bats
antiviral
viral
aecopd
pcr
etiology
hong
chromatography
active
components
separation
identification
cats
vaccine
fiv
petaluma
subtype
bioaerosols
human
concentrations
activities
we
nan
nan
unknown
cancer
regulation
dubs
diseases
target
fusion
the
cov
lfp
sars
sars
cov
vaccine
vsv
antibody
niv
nano
based
virus
conventional
pedv
spray
plasma
pigs
raw
mf59
muc1
adjuvant
yw002
hsp65
distinguish
perpetrator
forensic
microbial
elements
tft
mice
hsv
infected
hepatitis
mstrg
lncrnas
thermal
hypoxic
stress
nan
nan
pigs
wild
domestic
leptospira
porcine
calanolide
thia
activity
abstract
synthesis
approaches
ipc
hais
around
world
assay
murine
monoclonal
antibody
elisa
pcv2
infections
associated
uganda
among
emergency
us
evd
departments
patients
nan
transmission
pathogen
particle
particles
respiratory
nan
nan
protein
response
mhv
ctl
mice
nan
antihypertensive
drug
mortality
class
all
like
qx
strains
ibv
infection
proteins
protein
viral
nucleolar
nolss
flow
exhaled
characteristics
the
exhalation
lung
transplant
infection
complications
early
odn
ifn
cpg
cells
ipc
antibody
responses
ade
disease
human
schwann
cells
cell
cns
studies
nan
microbe
human
disease
microbial
as
nucleocapsid
rna
protein
virus
sars
psd
razu
structure
the
ag
dna
gene
mini
genetic
tn5
pigs
old
intestine
infected
fluid
project
training
taiwan
the
pgyd
infectious
infectome
environmental
diseases
agents
cells
microfilaments
infection
pedv
tgev
nan
research
public
oversight
ibcs
health
nan
sars
cov
human
phylogenetic
isolates
respiratory
immune
anal
tract
skin
sites
determinants
tourist
country
tourism
nan
viruses
picture
mechanisms
entry
uncoating
children
viral
bronchiolitis
viruses
identified
preoperative
recovery
gender
function
predictors
nan
nan
virus
host
infection
phase
viruses
nan
ia
cells
perivascular
microglia
antigen
poxvirus
vaccines
polyvalent
virus
formulations
antiserum
reference
sars
serum
abstract
disease
pain
government
many
society
dpp4
insulin
liver
hepatic
nafld
hrv
samples
fecal
children
respiratory
nan
nan
group
patients
19
ground
glass
travel
travelers
illnesses
diseases
trade
sars
patients
group
confirmed
icu
ab
anti
sars
cov
antibody
treatment
disinfection
air
non
thermal
lyp
f344
rats
cd4
cd8
protein
the
structural
terminus
virion
recombinant
elisas
virus
viral
viruses
3a
protein
sars
cov
cells
farms
odds
calf
mortality
significantly
patients
sars
svcam
levels
thrombocytopenia
de
la
los
virus
gastroenteritis
viruses
lung
liver
mice
inoculated
nan
vitro
tissue
engineering
in
fabrication
nan
nan
fusion
sars
cov
regions
membrane
nan
sars
site
cov
3clpro
moiety
rv
viral
protein
pa
vectors
cypa
cyclophilins
cyps
thus
crucial
nan
disease
infectious
models
methods
transmission
de
las
rinofaringitis
respiratorias
una
nan
nurses
nursing
mainland
china
working
nan
components
glycoprotein
enveloped
viruses
viral
cell
growth
ccv
fipv
tgev
mee
children
ome
hbov
viral
cells
proteases
endocytic
pathway
the
osteonecrosis
incidence
corticosteroid
patients
varying
nan
cbov
strains
gene
partial
ns1
nan
2019
ncov
novel
type
coronavirus
bronchitis
made
diagnosis
purely
symptoms
phase
children
health
iaq
study
nan
the
covid
19
case
report
pathogens
host
posttranslational
modifications
infection
vlp
several
production
vaccines
vlps
urban
denv
sylvatic
genotypes
human
practices
ems
current
intervention
surfaces
target
samples
viruses
enrichment
system
bpno
cu2
complex
units
the
the
contamination
nucleic
acids
lab
fiv
felv
cats
positive
vaccinated
virus
compounds
herpes
human
cytomegalovirus
nan
covid
19
dental
epidemic
emergency
tbk1
activity
kinase
antiviral
immunity
disease
chronic
kidney
present
unknown
antisense
antimicrobials
expression
this
specificity
viruses
vesicles
functional
membrane
cargo
elisa
western
blot
sera
obtained
covs
ccov
the
canine
emergence
glycoproteins
viral
the
domain
chapter
treatment
presenting
ed
fever
antimicrobial
health
effects
environmental
agents
air
nan
protein
elisa
proteins
pedv
infected
rna
protein
proteins
coronavirus
chaperone
nan
angiotensin
cardiovascular
ii
at1r
at2r
nan
flight
medical
emergencies
challenges
in
respiratory
infections
illness
coronaviruses
viruses
cases
incubation
period
days
covid
sars
mpro
cov
wt
fusion
los
de
la
en
el
ped
virus
pigs
old
porcine
nan
ms
role
cells
play
disease
er
proteins
specific
signals
rii
nan
nan
de
the
des
virus
asthme
protein
rabies
virus
plants
the
nan
infection
control
knowledge
principles
standards
hrps
wastewater
research
biological
chapter
triclosan
dioxins
chlorinated
formation
initial
prrsv
different
prrs
virus
immune
h5n1
avian
flu
influenza
health
nan
mammals
ighc
marine
genes
terrestrial
tlr
ifn
irak
viruses
deficient
include
whales
animals
mammals
dolphins
vasculitis
agents
infection
numerous
human
nan
nan
pcv3
genome
the
samples
circovirus
ev71
atp1b3
protein
could
infection
nan
nans
his
neu5ac
ehec
edl933
ltbi
set
identified
potential
models
et
al
novel
coronavirus
caused
nan
nan
infections
disease
inflammatory
dementia
may
influenza
h5n1
avian
commonly
remains
news
disease
healthmap
information
reports
vp1
the
nuclear
localization
capsid
collagen
hcol3a1
human
triple
helix
nan
support
electron
patterned
gold
thin
influenza
vaccine
antibody
response
rov
hrv
associated
infection
illness
bronchiolitis
sars
cov
coronavirus
wuhan
china
sgs
tudor
sn
uniprotkb
mi
phylogeny
short
branches
dataset
genes
nan
hpiv
pneumonia
due
atl
mogamulizumab
public
emergency
social
media
government
calves
diarrhoea
samples
signs
animals
respiratory
virus
collected
sot
patient
fip
expression
leukocytes
adhesion
molecules
lm
cells
cell
fusion
virus
nan
design
method
objective
methods
cfd
nan
the
enzyme
sars
main
proteinase
prrsv
pcr
type
typing
virus
protein
fibrillarin
orf3
virus
complexes
sars
nurses
team
staff
psychiatric
fmdv
empty
capsid
particles
the
mobility
article
mobilities
social
geographers
nan
nan
virus
risk
vaccine
influenza
cell
disease
preventive
behavior
networks
models
collection
bioaerosols
flow
sampling
high
transportation
textiles
the
use
safety
encephalitis
often
acute
viral
adem
hajj
pilgrims
vaccine
preventive
advice
genomes
sars
coding
cov
zcurve_cov
nan
cloud
computing
internetwork
phone
the
nan
rt
lamp
sapelovirus
the
one
nan
challenged
aibv
hens
laid
mibv
blood
transfusion
safe
patients
ttis
ms
disease
individuals
associated
immune
di
rna
bases
rnas
virus
sars
outbreak
the
cohort
exposed
abstract
this
chapter
describes
methods
microarrays
biodefence
research
the
microarray
topological
relations
two
sets
extended
de
en
des
surveillance
les
model
sustainability
the
part
process
3clpro
fip
cats
inhibition
fipv
nan
local
national
systems
study
international
nan
influenza
detection
emerging
infectious
diseases
nan
cpmv
virus
family
genome
two
frameshift
the
frame
antizyme
expression
sars
protein
cell
cov
memory
nan
80
the
patients
segment
lower
di
rub
orf
protein
rnas
powv
vaccine
mrna
virus
tick
et
technique
biological
resolution
large
infection
viruses
host
rna
abstract
antiviral
nrav
lncrna
response
virus
nan
nan
influenza
virus
aris
acute
respiratory
nan
nan
regulations
local
reporting
requirements
abstract
nan
nan
denial
aids
asian
long
phenomenon
nan
canine
bocavirus
enteritis
novel
cabov
nan
cd4
cd8
iel
rats
aged
nan
rna
nsp12
nsp8
viral
complex
children
2009
virus
hini
infections
nan
the
polymer
composite
cellulose
ma
interaction
sars
cov
sgt
7a
pedv
strains
gene
substitutions
field
nan
sars
cov
epitopes
cell
proteins
respiratory
viruses
prevalence
samples
detected
coronavirus
feline
enteritis
intestinal
cells
ifitm1
cells
ifitm3
proteins
cancer
zikv
ebov
viruses
clr01
infection
immunisation
passive
vaccination
production
infection
food
gulf
states
workers
countries
maap
membrane
located
cells
the
nan
virus
genomes
genetic
viruses
the
nan
infectious
air
travel
disease
epidemics
organ
abstract
in
context
solid
meat
foodborne
safety
abstract
this
viral
proteases
assay
3cpro
activity
transshipment
selection
hub
factors
logistics
the
article
purpose
provide
practitioners
cfli
virus
viruses
pcr
respiratory
cov
host
receptor
cell
to
delivery
sirnas
nanoscale
cell
systems
infection
ruminants
cryptosporidium
severe
small
nanotechnology
the
nanomaterials
molecular
biological
transcription
prrsv
gfp
rhv
porcine
compounds
prrsv
cc50
pedv
protease
cov
protein
mers
sars
almost
virus
de
les
pcr
enfant
pharmacists
participants
government
china
tcm
h5n1
disease
influenza
interferon
induced
gc
content
sequences
amino
acid
banlangen
leaves
lc
apci
ms
periodic
solution
bifurcation
existence
theorem
32p
ibv
3h
protein
cells
ovm
sialic
acid
binding
role
population
rate
china
epidemic
the
health
one
viruses
approach
disease
treatment
rva
diarrhea
calves
igy
group
ggo
bronchiolitis
cap
the
jx17
strain
ibv
gene
gi
am
protein
allergic
asthmatic
genes
sorafenib
macrophages
autophagy
cell
cells
program
protein
files
printed
abstract
sars
guangdong
patients
cov
outbreak
viral
functions
host
gene
abstract
nan
interdisciplinarity
interdisciplinary
academic
order
research
cov
fp
sars
fusion
membrane
emcv
viruses
guano
caves
identification
pdcov
developed
piglets
first
study
shrimp
genotypes
orf4
yellow
head
m13ko7
phage
surface
detection
imaging
bronchitis
characterized
bronchial
inflammation
results
nan
nan
primates
humans
stool
the
may
proteins
viruses
human
complexity
the
pve
dogs
analysis
saliva
disease
polysaccharides
bioactivities
due
review
anti
bacterial
mucosal
diarrhea
coli
understanding
calves
ig
co
groups
starter
influenza
vaccination
mena
coverage
countries
de
la
en
sociedad
española
nan
fprs
fpr
formyl
receptors
family
ifn
sars
cov
replication
cells
sads
cov
pcr
based
detection
idiopathic
interstitial
pneumonia
acute
exacerbation
12
rva
detected
equine
g3p
di
rnas
species
nt
serial
nan
oc43
mice
viral
we
human
type
ifn
schedules
new
antiviral
hajj
gathering
mecca
kaaba
muslims
editing
hpiv3
found
rna
occur
enk
met
ac
acetylated
enkephalins
tlr
ibv
ligands
infection
the
sars
outbreak
acscs
the
hospitalization
sustainable
process
reengineering
management
healthcare
virus
pd
may
etiology
influenza
nan
mdef201
sars
cov
infection
treatment
care
recommend
health
approaches
performance
ppe
scenarios
001
we
used
attack
biological
bioterrorism
agroterrorism
level
mers
cov
hms
infection
rbd
cypa
compounds
structure
small
molecular
screening
identify
drug
med
chem
health
information
the
systems
record
immune
resistant
ne
diseases
disease
respiratory
dna
rna
virus
nucleic
studies
study
epidemiological
although
epidemiology
the
nursing
core
competencies
chinese
protein
terminal
hcov
tail
bind
detection
nucleic
acid
single
technologies
mers
cov
number
the
cases
two
prevention
epidemics
the
comparative
nan
gvn
virus
the
viral
disease
nan
nan
management
nutrition
the
successful
long
mosquito
human
bite
dengue
zika
pandemic
h1n1
2009
severity
however
virus
peperomia
sui
activity
influenza
nan
health
2019
united
states
cases
nan
nan
pathogens
foodborne
abstract
this
article
hiv
sequences
macao
subtypes
we
nan
viral
discuss
abstract
metagenomics
modeling
expression
mirna
lung
diseases
mirnas
model
we
epidemic
health
predictions
orf3
gene
pedv
protein
channel
infection
airborne
air
risk
ventilation
aggregates
amorphous
ca
gl
eg
nan
caninum
fed
cattle
tissues
dogs
biosecurity
external
internal
involves
operations
pneumonia
emergency
condition
often
treated
pig
wild
the
boars
domestic
coronavirus
viewed
previously
coronaviruses
cov
thermal
plume
human
the
heat
social
media
health
use
income
patients
beriate
haemophilia
safety
efficacy
mucosal
immunity
developing
inducing
replication
nan
nan
nan
immune
prrsv
development
response
virus
epidemics
respiratory
syndrome
among
hospitals
equine
viral
arteritis
disease
infrequently
nan
nan
influenza
h1n1
face
public
associated
hrv
strains
viruses
human
hrvs
nan
2019
ncov
bat
sequences
sars
nan
nan
cats
agp
group
serum
acid
research
osa
key
words
number
individuals
super
transmission
events
studies
blood
pandemic
reduced
influenza
impact
de
el
en
virus
los
emergency
response
evolvement
scenarios
decision
transport
diarrhea
mucosal
na
viral
nan
mouse
erythrocytes
abstract
partially
purified
medical
waste
infectious
wastes
factors
class
mhv
virus
following
infection
iv
apn
dpp
activities
ace
cf
microbiota
lung
studies
bacterial
nan
ifn
binding
assay
acts
immune
nan
sars
viral
the
coronavirus
covid
water
days
contaminated
potential
tgev
nan
binding
protein
sites
classification
pockets
replication
rna
viruses
vectors
vaccine
sars
cov
infection
patients
macaques
nan
bats
migratory
migration
temperate
tropical
ph
gradient
components
c6
classical
inhibitory
sars
cov
3clpro
phlorotannins
viral
functions
host
gene
abstract
assays
human
detection
abstract
currently
mers
rt
cov
lamp
detection
nan
biopharmaceuticals
plants
produce
recent
cost
binding
dna
fluorescence
flavonoids
the
sars
animal
coronavirus
patients
the
indomethacin
cells
replication
cyclooxygenase
hep
antibodies
monoclonal
therapeutic
may
researchers
bacteraemia
patients
mortality
mrsa
severity
nan
nan
nan
zikv
virus
model
the
2015
people
leaving
room
probabilistic
approach
nan
interferon
receptor
deficiency
mycobacterial
viral
nan
tourism
planner
planning
development
phenomenon
ibv
protein
rna
phosphorylated
the
mucosal
delivery
mucus
dealing
systems
nan
cell
clinical
recombination
mutations
phenotypes
severe
respiratory
patients
rvis
viral
tnf
mice
balb
degeneration
cd
bk
enzymes
metabolism
this
kinins
respiratory
ards
adults
viruses
viral
2019
sars
ncov
sarsr
cov
nan
one
calves
diarrhoea
enteropathogens
lesions
nan
nan
patients
cholecystectomy
biliary
stones
bile
nan
nan
model
time
varying
evolution
seirw
viruses
fever
chapter
families
ssrna
contact
pathogens
factors
human
transmission
disease
farmers
data
events
veterinary
de
la
las
health
salud
travel
travelers
management
abstract
international
scovs
sars
human
epidemic
taiwan
hcc
treatment
several
liver
prevention
sars
patients
symptoms
cases
time
hla
ifn
drb1
antibodies
alleles
nan
de
la
féline
le
cutaneous
nan
cbs
ic50
benserazide
proliferation
cell
adherence
antihypertensive
cardiovascular
patients
agents
rna
ms2
binding
proteins
protein
test
sucrose
wet
mount
lateral
this
paper
theory
high
inner
respiratory
viral
infections
wheezing
first
virus
viral
abstract
over
past
virus
administered
doses
100
mg
nan
disaster
self
emergency
medical
technicians
antibiotics
acute
otitis
media
common
sb
antiviral
ahgs
hsv
ad
nec
bacterial
may
species
pathogenic
biological
microbe
potential
weapon
pathogenic
de
des
he
est
dans
viral
proteins
propagation
ups
ubiquitination
diagnosis
fungal
based
infections
assays
research
clinical
health
well
disparities
pcr
effusions
qrt
antibody
fip
action
herbs
multiple
inflammation
mechanisms
view
obstruction
simple
premium
stakeholders
respiratory
oxygen
nosocomial
transmission
infections
nan
viral
amplification
techniques
na
infections
health
government
china
market
sector
patients
sars
acute
long
term
electrochemical
biosensors
low
amplification
biosensor
nan
firms
institutional
donate
pressure
companies
effects
new
abstract
the
year
job
satisfaction
differences
nurses
regional
breathing
dose
ventilation
results
inhalation
nan
na
d35
influenza
replication
viral
virus
conditions
middle
climatic
rh
strain
equine
coronavirus
isolated
horses
μm
side
chain
antiviral
found
nan
nan
protein
dengue
ns1
the
rns1
drug
clinical
potential
discovery
therapeutic
mice
deficient
type
stat1
ifn
lightup
probe
technology
the
stability
systemic
neurological
diseases
deficits
signs
hpv
18
11
amolimogene
16
global
health
international
law
the
mirnas
viral
viruses
cell
cells
2019
ncov
outbreak
wuhan
days
mrsa
ed
patients
hospital
bed
tpe
bearing
tetraphenylethylene
fluorescence
we
recreating
small
part
mers
virus
cells
epithelial
infection
viral
cultures
nan
antiviral
highlights
future
latest
developments
rhinitis
asthma
allergic
inflammatory
therapeutic
nan
sars
3clpro
cov
cleavage
substrates
bioterrorism
pakistan
threats
different
world
health
china
economic
equity
in
foals
disease
few
escape
gastrointestinal
nan
inhibitors
dubs
described
human
dub
molecular
techniques
use
detection
infectious
nan
ibv
mbl
chicken
rcmbl
viral
hiv
plants
the
southern
identified
1a
87
kda
protein
proteinase
infectious
detection
specific
diseases
virus
disease
host
genetic
variation
infectious
nan
bats
human
paramyxovirus
zoonotic
viruses
ibv
m41
recombination
eggs
two
anti
sars
scfv
11
cov
hrv
enteroviruses
required
clinical
primer
virus
mutant
parent
acid
influenza
nan
tgev
clpg
cs31a
fibrillae
aa
rule
modified
patients
the
nosocomial
cpg
h7n9
recombinant
cho
pelc
complement
diseases
cr1
abstract
exaggerated
tourists
number
china
tourism
the
hla
6802
6801
peptide
supertype
nan
em
virus
vc
herpes
viral
lymphoid
chemokines
tissue
multiple
sclerosis
nan
fcs
ige
serum
sera
dogs
hcmv
immediate
early
infection
drugs
virus
xmrv
xenotropic
murine
leukemia
rna
virus
detection
hybridization
biotinylated
factor
blood
plasma
immunoglobulin
this
nan
nan
papn
expression
the
coli
antibody
hrv
infections
respiratory
patients
hospitalized
ndiv
particles
ultrastructure
virus
cell
rpa
real
time
lfd
the
discovery
lrdi
treatments
medical
doses
pneumonia
elderly
remains
mortality
diseases
model
control
measures
the
hong
mscs
cells
macrophages
il
phenotype
nan
hood
infectious
the
diseases
effectively
reliability
repeated
samples
individual
among
2019
ncov
guideline
pneumonia
health
vaccination
hcp
coverage
among
seasonal
tudca
m2
influenza
er
inhibitor
nan
herds
calves
registered
use
antimicrobials
hypoplasia
clinical
the
myofibrillar
splayleg
virus
respiratory
prcv
tract
replication
neonatal
sick
cover
crias
presentation
disease
diseases
role
surveillance
control
viruses
living
in
organisms
complex
health
public
the
law
federal
nan
behaviors
mers
snss
use
information
exercise
ec
temperature
post
non
membrane
permeability
protein
cells
host
patients
ct
disease
type
features
pcr
viruses
mrt
respiratory
human
orfs
the
genome
sars
cov
ips
novel
h1n1
pandemic
infection
viral
viruses
often
associated
influenza
wildlife
parasite
one
health
triad
ifn
viral
first
replication
line
sirs
inflammatory
anti
cells
mice
nan
protein
the
gene
nsp10
sars
qce
hrvc
hrv
clinical
strain
regulation
receptors
decoys
cell
also
nan
travelers
ivs
chinese
hong
kong
potent
tylophorine
compounds
tgev
coronavirus
protein
graph
data
networks
used
nan
influenza
knowledge
level
skill
the
disease
fifth
viruses
known
contains
nan
demand
expo
forecasting
visitors
quantitative
adem
episode
we
hbv
reinfection
hbv
the
hiv
antiviral
award
nan
nan
nan
bat
populations
viruses
assays
virus
ph1n1
virus
influenza
elisa
seasonal
factors
animals
social
exposure
the
mrna
sequence
leader
junction
coronavirus
fusion
the
core
virus
proteins
nan
thnt
autoproteolysis
terminal
nucleophile
substrate
emerging
re
zoonoses
health
significant
calves
igg1
asc
brv
colostrum
particles
es
dma
virus
the
sars
cells
cov
protein
cho
genes
hcmv
lncrnas
infected
thp
middle
ear
raom
come
otitis
vlps
virus
foreign
many
structural
telemedicine
the
epidemic
situation
situations
bufcov
hku26
bcov
coronavirus
possessed
nan
viral
rna
mrna
degradation
gene
nan
bioinformatics
kde
bioscience
research
workflow
nan
emerging
vaccines
viruses
potential
the
abstract
polysubstituted
pyrimidinylphosphonic
triazinylphosphonic
acids
nan
ibv
open
reading
mrnas
three
particles
transmission
mode
virus
media
nan
mers
cov
hospital
respiratory
cluster
disease
new
virus
viruses
identify
nan
irt
diti
temperature
view
thermoguard
mutations
s3
s4
viable
virus
nan
ric
ze3
antigens
rics
zikv
virus
avian
infectious
bronchitis
diagnostic
virus
yichang
family
mesoniviridae
showed
igg
cr
fed
calves
absorption
respiratory
air
pathogens
surfaces
hajj
cells
2m
compound
cancer
nmr
with
second
highest
number
coronavirus
anxiety
sleep
quality
intervention
statistically
nan
protein
structural
cys
coronaviruses
we
di
orf
rna
rnas
viral
crcov
protein
bovine
including
4182
pedv
field
vaccine
rflp
isolates
stochastic
model
solution
abstract
in
nan
blood
reconstituted
fresh
whole
bypass
hand
care
health
hygiene
worldwide
systems
several
public
digital
data
bcx4430
virus
infections
viral
rna
system
epr
web
applications
display
hcov
nl63
phylogenetic
respiratory
patients
pyrazole
the
chemistry
synthesis
mentioned
lamp
histolytica
assay
the
dna
labour
geography
editorial
issue
important
dry
lot
cow
calves
cows
b0at1
ace2
hartnup
intestine
collectrin
nec
cases
nov
control
outbreak
nan
sars
cov
lipid
rafts
entry
spaceflight
indigotica
derivative
different
condition
savs
capsid
canine
nt
bari
antibody
detection
the
sars
monoclonal
potential
clinical
abstract
the
notion
health
care
mers
cov
transmission
nan
covid
19
cfr
coronavirus
china
nan
protein
sars
cells
cov
immune
tα1
peptide
production
increasing
this
vre
2005
patients
hospital
cases
we
different
nanostructures
assays
using
nan
viral
drugs
imaging
antibodies
infections
china
coronaviruses
outbreaks
syndrome
sars
contaminants
etc
waw
various
production
nan
nan
sars
infectious
disease
analyses
the
rotavirus
infection
adults
common
gastroenteritis
nan
disease
two
pulse
vaccination
thresholds
nan
protein
lipid
bilayer
chains
surface
nurses
front
line
covid
19
strategies
based
immune
infectious
diseases
nan
shedding
cats
virus
fecv
months
transmission
human
diseases
animal
zoonotic
pcr
feline
il
the
cytokine
tlr3
dsrna
molecules
expression
poly
disease
cirdc
pathogens
often
clinical
nan
sars
epitopes
protein
cov
cell
infection
air
risk
higher
transmission
cells
sars
protein
like
expression
nan
mucosal
vaccine
delivery
vaccines
oral
mouse
musculus
europe
laboratory
mice
gene
trtv
sequence
mrnas
using
nan
dlepv
the
wasp
fly
protein
sites
protein
ibv
linked
glycosylation
antiviral
agents
coumarins
lead
discovery
nan
wastewater
virus
treatment
removal
the
sequence
amino
acid
hcv
cdnas
nan
analysis
structure
prediction
computational
rna
human
hcov
cov
coronaviruses
including
immune
thrombocytopenia
itp
secondary
virus
prrsv
cell
c1
apoptosis
nsp4
nan
copd
bacteria
patients
microorganisms
airways
endemic
disease
model
number
state
calves
life
variation
mr
period
screening
spread
covid
19
traveller
a16
cv
neutralizing
assay
neutralization
nursing
study
students
identity
sars
tgev
pigs
virus
prcv
challenge
nan
ra
bal
patients
fluid
biomolecules
patients
severe
critical
the
ct
infectious
disease
diseases
world
issues
rabv
expression
viral
n580
n796
nan
air
quality
influenza
like
illness
nan
mers
cov
the
protein
neutralizing
nan
ifn
diseases
infections
feline
animals
8b
8a
8ab
sars
cov
rubella
il
snps
virus
specific
proteins
three
polymerase
complexes
complex
nan
hospitals
mobile
sars
practices
teams
gm
neurological
like
disease
sclerosis
pap
surfactant
alveolar
genes
oas1
issues
chapter
security
travel
transportation
nan
feeding
milk
day
kid
fed
orf1a
the
229e
orf1b
hcv
2019
ncov
cases
reported
different
samples
positive
adenovirus
viruses
waters
vaccines
mononegaviruses
viral
recombinant
viruses
m826
h7n9
ha
virus
antibody
cancer
patients
covid
19
comment
nan
nan
the
precautionary
measures
sars
study
phtr
health
public
travel
individuals
human
diarrhea
animal
virus
rotaviruses
subgenomic
mrnas
ldv
infected
rna
hcov
infection
children
oc43
nl63
human
virus
functional
genomics
cell
dogs
oocysts
caninum
sporulated
infection
orf
proteins
ldv
vp
native
nan
ace2
ras
angiotensin
the
acute
pneumonia
lung
children
ultrasound
clinical
rna
fragments
complex
70
oc
en
de
las
la
los
mrv
brv
gene
vivo
observed
nan
bieneusi
cryptosporidium
spp
peafowl
prevalence
pneumonia
viral
community
acquired
viruses
uris
rv
children
detected
sinusitis
asthma
respiratory
exacerbations
viruses
control
filmarray
respiratory
patients
testing
sofia
nan
evd
the
drc
health
one
patients
scap
the
common
severe
virus
mice
antibody
antibodies
directed
rt
the
fcov
lamp
npcr
nan
nan
sg
the
two
encoded
proteins
ompa
lacvax
shigellosis
lactis
the
industry
news
abstract
in
last
different
consider
dynamics
community
short
transmission
mers
cov
cross
host
unknown
ebv
adenoid
old
tonsil
tissue
nmr
activity
4m
found
virus
visibility
energy
air
hong
kong
nan
nan
cleavage
sites
mers
cov
canonical
mask
user
seal
check
test
nan
impact
disease
sars
infectious
management
pedv
virulent
strain
cv777
vaccine
im
cmv
patients
ebv
model
sars
annexin
a2
antibodies
s2
nan
hiv
ifitms
proteins
expression
viral
tim
mtim
the
binding
domain
infected
cells
prrsv
ms
protein
hepatitis
virus
mild
available
in
libraries
antigen
used
fragment
antigens
nan
2019
ncov
proteins
the
coronavirus
nan
dna
sting
responses
identification
sensing
pathogens
the
pcr
screening
microarrays
virus
esk
medium
cytopathic
effect
rv
rt
siba
rhinovirus
diagnosis
nan
cbp
nsp1
response
viral
ifn
fmd
vaccination
virus
mda
disease
recombination
the
rna
system
φ6
pdd
disease
abv
dilatation
psittacines
nan
nan
prv
cholesterol
virus
entry
depletion
emerging
viral
surveillance
genomics
disease
hp
the
tgev
vitro
amino
viruses
emerging
laboratory
infection
handling
nan
nan
nan
nan
nan
sars
patients
bmd
mg
normal
wildlife
urbanization
urban
human
cities
nan
de
la
en
los
series
glucoside
the
apigenin
quercetin
liquid
nan
ubiquitin
synthetic
methods
the
post
prrsv
terminal
eav
virus
kb
duty
care
abstract
this
chapter
sg
the
promoter
models
work
multiplex
rt
pcr
viruses
hemi
cvb3
infection
children
pre
school
viral
lncrnas
host
response
infections
ibs
form
replication
pi4p
strand
nurseries
eleven
patients
disease
tested
housing
scheme
public
marking
neighbourhood
activity
hiv
dna
thiophosphonomethoxy
adenine
mers
cov
kit
respiratory
rt
liquorice
in
different
europe
ancient
proteins
golgi
targeting
membrane
protein
gastrointestinal
tract
liver
important
clinical
nan
nan
lncrnas
cellular
virus
several
abstract
law
public
health
teaching
subject
nan
nan
the
chemical
hazards
reaction
reactive
macrophages
fmdv
hpi
replication
regulation
airway
tonsils
adenoids
obstruction
virus
rhinovirus
elisa
specific
antibody
assay
beds
icu
benefits
population
mortality
exercise
peak
cpet
limitation
days
cats
organism
cem
challenge
infection
infectious
disease
control
prevention
transmission
diarrhoea
iii
bonov
samples
the
imnv
indonesian
sequences
collected
vannamei
ms
at
present
time
cause
tick
borne
emerging
human
species
infectious
clinical
toward
molecular
biological
ibv
ck
ch
js
tahy
ae
literature
hlct
abstract
disease
cpp
assay
novel
water
polysaccharide
covid
19
rapidly
spreading
around
dls
fuzzy
rough
knowledge
reasoning
nan
nan
sars
proteinase
protease
virus
main
isolates
expression
oprd
resistance
mechanisms
utilization
diseases
care
disease
categories
nan
sars
hrct
metapneumovirus
patients
features
nan
amplification
based
non
pcr
technologies
mjltl2
shrimp
domain
in
hemocytes
sars
coronaviruses
research
coronavirus
series
nan
sars
the
cov
outbreak
kaohsiung
ibv
taiwan
attenuated
strain
chicks
h5n1
adenovirus
abstract
since
1997
pneumonia
atypical
used
describe
unusual
camels
blood
molecular
studies
animals
disease
dairy
calf
the
mortality
fecal
score
canine
puppies
age
data
sequence
knowledge
localization
sites
nan
nan
coiled
positions
repeat
nonpolar
side
nan
biosensor
application
applications
medical
biosensors
respiratory
multiplex
community
acquired
acute
ev71
3ab
activity
rna
protein
mers
cov
waterpipe
saudi
arabia
feature
classification
syndromic
surveillance
news
htv
brv
he
torovirus
sera
nan
infection
cells
sars
cov
vero
3cpro
inhibitors
hav
3c
proteinase
nan
paper
an
amendment
published
accessed
nan
medicine
chinese
tcm
hiv
aids
community
risk
home
difficile
strains
networks
network
contact
epidemic
properties
nan
gp33
vp1
ctl
vlps
response
airborne
bacteria
transmission
coli
tracer
pneumonia
afebrile
clinical
pneumonitis
infants
gene
protein
production
mammalian
cells
des
virus
la
une
par
management
china
disaster
system
emergency
rt
lamp
ibv
assay
virus
nan
ventilation
isolation
rooms
virus
room
mrsa
patients
period
infection
intubated
nan
hcws
cholera
emergency
response
years
nan
rti
cause
children
respiratory
leading
smart
software
could
predict
next
quantitation
radix
isatidis
detection
fingerprinting
il
children
severity
concentrations
day
corticosteroids
clinical
dose
treatment
patients
protein
orf2
isolates
gs
the
noroviruses
farms
michigan
wisconsin
bovine
replication
cyclophilin
hcov
immunosuppressive
interaction
fip
disease
virus
feline
cats
vaccine
pneumoniae
self
vaccines
epitope
nia
protease
recombinant
ppv
proteins
lncrnas
immunology
activation
immune
cell
nan
nan
nan
nan
53
ergic
arenavirus
required
propagation
viral
emerging
diseases
antiviral
bsaas
protein
granch
sequences
techniques
proteins
calpain
cvb3
mouse
vmc
treatment
nan
polymerase
chain
reaction
amplification
reverse
patient
trials
reported
outcome
clinical
domain
membrane
amino
terminal
signal
media
spokespersons
in
interviews
health
nan
de
13
le
et
ei
mps
virus
hcws
rna
used
polysaccharide
microarray
burkholderia
pseudomallei
mallei
the
iberian
lynx
lymphoid
feline
antimicrobial
respirators
ms2
coupons
control
viral
proteins
antibodies
sds
epitopes
insulin
transgenic
interferon
gamma
cells
markers
medicinal
plants
species
diseases
los
las
de
en
virus
biological
warfare
organisms
abstract
the
de
virus
infections
la
et
carnation
virus
viruses
cerv
tissues
molecular
tests
diagnostics
detection
identification
nan
we
effect
investor
news
companies
pdcov
protein
neutralizing
ctd
infection
gene
expression
microarray
genes
the
hiv
recombinant
vsv
anti
envelope
gene
coronavirus
foreign
genes
inserted
dif
testing
specimens
postmortem
positive
md
mayv
the
structural
nmr
nan
fip
three
cats
treated
polyprenyl
children
hmpv
rsv
virus
lrtis
protein
virus
assembly
particles
we
rsv
cell
nbreg
cells
respiratory
jhm
mhv
replicase
orf1a
processed
antivirals
compounds
antiviral
viral
development
viral
avian
flu
drugs
could
emergence
included
among
many
current
genes
the
rhabdoviruses
cell
diverse
cov
sars
respiratory
development
coronavirus
unknown
phosphate
analogues
biological
lack
prodrugs
adcml
surface
proteins
expressed
viral
gag
hiv
pol
proteolytic
proteins
infectious
travelers
diseases
tropical
infections
earthquake
depression
adolescent
the
growth
2019
ncov
haplotype
network
hap_011
mhv
ifn
cells
treatment
viral
nan
epidemic
individual
based
linkage
model
pneumonia
chest
ct
patients
visualized
dental
infection
knowledge
patients
level
control
healthcare
associated
infections
dynamics
assay
virus
tgev
pedv
diarrhea
prrsv
rafts
viral
lipid
raft
nan
calves
ntz
group
therapeutic
oocyst
nan
bcov
assay
rt
pcr
the
nan
countries
health
public
developing
potential
stx2
igy
stx2b
the
egg
nan
gp
antibodies
neutralizing
human
survivors
care
nursing
professional
standards
adapting
nan
sdav
amino
acid
protein
mhv
lung
exposure
toxicants
following
inhalation
viruses
isolates
hong
kong
adamantane
cells
cell
ace
lung
reduced
ev
recombinant
type
pig
feces
fagp
feline
hyposialylated
pathological
cats
sars
cov
animal
immunodominant
proteins
nan
hand
hygiene
attitude
practice
nursing
nan
virus
assays
respiratory
influenza
syncytial
the
affinity
measured
spr
fold
geranylated
catalpifolia
anti
cells
study
2019
ncov
cep
coronavirus
infection
nan
interferon
alfacon1
sars
cov
antiviral
angiogenesis
angiogenic
anti
process
pro
nan
ms
cells
cd4
role
pathogenesis
patients
human
cells
specific
hiv
nk
cells
melanoma
target
cmc
new
vaccines
traditional
viral
incidences
incident
outbreak
chapter
case
incidents
nan
nhap
aps
antibiotics
patients
pathogens
cells
mice
15
jhmv
cns
hsv
lamp
the
assay
tested
particles
technologies
virus
time
providing
references
internet
95
ci
we
the
asp
cows
fms
calving
rsv
childcare
illnesses
respiratory
children
de
les
le
la
des
hbov
respiratory
tract
worldwide
the
bacteria
sputum
lower
respiratory
abstract
stochastic
vaccination
transmission
system
abstract
affinity
abstract
although
often
exploited
drugs
hepatitis
treatment
antiviral
viral
air
filtration
news
abstract
sales
virus
immunodeficiency
fiv
infection
host
coronavirus
mers
sars
middle
east
vaccines
vaccine
materials
adjuvants
abstract
children
hcovs
gastroenteritis
cases
hcov
difficile
calves
pcr
toxins
inoculated
bovine
pathogens
bacteria
virus
viral
protein
nsp3
proteins
sars
cov
colostrum
management
important
health
calves
proteins
protein
infection
related
cellular
viruses
found
bacteria
children
samples
brd
pathogenesis
role
pathogens
abstract
nan
influenza
vaccination
or
h1n1
hk
nan
coronavirus
tgev
protein
cells
ef1a
sads
cov
ifn
swine
acute
tpcs
drugs
approved
ebola
pore
nan
nan
ccv
tgev
virus
neutralizing
titres
nl63
acid
hcov
ic50
anti
nan
humans
earth
changing
living
systems
ligand
approaches
structure
based
interaction
enzyme
the
mutants
quaternary
structure
cath
rmwts
patients
wait
capacity
sars
ptsd
survivors
post
the
grundfos
foundation
million
as
part
il
viremia
sc
plasma
levels
cells
sars
disease
pathogenesis
immune
pdcov
strains
henan
diarrhea
samples
motor
cat
disease
limbs
tetraparesis
nan
brsv
igg1
igm
herds
samples
nan
disease
abstract
still
regarded
major
nan
sars
cov
health
pneumonia
coronavirus
rotavirus
calf
diarrhoea
genotypes
study
influenza
respiratory
viruses
virus
ian
nan
nan
nan
nan
dogs
respiratory
cai
hai
cirdc
sars
cov
sequences
2020
betacov
nan
somni
bovine
extracellular
neutrophils
traps
niv
gfp
neutralization
test
using
mbr
wastewater
in
hospital
microorganism
food
safety
events
impact
firms
pla2
spla2s
roles
biological
enzymes
particles
like
virus
parvovirus
haemagglutination
data
disease
outbreak
we
epigro
mucosal
nasal
iga
psaa
lactobacillus
virus
pathogenesis
viruses
chapter
cell
ifn
type
irf
co
stat1
species
transmission
host
viral
fiv
toll
responses
il
adapter
tlr3
nan
he
isav
esterase
receptor
binding
ribavirin
porcine
nidovirus
replication
virus
gp
ebola
the
structure
trimeric
nan
elisa
iha
cft
antibodies
sera
respiratory
viruses
immunofluorescent
abstract
the
pathogen
discovery
clinical
including
novel
nan
mhv
a59
nucleotide
homology
human
vaccines
mmmsc
cbpp
disease
mycoides
pentoxifylline
jev
50
antiviral
activity
nan
endothelial
aeca
systemic
autoantibodies
pathogenic
the
january
medications
symptoms
clinic
virus
sars
science
airborne
monitoring
china
2019
severe
acute
respiratory
cubic
cellular
viral
virus
membranes
calves
pens
bw
block
per
ec50
μm
antiviral
si
activity
granulomatous
lesions
granulomas
seen
types
nan
btov
samples
cattle
231
reported
viruses
adapted
er
stress
immune
sias
cells
many
different
surfaces
ifn
genes
upregulated
sars
cov
the
intestinal
pigs
naturally
infected
650
s450
protein
sars
β6
nan
nan
2b
prrsv
protein
virion
virus
nan
nan
manure
swine
pathogens
health
application
chickens
h4n6
lpaiv
infection
kul01
homocarbovir
epi
homoabacavir
abstract
carbocyclic
early
warning
based
infectious
diseases
cov
mers
animal
emerging
pathogens
relaxin
pregnancy
pregnant
females
diagnostic
data
social
new
big
mining
cirdc
canine
pathogens
dogs
respiratory
gondii
cat
sand
found
old
giardia
cryptosporidium
recreational
horses
trails
nan
nan
pip
binding
3c
proteins
using
sars
de
respiratory
le
la
nan
codon
usage
bias
cytosine
deamination
nan
article
infectious
diseases
bacterial
common
cells
12
activates
promotes
viral
rna
kda
viral
vitro
an
isg15
function
host
infection
known
nan
calves
diarrhea
bacteria
eaea
strains
epidemic
formula
see
text
japan
virus
mva
vector
system
development
nan
chemical
the
reaction
safety
reactive
dna
flow
channel
target
hybridization
nan
sars
emopd
patients
infection
control
prediction
elispot
assays
binding
software
vaccine
ebv
gp350
major
the
schizophrenia
new
brain
gut
review
years
cats
feline
fip
remission
isolates
acanthamoeba
air
conditioners
malaysia
ck
ch
isolates
ibv
lhb
nan
protein
applications
interactions
abstract
chips
hamster
syrian
we
transcripts
data
pmws
pigs
the
lymphoid
lesions
nan
nan
eav
elisa
equine
recombinant
antigen
infection
cultures
viral
glial
cells
nan
care
health
risk
clinicians
respond
virus
receptor
host
based
infection
gp
ebov
hpiv3
vaccine
titers
cov
protein
covs
immune
sars
nursing
professionalism
intention
stress
experience
rotavirus
antibodies
calves
igm
antibody
nan
lccs
study
carriers
aviation
industries
nan
health
human
animal
we
diseases
dogs
samples
cecov
positive
type
treatment
acute
sinusitis
glabra
day
lactis
llo
monocytogenes
strains
vaccine
infectious
resistance
antimicrobial
diseases
ivig
cpv2c
cpv2a
cpv2b
argentine
population
domain
swapping
sbms
protein
symmetrized
ferret
kits
staphylococcus
positive
bacteria
waste
infectious
management
materials
medical
pcr
rt
immunochromatographic
strip
virus
nan
caninum
bats
domestic
hosts
serve
vee
virus
domain
region
nonstructural
er
upr
protein
coronavirus
stress
hcw
isolation
wbf
observation
data
may
while
coronavirus
death
rate
apn
identified
exon
variations
intron3
nan
bamg
bladder
response
electrical
months
standard
precautions
nursing
knowledge
online
nan
rna
fcov
genomic
sequence
c1je
mafa
alleles
drb
dqb1
30
ish
virus
volunteers
14
isolation
nan
rt
lamp
rna
solution
influenza
cats
henselae
neurological
disease
titer
a9
tgev
virus
replication
p38
preventive
high
behavior
001
the
facemasks
masks
respirators
reuse
use
nan
respiratory
this
virus
early
study
assays
amplification
testing
respiratory
nucleic
adjuvant
inulin
advax
delta
adjuvants
assays
three
samples
two
respiratory
localization
sars
nucleolar
cytoplasm
the
public
health
healthcare
system
china
surface
virus
carbohydrate
important
viruses
nan
genes
replication
host
response
methylation
nan
viruses
treatment
sewage
conventional
human
the
method
new
sequences
measure
nan
03
virus
humans
animals
mrv
science
interest
tourism
studies
new
virus
viruses
intracellular
entry
cells
viruses
enteric
disease
route
entry
hiv
syphilis
gay
sex
saunas
nan
prrsv
mir
infection
26a
mirnas
american
nurse
disasters
made
leaders
protein
ectodomain
glycosylation
ibv
coronavirus
pcr
sars
assays
cov
epidemic
indole
drugs
structure
compounds
antiviral
orf1a
the
tgev
orf1b
virus
nan
nan
hcmv
patients
disease
autoantibodies
cd13
respiratory
clinical
middle
east
syndrome
epidemics
networks
mitigation
severity
infection
care
infection
special
intensive
team
nan
nan
viruses
sialic
acid
receptors
structural
nan
aquaculture
animal
food
protein
farming
development
researchers
abstract
the
emergence
proteins
sars
accessory
the
virus
dromedary
mers
cov
infection
vaccination
infection
porpv
swh1n1
pigs
infected
host
cells
the
interactions
virus
nan
cov
receptor
rbd
the
proteins
respiratory
syndrome
coronavirus
disease
2019
jev
infection
chemokines
inflammatory
cns
nan
rmv
gag
responses
vaccine
specific
h7
vlps
tm
h7n9
in
nan
nan
nan
hap
rvs
patients
mpcr
hospital
leader
trypanosome
mrnas
sequence
containing
nan
pcr
intestinalis
foetus
mt
assay
cells
therapeutic
biomaterials
well
solid
pcr
pathogens
genetic
known
methods
pedv
virus
peptide
porcine
infection
crcov
pcr
assay
respiratory
coronavirus
viral
membranotropic
peptides
used
many
calves
mesenteric
lymphocytes
virulent
ctl
nan
nan
hcv
the
rna
replication
therapy
travel
outbreak
cases
95
covid
nan
age
calves
cryptosporidium
days
30
ribavirin
be
literature
approval
immediate
enzyme
analyte
assay
sandwich
elisa
hcov
virus
hospital
surfaces
oc43
19
covid
current
spread
countries
sars
cov
model
3c
like
nan
nan
mers
cov
translocation
endolysosomal
system
ndv
fusion
cells
cell
ph
nan
activities
plant
creosote
bush
lignans
rna
viruses
stranded
gc
coding
bicp27
nucleolus
nls
nols
eyfp
ifn
liposome
mice
lip
encapsulation
nan
abstract
thousands
french
researchers
joining
nan
mers
cov
rla
camels
respiratory
hydroxy
antimicrobial
the
complexes
coumarin
vaccines
delivery
vaccine
effective
animal
softbills
drug
using
complicated
choice
nan
nan
nan
nan
one
cases
ade
observed
possible
pedv
3clpro
substrate
3clpros
genus
emergency
management
systems
efforts
knowledge
model
biological
public
health
international
heart
transplantation
therapy
patients
failure
disease
outbreak
19
as
covid
cats
group
gondii
samples
antibodies
isolation
hospital
audit
beds
infection
protein
packaging
rna
signal
sars
nan
infection
cns
barrier
structures
resident
epidemic
outbreaks
sc
disruption
term
cds
delivery
gene
use
drug
reactive
herbal
metabolites
toxicity
proteins
electric
two
wheelers
urban
environmental
macrophages
different
macrophage
phenotypes
diseases
sinupret
antiviral
activity
virus
respiratory
nan
peptides
mice
hcv
ctl
immunized
cov
sars
viral
nsp1
the
influenza
the
avian
virus
aiv
rna
elements
genome
cis
acting
calves
lesions
ehec
two
the
hbov
respiratory
summary
human
bocavirus
nan
nan
nan
trna
knowledge
structure
like
also
coronavirus
china
2019
novel
first
nan
lonicera
species
used
flj
its
nan
serum
diagnostic
options
specimen
types
ifnα
tgev
cells
virus
secretion
diagnostic
studies
methods
clinical
the
respiratory
failure
mortality
transplantation
patient
protein
terminal
import
nuclear
coronavirus
human
emerge
pathogens
cause
new
il
children
10
rsv
regulatory
the
fatigue
il
symptom
allele
de
la
el
por
diarrea
retinal
mice
phase
inflammation
coronavirus
sars
wb
elisa
positive
s2
diseases
disease
infectious
cattle
population
nan
blood
cortisol
acth
immunization
the
tea
anti
different
polyphenols
antimicrobial
patients
2019
ncov
pneumonia
11
abstract
in
presence
infectious
diseases
modifications
group
well
antimalarial
primaquine
nan
nan
influenza
viruses
two
like
virus
nan
strain
synthesis
purdue
115
52
nan
la
de
las
el
bronquiolitis
hepatitis
associated
viruses
liver
overview
research
new
develop
order
emerging
covs
conserved
group
hairpins
coronavirus
occur
talus
treatment
earlier
stage
nan
rna
faecal
samples
fcov
rt
nan
knowledge
multiple
experts
systems
domain
the
enzymes
chapter
coronavirus
like
china
health
global
medical
control
circrnas
infection
pedv
circrna
the
nan
outbreak
coronavirus
2019
information
this
gene
barriers
vectors
therapy
overcome
ehv
cells
equine
derm
enters
2013
the
h7n9
virus
hong
animal
infectious
impulsive
diseases
health
inflammasome
lung
respiratory
activation
role
the
dairy
parlour
human
farm
nan
coronavirus
bat
novel
human
betacoronavirus
translation
amino
mutated
probability
acid
genetic
human
susceptibility
studies
evidence
vlps
vaccines
virus
field
veterinary
7b
proteins
mabs
protein
expressed
the
units
building
wind
transmission
nan
domain
nsp3
domains
cov
coronavirus
vesicles
transition
endoplasmic
situ
transitional
mva
virus
vaccinia
vaccine
vector
a1
hnrnp
protein
sars_n
binding
nan
nan
nan
milk
immune
igs
antibodies
colostrum
respiratory
detection
amplification
nucleic
acid
ag
silver
tgev
nm
infection
nan
recombination
viruses
dna
rna
genetic
students
learning
scientific
sts
unit
me
organosulfurs
functions
murine
immune
nan
nk
cells
infection
cell
receptors
nan
viral
disease
viruses
may
composition
r0
daily
cases
covid
19
nan
dose
serotherapy
viral
gvhd
low
preanalytical
veterinary
error
synovial
fluid
nan
testing
cartridge
based
molecular
filmarray
nan
nan
les
et
de
un
patients
bacterial
bacteria
communities
gut
the
siv
prrsv
infection
virus
infections
screening
ps
new
libraries
vs
coevolution
spreading
the
mechanisms
epidemic
the
epitopes
expression
pex
polyclonal
viruses
biotechnology
applications
genetic
material
compounds
chinese
respiratory
2019
used
nan
china
taiwan
chinese
economic
greater
3clpro
sars
cov
assays
development
the
heart
rate
health
monitoring
nan
model
the
infectious
classes
one
rna
kb
anti
abstract
purified
h1n1
influenza
ha
84
epitopes
viral
infection
infections
immune
common
cells
il10
cd8
ifng
gc
protein
the
amino
m42
two
viral
functions
host
gene
abstract
hadv
330
children
arti
clinical
criteria
in
design
the
example
rhinovirus
colds
common
many
disease
nan
nan
cd8
cells
hla
0201
sars
nan
ccov
strains
iib
samples
one
mechanisms
human
understanding
cellular
membrane
cystatins
inhibitors
role
cancer
important
sars
nucleocapsid
cov
protein
ssdna
the
mci
patient
care
casualties
public
government
also
outbreak
2019
mv
hu191
vaccine
strain
rmv
incidence
tb
the
model
china
rotavirus
diagnosis
incidence
children
years
col
d7
calves
μl
colostrum
hmpv
respiratory
infections
children
infection
cells
virus
infection
brain
present
nan
virus
infection
results
outcomes
variability
nan
nan
benzotriazole
inhibitors
the
mpro
sars
cats
thrombocytopenia
immune
mediated
platelet
nanomechanical
sensors
time
applications
volume
nan
the
siv
immunoassay
detection
assay
filters
viruses
air
virus
presence
infection
hospital
emergency
management
prevention
rna
viruses
virus
outbreak
coronavirus
media
risk
legacy
social
perceptions
patients
group
interferon
response
hcv
schedules
nurses
nursing
needs
weeks
nan
innate
mechanisms
antiviral
barriers
infections
cck
administration
μg
in
the
la
hmgb1
de
dans
protéine
cells
cat
bone
marrow
atypical
exosomes
cells
diseases
various
therapeutic
health
countries
conflict
region
affected
nan
nan
sars
the
s1b
cov
mutation
nan
pflc
method
in
proteins
biotechnology
serovars
leptospiral
cross
reactivity
burgdorferi
nan
viruses
organisms
host
classification
biological
nan
protein
viral
hepatitis
new
clotting
bacterial
dna
new
studies
bacteria
cepi
vaccine
development
equitable
access
the
novel
coronavirus
emerged
wuhan
nan
pkr
csfv
swine
protein
viral
se
understanding
chicken
chickens
current
poultry
diseases
article
avian
impact
nan
hrv
viruses
cf
exacerbation
detected
emergency
skill
skills
health
response
the
sensors
sensor
response
coverage
blood
virus
transfusion
hepatitis
poland
virus
samples
purified
gel
gc
848
inactivated
vaccine
ibv
live
nan
cells
virus
rotavirus
showed
microvilli
quasispecies
viruses
evolution
rna
in
nan
health
diseases
international
communicable
global
nan
herds
hm
calves
the
herd
nan
coronavirus
fecv
sequences
nucleocapsid
ece
rna
viral
protein
families
bunyaviridae
adenovirus
transplant
lung
recipients
plasma
pedv
proteins
infected
vero
e6
coronavirus
2019
severe
patients
respiratory
respiratory
swabs
study
self
nasal
autophagy
immune
process
evidence
recent
emodin
cancer
low
effects
potential
gwass
studies
complex
diseases
traits
respiratory
disease
inhalation
tract
diseases
virus
blood
transmitted
agents
emerging
cellular
viruses
control
this
pi3k
nan
virus
rbtov
trout
rainbow
the
mscs
cells
lung
chicken
avian
quarantine
infection
review
psychological
included
astroviruses
human
tests
astrovirus
cause
sera
the
neutralization
elisa
foals
who
information
people
misinformation
covid
nan
infection
hrv
co
hbov1
severe
the
strains
real
time
pcr
wheezing
ige
rhinovirus
children
titers
host
innate
immune
responses
tlrs
the
dfict
novel
test
gold
nan
unknown
nan
mita
pathogens
studies
innate
immune
env
cysteines
804
811
815
host
viral
infection
disease
may
the
intervention
children
nurseries
toys
propagation
virus
cells
viral
in
macrophage
microglia
cells
class
isolated
pancreas
human
spontaneous
veterinary
species
cells
ray
microscopy
virus
vacv
anti
iso
hiv
sulfur
compounds
nan
nan
mmp
distemper
mmps
dogs
leukoencephalitis
nan
baculoviruses
vivo
gene
therapy
transduction
space
housing
shared
private
study
the
method
early
methods
coverage
nan
nan
nan
emodin
revandchinone
anti
rhubarb
anthraquinone
de
hbov
patients
el
en
tobacco
control
asia
region
who
nan
influenza
pandemic
duty
treat
case
vaccines
mucosal
dna
pulmonary
application
experimental
offspring
calves
control
specific
crv
infections
virus
may
patients
sars
protein
3a
cov
cells
rotavirus
showed
elisa
test
monoclonal
cell
virus
lines
persistent
infections
cov
plpro
mers
activity
viral
nan
clinical
simulation
new
this
role
isatidis
radix
virus
influenza
epiprogoitrin
hubei
residents
trying
stay
positive
nan
extracts
anti
the
inflammatory
sfe
solution
ph
nsp7
structures
the
viral
d85
mutant
liver
infection
mers
cov
infection
cases
health
tcb
community
etcb
hospitals
enhanced
study
university
students
mers
this
ebi3
virus
il
mice
cytokines
nan
nan
future
discoveries
likely
made
morphologists
chapter
viruses
describes
food
the
oral
pex
treatment
antibiotics
antibiotic
nan
mammals
china
intermediate
monitoring
confirmed
nan
sp600125
virus
viral
inhibitor
jnk1
host
hosts
codon
usage
bstvs
bvdv
infections
pi
vaccinations
role
model
bioterrorist
presented
attack
panic
exacerbations
bronchiectasis
viruses
patients
virus
pylori
infection
hospital
direct
patient
influenza
risk
fatality
disease
h7n9
igy
mice
typhimurium
groups
specific
death
disorders
found
associated
due
animals
infection
infected
leishmania
intravenously
data
farm
calf
level
management
insurance
smthes
risk
uptake
concerns
2009
h1n1
virus
swine
influenza
nan
viral
cov
lung
infection
lesions
non
contact
apparatus
the
high
respiratory
infection
hcws
wearing
mask
nan
common
respiratory
viral
infections
also
hospital
acquired
infections
neonates
care
genomic
mers
cov
sub
respiratory
patients
sars
we
findings
disease
offspring
immune
larvae
significantly
genes
nan
stress
care
trauma
level
war
eado
derivative
activity
virus
ec50
nan
from
symptoms
fatality
rate
stockpiling
disaster
response
icps
infection
control
nan
ngs
viral
rt
pcr
pathogens
tlr4
specific
breed
diseases
polymorphisms
synthesis
propargylated
isatin
chloroquinoline
conjugates
pcr
rt
real
time
internal
nan
ev
et
pcr
de
infections
severe
pneumonia
tem
patients
tests
ir
hematopoietic
mice
effects
system
the
infectious
bronchitis
virus
middle
type
ifn
immune
virus
host
nan
cattle
infectious
transmission
evidence
supporting
calls
respiratory
nhs
direct
variation
tourism
demand
inbound
this
paper
gp5
the
prrsv
gp4
proteins
surveillance
nvhap
patients
ci
99
pcr
rt
sars
rna
extraction
ag
126
new
world
alphaviruses
virus
sendai
tlr4
respiratory
rsv
pathogens
microorganisms
pathogenic
the
repertoire
nan
inhibitor
inhibitors
the
active
gi
nan
envelope
bvs
em
bv
spikes
rats
virus
days
infection
amphetamine
respiratory
nl63
influenza
human
tract
two
governance
sars
political
tourism
immunogenicity
regulatory
cell
epitopes
screening
defensins
antiviral
defensin
viral
activity
tmv
recombinants
foreign
fused
susceptible
dengue
travellers
fever
df
risk
the
cases
wuhan
hubei
number
nan
textiles
medical
disposable
reusable
infectious
safety
framework
immunotoxicity
evaluation
pharmaceuticals
antibacterial
materials
bioactive
properties
infection
patients
disease
liver
healthcare
medical
revitalisation
industrial
policy
it
hong
nan
ig
cells
bovine
con
anti
cryptosporidiosis
cryptosporidium
species
economic
disease
cases
electron
microscopy
survey
elisa
nuclear
rna
nucleus
proteins
viruses
health
global
human
security
the
nan
rats
disease
resistance
cellular
cns
pec
virucidal
br
the
pc
diseases
viruses
cause
animals
humans
nan
cats
vaccinated
ccv
dose
weeks
hygiene
hand
community
the
id
retroviral
effective
replication
viral
csfv
nan
fiv
porcine
vectors
well
pig
respiratory
mpcr
infections
pediatric
march
cells
epitopes
cd8
restricted
jhm
protein
glycan
flexibility
glycans
molecular
vaccines
immune
new
given
system
nan
nan
nan
hospital
personnel
symptoms
exposed
unexposed
slev
assay
reaction
eeev
strains
nan
cells
cxcl13
cns
humoral
responses
bmem
asc
cns
cells
stimulation
the
following
highlights
summarize
research
assay
samples
human
enterovirus
parechovirus
2019
public
health
ncov
currently
office
policy
research
making
harm
3c
the
vitro
macrocyclic
inhibitor
cells
dcs
family
dc
subsets
rdrp
mabs
coronavirus
rna
replication
sars
3clpro
cov
protease
activity
nan
substrate
mpro
dimerization
r298a
binding
nan
cooperation
harmonisation
important
this
current
pathogens
diseases
emerging
disease
we
nan
nan
cell
oiv
infection
activation
loss
alrti
viruses
respiratory
agents
pneumoniae
family
digoxin
reduced
increased
the
surface
sampling
viruses
acute
gastroenteritis
produce
fresh
sources
pathogens
survival
ca2
naadp
evoked
system
inhibition
zinc
immune
ageing
infections
may
children
rsv
hmpv
viral
respiratory
nan
persistence
mouse
virus
cells
oligodendrocytes
ei
sources
entries
disease
phe
nan
tourism
hsr
china
applied
spain
asthma
the
exacerbations
study
psychosocial
de
la
las
que
infecciones
cepi
global
disease
early
activities
acute
nippv
arf
eti
patients
surveillance
health
public
syndromic
response
blood
transfusion
transplantation
may
infectious
cov
sars
coronavirus
incubation
time
influenza
virus
genetic
studies
human
cases
epidemic
outbreak
spot
date
rna
cell
rhs
retroviruses
viruses
nl63
specific
detection
assay
pcr
disease
model
population
models
individuals
viruses
bativs
bat
influenza
ha
hbv
compound
cells
the
hepg
gapdh
expression
glycolytic
two
isoforms
nan
dogs
adult
elderly
t400
diet
egfr
cells
mutant
lung
ace2
model
particle
hybrid
the
time
nan
rna
kb
rnas
cymv
kda
nan
nan
viruses
cmvs
herpes
cap
cytomegaloviruses
infectious
diseases
human
among
21
or
95
ci
patients
flu
protein
sequences
peptides
chameleon
heptapeptide
nan
nan
nan
nan
vs
lactation
daughters
mult
first
nan
virus
clearance
day
viral
rna
severe
hmpv
associated
cap
ifv
asc
pedv
pid
tissues
iga
hkia
passenger
hong
kong
destinations
nan
de
la
en
el
los
ace2
xenopus
expression
mammalian
angiotensin
pedv
variant
us
virulent
strain
nan
pigs
prrsv
immune
infected
infection
tourism
spatial
changes
study
beijing
nan
tgev
group
pigs
the
cd4
cq
hcq
interesting
intracellular
vitro
water
fresh
available
activities
problem
care
aging
geriatric
china
healthcare
sars
cov
virus
molecular
publisher
system
air
dehumidification
proposed
exchanger
sars
cov
bats
betacoronavirus
emergence
nan
mers
cov
humans
vaccines
respiratory
s2
rna
rdrp
insect
activity
nan
one
gene
mv
genes
mibe
delivery
oligonucleotides
applications
human
diseases
er
clsv
auxiliary
replicase
found
cell
genetic
gene
normal
veterinary
leader
rna
mrnas
nucleotides
rnas
nan
sampling
bioaerosol
airborne
pathogen
review
pyrolysis
waste
cellulosic
stage
medical
nan
nan
mice
ifit1
ifit2
ifit
proteins
protein
interaction
membrane
nucleocapsid
two
health
public
three
domains
practice
nan
de
la
los
en
del
protein
sars
cov
virus
hence
nan
unknown
virus
used
patient
serological
assays
nan
therapy
children
mp
refractory
methylprednisolone
outbreak
urban
global
health
data
nan
nervous
system
viruses
may
infection
camels
virus
arabian
local
strains
padre
mouse
mhv
autoab
adjuvant
the
tgev
rna
genome
terminal
wasp
host
dprv
reovirus
defence
replication
sars
promazine
cov
phenothiazine
nan
329
among
pathogens
viruses
respiratory
value
superstitions
across
different
plates
vaccinia
virus
tgev
recombinant
000
replication
organelles
role
the
rna
cases
cluster
appendicitis
features
acute
diseases
surveillance
infection
seasonality
the
blood
viruses
viral
transfusion
new
antiviral
cycloaddition
reactions
compounds
the
rhabdoviruses
bats
bat
virus
the
nan
cmv
pneumonia
infection
diagnosis
clinical
virus
viral
fitness
quasispecies
mutant
ali
acute
lung
injury
leading
viruses
hepatitis
human
animal
homologues
nan
virus
elisa
antibody
tge
the
super
spreading
cov
outbreaks
occurs
bcv
rotavirus
parvum
respectively
rapid
diseases
emerging
driving
emergence
today
nsp10a
nsp10
prrsv
production
amino
protein
poifn
rpoifn
duroc
landrance
virus
replicative
organelle
complex
rna
ash
mw
ashes
rees
elements
risk
pneumonia
cap
illness
therapy
piglets
pedv
sows
infected
pcv2
respiratory
aecopd
patients
viral
infection
sars
host
cells
infection
genes
influenza
virus
viruses
respiratory
illness
mfsmxa
series
method
cross
multifractal
pdcov
day
old
piglets
2014
vaccine
sars
cov
the
monkeys
mongooses
masked
palm
the
civets
locus
using
approaches
qtl
genetic
health
animal
veterinary
public
human
sinv
macro
domain
nsp3
amino
coc
coci
visits
copd
asthma
nan
microbial
gastrointestinal
dogs
cats
gut
pcr
de
et
des
mpn
salmonella
cows
dublin
antibodies
calf
strand
hybridisation
interaction
electrochemical
the
transitions
spatial
epidemics
pattern
diseases
epitopes
cell
conserved
protein
rvfv
rabbits
disease
weeks
old
nzw
usg
dur
research
dual
use
critical
care
mass
casualty
critically
nan
nan
hlsv
7a
stretch
the
8a
transmission
decontamination
agents
air
infection
lung
activity
enac
malaria
pbk
sars
mers
gave
us
ample
nan
nan
helicases
dexd
box
rna
viral
ms
patients
controls
dqwl
titers
laboratory
considerations
diagnostic
diagnosis
appearance
chicks
broiler
spf
is
885
vaccine
sars
responses
the
cov
hiv
avfc
cells
hmgs
targeting
cellular
viral
machinery
mirnas
adenoviral
protein
microarrays
systems
interactions
biological
asthma
age
serum
years
virus
degradation
iopromide
peroxydisulfate
initial
solution
influenza
symptoms
the
emergency
treatment
nan
nan
sars
cov
vaccines
the
outbreak
nan
nan
nan
bovine
brd
calves
treatment
year
nan
cpv
assay
type
mgb
discriminate
sirna
viral
replication
gene
virus
cruise
ship
infectious
diseases
passengers
infection
prevention
healthcare
transmission
patients
livestock
micro
human
transmission
contact
evolution
parallel
virus
genomes
adaptation
h1n1
pneumonia
influenza
pandemic
disease
infection
control
audit
review
the
method
virus
tgev
prcv
the
ifn
prrsv
isolates
sensitivity
polyi
cov
nsp13
structure
rna
coronavirus
lambs
parasitic
infections
reproductive
cause
fip
ocular
disease
feline
infectious
nan
orf
fipv
sequence
tgev
end
nan
nan
nos
activity
shrimps
japonicus
chinensis
rna
ribosome
prf
downstream
stimulatory
strategies
human
adaptation
mitigation
climate
noroviruses
viruses
bovine
norovirus
cattle
viral
virus
asfv
pathways
replication
the
screening
sars
cov
antiviral
approximate
description
rough
reasoning
concepts
infection
elderly
role
plays
significant
protein
membrane
cell
small
permeability
nan
2019
findings
ncov
lungs
since
protein
virus
proteins
mw
000d
nan
nan
nan
mean
in
transition
times
recovery
nan
nan
ibv
farms
isolated
the
91
nan
protein
hcv
the
229e
sequence
ebola
immunosensor
virus
the
tested
coronavirus
plps
isg15
cov
among
threat
viruses
agents
the
risk
nan
nan
nan
associated
infections
preterm
adverse
pregnancy
tjr
primary
revision
total
taiwan
luteolin
chrysoeriol
fce
diosmetin
apigenin
incidence
herd
level
herds
dairy
cell
rvfv
fusion
virus
glycoprotein
pigs
virus
prrsv
parasuis
groups
sars
mice
cov
adult
il
nan
2020
online
feb
paragraph
frequency
nan
peptides
cats
feline
coronavirus
peptide
nan
nan
nan
perfringens
difficile
report
clostridium
type
host
viruses
virus
nucleo
cytoplasmic
protein
sars
antigen
could
nucleocapsid
sars
cov
2019
recent
reported
nan
nf
κb
nsp1
pedv
cytokines
nan
pressure
negative
theatre
positive
design
nan
ntds
elimination
control
diagnostics
surveillance
nephure
day
kg
bw
food
ferrets
emergency
disease
treatment
becoming
sars
health
facemask
wearing
the
households
children
milk
melamine
young
nan
mice
virus
67n
suckling
mb
activity
showed
anti
hiv
ec50
cell
cells
ifn
nipc
among
frameshifting
ribosomal
programmed
used
production
respiratory
human
wheezing
infection
viruses
nan
nan
nan
mrna
sequence
rna
two
nt
models
biology
multi
computers
complex
fip
population
cats
sire
7a
samples
rt
pcr
tmev
rtv
proteins
pd
biomarkers
csf
the
caastv
dogs
strains
gastroenteritis
uk
n1
strains
ibv
ck
aus
polygonum
multiflorum
anti
china
plant
respiratory
oil
group
upper
patients
nan
nan
idv
calves
respiratory
vaccinated
tcid50
ph
ha
conserved
series
conformational
emergency
airport
management
command
public
patients
liver
severe
covid
19
cns
viral
cells
cell
infection
ifn
virus
type
bat
ifns
infection
sars
cov
post
rna
influenza
protease
airway
proteases
viruses
nan
2019
ncov
cases
it
including
rat
rattus
norvegicus
the
europe
tissues
lymphoid
fipv
lymph
node
proteins
regulated
viral
fish
proteasome
saon
different
prevention
treatment
effects
reactivation
mhv68
macrophages
ifn
genes
influenza
virus
herds
infection
pigs
nan
impacts
family
positive
negative
social
adherence
patients
antihypertensive
drug
blockers
respiratory
infections
emergence
diseases
spread
dc
domains
neck
sign
signr
copd
lung
respiratory
patients
cells
angiotensin
pah
pulmonary
lung
therapeutic
bile
replication
pec
acids
acid
diseases
infectious
new
although
emergence
nan
nan
ttp
following
infection
plasmapheresis
we
cell
membrane
plasma
proteins
the
respiratory
defensins
canine
cbd103
cbd108
abstract
hetero
diels
alder
reactions
respiratory
hepatitis
results
influenza
virus
infectious
care
aerosols
engineering
transmission
ibv
virus
viral
aiv
viruses
il
turkey
10
chicken
the
dna
microspheres
vaccine
vaccines
low
nan
sg
stress
sgs
pbs
translation
nan
nan
nan
sars
glycyrrhizin
antiviral
compounds
treatment
pregnancy
infections
infection
fetus
may
the
viral
virus
chickens
rss
nan
child
maltreatment
internet
based
approaches
natural
drugs
products
antiviral
new
cns
viral
cells
infection
system
viral
mitochondria
mitochondrial
proteins
involved
gene
yhv
shrimp
method
assay
anti
viral
filter
dust
loading
pertussis
vaccine
reference
meeting
standardization
nan
kampo
medicines
infectious
oriental
herbs
nan
mhc
tnf
class
expression
antigens
tourism
market
authorities
policy
risk
epidemic
threshold
recovery
nonuniform
transmission
nan
clinical
ngs
viral
specimens
primer
cleavage
mrna
rna
induced
expression
patients
d68
2014
ev
respiratory
nan
coronavirus
sars
cov
may
respiratory
nan
h1n1
viruses
the
influenza
study
pneumonia
acute
organizing
the
histologic
de
la
infecciones
infections
las
canine
cavs
chv
pathogens
type
ev71
antiviral
based
several
development
p3
inhibitory
potent
lead
compound
days
ccv
inoculation
virus
detected
hcai
associated
infection
days
paediatric
samples
igem
microscopy
dem
technique
response
vaccines
antibody
rabies
dna
silica
infection
observed
injection
mhv3
hdps
antibiotics
neonatal
disease
use
nan
textiles
abstract
the
durability
endangered
les
de
sur
la
et
biosensors
pesticides
developed
used
most
nan
information
awareness
epidemic
network
networks
anti
species
psoralea
traditional
the
waste
health
care
medical
management
cancer
signatures
genomic
molecular
outcomes
nan
taiwan
strains
ibv
the
genes
rna3
recombination
cp
bbox
sgrna3a
hag
cells
l1210
growth
29
prv
group
response
vaccination
weeks
health
zoonoses
public
risk
animal
nan
nan
critical
care
emcc
task
force
2019
health
ncov
infection
coronavirus
nan
infectious
diseases
pathogens
abstract
emerging
ferret
immune
assays
genes
the
nan
vectors
poxviral
induction
immunity
in
two
rna
cis
acting
utr
nan
innate
immune
nsp1
vp3
rotavirus
genetic
viral
diversity
including
abstract
nan
nan
nan
polypeptides
molecular
weight
proteins
500
protein
synthesis
viruses
translation
strategies
reduced
dpi
pulmonary
respiratory
lung
nan
rna
shape
secondary
structure
mhv
intestinal
g9
rvas
small
mlns
virus
neutralization
tgev
mabs
neutralized
nan
nan
people
homelessness
experiencing
19
covid
cdv
canine
type
rt
the
nan
hsv
vectors
ata
production
titers
nan
nan
human
papillomaviruses
role
induced
tumorigenesis
nan
immune
therapy
ov
ovs
tumor
viral
infection
chronic
rna
sequences
nan
rna
pseudoknot
structures
role
ribosomal
pedv
autophagy
replication
cells
proteins
gold
hybridization
strand
in
complementary
nan
hormone
mir
5p
mirna
mirnas
ic
advanced
practice
infection
nurses
al2o3
bactericidal
ag
agcl
surface
rats
exposed
3500
ppm
1500
su
fusion
domain
membrane
dimerization
exacerbations
hrvs
infection
asthma
copd
ccl2
mice
ccr2
infection
within
vaccines
vaccine
immune
epitopes
targeting
patients
zikav
adult
infection
neurologic
school
preparedness
bioevent
disaster
bioevents
rv
disease
human
infection
models
covid
19
2019
china
case
cryoem
model
the
atomic
chapter
virus
viruses
lipid
host
replication
viruses
drosophila
cells
organisms
function
respiratory
children
rhinovirus
bronchiolitis
viral
asthma
virus
relationships
respiratory
tract
nan
nan
phage
removal
membrane
layer
cake
techniques
diagnosis
respiratory
infections
viruses
nan
geriatric
life
rabbit
years
rabbits
rules
newton
applications
philosophy
truth
nan
patients
treatment
methylprednisolone
series
pulsed
care
duty
views
nature
health
patients
pregnant
we
maternal
sars
sars
cov
host
species
coronaviruses
respiratory
carriage
or
symptoms
signs
epidemic
medical
may
waste
temporary
spatial
epidemiological
data
systems
tools
amoxicillin
patients
bacterial
infection
viral
nan
sars
cov
tcm
sinensis
also
5α
cholestane
2β
3α
sodium
nan
blood
count
hemoglobin
changes
total
influenza
assay
neutralizing
pn
antibody
using
virus
the
summary
many
nan
detection
the
depsi
sensitive
influenza
hydrolase
ap4a
human
abstract
asymmetrical
sars
cov
prime
boost
severe
sleep
attachment
symptoms
health
associated
ifn
il
type
iii
receptor
diseases
infectious
activities
increasing
publication
infections
the
biopsy
malabsorption
enteropathy
allergy
factors
environment
allergic
risk
health
diseases
disease
agent
microorganisms
nan
mers
cov
reported
cases
source
memory
cd4
mφ
respiratory
responses
tissue
production
tcf
local
cytokine
recombination
ibv
conditions
frequency
virus
cycle
cell
cells
ibv
apoptosis
hcws
antibody
ph1n1
first
wave
vaccination
continuous
strategy
case
vaccine
infection
control
hospital
compliance
in
jhmv
amino
terminal
peplomer
glycoprotein
nan
nan
nan
ikkɛ
signaling
immune
transcription
factors
common
nwc
this
article
provides
cells
rgnnv
infection
p53
cell
ppe
transmission
donning
doffing
ebola
bovine
interferons
interferon
potential
viral
source
the
building
sensors
release
cell
ide
virus
vzv
infection
prrsv
dub
nsp11
activity
prrs
nan
nan
paramyxoviruses
animal
many
disease
also
nan
nan
nan
sars
cov
protein
coronavirus
cell
cd4
cell
sars
coronavirus
in
articles
china
top
author
the
pandemic
care
h1n1
staff
intensive
ibv
elisa
antibody
nsp5
the
cap
children
bacterial
viruses
cases
baff
autoimmunity
system
role
sle
feeding
dairy
cattle
abstract
utilize
protein
cellular
proteins
filamin
sorting
channel
protein
lipids
charged
cov
kda
hspcft
protein
transport
membrane
nan
feline
vaccines
cell
virus
canine
mhc
variation
inbreeding
evidence
genes
the
molecular
pidaa
molecule
analysis
cloned
mrnas
sequences
ibv
clones
s1
sars
cov
s2
antibodies
compounds
tomentin
vs
plpro
new
calves
study
operations
the
dairy
42
type
strains
circulating
positive
ev71
rt
lamp
hfmd
the
nan
dna
hydrogels
gels
properties
various
virus
the
replication
studied
observed
mers
treatment
cov
animals
disease
current
environmental
wastewater
sewage
sludge
hyenas
hyena
spotted
anti
specific
lung
seen
early
findings
patients
serum
samples
antibodies
pedv
iga
patients
ill
we
data
covid
patients
imported
tertiary
groups
viral
nan
foals
important
infectious
causes
it
pcr
multiplex
respiratory
viruses
real
golgi
er
traffic
bfa
organelle
fcv
cats
individual
virus
shed
hcws
hajj
symptoms
mecca
respiratory
chronic
tonsillitis
patients
days
kumarabharana
contacts
hcws
based
work
working
nan
hbov
respiratory
assay
detected
patients
sequence
protein
region
human
coronaviruses
pregnancy
infections
mortality
maternal
deaths
nan
rotaviruses
genome
profiles
analysis
the
vaccine
antibody
result
coronavirus
antigen
hiv
men
quality
life
cognitive
nan
nan
prf
pna
rna
sars
cov
cases
patients
the
portion
current
de
les
et
diarrhea
invasive
sars
iii
patients
care
health
nan
fipvs
fipv
fecv
isolates
fecvs
strain
hvrs
beaudette
recombinant
ibvs
virus
cells
infectious
temperature
human
cells
per
μl
wuhan
showed
de
el
la
las
es
like
structures
atragin
domain
the
re
inhaled
exhaled
breathing
fraction
the
higher
health
disease
group
animals
humans
zoonoses
diseases
vertebrate
calves
day
neonates
weanlings
lymphoid
hbov
infections
children
samples
pcr
knowledge
attitude
pilgrims
practices
mers
patients
days
clinical
radiological
viral
acute
respiratory
pulmonary
influenza
vaccination
nan
activity
bay
leaf
it
food
points
95
the
bci
clinical
legionella
species
pcr
assay
23s
pain
fops
discomfort
disease
cases
rnai
viruses
also
machinery
rna
asthma
treatment
factors
variable
inception
human
mers
vaccines
summary
the
nan
nan
roc
chapter
taiwan
status
china
hcov
oc43
species
coronavirus
cells
if
covid
19
virus
transmitted
cf
bacteria
may
patients
aggressive
pep
infection
mers
cov
hcws
pigs
group
titres
treatment
hours
foals
rotaviruses
remain
diarrhoea
development
nan
health
behaviors
could
show
h1n1
interferons
viral
infections
this
article
sars
electron
respiratory
lung
cov
nan
neutralizing
rbd
mabs
mers
cov
cd13
cells
terminal
functions
leucocyte
filmarray
lda
respiratory
real
time
astrocytes
reactive
cells
nervous
system
di
il
una
della
che
trypsin
inhibitor
inhibited
the
black
hbov
among
sari
children
993
nan
rsv
sentinel
respiratory
children
years
quarantine
cases
total
sars
singapore
the
coronaviridae
family
include
two
nan
cmv
cases
infection
and
or
ms
genetic
susceptibility
hla
alleles
brsv
herds
bcv
cows
risk
diarrhea
usa
april
2013
severe
the
gene
virions
envelope
nm
days
research
reb
time
virus
nan
number
gi
diseases
exist
organisms
nan
ferrets
examination
revealed
microorganisms
later
the
concept
reverse
genetics
enabled
bbb
cells
cns
brain
entry
covid
19
suspected
cases
china
calves
prevalence
infection
cryptosporidium
survey
virus
ns
ms
htcc
obtained
virus
antigens
ctls
specific
infections
nan
protein
homologous
universe
residue
segments
tgev
protein
eif4a2
cells
coronavirus
hcov
respiratory
viral
nl63
813
test
article
day
the
mg
cell
cultures
virus
cpe
nl63
ion
protein
coronavirus
channels
virus
rotavirus
vp7
protein
vector
virus
hcp
1β
polysaccharide
the
part
nucleotide
rna
genome
we
human
ifn
activation
tgev
infection
responses
leader
rna
end
mrnas
sequences
mva
vaccine
site
draining
lymph
parasites
foodborne
in
control
often
complexes
many
multiprotein
expression
technologies
fetal
may
placental
clots
function
nan
health
climate
change
aboriginal
vulnerability
subgenomic
mrnas
coronavirus
rna
sequence
site
sites
residues
the
residue
kda
antigens
sera
horses
50
nan
es
hospitality
management
previous
field
hbsag
hbv
dna
viral
chb
nan
infections
pretravel
advice
activities
consultation
nan
beds
state
health
plan
including
nan
carriage
micro
aureus
polymicrobial
diseases
hcov
couples
et
des
les
article
this
revision
previous
edition
mrna
mrnas
replication
cycle
used
ligand
vs
screening
binding
target
rdv
rna
cov
inhibitor
respiratory
patients
sars
cov
pneumonia
survivors
rv
hiv
cases
identified
respiratory
nan
la
en
de
el
las
host
damage
pathogens
toxins
infections
sars
cov
elderly
high
susceptibility
temperature
forehead
handheld
infrared
fever
viruses
respiratory
presence
or
ci
incubation
period
covid
19
infectivity
protein
mers
588
cov
s377
virulence
treatment
pathogen
rate
optimal
social
twitter
facebook
studies
research
treatment
the
organic
matter
land
medical
the
fragility
model
relief
interval
serial
pairs
covid
19
nan
hiv
assay
pr
selective
this
pe
complement
patients
expression
controls
pedv
cell
cells
dendritic
responses
length
genome
subgenomic
rna
mrna
calves
cows
cattle
bcv
responses
nan
abstract
gastroentrology
2001
120
607
health
wuhan
china
sars
cov
nan
virus
chikv
denv
hepatitis
infection
deposition
particle
bends
velocity
behind
assay
peptides
virus
like
particles
cpg
bw001
human
pbmcs
sars
viral
mrnas
translational
translation
synthesis
the
dianthoviruses
genome
dianthovirus
genera
mabs
neutralizing
antibodies
antiviral
viral
cpcr
rt
prototype
mix
dna
health
coverage
canada
provincial
governments
influenza
children
detected
viruses
ili
treatment
elp
studies
mycobacterium
clinical
mers
transmission
cov
mathematical
model
risk
virus
pi
issues
pathogen
lung
tlrs
infectious
host
associated
pcr
real
time
sars
enhanced
methylation
aromatic
conserved
region
vi
ampv
ibv
genes
recombinant
virus
nan
pcr
chapter
real
time
microbiology
nan
nan
vaccine
development
rational
design
advances
reserve
china
late
abstract
stockpiling
nan
ifn
the
innate
infections
type
filter
anti
viral
sa
filtration
nan
species
disease
nidovirus
causes
viruses
hmpv
bronchiolitis
viral
rsv
pathogen
in
ot
effects
the
substances
sars
identified
prevention
appeared
global
economic
natural
disasters
recent
cities
the
respiratory
additional
protection
equipment
coronavirus
hyenas
levels
samples
sera
quaternary
ammonium
antimicrobial
biomaterials
based
prcv
positive
elisa
macelisa
sera
nan
covid
19
pneumonia
patients
pathology
nan
nan
signature
healthcare
framework
hospitals
the
influenza
ive
adjusted
conditions
positive
gl
recombinant
cells
kda
authentic
niv
virus
vaccine
vaccinated
hev
cd209
sars
patients
snp
promoter
viral
disease
particles
proteins
development
nan
precautions
standard
infection
control
patients
rotavirus
virus
specific
intestinal
important
pcr
respiratory
viruses
infections
children
virus
influenza
2009
europe
in
influenza
viruses
types
abstract
the
calves
db
ncd
la
nsaid
immune
ibv
associated
cells
response
translation
caulimoviridae
viruses
basic
viral
use
surgical
ppe
respirator
control
agp
feline
fip
acid
fagp
nan
nan
die
wirkung
der
und
gegenüber
nan
pneumonia
imaging
lung
the
role
protα
immune
100
109
the
the
uveitis
inflammation
causes
blood
nan
eu
eea
countries
detection
2019
fcv
strains
bile
all
strain
patients
cancer
radiation
oncologist
item
nan
service
professionals
exposure
well
lack
abstract
competition
elisa
utilizing
mab
cov
covs
respiratory
reverse
genetic
nan
nurses
emergency
the
influenza
pandemic
mini
training
cex
pgy
ed
colostrum
management
successful
article
discusses
extracts
camaldulensis
the
essential
ml
nan
china
we
risk
number
formula
children
cfpngs
cap
antibiotic
hospitalized
influenza
humans
viruses
seasonal
mild
nan
cells
apoptosis
infected
viruses
viral
viruses
factor
the
inactivation
human
main
vaccine
animal
models
summary
rna
sg
rnas
strand
the
treatment
calves
hl
cryptosporidium
treated
vaccine
sars
cells
responses
cov
flow
rates
airborne
using
reduced
nan
development
drugs
approach
the
antivirals
zikv
virus
vaccines
infection
cases
vaccine
cell
epitopes
cchf
the
isg
continued
immune
preparations
freedom
pp60
protein
p57
the
nucleocapsid
algae
the
food
bioactive
compounds
nan
knowledge
medical
language
data
mining
the
hospitals
hospital
cleaning
environment
nan
nan
the
elisa
sera
negative
95
lung
cordyceps
fibrosis
treatment
cell
nan
nan
hapn
transgenic
mice
cells
mouse
nan
et
de
été
infection
new
rsv
infants
nicu
palivizumab
disease
inos
activation
dsrna
nf
κb
methods
emerging
genomics
responses
infection
health
public
care
canada
this
documents
information
different
the
search
nan
the
yu
ping
feng
san
children
respiratory
influenza
ili
viruses
viral
virus
antiviral
host
new
metal
tagged
protein
best
chip
spray
sirna
the
drying
nps
sars
china
spread
within
quickly
nan
calves
zinc
placebo
treated
met
dengue
tropical
the
rapid
diagnostic
mycoplasmas
isolated
species
domestic
cats
cats
activity
aqueous
humor
il
unknown
cpv
canine
fplv
feline
parvoviruses
human
viral
proteome
virus
amino
fusion
peptide
dv
interaction
membrane
inflammation
microrna
regulation
sirt1
up
nan
exposure
wildcats
the
pathogens
felis
urban
service
development
asia
pacific
social
media
business
process
smes
unknown
nan
nucleolus
human
viral
nucleolar
infection
filovirus
virus
infection
pseudo
filoviruses
virus
entry
mβcd
lipid
cholesterol
ad
antiviral
agents
fmdv
the
viruses
host
zoonotic
reservoir
hosts
data
mobile
disaster
disease
use
viruses
influenza
virus
detected
respiratory
mers
cov
ab
virus
prophylactic
nan
sars
proteinase
the
3cl
binding
nhe3
significantly
tgev
surface
infection
nan
asian
palm
severe
necrosis
pancreatic
rna
oligonucleotides
viral
viruses
antisense
b2
macrophages
b19
innate
virus
hts
cns
viral
cause
studies
rna
genome
cd
91
end
the
infection
children
sars
infected
indigotica
extracts
isatis
activity
prv
ea
fraction
cordata
denv
the
pcr
rt
long
genomic
the
ace2
rh
sars
entry
cov
nan
sdp
broilers
feed
14
35
viruses
air
samples
rt
pcr
cells
infected
detection
determinants
acetone
ub
dubs
ubl
activity
enzymes
2019
ncov
sars
coronaviruses
an
de
les
et
acute
bronchitis
nanotechnology
application
000
sialic
in
misinformation
cocaine
russia
cures
among
nan
protein
nc
viral
review
briefly
water
detection
techniques
monitoring
contaminants
oc43
infection
infectious
respiratory
human
protein
cellular
proteins
tgev
cell
nan
nan
viral
viruses
intracellular
various
organelles
rr
calf
prevalence
shedding
calves
titers
giant
pandas
canine
cpv
viral
the
self
autoimmune
tolerance
viral
active
antiviral
drug
drugs
ncovid
19
non
patients
2019
virus
virome
sequencing
analysis
hts
heics
sars
hospital
nckuh
outbreak
plant
programs
health
certification
material
nan
peptides
tb
the
rifampicin
effective
respiratory
viruses
bovine
calves
abstract
viral
vaccines
advancement
in
development
immune
passive
colostrum
transfer
igg
mhv
jhm
mip
s4r22
a59
pandemic
disease
influenza
virus
infection
viruses
virus
used
techniques
methods
mrsa
95
ci
first
quarter
influenza
vaccines
human
pandemic
infections
prrsv
pigs
prcv
siv
virus
nan
influenza
vlps
vaccine
protein
viruses
nan
prrsv
abstract
porcine
reproductive
respiratory
biology
vaccines
vaccine
structural
synthetic
patients
diagnosis
rr
mers
delays
infection
students
prevention
nursing
training
cognitive
concept
concepts
learning
computing
cns
dth
virus
post
challenge
gene
silencing
sirnas
viral
small
am
cells
prv
infected
the
gfp
vtt
mvtt2
cell
viral
nan
this
article
describes
health
care
clec4g
sign
gene
pclec4g
primates
viruses
identification
the
examples
emerged
2019
ncov
pandemic
quickly
world
sars
disease
rt
pcr
crna
pedv
virulent
strains
strain
ch
sars
elderly
prevention
affected
disease
hcv
cd81
virus
host
protein
nan
fipv
type
s1
peptides
infection
apbd
background
failure
diaphragmatic
leukodystrophy
infections
virus
new
continue
immune
alkaloids
narcissus
the
different
chapter
nan
nan
vaccines
virus
morbilliviruses
species
populations
acid
chlorogenic
cordata
antioxidant
ms
iaq
hotel
air
audit
concentration
nan
mixed
pathogens
infections
patients
children
nan
nan
genes
group
specific
coronavirus
viruses
recombination
recombinant
prrsv
experimental
sequences
mood
influenza
disorders
history
seropositivity
climate
change
parasite
interactions
also
ifitm
viruses
human
proteins
entry
rna
ibv
showed
mutation
nsp9
rna
hcv
caused
viruses
nucleoside
zika
evidence
response
public
emergency
nan
blood
rule
antibiotics
prediction
in
nan
rvp
assay
detection
rt
pcr
rna
coronavirus
genomes
like
replicase
h1n1
influenza
this
study
conducted
bd
max
ingenius
aries
required
global
health
article
governance
policy
grafting
backbone
side
epitope
motifs
nan
nan
lagos
ebola
nigeria
case
19
nan
infections
hcov
oc43
clusters
sequences
sars
epidemic
taiwan
control
ministry
nan
nan
nan
gps
crucial
viral
53
the
ifn
induction
prevent
sars
transcription
nan
immunomagnetic
detection
bead
based
microfluidic
wheezing
vitamin
levels
history
patients
proteins
low
lmw
serum
plasma
niv
virus
protein
cathepsin
ph
virus
theiler
murine
encephalomyelitis
rna
development
process
cpg
integration
chinese
hospitals
planning
mass
preparedness
term
femv
infection
ckd
cats
presence
nan
mrv
type
s1
pcr
strain
in
practice
fcov
ifa
test
systems
two
the
nervous
immune
ptov
porcine
strain
bres
the
sars
cov
rbd
protein
binding
rna
gene
mers
cov
complete
factors
critical
method
important
the
nan
nan
mers
cov
middle
east
protein
de
une
des
en
et
nan
rna
106
virus
hr
pi
middle
east
new
respiratory
disease
ebola
virus
human
since
africa
viral
ion
proteins
virus
channel
sars
cov
rdis
dis
expressing
viral
host
glycoproteins
fusion
entry
nan
pcr
aspergillosis
patients
predictive
serum
host
virus
interaction
protein
viruses
simulation
outbreak
nursing
teach
public
cns
the
immune
barrier
cells
protein
conformational
dynamics
changes
molecular
nan
hmpv
respiratory
specimens
associated
children
sars
cov
mabs
protein
two
hiv
diarrhoea
cause
abstract
related
2019
novel
coronavirus
reported
incubation
wildlife
zoonoses
emerging
control
management
influenza
h5n1
viruses
avian
infection
nan
replication
rna
viruses
organelles
significant
herds
brsv
bcv
antibody
milk
mice
vaccine
elicited
virus
protein
nan
unknown
fip
cats
fcov
deletions
gene
nan
mitochondrial
innate
system
abstract
immunity
cell
diversity
new
thymic
the
cov
nsp16
the
respiratory
syndrome
pandemic
patients
influenza
people
june
tourists
tourism
whl
results
effect
nan
virus
replication
cellular
infection
viruses
secretory
granule
sorting
formation
granules
fragments
rdv
cdna
viral
sets
year
disaster
covid
19
health
de
et
des
la
les
nan
hedge
jet
fuel
airlines
futures
nan
tweet
diffusion
perceived
structural
virality
ch
strain
ldt3
ck
lgx
nan
feline
coronaviruses
the
abstract
prevalence
herds
prcv
446
serum
samples
his
cypa
surface
csa
stable
antibodies
motif
spike
protein
neutralizing
ventilation
lvb
hvb
rooms
dormitory
ift
participants
knowledge
emergency
en
porcine
orthoreoviruses
10
strains
korean
nan
nan
cap
pneumonia
pathogens
management
well
hadv
hbov
detection
pcr
samples
nan
numerical
population
model
sars
disease
nan
nan
ifn
pdcs
type
infection
signaling
response
stress
cellular
model
p53
diseases
infectious
floods
or
95
sars
cov
chlorine
days
wastewater
nan
opportunistic
patients
infections
pathogens
defects
risk
research
proximity
sociocultural
experience
transmembrane
proteins
the
integral
membrane
cov
coronavirus
protein
respiratory
syndrome
nan
nan
population
mexico
hemorrhagic
fevers
epidemic
nan
nan
nan
ccsp1
ali
membrane
pla2
ebp
sars
risk
patients
infection
nosocomial
purines
receptors
nucleoside
analogues
purine
disease
autoimmune
cns
infections
associated
em
viruses
electron
microscopy
diagnostic
airport
efficiency
airports
stage
analysis
nan
βglu
the
therapeutic
new
agents
steviol
ste
sweet
rebaudiana
glycosides
nan
lung
biopsy
lymphoma
ptcl
involvement
probe
fipv
rna
hybridization
infected
pedv
epidemic
diarrhea
pig
disease
hmpv
caap
rsv
patients
001
heifers
replacement
herd
achieve
body
ras
mas
ang
angiotensin
years
filter
aerosols
backpulse
backblow
loaded
unfolding
pseudoknot
frameshifting
rna
pseudoknots
nan
ap
i50
μm
inhibitors
ec
spinal
cats
common
cord
feline
proteases
protease
enzyme
market
synthesis
study
infection
control
km
icps
nan
the
enzymes
chapter
structural
arterivirus
puppies
diarrhea
risk
enteropathogens
fecal
de
en
los
se
el
mhc
expression
astrocytes
class
macrophages
hcai
incidence
mrsa
consumption
vre
cov
mers
disulfiram
sars
plpro
movements
animal
disease
risks
spread
alri
vitamin
children
studies
vdd
disease
cases
patients
respiratory
p1
oiv
rtlamp
real
time
assay
family
caregivers
care
disease
public
nan
arylsulfonyl
abstract
the
formal
cyclization
parvum
cattle
infections
calves
major
oscillatory
we
organisms
clocks
coherent
translocation
abstract
the
past
year
nan
patients
sars
clinical
severe
hospital
sars
cov
respiratory
syndrome
tmprss2
room
ventilation
airborne
transmission
infection
nan
rats
virus
week
old
routes
human
influenza
to
emerging
viral
the
care
intervention
nurses
willingness
interactions
microbial
identifying
ligand
infection
skin
cat
fragility
syndrome
associated
virus
vlp
foreign
hepatitis
orally
cells
cell
epec
intestinal
human
nan
activation
ccl3
infection
dc
the
translational
errors
gene
in
vectors
virus
erythrocytes
receptors
hev
influenza
nan
work
life
balance
hotel
employees
virus
coronavirus
extracts
replication
mhv
blood
borne
office
health
chapter
vaccine
expression
large
subunit
vaccines
nan
nan
coronaviruses
diversity
cov
europe
species
astv
diarrhoea
calves
calf
presence
mhv
huh
cells
jhm
infection
infectious
animal
herd
environment
factors
ppv
detection
porcine
lamp
parvovirus
prescriptions
three
bsrf
virus
ef
uncertainty
numerical
decision
qualitative
non
bands
64
000
acv1
virus
coli
the
adhesins
receptors
pathotypes
antibodies
intestinal
oral
virus
response
structure
protein
binding
solution
nmr
sudden
deaths
infectious
involving
due
vaccination
influenza
population
common
vaccine
nan
bat
viruses
virus
in
linked
nan
lps
prrsv
pigs
respiratory
the
nan
ibv
encoded
sequence
24
kda
et
al
2018
three
recent
nan
ang
liver
ccl4
ras
dose
cholesterol
membrane
cell
lipid
rafts
nan
kda
cleavage
products
proteins
cells
quercetin
slms
lipid
the
microparticles
cases
isolation
transmission
contact
tracing
abstract
facile
high
yielding
protocol
nan
bumble
commercial
bees
wild
populations
research
methods
health
protocols
share
social
disease
singapore
foreign
measures
phage
displayed
peptide
used
epitopes
likely
future
bioweapons
pathogens
discussed
specimens
respiratory
rp
biofire
filmarray
family
respiratory
rna
members
large
sars
spike
scfv
cov
protein
cubic
membranes
cell
this
well
fcov
viral
cats
infection
breeding
sars
march
cases
july
2003
peritoneal
oxygen
ombs
rats
ventilation
golgi
trans
lamellae
mammalian
network
biopsy
hct
lung
cohort
biopsies
nan
kmf
cancer
the
health
associated
food
liberalization
increased
global
globalization
the
instruments
dental
samples
used
lz
words
lempel
ziv
complexity
ari
hajj
study
subjects
among
days
the
peak
internet
searches
nan
nan
porcine
9cfr
testing
bovine
viruses
patients
acute
respiratory
illness
bacterial
infection
control
oiv
nosocomial
early
emerging
zoonoses
medicine
diagnosis
important
virus
disease
viral
pathogenesis
processes
ua
tcll
effect
pts
hnei
quarantine
disease
model
susceptible
individuals
strain
organs
genetic
pantropic
450
herds
pigs
diarrhoea
among
growing
otu
domain
viral
ub
isg15
dairy
disease
respiratory
brd
cattle
iot
disease
based
system
infectious
app
animals
acute
phase
proteins
respiratory
severe
pneumonia
viruses
requires
akt
ev71
activation
pi3k
mapk
nan
maripoc
respiratory
positive
the
viruses
viruses
new
agents
many
pneumonia
levels
airborne
contamination
rooms
air
patients
staff
emergency
arriving
crowding
cats
infections
respiratory
case
feline
cats
fse
evidence
infection
feline
sequences
bovine
coronavirus
bcov
phylogenetic
virus
hepatitis
well
foodborne
methods
mers
cov
disease
severe
marmosets
viruses
clinical
syndromes
different
summary
nsp11
endoribonuclease
ifn
production
inhibit
virus
infections
ifns
outbreaks
in
hrv
lrti
patients
respiratory
hm
persistence
chlamydiae
abstract
under
stress
as
atypical
pneumonia
began
appear
nan
hpiv
patients
among
genetic
years
respiratory
rodents
diseases
species
practitioners
nitazoxanide
clinical
respiratory
mers
cov
de
et
patients
icu
le
sequence
protease
coronaviridae
the
torovirus
nan
sars
cov
mpro
p2
substrate
nan
mers
cov
evolution
transmission
the
cxcl10
activation
survival
lymphocytes
apoptosis
sequences
protein
similarity
sequence
research
amino
protein
the
sequence
peplomer
respiratory
among
returning
hajj
mers
adp
viral
viruses
domain
macrodomain
chest
acute
respiratory
illness
patient
pedv
predictive
random
forest
accuracy
siderocalins
pathogens
host
the
siderophore
virus
ebov
guinea
filoviridae
could
c6h4
phosphonates
activity
range
br
demyelinating
in
ms
many
mechanisms
des
de
et
les
la
respiratory
coronaviruses
hcovs
pathogens
syndrome
nan
emergent
patients
non
waiting
time
ibv
greater
apoptosis
strains
885
inhibitors
sars
cov
tanshinones
proteases
nan
virus
amplified
products
primers
type
innate
immunity
hiv
the
concepts
ha3g
hiv
sars
cov
nc
organ
cultures
bovine
bc
coronavirus
markov
transport
spaces
matrices
contaminant
rabbits
rabbit
virus
poxviruses
papillomavirus
brsv
calves
respiratory
inoculated
disease
hospitals
availability
vs
structural
resources
galápagos
disease
species
pathogens
poultry
tmv
virus
development
in
particles
27
samples
cryptosporidium
calves
parvum
cells
airway
shape
mhc
class
linkage
specific
dubs
employ
different
nan
wind
twisted
the
speeds
winds
nan
epithelial
plasma
exudation
regeneration
asthma
cells
hla
antigen
molecules
glial
virus
cells
dengue
cox
expression
vectors
arboviruses
virus
changes
human
transgenic
angiotensin
ace2
ang
models
summary
domestic
animals
complementary
experimental
like
gastroenteritis
particle
one
nm
mbl
ibv
induced
vaccine
serum
nan
nan
nan
pandemic
vaccine
influenza
hcws
2009
sars
hc
study
results
acute
surveillance
system
global
the
developed
transfusion
blood
practices
shown
improved
anti
nucleosides
cytotoxicity
antiviral
synthesized
3a
protein
apoptosis
channel
activity
s15
site
ribosomal
protein
messenger
alkaloids
methods
chemical
antiviral
activities
nan
2019
the
outbreak
novel
coronavirus
antibodies
neutralizing
human
mabs
s1
sirna
nanoparticles
gene
potential
amine
proteins
virus
glycosylated
glycosylation
viruses
nan
nan
site
trnas
translocation
translocase
ef
il
10
mice
cell
th17
3c
like
catalytic
proteases
fold
risks
chapter
assess
supply
chains
sequences
distance
genome
sequence
complete
nan
nan
asthma
genotype
gerd
ppi
tailored
novel
genotype
ibv
recombination
virus
nxtag
assay
nucleic
luminex
respiratory
gaspers
air
cabin
model
infection
nucleic
acid
2019
samples
patients
plasma
therapy
antibodies
immunized
donors
nan
nan
uv254
relative
humidity
dose
temperature
cov
nsp1
mers
in
viral
foreign
trading
investors
stock
market
pcr
virus
the
time
assays
health
agriculture
synopsis
huge
impacts
improve
compliance
hand
hygiene
there
vaccine
health
sustainable
development
vaccination
vri
children
surgery
outcomes
chd
cells
proteins
surface
48
positive
aureus
nanoparticles
np
based
detection
salmonella
enterica
urinary
lesions
septicaemia
resistance
antimicrobial
use
the
problem
nan
children
travel
special
overseas
medical
de
des
les
un
une
nan
therapies
the
current
small
self
viruses
detection
respiratory
molecular
use
scov
sars
cov
emergence
origins
mannheimia
species
abstract
varigena
identified
variants
virus
antigenic
neurovirulence
mouse
de
infections
en
techniques
viral
abstract
this
chapter
examines
topics
sars
cov
immune
high
responses
prrsv
autophagy
infection
cells
lc3
global
outsourcing
years
sourcing
strategy
nan
assay
multiplex
clinical
the
singleplex
rats
group
β1
tgf
31
virus
immunodeficiency
fiv
biv
feline
fcov
infected
infection
viral
cats
urban
inequality
spatial
in
assumed
cgas
signaling
like
cyclic
dncv
respiratory
virus
hmpv
disease
hct
pedv
autophagy
rapamycin
cells
infection
approaches
immune
specific
agents
natural
calpain
inhibitors
inhibitor
development
potent
nan
nan
nan
ethical
questions
paper
importance
issues
2019
coronavirus
bat
ncov
sequence
nan
nan
brucellosis
cd14
95
iranian
the
3clpro
activity
sars
cov
inhibitory
rhinovirus
human
type
species
associated
pharyngitis
infants
younger
years
usual
asthma
exacerbations
respiratory
viruses
virus
slippery
frameshifting
uuua
frameshift
two
nan
nan
virus
horses
ecov
enteric
adult
nan
population
reproductive
heterogeneity
finite
number
hev
rna
altona
extracted
the
pkd
cats
genetic
the
chartreux
mbl
rrv
induced
linked
glycans
the
in
detection
rt
rpa
lynxes
felv
the
iberian
lynx
viral
infections
development
autoimmune
disease
nan
respiratory
disease
prdc
pathogens
associated
pcr
detection
rva
rt
rtrt
mers
outbreak
transmission
model
2015
pcv2
pmws
herds
pigs
antigen
water
stormwater
alternative
potable
fecal
sars
activity
cov
helicase
compounds
tourism
business
financial
firms
conditions
copd
burden
disease
health
countries
cdc
risk
media
public
news
nan
numbers
cell
sars
weeks
subsets
nan
data
disease
gps
sources
google
viruses
lipid
proteins
viral
unenveloped
nec
infants
theory
clinical
syndrome
he
mhv
expression
leader
rna
mercury
bn
rats
gvhl
ox22
ctl
specific
sars
protein
antibody
nan
unknown
nan
sars
respiratory
cov
largely
patients
protein
novel
scale
screens
virus
nan
peptides
fusion
cell
antiviral
entry
felv
fiv
cats
cause
virus
travel
collected
surveillance
information
variables
mers
cov
epitopes
infection
cell
nan
nan
virus
response
infections
ifn
viral
hcov
229e
pathologies
infection
monocytes
microglia
cns
immune
cells
brain
coli
ehec
diarrheagenic
classes
cause
nan
nan
infections
antiviral
drugs
treat
acute
viruses
virus
evolution
parameters
nature
hbv
compound
dna
antigen
hepatitis
molecular
aegis
beacons
rna
signal
lamp
the
detected
trypanozoon
test
virus
tissue
human
3d
including
ccov
fluorogenic
rt
pcr
assay
lectin
mimics
lectins
non
chemical
nan
compounds
the
activity
highest
data
tree
life
knowledge
species
also
nan
nan
nan
spike
cell
host
coronavirus
coronaviruses
nan
two
virus
orfs
orf3
polypeptides
nan
lung
respiratory
early
hsct
acute
renale
parasitism
kidney
the
diagnosis
pigs
viruses
isolated
disease
antibody
kd
disease
children
age
immune
sapns
the
peptide
et
al
nan
factors
viral
host
rna
replication
exposure
patient
leptospirosis
hemorrhage
ecmo
viruses
rabies
cause
summary
the
tourism
economic
relationships
development
real
host
enteroviruses
cholesterol
replication
hijacking
nan
3cpro
svv
deubiquitinating
activity
ubiquitination
nan
ig
ab
diverse
expressed
diversity
virus
species
specific
ribonucleoprotein
viruses
nan
di
un
le
la
febbre
plans
pandemic
planning
children
families
ccov
tgev
like
sera
recombinant
cells
type
rcov
virus
chemokines
gp180
two
the
90
gp23
nan
nan
polyadenylation
bamv
rna
activity
replicase
patients
allergic
rhinitis
respiratory
viruses
yokv
bats
fruit
bat
samples
nan
health
brics
uhc
countries
public
pigs
prrsv
dpi
vr
2385
farms
sows
suis
eimeria
the
nan
studies
biochemical
solutions
cells
dilute
gasper
jet
models
induced
model
disease
covid
19
patients
seriousness
virus
avian
h7n9
human
infections
pneumoniae
cap
common
cause
resistance
respiratory
responses
mucosal
immunization
immunity
health
public
detection
the
conditions
nan
human
health
chikungunya
virus
abstract
nan
dyspnea
undifferentiated
patients
respiratory
distress
group
calves
groups
hn
oocyst
tcm
china
chinese
health
study
nan
nan
phlorotannins
compounds
show
biological
activities
nan
nan
control
slime
enzymes
methods
use
ppm
teg
vapor
hp
viruses
pertussis
achromobacter
xylosoxidans
bordetella
two
rna
protein
viral
the
form
cats
fiv
feline
western
blot
sars
household
disinfectants
cov
virus
villus
viral
diarrhea
001
cells
nan
deoxy
difluoro
activity
virus
abstract
pprv
strains
china
2013
peste
frscv
frecv
sequence
one
protein
nan
rabies
vaccines
animals
human
nto
chapter
the
carbohydrate
using
stowell
nsp4
proteinase
eav
the
structural
human
pathogens
virus
influenza
viruses
strains
covs
zoo
one
aa
ifn
hiv
response
infection
immune
nan
coronavirus
canine
bgf
associated
strain
grft
jev
activity
glycosylated
infection
pkr
3cpro
protein
fmdv
infection
nan
respiratory
no2
exposure
infection
asthma
diseases
role
changing
infectious
article
nan
nan
respiratory
patients
samples
influenza
the
microfluidic
development
although
devices
attention
birds
species
novel
human
avian
people
time
patches
patch
infected
tuberculosis
svm
classifier
diagnostic
proteomic
nan
pdcov
strains
protein
china
showed
model
well
exposure
mixed
zone
healthcare
the
challenges
determine
systems
patients
aecopd
bacteria
pathogens
among
xrn1
dsrna
host
virus
mrna
structural
fmdv
antibodies
diva
proteins
ace2
angiotensin
ace
functions
ii
nan
patients
avn
sars
plain
radiographs
pedv
study
cells
infection
antiviral
proteins
vaccines
respiratory
disease
main
patients
liver
enzymes
alkaline
phosphatase
nan
pedv
papn
infection
polarized
cells
hybridization
dna
the
efficiency
pre
virus
ibv
strains
control
the
nan
therapy
patients
mers
cov
ribavirin
nan
host
acth
sars
corticosteroids
response
nan
children
hbov
lower
respiratory
tract
parents
hss
communication
health
care
nan
pneumonia
cap
common
cause
risk
hospital
rooms
pathogens
patient
surfaces
host
mitochondria
responses
upon
infection
protein
apoptotic
cell
akt
pathway
ppe
use
studies
available
low
nan
virus
influenza
aloesaponarin
tetra
acetyl
cilia
patches
beating
we
the
virus
samples
chandipura
encephalitis
rna
apn
the
125i
role
rb
cov
sars
binding
pathogens
syndrome
nan
prv
infection
dg
inhibitory
virus
malaria
japan
patients
cases
imported
sars
cell
fusion
virus
activation
outbreak
cryptosporidiosis
lambs
identified
sheep
this
article
reproduced
previous
edition
protein
oc43
rna
hcov
the
sars
the
cells
thyroid
patients
protein
ibv
sera
nucleocapsid
specific
patients
sars
respiratory
failure
probable
nan
nan
patients
group
blood
pct
value
patients
days
19
the
icu
patients
infection
vaccine
influenza
h1n1pdm09
de
el
las
la
en
nan
nan
influenza
virus
pkc
production
compounds
ibv
s1
structure
spike
predicted
frc
knowledge
containment
phase
study
rna
replication
protoplasts
viral
mutations
sars
proteases
coronavirus
serine
in
virus
cultures
rna
infected
cells
de
patients
diarrhoea
des
et
binding
protein
membrane
nucleocapsid
mouse
companion
ferrets
pet
owners
the
dental
procedures
literature
aerosols
the
nan
respiratory
viruses
acute
lower
tract
nan
patients
bronchiolitis
magnesium
time
95
nan
nan
health
income
systems
countries
care
nan
nan
human
hcov
infection
generally
coronaviruses
nan
healthcare
workers
events
childhood
adversity
nan
respiratory
assay
specimens
influenza
virus
nan
resources
research
researchers
disaster
management
tcov
poults
day
old
chicks
biotechnology
role
european
programme
research
vaccines
responses
respiratory
immune
infection
mir
223
denv2
replication
stmn1
sars
cov
protein
in
b23
respiratory
acute
severe
bronchiolitis
vs
ag
nps
etc
crystals
size
rotavirus
infection
associated
necrotizing
enterocolitis
respiratory
surveillance
data
systems
syndrome
pertussis
vaccine
disease
the
infection
membrane
fission
escrt
viruses
enveloped
nan
nan
the
subunits
spike
coronavirus
structure
vaccines
features
special
care
time
cathepsins
proteins
lysosomes
cathepsin
lysosomal
e5
viroporin
hpv
high
we
vaccines
vaccine
the
veterinary
human
influenza
h5n1
human
infections
abstract
as
coronavirus
spreads
countries
china
coronavirus
cats
feline
infection
infectious
ed
influenza
diagnosis
testing
cost
mhv3
cells
intrahepatic
infected
mice
nan
coronavirus
virus
however
derived
five
patients
sars
95
ci
study
sgrna
showed
viral
sars
cov
immune
fip
clinical
signs
may
respiratory
pneumonia
mers
patients
failure
covid
19
respiratory
outbreak
pneumonia
nan
ppmo
prrsv
prrs
combination
cell
tb
policy
needed
abstract
there
family
well
child
changes
siblings
nan
ms1
abietina
garv
the
population
nan
infection
sars
cov
positive
pcr
nan
the
catalytic
his
virus
cavv
no
respiratory
infected
prcv
prrsv
hospital
median
range
patients
day
viruses
virus
malaysia
hiv
zoonotic
disease
human
zoonotic
diseases
animal
prrsv
jak
response
stat
signaling
diagnosis
denv
dengue
patient
point
apoptosis
cells
chloroquine
apoptotic
anti
nan
sirna
rna
applications
based
delivery
nan
nan
nan
nan
ifn
replication
treatment
sars
fold
products
customers
recommendation
analysis
recommend
text
lesions
the
studies
upper
nan
nan
sars
cov
coronaviruses
coronavirus
respiratory
nan
nan
type
fcov
ii
infection
fip
nan
arenavirus
vaccines
arenaviruses
cause
hf
nan
nan
nan
steroid
virus
vs
combination
treatment
nan
et
des
de
2013
psoriasis
travel
imported
cases
international
infectious
chitosan
viral
transfection
polyplexes
efficient
protein
membrane
sars
cov
aggregation
care
pandemic
influenza
optometrists
event
nan
sps
adherence
nurses
the
study
nan
quarantine
health
correct
implementation
measures
whooping
cough
first
epidemic
epidemics
nc
solium
endemic
areas
health
nan
animals
vaccines
humans
preventing
framework
de
les
et
patients
cas
nan
dengue
rt
pcr
laboratory
diagnosis
nan
anfis
mars
shuffling
inhibitory
pyridine
h5n1
ducks
infection
chickens
may
nan
nan
nan
influenza
karbala
infections
mers
cov
risk
mers
cov
model
patients
fipv
orf
6b
the
ccv
animals
zoonotic
laboratory
human
risks
in
dogs
coughing
shelter
days
sirna
release
excipients
used
interaction
synthesis
applications
nanoparticles
abstract
this
p8
p10
domain
2a
protein
patients
viral
load
disease
288
pmo
pna
oligomers
conjugates
ahx
bcov
igg1
calves
animals
group
nan
desiccant
air
passive
active
dehumidification
air
travel
health
important
borne
nan
clinical
research
study
care
participants
immunosensors
development
analysis
developed
recent
models
infectious
transmission
change
factors
nan
ck8
positive
foci
18
gst
mers
cov
syndrome
cardiac
middle
nan
de
des
la
transmission
mers
nan
nan
response
the
planning
emergency
influenza
calves
vs
serum
protein
blood
the
ibv
gene
isolates
strains
china
initiative
health
belt
road
choline
human
chd
glycine
betaine
gene
cells
abstract
transient
expression
health
professionals
risks
occupational
services
pcv2
pi
day
infection
ifn
tourism
study
npi
non
pharmaceutical
knowledge
disease
mers
cov
epidemiological
proteins
identified
civ
in
invertebrate
ace2
calmodulin
angiotensin
converting
enzyme
rd
patients
hcais
radiology
health
asthma
women
pregnancy
common
without
nsp1β
nsp1α
interferon
inhibit
the
compounds
the
influenza
activity
camphor
fluidic
sfm
we
modular
integrated
virus
pedv
cell
protein
diarrhea
nan
influenza
formulations
vaccination
dry
vaccine
sars
policies
health
care
certain
nan
mucosal
species
vaccines
infections
veterinary
bovine
norovirus
genotype
noroviruses
cattle
nan
prrsv
european
american
bp03
isolates
nan
cd200r1
signaling
pathway
pathogens
cd200
maps
nucleic
cells
image
series
nan
inflammatory
conditions
affecting
central
nervous
poifn
porcine
expression
recombinant
cell
nan
preparedness
ebola
outbreak
training
study
nan
anatis
house
flies
16s
protozoan
fusion
protein
changes
one
virus
cells
viral
sars
cov
irradiated
macular
edema
brb
breakdown
variety
nan
nan
eav
infection
clathrin
cells
dependent
virus
les
le
infections
influenza
de
la
anemia
las
una
nan
calnexin
two
transcript
protein
er
virus
disinfection
inactivation
enteric
number
influenza
pneumonia
95
ci
laboratory
air
pollution
the
high
stocks
resistance
oseltamivir
influenza
pcr
h275y
nan
patients
cov
virus
sars
coronavirus
proteins
antibodies
expression
protein
igy
viral
day
rna
retina
within
biomarkers
week
weeks
infection
regulated
camels
mers
cov
we
human
unknown
objects
moving
relative
gis
space
tfi
tgev
the
virulent
sequence
unknown
pneumonia
bacterial
common
clinical
diagnosis
nan
nan
gvn
viruses
the
emerging
viral
dogs
brazilian
areas
animals
wild
frameshift
sequence
pol
gag
frameshifting
10
cxcl
promoter
tb
135g
cells
ggnnv
sb
caspase
apoptosis
3b
protein
localization
nucleolus
dsred
la
et
auto
un
des
sound
frequency
the
disease
signals
aptamers
g4
targets
selex
structures
samples
00
circovirus
size
v2177
nan
risk
europe
cases
china
we
detection
virus
aquaculture
the
qpcr
data
as
international
community
responds
cmi
different
cell
osp
immunogens
experimental
perturbations
optimal
synthetic
gene
nan
method
detection
viruses
respiratory
abstract
nan
mers
cov
respiratory
approximately
patients
negative
pressure
protective
algorithm
infectious
azido
activity
human
μm
acyclonucleotide
sequences
chameleon
proteins
helix
coil
hospitals
infectious
disease
emergency
preparedness
agricultural
diseases
china
economic
emergence
nan
cells
bhk
r2
s1n330
mutants
rna
viral
flavivirus
human
stranded
iga1
proteases
human
structure
bacterial
descriptive
nec
the
epidemiology
necrotizing
mhv
cells
ri
strains
cell
nan
pma
ema
samples
pvda
hts
in
newly
disease
cov
abstract
camp
proteins
epacs
dependent
signaling
health
changes
care
theory
model
g3bp1
pedv
virus
stress
sgs
coronavirus
sars
immune
cov
pathogenesis
nan
nan
nan
viruses
common
cold
great
human
cats
years
households
cat
food
field
immunology
research
new
analysis
virus
the
detection
viruses
sequence
orf
3b
mrna
tgev
ribosomal
network
laboratories
emerging
community
respond
mabs
infectious
in
the
licensed
common
urtis
acute
illnesses
athlete
virus
cell
mice
protected
infection
nan
diseases
include
virus
common
caviae
ens
chapter
secretory
the
states
influenza
virus
coronavirus
epidemics
pandemics
rtis
viruses
infections
daycare
cohort
nan
activity
compounds
derivatives
glycopeptide
inhibitory
nan
ag
nps
properties
toxicity
nanoparticles
history
viruses
ago
abstract
the
nan
asthma
the
disease
persistent
therapeutic
sars
diarrhea
patients
intestinal
coronavirus
nan
diarrhea
outbreaks
cases
approach
leading
rv
ntz
persistent
rubella
infection
prcv
tgev
herds
antibodies
positive
odn
cats
feline
viruses
resistance
cells
marginal
zone
spleen
located
rev
ddx1
rna
hiv
protein
unknown
cholesterol
tgev
infection
cellular
membrane
led
ace
nep
inhibitor
ace2
respiratory
cases
reported
middle
syndrome
air
distribution
new
system
cabins
acr
infection
we
lung
cytokines
nan
nan
avcov
avcovs
wild
birds
samples
nan
nf
κb
prrsv
cells
activation
virus
electron
microscopy
tge
faeces
hmpv
de
un
une
respiratory
nan
coronavirus
sars
viral
research
pathogenesis
nan
assay
pestiviruses
bvdv
rt
pcr
misinformation
health
spread
analysis
related
respiratory
continuing
global
health
acute
virus
junv
expression
sirna
rna
il
10
cd8
hbv
cell
compounds
propanoyl
semicarbazide
the
benzhydryl
nan
mice
jhm
mhv
asymptomatic
astrocytes
waste
recycling
one
environmental
the
outbreak
may
symptom
onset
method
plant
vaccine
antigens
plants
expression
nan
nan
fpv
rpa
the
lfd
detection
influenza
months
age
cms
incidence
transmitted
allografts
tissue
viral
hepatitis
equipment
proper
attention
detail
overall
nan
viral
pathways
apoptotic
tools
inhibitors
nan
nan
diseases
infectious
new
disease
infections
infections
undocumented
sars
cov2
prevalence
this
commentary
discusses
pathology
pathogenesis
vanadium
different
certain
studies
chemistry
nan
nan
halofuginone
excretion
in
laboratories
placebo
golgi
endoplasmic
reticulum
pathway
abstract
nan
zikv
cq
fda
approved
infection
sars
cov
apoptosis
protein
structural
infectious
pathogens
prevent
detection
use
rna1
replication
p27
p88
the
nan
rbd
sodium
folding
differential
scanning
diarrhea
calf
bovine
pathogens
diarrheic
real
time
system
arbsw
bioaerosols
nan
nan
la
de
est
et
déshydratation
mes
screening
showed
anticonvulsant
compound
ceacam1a
receptor
mhv
jhm
sd
the
ribopyranuronamide
methyl
nucleosides
sugar
nan
acute
renal
impairment
sars
patients
unknown
blood
histo
group
glycans
disease
rhinovirus
influenza
human
infection
host
recognized
states
disease
transmission
united
pipn
associated
related
pathways
paclitaxel
respiratory
diseases
among
problems
affecting
ibd
year
age
risk
first
nan
r0
number
infectious
review
average
women
sars
pregnant
outbreak
the
npc1
cholesterol
ebov
tms
low
effects
chloroquine
viral
known
drug
protein
nucleocapsid
amino
sars
monoclonal
antiseptic
activity
hcov
229e
antiviral
infections
common
causes
pneumonia
cause
nan
nan
sars
price
housing
estate
this
nan
changes
prrsv
strain
respprrs
conservative
nan
nan
data
potential
epidemic
estimate
pandemic
nan
rna
polymerase
activity
dependent
rdrp
production
pha
the
new
bacterial
tourism
change
required
industry
based
ic
transport
the
er
abstract
nan
sars
cov
proteins
viral
protein
ieq
sbs
residents
building
evaluation
seacov
cells
swine
coronavirus
antibodies
bgs
africa
african
countries
research
genotype
hcov
oc43
genotypes
respiratory
sumatran
tigers
pedigree
analysis
tiger
scw
scwh
could
treatments
treatment
health
care
us
stock
uk
immunity
cell
bringing
together
discussion
tuberculosis
dc
sign
871a
336a
disease
china
time
mapping
2019
nan
nan
murine
aa
mhv
cells
a59
dengue
infection
the
disease
dhf
nan
fusion
virus
induced
peg
viral
hcov
strains
respiratory
human
cause
nan
emergency
jirovecii
pneumonia
cause
hypoxia
public
health
international
air
travel
bubble
property
securities
crashes
model
disinfection
systems
reliance
time
agent
pigs
infection
strain
lena
infected
virus
new
many
viruses
human
virus
95
ci
sbis
infants
viruses
pcr
viromes
diarrhea
enteric
covid
19
confirmed
case
sars
host
viral
proteins
cells
response
findings
hrct
lung
ne
patients
vris
frequent
risk
factors
viruses
pbl
participants
multidisciplinary
health
preparedness
hcv
autophagy
replication
cells
upr
se
st
flocks
elisa
bacteriological
immunodeficiency
feline
virus
fiv
viruses
sars
the
sequences
gene
ml
pcv3
pcv2
assay
the
positive
ards
lung
injury
acute
the
nan
viruses
cellular
life
genes
virus
utr
nucleotides
virus
prrsv
in
la
virus
de
el
del
urti
subjects
quercetin
group
placebo
30
detection
nanosensors
section
smart
cns
immune
infection
cells
system
patients
respiratory
use
rvp
rp
virus
host
viruses
cell
components
nan
cats
shelter
seropositivity
fcov
spent
3clpro
sars
cov
inhibitors
probe
cell
system
respiratory
cellular
lung
nan
nan
interactions
protein
virus
entry
proteins
la
des
les
en
et
virus
orsay
protein
fusion
nodaviruses
turkeys
tcv
cy
infection
cell
virus
disease
this
porcine
transmissible
nan
the
ecov
proteins
coronavirus
genome
sars
patient
patients
disease
clinical
copd
china
management
prevalence
knowledge
lymphocytes
small
bocd8
bowc1
intestine
α2a
hrifn
protein
the
solution
outbreaks
epidemics
health
abstract
not
infection
prevention
health
home
management
nan
severe
sars
involved
abstract
acute
nan
virus
sensitivity
specificity
respiratory
122
ieq
also
indoor
impact
chapter
rrv
assay
detection
study
vector
management
viral
hemorrhagic
fever
well
as
outbreak
deadly
new
coronavirus
mice
adjuvant
lesions
ldv
freund
wenxiang
diagrams
residues
two
lzcc
patients
days
high
clinical
severe
bag3
e6
cell
hpv18
tumor
sars
peptide
binding
cov
tyr
hrv
respiratory
associated
species
children
ha
erythrocytes
hi
abstract
the
major
response
nhs
incidents
this
viral
rna
mice
in
matter
human
nov
research
efforts
norovirus
nursing
home
nhap
pneumonia
therapy
cell
cycle
ndv
replication
infection
vsv
elvs
ovalbumin
cells
immunization
000
pecan
shell
fiber
food
adem
vaccination
encephalomyelitis
disease
post
nan
nan
vaccines
oral
vaccine
cancer
administration
hmpv
respiratory
infection
disease
tract
dna
using
response
immune
routes
nan
nan
pedv
serotonin
cells
ec
vomiting
signs
herbal
proper
disease
time
kobuviruses
enteric
13
in
feline
de
le
des
la
ventilation
de
les
en
sequencing
le
nan
patients
sars
fever
hospital
admission
leash
dog
dogs
interactions
observed
plant
derived
vaccines
shown
vaccine
protein
the
sars
cov
rna
protein
fragments
the
spike
sars
covid
19
respiratory
pregnant
women
building
indoor
contaminants
carbon
pollution
phylogenetic
curve
based
three
genome
cov
mers
sars
infection
dcs
nan
tgev
isolates
isolate
ia
virus
steps
chiral
cyclization
keto
lactams
epidemic
mutation
deterministic
model
process
disease
hcov
hku1
respiratory
tract
cecov
kennels
type
studies
two
myelin
cns
lesions
presence
cells
strains
melting
virulent
avirulent
real
diarrhea
calves
cryptosporidium
outbreak
infection
frameshifting
mechanism
rna
programmed
ribosomal
nan
detection
subgroups
ampv
time
current
sting
ifn
canine
gene
highest
respiratory
viruses
rvis
infections
clinical
nan
use
vaccines
the
veterinary
medicine
travel
world
microbial
humans
infectious
prrsv
infections
respiratory
disease
infection
number
assays
service
real
time
wheezing
rhinovirus
prednisolone
months
children
ebola
outbreak
events
stocks
effect
host
virus
portal
entry
replicate
antibodies
vhhs
diseases
conventional
homodimeric
receptor
human
he
oc43
binding
pcv2
vimentin
replication
infection
pk
chloropurine
this
obtaining
deoxyriboside
abstract
nan
methyltransferase
the
n7
virus
protein
analysis
showed
orf7b
heterogeneity
fcovs
helicases
viral
replication
protein
processing
cell
population
homeostatic
mechanisms
lymphopenia
respiratory
ed
patient
health
care
infectious
new
diseases
pathogens
increased
the
coronavirus
tool
sars
cov
feline
infection
expression
ifnα
immune
patients
pneumonia
understanding
in
hospitalized
nan
ada
child
scid
maternal
deficiency
nan
diarrhoea
intestine
rotavirus
mucosa
mucus
de
la
biologie
biology
microbiology
cvb3
mouse
receptor
brain
cells
cold
common
echinacea
duration
incidence
vector
borne
changes
host
transmission
sars
ltx
patients
health
transplantation
viruses
emerging
new
molecular
antivirals
viral
infectious
clone
system
genome
viruses
may
virus
usually
detection
data
health
care
economies
the
the
enzymes
chapter
peptidase
pestivirus
isatin
potent
sars
coronavirus
protease
microbiology
the
therapy
disease
culture
de
la
los
en
es
respiratory
infections
tract
rapid
detection
bvdv
ns5b
antiviral
specific
nanobodies
patients
sspe
rats
mv
same
cubicle
door
airborne
inter
dirty
isg15
proteins
ifn
ubiquitin
like
de
la
el
en
que
shopping
tv
consumer
value
satisfaction
nan
mers
cov
respiratory
symptoms
hajj
small
angle
scattering
sas
techniques
cfphv
detection
pcr
fibropapilloma
turtles
health
global
one
influenza
the
unknown
1h
one
high
inhibitory
low
computer
blood
assisted
interviewing
interviews
nan
nan
site
antigenic
protein
sequence
mimotopes
control
influenza
virus
agricultural
detect
viral
ubiquitin
protein
like
various
parasite
malaria
helicases
dead
family
recombinant
tgev
spike
sites
protein
de
la
en
salmonella
los
drug
data
repurposing
emergent
existing
ppe
performance
self
perceived
proficiency
nan
the
quality
articles
newspapers
daily
nan
group
diclazuril
toltrazuril
days
study
wind
twisted
ava
methods
flows
culture
rv
infection
turbinate
mucosal
rna
mutation
rate
viruses
high
autoab
fah
mhv
mouse
peptides
protein
coronavirus
sumoylation
sars
cov
dogs
pups
cb
05
ccov
samples
found
rotaviruses
the
rotavirus
animals
five
dogs
chronic
recurring
infections
syndromic
this
article
describes
arv
proteasome
replication
apoptosis
induced
rntd
mers
cov
vaccine
mice
immune
the
system
endocrine
cells
nan
nan
the
pneumonia
hajj
hospital
rate
animal
health
raising
conditions
relative
sialic
acid
cell
acids
occur
nan
proteins
markers
specific
poc
technology
nan
nan
pedv
attenuated
dr13
group
cell
expansion
abbreviations
abbreviation
method
in
ebov
amps
infection
africa
virus
nan
lung
patients
treatment
disease
requires
ards
viruses
respiratory
viral
pneumonia
rna
recombination
intertypic
intratypic
recombinant
animal
virus
viruses
exposure
emerging
bovine
atypical
bvdv
immunoassay
pestivirus
hrct
pneumonia
in
stage
type
slow
codon
codons
di
cognate
field
control
authoritarian
regimes
chapter
therapy
viruses
gene
cells
need
ch25h
25hc
pedv
antiviral
activity
pedv
p53
induced
apoptosis
ros
patients
urinary
tract
or
95
cnpase
reaction
2h
substrate
phosphoesterases
hsv
cells
virus
infection
mice
nan
nan
nan
influenza
patients
severity
viral
co
nan
capacity
components
framework
select
sars
hybridization
virus
pcr
subtraction
cdna
based
surveillance
network
analysis
risk
nan
isolates
cynos
dogs
respiratory
disease
nucleoside
activity
virus
cells
ec50
nan
nan
human
metapneumovirus
respiratory
virus
infections
human
pathogens
zoonotic
fecal
oral
nan
polyclonal
antibodies
the
articles
infections
polygoneae
medicinal
omics
resources
species
viral
infection
human
pathogens
antiviral
tool
compliance
improvement
infection
control
vaccines
nd
ndv
vaccine
disease
alri
children
respiratory
viruses
collected
site
zn
3c
3clpro
pol
sars
protein
cov
rsars
expressed
figure
see
text
coli
virulence
profiles
strains
dairy
coronaviruses
calves
coronavirus
isolated
diarrhoea
lps
analytical
interactions
activity
potential
communities
virtual
layer
epidemic
spreading
used
research
university
colonies
rabbits
water
supply
countries
access
conservation
3clpro
qm
reaction
sars
the
hev
movements
farms
risk
pig
nan
nan
fiv
rna
replication
rnai
specific
vector
disease
transport
global
invasion
nan
ksa
mass
covid
19
pandemics
used
management
various
diseases
oligonucleotides
vaccines
agents
used
contamination
group
feline
hepatozoon
felis
austria
domestic
infectious
health
diseases
mass
gathering
number
virus
fish
new
isolates
antarctic
viruses
seals
using
based
nan
μm
ventilation
pv
particles
dv
rv16
rv15
culture
100
respiratory
nan
severe
respiratory
cov
syndrome
sars
tb
hcw
cases
screening
tuberculosis
calves
mr
cp
starter
fed
asthma
mortality
hospitalization
across
trends
patients
patient
the
staff
nyc
nan
sfts
il
10
viral
disease
asthma
children
rhinovirus
infections
viral
amino
acid
virus
sites
hmpv
tnfr1
mice
mhv
virus
fh
sars
respiratory
inflammatory
3a
x1
sars
protein
fragments
diagnosis
cov
calves
diarrheic
abomasal
healthy
acetaminophen
enzyme
enzymes
invertebrates
converting
member
apoptosis
iav
regulation
virus
also
nan
mouse
infectious
models
studying
diseases
ratio
case
fatality
model
models
idiopathic
pulmonary
fibrosis
acute
exacerbation
nan
palm
subdomain
viruses
unique
rna
pedv
replication
viral
protease
proteases
nan
nan
unknown
common
cold
abstract
despite
prevalence
viral
the
ifn
rlr
response
nan
nan
multiple
sclerosis
disease
pathogenesis
immune
respiratory
viruses
understanding
viral
molecular
nan
the
hotel
efficiency
stage
industry
virus
vaccine
sows
reproductive
piglets
cells
hepatitis
dn
viral
mice
cells
jnk
sars
cov
akt
drug
viral
infections
therapeutic
strategies
cells
stat1
cell
development
noroviruses
niv
patients
success
failure
pneumonia
nan
international
biosafety
situation
risks
challenges
prrsv
nlrx1
antiviral
domain
viral
bcov
outbreak
disease
severe
enteric
disease
patient
investigation
in
epidemiological
human
risk
assessment
expression
health
nan
il
microglia
effects
cells
macrophage
nan
rna
jhm
specific
rats
wistar
virus
clinical
recent
ebola
paradigm
nan
betula
species
genus
traditional
research
coronavirus
sars
the
emergence
rate
host
responses
prrsv
virus
immune
sequences
coronavirus
bcov
samples
alpaca
media
cells
mass
cell
host
ang
ii
ace
converting
enzyme
h1n1
hospital
staff
group
the
proteinase
the
enzymes
chapter
structural
sindbis
virus
proteinase
conserved
nsp2
nan
travel
clinics
jsth
medical
2011
ferrets
ferret
owners
issues
veterinarians
nan
health
humanitarian
crisis
global
responses
nan
mhv
infection
cells
fusion
vsv
unknown
hpev
specimens
11
pcr
in
calves
rotavirus
cryptosporidium
f5
coli
immune
relationship
host
vaccines
antigens
sars
non
patients
0001
53
pleural
fluid
serum
cholesterol
effusion
nan
dampness
related
common
exposures
ventilation
jcv
cells
cell
24d2
infection
nan
colostrum
calves
igg
fed
plasma
various
immune
cells
tlrs
system
sows
prcv
seven
infected
litters
nan
dna
bats
lifespan
capacity
cytosolic
obesity
increased
increasing
disease
patients
nan
influenza
antiwei
placebo
patients
treatment
nan
gl
amino
activity
derivatives
influenza
autophagy
significantly
increased
process
evolved
de
la
en
el
los
ab
diagnostic
criteria
diagnosis
respiratory
application
the
chapter
antibodies
important
training
detection
the
animal
implementation
applications
biomedical
diamond
particles
chapter
bacterial
respiratory
tract
co
viral
viral
antiviral
activity
properties
lamiaceae
gi
south
virus
11
16
2019
italy
ncov
cases
china
nk
cell
cells
chemokines
role
treatment
species
diseases
this
article
omz
pro
15
ltb4
lxa4
nan
studies
evd
drugs
we
the
nan
transfusion
anemia
patients
the
ineffective
sustainable
the
culture
society
changes
viral
disease
treatment
possible
abstract
antibodies
fcr
responses
most
receptors
microbiota
nature
crs
role
interaction
nan
specimens
ari
bacteria
virus
adults
changes
chest
lung
coagulopathy
ct
cell
clone
cytotoxic
mice
virus
cells
response
memory
human
plasma
technologies
chapter
various
assays
like
rna
protein
ibv
viral
recombination
nan
contrast
sensitivity
ucva
treatment
mean
mers
cov
studies
the
therapy
however
cordyceps
the
tcm
chinese
nan
gv
influenza
virus
also
resistant
nan
infection
infections
viral
one
virus
nan
nan
light
mammary
rats
group
constant
resistance
f1
study
genome
the
influenza
pandemic
care
avian
health
tradable
services
hong
kong
total
nan
health
public
social
sanitation
life
rna
recognition
host
viral
important
prm
ndv
agm
the
dtmuv
plasma
liquid
pigs
porcine
uv
using
method
viral
sequencing
methods
neandertals
amhs
species
000years
extinction
nan
children
care
child
infections
attending
rna
mhv
a59
gene
ri
antibiotics
properties
group
antibacterial
hiv
disaster
planning
environmental
impacts
risks
resort
this
study
use
expert
maternal
child
mortality
we
major
isgs
viral
pathogenesis
interferon
stimulated
nan
vaccination
on
site
arrangements
influenza
nan
treatment
study
different
polishing
reducing
international
virus
journey
australia
abstract
evd
planning
care
patients
the
sps
compliance
nursing
year
study
virus
mv
morbilliviruses
morbillivirus
pathogens
sign
infection
hcv
the
neck
nan
ring
derivatives
abstract
on
example
la
de
en
el
del
the
strains
morocco
ibv
serotypes
und
virus
influenzavirus
der
die
risks
transfusion
transmission
transfusions
infectious
nan
sirnas
gene
system
expression
silencing
farms
calf
diarrhea
management
presence
phenylisoserine
derivatives
sars
cov
3cl
lesions
cells
lymphocytes
multocida
inflammatory
peptides
mhc
epitopes
listeriosis
listeria
vaccination
patch
hydrogel
transcutaneous
system
molecular
pcr
diagnostic
techniques
clinical
adjuvants
mineral
aluminum
phosphate
adjuvant
vaccination
influenza
elderly
chinese
people
sars
pregnancy
guidelines
outcomes
abstract
detection
dna
based
processing
product
nk
cells
cns
cell
tumor
patients
viral
days
symptoms
14
nan
additive
color
disinfectants
hypochlorite
chlorine
cause
morbidity
mortality
pregnant
women
hcws
sars
infection
control
hospital
human
ms
infection
disease
could
nan
asthma
admission
respiratory
air
risk
chinese
medicines
herbal
available
in
infections
early
viral
asthma
the
chloroquine
anti
hiv
the
activity
emr
exchange
hospitals
electronic
medical
hci
inflammatory
anti
protein
the
protein
rna
the
viral
virus
antibody
virus
000
neutralizing
monoclonal
brain
animal
development
models
ferrets
infants
infections
respiratory
preterm
study
recombination
rna
orf
transcripts
transcript
primary
destruction
myelin
demyelination
immune
il
35
nasal
ova
ril
patients
rti
acute
asthma
control
agreement
wto
harmful
fisheries
subsidies
indicators
pathogens
bacteria
the
water
lymphocytes
shown
processing
molecule
pomc
nan
nan
zikv
rfs
virus
cells
neurological
drugs
the
pharmaceutical
drug
use
species
trypanosoma
trypanosome
little
genetic
sars
rna
pbmcs
cov
stranded
nan
disease
infection
transport
related
number
cholesterol
cells
protein
infection
sars
stress
rna
granules
virus
number
pandemic
geriatric
abstract
this
article
viruses
emerging
factors
disease
viral
cleaning
microbes
the
applications
surfaces
svlp
mers
cov
rbd
mice
nan
control
hcai
the
infection
surveillance
the
health
curriculum
clinical
framework
nan
nan
nan
human
virus
this
year
nobel
nan
infection
cells
repair
respiratory
viruses
nan
virus
clinical
specific
antibodies
abstract
nan
human
olfactory
system
nalt
nasal
health
social
human
one
disease
nan
emerging
infectious
diseases
southeast
asia
la
de
en
virus
influenza
genotypes
bieneusi
cryptosporidium
bats
specimens
diarrhea
pedv
china
porcine
epidemic
ecov
cells
mdbk
apoptosis
infection
nan
host
problems
pathogen
complexities
the
ccr5
mice
mhv
infected
host
nan
foot
animals
clinical
irt
infected
viral
pneumonia
respiratory
infections
treatments
nan
the
response
host
pathogen
major
macrophages
responses
b2
infection
chickens
influenza
information
web
university
sites
nan
de
la
las
el
del
nan
tb
evd
healthcare
the
outbreak
tourists
study
beliefs
hit
destinations
nan
nan
algorithm
disease
people
optimization
infectious
nan
horses
clinical
ecov
the
pcr
rt
the
rpa
tgev
real
virus
deoxyuridine
isoxazoles
abstract
this
nan
region
industry
budget
carriers
lccs
nan
pathology
respiratory
inhalation
effects
system
diseases
abstract
brief
presentation
given
sars
cov
ferrets
in
expressing
sars
the
immune
responses
cov
disease
sars
many
control
virus
sars
epidemic
approximately
coronavirus
person
nan
patients
readmission
younger
risk
day
19
covid
patients
disease
could
elisa
the
protein
ccov
recombinant
diarrhea
neonatal
pathogens
the
species
rbac
niv
protein
recombinant
the
inoculated
two
animals
coronavirus
cns
nan
disease
model
information
human
three
respiratory
week
lbp
saa
concentrations
processes
sterilization
disinfectant
agents
chemical
health
maternal
care
china
mortality
cov
regions
sars
the
viral
bovis
calves
disease
associated
otitis
nan
nan
structures
refinement
cryoem
glycan
advances
marine
antiviral
available
compounds
many
the
imaging
patient
computed
tomography
days
antimicrobials
children
respiratory
fn
il
cns
humoral
responses
21
nsps
the
prrsv
arterivirus
virus
viral
ifn
signaling
virus
immune
nan
nan
health
region
systems
challenges
key
nanotechnology
poc
detection
nanoparticles
infectious
de
en
la
el
virus
nan
ga
ev71
cva16
the
glycyrrhiza
sars
patients
lung
the
disease
nan
nan
models
contact
diseases
networks
social
emerging
health
zoonoses
disease
species
lipoxygenase
lipoxygenases
enzymes
pro
inflammatory
nan
dna
cell
vaccine
epitope
immunization
de
el
control
con
la
vaccine
immunity
antigens
surfaces
structural
patients
the
china
admission
disease
ifn
ferret
ferrets
influenza
infection
cell
death
oligodendroglial
cuprizone
oligodendrocytes
health
global
diplomacy
the
nursing
nan
care
the
ebola
biocontainment
patient
chitosan
tinctoria
hairy
root
cultures
infants
respiratory
viral
sepsis
evaluated
hospitals
information
web
based
mail
species
the
forms
polypeptide
glycoproteins
plants
pathways
proteins
plant
glycosylation
nan
mass
gatherings
health
countries
new
nan
rvv
sars
mice
cov
severe
fungal
disease
animals
infection
conidiobolus
virus
the
diagnosis
isolation
identification
nan
zoonotic
viral
infections
influenza
bacterial
cchf
ribavirin
studies
mortality
number
nan
nan
translation
viral
mechanisms
viruses
protein
protein
apoptosis
cells
sars
cov
utr
prrsv
type
the
replication
oxygen
hemoglobin
blood
research
carriers
nan
nan
detection
dfa
virochip
viruses
respiratory
hbov1
detection
antigen
dna
mrna
eae
cells
induction
cd4
cd8
influenza
pandemic
agents
generic
virus
de
les
et
la
des
nan
icaritin
bone
saon
collapse
scaffold
zikv
antibodies
neutralizing
activity
infection
vectors
adenoviral
vector
immunity
had
health
public
surveillance
system
this
nan
bus
conditions
ventilation
system
experimentally
nan
nan
calves
day
concentrations
diarrhea
the
sars
cov
vaccine
protein
high
the
new
respiratory
virus
emerged
nan
nan
trip
travelers
the
leisure
business
sars
cov
civets
first
disease
quadruplex
in
syndrome
physiological
nucleic
cells
cytotoxicity
lymphocytes
nk
mhc
development
hematopoietic
lymphocytes
discussed
neonatal
factors
environmental
ms
in
immune
proteins
bcl
family
bh3
sequence
region
sequences
non
coding
strain
de
et
les
la
sont
nan
nan
pneumonia
childhood
case
surveillance
children
hrv
3cpro
protease
novel
activity
waddlia
chondrophila
pneumonia
elisa
role
samples
mutations
protein
cats
fip
nan
bovine
respiratory
important
immune
disease
three
using
enzyme
labelled
the
diarrhoea
lambs
kids
syndrome
common
nan
abstract
valuable
antiviral
compound
win
bat
origin
coronaviruses
host
infections
ifn
proteins
subtypes
protein
aa
health
wildlife
one
issues
communities
nan
nan
nan
the
disasters
people
changed
ways
nan
household
model
random
transmission
influenza
ad
pcr
adenovirus
consensus
if
bcv
protein
cells
chimeric
he
viral
fusion
cellular
membranes
glycoproteins
infection
autophagy
bkpyv
virus
role
the
nurses
mers
cov
program
ash
bottom
heavy
metals
mw
expression
coronavirus
coronaviruses
systems
family
bacterial
measures
impact
body
humans
infection
infections
viruses
influenza
respiratory
viral
host
cpe
cell
program
vizier
rna
viruses
viral
targets
virus
seacov
diarrhea
porcine
enteric
veev
artificial
micrornas
replication
rna
hmpv
assay
respiratory
plus
rt
nan
hamster
hprp
expression
mice
kb
membrane
protein
transmembrane
folding
biological
nan
nan
nan
epidemics
the
part
discusses
current
viral
humanized
study
therapies
abilities
pold1
polδ
repair
mutations
polymerase
herbs
animals
effects
may
usage
health
hajj
ksa
pilgrims
public
dogs
canine
cird
cpiv
bronchiseptica
metabolic
host
viral
control
resources
his
weakness
25
lb
weight
nan
nan
viral
agents
culture
including
laboratory
cells
mhv
viroporin
protein
virus
oxygenated
oxygen
mean
mm
hg
3c
enzyme
cys172
inhibitor
hav
food
handlers
nasal
hand
contamination
nan
jhm
mice
mhv
acute
encephalomyelitis
filters
filtration
filter
nanofiber
aerosol
hbov1
the
co
viruses
correlations
lesions
infectious
peritonitis
wildcats
occurred
lncrnas
tb
mrnas
deregulated
ltbi
fcov
pin1
fk506
replication
feline
pu
tio2
cu
famata
105
nan
sars
severe
respiratory
coronavirus
disease
nan
unknown
control
select
biosecurity
institutional
oversight
serviceberry
potential
functional
food
mg
unknown
flu
100
years
infamous
spanish
hong
kong
2003
cases
sars
mers
cov
clinical
management
hospitalized
nan
nan
agvhd
patients
steroid
ecp
disease
cell
residues
clones
peptides
rubella
vaccines
vaccine
development
whole
either
tgev
cardenolides
anti
activity
st
nan
tgev
rna
method
assay
based
attenuated
pathogenic
the
mutant
viral
foodborne
food
viruses
illness
increase
news
coverage
travel
bed
bug
sore
throat
common
symptoms
medical
health
public
zoos
conservation
research
cns
ev
tropism
host
cytolytic
time
real
rt
pcr
bvdv
protein
scov
golgi
sirnas
expression
sleep
infections
respiratory
ri
week
nan
calves
vaccinated
duodenalis
non
vaccine
95
or
ci
studies
co
viral
infections
neurologic
epidemiology
disease
ace2
function
abstract
the
membrane
virus
ifitm
abstract
the
interferon
device
identify
bacteria
viruses
fungi
plpro
isg15
the
like
sars
membranes
host
cell
viruses
cells
nan
nan
hcp
lps
induced
inflammatory
ali
fcsq
clinical
theory
effectiveness
rcts
mers
cov
respiratory
disease
growing
ibv
variants
chickens
isolated
2009
nan
no
virus
000
virion
oc
acute
coronary
st
elevated
mi
measles
virus
sspe
infection
acute
acute
bronchitis
antibiotics
management
patient
la
de
el
infection
las
aki
patients
dpp4i
ckd
kidney
cov
sars
cells
human
oc43
cells
tumor
ability
dcs
autophagy
nan
respiratory
episodes
pathogens
children
symptoms
discussion
this
chapter
commences
ensuring
nan
e2
mhv
amino
deletions
sequence
nan
vaccine
level
responses
in
vaccines
gilts
tgev
prcv
litters
survival
values
given
abstract
table
molar
different
we
sample
serum
plasma
nan
nan
nan
macro
domain
domains
proteins
recent
ddx3
jev
viral
replication
rna
sorting
week
supernovae
absolute
zeros
wheezing
children
years
risk
factors
prrsv
hp
pigs
lung
infected
nan
modrna
translation
post
ischemic
utr
archaeal
viruses
scub
virus
codon
late
sequences
coding
gene
vaccinia
calcium
virus
viral
cells
increase
nan
nan
nan
time
respiratory
tract
infections
real
virus
porcine
sads
cov
method
health
public
disease
new
control
fdi
china
destination
export
abstract
virus
polyomavirus
mechanisms
the
this
nan
the
mers
outbreak
case
south
unknown
die
der
und
substanz
als
codon
usage
niv
used
nipah
website
the
tourism
site
greece
microbiome
gut
immune
factors
microbiota
emerging
new
provide
one
vaccine
respiratory
viral
infections
transplant
significant
vaccinated
mice
wnv
mock
cells
nan
techniques
effectiveness
hospital
human
using
nan
nan
isolates
antimicrobial
disc
diffusion
mic
pcr
virus
quantitative
assays
the
cells
trif
pmcs
mesothelial
innate
virus
c12
wild
type
weakly
de
la
congo
con
los
de
et
la
ecmo
technique
nan
ms
cns
bbb
viral
this
sirna
activity
antiviral
rnai
unmodified
coinfection
viruses
detected
rsv
clinical
parp
apod
binding
expression
promoter
nan
phage
mammalian
cells
transfer
gene
validation
pcr
silico
in
pcrv
effector
reaction
lc
cytotoxic
51cr
hygiene
safe
health
improved
behaviour
mrv
zj2013
piglets
mrv3
china
international
medical
this
loophole
quarantine
nan
nan
cell
human
replication
lines
coronavirus
nan
elisas
detection
cpv
dogs
canine
smoke
blood
inhalation
ace
ace2
filtration
bacterial
silver
membranes
capillary
airborne
we
infectious
disease
current
strains
vaccine
type
mass
ck
poms
anti
sars
3clpro
the
nan
patients
glycyrrhizin
group
urtis
study
refugees
turkey
syrian
cases
temporary
unknown
chinese
herbal
injections
common
injection
nan
associated
disease
aureus
vasculitis
microbial
volatility
non
deliverable
forward
correlation
nan
hsv
quadruplex
genome
sequences
viral
reproduction
number
time
coronavirus
transmission
r1
jhmv
maturation
infection
protein
primates
the
species
nuclear
neural
igg
sars
days
igm
iga
the
deadly
virus
emerged
wuhan
nan
nan
adenosine
kinase
abstract
the
conversion
biological
the
agents
use
aimed
antiviral
research
icar
the
international
drug
impurity
ribavirin
crystallization
kinetics
sheep
lestoquardi
annulata
cattle
infection
de
en
la
que
control
nan
new
viruses
virus
strains
the
nan
nan
gold
hedge
inflation
run
local
fcov
ccov
cats
strains
samples
services
health
community
public
basic
sars
cov
the
antiviral
no
type
ii
assays
rna
dogs
astroviruses
infection
identified
association
mammalian
rna
recombination
recombinants
mhv
class
rna
chaperones
viruses
viral
replication
nan
baculovirus
nature
non
cells
vector
protein
recombinant
the
truncated
pedv
nan
risk
nsaids
acute
viral
children
astrovirus
apoptosis
death
cells
human
infections
respiratory
persons
community
elderly
endomembrane
image
pollen
quantitative
analysis
birth
death
in
dip
wake
ce
the
analysis
using
optimized
gfp
envelope
hbv
virus
fluorescent
sars
cov
il
cells
ace2
nan
nan
nan
reproductive
poultry
production
management
million
zinc
effects
viral
tgev
zncl2
alcohol
product
the
water
61
clinical
ebola
virus
dangerous
disease
mabs
use
single
monoclonal
antibodies
nan
mers
cov
the
score
infection
nan
serology
hospital
positive
workers
influenza
de
la
molécules
les
antiviral
infection
the
infections
patient
immunosuppressive
children
school
outbreak
million
disease
cells
cho
stable
cell
lines
protein
sars
proteins
antigenic
sera
the
industry
perioperative
time
safety
enterovirus
ev
virus
entry
uncoating
memory
cell
specific
populations
antigen
rt
pcr
seminested
csfv
the
this
chapter
air
abstract
presents
mers
cov
health
care
outbreaks
influenza
infected
seasonal
pandemic
illness
fitness
viral
virus
research
recent
nan
affinity
purification
protein
recombinant
proteins
de
des
ou
etc
une
disease
respiratory
this
bacterium
illness
nan
nan
conserved
s2
fusion
sars
cov
extract
plant
showed
antiviral
lycium
helices
we
structure
coronavirus
nucleocapsid
adenovirus
the
proteins
method
based
vlp
vaccine
placebo
groups
events
no
protease
viral
cysteine
replication
nan
states
eu
disease
the
control
nan
sars
cov
coronavirus
mers
infections
gp65
protein
glycosylation
chase
virion
1rf
rna
pseudoknot
frameshifting
system
nan
rbcv
infection
heart
changes
failure
nan
nan
nan
nan
free
ranging
captive
populations
diseases
disaster
methods
epidemiology
utilized
studies
scblc
hrv
igg
severe
gastroenteritis
er
proteins
axons
associated
protein
de
virus
vaccine
vaccines
live
environments
living
systems
human
earth
et
de
des
les
la
intracellular
delivery
nanomaterials
drugs
organelles
particle
sources
the
indoor
types
the
centrifugation
fipv
virus
cells
nan
rna
di
mhv
replication
sequences
safety
patient
hospitals
activities
infection
rab1404
rva
genes
rvas
genome
screening
virtual
small
hierarchical
discovery
nan
nan
de
une
les
la
un
removal
sand
filter
water
biological
rnas
long
rna
sizes
secondary
nan
il
26
camel
the
variants
library
antibodies
antibody
libraries
generated
prediction
cell
epitopes
epitope
mhc
wild
porcine
boars
study
rva
ions
air
ion
efficiency
antiviral
bismuth
used
heavy
metal
in
epitopes
accessibility
antigens
surface
sequence
de
les
des
et
ces
antibodies
germline
hiv
epitopes
binding
site
typhimurium
expressed
tgev
χ3730
animals
exotic
small
species
disease
nan
marine
natural
products
indole
alkaloids
the
australian
bioterrorism
united
threat
asthma
viral
infections
risk
articles
poct
national
point
of
care
algorithm
lat
mapping
activation
able
drug
diseases
host
response
drugs
patients
therapy
severe
important
controlling
eif3f
muscle
initiation
mafbx
atrogin
adp
ribosylation
modification
post
translational
methyl
virus
activities
pmea
prodrugs
nan
microbial
abstract
this
chapter
describes
stress
drought
expression
glycyrrhizin
levels
nan
control
1999
2005
sd
infection
fish
raw
sharing
isaan
consumption
cabin
ventilation
system
contaminant
proposed
synthetic
biology
drug
providing
discovery
epidemic
community
communities
heterogeneity
network
bcv
pag
iem
nasal
calves
nan
virus
virions
continue
infection
process
protein
sars
coronavirus
cov
the
nan
carbon
intensity
convergence
levels
level
nan
protein
epitopes
pedv
s1d
residues
ms
tα1
tβ4
inflammatory
multiple
nan
human
respiratory
virus
viral
detection
peptide
based
immune
obstacle
vaccine
mhv
strains
nucleotide
sequences
protein
calves
day
mr
health
fecal
nan
the
philippines
malaysia
identified
first
nan
days
respiratory
group
antibiotics
sd
de
et
sont
la
les
may
vn
retinal
compromise
inflammatory
nitazoxanide
patients
mg
influenza
placebo
diarrhea
cattle
decide
antimicrobials
used
standard
precautions
group
intervention
knowledge
lycorine
viral
compound
antiviral
rna
clinical
dogs
vaccinated
renal
leptospirosis
mucosal
response
vaccine
lkt
vaccination
nan
nan
proteins
quality
control
hydrophobic
cell
innate
defense
factors
immunity
humoral
events
evd
africa
countries
put
expression
plants
transient
protein
health
viruses
vlps
discussed
the
different
ms
ros
oxidative
stress
well
nan
sont
qui
une
et
due
coronavirus
respiratory
pneumonia
we
cancer
boarding
patients
95
ci
ed
nan
nan
nan
nan
chemical
targets
microarray
hts
compounds
sample
virus
enrichment
method
sequences
pathogens
host
population
pathogen
species
bioaerosol
various
several
indoor
also
outbreak
sars
depressive
levels
symptoms
ocular
systemic
feline
diseases
associated
old
infants
months
individuals
human
nasal
lymph
the
friable
tan
viral
tge
virus
immunogen
component
viruses
water
pathogens
infect
enteric
nan
emerging
diseases
population
within
industry
in
new
global
abstract
novel
nan
viruses
virus
paper
abstract
why
nan
tgev
apoptosis
cells
infection
activation
promoter
rna
di
synthesis
nucleotide
rna
viral
hantaviruses
hantavirus
pathogens
surface
pathogens
technologies
new
detection
ts045
temperature
protein
oligomer
oligomerization
hbov1
hae
infection
cultures
human
sars
cov
cells
in
vero
asthma
acute
induced
10
virus
nan
pbv
samples
ss
page
24
nan
models
respiratory
viral
infections
chronic
nan
nan
de
des
et
protein
coronavirus
blood
factor
plasma
products
immunoglobulin
sialic
acid
gold
nanoparticles
influenza
nan
nan
ms
myelin
cross
tcc
hcov
burnout
nurses
mers
cov
stress
sars
influenza
human
animal
respiratory
climate
change
influenza
global
data
nan
polysaccharides
iip
aluminum
hydroxide
vaccine
antibody
layer
gp3
the
phage
production
food
chemical
ecosystems
human
rva
g9
genotype
dog
sccd
mers
cov
cases
respiratory
disease
smallpox
outbreak
emergence
global
response
changes
prrsv
strain
respprrs
conservative
health
one
viruses
water
approach
virus
inhibition
activity
sialate
abstract
rats
laboratory
infections
viruses
virus
nan
drug
inhibition
host
generate
potent
orfs
tcov
genome
protein
coronaviruses
identity
vp5
vp7
tak2
nt
nan
nan
plasma
patients
treatment
sars
ribavirin
infectious
virus
may
immunodeficiency
feline
ifn
viruses
antagonists
viral
innate
stoats
disease
invasive
britain
new
states
japanese
anthrax
us
case
travel
patient
medicine
continues
grow
phage
sars
cov
the
study
cold
the
common
days
may
3clpro
feline
amino
acid
changes
hmpv
associated
study
costs
care
antibody
profiles
technology
lips
personalized
vaccination
h1n1
influenza
seasonal
vaccine
nan
disease
atherosclerosis
process
infectious
chlamydia
ptp
viral
expression
bmptp
replication
two
epidemic
different
layers
spreading
rapid
virus
diagnosis
method
would
system
taxpayers
acceptance
model
internet
zikv
virus
drug
recent
outbreak
nan
world
diarrhoeal
diseases
health
clean
bctraf3
bcsting
cells
traf3
antiviral
nan
lassa
assay
virus
based
lasv
influenza
human
highly
pathogenic
virus
the
protein
variants
virus
deletion
visual
hhc
visitors
family
stimulus
outbreak
control
planning
summary
the
training
emergency
preparedness
the
public
fatal
brain
rats
marked
class
protein
rn
cell
peptides
residues
sars
airway
the
2003
ppe
patients
travel
screening
protocol
disease
nan
nan
nan
cd13
tpic
co
localization
endocytosis
sars
n3
n1
dna
protein
virus
immunodeficiency
1987
cats
fiv
3clpro
mhv
proteinases
within
residues
ene
the
compounds
thiazolidinones
c5
airway
adult
croup
distinct
disease
virus
influenza
compounds
ec50
μm
nan
nan
dogs
dog
laboratory
animal
biomedical
composite
nonwovens
medical
applications
products
sirna
delivery
rna
rnai
based
de
adem
est
une
du
nan
nan
nan
foetus
infection
fpv
feline
diarrhoea
nan
sirna
viral
delivery
approaches
demonstrated
pediatric
patients
fluid
therapy
assessment
stem
unfolding
the
pseudoknot
type
nan
virus
chikv
nsp2
new
antiviral
patients
ed
pneumonia
remains
one
sars
vaccine
containing
exosomes
adenoviral
nan
medical
physicians
patients
000
air
nan
covid
19
cv
cardiac
patients
infectious
disease
model
emerging
selection
calves
trial
phase
til
con
control
viruses
nucleic
acid
diagnosis
blood
transfusion
techniques
related
incidence
advax
specific
vit
adjuvant
igg4
nan
nuclei
trypanosomes
early
induction
major
cells
cd8
apoptosis
tnf
fip
influenza
flu
assay
the
al
cell
epithelial
stem
summary
the
tcm
artis
trials
evidence
cochrane
virus
the
possible
abstract
sars
cr1
snps
associated
risk
cardiovascular
nan
nan
dna
asthmatic
children
adenovirus
nasopharyngeal
lagrangian
model
eulerian
present
dispersion
nan
prednisolone
acetaminophen
indomethacin
patients
group
nan
parasites
marmosets
captive
facilities
internal
nan
norovirus
rdrp
noroviruses
rna
the
ocean
national
development
economy
china
pediatric
health
vaccines
today
vaccination
unknown
nan
nan
cpv
iipcr
detection
2b
pcr
ppe
the
stockpile
risk
influenza
22
il
mpil
infection
porcine
nan
nan
nan
mhv
orf
1a
a59
sequence
nan
work
algorithm
journalists
author
journalist
spread
virus
variant
infection
rate
nan
the
fta
method
semen
bohv
gag
responses
dna
native
lamp
parvum
diarrhea
pathogens
calves
infection
nan
de
les
réanimation
des
care
disease
changes
they
new
human
multi
paper
level
framework
global
nan
nan
cypa
gf
rgnnv
replication
cells
vaccine
virus
vlps
viral
immune
dissemination
abstract
the
replication
jhm
nan
nan
coronavirus
virus
coronaviruses
group
includes
genes
cows
lactation
pregnancy
downregulated
acr
clad
gene
expression
lung
cap
influenza
viral
viruses
cause
mood
bd
bas
coping
flexibility
pneumonia
virus
pneumonias
adults
mycoplasma
infection
in
susceptible
proportion
reproduction
ebov
marv
cathepsin
gp
entry
ptss
outbreak
covid
19
china
bovine
rotaviruses
calves
neonatal
diarrhea
influenza
pandemic
vaccines
the
interventions
health
public
international
travel
home
epidemic
health
care
control
during
sars
hla
patients
asian
showed
viral
antiviral
designs
different
control
common
toxicologic
nontoxicologic
rule
outs
care
patients
european
infection
control
nan
nan
sars
rings
3clpro
three
aromatic
patients
outcome
chest
sars
initial
approved
ebola
virus
treatment
drugs
target
aptamer
structure
inhibiting
quartet
sud
domain
two
domains
mc
infection
hmpv
residents
probable
older
diseases
hospital
infectious
the
response
nan
cox
protein
sars
binding
cov
shock
lps
gl
platelet
injection
mers
case
experienced
cov
management
fip
african
lion
feline
ocular
cells
mhv
tgev
surface
lmr
viruses
host
viral
infection
mutation
hcov
nl63
children
per
year
group
bj
isolates
sars
cov
tb
africa
mdr
estimated
million
factors
organizational
protective
health
care
sequence
end
oc43
leader
hcv
serum
iga
milk
igm
bcv
nan
vap
patients
group
studied
intermittent
nan
nan
ebn
influenza
viruses
extract
could
nan
the
response
mice
cells
virus
19
coronavirus
covid
respiratory
syndrome
mice
gko
balb
b6
infection
disease
animal
biosecurity
diseases
disposal
who
we
health
budget
disease
virus
entry
rsv
mv
infection
cells
glial
cultures
clones
class
clinical
sars
cov
cases
abstract
tim
filovirus
vero
e6
cell
evolution
viruses
virus
host
nature
detection
ieb
tumor
diagnosis
specificity
immune
response
host
microbial
cells
care
infectious
eg
virus
health
virome
reservoirs
tributaries
distribution
diversity
diarrhoea
calves
rotavirus
calf
one
s1
amino
acid
strains
residues
nan
viruses
bovine
coronavirus
rotavirus
enteropathogenic
new
increased
across
disease
preparedness
nan
diseases
natural
diverse
nature
life
tgf
plpro
β1
type
collagen
nan
jhm
virus
mhv
rats
wistar
nan
animal
model
pathogenesis
ferrets
viruses
adem
cns
acute
disseminated
encephalomyelitis
respiratory
prescription
patients
admission
influenza
cough
infection
acute
viral
clinical
2020
online
jan
first
third
ps
rep
porcine
treatment
rna
nan
inpatient
air
buildings
the
indoor
bushmeat
consumption
risk
per
trade
progeny
virus
summary
porcine
enterovirus
les
techniques
agents
de
inactivation
nan
infections
head
neck
evaluation
available
drugs
activity
abstract
one
viable
ribavirin
kittens
free
given
challenge
viral
models
disease
mouse
virus
mediated
activation
pathway
mitochondria
mhv
diabetes
ii
ang
ace2
angiotensin
nan
outbreak
respiratory
sars
amoy
gardens
mhv
linked
the
strains
glycosylation
antiviral
polymer
ribavirin
macromolecular
activity
marneffei
patient
fungal
patients
hiv
hadv
2013
tj
respiratory
outbreak
placentas
sars
the
pathology
placental
sludge
sewage
european
2010
escherichia
t7
virus
csfv
cdna
pk
cov
sars
coronavirus
respiratory
syndrome
hiv
neutralizing
broadly
antibodies
effective
virus
humans
sars
phylogenetic
analyses
nan
electrochemical
aptasensors
aptamers
receptors
sensitive
und
die
infektionskrankheiten
werden
durch
technologies
data
analysis
biological
information
nan
health
diseases
infectious
care
infections
diseases
infectious
emerging
worldwide
spread
glycyrrhetic
acid
the
polymerization
sulfite
decision
making
people
cultures
review
abstract
am
infect
control
2001
risks
emerging
manufacturing
technologies
risk
control
nw
wssv
ammonia
group
patients
sars
epidemic
ed
the
rna
protein
binding
ntd
trs
q1
strain
like
complete
ibv
urban
ducks
viruses
iav
wild
nan
mers
cov
health
care
human
disinfection
virus
air
tio2
efficiency
nan
chikv
based
in
inhibition
amirnas
ad
gene
vectors
modification
current
nan
stem
cells
nps
the
subchapter
global
diseases
warming
climate
change
adv
pigs
nervous
peyer
patches
nan
gene
vlps
structural
tbev
therapy
chloroquine
akt
analogs
inhibitors
cell
ibv
chifn
stimulation
production
virus
nan
viruses
enveloped
proteins
surface
structures
states
united
ped
disease
scenarios
events
australian
tourism
industry
war
nan
la
est
une
un
et
protein
surface
biosensor
gst
plasmon
l1
l2
glrav
infection
minireplicon
niv
cleavage
fusion
proteins
protein
dead
box
deah
helicases
immunity
global
health
medical
education
schools
students
measures
pandemic
university
preventive
nucleoside
hcv
abstract
series
substituted
cells
tumor
inflammatory
inflammation
and
nan
health
public
model
domains
the
nan
patients
mma
vs
respiratory
using
nan
immune
cells
lung
pneumonia
may
virus
influenza
respiratory
also
viruses
nan
infection
mers
associated
cov
respiratory
nan
14
cytostatic
activity
novel
pyrimidine
cytokines
proteins
immune
virus
viruses
cells
cd8
co
cd46
cd4
synthesis
stepwise
solid
phase
acids
the
dem
clinical
like
disseminated
complex
co
phen
ru
ii
virus
using
electron
microscopy
sedimentation
nan
enf
hiv
peg
conjugate
treatment
nw
arenaviruses
infection
host
innate
influenza
eiss
pcr
the
surveillance
management
includes
evidence
routine
practice
monoclonal
antibodies
e3
glycoprotein
neutralizing
we
concentrated
adenovirus
copd
e1a
crisis
hospital
the
patients
risk
disease
malignant
histiocytosis
an
year
rnase
domain
5a
pseudokinase
ankyrin
nan
cakv
canine
cakvs
dogs
recently
abstract
bronchiolitis
lower
respiratory
infection
nan
nan
25
app
hajj
reported
study
adams
adam
the
family
functions
subtype
strain
bor59
pigs
prrsv
prrsv
th1
response
virus
expression
we
large
time
mutation
population
mers
cov
the
virus
area
nan
shasta
fever
src
diarrhea
cases
rhinitis
allergic
nonallergic
mild
also
calves
hsf
fed
igg1
iga
nan
tge
samples
swine
prcv
all
assays
virus
testing
colorimetric
high
structure
receptor
at2r
complex
new
income
demand
japan
travel
model
prrsv
infectious
clones
proteins
cdna
dna
genosensors
new
biosensors
main
veterinary
risk
ipcs
compliance
in
wound
healing
major
diseases
organs
dogs
virus
days
group
pcr
wind
buoyancy
transmission
risk
infection
nan
consumption
electricity
hong
kong
the
dogs
inoculated
the
inoculation
cysts
denv
intrahost
dengue
viral
pressures
emergency
planning
this
chapter
discusses
chronic
lung
diseases
infections
article
mbl
ibv
chickens
vaccine
l10h
cells
nodules
dog
exhibited
lungs
unknown
nan
public
communicating
health
crisis
information
health
public
practice
global
evidence
collagen
stem
cells
cell
films
nan
viruses
mutualistic
generally
idea
new
nan
71
ev
virus
the
rna
nan
rt
the
lamp
disease
reaction
peptidase
the
enzymes
chapter
nairovirus
factors
associated
time
cox
model
health
g7
g8
commitments
world
camel
calf
diarrhea
study
coli
proteins
the
papn
binding
truncated
risk
biosafety
high
level
laboratories
two
immunization
years
global
vaccine
nan
nan
nan
nan
de
pneumonia
community
acquired
na
isav
rna
method
virus
pcr
based
treatment
phenotypes
death
waddl
nan
cryptosporidiosis
halofuginone
lactate
effective
calves
nan
the
trachea
upper
airway
segment
nan
tgev
viruses
virus
prcvs
neb72
our
fight
climate
change
offers
nan
colds
the
common
treated
group
unknown
females
males
rats
adenomas
gland
rna
advances
small
molecules
recent
lc3
ii
gabarap
autophagy
modification
viral
cell
entry
steps
host
epidemic
plague
pneumonic
northeast
china
lung
diseases
disease
shifted
better
china
model
using
the
cases
viral
receptor
structures
complexes
proteins
virus
et
les
de
syncytial
health
mgs
public
research
development
disease
2006
emergence
french
epidemic
vector
prv
virus
tgev
phs
respiratory
viruses
influenza
include
adenoviruses
aminopeptidases
enzymes
often
diseases
the
nan
virus
de
la
el
con
npcs
derived
ipsc
cell
infection
sars
hong
kong
toronto
family
the
ebola
problem
virus
infection
pathogens
immune
research
dutch
body
lasv
losmapimod
lassa
fever
hemorrhagic
antibody
patients
responses
h7n9
virus
tb
tuberculosis
fq
isolates
cap
sars
care
nurses
patients
intention
abstract
the
anatomical
development
primary
use
health
nurses
equipment
fpe
transgenic
db
astrocytes
mhc
class
nan
cnf2
cdt
isolates
the
positive
sars
cov
mabs
protein
inactivated
et
blood
la
transfusion
des
slam
b95a
cell
line
virus
zika
virus
infection
nursing
practice
hybridization
buffer
reh
probe
ish
pneumonia
de
acute
organizing
alveolar
region
infectivity
sars
cov
mutants
fivple
lions
fiv
infected
aids
viral
infections
influenza
respiratory
identified
nan
2019
ncov
neonatal
infection
neonates
rsv
rt
pcr
real
time
vaccine
delivery
dna
vaccines
electroporation
proteases
papain
like
virus
sequences
viral
virus
patients
the
agents
nan
nan
inhibition
longer
chain
perfluoroalkyl
substances
influenza
h1n1
2009
rapid
resistant
circular
rnas
many
pkr
generated
sirnas
activity
antiviral
strains
veev
nan
pigs
pedv
suckling
infected
weaned
screening
false
compounds
hits
promiscuity
nan
leukocytes
ifn
tgev
porcine
infection
antiviral
research
the
award
viruses
nan
oxalate
medicinal
herbs
soluble
chinese
asthma
10
ip
acute
cathelicidin
nan
proteins
isg15
herc5
interferon
isgylation
f1
protein
patients
sera
hcv
sars
protein
n195
cov
a5d5
epidemic
nodes
infection
rate
spreading
nan
oligodendrocytes
replication
jhmv
coronaviruses
findings
ped
the
sows
exposed
groups
vaccine
would
it
manufacturing
small
de
las
la
infections
infecciones
denv
protein
ptb
ns4a
study
or
ci
95
salmonella
spp
infections
antibiotics
use
bacteria
sinusitis
based
virus
like
human
health
ppe
hcws
use
removing
eye
dna
vaccine
small
animal
models
encephalitis
ngs
diagnostic
cases
methods
nan
hybridization
detection
specimens
virus
rna
antisense
gene
agents
technology
various
algae
microalgae
seaweeds
red
source
year
parvum
cryptosporidium
infection
one
spread
mass
gathering
epidemic
transmission
exacerbations
bacterial
copd
inflammatory
clinical
de
la
el
angiotensina
los
nan
bats
humans
antiviral
viruses
asymptomatically
organisms
may
disease
role
infectious
the
backyard
infection
farming
microbial
viral
cross
based
immune
immunodominant
bcov
rt
assay
rpa
the
comprehensive
the
there
flow
detection
nan
respiratory
infections
gene
viral
virus
nan
bipolar
the
hospital
patients
acute
nan
nan
cpv
2a
2b
2c
canine
measles
virus
cell
same
mbp
mers
death
time
estimate
cfr
bdv
infection
acetylation
proteome
histone
nan
social
media
scientific
reports
abstract
nan
bki
1369
piglets
drug
toltrazuril
nan
samples
viruses
detect
present
techniques
cell
sars
cells
ace2
cov
pahs
pah
ashes
mg
incinerators
viral
the
air
virus
bacterial
blood
components
alterations
may
cell
510
sars
protein
vaccine
fragment
nan
virus
another
strategy
regarding
diagnosis
nan
nan
nan
stillbirths
infection
income
cause
countries
surveillance
novel
disease
approaches
health
amplification
rpa
technique
phase
well
astroviruses
bats
sequences
virus
diversity
flocked
swabs
washes
viruses
group
respiratory
acute
non
invasive
ventilation
helix
thermodynamic
membrane
protein
energies
pathogens
disease
discussed
viruses
variety
xanthones
coumarins
compounds
genus
potential
virus
probes
viruses
the
high
the
optical
biosensors
planar
years
nan
nan
nan
torovirus
toroviruses
viruses
associated
open
evaluation
rpps
health
care
h1n1
gastric
cat
thickening
wall
year
viral
infections
clinical
new
viruses
nan
nan
nan
ifn
antiviral
viruses
host
lindenmann
infectious
diseases
new
research
pathogenic
vp1
the
proteins
rna
homology
nan
immune
γδ
cell
cells
infectious
pneumonia
pneumoniae
children
il
asthmatic
diagnosis
csf
infections
nervous
system
gastroenteritis
viral
common
disease
cases
the
mers
cov
virus
transmission
sars
cov
nitric
oxide
no
nan
day
salivary
21
oral
fluticasone
pigs
prrsv
lps
signs
respiratory
nan
nan
health
the
diseases
sanitation
care
rotavirus
intestinal
abstract
diarrhea
major
fpr
formyl
n192
r190
peptide
diseases
prdxs
signaling
redox
cell
helicases
cellular
assembly
activity
helicase
respiratory
spain
adeno
card
letitest
nan
outbreaks
outbreak
fbdos
reported
food
viral
the
population
randomly
rate
ace
ali
dd
patients
genotype
ibv
in
cuban
flocks
infectious
transmission
viruses
routes
knowledge
respiratory
de
los
en
las
infecciones
pcr
rt
csfv
mrt
the
cell
cov
virus
receptors
sialic
nan
disease
systemic
coronavirus
frscv
laboratory
indexing
spatial
information
son_lsii
semantic
host
viral
interactions
glycan
glycans
therapy
abrs
amoxicillin
antibiotic
the
nan
nan
ipi
enteric
covs
cells
swine
food
nanosensors
products
industry
detection
lkt
leukocytes
bhv
increased
infection
mers
patients
ha
hospital
risk
nan
host
battle
the
warfare
ancient
samples
vaccine
canine
cpv
field
donkeys
metabolic
species
endocrine
syndrome
nan
nan
de
virus
los
el
coronavirus
cells
structure
infection
the
lymph
du
pp
patients
the
serious
cell
function
vaccine
efficacy
summary
respiratory
influenza
tract
viruses
virus
recombination
viruses
viral
new
evolutionary
nan
pgp
compound
compounds
drugs
cns
pilgrims
respiratory
viruses
hajj
the
dengue
positive
rapid
he
test
disease
enm
ecology
biological
framework
specific
cd8
cells
peptide
sars
disease
mice
jhmv
demyelinating
the
viral
species
the
viruses
animal
the
antiviral
new
award
lecture
public
health
government
ethical
issues
health
diseases
noncommunicable
policy
infectious
pigs
10
pcv2
il
infection
autophagy
dv2
formation
viruses
autophagic
infections
viral
spread
significant
rapid
animals
common
ganglia
autonomic
one
egg
yolk
ultrafiltration
immunoglobulin
specific
are
really
mutations
away
end
air
distributions
cabins
experimental
measurements
delivery
cells
target
exosome
goal
tcov
turkey
pcr
the
rrt
dogs
vaccination
trypanosoma
rangeli
cruzi
malaria
species
diagnosis
risk
rapidly
use
pmos
sequences
viral
may
nan
adenovirus
specimens
array
in
well
gvn
research
current
the
viral
rsv
children
respiratory
virus
viral
peptides
peptide
avian
heterophil
16
cats
inherited
clinical
axonal
electrodiagnostic
zoonotic
potential
human
including
tularaemia
colds
usually
nuisance
last
year
human
models
specific
agents
study
de
la
en
los
se
patients
necrophorum
pathogens
pharyngotonsillitis
controls
isg
sars
cov
global
iav
strain
canine
strains
96
amino
elderly
disease
respiratory
tract
infections
epidemic
bird
flu
spread
transmission
patients
lymphopenia
covid
19
severe
nan
viral
zoonotic
infections
important
infectious
patients
influenza
season
respiratory
tested
diseases
poor
health
poverty
infectious
proteins
ifitm
virus
cells
cell
mce
this
review
separation
microfluidic
hrsv
rt
lamp
pcr
samples
genomes
hcov
hcovs
cov
recombination
disease
md
copd
credit
the
derivatives
series
lipophilic
glycopeptide
activity
microchip
electrophoresis
chip
analysis
pmma
autophagy
induced
coronavirus
ibv
infection
infections
children
viral
respiratory
viruses
sars
gln
ser
octapeptide
catalytic
diseases
imported
infectious
surveillance
the
the
diseases
time
force
infection
viruses
emerging
africa
virus
the
nan
nan
clinical
molecular
methods
human
implementation
nan
hrv
c15
34
human
viruses
editors
as
readers
aware
pages
nan
g3139
bcl
cells
apoptosis
cancer
nan
antiviral
activation
viruses
viral
signaling
nan
nan
cat
central
hypernatraemia
diabetes
insipidus
oh
research
health
study
approach
cdm
κb
nf
hsv
cells
nan
nan
influenza
years
95
ci
per
nan
nan
nan
na
influenza
ata
activity
structurally
di
il
un
la
delle
infections
the
dna
microarrays
diagnosis
nan
mers
the
middle
east
respiratory
programs
training
year
the
month
influenza
ve
aged
months
95
brain
cells
plasma
the
cortical
air
method
the
contaminant
proposed
nan
induced
dmvs
rna
viruses
dmv
affinity
discovery
identification
methods
technologies
mers
cov
camels
the
camel
a1
hnrnp
protein
mhv
proteins
children
sars
adults
hong
kong
the
areal
maup
data
article
microsatellites
ebolavirus
genomes
coding
regions
cancer
new
protein
complex
networks
signs
calves
association
eimeria
samples
virus
respiratory
mers
cov
infection
processes
pial
astrocytes
the
myelin
public
health
competencies
family
medicine
zinc
mice
efficiency
tta
old
calves
diarrhoea
herds
neonatal
coli
evd
patients
policy
care
ethical
infectious
antibodies
glycoprotein
abstract
infection
les
de
pneumopathies
en
aiguës
nan
copd
disease
mechanisms
mets
comorbidities
the
phe
unsaturated
3cl
protease
ventilation
use
summary
acute
respiratory
sars
antibody
n18
cov
protein
sars
np
ml
nasopharyngeal
aspirate
2019
ncov
persons
infection
confirmed
syncytin
protein
nhr
chr
helix
nan
production
plants
vaccines
proteins
provides
el
de
en
la
por
domain
hev
replication
residues
analysis
sonnei
resistance
dominant
isolates
subtype
hand
care
health
hygiene
washing
nan
respiratory
viral
viruses
human
diagnostic
m2mϕ
pmn
ii
gl
mϕ
cell
pb
contact
enhancement
response
nan
hospitals
data
emergency
department
chief
gp41
patients
proteins
antibody
responses
research
science
foresight
the
future
protein
sars
cov
terminus
plasma
nan
coronavirus
lettuce
fecal
transmission
infectious
nan
fly
cows
deltamethrin
group
intramammary
the
global
may
news
coronavirus
nan
real
estate
prices
china
chinese
hcovs
children
age
nasal
respiratory
virus
viral
viruses
chapter
infection
nan
gc
chol
psm
dopc
interaction
rotavirus
etec
calves
inoculated
mucosal
influenza
nk
cell
titers
antibody
patients
infection
viruses
adults
viral
influenza
h2
primers
probes
virus
utr
prrsv
virus
type
the
viral
activity
antiviral
monoclonal
antibodies
colds
children
the
adults
nasal
cov
animal
coronaviruses
respiratory
severe
resistance
mutation
2008
influenza
viruses
hec
human
cell
cells
mouse
disease
nd
may
due
mortality
structure
paper
issue
reports
crystal
1a
rm
derivatives
respiratory
viral
pdcov
nemo
ifn
nsp5
cleavage
nan
water
pathogens
deaths
regions
major
cells
community
communities
in
response
companies
pharma
large
smes
many
gastrointestinal
problems
calves
diseases
bovine
expressed
immune
responses
antigens
corn
les
mhv3
de
dans
cellules
nan
anti
idiotypic
human
ige
antibodies
sars
expressed
cells
rrbd
responses
nan
sars
cov
disease
viral
ph
sequence
method
biological
comparison
sequences
mhv
antigenic
strains
e2
antibodies
fusion
residues
peptide
sars
cov
des
être
peut
pour
par
nan
sars
proteinase
respiratory
experimental
cov
rna
enzymes
mechanistic
structural
metabolism
apod
arachidonic
acid
cholesterol
kainate
surveillance
syndromic
systems
disease
field
vegrandis
the
bats
present
study
nan
nan
nan
frameshifting
rna
specific
interaction
ribosome
oral
fluid
rna
hev
stabilizing
mhf
infection
infected
cmhm
cats
treg
cells
infection
cruzi
il
studies
btv
infection
experimental
host
dans
de
le
les
des
virus
meta
transcriptomics
evolution
viruses
nan
protein
technological
applications
microarrays
innovations
filters
the
das
treated
relative
nan
pediatric
uri
testing
pathogens
isolation
infection
genes
re
hpi
first
sars
cov
the
pcr
amplification
patients
sars
ribavirin
receiving
the
domain
mhv
nsp15s
virus
sars
disease
threats
pathogen
the
study
ifn
viral
antiviral
cytokines
system
control
mrsa
abstract
recent
evidence
management
overview
reproductive
breeding
production
nan
impact
disease
scenarios
5bn
economic
95
ci
patients
severe
disease
expression
orf7a
cell
cycle
cells
3a
gene
ck
ch
strains
viral
virus
roles
cell
exploit
nan
φ6
virus
aggregation
sediment
sediments
ml
method
plasma
the
feline
value
elements
measures
discuss
decision
chlorine
containing
drugs
compounds
market
abpp
interactions
activity
profiling
methods
nvhap
patients
hospital
control
vs
lung
rejection
allograft
greater
transplant
lesions
feline
fip
cutaneous
coronavirus
ob
brain
cells
agents
neuronal
nan
nan
influenza
pandemics
networks
international
critical
world
livestock
production
developed
developing
mycobacteriosis
caused
mycobacteria
cats
mycobacterium
nan
nan
receptors
ligands
pathogens
type
endogenous
npc1
entry
fusion
gpcl
ebola
viruses
human
respiratory
transmission
person
pdcov
infection
apoptosis
caspase
mitochondrial
ffrs
fit
subjective
n95
ffr
2019
china
pneumonia
clinical
novel
environmental
problems
abstract
drawing
insights
nan
sequence
open
reading
frames
polypeptide
prep
001
study
reduced
median
kidney
marrow
donor
dla
identical
cells
il
10
expansion
tumor
nan
nan
nan
heat
health
the
three
related
100
influenza
human
respiratory
pcr
influenza
recombinant
recombination
strains
sequences
health
care
status
abstract
the
cat
pleural
biliothorax
the
bilirubin
horses
the
diseases
enteric
agents
nan
nan
nos
ii
jhm
results
infection
compounds
anti
icam
expression
significant
bcv
calves
serum
elisa
antibody
host
animal
evaluation
virus
infection
sliding
selective
treatment
equilibrium
emerging
viruses
animals
vertebrate
the
viral
vectors
heterologous
tgev
prrsv
domains
diarrhoea
study
animals
calves
turnout
post
traumatic
literature
women
stress
multiple
detection
target
rapid
emerging
nan
calves
immunized
rotavirus
specific
culture
care
transplant
critical
infection
post
infected
coronavirus
ccv
elisa
feline
health
care
virus
pandemic
effective
work
environment
nurses
nursing
the
influenza
plex
id
samples
positive
activities
sempervirens
plant
mediterranean
the
crcov
respiratory
the
gene
protein
hadv
patients
years
632
infected
h1n1
acute
ards
influenza
lung
vaccine
the
cells
leishmania
higher
epidemics
new
threat
risk
bioterrorism
human
viruses
bovine
sampling
samples
latex
glucose
modified
allyl
con
sars
infectious
in
disease
study
cells
bvdv
infection
at
bt
asthma
atypical
pneumoniae
bacteria
studies
nan
nan
dogs
igg
csf
cdv
myelin
proteomics
host
pathogen
vector
interactions
hmpv
sudden
death
infection
children
nan
pathogens
emerging
molecular
infectious
diseases
respiratory
duration
symptoms
samples
clinical
respiratory
viruses
the
virus
patients
sars
the
chest
positive
likelihood
nan
8ab
protein
atf6
er
sars
mutations
frequencies
amino
acid
pairs
protein
3a
sars
spike
cov
suis
pigs
oocysts
coccidia
village
viruses
host
virulence
cause
usually
ifn
pbov
np1
structural
isgf3
nan
nan
fipv
cats
fip
real
time
coronavirus
people
hiv
million
perspective
pdcov
codon
bias
identified
in
hsv
tricyclic
derivatives
activity
inhibitory
nan
ferrets
hepatic
liver
diagnostic
ferret
nan
sequence
amino
acids
arg
spike
sars
rbd
vaccine
raav
cov
stem
loop
pseudoknot
frameshifting
efficient
nan
bronchiolitis
associated
snps
ccl5
tlr9
nan
mers
cov
anti
mycophenolic
acid
lung
diseases
disease
shifted
better
transmission
health
infection
anesthesia
providers
nan
nan
unknown
ige
dogs
vaccines
allergic
reactions
sars
hais
period
risk
pre
patients
sars
lung
2003
pulmonary
influenza
rt
pcr
previous
method
fusion
peptide
f1
protein
segment
nan
pedv
genes
intestinal
degs
annotated
nan
highly
healthcare
patients
new
infectious
icd
the
disease
set
ivig
chloroquine
fip
effect
feline
induced
model
bifurcation
abstract
in
paper
nan
proteins
conformation
diseases
plant
protein
2c5
phage
mab
peptide
clones
surveillance
disease
crisis
health
public
nan
diarylheptanoids
virus
isolated
galangal
antitumor
trade
transport
networks
gateway
hub
sars
cov
analysis
evolution
complete
calves
hea
dia
cumulative
intake
nan
nan
nan
nan
bushmeat
food
people
human
trade
nan
human
diseases
pathogens
infectious
fever
heart
muscles
peripheral
cells
cat
infection
virus
cases
respiratory
viral
aureus
food
humans
isolates
colonization
nan
ffa
virus
pedv
titration
assay
nan
sars
nelfinavir
drugs
cov
cells
visits
01
ed
the
sars
zooepidemicus
haemorrhagic
disease
pneumonia
dogs
design
ph
challenges
hong
kong
mers
dpp4
disease
alveolar
type
nan
nan
brd
calves
coughing
calf
early
coronavirus
disease
cov
virus
therapeutic
methods
used
mab
mabs
development
tlrs
emerging
in
expression
analysis
orf1
hev
pcp
mutants
replication
nan
nan
anti
infective
respiratory
tract
infections
respiratory
agents
viral
infections
several
nan
nan
vaccinated
cows
calves
herds
controls
sequences
protein
canine
ccv
sequence
mitochondrial
proteins
proteinase
damage
mitochondria
calves
col
colostrum
cells
innate
cbp1s
corn
csl
polysaccharides
lung
people
symptoms
flu
lay
study
infection
seasonal
synchrony
regions
three
viruses
variation
recombination
genetic
mutation
ubiquitin
usp2
protease
prostate
structure
respiratory
pathogens
pcr
pediatric
patients
case
mers
jeddah
2015
confirmed
respirators
filtration
penetration
models
results
nan
des
de
et
en
la
nan
nan
disease
caused
humans
domestic
populations
nan
nan
activity
helicase
5b
showed
scv
mers
cov
patients
contacts
time
nan
crcov
three
spike
strains
bcov
nan
microglia
encephalitis
activation
neurons
astrocytes
sars
dental
infection
outbreak
control
surfaces
infection
microorganisms
measures
strategies
detection
methods
viruses
ebv
techniques
de
la
las
en
son
mucosal
immune
sites
distal
system
nan
orf2
sequence
amino
nucleotide
the
aom
microbiology
this
bacterial
streptococcus
parva
cytokines
infected
african
inflammatory
complexes
multiprotein
expression
biological
cell
patients
cbo
lb
bo
biopsy
nipah
urban
outbreaks
person
india
nan
cyano
conditions
abstract
starting
library
feline
ffv
vectors
using
infectious
ibv
gga
mir
30d
in
the
microarray
virus
canine
respiratory
ck
ch
lzj
111113
ibv
diagnostic
em
techniques
to
eqa
nan
nan
nan
hmpv
direct
antigen
test
shell
pedv
assay
nanopcr
detection
diarrhea
rnai
genes
used
mammalian
double
nan
ang
angiotensin
pulmonary
ras
lung
individual
models
ibms
infectious
understanding
high
density
air
urban
study
cj
antiviral
t4
juices
cranberry
nan
nan
respiratory
ifa
temperature
incidence
seasonal
sera
coronavirus
oc43
children
france
dengue
virus
spread
associated
prevalent
nan
approach
new
we
processes
vaccine
nan
coli
isolates
resistance
antimicrobial
camels
the
emerging
threatened
humanity
novel
mice
virus
dobrava
saaremaa
inoculated
nan
new
humans
potential
filoviruses
outbreaks
nan
storage
tracheal
sampling
virus
ibv
epitopes
jev
human
vaccine
cell
nan
iristectorin
extraction
iluae
tectoridin
ionic
bond
gln
the
peptide
ser
proteins
sumo
expression
sars
cov
information
medicines
source
available
represent
clinical
disease
diagnosis
this
article
rc
bs
pi
cows
vaccinated
patients
41
2019
ncov
infection
virus
anti
respiratory
acute
pm
resources
research
bei
reagents
biodefense
psychological
social
intervention
model
covid
foam
cordierite
tio2
bactericidal
air
compounds
ic50
series
derivatives
obtained
nan
expression
protein
ha1
culture
recombinant
syndrome
severe
acute
respiratory
h5n1
nurses
sars
crisis
historical
nursing
protein
expression
high
level
recombinant
cystatin
sa2
antibodies
sa1
cross
nan
und
virus
die
post
das
epithelial
antiviral
influenza
respiratory
viral
protein
expressed
the
sars
expression
nan
vacv
agents
ea
la
growth
gta
hotel
equity
return
gs
padpr
adp
binding
poly
ribose
species
bupleurum
genus
diseases
constituents
antiviral
therapy
infection
viral
human
nan
microorganisms
factors
host
disseminated
infections
respiratory
clinical
impact
assays
multiplex
student
debates
course
debate
performance
nan
nan
human
genome
history
hgp
chapter
protection
facial
use
nurses
compliance
biotin
tr
monoclonal
fia
eia
bats
immune
reservoir
hosts
numerous
nan
mbl
role
molecules
host
infectious
structure
prior
knowledge
disorientation
non
cells
growth
virus
murine
microcarriers
stec
isolates
o156
h25
isolated
2019
ncov
rate
outbreak
china
er
system
class
host
pathogen
cell
virus
viral
viruses
membrane
agncs
nanoclusters
hiv
nm
based
sars
cov
gene
egfp
sirnas
env
inhibitors
the
hiv
cell
respiratory
summary
although
advances
immunosuppression
calves
fed
20
fat
16
nan
prrsv
strains
vaccines
effective
heterogeneity
allo
ls
syndrome
pneumonia
bronchiolitis
human
recent
study
provides
platform
nan
the
wuhan
whole
public
detection
children
bronchiolitis
detected
often
considered
health
care
demand
provides
information
disease
respiratory
calves
experience
operations
nan
community
pharmacists
public
several
individuals
acute
exacerbations
patients
management
clinical
allplex
rp1
fluav
hrsv
assay
nan
tested
activity
test
qct
safety
proteins
signal
resident
information
the
endou
coronavirus
viral
replication
nsp15
protein
based
yeast
source
fish
de
14
en
years
años
golgi
compartment
membrane
function
traffic
emergency
hct
plan
preparedness
come
pedv
alveolar
porcine
respiratory
tract
nan
nan
nan
nan
bvdv
infections
bcov
bovine
virus
hcov
samples
coronaviruses
positive
hku1
influenza
pandemic
first
responders
paramedics
rna
information
storage
systems
based
nan
nan
nan
peptides
pd4
reduction
activity
virus
optimal
in
paper
epidemic
considered
nan
rats
jhm
lesions
virus
mutants
stage
ct
days
lung
abnormalities
attacks
terrorist
impact
european
terrorism
oc43
assay
hcov
elisa
patients
salmonella
mhv
mice
resistance
infection
cases
transmission
person
the
disease
viruses
virus
electron
human
disease
sars
3clpro
the
novel
cov
codon
usage
evolutionary
mammalian
astroviruses
sample
biological
samples
stored
techniques
sequence
polypeptide
molecular
weight
abstract
nan
infectious
diseases
captive
disease
populations
protein
the
mrna
e1
matrix
sexual
transmission
cases
end
waiting
arthropod
different
diseases
circulation
abstract
bovine
coronaviruses
respiratory
coronavirus
like
nan
nan
nan
dna
this
diagnosis
hybridization
genosensor
kd
vs
cases
disease
viral
mrna
genes
stability
intron
found
tba
thrombin
quadruplex
fam
conjugated
ipf
patients
non
ilds
virus
polyproteins
chains
proteins
maturation
structural
nan
films
temperature
ni
spinel
obtained
nan
replication
virus
denv
rna
membranes
hmpv
anti
igg
cells
recombinant
respiratory
immunity
infections
pneumonia
elderly
infection
immune
viral
the
mechanism
lactoferrin
calves
gain
preweaning
weight
nan
listeria
various
infections
including
central
pee
antiviral
activity
range
anps
measles
virus
vaccines
vaccine
single
studies
travelers
perception
used
risk
nan
unknown
viruses
efficient
human
pathogens
form
protein
bcv
ns2
infected
cells
technologies
clinical
diagnostic
health
diseases
nan
mutations
feline
virus
fipv
current
cov
virus
surfaces
influenza
sars
fcov
cells
fip
gna
nelfinavir
assay
porv
lpmv
detection
real
orf
respiratory
cov
apoptosis
sars
protein
nps
np
corona
parameters
infection
emergency
management
disasters
prevention
decision
making
strategic
shock
stable
episodes
pd
peritonitis
1994
year
pedv
evolution
emerging
animal
variants
nan
rna
residues
ibv
protein
amino
assays
respiratory
two
samples
pathogens
nan
nan
nadc3
nad
sirt1
cells
cellular
yeast
surface
protein
display
libraries
infection
mers
healthcare
patients
control
chloroquine
abstract
recent
publications
brought
lrg
patients
assay
sera
glycoprotein
ibv
groups
nucleocapsid
coronaviruses
highly
nan
pahs
pollution
measures
chinese
government
la
de
les
sont
est
uda
virus
sars
cov
mice
dna
mb
covalent
in
methylene
mri
cats
disease
findings
spinal
nan
nan
nan
hotel
sector
disaster
tourism
literature
prodrug
approach
antiviral
anticancer
application
gltscr2
viral
replication
chicken
infection
virus
jhm
rna
passages
molecular
nanotechnology
nanocarriers
delivery
including
high
nan
mers
dromedaries
cov
human
beings
antibodies
hcov
adults
ri
binding
studies
hajj
respiratory
pilgrims
symptoms
wnv
jev
encephalitis
infection
virus
arbs
including
arb
therapy
patients
ra
treatment
il
towards
inflammatory
nan
mef
nph
pcr
results
the
immunochemotherapy
mpl
se
dogs
glucantime
sars
children
disease
the
cov
nan
food
in
applications
packaging
nanoparticles
host
cells
infection
viral
requirements
utilization
lab
use
tests
metrics
invasive
ventilation
19
non
covid
participants
kg
mg
sab
301
os
rs
potential
herbal
components
laboratories
viruses
adventitious
virus
assay
nan
test
norovirus
rapid
samples
the
transmission
influenza
inactivation
airborne
virus
ppe
hcp
approach
selection
health
proteinase
cleavage
cells
ibv
site
virions
mrnas
ibv
grna
the
nan
neurological
manifestations
covid
19
cns
receptors
ligand
immune
coactivating
inhibitory
lfd
rt
rpa
bpiv3
assay
elisa
fusion
hiv
two
interaction
bronchiolitis
disease
the
rv
therapies
juveniles
dipylidium
infection
prevalence
increased
activity
nl63
compounds
antimicrobial
also
er
polypeptides
oligosaccharide
erad
nascent
bovine
brdc
bed
microarray
pcr
hpv
vaccination
2008
programme
introduction
calves
parvum
faeces
custard
like
respiratory
function
intervention
patients
rehabilitation
lambs
puppies
samples
isolates
antimicrobial
virus
vaccine
mice
candidate
chp
cp
tmv
infected
xanthi
nn
calves
prebiotic
diarrhea
effects
calf
employment
urban
areas
rural
people
silver
public
environmental
antibacterial
analysis
virus
cardiomyopathy
myocarditis
cats
viral
nan
nan
inactivation
uv
airborne
the
sources
nan
nan
hr1
hr2
the
coronavirus
spike
hrsv
on1
genotype
2013
the
methods
molecular
statistical
detecting
synonymous
reinfection
iga
bhv1
calves
reactivation
filtration
composite
different
filter
combining
nan
energy
method
simulation
performance
probability
nan
protein
labelled
abstract
we
report
stigma
sars
residents
health
ag
rna
synthesis
hydroxyguanidine
virus
compounds
sars
cases
dad
acute
lung
oligodendrocytes
brains
transplanted
normal
myelin
travel
participants
the
travelers
pre
rt
pcr
cherry
leafroll
virus
hrv
infection
respiratory
subjects
viral
swine
biomedical
research
along
used
nan
dna
antibodies
genes
vh
vl
covid
19
respiratory
disease
outbreak
ili
virus
household
influenza
swabs
the
innate
infections
system
cells
sepsis
dcr3
the
decoy
receptor
hcv
celastrol
ho
activity
expression
intestinal
perfringens
type
goat
diarrhea
ifn
host
viruses
response
hosts
nan
respiratory
rv
viruses
h3n2
hcov
allergy
world
history
organization
iaaci
mva
vp2
mice
challenge
antiserum
health
care
district
planning
influenza
nan
dna
vaccines
engineering
vaccine
recombinant
pomc
26
amino
acids
terminal
influenza
ed
children
pediatric
emergency
sporotrichosis
schenckii
elisa
the
diagnosis
nan
nan
transition
state
antiviral
activities
coronavirus
nan
nan
nan
pla2
inhibitors
inflammatory
diseases
importance
stocks
three
sentiment
premiums
returns
malaria
ebola
disease
virus
health
5a
5b
virus
represent
messenger
up
coronavirus
unexplained
pneumonia
sars
disorders
human
examples
viral
syndrome
ems
taiwan
country
hospital
care
ppc
water
type
poor
air
genomes
diversity
viruses
range
virus
viruses
host
interactions
in
virus
rna
species
the
rnas
specific
social
media
risk
perceptions
study
ga
syncytia
infection
fragmentation
mhv
respiratory
infection
control
the
sars
nan
the
exhaled
airflow
human
subjects
species
coronavirus
the
novel
natural
hirs
hospital
rooms
european
isolation
genetic
immune
cc
mouse
strains
antiviral
screening
the
virus
viral
trypsin
zt
cod
atlantic
characterized
virus
infections
wheezing
in
rhinovirus
new
welcome
year
issue
biomedical
nan
medical
infectious
science
virology
sciences
outbreak
south
korea
mers
the
elisa
ibv
the
414
aa
nan
nan
ash
hw
samples
ashes
present
thrombocytosis
number
platelets
extreme
000
nan
cchf
disease
region
countries
cchfv
nan
mastv5
astroviruses
wild
cause
worldwide
croup
atypical
case
clinical
management
neutrophils
rsv
induced
respiratory
asthma
aptamers
the
imaging
therapeutic
intracellular
pyats
typhimurium
χ3987
protein
tgev
calves
virus
bovine
respiratory
days
ms
inflammation
multiple
sclerosis
chemokines
nan
tmca
ester
amide
agents
medicinal
vaccines
pmv
plant
made
discussed
torovirus
four
btov
orfs
encode
transmission
covid
19
sars
cov
patients
non
invasive
ventilation
pneumonia
information
infectious
diseases
infection
control
scs
taiwan
china
actions
developments
nan
australia
chinese
elasticities
high
run
nan
app
proteins
infections
response
pentraxins
patients
ifn
disease
ms
significantly
influenza
surveillance
cases
region
countries
protein
transport
sfv
fast
slow
ibv
vaccine
dna
the
chickens
epitopes
2019
ctl
ncov
cell
de
les
le
ccr5
en
caws
injection
neutrophil
activation
il
economic
forecasting
identification
relationships
hall
well
being
cities
levels
we
health
livestock
industries
strive
improve
influenza
ili
illness
respiratory
cases
nan
cell
respiratory
virus
human
metapneumovirus
aids
nursing
supplement
hiv
nurses
radix
glycyrrhizae
hrsv
licorice
viral
nan
cats
rna
gs
441524
feline
nan
nan
nan
gene
orf
mhv
reading
frame
production
disease
molecular
biomarkers
response
nan
discomfort
virus
patient
nasal
four
nan
nan
en
une
virus
infections
la
candidate
vaccine
leishmania
lymphocytes
immune
ebov
in
rate
reported
recent
fipv
protein
vector
virus
mediated
disease
surveillance
could
information
project
nan
mean
dynamics
field
models
structure
bf2
15
peptide
mhc
tetramer
ppe
hcp
this
study
aimed
pcr
rt
becv
real
time
travel
purposes
care
the
risk
sirna
delivery
lnp
rna
rnai
viruses
respiratory
aecopd
detected
studies
the
emergence
new
coronavirus
china
thin
film
antibacterial
visible
light
de
rhinovirus
infections
children
cas
nan
fusion
heptad
repeat
glycoprotein
region
production
human
proteins
plant
health
human
xenotransplantation
cells
infections
allotransplantation
ferret
cd4
fecd4
model
virus
nan
nan
detection
antigens
biosensor
jev
serum
usage
edi
china
organizations
hospitals
nan
emerging
viruses
infectious
diseases
recent
infection
tregs
immunity
pathogen
also
hospital
in
mortality
volume
length
nan
preschool
wheezing
may
the
prognosis
protein
phosphorylated
coronavirus
sites
the
di
rnas
defective
three
passage
astrovirus
cells
infected
cell
cultures
dc
immune
porcine
characterized
also
acute
disseminated
encephalomyelitis
h1n1
virus
infections
compounds
clinical
antiviral
half
dengue
virus
infection
denv
fever
nan
the
treatment
effective
nutritional
supplement
hospitals
infection
control
nosocomial
facilities
und
der
eine
die
gasaustausch
nan
cases
hubei
epidemic
china
february
nsp1
host
sars
proteins
coronavirus
viral
expression
replication
abstract
stress
gt
protein
1a
hexameric
1b
linked
oligosaccharides
protein
the
virus
parameters
authorities
quarantine
outbreaks
human
health
life
mortality
population
expectancy
covid
travelers
19
on
2019
sars
cov
cytokine
new
ssrna
nan
abstract
selection
interesting
papers
published
mscs
tnf
ibd
treated
cat
nan
spp
rabbits
eimeria
presence
pathogens
lycorine
drug
anticancer
therapeutic
cancers
hajj
cap
cases
pneumoniae
pilgrims
peptide
3cpro
cleavage
specificity
p1
infection
healthcare
control
workers
staff
feline
fcov
the
three
workshops
entry
protein
virus
binding
receptor
nan
cats
fip
purebreed
prevalence
although
cov
sars
rsars
mice
virus
stem
the
frameshifting
loop
half
health
care
environments
workers
infections
distribution
minor
reproduction
number
final
water
food
production
the
quality
nan
nan
nan
29
il
it
immunological
type
respectively
human
anticipated
to
responses
nan
baculoviruses
baculovirus
viruses
gene
proteins
glycan
interactions
protein
types
receptors
bal
positive
aga
or
ahsct
de
et
la
parkinson
prion
8b
8ab
ifn
proteins
sars
nan
nan
sars
cov
cells
infection
elimination
nan
mrna
1prf
recent
results
ribosome
sars
cov
acute
type
also
glycoproteins
hr
structural
virus
postinoculation
nan
infection
global
need
within
patients
translation
viral
coronavirus
rna
two
hesperetin
crayfish
wssv
challenge
innate
pcv2
pigs
infected
swedish
pmws
influenza
assay
reactivity
fluchip
8g
schistosomiasis
control
the
people
republic
nan
cleaning
microbes
the
applications
surfaces
ai
broad
systems
abstract
artificial
vaccine
whole
killed
virus
dna
nan
dpp
iv
gp
ban
two
de
et
les
en
virus
respiratory
mouse
disease
mers
dose
rsv
transcription
replication
structure
these
dose
mabs
tgev
challenge
antibodies
nan
programs
management
diagnostic
rats
monitoring
marine
compounds
drugs
the
array
20
patients
pediatric
common
laboratory
asthma
agents
evidence
infectious
pneumoniae
nan
nan
sars
cov
anti
dreadful
infection
cchf
the
children
mean
fever
potential
sars
discovery
used
lrd
diarrhea
aids
treatment
therapy
patients
hiv
ifitm1
cell
viruses
mutations
placebo
interferonα
2a
given
in
magal
gastrointestinal
pilgrims
the
grand
viruses
environmental
cell
the
detection
family
cause
hiv
viruses
infect
respiratory
tract
infections
pneumonia
bacteria
cd14
lps
infection
prcv
lungs
de
la
el
en
septifast
china
epidemic
2019
covid
19
intestinal
bacteria
disease
complex
important
tourism
the
policy
cep
centre
antibodies
antibody
treat
diseases
including
bcl
proteins
bh3
cell
protein
patients
capacity
health
months
sd
nl63
hcov
respiratory
children
pcr
prrsv
vaccines
virus
protection
vaccinated
nan
3a
sars
cov
protein
gene
host
response
microbe
agent
microbial
plaque
deae
trypsin
agarose
media
mers
cov
reported
israel
evidence
nan
pm2
psychiatric
diseases
the
ed
arss
infection
diseases
regulate
signaling
models
organ
human
animal
in
nan
glycosylation
ms
vsp
site
virus
sars_np
binding
hcypa
sars
proteins
nan
nan
eggs
infection
day
dogs
groups
phage
sars
antibody
chicken
antibodies
nan
2019
ncov
sars
cov
antibodies
legal
psychiatric
consultant
patient
in
nan
studies
indoor
ventilation
hospital
engineering
de
coronavirus
et
lésions
inflammation
diarrhea
calves
administration
documented
efficacy
quarantine
health
correct
implementation
measures
nan
dmy
chemical
bioavailability
poor
activities
respiratory
tract
patients
infections
12
endemic
mosquito
illnesses
diseases
borne
nan
tgev
js2012
piglets
strain
purdue
respiratory
resistant
new
tract
infections
nucleic
acids
receptors
recognition
like
measures
infected
persons
quarantine
whether
nan
mortality
patients
influenza
icu
hospital
health
high
shenzhen
migrants
the
environment
neighborhood
indoor
health
occupant
flaviviruses
frameshifting
ribosomal
rna
virus
patients
study
cap
pneumonia
pathogens
the
orf
virus
cdna
potential
sars
cov2
we
day
2019
activity
ptb
compounds
derivatives
novel
cb
05
infection
cells
day
skin
the
patients
bank
allograft
hbd
rbd
innate
cells
immune
virus
tgev
protein
the
recombinant
selenium
patients
measles
acute
clinical
nan
rbd
protein
sars
cov
receptor
gastroenteritis
viral
viruses
agents
disease
health
safety
buildings
building
performance
pparγ
expression
sirna
fat
adipocyte
information
disease
driven
adaptive
epidemic
frameshifting
frameshift
process
target
required
nan
nan
students
hygiene
outbreak
sars
hand
fah
mhv
ab
results
mouse
wind
pedestrian
level
environment
velocity
ibv
day
old
vaccination
immune
epidemic
network
rewiring
strategy
relation
urban
policies
transportation
management
fuel
fusion
tm
protein
intermediate
viral
disease
ebola
virus
chapter
the
mbp
the
mv
cells
viral
viruses
hpv
virus
vaporized
disinfection
immunity
abstract
this
chapter
describes
prrsv
il
expression
jnk
pathways
cimicifuga
glycosides
triterpenoid
the
plants
entry
inhibitors
peptide
interfaces
peptides
nan
manuscript
world
health
organization
retains
9b
protein
cells
amino
acid
hav
3cpro
luciferase
activity
biosensor
clinical
culture
viral
diagnosis
conventional
influenza
h3n2
human
antibodies
broad
global
countries
development
advance
low
pseudoknot
frameshifting
structure
stems
the
csf
cats
signs
diagnosis
clinical
time
delay
models
effect
spatial
aptamers
aptamer
detection
nucleic
acid
silvestrol
translation
cells
cov
viral
clothing
protective
performance
textiles
protection
aom
children
infection
fluticasone
viral
nan
nan
influenza
countries
surveillance
viruses
pandemic
ib
end
strains
h120
d274
nan
significant
acs
circadian
study
day
theaflavin
ec50
crude
peaks
tf2a
rna
dendritic
receptors
antiviral
cells
fever
dsrna
the
pathogens
studies
papillomavirus
rapv
l1
e1
open
nan
nan
diseases
clostridial
enteritis
result
clostridium
canine
vitro
dogs
chagasi
cells
nan
infections
major
infection
abstract
cause
students
mers
medical
awareness
sciences
gb
strain
2762
virus
the
parasites
sympatric
sympatry
species
speciation
nan
de
la
pi
que
una
aspergillus
meningitis
case
described
cases
protein
fusion
cleavage
the
domain
isolation
pediatric
airborne
negative
pressure
influenza
vaccine
adjuvant
hi
dose
treg
cell
cells
transcription
factor
replicative
function
domains
abstract
replication
records
news
scientific
quality
assessments
innate
immunity
tissue
humoral
repair
vlps
vaccines
one
veterinary
animal
vectors
xenogenic
gene
replication
utility
many
drugs
viral
over
past
virus
taxonomy
nomenclature
virologists
entities
patients
group
nippv
fob
ii
nucleoside
analogues
this
two
articles
underutilized
high
fruit
diseases
compounds
exposure
post
lung
inflammatory
response
vaccination
development
immune
response
vaccine
nan
wind
lift
up
area
buildings
nan
substances
nasal
respiratory
the
in
casv
gp2
virus
fusion
the
cov
covs
respiratory
reverse
genetic
metabolism
host
viral
reactions
metabolites
droplets
secretion
lipid
dairy
glands
cf
increased
viral
respiratory
infections
skin
disease
exotic
animal
diagnostic
novel
viruses
zoonotic
infections
pose
nan
nan
severe
sars
respiratory
syndrome
cov
nan
nan
nan
climate
country
study
news
change
nan
membrane
proteins
er
sps
structures
virus
infections
compounds
clinical
antiviral
nan
e1
273
clones
cell
site
quantitative
assays
pcr
abstract
here
mers
cov
contacts
2013
patients
nan
nan
nw
calves
w2
w5
old
nan
nan
tb
management
10
compliance
hajj
croup
virus
children
vs
wheezing
nan
nan
replication
hcov
shown
cov
immunophilin
sars
cov
targets
new
drug
pneumonia
presenting
symptoms
pain
common
nan
nan
nan
mers
cov
the
respiratory
severe
somnus
dispar
calves
exposed
one
patients
poct
group
antibiotics
use
patients
group
elderly
young
middle
network
research
public
structural
networks
antiviral
influenza
data
treatment
might
unknown
mtase
mutations
virus
activity
replication
resistant
vancomycin
mrsa
isolates
2003
coronavirus
replication
hcov
cov
fk506
ha
viruses
virus
fluid
replicate
crcov
canine
coronavirus
dog
respiratory
activity
substituted
8m
series
dibenzyl
cells
joint
inflammation
products
inciting
risk
transfusion
transmission
tt
models
nan
gvhd
day
days
ptcy
atg
elp
tag
proteases
proteins
without
rabv
sirnas
expressing
genes
adenoviruses
sars
protease
3clpro
covalent
main
influenza
disease
spread
avian
pandemic
antibody
vaccine
felis
the
combined
nan
non
typeable
influenzae
exacerbations
viral
nan
nan
sign
tuberculosis
dc
neck
region
virus
oncolytic
viruses
virotherapy
promising
dc
sign
interactions
leprae
lectin
nan
nan
pmws
pigs
clinical
signs
pcv2
respiratory
children
the
infections
artis
streptococcus
fructus
antimicrobial
activity
tcms
segmentation
area
method
we
convex
treated
calves
groups
the
hfl
canine
the
parvovirus
type
new
nan
different
species
bat
bats
samples
aex
exosomes
gm
csf
crc
enclosed
spaces
sc
air
airborne
nan
nan
transmission
number
cases
disease
time
sars
recombinant
vaccine
mv
coronavirus
us
researchers
found
inhibitors
cathepsin
position
activity
extensive
study
pi4k
strain
pedv
amino
variant
ped
nan
de
la
el
en
las
book
environmental
microbiology
microorganisms
activities
systems
internet
based
data
event
the
sequence
rna
tgev
subgenomic
gps
veterinarians
one
health
expert
nan
protein
nucleolus
cells
egfp
localization
market
stock
efficiency
behaviour
the
nan
milk
wd
herd
production
outbreak
nan
choleraesuis
prrsv
pigs
group
factors
nan
nan
cells
immunity
dcs
pathogens
responses
social
student
cultural
the
base
nan
round
pneumonia
well
fever
antibiotics
calves
mortality
slaughter
farm
day
caninum
cows
neospora
reported
number
de
la
dans
biology
biologie
lung
antigens
viral
exosomes
respiratory
expression
enzymes
small
number
intestinal
fish
viruses
families
new
listed
there
criteria
pandemic
covid
19
coronavirus
tgev
group
the
antigenic
outbreak
in
saudi
arabia
special
exacerbations
copd
exacerbation
symptoms
recovery
virus
diagnostic
techniques
turkeys
the
brain
angiotensin
peptides
physiological
renin
hl
the
fecal
presence
dose
this
rise
study
showed
sputum
nan
nan
respiratory
tract
lymphoid
tissues
associated
nan
development
cavern
environment
hong
kong
models
public
health
administrators
mathematical
ribavirin
nucleoside
activity
protides
monophosphate
nan
cells
remyelination
transplantation
progenitor
virus
sars
cov
3clpro
active
two
rna
mutants
strand
synthesis
group
pneumonia
chapter
clinical
considered
primarily
a2mc2
ifn
prrsv
cells
porcine
disease
families
crohn
stool
negative
viruses
the
water
viral
enteric
wheezing
infection
associated
respiratory
children
clinical
laboratory
epidemiologic
histopathologic
findings
zoonotic
fevers
unknown
origin
immune
nan
sirna
hbv
dual
viral
system
bcp
extraction
purified
antioxidant
water
ribosome
errors
trna
reading
structural
service
centralized
access
hospital
many
aloe
emodin
cells
ml
ifn
nan
viruses
rna
different
genetic
error
nan
nan
mers
cov
s1
dna
vaccine
nan
nan
emissions
aviation
international
demand
rising
microarrays
probes
virus
patient
host
cov
mers
plpro
antiviral
middle
health
telephone
the
group
sars
feline
pcr
caliciviruses
cats
enteric
vaccines
disease
animals
vaccination
animal
nan
h1n1
influenza
rapid
negative
pneumonia
mers
outbreak
cases
siq
korea
pharmacophore
diketoacid
sars
cov
ntpase
life
suicide
suicidal
depression
older
class
specific
antibodies
igm
iga
subjects
influenza
ili
children
pcr
g2
g1
proteins
ptv
glycosylation
virtual
individuals
networks
layer
process
nan
rotavirus
calves
bovine
llr
85
examples
readthrough
frameshifiting
codons
abstract
nan
cases
patients
ct
chest
showed
mers
cov
respiratory
tested
march
guinea
bohv
vaccines
vaccine
ab
virus
h1n1
de
les
et
tgev
pedv
viruses
animals
effective
reproductive
the
pathogens
causes
clinical
s1p1
receptor
the
compounds
agonists
nan
south
health
development
knowledge
assistance
nan
scientists
australia
completed
initial
research
nan
test
binding
influenza
virus
strip
cnts
drug
walled
high
graphene
stem
lung
cells
biology
progenitor
cdv
strains
samples
designed
dogs
do
risks
lethal
flu
virus
nan
puppies
bronchiseptica
acute
four
bronchopneumonia
persistence
data
food
natural
factors
protein
kda
eav
arteriviruses
virus
the
method
change
travelers
alert
quinone
methide
triterpenes
isolated
inhibitory
brv
torovirus
genes
orf
gene
np
hcov
oc43
three
infection
virus
neutralising
antibody
sows
inoculated
severity
outbreak
the
infection
method
mannich
bases
the
activity
biological
csa
treatment
infection
viral
mhv3
abstract
the
recent
global
outbreak
rna
hcv
syncrip
replication
protein
nan
rinderpest
virus
hemagglutinin
oral
rpv
influenza
virus
dogs
dog
canine
strains
infected
passaged
tgev
glycoproteins
clemastanin
indigoticoside
high
chromatography
nmr
medical
knowledge
practice
residents
sp
innate
immune
bronchiolitis
psrw
rsv
calves
coronavirus
control
treated
treatment
effusive
cats
fip
bilirubin
weeks
microarray
technology
detection
developments
carbohydrate
nan
vaccine
epitope
multi
dna
ibv
covid
19
treatments
coronavirus
infection
229e
hcov
fusion
protein
core
nan
nan
icp0
activation
tak1
jnk
the
nan
families
peptidases
different
peptidase
structures
crises
restaurants
the
sars
crisis
dogs
cats
diarrhea
prevalence
spp
bmap
28
peptides
vitro
two
patients
ade
culture
negative
pneumonia
trajectories
md
we
new
puva
ifn
response
prrsv
either
virus
carbohydrates
carbohydrate
biological
important
cell
sars
coronavirus
sars_cov
protease
acute
cells
cns
cell
activation
cln
chronic
disease
surveillance
systems
policy
nan
mass
hajj
the
infectious
diseases
payment
reform
insurance
system
china
padv
delivery
serotype
specific
recombinant
la
de
une
mmol
acidose
nan
cell
death
iav
influenza
virus
low
tropical
challenges
abstract
settings
nan
health
sars
seeking
behaviors
2003
biological
guidance
hazards
federal
regulations
nan
dna
vaccination
infectious
human
vaccine
tax
yrd
urban
agglomerations
system
nan
piglets
nk
activity
pbl
treatment
ace2
ras
ang
angiotensin
converting
ammonium
chloride
virus
mhv
cells
virus
viruses
collection
impinger
filter
the
research
publication
children
asthma
nan
tuberculosis
pclts
infection
tb
mycobacterium
tslp
virus
type
asthma
sputum
ibv
different
ck
ch
lgx
nan
p7
virus
hcv
the
protein
cns
encephalitis
acute
adem
forms
nan
assay
btv
based
cpe
the
mers
cov
infection
middle
east
nan
nan
asthma
respiratory
children
exacerbation
exacerbations
ifn
response
genes
lncrnas
major
de
la
et
transmission
les
hc
pro
proteinases
virus
potyvirus
covid
19
drug
niclosamide
cov
not
avail
protein
the
mhv
rna
nucleocapsid
virus
diseases
factors
abstract
epidemiology
the
transmission
disorder
modes
protein
pcv2
co
prrsv
infected
tregs
cell
in
abstract
adoptive
immunotherapy
responses
immune
assays
host
hamster
replication
host
virus
viruses
cell
filter
aerosols
drop
nanofiber
pressure
tm
domains
the
protein
app
deflation
pass
exchange
rate
through
de
el
en
las
los
guaroa
ifn
treatment
oropouche
viruses
pneumonia
the
treatment
one
patients
3b
necrosis
apoptosis
protein
154
seb
using
phage
binding
peptide
ibv
1d5
mabs
6a12
ibvs
nan
intestinal
microbiota
viral
infection
probiotics
infections
kidney
transplant
infectious
including
travelers
malaria
data
risk
japanese
fertiqol
fertility
life
quality
items
spike
pedv
us
analysis
strains
malaria
control
health
africa
countries
system
blood
new
the
canadian
infection
2003
infected
control
respiratory
nan
mg
mucosal
immune
immunity
the
delays
restrictions
tested
covid
19
markets
real
estate
stock
market
nab
ad41
children
ad5
positive
ibv
strain
new
strains
isolate
rna
viral
coronavirus
molecular
coronaviruses
nan
de
la
el
en
que
pcv2
infection
shrnas
viral
disease
er
stalling
associated
polypeptides
we
tcov
the
sequence
polyprotein
genome
plants
proteins
bioreactors
plant
include
nan
dogs
canine
cird
crcov
cynos
population
susceptible
final
size
hsu
host
five
years
human
postgenomic
sars
cov
s2
gp41
two
tgev
pur
infection
intestinal
tissue
nan
pathogens
air
airborne
infectious
agents
ace2
ii
angiotensin
acts
physiological
fcov
ii
viral
type
samples
cell
virus
porcine
3d4
lines
data
related
viral
disease
land
dogs
virus
mvc
disease
adult
tsv
resistant
the
transcriptomic
response
malaria
falciparum
treatment
grade
severe
epidemic
media
coverage
cases
analysis
protein
il
pbmc
we
mrna
virus
infection
disease
response
viruses
sars
daily
or
95
ci
nan
outbreak
chv
fog
computing
cloud
nan
de
neonatal
respiratory
vírus
na
mers
cov
outbreak
patients
infection
polyprotein
viruses
virus
many
viral
pneumophila
legionella
pneumonia
pathogen
intracellular
cholesterol
prrsv
virus
cell
marc
de
en
des
syndrome
la
2019
coronavirus
ncov
genomic
sequence
nan
samples
canine
dogs
viruses
cdv
clinical
ade
zikv
denv
the
pneumonia
one
age
hospital
management
viruses
foodborne
food
infection
agents
iga
tcv
the
specific
antibody
sign
mdc
ebov
gp
hdc
nan
nan
fip
cats
neurological
il
disease
nan
viral
copd
infections
prevalence
acute
respiratory
infants
rvis
days
positive
zika
virus
transmission
outbreak
epidemic
ngs
research
vaccine
generation
sequencing
entry
sars
hr2
peptides
two
trali
complement
acute
transfusion
role
sars
coronavirus
evolutionary
history
cov
nucleic
acid
proteins
chaperone
rna
nan
inhibitors
pma
sars
coordinated
zn2
stigma
towards
disease
public
three
nan
frameshifting
two
human
pathogens
hiv
fusion
cells
type
mutant
infected
care
critical
population
treatment
ill
sgs
pbs
stress
cell
granules
premature
respiratory
morbidity
health
susceptibility
proteinase
the
enzymes
chapter
specificity
nan
rotavirus
colostrum
bovine
human
the
nan
influenza
negative
virus
ive
positive
mers
rt
cov
assays
iipcr
coronavirus
ferret
mink
infections
3clpro
graphene
based
nanomaterials
basic
building
nan
spices
pepper
in
briefly
abstract
aaeapn
cells
membrane
cry4ba
two
nan
patients
virus
pcr
diagnostic
detection
rva
strains
calves
bovine
g8
nan
patients
evidence
the
conflict
casualties
cleavage
glycoprotein
glycoproteins
fusion
subunits
proteins
capsid
viral
signaling
virus
nan
nan
nan
economic
events
impact
visa
tourism
microorganisms
dust
transport
topsoils
may
antiviral
landscape
systems
responses
approaches
health
public
legislation
infectious
disease
tests
disorders
detecting
autoimmune
immune
methods
used
viral
diagnosis
immunological
nan
nan
organisms
airborne
protection
micro
transmitted
rehabilitation
respiratory
epidemic
sars
patients
cats
multiple
myelomas
treatment
therapy
ferret
ophthalmic
provided
common
this
antibodies
germline
hiv
virus
sars
viruses
disorders
immunity
associated
outbreaks
opv
children
age
polio
otitis
nan
nan
pneumoniae
atypical
pneumonia
clinical
pathogens
nan
way
governance
cities
potential
lead
health
one
development
china
africa
elements
sl2
hcov
229e
sl1
specific
cell
promoters
lcmv
cells
nan
infection
mhv
genes
ms
autoimmune
infection
maternal
immune
pregnancy
models
respiratory
disease
viruses
patients
cause
total
spectroscopy
baicalin
baicalein
atr
gross
lesions
gastrointestinal
tract
changes
health
income
countries
world
increasingly
nan
the
wind
boundary
plw
new
ifn
type
ifns
family
new
droplets
respiratory
exposure
airborne
spread
nan
dcs
induce
immune
responses
pulsed
nan
fungi
molecules
derived
plants
marine
infected
staff
patients
sars
droplets
cbrne
explosives
this
hci
projects
target
new
drug
projects
evidence
global
potential
unknown
microorganisms
we
nan
pdcov
the
lineage
china
porcine
vaccine
syringe
device
would
pandemic
marine
technologies
omics
genome
sequencing
nan
nan
sars
scoring
system
group
cases
virus
pedv
porcine
epidemic
re
antibodies
mers
deadly
coronavirus
sprung
fip
challenge
tnf
ifn
cats
vaccines
development
significant
impact
public
coronavirus
china
an
epidemic
novel
nan
calves
challenge
coli
dose
108
calves
the
cows
vaccinated
tests
epidemic
china
covid
19
number
amiloride
fmdv
antiviral
cvb3
replication
cellular
rna
degradation
gene
expression
ampv
expression
sirnas
rna
sirna
nan
trtv
polypeptides
gp82
family
rna
number
2019
ncov
infection
reproduction
questionnaire
the
staff
variables
data
glial
cell
cells
class
mhc
paneth
cells
alpacas
days
fetuses
nan
ev71
rnas
infection
lncrna
mrna
public
health
china
system
pheris
evd
the
care
patients
intensive
xanthatin
the
hep
g2
cell
nan
days
calves
growth
acute
phase
health
needs
infection
control
knowledge
control
sars
bmh
nosocomial
infection
viruses
children
cystic
fibrosis
bacteria
viruses
respiratory
immune
system
especially
research
vaccines
the
number
important
herpesvirus
virus
novel
detected
pcr
viruses
cattle
picornavirus
utr
p1
cf
specialist
centre
disease
also
nan
codon
coronavirus
host
gallus
genes
glycyrrhetic
acid
glycyrrhizin
capillary
10
protein
cysteine
motif
palmitoylation
rich
morbidity
diarrhoea
child
spatial
fever
hcov
method
229e
oc43
the
cmg
clinical
sequencing
metagenomics
specimen
polymorphic
genome
sites
bj202
sars
rna
protein
binding
mhv
140k
animals
mice
may
polygamous
rodents
nan
study
contamination
wind
the
air
proteins
amyloid
amyloidogenic
sequence
peptide
melatonin
covid
19
patients
likely
cases
disease
the
confirmed
covid
brought
commercial
airline
united
states
nan
the
azanucleosides
nitro
abstract
acyclic
vaccination
respiratory
herd
medication
hyopneumoniae
exacerbations
copd
pharmacological
airway
pulmonary
adem
ms
disease
illness
children
european
regulatory
medicine
shortages
healthcare
management
important
security
abstract
to
viruses
due
infections
europe
recent
nan
de
transfusion
des
une
ces
blood
pathogens
pathogen
inactivation
transfusion
2019
ncov
neonates
cases
born
sars
genome
coronavirus
cov
abstract
assays
coronavirus
patients
sars
infected
growth
enzymes
haematopoietic
aminopeptidases
found
hc
mice
virus
the
diet
celastrol
denv
anti
specific
antiviral
cases
sars
sequence
identity
coronavirus
influenza
screening
local
evaluation
system
emergency
emergencies
response
internal
external
spike
binding
s1
beaudette
s2
nanoparticles
effective
applications
nanomaterials
environmentally
neuraminidase
anti
ches
cpnanicd
agents
nan
rna
di
satrna
clones
vitro
cells
hrt
18
bcv
antigen
mammalian
gene
riboswitches
regulatory
mechanisms
nan
rna
106
the
virus
hr
lrp
amplification
rna
templates
hcv
polar
adenovirus
spsadv
entire
genome
229e
cov
surfaces
classroom
viable
prrsv
nsp1α
may
targeting
replication
nan
corticosteroid
patients
group
groups
corticosteroids
nan
plasma
products
fractionation
derived
developing
mers
cov
sera
coronavirus
camels
nan
nan
nan
hotel
hong
kong
sars
industry
nan
nan
chikv
antivirals
reported
chikungunya
virus
sorting
transmembrane
domains
determinants
tmd
infectious
the
diseases
often
disease
nan
lamp
dna
gondii
nested
pcr
nan
nan
hajj
vaccination
pneumococcal
knowledge
travel
viral
cpbvdv
sd
protein
p80
nan
outbreak
there
currently
pneumonia
unknown
respiratory
viruses
rt
pcr
esi
nan
nan
nan
vector
multi
host
dynamics
species
poe
rosenzweig
memory
local
the
lt
patients
high
scores
liver
ndv
ibv
still
study
ivory
nan
nan
influenza
pandemic
virus
recent
avian
model
stochastic
disease
media
coverage
passive
immunity
antibodies
refers
individual
major
epidemic
delay
impact
reduction
sumo
viral
ubiquitin
important
cell
respiratory
infections
2b
military
viral
sars
the
features
three
patients
hla
a24
peptides
mtb
patients
cov
rdv
activity
known
human
nan
nan
kpna2
cancer
role
potential
biomarker
polyomaviruses
ki
wu
the
clinical
unknown
protein
recombinant
igg
surface
pedv
the
coronavirus
sars
cov
false
virus
pr
transfusion
years
uv
nan
vpu
release
viral
hiv
efficiency
decahydroisoquinolin
inhibitor
sars
3clpro
scaffold
nan
network
disease
snn
metapopulation
infectious
di
la
il
disidratazione
una
pcr
technique
specific
veterinary
summary
transmission
sequences
viruses
used
trees
blood
service
system
challenges
issues
nan
asthma
trigger
many
triggers
aspirin
de
flu
des
vaccination
le
ferret
include
therapeutic
plan
must
asthma
corticosteroids
children
may
the
mice
demyelination
2m
virus
c57bl
nan
nan
pneumomediastinum
time
detection
patients
opacity
developing
chapter
sanitation
countries
goals
frameshift
group
stem
pseudoknot
type
covid
19
patients
pneumonia
nine
trans
cis
tk
the
isoxazolidine
patients
radiographic
score
mers
intubation
chinese
tourism
economic
china
time
interferon
the
leucocytes
trout
virus
nan
agents
public
health
disease
infectious
rna
adjuvant
vaccine
protein
efficacy
hybridization
oligonucleotide
using
time
genosensors
nan
2019
ncov
disease
coronavirus
respiratory
ferret
il
human
structure
while
reservoirs
interventions
multihost
systems
crucial
hsv
gd
m27f
the
therapeutic
within
motifs
unique
amino
databases
loop
the
frameshifting
prf
structure
step
the
information
week
policies
infants
preterm
respiratory
term
admissions
reaction
reformatsky
using
zinc
metal
resistance
class
integrons
sonnei
antimicrobial
abstract
coronaviruses
jhmv
a59v
shown
nan
nan
nan
nan
saon
induction
rats
weeks
the
hcws
positive
mers
cov
tested
ncs
evaluated
pups
pregnancy
day
viruses
the
virus
enveloped
host
nan
domain
sud
sars
rtc
macrodomains
rdrp
sars
activity
cov
gst
bht
lps
the
fever
liver
injury
associated
fpr
several
stroke
spr
diagnostics
portability
infrastructure
abstract
chagasi
cvl
infection
cells
macrophages
nan
rbd
sars
cov
raav
responses
nan
antibody
fc
9e2
wnv
gene
nan
apoptosis
civ
cf
cells
caspase
isolation
patient
zone
airborne
expedient
gastrointestinal
review
common
disorders
donkeys
bcov
bucov
strains
coronavirus
displayed
ehv
sirna
horses
virus
viral
tests
laboratory
important
workup
chronic
water
microbial
molecular
tools
pathogens
frameshifting
serum
trna
horse
frameshift
pspa
monocytes
human
pneumococcal
protein
sars
cov
human
cells
airway
influenza
respiratory
associated
viruses
develop
acid
aminoalcohol
lactone
abstract
aldol
protein
arv
lab
mucosal
immunization
assembly
particles
viral
viruses
virus
nan
nan
bioinformatics
studies
research
available
omics
abrd
the
herds
syndrome
time
plant
viruses
emergence
crops
wild
dogs
domestic
wild
cdv
exposure
nan
degradation
vuv
uv
ps
ph
nan
nan
pneumonia
children
years
cause
age
nan
mice
virus
balb
protein
fodrin
the
microbes
changed
might
acetone
nan
virus
mxa
respiratory
children
infections
spread
respiratory
pathogens
hajj
resulting
nan
vrti
patients
hsct
respiratory
allo
nan
virus
genome
sequencing
protocol
sequence
nan
activity
protease
the
3c
like
bacteria
protection
masks
efficacy
new
cpg
dna
tgev
itgev
plus
nan
nan
replication
immunophilins
cyclophilins
hiv
viral
health
conditions
transitions
infectious
disease
safety
unit
adherence
climate
level
influenza
public
pandemic
emergency
health
viruses
capsid
the
icosahedral
abstract
cruzi
species
population
structure
traits
hcovs
respiratory
discovered
including
cause
exchanges
influenza
pandemic
framework
the
sequence
genotype
sars
bgi
complete
genosensor
sars
gold
film
three
chickenpox
isolation
room
patient
negative
nan
transfusion
data
blood
utilization
continues
nan
attenuated
strain
ib
ibv
the
risk
quantitative
assessment
viruses
abstract
hid
ems
training
the
disease
network
signaling
cellular
the
diverse
delivery
vaccine
adjuvants
viral
responses
health
bioaerosols
microorganisms
diseases
exposure
dendrimers
cationic
carbosilane
cell
fluidity
resilience
disease
physical
studies
quality
vaaes
anaphylaxis
dogs
signs
events
nan
nan
patients
bali
mros
resistant
multi
mhv
receptor
ntd
residues
receptors
viruses
virus
flu
previously
newly
sars
cov
rnai
could
virus
display
cell
surface
targeted
proteomes
gene
antiviral
therapy
viral
sequences
feline
virus
detected
samples
serum
virus
ifn
type
infected
nsp1β
nan
sars
civets
cov
cerebrum
infection
nan
cells
nk
innate
role
defense
mechanisms
ribavirin
viruses
antiviral
clinical
market
human
to
2019
transmission
canine
cird
respiratory
dogs
crcov
wash
hands
thoroughly
demyelination
myelin
damage
axonal
review
sars
cov
abstract
severe
acute
care
refugees
common
country
primary
nan
nan
covs
kenya
genus
bat
bats
sars
cov
sud
coronavirus
molecular
tree
species
the
phylogeny
viruses
severe
the
prrsv
lesions
hyorhinis
nan
ifn
plzf
innate
promyelocytic
leukemia
patients
coronavirus
anesthetic
management
severe
sars
oas
mxa
the
allele
en
infections
les
et
nosocomial
ibv
the
is
1494
like
breeders
feline
the
virus
infectious
human
pathogens
emerge
cause
new
nan
ifn
response
btv
protein
production
probiotics
diarrhea
prevention
treatment
evidence
h5
ha
binding
yeast
highly
respiratory
cause
viral
may
older
de
les
le
des
et
p53
akt
pi3k
replication
reovirus
nan
complement
cell
intracellular
the
system
ev
d68
respiratory
patients
disease
wnvcp
hsp70
wnv
the
role
calves
prophylactic
control
treatment
milk
implementation
ohsems
higher
education
study
research
companies
technologies
they
require
mass
hms
data
spectral
profiling
autoimmune
reactivity
retinal
in
disease
nk
cells
expression
bm
unique
specific
sv
asc
brain
antibody
ca
pd
patients
surgery
t2
stec
shiga
toxin
producing
coli
models
realized
volatility
jumps
var
proteinase
1b
1a
3c
like
nan
children
influenza
encephalopathy
11
neurological
dchev
virus
the
protein
vlps
caring
kitson
australian
beginning
abstract
study
vibrational
molecular
chemical
modes
nan
asthma
role
viral
respiratory
review
chikv
severe
diabetes
diseases
patients
viral
lncrnas
processes
including
regulatory
gno
inhibition
antiviral
effect
influenza
ibv
virus
entry
using
lipid
cells
nk
fipv
cats
infection
p100
peav
piglets
newborn
gds04
vlps
the
structural
vlp
elements
transcription
canonical
isgs
pathogen
rapidly
group
hrvcs
children
hrvs
disease
laboratory
accurate
the
infectious
diseases
nan
peptides
abstract
an
improved
procedure
nan
hb
il
breeds
study
cats
molecules
ldv
study
viral
virucidal
papaverine
cells
viral
drug
treatment
proteins
rotavirus
idps
idprs
disorder
de
et
la
ecmo
technique
2019
ncov
novel
coronavirus
human
airlines
awa
legacy
strategy
the
nan
sars
pneumonia
pct
low
viral
protein
vaccine
the
sars
eosinophilic
gm
licorice
group
levels
antioxidant
nan
nan
cats
vaccinated
fipv
response
challenge
scale
free
networks
epidemic
outbreak
system
abstract
the
outcome
viral
red
pandas
groups
anaesthesia
used
pd
cases
clinical
parkinson
refers
abstract
acyclic
azanucleosides
phosphonomethoxy
function
nan
nan
cats
fip
isothermal
amplification
rt
icu
19
patients
sars
covid
strain
h120
ck
ch
lhlj
herbal
medicines
infrared
nir
spectroscopy
nan
buffalo
buffaloes
reared
milk
adult
nan
pigs
neonatal
vn
antibody
higher
nan
vaccine
vaccines
access
global
partnerships
membrane
virions
glycosylation
coronavirus
complex
the
respiratory
covs
study
burden
sars
cov
receptor
host
species
infectious
animal
spread
based
risk
virus
influenza
pcr
poc
panel
nan
nan
ifn
brain
mhc
antigen
virus
s1
gene
serotype
ibv
italy
prcv
viruses
influenza
respiratory
swine
first
disease
well
abstract
during
drug
delivery
development
this
molecules
wavelet
change
points
economies
effects
irradiation
brain
mhc
expression
lymphocytic
nan
travel
tropics
fever
returning
abstract
nan
microarray
pcr
species
respiratory
positive
rsv
rt
lamp
respiratory
the
nsp3
veev
viral
identify
host
spectrum
raman
benzotriazole
atom
sers
sars
study
genes
ards
lung
nan
viruses
respiratory
virus
duplex
pcr
disease
pathogens
release
the
may
control
optimal
time
epidemic
results
gas
streptococcus
pyogenes
estimated
rhd
101
115
cells
pseudoparticles
n1
respirators
working
group
respiratory
compliance
health
animal
emergence
viral
human
de
un
la
maladie
kawasaki
aris
abstract
acute
respiratory
infections
nan
nan
catalytic
triad
type
h39
s118
disease
diseases
one
changes
etiology
genes
virus
hrsv
rna
respiratory
dna
peptide
mice
boosted
salmonella
marine
organisms
dredging
trawling
collected
selection
plant
drug
discovery
in
hmgb1
preconditioning
group
could
myocardial
respiratory
viruses
virus
patients
the
oh
health
responsibilities
resource
allocation
cyhv
virus
cholesterol
lipid
entry
children
mp
camp
cap
pneumonia
urban
human
areas
people
livestock
1b
kda
cleavage
3c
like
viruses
the
infections
pcr
method
mhv
infection
mice
cd28
hepatitis
we
still
scrambling
understand
dangerous
infectious
diseases
pregnant
women
questions
respiratory
tract
infections
acute
common
proteins
interactions
accessory
among
protein
relationship
cultivation
strategies
chinese
government
arrest
viral
dna
cycle
g2
nan
tcp
dopamine
randomized
unstable
patients
nan
pp1
pips
mouse
models
protein
sars
coronavirus
human
monoclonal
antibody
health
community
aerial
spraying
public
mers
cov
g2
targeting
s1
we
know
changing
seasons
help
nrf2
viral
expression
replication
entry
cell
virus
viral
signaling
viruses
proteins
abstract
we
propose
nomenclature
nan
nan
upt
the
pestis
assay
particles
development
factors
studies
this
important
sars
lungs
patients
cell
types
estimates
value
vsl
landmine
clearance
viral
obtained
pigs
infected
nasal
patients
sars
the
study
two
ic
assay
pedv
diarrhea
detect
respiratory
coronavirus
canine
samples
presence
hsv
mice
inhibition
gene
abstract
clinical
common
signs
abstract
in
co
infection
influenza
patients
viral
rt
assay
ecov
lamp
pcr
transplant
crv
haplocy
donor
patients
viruses
virus
factories
cellular
abstract
zikv
ar
12
infected
treatment
porcine
pedv
tgev
porv
pdcov
homology
protein
models
modeling
addition
2019
sars
like
in
ncov
nan
disease
inhalation
respiratory
tract
diseases
influenza
vaccination
vaccines
older
decision
peav
bat
swine
coronaviruses
newly
nan
disease
media
coverage
dispersal
patches
antiviral
viruses
activity
bioaron
virus
hajj
diseases
respiratory
effectiveness
infectious
thiamine
mr
deficiency
imaging
progressive
nanomaterials
biosensors
chapter
care
the
nan
nan
rna
rdrp
dynamics
the
fidelity
spag9
specific
jnk
sirna
bs
nan
model
forecasting
tourist
arrivals
anfis
nan
mcpip1
ifnβ
immune
innate
expression
akt
sars
cells
cov
activation
compound
nmda
receptor
antagonist
abstract
nan
prrsv
ifn
infection
irf3
activation
feline
fipv
activation
fip
cats
diseases
feline
this
paper
infectious
nepal
china
travel
year
tourists
outbreak
world
you
ebola
people
nan
mers
patients
hospital
the
undergoing
nan
nan
hbv
psuper
hbvs1
rna
genotypes
sars
cov
laboratories
positive
results
binding
compounds
activity
drug
cqr
nan
sars
cov
protein
characteristic
genome
pmv1
emergence
events
the
avian
mers
cov
detection
laboratories
negative
nan
replication
rna
viruses
strand
complexes
ipc
the
hospitals
infection
survey
callitrichids
small
wild
endangered
species
bocv
respiratory
clade
based
study
dc
sign
immune
dendritic
cell
nan
nan
polyomavirus
wu
found
wupyv
respiratory
segment
the
copy
gene
genome
lectins
classified
according
classification
chapter
cpv
dna
vaccine
replicon
based
hantavirus
bat
virus
abstract
hantaviruses
jev
ddx5
replication
rna
helicase
infection
demyelinating
genes
immune
the
nan
climate
change
events
adaptation
potential
pedv
zhejiang08
virus
attenuated
high
rv
children
wheezing
respiratory
symptomatic
profilin
qcdc
alone
plus
adjuvant
ibv
study
13
isolates
is
virus
human
cells
infected
know
mhv
two
antibody
antigen
assay
host
mechanisms
immune
in
asthma
hs
proteins
deps
functional
pathway
rats
rnu
resistance
cns
disease
de
la
los
crisis
las
gsk983
virus
cell
replication
viruses
crisis
signal
tourism
detection
the
svcv
arg
induced
replication
virus
pilgrims
influenza
vaccination
hajj
saudi
de
en
las
la
los
ups
the
ubiquitin
proteasome
aspects
nan
antivpp
antiviral
peptides
model
viral
pdcov
apn
the
receptor
anpep
hospital
patients
burn
center
in
coronary
one
artery
disease
chinese
rsv
mvaik
subgroup
cotton
rats
recombination
gene
frequency
mutants
within
health
international
global
law
the
pcr
assays
pathogens
respanel
respiratory
nan
il
infection
17
gcrv
the
rtgev
cells
protein
δe
tgev
astrocytes
veev
may
human
virus
axons
astrocytes
axonal
two
days
model
transmission
sars
infected
localised
the
award
nucleoside
antiviral
analogs
viral
infection
immune
infections
disease
dna
hybridization
binding
different
solution
public
chapter
health
threats
moment
cats
fip
3c
7b
genes
ane
ranbp2
mutation
encephalopathy
familial
virus
the
lassa
imidazole
real
signal
lamp
osd
detection
hcr
disease
program
outbreak
health
india
hobi
like
pestiviruses
bvdv
assay
diseases
cause
agents
foodborne
world
2019
ncov
ace2
viral
patients
structure
worldwide
cooperative
efforts
understand
nitrogen
metabolites
deficiency
indigotica
accumulation
fractures
weather
severe
warnings
fracture
nan
nan
protein
sars
nsp9
the
fold
respiratory
tract
infections
acute
common
nan
nan
animal
vaccination
controlling
health
purposes
ps20
infection
mice
mhv
neutrophils
lesions
patients
ct
chest
the
nan
severe
respiratory
virus
disease
wuhan
coping
strategies
use
anxiety
coronary
tm
acute
level
disorders
discuss
rv
viremia
cases
controls
similar
nan
this
article
reviews
virology
history
angiotensin
ii
ang
central
ras
lta
prcv
il
respiratory
inoculated
group
piglets
pedv
antibody
sows
abstract
severe
acute
respiratory
syndrome
fbl
p53
ribosome
cancer
ribosomes
nan
nan
ibv
new
cluster
strain
strains
nan
cpv
vaccine
2b
days
vaccines
nan
nucleic
acid
veterinary
probe
infectious
reported
china
cases
2019
wuhan
door
air
doorway
across
induced
prrsv
vaccine
pigs
kv
adj
nan
de
et
un
une
les
host
lipids
lipid
pathogens
role
nan
de
en
la
los
pri
pedv
reverse
genetics
cell
virus
nc
proteins
binding
serum
the
covs
diseases
respiratory
rna
coronaviruses
ipf
studies
etiology
acute
aex
nan
healthcare
workers
cases
mers
cov
hbv
genes
sperm
gene
introduced
polyolefins
medical
antimicrobial
use
textiles
patients
wuhan
infection
suspected
2019
severe
viral
pneumonia
respiratory
virus
cbc
every
results
abnormal
complete
nan
nan
nan
bat
bats
rig
stat
ifn
healthcare
mers
compliance
infection
patient
des
les
le
de
la
emergency
disaster
describes
toronto
abstract
this
reprint
roldão
silva
mellado
gps
immune
animal
lectins
ginseng
infections
hospital
hais
control
veterinary
nan
kd
disease
it
cause
the
the
detection
virus
assay
clinical
protein
sars
cov
9b
accessory
fever
trench
disease
the
quintana
orf
rna
pp1ab
like
hcv
related
critical
incidents
work
traumatic
nan
don
pigs
prrsv
contaminated
specific
public
health
clinical
laboratories
economic
diseases
infectious
health
emerging
global
human
gp
a82v
mutation
ebov
nan
dhv
codon
strains
bias
isolated
cows
injections
group
cyanocobalamin
dairy
ciliary
beat
cilia
pcd
hz
health
challenge
public
agency
france
infections
kidney
liver
heart
pancreas
nan
method
similarity
markets
the
financial
the
intestinal
scutellaria
baicalensis
metabolites
cxcl10
cxcl9
cxcl11
sars
cxcr3
shedding
fecv
cats
the
fhv
diseases
wild
viral
boar
populations
invasive
niv
patients
ventilation
care
nutrition
hboc
hemoglobin
day
embryonic
infections
risk
developing
transplant
recipients
crcov
antiviral
canine
respiratory
infection
iron
host
evolutionary
microbial
pathogen
des
une
et
la
microscopie
ace2
binding
the
sequence
charged
pcv2
pcs
dpi
antibody
specific
infections
severe
viral
occur
world
hallway
ventilation
patient
room
pm
nan
culture
diagnostic
virology
cell
cells
plasma
cancer
proteins
patients
pancreatic
sars
host
responses
immune
severe
plasma
infectious
viruses
agents
human
infectious
host
diseases
emerging
agents
nan
sars
human
epidemics
viruses
might
air
the
pathogens
distribution
risks
nan
transcription
sequence
di
rna
sequences
cephalotaxus
alkaloids
the
hht
family
de
une
en
et
la
nan
hajj
respiratory
pilgrims
viruses
infections
sars
cov
inhibitors
replication
3clpro
uti
urinary
tract
infection
culture
nan
product
development
an
approach
management
nan
community
acquired
pneumonia
or
abstract
cov
severe
respiratory
sars
bat
cats
fip
fcov
il
infected
tiv
asp
influenza
mice
aged
cpv
ccov
european
survey
canine
nan
nan
virus
hantavirus
proteins
infected
cells
atg
engraftment
weeks
canine
gy
red
blood
cells
cell
parasite
antibodies
monoclonal
present
abstract
engineering
reproductive
survival
factors
beef
pregnancy
nan
nan
prrsv
5up1
disease
specific
anti
de
en
el
los
niños
nanotechnology
including
nanoscaled
approximately
field
acute
bronchitis
antibiotic
adults
cough
rna
viral
antiviral
associated
viruses
nan
nan
sars
protein
cov
vlps
vaccine
hcov
oc43
may
229e
associations
diarrhea
in
neonatal
farms
outbreaks
de
les
des
virus
et
nan
ibv
rt
gene
developed
clinical
fwr
study
public
in
behaviour
mers
patients
macrolide
therapy
macrolides
hcmv
baicalein
genistein
early
action
infections
athlete
complications
pulmonary
cardiac
screening
travelers
airports
disease
spread
nan
adv
tracheal
epithelial
cells
epithelium
calves
bvdv
infected
virus
bcv
host
mrna
protein
nuclear
production
nan
the
spread
coronavirus
beyond
china
influenza
hcws
rcts
patients
visitors
government
abstract
southeast
asia
exhibits
de
patients
les
des
dans
waste
south
legislation
africa
veterinary
cancer
prostate
information
seeking
intention
proteins
sequence
known
in
methods
nan
auc
analysis
protein
using
quaternary
occupational
infection
risks
workers
following
continue
emerging
viral
pathogens
new
widespread
transmission
european
eu
eea
cats
fip
fipv
incidence
the
metagenomics
rna
virus
century
recent
vzv
infection
varicella
cells
infected
virus
humans
clinical
features
diagnosis
arau
cell
antiviral
activity
monophosphate
legitimacy
alibaba
platform
acceptance
building
nucleic
acid
infectious
diseases
diagnostic
comparative
models
we
in
perspective
vrc
participants
320
319
weeks
b5
cv
coxsackievirus
b3
pseudovirus
viral
log10
copies
ml
loads
rv
e2
proteins
et
expression
coagulation
ncp
survivors
results
novel
patients
hospital
viral
survivors
wuhan
gene
ayn
5a
virus
ibv
nan
pneumonia
bacterial
common
clinical
diagnosis
de
en
se
el
virus
transfusion
donor
recalls
hospital
services
nan
coiled
coil
membrane
fusion
proteins
nan
infections
bacterial
parasitic
diseases
uncommon
pkr
cells
cns
il
protein
iav
antiviral
pai
isgs
viruses
aminopeptidase
high
brain
nucleus
also
antioxidant
extracts
natural
mycelia
activities
waste
microorganisms
potential
contamination
groundwater
glycans
sars
complex
cov
mass
cird
respiratory
disease
dogs
kennelled
infectious
the
viruses
agents
represent
rna
helix
the
terminal
region
dcs
tgev
shxb
virulent
in
cats
inoculated
fipv
tissues
feline
case
2019
ncov
confirmed
infection
2019
the
cov
china
cases
interferon
sars
antiviral
cov
caco2
patients
137
2019
ncov
treatment
diseases
travelers
infections
patients
common
collected
bovine
specimens
respiratory
nucleic
ibv
cell
human
lines
animal
nos
ii
injection
spinal
cord
sars
surface
liposomal
peptide
cov
tmev
specific
responses
demyelinating
disease
adem
children
treatment
disease
central
surveillance
events
new
effective
systems
patients
samd9l
samd9
syndrome
mirage
iem
viruses
staining
detection
use
strand
rna
viruses
negative
prototype
building
ventilation
bay
bays
the
viruses
biosensors
detection
real
viral
denv
infection
impedance
based
virus
infection
animals
parvum
neonatal
calves
nan
mabs
virus
two
a8
flv
infections
produced
article
bacterial
pathogens
nan
production
mfs
cells
tlr3
expression
anti
important
heterocyclic
biginelli
in
species
human
trichomonads
zoonotic
parasites
mucosal
vaccines
hiv
meeting
recent
sars
rna
research
coronavirus
cov
rabies
human
cases
control
one
respiratory
viral
airway
major
adults
calves
hr
compared
respiratory
herds
nan
mice
response
ctl
c57bi
balb
hbov
respiratory
tract
infections
children
alkaloids
this
diverse
also
chapter
tetracyclines
anti
antibiotics
effective
including
quarantine
public
health
newly
emerging
nan
hrv
rna
children
virus
ome
yf
who
vaccines
working
group
civ
polypeptides
disulfide
bonds
the
covs
cov
detection
range
humans
patients
days
mg
median
influenza
hdpp4
rbd
binding
mers
cov
nan
cysteines
free
cysteine
proteases
form
compounding
factor
outbreak
potential
general
world
coronavirus
covid
19
mers
harm
estimates
medical
drugs
healthcare
intestinal
calves
infected
functions
retinyl
binding
protein
hemts
dissociation
constants
ferret
young
posterior
paresis
urinary
costs
this
study
per
available
cells
fipv
positive
cats
infected
il
infection
mice
cytokines
virus
cell
microenvironment
cells
growth
proteolytic
translational
recoding
reading
frame
codon
cyps
replication
virus
cyp
cyclophilins
assay
nxtag
human
in
luminex
bartonella
species
bats
small
mammals
adjuvanted
as03
non
group
vaccine
protein
tgev
recombinant
casei
igg
pprv
epitopes
motifs
protein
minimal
ginseng
quinquefolius
the
panax
years
hemorrhagic
positive
calf
cpb2
the
mers
cov
the
respiratory
human
spatiotemporal
studies
healthcare
analyses
settings
nan
use
medicines
healthcare
pregnancy
herbal
nan
supplier
switching
process
practices
processes
nan
infections
respiratory
multiple
viral
clinical
use
precautions
article
this
provides
host
new
infectious
diseases
emergence
de
la
et
les
des
nan
group
progression
patients
improvement
stabilization
vectors
adv
nonhuman
vector
gene
cov
mers
covs
human
using
spe
useful
practice
well
serum
nan
pcs
enzymes
step
protein
specific
based
the
influenza
web
european
sars
cov
protein
qs21
protection
ild
lung
clinical
ilds
idiopathic
un
la
de
patients
et
sars
patients
the
coronavirus
causes
nan
cycles
equipment
decontamination
rooms
h2o2
influenza
the
sofia
fia
sensitivity
filmarray
verigene
rv
summary
diagnostic
needs
family
anxiety
based
icu
protein
the
galectin
family
chicken
disasters
mental
psychiatric
millions
rehabilitation
de
en
la
sinusitis
aguda
hp
prrsv
swine
rjxwn06
vr
nan
brov
bcov
cases
the
lesions
mutants
rnas
replication
di
deletion
cov
bat
sars
hku2
spike
nan
2019
pneumonia
ncov
novel
wuhan
sars
inhibitors
cov
3clpro
lpv
pedv
elisa
s1
igg
diagnostic
sars
respiratory
human
transmission
viral
2019
covid
19
cases
patients
eif3i
vsv
replication
the
protein
autoimmune
specific
cell
nervous
system
nan
nan
cleaning
resistant
hospital
pathogens
risk
mers
binding
rbd
dpp4
mechanism
feline
diethylcarbamazine
in
cats
results
expansion
carousel
passengers
baggage
capacity
de
en
la
el
las
codon
usage
hbov
bias
genes
eis
officers
korea
phds
service
pk
15
cells
ifn
pbl
drug
one
approaches
np
the
feline
ocular
viral
cats
disease
chikungunya
fever
disease
reports
publications
virus
bn
human
rna
could
nan
hazard
control
health
resource
hierarchy
species
primates
virus
coronavirus
viruses
nan
sars
igy
coronavirus
acute
high
3a
chikv
activity
analogues
cov
care
duty
hcps
health
this
etm
ion
channel
activity
transmembrane
days
patients
shedding
culture
pcr
health
2019
ncov
patients
mental
diarrhea
epidemiological
consequences
symptom
great
cast
er
dnj
antiviral
linked
sars
ifa
protein
based
virus
cmv
renal
transplant
induced
insufficiency
nan
heroin
héroïne
asthma
les
asthme
nan
de
la
les
une
et
cells
activity
network
effector
autoimmune
nan
isolates
genome
polymorphism
number
snvs
pharyngitis
nsaias
pain
better
penicillin
pandemic
control
summary
on
11
newbury1
amino
acid
capsid
caliciviridae
nan
bovine
virus
befv
assay
lfd
nan
fcov
feline
infectious
peritonitis
sg
this
review
describes
recent
advances
covid
19
we
presented
case
wheezing
factors
children
care
young
nucleoside
analogues
series
position
ring
processing
nsp7
respiratory
coronavirus
formation
ebola
nurses
likely
institute
doctors
expression
gene
transcriptional
immune
system
fipv
protein
neutralizing
cats
activity
spla2
spla2s
iid
iie
iif
brd
animals
the
industry
infrared
disease
dynamics
behavior
complex
human
nan
abstract
this
chapter
examines
general
unborn
child
infections
mother
pregnancy
diseases
infectious
idi
okinawa
initiative
arthropod
characteristics
viruses
the
reovirus
nan
cough
patients
although
acute
it
cdsmp
self
subjects
the
program
reduce
this
feature
briefly
looks
rna
granules
viruses
bodies
proteins
nan
sars
protein
cov
peptides
ion
proteinase
control
the
enzymes
chapter
human
retroviruses
viruses
genome
elements
class
ii
expression
mhv
the
host
factors
genes
viruses
replication
prrs
mtb
wcl
mlv
mucosal
pdcov
ipec
j2
cells
cell
de
virus
hbov
les
dans
virus
disease
demyelinating
may
ms
nan
nsp9
ddx5
cells
prrsv
viral
mir
34
449
family
regulation
amines
several
noradamantyl
methyl
dimethyl
tissue
ms
patients
hcv
229e
nan
pdcov
in
diarrhea
piglets
infection
ifn
dukpna4
jev
duck
expression
virus
respiratory
bocavirus
new
children
orf7a
sars
cov
protein
transmembrane
the
enzymes
chapter
specificity
hepatitis
immunity
swine
lactogenic
piglets
pedv
nan
brd
brdx
pens
times
treated
2019
ncov
cases
china
outbreak
nursing
staff
diseases
hospitalization
risk
infants
acdmpv
atypical
pulmonary
lung
fever
itds
sensitivity
specificity
high
nan
severe
initial
thoracic
ferret
respiratory
les
infections
de
des
et
oxygen
masks
exhaled
respiratory
may
replication
viral
factors
pharmacological
effective
lymphocytes
ifn
cd3
cd4
the
polymerase
rna
peak
two
late
health
public
policy
law
two
nan
nan
prime
response
boost
hcv
dna
nan
coiled
coils
protein
interfaces
structural
emergency
shanghai
prehospital
medical
ambulance
influenza
pandemic
patients
the
clinical
tmev
axonal
inflammatory
lesions
mice
tcr
mice
cell
tg
epitope
health
care
respiratory
transmission
viral
influenza
relatively
mortality
clinical
viral
glycoprotein
g2
golgi
complex
the
carvs
infections
respiratory
sot
recipients
outbreak
lessons
kikwit
ebola
epidemic
strength
age
handgrip
population
rheumatoid
sars
16
cov
protein
sera
nan
vaccine
health
developing
global
vaccines
virus
rna
cell
influenza
lines
ad
may
pathogenesis
biomarkers
abstract
myocarditis
cardiac
life
threatening
disease
nan
hiv
infection
management
years
children
nan
proteins
plant
toxic
role
applications
risk
factors
the
kumbh
mela
dengue
china
including
global
abstract
cnnphv
dogs
tissues
nphv
rna
2019
coronavirus
ncov
in
pregnant
silicon
si
solar
et
al
diabetes
ace2
the
patients
low
psychological
covid
19
impact
health
nan
sirna
cvb3
2a
prna
folate
nuclear
export
dp2392
e10
influenza
cov
sars
sl
protein
ssl
laboratory
risk
infectious
agents
exposure
ventilators
units
de
dans
des
synthesis
viruses
technology
biosciences
template
pedv
high
competitive
elisa
diarrhoea
ccr5
cells
inflammation
inflammatory
mononuclear
nan
cathepsin
pocatb
smrv
uv
inactivated
chronic
lung
factors
major
term
respiratory
coronavirus
disease
dogs
several
gluc
virus
recombinant
glycoprotein
the
nan
medicines
traditional
african
diseases
scientific
pulmonary
the
treatment
infections
mycobacterial
unknown
k2p170
strain
vaccine
nephropathogenic
ibv
virus
magnetic
this
detection
igg
nan
nan
travel
health
hong
kong
services
vs
marcescens
resistance
taiwan
isolates
cells
situ
peripheral
blood
method
nan
viruses
rsv
influenza
seasonal
respiratory
dna
synthetic
made
synthesis
projects
cases
h7n9
age
years
among
shfv
virus
baboon
hemorrhagic
fever
unknown
pestis
antigens
dna
proteins
gene
synthesis
minus
strand
strands
replication
rumen
age
starter
calves
straw
nan
nan
nan
health
closure
in
influenza
pandemic
nan
nan
glycoproteins
membranes
virus
plasma
thus
lung
nebulizer
ml
jet
injury
cap
etiology
severity
patients
the
de
la
los
en
virus
sgmrnas
longer
template
grna
coronaviruses
the
guideline
practice
care
society
nan
respiratory
medicine
diseases
the
china
la
de
des
et
viral
plants
mediterranean
anti
olive
oil
nan
ndv
vector
intracellular
extracellular
forms
nan
cell
experimental
virus
evolution
culture
nan
frameshifting
gag
rsv
site
frameshift
nan
nan
nan
cypa
virus
demonstrated
replication
viruses
nan
pcr
fiv
dna
proviral
detected
disease
cns
monocytes
viral
dendritic
systems
biology
research
interactions
biological
agents
biological
next
generation
highly
viruses
respiratory
children
age
study
nan
nan
nan
bismuth
enzyme
cbs
inhibition
interaction
tacaribe
virus
compounds
new
viral
3a
terminal
anti
antibody
aa
techniques
viruses
sequencing
also
viral
gb
period
sga
medical
centers
nan
sars
coronavirus
treatment
coronaviruses
mers
sign
gene
dc
specific
fish
introduction
risk
model
eu
the
μm
peptide
the
gel
it
canine
outbreaks
italy
three
in
escmid
study
this
infections
document
nan
de
el
en
hospital
36
respiratory
measures
italy
acute
spread
nan
disaster
risks
risk
disasters
public
fcv
cat
disease
vsd
oscar
air
indoor
quality
hotel
iaq
viral
compounds
treatment
assay
inhibition
vaccines
viral
developed
effective
infections
house
building
development
industries
region
measures
sars
precautionary
staff
epidemics
asymptotic
solution
abstract
in
study
reported
cases
coronavirus
we
two
de
la
virus
el
chikungunya
pdcs
infected
shiv
hiv
virus
doctors
influenza
study
conducted
public
modifications
reversible
rnas
rna
mrna
bovine
per
cent
antibodies
pi
milk
fed
calves
protein
villi
patients
respiratory
poct
rsv
influenza
pedv
sows
inactivated
vaccine
strain
nan
de
et
la
le
des
tgev
test
the
competitive
inhibition
airlines
would
tax
competition
among
nan
nan
cats
fip
lymphocytes
fcov
subsets
nan
pack
outbreak
wild
dogs
disease
nan
influenza
emergency
departments
seasonal
causes
ev71
3cpro
the
proteolytic
structure
proteins
tgev
specific
protein
purified
rabbit
pet
rabbits
common
veterinary
nan
information
model
practices
sharing
the
cell
surface
peptidases
functions
the
trifluoromethyl
amino
11
4s
tert
nan
foetus
lamp
bovine
amplification
the
pollutant
transmission
ventilation
window
cross
nan
nan
period
control
epidemic
disease
model
data
seasonal
several
diagnosis
childhood
floor
transport
it
air
window
viruses
viral
metagenomic
koch
postulates
cells
lnc173
hiv
linc00173
lncrnas
virus
etv
the
horse
cell
nan
infection
mers
cov
mortality
31
on
31
december
2019
cluster
nan
protein
cells
str2
expression
intron
intestinal
lymphocytes
feline
cd4
malt
nan
mp
s264l
3d
g64r
polymerase
virus
patients
cases
respiratory
children
il
tnf
respiratory
disease
cytokines
membrane
plasma
viruses
viral
cell
publishing
party
state
industry
firmly
eedv
assay
lamp
virus
the
ifn
type
cns
viral
microglia
nan
sars
cells
stat3
cov
infected
transmission
pathways
identification
allows
existence
resistant
hospital
antimicrobial
meropenem
ciprofloxacin
alvac
type
up
regulated
the
factor
viii
remains
protein
antigen
nws
based
biosensors
fet
fets
rate
changes
real
interest
lagged
health
human
coronavirus
emergence
covid
findings
abstract
lymphadenopathy
splenomegaly
common
substances
milk
pathogens
mother
antimicrobial
virus
understanding
viruses
yeast
fundamental
korea
virus
g2a
outbreaks
pedv
nec
necrotizing
enterocolitis
body
research
air
hvac
infectious
filtration
recirculating
gl
extraction
imprinted
solid
phase
sars
lymphopenia
cd4
cd8
lymphocyte
the
enzymes
chapter
peptidase
third
rv
dccs
diarrhea
children
episodes
gene
sequence
region
leader
libraries
rna
respiratory
amplification
iroad
viral
infections
viral
the
analysis
neonatal
nan
cov
3clpro
hku4
inhibition
coronaviral
dpp4
expression
oxldl
cd36
deficiency
sars
cov
elisa
igg
the
the
drug
days
infection
diarrhoea
species
disease
research
population
genetic
diseases
threats
health
mers
the
information
spread
networks
formula
see
plex
id
concordance
101
sm
ptx3
pentraxin
crp
pentraxins
short
nan
liquid
separation
solids
treatment
production
mabs
protein
used
reactivity
coronavirus
nan
residents
respiratory
cases
covs
outbreaks
terminal
fragment
σ1
heptad
reovirus
rna
virus
swab
blood
patients
virus
host
emerging
wnv
antiviral
hpiv2
hae
human
respiratory
model
air
patient
autoimmune
retinopathy
role
health
the
public
diseases
emergency
de
rv
une
en
et
samples
the
cap
pneumoniae
children
use
biosensors
the
development
biosensor
government
crisis
hong
kong
sars
health
anthropology
research
environmental
medical
h120
protection
cr88
challenge
results
nan
the
effects
dynamics
one
model
nan
steroids
rsv
patients
viral
systemic
des
les
hcovs
coronavirus
sont
abortion
burnetii
neonatal
leptospira
mortality
type
fcov
fip
types
ii
molecular
farming
tobacco
provide
use
mers
chadox1
mva
tpa
vaccines
nan
mucosal
the
mucosa
immune
essential
response
virus
infection
acute
cell
rotavirus
species
the
genus
tentative
fluid
pediatric
size
patient
administration
new
h7n9
influenza
emerging
abstract
node
centrality
strategy
well
known
fractional
based
disease
solution
numerical
inhibitors
amino
acids
abstract
series
the
levels
flaxseed
weaning
acids
infections
emerging
clinical
outbreaks
population
2019
ncov
sars
novel
coronavirus
avrvs
group
samples
in
rotaviruses
nan
rnai
vivo
since
use
first
the
health
study
americans
avoidance
insect
baculoviruses
virus
odv
pests
nan
sars
coronavirus
days
viral
illness
pedv
protein
cell
porcine
the
infectious
training
the
diseases
uems
colts
challenge
reproductive
tract
virus
fiber
ad3
virus
ad2
peptide
leakage
respirators
gross
user
seal
cell
exosomes
specific
exosome
cells
viruses
rna
treatment
infections
virus
culture
viral
viruses
respiratory
sensitive
rna
scv
sars
aptamers
helicase
nan
nan
nan
de
la
en
las
respiratory
vaccines
significant
clinical
zika
virus
nan
public
social
media
eids
frames
pcr
real
time
panel
different
h5n1
strain
treatment
infections
drugs
nan
strain
pathogen
strains
behaviour
virulent
rna
protein
11
nucleotide
virus
the
meeting
nanomedicine
aanm
lectures
3d8scfv
coli
gene
gastrointestinal
feed
nan
ncds
infections
the
aetiological
control
hydroxyl
groups
ring
described
apoptosis
nan
hm2017
strain
pedv
china
hpi
nan
viral
infections
transmitted
virus
often
lectin
purified
activity
cells
mannose
this
naked
mole
rat
research
nan
nan
cerebrospinal
fluid
encephalitis
abstract
we
pigs
nano
kag
vaccinated
in
nan
il
balf
ifn
serum
cytokines
gp23
sds
000
gp90
gp180
diseases
guinea
used
research
infectious
urban
health
framework
population
living
parvum
colostrum
anti
igg
dams
cell
bestatin
cells
inhibition
mediated
sars
cov
plasma
treatment
sd
e2
glycoprotein
virus
cell
subunits
we
remain
vigilant
act
first
nan
nan
wu
assays
ki
kiv
wuv
influenza
virus
viruses
mdck
cells
nursing
shortage
china
article
solutions
coronavirus
fusion
entry
protein
cell
ppv
er
stress
factor
replication
health
climate
change
outcomes
drivers
nan
virus
rna
viral
protein
elements
techniques
methods
culture
important
these
cdv
vaccine
strains
samples
positive
viruses
3c
chapter
the
proteinases
cvb3
lamp
rt
detection
amplification
nan
cases
covid
19
south
korea
farms
pigs
the
health
spf
nan
ova
shsp
responses
mice
conjugated
nan
protease
3cl
eov
proteolytic
cleavage
respiratory
pcr
assays
multiplex
different
nan
epidemic
epidemics
everything
view
the
sars
cov
pros
furin
processing
ifns
specific
activity
innate
mechanisms
nan
cns
ifn
oligodendroglia
infection
jhmv
bik
hcv
ns5b
rna
replication
fca
flp
herd
median
management
pcr
330
babesiosis
disease
among
nan
abstract
mediawatch
lethal
virus
outbreaks
ifn
pneumococcal
infection
lung
bacterial
ccov
virus
inactivation
coronavirus
the
nan
replacements
health
management
dry
dairy
influenza
virus
pb1
pb2
polymerase
hypothalamic
cytokines
tumor
food
intake
neopterin
serum
cchf
levels
in
gp3
proteins
canine
ccov
feline
nan
two
rotavirus
summary
an
epidemiological
infectious
ks
syndrome
disease
genetic
pbmc
prv
ifn
production
infection
les
de
et
diagnostic
la
vics
del
vaccines
subgroup
subspecies
nan
cme
study
canis
dogs
canine
food
borne
disease
viruses
reliable
patients
months
postoperatively
the
18
abstract
no
il
optimum
mixing
ratio
extract
nan
nan
nan
nan
tha
patients
pt
study
functional
proteins
serum
evs
deiminated
llama
patent
pools
pool
initiated
various
2019
ncov
china
wuhan
to
rmv
sars
cov
mv
induced
herba
anticomplementary
cp
ap
complement
densely
populated
areas
rural
china
pdcov
us
diarrhea
pedv
strains
strains
ibv
ck
ch
ldl
nan
sars
cov
3cl
protease
drugs
influenza
mbl
deficiency
h1n1
2009
nan
nan
mhv
pp60
antigenic
conservation
antibodies
spread
models
epidemic
pandemics
the
il
induction
ibv
p38
mapk
antiviral
bats
irf3
responses
residue
plpro
unfolding
urea
enzyme
domain
cov
pv
using
inhibitors
3clpro
antigen
responses
immune
infection
innate
species
impacts
non
invasive
human
mice
ifn
young
adult
x03b3
nan
pharyngitis
gabhs
children
adults
caused
defensins
birds
defensin
expression
found
microbial
forensics
policy
important
education
de
et
une
la
maladie
patients
influenza
exacerbations
nonbacterial
forced
regulation
light
handed
the
airports
3c
protein
replication
fcov
gene
cellular
viral
proteins
viruses
gain
rvi
patients
hsct
respiratory
mortality
oh
nepal
approach
poor
health
nan
cells
differentiation
cd8
expansion
antigen
disease
significant
cryptosporidiosis
animals
several
ibv
probes
strains
oligonucleotide
oligonucleotides
rsv
bronchiolitis
nebulized
commonest
cause
nan
elisa
ped
pedv
developed
antibodies
medical
theories
level
disease
understanding
viruses
diseases
the
chapter
proteases
cell
viral
prion
may
products
safety
vaccines
studies
preclinical
toxicology
n95
mask
totobobo
masks
use
cattle
bcov
seroprevalence
goats
sheep
sars
cov
group
genotype
divided
2019
ncov
the
cov
public
sars
v2163
strain
il
lethal
viruses
respiratory
agents
virus
person
il
ifnγ
activation
mφ
12
gloving
ppe
hands
double
transfer
nan
nan
calves
virus
inoculated
attenuated
responses
metal
biological
range
potential
complexes
gp
addition
transport
oligosaccharides
presence
patients
uveitis
fluids
virus
human
nan
nan
nan
global
climate
infectious
quality
there
de
la
les
le
virus
nan
nan
event
events
relationships
temporal
evolution
2019
patients
virus
china
ncov
health
growth
environmental
limits
contemporary
human
coronavirus
sars
respiratory
surfaces
p53
cells
the
caspase
activation
sites
mhv
leader
rna
transcription
lift
up
buildings
wind
areas
microbiota
this
article
provides
brief
respiratory
infection
human
the
viruses
the
cheetahs
myelopathic
sequences
mitochondrial
dogs
fml
asymptomatic
vaccine
infected
assets
demand
wealth
financial
this
nan
acute
lung
histologic
features
damage
2019
health
wuhan
china
due
disease
shedding
kinetics
laboratory
response
rna
nidoviruses
large
the
genomes
nan
influenza
respiratory
viruses
acute
infections
sars
cov
viral
protein
entry
germicidal
cell
tio2
cells
the
sars
bats
human
we
sarsr
vaccines
limitations
use
health
developing
nan
health
patients
workers
international
may
nan
drug
transport
lymphatic
systemic
lipid
outbreak
public
communication
outbreaks
the
transmission
studies
airborne
aerosols
n95
nan
nan
vlps
rhdv
epitope
chimeric
virus
virus
piv3
goat
the
respiratory
nan
ur
uvgi
uv
germicidal
systems
mucosal
immune
pathogens
tissues
responses
virus
infections
overseas
viral
acquired
virus
diseases
nipah
bats
region
nan
patients
asthma
serum
igg
viral
pediatric
patient
rare
data
electronic
bats
cruzi
tcbat
mammals
these
reported
cases
promed
we
coronavirus
type
ferruginol
anti
analogues
dengue
phenotypic
processes
groups
studies
composition
sars
cov
entry
virus
protein
preterm
births
spontaneous
birth
labour
hcmv
ad5f35
ctl
vaccine
hla
cov
vaccines
covs
humans
sars
exposure
areas
common
cause
febrile
nan
prrsv
ifn
induction
mo
dc
cox
hcv
development
protein
hepatitis
emergency
traveler
diseases
summary
the
rna
viruses
viral
signaling
host
nan
infected
individuals
infection
state
epidemic
puppies
spp
cpv
diarrhoea
ccov
tgev
protein
cell
iec
cycle
use
veterinarians
ppe
likely
zoonotic
tio2
the
coated
coatings
coating
anti
cells
tissues
spleen
3c3
matrix
virus
proteins
protein
their
virus
viruses
cell
cells
culture
pleural
fluid
ppe
pe
children
protein
transmembrane
tested
sars
domain
view
describe
common
colds
problem
measures
dogs
welfare
studies
animal
nan
ifn
activity
infected
antigenic
summary
nan
virus
viruses
shellfish
detection
hepatitis
policy
2007
public
study
1999
complex
multiprotein
essential
catalyzed
machines
culture
patients
subjects
positive
sputum
shfv
cells
proteins
the
virus
display
peptide
vaccines
the
surface
nan
chronic
caudal
stomatitis
alveolar
buccal
cep
anti
drug
the
effects
cases
hiv
female
male
the
health
organization
the
world
global
mechanism
the
frame
monitoring
suggested
rna
p28
two
protein
infected
iels
cells
rat
the
cell
tgfβ
prrsv
study
response
expression
leung
2020
online
10
1016
nan
papn
pedv
domain
cells
vii
nan
chcp
complement
cordata
system
used
na
clinical
opportunities
molecular
laboratory
lysosomal
lysosomes
degradation
cell
hydrolases
nan
phbs
clinical
phb
ligands
prohibitins
canine
mdck
sp
rpmi
medium
single
particle
sample
cryoem
structural
nan
de
en
la
coronavirus
los
provides
it
use
care
gerbils
hbv
the
protein
liver
biological
protein
coronavirus
virus
replication
cell
sars
spatial
beijing
spread
the
protease
inhibitor
3c
ev71
family
neutrophils
functions
immune
chemokines
recent
nan
myelin
disorders
whether
human
repair
nan
patients
lung
sars
igg
results
pregnancy
respiratory
infections
disorders
complicate
nan
vero
cells
pedv
apn
porcine
opiate
papers
include
responses
activity
influenza
multiple
ha
detection
high
cells
lymphocytes
81
among
fraction
the
suicide
hk
media
risk
information
reproduction
processes
make
room
nan
viruses
host
population
viral
numbers
clinical
the
development
trial
vaccine
cystatin
the
also
well
marker
nan
nan
pi
infection
bal
respiratory
infiltration
influenza
1918
pandemic
lethality
circulation
nan
mechanisms
signaling
cytokine
mammalian
cells
panels
clones
gene
human
the
infections
travellers
cases
transmitted
arriving
nan
mrna
cellular
viral
xrn1
decay
health
uk
preparedness
border
port
nan
mphi
health
public
medicine
10
pu
cells
cor
transcriptional
metabolic
infections
common
marmosets
disease
virus
gi
diet
the
nutrients
normal
cf
exacerbations
pulmonary
quality
life
hiv
cells
dendritic
viral
lectin
flow
cytometry
viral
diagnosis
rapid
kinetochore
skp1
dna
protein
intrinsic
s1
sites
ark99
mass41
identified
dna
device
amplification
hbv
reaction
rhinosinusitis
clinical
the
american
definitions
nc
mucosal
sars
prime
boost
mers
cov
the
binding
antibody
health
curriculum
medical
community
university
nan
sars
cov
genes
infection
dna
games
mass
gathering
africa
risk
nan
bgp
the
proteins
several
mouse
limbic
encephalitis
entity
clinical
presentation
positive
subjects
intradermal
rashes
children
inhibitors
drugs
antiviral
viral
infections
les
des
de
et
la
mrarf1
mrarf2
wssv
arfs
hepatopancreas
mrsa
consumption
ha
prevalence
incidence
disease
emergency
condition
outbreak
rapid
imaging
diagnostic
neonatal
foals
sonographic
acute
respiratory
viral
fri
ards
cells
ccr5
mice
mhv
cns
fcv
mefloquine
antiviral
isolates
vitro
bereavement
nurses
care
support
cluster
stochastic
model
isolation
it
coefficient
nan
cfd
released
bacteria
time
source
well
abstract
review
given
pathogenetic
technique
tgev
infected
cells
antigens
wound
surgical
key
words
classification
nan
virus
passage
subpopulations
p70
p110
air
coli
isolated
downwind
samples
poct
viruses
antibiotics
positive
testing
farms
biosecurity
measures
veal
all
nan
disease
the
network
laboratories
new
virus
vaccine
viruses
west
nile
sunlight
ventilation
infection
transmission
pathogens
isolation
nurses
precautions
the
compliance
nan
nan
human
disease
models
cardiac
animal
nan
information
super
spreading
model
propagation
nucleic
colorimetric
acid
cpe
responses
nan
nan
respiratory
infection
mortality
high
illness
traditional
drugs
antiviral
human
medicine
nan
nan
immune
dna
pcdnam
pcdnasa
pcdnasb
viral
the
respiratory
cells
h5n1
healthcare
providers
survivors
experienced
outbreak
cpv
feline
variants
infection
fpl
ibdv
line
il
chickens
srbc
bone
day
corticosteroid
osteonecrosis
markers
virus
infection
viruses
compounds
screening
data
epijson
format
epidemiological
tools
avian
lpai
viruses
four
influenza
adenovirus
brushtail
partial
genome
marsupial
phenotype
strains
clinical
resistance
ir
nsp4
cells
replicase
dmvs
icv
cip
intestinal
the
disorders
clinical
ct
initial
opacifications
covid
19
nan
evidence
guidelines
recommendations
practice
based
nl63
hcov
hmpv
children
frequency
hpiv
patterns
circulation
hpivs
2019
data
resilience
residual
variance
used
hotels
the
spatial
attractions
relationships
spike
protein
peptides
neutralizing
antibody
tuberculosis
control
health
public
system
nan
nan
ibv
poultry
regions
industry
mena
nan
nan
il
protein
nf
κb
sars
viruses
effects
enteric
intestinal
viral
nbu
abstract
caring
patients
ebola
zoonoses
diseases
health
presented
abstract
dna
the
pathogens
detect
infections
nan
ibv
innate
infection
immune
trachea
multipred2
hla
prediction
binding
class
diarrhea
lactoferrin
calves
diagnosis
treatment
microarrays
applications
understanding
immune
responses
nan
95
adjusted
or
ci
community
hp
fever
positive
calves
crd
nan
particles
saw
produced
blade
human
ace2
receptor
sars
cov
infection
bioterrorism
critical
care
diagnosis
likely
patients
disease
type
covid
19
nan
influenza
avian
viruses
pandemic
virus
sars
infected
cells
understanding
induced
ifn
sc
gestation
detected
hematopoietic
protein
prrsv
nucleolus
virus
cytoplasm
rnase
antiviral
activated
viral
replication
nan
de
el
influenza
virus
la
nan
nan
nan
ccov
strains
iib
type
detected
recombination
recombinant
viruses
prrsv
orf
nan
mt
nhr
hiv
fusion
coiled
infection
complex
control
cra
incidence
prrs
pigs
prrsv
cells
mlv
nan
nan
nan
family
wuhan
patients
novel
coronavirus
2019
uncertainties
wuhan
novel
coronavirus
programs
biological
assets
threat
mitigation
membrane
channels
transporters
electron
proteins
polyomaviruses
capsid
proteins
dna
small
nan
government
china
chapter
hong
kong
cases
linked
2019
reported
china
de
les
patients
la
une
nan
respiratory
receptors
entry
coronaviruses
identified
mir
208
3p
arid2
expression
assessment
case
patients
sars
public
nan
remyelination
lesions
repair
axons
myelin
mers
hcws
we
cases
confirmed
tourism
event
hallmark
events
taiwan
food
safety
this
article
provides
health
ict
nursing
global
globalization
calves
algorithm
antimicrobial
farm
diarrhoeic
capsid
spikes
immature
particles
icosahedral
sars
8b
accessory
cov
study
s100a9
protein
bvdv
the
cells
nan
adrenal
damage
clinical
infection
endocrine
method
sequences
genome
sequence
genomes
nan
type
hsv
b3
dihydrocaffeoyl
catechols
lesion
computer
lung
radiologists
the
nan
pedv
elisa
samples
herds
porcine
epithelium
mycoplasma
inoculation
organ
bovis
molecular
diagnostic
cf
tests
detection
btov
cattle
brazilian
80
samples
virus
inactivation
bpl
fa
inactivated
aptamers
assay
ligands
the
aptamer
cellular
virus
infection
viral
thus
opportunistic
infections
patients
defects
cause
viruses
the
unique
classification
properties
swine
vaccines
virus
pedv
effective
nan
vcp
wnv
expression
protein
role
virus
subfamily
peritonitis
fip
the
fit
participants
passed
chest
n95
fcv
fexaramine
diseases
strains
cell
nan
ica
detection
ml
diarrhea
pedv
ndv
mirna
np
cells
expressing
prrsv
immune
nsp1
ifn
virus
mortality
at
we
elderly
1998
type
cells
alveolar
ii
cell
astrocytes
ia
virus
jhm
lps
sts
ri
strains
mice
jhmv
sars
ata
cov
viral
compared
hunov
con
gii
detection
region
nan
ang
ace2
ii
the
purified
nan
filter
collection
the
efficiency
virus
nan
unknown
vaccine
fip
cats
fcov
vaccination
cell
function
immune
aging
influences
fly
ash
carbon
constituents
pcdd
nmr
metal
spectroscopy
biological
systems
plasma
membranes
cells
specific
cell
influenza
viruses
types
abstract
the
nan
body
preserving
abstract
appropriate
precautions
rotavirus
diarrhoeic
lambs
infection
faecal
ros
rna
genome
host
replication
acute
eae
mhv
susceptibility
vaas
nan
nan
s1
recombinant
protein
neutralizing
antigenicity
infants
erythromycin
nutrition
placebo
parenteral
cloned
cat
donor
second
generation
unknown
nan
advansure
assay
seeplex
time
pcr
nan
the
middle
eastern
coronavirus
started
nan
protein
microarrays
microarray
technology
in
bat
risk
spillover
human
study
nan
biological
chapter
threats
bioterrorism
this
infection
disease
copd
this
article
typhimurium
the
antibodies
plant
tm43
nan
sl
sequence
small
rnas
reiteration
nan
nan
virus
eav
infected
infection
may
diseases
term
tropical
noncommunicable
disease
cd
the
properties
effects
cells
nan
nan
feno
pcr
virus
exacerbation
asthma
vaccine
development
use
vaccines
new
health
conditions
transitions
infectious
disease
ace2
activity
mrna
species
kidney
de
la
en
viral
entry
stress
tia
foci
poliovirus
granules
nan
lectin
pcl
wssv
crayfish
type
dogs
cats
virus
infectious
agents
stresses
cauliflower
h41
h69
flooding
nan
viral
antiviral
designs
different
control
nan
fagprp
feline
fip
cells
agp
nan
diseases
urinary
tract
reviewed
covering
infections
aureus
mupirocin
patients
wound
femv
cats
samples
kidney
urine
tgev
signaling
anti
activity
cardenolides
health
care
resources
surge
capacity
hospitals
care
critical
regionalization
patients
nan
singapore
changes
sars
outbreak
emergency
nan
ole
ht
hiv
fusion
we
adenoviruses
cell
line
the
different
population
disease
spatial
resolution
data
sars
ic
hcws
healthcare
the
e1
e2
secreted
rv
cell
assembly
virus
capsids
hepatitis
capsid
models
contact
diseases
networks
social
nan
protein
sars
the
virus
cells
polycyclic
m2
proton
channel
h1n1
nan
nan
avian
flu
diseases
sars
countries
nan
cell
autoreactive
cells
peptides
mhc
nsp15
activity
protein
endoribonuclease
mutants
sleep
viral
psychomotor
23
performance
article
this
updated
version
previous
nan
there
increasing
concern
covid
19
msa2
lactis
non
covalently
genetically
cq
229e
hcov
replication
human
patients
covid
19
cancer
authors
sars
cov
ml
mizoribine
ribavirin
autophagy
viral
viruses
functions
lysosomal
flavonoids
antibacterial
activity
research
groups
nan
rectivirgula
mcp
ccr2
mice
hp
studies
contact
precautions
transmission
mdro
lncrnas
pedv
expression
infection
lncrna
nan
tourism
arrivals
visitor
markets
volatility
strains
garv
porcine
g8p
genotypes
vaccines
testing
novel
nonclinical
development
sars
cov
respiratory
severe
acute
disease
bovine
abstract
immunization
programs
viral
virus
use
protocol
the
dogs
infection
cb
05
strain
nan
antibodies
human
monoclonal
field
method
vaccine
development
epidemic
research
infectious
forensic
distinguish
perpetrator
immune
response
virus
wnv
viral
synthetic
mice
new
mdts
the
md
analysis
must
refugee
children
international
adoptees
in
induced
hpai
pigeon04
mice
intracellular
antibody
antibodies
the
technology
mers
cov
elisa
elisas
mn
nan
ed
based
disease
biomarkers
care
hla
ctl
sars
a2
specific
tree
species
the
phylogeny
viruses
ac
elisa
virus
dev
detection
spread
transmission
animal
indirect
epidemiological
rna
disse
synthesis
cells
infected
eids
transfusion
the
risk
diseases
the
ions
negative
air
ventilation
nan
now
federal
billion
appropriations
bill
nan
fusion
domain
spike
membrane
cys
pathogens
genes
expression
mice
response
cyclophilin
replication
cellular
cov
coronaviruses
respiratory
detected
patients
rvp
viral
de
virus
coronavirus
le
un
risk
death
cfr
course
epidemic
cell
the
cytotoxic
also
two
diarrheal
per
mortality
pediatric
year
conferences
environmental
mission
health
scientific
diarrhea
epidemiological
consequences
symptom
great
spinal
cord
feline
cells
this
safety
laboratory
hazards
laboratories
biomedical
nan
gi
disease
exotic
small
veterinary
respiratory
failure
abstract
year
old
nan
nan
diseases
infectious
eid
globally
borne
rna
sars
coronavirus
cells
disease
mers
cov
infection
associated
clinical
real
still
summary
four
decades
nan
cases
pneumonia
study
the
controls
dogs
foetus
identified
pcr
hominis
peptide
aldehyde
abstract
we
investigated
disease
lyme
tourism
implications
paper
bacteria
viral
illnesses
mutate
human
metagenomics
viruses
clinical
samples
tool
human
respiratory
virus
propagation
pathogens
fcov
primer
tgev
ccov
coronavirus
coronavirus
cheetah
feline
the
cell
nan
cryptosporidium
cattle
samples
farms
detected
cell
treg
cells
th1
responses
hcov
nl63
influenza
infection
patients
nan
nan
nan
unknown
incidence
sites
iav
rsv
ibv
activity
influenza
pps
anti
pomegranate
outbreak
infectious
disease
outbreaks
analysis
nan
did
criteria
level
according
quality
therapy
renal
disease
treatment
avian
ibv
pathogenicity
sd
sz
qx
nan
transmission
methods
using
traditional
epidemiological
nan
concept
three
way
attribute
reductions
farms
type
broiler
the
ibv
de
en
la
se
los
reported
deaths
2009
public
health
zikv
zika
effect
ribavirin
replication
activity
antiviral
ec50
hydroxy
quinazoline
viral
fip
infection
cats
feline
nan
cns
synthesis
intrathecal
infection
viral
eav
molecular
equine
arteritis
virus
cats
fip
cytokine
infected
feline
nan
nan
nan
in
late
december
2019
cluster
ace
angiotensin
two
well
inhibitors
nan
essay
population
demography
economic
theories
earthquake
fear
upper
floors
we
brv
calves
colostrum
diarrhea
sa11
nan
bkov
diarrheic
china
the
sequences
nan
m2e
fp
influenza
vaccines
highly
2d
graphical
representation
abstract
we
type
sars
cov
two
viruses
delivery
cellular
uptake
therapeutic
mechanism
phosphonates
trans
cis
yl
mixture
patients
ioaes
fenestrated
stent
branched
building
pollutant
position
angle
dispersion
testing
fit
solution
taste
could
probe
rna
ibv
mass41
viral
aiir
the
pathogenic
research
concentration
influenza
humans
respiratory
infections
global
nan
enva
target
binding
receptor
assays
jejunostomy
tacrolimus
administration
oral
trough
nan
bdv
sheep
horses
p24
borna
care
critical
emcc
task
force
nan
tourism
hong
kong
governance
political
angiotensin
the
enzymes
chapter
converting
pcr
rt
real
time
btov
sars
cov
disease
2003
may
viral
infections
multiple
respiratory
infection
detection
the
methods
sensors
volume
nan
design
nanoparticles
self
sapns
vaccine
doi
vaccines
the
issues
extended
cats
virus
fipv
inoculation
antigen
wnv
jev
reactivity
elisa
mabs
viruses
species
different
interspecies
transmission
nan
sequence
virus
polymerase
part
coronaviruses
nan
models
the
arfima
forecasts
abstract
hosts
novel
host
adaptation
original
aids
patients
weight
loss
summary
mers
remdesivir
cov
treatment
clinical
healthcare
nurses
experiences
mers
cov
carnivores
molecular
canine
cpv
virus
strategies
control
csa
use
following
cell
cells
endosomal
surface
hcov
nan
sars
assays
samples
the
antibodies
dc
lsectin
sign
viral
signr
isolates
sars
sequence
virus
sequences
viruses
approaches
based
virus
new
production
trade
sharing
business
we
nan
nan
respiratory
viruses
mortality
virus
common
mb
theraflex
plasma
log
sars
nan
nan
glycoprotein
adjuvant
vaccine
per
dose
the
antiviral
research
icar
31st
nan
air
ventilation
system
particles
outdoor
nan
enterotoxin
sea
seb
peptide
mabs
sign
ibv
dc
infection
virus
nan
fifn
fipv
cats
mabs
fip
salmonella
increasing
bovine
prevalence
producers
nan
ferrets
ferret
the
cdv
new
rcn
bats
mva
vectors
expression
igg
sars
levels
detected
patients
copd
respiratory
admissions
children
exacerbations
hiv
life
pediatric
infection
the
nan
covid
19
ncapp
treatment
diagnosis
nan
tests
des
de
le
diagnostic
viral
fmdv
replication
autophagy
cells
detection
animal
pathogens
the
assays
95
ci
respiratory
days
temperature
sars
animal
model
models
immunotherapy
nan
nan
tnf
alpha
feline
fip
cats
antibodies
neutralizing
in
sars
cov
pancreatitis
cats
acute
dogs
may
ards
ang
axis
vili
respiratory
krg
virus
ginseng
human
steaming
protein
encoded
virus
kda
lv
nan
respiratory
viruses
exacerbations
cf
exacerbation
based
irt
vital
screening
visible
viruses
respiratory
infections
pneumonia
the
viruses
nov
food
viral
may
nan
nan
group
ort
chickens
infected
infection
astrovirus
infection
abstract
astroviruses
small
emergency
agency
cross
information
capacity
plasmids
family
replication
origins
strand
measles
caucasians
antiviral
snps
haplotype
biosensors
research
applications
clinical
cancer
nan
the
2019
coronavirus
respiratory
disease
nan
infection
viral
viruses
community
prevention
tchm
in
recent
viral
mechanisms
antioxidant
phenolic
medicinal
herbs
traditional
fusion
proteins
viral
membrane
surface
nan
fip
cells
antibody
titers
cats
nan
leptospira
spp
bats
species
frequency
duplex
rna
nsp13
dna
increased
nan
sars
cov
findings
replication
strains
health
caregivers
burden
mental
physical
lna
rna
locked
nucleic
acid
sars
cov
rna
effective
antiviral
phcovs
isolated
pheasants
ibvs
different
mpro
the
peptidase
sars
ape
il
response
chagasi
ifn
immune
rapid
detection
2019
coronavirus
covid
golgi
rna
membranes
1a
replication
jhmv
mhv3
oligodendrocytes
virus
the
transmission
events
primary
to
covid
cases
disease
number
stages
asymptomatic
fan1
dna
flap
hfan1
monomeric
network
social
analysis
the
this
new
epidemics
in
current
era
nan
tuberculosis
treatment
active
case
finding
respiratory
viruses
influenza
travellers
symptom
cholesterol
bohv
depletion
virus
cell
si
ni
san
glycyrrhizin
mice
donors
outbreak
beliefs
avian
influenza
mers
cov
spike
protein
nanoparticles
h120
virus
ibv
strain
infectious
la
de
en
diferentes
los
nan
genus
the
cells
betatetravirus
viruses
rna
subgenomic
di
strand
genomic
nan
fipv
type
peptides
epitopes
domain
virus
mice
infection
mhv3
infected
attack
nuclear
terrorist
radiology
community
cathepsin
pec
mnv
fcv
entry
indel
pedv
strains
non
receptors
2019
ncov
virus
bat
sars
nan
fidelity
rna
replication
virus
viral
nan
alrips
patients
pulmonary
alri
alrihl
protein
er
e19
class
antigens
the
method
pls
toc
ssc
virus
multiplex
the
rt
pcr
qc
cmm
pattern
biopotency
assays
wound
90
regenerated
fetida
repair
vaccination
nurses
influenza
factors
perceived
nan
domains
disaster
nurses
review
competencies
3clpro
compounds
the
sars
cov
ibv
asc
infection
cells
pbmc
colostrum
spp
cryptosporidium
quality
calf
sars
education
healthcare
staff
the
cdv
virus
infection
dogs
severe
nan
virus
bcv
clinical
the
this
nan
antifungal
gel
peptide
chromatography
ic50
mhv
il
uv
cells
balb
respiratory
viral
transplant
infections
ips
nan
health
care
estimates
suggest
covid
prrsv
protein
could
the
virus
nan
sars
2003
who
acute
severe
epidemiologic
cases
outbreak
emerging
age
health
population
genomics
public
genomic
sars
cov
rbd
host
cell
hsv
activation
nf
κb
cordata
nan
emergency
sick
early
physicians
trained
nan
vaccines
diseases
immune
responses
reverse
nan
nan
vaccines
live
vaccine
it
including
sars
cov
quarantine
led
coronavirus
cities
saan
structure
core
the
receptor
rbd
antibody
the
structures
sars
disease
outbreak
the
global
nan
nan
model
research
the
cotton
rat
gl
glucopyranuronosyl
30
18α
acid
nan
nan
sars
cov
the
epithelial
cells
extract
hc
vapor
rpf
the
health
care
environmental
hygiene
overview
infected
damage
influenza
depleted
alveolar
infections
infants
neonatal
continue
cause
nan
vaccination
social
geo
patterns
effective
nan
nan
2019
novel
epidemic
challenging
global
nan
lat2
amino
lat1
cells
alanine
h1n1
human
clinical
case
definitions
chloramines
oxygen
concentrations
ros
different
nan
patients
urti
one
lrti
respiratory
disease
missing
spreader
outbreak
infectious
mhv
liver
virus
mice
infection
respiratory
patients
viruses
virus
pa
ccv
faecal
temperatures
20
material
2019
concern
umrah
saudi
arabia
immune
cancer
control
functions
regulatory
vap
surveillance
control
ventilator
associated
viral
replication
sites
golgi
budding
ifn
γr1
demyelination
cd8
rag1
3b
gene
product
cells
protein
nan
system
rna
cell
permeabilized
specific
mammary
recombinant
protein
the
expressed
atg16l1
defense
autophagy
atg5
atg12
treatment
cp
well
patients
evd
ethanol
surfaces
germicides
62
health
nan
glycoproteins
gvp
tunicamycin
monensin
in
nan
coronavirus
type
ii
case
fatal
lung
virus
cells
vectors
lentiviral
protein
pedv
elisa
recombinant
nucleocapsid
knowledge
network
study
keyword
scientific
pi4kb
replication
ros
genome
inhibition
communicable
travellers
risk
diseases
return
btov
btovs
strains
korean
pcr
lamp
new
time
pcr
microscopy
vp129
swil1β
il
virus
1β
vaccine
viral
designs
evolution
different
calves
vaccinated
brsv
hrsv
nsrs
veev
macro
adpr
proteins
md
the
efficacy
gaseous
disinfection
treatment
nan
pathogens
treatment
microbial
emergence
potential
fusion
fusogens
membrane
principles
fundamental
gc
on
femoral
head
mechanisms
hand
hygiene
recommendations
healthcare
guidelines
nan
plasma
safety
manufacturing
procedures
abstract
cov
infections
clinical
clinically
antigen
sars
cov
compounds
target
104
prm
protein
virus
cells
mve
children
azithromycin
amoxicillin
clavulanate
non
terminal
domain
protease
enzyme
unfolding
antigenic
virus
mabs
defined
tge
oc
symptoms
fears
swine
flu
immunity
respiratory
tract
lymphoid
effective
control
infection
hcws
fever
patients
nan
mers
cov
human
saudi
disease
mbp
cells
reactive
cytotoxic
oligodendrocytes
tgev
protein
fusion
core
spiker
january
taiwan
she
on
2020
lung
induced
vlp
mrsa
environment
respiratory
hygiene
compliance
health
care
protein
biological
well
studies
yeast
cv
protein
immunity
protection
vaccines
immune
response
the
systems
innate
il
rl
nvdr
mrna
resorptive
viruses
nervous
system
virus
important
polyprotein
proteinase
amino
p28
cleavage
blv
calf
two
month
old
gloves
bin
rubbish
pretest
posttest
smear
positive
pulmonary
g1
segment
organizational
system
development
compared
local
nan
cm
h2o
exhaled
air
ipap
hajj
hcov
emc
despite
person
clinical
technology
virology
mass
maldi
nan
ms
models
animal
pathogenesis
induced
viral
resplex
filmarray
respiratory
systems
unknown
infection
viral
decrease
meal
anorexia
nanoparticles
superior
activity
technologies
safety
patients
sars
cov
reactivation
covid
abstract
some
historical
remarks
made
extract
extracts
activity
virus
antiviral
sars
protein
cov
responses
the
regulation
case
regulatory
price
aviation
nan
heterogeneous
beliefs
short
sale
restrictions
critical
care
disaster
teams
effective
nan
mhv
ri
proteins
protein
the
40
antivirals
abstract
influenza
pandemics
viruses
virus
contamination
oysters
foodborne
assay
chv
canine
dna
the
infection
response
co
immune
data
co2
emissions
efficiency
urbanization
effect
calf
dairy
farms
morbidity
mortality
mers
cov
data
disease
common
nan
sorting
week
supernovae
absolute
zeros
virus
cells
diagnostic
viral
assays
dogs
cats
health
probiotic
human
natural
compounds
new
essential
major
nan
nan
regional
economic
integration
co2
marginal
cov
covs
viral
nsp1
host
tb
patients
admitted
via
eds
giardia
calves
calf
scouring
parasites
nan
nan
influenza
positive
pcr
vaccine
strains
nan
infection
age
months
children
hrvla
poms
organic
hiv
principle
potential
nan
vaccine
protection
arkga
spray
challenge
virus
neurologic
observed
tissues
animals
nan
nan
fip
feline
cats
positive
coronavirus
entry
gp
catl
cell
calu
delivery
sirna
nanoliposomes
lung
ecl
host
data
genomics
tools
gene
proteins
used
human
recombinant
bacteria
infections
rhinovirus
respiratory
hrv
treatment
nan
populations
pinnipeds
species
seals
knowledge
sars
proteins
antibodies
anti
3a
bcl
xl
vamp2
physically
interacts
k40
09
strain
attenuated
vaccine
nan
virus
rna
like
hpai
h5n1
sev
peptides
complete
virion
antigen
nan
probes
pcr
ds
detection
exposure
pmws
pcv2
pigs
sequences
group
samples
days
pedv
infectious
stored
cells
e2
mhv
anti
fcγr
mngs
viral
pathogens
protocol
pcr
hku1
hcov
children
arti
respiratory
exacerbations
copd
chronic
mucus
hypersecretion
inter
flat
transmission
dispersion
wind
nan
pedv
raj1102
virus
egfp
diarrhea
npcs
cells
replication
jhmv
virus
anisodamine
ms
hydroxyanisodamine
conjugated
metabolites
ectrim8
trim8
grouper
transcription
interferon
biological
bioterrorism
environment
warfare
war
nan
young
animals
compared
diseases
the
nan
hygiene
management
waste
patients
hids
vaccine
lipid
particles
the
vaccines
nan
nan
nan
cypa
replication
nidoviruses
huh7
cells
cpv
diagnosis
qcm
used
rapid
the
particles
mask
respirator
concept
rnai
treatment
since
demonstration
rna
silencing
suppressor
p22
dsrna
rna
spint2
fusion
cell
inhibitor
influenza
epidemic
epidemics
models
disease
modelling
hnpcs
ms
cells
model
transplantation
sars
outbreak
stock
hotel
taiwanese
influenza
clinical
respiratory
conference
the
nan
nan
food
organization
who
health
safety
rsv
detection
lna
novel
assay
laboratory
clinical
research
test
questions
sequences
different
similarity
in
method
platelets
platelet
sepsis
injury
ards
complexes
the
platinum
palladium
cytostatic
patients
viral
culture
ifa
diagnosis
fcov
cats
the
prevalence
malaysia
nan
il
21
tbe
nb
csf
nan
viruses
particles
virus
potential
form
nan
nan
internet
data
infectious
based
early
cq
histopathological
alterations
fish
96
nan
endouc
endou
expression
zebrafish
structure
in
viruses
compartments
assembly
abstract
compounds
models
active
inactive
validated
optometry
leadership
optometrists
state
event
hgs
growth
lgs
the
tourist
experimental
human
marmosets
animals
primate
nan
ibv
vlps
vaccine
report
proteins
public
health
principles
the
state
host
h5n1
pathogenesis
response
studies
virus
camels
shedding
reducing
mers
parasites
giant
panda
conservation
research
olfactory
medical
nasal
airway
disturbances
swine
diseases
system
abstract
disorders
nan
food
safety
risk
analysis
systems
sars
individuals
period
medical
patients
arteriviruses
the
family
strategy
virus
sio2
nr
the
nanoparticles
nanocomposites
viruses
respiratory
infections
asthma
also
samples
pigs
elisa
the
porcine
health
one
concept
emerging
the
bdv
cns
viruses
investigation
virus
data
analysis
development
methods
opportunities
isg15
antiviral
ifn
induced
ubiquitin
nan
ari
rna
viral
npa
virus
ace2
losartan
smoke
rats
pulmonary
zipper
protein
peptide
self
binding
gi
the
23
virus
ibv
nan
nan
chikv
virus
niclosamide
nitazoxanide
in
rv
host
viral
species
rvs
nan
infection
signaling
pathways
within
rlr
de
virus
la
les
est
pedv
hr2p
hr
regions
peptides
coli
etec
inoculated
samples
f4
cancer
recorded
wild
prevalence
wildlife
anti
nucleosides
cs
well
scientific
nan
tourism
responsible
significant
negative
consequences
care
sars
physicians
patients
direct
nan
nan
nan
compounds
the
fipv
viral
protease
dubs
proteins
target
cytokines
responses
virus
infection
upr
pedv
er
nan
rsv
infection
respiratory
we
host
conditions
neutral
unstable
ventilation
practices
sars
cov
masked
palm
civets
rti
hbov1
children
lrti
associated
coronavirus
children
we
first
described
viruses
respiratory
assays
well
infections
tcov
elisa
turkey
antibodies
little
infectious
incidence
disease
per
diseases
screening
virtual
lead
different
methods
nan
nan
risk
studies
discuss
dispersion
assessment
overlapping
genes
proteins
protein
two
communication
nursing
education
practice
mail
health
diseases
care
need
development
emerging
new
important
the
cross
mucosal
immunity
immune
molecular
primary
children
ifn
production
respiratory
infections
functional
properties
application
nanotechnology
textile
deaths
burden
pneumonia
million
among
proteins
poxvirus
similarity
genes
eukaryote
foodborne
transmission
pathogens
food
described
human
h7n9
virus
viruses
influenza
the
2019
ncov
deaths
first
pneumonia
organizing
afop
pattern
diagnosis
expression
ftnf
protein
gst
tnf
nan
the
related
management
appropriate
surgical
outbreaks
major
pandemic
infectious
disease
viruses
infections
respiratory
clinical
samples
nan
epidemic
health
nurses
confidence
sars
peptide
hr1
fusion
hr2
sars
mhv
protein
cells
expression
foreign
proteins
de
plasma
the
state
virus
discovery
the
rate
new
sars
cov
protein
patients
the
devices
conference
sessions
japan
society
h9
aiv
ibv
pcr
drt
nan
mers
therapeutic
cov
respiratory
effective
nan
binding
site
ii
parachloromercuribenzoate
angiotensin
igy
diseases
potential
oral
administration
calves
intravenous
fluid
therapy
acidosis
protein
membrane
coronavirus
the
sequence
control
infection
health
hospital
ethical
nan
icp
infections
cubicles
children
paediatricians
gusqs1
pastoris
copy
ergosterol
the
nan
calves
group
electropherotype
samples
rotaviruses
the
mers
cov
infection
outbreak
antifungal
the
peptides
peptide
gel
nan
influenza
virus
h1n1
catechin
gallic
nan
infections
antiviral
drugs
treatment
viruses
s1
protein
ectodomain
s2
ibv
99mtc
micelles
infection
inflammation
levofloxacin
rnai
therapeutics
rna
research
tool
viruses
zoonotic
rodents
database
rodent
nan
nan
acid
the
dicaffeoylquinic
liquid
study
ifn
cats
peptides
strains
fip
health
urban
country
rapid
urbanisation
diseases
new
respiratory
syndrome
virus
respiratory
viral
virus
analysed
upper
de
et
des
techniques
les
nan
bnip3
mhv
expression
infection
cells
global
h1n1
pandemic
health
surveillance
ctb
transgenic
chloroplast
chloroplasts
plants
kiv
wuv
respiratory
viruses
australian
contacts
sars
cov
patient
tested
inflammation
may
testicular
it
evident
nan
hid
healthcare
infectious
person
specific
10
patients
transplantation
autoimmune
range
nan
tgev
studies
immunity
immune
prcv
encephalitis
search
diagnosis
articles
we
2019
transmission
ncov
time
using
nan
resources
healthcare
infections
developing
world
nan
nan
sbmv
rymv
bean
virus
strain
emergence
novel
models
data
studying
nan
nan
nan
nan
ccov
elmo
02
the
strain
nan
jev
the
resurgence
virus
pigs
cysteine
motif
protein
proteins
residues
viruses
virus
water
methods
reduction
nan
laboratory
polio
the
health
pei
air
risks
management
abstract
given
nan
cations
the
constants
bhb
determined
rna
production
protein
structure
elements
cell
chromatography
proteins
supernatants
purification
host
ubiquitin
immune
viruses
proteins
nan
infection
transmission
h1n1
09
virus
animals
humans
zoonoses
diseases
vertebrate
shn2
phev
two
porcine
cell
ara
retinal
car
autoantibodies
antibodies
vaccination
vaccines
important
development
non
rna
viral
mrna
capping
cellular
nan
report
feline
the
1998
practitioners
acute
bronchitis
cough
treatment
common
nan
tripodal
platform
the
peptide
aib
care
assessment
symptom
patients
caregiver
virus
appearance
recognized
examples
abstract
lamp
amplification
diseases
this
developed
inhibitors
inhibitory
position
the
potent
fmdv
vp1
disease
rna
sirnas
nan
obstetrical
sars
infectious
outbreak
unit
nan
incidence
model
time
delay
function
nan
reverse
transcription
loop
mediated
isothermal
respiratory
virus
pcr
severe
sars
patients
sars
ua
hypouricemia
serum
nan
health
complexity
social
promote
community
virus
the
readily
virion
50
cov
mers
sars
animal
coronaviruses
cov
humans
covs
respiratory
disease
de
las
en
la
han
epe
disease
intracellularis
foals
organism
antibodies
hiv
gdes
domain
gp120
s1
344
arkdpi
y43h
spike
calves
mr
treatments
higher
fed
tgev
swine
infection
rna
high
se
calves
cows
ova
transfer
la
de
en
se
infección
virus
rabies
uk
threat
re
mammarenavirus
lasv
virus
high
vrnp
brd
calves
respiratory
ncd
arrival
copd
important
exacerbations
exacerbation
patients
activity
compounds
antiviral
assay
screening
ptov
farms
weeks
infection
piglets
calves
dam
colostrum
housed
hutches
nan
cats
dth
fipv
nine
challenge
nan
nan
nan
nan
model
city
predictions
using
covid
cell
virus
attachment
tgev
strains
expression
bav
he
genes
e3
severe
influenza
therapy
studies
inflammatory
nan
de
la
estudios
ic
95
protein
mbp
his6
protease
removed
nan
helicases
duplex
nucleic
unwinding
one
nan
ddx1
null
sirup
rna
flies
nan
patients
copd
sputum
mediators
asthma
cold
common
manual
acupuncture
symptoms
viral
the
diagnostic
enteric
infections
scov
molecular
the
protein
responsible
nan
particles
faeces
virus
like
samples
dna
biosensor
detection
using
probe
nan
ppmo
virus
sinv
veev
mice
mrna
rna
sequence
nt
transcription
precursor
s2
fusion
spike
cells
coli
ibv
inoculated
birds
il
lung
copd
cancer
tuberculosis
smoking
strains
pedv
korean
genome
diarrhea
surveillance
health
information
data
fundamental
nan
rt
lamp
bvdv
assay
detect
dengue
virus
disease
humabs
variable
er
ers
response
reproductive
proteins
adenovirus
antigen
the
sample
positive
protease
octahydroisochromene
scaffold
substituent
position
adem
mycoplasma
infection
plasmapheresis
pneumoniae
gene
s1
sequences
16
nucleotide
spatio
temporal
aspects
propagation
infectious
plpro
sars
cov
the
6mp
fiv
vaccine
immunodeficiency
infection
cats
nan
livestock
diseases
research
two
sector
the
innate
infections
system
cells
proteins
recombinant
the
vaccines
pathogens
nan
reporting
china
cases
outbreak
world
onn
new
oxonicotinonitrile
onns
nucleoside
pkr
rsv
we
replication
ap
mhc
mrna
infection
class
infected
nan
rubrum
igy
the
therapeutic
vitro
cds
polymeric
delivery
potential
genetic
quercetin
plasma
metabolites
calves
qa
nas
analogues
viral
inhibit
replication
growth
exponential
epidemic
disease
outbreak
viral
character
focused
bats
system
membrane
fusion
system
spgfp
abstract
species
scnt
animal
first
cell
guinea
pigs
pig
housed
food
fusion
cellular
membranes
viral
refolding
ga
conjugates
cd
showed
antiviral
rv16
assay
rv12
95
results
sars
cov
protein
pathway
coronavirus
isotope
nmr
labeling
the
current
much
number
exercise
the
scenario
loading
virus
the
uniform
droplets
ventilation
air
general
wards
infection
air
catalytic
oxidation
yeast
min
cases
mers
pilgrims
surveillance
middle
virus
enteritis
diarrhea
may
cause
nan
nan
ifn
mice
mhv3
infection
the
nan
shown
protein
dna
immune
antigen
new
virology
abstract
the
emergence
nan
nan
nan
protein
the
sars
disease
viral
ahv
def
infected
formation
observed
g1
gc
g2
expressed
er
nan
airline
firm
age
performance
abstract
respiratory
human
agents
disease
new
data
detection
anomaly
markov
model
the
patient
round
abstract
60
coronavirus
coronaviruses
groups
compared
three
antibody
bsabs
recombinant
next
generation
pdcov
august
first
time
us
fcv
ab
felines
specific
igg
hsv
emodin
infection
antiviral
vivo
in
african
disease
healthcare
pharmacists
nan
drug
hiv
delivery
targeted
therapy
gvn
the
emerging
viral
human
nan
antisense
delivery
oligodeoxynucleotides
polymers
strategy
antiviral
viruses
mucroporin
sars
cov
respiratory
pathogens
detection
diagnostic
tools
isolates
within
multocida
fur
pasteurella
rna
calicivirus
the
caliciviridae
family
cap
bacteria
typical
atypical
organisms
h7n9
ards
induced
group
patients
sars
the
crisis
psychological
distress
nan
trade
world
the
institutions
health
crcov
dogs
swedish
respiratory
canine
pathologies
de
des
la
vaccination
feeding
milk
day
kid
fed
sifitm3
fmdv
antiviral
host
infection
nan
protein
model
functions
proteins
hierarchical
nan
de
influenza
la
gripe
en
nan
nan
people
travel
air
means
infectious
matrix
substitution
different
pam
protein
acute
cases
patients
bronchitis
episodes
lasota
cleavage
protein
ndv
virulence
nan
expression
astrocytes
mhc
class
strains
alvac
ifn
mechanism
presence
nk
pedv
phylogenetic
gene
nsp3
genogroup
bats
bat
rabies
species
the
viral
mhv
mice
spinal
cord
nan
phosphorylation
viral
nsp2
proteins
related
time
disease
transport
regions
we
de
con
en
virus
la
bioaerosol
air
also
research
special
compounds
rna
bvdv
aryltriazene
antiviral
nan
assay
viral
infections
nir
methods
nan
genome
structures
retroviruses
the
fixation
respiratory
systems
health
influenza
several
nan
new
infectious
even
current
vaccination
samples
rpha
page
positive
detection
19
march
2020
cases
covid
sample
detection
system
dna
samples
cells
pbl
effects
virus
tgev
cell
rn2
jhmv
line
infection
infectious
disease
address
local
resources
disease
virus
boar
studs
infectious
nan
viral
disease
this
article
reviews
protocol
septicemia
visits
egdt
program
calves
lung
tx
respiratory
con
nan
nan
virus
biology
systems
influenza
host
nan
positive
samples
intestinalis
parvum
giardia
vaccination
small
practitioner
animal
regarding
kda
gene
protein
3b
tgev
nan
holling
type
system
model
general
nan
nan
nan
protein
antiviral
virology
translational
research
nan
gene
nt
protein
cu
t2
pneumonia
readmission
antibiotic
bacteria
90
future
logistics
services
industry
scenarios
nan
hrc
hrn
helical
structure
study
respond
risk
covid
19
the
tm
wt
protection
h3
h5
bioterrorism
social
abstract
the
possibility
sars
cases
units
various
healthcare
gac
activities
impact
hiv
northern
showed
sars
the
published
data
crcov
canine
dogs
the
coronavirus
sars
anti
protein
cov
s1
protein
ub3881
denv
mosquito
infection
the
global
challenges
health
nurses
nanoparticles
applications
multifunctional
analytical
bio
crises
pharmacists
times
civil
crisis
pcr
detection
molecular
clinical
diagnostic
veterinary
information
small
rodents
gaining
nan
luck
good
belief
economic
policy
nan
patients
cap
bacterial
viral
pneumonia
deslorelin
coyotes
gnrh
gonadorelin
species
bats
bat
virus
cell
viruses
whole
genome
sequencing
infection
methods
hamster
chinese
the
research
disease
pcr
samples
nucleotide
ccv
sequence
food
biosecurity
sustainable
security
agriculture
frameshifting
cuu
codons
codon
ribosomal
virus
cell
host
target
viral
group
treatment
patients
injection
control
food
borne
it
abstract
this
resistance
virus
viruses
target
protein
children
respiratory
viruses
samples
detected
rna
helicases
activity
cells
viruses
ace2
angiotensin
enzyme
ace
peptide
nan
cov
sars
svrnas
svrna
pathology
pcv
protein
cap
capsid
expression
nan
inflammation
immunity
various
pentraxins
ptx3
antibodies
recombinant
the
production
transgenic
safety
vaccines
studies
preclinical
toxicology
nan
autopsy
infections
infectious
postmortem
risk
sars
lymphocytes
acute
cov
patients
sars
protein
cov
ace2
chinese
fusion
protein
sars
nc
clinical
2019
coronavirus
ncov
respiratory
severe
genome
picornaviruses
virus
also
viral
nan
fiv
diaminopurine
pmpdap
antiretroviral
using
camel
ifn
protein
immune
response
feline
rfeifn
cells
virus
cell
nvhap
viral
patients
viruses
virus
samples
viral
sequences
clinical
hexamers
elisa
antibodies
breda
virus
sera
macro
chinese
hotel
stock
returns
bananin
scv
helicase
μm
class
patient
health
care
infection
number
enterovirus
blood
csf
specimens
vs
cap
severe
influenza
adenovirus
cmv
2019
ncov
january
2020
the
nan
viruses
virus
assays
detection
blood
infectious
diseases
caused
organisms
typically
unknown
nan
sot
recipients
need
pcps
lifelong
tbp
ed
triage
emergency
department
mirnas
rna
virus
cell
viral
human
metapneumovirus
pcr
rt
assays
nan
tissue
new
allograft
federal
standards
nan
protein
2009
lung
tissues
virus
cov
covs
human
cells
sars
tgev
prcv
the
infected
pigs
health
ghsa
steering
group
all
virus
ibv
cdna
genome
method
influenza
infection
virus
host
using
hong
kong
sars
viruses
genetically
interactions
emerging
to
respond
re
rna
di
rnas
disse
virus
nan
terminus
residues
proteases
membrane
amino
lambs
day
days
treatment
groups
viruses
brd
risk
bovine
induction
nan
ifnλ4
variants
structure
interferon
clinical
prevalence
calves
colostrum
dam
wk
nan
prognostic
respiratory
potential
upper
tract
il
inflammatory
pro
anti
target
nan
uat
pneumococcal
pneumonia
positive
serotype
calves
inoculated
strain
cnf2
colostrum
sjl
resistance
cell
virus
glial
pulmonary
the
section
covers
syndrome
nan
nan
mice
jhm
virus
mhv
inoculation
inactivated
gz50
sars
virus
mice
passenger
rampp
dengue
urban
risk
rna
replication
rnp
poly
positive
nan
immunity
respiratory
pathogens
this
article
animal
in
environment
paid
attention
hierarchical
contact
structure
strategy
social
cases
human
information
to
among
nan
ata
activity
telomerase
proteins
dnase
care
medical
ethical
disaster
disasters
angioedema
c1
treatment
hae
rare
nan
patients
hajj
health
care
clinics
nan
antibodies
antibody
immunoassay
multiplex
platform
nan
mers
cov
human
variant
phylogenetic
nan
haptoglobin
serum
concentration
the
acute
bacterial
pneumonia
pneumoniae
developing
the
cov
codon
virus
genes
the
nan
spike
l1114r
substitutions
recombinant
ph
fear
dsm
based
disorders
stress
pain
cats
djd
genes
clinically
tourism
economic
markets
source
we
pneumonia
outbreak
among
recruits
cultures
nan
nan
h7n9
iav
pfu
ml
nasal
de
la
una
virus
su
mhv
protein
2f
activity
sequence
every
century
mechanisms
lives
abstract
nan
nan
site
frameshifting
frameshift
slippery
ribosomal
iav
ha
h5n1
mabs
pseudovirus
nan
the
public
health
measures
adopted
reconstruction
the
projection
map
regularization
nan
amifn
subtypes
ifn
activity
giant
pedv
cells
cell
cycle
infection
nan
virus
immune
response
cns
must
nan
pdcov
ifn
production
nsp15
endoribonuclease
pregnancy
respiratory
complications
encountered
important
fipv
replication
monocytes
the
feline
nan
unknown
astroviruses
species
recombination
events
although
tgev
gilts
primed
piglets
litters
nan
assays
rt
h1
h3
rpa
nan
protein
the
prrsv
nsp4
nonstructural
at1r
receptor
angiotensin
function
drugs
major
nhs
response
incidents
this
caused
disease
occupational
also
work
the
disease
clinical
infections
acute
nan
cell
processes
viruses
virus
abstract
the
medical
event
disposition
classification
host
proteins
shutoff
pa
viral
nan
signatures
identify
genomic
used
pathogens
diarrhea
specific
infectious
calves
commonly
virus
mice
disease
edim
infection
vaccine
acam1000
the
dryvax
virus
type
fcov
ifnβ
fipv
ii
mev
sspe
virus
rna
sirnas
tissue
balt
lymphoid
ibalt
airways
drugs
chemistry
drug
activity
anti
nan
e2
protein
a59
amino
90b
hbv
gene
esirnas
expression
sirna
rov
asp
ova
responses
th1
children
croup
airway
obstruction
summary
based
sulfur
svi
new
therapeutic
sirna
r8
liposomes
delivery
the
systems
fertiliser
ha
cow
weight
treatment
diarrhea
calves
enterotoxigenic
escherichia
cats
ifn
fcov
fip
serum
pdcov
porcine
virus
anti
antibodies
patients
fda
access
drugs
investigational
nan
lung
pathology
pulmonary
neoplastic
many
antiviral
viral
critical
natural
products
asthma
associated
viral
infections
respiratory
project
we
discuss
research
enzymes
tests
laboratory
important
workup
chronic
viral
sirnas
feline
fcov
rna
inhibitory
virus
wssv
peptides
white
nan
ifn
sars
epithelial
cell
patients
fcrs
fcr
fcrls
biological
genes
saffold
virus
myocardium
human
cardioviruses
sars
mortality
cases
respiratory
study
sars
hcws
risk
high
working
caninum
neosporosis
puppy
cattle
farm
the
training
ecdc
surveillance
systems
lac
purification
glycoproteins
chromatography
glycoconjugates
nan
mhv
protein
fc
antibody
cells
mers
cov
infection
entry
inhibitors
nanoparticles
materials
properties
oral
delivery
host
infection
understanding
defense
mechanisms
pedv
attenuation
attenuated
virus
ccl81
une
de
et
des
est
diseases
immune
specific
immunomodulatory
treating
pain
methods
menstrual
researchers
participants
nan
cap
influenza
pneumonia
pcv13
vaccination
information
cancer
library
health
online
legionnaires
disease
cap
spontaneous
manifestations
sars
cov
rbd
mice
vaccinated
virus
particles
cells
cell
rna
mucins
ocular
gel
analysis
the
model
in
superspreaders
by
propagation
nan
covid
19
coronavirus
disease
2019
3clpro
sars
atpase
cov
protein
cov
mers
respiratory
μm
syndrome
model
number
disease
equilibrium
abstract
class
antigens
glial
virus
cells
aunps
lfis
analysis
smartphone
reader
nan
de
la
en
las
medical
pcr
assays
we
different
systems
derivatives
azoles
ring
activity
benzimidazole
fpv
isolated
virus
monkey
china
nan
ace2
diabetes
patients
covid
19
nan
amplification
detection
nucleic
acid
techniques
protein
recombinant
virus
tgev
endo
nan
nan
nan
buffalo
buffaloes
reared
milk
adult
viral
chemokine
response
infection
cns
unknown
de
las
la
en
una
disease
abstract
epidemiology
biostatistics
cornerstone
rna
viruses
virus
replication
proteins
nan
species
bat
host
co
transmission
proteinase
3clpro
27
a59
mhv
energy
the
global
us
order
coronaviruses
genome
proteins
associated
the
nan
cats
fcv
infection
field
disease
nan
nan
nan
antibody
mab
cocktail
virus
gp
pedv
cytotoxicity
compounds
escins
strong
clinical
manufacturing
ivig
improvements
procedures
asthma
disease
infections
common
respiratory
nan
fusion
protein
helix
bundle
virus
membrane
viral
fusion
fission
replication
advances
cell
lung
recent
stem
vocal
available
influenza
uris
development
vector
the
spatio
temporal
precipitation
nan
pedv
mapk
p38
infection
activation
suicide
suicides
death
the
celebrity
infections
pigs
porcine
pcv2
pastv4
sinv
treatment
don
cns
mice
stiv
das
elisa
detection
the
nan
calves
cr
vitamins
vitamin
d3
viruses
recent
need
antiviral
several
nan
hemagglutinin
cell
universal
vaccine
influenza
porcine
hybridization
rotavirus
gene
probes
sars
36
physical
hrqol
test
grp78
protein
mechanisms
unfolded
response
nan
rv
rsv
asthma
bronchiolitis
medication
radiology
global
low
countries
rad
patient
hospital
outbreak
per
million
equine
field
management
gastrointestinal
disease
mjsyn
protein
shrimp
syntenin
response
nan
cap
viral
prevalence
patients
risk
severe
cells
covid
19
cases
gl
go
the
loading
release
mers
cov
infection
disease
the
nan
nan
marine
infectious
diseases
natural
products
nurses
education
care
disaster
because
nan
nan
left
cat
skeletal
the
thin
fta
the
metabolism
human
fecal
nan
virus
reference
vaccine
in
response
nan
de
infections
bocavirus
virus
un
disease
cardiometabolic
dpp4
incretin
cardiovascular
spike
s4r
infection
mhv
neurovirulence
pedv
pigs
inoculated
infection
day
the
sites
multiplication
nouzilly
strain
inclusion
smears
bodies
found
percent
wind
re
entrant
corners
effect
n95
surgical
niosh
ffrs
fda
regulatory
policy
tissue
processes
innovation
urban
health
challenge
social
world
norkurarinol
rotavirus
induced
tlr3
poly
adenovirus
vaccine
process
development
use
niclosamide
dcs
cells
activation
lps
proteins
specific
virus
nine
jhmv
asthma
controls
hrv
respiratory
patients
nan
nan
ldl
cholesterol
approach
dmab
dapcsk9
nan
vaccine
virus
genotype
na
pigs
nan
viruses
better
diagnostics
cause
high
nan
de
et
les
la
des
nan
nan
hr
s2
monomer
hr2
trimer
wheeze
children
episodic
trigger
ics
health
care
system
across
country
nan
nan
sars
quercetin
inhibitor
molecular
new
mhv
cell
virus
protein
fusion
nan
immune
epigenetics
diseases
epigenetic
disruption
nan
hmpv
sars
outbreak
patients
infection
il
μg
bacteria
vitro
vs
disease
changes
proteins
mdv
host
figure
see
text
eav
ppmo
virus
infection
persistence
human
mers
cov
dromedary
respiratory
disease
global
infectious
data
programs
throat
swabs
self
rv
collected
covid
19
coronavirus
pneumonia
patients
aom
group
colonization
acute
respiratory
the
strengthening
chinese
center
disease
fibres
zinc
oxide
nano
cellulose
nc
ma
wt
rna
vlps
sars
economic
impact
outbreak
macro
compliance
analysis
emergency
study
systems
emr2
like
sites
egf
receptor
rt
lamp
detection
virus
csfv
rna
rnai
sirna
silencing
degradation
nan
baumannii
hospital
multi
drug
resistant
protein
sars
cov
binding
sp
the
day
igm
igg
ige
nan
cold
chain
systems
china
supply
blood
emerging
infection
hepatitis
infections
nan
rhinoviruses
asthma
wheezing
infections
viral
protein
insert
phage
viii
recombinant
nan
methods
study
abstract
graphical
representation
activity
5a
evaluated
antiviral
viruses
nan
mers
case
cfr
cases
the
mortality
mers
use
cov
the
nan
nan
pcv2
activation
replication
erk
viral
nan
nan
nan
number
cases
2019
ncov
infected
nan
atpase
vesicular
acidification
trafficking
function
korea
management
disasters
this
study
porcine
prdc
respiratory
pigs
among
fcov
infection
fip
cats
development
agents
adsorbent
rotavirus
coronavirus
99
nan
peptidases
cellular
cell
abstract
membrane
sera
bovine
coronavirus
parvovirus
rotavirus
nan
covid
review
19
issues
management
nan
nan
exacerbations
respiratory
copd
the
disease
certain
scenarios
technological
key
literature
cough
bronchiolitis
children
acute
chronic
prevention
epidemic
biological
attacks
fear
nan
ocular
eye
the
chapter
tissues
bat
pathogens
zoonotic
reservoirs
special
the
coronavirus
main
protease
mpro
cryptosporidium
giardia
humans
health
transmission
cases
hcws
reported
among
mers
influenza
care
cases
95
ci
information
mobility
propagation
patterns
epidemic
nan
viruses
different
two
form
given
ibv
1a
kda
infected
vero
autophagy
homeostatic
evolved
upon
evolutionarily
framework
ph
ethical
evaluation
policy
protein
fusion
abstract
266
bp
nan
nan
10
mab
anti
il
antibodies
nan
tropism
changes
cov
protein
species
emerging
health
diseases
hids
many
covid
19
hemodialysis
pneumonia
patients
nan
nan
mucosal
vaccine
delivery
immune
sublingual
may
infections
ear
nose
throat
data
ambulance
surveillance
dispatch
influenza
health
one
disease
we
efforts
respiratory
patients
viruses
pneumonia
128
tgev
cell
cycle
arrest
apoptosis
en
la
de
virus
niños
nan
infection
mers
cov
outbreak
healthcare
mers
korea
low
telephone
survey
mbl
immune
system
deficiency
may
dc
sign
hiv
one
region
analgesia
influenza
abstract
we
describe
narratives
income
literature
outbreaks
setting
major
due
infectious
abortion
udder
china
resistance
antibiotic
spread
healthcare
sars
nurses
unit
psychological
units
species
eggs
level
birds
identification
endorphin
mice
infection
vsv
tsg31
nan
les
de
puces
des
le
asthma
bacterial
host
viral
infections
vaccines
vaccine
use
development
immunological
cdp
involvement
programming
health
skills
mrna
frameshifting
1prf
the
translation
cellular
ubiquitin
viral
processes
innate
mers
cov
2012
antibody
middle
unknown
ionic
bmim
bf4
licl
reaction
we
neutralizing
mar
mutant
viruses
nan
egg
production
quality
syndrome
syndromes
nan
sars
rbd
epitopes
mabs
group
nan
nan
nan
fusion
membrane
protein
process
structures
site
scaffold
non
prime
substituent
hiv
compounds
inhibitors
active
activity
diseases
tropics
tropical
health
water
hsp90
the
molecular
proteins
17
mers
cov
host
middle
east
nan
groups
snh
chickens
h120
il
rt
influenza
lamp
samples
h1n1
respiratory
vaccines
viral
infants
children
tourism
efficiency
specialization
market
competition
rhinosinusitis
integrative
characterized
inflammation
mucosa
nan
costs
health
care
production
study
adjuvanted
protection
live
vaccines
adjuvants
infections
hemodialysis
patients
common
among
nan
control
hh
weeks
viral
outbreak
sam
methyltransferase
crystal
denv
enzyme
household
contacts
virus
case
patients
nan
respiratory
ftd
singleplex
multiplex
viruses
iberian
animals
igg
igm
electron
hbv
the
lamivudine
ch
pcr
cell
polarity
control
many
viruses
mitochondrial
antiviral
mitochondria
machineries
immunity
plants
infectious
antiviral
medicinal
infections
prf
translation
rna
stem
loop
sss
the
sentinel
surveillance
data
unknown
nan
serum
ace2
postoperative
pulmonary
major
nan
training
visual
standard
methods
respiratory
pcr
et
patients
multiplex
une
nan
rbd
s1
the
sars
binding
nan
000
the
vgp100
analysis
vp58
oct4
development
methylation
gene
exon
virus
dmm
treated
the
sindbis
reagents
the
pairs
samples
biological
ctb
proteins
the
ib
hhp
arenavirus
structure
gpc
receptor
binding
nan
scfv
gb
neutralizing
antibodies
hsv
influenza
vaccine
pandemic
the
using
lycopene
crtebi
pwsk29
coli
δwaac
veterinary
vaccines
events
the
use
pathogens
slim
clinical
samples
large
de
macrophages
les
alveolar
des
nl63
hcov
stored
showed
ambient
calf
farm
odds
management
scours
qs
21
vaccine
the
responses
the
sars
kit
patient
hcws
calves
dehydration
dehydrated
intravenous
fluids
phev
three
positive
genotypes
detection
viral
autophagy
cell
pathway
infections
nan
fnov
nov
gvi
m49
strain
covs
risk
the
recent
emergence
systems
air
industry
news
abstract
critical
care
viral
treatment
abstract
tgev
cells
cell
cycle
infection
nan
nan
amino
trifluoromethyl
alcohols
presented
abstract
porcine
epidemic
diarrhoea
type
ii
virus
infectivity
inactivation
berne
loss
synthesis
abstract
the
current
chapter
cultural
stressors
this
social
communities
nan
dnmt1
inhibitors
experimental
structure
docking
viruses
respiratory
tac
specimens
assay
major
studies
fut2
norovirus
infections
respirators
reusable
protection
n95
user
hev
encephalomyelitis
infected
pigs
nervous
respiratory
viruses
tract
diseases
associated
nan
virus
mice
spinal
cord
ifn
cell
membrane
entry
fusion
virus
respiratory
collected
specimens
virus
based
trainees
we
need
the
covid
tourism
peace
korean
mt
gumgang
nan
virus
egfp
ibv
cells
the
sars
abstract
ag7088
identified
good
nan
thymus
wasting
this
article
focuses
care
health
palliative
project
pcip
hiv
soe
virus
infection
viruses
yhv
pmchc
shrimp
clathrin
disease
nan
mcav
protein
fish
caveolin
the
nan
nan
nan
sgp
modification
mannosylation
viral
protein
energy
regional
co2
emissions
performance
antibodies
coronavirus
cov
receptor
respiratory
de
trachomatis
la
el
pcr
onset
admission
patients
we
estimated
abl
bcr
domain
sh3
oligomerization
contaminant
room
the
ventilation
bed
cancer
materials
peptide
transmittable
formed
case
clinical
testing
cases
important
nan
nan
vectors
humans
adenovirus
vaccines
studies
pedv
g2b
vsvmt
sδ19
emerging
nan
calves
diarrhea
pens
lime
parvum
old
mice
mt
immune
phx
wuhan
cases
2020
transmission
new
nan
sars
cov
proteinase
drugs
main
exosomes
molecules
proteins
mrnas
mirnas
nan
hr1
sars
cov
cp
hr2
abstract
functionalized
transistors
provide
effective
abstract
novel
benzoimidazophenyl
dialkylaminoalkylamides
dialkylaminoalkylbenzoimidazo
viruses
variation
genetic
recombination
processes
particle
dv
inhaled
dose
transient
95
calves
or
ci
brd
nan
proteins
orf1ab
sars
much
pathogenesis
meeting
threat
mers
coronavirus
called
nan
carboxypeptidase
the
activity
hog
intestinal
nan
ra
emergency
cdc
response
activities
mers
sars
cov
infections
severe
respiratory
samples
severe
mers
cov
protease
inhibitors
3cl
anti
abstract
mlscn
screening
nih
center
small
deletions
within
region
internal
terminal
algorithm
localization
temperature
face
eyes
mers
cov
hand
increase
based
sars
fibrosis
respiratory
pulmonary
cov
public
government
policies
chinese
covid
fever
travelers
most
febrile
patients
mhv
a59
strains
rnas
four
host
cell
proteins
viruses
dna
mrsa
messages
public
media
this
flavonols
glycosylated
biological
activities
library
interferon
segments
virus
tgev
yield
respiratory
calves
herds
samples
bcv
he
hcv
oc43
bovine
coronavirus
nan
sias
cellular
role
recognition
many
interferon
virus
mice
10
group
paper
devices
based
bioactive
potential
nan
nan
new
mabs
diagnostic
applications
conventional
health
one
the
virus
mers
aviation
countries
within
policies
abstract
sars
vaccine
purified
monkeys
the
the
vp1
protein
sequence
rna
unknown
tcov
chromatography
turkey
sucrose
size
pneumonia
severe
it
chest
sars
fluoro
glucopyranosyl
obtained
the
deoxy
variant
h1n1
pdm09
influenza
h1
mers
vaccines
cov
subunit
development
viruses
respiratory
new
humans
these
cyp40
cells
the
control
mitochondrial
emerging
viruses
respiratory
cause
outbreaks
mers
cov
respiratory
infection
case
nan
companies
health
covid
19
outbreak
economic
china
hong
kong
since
nan
rsv
outbreaks
cancer
patients
2007
nan
de
une
en
et
la
pvax
attenuated
typhimurium
tgev
sl7207
lambing
spp
protein
serum
lamb
ifns
antiviral
type
recognition
ifn
nan
fractional
order
abstract
model
nonlocal
def201
ev71
infection
mice
dose
vaccination
closeness
individuals
recovered
results
respiratory
copd
viral
disease
elderly
fcv
codon
usage
bias
orf2
nan
nodes
epidemic
community
important
spreading
there
signs
new
coronavirus
emerged
cc
mix
dat
clinical
the
viral
detection
loc
devices
the
nan
membranes
al2o3
filtration
the
efficiency
nan
nan
protein
sars
the
cov
responses
rhdv
using
samples
liver
spleen
performance
gdp
ta
growth
tourist
pneumonia
management
complications
leading
killer
hmpv
respiratory
human
metapneumovirus
recently
stem
bp
frameshifting
pseudoknot
11
protein
membrane
domain
the
fusion
disease
cns
jhm
virus
rats
field
subtilis
inactivation
films
viability
ev71
activity
trp
hiv
prototype
infectious
disease
mathematical
modeling
we
antiviral
virus
activity
values
6a
ibv
cells
particles
infected
virus
lower
urinary
tract
reflex
micturition
bpe
aerosol
vaccinated
mice
technique
pdcov
ca2
replication
infection
inhibited
nucleic
acid
ct
changes
positive
orf3
structure
sars
cov
abstract
3a
protein
coronavirus
sars
cov
nan
protein
peptide
sars
tagging
purification
ifn
antiviral
type
also
28
allergy
world
wao
history
iaaci
nan
nan
gag
hiv
env
viral
glycoprotein
dog
revealed
positive
cardiomyopathy
abstract
sars
proteins
cov
accessory
host
luteolin
lps
inflammatory
mediated
in
nan
rectus
aom
abstract
campylobacter
member
nan
pneumonia
bacterial
specific
vaccine
substantial
health
care
emergency
physicians
risk
liver
metabolic
infection
responses
tissue
pedv
papn
receptor
porcine
ped
diagnosis
patient
death
medical
diabetes
calves
control
diarrhea
treatment
outlined
nan
nan
nan
nanoparticles
oral
novel
size
properties
tb
respiratory
patients
viruses
95
infectious
diseases
global
diagnostic
nanoparticles
nan
amps
the
action
review
examines
silvestrol
utr
hev
polypurine
cr
les
de
mm3
et
la
alcohol
based
antimicrobial
products
skin
respiratory
viruses
detection
antigen
surveillance
crop
microbes
involved
transmission
biofilm
patients
adem
typically
acute
neuroimaging
nan
nan
nec
factors
barrier
bacteria
no
flu
h1n1
taiwan
sensitivity
ml
btov
respiratory
rbtov
suggesting
similarity
pharyngitis
clinical
pathogens
findings
viral
bone
dbm
matrix
commercial
biomaterial
children
patients
acute
disseminated
encephalomyelitis
ifnγ
recombinant
porcine
bovine
rpoifnγ
quadruplex
genes
motifs
formation
pgq
spike
virus
proteins
host
cell
nan
infectious
disease
diseases
athletes
precautions
nan
respiratory
viral
tract
virus
prevention
phase
rotavirus
found
cells
g1
mumps
parotitis
virus
viral
outbreak
parasites
pathogens
seabirds
the
birds
sars
cov
mpro
based
anti
nan
epidemic
the
coronavirus
study
results
cells
he
protein
enzyme
bcv
nan
nonclinical
development
species
nhps
used
avian
infectious
turkey
abstract
selected
zero
tours
outbound
commission
chinese
covid
19
reported
sars
cov
nan
nan
leader
sequences
gene
the
region
peptides
hsv
effective
hp1036
hp1239
ifn
enhancer
induced
genes
ifitm1
nan
desmethylicaritin
adipogenesis
protein
expression
lipid
nan
sars
travel
screening
outbreak
international
ppe
training
healthcare
assessment
wearing
ms
ebv
disease
the
infection
nan
furin
site1
site2
sequence
we
hbv
human
virus
specific
the
sars
environment
we
model
free
hku5
cd26
ctd
mers
cov
arthroscopy
abstract
techniques
sports
medicine
2019
ncov
coronavirus
ratg13
human
cells
viral
infection
respiratory
murine
nan
assays
commercial
available
abstract
development
biomarkers
normalization
circulating
mirnas
mirna
nan
type
calves
cases
enteritis
perfringens
cap
patients
viruses
pcr
respiratory
virus
herpes
influenza
simplex
antiviral
nan
the
uri
known
combination
nasal
nan
bats
diverse
roles
emergence
abstract
cells
rn2
state
interferon
viral
ubiquitin
inhibitors
enzymes
bortezomib
pathway
nan
viral
proteins
cases
well
still
exercise
immune
risk
infection
athletes
mers
antibody
human
lca60
development
nan
hpiv3
children
rb
rhpiv3
nb
bats
hbv
province
china
we
nan
human
coronavirus
respiratory
surfaces
coronaviruses
mers
cov
camels
population
middle
the
orf
gene
rna
sequence
nan
influenza
group
subjects
the
hr
protein
the
niv
purified
virus
zikv
cet
effective
virus
flavivirus
foreign
dna
genomes
methylation
ad12
urban
flow
building
air
study
viral
host
virus
pathogenesis
virologists
nan
infection
droplet
disease
transmission
droplets
2019
covid
predict
various
mathematical
nan
xdy
erm
pmvecs
actin
p38
multi
general
equilibrium
model
areas
influenza
2009
h1n1
pandemic
virus
cd200
production
pdc
ifn
ifnα
infectious
disease
economic
risk
crises
nan
dogs
gy
tbi
donor
engraftment
nec
patients
infection
control
cluster
tent
the
isolation
care
emergency
fluoro
abstract
deoxyaristeromycin
prepared
via
protein
indices
set
index
the
influenza
pandemic
occur
current
outbreaks
nan
health
care
laboratories
diagnostics
patient
virus
cases
asia
in
human
blood
transfusion
the
chapter
safety
s2
sars
over
expression
apoptosis
pcr
assay
virus
the
one
phosphonoamidate
but
enyl
analogs
μm
nan
medical
travel
air
flight
health
practice
pharmacy
research
approaches
evidence
nan
nan
patients
many
infected
general
hospitals
respiratory
coronaviruses
antiviral
acute
syndrome
mers
lca60
cov
treatment
reduced
nan
photoreceptor
degenerations
survival
secondary
primary
pcr
samples
positive
the
polymerase
dptv
helicase
hel
activity
dsrna
vaccine
understanding
correlates
systems
numerous
day
days
abstract
46
year
lt
cdata
no
abstract
available
nan
tac
simplexa
testing
flu
dfa
mhv
jhm
demyelinating
disease
protein
antiviral
viral
agents
virus
drugs
rnase
5a
activation
akap7
oas
nan
nan
covid
19
smokers
men
study
chpla2
chicken
infectious
bronchitis
ib
nan
sftsv
nsdv
ticks
viruses
tick
pigs
bronchiseptica
prcv
infected
respiratory
nan
gp120
recombinant
gag
salmonella
typhi
cns
cells
viral
immune
neurons
sars
cov
antibodies
nucleocapsid
protein
vaccines
the
nanoparticles
vaccine
delivery
sars
patients
cov
sewage
stools
health
the
key
goals
objectives
nan
ibv
immune
study
antibody
single
rna
mda5
ifn
strand
rig
ethanol
virucidal
viruses
activity
the
decision
making
problem
interval
valued
nanotechnology
the
nanomaterials
molecular
biological
sars
cov
replication
respiratory
unique
it
gastrointestinal
discusses
relevance
drug
cells
polarized
cell
epithelial
membrane
travel
health
advice
risk
particularly
viruses
novel
associated
canine
gastroenteritis
nan
nan
cough
bronchiectasis
therapeutic
chronic
treatment
ace2
face2
the
abstract
feline
zoonotic
emergence
sars
cov
reservoirs
sars
respiratory
spread
disease
coronavirus
ctl
specific
mv
virus
reduced
nan
dogs
disease
respiratory
cynos
antibody
patients
pulmonary
invasive
ventilation
used
isolates
strains
aa
rbcov
specific
des
de
virus
la
bronchiolitis
demyelination
cd4
cells
mice
mhv
agents
biological
the
weapons
war
virus
innate
immune
replication
ibv
2019
covid
19
coronavirus
pneumonia
nan
ch
ck
2010
jt
ibv
nan
nan
nan
influenza
pandemic
transmissibility
waves
past
collection
liquid
efficiency
sampling
packed
ups
cancer
therapeutic
strategies
cellular
protein
rsv
protection
calves
vaccinated
development
rural
electricity
market
provinces
replicase
domains
ibv
conserved
plpro
mers
cov
results
the
laboratories
pedv
adam17
infection
expression
apn
waste
by
food
agricultural
products
gc
virus
encephalitis
type
gene
sars
influenza
outbreak
human
avian
nasal
the
mucosal
development
delivery
viruses
emergence
viral
zoonotic
transmission
fas
virus
apoptosis
infection
mhv
prrsv
caspase
apoptosis
activation
infection
nan
pedv
pdcov
pcr
rrt
rt
strains
ibv
vaccine
lln
111169
sads
protein
cov
mab
3e9
ibv
vaccines
field
strains
vaccination
cats
fip
pon1
tac
assays
group
cardiopulmonary
bypass
ultrafiltration
the
agents
immune
innate
broad
spectrum
nan
cl
dl
sp
neurovirulence
rats
bronchiectasis
airway
spectrum
end
pbb
replication
aq
denv2
rna
virus
rotavirus
dogs
infected
polymerase
chain
figure
see
text
display
eukaryotic
virus
libraries
proteins
nan
expansion
human
medium
msc
mscs
masks
mask
respirator
rates
two
idrs
host
antimicrobial
defense
new
nan
blood
transfusion
care
system
clinical
or
95
ci
compliance
standard
exacerbations
asthma
subjects
fall
respiratory
activity
synthesized
compounds
potent
nmr
pgsa
dcpep
nc8
production
psip409
s1
sequences
strains
the
protein
nan
cat
syndrome
pituitary
vestibular
hyperadrenocorticism
viruses
cells
mechanisms
in
plasma
diarrhea
cov
covs
porcine
virus
unknown
autopsy
the
although
important
disease
viral
sars
anti
drugs
based
nanomaterials
chapter
sensors
the
use
virus
discovery
methods
clinical
detection
pro39
activity
the
virus
protease
nan
nan
human
229e
sequence
spike
protein
nan
pigs
tgev
prcv
immune
inoculation
respiratory
viruses
article
coronaviruses
tract
nan
infectious
using
virus
diseases
next
cases
human
transmission
time
zoonotic
receptor
fpr
receptors
responses
activation
virus
sk
passaged
mouse
cell
nipah
virus
niv
phylogenetic
evolutionary
cotton
hrv16
respiratory
immunization
challenge
group
reduqing
rdq
lhqw
granules
proteins
chikv
virus
infection
re
pcv2
piglets
pmws
pid
the
infectious
passengers
transmission
in
flight
presentation
domestic
ferrets
documented
adrenocortical
nan
recombinant
vlps
expression
sars
level
nan
nan
strains
24
ncp
probes
detected
h5n1
h7n9
poultry
influenza
virus
pedv
protein
study
1c9
epitope
vaccine
virus
outbreak
development
platform
nan
cyclophilins
mimicyp
viruses
host
sars
tac
ldts
assays
cdc
study
coronavirus
doubly
flexible
nucleoside
analogues
colds
illnesses
infecting
effects
naturally
nan
nan
nan
fcov
cats
feline
the
virus
pcr
rna
rotavirus
rt
extraction
sars
cov
bat
virus
spike
disease
chronic
living
specific
environment
the
ets
ats
thermosensor
thermometer
animals
wildlife
cases
potential
wild
nan
piglets
infected
rotavirus
the
haptoglobin
macroeconomic
effects
abstract
this
article
pharmaceutical
china
indian
as
factories
laboratory
diagnosis
equine
parasitic
diseases
enzymes
ubiquitin
the
proteins
chapter
based
lamp
sensing
sprlamp
prism
rsv
virus
role
infection
response
expression
co
infection
the
bevs
susceptibility
testing
phenotypic
clinical
rapid
type
fcwf
cells
cu
feline
influenza
vaccination
virus
respiratory
viruses
nan
virus
69
rn1
proteins
post
isolation
room
air
airborne
infectious
il
class
ii
expression
1β
herd
prcv
risk
size
serological
neutralizing
epitope
mab
neutralization
virus
ctl
responses
major
antigens
peptides
nan
nan
aepec
intestinal
kittens
microbiota
diarrhea
ace2
young
adult
female
aged
change
data
analysis
paper
studies
reovirus
different
the
two
infections
genus
family
coronaviridae
the
torovirinae
unknown
cpv
assay
lfs
rpa
the
cathepsin
nipah
fusion
virus
protein
scores
high
attitude
knowledge
participants
hmpv
human
piv3
virus
f2
activity
influenza
hydrophobic
virus
the
amplification
respiratory
viral
several
emerging
scanning
aug
mrnas
codon
upstream
cpv
cases
risk
factors
associated
nan
syphilis
cases
china
per
100
sars
cov
the
identified
predicted
de
la
las
bronquitis
crónica
ward
pressure
hospital
negative
isolation
lycorine
day
cells
study
anti
protein
oc43
hcov
human
coronavirus
mers
hcp
related
symptoms
exposure
viral
host
targets
virus
resistance
nan
evag
european
eu
partners
the
nan
yx10p90
chinese
ibv
strain
in
sars
cov
plpro
coronaviruses
deadly
viruses
entry
virus
detection
recognition
the
murine
coronavirus
jhm
different
china
antitumor
acid
cancer
effective
contingency
planning
crisis
business
team
this
chapter
discusses
high
rise
hypotheses
analysis
sars
new
abstract
vaccines
sars
virus
cov
vaccine
essential
oil
the
cell
asiatica
nan
recombinant
antibodies
production
milk
transgenic
the
ai
future
health
global
nan
removal
gown
ppc
contamination
iarm
pedv
suckling
immune
piglets
lactogenic
rnai
usa
gene
the
national
nan
patients
the
cases
covid
19
sirnas
airway
induced
allergen
sirna
atg5
hcv
autophagy
infection
ns5b
nan
factors
abstract
abiotic
climatic
temperature
adem
the
clinical
acute
mri
nan
countries
risk
capacity
covid
19
nan
rsv
ili
patients
53
hospitalized
pcr
assay
one
step
rt
apo
the
gdm
hne
diabetic
hyopneumoniae
ep
infection
used
herds
hmpv
virus
respiratory
children
infection
while
the
base
acid
cpv
enteritis
nan
nan
de
el
en
metapneumovirus
la
colostrum
calves
igg
days
plasma
rig
rna
n1
endogenous
h830a
hajj
pilgrims
respiratory
carriage
pneumococcal
isolation
facility
infectious
ward
diseases
nsp4
virus
mutant
n258t
mhv
coronavirus
rodents
identified
lrlv
lineage
cells
protein
tissue
pc2
mature
respiratory
infections
viruses
pivs
virus
oncolytic
viruses
agents
phase
trials
calf
cow
health
the
literature
virus
factors
restriction
inhibit
viruses
hmpv
ari
prevalence
hospitalized
95
viruses
autoimmune
disease
virus
infections
strain
endemic
outbreaks
new
emergence
clinical
covid
19
chloroquine
use
animal
models
genetic
model
as
s1
polypeptides
s2
the
bcv
stewardship
identification
results
antimicrobial
time
issues
ed
privacy
confidentiality
patient
nan
vaccination
cattle
vaccine
consider
risk
rnas
rna
activities
cellular
switch
oxygen
exhaled
air
infectious
min
cl
jhmv
variants
neurovirulence
rats
nan
sars
cov
model
clinical
therapeutics
dc
sign
virus
cells
h5n1
cox
hc
lps
induced
expression
nan
muns
arv
cells
munsc
avian
colorimetric
viruses
biosensors
detect
portable
virus
mutations
avian
ha
transmission
nan
fip
virus
antigen
monoclonal
polyclonal
source
method
localization
indoor
presented
akav
jnk
apoptosis
p38
mapk
elisa
ibv
the
specificity
taiwan
tgev
strains
attenuated
isu
prcv
nan
rabv
cns
rabies
virus
vnas
nan
nan
ras
kidney
renal
cardiovascular
effects
nan
genes
htlv
structural
rnai
technology
virus
zika
abstract
the
recent
the
ies
instrument
adolescents
experienced
canine
slam
cells
distemper
expressing
nan
protein
the
mrpe65
rpe65
structure
rlrs
signaling
studies
rna
rig
nan
particles
cells
rna
release
di
antigenic
identify
epitope
algorithms
structure
peptide
vaccines
antigens
based
use
nan
pdcov
age
us
2014
analysis
transmission
model
sars
nodes
disease
feline
gastrointestinal
diversity
microbiota
microbial
elastomeric
air
purifying
health
care
vaccine
susceptibility
virus
infection
induced
cchfv
pathogenesis
fever
virus
type
prrsv
trim25
protein
rig
host
food
pathogens
borne
safety
the
health
working
wellbeing
covid
19
impact
economic
crisis
the
government
nan
afop
literature
course
pneumonia
histologic
nan
gp
linked
processing
oligosaccharide
type
covs
cov
made
the
progress
demand
september
11
shock
this
vaccines
vaccine
gm
vector
based
viruses
different
rna
this
could
advax
wiv
influenza
adjuvanted
powder
bud
viral
release
virus
budding
water
viruses
virus
detection
hepatitis
coronavirus
vaccines
sars
the
caused
gx
spla2
infection
mice
role
clinical
study
pharyngo
the
scoring
apn
inhibitors
compounds
neutral
aminopeptidase
nan
bacterial
killing
activity
small
stress
cov
coronaviruses
outbreaks
covs
caused
sbr
mice
data
pathogen
free
clinical
disease
legionnaires
cap
laboratory
infections
viruses
viral
caused
detection
article
this
updated
version
previous
bm
microorganisms
cells
during
invasion
rna
viral
genome
synthesis
proteins
nan
antiviral
drug
hsv
infection
signaling
pedv
2014
netherlands
the
strains
ari
ip
10
concentrations
severity
mg
rt
pa
pte
patients
seizures
seizure
cats
fip
occurrence
virus
disease
viruses
demyelination
infected
sirna
delivery
pulmonary
rna
lung
tract
virus
respiratory
prcv
inoculation
ataxia
the
basis
diagnosis
differential
hospital
outpatient
unit
sars
information
nan
nan
building
chapter
ieq
factors
the
risk
management
programs
biosecurity
disease
hev
orf2
infection
si
rnai
nan
run
air
long
passenger
short
serotoninergic
neurons
the
infection
dysfunction
virus
viruses
established
feline
abstract
nan
factors
infectious
many
viral
emerging
pedv
protein
layer
vero
caspase
hpev
abstract
here
describe
case
neutralizing
rbd
fc
588
mers
nan
sows
mortality
piglet
tgev
protection
nan
environmental
disinfection
sodium
hypochlorite
hydrogen
nan
2019
ncov
public
the
laboratories
rna
structure
the
motifs
database
mers
respiratory
cases
reported
cov
the
kakegawa
isolate
density
coronavirus
pme
azac
prodrugs
bis
pmeo
care
fear
aids
risk
disease
vaccines
respiratory
effective
vaccine
viral
mammalian
infections
humans
animals
respiratory
bands
seminal
plasma
proteins
dogs
rabies
the
surveillance
animal
counties
exposure
airborne
dose
infection
specific
students
knowledge
sps
ic
years
nan
coronavirus
cov
development
vaccine
coronaviruses
small
use
rnai
become
vivo
rna
storage
fta
cards
articles
the
society
aasns
first
president
dc
sign
lsectin
ligand
gp
mumps
temperature
meteorological
factors
the
nan
nan
nan
nan
mpcr
group
vs
isolation
non
nan
myelin
protein
lipid
ms
diseases
nan
hr1
hr2
hiv
proteins
recombinant
feline
cats
forl
fiv
lesions
nan
2019
ncov
china
coronavirus
countries
nan
rna
the
cov
highly
coronaviruses
ifnγ
bat
alecto
viral
antiviral
disorders
intestinal
cattle
surgery
volvulus
enteritis
infectious
adult
ruminants
bacterial
hiv
tat
microglia
infection
expression
nan
viral
toll
diseases
current
number
nan
nan
cadmium
kg
the
tsp
vs
ethical
health
public
human
the
nan
sars
cov
tace
protein
severe
sequence
tertiary
structure
human
nt
respiratory
mers
cov
patient
patients
covid
19
we
report
diagnosis
hepatitis
hev
zoonotic
viruses
recent
the
rna
virus
jhm
intracellular
la
de
el
en
cf
park
ocean
plan
disney
hong
the
aids
hiv
vacuolar
myelopathy
zooepidemicus
animals
respiratory
disease
revealed
cov
syndrome
coronavirus
coronaviruses
acute
host
translation
infection
mrna
this
health
disease
women
sex
gendered
plastics
additives
compounding
looks
new
tgev
pegfp
u6
shrna
expressing
coli
pasture
fecal
spp
samples
carnivores
pathogens
chapter
several
disease
respiratory
secretions
nucleic
gene
pulmonary
nanoparticles
environment
chapter
the
influence
la
de
mayor
en
se
domain
structures
swapped
swapping
describes
de
en
la
los
parasitosis
ga
promastigotes
μm
ldhmgr
hmgr
bats
coronavirus
cov
presence
coronaviruses
microscopy
viruses
electron
viral
replication
vaccination
influenza
pod
hcws
hcw
samples
cats
stray
antibodies
feline
nan
mers
cov
reported
middle
east
severe
associated
disease
responses
influenza
dynamic
controllers
rna
applications
based
safety
measures
research
importance
security
tissues
viral
rna
possums
disease
us
pregnancy
embryonic
development
method
nan
infections
hajj
pilgrims
observed
fever
sars
ed
outbreak
the
95
vp3
ndv
disease
goose
gpv
health
influenza
surge
care
sort
virus
response
disease
abstract
inoculation
nan
genes
disease
embryo
development
human
nan
nurses
psychosocial
working
conditions
questionnaire
eae
calves
stx
strains
diarrheic
cklf1
tarc
ccl17
ccr4
transfected
influenza
host
virus
targeting
replication
virus
ibv
yn
genome
ryn
respiratory
infection
control
transmission
sars
disease
countries
clinicians
nonendemic
travelers
clinical
respiratory
tract
pathogens
diagnosis
pedv
strains
may
in
epidemic
nan
preparedness
plan
hospital
hospitals
hazard
domains
s2
in
models
ii
cells
membrane
viral
the
tubular
sterols
28s
the
sponge
found
emerging
virus
antiviral
immune
re
nan
the
building
wall
wind
day
ef
rabbit
intestinal
flora
inhibition
nan
nan
unknown
nan
influenza
surveillance
region
the
countries
hhv
6a
caspase
apoptosis
infection
saudi
asp
adoption
hospitals
implementation
prrsv
rna
detection
seminal
associated
nan
dehumidification
system
energy
heat
mechanical
virus
agent
tests
specific
viral
cases
mers
cov
transmission
secondary
prices
species
price
wild
tcm
present
randomised
studies
ebola
research
bat
coronaviruses
cov
bats
novel
nan
positive
results
respiratory
viruses
the
nan
nan
nan
rooting
root
phylogenetic
trees
may
gcrv
porcine
gcrvs
samples
bovine
orf6
sars
cov
ifn
npipb3
molecular
medicine
emerging
health
obesity
lung
cells
immunity
models
immune
growth
protecting
plastics
preventing
stain
protein
functional
similar
binding
site
cat
synovial
fluid
could
mycoplasma
lymphocyte
mesenteric
lymph
nodes
pedv
hrpo
the
column
bispecific
anti
nan
nan
gene
27
translation
vzv
rna
patients
cases
19
75
clinical
gl
il
effect
production
inhibited
rt
lamp
pcr
assay
ppgv
the
first
study
track
viral
19
covid
temperature
death
study
interactomes
tpc
trpml
intracellular
channels
nan
children
united
states
many
they
2019
ncov
new
coronavirus
analysis
nan
like
becs
viruses
nb
diarrheic
proteases
catalytic
base
eukaryotic
amino
nan
ibv
virus
time
tracheal
samples
viral
antiviral
diseases
agents
virus
infections
lung
disease
pulmonary
common
human
respiratory
tract
virome
viruses
cpv
detection
rna
cas13a
dogs
asthma
clinical
heterogeneity
this
age
poly
iclc
tlr
influenza
virus
mers
media
outbreak
public
mass
650
s450
abs
sars
anti
norovirus
noroviruses
antiviral
gastroenteritis
the
viruses
influenza
ch9cn2
virus
bat
virus
children
infection
severity
single
sperm
zp3
receptor
linked
oligosaccharides
unknown
curcumin
di
folyl
ethyl
10
rj
tregs
infected
virus
disease
patients
copd
exacerbations
respiratory
infection
nan
diseases
ferrets
may
since
introduction
monkeypox
cases
health
confirmed
outbreak
d68
ev
child
associated
respiratory
niv
protein
fusion
activation
needed
clusters
cases
reported
canine
disease
pregnancy
women
respiratory
risk
associated
nan
igy
yolk
passive
abstract
immunoglobulin
nan
nan
nan
viral
viroporins
membrane
proteins
small
hcws
influenza
ili
work
cases
hcw
china
disposal
management
facilities
tr
fia
eia
specimens
positive
highway
value
proximity
office
transportation
diseases
canis
feline
disease
the
pediatric
neck
masses
encountered
common
cbrn
incidents
management
incident
abstract
price
bubbles
copper
multiple
explosive
eco
mlv
infection
cathepsin
ca
nanocomplex
the
nanoparticles
ligand
electron
nan
de
des
et
les
blood
those
downplaying
coronavirus
ignore
lack
egr
mhv
infection
virus
expression
nan
mers
cov
cases
care
health
sars
recent
virus
laboratory
abstract
nan
nan
dideoxy
fluoro
7a
cytosine
13a
sars
hrqol
acute
anxiety
depression
nan
pcr
practice
molecular
diagnostics
the
nan
bnov
vp2
study
giii
diarrheic
neonates
children
nvri
hcov
incidence
nan
distributions
scale
mixture
model
heavy
nan
nan
nan
limonoids
10
11
radical
scavenging
children
respiratory
years
viruses
samples
sars
cov
inactivated
vaccine
protein
nan
cmv
blue
inhibited
atanyl
prl
droplet
dispersion
nuclei
ventilation
droplets
growth
plant
population
the
important
dengue
cases
fever
airport
screening
sars
respiratory
human
epidemic
syndrome
nan
nan
rsv
air
infants
bronchiolitis
urban
nan
fcov
protein
coronavirus
feline
enteric
nan
metal
rate
ligand
dissociation
copper
nan
placebo
group
echinacea
upper
respiratory
pr
p7
p2
gag
hiv
hcov
nl63
two
sars
human
mitochondria
denv
elongation
infection
virus
mers
cov
rbd
the
receptor
ifn
lung
pathogenic
respiratory
lethal
nan
model
pigs
biomedical
research
humans
covid
19
disease
ecdc
information
cell
tissues
apparent
cpe
infection
neuraminidase
n1
recombinant
heterologous
expression
thread
microfluidics
applications
based
development
sars
cov
sarsr
covs
orf8
identified
mers
cov
infection
clinical
health
countries
access
care
services
calves
rotavirus
age
30
infections
membrane
composite
moisture
liquid
layer
isg15
interferon
ubiquitin
proteins
protein
hiv
entry
envelope
glycoprotein
gp120
infected
astrocytes
mice
cells
spinal
97
96
98
readmission
rates
rt
lamp
fhmnv
assay
developed
porcine
viruses
host
cell
cov
bmnpv
digestive
proteins
juice
silkworm
influenza
pandemics
virus
studies
due
nan
livestock
animals
different
poultry
various
respiratory
viruses
emerged
humans
human
components
humoral
innate
proteins
response
nan
micafungin
patients
ia
225
therapy
copd
care
leading
cause
management
species
respiratory
infections
rhinoviruses
cause
disease
the
biosecurity
infectious
abstract
fusion
membrane
virus
cell
glycoprotein
viruses
cell
receptors
mammalian
glycans
covid
19
transmission
japan
health
common
article
ambulatory
right
antibiotic
crisis
evde
tourism
developing
countries
hmpv
eia
arti
biotrin
the
gastroenteritis
viral
dehydration
treatment
vomiting
possible
air
devices
is
test
nan
project
ed
emergency
surveillance
regional
nan
nan
respiratory
respifinder
smart22
22
results
nan
patients
pathogens
respiratory
may
treatment
hsv
proteins
infection
activity
chemical
nan
ecosystems
human
health
restoration
restoring
fipv
virus
recombinant
challenge
immunization
p17
p53
expression
cell
revealed
nan
nan
arteriviruses
the
virus
respiratory
via
hmpv
rsv
le
des
les
markets
industry
demand
thin
air
pidr
hcvser
entry
antibody
cells
species
human
animal
transmission
humans
rgo
au
nanohybrid
the
fluorescence
patent
citation
network
technology
study
malaria
viral
vaccine
vector
vectors
hev
infection
systems
available
information
et
de
sur
truies
les
cdv
rt
assay
lfs
rpa
nan
de
la
patient
une
sars
nan
de
en
el
la
virus
les
cutaneous
et
syndrome
cutanées
nan
cap
clinical
antimicrobial
patients
community
nan
reaction
various
indolyl
abstract
sulfonated
biocatalyst
ribavirin
using
bioprocess
packed
ipc
cell
blood
cells
could
abstract
severe
acute
respiratory
syndrome
protein
cap
methylation
domain
virus
ferrets
mycobacteriosis
clinical
included
ocular
the
l1
sequence
elements
consensus
nan
bovine
virus
disease
like
agent
nan
nan
nan
bioaerosol
microorganisms
non
culturable
impact
aus
beunruhigende
nachrichten
china
erste
care
organ
may
clinical
solid
epithelial
porcine
cells
ifn
antiviral
nan
nan
sars
enzyme
based
may
kz7088
ad
pathogens
sludge
deactivation
health
nan
virus
recombinant
rabbit
vaccine
rabbits
cpv
ccov
caribbean
strains
dogs
waste
medical
health
generation
care
nan
respiratory
acute
non
invasive
ventilation
sars
mpro
cov
disulfides
the
sars
virus
cov
the
covid
nan
infectious
diseases
hospitals
emerging
health
transfusion
blood
risk
wbc
ttis
sars
cov
entry
cells
antibodies
nan
nan
group
diarrhea
adult
cattle
rotaviruses
nan
collection
patients
self
collected
hcw
nan
patients
bioterrorism
ed
emergency
hospital
base
four
anticodon
trnas
codon
nan
nan
rna
turret
capping
dsrna
viruses
2019
ncov
oral
transmitted
swabs
protein
alternative
orf
9b
open
influenza
viruses
human
antigenic
antibody
pharyngitis
illnesses
acute
one
common
disease
therapy
meningococcal
first
serum
gl
ph
crude
it
acid
liposomes
vads
liposome
modification
immunization
disease
industry
diseases
criteria
stakeholders
water
lungs
system
legionella
patient
china
hospital
prevention
ncp
on
pharyngitis
bacterial
antibiotics
the
treatment
pedv
assays
infection
different
porcine
samples
biological
bacteria
different
fungi
nan
tgev
ros
infection
apoptosis
induced
dsrna
rna
rlrs
viruses
recognition
nan
filter
nanofiber
removal
hepa
filters
ebov
gp
chpv
infection
anti
prescription
disaster
psychotropic
danwon
ansan
nan
brms
agents
infections
viral
response
nan
nk
cell
cells
cytokines
chemokines
nan
mrnv
infection
sf9
cells
pathway
infections
viruses
new
virus
emerged
nan
nan
cancer
tof
ms
saa
mass
rna
polyadenylated
virus
major
viral
nan
nan
the
gallbladder
cancer
biomarkers
sensitivity
laboratory
clinical
microbiology
infection
must
nan
nan
ibv
cleavage
specific
chimeric
assay
ili
patients
asthma
se
symptoms
nan
fifn
antibodies
feline
immune
sheep
metal
schiff
bases
condensation
imine
nan
system
reference
health
public
the
aerosol
transmission
viruses
respiratory
enteric
cruise
operating
lines
three
major
bats
coronavirus
sars
reservoirs
related
sars
the
model
early
international
scv
helicase
coronavirus
recently
responsible
horses
ecov
known
fever
anorexia
nan
nan
derivatives
series
rare
abstract
investigation
protein
the
nt
sequence
mrna
bactericidal
the
al2o3
coli
ag
pediatric
pathology
pediatrics
number
many
mers
cov
patient
respiratory
samples
human
viruses
humans
retroviruses
simian
nan
the
mucosal
immune
immunologic
breast
nan
agglutination
test
the
la
porcine
nan
macaques
vsv
rvsv
wt
inoculation
rna
polymerase
virus
the
rgtp
nan
strain
week
the
factors
two
nan
nan
rna
viral
machinery
stability
cells
we
performance
device
abstract
provide
h5n1
virus
recommendations
influenza
evidence
sludge
sewage
organic
environmental
treatment
stress
gene
pathways
cell
expression
allochthonous
food
prey
inputs
model
de
el
23
con
bilateral
nan
cakov
kobuvirus
aiv
first
canine
care
uvgi
health
air
disinfection
animal
viruses
response
models
drug
health
global
uk
government
development
pcr
assays
real
time
the
lectins
many
recognition
various
found
nan
vaccine
vaccines
developing
global
community
radiation
abstract
the
disease
heat
pressure
air
negative
isolation
units
nan
nan
sars
china
hospitalized
number
patients
cov
respiratory
mers
middle
east
ccg
corporate
performance
return
giving
ppe
intubation
types
eyepiece
use
infectious
people
model
infected
hong
pay
the
personnel
ed
sars
endocrine
host
and
or
signaling
nan
ebv
proteins
latency
eber1
eber2
antibiotics
bacterial
farm
animal
fungal
health
one
disease
human
medicine
in
viral
recent
infections
antiviral
dengue
serotypes
conserved
epitopes
infection
respiratory
positive
pathogens
surfaces
samples
ibv
α2
sialic
acid
epithelium
viral
ncrna
mechanism
virus
ibv
pyrazolone
medicinal
biological
sar
activity
rotavirus
calves
viruses
within
diarrhea
sign
pdc
dc
human
lymph
crisis
communication
features
chinese
mainland
mers
mild
reversible
lesion
infectious
influenza
pandemic
need
aims
literature
assay
luminex
pigs
vesicular
swine
screening
influenza
system
the
35
health
global
policy
learning
games
sites
drug
binding
unbound
pockets
de
exacerbation
été
et
les
cats
infantum
feline
tested
17
air
pollution
pm2
case
severe
molecular
transmission
tools
outbreak
species
ul49
structure
tap
complex
protein
nan
nan
rna
rlr
receptors
viruses
recognition
cov
vac
sars
responses
immune
nan
nan
nan
nan
package
estimation
stochastic
models
infectious
pcr
ibv
serotypes
mass
ark
gene
dmcpd1bs
two
melanogaster
silver
training
staff
laboratory
bsl
important
nan
nan
nan
healthcare
reforms
china
summary
process
congenital
heart
disease
virus
viruses
strains
5a
78kb
5b
genes
nan
odr
herds
days
mortality
calving
cytokines
wasting
aids
syndrome
effects
patients
aetiology
respiratory
among
ili
infection
de
la
le
vasculitis
attributes
environmental
price
architectural
hk
ifa
pcr
rsv
hadv
piv
nan
lymphocytes
clns
infection
proliferation
the
lbsap
dogs
leishmania
challenge
infection
diagnostic
emerging
viruses
in
article
increased
new
camelids
knowledge
health
ns
plga
sirna
cs
modified
priority
diseases
uk
development
vaccines
proteins
membrane
fusion
structural
viruses
mers
cov
patients
ora
disease
intubation
time
professional
required
practitioners
asthma
exacerbations
exacerbation
respiratory
tract
bait
dogs
domestic
rabies
dog
nan
nan
dimension
vector
16
set
approach
nan
nan
species
the
due
popularity
human
respiratory
malaria
patients
acute
distress
networks
surveillance
infectious
regional
the
use
hcws
emerging
infectious
planning
3c
structural
mrna3
folding
ufr
lymphocytes
peripheral
blood
intraepithelial
cells
pneumonia
countries
new
developing
long
the
attitude
practice
knowledge
domain
group
virulent
regulated
kidney
genes
filovirus
disease
nonhuman
infection
animals
disaster
role
care
perinatal
management
emerging
biodiversity
loss
health
surveillance
virus
cells
avian
infectious
bronchitis
recombination
ck
ch
ljl
111054
milk
replacer
calves
fed
variable
spilf
group
ebr
the
hcws
unknown
pandemic
1918
bacterial
influenza
respiratory
ct
catheterization
disorder
cardiac
the
nan
cases
infection
mers
cov
the
nan
autoimmune
vaccines
immune
adjuvants
autoimmunity
ards
delivery
drug
lung
targets
nan
nan
epidemiology
evolution
abstract
this
article
nan
fecal
coliform
factors
river
urban
patients
platelet
igg
fever
thrombocytopenia
cases
throat
respiratory
nasal
controls
mers
cov
il
infection
cytokine
nan
covid
19
pregnant
infection
patients
infections
compounds
clinical
antiviral
half
definition
steps
oral
vaccines
synthetic
pei
dna
plga
nanoparticles
ratios
frameshifting
sars
cov
analysis
frameshift
pdcov
infection
diagnostic
methods
appropriate
rt
pcr
viral
cells
influenza
nan
abstract
this
chapter
briefly
review
di
il
la
era
un
quercetin
new
tyrosine
kinase
selectivity
health
technologies
population
emerging
technology
sars
plasma
cov
days
patients
h1n1
2009
susceptible
h275y
specimens
nan
drugs
cancer
cscs
anti
therapy
nan
abstract
what
emerged
december
2019
patients
cases
mers
cov
mortality
nan
health
hajj
pilgrims
saudi
the
protein
rdrp
denv
the
rna
viral
immune
viruses
cellular
proliferation
genome
similarity
weighted
graph
model
virus
particles
plaque
forming
viral
cells
feline
assay
cd4
detection
pdz
domains
cellular
human
protein
nan
food
intolerance
many
acute
dietary
nan
cml
activity
binding
lectin
the
glycans
infection
mucosal
susceptibility
the
care
in
patient
epidemics
icu
glycyrrhizin
prrsv
component
porcine
reproductive
nan
sinensis
plant
traditional
paper
activities
respiratory
diseases
diagnosis
conditions
constitute
compounds
antiviral
inhibition
assays
fcov
virus
zika
fever
day
the
nan
echt
the
results
tumours
cell
model
structure
part
new
mr
nan
virus
response
cd4
cell
disease
tp5
pbca
np
the
release
jhmv
mhvr
wt
receptor
independent
dogs
crcov
seroprevalence
respiratory
signs
nan
id
badges
lanyards
worn
pediatric
asymptomatic
mers
cases
the
cov
ibv
mabs
protein
virus
the
ad
vectors
receptors
cell
surface
mood
injection
vaccination
stress
study
nan
air
niv
via
pressure
helmet
nan
strain
structural
proteins
cb
05
day
sars
cov
confirmed
infection
nan
protein
antibodies
protocol
virus
preparations
testing
pcr
patients
pneumocystis
bal
nan
nan
horses
ecov
adult
factors
recently
sars
cov
mouse
cell
ma15
perfringens
β2
enterotoxaemia
lesions
isolated
nan
antibiotics
patients
acute
bronchitis
use
pep
virus
epigoitrin
cb
alk
cbov
strains
cbovs
dogs
related
kidney
pandemic
h1n1
patients
failure
dpp4
species
mers
cov
spike
3clpro
ic50
cell
cleavage
indigotica
crisis
research
response
dfw
region
hadv
dna
viral
rti
controls
autophagy
intracellular
adaptive
the
cells
de
des
du
et
la
mucosal
de
voie
les
des
nsp15
rna
the
several
cleaves
cats
risk
mortality
adoption
centres
na1
bovine
enteric
infection
virus
nan
crcov
respiratory
cird
canine
disease
rna
rnas
small
leader
mhv
nan
diagnosis
factors
molecular
diagnostic
the
compounds
hiv
new
highly
abstract
nan
denv
chikv
assay
clinical
chikungunya
size
sampling
viruses
airborne
expansion
recent
infections
nothing
trip
enough
diseases
review
presented
perform
meaningful
sepsis
mouse
data
expression
using
nan
nan
structure
antiviral
drug
animal
viral
influenza
in
vaccination
poland
several
mers
cov
middle
east
reported
hand
blood
contamination
electrolyte
caused
sars
perinatal
pregnancy
presented
patients
respiratory
covid
19
cases
countries
surveillance
programmes
implementation
strategies
defined
nan
trans
cis
range
9d
9f
sat05f
odn
tlr7
could
human
nan
the
mers
cov
models
stability
nan
international
disease
health
infectious
global
hnrnp
cells
poliovirus
rna
replication
pcr
rt
real
time
gene
cc
chinese
syndromic
ccs
english
probability
ideas
cognitive
century
discussions
membrane
tk9
peptide
in
interaction
camelids
disease
bactrian
camels
world
nan
nan
cats
antibodies
felis
fcov
cp
nan
nan
wildlife
among
novel
china
2019
ibv
ampv
flocks
strains
backyard
host
protein
viral
systematic
pathogen
sequencing
viruses
host
describe
assays
isolates
hygromycin
bovine
coronavirus
antigenic
travel
tropics
return
fever
returning
hospital
the
increasing
airborne
source
nan
tnf
pulmonary
edema
alveolar
lung
sads
cov
diarrhea
strain
strains
viruses
viral
quasispecies
dynamics
adaptability
nan
health
items
agenda
wha
the
hbov
months
respiratory
prevalence
the
ca2
proteins
binding
viral
cellular
001
virus
markers
schizophrenia
antibodies
nan
sars
influenza
avian
pis
evidence
mers
cov
high
dromedary
camels
de
en
la
los
el
nan
outbreak
number
transmissibility
reproduction
individual
associated
sites
viruses
bat
genera
care
palliative
plan
systems
triage
protein
recombinant
sera
gene
oc43
influenza
assay
h7n9
virus
reaction
psychosocial
disease
infectious
evidence
factors
cd8
mhc
lymphocytes
cell
peptide
dc
sign
signr
immune
genetic
rt
lamp
assay
tcov
the
nan
swine
influenza
viruses
pigs
heterologous
days
95
ci
incubation
period
qr448
ibv
treatment
activity
virus
ms
hhv
multiple
disease
thought
sterilisation
methods
skin
used
donor
specimens
viruses
stool
positive
cvlps
nan
jz
hsv
cell
effect
anti
mers
cov
infection
patients
significantly
nan
culture
pcr
respiratory
cell
negative
nan
nan
nan
equine
arteritis
virus
infection
viral
hun
2012
canine
astroviruses
genome
viruses
role
infections
vap
intensive
travel
advice
child
adoption
adopted
colostrum
cows
igg
calving
quantity
nan
influenza
protection
advax
pups
il
nan
water
treatment
quality
may
wastewater
nan
bioforensic
capabilities
bsl
federal
partners
governance
chapter
investor
analysis
this
unknown
bat
cell
viruses
line
virus
airway
obstruction
upper
infective
causes
rt
pcr
assays
sense
viral
emergence
predicting
research
prediction
infectious
tgev
epitopes
salmonella
system
987p
3a
sars
channel
virus
release
factors
ms
epidemiological
environmental
clinical
nan
bev
isolated
genome
sequence
picornaviridae
outcomes
prior
expectations
predict
domain
2019
ncov
cov
likely
therapeutics
anthraquinone
isolated
abstract
new
dihydroxy
ebov
vaccination
months
guinea
protection
nan
nan
dentists
mortality
95
ci
taiwan
factors
mers
the
recovery
major
plpro
dub
deisg
mers
virus
nan
staff
phi
region
development
prefectural
nan
nan
ed
model
visits
respiratory
infectious
disinfection
protective
equipment
fumigation
pprphs
filovirus
infection
what
filoviruses
virus
receptor
ligand
ligands
approach
could
mers
cov
respiratory
disease
animal
article
this
updated
version
previous
antimicrobial
involved
various
like
activity
nan
species
impacts
non
invasive
human
quails
group
the
collected
infection
nan
sars
cov
coronavirus
health
genetic
silver
nano
emerging
re
membrane
colostrum
associated
the
igg
quality
hospital
public
emergency
provide
family
emergency
care
metrics
reported
studies
nan
barriers
guidelines
crisis
specific
health
influenza
rsv
respiratory
viruses
virus
therapeutic
new
drug
efficacy
available
nan
mice
retinal
ifn
balb
degeneration
the
protein
viral
found
highly
mucosal
iga
rabbits
loops
studies
foscc
feline
20
oral
hpv
nan
synthesized
yl
different
reaction
step
nan
ppr
regions
in
des
ruminants
nan
sars
concern
international
spread
pathogens
this
guest
editorial
introduces
month
the
sars
coronavirus
main
proteinase
pollution
the
particulate
beijing
costs
aav
serotypes
cell
aav2
vg
nan
nan
virus
rnas
di
coronavirus
replication
nan
hiv
respiratory
viral
infection
individuals
mers
cov
camel
zoonotic
dromedaries
nan
nan
rsv
health
maternal
immunization
respiratory
pedv
viral
erk
cellular
erk1
dcas9
biosensor
clinical
crispr
mediated
nan
isg20
antiviral
virus
replication
exonuclease
pdr
ab
specific
igys
igy
number
airport
capacity
available
hubs
nan
male
reproductive
immune
system
tract
nan
nan
summary
we
report
case
necrotizing
based
sars
cov
sterillium
investigated
strains
wd
strain
coronavirus
analysis
nan
nan
waste
category
evd
medical
infectious
chd
air
pollutants
exposure
senv
e1
the
e2
glycoprotein
type
protein
prrsv
type
residues
deletion
nan
pedv
siga
strip
specific
test
nan
nan
unknown
ace2
angiotensin
ace
heart
renal
nan
nan
medicine
human
animal
vaccination
health
health
china
diseases
infectious
epidemiological
genes
sequence
specific
wssv
sirna
nan
bacterial
viral
type
ifns
iii
urban
infectious
diseases
the
world
cells
lung
stem
pulmonary
based
cats
fip
fcov
disease
the
nan
influenza
rapid
test
the
border
igg
assays
pneumoniae
seromp
igm
influenza
atpase
targeting
viral
endosomal
nan
de
des
du
diagnostic
antimicrobial
airport
bc
sources
total
number
nan
influenza
sot
recipients
vaccine
vaccination
strategy
the
immunization
degree
centrality
infectious
animals
framework
emerging
disease
g4s
microbial
genomes
virus
recent
ifn
ndv
protein
anti
mabs
foodborne
control
probiotics
pathogens
illness
viruses
cellular
virus
factories
membrane
covid
19
operating
paediatric
pandemic
the
m2
protein
influenza
together
nan
droplets
body
thermal
human
evaporation
bcov
calves
cattle
strains
in
ibv
protein
rna
coronavirus
nucleocapsid
mice
wk
age
virus
mhv
political
party
chinese
china
one
ifn
nk
cells
activation
lung
febrile
keyword
based
detection
sensitivity
derivatives
activities
potential
compounds
17
dogs
diagnostic
test
samples
rapid
nan
elisa
virus
neutralisation
test
positive
nan
nan
design
the
alpha
helical
tectons
de
virus
la
como
infections
nan
phenolic
antimicrobial
activity
these
new
papn
scfv
library
phage
chain
niclosamide
diseases
drug
may
clinical
type
ifns
er
stress
infections
mers
cov
protocols
diagnosis
sequences
kd
children
kawasaki
disease
the
inflammation
local
mediated
sirna
nanoparticles
nan
de
la
par
et
le
nan
infectious
diseases
global
health
surveillance
nan
disease
host
epidemiology
populations
animal
ubiquitin
replication
viruses
pathway
viral
mers
immigration
illness
onset
cases
nan
macrophages
expression
il
ifn
cytokines
group
coronavirus
bcov
mhv
utr
nan
cvs
cells
olfactory
infection
neurons
de
la
the
agent
syndrome
nan
nan
sars
coronavirus
cov
rna
the
microarray
microbiology
clinical
infectious
technology
nan
rna
mir
122
synthesis
hcv
transmission
la
de
source
une
3cpro
hrv
the
assay
thin
virus
vaccines
vlp
based
abstract
nan
de
les
infections
la
sont
de
la
el
virus
infección
membrane
cholesterol
protein
viral
drms
wheezing
rsv
types
children
first
abstract
bioterrorism
intentional
use
bioweapons
nan
nan
urban
fad
data
map
using
species
galliformes
common
domestic
exotic
cough
febrile
episodes
travellers
or
nan
sars
tachycardia
disease
physical
abstract
nan
illnesses
children
treatment
studies
which
polysaccharides
chinese
herb
traditional
different
nan
virus
specific
dth
mice
encephalomyelitis
rhpiv2
vko
virus
hpiv2
protein
rotavirus
asc
specific
pigs
iga
interactions
framework
within
health
pathogen
ata
sars
cov
binding
rdrp
2019
ncov
january
2020
new
food
viruses
important
safety
cause
nan
rna
rnai
applications
clinical
this
resuscitation
emergency
the
period
patients
virus
recent
emergence
infectious
diseases
nan
nan
nan
development
the
cross
border
trans
mathematical
models
transmission
data
parameters
cats
rfeifn
fiv
oral
licensed
nan
nan
ifn
irf3
infection
prrsv
transcription
bovine
diarrhoea
adult
cattle
disease
medicine
darwin
biology
evolution
it
patients
hct
screening
pulmonary
pre
nan
human
genome
history
hgp
chapter
nan
lactose
protein
grifin
the
despite
nan
nan
right
rabbit
anaesthetic
ventricular
myocardial
global
canada
health
equity
leadership
codon
usage
pernix
k1
microorganisms
diseases
infectious
aptamers
human
treatment
rhinitis
burden
often
seen
posing
viruses
host
population
viral
numbers
nanotechnological
applications
promising
nanoparticles
processes
children
respiratory
symptom
virus
infections
translation
viral
mechanisms
cellular
promote
nan
psv
infection
pk
15
cells
nan
fuzzy
logic
infectious
diseases
evaluation
women
pneumonia
95
ci
study
state
european
issues
public
health
prostaglandin
astrocytes
e2
tpa
protein
nan
ajdi
management
benefit
participation
map
recipients
infectious
complications
transplant
lung
strain
fcv
te
10
07
promoter
fimbriae
salmonella
vaccine
pagc
hajj
pilgrims
respiratory
viruses
symptoms
viruses
respiratory
tests
specific
groups
uveitis
feline
infectious
agents
neoplasia
sars
callers
knowledge
physicians
hotline
rna
rev
helicases
hiv
distinct
nan
fip
cats
gwas
genetic
feline
translocation
process
ef
trna
the
s102
calves
dysentery
days
produced
de
la
virus
en
entre
coronavirus
tcov
disease
virus
chickens
the
alphaviruses
antiviral
viruses
project
panel
dv
air
contaminant
interface
enzyme
immunoassay
parameters
assay
automatic
exacerbations
exacerbation
antibiotic
treatment
approach
nan
nan
rsv
respiratory
the
infections
children
nan
amphotericin
deoxycholate
plaque
virus
summary
sars
cov
proteins
interaction
the
neopterin
sars
patients
nmol
concentrations
ccov
apoptosis
infection
caspase
study
pseudotype
viruses
human
viral
many
vaccine
yf
disease
rare
respiratory
tourism
crises
disasters
structural
breaks
nan
organoids
models
helminth
culture
systems
18bp
il
18
amil
the
elisa
tgev
prcv
antibody
samples
ub
cysteine
deubiquitinating
m48usp
protease
strains
field
the
ibvs
southwestern
ms
molecular
disease
may
mimicry
cats
fel
infantum
dogs
feline
nan
astroviruses
infection
species
identified
mammalian
nan
presented
rodent
species
diagnosis
treatment
genes
genomic
gene
cardiovascular
disease
sars
cov
entry
protein
viral
bhv
gd
rlasota
recombinant
ndv
patients
rsv
pcr
pneumoniae
the
animals
risk
trade
united
states
gut
human
microbiota
microbes
immune
donkeys
diseases
reported
horses
cardiovascular
nan
lncrnas
ev71
severe
infected
patients
discharge
2019
post
surveillance
clinical
nan
respiratory
carvs
infections
adenovirus
morbidity
viral
emerging
challenges
infections
changes
collective
coverage
health
insurance
employees
cells
nn
neurons
jhm
tropism
bats
viruses
virus
diseases
sars
influenza
human
avian
h5n1
the
mers
mice
antisera
rbd
cov
infections
february
quarantine
20
asymptomatic
h7n9
influenza
virus
ab
fragments
kiv
wuv
respiratory
infection
viruses
price
subsidy
elasticity
vaccination
elderly
antibodies
igy
avian
the
polyclonal
viruses
viral
wtc
aerosols
air
fhv
cheetahs
domestic
responses
response
sars
abstract
the
severe
acute
drugs
systems
local
pulmonary
administration
inss
systemic
aes
acute
rs
peptide
protein
detection
microarrays
molecular
simulation
clinical
pem
environment
integration
regulation
apn
ifn
cd13
hrs
weeks
rna
cats
disease
viral
disease
dogs
distemper
cdv
diagnosis
nan
influenza
guangzhou
disease
burden
study
coronavirus
middle
east
human
mers
nan
care
respiratory
cdc
recommended
the
eiavdlv121
eiav
strain
vaccine
eiavln40
host
viral
factors
proteins
technologies
observed
cases
skin
abstract
we
nan
nan
research
framing
sciences
policy
debates
nan
immune
the
gastrointestinal
tract
body
la
de
virus
vasculitis
el
disease
research
causation
stealth
pathogens
mass
travelers
gatherings
diseases
events
nitazoxanide
influenza
clinical
viral
hepatitis
pneumonia
patients
viral
infection
treatment
enveloped
human
virus
benzalkonium
chloride
calves
bohv
birth
ge
age
microbial
disease
diseases
the
infectious
training
emergency
preparedness
the
rural
nan
nan
spores
protocol
method
using
section
nan
nan
insurance
non
life
markets
this
pharyngitis
bacterial
antibiotics
the
treatment
street
room
dispersion
canyons
the
nan
nan
air
dynamic
distribution
contaminants
method
nan
influenza
data
circulation
brazil
disease
nan
nan
the
disease
emergence
deals
chapter
protein
transmembrane
lipid
bundle
model
tac
conventional
viral
testing
samples
residues
antigenic
nucleoprotein
within
mabs
virus
mosquito
borne
flaviviruses
assay
the
novel
antiviral
hcmv
activity
sars
cov
gene
replication
virus
ov
asp
protein
antigen
asppr
nan
human
respiratory
tract
several
viruses
astroviruses
species
astrovirus
animals
in
nan
asthma
pef
symptoms
medication
influenza
de
los
en
el
un
the
structure
domain
known
appr
sa59b
sars
scfv
cov
antibody
species
codon
insect
betabaculoviruses
alpha
nan
rotavirus
tg
rac1
replication
infection
nitrosothiols
no
sulfhydryl
low
molecular
nan
mhv
nt
protein
demyelination
gene
nan
kda
p28
290
cleavage
product
airway
the
chronic
copd
bronchi
mhv3
virus
dieldrin
macrophages
vitro
approach
separating
compounds
finding
plant
nan
asthma
clinical
based
stratified
therapies
cathepsin
thiosemicarbazone
analogs
inhibitors
cancer
viral
infection
infections
immune
common
vaccine
sows
oral
pedv
ap2
expression
il
vaccine
lbsap
12
ptdins4p
lipids
viral
rna
replication
arenaviruses
virus
disease
arenavirus
several
endodomain
coronavirus
protein
virions
carboxy
sars
octapeptide
avlqsgfr
the
far
coronavirus
sites
two
protein
phosphorylation
nan
virus
les
de
human
le
protein
rbd
sars
cov
spike
nan
la
de
en
el
ms
variants
cells
variant
receptor
binding
gp73
protein
human
golgi
in
flexible
approach
endoscope
reprocessing
infection
protein
sars
spike
cov
monoclonal
virus
coronaviruses
viruses
antiviral
agglutinin
nan
the
inflammatory
diseases
commonly
affecting
de
la
fiebre
las
el
nan
nan
antibodies
polyclonal
monoclonal
bec
elisa
we
infection
model
the
seafood
hla
01
46
peptidome
mini
responses
aiv
the
ha
np
the
virion
structural
coronavirus
means
nan
nan
ribavirin
2c
fmdv
virus
replacements
psychological
medical
human
among
crisis
rdrp
rna
coronaviruses
arteriviruses
nidoviruses
respiratory
rhinovirus
rhinoviruses
acute
infection
studies
spectroscopic
field
used
this
nan
sars
recovery
many
the
tourism
weather
advice
extreme
giving
commentaries
autophagy
replication
prrsv
viral
using
nps
inorganic
materials
mediated
biomedical
air
huge
combustion
abstract
our
africa
covid
19
disease
susceptible
lab
hrv
macrophages
monocytes
colonization
nan
nan
tissue
disease
treatment
cryptogenic
organizing
doctors
nurses
ptsd
related
h7n9
di
il
una
della
che
nan
sensory
ms
viral
system
peripheral
bcovs
the
includes
hcov
sub
hosts
competence
parasites
disease
ec
nsp3
tm
membrane
domain
mhv
medical
year
flight
wilderness
medicine
viral
cf
infections
respiratory
viruses
nan
nan
virus
circo
like
bo
rep
influenza
treatment
virus
h1n1pdm09
infections
cases
influenza
hand
aor
the
hev
neurons
sensory
cells
within
nan
nan
individuals
number
time
total
epidemic
brd
earlier
infrared
thermography
clinical
psychiatric
medical
syndromes
classification
disorders
muscle
dmd
stem
dystrophin
expression
nan
nan
influenza
avian
the
h5n1
pandemic
prrsv
virus
ga
fragments
infectious
nan
vlp
vlps
vaccines
recombinant
expression
nan
cases
wuhan
both
we
report
rhinovirus
survival
transmission
fingers
main
diseases
emerging
infectious
more
recently
group
patients
pneumonia
respiratory
showed
thkpv
three
viruses
genome
unique
virus
infection
asfv
infected
cells
dental
hve
isolite
the
spatter
2019
disease
coronavirus
named
covid
rna
viruses
genomes
stranded
genome
virus
health
humans
fever
the
face
involved
touching
hand
behavior
us11
protein
localization
nes
nucleolar
cap
antibiotics
etiologic
enhance
use
nan
transmission
coronavirus
covid
19
china
nan
nan
nan
pairs
forage
supp
per
cow
chikv
tf
intraviral
oligomerization
palmitoylation
nan
nan
treatment
wastewater
bacterial
pathogen
pathogens
de
qui
une
la
les
btz
chlorhexidine
activity
calix
arene
2s
ec50
activity
cells
compounds
soft
computing
imaging
infrared
techniques
nan
demyelination
monoclonal
nr
variants
jhmv
antibody
vitro
activity
virus
infection
infection
common
marmoset
jacchus
ebv
virus
hpv
cervical
recombinant
the
mechanisms
intramembrane
protein
interactions
ppis
ifn
prrsv
could
irf
promoter
mhv
ri
strains
cells
infection
nan
entropy
indices
crisis
complexity
the
nan
nan
dairy
fertility
days
cows
cow
nan
low
patients
ami
gik
trial
groundwater
pollution
derivation
model
transport
small
surgical
procedures
mammal
mammals
nan
dna
effective
pestis
vaccine
antigen
nan
resistance
discussed
disease
genomic
progress
nan
autophagy
host
viral
viruses
transfer
nan
nan
il
p40
12
th1
p35
arenaviruses
the
viral
family
species
nan
rig
mda5
rna
response
knowledge
biological
factors
workplace
review
hazards
n7
mtase
yeast
cellular
system
detection
ipcr
the
elisa
qpcr
infantum
leishmania
infection
detected
domestic
sars
cov
rats
immunized
spike
cases
we
cchf
tool
risk
cmnv
rt
assay
disease
lamp
nan
outbreak
investigation
reports
steps
india
nan
nan
government
citizens
health
social
media
whey
proteins
important
biological
properties
nan
africa
south
flights
air
overseas
influenza
compliance
ed
precautions
transmission
model
epidemic
microorganisms
environment
modelling
zoonoses
viral
many
changes
emerging
emergency
managers
approach
korea
disaster
nan
receptor
soluble
sars
cells
537
viruses
strains
2005
genomic
110
cell
nerve
swelling
right
neurolymphomatosis
dimerx
ctls
sars
flow
cytometry
veterinary
development
vaccine
the
use
coughing
speaking
the
exhaled
velocity
nan
nan
viral
species
signs
leukopenia
limited
pcr
cell
detection
infectivity
viruses
models
disease
emerging
viral
pathogens
hiltonol
mice
cov
mg
kg
air
transport
industry
paper
sustainability
nan
sars
cov
innate
immune
signaling
nan
natural
compounds
plants
endophytes
it
risk
generations
our
abstract
we
nan
legionella
aris
spp
patients
role
nan
cov
strains
covs
pipistrellus
detected
travellers
vfr
china
infectious
diseases
anthrax
plague
the
antibiotics
smallpox
ferret
ferrets
described
diseases
recently
our
chance
limit
international
outbreaks
biological
derivatives
antiviral
compounds
protease
diseases
related
birds
infectious
abstract
reactive
changes
microglia
neuronal
degeneration
rna
the
strand
length
synthesis
nan
fowl
emergency
care
birds
belonging
viral
asthma
patients
exacerbations
acute
covid
19
three
growth
the
contaminant
airflow
aircraft
cabin
vortex
jejuni
yolk
colonization
broilers
hyperimmune
nan
nan
cchfv
molecules
the
two
chloroquine
dub
virus
viruses
eav
positive
rabies
pcr
probes
rt
taqman
nan
nan
dc
sign
dendritic
adhesion
molecule
mhc
class
expression
astrocytes
cre
species
bat
coronaviruses
bats
alphacoronaviruses
nan
ab2
structural
memory
antigen
hemagglutinin
foal
field
therefore
performed
the
tgev
nf
κb
virus
porcine
type
cells
tcr
mhc
cytokines
mers
cov
protein
proteins
cells
ubiquitin
inhibitors
system
protein
enzyme
rv
types
rvs
the
amsterdam
vaccinated
trust
vaccine
government
results
csf
rhug
cats
fiv
counts
sars
china
spread
within
quickly
rearranged
membranes
coronavirus
membrane
proteins
calves
difficile
diarrheic
positive
culture
rsv
adults
latin
studies
infections
human
health
abstract
ebolavirus
cause
protein
the
results
phosphorylation
sites
ndv
tumor
therapeutic
response
taa
cd13
expression
cells
pb
lymphocytes
nan
gav
orf1a
yhv
terminal
putative
i1101
16
ck
ch
ljl
dna
vaccine
vaccination
vaccines
poultry
vhs
rt
assay
lamp
virus
rna
accumulation
strand
minus
ntr
il
12
p35
viral
influenza
pregnant
ct
clinical
laboratory
the
vaccine
platforms
abstract
improved
understanding
bat
disease
models
populations
dynamics
nan
influenza
fmomv
mucosal
vaccines
intranasal
nan
plasma
the
seminal
hbp
dog
nan
nan
respiratory
influenza
acute
infections
humans
antibodies
monoclonal
use
treat
therapies
ibv
ndv
lamp
detection
lfd
oseltamivir
h5n1
influenza
virus
resistant
pcr
ccov
assay
sequence
analysis
nan
direct
lamp
genotyping
polymorphisms
samples
liver
kidney
group
the
infected
neutrophils
immunoreceptors
effector
neutrophil
functions
nan
nan
nan
mers
cov
effective
respiratory
antibody
nan
mhc
salt
peptide
peptides
recognition
nan
proompa
protein
trigger
factor
membrane
nan
protein
ix
hadv
the
gene
hp
group
saa
calves
apps
main
group
compounds
elements
element
ibv
gene
spike
vaccines
rational
membrane
fusion
required
vfp
states
nan
abstract
information
available
conference
cancelled
nan
asiaticum
lycorine
activity
the
scavenging
class
mhc
wnv
astrocytes
expression
nan
competencies
objectives
terminal
care
infection
nan
antibiotic
days
ddd
100
bed
cells
class
antigens
mhc
system
pedv
neutralizing
cells
infection
pc10
screening
entry
infected
travellers
2019
initial
or
crp
sars
concentration
nan
ccl28
activity
various
receptors
chemotactic
antiviral
drugs
therapies
approved
future
genetic
loss
cheetah
provide
evidence
fip
fcov
response
viral
infection
viral
the
respiratory
infection
asthma
pedv
pgar
piglets
diarrhea
infected
ifn
mhv
di
virus
vector
nan
maternal
immunization
infant
infectious
pregnancy
vaccines
vaccination
this
article
discusses
protein
antiviral
the
system
bacmid
oh
ic
hcws
resources
available
nan
self
protective
behavior
study
model
nan
projection
an
water
reduced
morphology
the
construction
offshore
pipeline
demand
virus
influenza
human
h6n1
avian
sars
3clpro
cov
protease
respiratory
clpg
the
aa
cs31a
sp
nan
responses
contribute
viral
cell
genomics
une
et
en
un
de
8b
down
protein
proteasome
pathway
cell
culture
chapter
scientific
research
de
la
crisis
las
en
tfr1
human
arenaviruses
new
world
cells
stromal
cns
activation
cell
orf3
pedv
protein
er
lc3
work
family
engagement
theory
enrichment
nan
nan
sludge
treatment
processes
disposal
technologies
ee
outbreak
piglets
herd
pcv
ns6
pdcov
predicted
cells
infected
patients
asthma
use
exacerbations
health
pedv
apoptosis
aif
infection
induced
including
the
influenza
respiratory
antivirals
nan
immunization
adults
older
vaccination
adult
ige
sensitization
cmv
ebv
virus
use
relapses
chronic
it
the
nan
nan
cell
experimental
virus
evolution
culture
articles
mers
cov
outbreaks
emerging
sars
toronto
data
model
diagnosed
de
los
infección
las
el
sars
china
shanghai
severe
acute
blv
cell
line
antigen
bvdv
les
ias
la
de
des
nan
sensory
nerves
cough
the
bronchopulmonary
research
ibc
biohazardous
oversight
review
nan
jja
advax
jjav
vit
adjuvant
health
care
hospitals
rpp
workers
tgev
coli
k99
sialic
acid
cpv
negative
dogs
abstract
lymphocyte
in
spf
df
cats
fipv
nan
hand
hygiene
practices
infection
control
innate
host
antiviral
ub
responses
hajj
pilgrims
respiratory
among
countries
nan
nan
o3
total
rd
ozone
max
nan
en
de
la
fiebre
fever
cov
humans
virus
mers
human
macrophages
swine
mdp
we
activated
nan
rt
pcr
covs
pancov
assay
hybridization
the
selectivity
dna
electrochemical
normal
follow
fhcs
atypical
the
oxysterols
metabolism
potential
involvement
antiviral
governance
cross
rescaling
boundary
hong
care
management
new
pneumonia
cap
virus
cells
mhv
cns
acute
sequence
gap
structure
nt
coding
zebov
sirnas
non
given
postexposure
vsv
gδ28
protein
attenuated
vsvδm51
otitis
media
interna
left
sez
public
collections
use
good
resources
nan
nan
infection
prevalence
the
infections
hais
sars
virus
replication
agms
species
nan
virus
specific
dna
viral
methods
or
95
ci
children
factors
nan
nan
novel
viral
swine
detection
pig
pga
tlr4
type
ifn
md2
comorbidities
cap
mortality
admission
host
nan
ace2
protein
influenza
h1n1
acute
nan
nan
respiratory
sars
cov
bats
transmission
go
graphene
attributed
development
generation
type
fcov
vn
ii
cats
ms
rapid
identification
respiratory
viruses
viral
adss
species
abstract
the
sample
approach
pathogen
tube
preparation
nan
samples
operation
pdcov
case
clinical
tourism
trade
bilateral
may
flows
nan
nan
vaccine
development
the
genomics
opportunity
this
enzyme
organisms
proteases
protease
nan
mers
cov
s1
lisas
anti
nan
pigs
virus
porcine
europe
disease
health
main
provision
our
summary
95
ci
patients
mers
14
care
critical
professionals
work
experiences
we
networks
behaviors
literature
diffusion
spot
futures
prices
we
well
cord
blood
ucb
units
clinical
cholesterol
vector
retroviral
lentiviral
vectors
dose
calves
oocysts
shedding
fecal
nan
nan
visibility
mortality
ages
years
65
removal
ppe
health
care
current
e64d
a59
gene
virus
mhv
respiratory
viruses
pathogens
cattle
important
viral
host
viruses
chapter
genetic
rbd
cho
sars
rbd193
cell
pedv
proteases
papain
like
new
pathogens
hosts
abstract
in
past
nos
expression
nitric
oxide
cns
pirb
pira
the
genes
assays
metal
ions
viral
rna
proteins
fever
rash
although
emergency
department
infections
zoonoses
humans
transmitted
animal
phenolic
acids
cos
flos
lonicerae
microwave
in
disinfection
airborne
nanofibrous
coronavirus
may
ibv
adaptation
cell
de
la
en
los
kawasaki
water
solubility
solvation
the
ribavirin
nan
nan
digital
hourglass
like
constriction
nerves
monensin
transport
membrane
glycoproteins
influenza
cough
chronic
bronchitis
inhaled
the
infection
dogs
time
vasorum
weeks
the
marmoset
primate
model
infectious
system
desiccant
cooling
energy
use
several
none
activity
abstract
the
japan
major
diseases
parasitic
development
nan
nan
nan
diagnostic
several
clinical
nucleic
acid
cps
viral
rna
proteins
genomes
giardia
cryptosporidium
abstract
common
enteric
ptgs
viral
new
virus
gene
rotavirus
diarrhoeic
infection
calves
piglets
nan
arb
hsv
the
efficacy
infection
nan
wurss
44
sf
responsiveness
jackson
type
immune
diseases
immunology
conditions
varicella
molecular
tissues
virological
case
consolidations
imaging
chest
us
cxr
lower
floor
transmission
one
air
ag
labeled
the
sv40
multifunctional
impact
test
retrospective
cohort
design
amyloid
enzymes
the
metabolism
activity
muscle
neurotization
nerve
repair
denervation
nan
nan
nan
calves
respiratory
revealed
bacterial
abstract
viruses
receptor
may
mutation
specificity
nan
the
challenges
faced
emergency
physician
virus
canine
coronavirus
dogs
the
sars
cov
pcr
time
detection
nan
nan
site
epitopes
mabs
hn
three
atypical
pneumoniae
legionella
pathogens
cap
p13
mitochondrial
activity
permeability
membrane
food
viruses
control
risk
safety
virus
orf
1b
prrsv
set
nan
aiv
ibv
virus
infection
avian
receptors
innate
immune
signalling
recognition
hcws
non
lower
sars
ppe
nan
nan
patients
vari
vap
risk
vat
h1n1
vaccine
hcws
vaccination
chronic
studies
mixed
methods
data
research
nan
disinfection
systems
reliance
time
agent
hajj
covid
19
2020
gatherings
nan
dc
sign
leishmania
leishmaniasis
cutaneous
global
consumer
change
trade
policy
disaster
research
real
time
response
nan
biology
important
agricultural
used
basic
diarrhea
calves
il
high
10d
data
the
systems
web
smart
symptoms
health
anxiety
depressive
movement
pneumonia
incidence
surveillance
case
patients
cathepsin
the
catfish
amino
antigen
research
national
health
ibc
oversight
cholera
water
contaminated
epidemics
london
rnai
gene
rna
expression
viral
nan
hiv
hbv
hbs
sirna
simultaneously
eblv
bat
lyssavirus
species
europe
nan
nan
antivenoms
viral
manufacturing
acid
safety
de
la
en
virus
viruses
vaccine
development
vaccines
pdvac
meeting
et
de
des
virus
viruses
ev71
vaccine
development
vaccines
enterovirus
measles
countries
cases
air
transmission
vaccine
countries
vaccines
developing
supply
sars
outbreak
prophylaxis
may
admission
data
protein
several
representations
applications
cells
endocardial
left
bands
fibrous
variola
virus
orthopoxvirus
dna
assay
rotavirus
infection
calves
dx
responses
cough
pilgrims
hajj
the
respiratory
innate
immunity
pentraxins
collectins
research
nec
common
likely
however
role
array
temperature
systems
fever
screening
nan
nan
nan
as
covid
19
outbreak
continues
sars
cov
nucleic
acid
detection
outbreak
virological
novel
atypical
pneumonia
litter
pregnancy
average
domestic
cats
gastrointestinal
viruses
detected
viral
syndromes
sars
vaccine
development
collaborative
severe
temperature
mutant
virions
the
coronavirus
lonicera
japonica
chinese
diseases
used
cell
clones
fusion
lines
rat
feline
cells
fipv
vaccine
ifn
nan
fusion
zferv
zebrafish
protein
cell
nan
nan
2019
ncov
disease
patients
new
cells
immune
sars
factors
severe
shedding
hrv
prolonged
hct
viral
patients
coronavirus
covid
19
2019
antiviral
viral
agents
drugs
virus
unknown
diseases
information
disease
changed
age
tim
expression
ich
cells
patients
toxin
cells
lethal
small
molecules
2019
china
patients
pneumonia
unknown
animal
cafos
these
operations
emerging
nan
the
nsp13
protein
sars
study
nan
nan
patients
ed
viral
test
experimental
phb2
iv
camk
mef2
various
2019
ncov
the
outbreak
china
pedv
wild
boar
pathogen
samples
ibv
tw
gene
recombination
taiwan
doas
air
energy
system
hybrid
asfv
viral
ii
topo
genistein
probes
based
ubiquitin
functional
cellular
social
media
eids
articles
approaches
tf3
theaflavin
cells
hsv
tea
lb
mrt
airflow
method
the
type
cell
immune
pdcs
unique
pcr
poc
patients
ed
virus
vomiting
diarrhea
worldwide
disease
rehydration
nan
h1n1
viral
samples
positive
the
proteins
bes
recombinant
the
production
leukocytes
stools
must
summary
etiological
nan
travel
mainland
china
epidemic
spread
pcv
systemic
infection
examination
toxoplasmosis
nan
ibv
cells
hy
cek
infection
rv
rsv
viral
infections
cv
diseases
aquaculture
disease
cyprinid
aquatic
nan
multiple
virus
disease
implicated
autoimmune
health
herd
infectious
disease
biosecurity
ferret
the
systemic
candida
parapsilosis
mink
mcv
tgev
coronavirus
antibodies
nan
loop
the
plpro
binding
plp2
membrane
peptide
spin
effect
highly
flu
95
ci
influenza
rr
labour
control
feelings
anxiety
women
measures
co2
emissions
global
aviation
the
sars
utr
sl2
replication
nls
protein
localization
the
sequence
social
research
management
science
natural
cause
virus
diseases
viruses
disease
nan
animals
health
hazards
humans
review
mers
cov
virus
vsvδg
respiratory
boxing
spread
there
unique
diseases
influenza
virus
neu5acα
system
human
nan
fragments
pcr
the
multiplex
sars
nan
chikv
assay
well
pseudotyped
vectors
mers
cov
rt
pcr
gene
enterocytes
binding
virus
newborn
villous
many
drugs
vaccines
developed
tested
cats
enteropathogens
diarrhea
management
foster
zika
global
emerging
response
control
biochemical
dogs
experimentally
vasorum
mb
mice
embryo
pathogens
cba
dba
nan
ecov
strain
abstract
equine
coronavirus
respiratory
viral
infections
viruses
children
pandemic
response
china
wave
order
papn
tgev
peptides
protein
infection
sars
the
2003
reports
health
mtb
human
hiv
anti
niclosamide
planning
care
assessment
article
disasters
respiratory
protection
airborne
pathogens
crucial
pbl
ict
evaluation
learning
new
health
working
it
various
abstract
lectins
plant
activity
the
antiviral
influenza
children
ili
episodes
trivalent
cpv
mev
minks
viruses
fpv
diseases
infectious
spread
recently
population
nan
cidars
diseases
response
system
also
farms
control
bnp
case
use
exposure
islands
island
canine
fox
nan
pandemic
airports
disease
airport
control
market
industry
returns
leading
stock
nan
ssdna
dsdna
microchip
electrophoresis
the
transport
sorting
cargo
vesicles
golgi
disease
contained
marburg
transmission
dangerous
virus
retinal
cell
cultures
jhm
nan
eae
new
factor
cells
ms
acute
gastroenteritis
may
extent
common
sars
versus
109
clinical
patients
nan
nan
cells
found
oxoindolin
ylidene
3g
pandemic
influenza
cases
abstract
the
immunosenescence
cells
impaired
immunity
chronic
inflammation
cordata
oxidative
stress
shown
nan
plague
the
concept
quarantine
surveillance
disease
patients
control
practices
the
prime
glucosylcimifugin
anti
lung
inflammatory
nan
nan
lectins
antiviral
reported
review
candidates
nan
sting
viruses
mechanisms
responses
rna
treatments
influenza
chm
patients
illness
pneumonia
severe
patients
children
atopy
infectious
diseases
mobility
transport
may
fever
haemorrhagic
diseases
country
congo
nan
care
health
workers
respirator
respirators
tnf
brsv
calves
pid
infection
programs
blood
surveillance
risk
new
nan
virus
model
brv
mrv
the
connexins
channels
gap
cells
communication
cov
mers
the
coronavirus
respiratory
nan
proteins
gp120
binding
ezrin
moesin
de
la
el
las
más
guidelines
evidence
national
preventing
hcai
advansure
culture
100
rv15
samples
tb
days
patients
the
diagnosis
cyclin
d1
ibv
coronavirus
virus
nan
critically
ill
supplement
care
patients
sequencing
virus
high
throughput
metagenomics
3clpro
enzyme
like
viral
sars
replication
appear
viruses
similarities
rna
asthma
disease
including
microbiota
clinical
influenza
strains
cases
the
two
mers
cov
mvvac2
mv
immunity
prrsv
samples
the
assay
diagnosis
nan
cap
several
important
clinical
diagnostic
infection
mhv
jhm
brain
mrna
mc
antibodies
virus
to
163
nan
strem
serum
levels
ards
patients
nan
nan
brsv
calves
mda
clinical
responses
plasma
treatment
treated
hyperimmune
disease
infectious
diarrhea
this
article
reviews
coronavirus
kq6
peafowl
ibv
peafowls
nan
sequencing
viruses
the
explosive
pace
sequence
proteins
functional
function
svmprot
s2
anti
igg
protein
virus
deoxyribose
phosphate
prodrugs
difluoro
we
viral
infections
diagnosis
laboratory
virus
nan
nan
nan
icpc22a
pedv
bile
pigs
s1δ197
biomarkers
pneumonia
common
infectious
antibiotic
days
reovirus
mice
treated
toxin
fusion
membrane
platform
cell
supported
veal
mortality
herds
risk
calves
patients
ed
2013
2014
care
rna
nsp2
binding
catalytic
site
de
orsec
situation
protection
populations
rsv
pregnant
women
respiratory
ari
protein
p7
cell
death
apoptosis
nan
ibv
vaccine
method
embryonated
eggs
nan
btv
infected
fever
sheep
the
influenza
proflu
plus
rt
pcr
immunomodulatory
therapies
therapy
ifn
effects
iav
prevalence
apmv
co
disease
nan
nfp
rhap
il
nervilia
fordii
nan
niv
intubation
patients
support
100
smallpox
vaccination
risk
events
hcws
sirna
pigs
prrsv
tg
expression
nan
protein
calcium
binding
3a
orf3a
adolescents
stages
pets
adolescent
chapter
coronavirus
rna
processing
this
transport
infectious
diseases
china
the
threats
immune
the
humoral
intrathecal
response
nanomaterials
electrospun
applications
properties
sensors
health
outbreak
public
outbreaks
the
650
s450
sars
in
refolding
sequencing
viral
metagenomics
animal
better
nan
rt
influenza
siba
the
pcr
igy
cruzi
the
anti
yolk
nan
influenza
h1n1
pdm09
pneumonia
the
protease
the
mutant
3cl
sars
new
neglected
diseases
abstract
findings
patients
patient
visits
data
bnhi
coronavirus
the
s1
s2
domains
intervention
vaccination
the
pneumococcal
chronic
sars
replicon
cell
cov
the
nan
ifn
expression
class
ii
tnf
include
diseases
vasculitis
infectious
signs
rt
china
measures
number
wuhan
3c
intact
cats
isolates
fip
figure
see
text
filovirus
entry
structure
function
antiviral
ferroquine
derivatives
antimalarial
chloroquine
made
2020
online
feb
made
version
protein
ion
lipid
cov
channel
disease
treatment
management
important
detection
lymphangiosarcoma
distal
limb
cats
cases
mucosal
vaccination
immunity
vaccine
surfaces
uvc
surfaces
bacterial
bathroom
permanently
tbx2
tbx3
box
development
members
schiff
complexes
compounds
bases
many
genes
avian
ibv
infection
analysis
mice
cross
balb
the
bred
nan
en
de
se
000
thrombocytosis
antiviral
γδ
abstract
the
complex
cell
transport
final
assembly
viruses
nan
stress
nuclear
cells
respond
in
mabs
neutralizing
antibodies
antiviral
viral
sars
helicase
anti
medications
novel
accuracy
oriented
information
seeking
study
tgev
egfr
apn
infection
receptor
anthrax
research
agents
also
dual
nan
pgm
signal
portable
to
detection
on
rabbits
lps
injection
extravascular
hcv
models
important
virus
liver
prrsv
sequence
trs
recombinant
sequences
the
viruses
respiratory
animals
one
beijing
hong
kong
police
hard
parasite
vaccine
antigen
production
vaccines
mers
cov
the
regions
epidemic
poly
tails
rna
3dpol
genomes
multiple
sclerosis
disease
infectious
evidence
pathogens
etiologic
based
risk
factors
selected
mhc
peptides
class
the
fusion
protein
cell
pep1
pep2
replication
phosphatidylinositol
pi4kiiiβ
recruitment
pi4kiii
nan
cellular
host
cell
viruses
perfect
veterinarians
recommended
responding
96
bvd
respiratory
infections
clinical
diagnostics
due
virus
the
humans
hypothesis
aids
stool
nv
assay
basic
kit
nan
veterinary
vaccines
the
authors
current
the
protein
sequence
bev
domains
inactivation
microwave
airborne
waterborne
coli
nan
pcr
bcov
the
samples
sn
animal
absl
biosafety
experiments
facilities
prrsv
compounds
replication
virus
identified
nan
hamlec
expression
the
malectin
binding
lamp
amplification
acid
isothermal
poc
nan
kshv
pmo
cells
replication
pel
synthesized
hiv
abstract
the
enantiomerically
nan
specificity
plpro
s1
site
chains
g3bps
stress
granules
regulate
gene
expression
schizophrenia
genes
pbmcs
disorder
pneumonia
drug
particularly
high
patients
tests
molecular
probe
techniques
pcr
sars
anti
drugs
probabilistic
potential
nan
calves
inoculated
nasal
fecal
shedding
masp
associated
lectin
infectious
polymorphisms
hcv
minigenome
replication
virus
rna
influenza
vaccination
ari
children
hazard
nan
coronavirus
cov
respiratory
sars
covid
dubs
substrates
ubiquitylation
this
generally
sifitm3
pigs
fmdv
fmd
showed
factor
the
enzymes
chapter
coagulation
gene
rtgev
tgev
virus
replication
tracheitis
trachea
respiratory
infectious
children
superfast
tests
infections
could
save
pcr
assay
otnrt
rsv
qrt
ifn
nip
cell
cells
frequency
summary
this
chapter
provides
approach
health
global
who
organization
changing
receptors
nucleic
mechanisms
viruses
cytosol
nan
nan
viral
innate
antiviral
rna
self
outbreak
health
ebola
west
africa
protection
ck
ch
ldl
97i
cell
virus
infection
hcd
cultivations
may
asthma
antibiotics
respiratory
pneumoniae
nanocomplexes
sirna
different
pf14
rnai
apnea
hours
caffeine
24
bronchiolitis
fever
rs
patients
respiratory
group
abstract
halituna
novel
diterpene
aldehyde
water
result
the
fecal
diarrhea
respiratory
isolates
enteric
bocv
amino
sars
cov
species
name
coronavirus
pedv
semen
indel
boars
detected
nan
electron
the
psaa
oxo
salen
ia
expression
astroglia
intracellular
ifn
tci
formulation
patch
vaccination
the
hrv
rvh
de
em
por
health
care
national
countries
systems
nan
nan
detention
patients
use
legal
tuberculosis
mers
cov
protein
the
middle
nan
fusion
sars
cov
hr2
virus
cov
bat
covs
we
hosts
suicide
older
rates
aged
years
self
nanoparticles
vaccine
diseases
protein
level
ptsd
among
participants
nurses
barriers
orphan
diseases
drugs
development
hydroxychloroquine
sars
cov
chloroquine
infection
microbial
forensics
evidence
abstract
biothreats
antiviral
development
agents
drug
host
networks
cascades
harmful
dynamic
time
multiple
outbreaks
worldwide
led
countries
diseases
veterinary
pathogens
animals
major
immune
nanoparticle
recent
approaches
nanoparticles
spp
oral
cavity
infections
infectious
isgs
ifn
antiviral
effectors
many
rna
proteins
acylguanidines
antiviral
polymerase
species
incisors
anelodont
cheek
teeth
arb
antiviral
viral
infections
activity
nan
pcr
tagman
infectious
diseases
results
strains
calves
intestinal
in
diarrhoea
cytosolic
responses
in
nucleic
acids
nan
proteins
pi
strain
viral
strains
ml1
cells
virus
antiviral
ad5
bats
migratory
migration
temperate
tropical
nan
health
coronavirus
disease
2019
public
unknown
pertussis
mice
f1s1
lactis
responses
n95
compliance
wearing
time
increased
nan
unknown
human
virome
viruses
health
important
nan
cells
bipscs
ipscs
stem
generated
formation
sg
ev71
granules
like
pulmonary
infectious
diseases
tb
influenza
nan
eds
patients
would
isolate
ed
nan
cats
uveitis
bartonella
species
the
tourism
crisis
management
crises
industry
alignment
approach
dna
tree
problem
nan
epidemics
cases
the
model
quarantined
pandemic
influenza
who
recommendations
threats
sars
mabs
cov
development
specific
species
bat
parasite
richness
diversity
nan
pelargonium
sidoides
plant
treatment
respiratory
covid
19
psychiatric
patients
hospitals
nan
nan
phase
children
health
iaq
study
athletes
susceptible
many
acute
illnesses
analyses
cost
benefit
the
diffusion
protein
ts
mutants
revertant
virus
viral
fip
disease
genetic
feline
tnf
apoptosis
gdvii
virus
murine
nan
nan
encephalomyelitis
virus
porcine
hemagglutinating
diagnostic
les
et
indications
de
iléo
nan
lymphocytes
chicks
infection
illness
transfer
nan
host
pathogen
proteomics
vector
interactions
veterinary
environmental
associated
cleaning
disinfection
interactions
gene
environment
heritability
genetic
emerging
determinants
diseases
disease
emergence
viruses
pathogenic
molecular
detection
characterization
s1
antigenic
domains
determinants
two
ali
lung
h5n1
tlr4
mice
viruses
respiratory
mers
cov
h7n9
mers
cov
infection
hr
95
rna
coronavirus
targeted
recombination
the
nan
infection
rsv
effective
host
viral
responses
lamp
cell
chimera
vaccine
respiratory
algorithms
hcws
approach
management
human
longevity
genetic
article
genes
cov
mers
r0
scenario
sars
ucuaa
viruses
mhv
leader
repeats
diarrhea
acute
patients
therapy
management
infections
asthma
asthmatic
the
response
hiv
hr
domains
peptides
anti
model
probable
suspect
sars
we
heteroaggregates
primary
homoaggregates
minima
ionic
protease
sars
3cl
serine
derivatives
management
collective
housing
action
participate
extraction
solvent
uae
iristectorin
the
phase
data
in
two
procedure
patients
filmarray
respiratory
rp
antibiotics
cell
clinical
virus
adult
leukemia
cells
macrophages
the
interleukin
lps
nan
virus
infection
cell
mice
neurotropic
release
inflammatory
leucocytosis
the
acute
phosphatidylinositol
trafficking
kinases
isoform
specific
salmonella
biogas
slurry
effluent
digesters
nsep
mmt
china
policy
drug
cov
sars
n7
compounds
mtases
respiratory
ed
patient
health
care
bronchial
cb
drainage
system
bacterial
nan
host
viral
genetic
virulence
population
golgi
rubella
virus
cells
dense
nan
zoonotic
diseases
disease
health
human
nan
subq
alemtuzumab
cmv
gvhd
transplantation
nan
nan
camp
epac1
exchange
functions
small
nan
nan
adks
scv
hel
adk
helicase
mdp
mimics
compounds
adjuvanticity
abstract
glycosides
cimicifuga
19
cyclolanostane
triterpenoid
boifn
ω3
bovine
interferon
amino
patients
drill
respiratory
the
nyc
adem
pediatric
consensus
definition
clinical
autophagy
cvb3
er
lc3
infection
blood
components
us
article
recalls
triton
100
inactivation
serum
serological
nan
cells
coronaviruses
polarized
release
might
dc
signr
five
infection
neck
vaccine
development
cryptosporidiosis
possible
target
orf4
tgev
polypeptide
membrane
protein
nan
clinical
map
respiratory
samples
platform
nan
vpd
health
diphtheria
pertussis
polio
nan
fipv
cathepsin
feline
host
cell
nan
gd1
classical
human
disease
gba1
de
diagnóstico
en
el
las
immune
rna
viruses
viral
response
nan
protein
csfv
mab
the
replication
avb
year
regarding
2004
2014
infection
cell
cells
epithelial
viruses
fluid
parenteral
balance
effective
intravenous
set
richard
smyth
hcps
tested
100
potentially
nasopharyngeal
gal
world
epitopes
old
anti
gene
transgene
recent
trials
expression
the
molecular
mimicry
describes
peptides
nan
dynamics
viral
host
understanding
spread
vivo
mo
71
ev
antiviral
nan
databases
scientific
dna
virus
greater
chikv
infection
disease
developing
for
proteins
qs
antibody
mutant
the
diseases
wildlife
livestock
interface
animal
oral
drug
induced
reactions
animals
virus
we
h7n9
human
associated
nan
time
vaccine
control
influenza
restrictions
viruses
toilets
human
virus
adenovirus
la
las
en
de
infections
he
protein
mhv
virus
vector
viruses
substitutions
mhv
mceacam1a
murine
we
re
discovering
hordes
potentially
nan
disease
rabbit
rhd
cases
abstract
rig
recognition
antiviral
immune
viruses
the
cov
virus
respiratory
ncov
caninecv
canine
gastroenteritis
dogs
infections
covid
19
lung
since
beginning
water
htcc
chitosan
drinking
virus
asthma
immune
still
respiratory
new
patients
rsv
found
hospitalized
infection
hotel
stock
performance
itd
study
host
viral
electron
viruses
cell
high
vesicles
nanosized
membrane
analysis
plant
protein
expression
rn
mice
fusion
protein
to
deliver
genetic
plant
growth
curves
water
chapter
nan
flaviviruses
rnai
arthropod
borne
flavivirus
faculty
development
program
skills
general
autoantibodies
appetite
peptides
directed
regulating
micromolar
anti
activity
the
several
cleavage
assay
the
cys145
site
outbreak
values
aboard
princess
ship
nan
nan
new
knowledge
vaccine
case
given
controller
parameters
predictive
small
world
century
infectious
diseases
impact
bacteria
mhp
siv
h1n1
h1n2
swine
measures
preventive
factors
associated
adopted
nan
viruses
host
enveloped
targeting
cell
viral
asthma
studies
support
atopic
atg5
autophagy
gondii
vivo
required
papn
pedv
virus
infection
apn
ali
pathways
understanding
lung
injury
virus
pneumonia
pathogens
respiratory
clinical
hydrologic
analysis
modeling
atmosphere
cycle
risk
bcov
brsv
factors
seropositivity
sfr
design
nicu
the
family
nan
nan
norovirus
genome
specific
antiviral
pmos
properties
food
packaging
grade
biopolymers
nan
health
pilgrims
public
mass
hajj
nan
nan
rt
den
denv
lamp
infection
nan
lf
activities
iron
this
applications
nan
viruses
resin
anion
exchange
liquid
rig
helicases
viral
bat
like
tb
default
p4p
rate
treatment
fab
mab
4e11
cloned
the
mortality
antipsychotic
related
increased
cardiovascular
communicable
diseases
human
global
threat
nan
health
pandemic
collaboration
potential
public
idv
bovine
virus
epidemiology
surveillance
markets
sars
wet
live
influenza
nan
disorders
diagnosis
methods
techniques
autoimmune
pneumonia
testing
acquired
associated
antimicrobial
nidoviruses
size
the
large
kb
angiotensin
ace2
renin
the
ras
ic
mers
cov
transmission
hcws
hku4
rbd
hcd26
mers
cov
diarrhoea
pcmv
pigs
suis
infection
nan
de
et
des
les
la
diseases
bangladesh
microorganisms
also
the
parvum
cryptosporidium
bovis
samples
calves
sars_np
protein
the
showed
oligomer
rna
ibv
virus
acid
virions
inflammatory
genes
control
livestock
macrophages
article
rabbits
the
diagnostic
respiratory
m1
cp
m2
benthamiana
movement
dose
vaccine
hpiv3
children
months
virus
recombination
vaccines
vectored
wild
patients
sars
dialysis
could
associated
sars
cases
hypoxemic
controls
contact
nan
nan
respiratory
npa
swabs
facial
tissues
nan
nan
tick
borne
infections
united
states
assay
an
elisa
detection
pigs
ccv
strain
coronavirus
virus
dogs
isolation
patients
risk
tb
piws
alpha
fip
ftnf
mab
tnf
monoclonal
antibodies
influenza
treatment
several
disaster
nursing
emergency
nurses
core
bacteria
viruses
replication
recruit
membrane
replication
host
rna
viral
factors
ibv
erythrocytes
α2
linked
acid
nan
vaccine
the
vector
rvsv
virus
polyolefins
medical
antimicrobial
use
textiles
nan
nan
neonates
infants
infections
neonatal
vulnerable
disease
spread
delays
dynamics
infectious
the
molecular
electron
ring
parameters
nan
ebolavirus
entry
gp
host
expression
hcv
gs
327073
inhibitors
selective
apod
bone
expression
null
msc
ptsd
social
group
impact
individual
history
new
diseases
disease
human
surveillance
pandemic
global
disease
influenza
nan
hku23
ntd
betacov
structure
the
binding
mhv
rna
viral
rnas
nan
cases
cchf
travel
associated
risk
grapevine
virus
viruses
microarray
probes
regional
hong
kong
shenzhen
cross
covid
19
public
disease
taken
nan
air
system
heat
fresh
exhaust
proteases
endolysosomal
highly
cellular
compartment
viruses
cellular
receptors
use
entry
sars
cov
emerging
infectious
structure
mental
health
effects
epidemic
the
nan
samples
mers
cov
igg
bd
antibody
mab
maternal
ibv
chicks
lynx
carnivores
parvovirus
spp
iberian
nan
amiodarone
lbpa
different
studied
since
nan
vaccines
rotavirus
enteric
intestinal
effective
health
behaviors
sars
habitual
practice
mice
cells
virus
oral
week
p53
viral
pedv
infection
ifn
nan
wisconsin
2003
reported
may
received
de
la
en
et
les
scientific
research
in
recent
development
ppe
use
studies
available
low
igy
ev71
the
specific
yolk
hpaiv
h5n1
poultry
network
china
protein
sars
cov
proteins
binding
pedv
g2b
central
strains
g2a
or
respiratory
risk
factors
bcv
jump
hong
kong
points
real
pna
pnas
dna
backbone
due
nan
nan
nan
disease
budesonide
formoterol
obstructive
airway
disease
must
emerging
public
health
nan
virus
living
the
plants
animals
nan
nan
influenza
participants
days
vs
plasma
two
sequences
poisson
model
words
virus
smallpox
vaccinia
prior
the
mir
ibv
5p
146a
study
nan
nan
nan
nan
ebola
epidemic
health
west
africa
nan
virus
coronavirus
disease
2019
covid
asthma
ed
acute
management
guideline
nan
hcp
intestinal
microbiota
h1n1
infection
knowledge
risk
h1n1
preventive
precautions
ffr
influenza
uvgi
contaminated
ffrs
sbme
simulation
education
commonly
used
nan
antifungal
compounds
compound
showed
comparable
rvb
rv
samples
cause
disease
organ
transplant
risk
transplantation
infectious
ace
angiotensin
xcace
soluble
active
nan
berberine
the
sensor
fluorescence
membrane
cns
acetyl
neu5acα2
galnac
structures
bcv
strains
avirulent
the
sequences
vaccine
vaccines
development
several
respiratory
temporary
disease
migrant
workers
migration
nan
cov
mers
the
syndrome
sars
diarrhea
infants
minirotavirus
calicivirus
patients
disease
humans
the
demyelinating
variety
bacterial
pathogens
breath
exhaled
mrsa
nan
nan
gag
suppression
codon
the
pol
indoor
air
gcc
countries
pollutants
2019
ncov
viral
coronavirus
suggest
nan
japanese
companies
study
behavior
travel
nan
prrsv
pcv2
infected
ams
the
middle
respiratory
east
syndrome
coronavirus
rna
virus
recombination
genome
events
sars
cov
the
virus
highly
four
fusion
structural
domains
entry
children
hospital
child
two
different
sneeze
stations
station
sars
respiratory
cells
intestinal
this
systemic
tissue
derivatives
position
abstract
series
amino
symptoms
abstract
in
double
blind
respiratory
copd
viral
disease
elderly
viral
abstract
this
chapter
describes
spiroforme
samples
29
in
presence
group
e1
wssv
groups
e2
nan
pcr
pedv
rt
disinfectants
detection
gastrointestinal
differentiating
abdominal
an
understanding
nan
nan
nan
femv
cats
cells
feline
kidney
peribronchovascular
diseases
predominantly
distribution
computed
pedv
elisa
antigen
purification
sera
de
en
cap
virus
vr
the
recently
inaugurated
institut
pasteur
tcov
elisa
turkey
anti
serum
monoclonal
leishmania
vivo
antibody
one
seizure
withdrawal
aed
outbreak
sars
virus
host
chapters
viral
infections
invasive
niv
patients
ventilation
care
nan
pdcs
il
ifn
virus
tgev
different
diseases
individual
risk
two
nan
cheetahs
breeding
facilities
management
captive
nan
la
de
en
el
las
mers
spread
rapid
cov
abstract
translation
mhv
leader
cells
infected
optimal
control
sub
strategies
isolation
lymphadenopathy
refers
process
lymphadenitis
inflammatory
de
des
sont
les
micro
nan
lozenge
respiratory
tract
infections
lozenges
transmission
household
influenza
studies
information
ds
respiratory
patients
pneumonia
symptoms
pcr
gene
virus
tcov
ibv
pharyngitis
acute
million
pathogens
bacterial
viral
respiratory
testing
lower
tract
viruses
the
17
subtypes
subtype
in
attempt
stem
spread
coronavirus
nan
docking
respiratory
sars
viral
protease
sars
epidemiology
outbreaks
contacts
the
this
commentary
highlights
article
ng
nan
nan
nan
mers
cov
griffithsin
spike
entry
nan
diseases
new
emerging
present
constant
nan
protein
pdcov
proteins
pk
cells
ibv
ribv
chickens
h52
genes
diarrhea
rotaviruses
alpaca
crias
isolates
ota
pcv2
replication
low
doses
mers
cov
positive
results
patients
nan
model
anfis
the
confirmed
cases
virus
infections
viral
the
children
disease
population
free
reproduction
number
filter
stage
hepa
first
marcescens
covid
19
jan
china
outbreak
brain
angiotensin
binding
receptors
angiotensins
nan
sars
nsp16
nsp10
cov
interaction
antibodies
serum
igome
specificities
abstract
nan
model
farr
mathematical
idea
law
antigens
recombinant
subunit
vaccines
seed
vaccination
hib
introduction
impact
rcp
rnase
5a
mhv
virus
jha
food
spoilage
production
contamination
microorganisms
viral
agent
abstract
the
target
plume
cm
h2o
air
mask
sera
antibodies
bovine
positive
test
influenza
95
ci
liat
rsv
cpvs
membranes
golgi
factories
rubv
mers
cov
the
years
aged
nan
ebv
virus
research
therapy
abstract
nan
bear
herpesvirus
neurological
detected
dna
the
follow
actors
fieldwork
field
recombination
rna
sites
within
gene
rdrp
rna
fidelity
nucleotide
viruses
nan
hadv
55
patients
pneumonia
cases
the
firm
capital
value
assets
cell
line
lab
strains
antiviral
vaccine
virus
recombination
strains
analysis
activities
rna
triphosphatase
mutational
effects
influenza
surveillance
region
the
countries
may
include
tm
acute
diagnostic
ecsod
extracellular
oxidative
stress
exercise
cells
na
arg
bhk
gln
nan
nan
sars
patients
the
case
disease
viruses
host
cell
replication
biology
virus
larger
cells
glycoprotein
wt
cells
mhv
basolateral
epithelial
virus
km22
strains
genes
the
bronchiseptica
nan
method
sequence
sequences
spectra
moments
binding
shfv
ncr
sl
structure
quadruplex
labels
detection
various
in
window
opening
behaviors
indoor
different
nan
in
viruses
rvsvin
prototypic
virus
virus
in
proteins
virology
studying
omp
multocida
isolates
strains
types
coronaviruses
2003
respiratory
cov
abstract
networks
hierarchical
human
network
spreading
vaccine
immune
adjuvant
particle
adjuvants
nan
marine
species
compounds
antimicrobial
environment
pathogens
biosensors
diseases
caused
reliable
health
public
cdc
emerging
global
biocidal
materials
microorganisms
functions
medical
microarrays
many
constructed
dozens
millions
fipv
virus
veterinary
years
several
syringes
infection
administration
control
recommendations
cathepsin
ec
22
cysteine
inhibitors
reports
review
case
anaphylactic
shock
pcv2
infections
disease
pcvad
porcine
epithelial
response
cells
airway
cell
assays
time
influenza
viral
real
nan
emerging
disease
public
health
diseases
viral
modifications
rna
life
cycles
pneumonia
diagnosis
spectrum
pathogens
microorganisms
look
medical
device
industry
this
b2
b8
b19
birds
chicks
flu
pandemic
responses
this
potential
dna
vaccine
ibv
bicistronic
vaccines
health
international
global
law
solutions
immune
life
early
well
abstract
nan
nan
csf
il
microglia
gm
astrocytes
ms
cells
inflammatory
cd4
disease
nan
conference
health
abstract
the
1968
rv
quercetin
viral
treatment
infection
nan
h5n1
virus
influenza
avian
mechanisms
nan
nan
cc
fr
cov
wtsars
also
nan
nan
die
auf
von
der
oder
mers
cov
hr2p
m2
fusion
the
influenza
viruses
contain
single
recombinant
hn
virus
cells
infected
dba
diagnosis
rpl5
rps19
patients
health
principles
colony
monitoring
program
mers
rbd
cov
trimeric
neutralizing
cells
infected
pedv
interferon
observed
nan
pedv
us
strains
strain
highly
system
the
disease
requirements
syndromic
hiv
cholesterol
virus
entry
cells
extraction
ms
method
qtof
acid
nan
wildlife
zoonotic
human
pathogens
india
neutropenia
children
fever
bacterial
viral
nan
the
pedv
virus
pregnant
sows
prrsv
pigs
the
infection
mutation
vaccination
exposure
model
population
initial
hajj
respiratory
influenza
2009
h1n1
nan
pvm
protection
response
cell
pneumonia
diarrhoea
the
villous
enterocytes
epidemic
mers
cov
rapid
assay
showed
nan
the
enzymes
chapter
hat
third
patients
pnae
npae
hospitalizations
etiology
cells
coronavirus
antigen
plasma
antibodies
the
appearance
south
china
subsequent
nan
response
funding
requested
billion
updates
tb
vaccine
12
il
survival
ifn
tgev
treated
ml
cells
antiviral
interferon
agents
sars
assays
nan
pcr
diagnostic
the
development
molecular
rfid
technology
healthcare
reliability
hospital
nan
nan
nan
wheezing
children
symptoms
wheeze
life
synthesis
purine
conditions
different
n9
fip
this
review
although
problem
ace2
ang
angiotensin
ace
enzyme
viral
ups
cellular
proteins
viruses
as
coronavirus
outbreak
continues
science
nan
nan
sars
disease
language
framing
used
peptides
liposomal
sars
ctls
derived
ebola
virus
rapid
ebov
detection
immune
mavs
hmpv
evasion
m2
p11a
glioma
streptodepsipeptide
ms
streptodepsipeptides
inefficiency
inter
temporal
peer
group
nan
nan
nan
makona
ebov
s2
cells
vlps
nan
building
unit
the
upstream
wind
patients
viruses
drug
active
associated
protein
dcc
templated
chemistry
employed
reducing
hts
agent
compounds
agents
obrv
seg
10
contain
open
coronaviruses
projections
the
particles
major
patients
acute
copd
exacerbations
chronic
system
complement
functions
immune
infection
ims
performance
dirs
mas
hotel
ae
bacteria
species
aeec
attaching
cdv
astrocytes
strain
infection
astrocyte
sars
cov
cell
vaccine
epitopes
sars
vectors
wpre
the
cov
nan
nan
transmission
aerosol
infectious
patients
with
chikungunya
epidemics
virus
fever
epidemiological
immunity
response
calves
in
article
rumor
response
strategies
type
intention
ace2
abstract
explorations
s1
subsite
influenza
region
surveillance
countries
the
infant
milk
years
human
development
drugs
bismuth
characterization
potential
targets
research
mers
meeting
since
who
bacterial
colonization
wheezing
children
virus
influenza
nat
isothermal
alere
dad
cathepsins
natural
inhibitors
products
cathepsin
nan
vaccine
tb
il
12
efficacy
hamster
research
the
features
experimental
models
small
world
network
reported
antiviral
activities
the
activity
virus
lc3
replication
cov
vesicles
er
nan
method
release
contaminant
time
the
nan
patient
influenza
patients
near
assays
g4
ncl
g4s
binding
folding
cxcl10
diseases
infectious
chemokine
10
ca
pedv
chlamydial
cell
dually
nan
glial
remyelination
cells
transplantation
transplant
gene
gp5
prrsv
protein
antibody
pregnancy
group
farm
asp
loss
antibiotics
knowledge
nonadherence
score
001
nan
95
ci
or
disease
01
nan
hiv
ifitm
env
proteins
infection
nan
scov
mice
chimeric
vlps
neutralizing
cells
lysis
jhmv
viral
protein
coxsackievirus
benserazide
novel
enzyme
viral
amoy
gardens
the
patients
sars
travel
pretravel
consultation
based
risk
pltcfs
interventions
care
associated
infections
sars
hcws
outbreak
mainland
china
healthcare
it
adoption
systems
with
de
las
en
la
el
small
animal
the
clinicians
pathologists
virus
respiratory
cells
infection
calu
wheeze
therapy
children
inhaled
effective
felids
haemominutum
wild
persian
feline
ibv
simple
pcr
viral
rna
fusion
membrane
protein
lipid
why
yellow
fever
vaccine
yel
avd
infection
the
cv
777
intestinal
elisa
sera
ipma
blocking
assay
associated
system
cows
biv
infections
sars
cov
vaccines
virus
protein
nan
drug
endemic
equilibrium
resistant
analysis
nan
chip
virus
type
prodect
bcs
antibodies
mammalian
igy
egg
diagnostic
community
acquired
pneumonia
common
pathogens
viruses
techniques
the
amplification
agents
aps
ibv
il
antiviral
replication
virus
parental
jhm
the
32
factors
emergence
new
introduction
infections
research
used
biosafety
animal
synthetic
network
traffic
can
found
aviation
respiratory
mers
cov
catalonia
samples
enhance
do
stress
hormones
corticosterone
nan
influenza
host
infection
virus
viral
protein
the
lung
sars
cov
nan
drugs
effects
adverse
the
side
acs
respiratory
febrile
presenting
scd
codon
usage
synonymous
prrsv
orfs
influenza
pandemic
air
travel
transmission
journal
abstract
publishers
note
introduces
nan
asthma
infections
respiratory
disease
associations
patients
influenza
pb
h1n1
pdm09
nan
nan
ovalbumin
sensitization
influenza
virus
ige
cell
apoptosis
system
tissues
mechanisms
nan
infectious
approach
cdna
je
dna
nan
smallpox
vaccines
lc16m8
currently
vaccine
sars
vaccine
day
cov
inactivated
tourism
demand
jeju
conditional
among
hgf
selectin
endothelial
expression
induced
unknown
mice
hcov
roc43
ns2delrluc
replication
nan
csfv
targeting
viral
ns3
gene
virus
replication
understanding
key
step
nan
nan
de
la
des
et
influenza
vasculitides
systemic
children
vasculitis
disease
control
infection
practice
health
care
family
growth
erbb
factor
receptor
spread
premises
infected
network
contact
bone
showed
anfh
early
stage
nan
pd
study
persons
disease
colds
engineered
synthetic
yet
dna
non
safety
care
nursing
patients
health
this
virus
study
believed
agent
emergency
pediatric
respiratory
illnesses
huge
virus
save
world
infection
first
proteins
ibv
vlp
virus
formation
nan
sgp
ebov
macrophages
macrophage
infected
mers
samples
respiratory
patients
cov
nac
influenza
h9n2
swine
virus
cov
serological
assays
sars
novel
ic
assay
cd
respectively
nested
vectors
vaccine
adenoviral
vaccines
adenoviruses
privatisation
airport
research
literature
whether
nan
mortality
shock
famine
long
run
mucosal
protective
papers
report
surfaces
nan
nan
ifn
lead
dysregulated
type
interferon
virus
3c
proteins
protein
virion
infections
solid
organ
transplant
recipients
nan
nan
emmprin
tumor
cancer
cells
viral
ta
ja1
lectin
proteins
the
unknown
air
pathogens
airborne
indoor
human
sars
cov
hr2
derived
t20
dimethylamino
dideoxythymidine
hiv
compound
phenylalanyl
bovine
calves
month
respiratory
virus
nan
pigment
shell
the
brown
hen
nan
authors
hiv
vaccine
important
data
nan
masks
fit
surgical
used
filter
acid
antigen
ovalbumin
degradable
cationic
plasma
products
fractionated
protein
modern
evs
the
ability
cells
form
nan
s2
ibv
protein
broad
epitopes
4egi
translation
eif4e
mrnas
protein
hrv
lrti
children
pcr
genotypes
nan
antiviral
sirnas
targeting
genes
identified
nan
ifnγ
neonates
brain
viral
neonatal
nan
rhinosinusitis
clinical
the
american
definitions
pneumoniae
cap
pathogens
antimicrobial
clinical
tests
pancreatic
specific
diagnosis
serum
de
infections
en
techniques
viral
virus
la
de
des
spécificité
including
discussed
acid
abstract
viral
common
haws
work
high
environments
pcp
mhv
p72
p65
jhm
prv
dna
lamp
detection
using
clusters
spatial
spatio
temporal
disease
sars
the
airway
periods
period
nan
nan
sars
nested
rt
pcr
primers
nan
nan
mouse
the
strains
identify
disease
international
health
regulations
provisions
may
piglets
pcv
tgev
virus
inoculation
nan
membrane
membranes
highly
3d
cellular
algorithm
mining
minimum
items
tree
vp2
ltb
protein
casei
mucosal
rna
viruses
replication
membrane
host
nan
prrs
clinical
disease
management
signs
nan
antibodies
mabs
diseases
combinations
therapeutic
bvdv
genotype
isolates
primer
pairs
technology
immunoassays
there
assessment
status
nan
molecular
respiratory
techniques
filmarray
non
neutralizing
pedv
epitopes
mabs
s2
nan
chemokines
rabv
cells
rabvs
rabies
nan
lung
infection
viral
because
essential
nucleic
acid
immunity
mechanisms
acids
cats
fip
apps
exposed
fcov
chv
baits
freeze
infectivity
oral
de
la
des
the
le
minelute
virus
kit
nucleic
inc
vaccines
virus
cov
viral
attenuated
ace2
2019
ncov
rbd
molecular
qsar
benzoimidazol
yl
antimicrobial
activity
nan
ifn
pedv
protein
cbp
nsp1
wnv
proteasome
genome
viruses
host
respiratory
asthma
viruses
years
life
cases
beijing
covid
19
patients
nan
the
membrane
proteins
viral
channels
nan
vinylphosphonate
isoxazolidines
allyl
well
disubstituted
nan
sars
codes
cov
zip
detection
nan
care
travel
health
literature
medical
osteonecrosis
commonly
occurring
hip
also
nan
zikv
knowledge
participants
associated
attitudes
disease
legionnaires
diagnostic
h1n1
triad
cell
cysteine
fusion
cluster
the
h1n1
severe
respiratory
extra
corporeal
protease
using
3cl
compound
inhibition
bronchiolitis
care
use
recommended
evidence
nan
nan
passengers
february
we
crew
cruise
virus
human
japan
airway
epithelia
des
les
virus
sars
une
2019
ncov
cov
coronavirus
health
person
human
exhaled
air
it
nan
ms
mhc
genes
hla
class
protein
movement
subcellular
infection
induced
protein
turkey
tcov
the
expressed
nan
bw
phase
tul
calves
con
viruses
insect
specific
new
virus
nan
3d
curves
dna
sequences
curve
glycoproteins
g1
g2
virus
ptv
droplets
particles
sneezing
coughing
the
quail
diseases
variety
an
increasing
10
serum
ip
ami
patients
rnas
rna
non
coding
virus
nan
compounds
sars
protease
abstract
series
macrophages
cells
virus
mhv3
effect
mhc
increase
class
mice
lcmv
tv
virus
protease
proteases
norwalk
vp4
native
reassortant
three
dimensional
important
glycoproteins
cmv
infectivity
cast
bvdv
disease
pestivirus
biology
bovine
plant
virus
viruses
nucleolus
proteins
homology
rdrp
genera
models
modelling
staff
vaccination
vaccine
influenza
among
the
ring
groups
chalcogen
external
de
la
virus
les
et
nan
isolation
wards
approach
facilities
hospitals
unknown
nan
nan
la
de
en
los
virus
pedv
pvax1
18
s1
protein
scirak1
fish
cells
blood
receptor
e2
virus
transformed
cell
fipv
nan
enteritis
ruminants
common
infectious
pathogens
maps
heat
interest
influenza
dot
patients
opacities
mers
cov
the
nan
nvac
immunization
vaccine
reports
review
care
critical
articles
the
search
e2
sites
virus
antibodies
antibody
mouth
bls
sars
hong
kong
ibv
beaudette
residues
s2
terminus
temperature
outpatient
risk
cold
visits
fip
cat
first
showed
increased
frcs
expression
cell
ln
reticular
edicts
cdc
diseases
line
time
sars
cov
genomic
the
human
the
designed
hydrolysis
activity
comfa
nan
vaccines
the
new
development
challenges
nan
exercise
training
musculoskeletal
health
related
unknown
nan
vaccine
early
innate
immune
ip
neopterin
patients
df
early
healthy
de
la
des
infectious
infection
nan
sars
lymphopenia
glucocorticoids
respiratory
caused
the
yll
rate
cancer
death
respiration
camera
the
recorded
using
mφ
metabolic
diseases
infectious
macrophages
influenza
military
respiratory
1354
virus
astrovirus
identified
outbreak
diarrhea
cheetahs
nan
svcv
ani
svc
rate
spring
disaster
management
decentralized
governance
much
innate
immune
biodefense
strategies
pathogens
pathogen
blood
technologies
reduction
the
group
lunch
120
60
rate
bovine
viruses
human
samples
variability
patients
h1n1
month
median
iqr
asthma
respiratory
infections
viral
risk
hais
hcws
patients
hospital
knowledge
nan
nan
responses
host
disease
cattle
pathogen
fusion
hr2
apmv
paramyxovirus
membrane
the
health
threats
detection
risk
mice
antibody
protection
passive
non
lactose
nec
pathogenic
pneumoniae
strain
ferret
model
assays
cytokine
morbillivirus
care
respiratory
acute
ventilation
intensive
model
garch
heavy
tailed
pttgarch
spike
protein
binding
grp78
covid
pom
pva
pei
the
chemical
delays
health
system
delay
days
nan
nan
frameshifting
rna
pseudoknot
rsv
loop
nan
foster
1999
free
rodents
barrier
rsv
rt
pcr
samples
respiratory
nan
influenza
pika
pandemic
vaccine
the
surveillance
data
strategies
systems
infectious
porcine
virus
type
strains
ge
hbov
respiratory
acquired
children
hospital
rsv
aps
associated
we
infection
nan
preparedness
health
emergency
development
public
nan
nan
nippv
patients
sars
health
respiratory
kittens
fipv
non
sensitized
antibody
proteins
viral
channel
host
life
cultures
one
patients
isolates
five
space
society
subjects
approach
social
virus
antibodies
ha
mabs
influenza
cdv
vivo
replication
gene
genetic
wild
type
strains
cdv
canine
lipid
rafts
cholesterol
cells
sars
mers
cov
recent
abstract
the
nan
id
tumor
insect
proteins
derived
piglets
cells
infected
prrsv
cd8
10
virus
ibv
mass
conn
mask
o2
n95
nonrebreathing
modified
binding
peptide
antibody
short
site
la
de
las
en
el
public
health
practice
course
framework
protein
tm
etm
model
the
nan
syk
sirna
fcεri
the
inflammatory
complexes
fcγ
ade
increased
receptors
protein
start
mrna
kda
reading
sequence
structure
hiv
stem
loop
tuberculosis
outbreak
tb
methods
results
np
the
sars
protein
cov
il
ifn
12
23
role
nan
respiratory
children
hospitalizations
viruses
virus
research
recombinant
emerging
guidelines
molecules
prrsv
ppmo
prrs
replication
5up2
pilgrims
the
vaccine
hajj
umrah
flying
health
policy
risk
public
aeruginosa
viral
sputum
density
exacerbation
the
drug
hiv
antiviral
this
yearly
revaccination
vaccination
adult
interview
patients
cap
subjects
the
rv
cov
mers
the
virus
respiratory
information
internet
travel
useful
eg
nan
mgrft
antiviral
grft
monomeric
activity
nanoparticles
nps
properties
the
antimicrobial
abstract
this
chapter
describes
pathogenesis
mbcs
formation
immunity
cells
memory
fipv
79
type
mabs
strain
hiv
cd4
downmodulation
cell
surface
nan
nan
health
public
influenza
crisis
pandemic
nan
virus
h7n9
human
viruses
effects
crcov
bj232
respiratory
coronavirus
genome
microcantilever
chain
transmission
biochemical
length
nan
sarcoids
local
mmp
clinical
expression
nan
china
γcov
ck
14
ibv
exosomes
lung
recipients
costimulatory
dysfunction
based
screening
vs
hts
3clpro
agencies
incident
jurisdictions
system
command
maintenance
tss
the
criteria
processes
rms
health
material
bedding
evidence
viruses
adenoviruses
40
41
rotavirus
hadv
infections
co
burden
positive
nan
nan
nan
hadv
b14
fri
first
in
nan
rna
hev
rnai
antiviral
infection
nan
adp
protein
virus
ribosylated
infection
nan
nan
nan
covid
19
taiwan
lag
gt
bats
viruses
field
zoonotic
this
iot
devices
could
medical
abstract
nan
tick
infestation
cattle
infested
pbl
corticosteroid
patients
ldh
outcomes
adverse
mers
outbreaks
ksa
estimated
using
nan
nec
infections
considered
play
important
linked
oligosaccharides
forms
hsv1
glycoproteins
aviation
the
impacts
emissions
forcing
nan
viruses
rna
despite
evolution
vertebrates
nan
antibodies
cell
neutralizing
successful
vaccines
nan
aerosol
based
pcr
aerosols
this
measurements
taxi
vs
non
temperature
profilin
qcdc
il
control
compared
rodent
clinical
pathology
laboratory
rodents
coronavirus
part
protein
the
kb
alkaloids
ta
cough
also
total
sars
cov
viral
the
s2
viral
illness
load
respiratory
acute
hfmd
pcr
pathogen
patients
rt
health
infectious
diseases
public
sporting
calves
samples
healthy
pcr
pathogenic
cov
hbov
respiratory
recipients
rvi
illness
mers
serological
phylogenetic
case
vaccines
prrsv
adaptive
immune
responses
compounds
hit
mers
compound
binding
infection
novel
coronavirus
probably
bat
risks
cost
benefit
systems
this
identified
sites
frameshifting
viruses
frameshift
ifn
myotis
high
megabats
antiviral
calves
vaccine
bovis
the
signs
nan
nan
disaster
hospital
nurses
readiness
response
cyclophilin
leishmania
cd147
binding
signaling
nan
aptamers
cells
pathogens
applications
recent
nan
nan
model
we
the
disease
number
ga
astrocytes
bfa
processes
perikarya
piglets
detected
suis
weaners
species
sars
3clpro
benzotriazole
ester
summary
nan
rna
synthesis
genome
nidovirus
negative
copd
hmpv
patients
respiratory
identified
nan
amplification
respiratory
used
molecular
summary
giardia
observed
sheep
days
faeces
mrna
assay
taqman
pcr
detection
vaccinia
expression
recombinant
gene
foreign
time
survival
model
the
probability
d2
the
peptides
neutralizing
peptide
rotavirus
etec
calves
inoculated
infection
nan
the
csncfs
cellulose
fibers
developed
animals
chapter
provides
used
research
nan
nan
microwave
samples
electron
processing
the
rna
hcv
core
protein
rdrp
ian
ithrcs
niger
production
the
calf
data
calving
whether
cross
cns
cytokine
network
roles
il
il
sars
protein
tnf
response
patients
nursing
sars
treatment
care
nan
nan
animals
virology
viruses
this
chapter
ovm
mice
food
plasma
sensitized
mustelids
species
humans
abstract
this
host
proteins
rlrs
viral
antiviral
virus
infectious
denv
the
clone
nan
virus
antiviral
infections
treatment
human
pedv
na
colostrum
milk
neutralizing
nan
ibv
strains
china
study
s1
spike
glycoprotein
protective
a59
murine
nan
change
business
cornerstone
program
organization
nan
contact
rtls
emr
pertussis
tracing
abnormalities
protein
multiple
sclerosis
present
risk
death
among
cases
infected
osteonecrosis
risk
steroids
related
studies
saliva
2019
ncov
detected
patients
de
virus
respiratory
enfants
infections
unknown
sars
cov
patients
intra
host
nan
ifn
apol1
associated
collapsing
glomerulopathy
ad
pathogens
digestate
feedstock
different
disorders
diagnostic
digestive
tract
common
nan
feline
immune
abstract
immunological
features
bdv
cells
ol
hu
h1
cats
risk
study
prevalence
infection
influenza
hcp
outbreak
pandemic
h1n1
nan
dtmuv
ups
in
infection
duck
nan
mv
measles
virus
cloned
antigens
coli
sequences
frameshift
mutations
toxicity
covid
19
control
use
prevention
glocalization
tourism
the
guides
global
nan
virus
found
sea
disease
china
factors
behaviour
using
influenza
vaccination
mhv
macrophages
apoptosis
balb
cells
evaluation
resource
thousands
people
united
protein
ic
sars
cov
activity
dmuch
recombinant
magainin
ubiquitin
purified
conjugates
antimalarial
chloroquine
abstract
series
calves
risk
infection
study
farms
brsv
cells
pm
infection
epithelial
nan
infants
bronchiolitis
respiratory
infection
rsv
azacytosine
phosphonomethoxy
prepared
fpmp
azac
h5n1
ha
amirna
1405
influenza
nan
nan
der
hepatitis
und
infectious
während
inulin
immune
delta
vaccines
potent
host
immune
cgas
sting
pathway
influenza
neutralizing
vaccine
ha
antibodies
virus
calves
the
bovine
coronavirus
patients
deficiency
rag1
dclre1c
cid
mabs
gp100
strains
bcv
reacted
noroviruses
understanding
biology
viruses
small
mk
fusion
activity
p10
h1381r
nan
prrs
seropositive
herds
risk
seropositivity
the
intensity
symptoms
rhinorrhea
secondary
et
des
la
de
en
blood
convalescent
plasma
the
disease
representation
based
invariants
vectors
the
rv
rsv
bronchiolitis
risk
respiratory
viral
human
organism
eukaryotic
the
bcv
egg
yolk
calves
colostrum
disaster
preparedness
nursing
article
review
norovirus
inhibitors
protease
based
abstract
biosafety
sins
model
laboratories
management
transplantation
infections
prevention
treatment
factors
influenza
assay
viruses
pcr
pandemic
pedv
elisa
samples
elisas
pigs
nan
bradykinin
potentiating
results
potentiation
inhibition
infection
fetal
dose
maternal
tissues
nan
kaa
anti
influenza
lectin
using
protein
infected
cells
surface
the
cov
dmvs
er
mhv
replication
hcv
analogues
anti
agents
masked
isolates
pedv
korean
terminal
region
eid
agents
virus
blood
safety
antibody
immunization
the
brv
lactogenic
hr2
sars
cov
entry
hr1
the
assay
microsphere
based
immunoassay
collusion
wars
price
china
fare
cells
serine
influenza
protease
camostat
pregnancy
loss
infectious
among
causes
detection
viral
aptamers
use
sensitivity
systems
delivery
rnai
viral
sirna
nan
protein
targets
small
modulators
proteasome
nan
virus
viral
infections
rabbits
disease
nan
viruses
multiple
vs
respiratory
cases
tsl
eo
activity
staphylococcus
aureus
ifn
mice
mhv3
mф
balb
new
cc
mission
we
created
nan
health
nhii
information
safety
quality
qsar
indicated
hydrazides
synthesized
antibacterial
respiratory
aerosols
therapeutic
disorders
the
nsp16
cap
sars
cellular
cov
nan
les
de
est
le
infection
nan
nan
nan
frameshifting
sequence
the
rna
efficient
macrophages
fipv
tnf
alpha
fapn
nan
sars
struggle
quarantine
patients
fever
kda
mhv
bcv
sequence
protein
infections
viral
specific
passive
immunity
lymphocyte
proliferation
cd8
feline
cell
nan
vasorum
cats
abstrusus
cat
patent
viruses
cell
genome
cells
cellular
ndv
disease
vaccine
newcastle
nd
nan
vp40
virus
the
octameric
rna
nursing
students
the
additional
it
sias
ac
cell
acetylation
proteins
nan
protein
the
sars
results
region
ifitm
poifitm1
virus
family
viral
calves
pi
disease
mortality
occurrence
isatin
conjugates
chloroquine
3d7
w2
nan
business
network
structure
strategies
the
pneumonia
rv
patients
associated
ifv
duck
detection
virus
viruses
viral
ifitm1
snps
polymorphisms
uc
we
mers
celisa
cov
test
antibodies
influenza
pandemic
health
services
ohpip
egcg
derivatives
the
fatty
acids
nan
global
outbreak
sars
serious
disease
molecular
recent
microbiology
infection
control
model
particle
markov
chain
this
emergencies
ferrets
the
in
last
nan
cns
virus
immune
lymphocytes
infected
ccov
strains
dogs
iia
iib
il
mrna
ifnγ
recombinant
fipv
influenza
h1n1
severe
pandemic
counts
spongiform
neurodegeneration
degeneration
diseases
ubiquitin
tourism
new
zealand
lcc
domestic
viruses
cell
virus
animal
cultures
viral
sequencing
this
sequence
sequences
beclin
autophagy
orthologs
regulation
diverse
vaccine
cell
manufacturing
process
adventitious
blood
risk
transfusion
pathogen
inactivation
eye
viruses
ocular
including
the
ifit1
actions
cellular
replication
abstract
cell
fusion
cholesterol
mhv
cells
nan
mers
cov
african
dromedary
camels
epidemic
disease
need
models
parameters
influenza
patients
cepheid
xpert
flu
coronavirus
covid
19
ncip
imaging
cases
ncip
days
the
2019
derivatives
phenyloxyethyl
cinnamyl
found
activity
drug
nano
h3pmo12o40
magnetic
field
covid
19
patients
data
comorbidities
spike
receptor
binding
entry
fusion
hcv
sirnas
target
conserved
ires
patients
transplantés
non
et
13
respiratory
viruses
viral
human
specimens
scientists
article
dual
use
public
infectious
based
microorganism
terrain
infection
care
health
outbreaks
settings
outbreak
cats
clinical
fip
blood
samples
plants
transgenic
virus
recombinant
glycoprotein
sars
cov
patients
detection
gene
nan
systems
data
fusion
chapter
information
leukopenia
thrombocytopenia
febrile
cytopenias
jejuni
nan
qf
infections
anti
inflammatory
atg
cats
images
lesions
inflammatory
weighted
tempol
cns
encephalomyelitis
ms
viral
autophagy
cells
transport
membrane
autophagosomes
migrants
wuhan
province
hubei
2019
patients
risk
infection
treatment
immunosuppression
the
th
complexes
pcno
acid
cnts
surface
engineered
applications
the
virus
murine
infections
mice
impact
hiv
model
population
sexual
network
viral
patients
load
oseltamivir
nontreated
nan
embryo
camelid
camel
transfer
species
sepsis
diagnosis
context
systemic
inflammation
catenin
hexachlorophene
cells
results
siah
viral
vector
a59
protein
antibodies
ocular
eye
toxicity
abstract
the
sss
anti
rb
effects
metabolism
infectious
assays
disease
agents
used
ps
cytokine
inflammatory
the
molecule
nan
head
sitting
different
postures
upright
nan
china
bat
century
research
bats
middle
health
medical
east
countries
host
cell
viral
viruses
proteins
quality
tqip
hospitals
productivity
efficiency
disease
pdd
proventricular
dilatation
fatal
single
1999
multiple
radiotherapy
fraction
tissue
cpv
type
dogs
dna
virus
knu
141112
pedv
korean
nan
spp
like
genera
forms
species
exon
containing
mbp
mice
eae
infection
pathogenesis
sequence
events
it
gp140
destroyed
integrity
virion
gp120
vanadium
compounds
also
biological
several
nan
sars
impact
isolation
possible
diseases
fheprx
enzyme
cys
hydrogen
peroxide
cough
drugs
fibers
reflex
chronic
fecal
testing
common
diagnostic
techniques
rhinovirus
infections
rtis
infants
placebo
parasites
among
plasticity
even
hosts
bacterial
internalization
cells
studies
entry
feline
fiv
myocardium
cardiomyopathy
hcm
gene
protein
ibv
tcov
the
health
care
china
important
system
garv
bovine
coronavirus
bcov
calves
human
bacterial
viral
lrti
patients
tio2
coated
cordierite
foam
activity
virus
tpck
the
antiproteinase
agents
water
health
drinking
the
guidelines
viral
virus
electron
cells
occurred
sars
proteins
the
structural
functions
nan
viral
ifn
translation
cellular
isgs
nan
s1
rfpv
il18
18
virus
nan
epitope
decoy
antibody
neutralizing
vaccine
mice
deficient
vaccine
gamma
protection
nan
ormosil
pom
the
hybrids
bacteria
ns1
cells
infected
vero
je
dna
dc
targeting
vivo
vaccine
virus
hendra
bats
flying
group
nan
turkey
coronavirus
protein
the
intestinal
nan
liver
region
diseases
global
hepatitis
proteins
sars
cov
accessory
orfs
nan
nan
economic
we
dangerous
moment
three
nan
novel
hosts
populations
emergence
zoonotic
issues
international
may
medical
conditions
nan
rna
cis
acting
elements
structures
mucosal
immune
vaccines
cells
regulatory
protein
neutralization
regulation
cytokines
steps
responses
emotional
the
behavioral
avian
development
approval
new
therapeutics
vaccines
derivatives
activity
taxchinin
13
15
virus
patient
used
serological
assays
sialic
acid
acids
functions
cell
bronchiolitis
infants
radiographs
inconsistent
children
hpv
vaccines
vaccine
mv
recombinant
virus
parental
prrsv
transcripts
clone
cases
human
case
we
data
nan
tcm
pneumonia
therapy
heart
failure
fast
action
help
world
contain
respiratory
tract
based
acute
infections
diarrhea
rotaviral
coronaviral
infections
virus
food
crisis
crises
impact
long
nan
ebola
blood
transfusion
therapy
treatment
recent
abstract
years
seen
inexplicable
growth
posttraumatic
health
cancer
hiv
detection
ligation
genotyping
sensitivity
lcr
nan
user
seal
check
respirators
the
nan
getting
full
picture
coronavirus
outbreak
rna
pseudoknots
control
structural
functional
peptides
protein
sars
p8
cov
fcov
cats
fip
microbiota
healthy
nan
influenza
used
laboratory
data
activity
replicating
vectors
vaccine
target
vector
apn
pedv
s1
tgev
infection
period
patient
familial
cluster
coronavirus
pneumonia
hap
exposure
bacterial
microbial
patients
lopinavir
covid
19
initial
nan
nan
nan
traditional
medicine
paper
development
analysis
cov
the
mers
plpro
structure
nan
il
13
rsv
mice
infection
sars
polymorphisms
ccl2
mbl
control
nan
p65
gene
polyprotein
protein
a59
sars
cov
risk
transfusion
asymptomatic
virus
gi
norovirus
protease
gii
poct
care
testing
laboratory
analytical
nan
samples
rsv
influenza
assay
assays
nan
ctf13
kinetochore
protein
essential
assays
exposure
elf
emf
rats
like
nan
nan
carv
vs
prospective
recipients
cohort
hens
reproductive
diseases
backyard
usually
respiratory
human
hbov
diseases
bocavirus
qy16
sequence
ibv
genome
results
nan
bcv
sequence
amino
ser
thr
nan
respiratory
sars
history
travel
contact
toilet
plume
infectious
the
aerosols
il
age
monocytes
transcription
levels
sars
ribavirin
ifn
cov
type
hiv
arti
africa
negative
or
human
using
labelling
aminopeptidase
cd
baculovirus
protein
transduction
ve
gene
nan
burden
diseases
global
health
infectious
19
covid
outbreak
ace2
neurological
syndrome
immune
response
association
infections
mycoplasma
pneumoniae
respiratory
patients
non
nephritis
virus
ibv
per
cent
phosphonomethoxy
synthesis
propanoic
acid
analogues
sars
we
peptides
membranes
cov
genomic
rna
subgenomic
the
protein
respiratory
the
study
men
isolation
prrsv
virus
protein
the
myristoylation
chapter
nucleosides
this
three
chapters
sars
cov
ade
infection
proteins
canine
samples
mastv5
astrovirus
enteric
ad
human
chad3
vectors
based
cystatin
expressed
protease
inhibitor
various
dengue
proteins
reporter
protein
pseudotype
de
la
el
los
en
protocol
rpe
we
use
experiences
research
development
hilleman
vaccines
flu
nan
nan
nan
nucleoside
articles
antiviral
drugs
virologists
pcr
real
time
cpv
samples
nan
the
response
outbreak
china
lessons
infants
respiratory
viral
bronchiolitis
remains
rna
elements
coronavirus
cis
acting
cdv
pups
vaccination
virus
weeks
ggd
iav
h1n1
infected
mice
milk
immune
preparations
colostral
microbial
infectious
diseases
lead
may
better
cases
2019
china
jan
ncov
nan
ccov
ii
genome
coronavirus
present
ibv
nucleocapsid
protein
immune
virus
nan
igm
calves
treatment
pga
responses
mass
gatherings
hazards
health
including
hrv
asymptomatic
symptomatic
students
viral
nan
patients
copd
may
required
diagnosis
electrodes
film
readout
thick
thin
bacterial
pneumonia
non
patients
thin
ptx3
inflammation
mice
ova
production
nan
expression
mitochondrial
fission
nnv
drp1
damage
liver
sod1
ifn
viral
nan
gspe
ato
mg
kg
mice
new
immune
vaccine
immunomics
biology
nan
hmpv
mli
summary
37
year
delivery
platform
novel
ms2
vlps
public
health
pandemic
decision
making
vaccines
etec
infections
animals
use
cystatins
the
superfamily
primarily
molecular
vortex
indoor
core
region
study
new
summary
who
report
argues
hpai
vaccine
laboratory
among
influenza
shock
organ
perfusion
veterinarians
emergency
neutralizing
non
antibodies
combination
enabling
ventilation
natural
rate
infection
high
nan
nan
lsace
rsv
infection
planthoppers
ace
viral
antiviral
dna
networks
infection
china
uers
cities
performance
urban
sars
nl63
ace2
cov
hcov
rna
antiviral
rdrp
nucleotide
analog
calves
diarrhea
calf
shedding
oocysts
interactions
transmembrane
helices
proteins
important
mers
cov
cases
healthcare
infection
hev
virus
animals
humans
protein
apn
expression
surface
induction
well
pollution
air
mortality
using
cardio
sars
outbreak
unknown
treatments
controlled
sgrna3a
rna3
in
co
truncated
nan
ikbkb
immune
deficiency
cases
infections
25
sma
children
nusinersen
smn2
hmpv
clinical
pneumonia
complications
respiratory
nan
molecular
epidemiology
disease
study
literature
qx
viral
vaccine
kidney
ibv
nan
jhm
virus
infections
glial
the
causes
acquired
pneumonia
abstract
the
nephropathy
in
segmental
found
glomeruli
infants
clinical
diarrhoea
clostridium
stools
pathogen
recognition
type
receptors
lectins
hev
host
hev3
hev4
sites
dm
responses
calves
showed
circulating
illnesses
group
vs
respiratory
associated
m41
beaur
virulent
commercial
vaccines
pathogens
foodborne
health
food
detection
nan
adp
ribose
macro
poly
domain
hiv
aids
government
control
china
nan
nan
respiratory
may
facial
protection
organisms
risk
perception
public
mers
the
coyotes
behavior
non
physiological
behavioral
nan
tylvalosin
lung
anti
inflammatory
mouse
screening
virtual
drug
discovery
antiviral
strains
the
american
described
mass
nan
virus
zika
the
identified
women
antibodies
viruses
neutralization
antibody
dependent
sars
psychiatric
outbreak
study
health
turkeys
tcov
dna
dose
fragment
pedv
porcine
disease
virus
swine
temperature
outpatient
visits
high
indices
sensors
immune
including
cgas
inducible
sts
loaded
exercise
children
group
spp
risk
occupational
culturable
flora
pdz
the
protein
module
signaling
sarcoidosis
studies
th1
immunologic
infectious
ibv
variants
african
serotypes
regions
nan
face
masks
use
knowledge
attitudes
diseases
the
clinical
features
pathology
sars
corticosteroid
patients
critical
hospitalization
uveitis
feline
disease
causes
immune
fusion
hr1
hr2
hcov
229e
risk
factors
individual
environmental
air
allo
lss
hct
rv
npas
farms
the
001
risk
or
nan
assays
respiratory
seeplex
anyplex
ii
viral
treg
cns
control
persistence
nan
nan
virus
new
many
viruses
human
nan
yang
subnet
channel
treatise
symptoms
nan
bovine
bnov
bnovs
pcr
giii
health
anthropology
research
environmental
medical
prrsv
vaccines
development
strains
progresses
nan
animals
common
may
marmosets
severe
ha
stem
bnabs
different
d3
infectious
disease
article
spatial
models
ltb4
neutrophils
nasal
activity
virus
viruses
disease
culture
cell
attenuation
speaking
coughing
air
the
size
infections
cross
species
deadly
problem
amino
nanoparticles
ssdna
silica
in
ah65
bcov
respiratory
enteric
tc
feno
values
wheeze
children
baseline
applications
nsm
presented
nanomaterials
properties
nan
ifn
cells
jhmv
glial
infected
it
said
streaming
30
minutes
rbd219
n1
mg
sars
process
diarrhoea
pneumonia
episodes
childhood
million
nan
virus
sequence
viral
genome
analysis
nan
nan
nan
hcws
experiences
patients
the
suspected
protein
sars
cov
disease
epitopes
fip
inflammatory
lesions
cells
feline
proliferation
hypervitaminosis
changes
treated
30days
nan
neutralizing
scv
assay
activities
the
viral
diseases
within
health
one
ace2
coronavirus
sars
cov
domain
vae
ventilator
associated
this
new
molecular
important
we
microbiology
discuss
nan
nan
abstract
the
synthesis
dimethylamino
phenyl
rt
mouse
mhv
lamp
strains
antibody
culture
lymph
node
leucocytes
pcr
respiratory
rt
infections
assays
viruses
viral
dynein
assembly
infection
nan
ifng
patients
susceptibility
chagas
disease
pharyngitis
children
acute
antimicrobial
group
calves
milk
replacer
feeding
postweaning
replication
membranes
complexes
membrane
helicase
2019
ncov
china
people
abstract
dc
carbohydrate
crd
repeat
structure
nan
viral
feline
infection
replicating
particular
ifn
viral
immune
signaling
acute
high
respiratory
sars
cov
testing
oro
entry
hela
cells
clathrin
to
electron
surface
properties
the
cell
lsectin
immune
liver
hepatic
vsv
vp1
immune
vaccine
induce
tuberculosis
anti
azedarach
chinensis
extracts
nan
mers
cov
assays
assay
pcr
disease
ben
the
endemic
unique
compounds
compound
series
aminoquinoline
synthesized
replication
cells
the
murine
mhv3
scmc
porcine
ifn
leukocytes
virus
infection
mers
transmission
cov
secondary
influenza
icu
severe
care
use
nan
residues
s1
ace2
protein
in
mers
cov
genomes
saudi
sequences
herd
sows
herds
least
tge
nan
qds
zr
synthesized
conjugated
chiral
infection
trends
control
literature
prevention
wastewater
disinfection
particles
processes
treatment
autoantibodies
viral
mhv
mice
cns
2h6
ns1
viral
protein
virus
vaccination
development
research
ebola
vaccines
infants
lung
colds
rw
common
rabbit
rabbits
viruses
diseases
virus
pathogens
virus
emerging
zoonotic
global
nan
residents
preparedness
disaster
first
aid
activity
azetidine
dipeptide
hcmv
terminus
nan
hospitals
control
infection
survey
nosocomial
children
om
treatment
chronic
disease
nan
bone
rnas
small
important
non
nan
layer
dc
sign
inhibition
cells
pedv
entry
mediated
cells
clathrin
nan
sars
cov
proteases
the
coronaviruses
antibody
virus
the
surface
crystal
gl
ebv
antiviral
acid
18β
2019
ncov
virus
shows
homology
nan
deubiquitinases
ubiquitin
signaling
protein
key
nan
ppe
contamination
doffing
the
hcw
domestic
cheetahs
cheetah
cells
pbm
age
immune
mouse
related
function
antiviral
cov
coronaviruses
development
mers
clinical
infants
evidence
respiratory
viral
rna
disse
mhv
sequence
di
emerging
infectious
diseases
medicine
new
genetic
disease
cov
critical
host
vaccination
abstract
protection
food
animals
nan
pestivirus
bvdv
assay
hobi
like
balb
cv
tumor
expressed
mmtv
nan
patients
crs
infection
disease
found
study
formulation
auc0
the
arbidol
sars
care
health
policy
practice
nan
nan
viruses
foodborne
virus
food
review
ards
in
syndrome
expression
patients
or
95
ci
liquid
calves
asia
genomic
genomics
abstract
in
nan
kd
acute
etiology
clinical
disease
mice
rtnf
optic
nerve
found
pedv
viral
tgev
pdcov
replication
nan
nan
topic
system
task
human
in
this
article
reproduced
previous
edition
lamp
research
technology
two
review
sars
protein
expression
cells
cov
viral
pneumonia
cause
respiratory
infection
hbv
virus
genome
reverse
transcribing
replication
cell
factors
nv
pabp
sars
the
china
95
ci
sars
covid
19
outbreak
deaths
sars
nurses
stage
specific
in
sars
inhibitors
cov
mpro
structural
nan
international
air
travel
infection
legislation
calves
halofuginone
scfp
treatment
cryptosporidium
illness
it
respiratory
singapore
first
sars
care
patient
2003
pregnant
influenza
viral
prevent
increase
diseases
nucleic
magnetofection
acids
research
cells
lncrnas
phase
rna
expression
the
crocodilians
this
environment
palate
natural
mice
resistance
hiii
antibody
antibodies
vaccination
the
neonatal
immunology
article
de
des
virus
les
la
mabs
rbd
viral
sars
cov
epidemics
vaccines
vaccine
infectious
diseases
corroborative
data
microarray
studies
journals
nan
respiratory
viruses
acute
lower
tract
nan
de
los
el
la
del
virus
epidemic
diarrhea
causing
development
new
infections
public
health
many
ps
capsular
host
meningitidis
used
gastrointestinal
guinea
pigs
rabbits
the
sars
staff
ic
care
competency
hcws
sars
rt
first
pcr
elements
the
regions
viral
non
hiv
cd4
cell
human
infection
cytokine
storm
s1p1
endothelial
cells
sites
tgev
the
antigenic
structure
laboratory
health
disease
infectious
network
cold
common
type
wind
chinese
nan
sars
expression
cov
sirna
protein
nan
cases
mers
contacts
hcws
cov
tge
challenge
sows
level
classes
nan
mbp
encephalitogenic
rats
mv
cell
virus
cells
infected
interferon
18f
nan
genes
mhc
region
16
gga
il
felv
12
dna
18
oc43
hcv
coronavirus
protein
the
sars
animal
vaccines
models
candidate
infectious
epidemic
modeling
diseases
theoretical
reproduction
number
in
we
parameters
virus
camels
respiratory
mers
cov
nan
nan
mers
cov
information
hajj
evaluate
nan
air
data
dynamics
passenger
monthly
protein
np
adsorbent
the
purification
il
15
cd8
independent
mice
drugs
hcov
covid
19
newly
nan
nan
activity
furo
oxazine
the
isomer
infection
estimated
wuhan
virus
mean
technologies
new
technological
hospitals
used
cells
anti
ids
bvdv
receptor
volatility
trading
financial
market
modeling
inference
multiple
data
network
transmission
nan
nan
nan
cell
cd4
ltr
nadir
count
ubiquitin
polyubiquitin
cellular
protein
small
papn
pedv
porcine
virus
aminopeptidase
health
global
important
million
worldwide
patients
respiratory
the
clinical
coronavirus
nan
respiratory
human
severe
infections
ari
hmpv
infection
strains
amongst
genotypes
ultraviolet
cultures
tinctoria
hairy
root
nan
de
el
la
del
se
antibodies
spike
membrane
proteins
the
feline
protease
coronavirus
viral
3cl
de
en
et
des
la
emerging
diseases
global
the
university
nan
nan
nan
tnf
il
lps
disease
lung
nan
nan
microfluidic
yeast
detection
immunoassay
platform
respiratory
ari
viruses
seasonal
patterns
sars
cov
care
neonatal
critical
pneumonia
viruses
adults
respiratory
years
infection
sfts
mice
disease
treatment
th1
th2
mers
cov
high
propan
ethanol
ol
in
formulation
the
protein
utr
subunit
3b
labour
union
model
unite
here
nan
peak
italy
rate
epidemic
infected
human
protease
inhibitors
precise
activity
recoding
translational
mutant
tk
gene
angiotensin
ras
ii
paracrine
ace
hcov
hcovs
species
oc43
229e
de
en
virus
las
infecciones
structural
unit
root
breaks
oil
nan
nan
nan
diseases
mab
microbial
development
new
hcw
motion
air
walking
gaseous
rotavirus
outbreaks
effective
vaccine
techniques
nan
nan
nan
2019
ncov
lym
lung
the
mediators
vascular
permeability
blood
barrier
mpro
the
sars
structure
space
nan
patients
hrct
sars
scores
ggo
activity
tk
vzv
antiviral
tryptamine
two
kda
proteins
ns
oc43
2019
ncov
pneumonia
hrct
one
nan
uveitis
cats
feline
cases
common
patients
ocular
sars
complications
manifestations
plans
countries
influenza
outbreak
could
infections
uris
upper
respiratory
mouth
transportation
travel
outbreak
epidemic
locations
processing
12
cleavage
nsp10
nsp11
nan
drug
discovery
novel
many
anticancer
filmarray
respiratory
rp
samples
assay
allergic
nasal
group
nonallergic
rhinovirus
the
glycyrrhizin
separation
phase
one
infection
time
pcr
respiratory
filmarray
this
chapter
bioterrorism
infectious
diseases
cells
ifn
rpifn
j2
porcine
rva
diarrhea
calves
vaccination
strains
airway
subjects
asthma
recovery
cell
nan
bvdv
one
bovine
diarrheal
pcr
the
faecal
material
used
test
tourist
term
downgrade
stay
long
nan
dogs
the
infantum
infection
sandflies
disease
epizootic
enteropathy
ere
rabbits
phage
tgev
m7
peptide
elisa
protein
coronavirus
mhv
envelope
proteins
nan
marine
pharmacology
preclinical
compounds
natural
porcine
pcv2
lamp
detection
the
bronchiolitis
asthma
children
wheezing
hospitalization
approach
response
taiwan
enhanced
cooperation
aerosols
flushing
laden
disinfection
localized
tgev
strains
korean
amino
nucleotide
sars
cov
entry
viral
assay
rna
protein
lipids
binding
membrane
cells
genotype
oas1
transcript
expressed
nan
nan
pedv
q7r
replication
diarrhea
the
nan
ribavirin
hfrs
oliguria
individuals
iv
nsvs
rna
genome
rlr
ns
hrv
adults
severity
species
among
marmoset
also
use
primitive
non
griffithsin
the
structure
antiviral
complex
virus
vaccines
viral
species
vectors
lung
samples
patient
no
pathological
tsg101
mice
mgrn1
mutant
spongiform
microbiological
cases
microorganisms
information
cause
hh
icns
model
perception
attitude
nan
nan
vaccine
socially
two
optimal
level
sars
the
epidemic
epidemics
regions
cov
mers
infection
respiratory
sars
shla
ms
patients
serum
ii
community
china
healthcare
system
recent
pneumoniae
de
en
se
the
nan
calves
milk
xylose
fed
soy
viral
load
kinetics
sars
cov
translation
genes
emcv
initiation
the
de
en
virus
coronavirus
el
cxcl9
mhv
mice
viral
cell
methyltransferase
protein
abstract
the
3d
the
coronaviridae
viruses
species
interspecies
rna
viruses
positive
strand
sense
nan
prrsv
cells
virus
particles
baculovirus
ifn
viral
type
innate
infection
pom
bc
the
based
composites
sars
cov
vaccine
the
spike
bvdv
expression
lv
hv
mrna
nan
codon
usage
synonymous
sarscov
genes
no
airway
epithelium
synthesis
site
nan
hmlu
bhv
cells
mdbk
permissive
pedv
infected
pigs
piglets
korean
tgev
catechin
effect
treatment
transmissible
cell
influenza
mdck
cells
vaccine
prrsv
prb
nsp9
replication
marc
nan
multiple
sclerosis
lesions
tissue
show
coronavirus
distinctive
may
glycoproteins
e1
nan
nan
nan
casei
surface
food
grade
host
fip
lesions
case
orchitis
cat
glycoprotein
tunicamycin
envelope
el
e2
financial
index
mismis
stock
the
pandemic
control
response
taipei
strategies
nan
e2
glycoproteins
degradation
disulfide
conformation
parasites
exotic
ecosystems
prevention
need
hiv
virus
compounds
mdh
38
death
parents
fetal
perinatal
pd
rotavirus
gmt
sa11
titers
antibody
income
guaranteed
potential
benefits
cash
subjects
versus
intron
nucleotide
male
production
induced
total
proliferation
il
redondoviridae
human
in
issue
cell
sars
the
cov
hr
spike
secretion
protein
signal
peptide
amino
rabv
important
cdna
changed
new
microbial
infection
et
al
pathogen
nan
nan
ang
angiotensin
ii
at1
anti
health
care
acquired
viral
infections
passengers
particle
risks
approach
study
pedv
water
treatment
heated
abstract
nan
nan
nan
quarantine
outbreak
sars
level
measures
infections
asthma
asthmatic
the
response
il
pct
inflammatory
found
crp
integrin
motif
binding
may
receptor
rpe
cells
tlrs
tlr
expression
mrc
hcv
229e
abstract
clone
liver
adolescent
disease
article
discusses
nan
quality
nursing
ips
measures
associated
vaccine
15b
19a
serotype
non
virus
growth
epc
cells
herpes
epidemic
forecasts
case
zhejiang
model
saa
changes
inflammatory
clinical
use
nan
nan
ldt
events
spread
rabies
townships
chloroquine
sars
cov
antiviral
activity
events
regulations
abstract
several
past
nan
nan
nan
data
rods
health
surveillance
using
detection
influenza
oiv
lspcf
fob
engagement
suggestions
clinicians
disaster
literature
ub
proteases
ubl
many
ubls
csf
changes
the
volume
brain
emergencies
reproductive
abstract
theriogenology
practice
nan
ili
rates
influenza
vaccination
coverage
junv
akt
infection
cells
virus
nan
pedv
infected
epithelium
villous
pigs
the
disease
summary
current
outbreak
ibv
diversity
coronaviruses
rna
avian
mbr
applications
resources
china
m3
cats
virus
shedding
mutian
treatment
article
metropolitan
emergency
management
governance
shxb
virulent
tgev
immature
mo
nan
hiv
rt
lamp
assay
group
nan
human
rodents
species
this
includes
polluted
weather
non
bacteria
bacterial
ed
catheters
rates
studies
health
angiotensin
ras
also
podocytes
ii
patients
hsct
pathogen
icu
recipients
detection
rotavirus
bcov
nested
rt
nan
nan
health
public
bri
systems
global
assays
using
virus
pcr
developed
food
technology
industry
field
ethical
china
health
new
reported
cases
outbreaks
household
poultry
hpai
sanitation
patients
icu
influenza
co
infections
expression
host
replication
viral
assembly
pneumonia
digital
camera
film
digitizer
the
airway
exacerbations
asthma
acute
two
months
uveitis
eye
showed
sst
analysis
compounds
hplc
pharmacological
type
ccov
sera
positive
fragments
sars
protein
b1
antibody
cov
pb2
ml
interactions
vlps
domain
aged
protein
cells
linked
glycosylation
industrial
industries
creative
districts
sites
life
science
writing
this
scientific
nan
nan
nan
nan
nan
nan
nan
nan
nan
protein
orf4a
proteins
in
genes
demyelination
viruses
viral
diseases
demyelinating
nk
lsectin
liver
cells
cell
cdc1
cdc2
tissues
cdcs
dec205
bats
virus
reservoir
viruses
several
viral
the
article
considers
factors
pdcov
ifn
infection
irf3
deltacoronavirus
ccov
canine
strains
pantropic
iia
mers
case
china
antibody
igg
disease
media
coverage
stochastic
important
different
abstract
the
two
glycoproteins
spinous
pain
dorsal
syndrome
spinal
aviation
international
icao
problem
effects
nan
nan
nan
cov
covs
humans
disease
sars
influenza
seasonal
viral
h5n1
respiratory
nan
hcws
ppe
care
the
isolation
nan
nan
tcm
urtis
patients
chinese
medicine
plants
transgenic
production
proteins
collard
golgi
protein
ergic
the
membranes
replication
nsp1
viral
residues
protein
antibody
vitro
responses
cells
virus
the
guidelines
precautions
disease
control
nan
rnase
ns2
hepatitis
5a
viral
nan
live
vaccines
adjuvanted
delivery
improved
sars
cov
infection
memory
cells
particles
protein
virus
like
proteins
nk
celiac
cells
iels
disease
milk
human
health
animal
animals
the
subacute
sclerosing
panencephalitis
weeks
the
model
based
simulate
population
coronavirus
anti
drugs
clinical
compounds
nan
travel
preventable
risk
assessment
abstract
patients
ebola
virus
disease
care
epitopes
epitope
mcab
13
binding
mutants
virus
rna
is
ts
cities
infection
travel
rate
person
jhmv
demyelination
strain
demyelinating
induced
proteases
terminal
anchored
serine
transmembrane
molecules
cell
adhesion
cams
the
usp7
the
deubiquitinating
enzyme
emerging
felv
infection
cats
productive
non
isolation
patient
patients
adverse
contact
scorpions
venoms
scorpion
medical
venom
tube
taqman
assay
single
bvd
nan
wind
level
pedestrian
different
environment
nan
nan
nan
nan
hku1
hcov
elisa
based
infections
disease
system
alternative
food
non
nan
nan
rna
viruses
the
diversity
vertebrates
covid
19
countries
european
intensive
frameshifting
physical
programmed
ribosomal
methods
business
integration
organisational
firms
firm
nan
ribavirin
replication
sars
lungs
mice
risk
countries
2019
transmission
quantile
bacterial
viral
patients
infection
clinical
model
reservoir
transmission
virus
the
care
health
hais
facilities
prevention
tourism
disasters
events
natural
flows
policy
entrepreneurial
strategies
provide
diseases
kda
protein
the
virion
glycosylated
nan
targets
rna
rnas
infectious
non
patients
sars
cancer
chemotherapy
lung
virus
viruses
food
foodborne
hepatitis
neurodegenerative
disease
ncrnas
diseases
decades
oc43
patients
coronavirus
comorbidities
infections
nan
china
drug
discovery
in
development
immunity
prrsv
infection
protective
vaccine
mvttzci
vtt
intranasal
noninvasive
vaccine
nan
disease
bovine
virus
respiratory
cattle
protein
the
rna
high
predicted
sars
respiratory
cov
largely
patients
strains
isolated
predominant
ibv
s1
health
virus
mental
information
as
patients
cvlp
hiv
virus
stool
sdpp4
mers
cov
plasma
ng
sars
covs
bats
sl
china
days
the
covid
19
incubation
nan
nan
de
vírus
em
respiratory
viruses
international
countries
the
organizations
recovery
airport
this
economic
chapter
aviation
nan
calves
oes
iv
diarrhea
treatment
ccov
strains
samples
coronavirus
primers
crs
infectious
chronic
the
including
nan
rfeifn
globulins
feline
administration
kittens
the
mpro
enzyme
sars
ph
virus
ibv
lesions
strain
infection
hairy
roots
root
phenolic
transgenic
nan
nan
nan
associated
ventilator
events
patients
icu
mdd
family
beijing
face
to
cells
non
pbmc
ifnα
mhc
agents
conventional
resistance
development
antimicrobial
bcov
buffalo
bucov
isolation
biological
nan
pf
tcm
mechanisms
benefits
active
outsourcing
hotels
china
hotel
managers
np
nanoparticles
mwcnt
coated
mwcnts
chickens
3d8
scfv
transgenic
group
middle
ear
mucosal
immune
responses
molecules
gene
studies
hybrid
components
replacements
management
health
dry
herd
viruses
arthropod
recent
studies
virus
cancer
cervical
genes
tumor
cancers
he
a59
de
mice
infected
antiviral
synergistic
cytokines
state
alone
rrbd
monkeys
vaccine
mers
cov
global
spread
become
public
health
nan
manufacturing
vaccines
the
vaccine
could
nan
nan
it
take
time
develop
coronavirus
viruses
hiv
pis
activity
the
sars
protein
viral
cov
nucleocapsid
sars
cov
non
pneumonic
nucleocapsid
mhv
virus
spread
cell
the
nan
mustela
the
mustelidae
ferrets
family
protein
sars
cov
interaction
identified
virus
titers
ml
hr
purified
vt2y
apoptosis
primary
chicken
abstract
angiotensin
enzyme
ace2
converting
abstract
used
research
cricetus
dwarf
hamsters
scvme
protein
anti
fusion
spr
coiled
coil
the
protein
oligomerization
silver
influenza
copper
viral
solid
influenza
human
rapid
sars
avian
energy
service
saving
target
sectors
two
positive
disease
bifurcation
initial
sars
cov
compounds
assay
the
pcnt
chitosan
cnts
cwcnt
cnt
unknown
nan
nan
mtp
first
joint
injury
result
infections
choice
posttransplant
prophylaxis
critical
nan
masks
surgical
n95
filtration
level
sars
cov
infectious
disease
pandemic
hrv
patients
species
infected
hrvs
virus
breda
electron
microscopy
bovine
nan
diseases
west
tropical
useful
abstract
risk
human
abstract
constant
feature
signatures
genomic
anthrax
abstract
genome
osbp
itz
replication
inhibits
orp4
cervical
lymphadenopathy
infection
the
acute
guideline
rapid
advice
who
methods
rnai
virus
gene
rna
dsrna
hev
hepatitis
in
silvestrol
patients
feline
epithelial
cells
viral
cell
severe
acute
respiratory
syndrome
ribavirin
cellular
viral
budding
membrane
virus
la
en
de
les
et
cytometry
cell
global
editorial
issue
vaccine
vaccination
disease
infectious
update
protease
domain
the
semv
polyprotein
abstract
an
efficient
method
generation
biosensors
nanomechanical
the
cantilever
this
diseases
sirnas
lung
therapeutic
agents
nan
hiv
recombinant
rmv
expressing
antigens
nan
farms
seroprevalence
sampled
within
sows
host
parasite
parasites
understanding
specialization
nan
nan
nsp10
stranded
the
rna
mhv
virus
pedv
infectivity
the
coronavirus
colonies
behaviour
individual
collective
individuals
junv
horse
antibodies
virus
antisera
ccov
virus
vaccine
iib
developed
nan
nan
ms
inflammatory
diseases
demyelinating
acute
h7n4
influenza
patient
poultry
human
ifn
cell
antiviral
modulatory
types
nuclear
land
accident
fna
china
nan
nan
patients
ards
sars
years
developed
nan
response
signaling
interferon
immune
recognition
sars
treatment
ribavirin
the
clinical
activity
ic50
μm
aa
cells
nan
sequence
protein
amino
f15
rna
health
care
workers
occupational
this
nan
sars
hr1
hr2
peptides
cov
rt
pcr
respiratory
esi
ms
nan
viral
protein
nuclear
trafficking
targeting
this
article
covers
frequently
encountered
scores
osce
dops
small
scale
nan
viruses
number
airborne
survival
abstract
viral
protease
dub
activity
studies
oral
cavity
ace2
cell
2019
nan
clinical
bronchiolitis
rs12979860
snps
il28b
nanoparticles
influenza
magnetic
immunoassay
detection
rate
network
vaccination
transmission
initial
diagnostic
molecular
approach
laboratories
tests
encephalitis
acute
remains
the
diagnosis
nan
viral
infection
disorders
development
hypothesis
virus
disease
region
strains
bean
core
competency
pgy1
residents
clinical
nan
nan
nan
nan
rtis
travelers
due
travel
medical
nan
nan
mutation
infectious
virus
vitro
synthesized
immune
development
exposure
neonates
passively
virus
respiratory
infections
tests
specimens
enteric
tropism
recombinants
respiratory
tgev
health
pandemics
epidemics
human
chronic
viruses
interactions
components
process
virion
nan
nan
nan
viruses
the
viral
cells
host
nan
we
know
virus
responsible
deaths
nan
the
95
ci
cases
19
control
latest
infection
health
care
host
diseases
directed
infectious
treatment
aav8
transduction
two
proteins
genes
sars
cope
ethical
the
disease
nan
laboratory
new
abstract
in
light
care
prognosis
common
severe
community
four
factor
pccs
reversal
vitamin
picu
bronchiolitis
viral
admission
infants
sepsis
care
include
remains
intensive
abstract
this
chapter
describes
properties
infectious
diseases
research
develop
low
rain
particles
air
environments
concentration
mda5
promoter
expression
chmda5
dsred
hospital
imported
infections
uk
data
china
2010
g20
disease
life
cases
human
testing
the
protozoan
surface
microbial
methods
contamination
assessment
sars
cov
aged
model
the
compounds
pedv
abstract
five
ib
sinusitis
common
cold
patients
days
nan
protein
membrane
terminal
epitope
tag
de
et
les
des
la
renal
patients
the
dialysis
failure
cscatl
protease
cathepsin
cscatd
aspartic
closure
outbreak
cr
nosocomial
outbreaks
immune
respiratory
infection
syndrome
cov
lung
angiotensin
acute
ras
role
nan
unknown
clinical
medicine
pets
abstract
important
nan
sinensis
anti
research
properties
compounds
host
virus
pathogenesis
viral
interacts
nan
recurrent
wheezing
palivizumab
family
history
nan
bau
particles
growth
mbau
cbau
mers
cov
pathogen
cases
identified
events
factors
tourism
crisis
impacts
oe
use
ppe
infectious
risk
nan
rabies
virus
test
icts
dogs
nan
protection
respirator
filters
respiratory
respirators
nan
influenza
virus
gene
ics
rt
nan
nan
nan
nan
evd
program
educational
knowledge
confidence
infections
asthma
viruses
may
respiratory
two
recent
studies
provide
initial
hrv
patients
respiratory
detection
epidemiological
disease
swine
practices
occurrence
biosecurity
abstract
calves
pi
the
bvdv
cows
mers
cov
infection
human
used
dromedaries
contigs
novel
viral
circoviridae
pcr
mrt
virus
viruses
single
veev
egr1
kinase
cell
primary
viruses
enteric
disease
route
entry
cyd
based
complexes
original
gene
cell
jhm
cd4
protein
mhv
the
social
media
site
fun
asthma
outcomes
ed
acute
months
crs
sinonasal
tlr7
isgs
levels
nan
viral
stranded
viruses
host
cell
human
plant
extracts
polyphenols
research
nan
prrsv
hp
virulence
nsp9
piglets
health
gross
inflows
fdi
countries
modified
bc
vectors
ha
virus
oxymatrine
lung
injury
oleic
acid
sars
vaccines
protein
dna
cell
di
le
dei
infezioni
delle
ectrim13
ring
domain
trim13
grouper
viral
anti
patients
days
sars
human
humans
viruses
thus
species
nan
rna
strand
genomic
synthesis
negative
cnts
applications
drug
delivery
diverse
crc
stem
cells
fu
folfox
de
la
las
se
el
proteinase
polyprotein
3clpro
processing
orf1
cells
coronavirus
virus
particles
cell
nan
travel
infections
oman
associated
the
ndv
delivery
vectored
route
vaccines
allergic
allergy
athlete
seasonal
asthma
care
health
system
would
public
mda5
viral
rnas
cellular
rna
itemsets
ft
frequent
database
transactional
airway
cough
may
vibration
patients
antibodies
immunity
the
antigen
virus
mers
cov
transmission
middle
prevention
rva
strains
swine
cattle
published
anti
viral
hrc
cov
antibodies
diseases
silico
modeling
abstract
in
flight
world
in
aviation
powered
health
one
central
eastern
africa
nan
region
the
2013
leading
cause
tp
nasal
fitc
rats
intranasal
enolase
antibodies
scfv
clones
protein
pcr
nested
pedv
tgev
prv
assay
tgev
taqman
samples
tested
denv2
cells
cd8
cxcr5
infection
potassium
cordata
activities
water
h2o2
medical
health
workers
mental
problems
la
de
des
agents
et
immune
the
populations
evolution
influenced
nan
singapore
covid
19
despite
multiple
virus
ig
specific
serum
csf
adverse
events
dogs
space
time
pvs
bats
described
eidolon
helvum
nan
nan
influenza
asia
the
region
apaci
memory
cell
antigen
specific
populations
nan
the
prodrugs
protides
anps
use
catenin
leiomyoma
wnt
pathway
niclosamide
mers
cov
rbd
responses
fc
activation
complement
biomaterials
blood
created
mers
public
awareness
saudi
arabia
cd13
functions
targeting
aminopeptidase
widely
ga
glycyrrhizic
acid
drugs
activity
endothelial
cells
liver
infection
fenestrations
genotypes
genotype
recombinants
region
genetic
nan
microbial
forensics
education
training
capabilities
nan
nan
calves
the
infection
first
diarrheic
cap
antimicrobial
management
for
therapy
nan
pedv
licl
antiviral
vero
cells
nan
brsv
95
pci
multiplex
sensitivity
nan
pandemic
emerge
we
new
identify
savs
porcine
sav
korea
strains
terms
data
terminologies
methods
existing
ipnv
ifn
viral
virus
α1
patients
bacterial
infection
cap
identified
nasal
measures
peak
flow
monitoring
vaccine
pandemic
influenza
severe
countries
glycoprotein
coronavirus
tgev
lactobacillus
mucosal
horses
ecov
109
median
range
picornaviruses
clinical
viruses
diagnosis
infections
ocular
cov
infections
coronavirus
human
herds
herd
year
mortality
dairy
treatment
population
model
the
disease
emc
hcov
sars
antibody
antibodies
nevs
strains
novel
rdrp
yak
nan
disease
kawasaki
fever
elevated
conjunctival
hev
protease
rubv
binding
orf1
nan
difficile
perfringens
dogs
positive
netf
serrata
activities
pharmacological
anti
the
proteinase
hydrophobic
3clpro
membrane
kda
herd
positive
versus
score
or
unknown
de
les
pac
pts
la
nan
hmgb1
cells
lethal
pulmonary
antibodies
hong
kong
this
chapter
response
pangolins
research
trade
species
the
lgl
cat
lns
liver
articular
cov
3clpro
respiratory
syndrome
sars
the
samples
ccov
sequences
genetic
antiviral
marine
agents
diseases
new
infectious
travel
international
diseases
common
adp
ribosylation
protein
proteins
various
viruses
hosts
wildlife
instances
species
extract
hiv
activity
cells
virus
bone
with
million
repair
annually
sars
hcov
human
respiratory
coronaviruses
nan
tcv
the
sequence
protein
identity
drug
discovery
novel
many
anticancer
traf3
proteins
signaling
competitive
binding
outbreak
the
2019
covid
19
china
social
issues
abstract
experienced
methods
analysis
special
staining
ultrastructural
lb
biosafety
health
china
years
viruses
gas
blood
pharyngitis
children
respiratory
virus
viruses
causes
herpes
nidovirus
aabv
mlev
potential
new
nan
thermogram
breast
cancer
tool
clfnn
wupyv
respiratory
patients
children
detected
sars
protein
cov
spike
mab
disease
respiratory
experimental
microbiological
study
nan
virus
rna
effective
705
compounds
virus
viruses
clinical
h7n9
resistance
sirna
viral
sirnas
feline
fipv
viruses
foodborne
food
the
low
cytoplasmic
cells
virus
cell
vacuolization
nsp9
protein
hcov
229e
sars
nan
telephone
virus
fomites
may
novs
macrophages
feline
mutations
fecv
virus
cat
the
months
age
muscular
fear
infection
may
stigmatization
historically
angiotensin
ii
ace2
mas
effects
protein
σ1
molecular
monomeric
weight
fever
children
travel
many
infections
niv
gene
effective
virus
hev
air
emissions
quality
ground
airport
pcr
respiratory
mrt
rrt
virus
nan
calves
diarrhea
herd
risk
samples
de
la
en
el
los
ava
system
in
hong
kong
nan
nan
nan
infection
virus
data
cells
model
secretory
immature
cell
vesicles
formation
human
virus
pathogens
platforms
use
regions
annotation
genome
sars
cov
cell
immortalization
method
using
cpg2006
wind
twisted
flows
profiles
angles
nan
gondii
372
csfv
pcv
co
public
health
education
future
china
nan
phosphorylation
kinase
cells
sars
cov
infections
superinfection
chronic
coinfection
infected
patients
impairment
sars
mild
fvc
pedv
sads
cov
pdcov
gene
drug
lymphatic
transport
enterocyte
circulation
disclosure
china
push
model
foi
nan
mers
cov
cases
travelers
respiratory
system
baculovirus
expression
vaccines
the
bse
prion
diseases
disease
vcjd
virus
vlp
vlps
particles
derived
routes
airline
competition
period
type
bacteria
95
ci
age
months
nan
network
regulatory
the
disease
biomarkers
human
embryo
organ
cultures
patient
nan
nan
fox
foxes
urban
circovirus
vulpes
abstract
this
chapter
describes
properties
del5
orf3
vaccine
sows
attenuated
treatment
asthma
children
azithromycin
episode
surface
bacterial
bacteria
methods
display
xilp
activity
hiv
protein
xylanase
igy
produced
antibodies
abstract
immunoglobulin
immune
species
camelids
different
role
vaccine
leishmune
dogs
the
clinical
liver
injury
many
viral
infections
poly
adp
ribose
parylation
protein
sars
cov
mabs
the
antibodies
nan
virus
superinfecting
early
replication
superinfection
nan
structure
based
inhibitors
ray
inhibitor
nan
viruses
immunodeficiency
aids
patients
infection
influenza
viral
compounds
anti
virus
bacterial
infection
co
patients
mortality
disease
calves
clinical
signs
irt
research
cats
used
national
council
virus
mb
light
system
dengue
ms
disability
mitochondrial
neurological
disorder
nan
cov
covs
coronavirus
antiviral
development
sars
cases
dad
acute
lung
cnts
sample
filter
using
method
binding
virus
temperature
gp
cr
nan
crazy
paving
sign
pneumonia
ct
respiratory
influenza
ridt
using
viruses
porcine
apn
coronaviruses
transgenic
coronavirus
chikungunya
chikv
infections
antiviral
drugs
nan
plant
delivery
phase
production
oral
center
health
care
implementation
control
nan
lasv
fever
lassa
virus
human
or
diarrhoea
dogs
pathogens
diet
orfs
shfv
nt
end
we
nan
sign
dc
host
receptors
prrs
ptsd
subjects
sars
impact
scale
nan
replication
cycle
host
factors
polymorphisms
nan
knocking
expression
disease
related
genes
model
research
infection
virus
various
pregnancy
epac
er
miscarriage
early
activity
antiviral
cytotoxicity
antirotavirus
cc50
health
technology
transfer
developing
increased
public
health
pandemic
influenza
legal
nan
nan
nan
pcr
real
time
clinical
polymerase
tfna
20
patients
cap
abstract
virus
isoflavones
viruses
infectivity
flavonoids
influenza
pcr
viruses
shrt
the
antibodies
mouse
assay
detection
hepatitis
virus
eps
7630
effects
bronchitis
air
influenza
virus
patients
viral
nan
vivo
influenza
anti
antiviral
inflammatory
retailers
maximization
strategies
ess
disruptions
rsv
studies
infection
last
year
nan
lesions
caused
virus
bvdv
pathologic
sequence
curve
sequences
tree
comparison
ccov
a76
canine
type
ii
nan
flu
assays
automated
h1n1
oiv
cells
persistence
infected
vero
e6
rcvs
virus
rcv
proteins
rat
private
hospital
number
china
hospitals
gp41
cell
ectodomain
minor
based
pathological
tuberculosis
tb
halichoeri
studies
nan
nan
zoonotic
host
species
diseases
mammal
nan
healthcare
networks
infection
hospital
social
the
terrorism
united
states
terrorists
asthma
exposure
allergen
sensitization
allergens
genome
we
protein
coding
prediction
infection
without
incidence
close
contact
nan
autoradiographic
antigen
methods
indirect
immunofluorescence
gp
monoclonal
antibodies
mhv
viral
nan
chikv
chikungunya
fever
described
spread
de
la
los
una
en
nan
tgev
immune
amino
n321
epitopes
hcmv
using
assay
neutralizing
well
two
the
gene
proteins
open
hpiv
environmental
nosocomial
patients
transmission
expression
using
the
coronaviruses
helper
phosphorylation
viruses
replication
strand
rna
influenza
assay
filmarray
surveillance
ili
nan
this
reprint
ward
49
proteases
nan
nan
crystallization
proteins
proved
chemical
describe
unknown
nan
unknown
il
15
cns
cd8
cells
xylose
mice
small
newborn
intestine
respiratory
nucleic
acid
pcr
multiplexed
de
el
para
en
las
cov
viruses
virus
9b
rsars
glycosylation
linked
virus
recent
virulence
ed
environment
senior
management
the
cases
2020
coronavirus
january
risk
cysteine
cathepsins
the
proteases
reactive
viral
pneumonia
virus
influenza
acute
virus
viral
discovery
recent
advances
immunized
mice
ic
virus
sc
cat
genome
biology
genomics
species
snow
leopards
diseases
affecting
species
this
chapter
replaces
liang
zhang
mhv
amino
protein
nucleotide
sequences
pcr
pneumoniae
multiplex
abstract
we
nan
nan
the
coronavirus
2019
china
countries
hcv
liver
infection
animal
abstract
ahe
edema
case
symptoms
possible
respiratory
cov
patients
infection
viruses
influenza
mers
cov
patients
tested
patients
pcr
viruses
the
cap
hsr
air
services
the
travel
proteins
pedv
s1
orf3c
antibody
nan
china
negotiations
international
health
position
pedv
new
inhibitory
effect
based
wpd
virus
novel
possums
disease
immune
reproductive
male
cell
tract
core
competency
infection
control
nurses
nan
health
care
medical
practice
ethics
humans
virus
the
sars
hanta
de
la
et
en
em
pneumonia
radiological
infectious
radiographic
mechanisms
proteins
ms
proteomics
cells
techniques
nan
sars
protein
cov
viral
cleavage
nan
nan
outbreak
infb
hospital
influenza
methods
mers
cov
respiratory
uk
middle
viruses
influenza
respiratory
global
development
nurses
health
phs
public
nation
ifitm3
infection
cells
h5n1
human
nan
healthcare
apparel
pathogens
transmission
hcws
bvdv
animals
viral
bvd
viruses
pdcov
cells
llc
infected
pk
mass
gatherings
behavior
assembling
pilgrimage
fcov
type
u18666a
antiviral
cholesterol
les
droplet
well
concentration
phase
nan
rats
gf
chapter
gn
df
viruses
virus
olfactory
the
brain
nan
behaviour
epidemic
infection
vaccine
disease
respiratory
viruses
influenza
recent
advances
influenza
adults
experimental
oral
intranasal
cxcl13
cns
cell
anti
recruitment
sars
patients
plasma
pg
ml
nan
irt
temperature
body
infrared
non
nan
respiratory
human
coronaviruses
cns
associated
mers
infection
respiratory
cov
cases
the
2009
influenza
syndrome
author
nan
immunity
providing
approach
maternal
vaccination
tb
samples
lamp
negative
95
leukocyte
adhesion
deficiency
ii
investigation
hazards
biological
research
laboratory
biosafety
nan
nan
the
problem
algorithm
proposed
shortest
hku1
infections
patients
hcov
infected
vaccines
particles
viral
thus
subviral
di
il
un
che
la
kidney
molecular
mechanisms
the
complex
ifn
vp56
gcrv
host
irf7
health
statistics
data
corrected
predicted
prcv
tgev
gene
mrna
orf
patients
hubei
covid
19
presented
new
drug
companion
clinical
effective
cats
rt
pcr
fcov
blood
hfov
ventilation
ards
high
in
nan
lbsap
innate
the
however
immune
et
de
une
en
infection
cyclophilins
ecyps
extracellular
inflammatory
pathogenesis
nucleotide
acids
aerogel
used
recognize
middle
east
coronavirus
mers
cov
cells
ibv
3b
mammalian
virus
rotavirus
faeces
calves
excretion
day
nan
nan
china
average
mortality
health
care
de
et
le
des
en
nan
viruses
fusion
cellular
membranes
it
nan
allografts
increased
processing
used
orthopedic
nan
viruses
experiments
in
conditions
evolutionary
nan
moraxella
bovis
bovoculi
mycoplasma
179
rna
recombination
viruses
coronavirus
certain
nan
the
rabbit
orbital
orbit
bone
disinfection
sterilization
use
items
contact
nan
viral
vaccine
antigen
svlps
virus
er
pathways
abstract
many
inflammatory
pcr
brsv
virus
frt
assay
ccov
cell
cells
apoptotic
death
typhoid
chronic
carriers
cases
proteins
fatty
acids
glycoproteins
acid
the
fusion
virus
hr1
hr2
proteins
nan
tt51
male
offspring
rats
parental
health
mass
public
events
gathering
pandemic
the
influenza
2009
h1n1
nan
nan
models
malaria
nhp
human
plasmodium
calves
diarrhoea
d0
parvum
neonatal
the
repercussions
businesses
workers
supply
oxygen
hps
air
simple
mask
nan
risk
sterilization
allograft
the
infection
dengue
virus
cd4
pbmc
cells
cdv
viral
demyelination
virus
nervous
la
coronavirus
de
les
fecv
sl1
utr
genomes
contain
mutations
nan
intestinal
cat
revealed
focal
lymph
nan
fit
fitted
respirator
age
successful
acidosis
intestinal
systemic
acids
inflammation
sars
cov
entry
cell
viral
nan
nan
pulmonary
ali
systemic
endothelium
acute
nan
biosafety
laboratories
high
level
china
rt
may
sars
epidemic
patients
apn
surface
activity
processes
expression
ace2
22
sars
antiviral
activity
the
sexual
survivors
transmission
recrudescence
organoid
microbe
studies
cultures
recent
calves
contact
housing
pair
social
nan
la
de
en
que
epoc
rotavirus
survival
aerosolized
rh
the
crisis
emotions
secondary
communication
topics
sars
cov
the
civets
disease
nan
cap
rna
host
ifit1
methylation
avipoxviruses
like
viruses
three
genes
containment
use
highly
pathogenic
material
cyano
deoxy
hydrolysis
followed
acetylation
nan
nan
protein
lipid
ray
severe
acute
structure
tcae206
acetate
ion
crystal
assay
virus
pseudotype
detection
rabies
lipid
bilayers
cell
supported
membrane
human
humans
may
infectious
diseases
covid
19
person
transmission
disease
cd8
rsv
infection
cells
functions
global
pandemic
health
order
future
volatility
model
threshold
we
financial
rates
we
monthly
january
virginia
nan
trade
global
live
animals
countries
responses
immune
aging
may
viral
fire
fires
pah
pcdd
conditions
china
epidemic
2019
covid
19
amsterdam
coutinho
health
in
diseases
ari
children
clinical
diagnostic
viral
nan
nan
prevalence
the
bcv
brsv
antibody
nan
nan
nan
nan
respiratory
hcovs
associated
severe
cov
influenza
transmission
city
risk
places
piglets
pedv
egf
crypt
intestinal
surge
hospitals
health
care
capacity
hsr
air
domestic
services
the
nan
peptides
fipv
th1
identified
epitope
la
de
aom
en
es
nan
infection
virus
model
vitro
data
calves
bottle
suckled
fed
starter
psychiatric
institutions
diffusion
the
hospitals
annual
heating
cooling
cities
ventilation
100
maripoc
assay
respiratory
the
arteries
month
cat
hindlimb
paralysis
hominis
puppies
trichomonad
infection
feces
hcv
229e
oc43
human
log
cap
patients
immunocompromised
etiology
opportunistic
stock
macroeconomic
hotel
returns
rate
patients
abroad
diseases
the
travel
rt
based
qpcr
sads
cov
virus
qd
influenza
h5
h9
hmpv
adults
clinical
immunocompetent
study
proteases
serine
biological
processes
recent
nan
sampler
sampling
locations
new
personal
nrf2
keap1
phytochemicals
protein
high
tumor
interferons
immune
treatment
cells
cities
conflict
development
land
acquisition
mg
may
transmission
influenza
evidence
nan
nan
ferret
pmns
the
fpr
study
case
0001
cpv
disadvantage
infection
proteins
vcps
membrane
structural
computational
nan
viruses
virus
entry
delivery
enveloped
mdi
spacer
the
delivery
hospitalized
coronavirus
the
emergence
novel
2019
nan
security
online
etc
discuss
technology
nan
de
pneumonia
viral
infecção
respiratória
the
sars
enzyme
proteinase
dimer
pathogen
pathogens
coli
calf
diarrhea
dengue
cxcl10
cxcl11
vascular
association
dsrna
binding
rvp35
vp35
length
nan
nan
responses
sv5
wt
cpi
ifn
french
become
france
summary
the
nan
viral
viruses
detection
different
nucleic
fcovs
type
ii
orf7b
fecv
influenza
virus
endocytic
clathrin
polarized
cell
ir
p53
radiotherapy
gene
peptide
2c10
neutralizing
pedv
protein
infants
viral
respiratory
infections
preterm
anti
sars
cov
analogues
chloropurine
sars
we
social
people
public
calves
morbidity
mortality
the
birth
nan
nan
proteinase
control
the
enzymes
chapter
nitric
oxide
mice
virus
infection
nan
vaccine
virus
vaccines
different
sequence
fcov
agp
concentration
cats
studies
acyclic
activity
virus
derivatives
monoesters
nan
influenza
viral
assay
positive
four
tumor
activity
nucleosides
cell
library
measles
vaccine
vaccines
developed
recombinant
formyl
peptide
coronavirus
potent
receptor
host
pathogen
proteins
cell
protein
risk
blame
discourses
sars
epidemic
stress
nurses
anti
ebola
sierra
mers
cov
01
countries
camels
disease
coronavirus
this
ferret
systemic
abstract
cascade
reaction
involves
unique
nan
de
filmarray
por
virus
los
13
kit
clinical
respiratory
viruses
nan
nan
influenza
children
laboratory
501
virus
facemask
infections
respiratory
mgs
effectiveness
interferon
sars
cov
proteins
beta
development
glycan
arrays
new
high
nan
complexity
theory
consider
health
geography
immune
cns
mechanisms
the
privilege
bst2
release
jev
protein
enveloped
nan
influenza
vaccination
smokers
smoking
antibody
the
ventilation
wind
cross
air
mining
risk
involvement
china
people
medics
worldwide
look
out
mers
bronchiolitis
pneumonia
adult
patient
hospital
coastal
region
change
china
productivity
food
recent
technologies
environmental
contaminants
nan
diabetes
tropical
countries
infections
infectious
nan
ndv
ampv
live
h120
cr88
dna
ubiquitin
protein
response
in
nan
sars
cov
coronavirus
chloroquine
2019
mitochondrial
viral
mitochondria
infections
dynamics
acute
phase
response
the
infection
studies
novardis
military
training
controls
nan
nan
infectious
disease
sars
cov
china
nan
flav
hart
park
hpv
virus
coronavirus
human
infections
229e
the
presented
the
pathophysiologic
consequences
neonatal
cholesterol
protein
vapa
virus
entry
antibodies
infections
virus
hsv
hcmv
ip
arginine
response
group
vaccinated
pcr
et
de
igg
igm
toc
food
development
ar4d
researchers
endotoxins
mw
irradiation
airborne
eu
intestinal
endoscopy
pigs
cannulated
inoculated
culture
detection
methods
qcm
preparations
panic
psychological
victims
temporary
resettlement
we
antibiotic
pneumonia
patients
respiratory
nan
protein
sars
cov
proteins
two
unknown
nan
bismuth
used
heavy
metal
in
stat1
human
immunity
ifn
mediated
protein
prrsv
virus
cells
particles
calcium
serum
abdominal
revealed
severe
fragment
ligand
screening
methods
drug
nan
viruses
the
oligonucleotides
novel
may
compounds
4d
4f
μm
yl
rs1
ha2
chickens
s1
protein
nan
tourism
residents
island
economic
social
nan
nan
nan
biological
terrorism
event
disaster
effective
virus
evolution
viruses
in
emergence
p7
virus
genotype
viruses
hcv
viral
genomic
host
scale
antiviral
epidemic
vaccination
outbreaks
year
recurrent
mers
cov
small
molecule
therapeutics
oc43
hcov
strains
spike
two
fcv
cell
bret2
glosensor
based
respiratory
virus
infections
hematologic
the
pollutant
wind
migration
leeward
emission
outbreak
cases
initial
transmission
animals
children
disease
acute
viral
bronchiolitis
fipv
vascular
vegf
fip
effusion
evidence
masks
patients
public
places
coronavirus
complex
proteins
replication
rna
virus
porcine
pedv
pdcv
swine
strains
gene
ucd
ccv
six
ips
hct
days
within
120
samples
cryptosporidium
giardia
12
spp
h3n2
years
strains
pandemics
2000
compounds
they
potential
health
nutraceutical
structural
sars
proteins
research
community
exacerbations
symptom
copd
based
diaries
calves
sb
300
group
fecal
adult
antibody
positive
method
diarrhoea
nan
nan
nan
mat
microfiber
plga
the
pore
emerging
infections
virus
molecular
pathogens
nsp3
nsp4
membrane
replication
interaction
lpv
group
patients
17
covid
nan
vp3
ns2
pde
ctd
5a
fusion
cell
4a
seap
protein
cov
sars
bat
bats
sl
protein
rnp
sars
nucleic
acid
variants
e2
jhmv
sp
jhm
nan
nan
vaccines
nanoparticles
one
medical
development
chinese
sars
image
repair
discourse
health
surveillance
public
data
infectious
climate
change
diseases
infections
across
hev
veterinarians
management
private
infection
autoimmune
visual
optic
disorders
attack
research
abstract
the
hottest
developments
may
varis
chilling
influenza
host
stat1
pathogens
response
factors
family
funding
disorders
voice
scholarly
nih
disease
bluetongue
outbreak
in
reported
protein
sars
biosensor
in
cov
nan
nan
school
pandemic
preparedness
nurse
survey
pathogens
routes
may
clathrin
mediated
cmv
dna
bal
specimens
fluid
taste
smell
olfactory
gustatory
disorders
rna
denv
core
protein
structure
immunosuppression
virus
immune
responses
viruses
ms
models
tmev
disease
viral
pigs
group
prrsv
prv
antigen
data
interval
estimator
npmle
self
bst2
229e
enveloped
viruses
hcov
sez
housed
cats
fatal
dogs
system
in
screening
age
gender
respiratory
score
illness
coast
using
licl
hyopneumoniae
infection
activity
cells
haemolytica
biofilm
formation
cells
bovine
virus
particles
in
types
within
returns
global
industry
sentiment
local
nan
animal
epidemic
another
human
transmission
nan
autophagy
viral
recent
cells
innate
cpv
vaccine
wild
pcr
type
electricity
consumption
error
economic
growth
aglycones
anticomplement
flavonoids
tfst
intestinal
fusion
helix
form
pre
proteins
ms
virus
igg
brain
csf
nan
nerve
ramsay
hunt
syndrome
varicella
mers
cov
bsl
biocontainment
human
nan
gastroenteritis
viruses
disease
agents
diarrhea
nan
three
adjuvant
specific
antibodies
the
nan
bovine
respiratory
different
acute
phase
nan
pandemic
influenza
in
state
preparedness
nan
nan
nan
nan
packaging
signal
coronavirus
rna
selective
preribosomal
rna
nucleolus
assembly
nucleolar
solvent
extraction
uae
the
power
hrv
illness
associated
respiratory
children
smsv
virus
capsid
precursor
clinical
prrsv
studies
protein
structures
viral
gene
60
bypass
sequence
lacz
co
cell
inhibitory
pathways
inhibition
respiratory
detection
rapid
antigen
nucleic
seldi
tof
ms
research
diseases
bnp
vaccine
bovine
antibodies
bvd
pneumonia
health
care
surveillance
seeking
mice
infected
human
mv
pfu
hcmv
compounds
activity
abstract
infection
lambs
treated
coli
the
group
leptospira
spp
fragments
bats
pathogenic
fipv
oral
tolerance
feline
virus
sars
cov
receptor
spike
binding
infection
strains
subtype
strain
virus
hcws
patients
mask
respiratory
use
nan
3clpro
nitrile
inhibitors
coronaviral
infection
lncrnas
pdcov
novel
infection
lncrna
nan
ccov
dogs
cpv
respectively
canine
health
public
we
diseases
global
gag
rna
gene
based
vaccine
data
model
we
validation
models
ester
inhibitors
position
inhibitor
value
mbp
tmev
sera
frequently
demyelination
nan
s100a9
prrsv
protein
viral
amino
mrna
genomic
sequences
two
present
drug
discovery
binding
constants
experimentally
pattern
epidemic
degree
human
produces
nan
nan
astroviruses
bats
found
hosts
known
inflammasomes
viral
hepatitis
inflammation
roles
protein
the
prrsv
nls
cytoplasmic
multiple
sclerosis
viruses
the
involvement
mers
cov
humans
laboratory
diagnosis
cell
fusion
amino
sars
glycoprotein
nan
pathogen
canine
among
mortality
african
ribonucleases
data
also
rna
counterweights
calves
colostrum
milk
antimicrobial
replacer
air
the
international
transport
since
cyclooctaoxygen
sodium
eukaryotic
complex
oxygen
fiv
cells
infection
expression
cell
sars
iii
patients
care
health
cows
bovine
reproductive
disorders
antibodies
pathogens
detection
various
patients
point
nan
piglets
vaccine
prrsv
vaccination
pv
nan
gl
virus
treatment
reduced
cells
hcov
viruses
human
adults
nl63
nan
pharmacophore
sars
cov
model
compounds
migrating
activity
day
motility
postinfection
pppase
activity
jhmv
protein
may
outbreak
rok
areas
changes
visitors
calves
tocopherol
fa
oxidant
status
china
insurance
health
political
coverage
sows
respiratory
herds
affected
infection
samples
mlpa
dpo
culture
positive
nan
ferret
well
the
domestic
mustela
sars
vaccine
epidemic
started
disease
nan
behavior
nursing
mers
cov
disease
map19
masp
the
lectin
complement
biosafety
global
health
international
established
replication
viruses
virus
the
stages
nan
patients
prf
bacterial
viral
30
demyelination
may
viral
infection
in
dhori
sequence
rna
virus
influenza
influenza
care
cases
95
ci
the
telephone
grandmamma
told
croup
nan
nan
microbiome
be
indoor
research
microorganisms
system
delay
incubation
nonautonomous
we
risk
perception
affective
cognitive
mers
treatment
reasoning
model
optimal
bacterial
nan
pandemic
covid
19
experience
infectious
patients
metabolic
syndrome
ace2
polymorphism
dzguo
day
cl
mice
mg
nan
virus
inoculation
early
abstract
the
viral
we
gastroenteritis
pcr
risk
nan
patients
influenza
respiratory
viral
infections
jan
case
respiratory
days
individuals
virus
reti
pcr
tests
semen
mers
cov
hcws
health
care
de
los
la
en
diagnóstico
rnai
based
gene
development
technologies
biomarkers
lons
pathogen
clinical
acute
sars
coronavirus
assay
hcovs
229e
air
room
distribution
isolation
moving
spike
avian
coronavirus
virus
ibv
acute
gastroenteritis
diarrhea
million
cases
nan
nan
tourism
economic
causality
relationship
expansion
cells
class
mhc
glial
restricted
mycoplasma
calves
sand
bovis
swabs
ccv
elisa
dogs
antigen
antibody
virus
mhv
biologic
behavior
this
hbv
the
ml
system
iu
healthcare
patient
patients
system
room
nan
nan
de
en
virus
técnicas
para
nan
nan
new
models
pathogen
species
habitat
epithelial
maternal
cell
cultures
bcec
events
health
disease
beyond
public
nan
zeolites
prevention
present
review
role
we
ll
soon
know
covid
nan
host
slims
motif
viral
proteins
rabies
treatment
today
abstract
humankind
nsp16
pedv
ifn
antiviral
regulates
nan
nan
nan
nan
efficacy
upper
room
uvgi
cfd
covid
19
temperature
cases
confirmed
human
transmission
china
sustained
imported
children
faecal
extracts
in
group
fipv
fdc
sign
infection
fapn
cases
mers
cov
transmission
healthcare
acid
influenza
shikimic
neuraminidase
virus
cns
chemokines
infection
receptors
viral
the
regioselective
pyridoxine
methodology
yields
filter
porous
ceramic
cloth
hydroxyapatite
nan
proteinase
like
the
enzymes
chapter
tsl
no
treatment
microglia
lps
influenza
children
the
000
rate
pvm
mice
respiratory
virus
infection
vaccines
safety
public
vaccine
confidence
influenza
infection
scoring
system
rapid
nan
sars
nursing
staff
sleep
prevention
sars
cov
extracts
four
antiviral
np
aris
asthma
microbiome
colonization
nan
nan
95
ci
virus
wild
porcine
dental
covid
19
infection
health
influenza
virus
pilgrims
respiratory
uk
influenza
swine
test
non
viruses
rabies
virus
disease
novel
understanding
rnai
delivery
the
rna
sirna
nan
antizyme
frameshifting
pseudoknot
the
genes
il
levels
group
viral
patients
nfn
esn
development
electro
netting
species
host
many
resistance
specific
sars
human
cov
vaccine
mice
influenza
pandemic
disaster
particularly
epidemic
cell
related
ceacams
host
carcinoembryonic
nsp2
deletion
swine
2332
virus
nan
acute
convalescent
phase
neuropsychiatric
symptoms
viral
rna
detection
the
pcr
h5n1
protollin
clade
immunogenicity
vaccines
viral
infections
responses
in
host
viruses
mechanisms
cells
adept
evolving
emerging
bacterial
diseases
major
emergence
virus
viruses
disease
neurologic
cause
influenza
h1n1
pdm09
the
eastern
the
children
records
febrile
seizures
nan
nucleic
acid
virus
the
this
plant
antigen
plants
vaccines
transgenic
viral
host
response
viruses
replication
de
la
en
el
un
salmonella
igys
specific
typhimurium
enteritidis
nan
respiratory
asthma
risk
years
or
absorption
part
abstract
in
second
sars
vaccine
epitope
cov
protein
md
membrane
interactions
simulations
protein
rhodopsin
galactose
hr
ros
oligosaccharide
programs
mrm
research
operations
maintenance
protein
sars
cov
membrane
exposed
nan
nan
facemasks
viral
respiratory
trial
use
ffpe
viruses
tissues
novel
sequences
case
cluster
index
virus
hospital
leishmania
anti
ifat
elisa
cats
hepatitis
virus
liver
ns2
rnase
nan
detection
virus
prrsv
the
probe
assay
the
bcov
two
rt
alp11b
rva
alpaca
abstract
rotavirus
nan
pcv2
the
pmws
elisa
pigs
cells
protein
the
sars
vaccine
rna
viruses
virus
replication
viral
viruses
short
host
evolution
may
sars
cov
replication
hamsters
mortality
cov
sars
protein
structural
model
sars
vsv
cov
vaccine
single
proteins
coronavirus
residues
envelope
polypeptides
protein
ppis
native
stabilization
drug
antimicrobial
specific
the
infectious
diseases
tb
public
health
analysis
media
clinical
this
article
describes
signs
assay
the
cal
cvv
reaction
